PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Inukai, K; Funaki, M; Nawano, M; Katagiri, H; Ogihara, T; Anai, M; Onishi, Y; Sakoda, H; Ono, H; Fukushima, Y; Kikuchi, M; Oka, Y; Asano, T				Inukai, K; Funaki, M; Nawano, M; Katagiri, H; Ogihara, T; Anai, M; Onishi, Y; Sakoda, H; Ono, H; Fukushima, Y; Kikuchi, M; Oka, Y; Asano, T			The N-terminal 34 residues of the 55 kDa regulatory subunits of phosphoinositide 5-kinase interact with tubulin	BIOCHEMICAL JOURNAL			English	Article						insulin; microtubules; p55; PI 3-kinase	RECEPTOR TYROSINE KINASES; PP70 S6 KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; GLUCOSE-TRANSPORTER; SIGNAL TRANSDUCTION; P85-ALPHA GENE; GAMMA-TUBULIN; BETA-TUBULIN; INSULIN	There are five regulatory subunit isoforms of phosphoinositide 3-kinase (PI 3-kinase), which are classified into three groups: proteins of 85 kDa (p85 alpha and p85 beta), 55 kDa (p55 alpha and p55 gamma) and 50 kDa (p50 alpha). Structural differences between the three groups reside in the N-terminus. To elucidate the unique functional role of the 55 kDa regulatory subunits, GST (glutathione S-transferase) fusion proteins containing a unique N-terminal portion consisting of a 34-amino-acid sequence of p55 alpha or p55 gamma (GST-p55 alpha/gamma N1-34) were used as affinity matrices to screen rat brain cell extracts for proteins to which this portion binds specifically. A protein that bound was identified as beta-tubulin by protein sequencing. In addition, not only the beta isoform of tubulin, but also the alpha and gamma isoforms, were detected in the protein absorbed from cell lysates with GST-p55 gamma N1-34 and GST-p55 alpha N1-34 by immunoblotting. Indeed, the only regulatory subunit present in the purified microtubule assembly from rat brain was the 55 kDa isoform; neither 85 kDa nor 50 kDa subunits were detected. These results indicate endogenous binding of 55 kDa regulatory subunits of PI 3-kinase to tubulin in the brain. Finally, we measured tubulin-associated PI 3-kinase activity in CHO/IR cells overexpressing each of the five regulatory subunit isoforms. Only in cells expressing p55 alpha or p55 gamma was there a significant elevation of tubulin-associated PI 3-kinase activity in response to insulin. These results suggest that the p55 alpha and p55 gamma regulatory subunits have important roles in regulating PI 3-kinase activity, particularly for microtubules at the cell periphery.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1130033, Japan; Asahi Life Fdn, Inst Adult Dis, Shinjuku Ku, Tokyo 1600023, Japan; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Yamaguchi 7558505, Japan	Asano, T (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/S0092-8674(05)80081-9; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; PONS S, 1995, MOL CELL BIOL, V15, P4453; HU P, 1993, MOL CELL BIOL, V13, P7677; Ettinger SL, 1996, J BIOL CHEM, V271, P14514; KAPELLER R, 1995, J BIOL CHEM, V270, P25985; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; GOLD MR, 1994, J BIOL CHEM, V269, P5403; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; OKADA T, 1994, J BIOL CHEM, V269, P3568; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; Best A, 1996, J BIOL CHEM, V271, P3756; CANTLEY LC, 1991, CELL, V64, P231; Dahl J, 1996, MOL CELL BIOL, V16, P2728; FRANKE TF, 1995, CELL, V81, P723; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200; Inukai K, 1996, J BIOL CHEM, V271, P5317; Inukai K, 1997, J BIOL CHEM, V272, P7873; Itoh T, 1996, J BIOL CHEM, V271, P27931; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V208, P985, DOI 10.1006/bbrc.1995.1431; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; OKA Y, 1988, J BIOL CHEM, V263, P13432; RAO S, 1994, J BIOL CHEM, V269, P3132; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WOLFF J, 1995, J BIOL CHEM, V270, P16809	35	32	34	PORTLAND PRESS	LONDON	59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND	0264-6021			BIOCHEM J	Biochem. J.	MAR 1	2000	346		2				483	489		10.1042/0264-6021:3460483		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	295PP	WOS:000085977300031		
J	Mino, T				Mino, T			Microbial selection of polyphosphate-accumulating bacteria in activated sludge wastewater treatment processes for enhanced biological phosphate removal	BIOCHEMISTRY-MOSCOW			English	Review						Acinetobacter; activated sludge; anaerobic-aerobic process; ecological selection; enhanced biological phosphate removal (EBPR); glycogen; Lampropedia; microbial community; Microlunatus phosphovorus; polyhydroxyalkanoates (PHAs); polyphosphate-accumulating bacteria; Rhodocyclus; wastewater treatment	16S RIBOSOMAL-RNA; TARGETED OLIGONUCLEOTIDE PROBE; EXCESS PHOSPHORUS REMOVAL; IN-SITU IDENTIFICATION; CITRIC-ACID CYCLE; ACINETOBACTER STRAIN-210A; MICROLUNATUS-PHOSPHOVORUS; ORGANISM CULTURES; ACETATE UPTAKE; METABOLISM	Activated sludge processes with alternating anaerobic and aerobic conditions (the anaerobic-aerobic process) have been successfully used for enhanced biological phosphate removal (EBPR) from wastewater. It is known that polyphosphate-accumulating bacteria (PAB) play an essential role for EBPR in the anaerobic-aerobic process. The present paper reviews limited information available on the metabolism and the microbial community structure of EBPR, highlighting the microbial ecological selection of PAB in EBPR processes. Exposure of microorganisms to alternate carbon-rich anaerobic environments and carbon-poor aerobic environments in the anaerobic-aerobic process induces the key metabolic characteristics of PAB, which include organic substrate uptake followed by its conversion to stored polyhydroxyalkanoate (PHA) and hydrolysis of intracellular polyphosphate accompanied by subsequent Pi release under anaerobic conditions. Intracellular glycogen is assumed to function as a regulator of the redox balance in the cell. Storage of glycogen is a key strategy for PAB to maintain the redox balance in the anaerobic uptake of various organic substrates, and hence to win in the microbial selection. Acinetobacter spp., Microlunatus phosphovorus, Lampropedia spp., and the Rhodocyclus group have been reported as candidates of PAB. PAB may not be composed of a few limited genospecies, but involve phylogenetically and taxonomically diverse groups of bacteria. To define microbial community structure of EBPR processes, it is needed to look more closely into the occurrence and behavior of each species of PAB in various EBPR processes mainly by molecular methods because many of PAB seem to be impossible to culture.	Univ Tokyo, Dept Environm Studies, Bunkyo Ku, Tokyo 1138656, Japan	Mino, T (reprint author), Univ Tokyo, Dept Environm Studies, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						AMANN RI, 1990, J BACTERIOL, V172, P762; WENTZEL MC, 1988, WATER SA, V14, P81; SMOLDERS GJF, 1994, BIOTECHNOL BIOENG, V43, P461, DOI 10.1002/bit.260430605; BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910; Smolders GJF, 1996, WATER RES, V30, P2748, DOI 10.1016/S0043-1354(96)00127-3; ARUN V, 1988, WATER RES, V22, P565, DOI 10.1016/0043-1354(88)90056-5; Mino T, 1998, WATER RES, V32, P3193, DOI 10.1016/S0043-1354(98)00129-8; Kawaharasaki M, 1998, WATER SCI TECHNOL, V37, P481, DOI 10.1016/S0273-1223(98)00173-5; WAGNER M, 1994, APPL ENVIRON MICROB, V60, P792; BONTING CFC, 1992, ARCH MICROBIOL, V158, P139, DOI 10.1007/BF00245217; VANGROENESTIJN JW, 1989, APPL ENVIRON MICROB, V55, P219; SATOH H, 1992, WATER SCI TECHNOL, V26, P933; THAUER RK, 1988, EUR J BIOCHEM, V176, P497, DOI 10.1111/j.1432-1033.1988.tb14307.x; JENKINS D, 1991, WATER RES, V25, P1471, DOI 10.1016/0043-1354(91)90177-R; BARNARD JL, 1975, WATER RES, V9, P485, DOI 10.1016/0043-1354(75)90072-X; COMEAU Y, 1986, WATER RES, V20, P1511, DOI 10.1016/0043-1354(86)90115-6; WENTZEL MC, 1989, WATER SA, V15, P89; Brdjanovic D, 1997, J ENVIRON ENG-ASCE, V123, P144, DOI 10.1061/(ASCE)0733-9372(1997)123:2(144); Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884; Pereira H, 1996, WATER RES, V30, P2128, DOI 10.1016/0043-1354(96)00035-8; LIU WT, 1994, J FERMENT BIOENG, V77, P535, DOI 10.1016/0922-338X(94)90124-4; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516; BONTING CFC, 1992, FEMS MICROBIOL ECOL, V102, P57, DOI 10.1111/j.1574-6968.1992.tb05795.x; Christensson M, 1998, APPL MICROBIOL BIOT, V49, P226; CLOETE TE, 1987, P IAWPRC INT C BIOL, P335; COMEAU Y, 1987, P IAWPRC SPEC C ROM, P39; Kampfer P, 1996, MICROBIAL ECOL, V32, P101; Gottschalk G., 1986, BACTERIAL METABOLISM; HESSELMANN RPX, 1999, IN PRESS SYSTEM APPL; Hiraishi A, 1998, APPL ENVIRON MICROB, V64, P992; HIRAISHI A, 1989, APPL ENVIRON MICROB, V30, P197; HIRAISHI A, 1997, JPN J WATER TREAT BI, V33, P137; HIRAISHI A, 1990, J FERMENT BIOENG, V69, P368, DOI 10.1016/0922-338X(90)90247-T; Inoue Y, 1996, POLYM INT, V39, P183; Kawaharasaki M, 1999, WATER RES, V33, P257, DOI 10.1016/S0043-1354(98)00183-3; KNIGHT GC, 1995, WATER RES, V29, P2081, DOI 10.1016/0043-1354(95)00024-F; KORTSTEE GJJ, 1994, FEMS MICROBIOL REV, V15, P137, DOI 10.1016/0168-6445(94)90109-0; Liu WT, 1998, WATER SCI TECHNOL, V37, P417, DOI 10.1016/S0273-1223(98)00141-3; LOTTER LH, 1985, WATER SCI TECHNOL, V17, P127; MARAIS GV, 1982, P POST C SEM PHOSPH, V2, P5; MATSUO Y, 1985, 40TH P ANN C JAP SOC, V40, P989; Maurer M, 1997, WATER RES, V31, P907, DOI 10.1016/S0043-1354(96)00369-7; MINO T, 1985, WATER SCI TECHNOL, V17, P11; MINO T, 1996, P 10 FOR APPL BIOT B, V1, P1769; MINO T, 1994, WATER SCI TECHNOL, V29, P67; Mino T., 1987, P IAWPRC INT C BIOL, P27; MINO T, 1997, P 7 INT S MICR EC, P509; Mino T., 1984, WATER SCI TECHNOL, V17, P93; MINO T, 1984, JPN J WATER POLLUT R, V7, P605; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; NAKAMURA K, 1991, J FERMENT BIOENG, V71, P258, DOI 10.1016/0922-338X(91)90278-O; NAKAMURA K, 1995, INT J SYST BACTERIOL, V45, P17; Pramanik J, 1999, WATER RES, V33, P462, DOI 10.1016/S0043-1354(98)00225-5; RABINOWITZ B, 1987, P IAWPRC SPEC C BIOL, P349; Satoh H, 1996, WATER SCI TECHNOL, V34, P8; SELIG M, 1994, ARCH MICROBIOL, V162, P286, DOI 10.1007/BF00301853; SHMITZ RA, 1990, ARCH MICROBIOL, V154, P274; SMOLDERS GJF, 1995, BIOTECHNOL BIOENG, V47, P277, DOI 10.1002/bit.260470302; STANTE L, 1996, 614B U GENT MED FAC; Stante L, 1997, WATER RES, V31, P1317, DOI 10.1016/S0043-1354(96)00351-X; Sudiana IM, 1998, WATER SCI TECHNOL, V38, P69, DOI 10.1016/S0273-1223(98)00679-9; TANDOI V, 1998, WATER RES, V32, P903; UBUKATA Y, 1994, WATER RES, V28, P247, DOI 10.1016/0043-1354(94)90141-4; vanLoosdrecht MCM, 1997, ANTON LEEUW INT J G, V71, P109, DOI 10.1023/A:1000150523030; VANGROENESTIJN JW, 1987, ARCH MICROBIOL, V148, P14; WAGNER M, 1993, APPL ENVIRON MICROB, V59, P1520; WENTZEL MC, 1991, WATER SCI TECHNOL, V23, P567	67	35	42	CONSULTANTS BUREAU	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0006-2979			BIOCHEMISTRY-MOSCOW+	Biochem.-Moscow	MAR	2000	65	3					341	348				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	305NB	WOS:000086545700011		
J	Iwata, E; Wakabayashi, Y; Kakuma, Y; Kikusui, T; Takeuchi, Y; Mori, Y				Iwata, E; Wakabayashi, Y; Kakuma, Y; Kikusui, T; Takeuchi, Y; Mori, Y			Testosterone-dependent primer pheromone production in the sebaceous gland of male goat	BIOLOGY OF REPRODUCTION			English	Article							HORMONE PULSE-GENERATOR; SECRETION; EWES; RAMS	To test the hypothesis that the primer pheromone responsible for inducing the "male effect" is produced in the sebaceous gland androgen dependently, we examined the correlation between morphological changes of sebaceous glands and the pheromone activity in skin samples taken from castrated goats that had been treated with testosterone. Five castrated goats were implanted s.c. with testosterone capsules to maintain physiological levels of plasma testosterone for four weeks. Skin samples were obtained from the head region on Day 0 (the day of testosterone implant), Day 7, Day 14, Day 28 (the day of testosterone removal), Day 36, Day 42, and Day 56, Matched blood samples were also collected for measurement of testosterone concentration. The pheromone activity of the ether-extracts of the upper dermal layer containing sebaceous glands was assessed by its stimulatory effect on the hypothalamic GnRH pulse generator, which was monitored for changes of specific multiple unit activity (MUA) in ovariectomized estradiol-primed goats as described previously. The sebaceous gland enlarged during the testosterone treatment but reduced in size after testosterone removal. The pheromone activity first appeared in 2 out of 5 goats on Day 7 and in all the 5 goats by Day 28. Fourteen days after testosterone removal (Day 42), the pheromone activity was no longer detectable in any of the 5 goats. In short, the sebaceous gland size and the pheromone activity shifted almost in parallel. The present results provide strong support for the view that the primer pheromone is produced testosterone dependently in the sebaceous gland of the male goat.	Univ Tokyo, Lab Vet Ethol, Dept Vet Med Sci, Bunkyo Ku, Tokyo 1138657, Japan	Mori, Y (reprint author), Univ Tokyo, Lab Vet Ethol, Dept Vet Med Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						CHEMINEAU P, 1987, LIVEST PROD SCI, V17, P135, DOI 10.1016/0301-6226(87)90059-5; CLAUS R, 1990, ANIM REPROD SCI, V22, P27, DOI 10.1016/0378-4320(90)90035-E; COHENTANNOUDJI J, 1994, PHYSIOL BEHAV, V56, P955, DOI 10.1016/0031-9384(94)90329-8; DOWNING DT, 1982, ARCH DERMATOL RES, V272, P343, DOI 10.1007/BF00509066; Hamada T, 1996, NEUROENDOCRINOLOGY, V64, P313, DOI 10.1159/000127134; HAY JB, 1978, J ENDOCRINOL, V79, P29, DOI 10.1677/joe.0.0790029; JENKINSO.DM, 1967, BRIT VET J, V123, P541; Kanai Yukio, 1995, Journal of Reproduction and Development, V41, P57, DOI 10.1262/jrd.41.57; KEALEY T, 1986, BRIT J DERMATOL, V114, P181, DOI 10.1111/j.1365-2133.1986.tb02796.x; Knobil E, 1980, Recent Prog Horm Res, V36, P53; Lincoln D W, 1985, Recent Prog Horm Res, V41, P369; MARTIN GB, 1986, LIVEST PROD SCI, V15, P219, DOI 10.1016/0301-6226(86)90031-X; MARTIN GB, 1980, ANIM REPROD SCI, V3, P125, DOI 10.1016/0378-4320(80)90039-1; MIYAMOTO A, 1992, J ENDOCRINOL, V135, P103, DOI 10.1677/joe.0.1350103; MORI Y, 1990, JPN J VET SCI, V52, P339; Mori Y, 1995, J Reprod Fertil Suppl, V49, P231; MORI Y, 1991, NEUROENDOCRINOLOGY, V53, P392, DOI 10.1159/000125746; NISHIHARA M, 1991, NEUROENDOCRINOLOGY, V54, P321, DOI 10.1159/000125909; Nishihara M, 1999, REV REPROD, V4, P110, DOI 10.1530/ror.0.0040110; NISHIHARA M, 1994, PULSATILITY NEUROEND, V20, P114; OTT RS, 1980, THERIOGENOLOGY, V13, P183, DOI 10.1016/0093-691X(80)90127-2; SHELTON M, 1960, J ANIM SCI, V19, P368; UNDERWOOD EJ, 1944, J AGR WA 2, V2, P135	23	46	48	SOC STUDY REPRODUCTION	MADISON	1603 MONROE ST, MADISON, WI 53711-2021 USA	0006-3363			BIOL REPROD	Biol. Reprod.	MAR	2000	62	3					806	810		10.1095/biolreprod62.3.806		5	Reproductive Biology	Reproductive Biology	287XV	WOS:000085533500041		
J	Otsuka, H; Nagasaki, Y; Kataoka, K				Otsuka, H; Nagasaki, Y; Kataoka, K			Surface characterization of functionalized polylactide through the coating with heterobifunctional poly(ethylene glycol)/polylactide block copolymers	BIOMACROMOLECULES			English	Article							REACTIVE POLYMERIC MICELLE; PRIMARY AMINO GROUP; PROTEIN ADSORPTION; ONE END; HYDROXYL GROUP; OXIDE SURFACES; CONTACT ANGLES; SOLID-SURFACES; FORMYL GROUP; GLYCOL)	An AB-type block copolymer composed of alpha -acetalpoly(ethylene glycol) (PEG) as the hydrophilic segment and polylactide (PLA) as the hydrophobic segment was synthesized and utilized to construct a functionalized PEG layer possessing a reactive aldehyde group at the free end of the tethered PEG chain by simple coating on polylactide substrates. Detailed characterization of the functionalized PEGylated surfaces was done from the physicochemical (contact angle and zeta potential) as well as the biological (protein adsorption) point of view to highlight their potential utility as biofunctional interfaces. The amount of protein adsorption was inversely correlated with the degree of water structuring around the PEG molecules, which facilitates the formation of a strongly bound water film to increase the surface hydration. For these surfaces investigated, the extent of surface hydration was more important in determining the materials biocompatibility rather than the actual PEG molecular weight, as evidenced by an extremely low receding contact angle directly related to the adhesive energy of a water molecule. Furthermore, the contact angle relaxation less than a few minutes proved to be determinant for the receding contact angle and resultant hysteresis, caused by rearrangement of the hydrophilic PEG component. Aldehyde groups were confirmed to be present at the tethered PEG chain end using an electron spin resonance probe and can be derivatized with bioactive molecules with amino or hydrazide functionality. The functionalized PEG layer thus prepared on a biodegradable polylactide surface has both nonfouling and ligand-binding properties and may have promising utility as engineered biomaterials including tissue engineering scaffolds.	Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Tokyo 1138656, Japan; Sci Univ Tokyo, Dept Mat Sci & Technol, Chiba 2788510, Japan	Kataoka, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Hongo 7-3-1, Tokyo 1138656, Japan.		Kataoka, Kazunori/K-7108-2012	Kataoka, Kazunori/0000-0002-8591-413X			Andrade JD, 1985, SURFACE INTERFACIAL, V1; ANDRADE JD, 1991, Patent No. 5075400; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610; AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537; GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211; LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X; UCHIDA E, 1994, LANGMUIR, V10, P1193, DOI 10.1021/la00016a037; Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j; PENN LS, 1980, J COLLOID INTERF SCI, V78, P238, DOI 10.1016/0021-9797(80)90514-7; NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2; Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513; Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575; EICK JD, 1975, J COLLOID INTERF SCI, V53, P235, DOI 10.1016/0021-9797(75)90010-7; TROUGHTON EB, 1988, LANGMUIR, V4, P365, DOI 10.1021/la00080a021; LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381; Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k; LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4; BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123; BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K; BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070; Burns NL, 1998, BIOMATERIALS, V19, P423, DOI 10.1016/S0142-9612(97)00225-1; Dunn SE, 1997, J CONTROL RELEASE, V44, P65, DOI 10.1016/S0168-3659(96)01504-0; Feast W., 1987, POLYM SURFACES INTER; FEAST WJ, 1987, POLYM SURFACES INTER, V2; GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9; GOLANDER CG, 1992, POLYETHYLENE GLYCOL, pCH15; Good R.J., 1979, SURFACE COLLOID SCI, V11; Harris JH, 1993, POLYETHYLENE GLYCOL; HERMANS J, 1982, J CHEM PHYS, V77, P2193, DOI 10.1063/1.444026; Johnson Jr R. E., 1964, ADV CHEM SER, V43, P112, DOI 10.1021/ba-1964-0043.ch007; Johnson R. E., 1969, SURF COLLOID SCI, P85; KIM YJ, 1994, POLYM BULL, V33, P1, DOI 10.1007/BF00313466; Levicky R, 1998, MACROMOLECULES, V31, P3731, DOI 10.1021/ma9717653; LLANOS GR, 1993, J BIOMED MATER RES, V27, P1383, DOI 10.1002/jbm.820271105; LYMAN DJ, 1974, ANGEW CHEM, V86, P145, DOI 10.1002/ange.19740860403; Malmsten M, 1996, J COLLOID INTERF SCI, V177, P502, DOI 10.1006/jcis.1996.0064; NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P702, DOI 10.1021/bc00036a007; Nagasaki Y, 1997, MACROMOLECULES, V30, P6489, DOI 10.1021/ma9705026; NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P231, DOI 10.1021/bc00032a012; Nakayama Y, 1999, BIOMATERIALS, V20, P963, DOI 10.1016/S0142-9612(98)00252-X; OTSUKA H, 1974, ANGEW CHEM, V86, P145; OTSUKA H, IN PRESS ACS S SERIE; Perrin D. D., 1980, PURIFICATION LAB CHE; SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040; TERAYA T, 1990, POLYMER, V31, P1149, DOI 10.1016/0032-3861(90)90265-Z	47	103	107	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797			BIOMACROMOLECULES	Biomacromolecules	SPR	2000	1	1					39	48		10.1021/bm990005s		10	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	433ER	WOS:000168746700007		
J	Tanabe, T; Takata, I; Kuwabara, T; Warashina, M; Kawasaki, H; Tani, K; Ohta, S; Asano, S; Taira, K				Tanabe, T; Takata, I; Kuwabara, T; Warashina, M; Kawasaki, H; Tani, K; Ohta, S; Asano, S; Taira, K			Maxizymes, novel allosterically controllable ribozymes, can be designed to cleave various substrates	BIOMACROMOLECULES			English	Article							FUSION MESSENGER-RNA; METAL-ION MECHANISM; HAMMERHEAD RIBOZYME; MEDIATED CLEAVAGE; SELF-CLEAVAGE; DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE; PROMYELOCYTIC LEUKEMIA; SEQUENCE REQUIREMENTS; CATALYTIC RNAS; IN-VITRO	We demonstrated previously that an allosterically controllable novel ribozyme, designated the maxizyme, is a powerful tool for disruption of an abnormal chimeric RNA target [BCR-ABL (b2a2) mRNA], and we proposed that it might provide the basis for future gene therapy for the treatment of chronic myelogenous leukemia (Kuwabara et al. Mol. Cell 1998, 2, 617-627). The maxizyme has sensor arms that can recognize a specific sequence and, in the presence exclusively of such a specific sequence, it can form a cavity for capture of catalytically indispensable Mg2+ ions. Cleavage of the target RNA then occurs at a site distant from the specific sequence. Clearly, the specific sequences recognized by sensor arms should not be limited to those of the above mentioned abnormal chimeric target. Thus, to demonstrate the general applicability of maxizyme technology, we constructed maxizymes targeted to other mRNAs, such as PML-RAR alpha mRNA, sDLST mRNA, and BCR-ABL (bla2) mRNA, that are not cleaved with high specificity by the wild-type hammerhead ribozyme. Specific and efficient cleavage in vitro of these mRNAs by the custom-designed maxizymes demonstrated clearly that maxizyme technology is not limited to a specific case but may have broad general applicability in molecular biology and, also, in a clinical setting.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Univ Tokyo, Inst Med Sci, Dept Hepatol Oncol, Minato Ku, Tokyo 1088539, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba 3058562, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba 3058572, Japan; Nippon Med Sch, Inst Gerontol, Dept Biochem & Cell Biol, Kanagawa 2110063, Japan	Taira, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan.	taira@chembio.t.u-tokyo.ac.jp					Amontov SV, 1996, J AM CHEM SOC, V118, P1624, DOI 10.1021/ja9517734; Pontius BW, 1997, P NATL ACAD SCI USA, V94, P2290, DOI 10.1073/pnas.94.6.2290; Zhou DM, 1998, CHEM REV, V98, P991, DOI 10.1021/cr9604292; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; Grignani F, 1998, NATURE, V391, P815; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; NAKANO K, 1994, EUR J BIOCHEM, V224, P179, DOI 10.1111/j.1432-1033.1994.tb20010.x; Scott EC, 1999, NUCLEIC ACIDS RES, V27, P479, DOI 10.1093/nar/27.2.479; Kuwabara T, 1997, NUCLEIC ACIDS RES, V25, P3074, DOI 10.1093/nar/25.15.3074; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; YARUS M, 1993, FASEB J, V7, P31; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; MCCALL MJ, 1992, P NATL ACAD SCI USA, V89, P5710, DOI 10.1073/pnas.89.13.5710; NOWELL PC, 1960, SCIENCE, V132, P1497; SHIMAYAMA T, 1995, BIOCHEMISTRY-US, V34, P3649, DOI 10.1021/bi00011a020; BRATTY J, 1993, BIOCHIM BIOPHYS ACTA, V1216, P345, DOI 10.1016/0167-4781(93)90001-T; DAHM SC, 1991, BIOCHEMISTRY-US, V30, P9464, DOI 10.1021/bi00103a011; DAHM SC, 1993, BIOCHEMISTRY-US, V32, P13040, DOI 10.1021/bi00211a013; ECKSTEIN F, 1996, CATALYTIC RNA NUCL A, V10; FU DJ, 1994, J AM CHEM SOC, V116, P4591, DOI 10.1021/ja00090a007; GOODCHILD J, 1991, ARCH BIOCHEM BIOPHYS, V284, P386, DOI 10.1016/0003-9861(91)90313-8; HENDRY P, 1995, NUCLEIC ACIDS RES, V23, P3922, DOI 10.1093/nar/23.19.3922; Hertel KJ, 1996, EMBO J, V15, P3751; Inokuchi K, 1997, BRIT J HAEMATOL, V97, P837, DOI 10.1046/j.1365-2141.1997.1452959.x; [Anonymous], 1990, METHOD ENZYMOL; Kawasaki H, 1998, NATURE, V393, P284; KOIZUMI M, 1988, FEBS LETT, V239, P285, DOI 10.1016/0014-5793(88)80935-9; Koseki S, 1999, J VIROL, V73, P1868; KUUSELA S, 1997, CURR TOP SOLUTION CH, V2, P29; Kuwabara T, 1998, NAT BIOTECHNOL, V16, P961; Kuwabara T, 1999, P NATL ACAD SCI USA, V96, P1886, DOI 10.1073/pnas.96.5.1886; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; Kuwabara T, 1996, NUCLEIC ACIDS RES, V24, P2302, DOI 10.1093/nar/24.12.2302; Lilley DMJ, 1999, CURR OPIN STRUC BIOL, V9, P330, DOI 10.1016/S0959-440X(99)80044-X; LONG DM, 1994, P NATL ACAD SCI USA, V91, P6977, DOI 10.1073/pnas.91.15.6977; Lott WB, 1998, P NATL ACAD SCI USA, V95, P542, DOI 10.1073/pnas.95.2.542; Matuda S, 1997, BIOCHEM BIOPH RES CO, V241, P151, DOI 10.1006/bbrc.1997.7784; PERRIMAN R, 1992, GENE, V113, P157, DOI 10.1016/0378-1119(92)90391-2; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; SAWATA S, 1995, J AM CHEM SOC, V117, P2357, DOI 10.1021/ja00113a028; SHELDON CC, 1989, NUCLEIC ACIDS RES, V17, P5679, DOI 10.1093/nar/17.14.5679; SYMONS RH, 1992, ANNU REV BIOCHEM, V61, P641; SYMONS RH, 1989, TRENDS BIOCHEM SCI, V14, P445, DOI 10.1016/0968-0004(89)90103-5; Tanaka M. A., UNPUB; THOMSON JB, 1993, NUCLEIC ACIDS RES, V21, P5600, DOI 10.1093/nar/21.24.5600; TUSCHL T, 1993, P NATL ACAD SCI USA, V90, P6991, DOI 10.1073/pnas.90.15.6991; UCHIMARU T, 1993, FASEB J, V7, P137; UEBAYASI M, 1994, J ORG CHEM, V59, P7414, DOI 10.1021/jo00103a038; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; YOSHINARI K, UNPUB; Zhou DM, 1997, P NATL ACAD SCI USA, V94, P14343, DOI 10.1073/pnas.94.26.14343; Zhou DM, 1996, J AM CHEM SOC, V118, P5862, DOI 10.1021/ja9606790; ZHOU JM, IN PRESS J INORG BIO; ZOUMADAKIS M, 1995, NUCLEIC ACIDS RES, V23, P1192, DOI 10.1093/nar/23.7.1192	59	29	31	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	SPR	2000	1	1					108	117		10.1021/bm990009x		10	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	433ER	WOS:000168746700015		
J	Fujii, Y; Iwasa, H; Hirai, J; Takahama, Y; Hasumi, K; Eriguchi, M				Fujii, Y; Iwasa, H; Hirai, J; Takahama, Y; Hasumi, K; Eriguchi, M			Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001)	BIOMEDICINE & PHARMACOTHERAPY			English	Article						liver metastasis; LMFS; ND2001	CANCER METASTASIS; INVITRO	We examined the inhibitory effect of sodium D-glucaro-delta-lactam (sodium 5-amino-5-deoxy-D-glucosaccharic acid-delta-lactam: ND2001) upon liver metastases of the LMFS tumor. A permanent cell line, LMFS, was established from a spontaneously occurring murine retroperitoneal tumor of BALB/c mouse origin, and after a subcutaneous injection, the LMFS cells proliferated at the inoculation site (100% take) with liver metastases. ND2001 had little effect on the cell growth, cell cycle and phagokinesis of the LMFS cells in vitro. However, when the invasive activity was measured by the Boydem chamber method, the number of LR IFS cells was reduced, with inhibition rates of 98.0%. After the LMFS cells treated with ND2001 in vitro, the numbers of hepatic metastases of subcutaneous inoculation of treated cells were reduced dose-dependently, and those of intravenous inoculation were not found by microscopical study. When the LMFS tumor-bearing mice were treated with ND2001 (0, 30, 100 mg/kg/d) from day 1, ND2001 (30 mg/kg) inhibited the liver metastases with a rate of 56.4%, and when given from day 15, ND2001 (100 mg/kg) inhibited with a rate of 47.5%. But ND2001 showed neither cytocidal nor antitumor activity. Combination therapy of primary tumor resection and ND2001 administration revealed that preoperative use of ND2001 was more effective in preventing liver metastases. These results suggested that ND2001 might have a potential use as an anti-metastatic agent for operative patients without metastasis. (C) 2000 Editions scientifiques et medicales Elsevier SAS.	Univ Tokyo, Inst Med Sci, Dept Surg, Minato Ku, Tokyo, Japan; Electromed & Canc Inst, Dept Immunol, Tokyo, Japan	Fujii, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Surg, Minato Ku, 4-6-1 Shirokanedai, Tokyo, Japan.						KOIKE A, 1963, CANCER, V16, P716, DOI 10.1002/1097-0142(196306)16:6<716::AID-CNCR2820160605>3.0.CO;2-C; ALBINI A, 1987, CANCER RES, V47, P3239; KIJIMASUDA I, 1988, CANCER RES, V48, P3728; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; LIOTTA LA, 1986, CANCER RES, V46, P1; ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Fidler I. J., 1978, METHOD CANCER RES, V15, P399; FUJII Y, 1997, JPN J CANC CHEMOTHER, V24, P343; FUJII Y, 1993, JPN J CANCER RES, V84, P1055; FUJII Y, 1994, JPN J CANC CHEMOTHER, V21, P1627; ISHITSUKA H, 1980, GANN, V71, P112; KATO Y, 1992, J BIOL CHEM, V267, P11424; KOPPER L, 1982, J CANCER RES CLIN, V103, P31, DOI 10.1007/BF00410303; NICOLSON GL, 1982, BIOCHIM BIOPHYS ACTA, V695, P113, DOI 10.1016/0304-419X(82)90020-8; NIWA T, 1970, AGR BIOL CHEM TOKYO, V34, P966; SAIKI I, 1989, JPN J CANCER RES, V80, P873; SCHWARZ RT, 1984, TRENDS BIOCHEM SCI, V9, P32, DOI 10.1016/0968-0004(84)90046-X; TSURUOKA T, 1973, Scientific Reports of Meiji Seika Kaisha, V13, P80; TSURUOKA T, 1995, JPN J CANCER RES, V86, P41	19	3	3	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0753-3322			BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2000	54	2					85	92		10.1016/S0753-3322(00)88857-5		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	303TL	WOS:000086440900005		
J	Kanda, T; Takai, K; Yokoyama, S; Takaku, H				Kanda, T; Takai, K; Yokoyama, S; Takaku, H			Specific inactivation of Escherichia coli tRNA(Phe) by antisense DNA-treatment under Mg2+-deficient conditions	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article							NUCLEOCAPSID PROTEIN; ANNEALING ACTIVITIES; MG2+ BINDING; TRANSFER-RNA; SITE; ION	The preparation of an Escherichia coli tRNA mixture lacking several specific species may be useful for applications ranging from cell-free protein preparation to protein engineering. We have already demonstrated that tRNA(Asp) can be inactivated, or 'knocked out', with practical specificity by an antisense strategy. In the present study, we synthesized five tRNA(Phe)-targeted antisense oligonucleotides and tested if this tRNA can also be inactivated specifically. The salt conditions used previously for the tRNA(Asp) inactivation were not applicable to tRNA(Phe). Instead, Mg2+-deficient conditions were found to be useful for the inactivation of tRNA(Phe) by the antisense oligonucleotides. These conditions were also applicable to the inactivation of tRNA(Asp). The susceptibility to the antisense DNAs can change drastically, depending on the concentration of Mg2+. (C) 2000 Elsevier Science Ltd. All rights reserved.	Chiba Inst Technol, Dept Ind Chem, Chiba 2750016, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	Takai, K (reprint author), Chiba Inst Technol, Dept Ind Chem, 2-17-1 Tsudanuma, Chiba 2750016, Japan.						AMANO M, 1992, EUR J BIOCHEM, V210, P671, DOI 10.1111/j.1432-1033.1992.tb17468.x; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.biophys.24.1.435; DERRICK WB, 1993, NUCLEIC ACIDS RES, V21, P4948, DOI 10.1093/nar/21.21.4948; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472; Murakami H, 1998, J AM CHEM SOC, V120, P7520, DOI 10.1021/ja971890u; YUE DX, 1994, BIOCHEMISTRY-US, V33, P8905, DOI 10.1021/bi00196a007; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; LAPADATTAPOLSKY M, 1995, NUCLEIC ACIDS RES, V23, P2434, DOI 10.1093/nar/23.13.2434; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; BARRELL BG, 1969, FEBS LETT, V3, P275, DOI 10.1016/0014-5793(69)80157-2; BOLTON PH, 1977, BIOCHIM BIOPHYS ACTA, V477, P10, DOI 10.1016/0005-2787(77)90156-3; CHOI BS, 1995, J BIOCHEM-TOKYO, V117, P515; Ehrenberg M., 1990, RIBOSOMES PROTEIN SY, P101; ISHIKAWA K, 1993, J MOL BIOL, V230, P529, DOI 10.1006/jmbi.1993.1169; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Kanda T, 1998, FEBS LETT, V440, P273, DOI 10.1016/S0014-5793(98)01471-9; Kanda T, 2000, J BIOCHEM-TOKYO, V127, P37; KARPEL RL, 1975, J MOL BIOL, V97, P519, DOI 10.1016/S0022-2836(75)80056-8; Keck JL, 1998, J BIOL CHEM, V273, P34128, DOI 10.1074/jbc.273.51.34128; NISHIMUR.S, 1967, BIOCHIM BIOPHYS ACTA, V142, P133, DOI 10.1016/0005-2787(67)90522-9; RABA M, 1979, EUR J BIOCHEM, V97, P305, DOI 10.1111/j.1432-1033.1979.tb13115.x; Serebrov V, 1998, NUCLEIC ACIDS RES, V26, P2723, DOI 10.1093/nar/26.11.2723; UCHIYAMA Y, 1994, J BIOCHEM-TOKYO, V116, P1322; Yabuki T, 1998, J BIOMOL NMR, V11, P295, DOI 10.1023/A:1008276001545	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896			BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAR	2000	8	3					675	679		10.1016/S0968-0896(00)00007-9		5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	293DH	WOS:000085835900023		
J	Xu, XH; Bhat, MB; Nishi, M; Takeshima, H; Ma, JJ				Xu, XH; Bhat, MB; Nishi, M; Takeshima, H; Ma, JJ			Molecular cloning of cDNA encoding a Drosophila ryanodine receptor and functional studies of the carboxyl-terminal calcium release channel	BIOPHYSICAL JOURNAL			English	Article							SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; CA-2+ RELEASE; EXPRESSION; BINDING; DERIVATIVES; AFFINITY	Ryanodine is a plant alkaloid that was originally used as an insecticide. To study the function and regulation of the ryanodine receptor (RyR) from insect cells, we have cloned the entire cDNA sequence of RyR from the fruit fly Drosophila melanogaster. The primary sequence of the Drosophila RyR contains 5134 amino acids, which shares similar to 45% identity with RyRs from mammalian cells, with a large cytoplasmic domain at the amino-terminal end and a small transmembrane domain at the carboxyl-terminal end. To characterize the Ca2+ release channel activity of the cloned Drosophila RyR, we expressed both full-length and a deletion mutant of Drosophila RyR lacking amino acids 277-3650 (Drosophila RyR-C) in Chinese hamster ovary cells. For subcellular localization of the expressed Drosophila RyR and Drosophila RyR-C proteins, green fluorescent protein (GFP)-Drosophila RyR and GFP-Drosophila RyR-C fusion constructs were generated, Confocal microscopic imaging identified GFP-Drosophila RS/R and GFP-Drosophila RyR-C on the endoplasmic reticulum membranes of transfected cells, Upon reconstitution into the lipid bilayer membrane, Drosophila RyR-C formed a large conductance cation-selective channel, which was sensitive to modulation by ryanodine. Opening of the Drosophila RyR-C channel required the presence of mu M concentration of Ca2+ in the cytosolic solution, but the channel was insensitive to inhibition by Ca2+ at concentrations as high as 20 mM. Our data are consistent with our previous observation with the mammalian RyR that the conduction pore of the calcium release channel resides within the carboxyl-terminal end of the protein and further demonstrate that structural and functional features are essentially shared by mammalian and insect RyRs.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Univ Tokyo, Dept Pharmacol, Tokyo, Japan	Ma, JJ (reprint author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.						Bhat MB, 1997, BIOPHYS J, V73, P1329; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; Bhat Manjunatha B., 1997, Journal of General Physiology, V110, P749, DOI 10.1085/jgp.110.6.749; Bhat MB, 1999, BIOPHYS J, V77, P808; Bhat MB, 1997, BIOPHYS J, V73, P1320; Bidasee KR, 1998, J BIOL CHEM, V273, P12176, DOI 10.1074/jbc.273.20.12176; Chen SRW, 1997, BIOPHYS J, V73, P1904; Du GG, 1998, J BIOL CHEM, V273, P33259, DOI 10.1074/jbc.273.50.33259; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.biophys.18.1.333; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HASAN G, 1992, DEVELOPMENT, V116, P967; MA JJ, 1994, BIOPHYS J, V67, P626; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; OTSU K, 1990, J BIOL CHEM, V265, P13472; PEPPER BP, 1945, J ECON ENTOMOL, V38, P59; Qi Y, 1998, J BIOL CHEM, V273, P34813, DOI 10.1074/jbc.273.52.34813; Schmitt M, 1997, J RECEPT SIGNAL TR R, V17, P185, DOI 10.3109/10799899709036603; Sutko JL, 1996, PHYSIOL REV, V76, P1027; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TAKESHIMA H, 1993, ANN NY ACAD SCI, V707, P165, DOI 10.1111/j.1749-6632.1993.tb38051.x; Tinker A, 1996, BIOPHYS J, V70, P2110; Usherwood PNR, 1995, TOXICOL LETT, V82-3, P247, DOI 10.1016/0378-4274(95)03558-3; WAGENKNECHT T, 1989, NATURE, V338, P167, DOI 10.1038/338167a0; WATERHOUSE AL, 1987, J MED CHEM, V30, P710, DOI 10.1021/jm00387a022; Welch W, 1996, BIOCHEMISTRY-US, V35, P7165, DOI 10.1021/bi9527294; Welch W, 1997, BIOCHEMISTRY-US, V36, P2939, DOI 10.1021/bi9623901; WITCHER DR, 1994, J BIOL CHEM, V269, P13076	33	50	58	BIOPHYSICAL SOCIETY	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0006-3495			BIOPHYS J	Biophys. J.	MAR	2000	78	3					1270	1281				12	Biophysics	Biophysics	290VD	WOS:000085697800017		
J	Ishii, M; Takishita, S; Iwasaki, T; Peerapornpisal, Y; Yoshino, J; Kodama, T; Igarashi, Y				Ishii, M; Takishita, S; Iwasaki, T; Peerapornpisal, Y; Yoshino, J; Kodama, T; Igarashi, Y			Purification and characterization of membrane-bound hydrogenase from Hydrogenobacter thermophilus strain TK-6, an obligately autotrophic, thermophilic, hydrogen-oxidizing bacterium	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						membrane-bound hydrogenase; quinone reduction; EPR; hydrogen bacterium; Hydrogenobacter	DESULFOVIBRIO-GIGAS HYDROGENASE; NAD-REDUCING HYDROGENASE; PYRUVATE-FERREDOXIN OXIDOREDUCTASE; FUMARATE REDUCTASE-ACTIVITY; 8-HYDROXY-5-DEAZAFLAVIN-REDUCING HYDROGENASE; CATALYTIC MECHANISM; ELECTRON-ACCEPTOR; IRON-HYDROGENASE; 4FE-4S CENTERS; NI	A membrane-bound hydrogenase was purified to electrophoretic homogeneity from the cells of Hydrogenobacter thermophilus strain TK-6, an obligately autotrophic, thermophilic, hydrogen-oxidizing bacterium. Solubilization and purification were done aerobically in the presence of Triton X-100. Three chromatography steps were done for purification; Butyl-Sepharose, Mono-Q, and Superose 6, in this order. Purification was completed with 6.73% yield of total activity and with 21.4-fold increase of specific activity when compared with the values for the membrane fraction. The purified hydrogenase was shown to be a tetramer with alpha(2)beta(2) structure, with a molecular mass of 60,000 Da for the large subunit and 38,000 Da for the small subunit. The purified hydrogenase directly reduced methionaquinone with an apparent fi, of around 300 mu M and with a turnover number around 2900 (min(-1)). Metal analysis and EPR properties of the hydrogenase have shown that the enzyme is one of the [NiFe]-hydrogenases. Also, optimum pH and temperature for reaction, thermal stability, and electron acceptor specificity were reported. Finally, a model is presented for energy and central metabolism of H. thermophilus strain TK-6.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan; Chiangmai Univ, Dept Biol, Chiangmai 50200, Thailand; Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3860018, Japan	Igarashi, Y (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	aigara@mail.ecc.u-tokyo.ac.jp					ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Dole F, 1997, BIOCHEMISTRY-US, V36, P7847, DOI 10.1021/bi963171i; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; TEIXEIRA M, 1989, J BIOL CHEM, V264, P16435; Deckert G, 1998, NATURE, V392, P353; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; FERNANDEZ VM, 1986, BIOCHIM BIOPHYS ACTA, V883, P145, DOI 10.1016/0304-4165(86)90145-5; TRANBETCKE A, 1990, J BACTERIOL, V172, P2920; ASSO M, 1992, BIOCHIM BIOPHYS ACTA, V1122, P50, DOI 10.1016/0167-4838(92)90126-X; DROSS F, 1992, EUR J BIOCHEM, V206, P93, DOI 10.1111/j.1432-1033.1992.tb16905.x; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; GUIGLIARELLI B, 1995, BIOCHEMISTRY-US, V34, P4781, DOI 10.1021/bi00014a036; WEBER K, 1969, J BIOL CHEM, V244, P4406; RIEDER R, 1984, EUR J BIOCHEM, V145, P637, DOI 10.1111/j.1432-1033.1984.tb08604.x; Grzeszik C, 1997, MICROBIOL-UK, V143, P1271; Dole F, 1996, BIOCHEMISTRY-US, V35, P16399, DOI 10.1021/bi961662x; BONJOUR F, 1986, FEMS MICROBIOL LETT, V35, P11, DOI 10.1111/j.1574-6968.1986.tb01490.x; CECCHINI G, 1986, J BIOL CHEM, V261, P1808; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; FERBER DM, 1995, BBA-BIOENERGETICS, V1229, P334, DOI 10.1016/0005-2728(95)00012-8; Fischer J, 1996, ARCH MICROBIOL, V165, P289, DOI 10.1007/s002030050329; Fontecilla-Camps JC, 1997, BIOCHIMIE, V79, P661, DOI 10.1016/S0300-9084(97)83499-2; FOX JA, 1987, BIOCHEMISTRY-US, V26, P4219, DOI 10.1021/bi00388a007; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.micro.47.1.351; Garcin E, 1998, BIOCHEM SOC T, V26, P396; ISHII M, 1987, J BACTERIOL, V169, P2380; ISHII M, 1989, J BACTERIOL, V171, P1788; Ishii M, 1996, BIOSCI BIOTECH BIOCH, V60, P1513; ISHII M, 1991, AGR BIOL CHEM TOKYO, V55, P3011; Ishizaka K, 1987, Int Rev Immunol, V2, P1, DOI 10.3109/08830188709044744; IWASAKI T, 1994, J BIOL CHEM, V269, P29444; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; JUSZCZAK A, 1991, J BIOL CHEM, V266, P13834; KAWASUMI T, 1980, AGR BIOL CHEM TOKYO, V44, P1985; KAWASUMI T, 1984, INT J SYST BACTERIOL, V34, P5; KITA K, 1988, BIOCHIM BIOPHYS ACTA, V935, P130, DOI 10.1016/0005-2728(88)90210-1; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MUTH E, 1987, EUR J BIOCHEM, V169, P571, DOI 10.1111/j.1432-1033.1987.tb13647.x; PINKWART M, 1983, FEMS MICROBIOL LETT, V17, P137; PITULLE C, 1994, INT J SYST BACTERIOL, V44, P620; ROBERTS LM, 1994, BIOCHEMISTRY-US, V33, P14339, DOI 10.1021/bi00251a048; SHIBA H, 1985, ARCH MICROBIOL, V141, P198, DOI 10.1007/BF00408058; TUSHURASHVILI PR, 1985, BIOCHIM BIOPHYS ACTA, V809, P145, DOI 10.1016/0005-2728(85)90057-X; UNDEN G, 1984, BIOCHIM BIOPHYS ACTA, V767, P460, DOI 10.1016/0005-2728(84)90044-6; Yoon KS, 1997, ARCH MICROBIOL, V167, P275, DOI 10.1007/s002030050443; Yoon KS, 1996, J BACTERIOL, V178, P3365; Yoon KS, 1996, FEMS MICROBIOL LETT, V139, P139, DOI 10.1111/j.1574-6968.1996.tb08193.x; Yoon KS, 1997, BIOSCI BIOTECH BIOCH, V61, P510	52	25	25	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	MAR	2000	64	3					492	502		10.1271/bbb.64.492		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	299LF	WOS:000086199500005		
J	Nishida, H; Ogura, A; Yokota, A; Yamaguchi, I; Sugiyama, J				Nishida, H; Ogura, A; Yokota, A; Yamaguchi, I; Sugiyama, J			Group I intron located in PR protein homologue gene in Youngia japonica	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						Youngia japonica; Protomyces inouyei; group I intron; horizontal transfer; miraculin homologue	AMINO-ACID-SEQUENCE; ALPHA-AMYLASE INHIBITOR; TASTE-MODIFYING PROTEIN; TRYPSIN-INHIBITOR; NUCLEOTIDE-SEQUENCE; HORIZONTAL TRANSFER; CLONING; EXPRESSION; PEPEROMIA; MIRACULIN	A Youngia japonica strain had a group I intron that was suggested to have been transferred from Protomyces inouyei, a pathogenic fungus of Y. japonica. It was located in the miraculin homologue coding gene by reverse complementation, The deduced amino acid sequence of this miraculin homologue of Y. japonica mas similar to the amino acid sequences of tobacco and tomato pathogenesis-related proteins.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	Nishida, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.	hnishida@iam.u-tokyo.ac.jp					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; HUNG CH, 1992, BIOCHEM BIOPH RES CO, V184, P1524, DOI 10.1016/S0006-291X(05)80056-7; THEERASILP S, 1989, J BIOL CHEM, V264, P6655; Bhattacharya D, 1996, MOL BIOL EVOL, V13, P978; DUJON B, 1989, GENE, V82, P91, DOI 10.1016/0378-1119(89)90034-6; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.biochem.59.1.543; VAUGHN JC, 1995, J MOL EVOL, V41, P563; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903; Karrer EE, 1998, PLANT MOL BIOL, V36, P681, DOI 10.1023/A:1005949304445; JOFUKU KD, 1989, PLANT CELL, V1, P1079, DOI 10.1105/tpc.1.11.1079; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; THEERASILP S, 1988, J BIOL CHEM, V263, P11536; Adams KL, 1998, J MOL EVOL, V46, P689, DOI 10.1007/PL00006349; AUGUR C, 1995, J BIOL CHEM, V270, P24839; Belfort M, 1995, J BIOL CHEM, V270, P30237; Brenner ED, 1998, PLANT PHYSIOL, V118, P237, DOI 10.1104/pp.118.1.237; Kumar S., 1993, MEGA MOL EVOLUTIONAR; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; LEAH R, 1989, PLANT MOL BIOL, V12, P673, DOI 10.1007/BF00044158; MAEDA K, 1986, BIOCHIM BIOPHYS ACTA, V871, P250, DOI 10.1016/0167-4838(86)90206-2; MASUDA Y, 1995, GENE, V161, P175, DOI 10.1016/0378-1119(95)00198-F; MILLIGAN SB, 1995, PLANT MOL BIOL, V28, P691, DOI 10.1007/BF00021194; NISHIDA H, 1995, MOL BIOL EVOL, V12, P883; NISHIDA H, 1993, J MOL EVOL, V37, P25; OHTSUBO KI, 1992, FEBS LETT, V309, P68, DOI 10.1016/0014-5793(92)80741-X; TAI HY, 1991, PLANT MOL BIOL, V16, P913, DOI 10.1007/BF00015084; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4553	27	2	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	MAR	2000	64	3					606	609		10.1271/bbb.64.606		4	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	299LF	WOS:000086199500023		
J	Sakakihara, Y				Sakakihara, Y			Ethical attitudes of Japanese physicians regarding life-sustaining treatment for children with severe neurological disabilities	BRAIN & DEVELOPMENT			English	Article						ethical attitude; severe neurological disabilities; life-sustaining treatment	GUIDELINES	Ethical attitudes of Japanese physicians regarding life-sustaining treatment for children with severe neurological disabilities (SND) were investigated by mailing a translated questionnaire which the Child Neurology Society (CNS) of the United States used for their survey. The questionnaire was sent to 202 council members of the Japanese Society of Child Neurology (JSCN), and the answers of 147 respondents (72.8%) were analyzed. It was found that the majority (85.0%) of respondents believed that the same level of care should be provided to children with SND as those without it. However, fewer respondents (15.6%) believed that cardiopulmonary resuscitation was indicated for children with progressive or degenerative brain disorders. With respect to the authoritative role of medical indications and family/guardian's wishes in clinical decision-making for children with SND, about 30% of respondents believed that medical indications should override family/guardian's wishes. However, almost as many respondents (29.9%) chose an ambivalent answer. If compared with the results of the preceding CNS survey, considerably more respondents gave ambivalent answers (average 26.6%) than in the CNS survey (5.8%). About half of the respondents (49.0%) acknowledged the need for ethical guidelines to help physicians make ethically difficult decisions. Although statistical comparison was not possible, there were considerable differences between the results of the current study and those of the CNS survey. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo, Japan	Sakakihara, Y (reprint author), Univ Tokyo, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.						Bernat JL, 1997, NEUROLOGY, V49, P321; KOHRMAN A, 1994, PEDIATRICS, V93, P532; Frader JE, 1996, PEDIATRICS, V98, P149; HENDEE WR, 1990, JAMA-J AM MED ASSOC, V263, P426; BONE RC, 1990, CHEST, V97, P949; LANKEN PN, 1991, ANN INTERN MED, V115, P478; Danis M, 1997, CRIT CARE MED, V25, P887; ASHWAL S, 1994, PEDIATR NEUROL, V10, P27, DOI 10.1016/0887-8994(94)90063-9; Berger JT, 1996, ARCH INTERN MED, V156, P2051; *CNS ETH COMM, 1994, ANN NEUROL, V36, P510; GLASSON J, 1995, JAMA-J AM MED ASSOC, V273, P330; Green MJ, 1996, ARCH INTERN MED, V156, P298, DOI 10.1001/archinte.156.3.298; Kassirer JP, 1998, NEW ENGL J MED, V339, P397, DOI 10.1056/NEJM199808063390608; Perkin RM, 1997, SEMIN NEUROL, V17, P239, DOI 10.1055/s-2008-1040935; TRUG RD, 1992, NEW ENGL J MED, V326, P1560; Weijer C, 1998, CAN MED ASSOC J, V159, P817	16	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604			BRAIN DEV-JPN	Brain Dev.	MAR	2000	22	2					113	117		10.1016/S0387-7604(99)00127-8		5	Clinical Neurology	Neurosciences & Neurology	302DB	WOS:000086349200008		
J	Yamada, M; Ariga, T; Kawamura, N; Ohtsu, M; Imajoh-Ohmi, S; Ohshika, E; Tatsuzawa, O; Kobayashi, K; Sakiyama, Y				Yamada, M; Ariga, T; Kawamura, N; Ohtsu, M; Imajoh-Ohmi, S; Ohshika, E; Tatsuzawa, O; Kobayashi, K; Sakiyama, Y			Genetic studies of three Japanese patients with p22-phox-deficient chronic granulomatous disease: detection of a possible common mutant CYBA allele in Japan and a genotype-phenotype correlation in these patients	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						chronic granulomatous disease; CYBA; mutation analysis; p22-phox expression; genotype-phenotype correlation	NEUTROPHIL CYTOCHROME-B; CYTOPLASMIC DOMAIN; NADPH OXIDASE; LIGHT CHAIN; MUTATIONS; SUBUNIT; ANTIBODIES; DIAGNOSIS; FAMILIES; P22-PHOX	Chronic granulomatous disease (CGD) is a disorder caused by defects in the NADPH oxidase responsible for superoxide generation in phagocytes. Cytochrome b558, an essential component of this enzyme, is a heterodimer formed by a 91 kDa glycoprotein (gp91-phox) and a 22 kDa polypeptide (p22-phox). Mutations in the p22-phox gene (CYBA) locus in 16q24 result in one of the rare autosomal recessive forms of CGD. We performed mutation analysis in three female CGD patients suspected of having this form of the disease and found two novel mutations in CYBA. Whereas patient 1 with severe phenotype had a homozygous nonsense mutation in exon 1 (C-35 --> T, Gln-3 --> stop), patients 2 and 3 with mild phenotype shared the same homozygous missense mutation in exon 2 (G-98 --> A, Gly-24 --> Arg). None of the parents of patients 2 and 3 is related. Therefore, this mutation could be a hot-spot or a common mutation in the Japanese population. Patients 2 and 3, but not patient 1, were demonstrated to have detectable p22-phox expression and significant granulocyte respiratory burst (ROB) activity. In this study, we were able to demonstrate an excellent correlation between genotype, p22-phox expression, ROB activity and clinical phenotype in these patients.	Hokkaido Univ, Sch Med, Dept Human Gene Therapy, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Sch Med, Dept Paediat, Sapporo, Hokkaido 060, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan; Saitama Med Sch, Dept Paediat, Moroyama, Saitama, Japan; Natl Childrens Hosp, Dept Infect Dis & Rheumatol, Tokyo 154, Japan	Ariga, T (reprint author), Hokkaido Univ, Sch Med, Dept Human Gene Therapy, Kita Ku, N-14,W-5, Sapporo, Hokkaido 0608638, Japan.		Ariga, Tadashi/A-4252-2012				EMMENDORFFER A, 1994, CYTOMETRY, V18, P147, DOI 10.1002/cyto.990180306; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Ariga T, 1998, PEDIATR RES, V44, P85, DOI 10.1203/00006450-199807000-00014; BUGHANIM HN, 1995, BLOOD, V86, P3575; Crockard AD, 1997, INT ARCH ALLERGY IMM, V114, P144; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; MALY FE, 1994, J BIOL CHEM, V269, P18743; MILLS EL, 1980, J CLIN INVEST, V66, P332, DOI 10.1172/JCI109861; NAKAMURA M, 1988, BLOOD, V72, P1550; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; Roos D, 1996, BLOOD, V87, P1663; Roos D, 1996, IMMUNOL TODAY, V17, P517; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; WHITEHEAD AS, 1984, NEW ENGL J MED, V310, P88, DOI 10.1056/NEJM198401123100204	18	17	18	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0007-1048			BRIT J HAEMATOL	Br. J. Haematol.	MAR	2000	108	3					511	517		10.1046/j.1365-2141.2000.01857.x		7	Hematology	Hematology	302EV	WOS:000086353500009		
J	Machida, U; Tojo, A; Takahashi, S; Iseki, T; Ooi, J; Nagayama, H; Shirafuji, N; Mori, SI; Wada, Y; Ogami, K; Yamada, Y; Sakamaki, H; Maekawa, T; Tani, K; Asano, S				Machida, U; Tojo, A; Takahashi, S; Iseki, T; Ooi, J; Nagayama, H; Shirafuji, N; Mori, SI; Wada, Y; Ogami, K; Yamada, Y; Sakamaki, H; Maekawa, T; Tani, K; Asano, S			The effect of granulocyte colony-stimulating factor administration in healthy donors before bone marrow harvesting	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						G-CSF; normal donors; bone marrow CD34(+) cells; marrow recovery; GM-CFU	STEM-CELL TRANSPLANTATION; BLOOD PROGENITOR CELLS; G-CSF; ALLOGENEIC TRANSPLANTATION; HOST DISEASE; FILGRASTIM; GRAFT; INTERLEUKIN-1; MOBILIZATION; COMBINATION	To investigate whether granulocyte colony-stimulating factor (G-CSF) administration to donors before harvest may lighten the burden imposed on them and accelerate the bone marrow (BM) recovery, we administered 2 mu g/kg/d of G-CSF for five consecutive days before the marrow harvest, All of the donors tolerated the G-CSF administration well without severe adverse events, After 5 d of G-CSF treatment, CD34(+) cells and granulocyte-macrophage colony-forming units (GM-CFU) in the donors' BM exceeded baseline values by 4.2-fold (range 0.71-316) and 1.6-fold (0.28-118) respectively. The concentration of total nucleated cells (x 10(7)/ml) in the graft increased from 1.61 (0.95-3.23) to 2.44 (1.27-4.01). Although we collected 1020 ml of BM and obtained 1.50 x 10(10) nucleated cells from unprimed donors, 940 ml of BM were sufficient to obtain 2.14 x 10(10) nucleated cells from primed donors. However, G-CSF-primed BM did not shorten the time to trilineage engraftment and the duration of hospitalization compared with unprimed BM, although primed BM contained more CD34(+) cells than baseline values. We consider that the advantages of BM priming are not the acceleration of BM recovery but rather the reduction of blood loss during BM harvesting.	Univ Tokyo, Inst Med Sci, Dept Haematol Oncol, Minato Ku, Tokyo 1088639, Japan; Tokyo Metropolitan Komagome Hosp, Dept Haematol, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Transfus Med & Cell Therapy, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Surg Ctr, Tokyo, Japan	Machida, U (reprint author), Univ Tokyo, Inst Med Sci, Dept Haematol Oncol, Minato Ku, Shirokanedai 4-6-1, Tokyo 1088639, Japan.						Isola LM, 1997, BONE MARROW TRANSPL, V20, P1033, DOI 10.1038/sj.bmt.1701029; HANSEN PB, 1995, BONE MARROW TRANSPL, V16, P373; JOHNSEN HE, 1992, BONE MARROW TRANSPL, V10, P229; KORBLING M, 1995, BLOOD, V86, P2842; Damiani D, 1997, BLOOD, V90, P36; STOPPA AM, 1994, BONE MARROW TRANSPL, V13, P541; DREGER P, 1994, BRIT J HAEMATOL, V87, P609, DOI 10.1111/j.1365-2141.1994.tb08321.x; Martinez C, 1999, BONE MARROW TRANSPL, V23, P15, DOI 10.1038/sj.bmt.1701526; SCHMITZ N, 1995, BLOOD, V85, P1666; ATKINSON K, 1991, BLOOD, V77, P1376; Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45; BENSINGER WI, 1995, BLOOD, V85, P1655; Dicke KA, 1997, EXP HEMATOL, V25, P34; Falzetti F, 1999, LANCET, V353, P555, DOI 10.1016/S0140-6736(99)00268-8; GISSELBRECHT C, 1994, LANCET, V343, P696, DOI 10.1016/S0140-6736(94)91579-2; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; IKEBUCHI K, 1988, BLOOD, V72, P2007; Kitamura S, 1997, Masui, V46, P946; LASKY LC, 1989, TRANSFUSION, V29, P552, DOI 10.1046/j.1537-2995.1989.29689318458.x; MCGLAVE PB, 1987, BLOOD, V70, P1325; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Nishihara M, 1998, EUR J IMMUNOL, V28, P855, DOI 10.1002/(SICI)1521-4141(199803)28:03<855::AID-IMMU855>3.0.CO;2-X; Russell N, 1996, BRIT J HAEMATOL, V93, P747, DOI 10.1046/j.1365-2141.1996.d01-1712.x; SCHMITZ N, 1988, BLOOD, V72, P1567; TAKAHASHI S, 1994, BONE MARROW TRANSPL, V13, P239	25	6	6	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0007-1048			BRIT J HAEMATOL	Br. J. Haematol.	MAR	2000	108	4					747	753		10.1046/j.1365-2141.2000.01910.x		7	Hematology	Hematology	315HM	WOS:000087107400013		
J	Kanno, M; Araie, M; Koibuchi, H; Masuda, K				Kanno, M; Araie, M; Koibuchi, H; Masuda, K			Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							HUMOR DYNAMICS; OUTFLOW FACILITY; TIME COURSE; HUMAN EYES; PRAZOSIN; RABBITS; TIMOLOL; MONKEYS; K-351; FLOW	Aims-To study the effects of topical nipradilol, a non-selective beta blocker with alpha blocking and nitroglycerin-like activities, on intraocular pressure (IOP) and aqueous humour dynamics in normal humans and in patients with ocular hypertension. Methods-Nipradilol (0.06%, 0.125%, 0.25%, 0.5%) was applied to normal volunteers (n = 12) to test for IOP lowering effects. In a second group of normal volunteers (n = 11), nipradilol (0.125% and 0.25%) and timolol (0.5%) were compared for IOP lowering effects. After a single administration of 0.25% nipradilol, TOP flare intensity in the anterior chamber, aqueous flow, uveoscleral outflow, tonographic outflow facility and episcleral venous pressure were either directly measured or mathematically calculated. Topical nipradilol (0.25%) was administered to 24 patients with ocular hypertension twice daily for 8 weeks. Results-Administration of 0.25% nipradilol decreased IOP with a maximum reduction of 4.2 mm Hg lasting 12 hours. A single instillation of both 0.25% nipradilol and 0.5% timolol reduced the TOP in normotensive human subjects to the same degree. A single instillation of 0.25% nipradilol decreased the aqueous flow rate in the treated eye by 20%. Nipradilol produced no significant effect in tonographic outflow facility or episcleral venous pressure, but uveoscleral outflow was increased. In patients with ocular hypertension, twice daily instillation of 0.25% nipradilol decreased IOP without tachyphylaxis for the 8 week test period. Conclusion-Topical nipradilol (0.25%) reduced IOP by decreasing the aqueous flow rate and probably also by increasing uveoscleral outflow. Nipradilol should be further investigated as a new antiglaucoma drug.	Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; JR Tokyo Gen Hosp, Sect Ophthalmol, Tokyo, Japan	Araie, M (reprint author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Kanno M, 1998, INVEST OPHTH VIS SCI, V39, P736; SCHUMAN JS, 1994, EXP EYE RES, V58, P99, DOI 10.1006/exer.1994.1199; NATHANSON JA, 1992, J PHARMACOL EXP THER, V260, P956; ZIMMERMAN TJ, 1984, ARCH OPHTHALMOL-CHIC, V102, P551; AZUMA I, 1994, J EYE, V11, P631; AZUMA I, 1991, Folia Ophthalmologica Japonica, V42, P710; BRUBAKER RF, 1986, CLIN OPHTHALMOL, V3, P1; FURUTA Y, 1994, THER RES, V15, P379; HAYASHI M, 1989, EXP EYE RES, V48, P621, DOI 10.1016/0014-4835(89)90004-3; IUGLIO N, 1984, GLAUCOMA, V6, P110; JONES RF, 1966, EXP EYE RES, V5, P208, DOI 10.1016/S0014-4835(66)80009-X; KAGEYAMA M, 1995, FOLIA OPHTHALMOL JPN, V46, P1066; KRUPIN T, 1980, ARCH OPHTHALMOL-CHIC, V98, P1639; Lam AKC, 1997, OPHTHAL PHYSL OPT, V17, P68, DOI 10.1111/j.1475-1313.1997.tb00526.x; MORI M, 1990, Folia Ophthalmologica Japonica, V41, P2204; MORI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1099; OHHIRA A, 1985, ARCH INT PHARMACOD T, V278, P61; OSHIKA T, 1991, ARCH OPHTHALMOL-CHIC, V109, P1569; OSHIKA T, 1990, INVEST OPHTH VIS SCI, V31, P527; SAKURAI M, 1991, JPN J OPHTHALMOL, V35, P156; SCRIABIN.A, 1973, ARCH INT PHARMACOD T, V205, P76; SERLE JB, 1984, ARCH OPHTHALMOL-CHIC, V102, P1385; SHIRASAWA Y, 1985, JPN J PHARMACOL, V39, P77, DOI 10.1254/jjp.39.77; SMITH BR, 1979, ARCH OPHTHALMOL-CHIC, V97, P1933; TANIGUCHI T, 1996, J JPN OPHTHALMOL SOC, V100, P279; TOMILINSON A, 1974, BR J OPHTHALMOL, V58, P68; UCHIDA Y, 1983, ARCH INT PHARMACOD T, V262, P132	27	38	39	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161			BRIT J OPHTHALMOL	Br. J. Ophthalmol.	MAR	2000	84	3					293	299		10.1136/bjo.84.3.293		7	Ophthalmology	Ophthalmology	291BZ	WOS:000085714600021		
J	Hidaka, K; Kubodera, T				Hidaka, K; Kubodera, T			Squids of the genus Abralia (Cephalopoda : Enoploteuthidae) from the western tropical Pacific with a description of Abralia omiae, a new species	BULLETIN OF MARINE SCIENCE			English	Article								Squids of the genus Abralia collected by a midwater trawl in the western tropical Pacific were examined. Five species were identified including Abralia omiae new species. This species is characterized by having five monotypic subocular photophores, two longitudinal broad bands of minute photophores on the ventral mantle, and a hectocotylized right ventral arm with two crests. The other four species identified were A. similis, A. trigonura, A. siedleckyi and A. heminuchalis. Materials from new localities for these species are discussed and comparisons to related species in several additional characters are made.	Univ Tokyo, Ocean Res Inst, Planktonol Div, Nakano Ku, Tokyo 1648639, Japan; Museum Nat Sci, Dept Zool, Shinjuku Ku, Tokyo 1690073, Japan	Hidaka, K (reprint author), Univ Tokyo, Ocean Res Inst, Planktonol Div, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.						REID SB, 1991, MAR BIOL, V109, P427, DOI 10.1007/BF01313508; Berry S. Stillman, 1909, Proceedings of the United States National Museum Smithsonian Institution Washington, V37; Berry S.S., 1913, P US NATL MUS, V45, P563; BERRY SS, 1914, B BUREAU FISHERIES, V32, P257; Burgess L. A., 1998, SMITHSONIAN CONTRIBU, V586, P271; BURGESS LA, 1992, B MAR, V49, P113; BURGESS LA, 1982, FISH B-NOAA, V80, P703; CAIRNS SD, 1976, B MAR SCI, V26, P233; Goodrich E. S., 1896, T LINN SOC LOND, V7, P1; GRAY JE, 1849, CATALOGUE MOLLUSCA C, V1; GRIMPE G., 1931, ZOOL ANZ, V95, P149; Hess SC, 1987, THESIS U MIAMI CORAL; Jefferts K., 1988, Bulletin of the Ocean Research Institute University of Tokyo, V26, P123; LIPINSKI M, 1983, VELIGER, V25, P255; LU CC, 1979, SMITHON CONTRIB ZOOL, V288; LU CC, 1975, J MAR BIOL ASSOC UK, V55, P369; Nesis K.N., 1977, Trudy Inst Okeanol, VNo. 107, P7; NESIS KN, 1987, CEPHOLOPODS WORLD; NESIS KN, 1987, ZOOL ZH, V66, P1693; Nesis K.N., 1975, Trudy Inst Okeanol, V100, P259; Okutani T., 1974, B TOKAI REG FISH RES, V80, P29; OKUTANI T, 1987, Bulletin of the National Science Museum Series A (Zoology), V13, P141; QUOY JRC, 1932, ZOOLOGIE VOYAGE ASTR, P321; RIDDELL DJ, 1985, FISH RES B, V27, P1; Roper C.F.E., 1975, Smithsonian Contributions to Zoology, VNo. 209, P1; Roper CFE, 1983, MEMOIRS NATIONAL MUS, V44, P48; SASAKI MADOKA, 1929, JOUR FAC AGRIC HOKKAIDO IMP UNIV SAPPORO, V20, P1; Stephen S.J., 1982, ANNOTATED CHECKLIST; Sweeney Michael J., 1998, Smithsonian Contributions to Zoology, V586, P561; TSUCHIYA K, 1991, Bulletin of the National Science Museum Series A (Zoology), V17, P69; TSUCHIYA K, 1988, Bulletin of the National Science Museum Series A (Zoology), V14, P119; Tsuchiya Kotaro, 1993, P571; VOSS GILBERT L., 1955, BULL MARINE SCI GULF AND CARIBBEAN, V5, P81; VOSS GL, 1959, B MAR SCI GULF CARIB, V8, P369; VOSS GL, 1963, SMITHSONIAN I B, V234, P1; Young RE, 1972, SMITHSONIAN CONTRIBU, V97, P1, DOI [10.5479/si.00810282.97, DOI 10.5479/SI.00810282.97)]; Young RE, 1998, SMITHSONIAN CONTRIBU, V586, P239	37	2	2	ROSENSTIEL SCH MAR ATMOS SCI	MIAMI	4600 RICKENBACKER CAUSEWAY, MIAMI, FL 33149 USA	0007-4977			B MAR SCI	Bull. Mar. Sci.	MAR	2000	66	2					417	443				27	Marine & Freshwater Biology; Oceanography	Marine & Freshwater Biology; Oceanography	295ZJ	WOS:000085998300010		
J	Tsuyumoto, I; Sawada, T				Tsuyumoto, I; Sawada, T			Ultrafast energy transfer dynamics at solid/liquid interfaces as investigated by photothermal spectroscopy	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							TRANSIENT REFLECTING GRATINGS; ELECTRON-TRANSFER; PHOTOCATALYSIS; ADSORPTION; SURFACES	Recent studies on ultrafast energy transfer at solid/liquid interfaces were reviewed, focusing on our developed photothermal techniques: femtosecond transient reflectivity (fs-TR) method, femtosecond transient reflecting grating (fs-TRG) method, and picosecond surface plasmon resonance transient reflecting grating (ps-SPR-TRG) method. Firstly, Pt/auqoues electrolyte interfaces were measured using the fs-TR method. An ultrafast relaxation component of 20 fs was first observed in the Pt/HCl tag) and Pt/H2SO4 tag) interfaces, in which the anions (Cl- and SO42-) have strong affinity to the Pt surface. It was suggested that this is due to the scattering of non-thermalized electrons by adsorbed anions. Secondly, TiO2/KSCN tag) interfaces were measured using the fs-TRG method. UItrafast relaxation components (110-690 fs) were observed in the TRG signals. This marked the first observation of the contribution of nonequilibrium holes to the energy transfer at TiO2/KSCN tag) interfaces. Thirdly, Au/NaCl tag) interfaces were measured using ps-SPR-TRG method, focusing at both the behavior of hot electrons and thermal diffusion. The results indicated that an ultrafast energy transfer process occurs prior to the heat diffusion and this process is hindered by the adsorbed ions.	Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; Kanazawa Inst Technol, Dept Environm Syst Engn, Nonoichi, Ishikawa 9218501, Japan	Sawada, T (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, 7-3-1 Hongo, Tokyo 1138656, Japan.						FANN WS, 1992, PHYS REV LETT, V68, P2834, DOI 10.1103/PhysRevLett.68.2834; BRORSON SD, 1987, PHYS REV LETT, V59, P1962, DOI 10.1103/PhysRevLett.59.1962; Hertel T, 1996, PHYS REV LETT, V76, P535, DOI 10.1103/PhysRevLett.76.535; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Nozik AJ, 1996, J PHYS CHEM-US, V100, P13061, DOI 10.1021/jp953720e; Tributsch H, 1998, SCIENCE, V279, P1891, DOI 10.1126/science.279.5358.1891; Shi ZC, 1996, J ELECTROANAL CHEM, V403, P225, DOI 10.1016/0022-0728(95)04313-6; BICANIC D, 1992, PHOTOACOUSTIC PHOTOT; DELIWALA S, 1995, CHEM PHYS LETT, V242, P614; Fox M. A., 1993, CHEM REV, V93, P34; Gao SW, 1995, SURF SCI, V344, pL1252; Harata A, 1999, ANNU REV PHYS CHEM, V50, P193, DOI 10.1146/annurev.physchem.50.1.193; HARATA A, 1995, ANAL CHIM ACTA, V299, P349, DOI 10.1016/0003-2670(94)00321-C; HARATA A, 1995, TRAC-TREND ANAL CHEM, V14, P504, DOI 10.1016/0165-9936(95)90812-2; Harata A, 1996, CHEM PHYS LETT, V249, P112, DOI 10.1016/0009-2614(95)01371-7; Harata A, 1996, PHYSICA B, V219-20, P629, DOI 10.1016/0921-4526(95)00834-9; HARATA A, 1998, P INT SEM PHOT PHEN, P64; Hibara A, 1997, CHEM PHYS LETT, V272, P1, DOI 10.1016/S0009-2614(97)00496-X; HIBARA A, 1998, P INT SEM PHOT PHEN, P209; Katayama K, 1998, PHYS REV B, V58, P8428, DOI 10.1103/PhysRevB.58.8428; Katayama K, 1996, APPL PHYS LETT, V69, P2468, DOI 10.1063/1.117500; KATAYAMA K, IN PRESS PHYS REV B; KATAYAMA K, 1998, P INT SEM PHOT PHEN, P213; Katayama K, 1999, B CHEM SOC JPN, V72, P2383, DOI 10.1246/bcsj.72.2383; Kolics A, 1996, J CHEM SOC FARADAY T, V92, P3727, DOI 10.1039/ft9969203727; LANTZ JM, 1994, J PHYS CHEM-US, V98, P4899, DOI 10.1021/j100069a022; MOISHITA T, 1998, P INT SEM PHOT PHEN, P219; Morishita T, 1999, J PHYS CHEM B, V103, P5984, DOI 10.1021/jp984729u; NISHIMURA H, 1993, JPN J APPL PHYS 1, V32, P5149, DOI 10.1143/JJAP.32.5149; Pelizzetti E., 1989, PHOTOCATALYSIS; Schmidt ME, 1996, J CHEM PHYS, V104, P2438, DOI 10.1063/1.470938; SHEN Q, 1993, JPN J APPL PHYS 1, V32, P3628, DOI 10.1143/JJAP.32.3628; SHI ZC, 1995, J ELECTROANAL CHEM, V384, P171, DOI 10.1016/0022-0728(94)03747-Q; TURCHI CS, 1989, J CATAL, V119, P483, DOI 10.1016/0021-9517(89)90176-0	34	1	1	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	MAR	2000	73	3					507	514		10.1246/bcsj.73.507		8	Chemistry, Multidisciplinary	Chemistry	302DU	WOS:000086350800001		
J	Seino, H; Mizobe, Y; Hidai, M				Seino, H; Mizobe, Y; Hidai, M			Preparation of sulfide-bridged di- or trinuclear pyrrolylimido and diazoalkane complexes derived from a tungsten dinitrogen complex	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							X-RAY CRYSTAL; MOLYBDENUM; CHEMISTRY; CLUSTERS; LIGAND; MO	Tungsten pyrrolylimido and diazoalkane complexes, cis,mer- [WCl2(NNC4H4)(PMe2Ph)(3)] and cis,mer- [WCl2(NN=CRR')(PMe2Ph)(3)], which are readily derived from the dinitrogen complex cis- [W(N-2)(2)(PMe2Ph)(4)], reacted with [PPh4](2)[WS4] to give the sulfide-bridged di- or trinuclear pyrrolylimido and diazoalkane complexes, [PPh4][WCl(NNC4H4)(PMe2Ph)(2)(mu-S)(2)WS2] (4) and [PPh4][WCl(NN=CRR')(PMe2Ph)(2)(mu-S)(2)WS2] (R = R' = Me (5a); R = Me, R' = Ph; R = H, R' = p-MeC6H4), or [{WCl(NNC4H4)(PMe2Ph)(2)(mu-S)(2)}(2)W] (7) and [{WCl(NN=CMePh)(PMe2Ph)(2)(mu-S)(2)}(2)W]. Treatment of 4 or 5a with tetraalkylthiuram disulfide resulted in the formation of sulfide-dithiocarbamate complexes: [W(NNC4H4)(PMe2Ph)(S2CNR,)(mu-S)(2)WS(S2CNR2)] (R = Et, Pr-i (9b)) and [W(NN=CMe2)(PMe2Ph) (S2CNEt2)(mu-S)(2)WS(S2CNEt2)]. On the other hand, replacement of two PMe2Ph Iigands in 4 and 5 by Ph2PCH2CH2PPh2 (dppe) afforded [PPh4][WCl(NNC4H4)(dppe)(mu-S)(2)WS2] and [PPh4][WCl(NN=CRR')(dppe)(mu-S)(2)WS2] (R = R' = Me; R = Me, R' = Ph (12b)), where 12b has been shown to react further with [RhCl(cod)](2) (cod = 1,5-cyclooctadiene) to give a bimetallic trinuclear complex [WCl(NN=CMePh)(dppe)(mu-S)(2)W(mu-S)(2)Rh(cod)] (13). Detailed structures have been determined by X-ray analyses for 4, 5a, 7, 9b, and 13.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biochem, Bunkyo Ku, Tokyo 1138656, Japan	Mizobe, Y (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan.						KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; SUTTON D, 1993, CHEM REV, V93, P995, DOI 10.1021/cr00019a008; SEINO H, 1994, J AM CHEM SOC, V116, P7433, DOI 10.1021/ja00095a067; AOSHIMA T, 1992, J ORGANOMET CHEM, V435, P85, DOI 10.1016/0022-328X(92)83462-Q; Beurskens P. T., 1992, DIRDIF PROGRAM SYSTE; BEVAN PC, 1978, J ORGANOMET CHEM, V160, P165, DOI 10.1016/S0022-328X(00)91210-5; BISHOP PT, 1988, J ORGANOMET CHEM, V341, P373, DOI 10.1016/0022-328X(88)89092-2; DILWORTH JR, 1982, J AM CHEM SOC, V104, P365, DOI 10.1021/ja00365a099; DILWORTH JR, 1983, J CHEM SOC DALTON, P1489, DOI 10.1039/dt9830001489; DILWORTH JR, 1981, J CHEM SOC CHEM COMM, P132, DOI 10.1039/c39810000132; DU SW, 1992, J CHEM SOC DALTON, P339; Giordano G., 1979, INORG SYNTH, V19, P218, DOI 10.1002/9780470132500.ch50; Hidai M, 1999, COORDIN CHEM REV, V185-6, P99, DOI 10.1016/S0010-8545(98)00250-1; Hidai M, 1996, B CHEM SOC JPN, V69, P819, DOI 10.1246/bcsj.69.819; HIDAI M, 1999, TOP ORGANOMET CHEM, V3, P227; HOWARD KE, 1986, J AM CHEM SOC, V108, P297, DOI 10.1021/ja00262a020; HOWARD KE, 1988, INORG CHEM, V27, P3561, DOI 10.1021/ic00293a025; Johnson B. F. G., 1987, COMPREHENSIVE COORDI, V2, P99; Kahlal S, 1998, J CHEM SOC DALTON, P1229, DOI 10.1039/a706923e; KISCH H, 1992, ADV ORGANOMET CHEM, V34, P67, DOI 10.1016/S0065-3055(08)60015-5; *MOL STRUCT CORP, 1985, TEXS CRYST STRUCT AN; *MOL STRUCT CORP, 1992, TEXS CRYST STRUCT AN; Muller A, 1981, ANGEW CHEM, V93, P957, DOI 10.1002/ange.19810931106; Ogo S, 1996, INORG CHEM, V35, P6093, DOI 10.1021/ic9601807; PAN WH, 1985, J CHEM SOC CHEM COMM, P927, DOI 10.1039/c39850000927; Sasagawa T, 1999, B CHEM SOC JPN, V72, P425, DOI 10.1246/bcsj.72.425; SIEDLE AR, 1986, INORG CHEM, V25, P4054, DOI 10.1021/ic00242a046; TANABE Y, UNPUB	30	6	6	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	MAR	2000	73	3					631	639		10.1246/bcsj.73.631		9	Chemistry, Multidisciplinary	Chemistry	302DU	WOS:000086350800014		
J	Mukawa, T; Muraoka, J; Shiraishi, S				Mukawa, T; Muraoka, J; Shiraishi, S			The reaction of nitrile oxide-quinone cycloadducts. IV. Acid-catalyzed dealkylative aromatization of the 1 : 1-C=C-adducts and based-induced rearrangement products of aromatic nitrile oxides with 2,5- and 2,6-dialkyl-p-benzoquinones	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							SUBSTITUTED PARA-BENZOQUINONES; DIENONE-PHENOL REARRANGEMENT	The 1,3-dipolar cycloadducts of aromatic nitrile oxides with 2,5- and 2,6-dialkyl-p-benzoquinones were treated with acetic anhydride/sulfuric acid to give isoxazole-fused hydroquinone diacetates in good yields. The base-induced rearrangement products from some of the 1,3-dipolar cycloadducts were treated with acetic anhydride/sulfuric acid to afford isoxazole-fused catechol diacetates and/or isoxazole-fused hydroquinone diacetates, depending on the slight difference in the substituents of the base-induced rearrangement products. The differences in the products are interpreted in terms of steric hindrance around the carbonyl and hydroxy moieties of the base-induced rearrangement products.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Shiraishi, S (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, Roppongi 7-22-1, Tokyo 1068558, Japan.						[Anonymous], 1992, TEXSAN CRYST STRUCT; BURLA MC, 1989, J APPL CRYSTALLOGR, V22, P389, DOI 10.1107/S0021889889004103; FRIMER AA, 1994, J ORG CHEM, V59, P1831, DOI 10.1021/jo00086a038; INOUE Y, 1992, B CHEM SOC JPN, V65, P2484, DOI 10.1246/bcsj.65.2484; MILLER B, 1975, ACCOUNTS CHEM RES, V8, P245, DOI 10.1021/ar50091a005; MILLER B, 1965, J AM CHEM SOC, V87, P5106, DOI 10.1021/ja00950a022; MILLER B, 1968, MECH MOL, V1, P247; MOORE GGI, 1979, J ORG CHEM, V44, P925, DOI 10.1021/jo01320a007; Mukawa T, 1999, B CHEM SOC JPN, V72, P2549, DOI 10.1246/bcsj.72.2549; SHIRAISHI S, 1983, B CHEM SOC JPN, V56, P3457, DOI 10.1246/bcsj.56.3457; SHIRAISHI S, 1992, B CHEM SOC JPN, V65, P2480, DOI 10.1246/bcsj.65.2480; teXsan, 1985, TEXSAN CRYST STRUCT; Whiting D. A, 1991, COMPREHENSIVE ORGANI, V3, P803; WOODGATE PD, 1974, AUST J CHEM, V27, P2243; ZYDOWSKY TM, 1980, J CHEM SOC PERK T 1, P1679, DOI 10.1039/p19800001679	15	2	2	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	MAR	2000	73	3					739	743		10.1246/bcsj.73.739		5	Chemistry, Multidisciplinary	Chemistry	302DU	WOS:000086350800027		
J	Lu, P; Toshima, N				Lu, P; Toshima, N			Catalysis of polymer-protected Ni/Pd bimetallic nano-clusters for hydrogenation of nitrobenzene derivatives	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							COLLOIDAL DISPERSIONS; PALLADIUM CATALYSTS; SUPPORTED PALLADIUM; STRUCTURAL-ANALYSIS; PLATINUM CATALYST; COPPER-CATALYSTS; ALLOYS; METAL; COMPLEXES; RUTHENIUM	Poly(N-vinyl-2-pyrrolidone)-protected Ni/Pd bimetallic colloidal nanoparticles, prepared by the polyol reduction method, have been proved to have a nanometer-sized alloy structure with both metals at zerovalent state by our previous study of TEM, XRD, EXAFS, and XPS analyses. Here, dispersions of these bimetallic nanoclusters with different composition ratios are extensively examined as catalysts for the hydrogenation of various nitrobenzene derivatives: i.e., p-nitrotoluene, p-nitroanisole, 1-nitronaphthalene, p-nitrobenzonitrile, and methyl p-nitrobenzoate, at 30 degrees C under an atmospheric pressure of hydrogen. These bimetallic nanoclusters exhibit excellent catalytic properties for the reduction of a nitro group to an amino group with high selectivity. The catalytic activity strongly depends on the metal composition of the particles. The maximum catalytic activity can be observed at a certain intermediate composition ratio, being 3-4 times greater than that of a monometallic colloidal Pd catalyst. A bimetallic nanocluster with the mole ratio of Ni : Pd = 1/4 was the most active catalyst for the hydrogenation of para-substituted nitrobenzenes. An approximately linear relationship exists between the hydrogenation rate of the substrate with an electron-donating or electron-withdrawing group and the corresponding Hammett constant of the substituent, as well as between the hydrogenation rate and the LUMO energy level of the substrate.	Tokyo Univ Sci, Dept Mat Sci & Engn, Yamaguchi 7560884, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Toshima, N (reprint author), Tokyo Univ Sci, Dept Mat Sci & Engn, Onoda Shi, Yamaguchi 7560884, Japan.						An Y, 1996, POLYM ADVAN TECHNOL, V7, P652, DOI 10.1002/(SICI)1099-1581(199608)7:8<652::AID-PAT564>3.0.CO;2-G; SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002; TOSHIMA N, 1994, LANGMUIR, V10, P4574, DOI 10.1021/la00024a031; PEUREUX J, 1995, CATAL TODAY, V25, P409, DOI 10.1016/0920-5861(95)00128-3; YONEZAWA T, 1995, J CHEM SOC FARADAY T, V91, P4111, DOI 10.1039/ft9959104111; PERENBOOM JAAJ, 1981, PHYS REP, V78, P173, DOI 10.1016/0370-1573(81)90194-0; Lu P, 1999, J PHYS CHEM B, V103, P9673, DOI 10.1021/jp992177p; Fang XM, 1997, APPL CATAL A-GEN, V161, P129, DOI 10.1016/S0926-860X(97)00038-0; Yu ZK, 1997, J MOL CATAL A-CHEM, V120, P247, DOI 10.1016/S1381-1169(96)00420-7; Torres GC, 1997, APPL CATAL A-GEN, V161, P213, DOI 10.1016/S0926-860X(97)00071-9; PETROV L, 1990, APPL CATAL, V59, P31, DOI 10.1016/S0166-9834(00)82185-5; REETZ MT, 1995, ANGEW CHEM INT EDIT, V34, P2240, DOI 10.1002/anie.199522401; HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533; CLARKE JKA, 1975, CHEM REV, V75, P291, DOI 10.1021/cr60295a002; YONEZAWA T, 1993, J MOL CATAL, V83, P167, DOI 10.1016/0304-5102(93)87017-3; TOSHIMA N, 1992, J PHYS CHEM-US, V96, P9927, DOI 10.1021/j100203a064; Baumgarten E, 1997, REACT FUNCT POLYM, V33, P71, DOI 10.1016/S1381-5148(97)00019-9; BODNAR Z, 1994, CATAL LETT, V26, P61, DOI 10.1007/BF00824032; BROWN JA, 1990, J CATAL, V124, P73, DOI 10.1016/0021-9517(90)90104-R; Burton J. J. G., 1977, ADV MAT CATALYSIS; *CHEM SOC JAP, 1984, KAG BINR; CHIO KI, 1991, J CATAL, V131, P36; COLLINS DJ, 1990, J MOL CATAL, V62, P57, DOI 10.1016/0304-5102(90)85239-E; DOWDEN DA, 1950, J CHEM SOC, P242, DOI 10.1039/jr9500000242; DOWDEN DA, 1950, DISCUSS FARADAY SOC, P184, DOI 10.1039/df9500800184; FEELEY JS, 1992, J CATAL, V136, P182, DOI 10.1016/0021-9517(92)90117-Z; FRISCH MJ, 1998, GAUSSIAN 98 REVISION, P75501; Gao J, 1998, REACT KINET CATAL L, V64, P351; Hammett L. P., 1970, PHYSICAL ORGANIC CHE; HAMMETT LP, 1935, CHEM REV, V17, P225; HARADA M, 1994, J PHYS CHEM-US, V98, P2653, DOI 10.1021/j100061a024; Hirai H., 1986, TAILORED METAL CATAL, P87; Hirai H., 1996, POLYM MAT ENCY, V2, P1310; Hlil EK, 1996, J PHYS CHEM-US, V100, P3102, DOI 10.1021/jp951440t; JIN JJ, 1994, REACT POLYM, V23, P95, DOI 10.1016/0923-1137(94)90006-X; KURSCHNER U, 1995, CATAL LETT, V34, P191; LI CP, 1994, APPL CATAL A-GEN, V119, P185, DOI 10.1016/0926-860X(94)85190-5; PARR RG, 1989, DENSITY FUNCTIONAL T, P75501; Patel DR, 1996, J MOL CATAL A-CHEM, V109, P141, DOI 10.1016/1381-1169(96)00007-6; Patel DR, 1998, J MOL CATAL A-CHEM, V130, P57, DOI 10.1016/S1381-1169(97)00197-0; PIZEY JS, 1974, SYNTHETIC REAGENTS, V2, P175; PONEC V, 1975, CATAL REV, V11, P41, DOI 10.1080/01614947508079981; PONEC V, 1983, ADV CATAL, V32, P149, DOI 10.1016/S0360-0564(08)60440-X; REETZ MT, 1994, J AM CHEM SOC, V116, P7410; Sachtler W. M. H., 1977, ADV CATAL, V26, P69, DOI 10.1016/S0360-0564(08)60070-X; SCHWAB GM, 1950, DISCUSS FARADAY SOC, P166, DOI 10.1039/df9500800166; Selvaraj PC, 1997, J POLYM SCI POL CHEM, V35, P105, DOI 10.1002/(SICI)1099-0518(19970115)35:1<105::AID-POLA12>3.0.CO;2-O; SHEFFER GR, 1989, J CATAL, V116, P488, DOI 10.1016/0021-9517(89)90115-2; Sinfelt J. H., 1983, BIMETALLIC CATALYSTS; SINFELT JH, 1976, J CATAL, V42, P227, DOI 10.1016/0021-9517(76)90257-8; SINFELT JH, 1977, ACCOUNTS CHEM RES, V10, P15, DOI 10.1021/ar50109a003; TIJANI A, 1991, APPL CATAL, V76, P255, DOI 10.1016/0166-9834(91)80051-W; Toshima N, 1996, CHEM LETT, P729, DOI 10.1246/cl.1996.729; TOSHIMA N, 1990, J MACROMOL SCI CHEM, VA27, P1225; Toshima N, 1996, NATO ASI 3 HIGH TECH, V12, P371; TOSHIMA N, 1989, CHEM LETT, P1769, DOI 10.1246/cl.1989.1769; Toshima N, 1996, MACROMOL SYMP, V105, P111, DOI 10.1002/masy.19961050115; WOJCIECHOWSKA M, 1995, J CHEM SOC FARADAY T, V91, P2207, DOI 10.1039/ft9959102207; Yada S, 1996, B CHEM SOC JPN, V69, P2383, DOI 10.1246/bcsj.69.2383	59	35	36	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	MAR	2000	73	3					751	758		10.1246/bcsj.73.751		8	Chemistry, Multidisciplinary	Chemistry	302DU	WOS:000086350800031		
J	Tsukamoto, K; Orimo, H; Hosoi, T; Miyao, M; Ota, N; Nakajima, T; Yoshida, H; Watanabe, S; Suzuki, T; Emi, M				Tsukamoto, K; Orimo, H; Hosoi, T; Miyao, M; Ota, N; Nakajima, T; Yoshida, H; Watanabe, S; Suzuki, T; Emi, M			Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus	CALCIFIED TISSUE INTERNATIONAL			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; CA2+-SENSING RECEPTOR; GENETIC-DETERMINANTS; OSTEOPOROSIS; CLONING; MASS; TWIN	A strong correlation between bone mass and genetic factors has been shown in twins and family studies. Some of the genes involved would regulate bone metabolism, bone formation, and resorption, all processes that determine bone mass. One candidate genes, calcium-sensing receptor (CASR) in the parathyroid gland, regulates calcium homeostasis by sensing decreases in extracellular calcium level and effecting an increase in secretion of parathyroid hormone (PTH) and calcium (Ca) reabsorption in the kidney. We have investigated a possible association between the CA-repeat polymorphism at the human CASR gene locus and the bone mineral density (BMD) of radial bone in 472 postmenopausal Japanese women, Genotypes were classified into nine groups according to the number of CA repeats present, from 20 to 12. BMD was expressed as the adjusted BMD, which was the body mass index (BMI), and age-adjusted average BMD. The 247 women who had an A3 allele (228 bp, containing 18 repeats of CA) had significantly lower adjusted BMD (mean +/- SD: 0.303 +/- 0.059 versus 0.316 +/- 0.063 g/cm(2); P = 0.0308) than the participants (n = 201) who did not carry an allele of that size. This result suggests that genetic variation at the CASR gene locus is associated with some determinants for BMD in postmenopausal women.	Nippon Med Sch, Inst Gerontol, Dept Biol Mol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan; Univ Tokyo, Fac Med, Dept Geriatr, Tokyo 113, Japan; Tokyo Metropolitan Inst Gerontol & Hosp, Itabashi Ku, Tokyo 1730015, Japan	Emi, M (reprint author), Nippon Med Sch, Inst Gerontol, Dept Biol Mol, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.						GARRETT JE, 1995, J BIOL CHEM, V270, P12919; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Kobayashi S, 1996, J BONE MINER RES, V11, P306; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; SLEMENDA CW, 1991, J BONE MINER RES, V6, P561; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; JANICIC N, 1995, AM J HUM GENET, V56, P880; Kleiman DG, 1988, ECOLOGY BEHAVIOR NEO, V2, P299; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Murray RE, 1997, BONE, V21, P89, DOI 10.1016/S8756-3282(97)00081-1; SANO M, 1995, BIOCHEM BIOPH RES CO, V217, P378, DOI 10.1006/bbrc.1995.2787; Tsukamoto K, 1998, J HUM GENET, V43, P280, DOI 10.1007/s100380050091; Watanabe I, 1998, J HUM GENET, V43, P75, DOI 10.1007/s100380050044	15	37	40	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0171-967X			CALCIFIED TISSUE INT	Calcif. Tissue Int.	MAR	2000	66	3					181	183		10.1007/PL00005835		3	Endocrinology & Metabolism	Endocrinology & Metabolism	282MA	WOS:000085220800004		
J	Miyao, M; Morita, H; Hosoi, T; Kurihara, H; Inoue, S; Hoshino, S; Shiraki, M; Yazaki, Y; Ouchi, Y				Miyao, M; Morita, H; Hosoi, T; Kurihara, H; Inoue, S; Hoshino, S; Shiraki, M; Yazaki, Y; Ouchi, Y			Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women	CALCIFIED TISSUE INTERNATIONAL			English	Article						osteoporosis; bone mineral density; genetic risk factor; methylenetetrahydrofolate reductase; homocysteine	CORONARY-ARTERY DISEASE; RISK FACTOR; GENETIC-POLYMORPHISM; RECEPTOR GENE; OSTEOPOROSIS; HOMOCYSTEINE; MASS; HOMOCYSTINURIA; DETERMINANTS; DAUGHTERS	The pathogenesis of osteoporosis is controlled by genetic and environmental factors. Considering the high prevalence of osteoporosis in homocystinuria, abnormal homocysteine metabolism would contribute to the pathogenesis of osteoporosis. It is known that the polymorphism of methylenetetrahydrofolate reductase (MTHFR), the enzyme catalyzing the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, correlates with hyperhomocysteinemia. In this study, we examined the association of this polymorphism with bone mineral density (BMD). BMD was measured by dual-energy X-ray absorptiometry (DXA) in 307 postmenopausal women. MTHFR AN polymorphism was analyzed using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). We compared BMD, clinical characteristics, and bone metabolic markers among MTHFR groups (AA, AV, VV). The groups did not differ in terms of baseline data. The values of lumbar spine BMD and total body BMD were as follows: lumbar spine: AA, 0.91 +/- 0.18, AV, 0.88 +/- 0.16, VV, 0.84 +/- 0.14 g/cm(2); total body: AA, 0.97 +/- 0.11, AV, 0.96 +/- 0.11, VV, 0.93 +/- 0.09 g/cm(2). In the VV genotype, lumbar spine BMD values were significantly lower than those of the women with the AA genotype (P = 0.016) and total body BMD was significantly lower than those of the women with AA genotype (P = 0.03) and AV genotype (P = 0.04). This is the first report that suggests that the VV genotype of MTHFR is one of the genetic risk factors for low BMD.	Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; Tokyo Metropolitan Geriatr Hosp, Endocrinol Sect, Tokyo 173, Japan; Res Inst & Practice Involut Dis, Nagano, Japan	Miyao, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Kobayashi S, 1996, J BONE MINER RES, V11, P306; Welch GN, 1998, NEW ENGL J MED, V338, P1042; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; Morita H, 1998, ARTERIOSCL THROM VAS, V18, P1465; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; KANG SS, 1991, AM J HUM GENET, V48, P536; TYLAVSKY FA, 1989, CALCIFIED TISSUE INT, V45, P265, DOI 10.1007/BF02556017; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Orimo H, 1998, J BONE MINER METAB, V16, P139, DOI 10.1007/s007740050038; Greenfield EM, 1997, LANCET, V350, P1263, DOI 10.1016/S0140-6736(05)62468-3; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Cooper GS, 1996, J BONE MINER RES, V11, P1841; SEEMAN E, 1989, NEW ENGL J MED, V320, P554, DOI 10.1056/NEJM198903023200903; PECK WA, 1993, AM J MED, V94, P646; CUMMINGS SR, 1993, LANCET, V341, P962; Guttormsen AB, 1996, J CLIN INVEST, V98, P2174, DOI 10.1172/JCI119024; HOPER JL, 1998, AM J EPIDEMIOL, V147, P17; KANG AH, 1973, J CLIN INVEST, V52, P2571, DOI 10.1172/JCI107449; KELLY PJ, 1993, J BONE MINER RES, V8, P11; Langdahl BL, 1997, BONE, V20, P289, DOI 10.1016/S8756-3282(96)00363-8; Lubec B, 1996, BBA-MOL BASIS DIS, V1315, P159, DOI 10.1016/0925-4439(95)00119-0; MELHUS H, 1994, LANCET, V344, P949, DOI 10.1016/S0140-6736(94)92297-7; Morita H, 1997, CIRCULATION, V95, P2032; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Nelson DA, 1997, J CLIN ENDOCR METAB, V82, P989, DOI 10.1210/jc.82.4.989; Sainz J, 1997, NEW ENGL J MED, V337, P77, DOI 10.1056/NEJM199707103370202; SANO M, 1995, BIOCHEM BIOPH RES CO, V217, P378, DOI 10.1006/bbrc.1995.2787; Schmitz C, 1996, CIRCULATION, V94, P1812; Shiraki M, 1997, J BONE MINER RES, V12, P1438, DOI 10.1359/jbmr.1997.12.9.1438; SILLENCE D, 1981, CLIN ORTHOP RELAT R, P11; VANDERMOOREN MJ, 1994, EUR J CLIN INVEST, V24, P733; WHITING SJ, 1981, J NUTR, V111, P1721; WOUTERS MGAJ, 1995, EUR J CLIN INVEST, V25, P801, DOI 10.1111/j.1365-2362.1995.tb01687.x	35	97	99	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0171-967X			CALCIFIED TISSUE INT	Calcif. Tissue Int.	MAR	2000	66	3					190	194		10.1007/s002230010038		5	Endocrinology & Metabolism	Endocrinology & Metabolism	282MA	WOS:000085220800006		
J	Funaki, M; Katagiri, H; Inukai, K; Kikuchi, M; Asano, T				Funaki, M; Katagiri, H; Inukai, K; Kikuchi, M; Asano, T			Structure and function of phosphatidylinositol-3,4 kinase	CELLULAR SIGNALLING			English	Review						p85/p110 type PI-kinase; PI 3-kinase; PI 4-kinase; D-3-phosphorylated phosphoinositide; D-4-phosphorylated phosphoinositide	RECEPTOR TYROSINE KINASES; PLECKSTRIN HOMOLOGY DOMAINS; GROWTH-FACTOR RECEPTORS; PHOSPHOLIPASE C-GAMMA; PHOSPHOINOSITIDE 3-KINASE; SH3 DOMAIN; REGULATORY SUBUNIT; 3T3-L1 ADIPOCYTES; INSULIN-RECEPTOR; CATALYTIC SUBUNIT	Activation of phosphatidylinositol (PI)-kinase is involved in the regulation of a wide array of cellular activities. The enzyme exists as a dimer, consisting of a catalytic and a regulatory subunit. Five isoforms of the regulatory subunit have been identified and classified into three groups comprising respectively 85-kDa, 55-kDa, and 50-kDa proteins. Structural differences in the N-terminal regions of the different group members contribute to defining their binding specificity, their subcellular distributions, and their capacity to activate the 110-kDa catalytic subunit. Two widely distributed isoforms of the catalytic subunit have been identified-p110 alpha and p110 beta. Despite the fact that they bind to the p85 alpha regulatory subunit similarly, p110 alpha and p110 beta appear to have separate functions within cells and to be activated by different stimuli. Moreover, although p85/p110 PI-kinase almost exclusively phosphorylates the D-3 position of the inositol ring in phosphoinositides when purified PI is used as a substrate in vitro, it appears to phosphorylate the D-4 position with similar or higher efficiency in vivo. Thus, it is highly probable that p85/p110 PI-kinase transmits signals to downstream targets via both D-3- and D-4-phosphorylated phosphoinositides. (C) 2000 Elsevier Science Inc. All rights reserved.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1130022, Japan; Asahi Life Fdn, Inst Adult Dis, Tokyo 1600023, Japan	Asano, T (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130022, Japan.						Akimoto K, 1996, EMBO J, V15, P788; Albert S, 1997, GENE, V198, P181, DOI 10.1016/S0378-1119(97)00313-2; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/S0092-8674(05)80081-9; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Stenmark H, 1996, J BIOL CHEM, V271, P24048; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; PONS S, 1995, MOL CELL BIOL, V15, P4453; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Liu Q, 1997, J IMMUNOL, V159, P829; HU P, 1993, MOL CELL BIOL, V13, P7677; KAPELLER R, 1995, J BIOL CHEM, V270, P25985; Salim K, 1996, EMBO J, V15, P6241; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; WANG J, 1995, J BIOL CHEM, V270, P12774; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Minshall C, 1996, J IMMUNOL, V156, P939; Leevers SJ, 1996, EMBO J, V15, P6584; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525; Shepherd PR, 1998, BIOCHEM J, V333, P471; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Harpur AG, 1999, J BIOL CHEM, V274, P12323, DOI 10.1074/jbc.274.18.12323; BACKER JM, 1992, EMBO J, V11, P3469; LIU XQ, 1994, RECENT PROG HORM RES, V49, P149; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Spear N, 1997, J NEUROCHEM, V69, P53; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Simonsen A, 1998, NATURE, V394, P494; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; LEV S, 1992, P NATL ACAD SCI USA, V89, P678, DOI 10.1073/pnas.89.2.678; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; Ishihara H, 1996, J BIOL CHEM, V271, P23611; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; ASANO T, UNPUB BIOCH J; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; DIEKMANN D, 1991, NATURE, V351, P4600; DOWNES CP, 1991, CELL SIGNAL, V3, P501, DOI 10.1016/0898-6568(91)90027-R; EVANS JL, 1995, CELL SIGNAL, V7, P365, DOI 10.1016/0898-6568(95)00007-C; Frevert EU, 1998, J BIOL CHEM, V273, P25480, DOI 10.1074/jbc.273.39.25480; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; FRY MJ, 1993, PHILOS T ROY SOC B, V340, P337, DOI 10.1098/rstb.1993.0076; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; Funaki M, 1999, J BIOL CHEM, V274, P22019, DOI 10.1074/jbc.274.31.22019; Gaidarov I, 1996, J BIOL CHEM, V271, P20922; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; GOUT I, 1992, BIOCHEM J, V288, P395; Hao WH, 1997, J BIOL CHEM, V272, P6393; HAYASHI H, 1993, J BIOL CHEM, V268, P7107; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; HU P, 1992, MOL CELL BIOL, V12, P981; INUKAI K, IN PRESS BIOCH J; Inukai K, 1996, J BIOL CHEM, V271, P5317; Inukai K, 1997, J BIOL CHEM, V272, P7873; Itoh T, 1996, J BIOL CHEM, V271, P27931; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052; KATAGIRI H, UNPUB BIOCH J; Katagiri H, 1996, J BIOL CHEM, V271, P16987; Kazlauskas Andrius, 1994, Current Opinion in Genetics and Development, V4, P5, DOI 10.1016/0959-437X(94)90085-X; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KLIPPEL A, 1992, MOL CELL BIOL, V12, P1451; KOHDA D, 1993, CELL, V72, P953, DOI 10.1016/0092-8674(93)90583-C; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; KOTANI K, 1994, EMBO J, V13, P2313; Kristiansen S, 1998, BIOCHEM J, V335, P351; Krugmann S, 1997, BIOCHEM SOC T, V25, pS604; Lambrechts A, 1997, EMBO J, V16, P484, DOI 10.1093/emboj/16.3.484; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lavan BE, 1997, J BIOL CHEM, V272, P11439; LIU XQ, 1993, MOL CELL BIOL, V13, P5225; LOWENTEIN EJ, 1992, CELL, V70, P83; Mak P, 1996, FEBS LETT, V397, P183, DOI 10.1016/S0014-5793(96)01179-9; MANO H, 1993, ONCOGENE, V8, P417; MATSUOKA K, 1992, P NATL ACAD SCI USA, V89, P9015; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991; MERILAINEN J, 1993, J CELL SCI, V105, P647; MIYAZATO A, UNPUB BIOCH J; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nakagawa T, 1996, J BIOL CHEM, V271, P12088; NOBLE MEM, 1993, EMBO J, V12, P2617; OSTRANDER DB, 1995, J BIOL CHEM, V270, P27045; PANAYOTOU G, 1992, EMBO J, V11, P4261; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; REEDIJK M, 1992, EMBO J, V11, P1365; Roche S, 1998, MOL CELL BIOL, V18, P7119; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shepherd PR, 1997, J BIOL CHEM, V272, P19000, DOI 10.1074/jbc.272.30.19000; Shimoke K, 1997, DEV BRAIN RES, V101, P197, DOI 10.1016/S0165-3806(97)00065-5; SHOELSON SE, 1993, EMBO J, V12, P795; SINGH SS, 1993, BIOCHEM BIOPH RES CO, V195, P104, DOI 10.1006/bbrc.1993.2016; Songyang Z, 1993, Cell, V72, P767; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Virbasius JV, 1996, J BIOL CHEM, V271, P13304; Wang QH, 1998, BIOCHEM J, V331, P917; WEISMAN LS, 1992, J BIOL CHEM, V267, P618; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; Wiedemann C, 1996, EMBO J, V15, P2094; WONG K, 1994, J BIOL CHEM, V269, P28878; Yang J, 1996, BIOCHEM J, V313, P125; Yao R, 1996, ONCOGENE, V13, P343; YOAKIM M, 1992, J VIROL, V66, P5485; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858	128	22	24	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0898-6568			CELL SIGNAL	Cell. Signal.	MAR	2000	12	3					135	142		10.1016/S0898-6568(99)00086-8		8	Cell Biology	Cell Biology	292VQ	WOS:000085816200002		
J	Fujii, Y; Wadati, M				Fujii, Y; Wadati, M			Correlation functions of finite XXZ model with boundaries	CHAOS SOLITONS & FRACTALS			English	Article							KNIZHNIK-ZAMOLODCHIKOV EQUATIONS; QUANTUM AFFINE ALGEBRAS; DIFFERENCE-EQUATIONS; ROOT SYSTEMS; S-MATRICES; VERTEX; REPRESENTATIONS	The finite XXZ model with boundaries is considered. We use the matrix product ansatz (MPA), which was originally developed in the studies on the asymmetric simple exclusion process and the quantum antiferromagnetic spin chain. The MPA demonstrates that the eigenstate of the Hamiltonian is constructed by the Zamolodchikov-Faddeev algebra (ZF-algebra) and the boundary states. We adopt the type I vertex operator of U-q((s) over cap l(2)) as the ZF-algebra and realize the boundary states in the bosonic U-q((s) over cap l(2)) form. The correlation functions are given by the product of the vertex operators and the bosonic boundary states. We express them in the integration forms. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	Fujii, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.						DAVIES B, 1993, COMMUN MATH PHYS, V151, P89, DOI 10.1007/BF02096750; GHOSHAL S, 1994, INT J MOD PHYS A, V9, P3841, DOI 10.1142/S0217751X94001552; FRENKEL IB, 1988, P NATL ACAD SCI USA, V85, P9373, DOI 10.1073/pnas.85.24.9373; SANDOW S, 1994, PHYS REV E, V50, P2660, DOI 10.1103/PhysRevE.50.2660; KULISH PP, 1991, J PHYS A-MATH GEN, V24, pL435, DOI 10.1088/0305-4470/24/8/009; ZAMOLODCHIKOV AB, 1979, ANN PHYS-NEW YORK, V120, P253, DOI 10.1016/0003-4916(79)90391-9; KLUMPER A, 1993, EUROPHYS LETT, V24, P293, DOI 10.1209/0295-5075/24/4/010; FRENKEL IB, 1992, COMMUN MATH PHYS, V146, P1, DOI 10.1007/BF02099206; FENDLEY P, 1994, NUCL PHYS B, V428, P681, DOI 10.1016/0550-3213(94)90369-7; DERRIDA B, 1993, J PHYS A-MATH GEN, V26, P1493, DOI 10.1088/0305-4470/26/7/011; Sasamoto T, 1997, J PHYS SOC JPN, V66, P2618, DOI 10.1143/JPSJ.66.2618; CHEREDNIK I, 1992, COMMUN MATH PHYS, V150, P109, DOI 10.1007/BF02096568; CHEREDNIK IV, 1984, THEOR MATH PHYS+, V61, P977, DOI 10.1007/BF01038545; DEVEGA HJ, 1993, J PHYS A, V6, pL519; Essler FHL, 1996, J PHYS A-MATH GEN, V29, P3375, DOI 10.1088/0305-4470/29/13/013; Faddeev L D, 1980, SOV SCI REV C, V1, P107; FODA O, 1995, PROG THEOR PHYS S, V118, P1, DOI 10.1143/PTPS.118.1; FODA O, 1994, LETT MATH PHYS, V32, P259, DOI 10.1007/BF00750668; HOU BY, 1995, COMMUN THEOR PHYS, V23, P163; INAMI T, 1994, J PHYS A-MATH GEN, V27, pL913, DOI 10.1088/0305-4470/27/24/002; JIMBO M, 1995, NUCL PHYS B, V448, P429, DOI 10.1016/0550-3213(95)00218-H; Jimbo M., HEPTH9610079; Jimbo M, 1994, CBMS REGIONAL C SERI; JIMBO M, 1995, NUCL PHYS B, V441, P437, DOI 10.1016/0550-3213(95)00062-W; Jimbo M, 1996, J PHYS A-MATH GEN, V29, P2923, DOI 10.1088/0305-4470/29/12/005; JIMBO M, 1992, PHYS LETT A, V168, P256, DOI 10.1016/0375-9601(92)91128-E; KLUMPER A, 1991, J PHYS A-MATH GEN, V24, pL955, DOI 10.1088/0305-4470/24/16/012; KLUMPER A, 1992, Z PHYS B CON MAT, V87, P281, DOI 10.1007/BF01309281; MATSUO A, 1993, COMMUN MATH PHYS, V151, P263, DOI 10.1007/BF02096769; SKLYANIN EK, 1988, J PHYS A-MATH GEN, V21, P2375, DOI 10.1088/0305-4470/21/10/015; SMIRNOV FA, 1992, ADV SERIE MATH PHYSI, V14; YUNG CM, 1995, NUCL PHYS B, V435, P430, DOI 10.1016/0550-3213(94)00448-N	32	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779			CHAOS SOLITON FRACT	Chaos Solitons Fractals	MAR	2000	11	4					565	579		10.1016/S0960-0779(98)00137-4		15	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	280FM	WOS:000085091600008		
J	Ohtake, T; Ogasawara, M; Ito-Akita, K; Nishina, N; Ujiie, S; Ohno, H; Kato, T				Ohtake, T; Ogasawara, M; Ito-Akita, K; Nishina, N; Ujiie, S; Ohno, H; Kato, T			Liquid-crystalline complexes of mesogenic dimers containing oxyethylene moieties with LiCF3SO3: Self-organized ion conductive materials	CHEMISTRY OF MATERIALS			English	Article							POLYMER ELECTROLYTES; MAGNESIUM SALTS; COLUMNAR PHASE; LITHIUM; BEHAVIOR; PHOTOCONDUCTION; SULFONATE; MOLECULES; NETWORKS; SPACERS	Mesomorphic dimeric compounds consisting of rigid mesogenic cores and flexible oxyethylene chains have been prepared as liquid-crystalline materials capable of complexing with ionic species. The incorporation of LiCF3SO3 into these materials results in the induction of smectic A phases and significant mesophase stabilization. The ion-dipole interactions between lithium ions and oxyethylene moieties have stabilized the mesomorphic layer structures. Ionic conductivities have been measured for the complexes forming homeotropically aligned molecular orientation of smectic phases. The highest value of conduction, which is observed for the direction parallel to the layer in the smectic A phase, is 5.5 x 10(-4) S cm(-1). These results suggest that the complexes of LiCF3SO3 with mesogenic rod-coil-rod molecules containing oxyethylene chains can function as self-organized ion conductive materials.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan; Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan	Kato, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.		Ohno, Hiroyuki/F-6459-2012	Ohno, Hiroyuki/0000-0001-9716-3495			PALEOS CM, 1995, ANGEW CHEM INT EDIT, V34, P1696, DOI 10.1002/anie.199516961; Ito K, 1997, J MATER CHEM, V7, P1357, DOI 10.1039/a700583k; Kato T, 2000, STRUCT BOND, V96, P95; OUCHI M, 1990, B CHEM SOC JPN, V63, P1260, DOI 10.1246/bcsj.63.1260; BENGS H, 1991, MAKROMOL CHEM-RAPID, V12, P439; ADAM D, 1994, NATURE, V371, P141, DOI 10.1038/371141a0; PRAEFCKE K, 1991, LIQ CRYST, V10, P147, DOI 10.1080/02678299108036421; Hawker CJ, 1996, MACROMOLECULES, V29, P3831, DOI 10.1021/ma951909i; Shimizu Y, 1998, THIN SOLID FILMS, V331, P279, DOI 10.1016/S0040-6090(98)00931-6; ALLOIN F, 1994, J ELECTROCHEM SOC, V141, P1915, DOI 10.1149/1.2055026; BODEN N, 1993, J CHEM PHYS, V98, P5920, DOI 10.1063/1.464886; Meyer WH, 1998, ADV MATER, V10, P439, DOI 10.1002/(SICI)1521-4095(199804)10:6<439::AID-ADMA439>3.0.CO;2-I; GRIFFIN AC, 1981, J AM CHEM SOC, V103, P4957, DOI 10.1021/ja00406a056; Lee M, 1998, CHEM MATER, V10, P1894, DOI 10.1021/cm980070t; Tamaoki N, 1997, ADV MATER, V9, P1102, DOI 10.1002/adma.19970091408; Bazuin CG, 1995, MACROMOLECULES, V28, P8877, DOI 10.1021/ma00130a027; Bruce P. G., 1997, SOLID STATE ELECTROC; BRUCE PG, 1993, J CHEM SOC FARADAY T, V89, P3187, DOI 10.1039/ft9938903187; COATES D, 1976, MOL CRYST LIQ CRYST, V37, P249, DOI 10.1080/15421407608084360; Demus D., 1998, HDB LIQUID CRYSTALS; Dias FB, 1998, ELECTROCHIM ACTA, V43, P1217, DOI 10.1016/S0013-4686(97)10022-6; Dias FB, 1996, J CHEM SOC FARADAY T, V92, P2599, DOI 10.1039/ft9969202599; Funahashi M, 1997, PHYS REV LETT, V78, P2184, DOI 10.1103/PhysRevLett.78.2184; Goodby JW, 1998, CHEM COMMUN, P2057, DOI 10.1039/a802762e; GOODBY JW, 1985, MOL CRYST LIQ CRYST, V122, P219, DOI 10.1080/00268948508074755; HESSEL V, 1993, MAKROMOL CHEM-RAPID, V14, P707; Hubbard HVSA, 1998, ELECTROCHIM ACTA, V43, P1239, DOI 10.1016/S0013-4686(97)10024-X; Imrie C. T., 1999, STRUCT BOND, P149; Imrie CT, 1999, ADV MATER, V11, P832, DOI 10.1002/(SICI)1521-4095(199907)11:10<832::AID-ADMA832>3.0.CO;2-Z; JIN JI, 1986, J CHEM SOC PERK T 2, P343, DOI 10.1039/p29860000343; KATO T, 1998, HDB LIQUID CRYSTAL B, V2, P969; Kihara H, 1996, CHEM MATER, V8, P961, DOI 10.1021/cm9505456; Lee M, 1996, MACROMOLECULES, V29, P5567, DOI 10.1021/ma951418y; McHattie GS, 1998, ELECTROCHIM ACTA, V43, P1151, DOI 10.1016/S0013-4686(97)10013-5; NIORI T, 1995, LIQ CRYST, V19, P139, DOI 10.1080/02678299508036731; Ohtake T, 1999, POLYM J, V31, P1155, DOI 10.1295/polymj.31.1155; PATEL JS, 1987, MOL CRYST LIQ CRYST, V144, P117, DOI 10.1080/15421408708084208; PERCEC V, 1993, J MATER CHEM, V3, P633, DOI 10.1039/jm9930300633; PERCEC V, 1994, J CHEM SOC PERK T 2, P31, DOI 10.1039/p29940000031; PERCEC V, 1992, MACROMOLECULES, V25, P2563, DOI 10.1021/ma00035a043; SHINKAI S, 1990, J CHEM SOC CHEM COMM, P303, DOI 10.1039/c39900000303; TAKEBE Y, 1994, J MATER CHEM, V4, P599, DOI 10.1039/jm9940400599; UJIIE S, 1994, CHEM LETT, P17, DOI 10.1246/cl.1994.17; Wright P. V., 1975, British Polymer Journal, V7, DOI 10.1002/pi.4980070505; Yoshizawa A, 1995, J MATER CHEM, V5, P2131, DOI 10.1039/jm9950502131	45	87	88	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0897-4756			CHEM MATER	Chem. Mat.	MAR	2000	12	3					782	789		10.1021/cm990706w		8	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	296LR	WOS:000086026300031		
J	Sakurai, T; Kim, JG; Suzuki, N; Matsuo, T; Li, DQ; Yao, YA; Masunaga, S; Nakanishi, J				Sakurai, T; Kim, JG; Suzuki, N; Matsuo, T; Li, DQ; Yao, YA; Masunaga, S; Nakanishi, J			Polychlorinated dibenzo-p-dioxins and dibenzofurans in sediment, soil, fish, shellfish and crab samples from Tokyo Bay area, Japan	CHEMOSPHERE			English	Article							WATER LAKE AREA; PCDDS; PCDFS; COASTAL; PCBS	Concentrations of tetra- to octa-chlorinated dibenzo-p-dioxins and dibenzofurans in samples collected in or near Tokyo Bay, Japan, with a densely inhabited catchment area, were congener-specifically determined and discussed. Analyzed in this study were samples of surface sediment covering the whole bay area, reference soil representing atmospheric impact, and fish, shellfish and crab commonly consumed as food. The range of concentrations were comparable to or higher than those in other parts of Japan. The origins of these compounds in the catchment area of the bay were investigated in terms of homolog and isomeric compositions in the sediment samples. Biota-sediment accumulation factors for benthic species declined as the degree of chlorination increased. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; Kanazawa Inst Technol, Nonoichi, Ishikawa 9218501, Japan; Yokohama Natl Univ, Inst Environm Sci & Technol, Kanagawa 2408501, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	Sakurai, T (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3050053, Japan.		Sakurai, Takeo/D-6384-2011; Masunaga, Shigeki/F-1315-2011	Sakurai, Takeo/0000-0002-4263-3469; Masunaga, Shigeki/0000-0003-0608-2337			KUTZ FW, 1990, CHEMOSPHERE, V20, P751, DOI 10.1016/0045-6535(90)90178-V; BIRMINGHAM B, 1989, CHEMOSPHERE, V19, P637, DOI 10.1016/0045-6535(89)90383-4; Yamashita T, 1998, JPN HEART J, V39, P389; CZUCZWA JM, 1986, ENVIRON SCI TECHNOL, V20, P195, DOI 10.1021/es00144a015; Sakurai T, 1998, CHEMOSPHERE, V37, P2211, DOI 10.1016/S0045-6535(98)00282-3; RYAN JJ, 1991, J CHROMATOGR, V541, P131, DOI 10.1016/S0021-9673(01)95990-4; BOSS R, 1992, CHEMOSPHERE, V25, P283; CREASER CS, 1990, CHEMOSPHERE, V21, P931, DOI 10.1016/0045-6535(90)90116-B; CREASER CS, 1989, CHEMOSPHERE, V18, P767, DOI 10.1016/0045-6535(89)90194-X; *ENV AG, 1998, CHEM ENV, P275; EVERS EHG, 1993, ENVIRON TOXICOL CHEM, V12, P1583, DOI 10.1897/1552-8618(1993)12[1583:PDADRI]2.0.CO;2; HASHIMOTO S, 1995, CHEMOSPHERE, V31, P3887, DOI 10.1016/0045-6535(95)00261-6; HASHIMOTO S, 1999, J ENV CHEM, V9, P53; Horstmann M, 1997, CHEMOSPHERE, V34, P1245, DOI 10.1016/S0045-6535(97)00422-0; IM SH, 1995, J ENV CHEM, V5, P625; KAIZUKA S, 1993, TOPOGRAPHY GEOLOGY H, P211; KIM JG, 1996, J ENV CHEM, V6, P541; KJELLER LO, 1995, ENVIRON SCI TECHNOL, V29, P346, DOI 10.1021/es00002a010; Mackay D, 1992, ILLUSTRATED HDB PHYS, VII, P368; MATSUMOTO E, 1981, CHISHITSU NEWS, V320, P47; MATSUMOTO E, 1983, Chikyukagaku, V17, P27; *MIN CONSTR, 1995, HYDR DAT BOOK; *MIN HLTH WELF, 1996, NAT NUTR SURV; *MIN HLTH WELF, 1998, POLL INV REP DIOX FO; MIYATA H, 1987, B ENVIRON CONTAM TOX, V39, P877, DOI 10.1007/BF01855869; MUIR DCG, 1985, CHEMOSPHERE, V14, P829, DOI 10.1016/0045-6535(85)90196-1; *NAT I ENV STUD, 1991, KAS ENV; *NAT LAND AG, 1995, DEV METR AR; OEHME M, 1989, FRESEN Z ANAL CHEM, V335, P987, DOI 10.1007/BF00466395; OGURA N, 1993, TOKYO BAY ITS ENV CH, P193; OSAKI Y, 1992, J ENV CHEM, V2, P523; PETREAS MX, 1992, CHEMOSPHERE, V25, P621, DOI 10.1016/0045-6535(92)90292-Y; Sakurai T, 1996, CHEMOSPHERE, V33, P2007, DOI 10.1016/0045-6535(96)00302-5; SHIMIZU M, 1997, BIOL TOKYO BAY, P143; TAKAYAMA K, 1991, J FOOD HYG SOC JPN, V32, P525; TAKAYAMA K, 1991, EISEI KAGAKU, V37, P125; US EPA, 1994, 1613 US EPA; Webster Thomas, 1994, P1; YAMAGISHI T, 1981, CHEMOSPHERE, V10, P1137, DOI 10.1016/0045-6535(81)90184-3; YASUHARA A, 1987, ENVIRON SCI TECHNOL, V21, P971, DOI 10.1021/es50001a010; Zook Douglas R., 1994, P79	41	71	71	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535			CHEMOSPHERE	Chemosphere	MAR	2000	40	6					627	640		10.1016/S0045-6535(99)00324-0		14	Environmental Sciences	Environmental Sciences & Ecology	282LH	WOS:000085219200007		
J	Terada, N; Hamano, N; Nomura, T; Numata, T; Hirai, K; Nakajima, T; Yamada, H; Yoshie, O; Ikeda-Ito, T; Konno, A				Terada, N; Hamano, N; Nomura, T; Numata, T; Hirai, K; Nakajima, T; Yamada, H; Yoshie, O; Ikeda-Ito, T; Konno, A			Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts	CLINICAL AND EXPERIMENTAL ALLERGY			English	Article						chemokines; eosinophils; eotaxin; fibroblasts; interleukin-13; interleukin-4; nasal allergy	MAST-CELLS; EOSINOPHIL ADHESION; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; B-CELLS; RECEPTOR; EXPRESSION; IL-4; CHEMOKINE; MECHANISM	Background There is increasing evidence that eotaxin is a key mediator in the development of tissue eosinophilia. However, the mechanism involved in the production of eotaxin has yet to be clarified, Most recently, it has been shown that interleukin (IL) -4 induces eotaxin in dermal fibroblasts. A novel cytokine termed IL-13, which binds to the alpha-chain of the IL-4 receptor, shares many biological activities with IL-4. It is known that fibroblasts express the IL-4 receptor and produce collagen type I upon stimulation with IL-4. Objective We investigated whether IL-13, as well as IL-4, are able to induce eotaxin production in human nasal mucosal fibroblasts (HNMFs). Furthermore, we investigated the effect of costimulation of IL-13 and TNF alpha on eotaxin production. Methods HNMFs, isolated from inferior nasal mucosa samples, were stimulated by various kind of cytokines for 1-36 h at 37 degrees C in 5% CO2. The change in the expression of eotaxin mRNA was then evaluated by reverse transcriptase-polymerase chain reaction and the Southern blot analysis. The amount of eotaxin in the culture media was measured by ELISA. Results IL-13 as well as IL-4 dose-dependently induced eotaxin expression in HNMFs. Furthermore, IL-13 and TNF alpha synergistically induced eotaxin expression in HNMFs, while they hardly induced eotaxin expression in endothelial cells, epithelial cells or eosinophils, The synergy was observed when pre-incubation of HNMFs with IL-13 was followed by a stimulation with TNF alpha, or HNMFs were simultaneously stimulated with IL-13 and TNF alpha. Conclusion These results strongly indicate that IL-13, as well as IL-4, may be important in eotaxin-mediated eosinophilic inflammation in nasal mucosa. In addition, in nasal mucosa, fibroblasts are the major cell source for eotaxin.	Chiba Univ, Sch Med, Dept Otorhinolaryngol, Chuo Ku, Chiba 2600856, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Bioregulatory Funct, Tokyo, Japan; Kinki Univ, Sch Med, Dept Microbiol, Sayama, Osaka 589, Japan; Nissui Pharmacuet Co Ltd, Res Inst, Yuki, Japan	Terada, N (reprint author), Chiba Univ, Sch Med, Dept Otorhinolaryngol, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.						Peled A, 1998, BLOOD, V91, P1909; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Kitaura M, 1996, J BIOL CHEM, V271, P7725; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Pawankar R, 1997, J CLIN INVEST, V99, P1492, DOI 10.1172/JCI119311; Bernstein JM, 1997, J ALLERGY CLIN IMMUN, V99, P165, DOI 10.1016/S0091-6749(97)70091-5; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Palframan RT, 1998, BLOOD, V91, P2240; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COSTA JJ, 1993, J CLIN INVEST, V91, P2673, DOI 10.1172/JCI116506; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; FINOTTO S, 1994, J IMMUNOL, V153, P2278; Ganzalo J A, 1996, Immunity, V4, P1; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; Hohki G, 1997, BIOCHEM BIOPH RES CO, V241, P136, DOI 10.1006/bbrc.1997.7785; Lugli SM, 1997, J BIOL CHEM, V272, P5487; Mochizuki M, 1998, J IMMUNOL, V160, P60; Nakajima T, 1998, FEBS LETT, V434, P226, DOI 10.1016/S0014-5793(98)00863-1; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V1; STEFFEN M, 1989, IMMUNOLOGY, V66, P445; Terada N, 1997, J IMMUNOL, V158, P5464; Uguccioni M, 1996, J EXP MED, V183, P2379, DOI 10.1084/jem.183.5.2379	33	58	58	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0954-7894			CLIN EXP ALLERGY	Clin. Exp. Allergy	MAR	2000	30	3					348	355				8	Allergy; Immunology	Allergy; Immunology	300UD	WOS:000086270400010		
J	Zhao, HJ; Hosoi, Y; Miyachi, H; Ishii, K; Yoshida, M; Nemoto, K; Takai, Y; Yamada, S; Suzuki, N; Ono, T				Zhao, HJ; Hosoi, Y; Miyachi, H; Ishii, K; Yoshida, M; Nemoto, K; Takai, Y; Yamada, S; Suzuki, N; Ono, T			DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines	CLINICAL CANCER RESEARCH			English	Article							STRAND BREAK REPAIR; CHRONIC LYMPHOCYTIC-LEUKEMIA; IONIZING-RADIATION; V(D)J RECOMBINATION; WORTMANNIN; INHIBITION; MUTATION; DAMAGE; MICE; RADIOSENSITIVITY	We investigated the relationship between DNA-dependent protein kinase (DNA-PK) activity and radiation sensitivity using 14 esophageal cancer cell lines, TE 1-14. DNA-PK activities differed significantly among the cell lines. The highest DNA-PK activity observed in TE-8 was more than two times higher than the lowest DNA-PK activity observed in TE-5. Significant correlation was observed between DNA-PK activity and D0 (r = 0.766; P = 0.0008). Western blots analysis revealed a significant correlation between DNA-PK activity and Ku70 expression, suggesting that the regulation in DNA-PK activity was associated with Ku70 expression. The data suggest that the measurement of DNA-PK activity and/or Ku70 expression may provide a useful way to predict radiation sensitivity.	Univ Tokyo, Fac Med, Dept Radiat Oncol, Bunkyo Ku, Tokyo 1130033, Japan; Tohoku Univ, Sch Med, Dept Radiat Res, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Med, Dept Radiol, Sendai, Miyagi 9808575, Japan	Hosoi, Y (reprint author), Univ Tokyo, Fac Med, Dept Radiat Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ALLALUNISTURNER MJ, 1995, CANCER RES, V55, P5200; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Shen HX, 1998, BBA-GEN SUBJECTS, V1381, P131, DOI 10.1016/S0304-4165(98)00020-8; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Sirzen F, 1999, EUR J CANCER, V35, P111; Sarkaria JN, 1998, CANCER RES, V58, P4375; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Burma S, 1999, J BIOL CHEM, V274, P17139, DOI 10.1074/jbc.274.24.17139; Chan DW, 1998, INT J RADIAT BIOL, V74, P217, DOI 10.1080/095530098141591; Christodoulopoulos G, 1998, CANCER RES, V58, P1789; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Hosoi Y, 1998, INT J CANCER, V78, P642, DOI 10.1002/(SICI)1097-0215(19981123)78:5<642::AID-IJC19>3.0.CO;2-3; Hosoi Y, 1998, Radiat Oncol Investig, V6, P151, DOI 10.1002/(SICI)1520-6823(1998)6:4<151::AID-ROI1>3.0.CO;2-X; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Kasten U, 1999, BRIT J CANCER, V79, P1037, DOI 10.1038/sj.bjc.6690166; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Muller C, 1998, BLOOD, V92, P2213; Muller C, 1997, ONCOGENE, V15, P2343, DOI 10.1038/sj.onc.1201402; MURNANE JP, 1985, EXP CELL RES, V158, P119, DOI 10.1016/0014-4827(85)90437-9; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Polischouk AG, 1999, INT J RADIAT ONCOL, V43, P191, DOI 10.1016/S0360-3016(98)00362-9; Song QZ, 1996, EMBO J, V15, P3238; Yarnold J, 1997, RADIOTHER ONCOL, V44, P1, DOI 10.1016/S0167-8140(97)00049-2	31	37	40	AMER ASSOC CANCER RESEARCH	BIRMINGHAM	PO BOX 11806, BIRMINGHAM, AL 35202 USA	1078-0432			CLIN CANCER RES	Clin. Cancer Res.	MAR	2000	6	3					1073	1078				6	Oncology	Oncology	294KF	WOS:000085909900044		
J	Kato, N; Sugiyama, T; Morita, H; Nabika, T; Kurihara, H; Yamori, Y; Yazaki, Y				Kato, N; Sugiyama, T; Morita, H; Nabika, T; Kurihara, H; Yamori, Y; Yazaki, Y			Genetic analysis of the atrial natriuretic peptide gene in essential hypertension	CLINICAL SCIENCE			English	Article						association; genetics; loci; polymorphism; salt sensitivity	FRAGMENT-LENGTH-POLYMORPHISMS; ALDOSTERONE-PRODUCING ADENOMA; BLOOD-PRESSURE; ANP GENE; LINKAGE DISEQUILIBRIUM; LOCUS; ASSOCIATION; EXPRESSION; EXTRACT; RELEASE	Atrial natriuretic peptide (ANP) plays an important role in the regulation of blood pressure through sodium-water homoeostasis. Accordingly, several investigators have raised the question of whether the gene encoding ANP is involved in the aetiology of essential hypertension or related phenotypes such as salt sensitivity. Most of the studies have used anonymous polymorphic markers of the gene, and made inconclusive claims about the disease relevance of ANP. Therefore, in order to find sequence variations with potential functional significance and to characterize the pattern of linkage disequilibrium between polymorphisms, we screened a 3368-bp genomic fragment of ANP. Subsequently we tested the association of detected polymorphisms with plasma ANP levels and with hypertension status. Two new polymorphisms were identified, in the 5'-untranslated region and exon I respectively, as well as th ree previously reported polymorphisms in intron 2 and exon 3. When analysed in 102 healthy normotensive subjects, none of the polymorphisms appeared to significantly affect plasma ANP levels. A case-control study in a Japanese population (255 hypertensive and 225 normotensive individuals) revealed a marginally significant association (P = 0.026) between an ANP polymorphism located in the 5'-untranslated region (C-664G) and hypertension, but no association for the other polymorphisms. Each of the uncommon variants has an allele frequency of less than 10% in Japanese people, which may have hampered our detection of a significant association between AN P variants and hypertension status (and plasma ANP levels). The pathophysiological relevance of ANP, however, needs to be further defined in relation to hypertension-associated phenotypes, and also should be examined in different ethnic groups.	Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068316, Japan; Inst Adult Dis Asahi Life Fdn, Shinjuku Ku, Tokyo 1600023, Japan; Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; Shimane Med Univ, Dept Lab Med, Izumo, Shimane 6930021, Japan	Kato, N (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.						WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; YASUE H, 1994, CIRCULATION, V90, P195; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; NEMER M, 1984, NATURE, V312, P654, DOI 10.1038/312654a0; LANG RE, 1985, NATURE, V314, P264, DOI 10.1038/314264a0; Halushka MK, 1999, NAT GENET, V22, P239; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; ATARASHI K, 1984, SCIENCE, V224, P992, DOI 10.1126/science.6326267; BARLEY J, 1991, J HYPERTENS, V9, P993, DOI 10.1097/00004872-199111000-00003; BERGE KE, 1994, CLIN GENET, V46, P433; Bihoreau MT, 1997, GENOME RES, V7, P434; BUCKLEY MG, 1993, J HUM HYPERTENS, V7, P245; BURNETT JC, 1984, AM J PHYSIOL, V247, P863; CAMARGO MJF, 1984, AM J PHYSIOL, V246, pF447; CHARTIER L, 1984, BIOCHEM BIOPH RES CO, V122, P171, DOI 10.1016/0006-291X(84)90455-8; Chiang FT, 1996, J HUM HYPERTENS, V10, P334; Daniel HI, 1997, J HUM HYPERTENS, V11, P113, DOI 10.1038/sj.jhh.1000389; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P9223, DOI 10.1093/nar/14.22.9223; Frossard PM, 1997, AM J HYPERTENS, V10, P1308, DOI 10.1016/S0895-7061(97)00303-8; GARCIA R, 1984, AM J PHYSIOL, V247, P34; Itoh H, 1997, ENDOCR J, V44, P389, DOI 10.1507/endocrj.44.389; KURTZ A, 1986, P NATL ACAD SCI USA, V83, P4769, DOI 10.1073/pnas.83.13.4769; LAPOINTE MC, 1988, J BIOL CHEM, V263, P9075; MASHARANI U, 1988, HUM GENET, V80, P307, DOI 10.1007/BF01790105; MORISE T, 1995, J INTERN MED, V237, P175; MORRIS BJ, 1993, CLIN SCI, V85, P189; NAKAMARU M, 1986, EUR J PHARMACOL, V123, P459, DOI 10.1016/0014-2999(86)90724-7; NEMAR M, 1986, NUCLEIC ACIDS RES, V14, P8696; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; RAMASAWMY R, 1992, HUM GENET, V90, P323; RAMASAWMY R, 1994, HUM GENET, V93, P355, DOI 10.1007/BF00212041; RAMASAWMY R, 1993, HUM GENET, V91, P509; RUBATTU S, 1997, HYPERTENSION, V30, P476; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; RUTLEDGE DR, 1995, J HYPERTENS, V13, P953, DOI 10.1097/00004872-199509000-00003; SAMSON WK, 1985, NEUROENDOCRINOLOGY, V40, P277, DOI 10.1159/000124085; Schorr U, 1997, J HYPERTENS, V15, P715, DOI 10.1097/00004872-199715070-00002; SEIDMAN CE, 1984, SCIENCE, V226, P1206, DOI 10.1126/science.6542248; SOBELL JL, 1992, GENOMICS, V12, P1, DOI 10.1016/0888-7543(92)90398-C; STOLLEY PD, 1982, CASE CONTROL STUDIES, P227; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Tunny TJ, 1996, BIOCHEM BIOPH RES CO, V223, P221, DOI 10.1006/bbrc.1996.0874; TUNNY TJ, 1995, BIOCHEM BIOPH RES CO, V215, P172, DOI 10.1006/bbrc.1995.2449; TUNNY TJ, 1994, BIOCHEM BIOPH RES CO, V204, P1312, DOI 10.1006/bbrc.1994.2606; WINEGRAD S, 1984, CIRC RES, V55, P565; WU JP, 1991, MOL ENDOCRINOL, V5, P1311; WU JP, 1989, J BIOL CHEM, V264, P6472	49	37	42	PORTLAND PRESS	LONDON	59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND	0143-5221			CLIN SCI	Clin. Sci.	MAR	2000	98	3					251	258		10.1042/CS19990220		8	Medicine, Research & Experimental	Research & Experimental Medicine	295GJ	WOS:000085958100004		
J	Sornek, RJ; Dobashi, R; Hirano, T				Sornek, RJ; Dobashi, R; Hirano, T			Effect of turbulence on vaporization, mixing, and combustion of liquid-fuel sprays	COMBUSTION AND FLAME			English	Article							PARTICLE DISPERSION; PREMIXED FLAME; DROPLETS; JET	The effect of turbulence properties on spray flame characteristics has been investigated experimentally in detail. A fine scale fluctuation was imposed on a spray by setting a grid in front of the spray nozzle. This simple way of changing the turbulence characteristics was proved to be a very effective way of increasing evaporation rate of the spray. It was found that the faster evaporation does not necessarily lead to faster combustion. As the turbulence characteristics change, evaporated fuel does not burn instantly but the flame whose characteristics are similar to those of a gaseous diffusion flame rather than to those of a heterogeneous spray flame can be observed. The results indicate that with the increase of evaporation rate, mixing of gaseous fuel and air becomes a controlling process of combustion. In the case of a jet mixing with the ambient air, the mixing between heterogeneous phases is more efficient than that between two homogeneous species. This fact is well known from the study of particle-laden jets. In this study its effects in reacting heterogeneous flows are shown. (C) 2000 by The Combustion Institute.	Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138565, Japan	Sornek, RJ (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138565, Japan.						AKAMATSU F, 1997, ATOMIZATION SPRAY, V7, P99; LONGMIRE EK, 1992, J FLUID MECH, V236, P217, DOI 10.1017/S002211209200140X; SQUIRES KD, 1991, J FLUID MECH, V226, P1, DOI 10.1017/S0022112091002276; CHUNG JN, 1988, J FLUID MECH, V186, P199, DOI 10.1017/S0022112088000102; Birouk M, 1996, COMBUST SCI TECHNOL, V113, P413, DOI 10.1080/00102209608935506; CHIU HH, 1977, COMBUST SCI TECHNOL, V17, P127, DOI 10.1080/00102207708946823; Chiu HH, 1997, ATOMIZATION SPRAY, V7, P1; DRING RP, 1978, J ENERGY, V2, P232, DOI 10.2514/3.47974; Furukawa J, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P405; Furukawa J, 1998, COMBUST FLAME, V113, P487, DOI 10.1016/S0010-2180(97)00239-3; GOKALP I, 1988, COMBUST FLAME, V71, P313, DOI 10.1016/0010-2180(88)90066-1; Hinze J., 1972, PROGR HEAT MASS TRAN, V6, P433; ONUMA Y, 1976, 16TH S INT COMB, P561; SORNEK RJ, IN PRESS NENSHO NO K; VIDETO BD, 1990, COMBUST SCI TECHNOL, V70, P47, DOI 10.1080/00102209008951611; WYGNANSK.I, 1969, J FLUID MECH, V38, P577, DOI 10.1017/S0022112069000358	16	23	23	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0010-2180			COMBUST FLAME	Combust. Flame	MAR	2000	120	4					479	491		10.1016/S0010-2180(99)00105-4		13	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	279UQ	WOS:000085063800007		
J	Yamamoto, S				Yamamoto, S			Effective implementations of multi-dimensional radix-2 FFT	COMPUTER PHYSICS COMMUNICATIONS			English	Article						FFT; multi-dimension; radix-2; RISC; vector super computer	FAST FOURIER-TRANSFORMS; ALGORITHM	The Fast Fourier Transform (FFT), is well known as a fast method for the Discrete Fourier Transform (DFT), and the calculation time is in proportion to N log N, where N is the system size. But unfortunately, inappropriate implementation with no care for the structure of the target machine increases the proportional coefficient by a factor of 10. We propose effective implementations in the case of multi-dimensional radix-2 FFT for the recent RISC workstation and the vector-type supercomputer, respectively. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Yamamoto, S (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Frigo M., 1997, MITLCSTR728; NOBILE A, 1986, COMPUT PHYS COMMUN, V40, P189, DOI 10.1016/0010-4655(86)90108-6; NOBILE A, 1986, COMPUT PHYS COMMUN, V42, P233, DOI 10.1016/0010-4655(86)90039-1; TEMPERTON C, 1983, J COMPUT PHYS, V52, P1, DOI 10.1016/0021-9991(83)90013-X; TEMPERTON C, 1992, SIAM J SCI STAT COMP, V13, P676, DOI 10.1137/0913039; TEMPERTON C, 1991, SIAM J SCI STAT COMP, V12, P808, DOI 10.1137/0912043; TEMPERTON C, 1985, J COMPUT PHYS, V58, P283, DOI 10.1016/0021-9991(85)90164-0	8	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-4655			COMPUT PHYS COMMUN	Comput. Phys. Commun.	MAR	2000	125	1-3					1	7		10.1016/S0010-4655(99)00456-7		7	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	285RA	WOS:000085401000001		
J	Shionoya, M				Shionoya, M			48th Symposium on Coordination Chemistry of Japan - Kochi, Japan, 26-28 September 1998 - Preface	COORDINATION CHEMISTRY REVIEWS			English	Editorial Material									Univ Tokyo, Tokyo, Japan	Shionoya, M (reprint author), Univ Tokyo, Tokyo, Japan.							0	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0010-8545			COORDIN CHEM REV	Coord. Chem. Rev.	MAR	2000	198						1	2		10.1016/S0010-8545(00)00345-3		2	Chemistry, Inorganic & Nuclear	Chemistry	311HU	WOS:000086879300001		
J	Kojima, N; Matsushita, N				Kojima, N; Matsushita, N			P-T phase diagram and Au valence state of the perovskite-type Au mixed-valence complexes M-2[(AuX2)-X-I][(AuX4)-X-III] (M = K, Rb, Cs; X = Cl, Br, I)	COORDINATION CHEMISTRY REVIEWS			English	Article; Proceedings Paper	48th International Conference on Coordination Chemistry	SEP   26, 1998-SEP 28, 1999	KOCHI UNIV, ASAKURA CAMPUS, KOCHI, JAPAN	Japan Soc Coordinat Chem, Chem Soc Japan	KOCHI UNIV, ASAKURA CAMPUS	Au complex; mixed-valence; valence transition; perovskite structure; bipolaron; P-T phase diagram	HIGH-PRESSURE; CRYSTAL-STRUCTURE; GOLD; MOSSBAUER; AU-197; X=CL	M-2[(AuX2)-X-I][(AuX4)-X-111] (M = K, Rb, Cs; X = Cl, Br, I) are perovskite-type gold mixed-valence complexes, In this review, we describe their structural P-T phase diagram, the pressure induced Au valence transition from the Au-I,Au- III state to the Au-II one, which is coupled with a structural phase transition. The metallic cubic phase appearing under high pressure and high temperature can be obtained as a metastable phase even at ambient pressure and room temperature. In the pressure region below the Au valence transition, Cs-2[(AuX2)-X-1][(AuX4)-X-III] (X = Cl, Br, I) show metallic behavior, which is attributed to the Au valence-fluctuation. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Kojima, N (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.						KOJIMA N, 1994, J AM CHEM SOC, V116, P11368, DOI 10.1021/ja00104a016; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; CAVA JRJ, 1988, NATURE, V332, P81; Chakraverty B. K., 1979, J PHYS LETT-PARIS, V40, pL99, DOI 10.1051/jphyslet:0197900400509900; DENNER W, 1979, ACTA CRYSTALLOGR A, V35, P360, DOI 10.1107/S0567739479000930; HAFNER SS, 1994, PHYS LETT A, V192, P385, DOI 10.1016/0375-9601(94)90224-0; KITAGAWA H, 1993, SYNTHETIC MET, V55, P1726; KITAGAWA H, 1991, J CHEM SOC DALTON, P3211, DOI 10.1039/dt9910003211; Kojima N, 1996, MOL CRYST LIQ CRYS A, V285, P295, DOI 10.1080/10587259608030816; KOJIMA N, 1991, SYNTHETIC MET, V41, P2347; Kojima N, 1997, SYNTHETIC MET, V86, P2175, DOI 10.1016/S0379-6779(97)81083-1; Matsushita N, 1997, ACTA CRYSTALLOGR C, V53, P663, DOI 10.1107/S0108270197000279; MATSUSHITA N, 1998, REV HIGH PRESSURE SC, V7, P329; STANEK J, 1982, J CHEM PHYS, V76, P2315, DOI 10.1063/1.443303; STANEK J, 1980, PHYS LETT A, V76, P333, DOI 10.1016/0375-9601(80)90510-1; STRAHLE J, 1979, Z ANORG ALLG CHEM, V456, P241, DOI 10.1002/zaac.19794560125; TANINO H, 1990, HIGH PRESSURE RES, V3, P183, DOI 10.1080/08957959008246070; VONTINDEMANS JCM, 1974, MAT RES B, V9, P1667	18	10	10	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0010-8545			COORDIN CHEM REV	Coord. Chem. Rev.	MAR	2000	198						251	263		10.1016/S0010-8545(99)00195-2		13	Chemistry, Inorganic & Nuclear	Chemistry	311HU	WOS:000086879300015		
J	Yamano, H; Miyajima, T; Koike, I				Yamano, H; Miyajima, T; Koike, I			Importance of foraminifera for the formation and maintenance of a coral sand cay: Green Island, Australia	CORAL REEFS			English	Article						coral sand cay; foraminifera sea level; The Great Barrier Reef	GREAT-BARRIER-REEF; HOLOCENE SEA-LEVEL; CARBONATE; PACIFIC; STATES; SHELF; OCEAN	CaCO3 production by reef-building organisms on Green Island Reef in the Great Barrier Reef of Australia is estimated and compared with the contribution of benthic foraminifera to the sediment mass of the vegetated sand cay. Major constituents of the cay are benthic foraminifera(mainly Amphistegina lessonii, Baculogypsina sphaerulata, and Calcarina hispida), calcareous algae (Halimeda and coralline algae), hermatypic corals, and molluscs. Among these reef-building organisms, benthic foraminifera are the single most important contributor to the sediment mass of the island (ca. 30% of total sediments), although their production of CaCO3 is smaller than other reef-building organisms. Water current measurements and sediment traps indicate that the velocity of the current around Green Island is suitable for transportation and deposition of foraminiferal tests. Abundant foraminifera presently live in association with algal turf on the shallow exposed reef flat, whose tests were accumulated by waves resulting in the formation and maintenance-of the coral sand cay.	Univ Tokyo, Fac Sci, Dept Geog, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Ocean Res Inst, Marine Biochem Lab, Nakano Ku, Tokyo 1648639, Japan	Yamano, H (reprint author), Natl Inst Environm Studies, Social & Environm Syst Div, 16-2 Onogawa, Tsukuba, Ibaraki 3050053, Japan.						CHAPPELL J, 1983, NATURE, V302, P406, DOI 10.1038/302406a0; BEAMAN R, 1994, J SEDIMENT RES A, V64, P881; Li C, 1998, SEDIMENTOLOGY, V45, P109, DOI 10.1046/j.1365-3091.1998.00133.x; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; BAXTER IN, 1990, GREEN ISLAND INFORMA; BUDDEMEIER RW, 1975, GEOL SOC AM BULL, V86, P1581, DOI 10.1130/0016-7606(1975)86<1581:HWRHEA>2.0.CO;2; CUBIT JD, 1985, 5TH P INT COR REEF S, V3, P111; DOWNEY WK, 1983, P INT GREAT BARR REE, P421; Drew E, 1983, CORAL REEFS, V2, P101, DOI DOI 10.1007/BF02395280; Emery K. O., 1954, US GEOL SURV PROF  A, V260A, P1; Flood P. G., 1988, P 6 INT COR REEF S T, V2, P219; FLOOD PG, 1986, CORAL REEFS, V5, P13, DOI 10.1007/BF00302166; FLOOD PG, 1986, J COASTAL RES, V2, P479; FOLK RL, 1964, J GEOL, V72, P255; Gourlay M. R., 1988, P 6 INT COR REEF S T, V2, P491; Grossman EE, 1998, CORAL REEFS, V17, P309, DOI 10.1007/s003380050132; Muller P.H., 1976, Maritime Sediments Spec Publ, VNo. 1A, P263; HARRIOTT VJ, 1989, MARINE PARK AUTHORIT, V15; Hopley D., 1982, GEOMORPHOLOGY GREAT; HUBBARD DK, 1990, J SEDIMENT PETROL, V60, P335; JELL J. S., 1965, J PALEONTOL, V39, P273; KINSEY DW, 1985, P 5 INT COR REEF C, V6, P505; KUCHLER DA, 1978, THESIS J COOK U; Langer MR, 1997, J FORAMIN RES, V27, P271; LARCOMBE P, 1995, MAR GEOL, V127, P1, DOI 10.1016/0025-3227(95)00059-8; MAIKLEM WR, 1968, SEDIMENTOLOGY, V10, P101, DOI 10.1111/j.1365-3091.1968.tb01102.x; MCLEAN RF, 1978, PHILOS T R SOC A, V291, P167, DOI 10.1098/rsta.1978.0097; McLean RF, 1994, COASTAL EVOLUTION LA, P267; MCLEAN RF, 1978, PHILOS T R SOC A, V291, P101, DOI 10.1098/rsta.1978.0093; NAKAMORI T, 1992, CONT SHELF RES, V12, P951, DOI 10.1016/0278-4343(92)90054-N; Pirazzoli P.A, 1991, WORLD ATLAS HOLOCENE; ROY P, 1991, J COASTAL RES, V7, P1057; SCHOFIELD JC, 1977, NEW ZEAL J GEOL GEOP, V20, P503; SCHOFIELD JC, 1977, NEW ZEAL J GEOL GEOP, V20, P531; Stoddart D. R., 1971, APPL COASTAL GEOMORP, P155; THOM BG, 1978, PHILOS T R SOC A, V291, P187, DOI 10.1098/rsta.1978.0098; THOM BG, 1978, PHILOS T R SOC A, V291, P37, DOI 10.1098/rsta.1978.0088; Todd R., 1960, Science Reports of the Tohoku University Geol Spec Vol, VVol. 4, P100; Tracey J.I.J., 1974, P 2 INT COR REEF S B, V2, P537; TUDHOPE A. W., 1988, 6TH P INT COR REEF S, V2, P583; Yamanouchi Hideo, 1993, Galaxea, V11, P107	41	56	58	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0722-4028			CORAL REEFS	Coral Reefs	MAR	2000	19	1					51	58		10.1007/s003380050226		8	Marine & Freshwater Biology	Marine & Freshwater Biology	312WA	WOS:000086965900007		
J	Taketo, MM; Takaku, K				Taketo, MM; Takaku, K			Gastro-intestinal tumorigenesis in Smad4 mutant mice	CYTOKINE & GROWTH FACTOR REVIEWS			English	Review						adenocarcinoma; colon cancer; Cowden disease; desmoplasia; familial adenomatous polyposis; invasion; juvenile polyposis; PTEN	FAMILIAL ADENOMATOUS POLYPOSIS; GROWTH-FACTOR-BETA; JUVENILE POLYPOSIS; GERMLINE MUTATIONS; KNOCKOUT MICE; APC GENE; CANCER; PTEN; CARCINOMA; RECEPTOR	The SMAD4 gene plays a key role in the TGF-beta signaling pathway. We inactivated its mouse homolog Smad4. The homozygous mutants were embryonically lethal, whereas the heterozygotes were viable and fertile. Although young heterozygotes appeared normal: old mice developed gastric and duodenal polyps similar to human juvenile polyps characterized by abundant stroma and eosinophilic infiltrations. These data are consistent with the reports that a subset of human juvenile polyposis kindreds carry germline mutations in the SMAD4 gene. We then introduced the Smad4 mutation into the Apc(Delta 716) knockout mice, a model for human familial adenomatous polyposis. Because both Ape and Smad4 are located on mouse chromosome 18, we constructed by meiotic recombination compound heterozygotes carrying both mutations on the same chromosome. In such mice, intestinal polyps developed into more malignant tumors than those in the simple Apc(Delta 716) heterozygotes, showing an extensive stromal cell proliferation and strong submucosal invasion. These results indicate that mutations in SMAD4 play a significant role in the malignant progression of colorectal tumors. (C) 2000 Elsevier Science Ltd. Al rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Tokyo 1130033, Japan	Taketo, MM (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Tokyo 1130033, Japan.						Anna CH, 1997, MAMM GENOME, V8, P443, DOI 10.1007/s003359900465; DESAI DC, 1995, BRIT J SURG, V82, P14, DOI 10.1002/bjs.1800820106; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Di Cristofano A, 1998, NAT GENET, V19, P348; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HORII A, 1992, CANCER RES, V52, P6696; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; JAGELMAN DG, 1988, LANCET, V1, P1149; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Howe JR, 1998, ANN SURG ONCOL, V5, P751, DOI 10.1007/BF02303487; BECKWITH PS, 1991, ARCH SURG-CHICAGO, V126, P825; Eng C, 1998, NAT GENET, V19, P223, DOI 10.1038/897; FENOGLIOPREISER CM, 1990, TUMORS INTESTINES, P31; Friedl W, 1999, GENE CHROMOSOME CANC, V25, P403, DOI 10.1002/(SICI)1098-2264(199908)25:4<403::AID-GCC15>3.0.CO;2-P; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; HAGGITT RC, 1986, AM J SURG PATHOL, V10, P871, DOI 10.1097/00000478-198612000-00006; JENNINGS MT, 1991, INT J CANCER, V49, P129, DOI 10.1002/ijc.2910490124; Kloppel G, 1993, PANCREAS BIOL PATHOB, P871; LUONGO C, 1993, GENOMICS, V15, P3, DOI 10.1006/geno.1993.1002; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; MULDER KM, 1988, CANCER RES, V48, P7120; Oshima H, 1997, CANCER RES, V57, P1644; Polyak K, 1996, BBA-REV CANCER, V1242, P185, DOI 10.1016/0304-419X(95)00009-5; ROTTERDAM H, 1989, PATHOLOGY STOMACH DU, P117; SUGIHARA K, 1982, DIS COLON RECTUM, V25, P766, DOI 10.1007/BF02553308; TAKAKU K, 1999, IN PRESS CANC RES, V59; Tamai Y, 1999, CANCER RES, V59, P2965; WALPOLE IR, 1989, AM J MED GENET, V3, P1; WILLIS RA, 1962, BORDERLAND EMBRYOLOG, P351	40	22	24	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-6101			CYTOKINE GROWTH F R	Cytokine Growth Factor Rev.	MAR-JUN	2000	11	1-2					147	157		10.1016/S1359-6101(99)00038-6		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	325ZM	WOS:000087707200016		
J	Narita, T; Saitoh, K; Kameda, T; Kuroiwa, A; Mizutani, M; Koike, C; Iba, H; Yasugi, S				Narita, T; Saitoh, K; Kameda, T; Kuroiwa, A; Mizutani, M; Koike, C; Iba, H; Yasugi, S			BMPs are necessary for stomach gland formation in the chicken embryo: a study using virally induced BMP-2 and Noggin expression	DEVELOPMENT			English	Article						BMP; digestive tract; ECPg; epithelial-mesenchymal interactions; Noggin; proventricular gland	EPITHELIAL-MESENCHYMAL INTERACTIONS; DIGESTIVE-TRACT; SPEMANN ORGANIZER; SONIC HEDGEHOG; INDUCTION; DIFFERENTIATION; XENOPUS; GENE; PROTEIN; LIMB	Epithelial-mesenchymal interactions are necessary for the normal development of various digestive organs, In chicken proventriculus (glandular stomach), morphogenesis and differentiation of the epithelium depend upon the inductive signals coming from underlying mesenchyme. However, the nature of such signals is still unclear despite extensive analyses carried out using experimental tissue recombinations. In this study we have examined the possible involvement of bone morphogenetic proteins (BMPs) in the formation of stomach glands in the chicken embryo. Analysis of the expression patterns of BMP-2, -4 and -7 showed that these BMPs were present in the proventricular mesenchyme prior to the initiation of the proventricular gland formation. BMP-2 expression, in particular, was restricted to the proventriculus among anterior digestive organs. Virus-mediated BMP-2 overexpression resulted in an increase in the number of glands formed. Moreover, ectopic expression of Noggin, which antagonizes the effect of BMPs, in the proventricular mesenchyme or epithelium, led to the complete inhibition of gland formation, indicating that BMP signals are necessary for the proventricular gland formation. These findings suggest that BMPs are of prime importance as mesenchymal signals for inducing proventricular glands.	Tokyo Metropolitan Univ, Fac Sci, Dept Biol, Tokyo 1920397, Japan; Univ Tokyo, Inst Med Sci, Dept Gene Regulat, Minato Ku, Tokyo 1088639, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Nippon Inst Biol Sci, Yamanashi 4080041, Japan	Narita, T (reprint author), Tokyo Metropolitan Univ, Fac Sci, Dept Biol, 1-1 Minamiohsawa, Tokyo 1920397, Japan.						DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Ishii Y, 1997, DEV GROWTH DIFFER, V39, P643; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Koike T, 1999, DIFFERENTIATION, V65, P13, DOI 10.1046/j.1432-0436.1999.6510013.x; Dosch R, 1997, DEVELOPMENT, V124, P2325; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; LEDOUARIN NM, 1975, MED BIOL, V53, P427; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Piccolo S, 1999, NATURE, V397, P707; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; FEKETE DM, 1993, P NATL ACAD SCI USA, V90, P2350, DOI 10.1073/pnas.90.6.2350; HAFFEN K, 1987, J PEDIATR GASTR NUTR, V6, P14, DOI 10.1097/00005176-198701000-00005; HAYASHI K, 1988, BIOCHEM BIOPH RES CO, V152, P776, DOI 10.1016/S0006-291X(88)80105-0; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Kameda T, 1999, GENES CELLS, V4, P175, DOI 10.1046/j.1365-2443.1999.00250.x; Kawakami Y, 1996, DEVELOPMENT, V122, P3557; LOU G, 1995, GENE DEV, V19, P2808; Murakami M, 1997, GENE, V202, P23, DOI 10.1016/S0378-1119(97)00468-X; Narita T, 1998, DEV GROWTH DIFFER, V40, P67; Noramly S, 1998, DEVELOPMENT, V125, P3775; OHUCHI H, 1992, FEBS LETT, V303, P185, DOI 10.1016/0014-5793(92)80515-I; Romanoff A.L., 1960, THE AVIAN EMBRYO; Sasai Y, 1996, EMBO J, V15, P4547; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; Tabata H, 1998, DEV GROWTH DIFFER, V40, P519; TAKIGUCHI K, 1988, DEV GROWTH DIFFER, V30, P241; TAKIGUCHI K, 1986, ROUX ARCH DEV BIOL, V195, P475, DOI 10.1007/BF00375887; URASE K, 1993, DEV GROWTH DIFFER, V35, P33; Urase K, 1996, ROUX ARCH DEV BIOL, V205, P382, DOI 10.1007/BF00377218; WESSELS NK, 1977, TISSUE INTERACTION D; YASUGI S, 1993, DEV GROWTH DIFFER, V35, P1; YASUGI S, 1990, ZOOL SCI, V7, P159; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725	40	62	64	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991			DEVELOPMENT	Development	MAR	2000	127	5					981	988				8	Developmental Biology	Developmental Biology	297MG	WOS:000086086200006		
J	Karashima, T; Sugimoto, A; Yamamoto, M				Karashima, T; Sugimoto, A; Yamamoto, M			Caenorhabditis elegans homologue of the human azoospermia factor DAZ is required for oogenesis but not for spermatogenesis	DEVELOPMENT			English	Article						Caenorhabditis elegans; germline; DAZ; meiosis; oogenesis; pachytene	MALE-STERILITY GENE; C-ELEGANS; SEX-DETERMINATION; CELL-CYCLE; GERM-LINE; CDC25 HOMOLOG; FISSION YEAST; RNA; MEIOSIS; GLP-1	DAZ (Deleted in Azoospermia), the putative azoospermia factor gene in human, encodes a ribonucleoprotein-type RNA-binding protein required for spermatogenesis, A Drosophila homologue of DAZ, called bottle, is also essential for spermatogenesis. A mouse homologue, Dazla, is implicated in both spermatogenesis and oogenesis, Here, we report the identification and characterization of daz-1, the single DAZ homologue in the nematode Caenorhabditis elegans, Loss of daz-1 function caused sterility in hermaphrodites, by blocking oogenesis at the pachytene stage of meiosis I, Epistasis analysis suggested that this gene executes its function succeeding gld-1, which governs the early pachytene stage in the oogenic pathway. Spermatogenesis did not appear to be affected in daz-1 hermaphrodites. Males defective in daz-1 produced sperm fully competent in fertilization, Analysis employing sex-determination mutants indicated that the daz-1 function was required for meiosis of female germline regardless of the sea of the soma, Transcription of daz-1 was restricted to the germline, starting Drier to the onset of meiosis and was most conspicuous in cells undergoing oogenesis, Thus, daz-1 in C, elegans is an essential factor for female meiosis but, unlike other DAZ family members so far reported, it is dispensable for male meiosis.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Japan Sci & Technol Corp, PRESTO, Kyoto, Japan	Yamamoto, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	myamamot@ims.u-tokyo.ac.jp	Sugimoto, Asako/I-7239-2015	Sugimoto, Asako/0000-0001-6001-4293			Agulnik AI, 1998, HUM MOL GENET, V7, P1371, DOI 10.1093/hmg/7.9.1371; Ajiro K, 1996, J BIOL CHEM, V271, P13197; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; FRANCIS R, 1995, GENETICS, V139, P607; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Zhang BL, 1997, NATURE, V390, P477; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; ELLIS RE, 1995, GENETICS, V139, P561; ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; HODGKIN J, 1986, GENETICS, V114, P15; NELSON GA, 1980, CELL, V19, P457, DOI 10.1016/0092-8674(80)90520-6; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Tabara H, 1996, NUCLEIC ACIDS RES, V24, P2119, DOI 10.1093/nar/24.11.2119; Ruggiu M, 1997, NATURE, V389, P73; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; IINO Y, 1995, GENETICS, V140, P1235; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; HARTWELL LH, 1974, BACTERIOL REV, V38, P164; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; FRANCIS R, 1995, GENETICS, V139, P579; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; BRENNER S, 1974, GENETICS, V77, P71; BARTON MK, 1987, GENETICS, V115, P107; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Christensen S, 1996, DEVELOPMENT, V122, P1373; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; COURNOT G, 1992, J BONE MINER RES, V7, P1; ELLIS HM, 1986, CELL, V44, P819; ELLIS RE, 1994, CIBA F SYMP, V182, P179; Graves LE, 1999, NATURE, V399, P802, DOI 10.1038/21682; Houston DW, 1998, DEVELOPMENT, V125, P171; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; JONES DR, 1995, PHYSIOL ZOOL, V68, P9; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; MAINES JZ, 1999, NAT CELL BIOL, V1, P71; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; Ohmachi M, 1999, GENES CELLS, V4, P325, DOI 10.1046/j.1365-2443.1999.00264.x; PARKHURST SM, 1994, SCIENCE, V264, P924, DOI 10.1126/science.8178152; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; Schedl T., 1997, C ELEGANS, P241; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; WHITECOOPER H, 1993, J CELL SCI, V106, P1035; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0; YANDELL MD, 1994, P NATL ACAD SCI USA, V91, P1381, DOI 10.1073/pnas.91.4.1381	57	117	132	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	MAR	2000	127	5					1069	1079				11	Developmental Biology	Developmental Biology	297MG	WOS:000086086200015		
J	Matsuoka, T; Fujiwara, H				Matsuoka, T; Fujiwara, H			Expression of ecdysteroid-regulated genes is reduced specifically in the wing discs of the wing-deficient mutant (fl) of Bombyx mori	DEVELOPMENT GENES AND EVOLUTION			English	Article						wing-deficient mutant fl; Bombyx mori; wing imaginal discs; ecdysteroid; metamorphosis	HORMONE-RECEPTOR SUPERFAMILY; ECDYSONE-INDUCIBLE GENE; DROSOPHILA NUCLEAR RECEPTOR; POLYMERASE CHAIN-REACTION; MOTH GALLERIA-MELLONELLA; DNA-BINDING PROPERTIES; DEVELOPMENTAL EXPRESSION; RIBOSOMAL-PROTEIN; MANDUCA-SEXTA; MESSENGER-RNA	The wing-deficient mutant, flugellos (fl), of the silkworm, lacks four wings in the pupa and the adult. Previous studies have suggested that the fl wing discs lose responsiveness to ecdysteroid during metamorphosis. To test this hypothesis at the molecular level we compared the expression of 12 genes when the wing discs from the wild-type (WT) and fl larvae were cultured in the presence or absence of 20-hydroxyecdysone (20E). Most of the genes tested here, ecdysteroid-inducible (EcR-A, -B1, and E75) and noninducible genes (actin A3, beta-tubulin, apterous (ap), USP, and BHR38) were normally expressed in the fl wing discs. However, the amounts of mRNAs of two ecdysteroid-inducible genes, BHR3 (early-late gene; Bombyx homologue to DHR3 and MHR3) and Urbain (wing-specific late gene), were reduced to about 50% and 20% of WT in the cultured fl wing discs, respectively. We analyzed developmental profiles of these mRNAs during metamorphosis. They also demonstrated decreased BHR3 and Urbain mRNA 2 days after the onset of wandering. This reduction in transcription of BHR3 in the fl mutant was observed only in the wing disc, not in the testis and fatbody. These results imply that the aberrant expression of the fl gene affects the downstream pathway of ecdysteroid signaling specifically in the wing discs and thus leads to a deficiency in wing formation.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Matsuoka, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo, Tokyo 1130033, Japan.						FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; DIBELLO PR, 1991, GENETICS, V129, P385; KOELLE MR, 1992, P NATL ACAD SCI USA, V89, P6167, DOI 10.1073/pnas.89.13.6167; MILNER MJ, 1987, ROUX ARCH DEV BIOL, V196, P191, DOI 10.1007/BF00376314; Kostrouchova M, 1998, DEVELOPMENT, V125, P1617; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; TZERTZINIS G, 1994, J MOL BIOL, V238, P479, DOI 10.1006/jmbi.1994.1306; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Kamimura M, 1997, EUR J BIOCHEM, V248, P786, DOI 10.1111/j.1432-1033.1997.t01-1-00786.x; Lan Q, 1999, MOL CELL BIOL, V19, P4897; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0; Lam GT, 1997, DEVELOPMENT, V124, P1757; Ashburner M, 1974, Cold Spring Harb Symp Quant Biol, V38, P655; Besson MT, 1996, ROUX ARCH DEV BIOL, V205, P333, DOI 10.1007/BF00377213; Carney GE, 1997, P NATL ACAD SCI USA, V94, P12024, DOI 10.1073/pnas.94.22.12024; Chan HYE, 1998, GENE, V212, P119, DOI 10.1016/S0378-1119(98)00145-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cohen SM, 1993, DEV DROSOPHILA MELAN, VII, P747; D'Avino PP, 1998, DEVELOPMENT, V125, P1733; DOIRA H, 1983, SERICOLOGIA, V23, P245; EMERY IF, 1994, DEVELOPMENT, V120, P3275; FISK GJ, 1995, P NATL ACAD SCI USA, V92, P10604, DOI 10.1073/pnas.92.23.10604; FRISTROM JW, 1982, DEV BIOL, V91, P337, DOI 10.1016/0012-1606(82)90040-9; Fujiwara H, 1997, DEV GENES EVOL, V207, P12, DOI 10.1007/s004270050087; FUJIWARA H, 1995, INSECT BIOCHEM MOLEC, V25, P845, DOI 10.1016/0965-1748(95)00023-O; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Hojyo T, 1997, DEV GROWTH DIFFER, V39, P599, DOI 10.1046/j.1440-169X.1997.t01-4-00007.x; HUET F, 1993, DEVELOPMENT, V118, P613; HUET F, 1995, DEVELOPMENT, V121, P1195; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; JINDRA M, 1994, INSECT BIOCHEM MOLEC, V24, P763, DOI 10.1016/0965-1748(94)90105-8; KAMIIE K, 1993, NUCLEIC ACIDS RES, V21, P742, DOI 10.1093/nar/21.3.742; Kamimura M, 1996, COMP BIOCHEM PHYS B, V113, P341, DOI 10.1016/0305-0491(95)02032-2; Kiguchi K., 1985, Bulletin of the Sericultural Experiment Station, V30, P83; MANDARON P, 1970, DEV BIOL, V22, P298, DOI 10.1016/0012-1606(70)90156-9; MILNER MJ, 1977, J EMBRYOL EXP MORPH, V37, P105; MOCHARLA H, 1990, GENE, V93, P271, DOI 10.1016/0378-1119(90)90235-J; MOUNIER N, 1986, BIOCHIMIE, V68, P1053, DOI 10.1016/S0300-9084(86)80179-1; NAGATA T, 1962, B FAC TEXT SCI, V3, P341; NAKAYAMA H, 1992, NUCLEIC ACIDS RES, V20, P4939, DOI 10.1093/nar/20.18.4939; Ohno C.K., 1992, MECH DEVELOP, V40, P13; Palli SR, 1996, INSECT BIOCHEM MOLEC, V26, P485, DOI 10.1016/0965-1748(96)00004-5; Palli SR, 1997, DEV GENET, V20, P36, DOI 10.1002/(SICI)1520-6408(1997)20:1<36::AID-DVG5>3.0.CO;2-A; PALLI SR, 1992, DEV BIOL, V150, P306, DOI 10.1016/0012-1606(92)90244-B; QIAN GX, 1998, J SERICOL SCI JPN, V67, P43; Sashihara S, 1996, MOL BRAIN RES, V42, P109, DOI 10.1016/S0169-328X(96)00118-0; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SEGRAVES WA, 1993, INSECT BIOCHEM MOLEC, V23, P91, DOI 10.1016/0965-1748(93)90086-8; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; SUTHERLAND JD, 1995, P NATL ACAD SCI USA, V92, P7966, DOI 10.1073/pnas.92.17.7966; SWEVERS L, 1995, INSECT BIOCHEM MOLEC, V25, P857, DOI 10.1016/0965-1748(95)00024-P; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; VanRaay TJ, 1996, GENOMICS, V37, P172, DOI 10.1006/geno.1996.0538; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Zhou BH, 1998, DEV BIOL, V193, P127, DOI 10.1006/dbio.1997.8798; Zhu X, 1996, DNA SEQUENCE, V6, P299, DOI 10.3109/10425179609020877	61	42	47	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0949-944X			DEV GENES EVOL	Dev. Genes Evol.	MAR	2000	210	3					120	128		10.1007/s004270050018		9	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	290ZN	WOS:000085707900002		
J	Neugebauer, S; Baba, T; Watanabe, T				Neugebauer, S; Baba, T; Watanabe, T			Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes	DIABETES			English	Article							ALDOSE REDUCTASE GENE; CELLS; PATHOGENESIS; ENDOTHELIUM; DISEASE; ECNOS; NO	A mutation of endothelial nitric oxide synthase (ecNOS)-a key enzyme of the endogenous nitrovasodilator system that is essential for the regulation of blood flow and blood pressure-may aggravate the progression to diabetic nephropathy and/or retinopathy. To investigate the association of ecNOS tandem repeat polymorphism with diabetic nephropathy, the ecNOS genotype was assessed in 82 Japanese type 2 diabetic patients without nephropathy, 94 patients with microalbuminuria, 39 patients with nephropathy, and 155 healthy control subjects. The analysis revealed that type 2 diabetic patients with nephropathy (not with microalbuminuria) were significantly different from type 2 diabetic patients without nephropathy and healthy control subjects in genotype distribution (P = 0.0423) and frequency of the ecNOS4a allele (19.2% vs. 7.3 and 7.1%, respectively; P = 0.0078). The odds ratio of progression to diabetic nephropathy in diabetic patients who carry the mutated allele is about 2.87 compared with noncarriers. The stepwise multiple regression analysis in these patients showed that hypertension (F = 9.760) and ecNOS gene polymorphism (F = 5.298) are the relevant variables for nephropathy. However, no association was found between the ecNOS4a allele and hypertension or diabetic retinopathy. These results imply that the ecNOS gene polymorphism may be associated with progression to diabetic nephropathy in Japanese type 2 diabetic patients.	Fukushima Med Coll, Dept Internal Med 3, Fukushima 9601247, Japan; Univ Tokyo, Fac Med, Dept Internal Med 1, Tokyo, Japan	Neugebauer, S (reprint author), Fukushima Med Coll, Dept Internal Med 3, 1 Hikarigaoka, Fukushima 9601247, Japan.						MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; RADOMSKI MW, 1987, LANCET, V2, P1057; LORENZI M, 1991, DIABETES, V40, P653, DOI 10.2337/diabetes.40.6.653; Sugimoto H, 1998, DIABETOLOGIA, V41, P1426, DOI 10.1007/s001250051088; MATTOCK MB, 1992, DIABETES, V41, P736, DOI 10.2337/diabetes.41.6.736; DERUBERTIS FR, 1994, DIABETES, V43, P1, DOI 10.2337/diabetes.43.1.1; Miyamoto Y, 1998, HYPERTENSION, V32, P3; BONNER TI, 1991, CYTOGENET CELL GENET, V58, P1850; GRAHAM A, 1991, HUM GENET, V86, P509; Heesom AE, 1997, DIABETES, V46, P287, DOI 10.2337/diabetes.46.2.287; KOMERS R, 1994, DIABETES, V43, P1190, DOI 10.2337/diabetes.43.10.1190; Lacolley P, 1998, J HYPERTENS, V16, P31, DOI 10.1097/00004872-199816010-00006; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; MONGADA S, 1993, NEW ENGL J MED, V329, P2002; Odawara M, 1998, DIABETOLOGIA, V41, P365, DOI 10.1007/s001250050917; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Tsukada T, 1998, BIOCHEM BIOPH RES CO, V245, P190, DOI 10.1006/bbrc.1998.8267; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Weekers L, 1999, DIABETOLOGIA, V42, pA266; Zanchi A, 1998, DIABETES, V47, pA52	21	89	105	AMER DIABETES ASSOC	ALEXANDRIA	1660 DUKE ST, ALEXANDRIA, VA 22314 USA	0012-1797			DIABETES	Diabetes	MAR	2000	49	3					500	503		10.2337/diabetes.49.3.500		4	Endocrinology & Metabolism	Endocrinology & Metabolism	290AU	WOS:000085654800025		
J	Shiratori, Y; Kato, N; Yoshida, H; Nakata, R; Ihori, M; Imazeki, F; Yokosuka, O; Kawase, T; Katamoto, T; Unuma, T; Nakamura, A; Ikegami, F; Hirota, K; Omata, M				Shiratori, Y; Kato, N; Yoshida, H; Nakata, R; Ihori, M; Imazeki, F; Yokosuka, O; Kawase, T; Katamoto, T; Unuma, T; Nakamura, A; Ikegami, F; Hirota, K; Omata, M			Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapy	DIGESTIVE DISEASES AND SCIENCES			English	Article						interferon; chronic hepatitis C; HCV RNA subtype; HCV RNA load; Amplicor-HCV monitor assay; competitive reverse-transcriptase PCR	CHRONIC HEPATITIS-C; POLYMERASE CHAIN-REACTION; TERM FOLLOW-UP; VIRUS-RNA; RANDOMIZED TRIAL; ALPHA; GENOTYPES; ALFA-2B; QUANTIFICATION; INFECTION	Adequate dosing of interferon (IFN) and its cost-effectiveness for sustained virological response were evaluated in relation to viral load and subtype. Prospective analysis of IFN therapy on 326 patients with chronic hepatitis C free from cirrhosis was performed using 9 or 6 million unit (MU) of IFN for six months daily and/or three times a week. Sustained virological response was achieved in 50-94% of patients with less than or equal to 2 x 10(4) copies/ml (competitive RT-PCR) or <100 x 10(3) copies/ml (Amplicor monitor) of HCV RNA by 468-1206 MU of IFN, but response was only 0-25% of the patients with greater than or equal to 2 x 10(5.5) copies/ml (competitive RT-PCR) or >200 x 10(3) copies/ml (Amplicor monitor), even with 468-1206 MU of IFN. A high sustained rate was demonstrated in patients with 100-200 x 10(3) copies/ml of HCV RNA by 901-1206 MU of IFN, in comparison to that with less than or equal to 900 MU of IFN. Multivariate analysis showed that IFN dose had a significant value for the efficacy of IFN therapy in patients presenting 100-200 x 10(3) copies/ml of HCV RNA. Cost efficacy analysis indicated that it cost approximately $10,000, $26,000, and $50,000-227,000 for one person-viral eradication in the patients with <100, 100-200, and >200 x 10(3) copies/ml, respectively. High-dose IFN is only cost effective in patients with intermediate viral loads, and IFN therapy could be recommended in patients with <200 x 10(3) copies/ml of HCV RNA.	Univ Tokyo, Dept Internal Med Gastroenterol, Bunkyo Ku, Tokyo 113, Japan; Japanese Red Med Ctr, Dept Gastroenterol, Tokyo, Japan; Chiba Univ, Sch Med, Dept Med 1, Chiba 280, Japan; Mitsui Mem Hosp, Dept Gastroenterol, Tokyo 101, Japan; JR Tokyo Gen Hosp, Div Gastroenterol, Tokyo, Japan; Asahi Chuo Hosp, Dept Med, Chiba, Japan; Kanto Teishin Hosp, Dept Hlth Care, Tokyo, Japan; Mitl Saiseikai Hosp, Dept Gastroenterol, Ibaraki, Osaka, Japan	Shiratori, Y (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; CASTILLO I, 1994, HEPATOLOGY, V19, P1342, DOI 10.1016/0270-9139(94)90225-9; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Poynard T, 1996, HEPATOLOGY, V24, P778; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; Chemello L, 1996, ANN INTERN MED, V124, P1058; CHEMELLO L, 1995, HEPATOLOGY, V22, P700, DOI 10.1016/0270-9139(95)90286-4; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Detmer J, 1996, J CLIN MICROBIOL, V34, P901; DI BA, 1989, NEW ENGL J MED, V321, P1506; DIODATI G, 1994, HEPATOLOGY, V19, P1; Dusheiko GM, 1995, HEPATOLOGY, V22, P1863, DOI 10.1016/0270-9139(95)90216-3; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347; JOUNET P, 1994, GASTROENTEROLOGY, V106, P686; KATO N, 1996, PROGR LIVER DIS, V16, P223; KATO N, 1993, HEPATOLOGY, V18, P16, DOI 10.1016/0270-9139(93)90500-M; LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T; LAU JYN, 1993, LANCET, V342, P1208, DOI 10.1016/0140-6736(93)92187-X; LAU JYN, 1995, LANCET, V346, P425, DOI 10.1016/S0140-6736(95)92786-7; LIN R, 1995, J HEPATOL, V23, P487, DOI 10.1016/0168-8278(95)80052-2; Lindsay KL, 1996, HEPATOLOGY, V24, P1034; MARTINOTPEIGNOUX M, 1995, HEPATOLOGY, V22, P1050, DOI 10.1016/0270-9139(95)90608-8; POYNARD T, 1995, NEW ENGL J MED, V332, P1457, DOI 10.1056/NEJM199506013322201; SARACCO G, 1993, HEPATOLOGY, V18, P1300, DOI 10.1016/0270-9139(93)90215-9; SHINDO M, 1991, ANN INTERN MED, V115, P700; Shiratori Y, 1997, GASTROENTEROLOGY, V113, P558, DOI 10.1053/gast.1997.v113.pm9247476; Shiratori Y, 1997, J HEPATOL, V27, P437, DOI 10.1016/S0168-8278(97)80346-7; YAMADA G, 1995, HEPATOLOGY, V22, P1351, DOI 10.1016/0270-9139(95)90135-3; YOSHIOKA K, 1992, HEPATOLOGY, V16, P293, DOI 10.1002/hep.1840160203; YOUNG KKY, 1995, J CLIN MICROBIOL, V33, P654	32	6	6	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0163-2116			DIGEST DIS SCI	Dig. Dis. Sci.	MAR	2000	45	3					565	574		10.1023/A:1005457510354		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	298RU	WOS:000086153600019		
J	Araki, S; Washitani, I				Araki, S; Washitani, I			Seed dormancy/germination traits of seven Persicaria species and their implication in soil seed-bank strategy	ECOLOGICAL RESEARCH			English	Article						distribution pattern; dormancy; germination; gap; moist chilling; soil seed-bank	CONTRASTING ECOLOGICAL BREADTH; GERMINATION CHARACTERISTICS; TEMPERATURE; DYNAMICS; VEGETATION; DORMANCY; FOREST; CYCLE; PLANT	In order to predict species-specific potential to form persistent soil seed-banks and to characterize the dynamics of their seed-banks, the seed dormancy/germination traits of seven Persicaria (Polygonum s.lat.) species sharing lakeshore habitats in central Japan were examined. Strict light requirements for seed germination were not observed in any of the species examined. Although all species required moist chilling (0-6 weeks) to break seed dormancy and were sensitive to temperature fluctuation, the degree of both responses varied between species. Seed germination of Persicaria hydropiper (L.) Spach, Persicaria lapathifolia (L.) S.F. Gray, and Persicaria longiseta (De Bruyn) Kitag. was more accelerated by temperature fluctuation and required shorter chilling periods compared with Persicaria japonica (Meisn.) H. Gross, Persicaria maackiana (Regel) Nakai, Persicaria thunbergii (Sieb. et Zucc.) H. Gross, and Persicaria sieboldi (Maisn.) Onki. Secondary dormancy was induced in all species at higher temperatures (24 and 30 degrees C). A persistent seed-bank strategy suggested by the dormancy/germination traits of the studied species was also demonstrated by seedling emergence from surface soils collected from the natural habitat immediately before seed dispersal, as well as by viable seed persistence for 13 months in the field in a seed burial experiment. In the natural habitat, the species with longer chilling requirements occurred in various microhabitats, including the interior of moist tall grasslands, whereas the species having higher sensitivity to temperature fluctuation were most frequently found in sparsely vegetated microhabitats.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan	Araki, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						GHERSA CM, 1992, FUNCT ECOL, V6, P460, DOI 10.2307/2389284; TACEY WH, 1980, J APPL ECOL, V17, P195, DOI 10.2307/2402974; Washitani I, 1997, BIOL CONSERV, V82, P67, DOI 10.1016/S0006-3207(97)00014-1; Sultan SE, 1998, J ECOL, V86, P363, DOI 10.1046/j.1365-2745.1998.00265.x; THOMPSON K, 1977, NATURE, V267, P147, DOI 10.1038/267147a0; HILL NM, 1989, J APPL ECOL, V26, P233, DOI 10.2307/2403664; BASKIN JM, 1985, BIOSCIENCE, V35, P492, DOI 10.2307/1309817; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; Araki S, 1998, FUNCT ECOL, V12, P492, DOI 10.1046/j.1365-2435.1998.00210.x; WASHITANI I, 1985, OECOLOGIA, V66, P338, DOI 10.1007/BF00378295; PAVLIK BM, 1993, BIOL CONSERV, V65, P267, DOI 10.1016/0006-3207(93)90059-A; ROBERTS EH, 1981, PLANT CELL ENVIRON, V4, P97, DOI 10.1111/j.1365-3040.1981.tb01044.x; WASHITANI I, 1990, FUNCT ECOL, V4, P543, DOI 10.2307/2389322; VANDERVALK AG, 1978, ECOLOGY, V59, P322, DOI 10.2307/1936377; HOGENBIRK JC, 1992, AQUAT BOT, V42, P361, DOI 10.1016/0304-3770(92)90055-N; Bungard RA, 1997, NEW ZEAL J BOT, V35, P525; STANIFORTH RJ, 1979, CAN J BOT, V57, P877; GRIME JP, 1981, J ECOL, V69, P1017, DOI 10.2307/2259651; Bertiller MB, 1996, ENVIRON MANAGE, V20, P123, DOI 10.1007/PL00006692; Bewley J. D., 1982, PHYSL BIOCH SEEDS RE, V2; FENNER M., 1985, SEED ECOLOGY; Grime JP, 1979, PLANT STRATEGIES VEG, P79; HARPER JL, 1977, POPULATION BIOL PLAN, P83; JUSTICE OL, 1941, MEMOIR CORNELL U AGR, V235, P3; KJAER A., 1940, PROC INTERNAT SEED TESTING ASSOC, V12, P167; Leck M. A., 1989, ECOLOGY SOIL SEED BA, P283; Nishihiro J, 1998, J PLANT RES, V111, P547, DOI 10.1007/BF02507790; Numata M, 1975, WEED FLORA JAPAN ILL; Rees Mark, 1997, P214; Salisbury E.J., 1942, REPROD CAPACITY PLAN; SILVERTOWN JW, 1993, INTRO PLANT POPULATI, P72; Simpson RL, 1989, ECOLOGY SOIL SEED BA, P3; Sokal RR, 1995, BIOMETRY; Sultan SE, 1998, OECOLOGIA, V115, P564, DOI 10.1007/s004420050554; VANDERVALK AG, 1981, ECOLOGY, V62, P688, DOI 10.2307/1937737; WATANABE YASUSHI, 1967, RES BULL HOKKAIDO NAT AGR EXP STA, V91, P31; YABUKI K, 1959, J AGR METEOROLOGY, V15, P49	37	17	21	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0912-3814			ECOL RES	Ecol. Res.	MAR	2000	15	1					33	46		10.1046/j.1440-1703.2000.00323.x		14	Ecology	Environmental Sciences & Ecology	290RF	WOS:000085689200004		
J	Miura, T; Hirono, Y; Machida, M; Kitade, O; Matsumoto, T				Miura, T; Hirono, Y; Machida, M; Kitade, O; Matsumoto, T			Caste developmental system of the Japanese damp-wood termite Hodotermopsis japonica (Isoptera : Termopsidae)	ECOLOGICAL RESEARCH			English	Article						head-width; lower termite; pseudergate; seventh sternite; sexual dimorphism; wing development	RHINOTERMITIDAE; POLYMORPHISM; SOLDIERS	Caste developmental pathways of the Japanese damp-wood termite Hodotermopsis japonica Holmgren were estimated by measuring body parts. From the size distribution of head-width, seven peaks were recognized in populations of larvae. Of these peaks, the seventh has a wide range and variance, indicating that it represents several instars. The individuals that make up the seventh peak, which take the role of workers (pseudergate), are suggested to enter the nymphal stage(s), which has brachypterous wing buds, prior to becoming alates. The pseudergates appear to be totipotent, that is, capable of differentiating into any caste, including reproductives and soldiers. Sixth instars and pseudergates have the potential to become soldiers via a presoldier stage. Although the evolution of caste systems in termites is controversial, the linear developmental pathway found in this study is thought to be the typical pattern in lower termites. Sexual discrimination was also investigated, males and females being easily distinguished by examining the seventh abdominal sternites of individuals older than fourth instar larvae. Both sexes appear to follow the same caste developmental pathway.	Univ Tokyo, Grad Sch Arts & Sci, Dept Biol, Meguro Ku, Tokyo 1538902, Japan	Miura, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Biol, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.						Myles TG, 1999, SOCIOBIOLOGY, V33, P1; WATSON JAL, 1977, AUST J ZOOL, V25, P25, DOI 10.1071/ZO9770025; Roisin Y, 1996, INSECT SOC, V43, P375, DOI 10.1007/BF01258410; Heath H, 1927, J MORPHOL PHYSIOL, V43, P387, DOI 10.1002/jmor.1050430206; Castle G.B., 1934, TERMITES TERMITE CON, P273; CLARKE PA, 1993, SOCIOBIOLOGY, V23, P167; Esaki T., 1956, Bulletin of the National Science Museum Tokyo N S, V3, P86; GRASSE PP, 1947, CR HEBD ACAD SCI, V214, P219; Hahn Patrick D., 1994, Sociobiology, V24, P313; HENDERSON G, 1993, SOCIOBIOLOGY, V21, P341; HENDERSON G, 1994, INSECT SOC, V41, P19, DOI 10.1007/BF01240570; IKEHARA S, 1959, SCI PAPERS RYUKYU U, V33, P31; Imms A. D., 1919, Philosophical Transactions of the Royal Society London B, V209; Jones S.C., 1980, Sociobiology, V5, P325; Kambhampati S, 1996, INSECT MOL BIOL, V5, P229, DOI 10.1111/j.1365-2583.1996.tb00097.x; Krishna K, 1969, BIOL TERMITES, VI, P1; LI S, 1982, ACTA ENTOMOL SINICA, V25, P311; Maekawa Kiyoto, 1998, Entomological Science, V1, P561; MATSUMOTO T, 1990, SHIROARI, V80, P3; Matsumoto T., 1985, Scientific Papers of the College of Arts and Sciences University of Tokyo, V35, P211; MENSABONSU A, 1976, INSECT SOC, V23, P155, DOI 10.1007/BF02223848; Miller E. M., 1969, P283; Miura T, 1998, ZOOL SCI, V15, P843, DOI 10.2108/zsj.15.843; Miura T, 1996, SOCIOBIOLOGY, V27, P223; MORGAN F. DAVID, 1959, TRANS ROY SOC NEW ZEALAND, V86, P155; MYLES TG, 1986, PAN-PAC ENTOMOL, V62, P293; MYLES TG, 1984, SOCIOBIOLOGY, V9, P163; Myles T.G., 1988, P379; Noirot C, 1969, BIOL TERMITES, VI, P311; NOIROT CHARLES, 1955, ANN SCI NAT ZOOL, V17, P399; Noirot C, 1985, CASTE DIFFERENTIATIO, P41; OKOTKOTBER BM, 1981, INSECT SOC, V28, P233, DOI 10.1007/BF02223626; ROISIN Y, 1992, INSECT SOC, V39, P313, DOI 10.1007/BF01323951; ROISIN Y, 1991, INSECT SOC, V38, P263, DOI 10.1007/BF01314912; Thorne BL, 1996, SOCIOBIOLOGY, V28, P253; WANG J, 1992, Scientific Papers of the College of Arts and Sciences University of Tokyo, V42, P95; Watson J. A. L., 1985, CASTE DIFFERENTIATIO, P27; WATSON JAL, 1975, INSECT SOC, V22, P415, DOI 10.1007/BF02224116; Watson J.A.L., 1981, Sociobiology, V6, P101; Weesner FM, 1969, BIOL TERMITES, VI, P19; ZIMET M, 1982, SOCIOBIOLOGY, V7, P1	41	35	36	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0912-3814			ECOL RES	Ecol. Res.	MAR	2000	15	1					83	92		10.1046/j.1440-1703.2000.00320.x		10	Ecology	Environmental Sciences & Ecology	290RF	WOS:000085689200008		
J	Ishibashi, K; Fujishima, A; Watanabe, T; Hashimoto, K				Ishibashi, K; Fujishima, A; Watanabe, T; Hashimoto, K			Detection of active oxidative species in TiO2 photocatalysis using the fluorescence technique	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						TiO2 photocatalysis; hydroxyl radical; fluorescence probe	HETEROGENEOUS PHOTOCATALYSIS; AROMATIC HYDROXYLATION; FILM PHOTOCATALYST; THIN-FILMS; RADICALS; DECOMPOSITION; DEGRADATION; RADIATION; DOSIMETER; COUMARIN	The active oxidative species (mainly corresponding to hydroxyl radicals ( . OH)) produced on TiO2 film photocatalyst in aerated aqueous solution have been quantitatively investigated by measuring the fluorescence derived by the reaction with either coumarin or terephthalic acid. Upon UV light illumination, coumarin in aqueous solution and terephthalic acid in NaOH solution were converted on the TiO2 film photocatalyst to highly fluorescent hydroxy products. Analysis of the resultant hydroxy compounds provides sensitive and specific monitoring of the generated active oxidative species. The rate of active species formation could be determined by the time dependence of the increase in concentration of the resultant hydroxy products. Using this fluorescence method, the effect of light intensity on the generation efficiency of active oxidative species was examined. The obtained results show that the efficiency of active oxidative species formation is constant at the UV intensity from 50 mu W cm (-2) to 15 mW cm (-2), which is consistent with the results for . OH detection reported recently by the use of other techniques. (C) 2000 Elsevier Science S.A. All rights reserved.	Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Hashimoto, K (reprint author), Kanagawa Acad Sci & Technol, Takatsu Ku, KSP Bldg,3-2-1 Sakado, Kawasaki, Kanagawa 2130012, Japan.		Fujishima, Akira/G-7701-2012; Hashimoto, Kazuhito/C-5011-2012	Hashimoto, Kazuhito/0000-0002-8384-8749			TURCHI CS, 1990, J CATAL, V122, P178, DOI 10.1016/0021-9517(90)90269-P; WALLING C, 1978, J AM CHEM SOC, V100, P4814, DOI 10.1021/ja00483a030; OLLIS DF, 1984, J CATAL, V88, P89, DOI 10.1016/0021-9517(84)90053-8; COLLINS AK, 1994, MED PHYS, V21, P1741, DOI 10.1118/1.597275; MATTHEWS RW, 1980, RADIAT RES, V83, P27, DOI 10.2307/3575256; PICHAT P, 1994, CATAL TODAY, V19, P313, DOI 10.1016/0920-5861(94)80189-4; ALEKABI H, 1989, LANGMUIR, V5, P250, DOI 10.1021/la00085a048; MILLS A, 1993, CHEM SOC REV, V22, P417, DOI 10.1039/cs9932200417; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5; BICKLEY RI, 1973, J CATAL, V31, P389, DOI 10.1016/0021-9517(73)90310-2; Sunada K, 1998, ENVIRON SCI TECHNOL, V32, P726, DOI 10.1021/es970860o; MCLEAN JR, 1988, ULTRASOUND MED BIOL, V14, P59, DOI 10.1016/0301-5629(88)90164-0; FUJIHIRA M, 1981, NATURE, V293, P206, DOI 10.1038/293206a0; BICKLEY RI, 1979, NATURE, V280, P306, DOI 10.1038/280306a0; OLLIS DF, 1990, ENVIRON PROG, V9, P229, DOI 10.1002/ep.670090417; MAKRIGIORGOS GM, 1993, INT J RADIAT BIOL, V63, P445, DOI 10.1080/09553009314550601; Ohko Y, 1997, J PHYS CHEM A, V101, P8057, DOI 10.1021/jp972002k; PRICE GJ, 1993, ULTRASONICS, V31, P451, DOI 10.1016/0041-624X(93)90055-5; OKAMOTO K, 1985, B CHEM SOC JPN, V58, P2015, DOI 10.1246/bcsj.58.2015; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; JAEGER CD, 1979, J PHYS CHEM-US, V83, P3146, DOI 10.1021/j100487a017; Schwarz PF, 1997, J PHYS CHEM B, V101, P7127, DOI 10.1021/jp971315c; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; MASON TJ, 1994, ULTRASON SONOCHEM, V1, pS91, DOI 10.1016/1350-4177(94)90004-3; Fang XW, 1996, ULTRASON SONOCHEM, V3, P57, DOI 10.1016/1350-4177(95)00032-1; ARMSTRONG WA, 1963, CAN J CHEM, V41, P1575, DOI 10.1139/v63-215; Sawunyama P, 1997, J PHYS CHEM B, V101, P11000, DOI 10.1021/jp9730095; ASHAWA SC, 1979, INT J APPL RADIAT IS, V30, P7, DOI 10.1016/0020-708X(79)90089-9; Barreto JC, 1995, LIFE SCI, V56, P89; RIEGEL G, 1995, J PHYS CHEM-US, V99, P4215, DOI 10.1021/j100012a050; Damme H.V., 1979, J AM CHEM SOC, V101, P4373; EBERHARDT MK, 1977, J ORG CHEM, V42, P832, DOI 10.1021/jo00425a013; EBERHARDT MK, 1989, J ORG CHEM, V54, P5922, DOI 10.1021/jo00286a024; GOLDSTEIN S, 1994, J PHYS CHEM-US, V98, P6586, DOI 10.1021/j100077a026; GOPAKUMAR K, 1977, RADIAT EFF DEFECT S, V32, P199, DOI 10.1080/00337577708233075; Grela MA, 1996, J PHYS CHEM-US, V100, P16940, DOI 10.1021/jp953562r; HARBOUR JR, 1986, ADV COLLOID INTERFAC, V24, P103; HASHIMOTO K, 1992, DENKI KAGAKU, V60, P1057; Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006; Ishibashi K, 1998, J PHYS CHEM B, V102, P2117, DOI 10.1021/jp973401i; ISHIBASHI K, UNPUB J PHYS CHEM; KHAN HM, 1995, J RADIOAN NUCL CH LE, V200, P521, DOI 10.1007/BF02162501; MATSUBARA H, 1995, CHEM LETT, P767, DOI 10.1246/cl.1995.767; NEGISHI N, 1995, CHEM LETT, P841, DOI 10.1246/cl.1995.841; OLLIS D F, 1991, Environmental Science and Technology, V25, P1523; PERAL J, 1988, J PHOTOCH PHOTOBIO A, V44, P209, DOI 10.1016/1010-6030(88)80093-5; RICHARD C, 1993, J PHOTOCH PHOTOBIO A, V72, P179, DOI 10.1016/1010-6030(93)85026-5; Schiavello M., 1988, PHOTOCATALYSIS ENV; SERPONE N, 1994, RES CHEM INTERMEDIAT, V20, P953, DOI 10.1163/156856794X00315; SOPYAN I, 1994, CHEM LETT, P723, DOI 10.1246/cl.1994.723; UCHIDA H, 1993, CHEM LETT, P1995, DOI 10.1246/cl.1993.1995; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Watanabe T., 1993, PHOTOCATALYTIC PURIF	54	428	449	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	1388-2481			ELECTROCHEM COMMUN	Electrochem. Commun.	MAR	2000	2	3					207	210		10.1016/S1388-2481(00)00006-0		4	Electrochemistry	Electrochemistry	290FY	WOS:000085666700014		
J	Hayashi, J; Takahashi, H; Doi, S; Kumagai, H; Chiba, T; Yoshida, T; Tsutsumi, A				Hayashi, J; Takahashi, H; Doi, S; Kumagai, H; Chiba, T; Yoshida, T; Tsutsumi, A			Reactions in brown coal pyrolysis responsible for heating rate effect on tar yield	ENERGY & FUELS			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FLASH PYROLYSIS; RAPID PYROLYSIS; CROSS-LINKING; DEVOLATILIZATION; REACTIVITY; CHAR; TEMPERATURE; DEPENDENCE; CATIONS	This study was carried out for the purpose of experimentally establishing the variation with heating rate of the extent of bridge breaking relative to that of cross-linking, which is a reasonable explanation of the heating rate effect on the tar yield in pyrolysis of low rank coals. A brown coal was pyrolyzed slowly at a heating rate of 0.167 K s(-1) and rapidly at 2-3 x 10(3) K s(-1), The yield of tar in the rapid pyrolysis increased with temperature and leveled off at 923 K and 26 mol-C per 100 mol-C in the coal, while 723 K and 15 mol-C in the slow pyrolysis, The loss of aliphatic carbon (Delta C-al) due to aromatization was employed as the measure for the extent of bridge breaking, assuming that the loss is indispensable to supplying donatable hydrogen to cap radicals formed by cleavage of bridges connecting aromatic clusters. The extent of cross-linking was elucidated from the yields of H2O and CO2 that are the major and plausible products of condensation among hydroxylic and carboxylic groups. The rapid pyrolysis was found to give the yield of H2O smaller than that in the slow pyrolysis at every Delta C-al, indicative of the activation energy for H2O formation smaller than that for the loss of aliphatic carbon. The larger ceiling yield of tar with higher heating rate was thus consistent with relatively enhanced bridge breaking and suppressed cross-linking such as dehydration condensation. Unlike the yield of H2O, that of CO2 as a function of Delta C-al little depended on the heating rate, suggesting that the CO2 formation is not responsible for the observed heating rate effect on the ceiling yield.	Hokkaido Univ, Ctr Adv Res Energy Technol, Kita Ku, Sapporo, Hokkaido 0608628, Japan; Hokkaido Natl Ind Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan; Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Hayashi, J (reprint author), Hokkaido Univ, Ctr Adv Res Energy Technol, Kita Ku, N13-W8, Sapporo, Hokkaido 0608628, Japan.		Tsutsumi, Atsushi/K-8988-2012	Tsutsumi, Atsushi/0000-0001-9679-4383			Hayashi J, 1999, ENERG FUEL, V13, P611, DOI 10.1021/ef980186b; SOLOMON PR, 1990, ENERG FUEL, V4, P319, DOI 10.1021/ef00021a017; SOLOMON PR, 1988, ENERG FUEL, V2, P405, DOI 10.1021/ef00010a006; IBARRA JV, 1991, FUEL, V70, P408, DOI 10.1016/0016-2361(91)90131-S; XU WC, 1987, FUEL, V66, P627, DOI 10.1016/0016-2361(87)90270-5; Manion JA, 1996, ENERG FUEL, V10, P776, DOI 10.1021/ef950219c; Hayashi J, 1999, ENERG FUEL, V13, P69, DOI 10.1021/ef9800922; TYLER RJ, 1980, FUEL, V59, P487, DOI 10.1016/0016-2361(80)90175-1; HIPPO EJ, 1979, FUEL, V58, P338, DOI 10.1016/0016-2361(79)90150-9; SOLOMON PR, 1990, ENERG FUEL, V4, P42, DOI 10.1021/ef00019a009; WORNAT MJ, 1992, ENERG FUEL, V6, P136, DOI 10.1021/ef00032a004; BRITT PF, 1995, COAL SCI TECHNOL, V24, P577; CYPRES R, 1985, FUEL, V64, P33, DOI 10.1016/0016-2361(85)90273-X; FLETCHER TH, 1992, ENERG FUEL, V6, P643, DOI 10.1021/ef00035a016; FRANKLIN HD, 1983, IND ENG CHEM PROC DD, V22, P39, DOI 10.1021/i200020a007; GIBBINSMATHAM J, 1988, ENERG FUEL, V2, P505, DOI 10.1021/ef00010a017; GONENC ZS, 1990, FUEL, V69, P383, DOI 10.1016/0016-2361(90)90104-X; HAYASHI J, 1995, ENERG FUEL, V9, P290, DOI 10.1021/ef00050a012; Hayashi J, 1996, ENERG FUEL, V10, P1099, DOI 10.1021/ef950118e; HAYASHI J, IN PRESS FUEL; HAYASHI J, 1995, ENERG FUEL, V9, P284, DOI 10.1021/ef00050a011; HAYASHI Y, 1993, BIOTHERAPY, V7, P63, DOI 10.1007/BF01878156; JONES JC, 1991, SCI VICTORIAN BROWN, pCH9; KAHN MR, 1989, FUEL, V68, P1522; LI CZ, 1993, FUEL, V72, P3, DOI 10.1016/0016-2361(93)90368-C; Matsuo Y, 1995, COAL SCI TECHNOL, V24, P929; SATHE C, 1998, P 15 PITTSB COAL C C; Serio M.A., 1993, PREPR PAP AM CHEM SO, V38, P577; SOLOMON PR, 1986, FUEL, V65, P182, DOI 10.1016/0016-2361(86)90005-0; SOLOMON PR, 1990, FUEL, V69, P754, DOI 10.1016/0016-2361(90)90042-O; STOMPEL ZJ, 1982, FUEL, V61, P817, DOI 10.1016/0016-2361(82)90308-8; SUUBERG EM, 1985, FUEL, V64, P1668, DOI 10.1016/0016-2361(85)90391-6; SUUBERG EM, 1987, ENERG FUEL, V1, P305, DOI 10.1021/ef00003a015; VASSALLO AM, 1987, FUEL, V66, P623; XU WC, 1987, FUEL, V66, P632, DOI 10.1016/0016-2361(87)90271-7; YOSHIDA T, 1982, FUEL, V61, P824, DOI 10.1016/0016-2361(82)90309-X	36	26	28	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624			ENERG FUEL	Energy Fuels	MAR-APR	2000	14	2					400	408		10.1021/ef9901490		9	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	296NW	WOS:000086031300018		
J	Wilde, K; Gardoni, P; Fujino, Y				Wilde, K; Gardoni, P; Fujino, Y			Base isolation system with shape memory alloy device for elevated highway bridges	ENGINEERING STRUCTURES			English	Article								Base isolation provides a very effective passive method of protecting bridges from the hazard of earthquakes. The proposed smart isolation system combines a laminated rubber bearing with a device made of shape memory alloy (SMA). The smart base isolation utilizes the different responses of the SMA at different levels of strain to control the displacements of the rubber bearing at various excitation levels. At the same time the hysteresis of the alloy is used to increase the energy dissipation capacity. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 113, Japan; Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA	Wilde, K (reprint author), Univ Tokyo, Dept Civil Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ACHENBACH M, 1986, INT J SOLIDS STRUCT, V22, P171, DOI 10.1016/0020-7683(86)90006-5; GRAESSER EJ, 1991, J ENG MECH-ASCE, V117, P2590, DOI 10.1061/(ASCE)0733-9399(1991)117:11(2590); Buckle I.G., 1990, EARTHQ SPECTRA, V6, P161, DOI DOI 10.1193/1.1585564; Clark P.W., 1995, P PASS DAMP SAN DIEG; CONSTANTINOU MC, 1985, J STRUCT ENG-ASCE, V111, P705; Duerig TW, 1990, ENG ASPECTS SHAPE ME, P3; HIGASHINO M, 1996, P 2 INT WORKSH STRUC; KAWASHIMA K, 1993, RECENT SELECTED PUBL, V2, P133; Kawashima K., 1993, RECENT SELECTED PUBL, P191; Kelly J. M., 1986, SOIL DYN EARTHQ ENG, V5, P202, DOI DOI 10.1016/0267-7261(86)90006-0; *NQ MIN WORK DEV, 1983, CIV DIV PUBL A, V818; TURKINGTON DH, 1989, J STRUCT ENG-ASCE, V115, P3000; Wilde K, 1998, P SOC PHOTO-OPT INS, V3325, P182, DOI 10.1117/12.310607	13	147	159	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-0296			ENG STRUCT	Eng. Struct.	MAR	2000	22	3					222	229		10.1016/S0141-0296(98)00097-2		8	Engineering, Civil	Engineering	237QJ	WOS:000082667300003		
J	Asami, Y; Ohtaki, T				Asami, Y; Ohtaki, T			Prediction of the shape of detached houses on residential lots	ENVIRONMENT AND PLANNING B-PLANNING & DESIGN			English	Article								In this paper we develop a model that predicts the shape of detached houses from the shape of residential lots by introducing the framework of the associative memory model. The model is based on the idea that, if the shapes of lots are similar, then the positions of associated houses may also be similar. To this effect, 'similarity indices' of lots are devised and transformed into probabilities. The overlay of sample house positions weighted by the probabilities predicts the probability density for each point in the lot covered by a house. The model is tested empirically with data from Hiratsuka city in the Kanagawa prefecture in Japan. The results of its sensitivity analysis by gradually changing the lot shape reproduces the actual tendencies of allocation of houses and yards for lots of limited area.	Univ Tokyo, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; Japan Telcom Co Ltd, Data Commun Sales Headquarters, Chuo Ku, Tokyo 1048508, Japan	Asami, Y (reprint author), Univ Tokyo, Dept Urban Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						ASAMI Y, 1995, REG SCI URBAN ECON, V25, P483, DOI 10.1016/0166-0462(95)02097-E; COLWELL PF, 1989, J URBAN ECON, V26, P90, DOI 10.1016/0094-1190(89)90030-2; HASEGAWA H, 1997, J ARCHITECTURE PLANN, V496, P153; KAJIWARA F, 1999, TOCHIKAKAKU SEIRI JI; Kohonen T., 1989, SELF ORG ASS MEMORY	5	1	1	PION LTD	LONDON	207 BRONDESBURY PARK, LONDON NW2 5JN, ENGLAND	0265-8135			ENVIRON PLANN B	Environ. Plan. B-Plan. Des.	MAR	2000	27	2					283	295		10.1068/b2629		13	Environmental Studies	Environmental Sciences & Ecology	298KZ	WOS:000086139400009		
J	Mizuhashi, S; Ikegaya, Y; Matsuki, N				Mizuhashi, S; Ikegaya, Y; Matsuki, N			Pharmacological property of tributyltin in vivo and in vitro	ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY			English	Article						tributyltin; organotin; alpha-adrenoceptor; muscarinic receptor	ORGANOTIN COMPOUNDS; THAIS-CLAVIGERA; RAT THYMOCYTES; APOPTOSIS; IMPOSEX; JAPAN	Tributyltin (TBT), an assumed endocrine-disrupting chemical, is widely known to show harmful effects in invertebrates including the dioecious snails. As for mammals, there are several reports concerning TBT toxicology, but few indications about general pharmacology of TBT. In the present study, we comprehensively examined the pharmacological effects of TBT both in vivo and in vitro. TBT (0.3 or 1.0 mg/kg attenuated the small intestinal propulsive activity measured by the charcoal method in vivo, and caused concentration-dependent relaxation of isolated guinea-pig ileum in vitro (1.0 x 10(-)8-3.0 x 10(-6) M). TBT induced concentration-dependent relaxation of guinea-pig trachea, which was not inhibited by pre-treatment with a beta-adrenoceptor antagonist. TBT caused a concentration-dependent contraction of rat aortae, and also evoked endothelium-dependent relaxation in the presence of an alpha-adrenoceptor antagonist. The relaxation was inhibited by a muscarinic receptor antagonist. TBT reduced the electrically evoked, sympathetic contractile responses of rat vas deferens, which were slightly prevented by an alpha(2)-adrenoceptor antagonist. These results suggest that TBT possesses diverse pharmacological properties in mammalian organs. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan	Ikegaya, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						IWAI H, 1981, J ANAL TOXICOL, V5, P300; IGNARRO LJ, 1989, FASEB J, V3, P31; Reader S, 1999, BBA-MOL CELL RES, V1448, P473, DOI 10.1016/S0167-4889(98)00166-9; AW TY, 1990, ARCH BIOCHEM BIOPHYS, V283, P46, DOI 10.1016/0003-9861(90)90610-B; PIETERS RHH, 1994, TOXICOLOGY, V91, P189, DOI 10.1016/0300-483X(94)02793-5; VIVIANI B, 1995, NEUROTOXICOLOGY, V16, P19; SNOEIJ NJ, 1987, ENVIRON RES, V44, P335, DOI 10.1016/S0013-9351(87)80242-6; HORIGUCHI T, 1994, J MAR BIOL ASSOC UK, V74, P651; Bettin C, 1996, HELGOLANDER MEERESUN, V50, P299, DOI 10.1007/BF02367105; Fent Karl, 1996, Critical Reviews in Toxicology, V26, P1, DOI 10.1080/1040844041696481; FUNAHASHI N, 1980, ACTA PATHOL JAPON, V30, P955; Horiguchi T, 1998, SCI TOTAL ENVIRON, V214, P65, DOI 10.1016/S0048-9697(98)00053-9; Kannan K, 1997, MAR POLLUT BULL, V34, P203, DOI 10.1016/S0025-326X(96)00146-4; PIVER W T, 1973, Environmental Health Perspectives, V4, P61, DOI 10.2307/3428183; RAFFRAY M, 1993, TOXICOL APPL PHARM, V119, P122, DOI 10.1006/taap.1993.1051; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; SMITH B S, 1981, Journal of Applied Toxicology, V1, P22, DOI 10.1002/jat.2550010106; Sumpter John P., 1998, Toxicology Letters (Shannon), V102-103, P337, DOI 10.1016/S0378-4274(98)00328-2; SUMPTER JP, 1998, TOXICOL LETT, P102; Thompson TA, 1996, J PHARMACOL EXP THER, V276, P1201; YALLAPRAGADA PR, 1991, J TOXICOL ENV HEALTH, V34, P229; ZUCKER RM, 1994, TOXICOL APPL PHARM, V127, P163, DOI 10.1006/taap.1994.1150	22	7	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1382-6689			ENVIRON TOXICOL PHAR	Environ. Toxicol. Pharmacol.	MAR	2000	8	3					205	212		10.1016/S1382-6689(00)00042-9		8	Environmental Sciences; Pharmacology & Pharmacy; Toxicology	Environmental Sciences & Ecology; Pharmacology & Pharmacy; Toxicology	340RY	WOS:000088549800006		
J	Matsue, S; Miyawaki, O				Matsue, S; Miyawaki, O			Influence of water activity and aqueous solvent ordering on enzyme kinetics of alcohol dehydrogenase, lysozyme, and beta-galactosidase	ENZYME AND MICROBIAL TECHNOLOGY			English	Article						solvent ordering; water activity; enzyme kinetics; enzyme-substrate affinity; hydrophobic interaction	POTASSIUM PHOSPHATE SOLUTIONS; ORGANIC-SOLVENTS; POLY(ETHYLENE GLYCOL); PENICILLIN ACYLASE; SALT-SOLUTIONS; STABILITY; HYDRATION; RELAXATION; POLYMER; UREAS	Effects of the water activity (a(w)) and the solvent ordering, as determined by the activity coefficient of water, were investigated on the enzyme kinetics of alcohol dehydrogenase, lysozyme, and beta-galactosidase in various aqueous solutions. The water activity and the solvent orderings were adjusted by addition of electrolytes (NaCl, KCl, CsCl, etc.) or nonelectrolytes (sugars, alcohols, urea, etc.) at various concentrations. Although the enzyme kinetics were strongly dependent on a(w), a(w) was not a complete determinant of the enzyme behavior in aqueous solutions. Enzyme kinetics were also dependent on the solvent ordering. At a fixed a(w), all the enzyme kinetic parameters tested had a good correlation with the solvent ordering parameter as represented by the parameter alpha, an index of the deviation of the water state from the ideal solution, determined from the activity coefficient of water in solutions. Solvent ordering was expected to affect the enzyme kinetics through its effect on the hydrophobic interaction between the enzyme and the substrate and also on the thermal fluctuation. (C) 2000 Elsevier Science Inc. All rights reserved.	Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Miyawaki, O (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aosato@mail.ecc.u-tokyo.ac.jp					ANDERSSON E, 1987, BIOCHIM BIOPHYS ACTA, V912, P317, DOI 10.1016/0167-4838(87)90034-3; ANDERSSON E, 1987, BIOCHIM BIOPHYS ACTA, V912, P325, DOI 10.1016/0167-4838(87)90035-5; Miyawaki O, 1997, BIOSCI BIOTECH BIOCH, V61, P466; UEDAIRA H, 1989, B CHEM SOC JPN, V62, P1, DOI 10.1246/bcsj.62.1; KOZAK JJ, 1968, J CHEM PHYS, V48, P675, DOI 10.1063/1.1668700; Bell G, 1997, ENZYME MICROB TECH, V20, P471, DOI 10.1016/S0141-0229(96)00204-9; MONSAN P, 1984, ANN NY ACAD SCI, V434, P48, DOI 10.1111/j.1749-6632.1984.tb29799.x; Ducret A, 1998, ENZYME MICROB TECH, V22, P212, DOI 10.1016/S0141-0229(97)00180-4; NOZAKI Y, 1963, J BIOL CHEM, V238, P4074; UEDAIRA H, 1990, B CHEM SOC JPN, V63, P3376, DOI 10.1246/bcsj.63.3376; CARREA G, 1982, BIOTECHNOL BIOENG, V24, P1, DOI 10.1002/bit.260240102; CASSELLS JM, 1988, ENZYME MICROB TECH, V10, P486, DOI 10.1016/0141-0229(88)90026-9; FRANKS F, 1991, TRENDS FOOD SCI  MAR, P68; HALLING PJ, 1992, PROGR BIOTECHNOL, V8, P13; HARNHAGERDAL B, 1986, ENZYME MICROBIOL TEC, V8, P322; HERSKOVI.TT, 1973, J PHYS CHEM-US, V77, P381, DOI 10.1021/j100622a016; HERSKOVITS TT, 1987, BIOCHIM BIOPHYS ACTA, V915, P157, DOI 10.1016/0167-4838(87)90295-0; KAMINSKY M, 1957, DISCUSS FARADAY SOC, P171; Lakshmi T. S., 1976, J PHYS CHEM-US, V80, P249, DOI 10.1021/j100544a008; LARRETAGARDE V, 1987, STUD ORG CHEM, V29, P247; LEE SB, 1995, J FERMENT BIOENG, V79, P473, DOI 10.1016/0922-338X(95)91264-6; Poklar N, 1995, J PROTEIN CHEM, V14, P709, DOI 10.1007/BF01886910; Saito A, 1997, BIOSCI BIOTECH BIOCH, V61, P1831; Troller J. A., 1978, WATER ACTIVITY FOOD; VONHIPPE.PH, 1969, ACCOUNTS CHEM RES, V2, P257, DOI 10.1021/ar50021a001; VONHIPPE.PH, 1965, J BIOL CHEM, V240, P3909; WONDRAK EM, 1991, FEBS LETT, V280, P344, DOI 10.1016/0014-5793(91)80327-Y; Zhang T, 1996, PROTEIN SCI, V5, P348	28	12	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-0229			ENZYME MICROB TECH	Enzyme Microb. Technol.	MAR	2000	26	5-6					342	347		10.1016/S0141-0229(99)00182-9		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	292XH	WOS:000085820300005		
J	Higashiyama, M; Miyoshi, Y; Kodama, K; Yokouchi, H; Takami, K; Nishijima, M; Nakayama, T; Kobayashi, H; Minamigawa, K; Nakamura, Y				Higashiyama, M; Miyoshi, Y; Kodama, K; Yokouchi, H; Takami, K; Nishijima, M; Nakayama, T; Kobayashi, H; Minamigawa, K; Nakamura, Y			p53-regulated GML gene expression in non-small cell lung cancer: a promising relationship to cisplatin chemosensitivity	EUROPEAN JOURNAL OF CANCER			English	Article						GML; NSCLC; cisplatin; chemosensitivity; p53; CD-DST	IN-VITRO CHEMOSENSITIVITY; MULTIDRUG-RESISTANCE; DRUG-SENSITIVITY; P53 PROTEIN; POOR-PROGNOSIS; IMAGE-ANALYSIS; HUMAN TUMORS; APOPTOSIS; CHEMOTHERAPY; TAXOL	The GML gene (glycosylphosphatidylinositol-anchored molecule-like protein gene) is a novel gene specifically induced by wild-type p53. which may participate in cell cycle control or the cell apoptotic pathway. Recent experiments suggest that the expression of this never gene in cancer cells is closely associated with sensitivity to certain anticancer drugs. To elucidate the role of the gene expression in cisplatin (CDDP) chemosensitivity of non-small cell lung cancer (NSCLC), 30 surgically resected materials were examined by reverse transcriptase-polymerase chain reaction (RT-PCR). GML gene expression was detected in 9 (30%) samples. Its incidence was significantly higher in immunohistochemically p53-negative (P = 0.040) or wild-type p53 tissues (P = 0.041). On in vitro chemosensitivity testing using 29 primary tissues, six samples with GML gene expression showed good sensitivity to CDDP. In particular, in tissues with immunohistochemically p53-negative accumulation. those with GML gene expression showed significantly better in vitro sensitivity to CDDP (P = 0.012). Clinically a good response to CDDP-based chemo(thermo)therapy for NSCLC patients with tumour residue or recurrence, was observed only in those with p53-negative accumulation and GML gene expression, in agreement with br vitro results. Thus. although the number of tested samples was small, GML gene expression is commonly detected in immunohistochemically p53-negative NSCLCs in close association with good sensitivity to CDDP. GML gene expression analysis may serve as a predictor of CDDP-based chemotherapy for patients with NSCLC. (C) 2000 Elsevier Science Ltd. All rights reserved.	Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Higashinari Ku, Osaka 5378511, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Dept Med Genet,Div Clin Genet, Osaka 5650871, Japan; Nitta Gelatin Inc, Res Lab Div, Osaka 5810024, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1080071, Japan	Higashiyama, M (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Higashinari Ku, Nakamichi 1-3-3, Osaka 5378511, Japan.						KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; Kobayashi H, 1997, INT J ONCOL, V11, P449; ALBERTI W, 1995, BRIT MED J, V311, P899; Beer TW, 1996, THORAX, V51, P526, DOI 10.1136/thx.51.5.526; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MIYASHITA T, 1995, CELL, V80, P293; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; KASTAN MB, 1991, CANCER RES, V51, P6304; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; ELDEIRY WS, 1994, CANCER RES, V54, P1169; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Bai F, 1996, CANCER, V78, P416; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Bunn PA, 1996, SEMIN ONCOL, V23, P18; Carney DN, 1996, SEMIN ONCOL, V23, P71; Cortazar P, 1997, CLIN CANCER RES, V3, P741; Francis PA, 1995, LUNG CANCER S, V12, P163; Furuhata T, 1996, ONCOGENE, V13, P1965; Higashiyama M, 1998, J SURG ONCOL, V68, P19, DOI 10.1002/(SICI)1096-9098(199805)68:1<19::AID-JSO5>3.0.CO;2-O; Kagawa K, 1997, BIOCHEM BIOPH RES CO, V241, P481, DOI 10.1006/bbrc.1997.7818; KATSURAGI K, 1995, BIOMED RES-TOKYO, V16, P273; Kawasaki M, 1997, CLIN CANCER RES, V3, P1195; Kimura Y, 1997, GENOMICS, V41, P477, DOI 10.1006/geno.1997.4680; Kimura Y, 1997, ONCOGENE, V15, P1369, DOI 10.1038/sj.onc.1201255; KODAMA K, 1989, CANCER, V64, P1422, DOI 10.1002/1097-0142(19891001)64:7<1422::AID-CNCR2820640710>3.0.CO;2-T; KOEZUKA M, 1993, INT J ONCOL, V2, P953; MITSUDOMI T, 1993, J NATL CANCER I, V85, P2018, DOI 10.1093/jnci/85.24.2018; Nishio M, 1996, J CLIN ONCOL, V14, P497; OTA E, 1995, BRIT J CANCER, V72, P550, DOI 10.1038/bjc.1995.372; PETRANKA JG, 1992, P NATL ACAD SCI USA, V89, P7876, DOI 10.1073/pnas.89.17.7876; RUSCH V, 1995, CANCER RES, V55, P5038; Shaw G L, 1996, J Cell Biochem Suppl, V24, P173; Shimamura A, 1996, CLIN CANCER RES, V2, P435; *STAT INF DEP, 1991, AG ADJ DEATH RAT MAL, P1; Tanigawa N, 1996, ANTICANCER RES, V16, P1925; TISHLER RB, 1995, CANCER RES, V55, P6021; Vasey PA, 1996, MOL PHARMACOL, V50, P1536; VOLM M, 1995, INT J ONCOL, V7, P1333	41	11	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0959-8049			EUR J CANCER	Eur. J. Cancer	MAR	2000	36	4					489	495		10.1016/S0959-8049(99)00261-0		7	Oncology	Oncology	299ZF	WOS:000086227800015		
J	Takita, J; Hayashi, Y; Takei, K; Yamaguchi, N; Hanada, R; Yamamoto, K; Yokota, J				Takita, J; Hayashi, Y; Takei, K; Yamaguchi, N; Hanada, R; Yamamoto, K; Yokota, J			Allelic imbalance on chromosome 18 in neuroblastoma	EUROPEAN JOURNAL OF CANCER			English	Article						allelic imbalance; chromosome 18; neuroblastoma; DCC	SQUAMOUS-CELL CARCINOMAS; TUMOR-SUPPRESSOR GENES; COLORECTAL-CANCER; PROSTATE-CANCER; FREQUENT LOSS; DELETION MAP; SHORT ARM; DCC-GENE; HETEROZYGOSITY; EXPRESSION	We previously demonstrated that chromosome 18 is frequently deleted in neuroblastoma, To further elucidate the role of chromosome 18 deletions in the development of neuroblastomas we examined 82 cases of neuroblastomas for allelic imbalance (AI) at 17 loci on chromosome 18 to define the common region of AI in neuroblastoma. AI at one or more loci on chromosome 18 was detected in 18/82 (22%) cases. AI on 180 was detected in 17/82 (21%)cases, whereas AI on 18p was detected in 4/82 (5%) cases. There was a distinct common region of AI at 18q21.1 between the D16S363 and D18S858 loci, In addition, cases 16 and 53, which did not show AI at 18q1.1, showed AI at 18pter-q12.3 between the D18S52 and D18S36 loci, indicating that another common region of AI may exist on chromosome 18. AI on chromosome 18 did not significantly correlate with any clinicopathological findings of patients with neuroblastoma. The common region of AI Lit 18q21.1 includes the DCC gene but not the Smad2 and Smad4 genes. However. our previous studies together with the present study indicated that the incidence of DCC mutation is much less than that of AI at 18q21.1 in neuroblastoma. These results indicate that novel tumour suppressor genes involved in the development of neuroblastoma are present at 18q21.1. and possibly at 18pter-q12.3. (C) 2000 Published by Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 1040045, Japan; Tokyo Metropolitan Komagome Hosp, Div Pediat, Tokyo 1138677, Japan; Natl Canc Ctr, Res Inst, Canc Informat & Epidemiol Div, Chuo Ku, Tokyo 1040045, Japan; Saitama Childrens Med Ctr, Iwatsuki, Saitama 3390077, Japan	Hayashi, Y (reprint author), Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Hahn SA, 1996, CANCER RES, V56, P490; Mehlen P, 1998, NATURE, V395, P801; Schutte M, 1996, CANCER RES, V56, P2527; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Shiseki M, 1996, GENE CHROMOSOME CANC, V17, P71, DOI 10.1002/(SICI)1098-2264(199610)17:2<71::AID-GCC1>3.0.CO;2-Y; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; CHENEVIXTRENCH G, 1992, ONCOGENE, V7, P1059; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FONG CT, 1992, CANCER RES, V52, P1780; HAHN SA, 1996, SCIENCE, V258, P1148; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Jones JW, 1997, ARCH OTOLARYNGOL, V123, P610; Kong XT, 1997, CANCER RES, V57, P3772; LATIL A, 1994, GENE CHROMOSOME CANC, V11, P119, DOI 10.1002/gcc.2870110208; LAWLOR KG, 1992, CELL GROWTH DIFFER, V3, P609; Maniatis T, 1982, MOL CLONING LAB MANU; MIYAKE S, 1994, CANCER RES, V54, P3007; PIERCEALL WE, 1994, J CELL BIOL, V124, P1017, DOI 10.1083/jcb.124.6.1017; Reale MA, 1996, CLIN CANCER RES, V2, P1097; Reyes-Mugica M, 1998, LAB INVEST, V78, P669; SCHLEIERMACHER G, 1994, GENE CHROMOSOME CANC, V10, P275, DOI 10.1002/gcc.2870100409; SHISEKI M, 1994, CANCER RES, V54, P5643; STANBRIDGE EJ, 1990, ANNU REV GENET, V24, P615; TAKEDA O, 1994, GENE CHROMOSOME CANC, V10, P30, DOI 10.1002/gcc.2870100106; Takei K, 1998, CANCER RES, V58, P3700; Takita J, 1997, CANCER RES, V57, P907; TAKITA J, 1995, ONCOGENE, V11, P1829; UCHIDA K, 1996, CANCER RES, V56, P2718; Ueda T, 1997, GENE CHROMOSOME CANC, V20, P140, DOI 10.1002/(SICI)1098-2264(199710)20:2<140::AID-GCC4>3.0.CO;2-3	33	19	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0959-8049			EUR J CANCER	Eur. J. Cancer	MAR	2000	36	4					508	513		10.1016/S0959-8049(99)00342-1		6	Oncology	Oncology	299ZF	WOS:000086227800018		
J	Obi, S; Shiratori, Y; Shiina, S; Hamamura, K; Kato, N; Imamura, M; Teratani, T; Sato, S; Komatsu, Y; Kawabe, T; Omata, N				Obi, S; Shiratori, Y; Shiina, S; Hamamura, K; Kato, N; Imamura, M; Teratani, T; Sato, S; Komatsu, Y; Kawabe, T; Omata, N			Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						haemobilia; percutaneous ethanol injection; ultrasonography	BILE-DUCT STONES; PAPILLARY BALLOON DILATION; LIVER-BIOPSY; HEMOBILIA; THERAPY; SPHINCTEROTOMY; EMBOLIZATION; MANAGEMENT; SONOGRAPHY; DIAGNOSIS	Objective Haemobilia often results from iatrogenic injury caused by therapeutic procedures. The objective of this study was to evaluate the efficacy of early diagnosis of haemobilia based on ultrasonography in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection. Patients and methods A combination retrospective and prospective study on the early detection of haemobilia caused by percutaneous ethanol injection was conducted on 365 patients in 1995-1996. The retrospective study reviewed the clinical, laboratory and imaging data of 172 patients who had undergone ethanol injection therapy in 1995, The results showed that ultrasonographic changes in the gallbladder, namely the rapid appearance of echogenic material in the gallbladder lumen, are a useful early sign of haemobilia, Based on the results of the retrospective study, a prospective study on the early detection of haemobilia was carried out in 1996, In the prospective study, percutaneous ethanol injection was halted as soon as haemobilia was detected, Results The incidence of haemobilia in the prospective group (3.6%) was not different from that in the retrospective group (4.7%). However, the mean duration between percutaneous ethanol injection and diagnosis of haemobilia was only 0.3 +/- 0.2 days in the prospective group, compared with 2.8 +/- 2.1 days in the retrospective group (P < 0.001), and the mean duration of jaundice in the prospective group (4.3 days) was significantly shorter than in the retrospective group (40.0 days) (P< 0.05), Conclusion Early diagnosis of haemobilia based on ultrasonographic findings of the gallbladder lumen effectively reduces the severity of haemobilia-related complications due to immediate interruption of the interventional procedure. Eur J Gastroenterol Hepatol 12:285 - 290 (C) 2000 Lippincott Williams & Wilkins.	Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, Tokyo 1130033, Japan	Shiratori, Y (reprint author), Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						LIVRAGHI T, 1986, RADIOLOGY, V161, P309; Bergman JJGHM, 1997, LANCET, V349, P1124, DOI 10.1016/S0140-6736(96)11026-6; SHIINA S, 1993, AM J ROENTGENOL, V160, P1023; BLOECHLE C, 1994, AM J GASTROENTEROL, V89, P1537; CURET P, 1984, WORLD J SURG, V8, P2; Kawabe T, 1996, ENDOSCOPY, V28, P694, DOI 10.1055/s-2007-1005579; Smith TP, 1996, RADIOLOGY, V198, P769; BISMUTH H, 1973, NEW ENGL J MED, V288, P617, DOI 10.1056/NEJM197303222881207; Child CG, 1964, LIVER PORTAL HYPERTE, P50; COELHO JCU, 1982, J CLIN ULTRASOUND, V10, P323, DOI 10.1002/jcu.1870100706; COUINAUD C, 1954, PRESSE MED, V62, P709; Counihan TC, 1996, AM SURGEON, V62, P757; FARMER DG, 1994, ANN SURG, V219, P236, DOI 10.1097/00000658-199403000-00003; GRANT EG, 1983, J CLIN ULTRASOUND, V11, P507, DOI 10.1002/jcu.1870110912; Imamura M, 1998, AM J ROENTGENOL, V171, P1031; KAMBAYASHI M, 1993, J TRAUMA, V34, P440, DOI 10.1097/00005373-199303000-00023; Komatsu Y, 1998, ENDOSCOPY, V30, P12, DOI 10.1055/s-2007-993721; LAFFEY PA, 1986, J CLIN ULTRASOUND, V14, P636, DOI 10.1002/jcu.1870140812; LEE MJ, 1995, AM J ROENTGENOL, V164, P215; LICHTENSTEIN DR, 1992, AM J GASTROENTEROL, V87, P1833; LIVRAGHI T, 1990, CARDIOVASC INTER RAD, V13, P146, DOI 10.1007/BF02575466; LYGIDAKIS NJ, 1991, HEPATO-GASTROENTEROL, V38, P454; Murata K, 1996, AM J GASTROENTEROL, V91, P160; SANDBLOM P, 1977, ANN SURG, V185, P356, DOI 10.1097/00000658-197703000-00018; SANDBLOM P, 1948, SURGERY, V24, P571; SAX SL, 1988, J CLIN ULTRASOUND, V16, P29, DOI 10.1002/jcu.1870160106; SHEU JC, 1987, HEPATO-GASTROENTEROL, V34, P255; SHIINA S, 1987, AM J ROENTGENOL, V149, P949; SHIINA S, 1991, Gastroenterologia Japonica, V26, P47; SIO DI, 1992, J CLIN ULTRASOUND, V20, P621; STARITZ M, 1983, ENDOSCOPY, V15, P197, DOI 10.1055/s-2007-1021507; Sugiura N, 1983, ACTA HEPATOL JPN, V24, P920	32	11	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0954-691X			EUR J GASTROEN HEPAT	Eur. J. Gastroenterol. Hepatol.	MAR	2000	12	3					285	290		10.1097/00042737-200012030-00005		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	295AB	WOS:000085942500005		
J	Nakao, M; Mutsuro, J; Obo, R; Fujiki, K; Nonaka, M; Yano, T				Nakao, M; Mutsuro, J; Obo, R; Fujiki, K; Nonaka, M; Yano, T			Molecular cloning and protein analysis of divergent forms of the complement component C3 from a bony fish, the common carp (Cyprinus carpio): presence of variants lacking the catalytic histidine	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						complement; C3; carp; thioester; catalytic histidine	COVALENT BINDING REACTION; 3RD COMPONENT; INTERNAL THIOESTER; C4; SEQUENCE; MECHANISM; SERUM; C-3	Unlike mammals, some bony fish species have been reported to possess multiple forms of the complement component C3, To explore the structural and functional diversity of bony fish C3, we have isolated eight distinct cDNA clones encoding C3 from a single carp (Cypri nus carpio). The eight sequences were grouped into five C3 types, designated C3-H1, C3-H2, C3-S, C3-Q1 and C3-Q2, each sharing 80-86% amino acid sequence identity with the others. A striking amino acid substitution was noted at the position corresponding to the catalytic histidine, which is conserved in C3 from all the animals analyzed to date and provides the thioester with the ability to bind covalently to hydroxy groups on the target cells or to be hydrolyzed quickly; C3-S, C3-Q1 and C3-Q2 have serine, glutamine and glutamine residues, respectively, in place of the histidine which is conserved in C3-H1 and C3-H2. On the other hand, five distinct C3 forms, named C3-1 to C3-5, were purified from the serum of a single carp. N-terminal sequencing and covalent binding to [H-3]glycine identified C3-1 as the translated product of C3-S, while C3-2 was that of C3-H1, and C3-5 that of C3-H2. C3-1 showed a hemolytic activity threefold higher than that of C3-2, whereas C3-5 was inactive, suggesting that the thioester catalytic mechanism is not a necessary determinant for C3 activity and that C3 lacking the catalytic histidine plays a significant role in the complement system of carp and probably other bony fish.	Kyushu Univ, Grad Sch, Div Bioresource & Bioenvironm, Lab Marine Biol Chem, Fukuoka 8128581, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	Nakao, M (reprint author), Kyushu Univ, Grad Sch, Div Bioresource & Bioenvironm, Lab Marine Biol Chem, Fukuoka 8128581, Japan.		NONAKA, MASARU/G-4929-2014				READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Gadjeva M, 1998, J IMMUNOL, V161, P985; Law SKA, 1997, PROTEIN SCI, V6, P263; Dodds AW, 1998, IMMUNOL REV, V166, P15; BECHERER JD, 1989, CURR TOP MICROBIOL I, V153, P45; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Dodds AW, 1998, DEV COMP IMMUNOL, V22, P207, DOI 10.1016/S0145-305X(98)00002-0; DODS AW, 1993, METHOD ENZYMOL, V233, P46; Gongora R, 1998, SCAND J IMMUNOL, V48, P651; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAW SKA, 1983, BIOCHEM J, V211, P381; Law SKA, 1995, COMPLEMENT; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NAKAO M, 1989, NIPPON SUISAN GAKK, V55, P2021; Nakao M, 1996, FISHERIES SCI, V62, P319; Nakao M, 1998, IMMUNOL REV, V166, P27, DOI 10.1111/j.1600-065X.1998.tb01250.x; Nakao M, 1996, MOL IMMUNOL, V33, P933, DOI 10.1016/S0161-5890(96)00053-3; Nakao M, 1998, J IMMUNOL, V161, P4811; NONAKA M, 1992, J IMMUNOL, V148, P3290; Nonaka M, 1998, IMMUNOL REV, V166, P59, DOI 10.1111/j.1600-065X.1998.tb01252.x; NONAKA M, 1984, J BIOL CHEM, V259, P6327; Ogata RT, 1998, J IMMUNOL, V161, P4785; REN XD, 1995, FEBS LETT, V368, P87, DOI 10.1016/0014-5793(95)00606-A; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; YANO T, 1994, MOL IMMUNOL, V31, P337	28	74	79	WILEY-V C H VERLAG GMBH	BERLIN	MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY	0014-2980			EUR J IMMUNOL	Eur. J. Immunol.	MAR	2000	30	3					858	866		10.1002/1521-4141(200003)30:3<858::AID-IMMU858>3.3.CO;2-D		9	Immunology	Immunology	292DV	WOS:000085779600017		
J	Yato, M; Ohkoshi, N; Sato, A; Shoji, S; Kusunoki, S				Yato, M; Ohkoshi, N; Sato, A; Shoji, S; Kusunoki, S			Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						anti-GM1 antibody; ataxic neuropathy; chronic inflammatory; demyelinating polyradiculoneuropathy (CIDP); ganglioside antibodies; steroid treatment; sural nerve biopsy	NEUROPATHY; IGM; POLYNEUROPATHY; PATIENT	We reported a 64-year-old male with an eight-month history of Salt disturbance and sensory impairment. The patient initially noticed unsteadiness of gait and numbness in his feet, and these symptoms progressed until he was unable to walk without assistance five months later. Vibratory sensation and position sense were markedly diminished, and deep tendon reflexes were absent in all extremities. Motor conduction velocities were slow with prolonged distal latencies, and sensory nerve action potentials (SNAP) were trot elicited. Sural nerve biopsy revealed a mild loss of myelinated fibres and segmental demyelination. Cerebrospinal fluid showed normal cell count with protein 526 mg/dL. Anti-GM1, anti-GM2 and anti-GA1 antibodies in serum were positive. We diagnosed chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) presenting ataxia. Steroid therapy provided immediate improvement of symptoms and signs. This case suggests that CIDP should be considered as one of the potential causes of ataxic neuropathy.	Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Fac Med, Inst Brain Res, Dept Neurol,Bunkyo Ku, Tokyo AAC, Japan	Ohkoshi, N (reprint author), Univ Tsukuba, Inst Clin Med, Dept Neurol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.						DENNYBROWN D, 1948, J NEUROL NEUROSUR PS, V11, P73, DOI 10.1136/jnnp.11.2.73; ASBURY AK, 1990, CURR OPIN NEUROL NEU, V3, P708; DALAKAS MC, 1986, ANN NEUROL, V19, P545, DOI 10.1002/ana.410190605; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; HITOSHI S, 1994, J NEUROL SCI, V126, P219, DOI 10.1016/0022-510X(94)90277-1; ILYAS AA, 1985, ANN NEUROL, V18, P655, DOI 10.1002/ana.410180605; Naganuma M, 1991, Rinsho Shinkeigaku, V31, P1186; NOBILEORAZIO E, 1990, NEUROLOGY, V40, P1747; SOBUE G, 1993, J NEUROL, V38, P463; Taylor BV, 1996, NEUROLOGY, V47, P951	10	5	5	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1351-5101			EUR J NEUROL	Eur. J. Neurol.	MAR	2000	7	2					227	230		10.1046/j.1468-1331.2000.00048.x		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	306KJ	WOS:000086595600015		
J	Hamba, M; Onodera, K; Takahashi, T				Hamba, M; Onodera, K; Takahashi, T			Long-term potentiation of primary afferent neurotransmission at trigeminal synapses of juvenile rats	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						LTP; metabotropic glutamate receptors; pain; primary afferent EPSC; trigeminal neuron	METABOTROPIC GLUTAMATE-RECEPTOR; BRAIN-STEM PREPARATION; SPINAL-CORD; PAIN HYPERSENSITIVITY; NEURONS; STIMULATION; ACTIVATION; MODULATION; DEPRESSION; PROJECTION	Primary afferent monosynaptic and polysynaptic excitatory postsynaptic currents (EPSCs) were recorded from brainstem trigeminal neurons by stimulation of the mandibular nerve attached to the brainstem preparation of juvenile rats. A high-frequency conditioning stimulus induced long-term potentiation (LTP) of high-threshold EPSCs in the majority of trigeminal caudal neurons in substantia gelatinosa, where both A- and C-fibres terminate. However, the same conditioning stimulus did not potentiate low-threshold EPSCs in caudal neurons or EPSCs recorded from neurons in the middle part of trigeminal interpolar nucleus, where C-fibres rarely terminate. LTP in caudal neurons could be induced after blocking N-methyl-d-aspartate (NMDA) receptors with D(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 50 mu m), after postsynaptic loading of the Ca2+ chelator BAPTA (10 mm), or even after completely blocking excitatory transmission with kynurenic acid during conditioning. However, LTP was blocked by the metabotropic glutamate receptor antagonist (+)-alpha-methyl-4-carboxyphenylglycine (1 mm). We suggest that LTP of the trigeminal primary afferent EPSCs is induced preferentially in the C-fibre inputs and that the induction mechanism involves metabotropic glutamate receptors, possibly at the presynaptic terminals.	Tokyo Med & Dent Univ, Grad Sch Dent, Dept Neurobiol, Div Maxillofacial Syst, Tokyo 1130034, Japan; Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan	Takahashi, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Dent, Dept Neurobiol, Div Maxillofacial Syst, Tokyo 1130034, Japan.						ALFORD S, 1995, J NEUROSCI, V15, P7528; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Neugebauer V, 1999, J NEUROPHYSIOL, V82, P272; RANDIC M, 1993, J NEUROSCI, V13, P5228; MENDELL LM, 1965, NATURE, V206, P97, DOI 10.1038/206097a0; HAYASHI H, 1984, J NEUROPHYSIOL, V51, P890; Sugimoto T, 1997, J COMP NEUROL, V378, P425, DOI 10.1002/(SICI)1096-9861(19970217)378:3<425::AID-CNE9>3.0.CO;2-5; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; Boxall SJ, 1996, NEUROSCIENCE, V74, P13, DOI 10.1016/0306-4522(96)00101-7; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; FULTON BP, 1987, NEUROSCI LETT, V73, P125, DOI 10.1016/0304-3940(87)90005-X; Hamba M, 1998, BRAIN RES PROTOC, V3, P7, DOI 10.1016/S1385-299X(98)00015-4; Hamba M, 1998, BRAIN RES, V785, P66, DOI 10.1016/S0006-8993(97)01382-6; HAYASHI Y, 1994, J NEUROSCI, V14, P3370; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; Liu XG, 1998, NEUROSCIENCE, V86, P1209, DOI 10.1016/S0306-4522(98)00107-9; Ohishi H, 1998, NEUROSCI RES, V30, P65, DOI 10.1016/S0168-0102(97)00120-X; ONODERA K, 2000, IN PRESS J PHYSL LON; SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201; Sugimoto T, 1997, NEUROSCI RES, V28, P361, DOI 10.1016/S0168-0102(97)00064-3; Svendsen F, 1998, NEUROREPORT, V9, P1185, DOI 10.1097/00001756-199804200-00041; THOMPSON SWN, 1990, EUR J NEUROSCI, V2, P638, DOI 10.1111/j.1460-9568.1990.tb00453.x; WOOLF CJ, 1986, J NEUROSCI, V6, P1433; Young MR, 1997, BRAIN RES, V777, P161	27	17	19	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	MAR	2000	12	3					1128	1134		10.1046/j.1460-9568.2000.01028.x		7	Neurosciences	Neurosciences & Neurology	300NH	WOS:000086258700038		
J	Ohara, N; Miyata, T; Kurata, A; Oshiro, A; Sato, O; Shigematsu, H				Ohara, N; Miyata, T; Kurata, A; Oshiro, A; Sato, O; Shigematsu, H			Ten years' experience of aortic aneurysm associated with systemic lupus erythematosus	EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY			English	Article						aortic aneurysm; systemic lupus erythematosus; corticosteroid	DISSECTION; MANIFESTATIONS; PATIENT	Background: aortic aneurysm is a rare but life-threatening cardiovascular complication in patients with systemic lupus erythematosus (SLE). The purpose of this study was to clarify the characteristic clinical features and the pathological mechanism of aneurysmal formation in these patients. Methods: among 429 patients operated on for abdominal aortic aneurysm (AAA) during the past 10 years, five cases with SLE were treated surgically. Their clinical data were reviewed, and the resected aneurysmal wall of the five patients was also examined histologically. Results: the mean age of the patients with SLE was 55 years, which was statistically younger than that of the other patients (mean 77 years, S.D. 7.9, p<0.05). They had received long-term corticosteroid therapy for the treatment of SLE for a mean of 23 years. Histologically, destruction of the medial elastic lamina was characteristic. Four patients had no complications in the postoperative follow-up period (mean 4 years), while the remaining patient died of rupture of a dissecting aneurysm two years after operation. Conclusion: prolonged steroid therapy may play a major role bz accelerating atherosclerosis, which cart result in aortic aneurysmal enlargement, possibly together with primary aortic wall involvement and/or vasculitic damage ill patients with SLE.	Univ Tokyo, Fac Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, Tokyo 1138655, Japan	Ohara, N (reprint author), Univ Tokyo, Fac Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						CERVERA R, 1992, ANN RHEUM DIS, V51, P156, DOI 10.1136/ard.51.2.156; DOHERTY NE, 1985, AM HEART J, V110, P1257, DOI 10.1016/0002-8703(85)90023-7; STEHBENS WE, 1993, HISTOPATHOLOGY, V22, P275, DOI 10.1111/j.1365-2559.1993.tb00119.x; BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; BERNHARD GC, 1969, ANN INTERN MED, V71, P81; BONFIGLI.TA, 1972, AM HEART J, V83, P153, DOI 10.1016/0002-8703(72)90133-0; CHAKRAVARTY K, 1992, ANN RHEUM DIS, V51, P1079, DOI 10.1136/ard.51.9.1079; DUGO M, 1993, CLIN NEPHROL, V39, P349; Guard RW, 1995, PATHOLOGY, V27, P224; Hussain KMA, 1998, ANGIOLOGY, V49, P649; Kimura K, 1989, Nihon Naika Gakkai Zasshi, V78, P591; Lam KY, 1997, J CLIN PATHOL, V50, P174, DOI 10.1136/jcp.50.2.174; LORENZEN.I, 1969, ACTA ENDOCRINOL-COP, V62, P67; MACLEOD CB, 1992, AM J CLIN PATHOL, V97, P58; Marubayashi Seiji, 1998, Hiroshima Journal of Medical Sciences, V47, P85; NASHEL DJ, 1986, AM J MED, V80, P925, DOI 10.1016/0002-9343(86)90639-X; OH WMC, 1974, BRIT HEART J, V36, P413; OHGE H, 1995, J JPN ASS THOR SURG, V46, P866; OKIE SE, 1983, J UROLOGY, V129, P803; PAZIRANDEH M, 1988, J RHEUMATOL, V15, P525; SCLAIR M, 1995, LUPUS, V4, P71, DOI 10.1177/096120339500400115; SEYAMA K, 1989, JIN TO TOUSEKI, V27, P1139; SHEARN MA, 1959, AM HEART J, V58, P452, DOI 10.1016/0002-8703(59)90163-2; WALTS AE, 1977, AM HEART J, V93, P378, DOI 10.1016/S0002-8703(77)80258-5; YETES DB, 1975, ANN RHEUM DIS, V34, P321; Yoshimoto K, 1989, Nihon Jinzo Gakkai Shi, V31, P1211	26	27	30	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1078-5884			EUR J VASC ENDOVASC	Eur. J. Vasc. Endovasc. Surg.	MAR	2000	19	3					288	293		10.1053/ejvs.1999.0982		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	302XT	WOS:000086392300011		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		OPAL Collaboration	Measurement of the production rate of charm quark pairs from gluons in hadronic Z(0) decays	EUROPEAN PHYSICAL JOURNAL C			English	Article							SEMILEPTONIC BRANCHING FRACTIONS; MICROVERTEX DETECTOR; E+E ANNIHILATION; HEAVY QUARKS; MONTE-CARLO; FRAGMENTATION; MULTIPLICITY; PHYSICS; MESONS; LEP	The rate of secondary charm-quark-pair production has been measured in 4.4 million hadronic Z(0) decays collected by OPAL. By selecting events with three jets and tagging charmed hadrons in tie gluon jet candidate using leptons and D*+/- mesons, the average number of secondary charm-quark pairs per hadronic event is found to be (3.20+/-0.21+/-0.38) x 10(-2).	Univ Bologna, Dipartmento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; Tech Hsch Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany; TRIUMF, Vancouver, BC V6T 2A3, Canada; Nucl Res Inst, Debrecen, Hungary; Univ Min & Met Krakow, Krakow, Poland; Univ Debrecen, Dept Expt Phys, Debrecen, Hungary	Abbiendi, G (reprint author), Univ Bologna, Dipartmento Fis, I-40126 Bologna, Italy.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012; 	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348; Watson, Nigel/0000-0002-8142-4678			Abbiendi G, 1999, EUR PHYS J C, V8, P217, DOI 10.1007/s100520050460; Abbiendi G, 1999, EUR PHYS J C, V8, P573, DOI 10.1007/s100520050492; AKERS R, 1993, Z PHYS C PART FIELDS, V60, P199; AKERS R, 1995, PHYS LETT B, V353, P595, DOI 10.1016/0370-2693(95)00633-V; AKERS R, 1994, Z PHYS C PART FIELDS, V63, P197; AKERS R, 1995, Z PHYS C PART FIELDS, V66, P19; AKERS R, 1995, Z PHYS C PART FIELDS, V67, P27; Albrecht H, 1996, PHYS LETT B, V374, P249, DOI 10.1016/0370-2693(96)00205-5; *ALEPH DELPHI L3 O, CENEP99015 ALEPH DEL; ALEXANDER G, 1995, PHYS LETT B, V364, P93, DOI 10.1016/0370-2693(95)01293-7; ALEXANDER G, 1991, Z PHYS C PART FIELDS, V52, P175; Alexander G, 1996, Z PHYS C PART FIELDS, V69, P543, DOI 10.1007/s002880050059; Alexander G, 1996, Z PHYS C PART FIELDS, V72, P1; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; ALTARELLI G, 1982, NUCL PHYS B, V208, P365, DOI 10.1016/0550-3213(82)90226-7; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; PETERSON C, 1983, PHYS REV D, V27, P105, DOI 10.1103/PhysRevD.27.105; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; SJOSTRAND T, 1987, COMPUT PHYS COMMUN, V43, P367, DOI 10.1016/0010-4655(87)90054-3; Abreu P, 1997, PHYS LETT B, V405, P202, DOI 10.1016/S0370-2693(97)00608-4; MANGANO ML, 1992, PHYS LETT B, V285, P160, DOI 10.1016/0370-2693(92)91316-2; Barate R, 1998, PHYS LETT B, V434, P437, DOI 10.1016/S0370-2693(98)00850-8; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; BETHKE S, 1988, PHYS LETT B, V213, P235, DOI 10.1016/0370-2693(88)91032-5; KARTVELISHVILI VG, 1978, PHYS LETT B, V78, P615, DOI 10.1016/0370-2693(78)90653-6; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; SJOSTRAND T, 1986, COMPUT PHYS COMMUN, V39, P347, DOI 10.1016/0010-4655(86)90096-2; ISGUR N, 1989, PHYS REV D, V39, P799, DOI 10.1103/PhysRevD.39.799; BARTEL W, 1986, Z PHYS C PART FIELDS, V33, P23; SEYMOUR MH, 1995, NUCL PHYS B, V436, P163, DOI 10.1016/0550-3213(94)00565-V; LONNBLAD L, 1992, COMPUT PHYS COMMUN, V71, P15, DOI 10.1016/0010-4655(92)90068-A; Miller DJ, 1998, PHYS LETT B, V435, P213, DOI 10.1016/S0370-2693(98)00773-4; BACINO W, 1979, PHYS REV LETT, V43, P1073, DOI 10.1103/PhysRevLett.43.1073; BALTRUSAITIS RM, 1985, PHYS REV LETT, V54, P1976, DOI 10.1103/PhysRevLett.54.1976; BETHKE S, 1992, NUCL PHYS B, V370, P310, DOI 10.1016/0550-3213(92)90289-N; COLLINS GP, 1992, PHYS TODAY, V45, P21, DOI 10.1063/1.2809866; COLLINS PDB, 1985, J PHYS G NUCL PARTIC, V11, P1289, DOI 10.1088/0305-4616/11/12/006; HENDERSON S, 1992, PHYS REV D, V45, P2212, DOI 10.1103/PhysRevD.45.2212; *LEP COLL, 1996, NUCL INSTRUM METH A, V378, P101; *LEPHF, 9801 LEPHF; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x; SEYMOUR MH, 1994, Z PHYS C PART FIELDS, V63, P99, DOI 10.1007/BF01577548; SJOSTRAND T, 1988, INT J MOD PHYS A, V3, P751, DOI 10.1142/S0217751X88000345	44	25	25	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	MAR	2000	13	1					1	13		10.1007/s100520000260		13	Physics, Particles & Fields	Physics	322CM	WOS:000087492700001		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Harsen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Harsen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		OPAL Collaboration	Search for pair-produced leptoquarks in e(+)e(-) interactions at root s similar or equal to 183 GeV	EUROPEAN PHYSICAL JOURNAL C			English	Article							P(P)OVER-BAR COLLISIONS; MONTE-CARLO; SCALAR LEPTOQUARKS; LIGHT LEPTOQUARKS; E+E ANNIHILATION; ROOT-S=1.8 TEV; HIGH-ENERGIES; Z0 DECAYS; W-BOSON; DETECTOR	A search for pair-produced leptoquarks has been performed using a sample of e(+)e(-) collision events collected by the OPAL detector at LEP at e(+)e(-) centre-of-mass energies of about 183 GeV. The data sample corresponds to an integrated luminosity of 55.9 pb(-1). The leptoquarks were assumed to be produced via couplings to the photon and the Z(0) and then to decay within a single fermion generation. No evidence for contributions from leptoquark pair production processes was observed. Lower limits on scalar and vector leptoquark masses are obtained. The existing limits are improved in the region of large decay branching ratio to quark-neutrino.	Univ Bologna, Dipartmento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; Tech Hsch Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany; TRIUMF, Vancouver, BC V6T 2A3, Canada; Univ Min & Met Krakow, Krakow, Poland; Univ Debrecen, Dept Expt Phys, Debrecen, Hungary	Abbiendi, G (reprint author), Univ Bologna, Dipartmento Fis, I-40126 Bologna, Italy.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012; 	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348; Watson, Nigel/0000-0002-8142-4678			ABACHI S, 1998, PHYS REV LETT, V81, P38; ABACHI S, 1995, PHYS REV LETT, V75, P3618, DOI 10.1103/PhysRevLett.75.3618; ABACHI S, 1998, PHYS REV LETT, V80, P2051; ABBIENDI G, UNPUB EUR PHYS J C; Abe F, 1998, PHYS REV LETT, V81, P4806, DOI 10.1103/PhysRevLett.81.4806; Abe F, 1997, PHYS REV LETT, V79, P4327, DOI 10.1103/PhysRevLett.79.4327; ABE F, 1995, PHYS REV LETT, V75, P1012, DOI 10.1103/PhysRevLett.75.1012; Abe F, 1997, PHYS REV LETT, V78, P2906, DOI 10.1103/PhysRevLett.78.2906; ABREU P, 1992, PHYS LETT B, V275, P222, DOI 10.1016/0370-2693(92)90878-8; Abreu P, 1999, PHYS LETT B, V446, P62, DOI 10.1016/S0370-2693(98)01525-1; Ackerstaff K, 1998, EUR PHYS J C, V1, P395, DOI 10.1007/s100520050093; Ackerstaff K, 1998, EUR PHYS J C, V5, P19, DOI 10.1007/s100520050245; Ackerstaff K, 1996, PHYS LETT B, V389, P416, DOI 10.1016/S0370-2693(96)01452-9; Ackerstaff K, 1998, EUR PHYS J C, V1, P425, DOI 10.1007/s100520050094; Ackerstaff K, 1996, PHYS LETT B, V389, P616, DOI 10.1016/S0370-2693(96)01451-7; ADEVA B, 1991, PHYS LETT B, V261, P169, DOI 10.1016/0370-2693(91)91346-W; AHMED T, 1994, Z PHYS C PART FIELDS, V64, P545; Aid S, 1996, PHYS LETT B, V369, P173, DOI 10.1016/0370-2693(95)01601-5; ALEXANDER G, 1991, PHYS LETT B, V263, P123, DOI 10.1016/0370-2693(91)91717-A; ANDERSON BE, 1994, IEEE T NUCL SCI, V41, P845, DOI 10.1109/23.322818; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; Anderson S, 1998, NUCL INSTRUM METH A, V403, P326, DOI 10.1016/S0168-9002(97)01093-0; JADACH S, 1994, COMPUT PHYS COMMUN, V79, P503, DOI 10.1016/0010-4655(94)90190-2; BUCHMULLER W, 1987, PHYS LETT B, V191, P442, DOI 10.1016/0370-2693(87)90637-X; PATI JC, 1974, PHYS REV D, V10, P275, DOI 10.1103/PhysRevD.10.275; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; VERMASEREN JAM, 1983, NUCL PHYS B, V229, P347, DOI 10.1016/0550-3213(83)90336-X; SJOSTRAND T, 1986, COMPUT PHYS COMMUN, V39, P347, DOI 10.1016/0010-4655(86)90096-2; BLUMLEIN J, 1993, PHYS LETT B, V304, P337, DOI 10.1016/0370-2693(93)90306-3; HEWETT JL, 1989, PHYS REP, V183, P193, DOI 10.1016/0370-1573(89)90071-9; Blumlein J., 1994, Nuclear Physics B, Proceedings Supplements, V37B, DOI 10.1016/0920-5632(94)90675-0; CATANI S, 1991, PHYS LETT B, V269, P432, DOI 10.1016/0370-2693(91)90196-W; COUSINS RD, 1992, NUCL INSTRUM METH A, V320, P331, DOI 10.1016/0168-9002(92)90794-5; DAVIDSON S, 1994, Z PHYS C PART FIELDS, V61, P613, DOI 10.1007/BF01552629; DECAMP D, 1992, PHYS REP, V216, P253; DERRICK M, 1993, PHYS LETT B, V306, P173, DOI 10.1016/0370-2693(93)91155-G; Engel R, 1996, PHYS REV D, V54, P4244, DOI 10.1103/PhysRevD.54.4244; ENGEL R, 1995, Z PHYS C PART FIELDS, V66, P203, DOI 10.1007/BF01496594; Farhi E., 1981, Physics Reports, V74, DOI 10.1016/0370-1573(81)90173-3; FRAMPTON PH, 1992, MOD PHYS LETT A, V7, P559, DOI 10.1142/S0217732392000525; FUJIMOTO J, 1996, KEKCP046; GINGRICH DM, PHYSICS LEP2, V2, P345; HEWETT JL, 1998, PHYS REV D; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x; SCHREMPP B, 1985, PHYS LETT B, V153, P101, DOI 10.1016/0370-2693(85)91450-9; SJOSTRAND T, 711293 CERNTH	47	11	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	MAR	2000	13	1					15	27		10.1007/s100520000273		13	Physics, Particles & Fields	Physics	322CM	WOS:000087492700002		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bird, SD; Blobel, V; Bloodworth, IJ; Bobinski, M; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Burgard, C; Burgin, R; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; del Pozo, LA; de Roeck, A; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Eatough, D; Estabrooks, PG; Etzion, E; Evans, HG; Fabbri, F; Fanti, M; Faust, AA; Fiedler, F; Fierro, M; Fleck, I; Folman, R; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon, J; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Gross, E; Grunhaus, J; Gruwe, M; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Hargrove, CK; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herndon, M; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hillier, SJ; Hobson, PR; Hocker, A; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Klier, A; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Lanske, D; Lauber, J; Lautenschlager, SR; Lawson, I; Layter, JG; Lazic, D; Lee, AM; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Markopoulos, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nellen, B; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oreglia, MJ; Orito, S; Palinkas, J; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Polok, J; Przybcien, M; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rascoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; Scharff-Hansen, P; Schieck, J; Schmitt, B; Schmitt, S; Schmitz, RE; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomson, MA; von Torne, E; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turcot, AS; Turner-Watson, MF; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bird, SD; Blobel, V; Bloodworth, IJ; Bobinski, M; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Burgard, C; Burgin, R; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; del Pozo, LA; de Roeck, A; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Eatough, D; Estabrooks, PG; Etzion, E; Evans, HG; Fabbri, F; Fanti, M; Faust, AA; Fiedler, F; Fierro, M; Fleck, I; Folman, R; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon, J; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Gross, E; Grunhaus, J; Gruwe, M; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Hargrove, CK; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herndon, M; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hillier, SJ; Hobson, PR; Hocker, A; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Klier, A; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Lanske, D; Lauber, J; Lautenschlager, SR; Lawson, I; Layter, JG; Lazic, D; Lee, AM; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Markopoulos, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nellen, B; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oreglia, MJ; Orito, S; Palinkas, J; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Polok, J; Przybcien, M; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rascoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; Scharff-Hansen, P; Schieck, J; Schmitt, B; Schmitt, S; Schmitz, RE; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomson, MA; von Torne, E; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turcot, AS; Turner-Watson, MF; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V; Zer-Zion, D		Opal Collaboration	A study of parton fragmentation in hadronic Z(0) decays using Lambda(Lambda)over-bar correlations	EUROPEAN PHYSICAL JOURNAL C			English	Article							E+E ANNIHILATION; BARYON PRODUCTION; MICROVERTEX DETECTOR; HIGH-ENERGY; LAMBDA; LEP	The correlated production of Lambda and <(Lambda)over bar> baryons has been studied using 4.3 million multihadronic Z(0) decays recorded with the OPaL detector at LEP. Lambda pairs were investigated in the full data sample and for the first time also in 2-jet and 3-jet events selected with the k(perpendicular to) algorithm. The distributions of rapidity differences, from correlated Lambda<(Lambda)over bar> pairs exhibit short-ranger local correlations and prove to be a sensitive tool to test models: particularly for 2-jet events. The JETSET model describes the data best but some extra parameter tuning is needed to improve agreement with the experimental results in the rates and the rapidity spectra simultaneously. The recently developed modification of JETSET, the MOdified Popcorn Scenarium (MOPS), and also HERWIG do not give satisfactory results. This study of di-lambda production in 2- and 3-jet events supports the short-range compensation of quantum numbers.	Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; CLRC Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 113, Japan; Univ Tokyo, Dept Phys, Tokyo 113, Japan; Kobe Univ, Kobe, Hyogo 657, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Duke Univ, Dept Phys, Durham, NC 27708 USA; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany	Abbiendi, G (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Palinkas, Jozsef/B-2993-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Schmitt, Bernd/H-9365-2013; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Schmitt, Bernd/0000-0002-5778-0680; Grandi, Claudio/0000-0001-5998-3070			ABREU P, 1997, PHYS LETT B, V416, P247; ABREU P, 1993, PHYS LETT B, V318, P249, DOI 10.1016/0370-2693(93)91815-5; ACKERS R, 1995, Z PHYS C, V67, P389; ACKERS R, 1994, Z PHYS C, V63, P181; ACKERSTAFF K, UNPUB EUR PHSY J; ACTON PD, 1993, Z PHYS C PART FIELDS, V58, P387; ACTON PD, 1993, PHYS LETT B, V305, P415, DOI 10.1016/0370-2693(93)91076-Y; ACTON PD, 1992, PHYS LETT B, V291, P503, DOI 10.1016/0370-2693(92)91411-2; AHIRA H, 1985, PHYS REV LETT, V55, P1047; Alexander G, 1997, Z PHYS C PART FIELDS, V73, P587, DOI 10.1007/s002880050350; Alexander G, 1996, Z PHYS C PART FIELDS, V72, P191, DOI 10.1007/s002880050237; Alexander G, 1997, Z PHYS C PART FIELDS, V73, P569, DOI 10.1007/s002880050349; ALEXANDER G, 1991, Z PHYS C PART FIELDS, V52, P175; Alexander G, 1996, Z PHYS C PART FIELDS, V69, P543, DOI 10.1007/s002880050059; ALEXANDER G, 1995, PHYS LETT B, V358, P162; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; ALTHOFF M, 1985, Z PHYS C PART FIELDS, V27, P27; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; ALTHOFF M, 1984, PHYS LETT B, V139, P126, DOI 10.1016/0370-2693(84)90047-9; BARTEL W, 1981, PHYS LETT B, V104, P325, DOI 10.1016/0370-2693(81)90135-0; ALTHOFF M, 1983, Z PHYS C PART FIELDS, V17, P5; Aoki M, 1998, PHYS LETT B, V440, P386, DOI 10.1016/S0370-2693(98)01296-9; Barate R., 1998, Physics Reports, V294, DOI 10.1016/S0370-1573(97)00045-8; Bohrer A., 1997, PHYS REP, V291, P107, DOI 10.1016/S0370-1573(97)00015-X; BROWN N, 1992, Z PHYS C PART FIELDS, V53, P629, DOI 10.1007/BF01559740; BUSKULIC D, 1994, Z PHYS C PART FIELDS, V64, P361; CATANI S, 1991, PHYS LETT B, V269, P432, DOI 10.1016/0370-2693(91)90196-W; DELAVAISSIERE C, 1985, PHYS REV LETT, V54, P2071, DOI 10.1103/PhysRevLett.54.2071; Eden P, 1997, Z PHYS C PART FIELDS, V75, P41, DOI 10.1007/s002880050445	33	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	MAR	2000	13	2					185	195		10.1007/s100520000207		11	Physics, Particles & Fields	Physics	303YE	WOS:000086454800001		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Merchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Merchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		OPAL Collaboration	A study of three-prong tau decays with charged kaons	EUROPEAN PHYSICAL JOURNAL C			English	Article							LEP; DETECTOR; PROGRAM; MESONS	From an analysis of the ionisation energy loss of charged particles selected from a sample of 147926 e(+)e(-)-->tau(+)tau(-) candidates recordec. in the OPAL detector at e(+)e(-) centre-of-mass energies near the Z(0) resonance, we determine the branching ratios: Br(tau(-) --> nu(tau)K(-)pi(-)pi(+)(pi(0))) = 0.343 +/- 0.073 +/- 0.031 % Br(tau(-)--> nu(tau) K- pi(-) K+(pi(0))) = 0.159 +/- 0.053 +/- 0.020 %, where the (pi(0)) notation refers to decay modes with or without an accompanying pi(0). The tau(-) --> nu(tau)K(-)pi(-)pi(+)(pi(upsilon)) final states occurring through tau(-) --> nu(tau)K-K-S(0)(pi(0)) are treated as background in this analysis. We also examine the resonant structure of tau(-) --> nu(tau) K(-)pi(-)pi(+) candidates. Under the assumption that the resonant structure is dominated by the K-1 resonances, we determine: R=Br(tau(-)-->nu(tau) K-1(1270))/Br(tau(-) --> nu(tau) K-1(1400)) + Br(tau(-) K-1(1270)) = 0.71 +/- 0.16 +/- 0.11. In all results, the first uncertainties are statistical and the second are systematic.	Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; CLRC, Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Dept Particle Phys, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany	Abbiendi, G (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012; 	Watson, Nigel/0000-0002-8142-4678; Lafferty, George/0000-0003-0658-4919; Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348; Sachs, Kirsten/0000-0002-6912-5800; de Jong, Sijbrand/0000-0002-3120-3367; Giacomelli, Paolo/0000-0002-6368-7220; Abbiendi, Giovanni/0000-0003-4499-7562			ACKERSTAFF K, 1995, Z PHYS C, V68, P555; Ackerstaff K, 1998, EUR PHYS J C, V4, P193, DOI 10.1007/s100520050197; STERNHEI.RM, 1971, PHYS REV B, V3, P3681, DOI 10.1103/PhysRevB.3.3681; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; JADACH S, 1994, COMPUT PHYS COMMUN, V79, P503, DOI 10.1016/0010-4655(94)90190-2; Li BA, 1997, PHYS REV D, V55, P1436, DOI 10.1103/PhysRevD.55.1436; JADACH S, 1993, COMPUT PHYS COMMUN, V76, P361, DOI 10.1016/0010-4655(93)90061-G; Finkemeier M, 1996, Z PHYS C PART FIELDS, V69, P243, DOI 10.1007/s002880050024; MANLEY DM, 1992, PHYS REV D, V45, P4002, DOI 10.1103/PhysRevD.45.4002; Fermi E, 1940, PHYS REV, V57, P485, DOI 10.1103/PhysRev.57.485; BARATE R, UNPUB EUR PHYS J C; Barate R, 1998, EUR PHYS J C, V1, P65, DOI 10.1007/s100520050062; BAUER DA, 1994, PHYS REV D, V50, pR13, DOI 10.1103/PhysRevD.50.R13; Bethe H., 1933, HDB PHYS           1, V24, P491; DAUM C, 1981, NUCL PHYS B, V187, P1, DOI 10.1016/0550-3213(81)90114-0; HAUSCHILD M, 1992, NUCL INSTRUM METH A, V314, P74, DOI 10.1016/0168-9002(92)90501-T; MILLS GB, 1985, PHYS REV LETT, V54, P624, DOI 10.1103/PhysRevLett.54.624; MIRKES E, 1997, NUCL PHYS B C, V55, P169; RICHICHI S, UNPUB PHYS REV D; SUZUKI M, 1993, PHYS REV D, V47, P1252, DOI 10.1103/PhysRevD.47.1252; 1988, EUR PHYS J C, V3, P1	23	30	30	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	MAR	2000	13	2					197	212		10.1007/s100520000272		16	Physics, Particles & Fields	Physics	303YE	WOS:000086454800002		
J	Abbiendi, G; Ackerstaff, K; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, GA; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Theirgen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, GA; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Theirgen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		OPAL Collaboration	Tau decays with neutral kaons	EUROPEAN PHYSICAL JOURNAL C			English	Article							OPAL JET CHAMBER; PARTICLE IDENTIFICATION; MICROVERTEX DETECTOR; BRANCHING RATIO; LEP; PROGRAM	The branching ratio of the tau lepton to a neutral kaon meson is measured from a sample of approximately 200,000 tau decays recorded by the OPAL detector at centre-of-mass energies near the Z(0) resonance. The measurement is based on two samples which identify one-prong tau decays with K-L(0) and K-S(0) mesons. The combined branching ratios are measured ed to be B(tau(-) --> pi(-)(K) over bar(0)nu(tau)(9.33 +/- 0.68 +/- 0.49) x 10(-3) B(tau(-) --> pi(-)(K) over bar(0)[greater than or equal to 1 pi(0)]nu(tau)) = (3.24 +/- 0.74 +/- 0.66) x 10(-3) B(tau(-) --> (K-K0)[greater than or equal to 0 pi(0)]nu(tau)) = (3.30 +/- 0.55 +/- 0.39) x 10(-3) where the first error is statistical and the second systematic.	Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; CLRC, Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany	Abbiendi, G (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Bailey, Ian/C-4011-2012; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012; 	Abbiendi, Giovanni/0000-0003-4499-7562; Lafferty, George/0000-0003-0658-4919; Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Bailey, Ian/0000-0002-8020-3662; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348; Sachs, Kirsten/0000-0002-6912-5800; Giacomelli, Paolo/0000-0002-6368-7220; Watson, Nigel/0000-0002-8142-4678			ABBIENDI G, CERNEP99095; ACCIARRI M, 1995, PHYS LETT B, V352, P487, DOI 10.1016/0370-2693(95)00509-J; Ackerstaff K, 1999, EUR PHYS J C, V8, P183, DOI 10.1007/s100520050458; Ackerstaff K, 1998, EUR PHYS J C, V4, P193, DOI 10.1007/s100520050197; AKERS R, 1995, Z PHYS C PART FIELDS, V67, P389; ALEXANDER G, 1996, Z PHYS C, V700, P357; Alexander G, 1996, PHYS LETT B, V369, P163, DOI 10.1016/0370-2693(95)01600-7; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; JADACH S, 1994, COMPUT PHYS COMMUN, V79, P503, DOI 10.1016/0010-4655(94)90190-2; JADACH S, 1993, COMPUT PHYS COMMUN, V76, P361, DOI 10.1016/0010-4655(93)90061-G; Finkemeier M, 1996, Z PHYS C PART FIELDS, V69, P243, DOI 10.1007/s002880050024; BRAATEN E, 1990, INT J MOD PHYS A, V5, P2737, DOI 10.1142/S0217751X90001264; Barate R, 1999, EUR PHYS J C, V10, P1; BARATE R, CERNEP99026; Barate R, 1998, EUR PHYS J C, V4, P29, DOI 10.1007/s100520050184; BIEBEL O, 1992, NUCL INSTRUM METH A, V323, P169, DOI 10.1016/0168-9002(92)90284-B; Coan TE, 1996, PHYS REV D, V53, P6037, DOI 10.1103/PhysRevD.53.6037; DAS T, 1967, PHYS REV LETT, V19, P859, DOI 10.1103/PhysRevLett.19.859; Finkemeier M., 1997, Nuclear Physics B, Proceedings Supplements, V55, DOI 10.1016/S0920-5632(97)00213-2; HAUSCHILD M, 1992, NUCL INSTRUM METH A, V314, P74, DOI 10.1016/0168-9002(92)90501-T; Hauschild M, 1996, NUCL INSTRUM METH A, V379, P436, DOI 10.1016/0168-9002(96)00607-9; LEFEBVRE M, UNPUB NUCL I METH; MATSUDA T, 1968, PHYS REV, V171, P1743; ONEDA S, 1987, PHYS REV D, V35, P397, DOI 10.1103/PhysRevD.35.397; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x	28	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	MAR	2000	13	2					213	223		10.1007/s100520000317		11	Physics, Particles & Fields	Physics	303YE	WOS:000086454800003		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lawson, I; Layter, JG; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		Opal Collaboration	Measurements of inclusive semileptonic branching fractions of b hadrons in Z(0) decays	EUROPEAN PHYSICAL JOURNAL C			English	Article							FORWARD-BACKWARD ASYMMETRY; UB-VERTICAL-BAR; BEAUTY HADRONS; HEAVY QUARKS; DETECTOR; LEP; GAMMA(Z(0)->B(B)OVER-BAR)/GAMMA(Z(0)->HADRONS); FRAGMENTATION; RESONANCE; LEPTONS	A measurement of inclusive semileptonic branching fractions of b hadrons produced in Z(0) decays is presented. An enriched Z(0) --> b (b) over bar sample is obtained with a lifetime flavour-tagging technique. The leptonic events are then selected from, this sample, and classified according to their origin, which is determined by comparing the distribution of several kinematic variables using artificial neural network techniques. Using 3.6 million multihadronic events collected with the OPAL detector at energies near the Z(0) resonance, the values BR(b --> lX) = (10.84 +/- 0.09 (stat.) +/- 0.21 (syst.) (+0.21)(-0.13) (model)) BR(b --> c --> lX) = (8.39 +/- 0.15 (stat.) +/- 0.22 (syst.) -(+0.33)(0.29) (model)). are measured, where b denotes all weakly decaying b hadrons and l represents either e or mu The second error includes all experimental systematic uncertainties whereas the last error is due to uncertainties in modelling of the lepton momentum spectrum in semileptonic decays and b quark fragmentation. The average fraction of the beam energy carrried by the weakly decaying b hadron, < x(E)> is measured to be < x(E)> = 0.709 +/- 0.003 (stat.) +/- 0.003 (syst.) +/- 0.013 (model) where the modelling error is dominated by the choice of b fragmentation model. The agreement between data and various semileptonic decay models and fragmentation functions is also investigated.	Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bologna, Dipartmento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr REs Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, Inst Expt Phys 2, DESY, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany	Abbiendi, G (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.		Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012; Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012	Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348; Watson, Nigel/0000-0002-8142-4678; Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373			Abbiendi G, 1999, EUR PHYS J C, V8, P217, DOI 10.1007/s100520050460; ABREU P, 1995, Z PHYS C PART FIELDS, V66, P323; ACCIARRI M, 1994, PHYS LETT B, V335, P542, DOI 10.1016/0370-2693(94)90391-3; Acciarri M, 1996, Z PHYS C PART FIELDS, V71, P379, DOI 10.1007/s002880050184; ACTON PD, 1993, Z PHYS C PART FIELDS, V58, P523; ADRIANI O, 1992, PHYS LETT B, V292, P454, DOI 10.1016/0370-2693(92)91203-L; AKERS R, 1993, Z PHYS C PART FIELDS, V60, P199; AKERS R, 1994, Z PHYS C PART FIELDS, V61, P209; AKERS R, 1994, Z PHYS C PART FIELDS, V63, P197; AKERS R, 1995, Z PHYS C PART FIELDS, V67, P555; AKERS R, 1995, Z PHYS C PART FIELDS, V65, P17; AKERS R, 1997, Z PHYS C, V74, P423; Alexander G, 1996, Z PHYS C PART FIELDS, V69, P543, DOI 10.1007/s002880050059; ALEXANDER J, 1996, Z PHYS C, V69, P543; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P479; ALTARELLI G, 1982, NUCL PHYS B, V208, P365, DOI 10.1016/0550-3213(82)90226-7; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; PETERSON C, 1983, PHYS REV D, V27, P105, DOI 10.1103/PhysRevD.27.105; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; Acciarri M, 1998, PHYS LETT B, V436, P174, DOI 10.1016/S0370-2693(98)00941-1; Neubert M, 1997, NUCL PHYS B, V483, P339, DOI 10.1016/S0550-3213(96)00559-7; KARTVELISHVILI VG, 1978, PHYS LETT B, V78, P615, DOI 10.1016/0370-2693(78)90653-6; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; Abbiendi G, 1998, PHYS LETT B, V444, P539, DOI 10.1016/S0370-2693(98)01387-2; Barate R, 1999, EUR PHYS J C, V6, P555, DOI 10.1007/s100520050366; ISGUR N, 1989, PHYS REV D, V39, P799, DOI 10.1103/PhysRevD.39.799; SCORA D, 1995, PHYS REV D, V52, P2783, DOI 10.1103/PhysRevD.52.2783; BAGAN E, 1995, PHYS LETT B, V351, P546, DOI 10.1016/0370-2693(95)00437-P; BAI JZ, 1998, PHYS REV D, V5800, P92; Barate R, 1998, EUR PHYS J C, V5, P205, DOI 10.1007/s100520050263; BUSKULIC D, 1994, Z PHYS C PART FIELDS, V62, P179; Buskulic D, 1996, PHYS LETT B, V384, P414, DOI 10.1016/0370-2693(96)00926-4; COLLINS PDB, 1985, J PHYS G NUCL PARTIC, V11, P1289, DOI 10.1088/0305-4616/11/12/006; Hauschild M, 1996, NUCL INSTRUM METH A, V379, P436, DOI 10.1016/0168-9002(96)00607-9; HENDERSON S, 1992, PHYS REV D, V45, P2212, DOI 10.1103/PhysRevD.45.2212; HONSCHEID K, 1998, EUR PHYS J C, V3, P522; Hwang DS, 1996, PHYS REV D, V54, P5620, DOI 10.1103/PhysRevD.54.5620; *LEP COLL, 1996, NUCL INSTRUM METH A, V378, P101; *LEP EL WORK GROUP, CERNEP99015; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x	41	21	21	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	MAR	2000	13	2					225	240		10.1007/s100520000323		16	Physics, Particles & Fields	Physics	303YE	WOS:000086454800004		
J	Honjo, K; Doi, K				Honjo, K; Doi, K			Immunopathological study on the development of swine serum-induced bile duct lesions in BALB/c and DBA/2 mice	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						BALB/c mice; bile duct lesions; DBA/2 mice; immunopathology; serum, swine	IGE ANTIBODY-RESPONSE	To compare the difference in the development of swine serum (SS)-induced bile duct lesion (BDL) between high responder BALB/c and low responder DBA/2 mice, the mice of both strains injected with SS twice a week for up to 4 weeks were killed and examined immunopathologically after the 2nd, 4th, 6th and 8th SS-injection, respectively. In BALB/c mice, BDL developed rapidly following the SS-injections, and a slight enlargement of common bile ducts accompanied with infiltration of T helper cells and eosinophils was detected after the 2nd SS-injection. From the 4th injection on, BDL was characterized by proliferation of mucous glands, hyperplasia and hypertrophy of biliary and glandular epithelial cells, periductal fibrosis, infiltration of eosinophils, plasma cells and T helper cells, and increase of mast cells, resulting in more apparent enlargement of common bile ducts. Several hypertrophied biliary and glandular epithelial cells were positive for mouse immunoglobulins and SS. BDL subsided after cessation of the SS-treatment. On the other band, in DBA/2 mice, immune response and inflammatory reaction were very weak, and only slight BDL were detected.	Univ Tokyo, Fac Agr, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan	Honjo, K (reprint author), Univ Tokyo, Fac Agr, Dept Vet Pathol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Altmann H W, 1980, Curr Top Pathol, V69, P69; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; COFFMAN RL, 1986, J IMMUNOL, V136, P949; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; ROPER RL, 1990, J IMMUNOL, V145, P2644; WATANABE N, 1977, J IMMUNOL METHODS, V14, P381, DOI 10.1016/0022-1759(77)90149-1; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; SATO Y, 1986, AM J PATHOL, V125, P431; BESCHORNER WE, 1990, IMMUNOLOGY IMMUNOPAT, P589; BHAMARAPRAVATI N, 1978, AM J TROP MED HYG, V27, P787; BROWN WR, 1990, IMMUNOLOGY IMMUNOPAT, P73; DANIELE RP, 1990, ANNU REV PHYSIOL, V52, P177; DESMET VJ, 1986, PROG LIVER DIS, V4, P97; DOI K, 1987, BRIT J EXP PATHOL, V68, P511; DOI K, 1990, HISTOL HISTOPATHOL, V5, P39; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P303; FALLONFRIEDLANDER S, 1987, P NATL ACAD SCI USA, V84, P3244, DOI 10.1073/pnas.84.10.3244; GERBER MA, 1991, AM J PATHOL, V139, P1081; HUNTSMAN DB, 1959, AM J CLIN PATHOL, V31, P91; IMAOKA K, 1986, LAB ANIM, V20, P321, DOI 10.1258/002367786780808686; ISHIZAKA K, 1976, ADV IMMUNOL, V23, P1, DOI 10.1016/S0065-2776(08)60318-1; ISHIZAKA K, 1988, ANNU REV IMMUNOL, V6, P513; ISSEROFF H, 1977, SCIENCE, V198, P1157, DOI 10.1126/science.929191; ITAGAKI S, 1987, ACTA PATHOL JAPON, V37, P1867; Kelso A, 1990, Adv Immunol, V48, P69, DOI 10.1016/S0065-2776(08)60752-X; KITAMURA K, 1985, JPN J VET SCI, V47, P301; LILLIE RD, 1965, HISTOPATHOLOGIC TECH, P32; MACH JP, 1970, NATURE, V228, P1278, DOI 10.1038/2281278a0; MOSSMAN TR, 1991, IMMUNOL REV, V123, P209; SATO H, 1988, JPN J VET SCI, V50, P299; SATO Y, 1989, AM J PATHOL; TOMASI TB, 1985, ADV HOST DEFENSE MEC, V4, P31	32	1	1	GUSTAV FISCHER VERLAG	JENA	VILLENGANG 2, D-07745 JENA, GERMANY	0940-2993			EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	MAR	2000	52	1					57	65				9	Pathology; Toxicology	Pathology; Toxicology	303QY	WOS:000086434600008		
J	Kumagai, A; Yamaoka, S; Takahashi, K; Fukuda, H; Wakabayashi, H				Kumagai, A; Yamaoka, S; Takahashi, K; Fukuda, H; Wakabayashi, H			Waterborne transmission of Flavobacterium psychrophilum in coho salmon eggs	FISH PATHOLOGY			English	Article						waterborne transmission; Flavobacterium psychrophilum; cold-water disease; coho salmon; egg; Oncorhynchus kisutch	CYTOPHAGA-PSYCHROPHILA; DISEASE	Fertilized coho salmon Oncorhynchus kisutch eggs were immersed in diluted broth culture of Flavobacterium psychrophilum (1.0 x 10(8), 1.0 x 10(6), 1.0 x 10(4) CFU/mL) for 30 min before water-hardening, after water-hardening and at eyed-egg stages. Just after exposure to the bacteria, the eggs were disinfected with povidone-iodine, and then discretely incubated in flowing water. After 7-28 days of incubation, F. psychrophilum was isolated only from the egg group which had been exposed to 1.0 x 10(8) CFU/mL before water-hardening. No bacteria were detected from the other egg groups exposed to 1.0 x 10(6) or 1.0 x 10(4) CFU/mL as well as the groups exposed to 1.0 x 10(8) CFU/mL after water-hardening or the group at the eyed-egg stage. The viable counts of F. psychrophilum in the contents of the infected eggs ranged from 10(3) to 10(7) CFU/g. Observations on the frozen sections stained by indirect immunofluorescent antibody technique revealed that many F. psychrophilum cells were located within the infected eggs at the eyed stage. It was concluded that F. psychrophilum entered the eggs during the water-hardening stage.	Miyagi Prefectural Freshwater Fisheries Expt Stn, Taiwa, Miyagi 9813625, Japan; Miyagi Prefecture Fisheries Res & Dev Ctr, Ishinomaki, Miyagi 9862135, Japan; Tokyo Univ Fisheries, Dept Aquat Biosci, Lab Aquat Pathol, Tokyo 1080075, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1138657, Japan	Kumagai, A (reprint author), Natl Res Inst Aquaculture, Fisheries Agcy, Nansei, Mie 5160193, Japan.	akumagai@nria.affrc.go.jp					Izumi S, 1997, FISH PATHOL, V32, P169; Brown LL, 1997, DIS AQUAT ORGAN, V29, P213, DOI 10.3354/dao029213; YOUSIF AN, 1994, DIS AQUAT ORGAN, V19, P15, DOI 10.3354/dao019015; Kumagai A, 1998, FISH PATHOL, V33, P123; Kumagai A, 1997, FISH PATHOL, V32, P231; LORENZEN E, 1992, DIS AQUAT ORGAN, V13, P231, DOI 10.3354/dao013231; WAKABAYASHI H, 1991, Fish Pathology, V26, P211	7	24	26	JAPAN SOC FISH PATHOL DEPT FISHERIES-FAC AGR	TOKYO	ACADEMY CENTER 358-5, YAMABUKI-CHO, SHINJUKU-KU, TOKYO, 162-0801, JAPAN	0388-788X			FISH PATHOL	Fish Pathol.	MAR	2000	35	1					25	28				4	Fisheries; Veterinary Sciences	Fisheries; Veterinary Sciences	295VB	WOS:000085987600005		
J	Yamada, Y; Kaku, Y; Wakabayashi, H				Yamada, Y; Kaku, Y; Wakabayashi, H			Phylogenetic intrarelationships of atypical Aeromonas salmonicida isolated in Japan as determined by 16S rDNA sequencing	FISH PATHOLOGY			English	Article						atypical Aeromonas salmonicida; phylogeny; 16S rDNA; PCR	INFECTION	Based on the nucleotide sequences of 16S rDNA, Japanese isolates of atypical Aeromonas salmonicida from different fish species can be divided into four groups; isolates from each species of fish (including fish reared in similar culture conditions) always belonged to the same group. Isolates from goldfish Carassius auratus had sequences identical to those from goldfish in the USA and formed the first group. Isolates from Japanese eel Anguilla japonica and marine fishes (greenling Hexagrammos otakii, Japanese flounder Paralichthys olivaceus, shotted halibut Eopsetta grigorjewi and Schlegel's black rockfish Sebastes schlegeli) formed the second group, and had identical sequences with those of A. salmonicida subsp. achromogenes JCM7875(T), A. salmonicida subsp. masoucida JCM7873(T) and A. salmonicida subsp. smithia ATCC49393(T). The third and fourth groups composed of isolates from coloured carp Cyprinus carpio and common carp C. carpio, respectively. This indicates that the expansion of ulcerative disease in recent years is caused by strains which have phyletic lines different from goldfish isolates.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1138657, Japan	Yamada, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Yayoi 1-1-1, Tokyo 1138657, Japan.	taro57060@yahoo.co.jp					HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Iida T., 1984, Fish Pathology, V19, P109; Iida T, 1997, FISH PATHOL, V32, P65; Izumikawa K, 1997, FISH PATHOL, V32, P67; Kaku Y, 1999, FISH PATHOL, V34, P155; Kitao T., 1984, Fish Pathology, V19, P113; Kwon MG, 1997, FISH PATHOL, V32, P109; NAKATSUGAWA T, 1994, FISH PATHOL, V29, P193; OTSUKA H, 1984, FISH PATHOL, V19, P101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SHOTTS EB, 1980, J FISH DIS, V3, P181, DOI 10.1111/j.1365-2761.1980.tb00442.x; TAKAHASHI K, 1975, FISH PATHOL, V9, P174; WEISBURG WG, 1991, J BACTERIOL, V173, P697; WILSON K, 1987, CURRENT PROTOCOLS MO	15	3	5	JAPAN SOC FISH PATHOL DEPT FISHERIES-FAC AGR	TOKYO	ACADEMY CENTER 358-5, YAMABUKI-CHO, SHINJUKU-KU, TOKYO, 162-0801, JAPAN	0388-788X			FISH PATHOL	Fish Pathol.	MAR	2000	35	1					35	40				6	Fisheries; Veterinary Sciences	Fisheries; Veterinary Sciences	295VB	WOS:000085987600007		
J	Kiryu, I; Ototake, M; Nakanishi, T; Wakabayashi, H				Kiryu, I; Ototake, M; Nakanishi, T; Wakabayashi, H			The uptake of fluorescent microspheres into the skin, fins and gills of rainbow trout during immersion	FISH PATHOLOGY			English	Article						migrating epithelial cell; uptake; fluorescent microsphere; immersion; rainbow trout; macrophage; injury	SALMO-GAIRDNERI RICHARDSON; PROLONGED EXPOSURE; ATLANTIC SALMON; ANTIGEN UPTAKE; IMMUNIZATION; REPAIR; WOUNDS; CELLS; FISH	To elucidate the process of the uptake of suspended particles into the skin, fins and gills of rainbow trout Oncorhynchus mykiss, 100 fingerlings were immersed in a suspension of 1 mu m diameter fluorescent microspheres and rinsed with water. The fate of microspheres adhering to body surface was traced for elapsed times ranging from 1 min to 24 h. Although most microspheres were removed in a 2 h-rinse with water, a few were observed by light microscopy to be located in both epidermal and dermal tissues which had microscopic injuries. As observed by electron microscopy, microspheres were taken up by migrating epithelial cells, or embedded in the dermis covered with these cells. Some of those microspheres embedded in dermis were endocytosed by macrophages. Such features were confirmed in artificial wound experiments. We conclude that microscopic injuries to trout could be an important route for the uptake of antigen administered by immersion, 2 to 24 h after fish suffer from injuries.	Natl Res Inst Aquaculture, Tamaki, Mie 5190423, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1138657, Japan; Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Fish Pathol, Fujisawa, Kanagawa 2528570, Japan	Kiryu, I (reprint author), Natl Res Inst Aquaculture, 224-1 Hiruta, Tamaki, Mie 5190423, Japan.	ikunari@nria-tmk.affrc.go.jp					Sanders EJ, 1995, INT REV CYTOL, V163, P105; Moore JD, 1998, FISH SHELLFISH IMMUN, V8, P393, DOI 10.1006/fsim.1998.0143; ANDERSON CD, 1975, J FISH BIOL, V7, P173, DOI 10.1111/j.1095-8649.1975.tb04588.x; IGER Y, 1990, J FISH BIOL, V36, P421, DOI 10.1111/j.1095-8649.1990.tb05622.x; PELETEIRO MC, 1990, J FISH DIS, V13, P225, DOI 10.1111/j.1365-2761.1990.tb00777.x; Asbakk K, 1998, J MAR BIOTECHNOL, V6, P30; Bereiter-Hahn J, 1986, BIOL INTEGUMENT, P443; GOLDES SA, 1986, J FISH DIS, V9, P147, DOI 10.1111/j.1365-2761.1986.tb00996.x; HICKEY GM, 1982, J EXP MAR BIOL ECOL, V57, P149, DOI 10.1016/0022-0981(82)90189-7; Kiryu I, 1999, FISH PATHOL, V34, P177; MITTAL AK, 1974, ACTA ANAT, V88, P424; Ototake M, 1998, FISH PATHOL, V33, P91; Ototake M, 1999, FISH PATHOL, V34, P151; PHROMSUTHIRAK P, 1977, J FISH BIOL, V11, P193, DOI 10.1111/j.1095-8649.1977.tb04113.x; PLATT H., 1963, JOUR PATH AND BACTERIOL, V86, P113, DOI 10.1002/path.1700860114; RAI AK, 1983, EXPERIENTIA, V39, P520, DOI 10.1007/BF01965185; ROUBAL FR, 1988, J FISH BIOL, V32, P545, DOI 10.1111/j.1095-8649.1988.tb05394.x; ZAPATA AG, 1987, J FISH BIOL, V31, P209, DOI 10.1111/j.1095-8649.1987.tb05315.x	18	9	9	JAPAN SOC FISH PATHOL DEPT FISHERIES-FAC AGR	TOKYO	ACADEMY CENTER 358-5, YAMABUKI-CHO, SHINJUKU-KU, TOKYO, 162-0801, JAPAN	0388-788X			FISH PATHOL	Fish Pathol.	MAR	2000	35	1					41	48				8	Fisheries; Veterinary Sciences	Fisheries; Veterinary Sciences	295VB	WOS:000085987600008		
J	Matsuhashi, N; Nakajima, A; Suzuki, A; Yazaki, Y; Takazoe, M				Matsuhashi, N; Nakajima, A; Suzuki, A; Yazaki, Y; Takazoe, M			Long-term outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn's disease	GASTROINTESTINAL ENDOSCOPY			English	Article; Proceedings Paper	Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy	MAY 17-28, 1998	NEW ORLEANS, LOUISIANA	Amer Soc Gastrointestinal Endoscopy			BALLOON DILATION		Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138655, Japan; Social Hlth Insurance Med Ctr, Tokyo, Japan	Matsuhashi, N (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						BLOMBERG B, 1991, ENDOSCOPY, V23, P195, DOI 10.1055/s-2007-1010654; FAZIO VW, 1993, DIS COLON RECTUM, V36, P355, DOI 10.1007/BF02053938; BREYSEM Y, 1992, GASTROINTEST ENDOSC, V38, P142, DOI 10.1016/S0016-5107(92)70379-4; BROWER RA, 1986, GASTROINTEST ENDOSC, V32, P38, DOI 10.1016/S0016-5107(86)71728-8; DOBSON HM, 1988, CLIN RADIOL, V39, P202; KIRTLEY DW, 1987, GASTROINTEST ENDOSC, V33, P399, DOI 10.1016/S0016-5107(87)71660-5; Matsuhashi N, 1997, GASTROINTEST ENDOSC, V45, P176, DOI 10.1016/S0016-5107(97)70243-8; SAYFAN J, 1989, BRIT J SURG, V76, P335, DOI 10.1002/bjs.1800760406	8	40	42	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0016-5107			GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAR	2000	51	3					343	345		10.1016/S0016-5107(00)70366-X		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	293LY	WOS:000085854400021		
J	Sugita, K; Taki, T; Hayashi, Y; Shimaoka, H; Kumazaki, H; Inoue, H; Konno, Y; Taniwaki, M; Kurosawa, H; Eguchi, M				Sugita, K; Taki, T; Hayashi, Y; Shimaoka, H; Kumazaki, H; Inoue, H; Konno, Y; Taniwaki, M; Kurosawa, H; Eguchi, M			MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia	GENES CHROMOSOMES & CANCER			English	Article							11Q23 CHROMOSOMAL TRANSLOCATIONS; DROSOPHILA-TRITHORAX; GENE REARRANGEMENTS; ALL-1 GENE; CHILDREN; PROTEIN; FUSES; ACETYLTRANSFERASE; FREQUENCY; CREB	We describe a boy with Fanconi anemia (FA) who developed acute lymphoblastic leukemia (ALL) (FAB-L I) followed by acute myeloid leukemia (AML) (FAB-M5) at relapse. The patient was diagnosed with early pre-B-cell ALL without preceding aplastic anemia and was treated with ALL-oriented chemotherapy which included doxorubicin (a total dose of 140 mg/m(2) administered), which is a topoisomerase II inhibitor. Complete remission was obtained, but after 38 weeks AML developed. The karyotype of ALL cells at diagnosis showed 46,XY, and that of AML cells at relapse was 46,XY, t(11;16)(q23;p13). An MLL gene rearrangement and MLL-CBP chimeric mRNA were found in AML, but not in ALL. A diagnosis of FA was confirmed by an increased number of chromosomal breaks and rearrangements in peripheral blood lymphocytes cultured with mitogen in the presence of mitomycin C. We conclude that this FA patient developed ALL followed by a therapy-related t(11;16)-AML resulting in an MLL-CBP fusion. Further examination of such patients would shed light on leukemogenesis in FA patients. (C) 2000 Wiley-Liss, Inc.	Dokkyo Univ, Sch Med, Dept Pediat, Div Hematol, Mibu, Tochigi 32102, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 113, Japan; Dokkyo Univ, Sch Med, Dept Clin Lab, Mibu, Tochigi, Japan; Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan	Sugita, K (reprint author), Dokkyo Univ, Sch Med, Dept Pediat, Div Hematol, 880 Kitakobayashi, Mibu, Tochigi 32102, Japan.						ALTER BP, 1992, CANCER GENET CYTOGEN, V58, P206, DOI 10.1016/0165-4608(92)90116-P; Rowley JD, 1997, BLOOD, V90, P535; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BUTTURINI A, 1994, BLOOD, V84, P1650; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Taki T, 1996, LEUKEMIA, V10, P1303; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; YETGIN S, 1994, AM J HEMATOL, V45, P94, DOI 10.1002/ajh.2830450117; Ida K, 1997, BLOOD, V90, P4699; PUI CH, 1989, NEW ENGL J MED, V321, P136, DOI 10.1056/NEJM198907203210302; Behm FG, 1996, BLOOD, V87, P2870; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; FELIX CA, 1995, BLOOD, V85, P3250; Taki T, 1997, BLOOD, V89, P3945; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; LIU JM, 1994, BLOOD, V84, P3995; MCCABE NR, 1992, P NATL ACAD SCI USA, V89, P11794, DOI 10.1073/pnas.89.24.11794; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; Satake N, 1997, GENE CHROMOSOME CANC, V20, P60, DOI 10.1002/(SICI)1098-2264(199709)20:1<60::AID-GCC9>3.3.CO;2-O; SUGITA K, 1993, AM J PEDIAT HEMATOL, V15, P99; YAMAMOTO K, 1993, ONCOGENE, V8, P2617	27	23	24	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	1045-2257			GENE CHROMOSOME CANC	Gene Chromosomes Cancer	MAR	2000	27	3					264	269		10.1002/(SICI)1098-2264(200003)27:3<264::AID-GCC6>3.0.CO;2-#		6	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	277PT	WOS:000084942500006		
J	Munakata, T; Adachi, N; Yokoyama, N; Kuzuhara, T; Horikoshi, M				Munakata, T; Adachi, N; Yokoyama, N; Kuzuhara, T; Horikoshi, M			A human homologue of yeast anti-silencing factor has histone chaperone activity	GENES TO CELLS			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; NUCLEOSOME ASSEMBLY PROTEIN-1; TRANSCRIPTION FACTOR-BINDING; DNA-REPLICATION INVITRO; ACTIVATING FACTOR-I; CHROMATIN STRUCTURE; SACCHAROMYCES-CEREVISIAE; STIMULATES TRANSCRIPTION; REMODELING FACTOR	Background: Structural changes in chromatin play essential roles in regulating eukaryotic gene expression. Silencing, potent repression of transcription in Saccharomyces cerevisiae, occurs near telomeres and at the silent mating-type loci, as well as at rDNA loci. This type of repression relates to the condensation of chromatin that occurs in the heterochromatin of multicellular organisms. Anti-silencing is a reaction by which silenced loci are de-repressed. Genetic studies revealed that several factors participate in the anti-silencing reaction. However, actions of factors and molecular mechanisms underlying anti-silencing remain unknown. Results: Here we report the functional activity of a highly evolutionarily conserved human factor termed CIA (CCG1-interacting factor A), whose budding yeast homologue ASF1 has anti-silencing activity. Using yeast two-hybrid screening, we isolated histone H3 as an interacting factor of CIA. We also showed that CIA binds to histones H3/H4 in vitro, and that the interacting region of histone H3 is located in the C-terminal helices. Considering the functional role of CIA as a histone-interacting protein, we found that CIA forms a nucleosome-like structure with DNA and histones. Conclusions: These results show that human CIA, whose yeast homologue ASF1 is an anti-silencing factor, possesses histone chaperone activity. This leads to a better understanding of the relationship between chromatin structural changes and anti-silencing processes.	Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol Corp, Exploratory Res Adv Technol, Horikoshi Gene Selector Project, Tsukuba, Ibaraki 3002635, Japan	Horikoshi, M (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; DeRubertis F, 1996, NATURE, V384, P589; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; KLEFF S, 1995, J BIOL CHEM, V270, P24674; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cb.11.110195.002511; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Ito T, 1997, GENES CELLS, V2, P593, DOI 10.1046/j.1365-2443.1997.1500348.x; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; Luger K, 1997, NATURE, V389, P251; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Singer MS, 1998, GENETICS, V150, P613; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; LESCURE A, 1994, EMBO J, V13, P1166; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Bando M, 1997, J BIOCHEM-TOKYO, V121, P591; CHEN H, 1994, EMBO J, V13, P380; EARNSHAW WC, 1980, CELL, V21, P373, DOI 10.1016/0092-8674(80)90474-2; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Freeman L, 1996, P NATL ACAD SCI USA, V93, P12780, DOI 10.1073/pnas.93.23.12780; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HORIKOSHI M, 1989, NATURE, V341, P299, DOI 10.1038/341299a0; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; ISHIMI Y, 1984, EUR J BIOCHEM, V142, P431, DOI 10.1111/j.1432-1033.1984.tb08305.x; Kamakaka RT, 1998, GENETICS, V149, P903; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; KIM TK, 1994, NATURE, V369, P252, DOI 10.1038/369252a0; Kim Tae Kook, 1994, Journal of Biological Chemistry, V269, P4891; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; KLEINSCHMIDT JA, 1988, EMBO J, V7, P1605; KLEINSCHMIDT JA, 1982, CELL, V29, P799, DOI 10.1016/0092-8674(82)90442-1; KOKUBO T, 1994, NATURE, V367, P484, DOI 10.1038/367484a0; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; MATSUMOTO K, 1993, J BIOL CHEM, V268, P10582; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; MEYERS RE, 1993, MOL CELL BIOL, V13, P7953; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; POON D, 1993, J BIOL CHEM, V268, P5005; RADEBAUGH CA, 1994, MOL CELL BIOL, V14, P597; Sandbrink R, 1994, Neurobiol Dis, V1, P13, DOI 10.1006/nbdi.1994.0003; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SEIPEL K, 1993, NUCLEIC ACIDS RES, V21, P5609, DOI 10.1093/nar/21.24.5609; Sherman JM, 1997, TRENDS GENET, V13, P308, DOI 10.1016/S0168-9525(97)01198-0; Smith JS, 1999, MOL CELL BIOL, V19, P3184; SMITH S, 1991, EMBO J, V10, P971; Travers A, 1999, CELL, V96, P311, DOI 10.1016/S0092-8674(00)80543-7; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; TUGENDREICH S, 1993, P NATL ACAD SCI USA, V90, P10031, DOI 10.1073/pnas.90.21.10031; Utley RT, 1998, NATURE, V394, P498; Wolffe A, 1998, CHROMATIN STRUCTURE; Wolffe AP, 1997, GENES CELLS, V2, P291, DOI 10.1046/j.1365-2443.1997.1260323.x; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S	97	95	99	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1356-9597			GENES CELLS	Genes Cells	MAR	2000	5	3					221	233		10.1046/j.1365-2443.2000.00319.x		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	308EV	WOS:000086698300006		
J	Ozawa, K; Nagahara, H				Ozawa, K; Nagahara, H			Kinetics of diffusion-controlled evaporation of Fe-Mg olivine: Experimental study and implication for stability of Fe-rich olivine in the solar nebula	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							TYPE-3 ORDINARY CHONDRITES; FAYALITIC OLIVINE; DARK INCLUSIONS; ORIGIN; ALLENDE; MATRICES; SYSTEM; CONDENSATION; FORSTERITE; COMPONENTS	Evaporation is a process that caused chemical fractionation in the solar nebula. The evaporation rates of meteorite-forming minerals and silicate melts are key parameters for constraining the timescale of high temperature processes in the early solar nebula and for understanding the mechanisms of cosmochemical fractionation. The kinetics of evaporation of olivine (initial Fo = 92), the most common silicate in meteorites, was experimentally investigated at 1414 degrees C for various duration under continuous evacuation. The surface of olivine becomes more magnesian and the interior becomes zoned as evaporation proceeds, indicating preferential evaporation of the fayalite (Fa) component. The weight loss, surface composition, and interior zoning profile were analyzed using a semi-infinite one-dimensional diffusion model with boundary migration, and the controlling model parameters were optimized by fitting the experimental results. The evaporation rate of olivine shows notable composition and orientation dependence. As olivine becomes more magnesian, the evaporation rates of the (100), (010), and (001) surfaces decrease, among which the rate at the (001) surface is greatest (1.0 mu m/h at Fo = 91.8), which is about 2 orders of magnitude faster than that of pure synthetic forsterite. The estimated Fe-Mg fractionation factor shows anisotropy ranging from 0.017 to 0.035, which is significantly greater than the equilibrium value of the Fe-Mg distribution coefficient between olivine and gas, suggesting kinetic suppression of evaporation of the Fa component. The Fe-Mg interdiffusion coefficient at 1414 degrees C, which also shows notable composition and orientation dependence, is estimated to be 8.7 X 10(-15) m(2)/sec along the c-axis. The results were applied to constrain the timescale of heating for a spherical Fo50 olivine grain to retain the Fa component. Olivine dust similar to 1 mu m in diameter can retain 80% of the initial Fa component for one minute in vacuum, and for similar to 30 min at similar to 10 Pa P-H2 when heated at 1414 degrees C. Therefore, Fo50 olivine in chondrite matrices could have survived an incipient heating event depending on the ambient hydrogen pressure, if they were originally present in the solar nebula. Copyright (C) 2000 Elsevier Science Ltd.	Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan; Univ Tokyo, Fac Sci, Inst Geol, Tokyo 1130033, Japan	Ozawa, K (reprint author), Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan.						ALEXANDER CMO, 1989, EARTH PLANET SC LETT, V95, P187, DOI 10.1016/0012-821X(89)90096-4; KROT AN, 1995, METEORITICS, V30, P748; NAGAHARA H, 1994, GEOCHIM COSMOCHIM AC, V58, P1951, DOI 10.1016/0016-7037(94)90426-X; Dohmen R, 1998, AM MINERAL, V83, P970; HASHIMOTO A, 1990, NATURE, V347, P53, DOI 10.1038/347053a0; Watson EB, 1996, GEOCHIM COSMOCHIM AC, V60, P5013, DOI 10.1016/S0016-7037(96)00299-2; Wang JH, 1999, GEOCHIM COSMOCHIM AC, V63, P953, DOI 10.1016/S0016-7037(98)00286-5; BRADY JB, 1975, AM J SCI, V275, P954; Brearley A. J., 1996, CHONDRULES PROTOPLAN, P137; BUENING DK, 1973, J GEOPHYS RES, V78, P6852, DOI 10.1029/JB078i029p06852; Chakraborty S, 1997, J GEOPHYS RES-SOL EA, V102, P12317, DOI 10.1029/97JB00208; Clark A. M., 1971, Diffusion processes; Crank J, 1984, FREE MOVING BOUNDARY; DAVIS AM, 1990, NATURE, V347, P655, DOI 10.1038/347655a0; EBEL DS, 1998, LUNAR PLANET SCI C, V29, P1421; Housley R. M., 1983, CHONDRULES THEIR ORI, P145; HUA X, 1995, GEOCHIM COSMOCHIM AC, V59, P563, DOI 10.1016/0016-7037(94)00383-W; INOUE T, 1981, J CRYST GROWTH, V55, P307, DOI 10.1016/0022-0248(81)90028-2; *JANAF, 1982, THERM TABL S; JOHNSON CA, 1990, GEOCHIM COSMOCHIM AC, V54, P819, DOI 10.1016/0016-7037(90)90376-V; JUREWICZ AJG, 1988, CONTRIB MINERAL PETR, V99, P186, DOI 10.1007/BF00371460; Kojima T, 1996, GEOCHIM COSMOCHIM AC, V60, P2651, DOI 10.1016/0016-7037(96)00116-0; Krot AN, 1997, METEORIT PLANET SCI, V32, P31; KURAT G, 1989, Z NATURFORSCH A, V44, P988; LASAGA AC, 1979, GEOCHIM COSMOCHIM AC, V43, P455, DOI 10.1016/0016-7037(79)90158-3; LASAGA AC, 1982, AM J SCI, V282, P1264; LASAGA AC, 1980, AM MINERAL, V65, P1237; Misener D. J, 1974, GEOCHEMICAL TRANSPOR, P117; MORIOKA M, 1981, GEOCHIM COSMOCHIM AC, V45, P1573, DOI 10.1016/0016-7037(81)90286-6; NAGAHARA H, 1988, NATURE, V331, P516, DOI 10.1038/331516a0; NAGAHARA H, 1987, EARTH PLANET SC LETT, V85, P537, DOI 10.1016/0012-821X(87)90147-6; NAGAHARA H, 1999, P JAPAN ACAD B, V75, P1; Nagahara H, 1996, GEOCHIM COSMOCHIM AC, V60, P1445, DOI 10.1016/0016-7037(96)00014-2; NAGAHARA H, 1984, GEOCHIM COSMOCHIM AC, V48, P2581, DOI 10.1016/0016-7037(84)90307-7; Press W.H., 1992, NUMERICAL RECIPES C; RIDEAL E, 1952, PROC R SOC LON SER-A, V210, P291, DOI 10.1098/rspa.1952.0001; SACK RO, 1989, CONTRIB MINERAL PETR, V102, P41, DOI 10.1007/BF01160190; Tsuchiyama A., 1998, MINERAL J, V20, P113, DOI 10.2465/minerj.20.113; Tsuchiyama A., 1998, LUNAR PLANET SCI C, V29, P1538; TSUCHIYAMA A, 1995, LUNAR PLANET SCI, V26, P1423; Tsuchiyama A, 1999, GEOCHIM COSMOCHIM AC, V63, P2451, DOI 10.1016/S0016-7037(99)00190-8; WANG J, 1993, LUNAR PLANET SCI, V24, P1479; WANG J, 1994, 1107 ICOG USGS; WANG J, 1991, LUNAR PLANET SCI, V22, P1461; Weisberg MK, 1998, METEORIT PLANET SCI, V33, P1087; Weisberg MK, 1997, METEORIT PLANET SCI, V32, P791; WOOD JA, 1993, GEOCHIM COSMOCHIM AC, V57, P2377, DOI 10.1016/0016-7037(93)90575-H; Young ED, 1998, GEOCHIM COSMOCHIM AC, V62, P3109, DOI 10.1016/S0016-7037(98)00213-0	48	17	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037			GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	MAR	2000	64	5					939	955		10.1016/S0016-7037(99)00353-1		17	Geochemistry & Geophysics	Geochemistry & Geophysics	289NZ	WOS:000085630000014		
J	Utsugi, M; Nishida, Y; Sasai, Y				Utsugi, M; Nishida, Y; Sasai, Y			Piezomagnetic potentials due to an inclined rectangular fault in a semi-infinite medium	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						inclined fault; piezomagnetic potential; seismomagnetic effect		Analytical solutions for the piezomagnetic potentials are derived for strike-slip, dip-slip and tensile-opening fault motions with arbitrary dip and strike angles, so as to be applicable in various types of earthquakes. These solutions are expressed as the composition of elementary functions which are identical to the magnetic potentials produced by magnetic dipoles, quadrupoles and octupoles distributed on the fault plane and other planes. Therefore, the geomagnetic field changes due to the piezomagnetic effect are expressed by the superposition of the fields produced by these equivalent sources. Examples of calculated results show characteristic features for various types of fault motions as follows: (1) the pattern of the geomagnetic field changes becomes significantly different depending on the strike direction, although the maximum amplitude is almost the same for all directions; (2) the geomagnetic field change reaches a maximum at a dip angle of 90 degrees for strike-slip and tensile-opening fault motions and at 45 degrees for dip-slip fault motion.	Hokkaido Univ, Grad Sch Sci, Div Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan; Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Utsugi, M (reprint author), Hokkaido Univ, Grad Sch Sci, Div Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan.						NAGATA T, 1970, TECTONOPHYSICS, V9, P167, DOI 10.1016/0040-1951(70)90015-6; JOHNSTON MJS, 1994, B SEISMOL SOC AM, V84, P792; STEKETEE JA, 1958, CAN J PHYS, V36, P192; STACEY FD, 1965, PURE APPL GEOPHYS, V62, P96, DOI 10.1007/BF00875290; Maruyama T., 1964, B EARTHQ RES I TOKYO, V42, P289; SASAI Y., 1980, B EARTHQ RES I TOKYO, V55, P387; SASAI Y, 1994, J GEOMAGN GEOELECTR, V46, P329; Sasai Y, 1991, B EARTHQ RES I TOKYO, V66, P585; SASAI Y, 1991, J PHYS EARTH, V39, P299; Stacey F. D., 1964, PURE APPL GEOPHYS, V58, P5, DOI 10.1007/BF00879136; STACEY FD, 1972, PURE APPL GEOPHYS, V97, P146, DOI 10.1007/BF00875958	11	23	23	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0956-540X			GEOPHYS J INT	Geophys. J. Int.	MAR	2000	140	3					479	492		10.1046/j.1365-246X.2000.00953.x		14	Geochemistry & Geophysics	Geochemistry & Geophysics	286RT	WOS:000085459900002		
J	Sato, T; Kennett, BLN				Sato, T; Kennett, BLN			Two-dimensional inversion of refraction traveltimes by progressive model development	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						genetic algorithms; non-linear 2-D refraction inversion; progressive model development; pseudo-2-D structure; turning point approximation	CRUSTAL STRUCTURE; VELOCITY STRUCTURE; NANKAI TROUGH	We develop a systematic approach for the analysis of 2-D refraction experiments using traveltimes that allows progressive improvement of velocity structure through a sequence from 1-D models to pseudo-2-D models, and then 2-D models. The approach consists of three steps. First, 1-D velocity models are constructed for each segment of the profile using a genetic algorithm inversion, and then pseudo-2-D models are constructed using a turning point approximation. The purpose of this step is to provide an approximate image of 2-D velocity structure, and to infer the number and general location of layer boundaries. The second step uses 1-D layered modelling, again with a pseudo-2-D conversion, to generate a rough 2-D layered structure. The third step consists of smoothing the pseudo-2-D model in order to create initial models for use in 2-D inversion and the construction of a 2-D model using a Bayesian formulation of non-linear iterative inversion. All the steps exploit traveltime data for the first arrival and do not use any trial-and-error forward modelling. The progressive approach is efficient because the results of each step are employed as the initial model for the next step, The method is applied to real data from an along-strike experiment and also to a related synthetic example so that the quality of the solution can be judged. The results indicate that the method is robust, and this is confirmed by a further synthetic example that represents a survey across a trench and dipping subduction zone. The systematic approach to the inversion of refraction data enables a complex inversion to be undertaken in 1 or 2 days, The sequential approach allows the incorporation of additional information if desired.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan	Sato, T (reprint author), Chiba Univ, Fac Sci, Dept Earth Sci, Chiba 2638522, Japan.			Kennett, Brian/0000-0003-2206-5350			Akaike H., 1980, BAYESIAN STAT, P143; YABUKI T, 1992, GEOPHYS J INT, V109, P363, DOI 10.1111/j.1365-246X.1992.tb00102.x; ZELT CA, 1992, GEOPHYS J INT, V108, P16, DOI 10.1111/j.1365-246X.1992.tb00836.x; Mochizuki K, 1998, GEOPHYS RES LETT, V25, P2301, DOI 10.1029/98GL51867; ZELT CA, 1994, J GEOPHYS RES-SOL EA, V99, P11687, DOI 10.1029/93JB02764; McCaughey M, 1997, GEOPHYS J INT, V131, P87, DOI 10.1111/j.1365-246X.1997.tb00596.x; Sato T, 1998, GEOPHYS RES LETT, V25, P4011, DOI 10.1029/1998GL900104; SAMBRIDGE M, 1992, GEOPHYS J INT, V109, P323, DOI 10.1111/j.1365-246X.1992.tb00100.x; Marquering H, 1998, GEOPHYS J INT, V132, P521, DOI 10.1046/j.1365-246X.1998.00426.x; DIEBOLD JB, 1981, GEOPHYSICS, V46, P238, DOI 10.1190/1.1441196; JACKSON DD, 1985, J GEOPHYS RES-SOLID, V90, P581, DOI 10.1029/JB090iB01p00581; KENNETT BLN, 1990, PHYS EARTH PLANET IN, V59, P134, DOI 10.1016/0031-9201(90)90220-R; KENNETT BLN, 1976, PURE APPL GEOPHYS, V114, P647, DOI 10.1007/BF00875658; TOOMEY DR, 1994, J GEOPHYS RES-SOL EA, V99, P24135, DOI 10.1029/94JB01942; WIGGINS RA, 1969, J GEOPHYS RES, V74, P3171, DOI 10.1029/JB074i012p03171	15	8	8	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0956-540X			GEOPHYS J INT	Geophys. J. Int.	MAR	2000	140	3					543	558		10.1046/j.1365-246X.2000.00038.x		16	Geochemistry & Geophysics	Geochemistry & Geophysics	286RT	WOS:000085459900008		
J	Uyeshima, M; Schultz, A				Uyeshima, M; Schultz, A			Geoelectromagnetic induction in a heterogeneous sphere: a new three-dimensional forward solver using a conservative staggered-grid finite difference method	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						electrical conductivity; electromagnetic induction; electromagnetic modelling; mantle; numerical techniques	LONG PERIOD MAGNETOTELLURICS; ECCENTRICALLY NESTED SPHERES; ELECTRICAL-CONDUCTIVITY; GEOMAGNETIC INDUCTION; UPPER-MANTLE; MID-MANTLE; EQUATIONS; OLIVINE; GRADIENT; HYDROGEN	A conservative staggered-grid finite difference method is presented for computing the electromagnetic induction response of an arbitrary heterogeneous conducting sphere by external current excitation. This method is appropriate as the forward solution for the problem of determining the electrical conductivity of the Earth's deep interior. This solution in spherical geometry is derived from that originally presented by Mackle et al. (1994) for Cartesian geometry. The difference equations that we solve are second order in the magnetic field H, and are derived from the integral form of Maxwell's equations on a staggered grid in spherical coordinates. The resulting matrix system of equations is sparse, symmetric, real everywhere except along the diagonal and ill-conditioned. The system is solved using the minimum residual conjugate gradient method with preconditioning by incomplete Cholesky decomposition of the diagonal sub-blocks of the coefficient matrix. In order to ensure there is zero H divergence in the solution, corrections are made to the H held every few iterations. In order to validate the code, we compare our results against an integral equation solution for an azimuthally symmetric, buried thin spherical shell model (Kuvshinov & Pankratov 1994), and against a quasi-analytic solution for an azimuthally asymmetric configuration of eccentrically nested spheres (Martinec 1998).	Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan; Univ Cambridge, Dept Earth Sci, Inst Theoret Geophys, Cambridge CB2 3EQ, England	Uyeshima, M (reprint author), Univ Tokyo, Earthquake Res Inst, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Schultz, Adam/K-7394-2012				Abramowitz M., 1965, HDB MATH FUNCTIONS; SCHULTZ A, 1987, GEOPHYS J INT, V88, P733, DOI 10.1111/j.1365-246X.1987.tb01654.x; Xu YS, 1998, SCIENCE, V280, P1415, DOI 10.1126/science.280.5368.1415; MACKIE RL, 1994, RADIO SCI, V29, P923, DOI 10.1029/94RS00326; Olsen N, 1998, GEOPHYS J INT, V133, P298, DOI 10.1046/j.1365-246X.1998.00503.x; SCHULTZ A, 1993, GEOPHYS RES LETT, V20, P2941, DOI 10.1029/93GL02833; Smith JT, 1996, GEOPHYSICS, V61, P1319, DOI 10.1190/1.1444055; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; SCHULTZ A, 1994, GEOPHYS J INT, V116, P141, DOI 10.1111/j.1365-246X.1994.tb02133.x; MACKIE RL, 1993, GEOPHYSICS, V58, P1052, DOI 10.1190/1.1443481; Olsen N, 1999, GEOPHYS J INT, V138, P179, DOI 10.1046/j.1365-246x.1999.00854.x; BAI Q, 1993, PHYS CHEM MINER, V19, P460; HIRSCH LM, 1993, GEOPHYS J INT, V114, P21, DOI 10.1111/j.1365-246X.1993.tb01463.x; SCHULTZ A, 1990, PHYS EARTH PLANET IN, V64, P68, DOI 10.1016/0031-9201(90)90006-J; AXELSSON O, 1980, LINEAR ALGEBRA APPL, V29, P1, DOI 10.1016/0024-3795(80)90226-8; Axelsson O., 1994, ITERATIVE SOLUTION M; BAHR K, 1993, GEOPHYS RES LETT, V20, P2937, DOI 10.1029/93GL02134; BANKS RJ, 1969, GEOPHYS J ROY ASTRON, V266, P123; EGBERT GD, 1992, J GEOPHYS RES-SOL EA, V97, P15113, DOI 10.1029/92JB01252; EGBERT GD, 1992, J GEOPHYS RES-SOL EA, V97, P15099, DOI 10.1029/92JB01251; Everett ME, 1996, J GEOPHYS RES-SOL EA, V101, P2765, DOI 10.1029/95JB03541; EVERETT ME, 1995, PHYS EARTH PLANET IN, V92, P189, DOI 10.1016/0031-9201(95)03036-6; FAINBERG EB, 1993, GEOPHYS J INT, V113, P144, DOI 10.1111/j.1365-246X.1993.tb02535.x; FUJII I, 1995, IUGG 21 GEN ASS WEEK, V21, P63; FUJII I, 1998, EOS T AM GEOPHYS U S, V79, pF64; HIRSCH LM, 1993, GEOPHYS J INT, V114, P36, DOI 10.1111/j.1365-246X.1993.tb01464.x; KOYAMA T, 1998, P COND AN S, P279; Kuvshinov A.V., 1994, P 12 WORKSH EARTH BR, P83; KUVSHINOV AV, 1998, 14 WORKSH EL IND EAR, P129; Lahiri BN, 1939, PHILOS TR R SOC S-A, V237, P509, DOI 10.1098/rsta.1939.0001; Lizarralde D., 1995, J GEOPHYS RES, V100, p17 873; MACKIE RL, 1993, GEOPHYSICS, V58, P215, DOI 10.1190/1.1443407; Martinec Z, 1998, GEOPHYS J INT, V132, P96, DOI 10.1046/j.1365-246x.1998.00392.x; Martinec Z, 1999, GEOPHYS J INT, V136, P229, DOI 10.1046/j.1365-246X.1999.00713.x; ROKITYANSKY II, 1982, GEOELECTROMAGNETIC I; Schultz A., 1998, 3 DIMENSIONAL ELECTR, P451; SCHULTZ A, 1993, PHYZIKA ZEMLI, V10, P39; SCHULTZ A, 1990, GEOPHYS J INT, V101, P565, DOI 10.1111/j.1365-246X.1990.tb05571.x; SHANKLAND TJ, 1997, EOS T AM GEOPHYS UN, V78, P46; SHANKLAND TJ, 1993, NATURE, V366, P453, DOI 10.1038/366453a0; SINGER BS, 1995, GEOPHYS J INT, V120, P590, DOI 10.1111/j.1365-246X.1995.tb01841.x; Singer B.Sh., 1985, ELECTROMAGNETIC INDU; SMITH NHP, 1996, RODDS CHEM D-F, V3, P1; TARITS P, 1999, UNPUB GEOPHYS J INT; TOH H, 1999, INT S 3D EL MOD 3DEM; Xu YS, 1998, SCIENCE, V282, P922, DOI 10.1126/science.282.5390.922; ZHANG TS, 1992, GEOPHYS J INT, V111, P319, DOI 10.1111/j.1365-246X.1992.tb00580.x	47	26	26	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0956-540X			GEOPHYS J INT	Geophys. J. Int.	MAR	2000	140	3					636	650		10.1046/j.1365-246X.2000.00051.x		15	Geochemistry & Geophysics	Geochemistry & Geophysics	286RT	WOS:000085459900016		
J	Yokouchi, Y; Machida, T; Barrie, LA; Toom-Sauntry, D; Nojiri, Y; Fujinuma, Y; Inuzuka, Y; Li, HJ; Akimoto, H; Aoki, S				Yokouchi, Y; Machida, T; Barrie, LA; Toom-Sauntry, D; Nojiri, Y; Fujinuma, Y; Inuzuka, Y; Li, HJ; Akimoto, H; Aoki, S			Latitudinal distribution of atmospheric methyl bromide: Measurements and modeling	GEOPHYSICAL RESEARCH LETTERS			English	Article							CH3BR; OCEAN; DEGRADATION; EMISSIONS; LIFETIME; SOILS	The global distribution of atmospheric methyl bromide (CH3Br) obtained from extensive new measurements of atmospheric CH3Br from latitude 82.5 degrees N to 69.1 degrees S, showed a small decrease from mid- to high-latitudes, a gradient between the northern and southern hemispheres with a ratio of 1.2 to 1.3, and occasional high concentrations in the tropics. The observed data and modeled distributions of industrial CH3Br were used to apportion CH3Br between natural and industrial components for both hemisphere. We obtained an estimated man-made contribution of 4.3 pptv and 2.3 pptv in the northern and southern hemispheres, respectively and a natural (non-industrial) background concentration in both hemispheres of 6 pptv with a slight increase in the tropics.	Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; Atmospher Environm Serv, Toronto, ON M3H 5T4, Canada; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Tohoku Univ, Ctr Atmospher & Ocean Studies, Aoba Ku, Sendai, Miyagi 9800845, Japan	Yokouchi, Y (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3050053, Japan.		陽子, 横内/E-8041-2010; Nojiri, Yukihiro/D-1999-2010	Nojiri, Yukihiro/0000-0001-9885-9195			ANDREAE MO, 1996, J GEOPHYS RES, V101, P22603; MANO S, 1994, SCIENCE, V263, P1255, DOI 10.1126/science.263.5151.1255; Schauffler SM, 1998, GEOPHYS RES LETT, V25, P317, DOI 10.1029/98GL00040; Gan J, 1998, GEOPHYS RES LETT, V25, P3595, DOI 10.1029/98GL52697; WOFSY SC, 1975, GEOPHYS RES LETT, V2, P215, DOI 10.1029/GL002i006p00215; Moore RM, 1996, J GEOPHYS RES-OCEANS, V101, P20899, DOI 10.1029/96JC01248; Blake NJ, 1996, J GEOPHYS RES-ATMOS, V101, P24151, DOI 10.1029/96JD00561; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; BUTLER JH, 1994, GEOPHYS RES LETT, V21, P185, DOI 10.1029/94GL00071; BUTLER JH, 1996, METHYL BROMIDE ISSUE, pCH2; Czeplak G., 1974, ADV GEOPHYS B, V18, P57; JACOB DJ, 1987, J GEOPHYS RES-ATMOS, V92, P6614, DOI 10.1029/JD092iD06p06614; KHALIL MAK, 1993, J GEOPHYS RES-ATMOS, V98, P2887, DOI 10.1029/92JD02598; Lee-Taylor JM, 1998, J GEOPHYS RES-ATMOS, V103, P16039, DOI 10.1029/98JD00970; Li HJ, 1999, ATMOS ENVIRON, V33, P1881, DOI 10.1016/S1352-2310(98)00303-3; Lobert J. M., 1996, CMDL10 NOAA ERL; Lobert JM, 1997, GEOPHYS RES LETT, V24, P171, DOI 10.1029/96GL03928; LOBERT JM, 1995, SCIENCE, V267, P1002, DOI 10.1126/science.267.5200.1002; PENKETT SA, 1985, NATURE, V318, P550, DOI 10.1038/318550a0; Serca D, 1998, ATMOS ENVIRON, V32, P1581, DOI 10.1016/S1352-2310(97)00386-5; SHORTER JH, 1995, NATURE, V377, P717, DOI 10.1038/377717a0; SINGH HB, 1993, GEOPHYS RES LETT, V20, P133, DOI 10.1029/92GL02634; THOMAS WB, 1999, METHYL BROMIDE USE B, P36; *UNEP, 1997, PROD CONS OZ DEPL SU; Wingenter OW, 1998, GEOPHYS RES LETT, V25, P2797, DOI 10.1029/98GL02179; *WMO, 1998, SCI ASS OZ DEPL 1998, pCH10; YAGI K, 1995, SCIENCE, V267, P1979, DOI 10.1126/science.267.5206.1979; Yates SR, 1996, J ENVIRON QUAL, V25, P192; YOKOUCHI Y, IN PRESS NATURE; Yokouchi Y, 1999, J GEOPHYS RES-ATMOS, V104, P8067, DOI 10.1029/1998JD100013; Yvon SA, 1996, GEOPHYS RES LETT, V23, P53, DOI 10.1029/95GL03022; YvonLewis SA, 1997, GEOPHYS RES LETT, V24, P1227, DOI 10.1029/97GL01090	32	19	19	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0094-8276			GEOPHYS RES LETT	Geophys. Res. Lett.	MAR 1	2000	27	5					697	700		10.1029/1999GL010884		4	Geosciences, Multidisciplinary	Geology	288YJ	WOS:000085591800029		
J	Tokuda, Y; Oshika, T; Amano, S; Inouye, J; Yoshitomi, F				Tokuda, Y; Oshika, T; Amano, S; Inouye, J; Yoshitomi, F			Analgesic effects of sub-Tenon's versus retrobulbar anesthesia in planned extracapsular cataract extraction	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article							LOCAL-ANESTHESIA; SUBCONJUNCTIVAL ANESTHESIA; PERIBULBAR ANESTHESIA; TOPICAL ANESTHESIA; OCULAR ANESTHESIA; PERILIMBAL ANESTHESIA; VITREORETINAL SURGERY; PHACOEMULSIFICATION; INFILTRATION; INJECTION	Background: A prospective study was conducted to compare the analgesic effects of sub-Tenon's and retrobulbar anesthesia by assessing patients' response to the visceral stimulus. Methods: Seven hundred and twenty eyes of 720 patients underwent extracapsular cataract extraction and posterior chamber intraocular lens implantation. They received retrobulbar anesthesia with 3 ml lidocaine (225 eyes), retrobulbar anesthesia with 5 ml lidocaine (216 eyes), or sub-Tenon's anesthesia with 3 ml lidocaine (279 eyes). Pain scores were recorded when an acetylcholine chloride solution was injected into the anterior chamber to attain miosis after lens implantation. Results. Pain scores were significantly different among the three anesthesia groups (P<0.0001, Kruskal-Wallis test). The multiple comparison revealed that analgesic effects were highest with sub-Tenon's anesthesia, followed by 5-ml retrobulbar and 3-ml retrobulbar anesthesia. Conclusion: Sub-Tenon's anesthesia is an effective and reliable anesthetic method in cataract surgery.	Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan; Inouye Eye Hosp, Tokyo, Japan; Yoshitomi Eye Ctr, Fukuoka, Japan	Oshika, T (reprint author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ANDERSON CJ, 1995, J CATARACT REFR SURG, V21, P103; ANDERSON CJ, 1995, OPHTHALMIC SURG LAS, V26, P205; Roman SJ, 1997, BRIT J OPHTHALMOL, V81, P673, DOI 10.1136/bjo.81.8.673; Patel BCK, 1996, OPHTHALMOLOGY, V103, P1196; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; Fichman RA, 1996, J CATARACT REFR SURG, V22, P612; Zehetmayer M, 1996, J CATARACT REFR SURG, V22, P480; HANSEN EA, 1990, OPHTHALMIC SURG LAS, V21, P696; Anderson CJ, 1996, J CATARACT REFR SURG, V22, P1009; Arbisser LB, 1996, OPHTHALMIC SURG LAS, V27, P640; Behndig A, 1998, J CATARACT REFR SURG, V24, P1307; Briggs MC, 1997, EYE, V11, P639; Chittenden HB, 1997, BRIT J OPHTHALMOL, V81, P288, DOI 10.1136/bjo.81.4.288; Claoue C, 1996, J CATARACT REFR SURG, V22, P155; DUTTON GN, 1994, BRIT J OPHTHALMOL, V78, P238, DOI 10.1136/bjo.78.3.238; FUKASAKU H, 1994, J CATARACT REFR SURG, V20, P468; FURUTA M, 1990, OPHTHALMIC SURG LAS, V21, P22; Johnston RL, 1998, J CATARACT REFR SURG, V24, P407; KANSKI JJ, 1968, BRIT J OPHTHALMOL, V52, P936, DOI 10.1136/bjo.52.12.936; Kapran Z, 1996, Eur J Ophthalmol, V6, P131; KERSHNER RM, 1993, J CATARACT REFR SURG, V19, P290; Khoo BK, 1996, OPHTHALMIC SURG LAS, V27, P773; KHOO CY, 1990, BRIT J OPHTHALMOL, V74, P639, DOI 10.1136/bjo.74.10.639; KHURANA AK, 1994, ACTA OPHTHALMOL, V72, P727; LEARNING DV, 1998, J CATARACT REFR SURG, V24, P552; Maclean H, 1997, J CATARACT REFR SURG, V23, P277; Manners TD, 1996, EYE, V10, P367; MEADES K, 1993, AUST NZ J OPHTHALMOL, V21, P283, DOI 10.1111/j.1442-9071.1993.tb00975.x; MEIN CE, 1990, RETINA-J RET VIT DIS, V10, P47, DOI 10.1097/00006982-199001010-00008; MEIN CE, 1989, ARCH OPHTHALMOL-CHIC, V107, P1084; Nielsen PJ, 1998, J CATARACT REFR SURG, V24, P1136; NOVAK KD, 1995, J CATARACT REFR SURG, V21, P672; Oshika T, 1999, JPN J OPHTHALMOL, V43, P139, DOI 10.1016/S0021-5155(98)00070-7; PALLAN LA, 1995, J CATARACT REFR SURG, V21, P504; Petersen W C, 1990, Trans Am Ophthalmol Soc, V88, P136; PETERSEN WC, 1991, OPHTHALMIC SURG LAS, V22, P199; Rauz S, 1997, OPHTHALMIC SURG LAS, V28, P727; REDMOND RM, 1990, BRIT J OPHTHALMOL, V74, P203, DOI 10.1136/bjo.74.4.203; ROSENTHAL KJ, 1995, J CATARACT REFR SURG, V21, P499; Shammas HJ, 1997, J CATARACT REFR SURG, V23, P1577; SHAMMAS HJ, 1993, J CATARACT REFR SURG, V19, P116; SMITH R, 1990, BRIT J OPHTHALMOL, V74, P205, DOI 10.1136/bjo.74.4.205; SMITH RJH, 1988, BRIT J OPHTHALMOL, V72, P1, DOI 10.1136/bjo.72.1.1; STEELE MA, 1992, OPHTHALMIC SURG LAS, V23, P40; STEVENS JD, 1992, BRIT J OPHTHALMOL, V76, P670, DOI 10.1136/bjo.76.11.670; STEVENS JD, 1992, EYE, V6, P583; STEVENS JD, 1993, OPHTHALMIC SURG LAS, V24, P121; SWEENEY EJ, 1993, ANAESTHESIA, V48, P336, DOI 10.1111/j.1365-2044.1993.tb06958.x; Verghese I, 1996, Aust N Z J Ophthalmol, V24, P117, DOI 10.1111/j.1442-9071.1996.tb01564.x; Winder S, 1998, EYE, V12, P486; Winder S, 1999, J CATARACT REFR SURG, V25, P56, DOI 10.1016/S0886-3350(99)80011-X	51	4	4	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0721-832X			GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2000	238	3					228	231		10.1007/s004170050348		4	Ophthalmology	Ophthalmology	303XE	WOS:000086452100005		
J	Sorensen, A				Sorensen, A			Conflict, consensus or consent: implications of Japanese land readjustment practice for developing countries	HABITAT INTERNATIONAL			English	Article						land readjustment; Japanese urban planning; suburban development; public participation		This paper is relevant to the international effort to transfer an urban land development technique, land readjustment (LR), to several developing countries in South East Asia. The paper examines the model of the Japanese LR method presented by Japanese scholars and development experts to the international audience, and argues that in the context of attempts by several developing countries to adopt the method, there are several crucial shortcomings of the description of Japanese LR in the existing literature. Most important is that the history of opposition to LR in Japan is virtually ignored, and there is very little mention of the enormous commitments of local planning resources necessary to organise consent to projects. These issues are important for an understanding of the use of LR in Japan, and may also have implications for those attempting to make use of LR techniques in other countries. The paper briefly outlines the LR method and the project to export the method to South East Asia, examines the existing literature, and draws on case studies of project organising in three suburban cities in the Tokyo area. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Dept Urgan Engn, Tokyo, Japan	Sorensen, A (reprint author), Atsubetsu Higashi 1-1-4-12,Atsubetsu Ku, Sapporo, Hokkaido 0040001, Japan.						ACHARYA BP, 1989, HABITAT INT, V12, P103; APTER DE, 1984, AGAINST STATE; Archer R. W., 1994, HABITAT INT, V18, P37, DOI 10.1016/0197-3975(94)90016-7; ARCHER RW, 1987, 37 AS I TECHN HUM SE; ARCHER RW, 1992, LAND USE POLICY, P287; ARCHER RW, 1986, HABITAT INT, V10, P155, DOI 10.1016/0197-3975(86)90080-9; Broadbent J., 1998, ENV POLITICS JAPAN; Calder Kent E., 1988, CRISIS COMPENSATION; *CIT PLANN ASS JAP, 1995, CIT PLANN HDB; DEVAS N, 1993, MANAGING FAST GROWIN, P1; DOEBELE WA, 1987, SHELTER SETTLEMENT D, P110; DOEBELE WA, 1987, HABITAT INT, V11, P7, DOI 10.1016/0197-3975(87)90030-0; DOEBELE WA, 1982, LAND READJUSTMENT DI; Flanagan S., 1980, POLITICAL OPPOSITION, P187; HARDOY JE, 1981, SHELTE NEED RESPONSE; HAYASHI K, 1978, JAPANESE URBAN PLANN; HAYASHI K, 1982, LAND READJUSTMENT DI, P107; Hebbert M., 1994, PLANNING CITIES REGI, P70; HONJO M, 1984, URBAN DEV POLICIES L, P1; HONJO M, 1984, URBAN DEV POLICIES L, P15; HONJO M, 1986, URBAN DEV POLICIES P, P356; HWANG MC, 1986, URBAN DEV POLICIES P, P244; INOUE T, 1985, MIN CONST INT SEM KU, P7; Ishida Y., 1987, LAST 100 YEARS JAPAN; ISHIDA Y, 1986, COMPREHENSIVE URBAN, V28, P45; *JAP MOC, US GUID LAND READJ; *JAP MOC, 1991, EX MAN LAND READJ; *JAP MOC, 1985, INT SEM KUK SEIR TOK; *JAP MOC, 1995, SEL ABSTR INT SEM LA; King A. D., 1980, SHAPING URBAN WORLD, P203; KISHII T, 1993, 7 INT SEM LAND READJ; KISHII T, 1993, CITY PLANNING REV, V42, P10; Krauss E. S., 1984, CONFLICT JAPAN; *KUK SEIR TAIS ZEN, 1983, TRUTH OPP LAND READJ; *KUK SEIR TAIS ZEN, 1973, ALL OPP LAND READJ K; LARSSON G, 1993, LAND READJUSTMENT MO; LATZ G, 1989, AGR DEV JAPAN; Lewis Jack, 1980, POLITICAL OPPOSITION, P274; MASSER I, 1987, 3 WORLD PLANNING REV, V9, P205; McKean M. A., 1981, ENV PROTEST CITIZEN; Minerbi L., 1986, LAND READJUSTMENT JA; MISRA B, 1986, HABITAT INT, V10, P59, DOI 10.1016/0197-3975(86)90009-3; MISRA B, 1984, TRANSFERABILITY DEV; MIYAZAWA M, 1982, LAND READJUSTMENT DI, P91; MUHAMMAD Z, 1995, 8 INT SEM READJ KOB; NAGAMINE H, 1986, URBAN DEV POLICIES P; NAGAMINE H, 1988, CITY PLANNING REV TO, V38, P28; NAGAMINE H, 1986, HABITAT INT, V10, P51, DOI 10.1016/0197-3975(86)90008-1; NAKAMURA P, 1986, LAND READJUSTMENT JA, P17; Nakane Chie, 1970, JAPANESE SOC; NAKANO M, 1993, TOCHI KUKAKU SEIRI J, V42, P52; NARAI T, 1991, KUIKIKUBU SEIDO UNYO, V26, P697; NISHIYAMA Y, 1995, 8 INT SEM LAND READJ; NISHIYAMA Y, 1986, URBAN DEV POLICIES P, P315; NISHIYAMA Y, 1988, CITY PLANNING REV TO, V38, P39; NISHIYAMA Y, 1985, TOCHI SAIHAIBUN JIGY, V20, P301; Payne GK, 1984, LOW INCOME HOUSING D; PENALOSA E, 1980, WORLD C LAND POLICY, P15; Pugh C, 1997, THIRD WORLD PLAN REV, V19, P91; REICH MR, 1983, INT J ENVIRON STUD, V20, P199, DOI 10.1080/00207238308710036; RIMMER P, 1989, COMP URBAN COMMUNITY, V2, P156; Rix Alan, 1980, JAPANS EC AID POLICY; RODWIN L, 1987, SHELTER SETTLEMENT D, P3; SAITAMA P, 1997, REFERENCE MAT COLLEC; Sazanami H., 1985, MIN CONSTR INT SEM K, P26; SCHROEDER L, 1989, REGIONAL DEV DIALOGU, V10, P36; SINGSILARAK T, 1995, 8 INT SEM LAND READJ; SORENSEN A, 1999, IN PRESS URBAN STUDI; SORENSEN A, 1999, IN PRESS PROGR PLANN; SORENSEN A, 1998, THESIS U LONDON; Steiner K., 1980, POLITICAL OPPOSITION, P55; SUGIMOTO Y, 1986, DEMOCRACY CONT JAPAN, P65; TALKURPUTRA I, 1995, 8 INT SEM LAND READJ; TURNER J, 1968, J AM I PLANNERS, V24, P354; VOGEL EF, 1979, JAPAN NUMBER 1; Yasutomo D. T., 1986, MANNER GIVING STRATE	76	17	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-3975			HABITAT INT	Habitat Int.	MAR	2000	24	1					51	73		10.1016/S0197-3975(99)00029-6		23	Environmental Studies; Planning & Development; Urban Studies	Environmental Sciences & Ecology; Public Administration; Urban Studies	272LT	WOS:000084652200004		
J	Sato, H; Sugawara, Y; Yamasaki, S; Shimada, K; Takayama, T; Makuuchi, M; Kosuge, T				Sato, H; Sugawara, Y; Yamasaki, S; Shimada, K; Takayama, T; Makuuchi, M; Kosuge, T			Thoracoabdominal approaches versus inverted T incision for posterior segmentectomy in hepatocellular carcinoma	HEPATO-GASTROENTEROLOGY			English	Article						hepatocellular carcinoma; right oblique approach; inverted L incision; posterior segmentectomy	HEPATIC RESECTION; TRANSDIAPHRAGMATIC HEPATECTOMY; CIRRHOTIC-PATIENTS; LIVER RESECTION; MORTALITY; MORBIDITY; SURGERY	Background/Aims: The purpose of the present study was to clarify the indications for a thoracoabdominal right oblique approach and an inverted L incision in posterior segmentectomy of the liver for hepatocellular carcinoma. Methodology: Forty-six patients with hepatocellular carcinoma who underwent posterior segmentectomy with thoracotomy were divided into 2 groups according to the incision: thoracoabdominal right oblique incision (group A, n=17) and inverted L incision (group B, n=29). The perioperative factors of the patients in the 2 groups were compared retrospectively. Results: No significant; differences were found in the preoperative factors between the groups. However, a longer operation time (P=0.01) and more blood loss (P=0.02) were noted in group B. Although there was no significant difference between the groups in the overall morbidity rate (P=0.36), a higher rate of pleural effusion was recognized in group A (P=0.01). Conclusions: Thoracoabdominal right oblique incision may be suitable for use as an approach for posterior segmentectomy when manipulation of the left lobe is not required.	Univ Tokyo, Grad Sch Med, Dept Surg,Hepatobiliary Pancreat Surg Div, Bunkyo Ku, Tokyo 1138655, Japan; Natl Canc Ctr Hosp, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan	Sugawara, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg,Dept Hepatobiliary Pancreat Div, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; FRANCO D, 1985, SURGERY, V98, P949; Fuster J, 1996, ANN SURG, V223, P297, DOI 10.1097/00000658-199603000-00011; Kise Y, 1997, HEPATO-GASTROENTEROL, V44, P1397; Kokudo N, 1996, SURGERY, V119, P634, DOI 10.1016/S0039-6060(96)80187-5; *LIV CANC STUD GRO, 1997, CLASS PRIM LIV CANC; Makuuchi M, 1998, HEPATO-GASTROENTEROL, V45, P1267; SAVAGE AP, 1991, ANN SURG, V214, P689, DOI 10.1097/00000658-199112000-00008; SHIMADA M, 1995, ARCH SURG-CHICAGO, V130, P157; Shimada M, 1995, HEPATO-GASTROENTEROL, V42, P450; STIMPSON REJ, 1987, AM J SURG, V153, P189, DOI 10.1016/0002-9610(87)90812-9; Takayama T, 1998, HEPATO-GASTROENTEROL, V45, P376; Takenaka K, 1998, ARCH SURG-CHICAGO, V133, P80, DOI 10.1001/archsurg.133.1.80; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Tsugita M, 1995, INT SURG, V80, P242	15	14	14	H G E UPDATE MEDICAL PUBL LTD.	ATHENS	PO BOX 17160, ATHENS GR-10024, GREECE	0172-6390			HEPATO-GASTROENTEROL	Hepato-Gastroenterol.	MAR-APR	2000	47	32					504	506				3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	307EN	WOS:000086640500050		
J	Uchida, K; Watanabe, H; Kitahara, T				Uchida, K; Watanabe, H; Kitahara, T			Synthesis of (+/-)-(3R*, 4S*, 4aR*)-4,8-dihydroxy-3-methyl-3,4,4a,5-tetrahydro-1H-2-benzopyran-1-one	HETEROCYCLES			English	Article							SULFURANES; ESTERS	The insecticidal tetrahydroisocoumarin, (3R, 4S, 4aR)-4,8-dihydroxy3-methyl-3,4,4a,5-tetrahydro-1H-2-benzopyran-1-one, was synthesized as a racemate using one-pot esterification-Michael addition-aldol reaction of delta-hydroxy-alpha,beta-unsaturated aldehyde and diketene as a key step.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Uchida, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						ALDRIDGE DC, 1971, J CHEM SOC C, P1623, DOI 10.1039/j39710001623; Findlay JA, 1995, J NAT PROD, V58, P1759, DOI 10.1021/np50125a021; BURGESS EM, 1973, J ORG CHEM, V38, P26, DOI 10.1021/jo00941a006; DEVYS M, 1992, Z NATURFORSCH C, V47, P779; MUKAIYAMA T, 1979, ANGEW CHEM INT EDIT, V18, P707, DOI 10.1002/anie.197907073; ARHART RJ, 1972, J AM CHEM SOC, V94, P5003, DOI 10.1021/ja00769a036; BURGESS EM, 1970, J AM CHEM SOC, V92, P5224, DOI 10.1021/ja00720a041; ELIX JA, 1996, AUST J CHEM, V48, P917; FINDLAY JA, 1976, CAN J CHEM, V54, P3419, DOI 10.1139/v76-491; Frohn M, 1998, J ORG CHEM, V63, P2948, DOI 10.1021/jo9721195; GROVE JF, 1979, J CHEM SOC PERK T 1, P2048, DOI 10.1039/p19790002048; KRYSHTAL GV, 1979, SYNTHESIS-STUTTGART, P107; MARTIN JC, 1971, J AM CHEM SOC, V93, P2341, DOI 10.1021/ja00738a054; MEYER WL, 1977, J ORG CHEM, V42, P4131, DOI 10.1021/jo00445a031; NISHIDA R, 1983, 186 ACS NAT M WASH D; Nishikawa H. J, 1933, J AGR CHEM SOC JAPAN, V9, P772; NUDELMAN A, 1989, SYNTHESIS-STUTTGART, P387; PIETRUSIEWICZ KM, 1983, J ORG CHEM, V48, P788, DOI 10.1021/jo00154a006; SASAKI M, 1970, AGR BIOL CHEM TOKYO, V34, P1296; STODOLA FH, 1964, BIOCHEM J, V93, P92; STRUCK RF, 1967, TETRAHEDRON LETT, P1589; TANENBAU.SW, 1970, TETRAHEDRON LETT, P2377; Turner WB, 1983, FUNGAL METABOLITES, P82; YABUTA T, 1933, NIPPON NOGEIKAGAKU K, V9, P1264	24	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414			HETEROCYCLES	Heterocycles	MAR 1	2000	53	3					539	+				5	Chemistry, Organic	Chemistry	301LH	WOS:000086311300005		
J	Hashimoto, Y; Ogasawara, T; Hayashi, M; Saigo, K				Hashimoto, Y; Ogasawara, T; Hayashi, M; Saigo, K			Stereoselective synthesis of optically active beta-lactams by the reaction of chiral imines derived from erythro-2-amino-1,2-diphenylethanol with ester enolates	HETEROCYCLES			English	Article							DIASTEREOSELECTIVE ADDITION; AUXILIARY	Chiral imines, derived from (1S,2R)-2-methoxy-1,2-diphenylethylamine and aromatic aldehydes, reacted with ester enolates prepared from ketene silyl acetals and methyllithium to give beta-lactams in good yields with high diastereoselectivity. This method provides a useful and simple route for the construction of optically active beta-lactam skeletons.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1138656, Japan	Hashimoto, Y (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.						Fujieda H, 1997, J AM CHEM SOC, V119, P2060, DOI 10.1021/ja963581u; HART DJ, 1989, CHEM REV, V89, P1447, DOI 10.1021/cr00097a003; Cozzi PG, 1996, TETRAHEDRON LETT, V37, P1691, DOI 10.1016/0040-4039(96)00108-6; Fujisawa T, 1996, TETRAHEDRON LETT, V37, P3881, DOI 10.1016/0040-4039(96)00707-1; Georg G I, 1993, ORGANIC CHEM BETA LA; HART DJ, 1986, J AM CHEM SOC, V108, P6054, DOI 10.1021/ja00279a072; HASHIMOTO Y, 1995, CHEM LETT, P235, DOI 10.1246/cl.1995.235; Hayashi M, 1997, ENANTIOMER, V2, P293; Higashiyama K, 1998, SYNLETT, P489; Kagoshima H, 1998, J ORG CHEM, V63, P691, DOI 10.1021/jo971672j; Kleinman E. F., 1991, COMPREHENSIVE ORGANI, V2, P893; Matsui S, 1998, SYNTHESIS-STUTTGART, P1161; SAIGO K, 1983, TETRAHEDRON LETT, V24, P511, DOI 10.1016/S0040-4039(00)81450-1; SAIGO K, 1986, B CHEM SOC JPN, V59, P2915, DOI 10.1246/bcsj.59.2915; SAIGO K, 1982, B CHEM SOC JPN, V55, P1568, DOI 10.1246/bcsj.55.1568; Shimizu M, 1997, HETEROCYCLES, V45, P1883	16	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414			HETEROCYCLES	Heterocycles	MAR 1	2000	52	3					1001	+				5	Chemistry, Organic	Chemistry	310EN	WOS:000086813700001		
J	Okitsu, O; Oyamada, H; Furuta, T; Kobayashi, S				Okitsu, O; Oyamada, H; Furuta, T; Kobayashi, S			Mannich type reactions of acylhydrazones with silyl enolates for the synthesis of beta-amino ester, beta-amino ketone, beta-lactam, pyrazolidinone, and pyrazolone derivatives	HETEROCYCLES			English	Article							COMMERCIAL FORMALDEHYDE SOLUTION; ASYMMETRIC REDUCTIVE AMINATION; DIELS-ALDER REACTIONS; LEWIS-ACID CATALYSIS; LANTHANIDE TRIFLATE; FACILE SYNTHESIS; ALDOL REACTIONS; AQUEOUS-MEDIA; QUINOLINE DERIVATIVES; 3-COMPONENT REACTIONS	In the presence of a catalytic amount of a rare earth triflate, acylhydrazones reacted with silyl enolates to afford the corresponding beta-N'-acylhydrazino esters in high yields. A three-component reaction of an aldehyde, an acylhydrazine, and a silyl enolate was also performed successfully. The hydrazino esters thus obtained were readily converted to beta-amino ester, beta-amino ketone, beta-lactam, pyrazolidinone, and pyrazolinone derivatives.	Univ Tokyo, Grad Sch Pharmaceut Sci, CREST, Japan Sci & Technol Corp,JST,Bunkyo Ku, Tokyo 1130033, Japan	Okitsu, O (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, CREST, Japan Sci & Technol Corp,JST,Bunkyo Ku, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				ALEXAKIS A, 1991, SYNLETT, P625; Armstrong RW, 1996, ACCOUNTS CHEM RES, V29, P123, DOI 10.1021/ar9502083; KOBAYASHI S, 1994, J ORG CHEM, V59, P3590, DOI 10.1021/jo00092a017; BURK MJ, 1994, TETRAHEDRON, V50, P4399, DOI 10.1016/S0040-4020(01)89375-3; Kobayashi S, 1996, J AM CHEM SOC, V118, P8977, DOI 10.1021/ja961062l; WIPF P, 1995, TETRAHEDRON LETT, V36, P7819, DOI 10.1016/0040-4039(95)01660-A; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P7783, DOI 10.1016/0040-4039(96)01777-7; CLARAMUNT RM, 1991, ORG PREP PROCED INT, V23, P273; UGI I, 1994, ENDEAVOUR, V18, P115, DOI 10.1016/S0160-9327(05)80086-9; Kobayashi S, 1997, TETRAHEDRON LETT, V38, P4559, DOI 10.1016/S0040-4039(97)00854-X; Ugi I, 1996, TETRAHEDRON, V52, P11657, DOI 10.1016/0040-4020(96)00647-3; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Overman LE, 1997, J AM CHEM SOC, V119, P7159, DOI 10.1021/ja9712985; Kobayashi S, 1998, TETRAHEDRON LETT, V39, P5389, DOI 10.1016/S0040-4039(98)01081-8; BURK MJ, 1992, J AM CHEM SOC, V114, P6266, DOI 10.1021/ja00041a067; CLAREMON DA, 1986, J AM CHEM SOC, V108, P8265, DOI 10.1021/ja00286a027; DENMARK SE, 1987, J AM CHEM SOC, V109, P2224, DOI 10.1021/ja00241a073; Elguero J., 1984, COMPREHENSIVE HETERO, V5; ENDERS D, 1986, ANGEW CHEM INT EDIT, V25, P1109, DOI 10.1002/anie.198611091; Enders D, 1996, ANGEW CHEM INT EDIT, V35, P981, DOI 10.1002/anie.199609811; GUANTI G, 1987, TETRAHEDRON LETT, V28, P4331, DOI 10.1016/S0040-4039(00)96501-8; HLASTA DJ, 1991, J MED CHEM, V34, P1560, DOI 10.1021/jm00109a006; ISHIHARA K, 1994, SYNLETT, P963; JUNGHEIM L N, 1990, Drugs of the Future, V15, P149; KEES KL, 1995, J MED CHEM, V38, P617, DOI 10.1021/jm00004a008; KOBAYASHI S, 1995, CHEM LETT, P423, DOI 10.1246/cl.1995.423; KOBAYASHI S, 1992, TETRAHEDRON LETT, V33, P1625, DOI 10.1016/S0040-4039(00)91691-5; Kobayashi S, 1999, EUR J ORG CHEM, P15; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P3755, DOI 10.1016/S0040-4039(00)79220-3; KOBAYASHI S, 1994, B CHEM SOC JPN, V67, P2342, DOI 10.1246/bcsj.67.2342; KOBAYASHI S, 1995, SYNLETT, P233; Kobayashi S, 1997, SYNLETT, P1099; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P3731, DOI 10.1016/0040-4039(96)00671-5; Kobayashi S, 1997, TETRAHEDRON LETT, V38, P4819, DOI 10.1016/S0040-4039(97)01041-1; KOBAYASHI S, 1999, CHEM SOC REV, P1; Kobayashi S, 1998, TETRAHEDRON LETT, V39, P9211, DOI 10.1016/S0040-4039(98)02100-5; KOBAYASHI S, 1995, SYNTHESIS-STUTTGART, P1195; Kobayashi S, 1997, SYNLETT, P115; Kobayashi S, 1998, CHEM COMMUN, P981, DOI 10.1039/a801464g; Kobayashi S, 1998, CHEM COMMUN, P19, DOI 10.1039/a706498e; Kobayashi S, 1997, J AM CHEM SOC, V119, P10049, DOI 10.1021/ja971153y; Kobayashi S, 1998, SYNLETT, P1019; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P9221, DOI 10.1016/S0040-4039(96)02188-0; KOBAYASHI S, 1998, BIOTECHNOL BIOENG, V1, P23; KOBAYASHI S, 1995, TETRAHEDRON LETT, V36, P5773, DOI 10.1016/0040-4039(95)01096-Z; KOBAYASHI S, 1991, CHEM LETT, P2187, DOI 10.1246/cl.1991.2187; KOBAYASHI S, 1994, SYNLETT, P689; Kobayashi S, 1998, J ORG CHEM, V63, P4868, DOI 10.1021/jo9802776; Kobayashi S, 1999, CHEM LETT, P71; Kobayashi S, 1997, CHEM LETT, P1039; Kobayashi S, 1997, CHEM LETT, P831, DOI 10.1246/cl.1997.831; KODATA I, 1996, CHEM COMMUN, P841; Ishitani H, 1996, J ORG CHEM, V61, P1902, DOI 10.1021/jo951924l; MANABE K, 1999, SYNLETT, P545; Manabe K, 1999, TETRAHEDRON LETT, V40, P3773, DOI 10.1016/S0040-4039(99)00606-1; MUKAIYAMA T, 1990, CHEM LETT, P889, DOI 10.1246/cl.1990.889; MUKAIYAMA T, 1989, CHEM LETT, P1397, DOI 10.1246/cl.1989.1397; Nagayama S, 1998, CHEM LETT, P685, DOI 10.1246/cl.1998.685; OJIMA I, 1977, TETRAHEDRON LETT, P3643; ONAKA M, 1993, SYNLETT, P141; Oyamada H, 1998, SYNLETT, P249; PERRI ST, 1990, J ORG CHEM, V55, P6037, DOI 10.1021/jo00311a023; Schinzer D., 1989, SELECTIVITIES LEWIS; SEEBACH CD, 1979, SYNTHESIS-STUTTGART, P423; TAKAHASHI H, 1979, J CHEM SOC CHEM COMM, P668, DOI 10.1039/c39790000668; Tempest PA, 1996, ANGEW CHEM INT EDIT, V35, P640, DOI 10.1002/anie.199606401; THOM KF, 1971, Patent No. 3615169; Yamamoto H., 1999, LEWIS ACID REAGENTS	68	34	34	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414			HETEROCYCLES	Heterocycles	MAR 1	2000	52	3					1143	+				21	Chemistry, Organic	Chemistry	310EN	WOS:000086813700021		
J	Tomoda, S; Kaneno, D; Senju, T				Tomoda, S; Kaneno, D; Senju, T			Origin of pi-facial diastereoselection in carbonyl addition. Application of the exterior frontier orbital extension model to 1,3-diheteran-5-ones (heteroatom = O, S)	HETEROCYCLES			English	Review							NUCLEOPHILIC ADDITIONS; HYDRIDE REDUCTION; STEREOSELECTIVITY; CYCLOHEXANONE; STEREOCHEMISTRY; SUBSTITUENT; SYSTEMS	The exterior frontier orbital extension model (the EFOE Model) strongly suggested that reversal of pi-facial diastereoselection in nucleophilic additions of 1,3-diheteran-5-ones (heteroatom = O or S) may originate from the unique ground state conformation and the pi-facial difference in the LUMO extension around the carbonyl carbon rather than from transition state effects. Intrinsic reaction coordinate (IRC) and natural bond orbital (NBO) analyses of transition states of LiAlH4 reduction of these ketones have strongly indicated that the transition state effects (the torsional strain of the ketone moieties and the antiperiplanar effects involving the incipient bond proposed by the conventional theoretical models for pi-facial diastereoselection; the Felkin-Anh model and the Cieplak model) are not responsible for facial selection.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Tomoda, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.						ANH NT, 1976, J AM CHEM SOC, V95, P6146; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005; KLOPMAN G, 1968, J AM CHEM SOC, V90, P223, DOI 10.1021/ja01004a002; CIEPLAK AS, 1981, J AM CHEM SOC, V103, P4540, DOI 10.1021/ja00405a041; FRENKING G, 1991, ANGEW CHEM INT EDIT, V30, P1146, DOI 10.1002/anie.199111461; Feynman RP, 1939, PHYS REV, V56, P340, DOI 10.1103/PhysRev.56.340; WU YD, 1987, J AM CHEM SOC, V109, P908, DOI 10.1021/ja00237a051; ANH NT, 1977, NOUV J CHIM, V1, P61; HOFFMANN R, 1963, J CHEM PHYS, V39, P1397, DOI 10.1063/1.1734456; SALEM L, 1968, J AM CHEM SOC, V90, P543, DOI 10.1021/ja01005a001; Tomoda S, 1999, CHEM REV, V99, P1243, DOI 10.1021/cr980374z; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; CHEREST M, 1968, TETRAHEDRON LETT, P2199; CHEREST M, 1968, TETRAHEDRON LETT, P2205; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, P695; FLEMING I, 1977, FRONTIER ORBITALS OR; FRISCH MJ, 1997, GAUSSIAN 94 REVISION; Fukui K., 1997, FRONTIER ORBITALS RE; FUKUI K, 1979, THEORY ORIENTATION S; Gung BW, 1999, CHEM REV, V99, P1067, DOI 10.1021/cr9803636; Huzinaga S., 1984, GAUSSIAN BASIS SETS; IMAMURA A, 1968, MOL PHYS, V15, P225, DOI 10.1080/00268976800101011; JOCHIMS JC, 1974, TETRAHEDRON LETT, P571; KOBAYASHI YM, 1978, CHEM BER-RECL, V111, P3442, DOI 10.1002/cber.19781111018; LIBIT L, 1974, J AM CHEM SOC, V96, P1370, DOI 10.1021/ja00812a019; OHNO K, 1984, J CHEM PHYS, V81, P4447, DOI 10.1063/1.447412; Senda Y, 1999, B CHEM SOC JPN, V72, P285, DOI 10.1246/bcsj.72.285; Tomoda S, 1999, TETRAHEDRON, V55, P3871, DOI 10.1016/S0040-4020(99)00099-X; Tomoda S, 1999, CHEM COMMUN, P423, DOI 10.1039/a809117j; Tomoda S, 1997, TETRAHEDRON, V53, P9057, DOI 10.1016/S0040-4020(97)00598-X; Tomoda S, 1999, TETRAHEDRON, V55, P5303, DOI 10.1016/S0040-4020(99)00218-5; WIGFIELD DC, 1976, J ORG CHEM, V41, P3789; WIGFIELD DC, 1974, J AM CHEM SOC, V94, P543; WINSTEIN S, 1955, J AM CHEM SOC, V77, P5562, DOI 10.1021/ja01626a037; WU YD, 1993, J AM CHEM SOC, V115, P10992, DOI 10.1021/ja00076a068; WU YD, 1992, ANGEW CHEM, V104, P1087, DOI 10.1002/ange.19921040834; WU YD, 1992, ANGEW CHEM INT EDIT, V31, P1019, DOI 10.1002/anie.199210191	37	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414			HETEROCYCLES	Heterocycles	MAR 1	2000	52	3					1435	+				16	Chemistry, Organic	Chemistry	310EN	WOS:000086813700045		
J	Kobayashi, Y; Tsukihashi, F				Kobayashi, Y; Tsukihashi, F			Thermodynamics of oxygen in molten Ti-Al and Zr-Al alloys	HIGH TEMPERATURE MATERIALS AND PROCESSES			English	Article							TITANIUM	The solubility of oxygen in molten Ti-Al and Zr-Al alloys equilibrated with solid Al2O3 or ZrO2 was measured from 1673 to 1973 K. The standard Gibbs energies for the reactions of Al2O3(s) = 2Al (1, in Ti-Al alloy) + 30 (mass pct, in Ti-Al alloy) and ZrO2(s) = Zr (1, in Zr-Al alloy) + 20 (mass pct, in Zr-Al alloy) were determined as a function of temperature. The standard Gibbs energies of the dissolution of oxygen into molten titanium and zirconium were obtained by applying the regular solution model to the Tt-Al-O and Zr-Al-O systems.	Univ Tokyo, Sch Engn, Dept Met, Bunkyo Ku, Tokyo 1138656, Japan	Kobayashi, Y (reprint author), Natl Res Inst Met, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.						ABRIATA JP, 1986, BINARY ALLOY PHASE D, V2, P1797; DESAI PD, 1987, J PHYS CHEM REF DATA, V16, P109; OTSUKA S, 1981, T JPN I MET, V22, P558; Kobayashi Y, 1998, METALL MATER TRANS B, V29, P1037, DOI 10.1007/s11663-998-0072-4; Tsukihashi F, 1996, METALL MATER TRANS B, V27, P967, DOI 10.1007/s11663-996-0010-2; NIIYAMA H, 1991, J LESS-COMMON MET, V169, P209, DOI 10.1016/0022-5088(91)90069-G; OKABE TH, 1992, J ALLOY COMPD, V184, P43, DOI 10.1016/0925-8388(92)90454-H; BOWERS JE, 1961, J I MET, V90, P321; ESIN YO, 1974, RUSS METALL+, P86; Kobayashi Y, 1999, METALL MATER TRANS B, V30, P352, DOI 10.1007/s11663-999-0066-x; MAEDA M, 1993, MATER T JIM, V34, P599; MURRAY J, 1986, BINARY ALLOY PHASE D, V2, P1789; SAKAMOTO K, 1992, ISIJ INT, V32, P616, DOI 10.2355/isijinternational.32.616; SAKURAYA K, 1997, CURR ADV MAT PROCESS, V10, P202; SHIBATA T, 1993, CURR ADV MAT PROCESS, V6, P626; Turkdogan E. T., 1980, PHYS CHEM HIGH TEMPE, P81; Turkdogan E.T., 1980, PHYSICAL CHEM HIGH T, P5	17	8	8	FREUND PUBLISHING HOUSE LTD	LONDON	STE 500, CHESHAM HOUSE, 150 REGENT ST, LONDON W1R 5FA, ENGLAND	0334-6455			HIGH TEMP MATER PROC	High Temp. Mater. Process.	MAR	2000	19	3-4					211	218				8	Materials Science, Multidisciplinary	Materials Science	305HU	WOS:000086534400007		
J	Tabaian, SH; Maeda, M; Ikeda, T; Ogasawara, Y				Tabaian, SH; Maeda, M; Ikeda, T; Ogasawara, Y			Thermodynamic study of molten Si-Ti binary alloys	HIGH TEMPERATURE MATERIALS AND PROCESSES			English	Article								The thermodynamic properties of the Si-Ti system were studied by the Langmuir effusion method for alloys containing 0 similar to 58.7mass%Ti. Molten samples were held in a water-cooled copper crucible and heated by power from an electron beam inside a vacuum chamber. Weight changes before and after the evaporation were measured to calculate the rate of evaporation. Evaporating species were also monitored by a mass spectrometer. The vapor pressure of titanium was much lower than that of silicon in the molar composition range of this study. The vapor pressure of silicon was calculated using the Knudsen-Hertz equation. The thermodynamic properties of titanium were calculated by the Gibbs-Duhem equation and integral excess free energy of the Si-Ti system in the above composition range and between 1873-1948K were estimated.	Amirakbir Univ, Teheran, Iran; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Tabaian, SH (reprint author), Amirakbir Univ, Teheran, Iran.						BODARENKO SVP, 1974, SOV POWDER METALL, V12, P900; ESIN YO, 1981, IZV AKAD NAUK SSSR M, V2, P95; GOLTVIN YM, 1959, RUSS J PHYS CHEM, V33, P164; Kubaschewski O., 1979, METALLURGICAL THERMO; MURRAY JL, 1986, PHASE DIAGRAMS BINAR; ROBINS DA, 1955, ACTA METALL MATER, V3, P598, DOI 10.1016/0001-6160(55)90120-6; TOPOR SL, 1985, METALL T A, V17, P1217	7	0	0	FREUND PUBLISHING HOUSE LTD	LONDON	STE 500, CHESHAM HOUSE, 150 REGENT ST, LONDON W1R 5FA, ENGLAND	0334-6455			HIGH TEMP MATER PROC	High Temp. Mater. Process.	MAR	2000	19	3-4					257	264				8	Materials Science, Multidisciplinary	Materials Science	305HU	WOS:000086534400012		
J	Okui, N; Sakuma, R; Kobayashi, N; Yoshikura, H; Kitamura, T; Chiba, J; Kitamura, Y				Okui, N; Sakuma, R; Kobayashi, N; Yoshikura, H; Kitamura, T; Chiba, J; Kitamura, Y			Packageable antiviral therapeutics against human immunodeficiency virus type 1: Virion-targeted virus inactivation by incorporation of a single-chain antibody against viral integrase into progeny virions	HUMAN GENE THERAPY			English	Article							CELL-CYCLE ARREST; FUSION PROTEINS; NUCLEAR-LOCALIZATION; PRECURSOR PROTEIN; VPR PROTEIN; GENE; INFECTION; PARTICLES; HIV-2; G(2)	determine their activities as an antiviral agent packageable within virions and suitable for continued expression in cells, we tested a single-chain antibody (scAb) against human immunodeficiency virus type 1 (HIV-1) integrase and its three fusion proteins: fused to viral protein R (scab-Vpr), a double-cassette of the WXXF motif binding to Vpr (scAb-WXXF), and viral major capsid protein (scAb-CA), respectively. Cotransfection of human 293T cells with expression plasmid for scAb-Vpr or -WXXF along with HIV-I clone pLAI resulted in the production of a normal amount of progeny virions with infectivity decreased by more than 10(3)-fold. Immunoblot analyses showed that scAb-Vpr or -WXXF was associated with virions, whereas scAb or scAb-CA was not, suggesting that scAb-Vpr or -WXXF was incorporated into virions. The incorporation of scAb-WXXF appeared to be Vpr dependent, because the fusion protein was associated with the wild-type but not with Vpr-truncated HIV-I virions. Since G418-selected HeLa clones carrying expression plasmid for scAbWXXF were obtained much more frequently than those for scAb-Vpr, scAb-WXXF was inferred to be less toxic to cells than scAb-Vpr, These results suggest that scAb-WXXF may serve as a novel class of antiviral therapeutic that inactivates progeny HIV virions from within.	Natl Inst Infect Dis, Div Mol Genet, Tokyo 2080011, Japan; Univ Tokyo, Fac Med, Dept Urol, Tokyo 113, Japan; Sci Univ Tokyo, Tokyo 162, Japan; Int Med Ctr Japan, Res Inst, Tokyo, Japan	Kitamura, Y (reprint author), Natl Inst Infect Dis, Div Mol Genet, 4-7-1 Gakuen, Tokyo 2080011, Japan.						Agostini I, 1996, J MOL BIOL, V261, P599, DOI 10.1006/jmbi.1996.0485; HE JL, 1995, J VIROL, V69, P6705; NIWA H, 1991, GENE, V108, P193; Willetts KE, 1999, J VIROL, V73, P1682; Hrimech M, 1999, J VIROL, V73, P4101; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; RE F, 1995, J VIROL, V69, P6859; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; Stewart SA, 1997, J VIROL, V71, P5579; DIMARZIO P, 1995, J VIROL, V69, P7909; JOWETT JBM, 1995, J VIROL, V69, P6304; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Wu XY, 1997, EMBO J, V16, P5113, DOI 10.1093/emboj/16.16.5113; FARNET CM, 1991, J VIROL, V65, P1910; Bouhamdan M, 1996, J VIROL, V70, P697; WU XY, 1995, J VIROL, V69, P3389; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BouHamdan M, 1998, J BIOL CHEM, V273, P8009, DOI 10.1074/jbc.273.14.8009; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379; Kulkosky J, 1999, VIROLOGY, V255, P77, DOI 10.1006/viro.1998.9544; LU YL, 1993, J VIROL, V67, P6542; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Boeke JD, 1996, TRENDS MICROBIOL, V4, P421, DOI 10.1016/0966-842X(96)10065-2; COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11; DROPULIC B, 1994, HUM GENE THER, V5, P927, DOI 10.1089/hum.1994.5.8-927; HASEGAWA A, 1989, AIDS RES HUM RETROV, V5, P593, DOI 10.1089/aid.1989.5.593; HENDERSON LE, 1988, SCIENCE, V241, P199, DOI 10.1126/science.3388031; Ishikawa T, 1999, J VIROL, V73, P4475; KAPPES JC, 1988, J VIROL, V62, P3501; Kewalramani VN, 1996, VIROLOGY, V218, P326, DOI 10.1006/viro.1996.0201; Kitamura Y, 1999, J ACQ IMMUN DEF SYND, V20, P105; Kobinger GP, 1998, J VIROL, V72, P5441; Kulkosky J, 1999, BLOOD, V93, P1906; Liu HM, 1997, J VIROL, V71, P7704; Mahalingam S, 1997, J VIROL, V71, P6339; MAHALINGAM S, 1995, VIROLOGY, V207, P297, DOI 10.1006/viro.1995.1081; MATSUDA Z, 1988, P NATL ACAD SCI USA, V85, P6968, DOI 10.1073/pnas.85.18.6968; Miller MD, 1997, J VIROL, V71, P5382; Nakayama EE, 1998, FEBS LETT, V426, P367, DOI 10.1016/S0014-5793(98)00375-5; NATSOULIS G, 1991, NATURE, V352, P632, DOI 10.1038/352632a0; Nishino Y, 1997, BIOCHEM BIOPH RES CO, V232, P550, DOI 10.1006/bbrc.1997.6186; Okui N, 1998, J VIROL, V72, P6960; Park IW, 1996, J ACQ IMMUN DEF SYND, V11, P341; PEDEN KWC, 1995, HIV PRACTICAL APPROA, V1, P21; POMERANTZ RJ, 1995, AIDS, V9, P985, DOI 10.1097/00002030-199509000-00002; Rapaport E, 1998, VIROLOGY, V252, P407, DOI 10.1006/viro.1998.9459; Rey F, 1998, J GEN VIROL, V79, P1083; Serio D, 1997, P NATL ACAD SCI USA, V94, P3346, DOI 10.1073/pnas.94.7.3346; Varmus H, 1989, MOBILE DNA, P53; WONGSTAAL F, 1987, AIDS RES HUM RETROV, V3, P33, DOI 10.1089/aid.1987.3.33; Wu XY, 1996, J VIROL, V70, P3378; Wu XY, 1996, VIROLOGY, V219, P307, DOI 10.1006/viro.1996.0253; YU XF, 1988, NATURE, V335, P262, DOI 10.1038/335262a0	55	12	13	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	1043-0342			HUM GENE THER	Hum. Gene Ther.	MAR 1	2000	11	4					537	546		10.1089/10430340050015725		10	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	290CR	WOS:000085659100003		
J	Ohkawa, J; Taira, K				Ohkawa, J; Taira, K			Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter	HUMAN GENE THERAPY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-III PROMOTER; IN-VIVO; GENE-EXPRESSION; MAMMALIAN-CELLS; TET REPRESSOR; FUSION GENE; START SITE; TATA BOX; TRANSCRIPTION	In an effort to develop a regulatable derivative of the promoter of the human gene for U6 snRNA, we generated several constructs composed of the human U6 snRNA promoter and sequences derived from the gene for the tetracycline operator of a prokaryotic tetracycline resistance transposon, One of the constructs had strong transcriptional activity in the presence of tetracycline that was equivalent to 80% of the activity of the wild-type promoter. Furthermore, the transcriptional activity was almost completely repressed in the absence of tetracycline, Transcriptional activity became detectable within 4 hr after the addition of tetracycline to the culture medium. We used this system to control the functional activity of an antisense RNA for a chimeric gene derived from genes for the epidermal growth factor receptor (EGFR) and green fluorescent protein (GFP), A plasmid that expressed the chimeric gene and a plasmid that expressed the antisense RNA under the control of the inducible U6 promoter were used to cotransfect HeLa cells that were producing the tetracycline repressor protein (Tet R), Addition of tetracycline to the culture medium 12 hr after transfection resulted in the almost complete disappearance of the fluorescent signal due to the chimeric protein within 24 hr, Our results suggest that this expression system might be a useful tool for controlling the expression of functional RNAs, such as aptamers and antisense RNAs, both in basic research and in gene therapy.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan	Taira, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, 7-3-1 Hongo, Tokyo 1138656, Japan.						WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; MAYO KE, 1982, CELL, V29, P99, DOI 10.1016/0092-8674(82)90094-0; HARADA N, 1992, ENDOCRINOLOGY, V131, P2306, DOI 10.1210/en.131.5.2306; He YK, 1998, J NATL CANCER I, V90, P1080, DOI 10.1093/jnci/90.14.1080; Good PD, 1997, GENE THER, V4, P45, DOI 10.1038/sj.gt.3300354; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEGENKOLB J, 1991, ANTIMICROB AGENTS CH, V35, P1591; DINGERMANN T, 1992, MOL CELL BIOL, V12, P4038; DINGERMANN T, 1992, EMBO J, V11, P1487; Du ZM, 1998, HUM GENE THER, V9, P1551, DOI 10.1089/hum.1998.9.11-1551; Geiduschek E.P., 1992, TRANSCRIPTIONAL REGU, P247; GOOMER RS, 1992, NUCLEIC ACIDS RES, V20, P4903, DOI 10.1093/nar/20.18.4903; GOSSEN M, 1993, TRENDS BIOCHEM SCI, V18, P471, DOI 10.1016/0968-0004(93)90009-C; HILLEN W, 1984, J MOL BIOL, V172, P185, DOI 10.1016/S0022-2836(84)80037-6; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; ISRAEL DI, 1989, NUCLEIC ACIDS RES, V17, P4589, DOI 10.1093/nar/17.12.4589; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kawasaki H, 1998, NATURE, V393, P284; Kawasaki H, 1996, NUCLEIC ACIDS RES, V24, P3010, DOI 10.1093/nar/24.15.3010; Koseki S, 1998, J CONTROL RELEASE, V53, P159, DOI 10.1016/S0168-3659(97)00250-2; Kuwabara T, 1998, NAT BIOTECHNOL, V16, P961; Kuwabara T, 1999, P NATL ACAD SCI USA, V96, P1886, DOI 10.1073/pnas.96.5.1886; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; LESCURE A, 1991, NUCLEIC ACIDS RES, V19, P435, DOI 10.1093/nar/19.3.435; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; Luukkonen BGM, 1998, RNA, V4, P231; MATTAJ IW, 1988, CELL, V55, P435, DOI 10.1016/0092-8674(88)90029-3; MCBRYANT SJ, 1995, J MOL BIOL, V250, P315, DOI 10.1006/jmbi.1995.0379; NOONBERG SB, 1994, NUCLEIC ACIDS RES, V22, P2830, DOI 10.1093/nar/22.14.2830; OHKAWA J, 1993, P NATL ACAD SCI USA, V90, P11302, DOI 10.1073/pnas.90.23.11302; OJWANG JO, 1992, P NATL ACAD SCI USA, V89, P10802, DOI 10.1073/pnas.89.22.10802; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; SCHWEINFEST CW, 1988, GENE, V71, P207, DOI 10.1016/0378-1119(88)90093-5; SYROID DE, 1992, MOL CELL BIOL, V12, P4271; THOMPSON JD, 1995, NUCLEIC ACIDS RES, V23, P2259, DOI 10.1093/nar/23.12.2259; Ulmasov B, 1997, PLANT MOL BIOL, V35, P417, DOI 10.1023/A:1005819007549; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939	39	66	70	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	1043-0342			HUM GENE THER	Hum. Gene Ther.	MAR 1	2000	11	4					577	585		10.1089/10430340050015761		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	290CR	WOS:000085659100007		
J	Iida, A; Emi, M; Matsuoka, R; Hiratsuka, E; Okui, K; Ohashi, H; Inazawa, J; Fukushima, Y; Imai, T; Nakamura, Y				Iida, A; Emi, M; Matsuoka, R; Hiratsuka, E; Okui, K; Ohashi, H; Inazawa, J; Fukushima, Y; Imai, T; Nakamura, Y			Identification of a gene disrupted by inv(11)(q13.5;q25) in a patient with left-right axis malformation	HUMAN GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; HUMAN SITUS DETERMINATION; HUMAN CHROMOSOME-11; LATERALITY DEFECTS; SIGNALING PATHWAY; RFLP MARKERS; DNA MARKERS; INVERSUS; MOUSE; PITX2	An inv(11)(q13.5;q25) inversion was previously identified in a 9-month-old male patient with complex cyanotic heart defects, altered lung lobation, sym metric liver, and abnormally lobulated spleen (polysplenia). This chromosomal rearrangement was inherited from the phenotypically normal father. We termed these regions DHTX-A (disrupted in heterotaxy)- A at 11q13.5 and DHTX-B at 11q25. Here, we report the isolation and characterization of the inversion breakpoints and the gene that is disrupted by the DHTX-A breakpoint. The putative DHTX is identical to the UVRAG gene, which was originally identified as a gene that complements the UV sensitivity of xeroderma pigmentosum complementation group C. The 4-kb mRNA was found to be encoded by a large gene, at least 300 kb long, composed of 15 exons. The function of the gene product remains largely unknown. However, the near central portion of the UVRAG protein is predicted to contain a coiled-coil domain, which has been implicated in mediating protein-protein interactions. Southern analyses and fluorescence in situ hybridization (FISH) revealed that the DHTX-A breakpoint in the patient and his father lies within the intron between exons 6 and 7 of UVRAG. Northern blot analysis indicated strong expression in human fetal and adult tissues and in mouse embryonic day-7 and adult tissues, respectively. Whole mount in situ hybridization also showed that the Uvrag gene is expressed in the presomite-stage embryo. Several hypotheses are discussed to explain the relationship between the chromosomal inversion and the accompanying phenotypes.	Tokyo Womens Med Univ, Heart Inst Japan, Dept Pediat Cardiol, Shinjuku Ku, Tokyo 1628666, Japan; Univ Tokyo, Inst Med Sci, Human Genome Ctr, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; Saitama Childrens Med Ctr, Iwatsuki, Saitama 3398551, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1130034, Japan; Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Nagano 3908621, Japan; Natl Inst Radiol Sci, Genome Res Grp, Lab Human & Mouse Genome Mapping, Chiba 2638555, Japan; Nippon Med Sch, Inst Gerontol ROUKEN, Dept Mol Biol, Kanagawa, Japan	Iida, A (reprint author), John Wayne Canc Inst, Dept Mol Oncol, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.						ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALONSO S, 1995, AM J MED GENET, V56, P12, DOI 10.1002/ajmg.1320560105; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Izraeli S, 1999, NATURE, V399, P691; Ryan AK, 1998, NATURE, V394, P545; Kosaki K, 1998, SEMIN CELL DEV BIOL, V9, P89, DOI 10.1006/scdb.1997.0187; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901144; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Kosaki K, 1999, AM J HUM GENET, V64, P712, DOI 10.1086/302289; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; ARNOLD GL, 1983, AM J MED GENET, V16, P35, DOI 10.1002/ajmg.1320160107; Bartsch O, 1999, EUR J HUM GENET, V7, P748, DOI 10.1038/sj.ejhg.5200378; BEDDINGTON SP, 1999, CELL, V96, P195; CARMI R, 1992, AM J MED GENET, V44, P246, DOI 10.1002/ajmg.1320440228; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; Casey B, 1996, AM J MED GENET, V61, P325, DOI 10.1002/(SICI)1096-8628(19960202)61:4<325::AID-AJMG5>3.0.CO;2-T; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Freeman SB, 1996, AM J MED GENET, V61, P340; FUKUSHIMA Y, 1992, JPN J HUM GENET, V37, P149, DOI 10.1007/BF01899737; FUKUSHIMA Y, 1993, AM J HUM GENET S, V53; GENUARDI M, 1994, AM J MED GENET, V50, P101, DOI 10.1002/ajmg.1320500125; Harvey RP, 1998, CELL, V94, P273, DOI 10.1016/S0092-8674(00)81468-3; HORI TA, 1992, GENOMICS, V13, P129, DOI 10.1016/0888-7543(92)90212-B; INAZAWA J, 1992, JPN J CANCER RES, V83, P1248; INAZAWA J, 1993, GENOMICS, V17, P153, DOI 10.1006/geno.1993.1297; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; Kato R, 1997, JPN J HUM GENET, V42, P525, DOI 10.1007/BF02767029; KOIFFMANN CP, 1993, AM J MED GENET, V47, P568, DOI 10.1002/ajmg.1320470426; LAYTON WM, 1976, J HERED, V67, P336; Iida A., 1997, British Journal of Cancer, V75, P264, DOI 10.1038/bjc.1997.43; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; MURATA Y, 1994, HUM MOL GENET, V3, P1341, DOI 10.1093/hmg/3.8.1341; NIIKAWA N, 1983, AM J MED GENET, V16, P43, DOI 10.1002/ajmg.1320160108; Nomura M, 1998, NATURE, V393, P786; OANA S, 1995, EUR J CELL BIOL, V67, P42; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Pan YZ, 1998, AM J HUM GENET, V62, P1551, DOI 10.1086/301857; Perelman B, 1997, GENOMICS, V41, P397, DOI 10.1006/geno.1997.4623; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Reddy KS, 1999, AM J MED GENET, V84, P460, DOI 10.1002/(SICI)1096-8628(19990611)84:5<460::AID-AJMG10>3.0.CO;2-L; SALEH M, 1992, GENOMICS, V14, P970, DOI 10.1016/S0888-7543(05)80119-3; TOKINO T, 1991, AM J HUM GENET, V48, P258; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WILSON GN, 1991, AM J MED GENET, V38, P601, DOI 10.1002/ajmg.1320380420; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	55	29	30	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-6717			HUM GENET	Hum. Genet.	MAR	2000	106	3					277	287		10.1007/s004390051038		11	Genetics & Heredity	Genetics & Heredity	307PE	WOS:000086661100003		
J	Ohnishi, Y; Tanaka, T; Yamada, R; Suematsu, K; Minami, M; Fujii, K; Hoki, N; Kodama, K; Nagata, S; Hayashi, T; Kinoshita, N; Sato, H; Sato, H; Kuzuya, T; Takeda, H; Hori, M; Nakamura, Y				Ohnishi, Y; Tanaka, T; Yamada, R; Suematsu, K; Minami, M; Fujii, K; Hoki, N; Kodama, K; Nagata, S; Hayashi, T; Kinoshita, N; Sato, H; Sato, H; Kuzuya, T; Takeda, H; Hori, M; Nakamura, Y			Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population	HUMAN GENETICS			English	Article							MYOCARDIAL-INFARCTION; ETHNIC-DIFFERENCES; RISK; PROGRESSION; MUTATIONS; MARKERS	To investigate whether common variants in the human genetic background are associated with pathogenesis of ischemic heart diseases, we systematically surveyed 41 possible candidate genes for single-nucleotide polymorphisms (SNPs) by directly sequencing 96 independent alleles at each locus, derived from 48 unrelated Japanese patients with myocardial infarction, including 25.8 kb 5' flanking regions, 56.8 kb exonic and 35.4 kb intronic sequences, and 1.8 kb 3' flanking regions. In this genomic DNA of nearly 120 kb, we identified 187 SNPs: 55 in 5' flanking regions, seven in 5' untranslated regions (UTRs), 52 in coding elements, 64 in introns, eight in 3' UTRs, and one in a 3' flanking region. Among the 52 coding SNPs, 26 were non-synonymous changes. Allelic frequencies of some of the polymorphisms were significantly different from those reported in European populations. For example, the Q506R substitution in the coagulation factor V gene, the so-called "Leiden mutation", has a reported frequency of 2.3% in Europeans, but we detected the Leiden mutation in none of the Japanese genomes that we investigated. The allelic frequencies of the -33A>G SNP in the thrombomodulin gene were also very different; this allele occurred at a 12% frequency in the Japanese patients that we examined, although it had been detected in none of 82 Caucasians reported previously. These data support the hypothesis that some SNPs are specific to particular ethnic groups.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka, Japan; Osaka Univ, Sch Med, Dept Med Informat Sci, Osaka, Japan; Osaka Acute Coronary Insufficiency Study Grp, Osaka, Japan	Nakamura, Y (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; SANDHOLZER C, 1991, HUM GENET, V86, P607; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Ireland H, 1997, CIRCULATION, V96, P15; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Marsh S, 1999, GENOMICS, V58, P310, DOI 10.1006/geno.1999.5833; Cargill M, 1999, NAT GENET, V22, P231; Halushka MK, 1999, NAT GENET, V22, P239; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Beavan S, 1998, NEW ENGL J MED, V339, P351, DOI 10.1056/NEJM199807303390517; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Helley D, 1997, HUM GENET, V100, P245, DOI 10.1007/s004390050499; Housman D, 1998, NAT BIOTECHNOL, V16, P492, DOI 10.1038/nbt0698-492; KRANE DE, 1992, P NATL ACAD SCI USA, V89, P10533; Morita H, 1997, CIRCULATION, V95, P2032; SASSO EH, 1995, J CLIN INVEST, V96, P1591, DOI 10.1172/JCI118198; Tybjaerg-Hansen A, 1998, NEW ENGL J MED, V338, P1577, DOI 10.1056/NEJM199805283382203	25	64	66	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-6717			HUM GENET	Hum. Genet.	MAR	2000	106	3					288	292		10.1007/s004390051039		5	Genetics & Heredity	Genetics & Heredity	307PE	WOS:000086661100004		
J	Yamada, R; Tanaka, T; Ohnishi, Y; Suematsu, K; Minami, M; Seki, T; Yukioka, M; Maeda, A; Murata, N; Saiki, O; Teshima, R; Kudo, O; Ishikawa, K; Ueyosi, A; Tateishi, H; Inaba, M; Goto, H; Nishizawa, Y; Tohma, S; Ochi, T; Yamamoto, K; Nakamura, Y				Yamada, R; Tanaka, T; Ohnishi, Y; Suematsu, K; Minami, M; Seki, T; Yukioka, M; Maeda, A; Murata, N; Saiki, O; Teshima, R; Kudo, O; Ishikawa, K; Ueyosi, A; Tateishi, H; Inaba, M; Goto, H; Nishizawa, Y; Tohma, S; Ochi, T; Yamamoto, K; Nakamura, Y			Identification of 142 single nucleotide polymorphisms in 41 candidate genes for rheumatoid arthritis in the Japanese population	HUMAN GENETICS			English	Article							LINKAGE	Single-nucleotide polymorphisms (SNPs) can make an important contribution to our understanding of genetic backgrounds that may influence medical conditions and ethnic diversity. We undertook a systematic survey of genomic DNA for SNPs located not only in coding sequences but also in non-coding regions (e.g., introns and 5' flanking regions) of selected genes. Using DNA samples from 48 Japanese patients with rheumatoid arthritis (RA) as templates, we surveyed 41 genes that represent candidates for RA, screening a total of 104 kb of DNA (30 kb of coding sequences and 74 kb of non-coding DNA). Within this 104 kb of genomic sequences we identified 163 polymorphisms (1 per 638 bases on average), of which 142 were single-nucleotide substitutions and the remainder, insertions or deletions. Of the coding SNPs, 52% were non-synonymous substitutions, and non-conservative amino acid changes were observed in a quarter of those. Sixty-nine polymorphisms showed high frequencies for minor alleles (more than 15%) and 20 revealed low frequencies (<5%). Our results indicated a greater average distance between SNPs than others have reported, but this disparity may reflect the type of genes surveyed and/or the relative ethnic homogeneity of our test population.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo 108, Japan; Tokyo Univ Hosp, Dept Allergy & Rheumatol Internal Med, Bunkyo Ku, Tokyo, Japan; Yukioka Hosp, Dept Orthoped Surg, Kita Ku, Osaka, Japan; Osaka Minami Natl Hosp, Dept Rheumatol, Osaka, Japan; Osaka Minami Natl Hosp, Dept Clin Invest, Osaka, Japan; Tottori Univ, Dept Orthoped Surg, Tottori 680, Japan; Oita Med Univ, Dept Orthoped Surg, Hasana, Oita, Japan; Ishikawa Orthoped & Rheumatism Hosp, Kumamoto, Japan; Wakayama Med Coll, Dept Phys Med & Rehabil, Wakayama 640, Japan; Hyogo Coll Med, Sasayama Hosp, Sasayama, Hyogo, Japan; Osaka City Univ, Sch Med, Dept Internal Med 2, Abeno Ku, Osaka 545, Japan; Osaka Univ, Sch Med, Dept Orthoped, Osaka, Japan	Nakamura, Y (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.						Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; AHO K, 1986, J RHEUMATOL, V13, P899; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Cargill M, 1999, NAT GENET, V22, P231; Halushka MK, 1999, NAT GENET, V22, P239; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; LAWRENCE RC, 1994, RHEUMATOLOGY; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891	18	26	28	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-6717			HUM GENET	Hum. Genet.	MAR	2000	106	3					293	297				5	Genetics & Heredity	Genetics & Heredity	307PE	WOS:000086661100005		
J	Watanabe, MM; Mayama, S; Hiroki, M; Nozaki, H				Watanabe, MM; Mayama, S; Hiroki, M; Nozaki, H			Biomass, species composition and diversity of epipelic algae in mire pools	HYDROBIOLOGIA			English	Article						biomass; desmids; disturbance; diversity; diatoms; epipelic algae; mire	DISTURBANCE	The biomass, species composition and diversity of epipelic algae in two small pools of contrasting physicochemical characteristics in Miyatoko Mire were studied in 1992 (pool 3 =site B4 and pool 50 =site D2). A total of 93 species and 67 species of epipelic algae occurred at sites B4 and D2, respectively. Considerable differences were observed between the two sites in the seasonal fluctuations of species number, biomass and dominant species. At site B4, little changed with species number during April-August and markedly increased in October, while biomass was largest in April and gradually decreased during June-October. Diatoms and desmids occupied 33-82% and 15-63% of total algal biomass, respectively. At site D2, species number and biomass were small in April just after the snow-thaw, and increased in June and decreased in August and October. Diatoms occupied 90-98% of total algal biomass. The species diversity was always higher at site D2 than B4. As a result of analyses of water chemistry in the two pools, pool B4 can be recognized as a habitat experiencing high disturbance frequency. It is predicted that pools experiencing frequent disturbance will have less epipelic algal biomass and diversity.	Natl Inst Environm Studies, Tsukuba, Ibaraki 305, Japan; Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 184, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	Watanabe, MM (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 305, Japan.						RESH VH, 1988, J N AM BENTHOL SOC, V7, P433, DOI 10.2307/1467300; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SCARSBROOK MR, 1993, FRESHWATER BIOL, V29, P395, DOI 10.1111/j.1365-2427.1993.tb00774.x; BOURRELLY P, 1972, ALGUES DEAU DOUCE, V1; CROASDALE H., 1983, SYNOPSIS N AM DESM 2; GEITLER L, 1932, OESTERREICH SCHWEIZ, V14; Harris GP, 1986, PHYTOPLANKTON ECOLOG; HARRIS GP, 1983, ARCH HYDROBIOL, V88, P393; HIRANO M, 1943, ACT PHYTOTAX GEOBOT, V12, P71; HIRANO MINORU, 1942, ACTA PHYTOTAX ET GEOBOT, V11-12-(2), P272; HIRANO M, 1943, ACT PHYTOTAX GEOBOT, V12, P17; HIRATA T, 1995, RES REP NATL I ENV S, V134, P177; Hirose H. M., 1977, ILLUSTRATIONS JAPANE; HUBER-PESTALOZZI G., 1941, BINNENGEWASSER; Huber-Pestalozzi G, 1955, BINNENGEWASSER, V16/4; IWAKUMA T, 1995, RES REP NATL I ENV S, V134; Kobayasi H., 1981, P 6 S REC FOSS DIAT, P93; KOBAYASI H, 1988, BOT MAG TOKYO, V101, P239, DOI 10.1007/BF02488602; KOBAYASI H., 1977, B TOKYO GAKUGEI U 4, V29, P231; Komarek J., 1983, BINNENGEWASSER, V16; KOUWETS FAC, 1988, CRYPTOGAMIE ALGOL, V9, P289; Krammer K., 1991, SUSSWASSERFLORA MITT, V2; Krammer K., 1986, SUSSWASSERFLORA MITT, P876; Krammer K., 1988, SUSSWASSERFLORA MITT, V2; KRAMMER K., 1992, BIBLIOTHECA DIATOMOL, V26, P1; Margalef R, 1958, PERSPECTIVES MARINE, P323; MASING V, 1990, WETLANDS SHALLOW CON, V1, P313; May R.M., 1975, P81; MAYAMA S, 1991, Japanese Journal of Phycology, V39, P131; MAYAMA S, 1991, DIATOM RES, V5, P351; PATRICK R. M., 1966, MONOGR ACAD NATL SCI, V13, P1; PRESCOTT G. W., 1975, SYNOPSIS N AM DESM 2; Prescott G. W., 1981, SYNOPSIS N AM DESM 2; PRESCOTT G. W., 1977, SYNOPSIS N AM DESM 2; PRESCOTT G.W., 1984, BIBLIO DESMIDIACEARU, pi; REICE SR, 1990, ENVIRON MANAGE, V14, P647, DOI 10.1007/BF02394715; Rosenzweig Michael L., 1993, P52; Ruzicka J, 1977, DESMIDIACEEN MITTELE, V1/1; Starmach K, 1985, SUSSWASSERFLORA MITT, V1; TAKEHARA A, 1995, RES REP NATL I ENV S, V134, P45; Vinyard W. C., 1982, SYNOPSIS N AM DESM 2; VONLENZENWEGER R, 1987, ARCH HYDROBIOL S, V78, P47	43	20	21	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0018-8158			HYDROBIOLOGIA	Hydrobiologia	MAR	2000	421						91	102		10.1023/A:1003939824549		12	Marine & Freshwater Biology	Marine & Freshwater Biology	305LP	WOS:000086541800009		
J	Aizawa, T; Ishizaka, N; Taguchi, J; Nagai, R; Mori, I; Tang, SS; Ingelfinger, JR; Ohno, M				Aizawa, T; Ishizaka, N; Taguchi, J; Nagai, R; Mori, I; Tang, SS; Ingelfinger, JR; Ohno, M			Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats - Possible role in renoprotection	HYPERTENSION			English	Article						hypertension; angiotensin II; proteinuria; oxidative stress; kidney	SMOOTH-MUSCLE CELLS; CARBON-MONOXIDE; DIABETIC NEPHROPATHY; ENDOTHELIAL-CELLS; BLOOD-PRESSURE; NITRIC-OXIDE; EXPRESSION; INDUCTION; INHIBITION; BLOCKADE	In this study, we investigated the regulation and physiological role of heme oxygenase-1 (HO-1) in the kidney of rats with hypertension. Rats were continuously administered either angiotensin II (Ang II) or norepinephrine with an osmotic minipump for up to 7 days. Ang II infusion decreased the glomerular filtration rate (GFR) as determined through creatinine clearance (3.2+/-0.2 versus 1.2+/-0.2 mL/min with Ang II infusion, P<0.01) and increased proteinuria (9.7+/-1.3 versus 28.1+/-7.2 mg/d with Ang II infusion, P<0.01). In contrast, norepinephrine did not alter these laboratory values. Ang II infusion significantly increased HO-1 expression in mRNA (442+/-98% of control at day 5, P<0.01) and protein levels (314+/-49% of control at day 5, P<0.01). Immunohistochemistry showed that in the kidney of normotensive rats, HO-1 was expressed mainly in the basal side in the renal tubules. After Ang II infusion, HO-1 staining was more extensively dispersed in the tubular epithelial cells. The intraperitoneal administration of zinc protoporphyrin, an HO inhibitor, to Ang II-infused rats further decreased GFR (0.8+/-0.1 mL/min) and increased. proteinuria (52.5+/-13.0 mg/d). In contrast, the administration of hemin, an HO inducer, ameliorated the Ang II-induced decrease in GFR (2.4+/-0.2 mL/min) and increase in proteinuria (9.3+/-4.5 mg/d). These data suggest that HO-1 upregulation in the kidney of Ang II-induced hypertensive rats may exert a renoprotective effect against Ang II-induced renal injury.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Tokai Univ, Sch Med, Dept Pathol, Kanagawa 2591100, Japan; Massachusetts Gen Hosp, Pediat Nephrol Lab, Boston, MA 02114 USA	Ishizaka, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.						Agarwal A, 1998, J AM SOC NEPHROL, V9, P1990; AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Aizawa T, 1999, BIOCHEM BIOPH RES CO, V261, P302, DOI 10.1006/bbrc.1999.1020; AMANN K, 1993, J HYPERTENS, V11, P969, DOI 10.1097/00004872-199309000-00011; Amlal H, 1998, AM J PHYSIOL-CELL PH, V274, pC1047; Mosley K, 1998, KIDNEY INT, V53, P672, DOI 10.1046/j.1523-1755.1998.00798.x; Johnson RA, 1996, AM J PHYSIOL-HEART C, V271, pH1132; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; Chin SY, 1998, AM J PHYSIOL-RENAL, V274, pF876; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; VILE GF, 1993, J BIOL CHEM, V268, P14678; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Ingelfinger Jr, 1999, AM J PHYSIOL-RENAL, V276, pF218; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; HarrisonBernard LM, 1997, AM J PHYSIOL-RENAL, V273, pF170; Nielsen FS, 1997, DIABETES, V46, P1182, DOI 10.2337/diabetes.46.7.1182; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; BRUNE B, 1987, MOL PHARMACOL, V32, P497; Wang R, 1997, J BIOL CHEM, V272, P8222; BUZIO C, 1994, HYPERTENSION, V24, P763; COCEANI F, 1993, SCIENCE, V260, P739, DOI 10.1126/science.8484109; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; Himmelmann A, 1996, AM J HYPERTENS, V9, P850, DOI 10.1016/S0895-7061(96)00176-8; Hu Y, 1998, J HISTOCHEM CYTOCHEM, V46, P249; Ishizaka N, 1997, CIRCULATION, V96, P1923; Ishizaka N, 1997, HYPERTENSION, V29, P790; LEVERE RD, 1990, J CLIN INVEST, V86, P213, DOI 10.1172/JCI114686; Liu HJ, 1999, J CLIN INVEST, V103, P963, DOI 10.1172/JCI5206; Rodicio JL, 1996, J HYPERTENS, V14, pS69, DOI 10.1097/00004872-199609002-00014; RUILOPE LM, 1994, J HYPERTENS, V12, pS59; Wang YP, 1997, J AM SOC NEPHROL, V8, P1537; WEIDMANN P, 1995, NEPHROL DIAL TRANSPL, V10, P39; Zoja C, 1998, EXP NEPHROL, V6, P121; Zou LX, 1996, HYPERTENSION, V28, P669	37	107	110	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X			HYPERTENSION	Hypertension	MAR	2000	35	3					800	806				7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	296GJ	WOS:000086015800020		
J	Joki, N; Kaname, S; Hirakata, M; Hori, Y; Yamaguchi, T; Fujita, T; Katoh, T; Kurokawa, K				Joki, N; Kaname, S; Hirakata, M; Hori, Y; Yamaguchi, T; Fujita, T; Katoh, T; Kurokawa, K			Tyrosine-kinase dependent TGF-beta and extracellular matrix expression by mechanical stretch in vascular smooth muscle cells	HYPERTENSION RESEARCH			English	Article						mechanical stretch; tyrosine kinase; transforming growth factor-beta; smooth muscle cells; extracellular matrix	GROWTH-FACTOR-BETA; MESANGIAL CELLS; ANGIOTENSIN-II; CARDIAC MYOCYTES; STIMULATES SYNTHESIS; SIGNAL-TRANSDUCTION; COLLAGEN PRODUCTION; RAT; HYPERTENSION; INVOLVEMENT	Vascular hypertrophy, which is characterized by proliferation of vascular smooth muscle cells (VSMC) and accumulation of extracellular matrix(ECM), is a major pathological change in blood vessels after chronic exposure to hypertension. Blood pressure is transmitted to the arterial walls and counterbalanced by mechanical stress, leading to stretching of circumferentially oriented VSMC, which may play some role in the pathogenesis of vascular hypertrophy, The present study was designed, therefore, to investigate the effect of mechanical stretch on the expression of ECM components and transforming growth factor-beta (TGF-beta), a potent stimulator for ECM production, and to examine the signal transduction mechanisms of the induction of TGF-beta in cultured rat VSMC. VSMC were subjected to cyclic stretch to provide a maximal elongation of 20% at a rate of 60 cycles per minute for up to 24 h. Mechanical stretch stimulated TGF-beta 1 mRNA expression in a time- and elongation-dependent manner. Indeed, the secretion of TGF-beta proteins into the culture media was increased after stretch. Stretch also stimulated mRNA expression of the ECM components, type I and type IV collagen, and fibronectin, which was largely inhibited by addition of neutralizing antibody against TGF-beta. The tyrosine kinase inhibitors genistein and herbimycin A blocked the induction of TGF-beta 1 and type I collagen by stretch, while protein kinase C inhibitors, the calcium channel blockers nitrendipine and gadolinium, or Ca removal from the media had no effect. These results suggest that stretch induced, tyrosine kinase mediated autocrine/paracrine production of TGF-beta may play a critical role in the progression of vascular remodeling associated with high blood pressure. (Hypertens Res 2000; 23: 91-99).	Tokai Univ, Sch Med, Kanagawa 2591143, Japan; Univ Tokyo, Sch Med, Dept Internal Med, Tokyo 113, Japan; Takeda Chem Ind Ltd, Pharmaceut Res Labs 2, Osaka 532, Japan; Toho Univ, Ohashi Hosp, Tokyo 153, Japan; Fukushima Med Coll, Dept Internal Med 3, Fukushima, Japan	Kurokawa, K (reprint author), Tokai Univ, Sch Med, Kanagawa 2591143, Japan.						Reusch P, 1996, CIRC RES, V79, P1046; Hirakata M, 1997, KIDNEY INT, V51, P1028, DOI 10.1038/ki.1997.144; Riser BL, 1996, AM J PATHOL, V148, P1915; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; SADOSHIMA J, 1993, EMBO J, V12, P1681; FOLKOW B, 1982, PHYSIOL REV, V62, P347; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; LEVY BI, 1988, CIRC RES, V63, P227; KOMURO I, 1990, J BIOL CHEM, V265, P3595; LEUNG DYM, 1976, SCIENCE, V191, P475; Liu MY, 1996, J BIOL CHEM, V271, P7066; SAFAR ME, 1981, CIRCULATION, V63, P393; CHOBANIAN AV, 1990, HYPERTENSION, V15, P666; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1; Gruden G, 1997, P NATL ACAD SCI USA, V94, P12112, DOI 10.1073/pnas.94.22.12112; NODA M, 1994, J BIOL CHEM, V269, P17911; Bardy N, 1996, CIRC RES, V79, P70; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CHEN JK, 1987, P NATL ACAD SCI USA, V84, P5287, DOI 10.1073/pnas.84.15.5287; CHOBANIAN AV, 1992, AM J CARDIOL, V69, pE3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083; FROHLICH ED, 1977, HYPERTENSION PHYSIOP, P45; GRANDE JP, 1989, ARTERIOSCLEROSIS, V9, P446; HAMASAKI K, 1995, BIOCHEM BIOPH RES CO, V212, P544, DOI 10.1006/bbrc.1995.2004; HOMMA T, 1992, J BIOL CHEM, V267, P23129; Ivanov VO, 1998, ATHEROSCLEROSIS, V140, P25, DOI 10.1016/S0021-9150(98)00102-6; KANAME S, 1992, KIDNEY INT, V42, P1319, DOI 10.1038/ki.1992.423; KIM SJ, 1989, J BIOL CHEM, V264, P402; KOLLROS PR, 1987, LAB INVEST, V56, P410; Li Q, 1998, J VASC RES, V35, P93, DOI 10.1159/000025570; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Miyata T, 1998, J CLIN INVEST, V102, P828, DOI 10.1172/JCI2450; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; MULVANY MJ, 1993, AM J MED, V94, pS20; Nickenig G, 1998, HYPERTENSION, V31, P1272; OWENS GK, 1982, CIRC RES, V51, P280; Standley PR, 1999, AM J PHYSIOL-ENDOC M, V276, pE697; SUDHIR K, 1993, J CLIN INVEST, V92, P3003, DOI 10.1172/JCI116923; SUMPIO BE, 1988, ARCH SURG-CHICAGO, V123, P1233; Tamura K, 1999, J HYPERTENS, V17, P81, DOI 10.1097/00004872-199917010-00013; VANDENBURGH HH, 1992, AM J PHYSIOL, V262, pR350; WATSON PA, 1991, FASEB J, V5, P2013; WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054	45	39	44	JAPANESE SOC HYPERTENSION CENT ACADEMIC SOC, PUBL OFFICE	TOYONAKA	OSAKA, 14TH FL, SENRI LIFE SCI CENTER BLDG, 4-2 SHINSENRI- HIGASHI-MACHI 1 CHOME, TOYONAKA, 565-0082, JAPAN	0916-9636			HYPERTENS RES	Hypertens. Res.	MAR	2000	23	2					91	99		10.1291/hypres.23.91		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	304YU	WOS:000086512900001		
J	Shimosawa, T; Kanozawa, K; Nagasawa, R; Mitarai, T; Isoda, K; Takahashi, K; Ando, K; Tozawa, Y; Nagase, M; Sasaki, N; Fujita, M; Takano, K; Iiri, T; Fujita, T				Shimosawa, T; Kanozawa, K; Nagasawa, R; Mitarai, T; Isoda, K; Takahashi, K; Ando, K; Tozawa, Y; Nagase, M; Sasaki, N; Fujita, M; Takano, K; Iiri, T; Fujita, T			Adrenomedullin amidation enzyme activities in hypertensive patients	HYPERTENSION RESEARCH			English	Article						hemodialysis; blood pressure; IRMA	SMOOTH-MUSCLE CELLS; PLASMA ADRENOMEDULLIN; HEART-FAILURE; IMMUNOREACTIVE ADRENOMEDULLIN; HYPOTENSIVE PEPTIDE; RENAL-FAILURE; RAT; SECRETION; TISSUE	Adrenomedullin (AM) is a potent vasodilating peptide secreted from the vasculature of various organs. It is biologically active when its C-terminus is amidated. Recently, an RIA method was developed for measure ment of the active form of AM, or mature AM. We here employed this method to investigate the significance of amidation of AM in controlling cardiovascular function. Thirty-six patients under hemodialysis were recruited and divided into hypertensive (n = 25; 157/86 mmHg) and normotensive (n = 11; 116/66 mmHg) groups. Mature AM, immature AM and blood pressure were monitored during hemodialysis in all patients. There was a significant reduction in blood pressure during hemodialysis in both groups, although after hemodialysis blood pressure was still higher in hypertensives than in normotensives (139 +/- 14.8/76 +/- 2.5 mmHg vs. 110 +/- 5.1/66.7 +/- 3.1 mmHg). Mature AM before hemodialysis were lower in hypertensives than normotensives and it decreased in both groups. Although mature AM decreased more in normotensives than in hypertensives (-27 +/- 8% vs. -17 +/- 5%), at the end point, its revel was still higher in normotensives, The ratio of mature AM/immature AM decreased only in normotensives (-11.4 +/- 8.7%), whereas it remained stable in hypertensives (0.2 +/- 5.6%). Both groups showed similar changes in ANP, endothelin, catecholamines, cGMP, and NOx. The low level in mature AM level in hypertensives may have contributed to the higher blood pressure in this group. The attenuation of AM amidation in normotensives indicates that an unspecified amidative enzyme of AM was regulated in order to normalize blood pressure.	Univ Tokyo, Endocrine & Nephrol Dept, Bunkyo Ku, Tokyo 1128688, Japan; Saitama Med Sch, Dept Internal Med 4, Saitama, Japan; Saitama Med Sch, Dept Hemodialysis, Saitama, Japan	Fujita, T (reprint author), Univ Tokyo, Endocrine & Nephrol Dept, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.		Shimosawa, Tatsuo/A-2920-2015	Shimosawa, Tatsuo/0000-0002-8742-5129			Ando K, 1998, HYPERTENS RES-CLIN E, V21, P187, DOI 10.1291/hypres.21.187; Hayashi M, 1997, LANCET, V350, P1449, DOI 10.1016/S0140-6736(05)64211-0; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; SUGO S, 1994, BIOCHEM BIOPH RES CO, V203, P719, DOI 10.1006/bbrc.1994.2241; Ohta H, 1999, CLIN CHIM ACTA, V287, P131, DOI 10.1016/S0009-8981(99)00128-X; Hayashi M, 1999, BIOCHEM BIOPH RES CO, V258, P453, DOI 10.1006/bbrc.1999.0664; NISHIKIMI T, 1995, J AM COLL CARDIOL, V26, P1424, DOI 10.1016/0735-1097(95)00338-X; NUKI C, 1993, BIOCHEM BIOPH RES CO, V196, P245, DOI 10.1006/bbrc.1993.2241; Kato J, 1999, HYPERTENS RES-CLIN E, V22, P61, DOI 10.1291/hypres.22.61; JOUGASAKI M, 1995, CIRCULATION, V92, P286; Chun TH, 1997, HYPERTENSION, V29, P1296; Kohno M, 1996, HYPERTENSION, V27, P102; Kato J, 1996, J CLIN ENDOCR METAB, V81, P180, DOI 10.1210/jc.81.1.180; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; HIRATA Y, 1995, HYPERTENSION, V25, P790; Hirata Y, 1996, J CLIN ENDOCR METAB, V81, P1449, DOI 10.1210/jc.81.4.1449; Hirayama N, 1999, LIFE SCI, V64, P2505, DOI 10.1016/S0024-3205(99)00208-8; Ishihara T, 1999, CLIN NEPHROL, V52, P119; KITAMURA K, 1994, FEBS LETT, V341, P288, DOI 10.1016/0014-5793(94)80474-5; Kitamura K, 1998, BIOCHEM BIOPH RES CO, V244, P551, DOI 10.1006/bbrc.1998.8310; Majid DSA, 1996, AM J PHYSIOL-RENAL, V270, pF200; MALLAMACI F, 1998, KIDNEY INT, V54, P697; MIURA K, 1995, BRIT J PHARMACOL, V115, P917; Ohta H, 1999, CLIN CHEM, V45, P244; Toepfer M, 1998, NEPHRON, V80, P232, DOI 10.1159/000045174; WASHIMINE H, 1995, HISTOCHEM CELL BIOL, V103, P251, DOI 10.1007/BF01457408; YAMAGUCHI T, 1994, LIFE SCI, V56, P379, DOI 10.1016/0024-3205(94)00903-1	28	12	13	JAPANESE SOC HYPERTENSION CENT ACADEMIC SOC, PUBL OFFICE	TOYONAKA	OSAKA, 14TH FL, SENRI LIFE SCI CENTER BLDG, 4-2 SHINSENRI- HIGASHI-MACHI 1 CHOME, TOYONAKA, 565-0082, JAPAN	0916-9636			HYPERTENS RES	Hypertens. Res.	MAR	2000	23	2					167	171		10.1291/hypres.23.167		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	304YU	WOS:000086512900010		
J	Kanai, T; Suzuki, H; Kimura, F				Kanai, T; Suzuki, H; Kimura, F			Metamorphosis of arbitrary triangular meshes	IEEE COMPUTER GRAPHICS AND APPLICATIONS			English	Article									RIKEN, Inst Phys & Chem Res, Mat Fabricat Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Dept Precis Machinery Engn, Tokyo, Japan	Kanai, T (reprint author), RIKEN, Inst Phys & Chem Res, Mat Fabricat Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.						Aho A. V., 1983, DATA STRUCTURES ALGO; Cohen-Or D, 1998, ACM T GRAPHIC, V17, P116, DOI 10.1145/274363.274366; Kanai T, 1998, VISUAL COMPUT, V14, P166, DOI 10.1007/s003710050132; Lazarus F, 1998, VISUAL COMPUT, V14, P373, DOI 10.1007/s003710050149; MITCHELL JSB, 1987, SIAM J COMPUT, V16, P647, DOI 10.1137/0216045; Beier T., 1992, P SIGGRAPH 92, P35, DOI 10.1145/133994.134003; BOYER M, 1991, INT J ROBOT RES, V10, P570, DOI 10.1177/027836499101000512; CHEN JD, 1990, PROCEEDINGS OF THE SIXTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY, P360, DOI 10.1145/98524.98601; Cheung K. K., 1997, Proceedings. 1997 International Conference on Shape Modeling and Applications (Cat. No.97TB100098), DOI 10.1109/SMA.1997.634900; DeCarlo D, 1996, PROC GRAPH INTERF, P194; DELINGETTE H, 1993, P COMPUTER ANIMATION, P13; Duchamp T, 1997, HIERARCHICAL COMPUTA; Eck M., 1995, P SIGGRAPH 95, p173 , DOI 10.1145/218380.218440; Gomes J, 1998, WARPING MORPHING GRA; GREGORY A, 1998, P COMP AN, P64, DOI DOI 10.1109/CA.1998.681909; He T., 1994, P VIS 94, P85; HUGHES J, 1992, P ACM SIGGRAPH 92, P43, DOI 10.1145/133994.134004; Kent J. R., 1991, Proceedings. Graphics Interface '91; Kent JR, 1992, P SIGGRAPH, P47, DOI 10.1145/133994.134007; Lanthier M., 1997, Proceedings of the Thirteenth Annual Symposium on Computational Geometry, DOI 10.1145/262839.262984; Lee AWF, 1998, P SIGGRAPH 98, P95, DOI DOI 10.1145/280814.280828; Lerios A., 1995, P SIGGRAPH 95, P449, DOI 10.1145/218380.218502; Lorensen WE, 1987, P 14 ANN C COMP GRAP, P163, DOI 10.1145/37401.37422; Lucas L, 1996, J VISUAL COMP ANIMAT, V7, P193; MATYLA M, 1988, INTRO SOLID MODELING; Parent R. E., 1992, Journal of Visualization and Computer Animation, V3, DOI 10.1002/vis.4340030404; Press W.H., 1992, NUMERICAL RECIPES C; Sederberg T, 1993, P ACM SIGGRAPH 93, P15, DOI 10.1145/166117.166118; Sugihara K., 1989, Journal of Information Processing, V12; SUN YM, 1995, P 3 PAC C COMP GRAPH, P133	30	51	61	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0272-1716			IEEE COMPUT GRAPH	IEEE Comput. Graph. Appl.	MAR-APR	2000	20	2					62	75		10.1109/38.824544		14	Computer Science, Software Engineering	Computer Science	286MR	WOS:000085450200010		
J	Nitta, T; Shirai, Y; Okada, T; Imai, Y; Kobayashi, Y				Nitta, T; Shirai, Y; Okada, T; Imai, Y; Kobayashi, Y			High response excitation control of superconducting generator for stability of superconducting field winding	IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY			English	Article; Proceedings Paper	16th International Conference on Magnet Technology	SEP 26-OCT 02, 1999	NATL HIGH MAGNET FIELD LAB, PONTE VEDRA BEACH, FLORIDA	Natl High Magnet Field Lab, Natl Sci Fdn, State Florida, Brookhaven Natl Lab, BWX Technol Inc, Florida State Univ, Off Res, IEEE, Council Superconductiv, Magnex Sci Ltd, Oxford Instruments, Res Instruments Div, Princeton Plasma Phys Lab, NHMFL, Los Almos Natl Lab, Pulsed Field Facil, USN, Res Off, US DOE, Div High Energy Phys, US DOE, Superconductiv Program Elect Power, Vacuumschmeleze GmbH	NATL HIGH MAGNET FIELD LAB		POWER-SYSTEM	Superconducting Generators (SCG's) can improve power system stability in steady state and also in transient state with a high response excitation. The authors designed and made an experimental 100kVA SCG with high response excitation and carried out several experiments for power system stability using an artificial transmission lines. In this paper, a high response excitation control of SCG considering stability of the superconducting field winding is discussed and tested. A proposed control system has limiter(Over Excitation Limiter : GEL) functions for not only the field current but also for its differential-value (voltage). These factors affect a design of the field windings. Transient stability tests were performed by using the test generator and the artificial transmission lines with and without the proposed excitation control. The effects of the proposed control on the transient stability were studied.	Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan; Kyoto Univ, Dept Energy Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan; Kansai Univ, Osaka, Japan; Kansai Elect Power Co, Osaka, Japan; Toshiba Co Ltd, Tokyo, Japan	Nitta, T (reprint author), Univ Tokyo, Dept Elect Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						ALYAN MAAS, 1990, IEEE T POWER SYST, V5, P730, DOI 10.1109/59.65899; Nitta T, 1997, IEEE T APPL SUPERCON, V7, P539, DOI 10.1109/77.614560; Nitta T., 1988, Proceedings of the Twelfth International Cryogenic Engineering Conference, ICEC 12; Nitta T, 1997, IEEE T POWER SYST, V12, P906, DOI 10.1109/59.589760; OKADA T, 1989, P 11 INT C MAGN TECH, P562; SMITH JL, 1983, IEEE T MAGN, V19, P522, DOI 10.1109/TMAG.1983.1062384	6	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1051-8223			IEEE T APPL SUPERCON	IEEE Trans. Appl. Supercond.	MAR	2000	10	1					935	938		10.1109/77.828385		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	295DD	WOS:000085950700216		
J	Nitta, T; Chiba, M; Uematsu, H				Nitta, T; Chiba, M; Uematsu, H			Characteristic of AC surface spark voltage in LN2 and LHe	IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY			English	Article; Proceedings Paper	16th International Conference on Magnet Technology	SEP 26-OCT 02, 1999	NATL HIGH MAGNET FIELD LAB, PONTE VEDRA BEACH, FLORIDA	Natl High Magnet Field Lab, Natl Sci Fdn, State Florida, Brookhaven Natl Lab, BWX Technol Inc, Florida State Univ, Off Res, IEEE, Council Superconductiv, Magnex Sci Ltd, Oxford Instruments, Res Instruments Div, Princeton Plasma Phys Lab, NHMFL, Los Almos Natl Lab, Pulsed Field Facil, USN, Res Off, US DOE, Div High Energy Phys, US DOE, Superconductiv Program Elect Power, Vacuumschmeleze GmbH	NATL HIGH MAGNET FIELD LAB			The AC surface spark-over voltages on solid insulator with back electrode in liquid N-2 (LN2) and liquid He (LHe) were measured and discussed. The larger gap length did not give a higher spark-over voltage. The spark-over voltage in LHe was about two-thirds of that in LN2. Experimental studies were carried out on how bubbles in liquid influence surface spark-over voltage. The result shows that it does not influence the voltage.	Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Nitta, T (reprint author), Univ Tokyo, Dept Elect Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						HARA M, 1988, IEEE T ELECTR INSUL, V23, P769, DOI 10.1109/14.7351; HARA M, 1998, CRYOGENICS, V38; NITTA T, 1998, ICEC, V17, P279	3	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1051-8223			IEEE T APPL SUPERCON	IEEE Trans. Appl. Supercond.	MAR	2000	10	1					1325	1328		10.1109/77.828480		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	295DD	WOS:000085950700311		
J	Aizawa, K; Kodama, K; Kubota, A				Aizawa, K; Kodama, K; Kubota, A			Producing object-based special effects by fusing multiple differently focused images	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS FOR VIDEO TECHNOLOGY			English	Article						enhancement; focus; image content manipulation; image fusion; image reconstruction; multiple focus images; special effects		We propose a novel approach for producing special visual effects by fusing multiple differently focused images. This method differs from conventional image-fusion techniques because it enables us to arbitrarily generate object-based visual effects such as blurring, enhancement, and shifting. Notably, the method does not need any segmentation. Using a linear imaging model, it directly generates the desired image from multiple differently focused images.	Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan; Natl Ctr Sci & Informat Syst, Tokyo 1138656, Japan	Aizawa, K (reprint author), Univ Tokyo, Dept Elect Engn, 7-3-1 Hongo, Tokyo 1138656, Japan.						SUBBARAO M, 1994, INT J COMPUT VISION, V13, P271, DOI 10.1007/BF02028349; Irani M, 1998, P IEEE, V86, P905, DOI 10.1109/5.664279; WANG JYA, 1994, IEEE T IMAGE PROCESS, V3, P625, DOI 10.1109/83.334981; ASADA N, IEICE T D2, V78, P248; Bertero M., 1998, INTRO INVERSE PROBLE; BURT PJ, 1993, INT C COMP VIS, P173, DOI DOI 10.1109/ICCV.1993.378222; GORTLER S, P SIGGRAPH 96, P43; Kanade T, 1999, MIXED REALITY, P41; KODAMA K, 1997, IEICE T D2, P2298; Levoy M., P SIGGRAPH 96, P31; Naemura T, 1999, MIXED REALITY, P165; NGUYEN TC, ECCV92, P347	12	36	38	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1051-8215			IEEE T CIRC SYST VID	IEEE Trans. Circuits Syst. Video Technol.	MAR	2000	10	2					323	330		10.1109/76.825731		8	Engineering, Electrical & Electronic	Engineering	298YB	WOS:000086167400016		
J	Yamamoto, H				Yamamoto, H			A new recursive universal code of the positive integers	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Letter						Elias omega code; log-star function; universal code of positive integers; universal coding		A new recursive universal code of the positive integers is proposed, in which any given sequence can be used as a delimiter of codeword while bit "0" is used as a delimiter in known universal codes, e.g., Levenshtein code, Elias omega code, Even-Rodeh code, Stout code, Bentley-Yao code, etc. The codeword length of the proposed code is shorter than log(2)* n in almost all of sufficiently large positive integers although the known codes are longer than log(2)* n for any positive integer n.	Univ Tokyo, Dept Math Engn & Informat Phys, Bunkyo Ku, Tokyo 1138656, Japan	Yamamoto, H (reprint author), Univ Tokyo, Dept Math Engn & Informat Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						Ahlswede R, 1997, IEEE T INFORM THEORY, V43, P669, DOI 10.1109/18.556122; AMEMIYA T, 1993, IEICE T FUND ELECTR, VE76A, P447; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; Bell T. C., 1990, TEXT COMPRESSION; Bentley J. L., 1976, Information Processing Letters, V5, DOI 10.1016/0020-0190(76)90071-5; EVEN S, 1978, COMMUN ACM, V21, P315, DOI 10.1145/359460.359480; LEVENSHTEIN VI, 1998, COMMUNICATION; LEVENSHTEIN VI, 1968, PROBL CYBERN, V20, P149; Nakamura H., 1999, Transactions of the Information Processing Society of Japan, V40; STOUT QF, 1980, IEEE T INFORM THEORY, V26, P607, DOI 10.1109/TIT.1980.1056237	10	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0018-9448			IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	MAR	2000	46	2					717	723		10.1109/18.825850		7	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	293TT	WOS:000085870000039		
J	Yoshida, Y; Bowler, JR				Yoshida, Y; Bowler, JR			Vector potential integral formulation for eddy-current probe response to cracks	IEEE TRANSACTIONS ON MAGNETICS			English	Article						eddy-current testing; forward problem; integral formulation; probe response; vector potential	IDEAL CRACK	A boundary integral vector potential formulation has been developed to evaluate eddy-current interactions with three-dimensional finite cracks in conductors. The approach is compared with an electric field integral equation method also used for solving crack problems in eddy-current nondestructive evaluation. An important advantage of the vector potential integral formulation is that the kernel has a weak singularity, but a drawback is that two unknown functions must be found on the crack surface. One of these functions, the current dipole density, represents the effect of the:crack in terms of an induced source, and the other function is a solution of the two-dimensional Laplace equation. By contrast, the source:density alone is needed for a complete solution of the electric field integral equation. In order to determine the surface Laplacian for:finite cracks of arbitrary shape, a general numerical solution utilizing the boundary element technique is introduced. Numerical predictions of the eddy-current probe response to a crack give good agreement with experimental measurements, supporting the validity of the formulation.	Univ Tokyo, Nucl Engn Res Lab, Tokyo, Japan; Univ Surrey, Dept Phys, Guildford GU2 5XH, Surrey, England	Yoshida, Y (reprint author), Cent Res Inst Elect Power Ind, Abiko Res Lab, Dept Environm Sci, Chiba 2701194, Japan.		Bowler, John/J-8955-2012				Takagi T., 1994, International Journal of Applied Electromagnetics in Materials, V5; BOWLER JR, 1994, J APPL PHYS, V75, P8138, DOI 10.1063/1.356512; BOWLER JR, 1994, J APPL PHYS, V75, P8128, DOI 10.1063/1.356511; Bowler JR, 1997, IEEE T MAGN, V33, P4287, DOI 10.1109/20.620437; BOWLER JR, 1987, J APPL PHYS, V61, P833, DOI 10.1063/1.338131; BOWLER JR, 1994, ER1942064115 EMR XRS; BOWLER JR, 1991, J APPL PHYS, V70, P1107, DOI 10.1063/1.349615; Burke S. K., 1988, Journal of Nondestructive Evaluation, V7, DOI 10.1007/BF00565775; Chew W., 1990, WAVES FIELDS INHOMOG; DODD CV, 1968, J APPL PHYS, V39, P2829, DOI 10.1063/1.1656680; Hadamard J., 1952, LECT CAUCHYS PROBLEM; Harfield N, 1996, J APPL PHYS, V80, P4090, DOI 10.1063/1.363280; Kellogg O. D., 1953, FDN POTENTIAL THEORY; McKirdy D. McA., 1989, Journal of Nondestructive Evaluation, V8, DOI 10.1007/BF00566587; PAVO J, 1994, IEEE T MAGN, V30, P3407, DOI 10.1109/20.312670; Press W. H., 1992, NUMERICAL RECIPES FO; RAICHE AP, 1975, GEOPHYS J ROY ASTR S, V42, P1035; Roache P. J., 1976, COMPUTATIONAL FLUID; SABBAGH HA, 1986, IEEE T MAGN, V22, P282, DOI 10.1109/TMAG.1986.1064305; Tai C. T. ., 1994, DYADIC GREEN FUNCTIO; Yoshida Y, 1999, INT J APPL ELECTROM, V10, P77	21	17	17	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	MAR	2000	36	2					461	469		10.1109/20.825808		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	292JH	WOS:000085790200005		
J	Ando, S				Ando, S			Consistent gradient operators	IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE			English	Article						image processing; feature extraction; gradient; edge; corner; orientation	EDGE-DETECTION; IMAGES	Fine, accurate gradient information is required in many image-processing algorithms and systems including differential geometric methods, orientation analysis, and integrated vision sensors. In this paper, we propose optimal gradient operators based on a newly derived consistency criterion. This criterion is based on an orthogonal decomposition of the difference between a continuous gradient and discrete gradients into the intrinsic smoothing effect and the self-inconsistency involved in the operator. We show that consistency assures the exactness of gradient direction of a locally one-dimensional (1D) pattern in spite of its orientation, spectral composition, and subpixel translation. Stressing that inconsistency reduction is of primary importance, we derive an iterative algorithm which leads to accurate gradient operators of arbitrary size. We compute the optimum 3 x 3, 3 x 4, and 5 x 5 operators, compare them with conventional operators and examine the performance for one synthetic and several real images. The results indicate that the proposed operators are superior with respect to accuracy, bandwidth, and isotropy.	Univ Tokyo, Grad Sch Engn, Dept Math Engn & Informat Phys, Bunkyo Ku, Tokyo 1138656, Japan	Ando, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Math Engn & Informat Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961; ZUNIGA OA, 1987, IEEE T SYST MAN CYB, V17, P508, DOI 10.1109/TSMC.1987.4309068; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; HARALICK RM, 1984, IEEE T PATTERN ANAL, V6, P58; LYVERS EP, 1988, IEEE T PATTERN ANAL, V10, P927, DOI 10.1109/34.9114; LYVERS EP, 1989, IEEE T PATTERN ANAL, V11, P1293, DOI 10.1109/34.41367; Heath M, 1998, COMPUT VIS IMAGE UND, V69, P38, DOI 10.1006/cviu.1997.0587; Maintz JBA, 1996, IEEE T PATTERN ANAL, V18, P353, DOI 10.1109/34.491617; NEVATIA R, 1980, COMPUT VISION GRAPH, V13, P257, DOI 10.1016/0146-664X(80)90049-0; BASANO L, 1988, J OPT SOC AM A, V5, P1170, DOI 10.1364/JOSAA.5.001170; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679; CLARK JJ, 1989, IEEE T PATTERN ANAL, V11, P43, DOI 10.1109/34.23112; Davies E, 1990, MACHINE VISION THEOR; Davies E. R., 1984, Image and Vision Computing, V2, DOI 10.1016/0262-8856(84)90049-0; FLORACK LMJ, 1992, IMAGE VISION COMPUT, V10, P376, DOI 10.1016/0262-8856(92)90024-W; Florack L. M. J., 1994, Journal of Mathematical Imaging and Vision, V4, DOI 10.1007/BF01249895; FREI W, 1977, IEEE T COMPUT, V26, P988; Ganesan L, 1997, IEEE T SYST MAN CY B, V27, P823, DOI 10.1109/3477.623235; GREGSON PH, 1993, IEEE T PATTERN ANAL, V15, P682, DOI 10.1109/34.221169; Kittler J, 1983, IMAGE VISION COMPUT, V1, P37, DOI 10.1016/0262-8856(83)90006-9; KOPLOWITZ J, 1994, IEEE T PATTERN ANAL, V16, P1207, DOI 10.1109/34.387487; KORN AF, 1988, IEEE T PATTERN ANAL, V10, P610, DOI 10.1109/34.6770; MACHUCA R, 1983, IEEE T PATTERN ANAL, V5, P316; MACHUCA R, 1981, IEEE T PATTERN ANAL, V3, P103; Mallat S., 1992, IEEE T PATTERN ANAL, V14, P7; Martens JB, 1997, IEEE T IMAGE PROCESS, V6, P1103, DOI 10.1109/83.605408; NEVATIA R, 1986, HDB PATTERN RECOGNIT, pCH9; PAPOULIS A, 1965, PROBABILITY RANDOM V, pCH7; Robinson G.S, 1977, COMPUTER GRAPHICS IM, V6, P492, DOI 10.1016/S0146-664X(77)80024-5; WILSON R, 1992, IEEE T PATTERN ANAL, V14, P384, DOI 10.1109/34.120332	31	56	61	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0162-8828			IEEE T PATTERN ANAL	IEEE Trans. Pattern Anal. Mach. Intell.	MAR	2000	22	3					252	265		10.1109/34.841757		14	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	306EJ	WOS:000086584100004		
J	Hotate, K; Hasegawa, T				Hotate, K; Hasegawa, T			Measurement of Brillouin gain spectrum distribution along an optical fiber using a correlation-based technique - Proposal, experiment and simulation	IEICE TRANSACTIONS ON ELECTRONICS			English	Article						Brillouin scattering; optical fiber measurements; strain measurement; temperature measurement	SCATTERING	A correlation-based technique for measuring Brillouin gain spectrum distribution along an optical fiber is proposed, which employs frequency-modulated pump and probe lightwaves. The spatial-resolution of about 40 cm is demonstrated, which cannot be realized by the conventional pulse-based technique.	Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan	Hotate, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138656, Japan.	hotate@sagnac.t.u-tokyo.ac.jp					Agrawal G. P., 1995, NONLINEAR FIBER OPTI; KURASHIMA T, 1990, OPT LETT, V15, P1038, DOI 10.1364/OL.15.001038; VANDEVENTER MO, 1994, J LIGHTWAVE TECHNOL, V12, P585, DOI 10.1109/50.285349; HORIGUCHI T, 1990, IEEE PHOTONIC TECH L, V2, P352, DOI 10.1109/68.54703; HORIGUCHI T, 1995, J LIGHTWAVE TECHNOL, V13, P1296, DOI 10.1109/50.400684; KAUP DJ, 1979, REV MOD PHYS, V51, P275, DOI 10.1103/RevModPhys.51.275; ARECCHI FT, 1972, LASER HDB, V2, P1077; Fellay A., 1997, OFS12 WILL US, P324; HASEGAWA T, 1999, OFT996 IEICE; HASEGAWA T, 1998, P 22 M LIGHTW SENS T, P15; HOOK A, 1992, J LIGHTWAVE TECHNOL, V10, P493, DOI 10.1109/50.134204; HOTATE K, 1999, P OFS 13, P337; NARUSE H, 1999, P OFS 13, P502; THEVENAZ L, 1999, P OFS, V13, P345	14	235	242	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8524	1745-1353		IEICE T ELECTRON	IEICE Trans. Electron.	MAR	2000	E83C	3					405	412				8	Engineering, Electrical & Electronic	Engineering	298NY	WOS:000086147100023		
J	Nakura, T; Nakano, Y				Nakura, T; Nakano, Y			LAPAREX - An automatic parameter extraction program for gain- and index-coupled distributed feedback semiconductor lasers, and its application to observation of changing coupling coefficients with currents	IEICE TRANSACTIONS ON ELECTRONICS			English	Article						distributed feedback semiconductor lasers; DFB lasers; parameter extraction; coupling coefficient; gain coupling	BEHAVIOR	A reliable and automatic parameter extraction technique for DFB lasers is developed. The parameter extraction program which is named "LAPAREX" is able to determine many device parameters from a measured sub-threshold spectrum only, including gain- and index-coupling coefficients, and spatial phases of the grating at front and rear facets. Injection current dependence of coupling coefficients in a gain-coupled DFBlaser is observed, for the first time, by making use of it.	Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan	Nakura, T (reprint author), Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan.	nakano@ee.t.u-tokyo.ac.jp					Adams DM, 1996, IEEE J QUANTUM ELECT, V32, P1237, DOI 10.1109/3.517024; HAKKI BW, 1975, J APPL PHYS, V46, P1299, DOI 10.1063/1.321696; VANKWIKELBERGE P, 1990, IEEE J QUANTUM ELECT, V26, P1728, DOI 10.1109/3.60897; NAKANO Y, 1989, APPL PHYS LETT, V55, P1606, DOI 10.1063/1.102254; DENNIS JE, 1981, ACM T MATH SOFTWARE, V7, P348, DOI 10.1145/355958.355965; KOGELNIK H, 1972, J APPL PHYS, V43, P2327, DOI 10.1063/1.1661499; YARIV A, 1977, IEEE J QUANTUM ELECT, V13, P233, DOI 10.1109/JQE.1977.1069323; CHINN SR, 1973, IEEE J QUANTUM ELECT, VQE 9, P574, DOI 10.1109/JQE.1973.1077551; KETELSEN LJP, 1991, IEEE J QUANTUM ELECT, V27, P965, DOI 10.1109/3.83331; MAKINO T, 1988, IEEE J QUANTUM ELECT, V24, P1507, DOI 10.1109/3.7077; MORTHIER G, 1995, C OPT FIB COMM, P309; NAKURA T, 1995, C LAS EL OPT CLEO 97, P135; SODA H, 1986, IEEE J QUANTUM ELECT, V22, P637, DOI 10.1109/JQE.1986.1073020	13	18	18	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8524	1745-1353		IEICE T ELECTRON	IEICE Trans. Electron.	MAR	2000	E83C	3					488	495				8	Engineering, Electrical & Electronic	Engineering	298NY	WOS:000086147100037		
J	Kubota, K; Maeda, Y; Aihara, K				Kubota, K; Maeda, Y; Aihara, K			A study on the dynamics of a generalized logistic map	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						logistic map; Schwarzian derivative; bifunctional; intermittent chaos		Nonlinear dynamics of x(n + 1) = lambda{4x(n)(1 - x(n))}(q) is studied in this paper. Different from the logistic map (q = 1), in the case of q < q(1) = (root 33 - 3)/12 = 0.22871..., there exists subcritical bifurcation because the Schwarzian derivative cannot preserve its sign at the fixed point. Moreover, when q < q(2) = 0.17585... and lambda = 1.0, a stable period 1 orbit appears due to stabilization of the non-zero fixed point. Intermittent chaos due to the type 3 of intermittency is also found in this system.	Univ Air, Fac Liberal Art, Chiba 2618586, Japan; Univ Tokyo, Sch Engn, Tokyo 1138586, Japan; Tokai Univ, Dept Math, Hiratsuka, Kanagawa 2591292, Japan; Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138586, Japan	Kubota, K (reprint author), Univ Air, Fac Liberal Art, Chiba 2618586, Japan.						SINGER D, 1978, SIAM J APPL MATH, V35, P260, DOI 10.1137/0135020; Berge P., 1984, ORDER CHAOS; BRIGGS K, 1991, MATH COMPUT, V57, P435, DOI 10.2307/2938684; Katz L, 1996, CHAOS SOLITON FRACT, V7, P1495, DOI 10.1016/0960-0779(95)00120-4; Katz L, 1996, CHAOS SOLITON FRACT, V7, P1057, DOI 10.1016/0960-0779(95)00088-7; Nagashima H., 1992, INTRO CHAOS; POMEAU Y, 1980, COMMUN MATH PHYS, V74, P189, DOI 10.1007/BF01197757; Wynn P., 1956, MTAC, V10, P91, DOI 10.2307/2002183	8	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8508	1745-1337		IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	MAR	2000	E83A	3					524	531				8	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	298PA	WOS:000086147300019		
J	Imai, H				Imai, H			Computing the invariant polynomials of graphs, networks and matroids	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						Tutte polynomial; matroid; simplicial complex; network reliability; BDD	ARRANGEMENTS; ENUMERATION; COMPLEXITY; PLANAR	The invariant polynomials of discrete systems such as graphs, matroids, hyperplane arrangements, and simplicial complexes, have been theoretically investigated actively in recent years. These invariants include the Tutte polynomial of a graph and a matroid, the chromatic polynomial of a graph, the network reliability of a network, the Jones polynomial of a link, the percolation function of a grid, etc. The computational complexity issues of computing these invariants have been studied and most of them are shown to be #P-complete. But, these complexity results do not imply that we cannot compute the invariants of a given instance of moderate size in practice. To meet large demand of computing these invariants in practice, there have been proposed a framework of computing the invariants Ly using the binary decision diagrams (BDD for short). This provides mildly exponential algorithms which are useful to solve moderate-size practical problems. This paper surveys the BDD-based approach to computing the invariants, together with some computational results showing the usefulness of the framework.	Univ Tokyo, Dept Informat Sci, Tokyo 1130033, Japan	Imai, H (reprint author), Univ Tokyo, Dept Informat Sci, Tokyo 1130033, Japan.						ALON N, 1995, RANDOM STRUCT ALGOR, V6, P459, DOI 10.1002/rsa.3240060409; ANNAN JD, 1994, THESIS U OXFORD; AVIS D, 1992, DISCRETE COMPUT GEOM, V8, P295, DOI 10.1007/BF02293050; VALIANT LG, 1979, SIAM J COMPUT, V8, P410, DOI 10.1137/0208032; LIPTON RJ, 1979, SIAM J APPL MATH, V36, P177, DOI 10.1137/0136016; GREENE C, 1983, T AM MATH SOC, V280, P97, DOI 10.2307/1999604; TUTTE WT, 1954, CAN J MATH, V6, P80, DOI 10.4153/CJM-1954-010-9; BALL MO, 1983, NETWORKS, V13, P253, DOI 10.1002/net.3230130210; Bjorner A., 1992, MATROID APPL, P226, DOI 10.1017/CBO9780511662041.008; Bollobas B., 1985, RANDOM GRAPHS; BRYANT RE, 1986, IEEE T COMPUT, V35, P677; Brylawski T., 1992, MATROID APPL, P123, DOI 10.1017/CBO9780511662041.007; COLBOURN C. J., 1987, COMBINATORICS NETWOR; Edelsbrunner H., 1987, ALGORITHMS COMBINATO; Harms D. D., 1995, NETWORK RELIABILITY; Hayase K, 1995, LECT NOTES COMPUT SC, V959, P229; Hayase K, 1998, THEOR COMPUT SYST, V31, P579; IMAI H, 1998, DISCRETE STRUCTURES, V5, P1; Imai H, 1999, IEICE T FUND ELECTR, VE82A, P714; IMAI H, 1996, LECT NOTES COMPUTER, V1090, P68; Karger D. R., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, DOI 10.1145/225058.225069; Karger DR, 1997, PROCEEDINGS OF THE EIGHTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P334; Meinel C., 1998, ALGORITHMS DATA STRU; MINATO SL, 1992, RELIABILITY, V41, P225; OXLEY J. G., 1992, MATROID THEORY; PROVAN JS, 1986, SIAM J COMPUT, V15, P694, DOI 10.1137/0215050; SADAKANE N, 1995, SIGAL4811 IPSJ SIG; SEKINE K, 1997, THESIS U TOKYO; SEKINE K, 1998, T JSIAM, V8, P341; SEKINE K, 1995, 9509 U TOK DEP INF S; SEKINE K, 1999, UNPUB MILDLY EXPONEN; Sekine K., 1995, LECT NOTES COMPUTER, V1004, P224; Sekine K, 1997, IEICE T FUND ELECTR, VE80A, P682; Shier D. R., 1991, NETWORK RELIABILITY; TANI S, 1994, LECT NOTES COMPUTER, V834, P575; Welsh D. J. A., 1993, COMPLEXITY KNOTS COL; Welsh D.J.A., 1976, MATROID THEORY	37	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO, 105, JAPAN	0916-8532			IEICE T INF SYST	IEICE Trans. Inf. Syst.	MAR	2000	E83D	3					330	343				14	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	298NW	WOS:000086146900003		
J	Sugihara, K				Sugihara, K			How to make geometric algorithms robust	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						computational geometry; robust computation; exact arithmetic; topology-oriented method; symbolic perturbation; lazy evaluation		This paper surveys two methods for designing numerically robust geometric algorithms. The first method is the exact-arithmetic method, in which numerical computations are done in sufficiently high precision so that all the topological judgements can be done correctly. This method is usually accompanied with lazy evaluation and symbolic perturbation in order to reduce the computational cost and the implementation cast. The second method is the topology-oriented method, in which the consistently of the topological structure is considered as higher-priority information than numerical computation, and thus inconsistency is avoided. Both of the methods are described with the implementation examples.	Univ Tokyo, Dept Math Engn & Informat Phys, Tokyo 1138656, Japan	Sugihara, K (reprint author), Univ Tokyo, Dept Math Engn & Informat Phys, 7-3-1 Hongo, Tokyo 1138656, Japan.						Minakawa T, 1997, LECT NOTES COMPUT SC, V1350, P273; OISHI Y, 1995, GRAPH MODEL IM PROC, V57, P303, DOI 10.1006/gmip.1995.1027; HOFFMANN CM, 1989, COMPUTER, V22, P31, DOI 10.1109/2.16223; Sugihara K, 1994, INT J COMPUT GEOM AP, V4, P179, DOI 10.1142/S0218195994000124; [Anonymous], 1985, P ACM ANN S COMP GEO, DOI 10.1145/323233.323238; BENOUAMER M, 1993, P 2 S SOL MOD APPL M, P115, DOI 10.1145/164360.164403; Dobkin D., 1988, Proceedings of the Fourth Annual Symposium on Computational Geometry, DOI 10.1145/73393.73404; EDLSBRUNNER H, 1988, P 4 ACM ANN S COMP G, P118; FIELD DA, 1987, GEOMETRIC MODELING A, P91; Fortune S, 1993, P 9 ANN ACM S COMP G, P163, DOI 10.1145/160985.161015; Fortune S., 1989, P 30 ANN S FDN COMP, P494; GUIBAS L, 1989, PROCEEDINGS OF THE FIFTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY, P208; Hoffmann Christoph, 1989, GEOMETRIC SOLID MODE; Imai T., 1996, P 8 CAN C COMP GEOM, P107; INAGAKI H, 1992, P 4 CAN C COMP GEOM, P334; KARASICK M, 1991, ACM T GRAPHIC, V10, P71, DOI 10.1145/99902.99905; MILENKOVIC VJ, 1988, ARTIF INTELL, V37, P377, DOI 10.1016/0004-3702(88)90061-6; Minakawa T, 1998, OPTIM METHOD SOFTW, V10, P357, DOI 10.1080/10556789808805719; Ottmann T., 1987, P 3 ACM ANN S COMP G, P119, DOI 10.1145/41958.41970; SCHORN P, 1991, THESIS ETH ZURICH; SUGIHARA K, 1994, J COMPUT SYST SCI, V49, P391, DOI 10.1016/S0022-0000(05)80056-X; SUGIHARA K, 1992, IEICE T FUND ELECTR, VE75A, P468; Sugihara K., 1997, Proceedings. 1997 International Conference on Shape Modeling and Applications (Cat. No.97TB100098), DOI 10.1109/SMA.1997.634893; Sugihara K., 1989, Journal of Information Processing, V12; SUGIHARA K, 1994, COMP GRAPH FOR EUROG, pC45; SUGIHARA K, 1992, P IEEE, V80, P1471, DOI 10.1109/5.163412; Yap C. K., 1995, COMPUTING EUCLIDEAN, P452; Yap C. K., 1988, P 4 ANN ACM S COMP G, P134, DOI 10.1145/73393.73407	28	7	7	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO, 105, JAPAN	0916-8532			IEICE T INF SYST	IEICE Trans. Inf. Syst.	MAR	2000	E83D	3					447	454				8	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	298NW	WOS:000086146900015		
J	Nonaka, M; Yamada-Namikawa, C; Flajnik, MF; Du Pasquier, L				Nonaka, M; Yamada-Namikawa, C; Flajnik, MF; Du Pasquier, L			Trans-species polymorphism of the major histocompatibility complex-encoded proteasome subunit LMP7 in an amphibian genus, Xenopus	IMMUNOGENETICS			English	Article						LMP7; trans-species polymorphism; MHC; Xenopus	MHC CLASS-I; ZEBRAFISH; LINKAGE; GENES; EVOLUTION; ORGANIZATION; VERTEBRATES; RERIO	LMP7 (PSMB8) is a major histocompatibility complex (MHC)-encoded catalytic subunit of 20S immunoproteasome, which is responsible for the production of antigenic peptide to be presented by the MHC class I molecules. Two highly diverged allelic lineages of LMP7, termed LMP7A and LMP7B, have been identified previously in an amphibian, Xenopus laevis. Fourteen Xenopus species were analyzed by ge nomic Southern hybridization using LMP7A- and LMP7B-specific probes. Ten had both LMP7A and LMP7B, and the other 4 had only LMP7A. Identification of LMP7A and LMP7B was confirmed by reverse transcription-polymerase chain reaction/sequencing analysis of LMP7 mRNA including eight diagnostic amino acid residues that discriminate the two allelic lineages. These data suggest that these two allelic lineages were established more than 80 million years ago, and were transmitted from species to species. Trans-species evolution has so far been reported for MHC class I and II molecules in mammals and teleost fish, and is believed to be a basis for the extraordinary polymorphism of these molecules. A similar mode of evolution of the LMP7 alleles in Xenopus provides a possible explanation for the linkage of the LMP7 gene with the MHC in all vertebrates analyzed to date.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4670086, Japan; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Basel Inst Immunol, CH-4005 Basel, Switzerland	Nonaka, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, 7-3-1 Hongo, Tokyo 1130033, Japan.		NONAKA, MASARU/G-4929-2014				FLAJNIK MF, 1993, EMBO J, V12, P4385; Seeger A, 1996, MOL IMMUNOL, V33, P511, DOI 10.1016/0161-5890(96)00002-8; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Monaco JJ, 1995, ANNU REV GENET, V29, P729; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; BAEZ AM, 1996, BIOL XENOPUS, P328; BECK S, 1992, J MOL BIOL, V228, P433, DOI 10.1016/0022-2836(92)90832-5; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; Flajnik MF, 1999, J IMMUNOL, V163, P3826; Flajnik MF, 1999, IMMUNOL REV, V167, P59, DOI 10.1111/j.1600-065X.1999.tb01382.x; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; Graser R, 1998, IMMUNOGENETICS, V47, P318, DOI 10.1007/s002510050364; GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986; Hughes AL, 1997, IMMUNOGENETICS, V46, P82, DOI 10.1007/s002510050245; KIBEL HR, 1977, DEV IMMUNOBIOL, P299; Kobel HR, 1996, BIOL XENOPUS, P9; LAWLOR DA, 1988, NATURE, V335, P268, DOI 10.1038/335268a0; MAYER WE, 1988, EMBO J, V7, P2765; MCCONNELL TJ, 1988, NATURE, V332, P651, DOI 10.1038/332651a0; NAMIKAWA C, 1995, J IMMUNOL, V155, P1964; NARUSE K, IN PRESS GENETICS; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; Nonaka M, 1997, J IMMUNOL, V159, P734; Sato A, 1997, IMMUNOGENETICS, V46, P63, DOI 10.1007/s002510050243; Takami K, 1997, J IMMUNOL, V159, P6052; TANAKA K, 1992, NEW BIOL, V4, P173; Tymowska J., 1991, P259	29	26	26	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0093-7711			IMMUNOGENETICS	Immunogenetics	MAR	2000	51	3					186	192		10.1007/s002510050030		7	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	298VB	WOS:000086158900003		
J	Minoru, H				Minoru, H			Daniel Henry Holmes Ingalls (May 4, 1916-July 17, 1999) - In memoriam	INDO-IRANIAN JOURNAL			English	Biographical-Item									Univ Tokyo, Tokyo 106, Japan	Minoru, H (reprint author), Univ Tokyo, Tokyo 106, Japan.						DEJONG JW, 1984, INDO-IRAN J, V27, P223; MATILAL BK, 1991, J INDIAN PHILOS, V19, P227; POLLOCK S, 1985, J AM ORIENTAL SOC, V105, P387; Van Buitenen J. A. B., 1988, STUDIES INDIAN LIT P	4	0	0	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0019-7246			INDO-IRAN J	INDO-Iran. J.	SPR	2000	43	1					vii	ix				3	Asian Studies	Asian Studies	330TV	WOS:000087978000001		
J	Sokolov, M; Imoto, H; Saito, T				Sokolov, M; Imoto, H; Saito, T			Preparation and structure of K-2[Nb2O2(mu-OH)(2)(nta)(2)] center dot 4H(2)O; a complex of Nb(V) with a novel anti-{Nb2O2(mu-OH)(2)}(4+) core	INORGANIC CHEMISTRY COMMUNICATIONS			English	Article						niobium complexes; nitrilotriacetates; polynuclear complexes; crystal structures	CRYSTAL-STRUCTURE; ORGANOMETALLIC OXIDES; NIOBIUM; ISOMERIZATION; CHLORIDE	The reaction between Nb2S4aq4+ and K(3)nta (nta is nitrilotriacetate, N(CH2COO)(3)(3-)), followed by slow oxidation in air, leads to complete desulfurisation of the starting Nb(IV) complex, oxidation of Nb( IV) to Nb( V) and crystallisation of the title complex with hitherto unknown [Nb-2(O)(2)(mu-OH)(2)](4+) core. The crystal structure of the product has been determined. (C) 2000 Elsevier Science S.A. All rights reserved.	Russian Acad Sci, Inst Inorgan Chem, Novosibirsk 630090, Russia; Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130333, Japan	Sokolov, M (reprint author), Russian Acad Sci, Inst Inorgan Chem, Pr Lavrentyeva 3, Novosibirsk 630090, Russia.						Sokolov M, 1999, Z ANORG ALLG CHEM, V625, P989, DOI 10.1002/(SICI)1521-3749(199906)625:6<989::AID-ZAAC989>3.0.CO;2-G; Bosing M, 1998, INORG CHIM ACTA, V274, P251, DOI 10.1016/S0020-1693(97)06095-7; BOTTOMLEY F, 1992, ORGANOMETALLICS, V11, P326, DOI 10.1021/om00037a056; BOTTOMLEY F, 1993, ORGANOMETALLICS, V12, P4090, DOI 10.1021/om00034a050; DREW MGB, 1983, J CHEM SOC DALTON, P2251, DOI 10.1039/dt9830002251; HAHN M, 1984, INORG CHEM, V23, P3977, DOI 10.1021/ic00192a027; Hubert-Pfalzgraf L. G., 1987, COMPREHENSIVE COORDI, V3, P585; KIRILLOV.NI, 1973, ZH STRUKT KHIM, V14, P1075; LEICHTWEIS I, 1991, CHEM BER, V124, P253, DOI 10.1002/cber.19911240202; NISHIZAWA M, 1979, J CHEM SOC CHEM COMM, P707, DOI 10.1039/c39790000707; NISHIZAWA M, 1980, INORG CHEM, V19, P2284, DOI 10.1021/ic50210a019; Ooi BL, 1996, INORG CHEM, V35, P7452, DOI 10.1021/ic960803g; Ooi BL, 1998, INORG CHIM ACTA, V274, P103, DOI 10.1016/S0020-1693(97)05900-8; Sokolov M, 1998, INORG CHIM ACTA, V271, P222, DOI 10.1016/S0020-1693(97)05932-X; Sokolov MN, 1997, J CHEM SOC DALTON, P2059, DOI 10.1039/a700063d; SOKOLOV MN, 1998, KOORDINATS KHIM, V24, P828; WIEGHARDT K, 1985, INORG CHEM, V24, P3151, DOI 10.1021/ic00214a014; WIEGHARDT K, 1983, ANGEW CHEM INT EDIT, V22, P491, DOI 10.1002/anie.198304911	18	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-7003			INORG CHEM COMMUN	Inorg. Chem. Commun.	MAR	2000	3	3					96	98				3	Chemistry, Inorganic & Nuclear	Chemistry	294KZ	WOS:000085911600002		
J	Kurosaki, H; Hayashi, K; Goto, M; Shionoya, M; Kimura, E				Kurosaki, H; Hayashi, K; Goto, M; Shionoya, M; Kimura, E			Synthesis and characterization of the zinc(II) complex of a bleomycin analogue: a unique polymeric 2-[((2-(4-imidazoyl)ethyl)-amino) carbony]-6-[((2-amino-2-methylpropyl)amino)-methyl]pyridine zinc(II) nitrate complex	INORGANIC CHEMISTRY COMMUNICATIONS			English	Article						zinc complexes; bleomycin; crystal structures; NMR	DISTANCE GEOMETRY CALCULATIONS; A2 GREEN; STRUCTURAL CHARACTERIZATION; MOLECULAR-DYNAMICS; NMR-SPECTROSCOPY; D(CCAGGCCTGG); COPPER(II); BINDING; MODEL; ZN(II)CENTER-DOT-BLEOMYCIN	The reaction of 2-[((2-(4-imidazoyl)ethyl)amino)carbonyl]-6-[((2-amino-2-methylpropyl)amino)methyl]pyridine (L) with Zn-II(NO3)(2). 6H(2)O has afforded a novel one-dimensional polymeric Zn-II complex, (Zn-II(L)(NO3)(2))(n) (2). Complex 2 crystallizes in the space group P2(1)/n with a = 8.955(3), b = 13.216(3), c = 18.941 (3) Angstrom, beta = 103.39(2)degrees V = 2180.6(10) Angstrom(3), and Z = 4. The geometry of each Zn-II is approximately a trigonal bipyramid: three nitrogens and one oxygen of the amide group are coordinated to the zinc while the fifth site is occupied by the imidazole nitrogen of a neighboring unit. (C) 2000 Elsevier Science S.A. All rights reserved.	Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan; Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Hiroshima Univ, Sch Med, Inst Pharmaceut Sci, Minami Ku, Hiroshima 7348551, Japan	Goto, M (reprint author), Kumamoto Univ, Fac Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.						ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; AKKERMAN MAJ, 1990, J AM CHEM SOC, V112, P7462, DOI 10.1021/ja00177a003; AKKERMAN MAJ, 1988, EUR J BIOCHEM, V173, P211, DOI 10.1111/j.1432-1033.1988.tb13987.x; STUBBE J, 1987, CHEM REV, V87, P1107, DOI 10.1021/cr00081a011; Stubbe J, 1996, ACCOUNTS CHEM RES, V29, P322, DOI 10.1021/ar9501333; Claussen CA, 1999, CHEM REV, V99, P2797, DOI 10.1021/cr980449z; IITAKA Y, 1978, J ANTIBIOT, V31, P1070; BROWN SJ, 1989, INORG CHEM, V28, P3720, DOI 10.1021/ic00318a022; BROWN SJ, 1989, INORG CHEM, V28, P468, DOI 10.1021/ic00302a018; CaceresCortes J, 1997, EUR J BIOCHEM, V244, P818, DOI 10.1111/j.1432-1033.1997.00818.x; Calafat AM, 1997, J AM CHEM SOC, V119, P3656, DOI 10.1021/ja963392b; Cromer D. T., 1974, INT TABLES XRAY CRYS, V4; Hecht S. M., 1979, BLEOMYCIN CHEM BIOCH; KIMURA E, 1992, INORG CHEM, V31, P4314, DOI 10.1021/ic00047a019; Kurosaki H, 1999, INORG CHIM ACTA, V294, P56, DOI 10.1016/S0020-1693(99)00279-0; KUROSAKI H, 1988, NIPPON KAGAKU KAISHI, P691; KUROSAKI H, 1995, CHEM LETT, P691, DOI 10.1246/cl.1995.691; Kurosaki H, 1999, INORG CHEM, V38, P2824, DOI 10.1021/ic980510i; Lehmann TE, 1997, BIOCHEMISTRY-US, V36, P2807, DOI 10.1021/bi962748t; Lui SM, 1997, J AM CHEM SOC, V119, P9603, DOI 10.1021/ja963889l; MANDERVILLE RA, 1995, J AM CHEM SOC, V117, P7891, DOI 10.1021/ja00135a007; MANDERVILLE RA, 1994, J AM CHEM SOC, V116, P10851, DOI 10.1021/ja00102a087; *MOL STRUCT CORP, 1985, TEXS CRYST STRUCT AN; OTOVS JD, 1996, BIOCHEMISTRY-US, V35, P1458; SCHEICH LA, 1991, INORG CHEM, V30, P1677, DOI 10.1021/ic00007a052; Sucheck SJ, 1998, J AM CHEM SOC, V120, P7450, DOI 10.1021/ja9801801; SUGIURA Y, 1985, MET IONS BIOL SYST, V19, P81; Umezawa H., 1978, BLEOMYCIN CURRENT ST; Umezawa H, 1976, Prog Biochem Pharmacol, V11, P18; Wu W, 1996, J AM CHEM SOC, V118, P1281, DOI 10.1021/ja952497w; Wu W, 1998, J AM CHEM SOC, V120, P2239, DOI 10.1021/ja972125i; WU W, 1994, J AM CHEM SOC, V116, P10843, DOI 10.1021/ja00102a083; Wu W, 1996, J AM CHEM SOC, V118, P1268, DOI 10.1021/ja9524964; XU RX, 1994, BIOCHEMISTRY-US, V33, P907, DOI 10.1021/bi00170a009	34	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-7003			INORG CHEM COMMUN	Inorg. Chem. Commun.	MAR	2000	3	3					107	110				4	Chemistry, Inorganic & Nuclear	Chemistry	294KZ	WOS:000085911600006		
J	Komaki, K; Ishikawa, H				Komaki, K; Ishikawa, H			Genomic copy number of intracellular bacterial symbionts of aphids varies in response to developmental stage and morph of their host	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						pea aphid; Buchnera; polyploidy; real-time quantitative PCR; ageing; symbiosis; microscope photon-counting system	ENDOSYMBIOTIC BACTERIA; ACYRTHOSIPHON-PISUM; PEA APHID; BUCHNERA; DNA; GENETICS; PROTEIN; PLOIDY; GROWTH; CYCLE	Buchnera, endosymbiotic bacteria of aphids possess many genomic copies per cell. In this study, we estimated genomic copy number per Buchnera cell from host insects at various developmental stages and of two different morphs, apterae and alatae, by fluorimetry and real-time quantitative PCR. The results indicated that the genomic copy number of Buchnera increased during postembryonic development of insects to adulthood, and that it decreased during the host's ageing. In Buchnera from alatae, the genomic copy number per cell was about twice as many as in those from apterae. DAPT-staining showed that the distribution of the genomic DNA in the Buchnera cells from old insects tended to aggregate, suggesting that intracellular structure of the genomic DNA of Buchnera varies in response to the physiological conditions of their host. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Ishikawa, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.						MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; MALDONADO R, 1994, J BACTERIOL, V176, P3911; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; ISHIKAWA H, 1989, INT REV CYTOL, V116, P1, DOI 10.1016/S0074-7696(08)60637-3; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; SUZUKI T, 1986, J GEN MICROBIOL, V132, P443; MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566; Charles H, 1999, J MOL EVOL, V48, P142, DOI 10.1007/PL00006452; GRIFFITH.GW, 1973, J INSECT PHYSIOL, V19, P75, DOI 10.1016/0022-1910(73)90223-0; HARA E, 1990, SYMBIOSIS, V8, P271; HONGOH Y, 1994, ZOOL SCI, V11, P731; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; KUROIWA T, 1986, EXP CELL RES, V165, P199, DOI 10.1016/0014-4827(86)90544-6; Margulis L., 1970, ORIGIN EUKARYOTIC CE; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7; SKARSTAD K, 1985, J BACTERIOL, V163, P661; UNTERMAN BM, 1989, J BACTERIOL, V171, P2970	23	51	53	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748			INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	MAR	2000	30	3					253	258		10.1016/S0965-1748(99)00125-3		6	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	293JU	WOS:000085849100008		
J	Wada, H				Wada, H			Analyses of serum concentrations of apolipoproteins in the demented elderly	INTERNAL MEDICINE			English	Article						Apo E; Apo CII senile dementia; correlation coefficient	ALZHEIMERS-DISEASE; DENSITY-LIPOPROTEIN; PLASMA; GENE; CHROMOSOME-19; LOCALIZATION; LINKAGE	Objective The aim was to analyze serum concentrations of apolipoproteins in the demented elderly to elucidate some biological markers related to dementia. Patients and Methods Serum concentrations of apolipoproteins (AI, AII, B, CII, CIII, E) of patients with Alzheimer type dementia (AD), vascular dementia (VD) and controls (C) without dementia were compared among the three groups (ADI VD, C) and 15 correlation coefficients among the 6 measured items of apolipoproteins were analyzed. Results Serum levels of apo CII were significantly lower in AD group compared with VD or C groups. Serum levels of apo B, CIII and E were significantly lower in AD group compared with VD group, but not with C group. Analyses of correlations among the items of apolipoproteins revealed high significant correlations between apo E and/or apo CII and other items in AD group. Conclusion These results suggest that apolipoproteins such as apo CII, as well as apo E, might be involved in the pathogenesis of AD.	Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, Tokyo 1138655, Japan	Wada, H (reprint author), Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						American Psychiatric Association Delirium Dementia and Amnestic and Other Cognitive Disorders, 1994, DIAGN STAT MAN MENT, P133; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; Wada H, 1998, INTERNAL MED, V37, P509, DOI 10.2169/internalmedicine.37.509; ROMAN GC, 1993, NEUROLOGY, V43, P250; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; FOJO SS, 1984, BIOCHEM BIOPH RES CO, V122, P687, DOI 10.1016/S0006-291X(84)80088-1; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; LevyLahad E, 1996, ANN NEUROL, V40, P829, DOI 10.1002/ana.410400604; Martin JB, 1999, NEW ENGL J MED, V340, P1970; Mayeux R, 1996, ANN NEUROL, V39, P689, DOI 10.1002/ana.410390602; McConnell LM, 1998, NAT MED, V4, P757, DOI 10.1038/nm0798-757; MCKHANN G, 1984, NEUROLOGY, V34, P939; Relkin NR, 1996, LANCET, V347, P1091; SHACHTER NS, 1993, J LIPID RES, V34, P1699; TSUDA T, 1994, ANN NEUROL, V36, P97, DOI 10.1002/ana.410360118; YU CE, 1994, AM J HUM GENET, V54, P631	19	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918			INTERNAL MED	Intern. Med.	MAR	2000	39	3					220	222		10.2169/internalmedicine.39.220		3	Medicine, General & Internal	General & Internal Medicine	299VP	WOS:000086218800007		
J	Shigematsu, K; Yasuhara, H; Shigematsu, H; Muto, T				Shigematsu, K; Yasuhara, H; Shigematsu, H; Muto, T			Direct and indirect effects of pulsatile shear stress on the smooth muscle cell	INTERNATIONAL ANGIOLOGY			English	Article						pulsatile flow; tunica intima; hyperplasia; muscle, smooth, vascular; endothelium, vascular	CULTURED ENDOTHELIAL-CELLS; GROWTH-FACTOR; EXPANDED POLYTETRAFLUOROETHYLENE; BALLOON ANGIOPLASTY; SAPHENOUS-VEIN; MIGRATION; RELEASE; GRAFTS; FLOW; FEMOROPOPLITEAL	Background Anastomotic intimal hyperplasia is still an unsolved problem after small caliber prosthetic bypass grafting. Oscillatory turbulent flow occurs at the end to side anastomosis, and produces various effects on smooth muscle cells (SMCs) and endothelial cells (ECs), which compose intimal hyperplasia. We examined the influences of pulsatile oscillating shear stress on smooth muscle cells mitogenic activity induced by sheared endothelial cells. Methods. 1) Smooth muscle cells were cultured under three different pulsatile shear conditions (mean: 0, 6, and 60 dyne/cm(2)). 2) Endothelial cells were cultured under both static and sheared condition (mean: 60 dyne/cm(2)). Using the conditioned media from each well, SMCs were cultured under static and sheared conditions (60 dyne/cm(2)). Four groups of SMCs were devised by combining the two types of media and the two culture conditions. SMC colony spreading distances were measured as an index of combined migration and proliferation activity. An MTT assay and a cell counting assay were used to determine the proliferation activities of SMCs. Results. 1) SMC spreading activity was suppressed by shear stress. SMC proliferative activity was stimulated by pulsatile turbulent shear stress. 2) SIMC spreading activity was stimulated by mitogens derived from ECs under shear stress. However, this augmented SMC spreading activity was attenuated under sheared conditions. The mitogens derived from ECs under pulsatile shear stress had no effects on SMC proliferation activity. Conclusions. Pulsatile oscillating shear stress attenuates SIMC migration activity induced by EC-denve mitogens and stimulates SMC proliferative activity.	Univ Tokyo, Div Vasc Surg, Dept Surg, Bunkyo Ku, Tokyo 1138655, Japan	Shigematsu, K (reprint author), Univ Tokyo, Div Vasc Surg, Dept Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ANDO J, 1987, MICROVASC RES, V33, P62, DOI 10.1016/0026-2862(87)90007-0; KRAISS LW, 1991, ARTERIOSCLER THROMB, V11, P1844; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; BASSIOUNY HS, 1992, J VASC SURG, V15, P708; OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7; BODIN P, 1991, BRIT J PHARMACOL, V103, P1203; JOHNSTON KW, 1993, RADIOLOGY, V186, P207; DAVIES PF, 1984, J CLIN INVEST, V73, P1121, DOI 10.1172/JCI111298; CASSCELLS W, 1992, CIRCULATION, V86, P723; BUGA GM, 1991, HYPERTENSION, V17, P187; JOHNSTON KW, 1987, ANN SURG, V206, P403, DOI 10.1097/00000658-198710000-00002; CAPEK P, 1991, CIRCULATION, V83, P70; CRANLEY JJ, 1981, SURGERY, V89, P2; HSIEH HJ, 1992, J CELL PHYSIOL, V150, P552, DOI 10.1002/jcp.1041500316; KOYAMA N, 1991, ATHEROSCLEROSIS, V86, P219, DOI 10.1016/0021-9150(91)90218-R; KREMEN AF, 1986, J CARDIOVASC SURG, V27, P125; MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796; MARGOLIN DA, 1993, J VASC SURG, V17, P858; MO M, 1991, AM J PHYSIOL, V260, pH1698; PEVEC WC, 1992, J VASC SURG, V16, P60; Powell RJ, 1996, J VASC SURG, V24, P51, DOI 10.1016/S0741-5214(96)70144-1; SEIFERT RA, 1984, NATURE, V311, P669, DOI 10.1038/311669a0; Shigematsu K, 1997, EUR J VASC ENDOVASC, V14, P290, DOI 10.1016/S1078-5884(97)80241-9; STAALSEN NH, 1995, EUR J VASC ENDOVASC, V10, P168, DOI 10.1016/S1078-5884(05)80108-X; STERPETTI AV, 1992, J CARDIOVASC SURG, V33, P619; STERPETTI AV, 1993, SURGERY, V114, P911; STERPETTI AV, 1992, EUR J VASCULAR SURG, V6, P636, DOI 10.1016/S0950-821X(05)80841-2; STERPETTI AV, 1993, SURGERY, V113, P691; THOMPSON MM, 1992, EUR J VASCULAR SURG, V6, P487, DOI 10.1016/S0950-821X(05)80621-8; VEITH FJ, 1986, J VASC SURG, V3, P104; YOSHIZUMI M, 1989, BIOCHEM BIOPH RES CO, V161, P859, DOI 10.1016/0006-291X(89)92679-X	31	14	16	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590			INT ANGIOL	Int. Angiol.	MAR	2000	19	1					39	46				8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	315UE	WOS:000087130700007		
J	Kato, I; Miyazaki, T; Nakamura, T; Kudo, A				Kato, I; Miyazaki, T; Nakamura, T; Kudo, A			Inducible differentiation and apoptosis of the pre-B cell receptor-positive pre-B cell line	INTERNATIONAL IMMUNOLOGY			English	Article						apoptosis; gene rearrangement; pre-B cell receptor; surrogate light chain; tyrosine phosphorylation	SURROGATE LIGHT-CHAIN; MU-HEAVY-CHAIN; MOUSE BONE-MARROW; TYROSINE KINASE; GENE REARRANGEMENT; ALLELIC EXCLUSION; CROSS-LINKING; EXPRESSION; LAMBDA-5; LYMPHOCYTES	The function of the pre-B cell receptor (pre-BCR) during a cell differentiation is not precisely defined. To investigate the pre-BCR receptor activity, we have established pre-BCR-positive pre-B cell lines that are able to differentiate into immature a cells in vitro. Antibody cross-linking of the pre-BCR induced apoptosis and differentiation accompanied with tyrosine phosphorylation. A specific tyrosine-phosphorylated 43 kDa protein (p43) was found down-stream of the pre-BCR. The results demonstrated the receptor function of pre-BCR, which indicates that a ligand-like molecule or a cross-linking structure on the cell surface is possibly present.	Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Tokyo 1088639, Japan	Kudo, A (reprint author), Tokyo Inst Technol, Dept Life Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.		Kudo, Akira/C-7340-2015	Kudo, Akira/0000-0001-6289-3391			YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Takeda K, 1998, J IMMUNOL, V161, P4652; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; KOOPMAN G, 1994, BLOOD, V84, P1415; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; RETH M, 1987, EMBO J, V6, P3299; KUDO A, 1987, EMBO J, V6, P2267; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; ROLINK A, 1991, EMBO J, V10, P327; tenBoekel E, 1997, IMMUNITY, V7, P357; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; BAUER SR, 1993, TRANSGENE, V1, P33; BAUER SR, 1988, EMBO J, V7, P111; Doi T, 1999, INT IMMUNOL, V11, P933, DOI 10.1093/intimm/11.6.933; IGLESIAS A, 1991, EMBO J, V10, P2147; JACOBSEN K, 1990, EUR J IMMUNOL, V20, P2395, DOI 10.1002/eji.1830201106; Jugloff LS, 1997, J IMMUNOL, V159, P1096; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Kline GH, 1998, J IMMUNOL, V161, P1608; KOTTMANN AH, 1994, EUR J IMMUNOL, V24, P817, DOI 10.1002/eji.1830240407; KUDO A, 1987, EMBO J, V6, P103; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEFKOVITS I, 1997, IMMUNOLOGY METHODS M; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; Miyazaki T, 1999, INT IMMUNOL, V11, P1195, DOI 10.1093/intimm/11.8.1195; Papavasiliou F, 1996, J EXP MED, V184, P2025, DOI 10.1084/jem.184.5.2025; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PENNYCOOK JLM, 1997, IMMUNOLOGY METHODS M, V1, P237; SALAMERO J, 1995, EUR J IMMUNOL, V25, P2757, DOI 10.1002/eji.1830251007; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221	44	15	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178			INT IMMUNOL	Int. Immunol.	MAR	2000	12	3					325	334		10.1093/intimm/12.3.325		10	Immunology	Immunology	295RQ	WOS:000085982000010		
J	Martins-Green, M; Bixby, JL; Yamamoto, T; Graf, T; Sudol, M				Martins-Green, M; Bixby, JL; Yamamoto, T; Graf, T; Sudol, M			Tissue specific expression of Yrk kinase: implications for differentiation and inflammation	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						neuronal; hematopoietic; epithelial; injury; wound-healing	PROTEIN-TYROSINE KINASES; CHICKEN ERYTHROID-CELLS; CENTRAL-NERVOUS-SYSTEM; ROUS-SARCOMA VIRUS; PROTOONCOGENE PRODUCT; NEURAL TISSUES; CELLULAR-YES; RAT-BRAIN; C-SRC; RECEPTOR	The Src family of proto-oncogenes is a highly conserved group of non-receptor tyrosine kinases with very similar, but not identical, tissue distributions and functions. Yrk is a recently discovered new member of this family. Here we report the patterns of expression of this kinase in a variety of chicken tissues during development and after hatching, and experiments that correlate some of the observed patterns of expression with potential functions. The results show that the Yrk protein is primarily found in neuronal and epithelial cells and in monocyte/macrophages. In neuronal tissues of hatched chicks. Yrk is expressed in Purkinje cells, in the gigantocellularis of the brain-stem, and in retinal ganglion cells. In addition, staining for this kinase is also seen as thread-like and punctate patterns suggesting staining in neurites and growth cones. Epithelial cells express Yrk in the stomach during late developmental stages and after hatching but, in other epithelia such as in the peridermis, intestine and kidney, expression is high during development but low (skin) or undetectable (intestine and kidney) after hatching. These results suggest that Yrk may have several functional roles, specifically in cell migration and/or differentiation during neuronal and epithelial cell development and in maintenance of the differentiated phenotype. In this study we also show that significant levels of Yrk are detected in monocytes of the blood and in tissue macrophages. Analysis of chicken hematopoietic cell lines confirmed the expression of Yrk in cells of monocyte/macrophage lineage and show for the first time in experimentally-induced inflammation that Yrk kinase activity is high during the period of monocyte infiltration, raising the possibility that this kinase plays a role in inflammation and/or response to injury. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; Univ Miami, Neurosci Program, Miami, FL 33101 USA; Univ Tokyo, Inst Med Sci, Dept Signal Transduct, Tokyo 108, Japan; European Mol Biol Lab, D-69117 Heidelberg, Germany; Mt Sinai Med Ctr, Dept Biochem, New York, NY 10029 USA	Martins-Green, M (reprint author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.		Graf, Thomas/B-4252-2015	Bixby, John/0000-0003-1633-5318; Graf, Thomas/0000-0003-2774-4117			AKIYAMA Y, 1974, BIKEN J, V17, P105; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; MARTINSGREEN M, 1994, CANCER RES, V54, P4334; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; GRAF T, 1992, CELL, V70, P201, DOI 10.1016/0092-8674(92)90096-U; KUHAR SG, 1993, DEVELOPMENT, V117, P97; SWOPE SL, 1995, ANN NY ACAD SCI, V757, P197, DOI 10.1111/j.1749-6632.1995.tb17476.x; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; BARE DJ, 1993, ONCOGENE, V8, P1429; Beug H, 1982, J Cell Physiol Suppl, V1, P195; BIXBY JL, 1993, J NEUROSCI, V13, P3421; Bouwens L, 1988, Revis Biol Celular, V16, P69; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CHAN AC, 1994, J IMMUNOL, V152, P4758; CHEN YH, 1994, J BIOL CHEM, V269, P27372; CiesielskiTreska J, 1995, EUR J CELL BIOL, V68, P369; Collette Y, 1997, IMMUNOL TODAY, V18, P393, DOI 10.1016/S0167-5699(97)01104-3; DOUGLAS SD, 1986, CLIN IMMUNOL IMMUNOP, V40, P62, DOI 10.1016/0090-1229(86)90069-3; Duchemin AM, 1997, J IMMUNOL, V158, P865; ELBERG G, 1995, BBA-MOL CELL RES, V1269, P299, DOI 10.1016/0167-4889(95)00124-8; Fang KS, 1996, MOL BRAIN RES, V37, P1, DOI 10.1016/0169-328X(95)00240-S; FEIRABEND HKP, 1985, ACTA MORPHOL NEER SC, V23, P115; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; GOLAY J, 1988, CELL, V55, P1147, DOI 10.1016/0092-8674(88)90259-0; GREER P, 1994, MOL CELL BIOL, V14, P6755; HADLER WA, 1989, Z MIKROSK ANAT FORSC, V103, P573; Haigh J, 1996, CELL GROWTH DIFFER, V7, P931; HANAFUSA H, 1989, P 33 MEMBR PROT TARG, P237; HANAZONO Y, 1993, BLOOD, V81, P3193; HATTEN ME, 1990, SEMIN NEUROSCI, V2, P455; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; Jackson SP, 1996, THROMB HAEMOSTASIS, V76, P640; Jucker M, 1997, J BIOL CHEM, V272, P2104; LAKKE EAJF, 1985, ACTA MORPHOL NEER SC, V23, P127; Li QJ, 1999, J BIOL CHEM, V274, P15454, DOI 10.1074/jbc.274.22.15454; MACDONALD J W, 1970, British Veterinary Journal, V126, P89; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; Marchetti A, 1998, BRIT J CANCER, V78, P73, DOI 10.1038/bjc.1998.445; MARTINSGREEN M, 1992, J CELL SCI, V101, P701; METZ T, 1991, GENE DEV, V5, P369, DOI 10.1101/gad.5.3.369; Milner R, 1997, CLIN SCI, V92, P113; Miyazaki T, 1996, CANCER SURV, V27, P25; MOSCOVICI MG, 1983, VIROLOGY, V129, P165; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; NOLAN JP, 1988, T AM CLIN CLIMAT ASS, V100, P115; PARSONS JT, 1989, CURR TOP MICROBIOL, V147, P79; PERLMUTTER RM, 1995, CANCER SURV, V22, P85; SAMARUT J, 1985, MOL CELL BIOL, V5, P1067; SIEGFRIE.LM, 1972, J NATL CANCER I, V48, P791; SIEWEKE MH, 1989, CANCER RES, V49, P6419; SUDOL M, 1993, MOL BASIS HUMAN CANC, P203; SUDOL M, 1993, NEUROCHEM INT, V22, P369, DOI 10.1016/0197-0186(93)90019-2; SUDOL M, 1993, ONCOGENE, V8, P823; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUDOL M, 1989, MOL CELL BIOL, V9, P4545; Vaingankar SM, 1998, J BIOL CHEM, V273, P5226, DOI 10.1074/jbc.273.9.5226; ZHAO YH, 1991, ONCOGENE, V6, P1725; ZHAO YH, 1990, ONCOGENE, V5, P1629	65	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725			INT J BIOCHEM CELL B	Int J. Biochem. Cell Biol.	MAR	2000	32	3					351	364		10.1016/S1357-2725(99)00118-1		14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	286XX	WOS:000085475100009		
J	Yoshida, S; Unno, N; Kagawa, H; Shinozuka, N; Kozuma, S; Taketani, Y				Yoshida, S; Unno, N; Kagawa, H; Shinozuka, N; Kozuma, S; Taketani, Y			Prenatal detection of a high-risk group for intrauterine growth restriction based on sonographic fetal biometry	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article						ultrasonography; IUGR; birth weight; deviation; fetus; diagnosis	GESTATIONAL-AGE INFANT; BIRTH-WEIGHT; ULTRASONIC MEASUREMENT; CLINICAL-APPLICATION; PREDICTION; RETARDATION; PERCENTILE; DEVIATION; STANDARDS	Objective: This study was performed to evaluate the significance of sonographic fetal biometry in predicting low birth weight. Method: Five hundred and sixty-eight single-term pregnancies were analyzed. They were stratified into seven subgroups by birth weight deviation (BWD). Among the 568 pregnancies, 115 were revealed to be small-for-gestational-age (SGA) (birth weight less than mean -1.5 S.D.). When IUGR was suspected by routine sonographic fetal biometry, 'IUGR work-up' was carried out. The diagnostic performance of our screening method for the detection of SGA pregnancies in the general population was calculated. Result: The sensitivity, specificity, positive predictive value, negative predictive value and odds ratio of our screening method for the detection of SGA pregnancies in the general population were 73.0, 96.6, 83.2, 98.0% and 131.0, respectively. Conclusion: These data suggest that sonographic biometry is useful for the prenatal detection of high-risk cases of fetal growth restriction. (C) 2000 International Federation of Gynecology and Obstetrics.	Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan; Bokutoh Hosp, Dept Obstet, Tokyo, Japan; Natl Kasumigaura Hosp, Dept Obstet & Gynecol, Ibaraki, Osaka, Japan; Nagano Red Cross Hosp, Nagano, Japan	Unno, N (reprint author), Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan.						PATTERSON RM, 1986, OBSTET GYNECOL, V68, P459; SKOVRON ML, 1991, J ULTRAS MED, V10, P153; KRAMER MS, 1990, PEDIATRICS, V86, P707; EIKNES SH, 1982, ACTA OBSTET GYN SCAN, V61, P53; LARSEN T, 1995, EUR J OBSTET GYN R B, V60, P37, DOI 10.1016/0028-2243(95)02079-9; CAMPBELL S, 1975, BRIT J OBSTET GYNAEC, V82, P689, DOI 10.1111/j.1471-0528.1975.tb00708.x; BARKER DJP, 1997, FETUS NEONATE, V3, P255; BASKETT TF, 1989, CLIN PERINATOL, V16, P613; BLAND M, 1995, INTRO MED STAT, P238; CHANG TC, 1992, OBSTET GYNECOL, V80, P1030; David C, 1996, AM J OBSTET GYNECOL, V174, P1037, DOI 10.1016/S0002-9378(96)70347-2; DIVON MY, 1986, AM J OBSTET GYNECOL, V155, P1197; EIKNES SH, 1983, ACTA OBSTET GYN SCAN, V62, P117; MANNING FA, 1995, FETAL MED PRINCIPLE, P307; Manning FA, 1995, CURR OPIN OBSTET GYN, V7, P461, DOI 10.1097/00001703-199512000-00011; Mongelli M, 1996, OBSTET GYNECOL, V88, P844, DOI 10.1016/0029-7844(96)00285-2; ROBSON SC, 1997, FETUS NEONATE, V3, P297; Sciscione AC, 1996, AM J OBSTET GYNECOL, V175, P544; SCOTT KE, 1966, AM J OBSTET GYNECOL, V94, P951; Seeds JW, 1998, AM J OBSTET GYNECOL, V178, P658, DOI 10.1016/S0002-9378(98)70475-2; SHINOZUKA N, JAP J MED ULTRASONIC, V23, P877; SHINOZUKA N, 1987, AM J OBSTET GYNECOL, V157, P1140; SHINOZUKA N, 1994, ACT NEONATOL JPN, V30, P433; WARSOF SL, 1986, OBSTET GYNECOL, V67, P33; WEINER CP, 1985, OBSTET GYNECOL, V65, P323	25	8	9	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0020-7292			INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	MAR	2000	68	3					225	232		10.1016/S0020-7292(99)00226-X		8	Obstetrics & Gynecology	Obstetrics & Gynecology	298VF	WOS:000086159300004		
J	Fujii, T; Kozuma, S; Unno, N; Kuwabara, Y; Taketani, Y				Fujii, T; Kozuma, S; Unno, N; Kuwabara, Y; Taketani, Y			Successful pregnancy following antenatal closure of uterine wall defect	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article						uterine perforation; uterine rupture; uterine wall defect			Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan	Fujii, T (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan.						Chen L. H., 1995, Singapore Medical Journal, V36, P63; LINDELL G, 1995, ACTA OBSTET GYN SCAN, V74, P373, DOI 10.3109/00016349509024431	2	3	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0020-7292			INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	MAR	2000	68	3					261	262		10.1016/S0020-7292(99)00217-9		2	Obstetrics & Gynecology	Obstetrics & Gynecology	298VF	WOS:000086159300010		
J	Joko, S; Numaga, J; Kawashima, H; Namisato, M; Maeda, H				Joko, S; Numaga, J; Kawashima, H; Namisato, M; Maeda, H			Human leukocyte antigens in forms of leprosy among Japanese patients	INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES			English	Article							GROUP-SPECIFIC PRIMERS; TUBERCULOID LEPROSY; LEPROMATOUS LEPROSY; NORTH-INDIA; HLA; SUSCEPTIBILITY; SEGREGATION; POPULATION; ALLELES; INFECTION	Human leukocyte antigens (HLA) class II alleles were analyzed among Japanese leprosy patients to ascertain whether immunogenetic differences exist among the leprosy classification forms of Ridley and Jopling. Ninety-three unrelated Japanese leprosy patients (21 lepromatous, 24 borderline lepromatous. 17 mid-borderline, 26 borderline tuberculoid, 5 tuberculoid) and 114 healthy control subjects were investigated. The frequencies of HLA-DRB1*1501, -DRB5*0101, -DQA1*0102 and DQB1*0602 were significantly increased in all of the Japanese leprosy patients. The frequencies of HLA-DRB1*0405, -DQA1*03 and -DQB1*0401 were significantly decreased in the Japanese patients after correction of the p value. Conversely, there were no significantly different distributions of the HLA-DRB1, -DRB5, -DQA1, DQB1 alleles in the five subgroups of these patients. We conclude that HLA class II alleles were not associated with the form of leprosy. Other HLA, a non-HLA gene, and/or environmental factors may play a critical role in the different manifestations of leprosy.	Univ Tokyo, Fac Med, Dept Ophthalmol, Tokyo, Japan; Natl Leprosarium Tama Zensho En, Tokyo, Japan; Saitama Med Sch, Med Ctr, Blood Transfus Serv, Moroyama, Saitama, Japan	Numaga, J (reprint author), 3-2-1-241 Nishigahara,Kita Ku, Tokyo 1140024, Japan.						Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; AKIYAMA K, 1993, JPN J ELECTROPH, V37, P41; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; ISLAM SMM, 1994, INVEST OPHTH VIS SCI, V35, P3890; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; BALE UM, 1982, TISSUE ANTIGENS, V20, P141; Chakravartti M, 1973, TOPICS HUMAN GENETIC, V1, P1; Dessoukey MW, 1996, INT J DERMATOL, V35, P257, DOI 10.1111/j.1365-4362.1996.tb02998.x; GORODEZKY C, 1997, LEPROSY REV, V58, P401; Goto Masamichi, 1993, Japanese Journal of Leprosy, V62, P1; IZUMI S, 1982, VOX SANG, V42, P243; Joko S., 1995, Japanese Journal of Leprosy, V64, P112; KIM SJ, 1987, TISSUE ANTIGENS, V29, P146; LEVIS WR, 1982, JAMA-J AM MED ASSOC, V247, P3221, DOI 10.1001/jama.247.23.3221; MAEDA H, 1982, TISSUE ANTIGENS, V20, P327; MEHRA NK, 1995, INT J LEPROSY, V63, P241; MIYANAGA K, 1981, TISSUE ANTIGENS, V18, P331, DOI 10.1111/j.1399-0039.1981.tb01400.x; MOLKENTIN J, 1991, HUM IMMUNOL, V31, P114, DOI 10.1016/0198-8859(91)90014-Z; NOMURA N, 1991, TISSUE ANTIGENS, V38, P53, DOI 10.1111/j.1399-0039.1991.tb01881.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTA M, 1992, TISSUE ANTIGENS, V39, P187, DOI 10.1111/j.1399-0039.1992.tb01935.x; OTTENHOFF THM, 1984, TISSUE ANTIGENS, V24, P25; POLLACK MS, 1985, DIS MARKERS, V3, P119; RANI R, 1992, TISSUE ANTIGENS, V40, P124, DOI 10.1111/j.1399-0039.1992.tb02103.x; RANI R, 1993, TISSUE ANTIGENS, V42, P133, DOI 10.1111/j.1399-0039.1993.tb02179.x; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Roy S, 1997, J INFECT DIS, V176, P530; Sasazuki T, 1992, HLA 1991, V1, P397; SCHAUF V, 1985, TISSUE ANTIGENS, V26, P243; SERJEANTSON SW, 1983, P 2 AS OC HIST WORKS, P379; Soebono H, 1997, INT J LEPROSY, V65, P190; TODD JR, 1990, REV INFECT DIS, V12, P63; VANEDEN W, 1981, TISSUE ANTIGENS, V18, P189; VANEDEN W, 1985, J INFECT DIS, V151, P9; VANEDEN W, 1980, J INFECT DIS, V141, P693; VANEDEN W, 1982, HUM IMMUNOL, V4, P343, DOI 10.1016/0198-8859(82)90007-6; *WHO EXP COMM LEPR, 1998, TECH REP SER, V768; *WHO STUD GROUP, 1982, WHO TECH REP SER, V675	38	13	16	INT JOURNAL LEPROSY	GREENVILLE	BUSINESS & CIRCULATION OFFICE, 1 ALM WAY, GREENVILLE, SC 29601-9999 USA	0148-916X			INT J LEPROSY	Int. J. Lepr. Other Mycobact. Dis.	MAR	2000	68	1					49	56				8	Microbiology; Pathology; Tropical Medicine	Microbiology; Pathology; Tropical Medicine	315PU	WOS:000087122800007		
J	Yukawa, S; Kikuchi, M				Yukawa, S; Kikuchi, M			Complexity in a critical traffic flow	INTERNATIONAL JOURNAL OF MODERN PHYSICS C			English	Article						traffic flow; coupled-map modeling; entropy	CELLULAR-AUTOMATON MODEL; JAMMING TRANSITION; JAM	The traffic flow near the jamming transition is numerically studied by computer simulations of a coupled-map model. Just above the transition, a variety of velocities with which the traffic jams propagate are observed. The entropy of the traffic flow becomes maximum at the same time. Moreover, the current-concentration relation obtained by local measurements shows clear double-valued behavior near the critical concentration. From these properties, the traffic flow can be said as maximally complex near the critical concentration.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan	Yukawa, S (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						NAGATANI T, 1994, J PHYS SOC JPN, V63, P52, DOI 10.1143/JPSJ.63.52; KOMETANI E, 1959, OPER RES, V7, P704, DOI 10.1287/opre.7.6.704; NAGATANI T, 1993, PHYS REV E, V48, P3290, DOI 10.1103/PhysRevE.48.3290; HALL FL, 1986, TRANSPORT RES A-POL, V20, P197, DOI 10.1016/0191-2607(86)90094-4; HERMAN R, 1959, OPER RES, V7, P86, DOI 10.1287/opre.7.1.86; GAZIS DC, 1961, OPER RES, V9, P545, DOI 10.1287/opre.9.4.545; EDIE LC, 1961, OPER RES, V9, P66, DOI 10.1287/opre.9.1.66; BANDO M, 1995, PHYS REV E, V51, P1035, DOI 10.1103/PhysRevE.51.1035; SCHRECKENBERG M, 1995, PHYS REV E, V51, P2939, DOI 10.1103/PhysRevE.51.2939; YUKAWA S, 1994, J PHYS SOC JPN, V63, P3609, DOI 10.1143/JPSJ.63.3609; NAGEL K, 1993, PHYSICA A, V199, P254, DOI 10.1016/0378-4371(93)90006-P; NEWELL GF, 1961, OPER RES, V9, P209, DOI 10.1287/opre.9.2.209; Takayasu M, 1993, FRACTALS, V1, P860, DOI 10.1142/S0218348X93000885; NAGEL K, 1995, PHYS REV E, V51, P2909, DOI 10.1103/PhysRevE.51.2909; GREENBERG H, 1959, OPER RES, V7, P79, DOI 10.1287/opre.7.1.79; Bando M., 1994, JPN J IND APPL MATH, V11, P203; BIHAM O, 1992, PHYS REV A, V46, pR6124; Ceder A., 1976, TRANSPORT RES REC, P16; CHANDLER RE, 1958, OPER RES, V6, P163; CHOW TS, 1958, OPER RES, V6, P827, DOI 10.1287/opre.6.6.827; EASA SM, 1983, T RES REC, V869; Gazis D. C., 1959, OPER RES, V7, P449; HALL FL, 1987, TRANSPORT RES A-POL, V21, P191, DOI 10.1016/0191-2607(87)90013-6; Hurdle V.F., 1983, P 8 INT S TRANSP TRA; Kaneko K., 1993, THEORY APPL COUPLED; Krauss S, 1996, PHYS REV E, V54, P3707, DOI 10.1103/PhysRevE.54.3707; Leutzbach W., 1988, INTRO THEORY TRAFFIC; NAGATANI T, 1994, J PHYS SOC JPN, V63, P1228, DOI 10.1143/JPSJ.63.1228; NAGEL K, 1992, J PHYS I, V2, P2221; NAGEL K, 1994, ARTIFICIAL LIFE, V4; Navin F. P. D., 1986, Transport Planning and Technology, V11, DOI 10.1080/03081068608717327; NEWELL GF, 1963, J OPT RES JAPAN, V5, P9; PIPES LA, 1953, J APPL PHYS, V24, P274, DOI 10.1063/1.1721265; Tadaki S, 1999, J PHYS SOC JPN, V68, P3110, DOI 10.1143/JPSJ.68.3110; Tadaki S, 1998, J PHYS SOC JPN, V67, P2270, DOI 10.1143/JPSJ.67.2270; TADAKI S, 1994, PHYS REV E, V50, P4564, DOI 10.1103/PhysRevE.50.4564; Yukawa S, 1996, J PHYS SOC JPN, V65, P916, DOI 10.1143/JPSJ.65.916; YUKAWA S, 1995, J PHYS SOC JPN, V64, P35, DOI 10.1143/JPSJ.64.35; ZHANG XZ, 1995, PHYS REV E, V52, P4664, DOI 10.1103/PhysRevE.52.4664	39	2	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE	0129-1831			INT J MOD PHYS C	Int. J. Mod. Phys. C	MAR	2000	11	2					221	231		10.1142/S0129183100000213		11	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	313FN	WOS:000086989800002		
J	Maruyama, K; Usami, M; Kametani, F; Tomita, T; Iwatsubo, T; Saido, TC; Mori, H; Ishiura, S				Maruyama, K; Usami, M; Kametani, F; Tomita, T; Iwatsubo, T; Saido, TC; Mori, H; Ishiura, S			Molecular interactions between presenilin and calpain: Inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						presenilin; calpain; presenilin-cleavage; protease-inhibition; COS cells	FAMILIAL ALZHEIMERS-DISEASE; MUTATIONS; GENE; EXPRESSION; AUTOLYSIS; SECRETION; PROTEINS	Several mutations of presenilin (PS)-1, 2 result in early onset Alzheimer disease. Using the yeast two-hybrid system, the interaction between PS2 loop domain and the C-terminal region of mu-calpain was previously identified. Calpain is a calcium dependent-protease and there are two isoforms, m-calpain and mu-calpain, which differ in the calcium concentration required for activation. m-Calpain needs about 10(-3) M calcium ions, whereas mu-calpain about 10(-5) M. When PS and calpain were separately expressed in COS cells by cDNA transfection and then combined in vitro, or both were co-transfected to be co-expressed in vivo in COS cells, PS1 and PS2 reduced the casein proteolysis activity of m-calpain but not that of mu-calpain. Some of the PS mutations related to Alzheimer disease decreased this inhibitory activity. On the other hand, PS1 was cleaved by m-calpain and mu-calpain at a different site from those already reported (constitutive cleavage or alternative cleavage). These results suggest a regulatory function of presenilin on the calpain system.	Tokyo Inst Psychiat, Dept Mol Biol, Tokyo 1568585, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Osaka City Univ, Sch Med, Dept Neurosci, Osaka 5458585, Japan; Univ Tokyo, Dept Life Sci, Tokyo 1538902, Japan	Maruyama, K (reprint author), Tokyo Inst Psychiat, Dept Mol Biol, Tokyo 1568585, Japan.		Kametani, Fuyuki/G-4752-2011; Tomita, Taisuke/L-5427-2015	Kametani, Fuyuki/0000-0001-9125-7001; Tomita, Taisuke/0000-0002-0075-5943			Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kinbara K, 1998, BIOCHEM J, V335, P589; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Maruyama K, 1996, BIOCHEM BIOPH RES CO, V227, P730, DOI 10.1006/bbrc.1996.1577; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; SAIDO TC, 1994, FASEB J, V8, P814; Selkoe DJ, 1999, NATURE, V399, pA23; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; Shinozaki K, 1998, INT J MOL MED, V1, P797; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Chen TF, 1998, SCI TECHNOL WELD JOI, V3, P75; CROALL DE, 1991, PHYSIOL REV, V71, P813; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; Honda T, 1999, J NEUROCHEM, V72, P255, DOI 10.1046/j.1471-4159.1999.0720255.x; HUANG LY, NEURON, V17, P135; [Anonymous], 1991, METHOD ENZYMOL; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P22, DOI 10.1006/abbi.1998.1021; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Okochi M, 1998, NEUROBIOL AGING, V19, pS3, DOI 10.1016/S0197-4580(98)00045-1; SAIDO TC, 1992, J BIOCHEM-TOKYO, V111, P81; Sorimachi H, 1997, BIOCHEM J, V328, P721; Takahashi K, 1990, INTRACELLULAR CALCIU, P55; Yokota M, 1999, BRAIN RES, V819, P8, DOI 10.1016/S0006-8993(98)01334-1	36	14	15	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAR	2000	5	3					269	273				5	Medicine, Research & Experimental	Research & Experimental Medicine	285TG	WOS:000085403700008		
J	Kato, T; Inubushi, T; Kato, N				Kato, T; Inubushi, T; Kato, N			Prediction of lithium response by P-31-MRS in bipolar disorder	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Letter							MAGNETIC-RESONANCE SPECTROSCOPY; PHOSPHORUS-METABOLISM; ILLNESS		Univ Tokyo, Fac Med, Dept Neuropsychiat, Tokyo 1138655, Japan; Shiga Univ Med Sci, Mol Neurobiol Res Ctr, Otsu, Japan	Kato, T (reprint author), Univ Tokyo, Fac Med, Dept Neuropsychiat, Hongo 7-3-1, Tokyo 1138655, Japan.		Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952			DEICKEN RF, 1995, AM J PSYCHIAT, V152, P915; KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4; Steen VM, 1998, PHARMACOGENETICS, V8, P259; KATO T, 1994, PSYCHIAT RES-NEUROIM, V55, P41, DOI 10.1016/0925-4927(94)90010-8; MAJ M, 1989, J AFFECT DISORDERS, V17, P237, DOI 10.1016/0165-0327(89)90005-0; Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; CARROLL BJ, 1979, ARCH GEN PSYCHIAT, V36, P870; HARVEY NS, 1991, J CLIN PSYCHOPHARM, V11, P362; MURASHITA J, IN PRESS PSYCHOL MED	10	14	14	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1461-1457			INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	MAR	2000	3	1					83	85		10.1017/S1461145799001674		3	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	309ZK	WOS:000086799500011		
J	Nakamichi, K; Otsuka, H				Nakamichi, K; Otsuka, H			Attachment and penetration properties of bovine herpesvirus 1 recombinants expressing pseudorabies virus glycoproteins gC and gB	INTERVIROLOGY			English	Article						BHV-1; PrV; attachment; penetration	AUJESZKYS-DISEASE VIRUS; SIMPLEX VIRUS; CELL-SURFACE; HEPARAN-SULFATE; PRV GLYCOPROTEINS; GENE; BINDING; TYPE-1; ADSORPTION; SEQUENCE	Objective: Bovine herpesvirus 1 (BHV-1) has a relatively narrow host cell range in vitro and in vivo when compared to pseudorabies virus (PrV). The aim of this study was to elucidate whether homologous glycoproteins gC and gB from PrV can function in a heterologous BHV-1 background and whether the expression of these PrV glycoproteins influences the in vitro host cell specificity of BHV-1. Methods: We constructed BHV-1 recombinants in which PrV gC and gB were expressed either individually or in combination, and examined their attachment and penetration properties in permissive Madin-Darby bovine kidney (MDBK), semipermissive hamster lung (HmLu-1) and nonpermissive murine embryo fibroblast (A31) cells. Results: Two BHV-1 recombinants which expressed PrV gC exhibited remarkable competence in virus attachment to cells. The expression of PrV gB improved the virus attachment only a little but penetration, especially into HmLu-1 and A31 cells, was enhanced. Conclusions: These results indicate that PrV gC and gB can function in a BHV-1 environment and facilitate virus attachment and penetration by BHV-1. Copyright (C) 2000 S. Karger AG, Basel.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan	Otsuka, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835; LI YH, 1995, J VIROL, V69, P4758; Mettenleiter TC, 1996, VET IMMUNOL IMMUNOP, V54, P221, DOI 10.1016/S0165-2427(96)05695-4; FULLER AO, 1987, P NATL ACAD SCI USA, V84, P5454, DOI 10.1073/pnas.84.15.5454; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; FEHLER F, 1992, J VIROL, V66, P831; HEROLD BC, 1991, J VIROL, V65, P1090; KLUPP BG, 1991, VIROLOGY, V182, P732, DOI 10.1016/0042-6822(91)90614-H; METTENLEITER TC, 1990, J VIROL, V64, P278; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; LIGAS MW, 1988, J VIROL, V62, P1486; MIETHKE A, 1995, J GEN VIROL, V76, P1623, DOI 10.1099/0022-1317-76-7-1623; BYRNE KM, 1995, VIROLOGY, V209, P230, DOI 10.1006/viro.1995.1248; CAI W, 1988, Journal of Virology, V62, P2596; DELUCA N, 1982, VIROLOGY, V122, P411, DOI 10.1016/0042-6822(82)90240-9; FULLER AO, 1989, J VIROL, V63, P3535; GIELKENS ALJ, 1994, ACTA VET HUNG, V42, P227; HAMPL H, 1984, J VIROL, V52, P583; HIGHLANDER SL, 1987, J VIROL, V61, P3356; KIT M, 1992, Patent No. 4992051; KIT M, 1992, Patent No. 1299121; KIT S, 1992, ARCH VIROL, V124, P1, DOI 10.1007/BF01314621; Klupp BG, 1998, J VIROL, V72, P1949; LAWRENCE WC, 1986, J VIROL, V60, P405; LIANG XP, 1991, J VIROL, V65, P5553; LIANG XP, 1993, VIROLOGY, V194, P233, DOI 10.1006/viro.1993.1254; LittelvandenHurk SV, 1996, J GEN VIROL, V77, P1515; LUKACS N, 1985, J VIROL, V53, P166; METTENLEITER TC, 1986, VIROLOGY, V152, P66, DOI 10.1016/0042-6822(86)90372-7; METTENLEITER TC, 1994, ACTA VET HUNG, V42, P153; MEYER AL, 1991, BIOCHIM BIOPHYS ACTA, V1090, P267, DOI 10.1016/0167-4781(91)90116-4; MISRA V, 1988, VIROLOGY, V166, P542, DOI 10.1016/0042-6822(88)90525-9; Murata T, 1999, VIRUS RES, V61, P29, DOI 10.1016/S0168-1702(99)00023-4; OKAZAKI K, 1991, VIROLOGY, V181, P666, DOI 10.1016/0042-6822(91)90900-V; Otsuka H, 1996, ARCH VIROL, V141, P57, DOI 10.1007/BF01718588; PETROVSKIS EA, 1986, J VIROL, V59, P216; ROBBINS AK, 1987, J VIROL, V61, P2691; SAWITZKY D, 1990, J GEN VIROL, V71, P1221, DOI 10.1099/0022-1317-71-5-1221; Sawitzky D, 1996, VIRUS RES, V41, P101, DOI 10.1016/0168-1702(95)01277-X; Schwyzer M, 1996, VET MICROBIOL, V53, P17, DOI 10.1016/S0378-1135(96)01231-X; SPEAR PG, 1993, SEMIN VIROL, V4, P167, DOI 10.1006/smvy.1993.1012; TIKOO SK, 1995, ADV VIRUS RES, V45, P191, DOI 10.1016/S0065-3527(08)60061-5; WATHEN MW, 1984, J VIROL, V51, P57; WHITBECK JC, 1988, J VIROL, V62, P3319; WUDUNN D, 1989, J VIROL, V63, P52; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	47	6	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0300-5526			INTERVIROLOGY	Intervirology	MAR-APR	2000	43	2					87	94		10.1159/000025029		8	Virology	Virology	351MD	WOS:000089161500004		
J	Yuhara, M; Kagami, H; Nagao, K				Yuhara, M; Kagami, H; Nagao, K			Geochronological characterization and petrogenesis of granitoids in the Ryoke belt, Southwest Japan Arc: constraints from K-Ar, Rb-Sr and Sm-Nd systematics	ISLAND ARC			English	Article						geochronology; igneous activity; initial epsilon(Sr) and epsilon(Nd) values; Rb-Sr and K-Ar age; Ryoke belt; Southwest Japan	CONTINENTAL-MARGIN; PALEOGENE; ISOTOPE; ROCKS; AGES; MIGRATION; BEARING; RATIOS; CRUST	Rb-Sr and K-Ar chronological studies were carried out on granitic and metamorphic rocks in the Ina, Awaji Island and eastern Sanuki districts, Southwest Japan to investigate the timing of intrusion of the granitoids in the Ryoke belt. Intrusions of 'younger' Ryoke granitic magmas took place in the Ina district between 120 Ma and 70 Ma, and cooling began immediately after the emplacement of the youngest granitic bodies. Igneous activity in Awaji Island was initiated at 100 Ma and continued to 75 Ma. Along-arc variations of Rb-Sr whole-rock isochron ages suggest that magmatism began everywhere in the Ryoke and San-yo belts at almost the same time (ca 120 Ma). The last magmatism took place in the eastern part of both belts. Rb-Sr and K-Ar mineral ages for the granitoids young eastwards. The age data suggest that the Ryoke belt was uplifted just after the termination of igneous activity. Initial Sr and Nd isotopic ratios for the Ryoke granitoids indicate that most were derived from magmas produced in the lower crust and/or upper mantle with uniform Sr and Nd isotopic compositions. Several granitoids, however, exhibit evidence of assimilation of Ryoke metamorphic rocks or older Precambrian crustal rocks beneath the Ryoke belt.	Niigata Univ, Res Inst Hazards Snowy Areas, Niigata 9502181, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Tokyo 1130033, Japan	Yuhara, M (reprint author), Niigata Univ, Res Inst Hazards Snowy Areas, Niigata 9502181, Japan.						NAKAJIMA T, 1990, CONTRIB MINERAL PETR, V104, P381, DOI 10.1007/BF01575616; KAGAMI H, 1989, GEOCHEM J, V23, P209; KAGAMI H, 1988, GEOCHEM J, V22, P69; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Herzig CT, 1998, GEOCHEM J, V32, P21; Nakajima T, 1996, T ROY SOC EDIN-EARTH, V87, P183; NAKAJIMA T, 1994, LITHOS, V33, P51, DOI 10.1016/0024-4937(94)90053-1; LUGMAIR GW, 1978, EARTH PLANET SC LETT, V39, P349, DOI 10.1016/0012-821X(78)90021-3; YORK D, 1966, CAN J PHYS, V44, P1079; Fujii H, 2000, ISL ARC, V9, P37, DOI 10.1046/j.1440-1738.2000.00259.x; Shimizu H, 1996, GEOCHEM J, V30, P57; KAGAMI H, 1992, CONTRIB MINERAL PETR, V112, P165, DOI 10.1007/BF00310452; ARAKAWA Y, 1989, CONTRIB MINERAL PETR, V101, P46, DOI 10.1007/BF00387200; ASANO M, 1990, J GEOL SOC JPN, V96, P957; Harayama S., 1985, EARTH SCI, V39, P345; HARRINGTON SA, 1985, SERIALS LIBR, V10, P19, DOI 10.1300/J123v10n01_04; HARRISON TM, 1981, CONTRIB MINERAL PETR, V78, P324; HAYAMA Y, 1960, J GEOLOGICAL SOC JAP, V66, P87; Iizumi S., 1985, EARTH SCI, V39, P372; ISHIHARA S, 1971, GEOL SOC JAPAN J, V77, P441; Kamei A., 1997, J MINERALOGY PETROLO, V92, P316, DOI 10.2465/ganko.92.316; KATADA M, 1965, J MINERALOGY PETROLO, V53, P77; Kawano Y., 1994, GEOINFORMATICS, V5, P13; KIMINAMI K, 1993, MEMOIRS GEOLOGICAL S, V42, P167; Kinoshita O., 1986, J GEOL SOC JPN, V92, P723; KINOSHITA O, 1995, TECTONOPHYSICS, V245, P25, DOI 10.1016/0040-1951(94)00211-Q; Kutsukake T., 1979, MEMOIRS GEOLOGICAL S, V17, P47; KUTSUKAKE T, 1993, GEOL MAG, V130, P15; MORIKIYO T, 1986, CONTRIB MINERAL PETR, V94, P165, DOI 10.1007/BF00592933; Morioka K, 2000, ISL ARC, V9, P46, DOI 10.1046/j.1440-1738.2000.00260.x; MORISHITA T, 1995, 102 ANN M GEOL SOC J, P265; MORRIS PA, 1989, EARTH PLANET SC LETT, V92, P335, DOI 10.1016/0012-821X(89)90058-7; Murakami N., 1974, PAC GEOL, V8, P139; Nagao K., 1996, J MASS SPECTROM SOC, V44, P39; NAKAJIMA T, 1993, 100 ANN M GEOL SOC J, P358; Nishimura S., 1986, J GEOTHERM RES SOC J, V8, P145; OKANO O, 1982, JOINT M SOC MIN GEOL, P88; ONO A, 1981, J GEOL SOC JAP, V87, P249; Osanai Y., 1993, MEMOIRS GEOLOGICAL S, V42, P135; OWADA M, 1995, J MINERALOGY PETROLO, V90, P358, DOI 10.2465/ganko.90.358; OWADA M, 1995, 102 ANN M GEOL SOC J, P270; Sawada Y., 1994, J GEOLOGICAL SOC JAP, V100, P217; Shibata K., 1988, J GEOL SOC JPN, V94, P35; SHIBATA K, 1974, EARTH PLANET SC LETT, V21, P27; Stern T. W., 1981, US GEOL SURV PROF PA, V1185, P17; Suzuki C, 1998, HEPATOL RES, V12, P23, DOI 10.1016/S1386-6346(98)00045-X; TAINOSHO Y, 1985, EARTH SCI, V39, P358; TAKAGI H, 1984, J GEOL SOC JPN, V90, P81; Takahashi Y., 1992, J MINERALOGY PETROLO, V87, P291, DOI 10.2465/ganko.87.291; Takahashi Y, 1995, B GEOL SURV JPN, V46, P23; TAKAHASHI Y, 1992, B GEOLOGICAL SURVEY, V43, P335; Tanaka S., 1992, J SCI HIROSHIMA U C, V9, P435; Tanaka T., 1987, 94 ANN M GEOL SOC JA, P492; TSUCHIYA T, 1966, J FS HOKKAIDO U 4, V13, P87; WAGNER GA, 1977, MEMORIE I GEOLOGIA M, V30, P1; YAMANA S, 1988, THESIS TOKYO U JAPAN; YUHARA M, 1995, THESIS OKAYAMA U JAP; Yuhara M., 1998, B GEOLOGICAL SURVEY, V49, P477; YUHARA M, 1996, J MINERALOGY PETROLO, V91, P275; Yuhara M., 1995, J GEOLOGICAL SOC JAP, V101, P434; Yuhara M., 1994, J MINERALOGY PETROLO, V89, P269; Yuhara M., 1999, J GEOLOGICAL SOC JAP, V105, P181; YUHARA M, 1999, MEMOIRS GEOLOGICAL S, V53, P323; YUHARA M, 1999, 1999 JAP EARTH PLAN	64	16	18	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1038-4871			ISL ARC	Isl. Arc.	MAR	2000	9	1					64	80		10.1046/j.1440-1738.2000.00262.x		17	Geosciences, Multidisciplinary	Geology	337LG	WOS:000088362000007		
J	Suzuki, A				Suzuki, A			Plutonium politics	ISSUES IN SCIENCE AND TECHNOLOGY			English	Editorial Material									Univ Tokyo, Tokyo, Japan	Suzuki, A (reprint author), Univ Tokyo, Tokyo, Japan.							0	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0748-5492			ISSUES SCI TECHNOL	Issues Sci. Technol.	SPR	2000	16	3					11	12				2	Engineering, Multidisciplinary; Engineering, Industrial; Multidisciplinary Sciences; Social Issues	Engineering; Science & Technology - Other Topics; Social Issues	316KY	WOS:000087167200008		
J	Nishimura, KG				Nishimura, KG			Gains from price rigidity	JAPANESE ECONOMIC REVIEW			English	Article								This paper shows that there are substantial gains from price rigidity in an imperfectly competitive economy. Firms can increase their profits by agreeing some markets as markets of long-term contracts, of which prices are determined in advance to other spot market prices. Although they determine prices non-cooperatively in both markets, the mutual commitment making some markets' prices predetermined induces a price-price spiral between firms, which results in substantial gains for both firms. These gains outweigh the cost of inflexibility arising from price rigidity even though demand fluctuation is large and marginal cost is increasing. JEL Classification Numbers: E30, E32.	Univ Tokyo, Tokyo, Japan	Nishimura, KG (reprint author), Univ Tokyo, Tokyo, Japan.						BULOW JI, 1985, J POLIT ECON, V93, P488, DOI 10.1086/261312; BAUMOL WJ, 1962, AM ECON REV, V52, P1078; BENASSY JP, 1989, REV ECON STUD, V56, P217, DOI 10.2307/2297458; Blanchard Olivier J., 1990, HDB MONETARY EC; BLINDER AS, 1991, AM ECON REV, V81, P89; CARLTON DW, 1986, AM ECON REV, V76, P637; KOMIYA R, 1987, J JAPANESE INT EC, V1, P31, DOI 10.1016/0889-1583(87)90026-8; Marris R, 1964, EC THEORY MANAGERIAL; NISHIMURA KG, 1995, GRAINS PRICE RIGIDIT; NISHIMURA KG, 1992, IMPERFECT COMPETITIO; Okun A. M., 1981, PRICES QUANTITIES; Tirole J., 1988, THEORY IND ORG; Vanek Jaroslav, 1970, GEN THEORY LABOR MAN	13	0	0	BLACKWELL PUBL LTD	OXFORD	108 COWLEY RD, OXFORD OX4 1JF, OXON, ENGLAND	1352-4739			JPN ECON REV	Jpn. Econ. Rev.	MAR	2000	51	1					95	110		10.1111/1468-5876.00141		16	Economics	Business & Economics	292QF	WOS:000085806000007		
J	Komuro, I				Komuro, I			Molecular mechanism of mechanical stress-induced cardiac hypertrophy	JAPANESE HEART JOURNAL			English	Review						cardiac hypertrophy; mechanical stress; angiotensin II; protein kinase; ion channel; integrin	ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; RENIN-ANGIOTENSIN SYSTEM; MUSCLE CELL HYPERTROPHY; II-INDUCED HYPERTROPHY; GENE-EXPRESSION; CARDIOMYOCYTE HYPERTROPHY; VENTRICULAR MYOCYTES; CRITICAL ROLES; ION CHANNELS	Mechanical stress is a major cause of cardiac hypertrophy. Although the mechanisms by which mechanical load induces cardiomyocyte hypertrophy have long been a subject of great interest for cardiologists, the lack of a good in vitro system has hampered the understanding of the biochemical mechanisms. For these past several years, however, an in vitro neonatal cardiocyte culture system has made it possible to examine the biochemical basis for the signal transduction of mechanical stress. Passive stretch of cardiac myocytes cultured on silicone membranes activates phosphorylation cascades of many protein kinases including protein kinase C, Raf-1 kinase and extracellular signal regulated kinases, and induces the expression of specific genes as well as an increase in protein synthesis. During that process, the secretion and production of vasoactive peptides such as angiotensin II and endothelin, are increased and they play critical roles in the induction of these hypertrophic responses. Although the involvement of vasoactive peptides in the development of cardiac hypertrophy is clinically important, the "mechanoreceptor" which receives the mechanical stress and converts it into intracellular biochemical signals remained unknown. We have recently obtained evidence suggesting that ion channels and integrins may be the "mechanoreceptor", the activation of which leads to cardiac hypertrophy.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	Komuro, I (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; YAMAZAKI T, 1995, CIRC RES, V77, P258; MANN DL, 1989, CIRC RES, V64, P1079; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; SADOSHIMA J, 1995, CIRC RES, V77, P1040; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; SADOSHIMA J, 1993, EMBO J, V12, P1681; Nemoto S, 1998, MOL CELL BIOL, V18, P3518; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; Sadoshima J, 1996, EMBO J, V15, P775; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Aoki H, 1998, CIRC RES, V82, P666; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KOMURO I, 1990, J BIOL CHEM, V265, P3595; Kudoh S, 1997, CIRC RES, V80, P139; Jiang Y, 1996, J BIOL CHEM, V271, P17920; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; BAKER KM, 1992, ANNU REV PHYSIOL, V54, P227, DOI 10.1146/annurev.physiol.54.1.227; Bozkurt B, 1998, CIRCULATION, V97, P1382; Aikawa R, 1999, CIRC RES, V84, P458; Harada M, 1997, CIRCULATION, V96, P3737; Zou YZ, 1996, J BIOL CHEM, V271, P33592; Yamazaki T, 1996, J BIOL CHEM, V271, P3221; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; BAKER KM, 1990, AM J PHYSIOL, V259, pH324; BLENIS J, 1991, CANCER CELL-MON REV, V3, P445; BUSTAMANTE JO, 1991, J CARDIOVASC PHARM, V17, pS110, DOI 10.1097/00005344-199117002-00024; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Clerk A, 1998, J BIOL CHEM, V273, P7228, DOI 10.1074/jbc.273.13.7228; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; Glennon PE, 1996, CIRC RES, V78, P954; HAMASAKI K, 1995, BIOCHEM BIOPH RES CO, V212, P544, DOI 10.1006/bbrc.1995.2004; HAMMOND GL, 1979, P NATL ACAD SCI USA, V76, P2455, DOI 10.1073/pnas.76.5.2455; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Katoh Y, 1989, CIRCULATION S2, V80, pII; KIRA Y, 1984, AM J PHYSIOL, V246, pC247; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.physiol.55.1.55; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Komuro I, 1996, FASEB J, V10, P631; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LINZ W, 1989, CLIN EXP HYPERTENS A, V11, P1325, DOI 10.3109/10641968909038172; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; Post GR, 1996, J BIOL CHEM, V271, P8452; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413; Sah VP, 1996, J BIOL CHEM, V271, P31185; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; SCHNKERT H, 1990, J CLIN INVEST, V86, P1913; SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849; SIGURDSON W, 1992, AM J PHYSIOL, V262, pH1110; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; THORBURN J, 1994, J CELL BIOL, V126, P1565, DOI 10.1083/jcb.126.6.1565; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054; Zou YZ, 1998, CIRC RES, V82, P337	61	16	18	JAPAN HEART JOURNAL, SECOND DEPT OF INTERNAL MED	TOKYO	TOKYO UNIV HOSPITAL, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113, JAPAN	0021-4868			JPN HEART J	Jpn. Heart J.	MAR	2000	41	2					117	129		10.1536/jhj.41.117		13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	317RM	WOS:000087240800002		
J	Suzuki, T; Yamaoki, K; Nakajima, O; Yamazaki, T; Yamada, Y; Akioka, H; Yazaki, Y; Nagai, R				Suzuki, T; Yamaoki, K; Nakajima, O; Yamazaki, T; Yamada, Y; Akioka, H; Yazaki, Y; Nagai, R			Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels	JAPANESE HEART JOURNAL			English	Article						natriuretic peptides; biochemical diagnosis; cardiac function	VENTRICULAR SYSTOLIC DYSFUNCTION; CONGESTIVE-HEART-FAILURE; DIASTOLIC DYSFUNCTION; SECRETION; CARE	Early diagnosis and treatment of heart failure lead to improved survival; pre-clinical detection would thus be beneficial. A non-invasive biochemical testing method would indeed be ideal to screen for the condition. In the present study, we sought to determine whether circulating levels of B-type natriuretic peptide (BNP) correlate with cardiac function in asymptomatic subjects. 294 consenting asymptomatic subjects were examined. BNP levels in elevated patients (> 18.3 pg / ml) showed significant correlation with echocardiographic parameters of the systolic and diastolic functions (EF r = - 0.51, FS r = - 0.50, E / A r = 0.42, p < 0.01), Moderate correlation with the CTR on chest X-ray was also seen (r = 0.23, p < 0.01). Multiple regression analysis showed numerous echocardiographic and hemodynamic parameters including those of systolic and diastolic function in addition to left ventricular wall thickness, blood pressure and serum creatinine levels to be significantly associated with raised BNP levels. Elevated BNP levels reflect cardiac function (both systolic and diastolic) in the asymptomatic population. Detection of cardiac dysfunction by the non-invasive biochemical test may prove useful in early pre-clinical diagnosis of heart failure.	Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	Suzuki, T (reprint author), Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Yu CM, 1996, EUR HEART J, V17, P1694; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Suzuki T, 1998, AM HEART J, V136, P362, DOI 10.1053/hj.1998.v136.89908; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; Omland T, 1996, CIRCULATION, V93, P1963; YASUE H, 1994, CIRCULATION, V90, P195; Tsutamoto T, 1997, CIRCULATION, V96, P509; YOSHIMURA M, 1993, CIRCULATION, V87, P464; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; BONOW RO, 1992, ANN INTERN MED, V117, P502; Yamamoto K, 1996, HYPERTENSION, V28, P988; Bonow RO, 1996, CIRCULATION, V93, P1946; Clarkson PBM, 1996, CIRCULATION, V93, P2037; Muders F, 1997, AM HEART J, V134, P442, DOI 10.1016/S0002-8703(97)70079-6; NISHIMURA RA, 1989, MAYO CLIN PROC, V64, P181; REMES J, 1991, EUR HEART J, V12, P315; *SOLVD INV, 1991, NEW ENGL J MED, V285, P781; TSUJI T, 1994, CLIN CHEM, V40, P672; Yamamoto K, 1996, HEART, V75, P27, DOI 10.1136/hrt.75.6_Suppl_2.27; YANCY CW, 1989, DIS MON, V34, P467	22	21	36	JAPAN HEART JOURNAL, SECOND DEPT OF INTERNAL MED	TOKYO	TOKYO UNIV HOSPITAL, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113, JAPAN	0021-4868			JPN HEART J	Jpn. Heart J.	MAR	2000	41	2					205	214		10.1536/jhj.41.205		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	317RM	WOS:000087240800010		
J	Sugiyama, M; Itoh, H; Aoyama, J; Komiyama, H; Shimogaki, Y				Sugiyama, M; Itoh, H; Aoyama, J; Komiyama, H; Shimogaki, Y			Reaction analysis of aluminum chemical vapor deposition from dimethyl-aluminum-hydride using tubular reactor and Fourier-transform infrared spectroscopy: Theoretical process optimization procedure (1)	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						aluminum; chemical vapor deposition (CVD); dimethylaluminumhydride (DMAH); reaction analysis; Fourier-transform infrared spectroscopy (FT-IR)	VIBRATIONAL-SPECTRA; TRIMETHYLALUMINUM	Kinetic studies on the chemical vapor deposition (CVD) of aluminum from dimethylaluminumhydride (DMAH) were carried out to obtain the reaction model which is useful for the process optimization. Fourier-transform infrared spectroscopy (FT-IR) was used to monitor DMAH supplied to the reactor, which ensured the reliability of precursor delivery by the bubbling method. FT-IR was also used to identify the reaction product of DMAH. Aluminum deposition from DMAH yielded only trimethylaluminum (TMA). The analysis of aluminum deposition rate profile in the tubular reactor revealed that the rate limiting step was the surface reaction of DMAH and that the surface reaction was almost of the first order with respect to DMAH concentration. The analysis took account of the monomer-dimer equilibrium of DMAH in the reactor whose existence was suggested by quantum-chemical calculations. The activation energy of approximately 80 kJ/mol was estimated from the relationship between DMAH decomposition yield and the gas residence time in the tubular reactor.	Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Sch Engn, Dept Met & Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Semicond Acad Res Ctr, Minato Ku, Tokyo 1050004, Japan	Sugiyama, M (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Shimogaki, Yukihiro/B-9803-2008; Sugiyama, Masakazu/P-9616-2015	Shimogaki, Yukihiro/0000-0002-1186-8636; Sugiyama, Masakazu/0000-0002-4303-4038			ATIYA GA, 1991, SPECTROCHIM ACTA A, V47, P467, DOI 10.1016/0584-8539(91)80124-2; CORTRIN ME, 1993, SAND930478; GRADY AS, 1991, SPECTROCHIM ACTA A, V47, P47, DOI 10.1016/0584-8539(91)80177-K; HENRICKS.CH, 1967, INORG CHEM, V6, P1461, DOI 10.1021/ic50054a006; Komiyama H, 1999, CHEM ENG SCI, V54, P1941, DOI 10.1016/S0009-2509(98)00443-6; KONDOH E, 1995, J VAC SCI TECHNOL A, V13, P2863, DOI 10.1116/1.579605; Matsumiya Y, 1997, J CRYST GROWTH, V181, P437, DOI 10.1016/S0022-0248(97)00390-4; NAKAJIMA T, IN PRESS SURF SCI; Nakajima T, 1999, J MOL STRUC-THEOCHEM, V490, P155; RUSSELL DK, 1995, J CHEM SOC FARADAY T, V91, P3015, DOI 10.1039/ft9959103015; STRONGIN DR, 1991, J PHYS CHEM-US, V95, P1329, DOI 10.1021/j100156a055; Sugai K, 1997, J ELECTROCHEM SOC, V144, P1028, DOI 10.1149/1.1837525; SUGIYAMA M, 1998, ADV MET C 1998, P39; Wadayama T, 1996, APPL SURF SCI, V100, P575, DOI 10.1016/0169-4332(96)00341-8; WILLIS BG, 1996, P ADV MET INT SYST U, P29	15	10	10	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	MAR	2000	39	3A					1074	1079		10.1143/JJAP.39.1074		6	Physics, Applied	Physics	308HY	WOS:000086705600018		
J	Hirano, S; Kishimoto, A				Hirano, S; Kishimoto, A			Role of the interface in the temperature dependence of the resistivity of conductive composite thin films	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						percolation; electrically conductive composites; positive-temperature-coefficient-of-resistivity interface; interaction; thermal strain rate	COEFFICIENT; THERMISTORS	The role of the interface properties in the surface resistivity-temperature (rho(s)-T) behavior in air and nitrogen was studied in conductive composite thin films consisting of epoxy resin and electrically conductive filler. To examine the role of the interface, we investigated the rho(s)-T behavior at various heating rates. The physicochemical changes in the properties of epoxy resin with temperature were characterized using thermodilatometry, thermogravimetry, dynamic mechanical spectroscopy, and Fourier transform infrared spectroscopy. The thin films exhibited an anomalous positive-temperature-coefficient-of-resistivity (PTCR) transition around 130 degrees C. However, they showed negative-temperature-coefficient-of-resistivity (NTCR) behavior in air, but not in nitrogen, after the PTCR transition. The thermal and chemical analyses suggest that the number of OH functional groups in the epoxy resin influences the occurrence of the NTCR transition. The heating rate dependence of the rho(s)-T behavior showed that the anomalous PTCR effect in composite thin films occurs with a rapid thermal strain rate above the glass transition temperature of the matrix. This result suggests that composite thin films can be used in temperature sensors that will selectively detect a rapid environmental temperature increase. These results can be interpreted satisfactorily by considering the interaction between the components, which is strongly influenced by OH functional groups and the matrix thermal strain rate. We constructed a qualitative model of the anomalous resistivity-temperature behavior, focusing on the microscopic interaction between the components. The results show that the interface property plays a decisive role in controlling the resistivity-temperature behavior in conductive thermoset-matrix composites.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Hirano, S (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						Hirano S, 1998, APPL PHYS LETT, V73, P3742, DOI 10.1063/1.122880; KUSY RP, 1971, NATURE-PHYS SCI, V229, P58; MEYER J, 1973, POLYM ENG SCI, V13, P462, DOI 10.1002/pen.760130611; OHE K, 1971, JPN J APPL PHYS, V10, P99, DOI 10.1143/JJAP.10.99; Strumpler R, 1996, J APPL PHYS, V80, P6091, DOI 10.1063/1.363682; BURTON BL, 1993, J APPL POLYM SCI, V47, P1821, DOI 10.1002/app.1993.070471013; CARMONA F, 1992, J PHYS I, V2, P503; COPE A, 1960, ORGANIC REACTIONS, V11; GLAZER J, 1954, J POLYM SCI, V13, P355, DOI 10.1002/pol.1954.120137004; HIRANO S, 1998, JPN J APPL PHYS 2, V37, pL1190; Lin-Vien D., 1991, HDB INFRARED RAMAN C; MOFFATT DM, 1989, J MATER SCI, V24, P609, DOI 10.1007/BF01107449; MORIMOTO T, 1968, B CHEM SOC JPN, V41, P1533, DOI 10.1246/bcsj.41.1533; Nielsen L. E., 1994, MECH PROPERTIES POLY; SCHIERING DW, 1987, J APPL POLYM SCI, V34, P2367, DOI 10.1002/app.1987.070340703; Silverstein R. M., 1991, SPECTROMETRIC IDENTI	16	0	0	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	MAR	2000	39	3A					1193	1199		10.1143/JJAP.39.1193		7	Physics, Applied	Physics	308HY	WOS:000086705600046		
J	Uchiyama, H; Tanaka, N; Zama, H; Tajima, S; Morishita, T; Saiki, K; Koma, A				Uchiyama, H; Tanaka, N; Zama, H; Tajima, S; Morishita, T; Saiki, K; Koma, A			X-ray photoemission spectroscopy study for the flat YBa2Cu3Oy single-crystal surface prepared by chemical etching and O-2 annealing	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						YBa2Cu3Oy; single crystal; chemical etching; X-ray photoelectron spectroscopy	CORE-LEVEL	The effect of chemical etching with a HCl/methanol solution on a polished sample of single-crystal YBa2Cu3Oy (001) was investigated by emission-angle-dependent X-ray photoemission spectroscopy (XPS). By chemical etching, the extrinsic Ba state in the surface region was removed without the effect of halogen. The bulk state of Y was also restored in the surface by subsequent annealing in an oxygen atmosphere at 400 degrees C.	Int Superconduct Technol Ctr, Superconduct Res Lab, Koto Ku, Tokyo 1350062, Japan; Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Bunkyo Ku, Tokyo 1130033, Japan	Uchiyama, H (reprint author), Int Superconduct Technol Ctr, Superconduct Res Lab, Koto Ku, 1-10-13 Shinonome, Tokyo 1350062, Japan.		Saiki, Koichiro/E-4496-2011				Wei JYT, 1998, PHYS REV LETT, V81, P2542, DOI 10.1103/PhysRevLett.81.2542; VASQUEZ RP, 1989, J APPL PHYS, V66, P4866, DOI 10.1063/1.343805; BRUNDLE CR, 1993, SURF SCI REP, V19, P143, DOI 10.1016/0167-5729(93)90009-E; HUMLICEK J, 1982, J QUANT SPECTROSC RA, V27, P437, DOI 10.1016/0022-4073(82)90078-4; Tanaka N, 1999, JPN J APPL PHYS 2, V38, pL731, DOI 10.1143/JJAP.38.L731; VASQUEZ RP, 1994, SPECTROSCOPY HIGH TE; VASQUEZ RP, 1992, PHYSICA C, V190, P249, DOI 10.1016/0921-4534(92)90602-9; VASQUEZ RP, 1991, J ELECTRON SPECTROSC, V57, P317, DOI 10.1016/0368-2048(91)80018-P; YAMADA Y, 1993, PHYSICA C, V217, P182, DOI 10.1016/0921-4534(93)90810-D; Zama H, 1996, JPN J APPL PHYS 2, V35, pL421, DOI 10.1143/JJAP.35.L421	10	1	1	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	MAR	2000	39	3A					1320	1322		10.1143/JJAP.39.1320		3	Physics, Applied	Physics	308HY	WOS:000086705600071		
J	Watari, N; Ohnishi, S; Onishi, H; Iwasawa, Y				Watari, N; Ohnishi, S; Onishi, H; Iwasawa, Y			Total energy estimation for Pd/Al bimetallic surfaces by a parallel computation scheme	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						message-passing interface; parallel computation; total energy; density functional method; bimetallic surface; self-consistent-field; X-ray photoelectron spectroscopy	CLUSTER-MODEL; ADSORPTION; CO	A numerical calculation scheme for the multicenter problem in large molecules and clusters is presented by applying the message-passing inter-face (MPI) in a massively parallel computer that uses the density functional method. The multicenter problem associated with the Coulomb singularity of an atom is efficiently treated by the parallel processors by allocating several atoms into each processor element (PE). The order N-2/P tuning is obtained for the Coulomb energy calculation by using the MPI which transfers Coulomb potential field between PE's. This method is applied to estimate the total energy of the reconstructed Al/Pd bimetallic surface. The energy estimation by the charge density of a superposition of isolated atomic charge fragments predict a stabilization caused by the reconstruction, being consistent with a self-consistent-field (SCF) cluster calculation of the bimetallic surface.	NEC Informatec Syst Ltd, Miyamae Ku, Kawasaki, Kanagawa 2168555, Japan; NEC, Fundamental Res Lab, Tsukuba, Ibaraki 3058501, Japan; Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Watari, N (reprint author), NEC Informatec Syst Ltd, Miyamae Ku, 4-1-1 Miyazaki, Kawasaki, Kanagawa 2168555, Japan.						Thomas LH, 1927, P CAMB PHILOS SOC, V23, P542; HARRIS J, 1985, PHYS REV B, V31, P1770, DOI 10.1103/PhysRevB.31.1770; SALVAT F, 1987, PHYS REV A, V36, P467, DOI 10.1103/PhysRevA.36.467; BACHELET GB, 1982, PHYS REV B, V26, P4199, DOI 10.1103/PhysRevB.26.4199; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; Watari N, 1997, J CHEM PHYS, V106, P7531, DOI 10.1063/1.473751; DEPRISTO AE, 1987, PHYS REV A, V35, P438, DOI 10.1103/PhysRevA.35.438; Fermi E, 1928, Z PHYS, V48, P73, DOI 10.1007/BF01351576; Fuggle J.C., 1982, PHYS REV B, V27, P2145; HARRIS J, 1981, J CHEM PHYS, V75, P3904, DOI 10.1063/1.442546; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; MARCH NH, 1957, ADV PHYS, V6, P1; OHNISHI S, 1994, PHYS REV B, V49, P14619, DOI 10.1103/PhysRevB.49.14619; OHNISHI S, 1995, P INT S PAR DISTR SU, P285; Onishi H, 1997, SURF SCI, V392, pL51, DOI 10.1016/S0039-6028(97)00703-6; Shen YG, 1997, PHYS REV B, V56, P9894, DOI 10.1103/PhysRevB.56.9894; von Weizsacker CF, 1935, Z PHYS, V96, P431; WATARI N, 1995, CATAL TODAY, V23, P371, DOI 10.1016/0920-5861(94)00151-Q; WATARI N, UNPUB J PHYS C; WOODRUFF DP, 1994, CHEM PHYS SOLID SURF, V7, P465	20	0	0	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	MAR	2000	39	3A					1457	1461		10.1143/JJAP.39.1457		5	Physics, Applied	Physics	308HY	WOS:000086705600099		
J	Hainberger, R; Kamiya, T				Hainberger, R; Kamiya, T			Micro-optical platform for all-optical demultiplexing switch array	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article; Proceedings Paper	7th Microoptics Conference (MOC 99)	JUL 14-16, 1999	CHIBA, JAPAN	Japan Soc Appl Phys		planar integrated free-space optics; Fresnel zone lens; binary optics; all-optical switch; asymmetric Fabry-Perot saturable absorber switch; all-optical time division demultiplexing; optical gating		As it is free from electrical parasitics, the use of the all-optical switch array is an attractive approach for achieving very high-speed signal processing for optical communication and interconnection beyond the Gbit/s range. However, two incident beams and one outgoing beam for each switch may require a complex geometry, thus the module assembly procedure remains a serious obstacle for its realization. The present work reports the design, test fabrication, and characterization of an optical platform dedicated to all-optical demultiplexing at 1.55 mu m, using asymmetric Fabry-Perot saturable absorber switches as active devices, and off-axis binary Fresnel zone lenses as the focusing optics. Two different platform configurations were fabricated by a substrate stacking technique achieving spot sizes of 13 mu m and 22.5 mu m at the switch plane, with reasonable overlap between the pump and signal beams. The influence of wavelength variation, fabrication tolerance and throughput are discussed.	Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Hainberger, R (reprint author), Univ Tokyo, Dept Elect Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						Akiyama T, 1998, APPL PHYS LETT, V72, P1545, DOI 10.1063/1.120577; FERSTL M, 1992, P SOC PHOTO-OPT INS, V1732, P89; HERZIG HP, 1997, MICROOPTICS, P179; HIRANO A, 1999, IEEE J LIGHTWAVE TEC, V17, P873; JAHNS J, 1989, APPL OPTICS, V28, P1602, DOI 10.1364/AO.28.001602; MURATA N, 1991, J ADHESION, V35, P251, DOI 10.1080/00218469108041012; Sasaki H, 1998, APPL OPTICS, V37, P3735, DOI 10.1364/AO.37.003735; Song SH, 1997, APPL OPTICS, V36, P5728, DOI 10.1364/AO.36.005728; Takahashi R, 1996, APPL PHYS LETT, V68, P153, DOI 10.1063/1.116131; Testorf M, 1997, J OPT SOC AM A, V14, P1569, DOI 10.1364/JOSAA.14.001569; YAN RH, 1991, IEEE J QUANTUM ELECT, V27, P1922, DOI 10.1109/3.83394	11	4	4	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	MAR	2000	39	3B					1533	1537		10.1143/JJAP.39.1533		5	Physics, Applied	Physics	308HZ	WOS:000086705700017		
J	Kozuka, T; Aoki, Y; Nakagawa, K; Ohtomo, K; Yoshikawa, H; Matsumoto, K; Yoshiike, K; Kanda, T				Kozuka, T; Aoki, Y; Nakagawa, K; Ohtomo, K; Yoshikawa, H; Matsumoto, K; Yoshiike, K; Kanda, T			Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						HPV-16; long control region	GENE-EXPRESSION; DNA; E7; CARCINOMA; TRANSCRIPTION; SEQUENCES; E6; ASSOCIATION; PREVALENCE; NEOPLASIA	Expression of human papillomavirus 16 (HPV-16) oncogenes is markedly higher in cervical cancer cells than in precancerous cells, and the elevated expression is believed to be required for the malignant phenotypes. We compared cancer cell lines CaSki (with 200 to 400 copies of HPV-16 DNA per cell) and SiHa (with one to two copies of HPV-16 DNA per cell) for the E7 expression in cells and the enhancer-promoter activity of the isolated viral long control region (LCR), Although these parameters per cell were 10-fold higher in CaSki than in SiHa, the levels of the E7 mRNA and protein per HPV DNA copy were 10- to 20-fold higher in SiHa than in CaSki, Characterization of the isolated LCRs showed that, whereas the LCR from CaSki resembled the prototype in structure and activity, the LCR from SiHa, with a deletion of 38 base pairs, enhanced transcription from P97 as assayed by using a plasmid capable of expressing luciferase, The upregulation appeared to be due to removal of one of the silencer YY1-binding sites. Furthermore, we isolated and characterized LCRs from 51 cervical cancer patients' biopsies. Among them, one with a deletion including YY1-binding sites and the other with a substitution in a YY1-motif were found to enhance the transcription. These findings suggest that mutation affecting YY1-motifs in the LCR is one of the mechanisms enhancing the viral oncogene expression in the course of progression of cancer cells.	Natl Inst Infect Dis, Div Mol Genet, Shinjuku Ku, Tokyo 1628640, Japan; Univ Tokyo, Fac Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan	Kanda, T (reprint author), Natl Inst Infect Dis, Div Mol Genet, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.						HAWLEYNELSON P, 1989, EMBO J, V8, P3905; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918; BAKER CC, 1987, J VIROL, V61, P962; OConnor MJ, 1996, J VIROL, V70, P6529; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; YEE C, 1985, AM J PATHOL, V119, P361; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524; Meissner JD, 1999, J GEN VIROL, V80, P1725; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; DURST M, 1992, VIROLOGY, V189, P132, DOI 10.1016/0042-6822(92)90688-L; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; KANDA T, 1991, VIROLOGY, V182, P723, DOI 10.1016/0042-6822(91)90613-G; CROOK T, 1989, EMBO J, V8, P513; DOEBERITZ MV, 1991, P NATL ACAD SCI USA, V88, P1411, DOI 10.1073/pnas.88.4.1411; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; HIGGINS GD, 1992, J GEN VIROL, V73, P2047, DOI 10.1099/0022-1317-73-8-2047; LAIMINS LA, 1998, HUMAN TUMOR VIRUSES, P201; MAY M, 1994, EMBO J, V13, P1460; O'Connor MJ, 1998, J VIROL, V72, P10083; SMOTKIN D, 1989, J VIROL, V63, P1441; Veress G, 1999, J GEN VIROL, V80, P1035; von Knebel Doeberitz M., 1992, INT J CANCER, V51, P831; WATANABE S, 1992, VIROLOGY, V187, P107, DOI 10.1016/0042-6822(92)90299-5; WATANABE S, 1993, JPN J CANCER RES, V84, P1043; Yamada T, 1997, J VIROL, V71, P2463	29	17	18	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	MAR	2000	91	3					271	279				9	Oncology	Oncology	300QY	WOS:000086264700001		
J	Utada, Y; Haga, S; Kajiwara, T; Kasumi, F; Sakamoto, G; Nakamura, Y; Emi, M				Utada, Y; Haga, S; Kajiwara, T; Kasumi, F; Sakamoto, G; Nakamura, Y; Emi, M			Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						breast cancer; loss of heterozygosity; tumor suppressor gene; chromosome 6; yeast artificial chromosome (YAC)	TUMOR-SUPPRESSOR GENE; COMMONLY DELETED REGION; 2 DISTINCT REGIONS; CHROMOSOME 6Q; MINIMAL DELETION; RECEPTOR LOCUS; 2-CM INTERVAL; FREQUENT LOSS; PROXIMAL 6Q; II RECEPTOR	Allelic losses on the long arm of human chromosome 6 are frequently observed in cancers of the ovary, prostate, and breast. To identify the locations of putative tumor suppressor genes on 6q, we examined 192 primary breast cancers for patterns of allelic loss at 16 polymorphic microsatellite loci distributed along this chromosome arm. Allelic losses at one or more loci were observed in 105 (55%) of the tumors examined. Detailed deletion mapping with appropriate yeast artificial chromosome (YAC) contigs identified two distinct commonly deleted regions; one was confined to a 1-cM interval at 6q21 flanked by D6S1040 and D6S262 and the other to a 1-cM interval at 6q25.3 flanked by D6S305 and D6S411. Allelic losses at 6q21 were more frequent in invasive solid tubular and scirrhous carcinomas than in tumors of less aggressive histologic types (P=0.0006), Allelic loss at 6q25.3 was associated with loss of progesterone receptor (P=0.0256). Our results suggest the presence of two tumor suppressor genes for breast cancer an 6q that are likely to be associated with tumor progression and/or loss of hormonal dependency.	Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan; Tokyo Womens Med Univ, Daini Hosp, Dept Surg, Arakawa Ku, Tokyo 1168567, Japan; Inst Canc, Dept Surg & Pathol, Toshima Ku, Tokyo 1708455, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1088639, Japan	Emi, M (reprint author), Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Nakahara Ku, 1-396 Kusugi Cho, Kawasaki, Kanagawa 2118533, Japan.						DESOUZA AT, 1995, ONCOGENE, V10, P1725; Sheng ZM, 1996, BRIT J CANCER, V73, P144, DOI 10.1038/bjc.1996.27; SAITO H, 1993, CANCER RES, V53, P3382; Saito S, 1996, CANCER RES, V56, P5586; Theile M, 1996, ONCOGENE, V13, P677; Noviello C, 1996, CLIN CANCER RES, V2, P1601; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; Fujii H, 1996, GENE CHROMOSOME CANC, V16, P35, DOI 10.1002/(SICI)1098-2264(199605)16:1<35::AID-GCC5>3.0.CO;2-4; Takeuchi S, 1998, CANCER RES, V58, P2618; QUEIMADO L, 1995, GENE CHROMOSOME CANC, V14, P28, DOI 10.1002/gcc.2870140106; Sherratt T, 1997, CHROMOSOME RES, V5, P118, DOI 10.1023/A:1018418224660; DEVILEE P, 1991, ONCOGENE, V6, P1705; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; MENASCE LP, 1993, GENOMICS, V17, P263, DOI 10.1006/geno.1993.1320; Chappell SA, 1997, BRIT J CANCER, V75, P1324, DOI 10.1038/bjc.1997.224; Colitti CV, 1998, ONCOGENE, V16, P555, DOI 10.1038/sj.onc.1201523; Cooke IE, 1996, GENE CHROMOSOME CANC, V15, P223, DOI 10.1002/(SICI)1098-2264(199604)15:4<223::AID-GCC4>3.0.CO;2-3; Cooney KA, 1996, CANCER RES, V56, P4150; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hankins GR, 1996, ONCOGENE, V12, P2003; HARADA Y, 1994, CANCER, V74, P2281, DOI 10.1002/1097-0142(19941015)74:8<2281::AID-CNCR2820740812>3.0.CO;2-I; Iida A, 1998, GENE CHROMOSOME CANC, V21, P108, DOI 10.1002/(SICI)1098-2264(199802)21:2<108::AID-GCC5>3.0.CO;2-4; ITO I, 1995, BRIT J CANCER, V71, P438, DOI 10.1038/bjc.1995.89; IWASE H, 1995, BRIT J CANCER, V71, P448, DOI 10.1038/bjc.1995.91; IZUO M, 1989, JPN J SURG, V19, P612; LAUREYS G, 1988, GENOMICS, V3, P224, DOI 10.1016/0888-7543(88)90083-3; LEE JH, 1990, CANCER RES, V50, P1714; Iida A., 1997, British Journal of Cancer, V75, P264, DOI 10.1038/bjc.1997.43; Matsumoto S, 1997, GENE CHROMOSOME CANC, V20, P268; MILLER BL, 1991, NMR BIOMED, V5, P1; Nakata T, 1998, EUR J CANCER, V34, P417, DOI 10.1016/S0959-8049(97)10153-8; ORPHANOS V, 1995, BRIT J CANCER, V71, P290, DOI 10.1038/bjc.1995.58; SATO T, 1991, CANCER RES, V51, P5794; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X; Tsukamoto K, 1996, CANCER, V78, P1929, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1929::AID-CNCR13>3.0.CO;2-#; Tsukamoto K, 1998, CANCER, V82, P317, DOI 10.1002/(SICI)1097-0142(19980115)82:2<323::AID-CNCR11>3.0.CO;2-0; Yokota T, 1997, JPN J CANCER RES, V88, P959; Yokota T, 1999, CANCER, V85, P447	39	25	26	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	MAR	2000	91	3					293	300				8	Oncology	Oncology	300QY	WOS:000086264700004		
J	Kang, Y; Hirano, K; Suzuki, N; Enomoto, A; Morita, A; Irimura, T; Sakai, K				Kang, Y; Hirano, K; Suzuki, N; Enomoto, A; Morita, A; Irimura, T; Sakai, K			Increased expression after X-irradiation of MUC1 in cultured human colon carcinoma HT-29 cells	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						MUC1; radiation; colon carcinoma cell; expression; tumor marker	SOLUBLE FACTOR; DIFFERENTIAL EXPRESSION; PLASMINOGEN-ACTIVATOR; MONOCLONAL-ANTIBODIES; EPITHELIAL SIALOMUCIN; IONIZING-RADIATION; MOLECULAR-WEIGHT; EPISIALIN MUC1; CORE PROTEIN; TUMOR-CELLS	The effect of X-irradiation on production of MUC1 was studied with human colon carcinoma HT-29 cells. As evaluated by immunocytochemical staining, the percentages of MUC1-positive cells in cells at 4 days after 6 Gy irradiation and in unirradiated control cells were 52+/-3.5% (n=6) and 26+/-2.8% (n=6), respectively. Flow-cytomctric analysis of living cells showed that MUC1 began to rise from day 1, reaching a plateau by day 4 after 6 Gy irradiation. Western blot analysis with monoclonal antibody MY.1E12 against glycosylated MUC1 (mature form) showed dose-dependent increases of two bands (500 and 390 kDa) corresponding to two polymorphic MUC1 alleles, Premature forms of MUC1 (350 and 240 kDa) were detectable with monoclonal antibody IIMFG-2 only in irradiated cells, suggesting that new core protein synthesis had been induced. The transcriptional activity of the MUC1 gene was analyzed in terms of transient expression of MUC1-CAT reporter plasmids containing 5'-flanking sequences of the MUC1 gene fused to the bacterial chloramphenicol acetyltransferase (CAT) gene. The results of CAT assay Indicate that enhanced expression of MUC1 in irradiated HT-29 cells was due to upregulation of MUC1 transcription, and required the upstream promoter.	Univ Tokyo, Grad Sch Med, Dept Radiat Oncol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, Tokyo 1130033, Japan	Suzuki, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Radiat Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Morita, Akinori/D-1418-2011				BURCHELL J, 1987, CANCER RES, V47, P5476; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; LAN MS, 1990, J BIOL CHEM, V265, P15294; LIGTENBERG MJL, 1990, J BIOL CHEM, V265, P5573; SAHIJDAK WM, 1994, RADIAT RES, V138, pS47, DOI 10.2307/3578760; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353; Wesseling J, 1996, MOL BIOL CELL, V7, P565; BOOTHMAN DA, 1991, CANCER RES, V51, P5587; DOHI DF, 1993, J BIOL CHEM, V268, P10133; HILKENS J, 1988, J BIOL CHEM, V263, P4215; HO JJL, 1995, BIOCHEM BIOPH RES CO, V210, P866, DOI 10.1006/bbrc.1995.1738; IRIMURA T, 1988, CANCER RES, V48, P2353; IRIMURA T, 1990, CANCER RES, V50, P3331; KOVARIK A, 1993, J BIOL CHEM, V268, P9917; LANCASTER CA, 1990, BIOCHEM BIOPH RES CO, V173, P1019, DOI 10.1016/S0006-291X(05)80888-5; LITVINOV SV, 1993, J BIOL CHEM, V268, P21364; Lloyd KO, 1996, J BIOL CHEM, V271, P33325; Makiguchi Y, 1996, JPN J CANCER RES, V87, P505; Morimatsu A, 1996, J RADIAT RES, V37, P1, DOI 10.1269/jrr.37.1; SAWAYA R, 1994, INT J CANCER, V56, P214, DOI 10.1002/ijc.2910560212; SHIROTANI K, 1994, J BIOL CHEM, V269, P15030; Shirotani K, 1998, J BIOCHEM-TOKYO, V124, P585; STEIN B, 1989, MOL CELL BIOL, V9, P5169; SUZUKI N, 1984, CANCER RES, V44, P3505; SUZUKI N, 1983, CANCER RES, V43, P5451; Yamamoto M, 1996, JPN J CANCER RES, V87, P488	29	10	10	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	MAR	2000	91	3					324	330				7	Oncology	Oncology	300QY	WOS:000086264700008		
J	Zhao, B; Kimura, W; Futakawa, N; Abe, H; Kitayama, J; Nagawa, H; Makuuchi, M				Zhao, B; Kimura, W; Futakawa, N; Abe, H; Kitayama, J; Nagawa, H; Makuuchi, M			Significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in carcinoma of the papilla of vater	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						TP; Microvessel density; p53; prognosis	HUMAN COLORECTAL-CARCINOMA; HUMAN COLON-CANCER; TUMOR ANGIOGENESIS; GASTRIC-CARCINOMA; FACTOR EXPRESSION; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; ADENOCARCINOMA; PURIFICATION; EPITHELIUM	The expression of thymidine phosphorylase (TP) in carcinoma of the papilla of Vater was studied to clarify its significance in tumor progression and in determining prognosis. Fifty-nine cases of surgically resected carcinoma of the papilla of Vater were studied. Immunohistochemical staining was performed to evaluate the expression of TP, microvessel count and p53 overexpression. TP expression was demonstrated in tumor cells in 62.7% (37/59) of the cases. A higher frequency of regional lymph node metastasis was found in TP-positive tumors than in TP-negative tumors (P=0.006). TP-positive tumors were more advanced than TP-negative tumors with regard to clinical stage (P=0.035). TP-positive tumors had significantly higher microvessel density (27.6+/-10.1) than TP-negative tumors (20.4+/-10.0, P=0.01). Moreover, TP expression was significantly correlated with a poor prognosis (P=0.02). These suggest that in carcinoma of the papilla of Vater, TP production by tumor cells is correlated with tumor progression through its regulatory effect on neovascularization.	Univ Tokyo, Grad Sch Med, Dept Surg, Tokyo 1138655, Japan; Yamagata Univ, Sch Med, Dept Surg 1, Yamagata 9909585, Japan; Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Surg, Koshigaya, Saitama 3438555, Japan	Zhao, B (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				MIYADERA K, 1995, CANCER RES, V55, P1687; ALLEMA JH, 1995, SURGERY, V117, P247, DOI 10.1016/S0039-6060(05)80197-7; OBrien TS, 1996, CANCER RES, V56, P4799; HARAGUCHI M, 1994, NATURE, V368, P198, DOI 10.1038/368198a0; Igarashi M, 1998, CANCER, V82, P1225, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E; Koukourakis MI, 1997, BRIT J CANCER, V75, P477, DOI 10.1038/bjc.1997.83; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; MOGHADDAM A, 1995, P NATL ACAD SCI USA, V92, P998, DOI 10.1073/pnas.92.4.998; MOGHADDAM A, 1992, BIOCHEMISTRY-US, V31, P12141, DOI 10.1021/bi00163a024; LOWELL JA, 1992, ARCH SURG-CHICAGO, V127, P557; Fox SB, 1996, BRIT J CANCER, V73, P275, DOI 10.1038/bjc.1996.49; Kumar R, 1998, INT J ONCOL, V12, P749; Takahashi Y, 1996, J NATL CANCER I, V88, P1146, DOI 10.1093/jnci/88.16.1146; YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X; Takahashi Y, 1998, CLIN CANCER RES, V4, P429; KIMURA W, 1994, JPN J CANCER RES, V85, P161; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; KIMURA W, 1988, CANCER, V61, P1394, DOI 10.1002/1097-0142(19880401)61:7<1394::AID-CNCR2820610720>3.0.CO;2-M; Takebayashi Y, 1996, J NATL CANCER I, V88, P1110, DOI 10.1093/jnci/88.16.1110; MIYAZONO K, 1987, J BIOL CHEM, V262, P4098; FLEMMING ID, 1997, AM JOINT COMMITTEE C; FOLKMAN J, 1990, J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Folkman J, 1996, J NATL CANCER I, V88, P1091, DOI 10.1093/jnci/88.16.1091; Folkman J, 1992, Semin Cancer Biol, V3, P65; Futakawa N, 1996, HEPATO-GASTROENTEROL, V43, P260; Haba A, 1998, CANCER LETT, V122, P85, DOI 10.1016/S0304-3835(97)00375-3; Maeda K, 1996, BRIT J CANCER, V73, P884, DOI 10.1038/bjc.1996.177; Maeda K, 1997, INT J CANCER, V74, P545, DOI 10.1002/(SICI)1097-0215(19971021)74:5<545::AID-IJC12>3.0.CO;2-5; Mizutani Y, 1997, CANCER, V79, P1190, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1190::AID-CNCR18>3.3.CO;2-B; Nagaoka H, 1998, INT J ONCOL, V13, P449; Nishida M, 1996, BIOL PHARM BULL, V19, P1407; OBRIEN T, 1995, CANCER RES, V55, P510; PAULY JL, 1977, J NATL CANCER I, V58, P1587; PAULY JL, 1978, P SOC EXP BIOL MED, V157, P262; REYNOLDS K, 1994, J NATL CANCER I, V86, P1234, DOI 10.1093/jnci/86.16.1234; SCARPA A, 1993, AM J PATHOL, V142, P1163; Takao S, 1998, CLIN CANCER RES, V4, P1619; TAKEBAYASHI Y, 1995, CANCER LETT, V92, P1, DOI 10.1016/0304-3835(94)03754-7; TAKEBAYASHI Y, 1995, CANCER LETT, V95, P57, DOI 10.1016/0304-3835(95)03865-T; Takebayashi Y, 1996, JPN J CANCER RES, V87, P288; TOI M, 1995, INT J CANCER, V64, P79, DOI 10.1002/ijc.2910640202; Zhao B, 1999, AM J GASTROENTEROL, V94, P2128	42	6	6	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	MAR	2000	91	3					331	336				6	Oncology	Oncology	300QY	WOS:000086264700009		
J	Izumo, T; Maseki, N; Mori, S; Tsuchiya, E				Izumo, T; Maseki, N; Mori, S; Tsuchiya, E			Practical utility of the revised European-American classification of lymphoid neoplasms for Japanese non-Hodgkin's lymphomas	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						lymphoma; REAL classification; non-Hodgkin's lymphoma	MANTLE CELL LYMPHOMA; T-CELL; B-CELL; FOLLICULAR LYMPHOMA; SINGLE INSTITUTION; MALIGNANT-LYMPHOMA; PROGNOSTIC FACTORS; CLINICAL ANALYSIS; PROPOSAL	A clinicopathological study of 515 non-Hodgkin's lymphoma (NHL) cases was performed using the revised European-American classification of lymphoid neoplasms (REAL classification) in an HTLV1-nonendemic area of Japan. The following characteristics were revealed: 1) frequency of extranodal lymphomas was high (59%) with 79% B-cell lymphomas in this series, while the overall ratio of B:T/NK lineage was 3.7:1; 2 the most common type was the diffuse large B-cell lymphoma (46%), follicle center lymphomas occurred at an incidence lower (15%) than that in European and American populations, and marginal zone B-cell lymphomas accounted for as much as 12%; 3 peripheral T-cell lymphomas were common (19%), with the unspecified type predominant (11%), while adult T-cell lymphomas were present at a level equivalent to that among European and American patients (1%), Clear segregation of survival curves was rated according to cell lineage and B-cell lymphomas had a better prognosis than T/NK-cell lymphomas, Furthermore, new subtypes in the REAL classification, such as marginal zone B-cell and mantle cell lymphomas, exhibited distinct curves. Taken altogether, the REAL classification demonstrated advantages for assessment of Japanese NHL cases.	Saitama Canc Ctr, Dept Pathol, Ina, Saitama 3620806, Japan; Saitama Canc Ctr, Haematol Clin, Ina, Saitama 3620806, Japan; Univ Tokyo, Inst Med Sci, Dept Pathol, Minato Ku, Tokyo 1088639, Japan	Tsuchiya, E (reprint author), Saitama Canc Ctr, Dept Pathol, 818 Komuro, Ina, Saitama 3620806, Japan.						SAKURAI M, 1987, BLOOD, V70, P1554; AMAKAWA R, 1989, BLOOD, V73, P787; AOZASA K, 1985, EUR J CANCER CLIN ON, V21, P487, DOI 10.1016/0277-5379(85)90042-2; HARRIS NL, 1994, BLOOD, V84, P1361; ROSENBERG SA, 1982, CANCER, V49, P2112; Chan WC, 1997, BLOOD, V89, P3909; BRAYLAN RC, 1989, ARCH PATHOL LAB MED, V113, P627; Pittaluga S, 1996, BLOOD, V87, P4358; CARBONE PP, 1971, CANCER RES, V31, P1860; FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#; BANFI A, 1968, European Journal of Cancer, V4, P319, DOI 10.1016/0014-2964(68)90058-3; BANKS PM, 1992, AM J SURG PATHOL, V16, P637, DOI 10.1097/00000478-199207000-00001; *CANC SOC FINL, 1969, PUBL CANC SOC FINL, V15; Engelhard M, 1997, BLOOD, V89, P2291; FISHER RI, 1996, ANN ONCOL, V7, P3; FISHER RI, 1995, BLOOD, V85, P1075; Frizzera Glauco, 1997, Current Opinion in Oncology, V9, P392, DOI 10.1097/00001622-199709050-00002; GREER JP, 1984, J CLIN ONCOL, V2, P788; HANAOKA M, 1981, ACTA HAEMATOL JPN, V44, P4120; HARRIS NL, 1995, BLOOD, V85, P857; Harris NL, 1997, ANN ONCOL, V8, P11, DOI 10.1023/A:1008297208776; Hiddemann W, 1996, BLOOD, V88, P4085; Isaacson PG, 1994, EXTRANODAL LYMPHOMAS, P1; ISSACSON P, 1984, CANCER, V53, P2515; Issacson PG, 1987, HISTOPATHOLOGY, V11, P445; IZUMO T, 1996, JPN J LYMPHORETIC RE, V36, P145; JAFFE ES, 1984, CANCER INVEST, V2, P413, DOI 10.3109/07357908409040316; KADIN ME, 1983, HUM PATHOL, V14, P745; Katsumata N, 1996, JPN J CLIN ONCOL, V26, P445; KIKUCHI M, 1998, PATHOL CLIN MED, V16, P384; KWAK LW, 1991, CANCER, V68, P1988, DOI 10.1002/1097-0142(19911101)68:9<1988::AID-CNCR2820680924>3.0.CO;2-A; Lennert K, 1992, HISTOPATHOLOGY NONHO, V2; LUKES RJ, 1978, SEMIN HEMATOL, V15, P322; MASEKI N, 1987, CANCER RES, V47, P6767; MCINYK A, 1997, BLOOD, V89, P4514; MODAN B, 1969, BRIT J HAEMATOL, V16, P53, DOI 10.1111/j.1365-2141.1969.tb00378.x; MOHRI N, 1987, CURRENT ENCY PATHO B, V18, P119; NAKAMURA S, 1999, PATHOL CLIN MED, V17, P576; NANBA K, 1987, CURRENT ENCY PATHO B, V18, P153; OYAMA A, 1981, ACTA HAEMATOL JAPON, V44, P1411; Salar A, 1997, EUR J HAEMATOL, V59, P231; SHIMOYAMA M, 1991, ANN ONCOL, V2, P157; SHIMOYAMA M, 1993, LEUKEMIA LYMPHOMA, V10, P335, DOI 10.3109/10428199309148557; SHIMOYAMA M, 1992, GANN MONOGRAPH CANCE, V39, P43; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STALSBER.H, 1973, J NATL CANCER I, V50, P1685; SUCHI T, 1979, ACTA PATHOL JAPON, V29, P755; *T B CELL MAL STUD, 1981, JPN J CLIN ONCOL, V11, P15; TAJIMA K, 1979, JPN J CLIN ONCOL, V9, P495; TAJIMA K, 1992, GANN MONOGR CANCER R, V39, P129; TAMARU J, 1998, PATHOL CLIN MED, V16, P399; WARNKE RA, 1995, TUMORS LYMPH NODES S, P63; WEST KP, 1986, J PATHOL, V150, P89, DOI 10.1002/path.1711500203	53	10	10	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	MAR	2000	91	3					351	360				10	Oncology	Oncology	300QY	WOS:000086264700012		
J	Oda, T				Oda, T			Further decline of hepatitis B surface antigen (HBsAg) prevalence in Japan	JAPANESE JOURNAL OF CANCER RESEARCH			English	Letter									Univ Tokyo, Fac Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan	Oda, T (reprint author), Univ Tokyo, Fac Med, Dept Internal Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Maupas P, 1981, Prog Med Virol, V27, P1; Oda T, 1999, JPN J CANCER RES, V90, P1051; OKOCHI K, 1991, LANCET, V338, P1040	3	2	2	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	MAR	2000	91	3					361	361				1	Oncology	Oncology	300QY	WOS:000086264700013		
J	Morita, S; Okamoto, M; Abe, J; Yamagishi, J				Morita, S; Okamoto, M; Abe, J; Yamagishi, J			Bleeding rate of field-grown maize with reference to root system development	JAPANESE JOURNAL OF CROP SCIENCE			Japanese	Article						bleeding rate; diurnal change; maize; nodal root; root; root system; xylem sap; Zea mays L.	XYLEM SAP	Bleeding rate could be an effective index for the physiological activity of a whole root system in field-grown crops, because it is based on active water absorption caused by root pressure. We examined the bleeding rate of field-grown maize with reference to root system development. The bleeding rate decreased rapidly just after detopping, which suggested negative effects of shoot removal on bleeding in maize. The bleeding rate of different plants at every hour showed that it has a diurnal change pattern with the maximum value occurring at around 8 a.m. Then we examined the bleeding rate early in the morning with reference to shoot growth. It increased with shoot growth and root development to reach the maximum value at around tasselling and decreased thereafter. The number and diameter of nodal roots emerging acropetally along the stem were increasing until tasselling. Therefore significant positive correlations were evident between the bleeding rate and the root morphological traits, such as total number, diameter, and cross area of nodal roots of a whole root system until tasseling, although these relationships were not clear afterwards. Physiological activity per unit root mass was estimated on the assumption that bleeding rate is a product of root morphology and its physiological activity. The physiological activity per unit root mass increased in the former half of the growing period, then decreased, possible because of the relative relationship between the formation of new roots and the senescense of existing roots.	Univ Tokyo, Bunkyo 1138657, Japan	Morita, S (reprint author), Univ Tokyo, Bunkyo 1138657, Japan.						ANDERSEN PC, 1988, HORTSCIENCE, V23, P978; Schurr U, 1998, TRENDS PLANT SCI, V3, P293, DOI 10.1016/S1360-1385(98)01275-8; Kramer P. J., 1995, WATER RELATIONS PLAN, P167, DOI 10.1016/B978-012425060-4/50006-1; MACDOWALL F. D. H., 1964, CANADIAN JOUR BOT, V42, P115; MASUDA M, 1982, J JPN SOC HORTIC SCI, V51, P293; MINSHALL WH, 1968, NATURE, V202, P925; MORITA S, 1993, 15 INT BOT C ABSTR, P431; MORITA S, 1992, JPN J CROP SCI, V61, P101; TSUDA M, 1994, JPN J CROP SCI, V63, P131; VAADIA Y, 1960, PHYSIOL PLANTARUM, V13, P701, DOI 10.1111/j.1399-3054.1960.tb08092.x; WIDDERS I, 1982, PHYSIOL PLANTARUM, V56, P458, DOI 10.1111/j.1399-3054.1982.tb04540.x	11	5	7	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGR BUNKYO-KU, TOKYO, 113, JAPAN	0011-1848			JPN J CROP SCI	Jpn. J. Crop Sci.	MAR	2000	69	1					80	85				6	Agronomy	Agriculture	441AH	WOS:000169208500013		
J	Inoue, K; Amano, S; Oshika, T; Sawa, M; Tsuru, T				Inoue, K; Amano, S; Oshika, T; Sawa, M; Tsuru, T			A 10-year review of penetrating keratoplasty	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						graft survival; penetrating keratoplasty; rejection; 10-year evaluation	GRAFT FAILURE; RISK-FACTORS; REJECTION	Purpose: To survey the changes in indications for penetrating keratoplasty (PKP) and reevaluate the risk factors for allograft rejection and graft failure. Methods: We evaluated the records of 396 eyes of 335 patients who had undergone PKP at the Tokyo University Hospital between 1987 and 1997. Clinical results were analyzed by the Kaplan-Meier life table method and the log-rank test. Results: The overall rates of graft survival and rejection-free graft survival at 10 years were 72.2% sind 76.8%, respectively. The rates of graft survival and rejection-free graft survival were 98.8% and 86.6% in keratoconus, 87.0% and 56.5% in herpetic keratitis, 76.9% and 73.1% in corneal dystrophy and degeneration, 69.4% and 80.6% in nonherpetic keratitis, 62.5% and 75.0% in chemical burns, 61.8% and 72.1% in regrafting, and 51.1% and 79.8% in bullous keratopathy, respectively. The graft survival rates were statistically higher in the PKP alone group than in the combined operation group. The graft survival and rejection-free graft survival rates were statistically higher in the first operation group than in the regrafted;roup, and in the avascular cornea group than in the vascular cornea group. Conclusions: We recognized changes in indications for PKP. Combined operation, reoperation, and vascularization of recipient cornea were risk factors for graft failure. Jpn J Ophthalmol 2000;44:139-145 (C) 2000 Japanese Ophthalmological Society.	Univ Tokyo, Branch Hosp, Sch Med, Dept Ophthalmol,Bunkyo Ku, Tokyo 1128688, Japan; Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo, Japan; Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; Jichi Med Sch, Dept Ophthalmol, Tochigi, Japan	Inoue, K (reprint author), Univ Tokyo, Branch Hosp, Sch Med, Dept Ophthalmol,Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.						AKAKI Y, 1986, NIHON GANKA KIYO, V37, P83; WILLIAMS KA, 1992, OPHTHALMOLOGY, V99, P403; MAGUIRE MG, 1994, OPHTHALMOLOGY, V101, P1536; Yamagami S, 1996, ACTA OPHTHALMOL SCAN, V74, P584; BRADY SE, 1989, AM J OPHTHALMOL, V108, P118; COX DR, 1972, J R STAT SOC B, V34, P187; SMITH RE, 1980, ARCH OPHTHALMOL-CHIC, V98, P1226; Ing JJ, 1998, OPHTHALMOLOGY, V105, P1855, DOI 10.1016/S0161-6420(98)91030-2; Boruchoff S., 1994, CORNEA, P645; CHIKAMA T, 1993, NIHON GANKA KIYO, V44, P1493; FUKUDA M, 1995, ATARASHI GANKA, V12, P1789; HAVENER WH, 1958, ARCH OPHTHALMOL-CHIC, V60, P443; IWASHITA M, 1988, Nippon Ganka Gakkai Zasshi, V92, P1122; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASHIWAGI K, 1994, RINSHO GANKA, V48, P348; KERVICK GN, 1990, CORNEA, V9, P234; KUMAGAI K, 1989, ATARASHII GANKA, V6, P749; ROBIN JB, 1986, ARCH OPHTHALMOL-CHIC, V104, P87; Soda Takako, 1997, Rinsho Ganka, V51, P542; TAKAGI S, 1995, ATARASHII GANKA, V12, P1127; UEDA S, 1982, RINSHO GANKA, V36, P1041; WILSON SE, 1990, SURV OPHTHALMOL, V34, P325, DOI 10.1016/0039-6257(90)90110-H; YAMAGAMI S, 1994, JPN J OPHTHALMOL, V38, P311; Yamakawa Keita, 1997, Rinsho Ganka, V51, P1087	24	30	38	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0021-5155			JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAR-APR	2000	44	2					139	145		10.1016/S0021-5155(99)00190-2		7	Ophthalmology	Ophthalmology	296WA	WOS:000086048700008		
J	Kitamura, H; Murillo, MS; Weisheit, JC				Kitamura, H; Murillo, MS; Weisheit, JC			Atomic excitation in strongly coupled plasmas	JOURNAL DE PHYSIQUE IV			English	Article; Proceedings Paper	International Conference on Strongly Coupled Coulomb Systems	SEP 04-10, 1999	ST MALO, FRANCE	European Sci Fdn, CEA DAM, CNRS, Direct Gen Armement, European Res Off, Univ Paris Sud				In dense plasmas atomic excitation rates arising from scattering between atoms and surrounding plasma particles are formulated on the basis of the equations of motion for density matrices in a stochastic potential. This model enables us to treat strong transitions for which the first-order perturbation theory does not apply. Within a decorrelation approximation, which enables one to break up the higher-order correlation functions of plasma density fluctuations into the products of binary correlation functions (i.e., dynamic structure factors), the interaction is effectively summed to infinite order. This method is applied to two-level atoms in hydrogen plasmas. It is thereby demonstrated that when the plasma density is sufficiently high, low-frequency ion-density fluctuations may cause coherent atomic excitation between close lying states. Such coherent excitation cannot be described by the conventional collisional rate equations based on the first-order perturbation theory.	Univ Calif Los Alamos Natl Lab, Div Appl Phys, Los Alamos, NM 87545 USA; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan; Rice Univ, Dept Space Phys & Astron, Houston, TX 77005 USA	Kitamura, H (reprint author), Univ Calif Los Alamos Natl Lab, Div Appl Phys, POB 1663, Los Alamos, NM 87545 USA.						WEISHEIT JC, 1988, ADV ATOM MOL PHYS, V25, P101; Murillo MS, 1998, PHYS REP, V302, P1, DOI 10.1016/S0370-1573(98)00017-9; INOKUTI M, 1971, REV MOD PHYS, V43, P297, DOI 10.1103/RevModPhys.43.297; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; Griem H. R., 1997, PRINCIPLES PLASMA SP; ICHIMARU S, 1992, STAT PLASMA PHYSICS, V1, pCH7; MOSTOVYCH AN, 1991, PHYS REV LETT, V66, P612, DOI 10.1103/PhysRevLett.66.612; SHIMODA K, 1986, INTRO LASER PHYSICS, pCH7; Shore B. W., 1990, THEORY COHERENT ATOM, V1; Shore B. W., 1990, THEORY COHERENT ATOM, V2; Van Kampen N. G., 1976, Physics Reports. Physics Letters Section C, V24C, DOI 10.1016/0370-1573(76)90029-6; VINOVYCH AN, 1976, PHYS REV LETT, V4, P542	12	0	0	E D P SCIENCES	LES ULIS CEDEXA	7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS CEDEXA, FRANCE	1155-4339			J PHYS IV	J. Phys. IV	MAR	2000	10	P5					493	496		10.1051/jp4:2000595		4	Physics, Multidisciplinary	Physics	313YB	WOS:000087026300096		
J	Morisaki, N; Hashimoto, Y; Furihata, K; Imai, T; Watanabe, K; Mikami, Y; Yazawa, K; Ando, A; Nagata, Y; Dabbs, ER				Morisaki, N; Hashimoto, Y; Furihata, K; Imai, T; Watanabe, K; Mikami, Y; Yazawa, K; Ando, A; Nagata, Y; Dabbs, ER			Structures of ADP-ribosylated rifampicin and its metabolite: Intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756	JOURNAL OF ANTIBIOTICS			English	Article							INACTIVATION; NOCARDIA; STRAINS; NADP+	23-(O-ADP-Ribosyl)rifampicin [RIP-TAs (3, Na+ form), RIP-TAf (4, H+ form)] was obtained as an intermediate in the conversion process of rifampicin (1) to RIP-Mb (2) that is mediated by cell homogenates of Mycobacterium smegmatis DSM43756 or of Escherichia coli carrying a mycobacterial mono(ADP-ribosyl) transferase gene, in the presence of NADH. 23-[O-(5'-Phosphoribosyl)] rifampicin (5, RIP-TAp) was also obtained by the reaction of rifampicin with NADH in the presence of a homogenate of M. smegmatis. The structures of 3, 4, and 5 were determined by means of MS and NMR analyses.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Div Agr & Agr Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Chiba Univ, Res Ctr Pathogen Fungi & Microbial Toxicoses, Chuo Ku, Chiba 2608673, Japan; Chiba Univ, Grad Sch Sci & Technol, Dept Biotechnol, Inage Ku, Chiba 2718510, Japan; Univ Witwatersrand, Dept Mol & Cell Biol, Johannesburg, South Africa	Morisaki, N (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						ANDERSEN SJ, 1991, FEMS MICROBIOL LETT, V79, P247, DOI 10.1111/j.1574-6968.1991.tb04536.x; MAGGI N, 1966, CHEMOTHERAPY, V11, P285; WILLIAMS DL, 1994, ANTIMICROB AGENTS CH, V38, P2380; BREITMAI.E, 1972, EUR J BIOCHEM, V31, P234, DOI 10.1111/j.1432-1033.1972.tb02525.x; DABBS ER, 1987, FEMS MICROBIOL LETT, V44, P395, DOI 10.1111/j.1574-6968.1987.tb02320.x; DABBS ER, 1995, ANTIMICROB AGENTS CH, V39, P1007; DABBS ER, 1995, J ANTIBIOT, V48, P815; FURESZ S, 1970, ANTIBIOT CHEMOTHER, V16, P316; Imai T, 1999, MICROB DRUG RESIST, V5, P259, DOI 10.1089/mdr.1999.5.259; Lancini G, 1977, STRUCTURE ACTIVITY R, P531; MORI H, 1993, INT J GYNECOL CANCER, V3, P36, DOI 10.1046/j.1525-1438.1993.03010036.x; MORISAKI N, 1995, MAGN RESON CHEM, V33, P481, DOI 10.1002/mrc.1260330613; MORISAKI N, 1995, J ANTIBIOT, V48, P1299; NONAKA Y, 1985, J BIOCHEM-TOKYO, V97, P1263; Quan S, 1999, ANTIMICROB AGENTS CH, V43, P181; Quan SW, 1997, ANTIMICROB AGENTS CH, V41, P2456; RAGG E, 1991, BIOCHIM BIOPHYS ACTA, V1076, P49, DOI 10.1016/0167-4838(91)90218-O; Tanaka Y, 1996, MICROBIOL IMMUNOL, V40, P1; YAZAWA K, 1993, ANTIMICROB AGENTS CH, V37, P1313; YAZAWA K, 1994, J ANTIMICROB CHEMOTH, V33, P1127, DOI 10.1093/jac/33.6.1127	20	12	12	JAPAN ANTIBIOT RES ASSN	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAR	2000	53	3					269	275				7	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	298DR	WOS:000086124500007		
J	Ichinose, Y; Kawakami, Y; Ito, M; Kanehisa, H; Fukunaga, T				Ichinose, Y; Kawakami, Y; Ito, M; Kanehisa, H; Fukunaga, T			In vivo estimation of contraction velocity of human vastus lateralis muscle during "isokinetic" action	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						isokinetic knee extension; fascicle shortening velocity; force-velocity relationship	HUMAN KNEE EXTENSOR; FORCE-VELOCITY; TORQUE-VELOCITY; MOMENT ARMS; FIBER TYPE; IN-VIVO; QUADRICEPS; APONEUROSIS; LENGTH	To determine the shortening velocities of fascicles of the vastus lateralis muscle (VL) during isokinetic knee extension, six male subjects were requested to extend the knee with maximal effort at angular velocities of 30 and 150 degrees/s. By using an ultrasonic apparatus, longitudinal images of the VL were produced every 30 ms during knee extension, and the fascicle length and angle of pennation were obtained from these images. The shortening fascicle length with extension of the knee (from 98 to 13 degrees of knee angle; full extension = 0 degrees) was greater (43 mm) at 30 degrees/s than at 150 degrees/s (35 mm). Even when the angular velocity remained constant during the isokinetic range of motion, the fascicle velocity was found to change from 39 to 77 mm/s at 150 degrees/s and from 6 to 19 mm/s at 30 degrees/s. The force exerted by a fascicle changed with the length of the fascicle at changing angular velocities. The peak values of fascicle force and velocity were observed at similar to 90 mm of fascicle length. In conclusion, even if the angular velocity of knee extension is kept constant, the shortening velocity of a fascicle is dependent on the force applied to the muscle-tendon complex, and the phenomenon is considered to be caused mainly by the elongation of the elastic element (tendinous tissue).	Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo, Japan	Ichinose, Y (reprint author), Japan Womens Coll Phys Educ, Res Inst Phys Fitness, Setagaya Ku, 8-19-1 Kitakarasuyama, Tokyo 1578565, Japan.		fukunaga, tetsuo/C-6635-2009				Akima Hiroshi, 1995, Japanese Journal of Physical Fitness and Sports Medicine, V44, P267; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86; WICKIEWICZ TL, 1984, J APPL PHYSIOL, V57, P435; SPOOR CW, 1992, J BIOMECH, V25, P201, DOI 10.1016/0021-9290(92)90276-7; PERRINE JJ, 1978, MED SCI SPORT EXER, V10, P159; IVY JL, 1981, EUR J APPL PHYSIOL O, V47, P247, DOI 10.1007/BF00422470; Fukunaga T, 1997, J APPL PHYSIOL, V82, P354; LIEB FJ, 1968, J BONE JOINT SURG AM, VA 50, P1535; TAYLOR NAS, 1991, EUR J APPL PHYSIOL O, V62, P116, DOI 10.1007/BF00626766; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; BOBBERT MF, 1992, MED SCI SPORTS EXERC, V25, P251; FROESE EA, 1985, J APPL PHYSIOL, V59, P309; FUGLEVAND AJ, 1987, BIOMECHANICS A, V10, P559; Fukunaga T, 1996, J APPL PHYSIOL, V81, P1430; HARRIS RT, 1994, ACTA PHYSIOL SCAND, V152, P63, DOI 10.1111/j.1748-1716.1994.tb09785.x; HERZOG W, 1993, J ANAT, V182, P213; JAMES C, 1994, EUR J APPL PHYSIOL, V68, P41, DOI 10.1007/BF00599240; MARSHALL RN, 1990, EUR J APPL PHYSIOL O, V61, P263, DOI 10.1007/BF00357610; THORSTENSSON A, 1976, J APPL PHYSIOL, V40, P12; TRESTIK CL, 1993, J BIOMECH ENG-T ASME, V115, P225, DOI 10.1115/1.2895479; ZAJAC FE, 1992, J HAND SURG-AM, V17A, P799, DOI 10.1016/0363-5023(92)90445-U; ZUURBIER CJ, 1992, J BIOMECH, V25, P1017, DOI 10.1016/0021-9290(92)90037-2; ZUURBIER CJ, 1994, J BIOMECH, V27, P445, DOI 10.1016/0021-9290(94)90020-5	23	40	41	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	MAR	2000	88	3					851	856				6	Physiology; Sport Sciences	Physiology; Sport Sciences	291NC	WOS:000085742100007		
J	Zako, T; Deguchi, H; Kitayama, A; Ueda, H; Nagamune, T				Zako, T; Deguchi, H; Kitayama, A; Ueda, H; Nagamune, T			Refolding of firefly luciferase immobilized on agarose beads	JOURNAL OF BIOCHEMISTRY			English	Article						agarose beads; firefly luciferase; immobilization; renaturation	RETICULOCYTE LYSATE; PROTEIN	The renaturation yield of the denatured firefly luciferase decreased strongly with increasing protein concentration in a renaturation buffer, because of aggregation, In this study, firefly luciferase was immobilized on agarose beads at a high concentration, Although the protein concentration was extremely high (about 100-fold) compared to that of soluble luciferase, the renaturation yield was comparable with that for the soluble one. Thus, immobilization was shown to be effective for avoiding aggregation of firefly luciferase. It was also shown that the optimum buffer conditions for renaturation of the immobilized luciferase were the same as those for the renaturation in solution, Also, it was indicated that electrostatic interactions between a protein and the matrix have a negative effect on renaturation of the immobilized luciferase since the renaturation yield decreased at acidic pH only for the immobilized luciferase, These novel observations are described in detail in this paper.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Nagamune, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Ueda, Hiroshi/A-3515-2011; Zako, Tamotsu/C-3004-2012	Ueda, Hiroshi/0000-0001-8849-4217; 			FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; KOLB VA, 1994, EMBO J, V13, P3631; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; SCHRODER H, 1993, EMBO J, V12, P4137; Stempfer G, 1996, NAT BIOTECHNOL, V14, P329, DOI 10.1038/nbt0396-329; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; HAYASHI T, 1994, FEBS LETT, V350, P109, DOI 10.1016/0014-5793(94)00744-6; Herbst R, 1997, J BIOL CHEM, V272, P7099; HOROWITZ P, 1987, J BIOL CHEM, V262, P5587; JANOLINO V, 1985, Journal of Applied Biochemistry, V7, P33; LIGHT A, 1985, Biotechniques, V3, P298; NIMMESGERN E, 1993, FEBS LETT, V331, P25, DOI 10.1016/0014-5793(93)80290-B; PASTA P, 1980, BIOCHIM BIOPHYS ACTA, V616, P143, DOI 10.1016/0005-2744(80)90132-1; Soler G, 1997, BBA-PROTEIN STRUCT M, V1339, P167, DOI 10.1016/S0167-4838(96)00223-3	14	8	8	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	MAR	2000	127	3					351	354				4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	294UB	WOS:000085927800001		
J	Fujiwara, M; Ichinomiya, M; Motoyama, T; Horiuchi, H; Ohta, A; Takagi, M				Fujiwara, M; Ichinomiya, M; Motoyama, T; Horiuchi, H; Ohta, A; Takagi, M			Evidence that the Aspergillus nidulans class I and class II chitin synthase genes, chsC and chsA, share critical roles in hyphal wall integrity and conidiophore development	JOURNAL OF BIOCHEMISTRY			English	Article						Aspergillus nidulans; chitin synthase; conidiophore development; hyphal wall integrity; multigene family	NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; REGULATORY GENE; USTILAGO-MAYDIS; GROWTH; EXPRESSION; FUMIGATUS; ENCODES; NUCLEAR; DISRUPTION	Although many chitin synthase genes have been identified in a broad range of fungal species, there have been only a few reports about their role in fungal morphogenesis, In most cases, single gene disruption or replacement did not reveal their function, possibly because of functional redundancy among them. We obtained null mutants of Aspergillus nidulans chsA and chsC genes encoding non-essential class II and class I chitin synthases, respectively. The Delta chsA Delta chsC mutant exhibited growth defects on media supplemented with sodium dodecyl sulfate (SDS), high concentration of salts, chitin-binding dyes, or chitin synthase competitive inhibitors, suggesting loss of integrity of hyphal wall. Moreover, remarkable abnormalities of the double mutant were observed microscopically during its asexual development. The conidiophore population was drastically reduced, Interestingly, secondary conidiophores were occasionally produced from vesicles of the primary ones, The morphology of these conidiophores was similar to those of the A. nidulans developmental mutants, medusa (medA), abacus (abaA), and some kinds of bristle (brlA), lit situ staining patterns suggested that chsA was mainly expressed in the metulae, phialides, and conidia, whereas chsC was expressed in hyphae as well as conidiophores, These results suggest that ChsA and ChsC share critical functions in hyphal wall integrity and differentiation.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Horiuchi, H (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi, Tokyo 1138657, Japan.						ADAMS TH, 1990, MOL CELL BIOL, V10, P4912; ADAMS TH, 1990, P NATL ACAD SCI USA, V87, P5405, DOI 10.1073/pnas.87.14.5405; AGUIRRE J, 1993, MOL MICROBIOL, V8, P211, DOI 10.1111/j.1365-2958.1993.tb01565.x; AGUIRRE J, 1990, EXP MYCOL, V14, P290, DOI 10.1016/0147-5975(90)90026-P; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Borgia PT, 1996, FUNGAL GENET BIOL, V20, P193, DOI 10.1006/fgbi.1996.0035; Munro CA, 1998, MICROBIOL-SGM, V144, P391; Motoyama T, 1996, MOL GEN GENET, V251, P442, DOI 10.1007/s004380050188; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Takaya N, 1998, BIOSCI BIOTECH BIOCH, V62, P60, DOI 10.1271/bbb.62.60; Busby TM, 1996, GENETICS, V143, P155; FISCHER R, 1995, J CELL BIOL, V128, P485, DOI 10.1083/jcb.128.4.485; MILLER KY, 1992, GENE DEV, V6, P1770, DOI 10.1101/gad.6.9.1770; AufauvreBrown A, 1997, FUNGAL GENET BIOL, V21, P141, DOI 10.1006/fgbi.1997.0959; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; DIN AB, 1994, MICROBIOL-UK, V140, P2189; BOWEN AR, 1992, P NATL ACAD SCI USA, V89, P519, DOI 10.1073/pnas.89.2.519; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; CABIB E, 1987, ADV ENZYMOL RAMB, V59, P59; CHANG YC, 1992, GENETICS, V133, P29; CID VJ, 1995, MICROBIOL REV, V59, P345; CLUTTERBUCK AJ, 1994, MICROBIOL-UK, V140, P1169; CLUTTERB.AJ, 1969, GENETICS, V63, P317; Din AB, 1996, MOL GEN GENET, V250, P214; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; GOLD SE, 1994, MOL MICROBIOL, V11, P897, DOI 10.1111/j.1365-2958.1994.tb00368.x; HAN ST, 1993, EMBO J, V12, P2449; Heath I. B., 1990, TIP GROWTH PLANT FUN; Horiuchi H, 1999, J BACTERIOL, V181, P3721; May GS, 1992, APPL MOL GENETICS FI, P1; MELLADO E, 1995, MOL GEN GENET, V246, P353, DOI 10.1007/BF00288608; Mellado E, 1996, MOL MICROBIOL, V20, P667, DOI 10.1046/j.1365-2958.1996.5571084.x; MOTOYAMA T, 1994, BIOSCI BIOTECH BIOCH, V58, P2254; OAKLEY CE, 1987, GENE, V53, P293, DOI 10.1016/0378-1119(87)90019-9; Park IC, 1999, FEMS MICROBIOL LETT, V170, P131, DOI 10.1016/S0378-1097(98)00538-2; PRADE RA, 1993, EMBO J, V12, P2439; ROWLANDS RT, 1973, MOL GEN GENET, V126, P201, DOI 10.1007/BF00267531; Shimizu K., 1994, J CAREER ASSESSMENT, V2, P1, DOI 10.1177/106907279400200101; Sietsma JH, 1996, MICROBIOL-UK, V142, P1591; Specht CA, 1996, FUNGAL GENET BIOL, V20, P153, DOI 10.1006/fgbi.1996.0030; TIMBERLAKE WE, 1990, ANNU REV GENET, V24, P5; XoconostleCazares B, 1996, MICROBIOL-UK, V142, P377; YANAI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1828; YARDEN O, 1991, GENE DEV, V5, P2420, DOI 10.1101/gad.5.12b.2420	48	51	56	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	MAR	2000	127	3					359	366				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	294UB	WOS:000085927800003		
J	Okutsu, T; Kuroiwa, Y; Kagitani, F; Kai, M; Aisaka, K; Tsutsumi, O; Kaneko, Y; Yokomori, K; Surani, MA; Kohda, T; Kaneko-Ishino, T; Ishino, F				Okutsu, T; Kuroiwa, Y; Kagitani, F; Kai, M; Aisaka, K; Tsutsumi, O; Kaneko, Y; Yokomori, K; Surani, MA; Kohda, T; Kaneko-Ishino, T; Ishino, F			Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors	JOURNAL OF BIOCHEMISTRY			English	Article						genomic imprinting; IGF2; IGF2AS; imprinted genes; Wilms' tumor	BECKWITH-WIEDEMANN-SYNDROME; FACTOR-II GENE; DEPENDENT KINASE INHIBITOR; MOUSE IGF2; H19 GENE; P57(KIP2); REGION; 11P15; MICE; PCR	A large imprinted gene cluster in human chromosome 11p15.5 has been implicated in Beckwith-Wiedemann syndrome and Wilms' tumor. We have identified a paternally expressed imprinted gene, PEG8/IGF2AS, in this locus. It is transcribed in the opposite direction to the IGF2 transcripts and some genomic regions are shared with the IGF2 gene, as in the case of the mouse imprinted Igf2as gene reported previously by T. Moore ct al, As to the relationship between these genomic regions, the human and mouse genes are very similar but there is no homology in their middle parts. Interestingly, PEG8/ IGF2AS and IGF2 were found to be overexpressed in Wilms' tumor samples, at levels over ten and a hundred times higher than that in normal kidney tissues neighboring the tumors, respectively. These findings indicate that PEG8/IGF2AS is a good marker of Wilms' tumor and also suggest the possibility of PEG8/IGF2AS being one of the candidate Wilms' tumor genes.	Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Japan Sci & Technol Corp, JST, CREST, Kawagoe, Saitama 3320012, Japan; Teikyo Univ, Ichihara Hosp, Dept Obstet & Gynecol, Chiba 2990111, Japan; Univ Tokyo, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1130033, Japan; Saitama Canc Ctr, Ina, Saitama 3620806, Japan; Univ Tokyo, Dept Pediat Surg, Bunkyo Ku, Tokyo 1130033, Japan; Wellcome, CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Tokai Univ, Sch Hlth Sci, Isehara, Kanagawa 2591193, Japan	Ishino, F (reprint author), Tokyo Inst Technol, Ctr Gene Res, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.		Kohda, Takashi/C-2879-2014; 	Kohda, Takashi/0000-0002-6856-5601; Surani, Azim/0000-0002-8640-4318			Alders M, 1997, HUM MOL GENET, V6, P859, DOI 10.1093/hmg/6.6.859; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40; FEIL R, 1994, DEVELOPMENT, V120, P2933; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dao D, 1998, HUM MOL GENET, V7, P597, DOI 10.1093/hmg/7.4.597; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Beckwith JB, 1998, AM J MED GENET, V79, P268, DOI 10.1002/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO;2-I; BECKWITH JB, 1969, BIRTH DEFECTS, V5, P133; CATTANACH BM, 1990, DEVELOPMENT, P63; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HENRY I, 1989, HUM GENET, V81, P273; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Henry I., 1993, European Journal of Human Genetics, V1, P19; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; KUBOTA T, 1994, AM J MED GENET, V49, P378, DOI 10.1002/ajmg.1320490405; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; LITTLE M, 1991, NATURE, V351, P609, DOI 10.1038/351609a0; Mannens M., 1994, European Journal of Human Genetics, V2, P3; MANNENS M, 1990, CANCER RES, V50, P3279; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; Sapienza C, 1992, Semin Cancer Biol, V3, P151; Sun FL, 1997, NATURE, V389, P809; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TANIGUCHI T, 1995, ONCOGENE, V11, P751; TURLEAU C, 1985, ANN GENET-PARIS, V28, P93; Wang WH, 1996, J BIOL CHEM, V271, P27863; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223	54	40	47	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	MAR	2000	127	3					475	483				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	294UB	WOS:000085927800017		
J	Ikuta, T; Tachibana, T; Watanabe, J; Yoshida, M; Yoneda, Y; Kawajiri, K				Ikuta, T; Tachibana, T; Watanabe, J; Yoshida, M; Yoneda, Y; Kawajiri, K			Nucleocytoplasmic shuttling of the aryl hydrocarbon receptor	JOURNAL OF BIOCHEMISTRY			English	Article						aryl hydrocarbon (TCDD) receptor; nucleocytoplasmic shuttling; CYP1A1; AhR nuclear translocator (ARNT); leptomycin B	HEAT-SHOCK PROTEIN; AH-RECEPTOR; NUCLEAR EXPORT; DIOXIN RECEPTOR; MICE LACKING; BINDING; SIGNAL; CRM1; EXPRESSION; CLONING	The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that acts in concert with the AhR nuclear translocator (ARNT), and alters gene expression in response to environmental contaminants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), We have previously shown that AhR contains both a nuclear localization signal (NLS), AhR(13-39), and a nuclear export signal (NES), AhR(55-75), in its NH2-terminal region. In this study, we obtained direct evidence for the nucleocytoplasmic shuttling of AhR and show the biological significance of the shuttling in terms of the transcriptional activation of its target gene, CYP1A1. When AhR(13-75) fused with glutathione S-transferase (GST)-green fluorescent protein (GFP) was microinjected into the nucleus of a polykaryotic of BHK21 cell, the GST-AhR(13-75)-GFP migrated from one nucleus to the other. This event, nucleocytoplasmic shuttling, was completely inhibited in the presence of leptomycin B (LMB). The interaction between chromosome region maintenance 1 (CRM1) and endogenous AhR was shown by immunoprecipitation with antibodies to AhR followed by immunoblot analysis with antibodies to CRM1, The inhibition of the nuclear export of AhR by LMB repressed the transcriptional activation of the CYP1A1 gene. The findings suggest that nuclear-cytoplasmic shuttling of AhR is essential for the inducible expression of the CYP1A1 protein.	Saitama Canc Ctr, Res Inst, Ina, Saitama 3620806, Japan; Osaka Univ, Sch Med, Dept Anat & Cell Biol, Suita, Osaka 5650871, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo 1138657, Japan; Japan Sci & Technol, JSP, CREST, Yokohama, Kanagawa, Japan	Ikuta, T (reprint author), Saitama Canc Ctr, Res Inst, 818 Komuro, Ina, Saitama 3620806, Japan.		Yoshida, Minoru/C-8049-2014				Chang CY, 1998, MOL CELL BIOL, V18, P525; Carver LA, 1997, J BIOL CHEM, V272, P11452; WATANABE J, 1994, J BIOCHEM-TOKYO, V116, P321; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; ABBOTT BD, 1995, DEV DYNAM, V204, P133; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Freedman DA, 1998, MOL CELL BIOL, V18, P7288; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; Lees MJ, 1999, MOL CELL BIOL, V19, P5811; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; SAFE SH, 1986, ANNU REV PHARMACOL, V26, P371, DOI 10.1146/annurev.pa.26.040186.002103; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Fukuda M, 1997, NATURE, V390, P308; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; HAYASHI S, 1995, CARCINOGENESIS, V16, P1403, DOI 10.1093/carcin/16.6.1403; Bacsi SG, 1996, J BIOL CHEM, V271, P8843; Dong LQ, 1996, J BIOL CHEM, V271, P7942; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FitzGerald CT, 1996, ARCH BIOCHEM BIOPHYS, V333, P170, DOI 10.1006/abbi.1996.0378; KAWAJIRI K, 1986, EUR J BIOCHEM, V159, P219, DOI 10.1111/j.1432-1033.1986.tb09857.x; MATSUSHITA N, 1993, J BIOL CHEM, V268, P21002; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; RODORIGUEZ MS, 1999, J BIOL CHEM, V274, P9108; SWANSON HI, 1995, J BIOL CHEM, V270, P26292; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; Zhu JY, 1999, NATURE, V398, P256	40	38	39	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	MAR	2000	127	3					503	509				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	294UB	WOS:000085927800020		
J	Maganaris, CN				Maganaris, CN			In vivo measurement-based estimations of the moment arm in the human tibialis anterior muscle-tendon unit	JOURNAL OF BIOMECHANICS			English	Article						human tibialis anterior; moment arm; in vivo; reuleaux; tendon travel	ANKLE; KNEE; FLEXION; JOINT; MRI	The aim of this study was to estimate the moment arm of human tibialis anterior (TA) muscle-tendon unit at rest and during isometric dorsiflexion maximum voluntary contraction (MVC) from in vivo sagittal-plane magnetic resonance (MR) and ultrasound scans. Two methods were employed, both of them based on the assumption that the ankle joint complex and TA muscle-tendon unit operate in the sagittal plane. Using method A, moment arms were obtained from MR scans of the foot by measuring the perpendicular distance between a moving centre of rotation in the talo-crural joint and the TA tendon action line. Using method B, moment arms mere calculated from the ratio of TA tendon displacement, which was estimated from a planimetric muscle model using pennation angles and muscle thickness measured by ultrasonography, to the tibial rotation around the talus, which was measured from the foot MR scans. Using either of the two methods at rest, the estimated TA moment arm decreased from similar to 4.5 to similar to 2.9 cm in the transition from dorsiflexion to plantarflexion. Using method A, moment arms during MVC were larger by 0.9-1.5 cm (33-44%, P < 0.01) than the respective resting estimations. In contrast, no difference (P > 0.05) was found between the resting and MVC moment arm estimations of method B. Limitations in the oversimplified musculoskeletal model used raise questions for the validity of both method estimations. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Strathclyde, Scottish Sch Sport Studies, Glasgow G1 1XQ, Lanark, Scotland	Maganaris, CN (reprint author), Univ Tokyo, Dept Life Sci Sport Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.						AN KN, 1984, J BIOMECH ENG-T ASME, V106, P280; SPOOR CW, 1992, J BIOMECH, V25, P201, DOI 10.1016/0021-9290(92)90276-7; HOY MG, 1990, J BIOMECH, V23, P157, DOI 10.1016/0021-9290(90)90349-8; Fukunaga T, 1997, J BIOMECH, V30, P457, DOI 10.1016/S0021-9290(96)00171-6; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x; Maganaris CN, 1999, EUR J APPL PHYSIOL O, V79, P294, DOI 10.1007/s004210050510; CUTTS A, 1988, J ANAT, V160, P79; Isman R. E., 1969, B PROSTHET RES, V10, P97; MAGNARIS CN, 1999, CLIN BIOMECHANICS, V14, P661; PANJABI MM, 1982, J BIOMECH, V15, P537, DOI 10.1016/0021-9290(82)90007-0; REULEAUX F, 1963, KINEMATICS MACHINERY, P56; Sammarco G J, 1973, Orthop Clin North Am, V4, P75; SPOOR CW, 1990, J BIOMECH, V23, P1247, DOI 10.1016/0021-9290(90)90382-D; VANDENBOGERT AJ, 1994, J BIOMECH, V27, P1477, DOI 10.1016/0021-9290(94)90197-X	16	40	41	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	MAR	2000	33	3					375	379		10.1016/S0021-9290(99)00188-8		5	Biophysics; Engineering, Biomedical	Biophysics; Engineering	277YR	WOS:000084961600013		
J	Toda, K; Gotoh, Y; Asakura, T; Yabe, I; Furuse, H				Toda, K; Gotoh, Y; Asakura, T; Yabe, I; Furuse, H			Fluid viscosity of Aureobasidium pullulans cultures obtained at two different initial pH values	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						viscosity; Aureobasidium pullulans; exopolysaccharide solution; fluid structure	POLYSACCHARIDE PRODUCTION; EXTRACELLULAR POLYSACCHARIDE; CYANOSPIRA-CAPSULATA; BATCH CULTURE; SHEAR RATE; FERMENTATION; CYANOBACTERIA; RHEOLOGY	Aureobasidium pullulans IAM 5060 grown in media with initial pHs of 6 and 7 differed in its production of exopolysaccharides (EPS). Under the latter condition, EPS of a high molecular weight was produced in an especially large amount. The viscosity of the culture broths and the EPS solutions obtained by removing the microbial cells exhibited a marked non-Newtonian and complex behavior depending on the measurement method. The nature of the viscosity of the fluids is explained by means of several structural models of their constitutive particles.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Furuse, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						NAVARINI L, 1990, CARBOHYD POLYM, V12, P169, DOI 10.1016/0144-8617(90)90017-M; WECKER A, 1991, BIOTECHNOL LETT, V13, P155, DOI 10.1007/BF01025810; AUER DPF, 1990, APPL MICROBIOL BIOT, V32, P637, DOI 10.1007/BF00164732; CATLEY BJ, 1986, CARBOHYD RES, V153, P79, DOI 10.1016/S0008-6215(00)90197-6; CATLEY BJ, 1971, ARCH BIOCHEM BIOPHYS, V143, P138, DOI 10.1016/0003-9861(71)90193-7; Gibbs PA, 1998, APPL MICROBIOL BIOT, V49, P168, DOI 10.1007/s002530051154; Kouda T, 1996, J FERMENT BIOENG, V82, P382, DOI 10.1016/0922-338X(96)89155-0; LACROIX C, 1985, BIOTECHNOL BIOENG, V27, P202, DOI 10.1002/bit.260270216; LAPASIN R, 1992, CARBOHYD POLYM, V17, P1, DOI 10.1016/0144-8617(92)90017-K; LEDUY A, 1988, ENCY POLYM SCI ENG, V13, P650; LEDUY A, 1974, BIOTECHNOL BIOENG, V16, P61, DOI 10.1002/bit.260160106; LEE KY, 1993, BIOTECHNOL LETT, V15, P1021, DOI 10.1007/BF00129930; Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4; ONO K, 1977, AGR BIOL CHEM TOKYO, V41, P2113; POVOLO F, 1992, POLYM J, V24, P497, DOI 10.1295/polymj.24.497; REESLEV M, 1995, APPL MICROBIOL BIOT, V42, P910; RHO D, 1988, APPL MICROBIOL BIOT, V28, P361; SEVIOUR RJ, 1983, EUR J APPL MICROBIOL, V17, P178, DOI 10.1007/BF00505885; TAGUCHI R, 1973, AGR BIOL CHEM TOKYO, V37, P1583; ZAJIC JE, 1977, ENCY POLYM SCI TEC S, V2, P643	20	4	5	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723			J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2000	89	3					258	261		10.1016/S1389-1723(00)88829-5		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	312MJ	WOS:000086946800008		
J	Kawaguchi, H; Chikazu, D; Nakamura, K; Kumegawa, M; Hakeda, Y				Kawaguchi, H; Chikazu, D; Nakamura, K; Kumegawa, M; Hakeda, Y			Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						fibroblast growth factor; bone; osteoclast; prostaglandin; cyclooxygenase	OSTEOBLASTIC MC3T3-E1 CELLS; MESSENGER-RNA LEVELS; RAT LONG BONES; COLLAGEN-SYNTHESIS; MARROW CULTURES; STIMULATION; ACID; EXPRESSION; INHIBITION; INDUCTION	Fibroblast growth factor 2 (FGF-2 or basic FGF) is known to show variable actions on bone formation and bone resorption, This study was undertaken to elucidate the mechanisms whereby FGF-2 affects bone metabolism, especially bone resorption, using three different culture systems. FGF-2 at 10(-9) M and higher concentrations induced osteoclastic cell formation in the coculture system of mouse osteoblastic cells and bone marrow cells, and this induction was abrogated by nonsteroidal anti-inflammatory drugs (NSAIDs), Ca-45 release from prelabeled cultured mouse calvariae stimulated by FGF-2 (10(-8) M) was also inhibited by NSAIDs, and the inhibition was stronger by NSAIDs, which are more selective for inhibition of cyclooxygenase 2 (COX-2) than COX-1, suggesting the mediation of COX-2 induction. COX-2 was highly expressed and its messenger RNA (mRNA) level was stimulated by FGF-2 in osteoblastic cells whereas it was undetectable or not stimulated by FGF-2 in cells of osteoclast lineage. To further investigate the direct actions of FGF-2 on osteoclasts, resorbed pit formation was compared between cultures of purified osteoclasts and unfractionated bone cells from rabbit Long bones. FGF-2 (greater than or equal to 10(-12) M) stimulated resorbed pit formation by purified osteoclasts with a maximum effect of 2.0-fold at 10(-11) M, and no further stimulation was observed at higher concentrations. However, FGF-2 at 10(-9) M - 10(-8) M stimulated resorbed pit formation by unfractionated bone cells up to 9.7-fold, NS-398, a specific COX-2 inhibitor, did not affect the FGF-2 stimulation on purified osteoclasts but inhibited that on unfractionated bone cells. We conclude that FGF-2 at low concentrations (greater than or equal to 10(-12) M) acts directly on mature osteoclasts to resorb bone moderately, whereas at high concentrations (greater than or equal to 10(-9) M) it acts on osteoblastic cells to induce COX-2 and stimulates hone resorption potently.	Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan	Kawaguchi, H (reprint author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.						Manabe N, 1999, RHEUMATOLOGY, V38, P714, DOI 10.1093/rheumatology/38.8.714; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; KAWAGUCHI H, 1995, J CLIN INVEST, V96, P923, DOI 10.1172/JCI118140; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Kato T, 1998, J ORTHOPAED RES, V16, P654, DOI 10.1002/jor.1100160605; Okazaki H, 1999, CALCIFIED TISSUE INT, V64, P542, DOI 10.1007/s002239900646; Hurley MM, 1998, BONE, V22, P309, DOI 10.1016/S8756-3282(97)00292-5; Kameda T, 1996, BIOCHEM BIOPH RES CO, V220, P515, DOI 10.1006/bbrc.1996.0436; Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; KAWAGUCHI H, 1995, CLIN ORTHOP RELAT R, P36; AKATSU T, 1989, J BONE MINER RES, V4, P29; Miyamoto A, 1998, BIOCHEM BIOPH RES CO, V242, P703, DOI 10.1006/bbrc.1997.8046; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; ASPENBERG P, 1989, ACTA ORTHOP SCAND, V60, P473, DOI 10.3109/17453678909149323; CANALIS E, 1989, J ENDOCRINOL INVEST, V12, P577; CHIKAZU D, 1998, BONE S1, V23, pS244; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS DA, 1991, J BONE MINER RES, V6, P157; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; FULLER K, 1989, J BONE MINER RES, V4, P209; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539; HURLEY MM, 1994, J BIOL CHEM, V269, P9392; HURLEY MM, 1993, J BIOL CHEM, V268, P5588; HURLEY MM, 1992, ENDOCRINOLOGY, V130, P2675, DOI 10.1210/en.130.5.2675; KAWAGUCHI H, 1994, J BONE MINER RES, V9, P247; LERNER UH, 1987, CALCIFIED TISSUE INT, V40, P323, DOI 10.1007/BF02556694; MCCARTHY TL, 1989, ENDOCRINOLOGY, V125, P2118; NAGAI H, 1995, BONE, V16, P367, DOI 10.1016/8756-3282(94)00049-2; Nakamura K, 1997, J ORTHOPAED RES, V15, P307, DOI 10.1002/jor.1100150222; Nakamura K, 1998, INT ORTHOP, V22, P49, DOI 10.1007/s002640050207; Nakamura YS, 1998, STEM CELLS, V16, P229; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RODAN SB, 1989, J BIOL CHEM, V264, P19934; SIMMONS HA, 1991, J BONE MINER RES, V6, P1301; Wang J S, 1996, Acta Orthop Scand Suppl, V269, P1	40	55	56	AMER SOC BONE & MINERAL RES	DURHAM	PO BOX 2759, DURHAM, NC 27715-2759 USA	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	MAR	2000	15	3					466	473		10.1359/jbmr.2000.15.3.466		8	Endocrinology & Metabolism	Endocrinology & Metabolism	289FL	WOS:000085609800010		
J	Kiraku, J; Sugiyama, T; Ashida, T; Takahashi, N; Fujii, J; Kuro-o, M; Nagai, R				Kiraku, J; Sugiyama, T; Ashida, T; Takahashi, N; Fujii, J; Kuro-o, M; Nagai, R			Increases in intracellular calcium of arterial smooth muscle cells in transgenic mice overexpressing Na+/H+ exchanger	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						hypertension; salt; sodium-proton exchanger; calcium	SODIUM-PROTON EXCHANGE; HYPERTENSION	We produced transgenic mice overexpressing Na+/ H+ exchanger as a model of salt-sensitive hypertension and reported that dietary salt loading elevates blood pressure in these transgenic mice. We speculate that this blood pressure elevation may be attributed to the elevation of intraarterial smooth muscle Ca2+ concentration through Na+/Ca2+ exchange. To test this hypothesis, we measured the isometric tension of aortic rings and intracellular free calcium ([Ca2+](i)) of cultured smooth muscle cells. In the transgenic mice, the aortic ring contraction induced by 5 mM caffeine (percentage of 60 mM K-induced contraction) was significantly greater than control mice (60.1 +/- 5.58 vs. 44.8 +/- 3.18). The mean [Ca2+], in vascular smooth muscle cells (VSMCs) of transgenic mice (123.1 +/- 19.7 nM) was higher than those in VSMCs of control mice (66.6 +/- 7.2 nM). These observations suggest that dietary salt loading increases the concentration of calcium in arterial smooth muscle cells in this transgenic mice. These findings are helpful in tracing the causes of salt-sensitive hypertension.	Gunma Univ, Sch Med, Dept Internal Med 2, Maebashi, Gumma 3718511, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan; Univ Texas, SW Med Ctr, Dallas, TX USA	Kiraku, J (reprint author), Gunma Univ, Sch Med, Dept Internal Med 2, Maebashi, Gumma 3718511, Japan.						CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; BLAUSTEIN MP, 1988, J CARDIOVASC PHARM, V12, pS56; DIETRICH HH, 1994, AM J PHYSIOL, V266, pH1681; FEIG PU, 1987, HYPERTENSION, V9, P282; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; ELLIOTT P, 1988, BRIT MED J, V297, P319; Kiraku J, 1999, JPN J PHARMACOL, V80, P181, DOI 10.1254/jjp.80.181; KUROO M, 1995, CIRC RES, V76, P148; LIVNE A, 1987, LANCET, V1, P533; ROSSKOPF D, 1993, HYPERTENSION, V21, P607; WEBER A, 1968, J GEN PHYSIOL, V52, P750, DOI 10.1085/jgp.52.5.750	11	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0160-2446			J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	MAR	2000	35	3					511	513		10.1097/00005344-200003000-00024		3	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	288JP	WOS:000085559900024		
J	Sugiura, T; Miyauchi, S; Eguchi, S; Obata, H; Nanba, H; Fujino, Y; Masuda, K; Akura, J				Sugiura, T; Miyauchi, S; Eguchi, S; Obata, H; Nanba, H; Fujino, Y; Masuda, K; Akura, J			Analysis of liquid accumulated in the distended capsular bag in early postoperative capsular block syndrome	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article; Proceedings Paper	Symposium on Cataract, IOL and Refractive Surgery	APR, 1999	SEATTLE, WASHINGTON	IOL			INTRAOCULAR-LENS IMPLANTATION; ANTERIOR EYE SEGMENT; SODIUM HYALURONATE; CAPSULORHEXIS; DISTENSION; CHAMBER	Purpose: To analyze the transparent liquid between the posterior lens capsule and the posterior chamber intraocular lens (PC IOL) in early postoperative capsular block syndrome and discuss the mechanism of posterior capsule distention. Setting: Department of Ophthalmology, Tokyo University School of Medicine, and Tokyo,Research Institute, Seikagaku Corporation, Tokyo, Japan. Methods: This study evaluated 3 cases of capsular block syndrome presenting with,transparent liquid in the distended capsular bag 1 day after cataract surgery. The transparent liquid material between the posterior capsule and PC IOL was aspirated and analyzed using high-performance liquid chromatography (HPLC). Also, sodium hyaluronate was diluted using a dialyzer to determine whether the aqueous humor was drawn into the capsular bag by an osmotic gradient across the capsule. Results: The elution time of the samples was almost the same as that of sodium hyaluronate 1.0% (Healon(R)) The concentration of the samples ranged from 3.29 to 9.01 mg/mL by HPLC analysis. The sodium hyaluronate absorbed the physiological salt solutions through the dialyzer and expanded to 1.9 times its original volume. Conclusions: These results indicate that the main ingredient of the transparent liquid in capsular bags is sodium hyaluronate and that the distention is caused by aqueous humor being drawn into the capsular bag by an osmotic gradient across the capsule when the capsulorhexis diameter is smaller than that of the PC IOL and by viscoelastic material retained and trapped in the bag intraoperatively. J Cataract Refract Surg 2000; 26:420-425 (C) 2000 ASCRS and ESCRS.	Nihonmatsu Eye Hosp, Edogawa Ku, Tokyo 1320035, Japan; Tokyo Res Inst, Tokyo, Japan; Seikagaku Corp, Tokyo, Japan; Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo, Japan; Kushimoto Rehabilitat Ctr, Tokyo, Japan	Sugiura, T (reprint author), Nihonmatsu Eye Hosp, Edogawa Ku, 4-10-7 Hirai, Tokyo 1320035, Japan.						GIMBEL HV, 1990, J CATARACT REFR SURG, V16, P31; Eifrig DE, 1997, J CATARACT REFR SURG, V23, P450; Miyake K, 1998, J CATARACT REFR SURG, V24, P1230; DAVISON JA, 1990, J CATARACT REFR SURG, V16, P99; HOLTZ SJ, 1992, J CATARACT REFR SURG, V18, P310; IWATA S, 1985, JPN J OPHTHALMOL, V29, P187; MASKET S, 1993, J CATARACT REFR SURG, V19, P721; Miyake K, 1998, AM J OPHTHALMOL, V125, P429, DOI 10.1016/S0002-9394(99)80182-2; Miyauchi S, 1996, CURR EYE RES, V15, P131, DOI 10.3109/02713689608997405; MIYAUCHI S, 1984, CURR EYE RES, V3, P611, DOI 10.3109/02713688409003062; Nishi O, 1998, AM J OPHTHALMOL, V125, P545, DOI 10.1016/S0002-9394(99)80195-0; OTA I, 1997, JPN J OPHTHALMIC SUR, V10, P353	12	32	36	AMER SOC CATARACT REFRACTIVE SURGERY	FAIRFAX	4000 LEGATO RD, SUITE 850, FAIRFAX, VA 22030 USA	0886-3350			J CATARACT REFR SURG	J. Cataract. Refract. Surg.	MAR	2000	26	3					420	425		10.1016/S0886-3350(99)00430-7		6	Ophthalmology; Surgery	Ophthalmology; Surgery	291YU	WOS:000085768000029		
J	Kaji, Y; Amano, S; Oshika, T; Obata, H; Ohashi, T; Sakai, H; Shirasawa, E; Tsuru, T; Yamashita, H				Kaji, Y; Amano, S; Oshika, T; Obata, H; Ohashi, T; Sakai, H; Shirasawa, E; Tsuru, T; Yamashita, H			Effect of anti-inflammatory agents on corneal wound-healing process after surface excimer laser keratectomy	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							GROWTH-FACTOR BETA-1; PHOTOREFRACTIVE KERATECTOMY; STROMAL HAZE; EXPRESSION; RABBITS; COMPLICATIONS; RECEPTORS; MYOPIA	Purpose: To investigate the effect of anti-inflammatory agents on conjunctival inflammation and corneal haze formation after excimer laser keratectomy. Setting: Department of Ophthalmology, University of Tokyo Faculty of Medicine, Tokyo, Japan. Methods: After excimer laser keratectomy was performed in 21 rabbits (42 eyes), saline, betamethasone 0.1%, or diclofenac 0.1% was topically applied 6 times a day for weeks and then 3 times a day for 8 weeks. The degree of conjunctival inflammation was determined 1, 2, 3, and 7 days after the keratectomy. The degree of corneal haze was quantitatively measured using a digital analyzer before and once a week after the keratectomy. The expression of type IV collagen in the corneas at baseline and 4 and 2 weeks after the keratectomy was examined immunohistochemically. Results: Compared with saline, betamethasone and diclofenac significantly decreased early-phase conjunctival inflammation. Betamethasone significantly inhibited corneal haze formation compared with saline at 3 to 5 and 8 to 12 weeks. Diclofenac did not inhibit corneal haze formation significantly. Although betamethasone tended to be more effective in inhibiting corneal haze formation and deposition of type IV collagen than diclofenac, there was no statistical difference between the 2 anti-inflammatory agents. Conclusion: Topically applied betamethasone effectively suppressed corneal haze formation after excimer laser keratectomy. Diclofenac was not statistically effective in inhibiting corneal haze formation. J Cataract Refract Surg 2000; 26:426-431 (C) 2000 ASCRS and ESCRS.	Univ Tokyo, Fac Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan; New York State Univ, Dept Cell Biol, New York, NY USA; Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Nara, Japan; Jichi Med Sch, Dept Ophthalmol, Minami Kawachi, Tochigi, Japan; Yamagata Univ, Sch Med, Dept Ophthalmol, Yamagata 99023, Japan	Kaji, Y (reprint author), Univ Tokyo, Fac Med, Dept Ophthalmol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.						Anderson JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P54; Alio JL, 1998, J CATARACT REFR SURG, V24, P619; LATVALA T, 1995, BRIT J OPHTHALMOL, V79, P65, DOI 10.1136/bjo.79.1.65; Loewenstein A, 1997, J CATARACT REFR SURG, V23, P1174; BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L; ARSHINOFF S, 1994, J CATARACT REFR SURG, V20, P216; Frank S, 1996, J BIOL CHEM, V271, P10188; FURUKAWA H, 1997, J REFRACT SURG, V13, P457; GARTRY DS, 1992, ARCH OPHTHALMOL-CHIC, V110, P944; HANNA KD, 1989, ARCH OPHTHALMOL-CHIC, V107, P895; Kaji Y, 1998, J CATARACT REFR SURG, V24, P1441; Kaji Y, 1998, BRIT J OPHTHALMOL, V82, P462; Luo J, 1998, J NEUROCHEM, V71, P526; Mita T, 1998, GRAEF ARCH CLIN EXP, V236, P834, DOI 10.1007/s004170050168; Myers JS, 1997, J REFRACT SURG, V13, P356; NASSARALLA BA, 1995, OPHTHALMOLOGY, V102, P469; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; SOYA K, 1997, J JPN OPHTHALMOL SOC, V101, P152; Thom SB, 1997, J CATARACT REFR SURG, V23, P1324	19	16	18	AMER SOC CATARACT REFRACTIVE SURGERY	FAIRFAX	4000 LEGATO RD, SUITE 850, FAIRFAX, VA 22030 USA	0886-3350			J CATARACT REFR SURG	J. Cataract. Refract. Surg.	MAR	2000	26	3					426	431		10.1016/S0886-3350(99)00358-2		6	Ophthalmology; Surgery	Ophthalmology; Surgery	291YU	WOS:000085768000030		
J	Bannai, H; Yoshimura, M; Takahashi, K; Shingyoji, C				Bannai, H; Yoshimura, M; Takahashi, K; Shingyoji, C			Calcium regulation of microtubule sliding in reactivated sea urchin sperm flagella	JOURNAL OF CELL SCIENCE			English	Article						sliding velocity; dynein; central pair apparatus; calmodulin; quiescence; trypsin	CENTRAL-PAIR MICROTUBULES; IMPOSED HEAD VIBRATION; INNER DYNEIN ARMS; CHLAMYDOMONAS FLAGELLA; TETRAHYMENA CILIA; BEAT FREQUENCY; RADIAL SPOKES; PARAMECIUM; SPERMATOZOA; CALMODULIN	The changes in the bending pattern of flagella induced by an increased intracellular Ca2+ concentration are caused by changes in the pattern and velocity of microtubule sliding. However, the mechanism by which Ca2+ regulates microtubule sliding in flagella has been unclear To elucidate it, we studied the effects of Ca2+ on microtubule sliding in reactivated sea urchin sperm flagella that were beating under imposed head vibration, We found that the maximum microtubule sliding velocity obtainable by imposed vibration, which was about 170-180 rad/second in the presence of 250 mu M MgATP and <10(-9) M Ca2+, was decreased by 10(-6)-10(-5) M Ca2+ by about 15-20%. Similar decrease of the sliding velocity was observed at 54 and 27 mu M MgATP. The Ca2+-induced decrease of the sliding velocity was due mainly to a decrease in the reverse bend angle. When the plane of beat was artificially rotated by rotating the plane of vibration of the pipette that held the sperm head, the asymmetric bending pattern also rotated at 10(-5) M Ca2+ as well as at <10(-9) M Ca2+. The rotation of the bending pattern was observed at MgATP higher than 54 mu M (similar to 100 mu M ATP). These results indicate that the Ca2+-induced decrease of the sliding velocity is mediated by a rotatable component or components (probably the central pair) at high MgATP, but is not due to specific dynein arms on particular doublets, We further investigated the effects of a mild trypsin treatment and of trifluoperazine on the Ca2+-induced decrease in sliding velocity. Axonemes treated for 3 minutes with a low concentration (0.1 mu g/ml) of trypsin beat with a more symmetrical waveform than before the treatment. Also, their microtubule sliding velocity and reverse bend angle were not affected by high Ca2+ concentrations. Trifluoperazine (25-50 mu M) had no effect on the decrease of the sliding velocity in beating flagella at 10(-5) M Ca2+. However, the flagella that had been 'quiescent' at 10(-4) M Ca2+ resumed asymmetrical beating following an application of 10-50 mu M trifluoperazine. In such beating flagella, both the sliding velocity and the reverse bend angle mere close to their respective values at 10(-5) M Ca2+. Trypsin treatment induced a similar recovery of beating in quiescent flagella at 10(-4) M Ca2+, albeit with a more symmetrical waveform. These results provide first evidence that, at least at ATP concentrations higher than similar to 100 mu M, 10(-6)-10(-5) M Ca2+ decreases the maximum sliding velocity of microtubules in beating flagella through a trypsin-sensitive regulatory mechanism which possibly involves the central pair apparatus. They also suggest that calmodulin may be associated with the mechanism underlying flagellar quiescence induced by 10(-4) M Ca2+.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Int Christian Univ, Dept Biol, Tokyo 1818585, Japan	Shingyoji, C (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.						GIBBONS IR, 1987, NATURE, V325, P351, DOI 10.1038/325351a0; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; NAITOH Y, 1972, SCIENCE, V176, P523, DOI 10.1126/science.176.4034.523; WALTER MF, 1979, NATURE, V278, P69, DOI 10.1038/278069a0; SALE WS, 1988, J CELL BIOL, V107, P1793, DOI 10.1083/jcb.107.5.1793; SHINGYOJI C, 1991, J EXP BIOL, V156, P63; HOLWILL MEJ, 1976, J EXP BIOL, V65, P229; HYAMS JS, 1978, J CELL SCI, V33, P235; GIBBONS BH, 1972, J CELL BIOL, V54, P75, DOI 10.1083/jcb.54.1.75; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; TAKAHASHI D, 1985, CELL STRUCT FUNCT, V10, P327; TAKAHASHI K, 1991, J CELL SCI, V98, P183; BROKAW CJ, 1985, J CELL BIOL, V100, P1875, DOI 10.1083/jcb.100.6.1875; BROKAW CJ, 1985, CELL MOTIL CYTOSKEL, V5, P195; BROKAW CJ, 1977, J CELL BIOL, V75, P650, DOI 10.1083/jcb.75.3.650; BROKAW CJ, 1991, CELL MOTIL CYTOSKEL, V18, P123, DOI 10.1002/cm.970180207; BROKAW CJ, 1991, J CELL BIOL, V114, P1201, DOI 10.1083/jcb.114.6.1201; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; ESHEL D, 1989, CELL MOTIL CYTOSKEL, V14, P416, DOI 10.1002/cm.970140311; GIBBONS BH, 1980, J CELL BIOL, V84, P13, DOI 10.1083/jcb.84.1.13; GITELMAN SE, 1980, J CELL BIOL, V98, P764; GOODENOUGH UW, 1985, J CELL BIOL, V100, P2008, DOI 10.1083/jcb.100.6.2008; HABERMACHER G, 1995, CELL MOTIL CYTOSKEL, V32, P106, DOI 10.1002/cm.970320207; HOSOKAWA Y, 1987, J CELL BIOL, V105, P1297, DOI 10.1083/jcb.105.3.1297; IZUMI A, 1987, CELL MOTIL CYTOSKEL, V7, P154, DOI 10.1002/cm.970070207; KAGAMI O, 1992, J CELL SCI, V103, P653; Kamiya R., 1982, CELL MOTIL S, P169; KATADA J, 1989, CELL STRUCT FUNCT, V14, P751; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; MOGAMI Y, 1983, J CELL SCI, V61, P107; Nakamura K, 1997, NEC RES DEV, V38, P22; NAKAOKA Y, 1984, J CELL SCI, V65, P223; OHNISHI K, 1982, EXP CELL RES, V137, P217, DOI 10.1016/0014-4827(82)90022-2; OKAGAKI T, 1986, J CELL BIOL, V103, P1895, DOI 10.1083/jcb.103.5.1895; OMOTO CK, 1981, NATURE, V290, P708, DOI 10.1038/290708a0; Omoto CK, 1999, MOL BIOL CELL, V10, P1; Omoto CK, 1996, CELL MOTIL CYTOSKEL, V33, P88; OMOTO CK, 1980, J CELL BIOL, V87, P33, DOI 10.1083/jcb.87.1.33; OTTER T, 1984, CELL MOTIL CYTOSKEL, V4, P249; Sakakibara H, 1998, J CELL SCI, V111, P1155; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SHINGYOJI C, 1995, J CELL SCI, V108, P1359; SHINGYOJI C, 1991, J CELL SCI, V98, P175; SHINGYOJI C, 1995, J EXP BIOL, V198, P645; SMITH EF, 1992, SCIENCE, V257, P1557, DOI 10.1126/science.1387971; Takahashi K, 1982, Symp Soc Exp Biol, V35, P159; TANAKA M, 1988, CELL MOTIL CYTOSKEL, V9, P191, DOI 10.1002/cm.970090302; VALE RD, 1989, J CELL BIOL, V108, P2327, DOI 10.1083/jcb.108.6.2327; WALTER MF, 1981, EUR J CELL BIOL, V24, P97; YANO Y, 1980, J CELL SCI, V44, P169; Yoshimura M, 1999, CELL STRUCT FUNCT, V24, P43, DOI 10.1247/csf.24.43	52	54	54	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533			J CELL SCI	J. Cell Sci.	MAR	2000	113	5					831	839				9	Cell Biology	Cell Biology	298RL	WOS:000086152900010		
J	Boo, KS; Choi, MY; Chung, IB; Eastop, VF; Pickett, JA; Wadhams, LJ; Woodcock, CM				Boo, KS; Choi, MY; Chung, IB; Eastop, VF; Pickett, JA; Wadhams, LJ; Woodcock, CM			Sex pheromone of the peach aphid, Tuberocephalus momonis and optimal blends for trapping males and females in the field	JOURNAL OF CHEMICAL ECOLOGY			English	Article						aphid; sex pheromones; Tuberocephalus momonis; Lachnus tropicalis; Myzus lythri; Myzus dycei; Myzus persicae; attraction; gynoparae	SCHIZAPHIS-GRAMINUM; CHEMICAL ECOLOGY; PARASITOIDS; IDENTIFICATION; AGGREGATION; GREENBUG	Chemical analysis of the volatiles released by sexual females (oviparae) of the peach aphid, Tuberocephalus momonis, identified two ubiquitous aphid sex pheromone components, (4aS,7S,7aR)-nepetalactone and (4aS,7S,7aR)-nepetalactol, in a ratio of 4:1. In held trials in Korea, employing traps releasing the two compounds in differing ratios, the most effective sex pheromone blend for trapping male T momonis was found to be 85:15 nepetalactone-nepetalactol. Surprisingly, large numbers of presexual females (gynoparae) of this species were also collected when the catching rates were highest. In addition to T: momonis, over 20 other species of aphids were caught. particularly Myzus lythri, M. dycei, Lachnus tropicalis and M. persicae, in descending order of abundance.	IACR Rothamsted, Biol & Ecol Chem Dept, Harpenden AL5 2JQ, Herts, England; Nat Hist Museum, Dept Entomol, London SW7 5BD, England; Univ Tokyo, Lab Appl Entomol, Tokyo, Japan; Seoul Natl Univ, Dept Agr Biol, Suwon 441744, South Korea	Pickett, JA (reprint author), IACR Rothamsted, Biol & Ecol Chem Dept, Harpenden AL5 2JQ, Herts, England.			Choi, Man-Yeon/0000-0003-0769-380X			HARDIE J, 1994, ENTOMOL EXP APPL, V71, P95; Pickett JA, 1997, AGR ECOSYST ENVIRON, V64, P149, DOI 10.1016/S0167-8809(97)00033-9; CAMPBELL CAM, 1990, J CHEM ECOL, V16, P3455, DOI 10.1007/BF00982110; DAWSON GW, 1987, NATURE, V325, P614, DOI 10.1038/325614a0; DAWSON GW, 1989, PURE APPL CHEM, V61, P555, DOI 10.1351/pac198961030555; DAWSON GW, 1988, ENTOMOL EXP APPL, V48, P91; DAWSON GW, 1990, J CHEM ECOL, V16, P3019, DOI 10.1007/BF00979609; Dawson GW, 1996, BIOORGAN MED CHEM, V4, P351, DOI 10.1016/0968-0896(96)00012-0; EISENBACH J, 1980, J INSECT PHYSIOL, V26, P511, DOI 10.1016/0022-1910(80)90125-0; Gabrys BJ, 1997, J CHEM ECOL, V23, P1881, DOI 10.1023/B:JOEC.0000006457.28372.48; GENG W, 2000, IN PRESS ENTOMOL SIN; Hardie Jim, 1992, Chemoecology, V3, P113, DOI 10.1007/BF01370138; HARDIE J, 1991, ENTOMOL EXP APPL, V61, P97; Hardie J, 1996, PHYSIOL ENTOMOL, V21, P97, DOI 10.1111/j.1365-3032.1996.tb00841.x; Hardie J, 1997, J CHEM ECOL, V23, P2547, DOI 10.1023/B:JOEC.0000006665.05409.97; Hardie J., 1990, Chemoecology, V1, P63, DOI 10.1007/BF01325230; MARSH D, 1975, J ENTOMOL SER A, V50, P43; MARSH D, 1972, NATURE-NEW BIOL, V238, P31; Paik WH, 1972, ILLUSTRATED ENCY FAU, V13; PETTERSSON J, 1971, Entomologica Scandinavica, V2, P81; PETTERSSON J, 1970, Entomologica Scandinavica, V1, P63; Pickett J.A., 1990, P299; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; TAMAKI G, 1970, ANN ENTOMOL SOC AM, V63, P955	24	16	17	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0098-0331			J CHEM ECOL	J. Chem. Ecol.	MAR	2000	26	3					601	609		10.1023/A:1005415919226		9	Biochemistry & Molecular Biology; Ecology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology	299UE	WOS:000086215600002		
J	Finley, JP; Witek, HA				Finley, JP; Witek, HA			Diagrammatic complete active space perturbation theory: Calculations on benzene, N-2, and LiF	JOURNAL OF CHEMICAL PHYSICS			English	Article							SHELL HAMILTONIAN METHOD; AVOIDED CROSSINGS; POTENTIAL CURVES; WAVE-FUNCTIONS; BASIS-SETS; ROW ATOMS; AB-INITIO; MULTIREFERENCE; ABSORPTION; CR-2	Second-order diagrammatic complete active space perturbation theory (D-CASPT2) is designed to have the best qualities from multireference Moller-Plesset (MRMP) theory, complete active space perturbation theory CASPT2, and the effective valence shell Hamiltonian H-v method, including possessing a linked diagram theorem (LDT) and an efficient second-order formalism. The accuracy of this method is illustrated through calculations of the electronic excitation energies of N-2 and benzene, the spectroscopic constants of the N-2 ground state, and the ionic-neutral avoided crossing in the potential curves of LiF. (C) 2000 American Institute of Physics. [S0021-9606(00)30508-6].	Univ Lund, Ctr Chem, Dept Theoret Chem, S-22100 Lund, Sweden; Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	Finley, JP (reprint author), Univ Lund, Ctr Chem, Dept Theoret Chem, POB 124, S-22100 Lund, Sweden.		Witek, Henryk/A-3427-2012				ANDERSSON K, 1995, CHEM PHYS LETT, V237, P212, DOI 10.1016/0009-2614(95)00328-2; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; BRANDOW BH, 1967, REV MOD PHYS, V39, P771, DOI 10.1103/RevModPhys.39.771; NAKANO H, 1993, J CHEM PHYS, V99, P7983, DOI 10.1063/1.465674; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; SHEPPARD MG, 1981, J CHEM PHYS, V75, P4507, DOI 10.1063/1.442619; Astier R, 1969, CHEM PHYS LETT, V3, P399, DOI 10.1016/0009-2614(69)80149-1; HIRAYA A, 1991, J CHEM PHYS, V94, P7700, DOI 10.1063/1.460155; HIRAO K, 1992, CHEM PHYS LETT, V196, P397, DOI 10.1016/0009-2614(92)85710-R; NAKASHIMA N, 1980, J CHEM PHYS, V73, P5976, DOI 10.1063/1.440131; HIRAO K, 1993, CHEM PHYS LETT, V201, P59, DOI 10.1016/0009-2614(93)85034-L; ANDERSSON K, 1990, J PHYS CHEM-US, V94, P5483, DOI 10.1021/j100377a012; BAUSCHLICHER CW, 1988, J CHEM PHYS, V89, P4246, DOI 10.1063/1.455702; HIRAO K, 1992, CHEM PHYS LETT, V190, P374, DOI 10.1016/0009-2614(92)85354-D; Finley J, 1998, CHEM PHYS LETT, V288, P299, DOI 10.1016/S0009-2614(98)00252-8; BAUSCHLICHER CW, 1987, J CHEM PHYS, V86, P5595, DOI 10.1063/1.452534; Finley JP, 1998, J CHEM PHYS, V108, P1081, DOI 10.1063/1.475469; DUNNING TH, 1970, J CHEM PHYS, V53, P2823, DOI 10.1063/1.1674408; ROOS BO, 1995, CHEM PHYS LETT, V245, P215, DOI 10.1016/0009-2614(95)01010-7; WIDMARK PO, 1990, THEOR CHIM ACTA, V77, P291, DOI 10.1007/BF01120130; BLOCH C, 1958, NUCL PHYS, V6, P329, DOI 10.1016/0029-5582(58)90116-0; LINDGREN I, 1974, J PHYS B-AT MOL OPT, V7, P2441, DOI 10.1088/0022-3700/7/18/010; STEVENS JE, 1994, J CHEM PHYS, V101, P4832, DOI 10.1063/1.467406; BERKOVIC S, 1990, J CHEM PHYS, V92, P3680; Brandow B.H., 1977, ADV QUANTUM CHEM, V10, P187, DOI 10.1016/S0065-3276(08)60581-X; DOERING JP, 1969, J CHEM PHYS, V51, P2866, DOI 10.1063/1.1672424; Finley JP, 1996, PHYS REV A, V54, P343, DOI 10.1103/PhysRevA.54.343; Finley JP, 1998, J CHEM PHYS, V109, P7725, DOI 10.1063/1.477418; FINLEY JP, 1995, J CHEM PHYS, V102, P1306, DOI 10.1063/1.468919; HIRAO K, 1992, INT J QUANTUM CHEM S, V26, P517; LINDGREN I, 1986, ATOMIC MANY BODY THE; MARTIN CH, 1993, J CHEM PHYS, V99, P7833, DOI 10.1063/1.465662; ODDERSHEDE J, 1985, CHEM PHYS, V97, P303, DOI 10.1016/0301-0104(85)87039-7; Roos BO, 1996, ADV CHEM PHYS, V93, P219, DOI 10.1002/9780470141526.ch5; ROOS BO, 1992, CHEM PHYS LETT, V5, P192; Roos B.O., 1995, QUANTUM MECH ELECT S; ROOS BO, 1982, CHEM PHYS, V66, P197, DOI 10.1016/0301-0104(82)88019-1; SPIEGELMANN F, 1984, J PHYS B-AT MOL OPT, V17, P1235, DOI 10.1088/0022-3700/17/7/012; SPIEGELMANN F, 1984, J PHYS B-AT MOL OPT, V17, P1259, DOI 10.1088/0022-3700/17/7/013; Szabo A, 1982, MODERN QUANTUM CHEM	40	30	31	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	MAR 1	2000	112	9					3958	3963		10.1063/1.480947		6	Physics, Atomic, Molecular & Chemical	Physics	286QA	WOS:000085455600006		
J	Ikeda, E; Okumura, Y; Shimomura, T; Ito, K; Hayakawa, R				Ikeda, E; Okumura, Y; Shimomura, T; Ito, K; Hayakawa, R			Inclusion behavior between molecular nanotubes and linear polymer chains in aqueous solutions	JOURNAL OF CHEMICAL PHYSICS			English	Article							ALPHA-CYCLODEXTRIN; COMPLEX-FORMATION	The inclusion behavior between molecular nanotubes and linear polymer chains in aqueous solutions is experimentally investigated by measuring the optical absorption spectra of the solutions with iodine as a probe. It is found that the amount of polymer chains included into nanotubes increases with polymer length, which indicates a molecular recognition of the nanotube for the polymer length in the complex formation. Furthermore, the experimental results are compared with a theory based on the Flory-Huggins lattice model. They are in good agreement with each other and the inclusion energy between the molecular nanotube and the linear polymer chain is evaluated. (C) 2000 American Institute of Physics. [S0021-9606(00)70309-6].	Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 113, Japan	Ito, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 113, Japan.		Shimomura, Takeshi/B-9993-2013	Shimomura, Takeshi/0000-0001-9580-1019			THOMA JA, 1960, J AM CHEM SOC, V82, P4144, DOI 10.1021/ja01501a004; THOMA JA, 1958, J AM CHEM SOC, V80, P6142, DOI 10.1021/ja01555a060; HARADA A, 1993, NATURE, V364, P516, DOI 10.1038/364516a0; Ceccato M, 1997, J PHYS CHEM B, V101, P5094, DOI 10.1021/jp9638447; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039; Flory P. J., 1983, PRINCIPLES POLYM CHE; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Maeda M, 1983, NETSUSOKUTEI, V10, P103; NOLTEMEYER M, 1980, J AM CHEM SOC, V102, P2710, DOI 10.1021/ja00528a032; OKUMURA Y, UNPUB; Okumura Y, 1998, PHYS REV LETT, V80, P5003, DOI 10.1103/PhysRevLett.80.5003; PAINTER TJ, 1976, J CHEM SOC PERK T 2, P215, DOI 10.1039/p29760000215; SUKAWA H, 1989, POLYM J, V21, P403, DOI 10.1295/polymj.21.403; TAKEO K, 1972, STARKE, V24, P331, DOI 10.1002/star.19720241003; WENZ G, 1994, ANGEW CHEM INT EDIT, V33, P803, DOI 10.1002/anie.199408031	16	35	36	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	MAR 1	2000	112	9					4321	4325		10.1063/1.480978		5	Physics, Atomic, Molecular & Chemical	Physics	286QA	WOS:000085455600047		
J	Hasegawa, Y; Fujii, K; Yamada, M; Igarashi, Y; Tachibana, K; Tanaka, T; Onigata, K; Nishi, Y; Kato, S; Hasegawa, T				Hasegawa, Y; Fujii, K; Yamada, M; Igarashi, Y; Tachibana, K; Tanaka, T; Onigata, K; Nishi, Y; Kato, S; Hasegawa, T			Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article; Proceedings Paper	71st Annual Meeting of the Japan-Endocrine-Society	JUN 04, 1998	FUKUOKA, JAPAN	Japan Endocrine Soc			INSULIN-RECEPTOR SUBSTRATE-1; DEPENDENT DIABETES-MELLITUS; FACTOR-I; PITUITARY-STALK; BETA(3)-ADRENERGIC-RECEPTOR GENE; DEFICIENT PATIENTS; BONE-DENSITY; PROMOTER; BINDING; MUTATIONS	Height, which is partially determined by GH secretion, is genetically influenced. The purpose of this study was to identify polymorphisms in the GH-1 gene, which are associated with altered GH production. The subjects included prepubertal short children with GH insufficiency without gross pituitary abnormalities (n = 43), short children with normal GH secretion (n = 46), and normal adults in = 294). A polymorphism in intron 4 (P-1, A or T at base 1663) was identified. Two additional polymorphic sites (P-2, T or G at base 218, and P-3, G or T at base 439) in the promoter region of the GH-1 gene were also identified and matched with the P-1 polymorphism (A or T, respectively) in more than 90(ro of the subjects. P-1, P-2, and P-3 were considered to be associated with GH production, and the results of P-2 are explained as a representative in this abstract. For example, the allele frequency of T at P-2 in prepubertal short children with GH insufficiency without gross pituitary abnormalities (58.1%) was significantly different from that in short children with normal GH secretion and normal adults (37.0% and 43.5%, respectively, P < 0.001). Furthermore, significant differences were observed in maximal GH peaks in provocative tests (11.1 vs. 18.2 ng/mL, P = 0.006), insulin-like growth factor I so scores (SDS) (-2.4 vs. -0.8, P < 0.0001), and height (Wt) SDS (-3.7 vs. -3.0, P = 0/001) in children with the T/T or G/G genotypes at P-2, respectively. In the entire study group, significant differences in insulin-like growth factor SDS (T/T, -0.9; G/G, -0.2; P = 0.0009) and Ht SDS (T/T, -1.0; G/G, -0.4; P = 0.022) were observed between the T/T and G/G genotypes at P-2. These data indicate that GH secretion is partially determined by polymorphisms in the GH-1 gene, which explain some of the variations in GH secretion and Ht.	Tokyo Metropolitan Kiyose Childrens Hosp, Endocrinol Metab & Genet Unit, Tokyo 204, Japan; Kanagawa Childrens Hosp, Div Endocrinol & Metab, Kanagawa, Japan; Natl Childrens Med Res Ctr, Div Endocrinol & Metab, Tokyo, Japan; Gunma Univ, Dept Pediat, Maebashi, Gumma 371, Japan; Hiroshima Red Cross Hosp, Dept Pediat, Hiroshima, Japan; Univ Tokyo, Inst Mol & Cellular Biol, Tokyo, Japan; Keio Univ, Sch Med, Dept Pediat, Tokyo 108, Japan	Hasegawa, Y (reprint author), Tokyo Metropolitan Kiyose Childrens Hosp, Endocrinol Metab & Genet Unit, 1-3-1 Umezono Kiyose, Tokyo 204, Japan.	eet.phaseg@chp.kiyose.tokyo.jp	Hasegawa, Tomonobu/L-3331-2013				ALBERTSSONWIKLAND K, 1988, J CLIN ENDOCR METAB, V67, P493; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; BLUM WF, 1993, J CLIN ENDOCR METAB, V76, P1610, DOI 10.1210/jc.76.6.1610; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68; FUJISAWA I, 1987, RADIOLOGY, V165, P487; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; TANNER JM, 1970, ARCH DIS CHILD, V45, P755; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; KIKUCHI K, 1988, J CLIN ENDOCR METAB, V67, P817; BAXTER RC, 1986, ADV CLIN CHEM, V25, P49, DOI 10.1016/S0065-2423(08)60124-9; Binder G, 1996, J CLIN ENDOCR METAB, V81, P4047, DOI 10.1210/jc.81.11.4047; COGAN JD, 1993, J CLIN ENDOCR METAB, V76, P1224, DOI 10.1210/jc.76.5.1224; COGAN JD, 1995, J CLIN ENDOCR METAB, V80, P3591, DOI 10.1210/jc.80.12.3591; COHEN P, 1991, ACTA ENDOCRINOL-COP, V124, P74; DENOTO FM, 1981, NUCLEIC ACIDS RES, V9, P3719, DOI 10.1093/nar/9.15.3719; DUQUESNOY P, 1996, AM SOC HUM GENET, P430; Fujieda K., 1993, CLIN PEDIAT ENDOC S3, V2, P7, DOI 10.1297/cpe.2.Supple3_7; Giordano M, 1997, HUM GENET, V100, P249, DOI 10.1007/s004390050500; HAGER J, 1993, LANCET, V342, P1430, DOI 10.1016/0140-6736(93)92793-S; HASEGAWA T, 1995, J CLIN ENDOCR METAB, V80, P3284, DOI 10.1210/jc.80.11.3284; Hasegawa Y, 1996, EUR J ENDOCRINOL, V134, P184; HASEGAWA Y, 1994, ENDOCR J, V41, P531, DOI 10.1507/endocrj.41.531; HASEGAWA Y, 1993, CLIN PEDIATR ENDOC S, V2, P65; IGARASHI Y, 1993, HUM MOL GENET, V2, P1073, DOI 10.1093/hmg/2.7.1073; ILLIG A, 1971, ACTA PEDIAT SCAND S, V60, P607; MARTHENY AP, 1990, DEV BEHAV GENETICS N, P25; MARTIN G, 1994, J CLIN ENDOCR METAB, V79, P537; Matsuo N., 1993, CLIN PEDIAT ENDOCR S, V2, P1, DOI 10.1297/cpe.2.Supple1_1; Missarelli C, 1997, HUM GENET, V101, P113, DOI 10.1007/s004390050597; Miyata I, 1997, ENDOCR J, V44, P149, DOI 10.1507/endocrj.44.149; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; NYBORG JK, 1986, J BIOL CHEM, V261, P5018; PAI CK, 1994, J CLIN ENDOCR METAB, V78, P310; PEAK I, 1987, MOL CELL BIOL, V7, P1496; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; PHILLIPS K, 1990, ACTA GENET MED GEMEL, V39, P143; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; SLATER EP, 1985, MOL CELL BIOL, V5, P2984; SMITH DW, 1977, GROWTH ITS DISORDERS, P1; Suwa S, 1992, CLIN PEDIATR ENDOCRI, V1, P5; TAKADA M, 1994, J IMMUNOASSAY, V15, P263, DOI 10.1080/15321819408009577; TSUTOMU O, 1990, JPN J PEDIAT, V94, P1535; UNDERWOOD LE, 1980, PEDIATR CLIN N AM, V27, P771; Wagner JK, 1997, EUR J ENDOCRINOL, V137, P474, DOI 10.1530/eje.0.1370474; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Yanai K, 1997, J BIOL CHEM, V272, P30558, DOI 10.1074/jbc.272.48.30558	51	43	48	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	MAR	2000	85	3					1290	1295		10.1210/jc.85.3.1290		6	Endocrinology & Metabolism	Endocrinology & Metabolism	337WW	WOS:000088387000064		
J	Ocampo, JM; Kamata, N; Hoshino, K; Hirasawa, M; Yamada, K; Nishioka, M; Arakawa, Y				Ocampo, JM; Kamata, N; Hoshino, K; Hirasawa, M; Yamada, K; Nishioka, M; Arakawa, Y			Spectroscopic discrimination of non-radiative centers in quantum wells by two wavelength excited photoluminescence	JOURNAL OF CRYSTAL GROWTH			English	Article; Proceedings Paper	8th International Conference on Defects - Recognition, Imaging and Physics in Semiconductors	SEP 15-18, 1999	NARITA, JAPAN	Japan Soc Promot Sci, Japan Soc Appl Phys, Gakushuin Univ, Ratoc Syst Engn Co, Shin Etsu Handotai Co, Mitsubishi Mat Corp, Rigaku Corp, Sharp Corp, Mitsui Min & Smelting Co, Atago Bussan Co, NEC Corp, Japan Energy Co		photoluminescence; deep levels; nonradiative recombination; quantum well; AlGaAs	GAP; DONOR; MBE	Discrimination of non-radiative recombination centers in Si-doped GaAs/AlGaAs quantum well structures has been achieved by means of a two wavelength excited photoluminescence technique. In a crystal grown at 700 degrees C, traps were found neither in GaAs wells nor in Al0.2Ga0.8As barriers, but inside external Al0.4Ga0.6As layers which originally were left out of the doping region. These traps were classified as a pair: one originating in a lattice native defect or a residual impurity; and the other by Si atoms (possibly a DX center) diffused from the doped region. In contrast, traps were found even inside the GaAs wells in case of samples grown at 600 degrees C, reflecting deteriorated crystal quality. (C) 2000 Elsevier Science B.V. All rights reserved.	Saitama Univ, Fac Engn, Dept Funct Mat Sci, Urawa, Saitama 3388570, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Kamata, N (reprint author), Saitama Univ, Fac Engn, Dept Funct Mat Sci, 225 Shimo Ohkubo, Urawa, Saitama 3388570, Japan.						CHAND N, 1984, PHYS REV B, V30, P4481, DOI 10.1103/PhysRevB.30.4481; GRIMMEIS.HG, 1973, PHYS STATUS SOLIDI A, V19, P505, DOI 10.1002/pssa.2210190214; Hoshino K, 1998, JPN J APPL PHYS 1, V37, P3210, DOI 10.1143/JJAP.37.3210; Kamata N, 1997, SUPERLATTICE MICROST, V22, P521, DOI 10.1006/spmi.1996.0293; Kamata N, 1995, MATER SCI FORUM, V196-, P431; KAMATA N, 1993, MATER SCI FORUM, V117, P345; KAMATA N, 1999, IN PRESS RECENT RES; Kamata N, 1997, J LUMIN, V72-4, P797, DOI 10.1016/S0022-2313(97)00075-6; MONEMAR B, 1978, PHYS REV B, V18, P809, DOI 10.1103/PhysRevB.18.809; TAJIMA M, 1984, P 13 INT C DEF SEM, P997; WATANABE MO, 1984, JPN J APPL PHYS 2, V23, pL103, DOI 10.1143/JJAP.23.L103; WATANABE MO, 1984, JPN J APPL PHYS 2, V23, pL734, DOI 10.1143/JJAP.23.L734	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0248			J CRYST GROWTH	J. Cryst. Growth	MAR	2000	210	1-3					238	241				4	Crystallography; Materials Science, Multidisciplinary; Physics, Applied	Crystallography; Materials Science; Physics	294YA	WOS:000085937200049		
J	Takenaka, A; Komori, K; Morishita, T; Takahashi, SI; Hidaka, T; Noguchi, T				Takenaka, A; Komori, K; Morishita, T; Takahashi, SI; Hidaka, T; Noguchi, T			Amino acid regulation of gene transcription of rat insulin-like growth factor-binding protein-1	JOURNAL OF ENDOCRINOLOGY			English	Article							FACTOR-I; DIETARY PROTEINS; HEPATOMA-CELLS; NUTRITIONAL REGULATION; RESPONSE SEQUENCE; IGFBP-1 PROMOTER; MESSENGER-RNA; EXPRESSION; LIVER; IDENTIFICATION	To investigate the molecular mechanisms of increased transcription of the insulin-like growth factor-binding protein-1 (IGFBP-1) gene in dietary protein-deprived animals, the cis-acting sequence that is involved in this regulation was analyzed. We first: showed that IGPBP-1 gene transcription was up-regulated by amino acid deprivation in cultured liver cell lines: H4IIE and HuH-7. Since HuH-7 cells showed a greater increase in IGFBP-1 mRNA in response to amino acid deprivation, this cell line was used in further experiments. Using a promoter function assay, we found that up-regulation of promoter activity responding to amino acid deprivation was abolished by deleting the region between -112 and -81 bp from the cap site from the gene construct. This cis-acting region includes the insulin-responsive element (IRE) and glucocorticoid responsive element (GRE) of IGFBP-1. In summary, the present observation suggests that the 32-bp (-112 to -81) in the IGFBP-1 gene 5' promoter region is involved in the induction of the IGFBP-1 gene in response to amino acid deprivation.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Noguchi, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Allander SV, 1997, ENDOCRINOLOGY, V138, P4291, DOI 10.1210/en.138.10.4291; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4; POWELL DR, 1991, J BIOL CHEM, V266, P18868; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Pierreux CE, 1998, MOL ENDOCRINOL, V12, P1343, DOI 10.1210/me.12.9.1343; TAKENAKA A, 1993, BRIT J NUTR, V69, P73, DOI 10.1079/BJN19930010; BABAJKO S, 1993, BIOCHEM BIOPH RES CO, V196, P480, DOI 10.1006/bbrc.1993.2275; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; GANSS R, 1994, MOL ENDOCRINOL, V8, P895, DOI 10.1210/me.8.7.895; GUERRINI L, 1993, MOL CELL BIOL, V13, P3202; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; MARTEN NW, 1994, FASEB J, V8, P538; MIURA Y, 1992, BRIT J NUTR, V67, P257, DOI 10.1079/BJN19920029; MIURA Y, 1993, BIOSCI BIOTECH BIOCH, V57, P358; MURPHY LJ, 1990, MOL ENDOCRINOL, V4, P329; OOI GT, 1993, J BIOL CHEM, V268, P16664; OOI GT, 1990, MOL ENDOCRINOL, V4, P321; ORLOWSKI CC, 1990, ENDOCRINOLOGY, V126, P644; PAO CI, 1993, MOL ENDOCRINOL, V7, P1561, DOI 10.1210/me.7.12.1561; POWELL DR, 1989, INT CONGR SER, V881, P3; STRAUS DS, 1993, ENDOCRINOLOGY, V132, P1090, DOI 10.1210/en.132.3.1090; SUWANICHKUL A, 1990, J BIOL CHEM, V265, P21185; SUWANICKUL A, 1993, J BIOL CHEM, V268, P17063; TAKAHASHI S, 1990, BRIT J NUTR, V63, P521, DOI 10.1079/BJN19900139; Takenaka A, 1996, J ENDOCRINOL, V150, P33, DOI 10.1677/joe.0.1500033; UMEZAWA T, 1991, BRIT J NUTR, V66, P105, DOI 10.1079/BJN19910014; UNTERMAN TG, 1992, BIOCHEM BIOPH RES CO, V185, P993, DOI 10.1016/0006-291X(92)91725-6; UNTERMAN TG, 1994, BIOCHEM BIOPH RES CO, V203, P1835, DOI 10.1006/bbrc.1994.2401	32	21	21	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795			J ENDOCRINOL	J. Endocrinol.	MAR	2000	164	3					R11	R16		10.1677/joe.0.164R011		6	Endocrinology & Metabolism	Endocrinology & Metabolism	293VR	WOS:000085874500014		
J	Dou, S; Seikai, T; Tsukamoto, K				Dou, S; Seikai, T; Tsukamoto, K			Feeding behaviour of Japanese flounder larvae under laboratory conditions	JOURNAL OF FISH BIOLOGY			English	Article						feeding behaviour; Paralichthys olivaceus; attack posture; feeding rhythms and rates; food selectivity	ENVIRONMENTAL-CONDITIONS; PARALICHTHYS-OLIVACEUS; ATLANTIC SALMON; LIFE-HISTORY; RHYTHMS; SEA	Tank-reared Japanese flounder larvae, Paralichthys olivaceus, had a major feeding peak in the morning and a secondary peak in the afternoon throughout the larval development, with light being the primary factor regulating their feeding activity. The larvae consumed rotifers in preference to Artemia for up to 10 days, after which the food preference shifted to Artemia. Feeding rates of the larvae prior to 10 days post-batch depended on prey density, but in the old larvae, feeding rates were independent of prey density. Maximum feeding rate occurred at 19 degrees C. The occurrence of the attack posture, after its onset at first feeding (2 days post-hatch), increased up to 25 days, began to decrease when the larvae prepared to settle down, then disappeared after settlement. The occurrence frequency of the attack posture was positively related to fish density, but inversely related to starvation duration, and occurred most frequently at 19 degrees C. This posture depended on prey density in larvae prior to 10 days post-hatch, but became independent of prey density as the larvae developed. It was obvious that, for flounder larvae, attack posture was a behavioural character closely related to feeding and subject to larval development and environmental factors. (C) 2000 The Fisheries Society of the British Isles.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Kyoto Univ, Fac Agr, Fisheries Res Stn, Kyoto 625, Japan	Dou, S (reprint author), Chinese Acad Sci, Inst Oceanol, 7 Nanhai Rd, Qingdao 266071, Peoples R China.	szdou@ms.qdio.ac.cn					SPIELER RE, 1992, NATO ADV SCI INST SE, V236, P137; HUNTER JR, 1980, FISH B-NOAA, V78, P89; GIBSON RN, 1973, MAR BIOL, V22, P379, DOI 10.1007/BF00391398; Kadri S, 1997, J FISH BIOL, V50, P267, DOI 10.1006/jfbi.1996.0289; Dou SZ, 1995, NETH J SEA RES, V34, P195; BOUJARD T, 1992, ENVIRON BIOL FISH, V35, P109, DOI 10.1007/BF00002186; Seikai T., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P977; DOU SZ, 1999, IN PRESS AQUACULTURE; DOU SZ, 1992, MAR SCI, V4, P277; Eriksson L.-O., 1978, P69; Fukuhara O., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P81; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479; IKEWAKI Y, 1993, NIPPON SUISAN GAKK, V59, P951; IVLEV I, 1961, EXPT ECOLOGY FEEDING; Kadri S, 1997, J FISH BIOL, V50, P273, DOI 10.1006/jfbi.1996.0290; KAWAMURA G, 1985, B JPN SOC SCI FISH, V51, P155; KOHLER CC, 1980, CAN J FISH AQUAT SCI, V37, P1314, DOI 10.1139/f80-167; KUWAHARA A, 1983, B JPN SOC SCI FISH, V49, P1507; Miyazaki T, 1997, FISHERIES SCI, V63, P205; Muller K., 1978, P91; Richkus W. A., 1979, T NATL ACAD SCI US, V75, P6; YASUNAGA Y, 1985, B JPN SOC SCI FISH, V51, P227	22	26	30	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-1112			J FISH BIOL	J. Fish Biol.	MAR	2000	56	3					654	666		10.1006/jfbi.1999.1189		13	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	294MW	WOS:000085915900016		
J	Masaki, T; Muto, T				Masaki, T; Muto, T			Predictive value of histology at the invasive margin in the prognosis of early invasive colorectal carcinoma	JOURNAL OF GASTROENTEROLOGY			English	Article						malignant colorectal polyp; lymph node metastasis; rick factor; endoscopic polypectomy; local excision	ENDOSCOPIC POLYPECTOMY; MALIGNANT POLYPS; COLONIC POLYPS; METASTASIS; CANCER; ADENOMAS; RECTUM; RISK	To accurately select patients with malignant colorectal polyps who are at high risk of adverse outcome, we examined the predictive value of clinicopathological factors, with special attention paid to the histology at the invasive margin. We examined 75 submucosal carcinomas from 75 patients, initially resected by polypectomy, including endoscopic, trans-anal, trans-sacral, and trans-sphincteric local excision. The associations between clinicopathological features such as sex and age; tumor size, location, shape, depth of submucosal invasion, vascular invasion, histology at the central part, and histology at the invasive margin; and the presence or absence of a residual adenomatous component and adverse outcome were examined by univariate and multivariate logistic regression analyses. Lymph node metastases were found in 2 patients, local recurrence in 4, and distant metastases in 2. Univariate logistic regression analysis showed that unfavorable histology at the invasive margin was significantly associated with lymph node metastasis or local recurrence (P = 0.0373), whereas the association of lymphatic invasion and vascular (lymphatic or venous) invasion with lymph node metastasis or local recurrence had marginal significance (P = 0.0785; P = 0.0990). Multivariate logistic regression analysis, with unfavorable histology at the invasive margin and lymphatic invasion as independent variables, showed that unfavorable histology alone had significance (P = 0.0373) in predicting adverse outcome. Widely accepted criteria such as massive submucosal invasion, positive vascular invasion, and poorly differentiated histology, were less useful in predicting adverse outcome. These results suggest that unfavorable histology at the invasive margin is a useful risk factor for predicting lymph node metastasis or local recurrence in patients with malignant colorectal polyps.	Univ Tokyo, Dept Surg, Div Surg Oncol, Tokyo, Japan	Masaki, T (reprint author), Kyorin Univ, Dept Surg 1, 6-20-2 Shinkawa, Tokyo 1818611, Japan.						Ono M, 1996, CANCER, V78, P1179, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1179::AID-CNCR3>3.0.CO;2-5; CRANLEY JP, 1986, GASTROENTEROLOGY, V91, P419; MORSON BC, 1984, GUT, V25, P437, DOI 10.1136/gut.25.5.437; NIVATVONGS S, 1991, DIS COLON RECTUM, V34, P323, DOI 10.1007/BF02050592; GERAGHTY JM, 1991, GUT, V32, P774, DOI 10.1136/gut.32.7.774; MORSON BC, 1977, GUT, V18, P1045, DOI 10.1136/gut.18.12.1045; MULLER S, 1989, GUT, V30, P1385, DOI 10.1136/gut.30.10.1385; COVERLIZZA S, 1989, CANCER, V64, P1937, DOI 10.1002/1097-0142(19891101)64:9<1937::AID-CNCR2820640929>3.0.CO;2-X; HASE K, 1993, DIS COLON RECTUM, V36, P627, DOI 10.1007/BF02238588; Broders AC, 1920, J AMER MED ASSOC, V74, P656; CHRISTIE JP, 1988, AM SURGEON, V54, P93; COLACCHIO TA, 1981, ANN SURG, V194, P704, DOI 10.1097/00000658-198112000-00008; COOPER HS, 1983, AM J SURG PATHOL, V7, P613, DOI 10.1097/00000478-198310000-00002; FURUSAWA M, 1985, Stomach and Intestine (Tokyo), V20, P1087; HAGGITT R C, 1985, Gastroenterology, V89, P328; Morson BC, 1976, HISTOLOGICAL TYPING; MUTO T, 1991, WORLD J SURG, V15, P35; Okabe S., 1994, Journal of the Japan Society of Coloproctology, V47, P564; WILCOX GM, 1986, CANCER, V57, P160, DOI 10.1002/1097-0142(19860101)57:1<160::AID-CNCR2820570132>3.0.CO;2-N	19	36	36	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0944-1174			J GASTROENTEROL	J. Gastroenterol.	MAR	2000	35	3					195	200		10.1007/s005350050330		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	296WH	WOS:000086049400004		
J	Sato, K; Kawasaki, H; Nagayama, H; Enomoto, M; Morimoto, C; Tadokoro, K; Juji, T; Takahashi, TA				Sato, K; Kawasaki, H; Nagayama, H; Enomoto, M; Morimoto, C; Tadokoro, K; Juji, T; Takahashi, TA			TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors	JOURNAL OF IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; CD34(+) HEMATOPOIETIC PROGENITORS; LANGERHANS CELLS; TNF-ALPHA; TGF-BETA; T-CELLS; EXPRESSION; CC; ANTIGEN; LIGAND	We examined the effect of TGF-beta 1 on the chemotactic migratory ability of human monocyte-derived dendritic cells (DCs). Treatment of immature DCs with TGF-beta 1 resulted in increased expressions of CCR-1, CCR-3, CCR-5, CCR-6, and CXC chemokine receptor-4 (CXCR-4), which were concomitant with enhanced chemotactic migratory responses to their ligands, RANTES (for CCR-1, CCR-3, and CCR-5), macrophage-inflammatory protein-3 alpha (MIP-3 alpha) (for CCR-6), or stromal cell-derived growth factor-1 alpha (for CXCR-4). Ligation by TNF-alpha resulted in down-modulation of cell surface expressions of CCR-1, CCR-3, CCR-5, CCR-6, and CXCR-4, and the chemotaxis for RANTES, MIP-3 alpha, and stromal cell-derived growth factor-1 alpha, whereas this stimulation up-regulated the expression of CCR-7 and the chemotactic ability for MIP-3 beta. Stimulation of mature DCs with TGP-beta 1 also enhanced TNF-alpha-induced down-regulation of the expressions of CCR-1, CCR-3, CCR-5, CCR-6, and CXCR-4 and chemotaxis to their respective ligands, while this stimulation suppressed TNF-alpha-induced expression of CCR-7 and chemotactic migratory ability to MIP-3 beta. Our findings suggest that TGF-beta 1 reversibly regulates chemotaxis of DCs via regulation of chemokine receptor expression.	Univ Tokyo, Inst Med Sci, Dept Cell Proc, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Clin Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, AIDS Res Ctr, Minato Ku, Tokyo 1088639, Japan; Japanese Red Cross Cent Blood Ctr, Tokyo, Japan	Takahashi, TA (reprint author), Univ Tokyo, Inst Med Sci, Dept Cell Proc, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Kiefer R, 1998, J NEUROPATH EXP NEUR, V57, P385, DOI 10.1097/00005072-199805000-00002; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; LARSEN CP, 1990, J EXP MED, V171, P307, DOI 10.1084/jem.171.1.307; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Ogata M, 1999, BLOOD, V93, P3225; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Geissmann F, 1999, J IMMUNOL, V162, P4567; Rubbert A, 1998, J IMMUNOL, V160, P3933; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Lee WC, 1998, TRANSPLANTATION, V66, P1810, DOI 10.1097/00007890-199812270-00040; Strobl H, 1996, J IMMUNOL, V157, P1499; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Sozzani S, 1997, J IMMUNOL, V159, P1993; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Rollins BJ, 1997, BLOOD, V90, P909; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Sozzani S, 1998, J IMMUNOL, V161, P1083; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Sato K, 1999, J IMMUNOL, V162, P3865; Bayer EM, 1998, J HEPATOL, V28, P803, DOI 10.1016/S0168-8278(98)80230-4; Austyn J M, 1992, Semin Immunol, V4, P227; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Ayehunie S, 1997, BLOOD, V90, P1379; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Chan VWF, 1999, BLOOD, V93, P3610; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; DEEG HJ, 1988, BLOOD, V71, P1138; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; HUE FJ, 1996, NAT MED, V2, P52; Khandaker MH, 1999, BLOOD, V93, P2173; MAEDA H, 1995, J IMMUNOL, V155, P4926; MINCHALL EM, 1997, AM J RESP CELL MOL B, V17, P326; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; Sallusto F, 1996, J EXP MED, V184, P2411, DOI 10.1084/jem.184.6.2411; Sato K, 1999, BLOOD, V93, P34; Sato K, 1999, EXP HEMATOL, V27, P326, DOI 10.1016/S0301-472X(98)00046-0; Sato K, 1999, J IMMUNOL, V162, P4464; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; Steinman R M, 1991, ANNU REV IMMUNOL, V9, P271; SZABOLCS P, 1995, J IMMUNOL, V154, P5851; Yang D, 1999, J IMMUNOL, V163, P1737; Zhang Y, 1999, BLOOD, V93, P1208	48	107	114	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	MAR 1	2000	164	5					2285	2295				11	Immunology	Immunology	286YU	WOS:000085477100004		
J	Iizuka, T; Tanaka, T; Suematsu, M; Miura, S; Watanabe, T; Koike, R; Ishimura, Y; Ishii, H; Miyasaka, N; Miyasaka, M				Iizuka, T; Tanaka, T; Suematsu, M; Miura, S; Watanabe, T; Koike, R; Ishimura, Y; Ishii, H; Miyasaka, N; Miyasaka, M			Stage-specific expression of mucosal addressin cell adhesion molecule-1 during embryogenesis in rats	JOURNAL OF IMMUNOLOGY			English	Article							NONOBESE DIABETIC MICE; VASCULAR ADDRESSIN; T-CELL; MONOCLONAL-ANTIBODIES; HOMING RECEPTOR; BETA(7) INTEGRIN; LYMPH-NODES; L-SELECTIN; MADCAM-1; LYMPHOCYTES	Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is essential for lymphocyte trafficking to gut-associated lymphoid tissues and is implicated in inflammatory disorders in the gut and pancreatic islets, In this study, we examined the functional role of MAdCAM-1 during rat ontogeny using newly generated specific mAb, As previously observed in mice and humans, MAdCAM-1. was preferentially expressed in high endothelial venules (HEV) in gut-associated lymphoid tissues and venules of lamina propria in adult rats. Lymphocyte rolling and adhesion on HEV in Peyer's patches (PP) were completely abrogated with neutralizing anti-MAdCAM-1 mAb, in agreement with the notion that MAdCAM-1 is the principal HEV ligand for lymphocyte rolling and adhesion in adult PP. In the developing gastrointestinal tract, MAdCAM-1 was widely expressed in the venules of the lamina propria of fetal rats. In addition, MAdCAM-1 was also expressed in follicular dendritic cells in the neonatal PP, Interestingly, MAdCAM-1 expression was found also in nonmucosal tissues during ontogeny, MAdCAM-1 was transiently expressed in blood vascular endothelial cells in the fetal skin and neonatal thymus, Notably, MAdCAM-1-positive blood vessels were localized mainly in the cortico-medullary junction in the neonatal thymus and about 10-20% of thymocytes, most of which were either CD4, CD8 double positive or single positive specifically reacted with soluble MAdCAM-1 via integrin alpha(4)beta(7). After birth, MAdCAM-1 expression in thymus blood vessels disappeared and concomitantly, the soluble MAdCAM-1-reactive thymocytes were rapidly down-regulated. Our results suggest that MAdCAM-1 functions as a vascular addressin in not only mucosal, but also nonmucosal lymphoid tissues during ontogeny.	Osaka Univ, Grad Sch Med, Biomed Res Ctr, Dept Bioregulat, Suita, Osaka 5650871, Japan; Tokyo Med & Dent Univ, Dept Internal Med 1, Tokyo 113, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; Natl Def Med Coll, Dept Internal Med 2, Tokorozawa, Saitama, Japan; Univ Tokyo, Inst Med Sci, Dept Pathol, Tokyo, Japan	Miyasaka, M (reprint author), Osaka Univ, Grad Sch Med, Biomed Res Ctr, Dept Bioregulat, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.		Tanaka, Toshiyuki/D-1193-2010; Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336			Picarella D, 1997, J IMMUNOL, V158, P2099; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324; KUHNLEIN P, 1994, J IMMUNOL, V153, P979; BRIDEAU RJ, 1980, EUR J IMMUNOL, V10, P609, DOI 10.1002/eji.1830100807; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Yang XD, 1997, DIABETES, V46, P1542, DOI 10.2337/diabetes.46.10.1542; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; JEFFERIES WA, 1985, J EXP MED, V162, P117, DOI 10.1084/jem.162.1.117; Briskin M, 1997, AM J PATHOL, V151, P97; Cuff CA, 1998, J IMMUNOL, V161, P6853; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Szabo MC, 1997, J IMMUNOL, V158, P5584; KRAAL G, 1995, AM J PATHOL, V147, P763; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Viney JL, 1996, J IMMUNOL, V157, P2488; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Hanninen A, 1998, J IMMUNOL, V160, P6018; Iigo Y, 1997, AM J PHYSIOL-HEART C, V273, pH138; Iizuka T, 1998, BBA-GENE STRUCT EXPR, V1395, P266, DOI 10.1016/S0167-4781(97)00142-5; KONING F, 1987, SCIENCE, V236, P834, DOI 10.1126/science.2883729; McDonald SAC, 1997, IMMUNOLOGY, V91, P73, DOI 10.1046/j.1365-2567.1997.00217.x; MICHIE SA, 1995, AM J PATHOL, V147, P412; MIURA S, 1995, GASTROENTEROLOGY, V109, P1113, DOI 10.1016/0016-5085(95)90569-3; Palecanda A, 1999, J LEUKOCYTE BIOL, V65, P649; SAWADA R, 1994, J BIOL CHEM, V269, P1425; SHORTMAN K, 1987, J IMMUNOL, V138, P342; Stocker J.W., 1982, RES DISCLOSURE, V217, P155; SURH CD, 1993, J EXP MED, V177, P379, DOI 10.1084/jem.177.2.379; TAMATANI T, 1990, INT IMMUNOL, V2, P165, DOI 10.1093/intimm/2.2.165; TANAKA T, 1989, J IMMUNOL, V142, P2791	38	37	38	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	MAR 1	2000	164	5					2463	2471				9	Immunology	Immunology	286YU	WOS:000085477100025		
J	Tokuda, A; Itakura, M; Onai, N; Kimura, H; Kuriyama, T; Matsushima, K				Tokuda, A; Itakura, M; Onai, N; Kimura, H; Kuriyama, T; Matsushima, K			Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice	JOURNAL OF IMMUNOLOGY			English	Article							INDUCED PULMONARY FIBROSIS; C CHEMOKINE RECEPTOR; BRONCHOALVEOLAR LAVAGE; HOST-DEFENSE; EXPRESSION; DISEASE; CCR1; RECRUITMENT; LACKING; INJURY	We have investigated the involvement of chemokine receptor CCR1-positive cells in bleomycin-induced lung injury, a model of pulmonary fibrosis. After bleomycin challenge in C57BL/6J mice, the expression of CCR1 mRNA increased and peaked at day 7, which paralleled to the expression of its ligands, macrophage-inflammatory protein-1 alpha and RANTES, Immunohistochemical study showed that CCR1-positive cells accumulated in the interstitial inflammatory site. Furthermore, the treatment of anti-CCR1 Ab significantly reduced the accumulation of inflammatory cells and collagen deposition, resulting in dramatic improvement of survival. These results suggest that CCR1-positive cells play significant roles in the pathogenesis of pulmonary fibrosis subsequent to bleomycin-induced lung injury, and that CCR1 could be a novel molecular target for intervention therapy against pulmonary fibrosis.	Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; Chiba Univ, Sch Med, Dept Chest Med, Chiba 280, Japan	Matsushima, K (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						PIGUET PF, 1994, EUR RESPIR J, V7, P515, DOI 10.1183/09031936.94.07030515; Ogata M, 1999, BLOOD, V93, P3225; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Petrek M, 1997, EUR RESPIR J, V10, P1207, DOI 10.1183/09031936.97.10061207; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Warmington KS, 1999, AM J PATHOL, V154, P1407, DOI 10.1016/S0002-9440(10)65394-1; Murai M, 1999, J CLIN INVEST, V104, P49, DOI 10.1172/JCI6642; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Zhang SM, 1999, J IMMUNOL, V162, P4938; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Su SB, 1996, J LEUKOCYTE BIOL, V60, P658; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Piguet PF, 1997, INT J EXP PATHOL, V78, P43, DOI 10.1046/j.1365-2613.1997.d01-240.x; Boomars KA, 1998, EUR RESPIR J, V11, P1009, DOI 10.1183/09031936.98.11051009; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Gerard C, 1997, J CLIN INVEST, V100, P2022, DOI 10.1172/JCI119734; Hesselgesser J, 1998, J BIOL CHEM, V273, P15687, DOI 10.1074/jbc.273.25.15687; Keane MP, 1999, J IMMUNOL, V162, P5511; Kodama N, 1998, AM J RESP CELL MOL, V18, P526; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Ortiz LA, 1999, AM J RESP CELL MOL, V20, P825; Helene M, 1999, J Leukoc Biol, V65, P187; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P614; SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782; SMITH RE, 1994, J IMMUNOL, V153, P4704; STANDIFORD TJ, 1993, J IMMUNOL, V151, P2852; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619; Zhang K, 1997, J IMMUNOL, V158, P954; ZHANG K, 1994, J IMMUNOL, V153, P4733	31	69	73	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	MAR 1	2000	164	5					2745	2751				7	Immunology	Immunology	286YU	WOS:000085477100058		
J	Sasaki, M; Nakamura, S; Ohyama, Y; Shinohara, M; Ezaki, I; Hara, H; Kadena, T; Kishihara, K; Yamamoto, K; Nomoto, K; Shirasuna, K				Sasaki, M; Nakamura, S; Ohyama, Y; Shinohara, M; Ezaki, I; Hara, H; Kadena, T; Kishihara, K; Yamamoto, K; Nomoto, K; Shirasuna, K			Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome	JOURNAL OF IMMUNOLOGY			English	Article							TROPICAL SPASTIC PARAPARESIS; BASIC-PROTEIN PEPTIDE; RECEPTOR V-ALPHA; BETA GENE USAGE; HTLV-I; MULTIPLE-SCLEROSIS; LACRIMAL GLANDS; PROVIRAL DNA; TAX GENE; LYMPHOCYTES	To clarify the pathogenesis of human T lymphotropic virus type I (HTLV-I)-associated Sjogren's syndrome (SS), the TCR V beta gene usage by the infiltrating lymphocytes in the target organ was examined. The V beta families predominantly used in the labial salivary gland (LSG) from the HTLV-I-seropositive (HTLV-I+) SS patients were more restricted than those from the HTLV-I-seronegative (idiopathic) SS patients, and were commonly V beta 5.2, V beta 6, and V beta 7. The single-strand conformation polymorphism analysis revealed that T cell clonotypes with V beta 5.2, V beta 6, and V beta 7 accumulate in the LSG from the HTLV-I+ and idiopathic SS patients, Among junctional sequences of the most dominant V beta 7 transcripts, the conserved amino acid motif (QDXG:X is any amino acid) was found in six of the five HTLV-I+ SS patients and was also detected in two of the five idiopathic SS patients. Using the probes specific to the motif, the V beta 7 transcripts with the motif were detected in the LSG from all of the seven HTLV-I+ and five of the six idiopathic SS patients, but not from eight healthy subjects. The V beta 7 transcripts with this motif were also detected in the HTLV-I-infected T cell lines obtained from the LSG of an HTLV-I+ SS patient. The accumulation of HTLV-I-infected T cells expressing TCR with the conserved motif was thus indicated. These T cells were commonly present in patients with idiopathic SS and are strongly suggested to most likely be involved In the pathogenesis of both HTLV-I-associated and idiopathic SS.	Kyushu Univ, Fac Dent, Dept Oral & Maxillofacial Surg 2, Higashi Ku, Fukuoka 8128582, Japan; Beppu Univ, Jr Coll, Dept Food & Nutr, Oita, Japan; Kyushu Univ, Fac Med, Inst Neurol, Dept Neurol & Neuropathol, Fukuoka 812, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Immunol, Fukuoka 812, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan	Nakamura, S (reprint author), Kyushu Univ, Fac Dent, Dept Oral & Maxillofacial Surg 2, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.						ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; TERADA K, 1994, LANCET, V344, P1116, DOI 10.1016/S0140-6736(94)90630-0; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; CHOTHIA C, 1988, EMBO J, V7, P3745; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; OSAME M, 1986, LANCET, V1, P1031; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; MOCHIZUKI M, 1992, LANCET, V339, P1110, DOI 10.1016/0140-6736(92)90699-4; SUMIDA T, 1994, ARTHRITIS RHEUM, V37, P545, DOI 10.1002/art.1780370415; MARTIN R, 1991, J EXP MED, V173, P19, DOI 10.1084/jem.173.1.19; NISHIOKA K, 1989, LANCET, V1, P441; GESSAIN A, 1985, LANCET, V2, P407; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; BANKI K, 1992, P NATL ACAD SCI USA, V89, P1939, DOI 10.1073/pnas.89.5.1939; BOWNESS P, 1991, BRIT J RHEUMATOL, V30, P141; DWYER E, 1993, J CLIN INVEST, V92, P495, DOI 10.1172/JCI116593; EGUCHI K, 1992, ANN RHEUM DIS, V51, P769, DOI 10.1136/ard.51.6.769; FRANCHINI G, 1995, BLOOD, V86, P3649; FURUKAWA K, 1994, J CLIN INVEST, V94, P1830, DOI 10.1172/JCI117532; GIUSEPPINA LP, 1996, AM J HAEMATOL, V93, P287; GOLD DP, 1992, J IMMUNOL, V148, P1712; Griffiths DJ, 1997, J VIROL, V71, P2866; HARA H, 1994, J EXP MED, V180, P831, DOI 10.1084/jem.180.3.831; Homma M, 1986, Scand J Rheumatol Suppl, V61, P26; ITOYAMA Y, 1989, ANN NEUROL, V26, P257, DOI 10.1002/ana.410260212; ITOYAMA Y, 1988, NEUROLOGY, V38, P1302; KERCKHOVE CV, 1992, J EXP MED, V175, P57; KIRA J, 1991, ANN NEUROL, V29, P194, DOI 10.1002/ana.410290214; MARIETTE X, 1993, ARTHRITIS RHEUM, V36, P1423, DOI 10.1002/art.1780361015; Matsumoto I, 1996, J CLIN INVEST, V97, P1969, DOI 10.1172/JCI118629; MATSUMOTO Y, 1990, JPN J INT MED, V79, P1589; MIZUSHIMA N, 1995, CLIN EXP IMMUNOL, V101, P33; Mouri T, 1996, CANCER IMMUNOL IMMUN, V43, P10, DOI 10.1007/s002620050297; Nakamura S, 1997, J ORAL PATHOL MED, V26, P426, DOI 10.1111/j.1600-0714.1997.tb00243.x; OHYAMA Y, 1995, ORAL SURG ORAL MED O, V79, P730, DOI 10.1016/S1079-2104(05)80308-7; Ohyama Y, 1996, ARTHRITIS RHEUM, V39, P1376, DOI 10.1002/art.1780390816; Ohyama Y, 1998, ARTHRITIS RHEUM, V41, P1972, DOI 10.1002/1529-0131(199811)41:11<1972::AID-ART12>3.0.CO;2-M; SAGAWA K, 1995, J CLIN INVEST, V95, P852, DOI 10.1172/JCI117735; Scholz C, 1996, J IMMUNOL, V157, P2932; SUGIMOTO M, 1987, LANCET, V2, P1220; SUMIDA T, 1994, BRIT J RHEUMATOL, V33, P420; SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635; SUZUKI K, 1993, LAB INVEST, V69, P430; URSULA U, 1996, J VIROL, V70, P843; VERNANT JC, 1988, LANCET, V1, P177; WILEY CA, 1989, NEW ENGL J MED, V320, P992, DOI 10.1056/NEJM198904133201507; YAMAMOTO K, 1995, BIOCHEM BIOPH RES CO, V208, P1040, DOI 10.1006/bbrc.1995.1439; YAMAMOTO K, 1992, INT IMMUNOL, V4, P1219, DOI 10.1093/intimm/4.11.1219; Yamano S, 1997, J CLIN PATHOL, V50, P223, DOI 10.1136/jcp.50.3.223	50	25	26	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	MAR 1	2000	164	5					2823	2831				9	Immunology	Immunology	286YU	WOS:000085477100068		
J	Zhou, JM; Nakamatsu, Y; Kuwabara, T; Warashina, M; Tanaka, Y; Yoshinari, K; Taira, K				Zhou, JM; Nakamatsu, Y; Kuwabara, T; Warashina, M; Tanaka, Y; Yoshinari, K; Taira, K			Chemical and enzymatic probing of effector-mediated changes in the conformation of a maxizyme	JOURNAL OF INORGANIC BIOCHEMISTRY			English	Article						chronic myelogenous leukemia; maxizyme; chemical probing; alkaline hydrolysis; RNase T1	IN-VITRO SELECTION; SECONDARY STRUCTURE; HAMMERHEAD RIBOZYME; ESCHERICHIA-COLI; MESSENGER-RNA; TETRAHYMENA RIBOZYME; CATALYTIC SUBUNIT; DNA ENZYMES; CLEAVAGE; SITE	The protein encoded by chimeric BCR-ABL mRNA causes chronic myelogenous leukemia (CML). We showed previously that a novel allosterically controllable ribozyme, of the type known as a maxizyme, can cleave this mRNA, with high specificity and high-level activity in vivo. We designed the maxizyme in such a way that it was able to form an active core with which to capture the catalytically indispensable Mg2+ ions only in the presence of the BCR-ABL mRNA junction. In order to probe the putative conformational changes, we used a weakly alkaline solution (pH 9.2) in the presence of 25 mM Mg2+ ions to hydrolyze differentially phosphodiester bonds that were located in different environments. Phosphodiester bonds in single-stranded regions were clearly more susceptible to attack by alkali than those within a double-stranded helix. As indicated by earlier data obtained in vivo, our results demonstrated that the active conformation was achieved only in the presence of the junction within the chimeric BCR-ABL mRNA. Moreover, we demonstrated that the use of mild alkaline solutions to probe RNA structures is very informative. (C) 2000 Elsevier Science Inc. All rights reserved.	Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Taira, K (reprint author), Natl Inst Adv Interdisciplinary Res, 1-1-4 Higashi, Tsukuba, Ibaraki 3058562, Japan.	taira@chembio.t.u-tokyo.ac.jp	Tanaka, Yoshiyuki/B-1730-2008				Amontov SV, 1996, J AM CHEM SOC, V118, P1624, DOI 10.1021/ja9517734; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62; Zhou DM, 1998, CHEM REV, V98, P991, DOI 10.1021/cr9604292; PORTA H, 1995, BIO-TECHNOL, V13, P161, DOI 10.1038/nbt0295-161; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Warashina M, 1999, CHEM BIOL, V6, P237, DOI 10.1016/S1074-5521(99)80039-8; LEOPOLD LH, 1995, BLOOD, V85, P2162; Morita M, 1999, J BACTERIOL, V181, P401; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Kuwabara T, 1997, NUCLEIC ACIDS RES, V25, P3074, DOI 10.1093/nar/25.15.3074; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Bernal JJ, 1997, RNA, V3, P1052; PAN T, 1992, NATURE, V358, P560, DOI 10.1038/358560a0; NOWELL PC, 1960, SCIENCE, V132, P1497; SHIMAYAMA T, 1995, BIOCHEMISTRY-US, V34, P3649, DOI 10.1021/bi00011a020; Araki M, 1998, NUCLEIC ACIDS RES, V26, P3379, DOI 10.1093/nar/26.14.3379; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Felden B, 1997, RNA, V3, P89; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; HEUER TS, 1991, P NATL ACAD SCI USA, V88, P11105, DOI 10.1073/pnas.88.24.11105; [Anonymous], 1990, METHOD ENZYMOL; KAZAKOV S, 1991, P NATL ACAD SCI USA, V88, P9193, DOI 10.1073/pnas.88.20.9193; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; LAGGERBAUER B, 1994, EMBO J, V13, P2669; LANGE W, 1994, FEBS LETT, V338, P175, DOI 10.1016/0014-5793(94)80359-5; MATSUO M, 1995, J BIOL CHEM, V270, P10097; McGregor A, 1999, J BIOL CHEM, V274, P2255, DOI 10.1074/jbc.274.4.2255; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Narlikar GJ, 1997, BIOCHEMISTRY-US, V36, P2465, DOI 10.1021/bi9610820; Phillips C, 1999, NUCLEIC ACIDS RES, V27, P429, DOI 10.1093/nar/27.2.429; Tang J, 1997, RNA, V3, P914; Tang J, 1998, NUCLEIC ACIDS RES, V26, P4214, DOI 10.1093/nar/26.18.4214; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; Urvil PT, 1997, EUR J BIOCHEM, V248, P130, DOI 10.1111/j.1432-1033.1997.t01-1-00130.x; Ushida C, 1997, J BIOCHEM-TOKYO, V122, P1202; WANG JF, 1992, SCIENCE, V256, P526, DOI 10.1126/science.1315076; WRZESINSKI J, 1995, FEBS LETT, V374, P62, DOI 10.1016/0014-5793(95)01077-R; Zagorowska I, 1998, NUCLEIC ACIDS RES, V26, P3392, DOI 10.1093/nar/26.14.3392	42	11	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0162-0134	1873-3344		J INORG BIOCHEM	J. Inorg. Biochem.	MAR	2000	78	4					261	268		10.1016/S0162-0134(00)00005-2		8	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	322MN	WOS:000087513500001		
J	Woods, JM; Katschke, KJ; Volin, MV; Ruth, JH; Woodruff, DC; Amin, MA; Connors, MA; Kurata, H; Arai, KI; Koch, AE				Woods, JM; Katschke, KJ; Volin, MV; Ruth, JH; Woodruff, DC; Amin, MA; Connors, MA; Kurata, H; Arai, KI; Koch, AE			Adenoviral interleukin (IL)-4 gene therapy reduces rat adjuvant-induced arthritis (AIA) bony destruction, synovial leukocytosis, and angiogenesis	JOURNAL OF INVESTIGATIVE MEDICINE			English	Meeting Abstract									Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Univ Tokyo, Inst Med Sci, Tokyo, Japan; Vet Adm Chicago Healthcare Syst, Lakeside Div, Chicago, IL 60611 USA			Koch, Alisa/B-6894-2011					0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1081-5589			J INVEST MED	J. Invest. Med.	MAR	2000	48	2				143	205A	205A				1	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	302CE	WOS:000086346700155		
J	Woods, JM; Katschke, KJ; Volin, MV; Ruth, JH; Woodruff, DC; Amin, MA; Connors, MA; Kurata, H; Arai, KI; Koch, AE				Woods, JM; Katschke, KJ; Volin, MV; Ruth, JH; Woodruff, DC; Amin, MA; Connors, MA; Kurata, H; Arai, KI; Koch, AE			Interleukin-13 adenoviral gene therapy reduces rat adjuvant-induced arthritis (AIA) associated inflammation and bony destruction	JOURNAL OF INVESTIGATIVE MEDICINE			English	Meeting Abstract									Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Univ Tokyo, Inst Med Sci, Tokyo, Japan; Vet Adm Chicago Hlth Care Syst, Lakeside Div, Chicago, IL 60611 USA			Koch, Alisa/B-6894-2011					0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1081-5589			J INVEST MED	J. Invest. Med.	MAR	2000	48	2				144	205A	205A				1	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	302CE	WOS:000086346700156		
J	Dobashi, R				Dobashi, R			Publisher's note	JOURNAL OF LOSS PREVENTION IN THE PROCESS INDUSTRIES			English	Editorial Material									Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Dobashi, R (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.							0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-4230			J LOSS PREVENT PROC	J. Loss Prev. Process Ind.	MAR	2000	13	2					V	V				1	Engineering, Chemical	Engineering	285JP	WOS:000085386200001		
J	Takeuchi, S; Shimoyama, I				Takeuchi, S; Shimoyama, I			A three-dimensional shape memory alloy microelectrode with clipping structure for insect neural recording	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						microelectrode; neural recording; SMA thin film	NI THIN-FILMS; SILICON; ELECTRODE; STIMULATION; INTERFACE; BEHAVIOR; TISSUE; SYSTEM; MUSCLE; ARRAY	A microelectrode, with clipping structure for neural recording from a free-moving insect, was designed and fabricated using a shape memory alloy (SMA) thin film. The SMA thin films (titanium nickel; Ti-48at, %Ni) are deposited by RF magnetron sputtering and patterned by HF-HNO3 wet etching. The transformation temperatures of the SMA thin films were measured at 54 degrees C (A*) and 50 degrees C (M*). The SMA microelectrode consists of a degrees"hook" structure (720 mu m x 480 mu m) and two "C"-shape probes (600 mu m x 70 mu m). The electrode impedance is about 5 k Ohm at 1 kHz, The desired three-dimensional (3-D) shape is given to the electrode by a bonded wire, The clinging force of the electrode to the nerve is enhanced by the 3-D structures. The SMA microelectrode can clip a nerve cord tightly. The damages of the nerve by thermal actuation of the clip are not observed by physiological analysis, The neural activity from a living insect was successfully recorded with this SMA microelectrode. [423].	Univ Tokyo, Dept Mechano Informat, Tokyo 1138656, Japan	Takeuchi, S (reprint author), Univ Tokyo, Dept Mechano Informat, Tokyo 1138656, Japan.						CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505; ISHIDA A, 1995, MATER RES SOC SYMP P, V360, P381; Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L; Krulevitch P, 1996, J MICROELECTROMECH S, V5, P270, DOI 10.1109/84.546407; KOVACS GTA, 1994, IEEE T BIO-MED ENG, V41, P567, DOI 10.1109/10.293244; NAPLES GG, 1988, IEEE T BIO-MED ENG, V35, P905, DOI 10.1109/10.8670; Benard WL, 1998, J MICROELECTROMECH S, V7, P245, DOI 10.1109/84.679390; AKIN T, 1994, IEEE T BIO-MED ENG, V41, P305, DOI 10.1109/10.284958; Wolf RH, 1995, J MICROELECTROMECH S, V4, P206, DOI 10.1109/84.475547; RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3; Ishida A, 1995, MATER T JIM, V36, P1349; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; BANKS DJ, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P798, DOI 10.1109/IEMBS.1994.415149; Chen JK, 1997, IEEE T BIO-MED ENG, V44, P770; Dario P, 1997, J MICROMECH MICROENG, V7, P233, DOI 10.1088/0960-1317/7/3/041; DELCOMYN F, 1976, J INSECT PHYSIOL, V22, P1223, DOI 10.1016/0022-1910(76)90098-6; Ensell G, 1996, J MICROELECTROMECH S, V5, P117, DOI 10.1109/84.506199; Fischer H, 1996, J NEUROSCI METH, V64, P39, DOI 10.1016/0165-0270(95)00083-6; Frazier A.B., 1993, IEEE MICR EL MECH SY, P195; Grummon DS, 1995, J PHYS IV, V5, P665; HETKE JF, TRANSDUCERS 91, P764; HOOGERWERF AC, 1994, IEEE T BIO-MED ENG, V41, P1136, DOI 10.1109/10.335862; Ishida A, 1999, J ENG MATER-T ASME, V121, P2, DOI 10.1115/1.2815996; Kahn H, 1998, J MICROMECH MICROENG, V8, P213, DOI 10.1088/0960-1317/8/3/007; Kawamura Y, 1995, J PHYS IV, V5, P683; Kim C.-J., 1992, Journal of Microelectromechanical Systems, V1, DOI 10.1109/84.128053; KURIBAYASHI K, 1990, IEEE C MICR MECH SYS, P217, DOI 10.1109/MEMSYS.1990.110279; KURIBAYASHI K, 1993, IROS 93 : PROCEEDINGS OF THE 1993 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOL 1-3, P1697, DOI 10.1109/IROS.1993.583865; MIYAZAKI S, 1994, IEEE INT MICRO ELECT, P176; NAKAMURA Y, 1997, IEEE MICR EL MECH SY, P262; STIEGLITZ T, 1998, MICROSYST TECHNOL, P131; STIEGLIZ T, 1996, P ANN INT IEEE ENG M, P365; STOUT JF, 1987, Z VERGL PHYSIOL, V74, P26; Toda R, 1998, SENSOR ACTUAT A-PHYS, V66, P268, DOI 10.1016/S0924-4247(98)01701-4; YE S, 1995, J NEUROSCI METH, V60, P199, DOI 10.1016/0165-0270(95)00013-K	35	54	55	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1057-7157			J MICROELECTROMECH S	J. Microelectromech. Syst.	MAR	2000	9	1					24	31		10.1109/84.825773		8	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	293MY	WOS:000085857600004		
J	Hoshino, K; Mura, F; Shimoyama, I				Hoshino, K; Mura, F; Shimoyama, I			Design and performance of a micro-sized biomorphic compound eye with a scanning retina	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						compound eye; microlens array; optical flow; photodiode; piezoelectric actuator; scanning retina	VISION; CHIPS	In this paper, we propose a design of a biomorphic micro visual sensor equipped with a mechanical scanning system. The sensor is inspired by the structure of the fly's compound eye, which was found to possess a unique muscle and tendon actuation system for its scanning retina. The improvement in micro-opto-electro-mechanical systems encourages the design of reliable, efficient, and integrated smart visual sensors for robotic applications, in particular, for the autonomous visually guided navigation of mobile robots. We have verified the effect of retinal scanning for a robotic visual system through the construction of a large-scale prototype at the millimeter scale. The performance of a newly fabricated microelectromechanical system prototype whose size approaches the order of the insects' compound eyes is then evaluated in comparison with that of the large-scale prototype. The micro-sized visual sensor is composed of a scanning microlens array (120 mu m in lens diameter) and a photo-diode array. The actuation of the microlens array induces a rotation of the visual axes. According to the principle of retinal scanning, the micro-sensor is able to retrieve the local angular velocity with enhanced reliability. [445].	Univ Tokyo, Dept Mechano Informat, Tokyo 1138656, Japan	Hoshino, K (reprint author), Univ Tokyo, Dept Mechano Informat, Tokyo 1138656, Japan.		Hoshino, Kazunori/C-3988-2014	Hoshino, Kazunori/0000-0002-7080-7825			Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; BERNARD T, P IROS 97 GREN FRANC, P752; FRANCESCHINI N, 1994, P 22 GOTT NEUR C, P268; FRANCESCHINI N, 1992, PHILOS T ROY SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; Hausen K., 1993, VISUAL MOTION ITS RO, P203; HORRIDGE GA, 1978, PHILOS T ROY SOC B, V285, P1, DOI 10.1098/rstb.1978.0093; Hoshino K., 1998, Proceedings. 1998 IEEE International Conference on Robotics and Automation (Cat. No.98CH36146), DOI 10.1109/ROBOT.1998.677389; IKEDA I, 1993, 7 INT C SOL STAT SEN, P128; KIMACHI T, 1998, 16 SENS TECH S, P171; KOBAYASHI H, 1995, NEURAL NETWORKS, V8, P87, DOI 10.1016/0893-6080(94)00058-T; KOBAYASHI M, P IEEE LEOS MOEMS 97, P171; Land M.F., 1989, P90; LANGE E, 1994, IEEE MICRO, V14, P29, DOI 10.1109/40.331383; Mead C., 1989, ANALOG VLSI NEURAL S; Mura F, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P47, DOI 10.1109/IVS.1996.566350; MURA F, 1996, P IEEE ICRA LEUVEN B, P1859; NUSSBAUM P, 1996, P EUR S LAS OPT VIS, V2783, P1; QUESTA P, P IROS 96, P1622; SNYDER AW, 1979, HDB SENSORY PHYSL, V7, P215; TOSHIYOSHI H, 1993, 7 INT C SOL STAT SEN, P128; WAGNER H, 1986, PHILOS T R SOC LON B, V330, P312; WEHNER R, 1981, HDB SENSORY PHYSL, V7, P551; YASUDA T, 1997, J MICROELECTROMECH S, V7, P90	24	18	18	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1057-7157			J MICROELECTROMECH S	J. Microelectromech. Syst.	MAR	2000	9	1					32	37		10.1109/84.825774		6	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	293MY	WOS:000085857600005		
J	Suzuki, E; Rose, D; Chiba, A				Suzuki, E; Rose, D; Chiba, A			The ultrastructural interactions of identified pre- and postsynaptic cells during synaptic target recognition in Drosophila embryos	JOURNAL OF NEUROBIOLOGY			English	Article						fasciclin III; growth cone; microprocess; synaptogenesis; Toll	GROWTH CONE GUIDANCE; AXON GUIDANCE; NEUROMUSCULAR-JUNCTION; ADHESION MOLECULES; FASCICLIN-III; CHOICE POINTS; MOTOR; MECHANISMS; PROTEIN; SYNAPTOGENESIS	During the development of neural networks, what sets synaptogenic interactions apart from nonsynaptogenic interactions is not well understood at the subcellular level. Using a combination of intracellular dye injection and electron microscopy, we show that a specific motoneuron (RP3) and its synaptic partners (muscles 6 and 7), both often bearing microprocesses, develop intimate membrane contact sites characterized by junctional structures, prior to their initiating synaptogenesis in Drosophila embryos, Other motoneuron growth cones that extend alongside the RP3 growth cone to innervate surrounding muscles do not form such contacts with muscles 6 and 7, We also examined how specific target recognition molecules affect the development of these ultrastructural associations between synaptic partner cells. When Fasciclin III (Fas3), a "positive" target recognition molecule for RP3, is ectopically expressed in neighboring muscles, the RP3 growth cone ectopically develops membrane contact sites with Fas3-misexpressing muscles with which it would not normally associate. In contrast, when Toll, a "negative" target recognition molecule normally expressed by a subset of muscles that surrounds muscles 6 and 7, is misexpressed on muscles 6 and 7, the RP3 growth cone fails to exhibit its normal close contact with these muscles. We propose that the formation of close membrane associations and junctional structures can be regulated under the influence of synaptic target recognition molecules and signifies the beginning of subcellular events during synaptic target recognition. (C) 2000 John Wiley & Sons, Inc.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Tokyo 1088639, Japan; JST, CREST, Kyoto, Japan	Chiba, A (reprint author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.						Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; HAYDON PG, 1995, TRENDS NEUROSCI, V18, P196, DOI 10.1016/0166-2236(95)93901-9; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; Landgraf M, 1997, J NEUROSCI, V17, P9642; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; Chiba A, 1996, DEV BIOL, V180, P424, DOI 10.1006/dbio.1996.0316; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545; BROADIE K, 1993, DEVELOPMENT, P227; CHIBA A, 1999, NEUROMUSCULAR JUNCTI, P1; CHIBA A, 1993, J NEUROSCI, V13, P714; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Chiba A, 1998, BIOESSAYS, V20, P941, DOI 10.1002/(SICI)1521-1878(199811)20:11<941::AID-BIES9>3.0.CO;2-D; Fawcett D.W., 1981, CELL; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; HALPERN ME, 1991, J NEUROSCI, V11, P3227; KESHISHIAN H, 1993, TRENDS NEUROSCI, V16, P278, DOI 10.1016/0166-2236(93)90182-L; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Kose H, 1997, DEVELOPMENT, V124, P4143; LUBKE J, 1993, MICROSC RES TECHNIQ, V24, P2, DOI 10.1002/jemt.1070240103; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Nose A, 1997, DEVELOPMENT, V124, P1433; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; O'Leary DDM, 1999, CELL, V96, P255; Peters A, 1991, FINE STRUCTURE NERVO; PROKOP A, 1999, IN PRESS CELL TISSUE; Rose D, 1999, J NEUROSCI, V19, P4899; Rose D, 1997, DEVELOPMENT, V124, P1561; SCHMID A, 1999, IN PRESS DEVELOPMENT; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SINK H, 1991, DEVELOPMENT, V112, P307; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wolf B, 1998, DEVELOPMENT, V125, P3853; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	46	11	11	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0022-3034			J NEUROBIOL	J. Neurobiol.	MAR	2000	42	4					448	459		10.1002/(SICI)1097-4695(200003)42:4<448::AID-NEU6>3.0.CO;2-H		12	Neurosciences	Neurosciences & Neurology	290BJ	WOS:000085656200006		
J	Darmanto, W; Inouye, M; Takagishi, Y; Ogawa, M; Mikoshiba, K; Murata, Y				Darmanto, W; Inouye, M; Takagishi, Y; Ogawa, M; Mikoshiba, K; Murata, Y			Derangement of Purkinje cells in the rat cerebellum following prenatal exposure to X-irradiation: Decreased reelin level is a possible cause	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						cerebellum; extracellular matrix protein; foliation; Purkinje cell; radiation; reelin	MUTANT MOUSE; GENE; EXPRESSION; PROTEIN; MICE; CR-50; ORGANIZATION; ANTIBODY; NEURONS; ANTIGEN	It has been reported that prenatal X-irradiation of rats during the late gestation period causes heterotopic Purkinje cells in the internal granular layer (IGL) of the abnormally foliated cerebellum. The present study was designed to demonstrate the process of X-ray-induced derangement of Purkinje cells and their surrounding cells. In addition, the expression of some morphoregulatory molecules was examined to determine which molecules are involved in the abnormal pattern of Purkinje cells. Pregnant rats (n = 22) were exposed to 2.5 Gy X-radiation on gestation day 21 and the cerebellum of progeny was examined histologically and by immunohistochemistry to identify Purkinje and Bergmann cells. At 12 h after exposure, extensive cell death was observed in the external granular layer (EGL). By postnatal day (P) 9, while Purkinje cells with well-developed dendrites aligned underneath the EGL in the control cerebellum, Purkinje cells with shorter and abnormally oriented dendrites failed to align and remained in the heterotopic location in the IGL. Bergmann cells and their fibers were also disoriented but later recovered in their proper position. Abnormal folia developed in the irradiated rats. Using immunohistochemistry, we next examined the levels of the neural cell adhesion molecule (NCAM), fibronectin, tenascin, and Reelin. Among them, only the level of Reelin was affected significantly. Reelin decreased strikingly in the premigratory zone of the EGL and IGL in the irradiated cerebellum on P1, and dr decrease continued until P9. Decreased Reelin expression was demonstrated quantitatively by Northern blot analysis and the correlation between the mRNA and protein levels was well presented. The expression of reelin mRNA decreased significantly by irradiation from PO, bring almost one third of the level in controls on P4, and tended to recover up to P9. It is thus indicated that X-irradiation causes a marked decrease in the level of Reelin at the critical stage for the alignment of Purkinje cells. Since Reelin has been shown to play an important role in the migration of neural cells, it is suggested that the decrease in Reelin by X-irradiation is an important factor for the derangement of Purkinje cells.	Nagoya Univ, Environm Med Res Inst, Dept Teratol & Genet, Chikusa Ku, Nagoya, Aichi 4648601, Japan; RIKEN, Brain Sci Inst, Wako, Saitama, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan	Inouye, M (reprint author), Nagoya Univ, Environm Med Res Inst, Dept Teratol & Genet, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.						OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Sato M, 1996, J RHEUMATOL, V23, P432; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; ALTMAN J, 1978, J COMP NEUROL, V179, P49, DOI 10.1002/cne.901790105; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Goldowitz D, 1997, J NEUROSCI, V17, P8767; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077; YUASA S, 1991, ANAT EMBRYOL, V184, P195, DOI 10.1007/BF01673256; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COWEN D, 1960, J NEUROPATH EXP NEUR, V19, P488, DOI 10.1097/00005072-196010000-00002; CROSSIN KL, 1990, EXP NEUROL, V109, P6, DOI 10.1016/S0014-4886(05)80004-4; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3<235::AID-BIES7>3.3.CO;2-4; Darmanto Win, 1997, Environmental Medicine (Nagoya), V41, P93; GOFFINET AM, 1983, ANAT EMBRYOL, V168, P73, DOI 10.1007/BF00305400; GOFFINET AM, 1984, DEV BRAIN RES, V16, P263, DOI 10.1016/0165-3806(84)90031-2; GOLDOWITZ D, 1990, DEV BRAIN RES, V52, P151, DOI 10.1016/0165-3806(90)90230-V; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; INOUYE M, 1979, TERATOLOGY, V20, P353, DOI 10.1002/tera.1420200306; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MIKOSHIBA K, 1980, DEV BIOL, V79, P64, DOI 10.1016/0012-1606(80)90073-1; Miyata T, 1996, J COMP NEUROL, V372, P215; Miyata T, 1997, J NEUROSCI, V17, P3599; MURATA Y, 1990, MOL ENDOCRINOL, V4, P693; SEKI T, 1991, ANAT EMBRYOL, V184, P395, DOI 10.1007/BF00957900; SHELDON M, 1997, EMBO J, V16, P121; Yoneshima H, 1997, NEUROSCI RES, V29, P217, DOI 10.1016/S0168-0102(97)00088-6	27	6	6	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAR	2000	59	3					251	262				12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	292KW	WOS:000085794100008		
J	Nakagami, Y; Abe, K; Nishiyama, N; Matsuki, N				Nakagami, Y; Abe, K; Nishiyama, N; Matsuki, N			Laminin degradation by plasmin regulates long-term potentiation	JOURNAL OF NEUROSCIENCE			English	Article						plasmin; long-term potentiation; hippocampus; laminin; extracellular matrix; synaptic plasticity; organotypic culture	CELL-ADHESION MOLECULES; NEURONAL DEGENERATION; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; GROWTH-FACTOR; LATE-PHASE; ACTIVATOR; TISSUE; BRAIN; MICE	Plasmin is converted from its zymogen plasminogen by tissue type or urokinase type plasminogen activator (PA) and degrades many components of the extracellular matrix (ECM). To explore the possibility that the PA-plasmin system regulates synaptic plasticity, we investigated the effect of plasmin on degradation of ECM and synaptic plasticity by using organotypic hippocampal cultures. High-frequency stimulation produced long-term potentiation (LTP) in control slices, whereas the potentiation was induced but not maintained in slices pretreated with 100 nM plasmin for 6 hr. The baseline synaptic responses were not affected by pretreatment with plasmin. The impairment of LTP maintenance was not observed in slices pretreated with 100 nM plasmin for 6 hr, washed, and then cultured for 24-48 hr in the absence of plasmin. To identify substrates of plasmin, the expression of three major components of ECM, laminin, fibronectin, and type IV collagen, was investigated by immunofluorescence imaging. The three ECM components were widely distributed in the hippocampus, and only laminin was degraded by plasmin pretreatment. The expression level of laminin returned to normal levels when the slices were cultured for 24-48 hr after washout of plasmin. Furthermore, preincubation with anti-laminin antibodies prevented both the degradation of laminin and the impairment of LTP maintenance by plasmin. These results suggest that the laminin-mediated cell-ECM interaction may be necessary for the maintenance of LTP.	Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan	Matsuki, N (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; PAULSSON M, 1988, EUR J BIOCHEM, V177, P477, DOI 10.1111/j.1432-1033.1988.tb14397.x; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Nakagami Y, 1997, JPN J PHARMACOL, V75, P319, DOI 10.1254/jjp.75.319; Frey U, 1996, J NEUROSCI, V16, P2057; Tsirka SE, 1997, J NEUROSCI, V17, P543; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; MARS WM, 1993, AM J PATHOL, V143, P949; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; WARE JH, 1995, J NEUROBIOL, V28, P9, DOI 10.1002/neu.480280103; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; PLOW EF, 1995, FASEB J, V9, P939; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Staubli U, 1998, J NEUROSCI, V18, P3460; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; SUMI Y, 1992, DEVELOPMENT, V116, P625; Patton BL, 1998, NATURE, V393, P698; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Lauri SE, 1999, J NEUROSCI, V19, P1226; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P417, DOI 10.1002/hipo.450030404; Bahr BA, 1997, J NEUROSCI, V17, P1320; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; MEIRI N, 1994, P NATL ACAD SCI USA, V91, P3196, DOI 10.1073/pnas.91.8.3196; Mizutani A, 1997, BRAIN RES, V761, P93, DOI 10.1016/S0006-8993(97)00338-7; Mizutani A, 1996, BRAIN RES, V739, P276, DOI 10.1016/S0006-8993(96)00834-7; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NATHAN T, 1990, BRAIN RES, V531, P55, DOI 10.1016/0006-8993(90)90757-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; SALONEN EM, 1984, FEBS LETT, V172, P29, DOI 10.1016/0014-5793(84)80866-2; SHEA TB, 1992, FEBS LETT, V307, P190, DOI 10.1016/0014-5793(92)80765-9; STAUBLI U, 1990, BEHAV NEURAL BIOL, V53, P1, DOI 10.1016/0163-1047(90)90712-F; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Xiao P, 1991, Neuroreport, V2, P461, DOI 10.1097/00001756-199108000-00013; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I	43	95	104	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 1	2000	20	5					2003	2010				8	Neurosciences	Neurosciences & Neurology	286TR	WOS:000085462600037		
J	Shin, M; Nishihara, T; Iai, S; Eguchi, T				Shin, M; Nishihara, T; Iai, S; Eguchi, T			Benign aqueductal cyst causing bilateral internuclear ophthalmoplegia after external ventricular drainage - Case report	JOURNAL OF NEUROSURGERY			English	Article						aqueductal cyst; internuclear ophthalmoplegia; neuroendoscope	MALFORMATION; DISTORTION; STENOSIS; MR	The introduction of magnetic resonance (MR) imaging to the field of neuroimaging has allowed detection of various lesions that cause aqueductal stenosis. The authors report the case of a 3-year-old boy in whom a benign ventricular cyst developed in the aqueduct. The patient became drowsy after having complained of headache and vomiting, MR imaging revealed mild triventricular dilation and a normal-sized fourth ventricle. Repeated MR imaging performed 1 week later revealed an aqueductal cyst that had markedly enlarged during the intervening period. An external ventricular drainage system was installed, but recovery of consciousness in the child was unsatisfactory and a new bilateral internuclear ophthalmoplegia developed. Fenestration of the cyst wall and placement of a ventriculocisternostomy in the third ventricle were performed simultaneously by using a flexible neuroendoscope. By 2 weeks postsurgery, the patient's neurological symptoms had completely resolved. This case illustrates that simple rerouting of ventricular cerebrospinal fluid (CSF) can aggravate the symptoms of this rare lesion by causing severe compression of periaqueductal structures by a cyst that main rains a high intracystic pressure. Endoscopic surgery was an excellent choice of treatment to achieve both cyst fenestration and normalization of intracranial CSF pressure by creating a ventriculocisternostomy.	Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; Kameda Gen Hosp, Dept Neurosurg, Kamogawa, Japan	Shin, M (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						NISHIZAKI T, 1985, NEUROSURGERY, V17, P822; ARNOLD AC, 1990, NEUROLOGY, V40, P1850; Blackmore CC, 1996, AM J NEURORADIOL, V17, P458; FISHER CM, 1967, J NEUROL NEUROSUR PS, V30, P383, DOI 10.1136/jnnp.30.5.383; Santamarta D, 1995, MINIM INVAS NEUROSUR, V38, P133, DOI 10.1055/s-2008-1053473; REKATE HL, 1992, PEDIATR NEUROSURG, V18, P257, DOI 10.1159/000120672; WOODY RC, 1985, J CLIN NEURO-OPHTHAL, V5, P124; ARNOLD AC, 1990, J CLIN NEURO-OPHTHAL, V10, P278; BARKOVICH AJ, 1989, AM J NEURORADIOL, V10, P471; BINITIE O, 1984, J NEUROL NEUROSUR PS, V47, P1066, DOI 10.1136/jnnp.47.10.1066; Cinalli G, 1999, J NEUROSURG, V90, P227, DOI 10.3171/jns.1999.90.2.0227; COGAN DG, 1970, NEUROLOGY, V20, P629; Flipse JP, 1997, J NEUROL SCI, V148, P53, DOI 10.1016/S0022-510X(96)05330-0; GASS A, 1997, J NEUROL NEUROSUR PS, V6, P564; HALLER KA, 1990, OPHTHALMOLOGY, V97, P1162; LEE BCP, 1987, CLIN RADIOL, V38, P527, DOI 10.1016/S0009-9260(87)80145-9; OKA K, 1993, SURG NEUROL, V40, P230, DOI 10.1016/0090-3019(93)90072-9; PASCUALCASTROVIEJO I, 1991, CHILD NERV SYST, V7, P257, DOI 10.1007/BF00299008; WATANABE A, 1991, J NEUROSURG, V75, P960, DOI 10.3171/jns.1991.75.6.0960; WILLIAMS B, 1975, CHILD BRAIN, V1, P364	20	10	10	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2000	92	3					490	492		10.3171/jns.2000.92.3.0490		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	285DX	WOS:000085375400021		
J	Konishi, T; Asano, T; Ishii, Y; Soga, K; Inoue, H; Makishima, A; Inoue, S				Konishi, T; Asano, T; Ishii, Y; Soga, K; Inoue, H; Makishima, A; Inoue, S			Effects of Eu2O3 on liquid-liquid phase separation of PbO-B2O3, BaO-B2O3 and SrO-B2O3 glasses	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article							MELTS; IMMISCIBILITY; MICROSPHERE; SYSTEMS; RATES	The effects of Eu2O3 On liquid-liquid phase separation were studied in the RO-B2O3-Eu2O3 (R represents Pb, Ba or Sr) systems. The results from the in situ observation of the phase separation showed that, in every case, Eu2O3 addition increased the immiscibility temperatures and the effect was more pronounced as the RO content decreased. The Eu distribution in the phase-separated microstructure was examined with an electron probe microanalyser (EPMA) and a field emission scanning electron microscope (FE-SEM) with an energy dispersive X-ray spectrometer (EDS), It was found that the Eu dissolved preferentially in the RO-rich phase droplets with a uniform distribution. A comprehensive account for these effects of Eu2O3 on both the immiscibility temperature and the microstructure was given by considering the RO-B2O3-Eu2O3 ternary phase diagram. For the SrO-B2O3-Eu2O3 system, the Eu2O3 concentration in the droplets was measured with EDS analysis to be found adjustable by changing batch composition. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Res Inorgan Mat, Tsukuba, Ibaraki 3050044, Japan	Konishi, T (reprint author), Univ Tokyo, Sch Engn, Dept Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						INOUE S, 1995, J MATER RES, V10, P1561, DOI 10.1557/JMR.1995.1561; Miura K, 1997, J NON-CRYST SOLIDS, V213, P276, DOI 10.1016/S0022-3093(96)00671-0; John S, 1996, PHYS REV A, V54, P3642, DOI 10.1103/PhysRevA.54.3642; LEVIN EM, 1949, J AM CERAM SOC, V32, P99, DOI 10.1111/j.1151-2916.1949.tb18932.x; TAKAMORI T, 1976, J AM CERAM SOC, V59, P377, DOI 10.1111/j.1151-2916.1976.tb09499.x; Inoue S, 1997, J AM CERAM SOC, V80, P2413; Crichton SN, 1997, J NON-CRYST SOLIDS, V215, P244, DOI 10.1016/S0022-3093(97)00115-4; GELER RF, 1937, J RES NAT BUR STANDA, V18, P585; HAGEMAN VBM, 1987, PHYS CHEM GLASSES, V28, P183; Hoch M, 1996, J PHASE EQUILIB, V17, P290, DOI 10.1007/BF02665555; Inoue S, 1997, PHYS CHEM GLASSES, V38, P197; Inoue S, 1999, J NON-CRYST SOLIDS, V247, P1, DOI 10.1016/S0022-3093(99)00081-2; LEVIN EM, 1958, J AM CERAM SOC, V41, P175, DOI 10.1111/j.1151-2916.1958.tb13535.x; Levin E.M., 1969, PHASE DIAGRAMS CERAM; MACEDO PB, 1974, J RES NBS A PHYS CH, VA 78, P53, DOI 10.6028/jres.078A.007; NAKASHIMA K, 1991, MATER T JIM, V32, P37; Ohta Y., 1982, Yogyo-Kyokai-Shi, V90; SIMMONS JH, 1973, J AM CERAM SOC, V56, P284, DOI 10.1111/j.1151-2916.1973.tb12490.x; WANG YZ, 1995, OPT LETT, V20, P770; Yao Z, 1998, J CERAM SOC JPN, V106, P1043, DOI 10.2109/jcersj.106.1043	20	10	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093			J NON-CRYST SOLIDS	J. Non-Cryst. Solids	MAR	2000	265	1-2					19	28		10.1016/S0022-3093(99)00878-9		10	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	293NV	WOS:000085859800003		
J	Uchida, S; Tachibana, M; Watanabe, A; Wada, Y; Shigenaka, N; Ishigure, K				Uchida, S; Tachibana, M; Watanabe, A; Wada, Y; Shigenaka, N; Ishigure, K			Effects of hydrogen peroxide on intergranular stress corrosion cracking of stainless steel in high temperature water, (II) Optimization of crack propagation rate measurement system	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						BWR type reactors; water chemistry; stress corrosion; cracking; stainless steel; potential drop method; cracks; crack propagation rate; electrochemical corrosion potential; robustness; hydrogen peroxide; measuring methods; errors; reliability; S/N ratio; temperature dependence; temperature coefficient		In order to determine a crack propagation rate of less than 10(-8) mm/s in a 24-hour integrated measurement, major parameters of a coupled system of a constant tension specimen and crack depth measurement, based on potential drop method, have been optimized. Influences of sensor geometry, location for detecting potential drop and data processing of the ratio of signal to noise (S/N) were optimized by applying Taguchi's Method. Then a suitable sensor geometry and data processing method were proposed to get a robust measurement system with higher sensitivity and lower susceptibility for geometrical and procedural fluctuations. By applying the optimal crack propagation rate measurement system, it was confirmed that a crack propagation rate of 1x10(-8) mm/s can be measured under a low concentration condition of hydrogen peroxide with less than a 20% error by a 24-hour integrated measurement.	Hitachi Ltd, Power & Ind Syst R&D Lab, Hitachi, Ibaraki 3191221, Japan; Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1130033, Japan	Uchida, S (reprint author), Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy & Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan.						ANDRESEN PL, 1992, BR NUCL ENERGY SOC, V1, P169; JOHNSON HH, 1965, MATER RES STANDARD, V5, P442; ANZAI H, 1994, CORROS SCI, V36, P1201, DOI 10.1016/0010-938X(94)90144-9; Ealey L. A., 1988, QUALITY DESIGN TAGUC; Ford F. P., 1987, NP5064M EPRI; Huber PJ, 1981, ROBUST STAT; MIYAMOTO H, 1992, J SOC MECH ENG; NAKAJIMA S, 1982, JAERI M, V82, P16; TAGUCHI G, 1998, QUALITY ENG SERIES, V3; UCHIDA S, 1995, NUCL TECHNOL, V110, P250	10	11	12	ATOMIC ENERGY SOC JAPAN	TOKYO	1-1-13 SHIMBASHI MINATO-KU, TOKYO, 105, JAPAN	0022-3131			J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	MAR	2000	37	3					257	266				10	Nuclear Science & Technology	Nuclear Science & Technology	312MU	WOS:000086947700008		
J	Ogawa, N; Satsu, H; Watanabe, H; Fukaya, M; Tsukamoto, Y; Miyamoto, Y; Shimizu, M				Ogawa, N; Satsu, H; Watanabe, H; Fukaya, M; Tsukamoto, Y; Miyamoto, Y; Shimizu, M			Acetic acid suppresses the increase in disaccharidase activity that occurs during culture of Caco-2 cells	JOURNAL OF NUTRITION			English	Article; Proceedings Paper	1998 Joint International Meeting of the Japanese-Association-for-Animal-Cell-Technology/European-Society-for-Animal-Cell-Technology (JAACT/ESACT)	JUL 26-30, 1998	KYOTO, JAPAN	Japanese Assoc Anim Cell Technol, European Soc Anim Cell Technol		Caco-2 cells; acetic acid; disaccharidase	CHAIN FATTY-ACIDS; INTESTINAL EPITHELIAL-CELLS; PLASMA-MEMBRANE PROTEINS; SUCRASE-ISOMALTASE GENE; INTRACELLULAR-TRANSPORT; HUMAN-COLON; BIOGENETIC PATHWAYS; LINE CACO-2; WHEAT BRAN; EXPRESSION	To understand how blood glucose level is lowered by oral administration of vinegar, we examined effects of acetic acid on glucose transport and disaccharidase activity in Caco-2 cells. Cells were cultured for 15 d in a medium containing 5 mmol/L of acetic acid. This chronic treatment did not affect cell growth or viability, and furthermore, apoptotic cell death was not observed, Glucose transport, evaluated with a nonmetabolizable substrate, 3-O-methyl glucose, also was not affected. However, the increase of sucrase activity observed in control cells (no acetic acid) was significantly suppressed by acetic acid (P < 0.01). Acetic acid suppressed sucrase activity in concentration- and time-dependent manners. Similar treatments (5 mmol/L and 15 d) with other organic acids such as citric, succinic, L-maric, L-lactic, L-tartaric and itaconic acids, did not suppress the increase in sucrase activity. Acetic acid treatment (5 mmol/L and 15 d) significantly decreased the activities of disaccharidases (sucrase, maltase, trehalase and lactase) and angiotensin-I-converting enzyme, whereas the activities of other hydrolases (alkaline phosphatase, aminopeptidase-N, dipeptidylpeptidase-IV and gamma-glutamyltranspeptidase) were not affected. To understand mechanisms underlying the suppression of disaccharidase activity by acetic acid, Northern and Western analyses of the sucrase-isomaltase complex were performed. Acetic acid did not affect the de novo synthesis of this complex at either the transcriptional or translational levels. The antihyperglycemic effect of acetic acid may be partially due to the suppression of disaccharidase activity. This suppression seems to occur during the post-translational processing.	Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Nakano Vinegar Co Ltd, Handa 4758585, Japan	Shimizu, M (reprint author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.						HOWELL S, 1992, BIOCHEM J, V284, P595; RODGER G, 1984, J FOOD SCI, V49, P714, DOI 10.1111/j.1365-2621.1984.tb13194.x; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; GILBERT T, 1991, J CELL BIOL, V113, P275, DOI 10.1083/jcb.113.2.275; MIYAMOTO K, 1993, BIOCHEM J, V295, P211; FORSTNER GG, 1968, BIOCHEM J, V106, P381; EBIHARA K, 1988, AGR BIOL CHEM TOKYO, V52, P1311; POMARE EW, 1985, J CLIN INVEST, V75, P1448, DOI 10.1172/JCI111847; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; GARCIA M, 1993, J CELL SCI, V104, P1281; BELL TA, 1972, J FOOD SCI, V37, P446, DOI 10.1111/j.1365-2621.1972.tb02660.x; BLAIS A, 1987, J MEMBRANE BIOL, V99, P113, DOI 10.1007/BF01871231; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; BRIGHENTI F, 1995, EUR J CLIN NUTR, V49, P242; BROYART JP, 1990, BIOCHIM BIOPHYS ACTA, V1087, P61, DOI 10.1016/0167-4781(90)90121-H; CHANTRET I, 1992, BIOCHEM J, V285, P915; CHENG BQ, 1987, BRIT J NUTR, V57, P69, DOI 10.1079/BJN19870010; COPPINI D, 1975, ATTI SOC NAT MAT MOD, V106, P73; CUMMINGS JH, 1983, LANCET, V1, P1206; DAHLQVIST A, 1964, ANAL BIOCHEM, V7, P18, DOI 10.1016/0003-2697(64)90115-0; DANIELSEN EM, 1992, BIOCHEMISTRY-US, V31, P2266, DOI 10.1021/bi00123a008; ITOH H, 1978, JOZO KYOKAISHI, V73, P200; Louvard D, 1975, Biochim Biophys Acta, V375, P235; Marchetti MC, 1997, NUTR CANCER, V28, P74; MARUYAMA E, 1980, HOME EC, V31, P568; MEYER-WYSS B, 1991, Gastroenterology, V100, pA469; NAIM HY, 1993, BIOCHEM J, V296, P607; NAKAJIMA A, 1988, J JPN SOC NUTR FOOD, V41, P487; PINTO M, 1983, BIOL CELL, V47, P323; QUARONI A, 1993, BIOCHEM J, V292, P725; SEUSS I, 1993, FLEISCHWIRTSCHAFT, V73, P292; SJOTRO H, 1983, CIBA F SYMP, V95, P50; Stein J, 1996, EUR J CLIN INVEST, V26, P84, DOI 10.1046/j.1365-2362.1996.113252.x; STEWART TA, 1981, METHOD ENZYMOL, V80, P450; STIEGER B, 1988, J CELL BIOL, V106, P1853, DOI 10.1083/jcb.106.6.1853; TOPPING DL, 1985, ANN NUTR METAB, V29, P325, DOI 10.1159/000176989; TRABER PG, 1994, J LAB CLIN MED, V123, P467; WHITE J, 1971, PROCESS BIOCHEM, P21; Yonemoto C, 1995, J JPN SOC NUTR FOOD, V48, P441; ZWEIBAUM A, 1991, NATO ADV SCI I A-LIF, V218, P27	42	35	42	AMER SOC NUTRITIONAL SCIENCE	BETHESDA	9650 ROCKVILLE PIKE, RM L-2407A, BETHESDA, MD 20814 USA	0022-3166			J NUTR	J. Nutr.	MAR	2000	130	3					507	513				7	Nutrition & Dietetics	Nutrition & Dietetics	289EH	WOS:000085607200002		
J	Fukui, N; Tashiro, T; Hiraoka, H; Oda, H; Nakamura, K				Fukui, N; Tashiro, T; Hiraoka, H; Oda, H; Nakamura, K			Adhesion formation can be reduced by the suppression of transforming growth factor-beta 1 activity	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article							COLLAGEN TYPE-I; FACTOR-BETA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; RAT; CELLS; QUANTITATION; INHIBITOR; FIBROSIS; ANTIBODY	Surgery or trauma often results in restrictive adhesions around joints or tendons that cause severe functional impairment. The formation of adhesion is essentially a fibrogenetic process; therefore, peptide growth factors, such as transforming growth factor-beta, are assumed to pray central roles in its development. The purpose of this study was to test the hypothesis that suppression of transforming growth factor-beta 1 activity reduces adhesion formation. Sixty rabbits were prepared and randomly divided into six groups of 10. Intraarticular adhesions were created in the right knee joints by cortical bone shaving and subsequent cast immobilization for 4 weeks. In animals in three of the six groups, transforming growth factor-beta 1 activity was suppressed by continuous administration of the neutralizing antibody in three graded doses: animals in the other three groups were used as controls. Four weeks after the surgery the casts were removed and the adhesions were assessed macroscopically, histologically, biomechanically, and biochemically. Gross observation showed that the neutralizing antibody had suppressed adhesion formation in a dose-dependent manner. This is consistent with biomechanical measurement results demonstrating that the antibody reduced the flexion contractures. Histologically, the adhesion in our model was fibrous tissue and the adhesions in the animals in the antibody groups were thin and loose in comparison with the controls. Biochemical analyses further supported these results, demonstrating that administration of the antibody reduced collagen content in the adhesions with a predominance of type-I collagen. Thus, this study showed that suppression of the actions of transforming growth factor-beta 1 reduced adhesion formation. Considering the various possible measures to control the activity of the growth factor, suppression of transforming growth factor-beta may be a novel, potent approach to preventing adhesions.	Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan	Fukui, N (reprint author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.						BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; ROTHKOPF DM, 1991, J HAND SURG-AM, V16A, P694, DOI 10.1016/0363-5023(91)90196-I; WILLIAMS RS, 1992, J SURG RES, V52, P65; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; MURPHY PG, 1994, BIOCHEM CELL BIOL, V72, P403; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; RYAN CK, 1995, AM J SURG, V169, P154, DOI 10.1016/S0002-9610(99)80125-1; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Chang J, 1997, PLAST RECONSTR SURG, V100, P937, DOI 10.1097/00006534-199709001-00016; Rodeo SA, 1997, J ORTHOPAED RES, V15, P427, DOI 10.1002/jor.1100150316; PETERSON WW, 1990, J HAND SURG-AM, V15A, P48; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; SZABO RM, 1990, J HAND SURG-AM, V15A, P480, DOI 10.1016/0363-5023(90)90066-Z; KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; KLOEN P, 1995, J HAND SURG-AM, V20A, P101, DOI 10.1016/S0363-5023(05)80067-X; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; ZHANG K, 1995, J INVEST DERMATOL, V104, P750; Miller JA, 1997, J BIOMED MATER RES, V38, P25, DOI 10.1002/(SICI)1097-4636(199721)38:1<25::AID-JBM4>3.0.CO;2-J; STEWART MJ, 1966, J BONE JOINT SURG AM, VA 48, P784; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; KETCHUM LD, 1971, PLAST RECONSTR SURG, V47, P471, DOI 10.1097/00006534-197105000-00011; BIGLIANI LU, 1990, SHOULDER, V1, P278; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CHAN D, 1984, ANAL BIOCHEM, V139, P322, DOI 10.1016/0003-2697(84)90012-5; CHEGINI N, 1994, OBSTET GYNECOL, V83, P449; CHERRY GW, 1994, OXFORD TXB SURG, P1; CLORE JN, 1979, P SOC EXP BIOL MED, V161, P337; CREELY JJ, 1992, AM J PATHOL, V140, P45; CROMACK DT, 1987, J SURG RES, V42, P622, DOI 10.1016/0022-4804(87)90005-9; FORREST L, 1983, BRIT J SURG, V70, P133, DOI 10.1002/bjs.1800700302; HAGBERG L, 1991, J BIOMECH, V24, P935, DOI 10.1016/0021-9290(91)90171-I; KESSLER FB, 1986, J HAND SURG-AM, V11A, P241; Ketchum L D, 1977, J Hand Surg Am, V2, P428; KIM SJ, 1989, J BIOL CHEM, V264, P7041; LITTLEFIELD WG, 1992, J HAND SURG-AM, V17A, P691, DOI 10.1016/0363-5023(92)90318-J; Lucas PA, 1996, J SURG RES, V65, P135, DOI 10.1006/jsre.1996.0355; Morrey BF, 1993, ELBOW ITS DISORDERS, P476; MURAKAMI S, 1995, AM J SPORT MED, V23, P763, DOI 10.1177/036354659502300622; NAGY P, 1991, HEPATOLOGY, V14, P269, DOI 10.1016/0270-9139(91)91414-V; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; POTENZA AD, 1963, J BONE JOINT SURG AM, V45, P1217; POTENZA AD, 1962, J BONE JOINT SURG AM, V44, P49; SHAH M, 1995, J CELL SCI, V108, P985; STRAUCH B, 1985, J HAND SURG-AM, V10A, P790	49	29	29	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192 USA	0736-0266			J ORTHOPAED RES	J. Orthop. Res.	MAR	2000	18	2					212	219		10.1002/jor.1100180208		8	Orthopedics	Orthopedics	312NK	WOS:000086949200007		
J	Suda, T; Katano, H; Delsol, G; Kakiuchi, C; Nakamura, T; Shiota, M; Oshimura, M; Higashihara, M; Mori, S				Suda, T; Katano, H; Delsol, G; Kakiuchi, C; Nakamura, T; Shiota, M; Oshimura, M; Higashihara, M; Mori, S			High expression of HHV-8 gene products on AIDS-associated, but not on AIDS-unrelated multicentric Castleman's disease	JOURNAL OF PATHOLOGY			English	Meeting Abstract									Univ Tokyo, Inst Med Sci, Dept Pathol, Minato Ku, Tokyo 1088639, Japan								0	0	0	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0022-3417			J PATHOL	J. Pathol.	MAR	2000	190			S			64A	64A				1	Oncology; Pathology	Oncology; Pathology	294XF	WOS:000085935300257		
J	Tamura, Y; Yuhara, M; Ishii, T				Tamura, Y; Yuhara, M; Ishii, T			Primary arc basalts from Daisen volcano, Japan: Equilibrium crystal fractionation versus disequilibrium fractionation during supercooling	JOURNAL OF PETROLOGY			English	Article						arc volcanism; Daisen volcano; olivine fractionation; primary magma; supercooling	SHIRAHAMA GROUP; MANTLE WEDGE; BIMODAL MAGMATISM; SOUTHWEST JAPAN; MELTS; COMPLEX; OLIVINE; TEMPERATURE; DIAMOND; GENESIS	Daisen volcano, southwest Japan, has been thought to be an exclusively dacitic volcano, lavas having trace element patterns with a garnet signature. We studied the basalts at the western foot of the volcano and made two unexpected findings. (1) The homogeneity of Sr-87/Sr-86 in Daisen basalts (Sr isotopic variability less than or equal to 0.0003) contrasts with great variations in basalts from nearby monogenetic fields. Moreover, the basalts and dacites from Daisen volcano have the same Sr-87/Sr-86 and Nd-143/Nd-144, indicating that these rocks have a close genetic relationship. The calculated primary basaltic magma of Daisen volcano suggests a segregation depth of similar to 60 km (similar to 18 kbar), and higher Sm/Yb ratios in the Daisen basalts relative to NE Japan arc basalts suggest that the segregation took place between the garnet and spinel peridotite stability fields. (2) The effects of fractional crystallization were distinguished from those produced by supercooling on the basis of olivine morphology and chemical relationships between olivines and host basalts. Supercooled magmas become magnesian through fractionation of iron-rich olivines and are seemingly anomalous because they contain iron-rich olivines despite their magnesian bulk-rock chemistry.	Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; Niigata Univ, Res Inst Hazards Snowy Areas, Niigata 9502181, Japan; Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan	Tamura, Y (reprint author), Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan.						MORRIS PA, 1995, GEOLOGY, V23, P395, DOI 10.1130/0091-7613(1995)023<0395:SMAAEO>2.3.CO;2; KAGAMI H, 1989, GEOCHEM J, V23, P209; MCCULLOCH MT, 1991, EARTH PLANET SC LETT, V102, P358, DOI 10.1016/0012-821X(91)90029-H; DONALDSON CH, 1976, CONTRIB MINERAL PETR, V57, P187, DOI 10.1007/BF00405225; BAKER MB, 1994, GEOCHIM COSMOCHIM AC, V58, P2811, DOI 10.1016/0016-7037(94)90116-3; HIROSE K, 1993, EARTH PLANET SC LETT, V114, P477, DOI 10.1016/0012-821X(93)90077-M; Ewart A, 1998, J PETROL, V39, P191, DOI 10.1093/petrology/39.2.191; TATSUMI Y, 1983, J GEOPHYS RES, V88, P5815, DOI 10.1029/JB088iB07p05815; WALKER D, 1979, CONTRIB MINERAL PETR, V70, P111, DOI 10.1007/BF00374440; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; Shibata T, 1997, J GEOPHYS RES-SOL EA, V102, P8051, DOI 10.1029/96JB03661; Falloon TJ, 1997, EARTH PLANET SC LETT, V152, P149, DOI 10.1016/S0012-821X(97)00155-6; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.earth.14.1.493; BALLHAUS CG, 1989, J PETROL, V30, P1443; Cox K.G., 1979, INTERPRETATION IGNEO; Fujibayashi N., 1988, J MINERAL PETROL EC, V84, P429; FUJIMAKI H, 1991, J MINERALOGY PETROLO, V86, P16; Gill JB, 1981, OROGENIC ANDESITES P; ISHIGA H., 1989, J GEOL SOC JAPAN, V95, P129; Ishiwatari A., 1997, J GEOLOGICAL SOC JAP, V103, P565; KINZLER RJ, 1990, GEOCHIM COSMOCHIM AC, V54, P1255, DOI 10.1016/0016-7037(90)90151-A; Kushiro I., 1996, GEOPHYS MONOGR, V95, P109; NAKANISHI I, 1980, TECTONOPHYSICS, V69, P1, DOI 10.1016/0040-1951(80)90125-0; ONO K, 1981, VOLCANOES JAPAN; Pearce J.A, 1982, ANDESITES, P525; Price RC, 1999, J PETROL, V40, P167, DOI 10.1093/petrology/40.1.167; Rollinson H., 1993, USING GEOCHEMICAL DA; Sato H, 1977, LITHOS, V10, P112; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Takahashi E., 1986, B VOLCANOLOGICAL SOC, V30, pS17; TAMURA Y, 1995, J PETROL, V36, P417; Tamura Y, 1996, J PETROL, V37, P1307, DOI 10.1093/petrology/37.6.1307; TAMURA Y, 1994, J PETROL, V35, P619; TEGNER C, 1993, J PETROL, V34, P681; Tsukui M., 1985, J GEOLOGICAL SOC JAP, V91, P279; Tsukui M., 1984, J GEOL SOC JPN, V90, P643; TSUKUI M, 1985, J VOLCANOL GEOTH RES, V26, P317, DOI 10.1016/0377-0273(85)90062-9; UTO K., 1989, THESIS U TOKYO; YAMASHITA S, 1994, J GEOPHYS RES-SOL EA, V99, P22285, DOI 10.1029/94JB00282	39	43	43	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-3530			J PETROL	J. Petrol.	MAR	2000	41	3					431	448		10.1093/petrology/41.3.431		18	Geochemistry & Geophysics	Geochemistry & Geophysics	286WC	WOS:000085471000007		
J	Yamano, K; Yamamoto, K; Kotaki, H; Takedomi, S; Matsuo, H; Sawada, Y; Iga, T				Yamano, K; Yamamoto, K; Kotaki, H; Takedomi, S; Matsuo, H; Sawada, Y; Iga, T			Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: Implication of concentrative uptake of inhibitors into liver	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							INTESTINAL-ABSORPTION; SYSTEMIC ANTIMYCOTICS; ORAL BIOAVAILABILITY; CYTOCHROME-P-450; PHARMACOKINETICS; KETOCONAZOLE; TROLEANDOMYCIN; ITRACONAZOLE; LIDOCAINE; PHARMACODYNAMICS	To evaluate the degree of drug-drug interaction concerning metabolic inhibition in the liver quantitatively, we tried to predict the plasma concentration increasing ratio (R) of midazolam (MDZ) by erythromycin (EM), diltiazem (DLZ), or verapamil (VER) in rats. MDZ was administered through the portal vein at the steady state of plasma concentration of these inhibitors. The R values in the area under the plasma concentration curve of MDZ in the presence of EM, DLZ, and VER were 2.02, 1.64, and 1.30, respectively. The liver to plasma unbound concentration ratios of EM, DLZ, and VER at the steady state after infusion were 20.8, 1.02, and 3.01, respectively, suggesting concentrative uptake of EM and VER into the liver. The predicted R value in the presence of EM calculated by use of plasma unbound concentration was 1.03, whereas the value calculated with liver unbound concentration was 1.61, which was very close to the observed value. These findings indicated the need to consider the concentrative uptake of inhibitors into the liver for the quantitative prediction of metabolic inhibition. However, the predicted values in the presence of DLZ or VER calculated by use of liver unbound concentration were still underestimated. This result may be due to the metabolic inhibition by the metabolites of both inhibitors. Therefore, when predicting the degree of metabolic inhibition quantitatively, the inhibitory effect by coadministered drugs and the disposition of these metabolites in the liver must also be considered.	Fujisawa Pharmaceut Co Ltd, Biopharmaceut & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan; Tokyo Univ Hosp, Fac Med, Dept Pharm, Tokyo 113, Japan; Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pharm, Tokyo, Japan; Gunma Univ, Sch Med, Dept Clin Pharmacol, Maebashi, Gumma 371, Japan; Kyushu Univ, Fac Pharmaceut Sci, Fukuoka 812, Japan	Yamano, K (reprint author), Fujisawa Pharmaceut Co Ltd, Biopharmaceut & Pharmacokinet Res Labs, Yodogawa Ku, 1-6 Kashima 2 Chome, Osaka 5328514, Japan.						AHONEN J, 1995, BRIT J CLIN PHARMACO, V40, P270; Floren LC, 1997, CLIN PHARMACOL THER, V62, P41, DOI 10.1016/S0009-9236(97)90150-8; Ito K, 1998, PHARMACOL REV, V50, P387; Yamazaki M, 1996, PHARMACEUT RES, V13, P497, DOI 10.1023/A:1016077517241; OLKKOLA KT, 1994, CLIN PHARMACOL THER, V55, P481; OMURA T, 1964, J BIOL CHEM, V239, P2370; BALDWIN SJ, 1995, XENOBIOTICA, V25, P261; OLKKOLA KT, 1993, CLIN PHARMACOL THER, V53, P298; HOFFMAN DJ, 1995, PHARMACEUT RES, V12, P889, DOI 10.1023/A:1016221322886; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; BACKMAN JT, 1994, EUR J CLIN PHARMACOL, V46, P551; DELAFORGE M, 1984, CHEM-BIOL INTERACT, V51, P371, DOI 10.1016/0009-2797(84)90162-5; DELAFORGE M, 1988, CHEM-BIOL INTERACT, V68, P179, DOI 10.1016/0009-2797(88)90015-4; FEE JPH, 1987, CLIN PHARMACOL THER, V41, P80; FRANKLIN MR, 1991, METHOD ENZYMOL, V206, P559; Ghosal A, 1996, DRUG METAB DISPOS, V24, P940; GOMEZ DY, 1995, CLIN PHARMACOL THER, V58, P15, DOI 10.1016/0009-9236(95)90067-5; GRAY MR, 1987, DRUG METAB DISPOS, V15, P22; HUNG J, 1988, CLIN PHARMACOL THER, V43, P466; KREMERS P, 1981, EUR J BIOCHEM, V118, P599, DOI 10.1111/j.1432-1033.1981.tb05561.x; LINDSTROM TD, 1993, ANTIMICROB AGENTS CH, V37, P265; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUBUCHI Y, 1992, BIOCHEM PHARMACOL, V43, P2551; MEIJER DKF, 1990, J PHARMACOKINET BIOP, V18, P35, DOI 10.1007/BF01063621; Murray M, 1996, J PHARMACOL EXP THER, V279, P1447; NELSON WL, 1988, DRUG METAB DISPOS, V16, P834; Olkkola KT, 1996, ANESTH ANALG, V82, P511, DOI 10.1097/00000539-199603000-00015; PESSAYRE D, 1983, J PHARMACOL EXP THER, V224, P685; SAVILLE BA, 1989, J PHARM SCI, V78, P1003, DOI 10.1002/jps.2600781207; SAWADA Y, 1996, J PRACT PHARM, V47, P1535; SCHWARTZ JB, 1985, BRIT J CLIN PHARMACO, V19, P512; TABATA K, 1995, PHARMACEUT RES, V12, P880, DOI 10.1023/A:1016217221977; Takedomi S, 1998, DRUG METAB DISPOS, V26, P318; TINEL M, 1989, J PHARMACOL EXP THER, V250, P746; Yamano K, 1999, DRUG METAB DISPOS, V27, P395; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; Yamazaki Hiroshi, 1996, Journal of Toxicological Sciences, V21, P215; YEUNG PKF, 1990, DRUG METAB DISPOS, V18, P1055	38	28	29	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAR	2000	292	3					1118	1126				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	287RX	WOS:000085520900039		
J	Kitazawa, T; Hosoya, K; Takahashi, T; Sugiyama, Y; Terasaki, T				Kitazawa, T; Hosoya, K; Takahashi, T; Sugiyama, Y; Terasaki, T			In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article							ORGANIC ANION TRANSPORTER; CHOROID-PLEXUS; BRAIN-BARRIER; HUMAN LIVER; FUNCTIONAL-CHARACTERIZATION; EXPRESSION CLONING; ESTRONE-SULFATE; RAT-BRAIN; 3'-AZIDO-3'-DEOXYTHYMIDINE; 2',3'-DIDEOXYINOSINE	The efflux transport of oestrone-3-sulphate, a steroid hormone sulphate, across the blood-cerebrospinal fluid barrier has been examined following its intracerebroventricular administration. [H-3]Oestrone-3-sulphate was eliminated from cerebrospinal fluid (CSF) with an apparent efflux clearance of 205 mu L min(-1) per rat. There was 25% of unmetabolized [H-3]oestrone-3-sulphate in the plasma 5 min after intracerebroventricular administration, indicating that at least a part of [H-3]oestrone-3-sulphate is transported from CSF to the circulating blood across the blood-CSF barrier. This efflux transport was inhibited by co-administration of excess oestrone-3-sulphate (25 mM10 mu L =0.25 mu mol) into rat cerebral ventricle. To characterize the oestrone-3-sulphate transport process, an in-vitro uptake experiment was performed using isolated rat choroid plexus. Oestrone-3-sulphate uptake by isolated rat choroid plexus was found to be a saturable process with a Michaelis-Menten constant (K-m) of 18.1 +/- 6.3 mu M, and a maximum uptake rate (V-max) of 48.0 +/- 15.1 pmol min(-1) mu L-1 of tissue. The oestrone-3-sulphate transport process was temperature dependent and was inhibited by metabolic inhibitors such as 2,4-dinitrophenol and rotenone, suggesting an energy dependence. This uptake process was also inhibited by steroid hormone sulphates (1 mM dehydroepiandrosterone sulphate and 1 mM oestrone sulphate), bile acids (1 mM taurocholic acid and 1 mM cholic acid) and organic anions (1 mM sulphobromophthalein and 1 mM phenolsulphonphthalein), whereas 1 mM p-aminohippuric acid, 1 mM p-nitrophenol sulphate, 0.1 mM methotrexate and the cardiac glycoside, 2.5 mu M digoxin, had little effect. In conclusion, these results provide evidence that oestrone-3-sulphate is transported from CSF to the circulating blood across the blood-CSF barrier via a carrier-mediated efflux transport system.	Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan; Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808578, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan	Terasaki, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan.		Terasaki, Tetsuya/K-6730-2012	Terasaki, Tetsuya/0000-0002-6332-7575			Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; Saito H, 1996, J BIOL CHEM, V271, P20719; Kakee A, 1997, J PHARMACOL EXP THER, V283, P1018; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Bossuyt X, 1996, J HEPATOL, V25, P733, DOI 10.1016/S0168-8278(96)80246-7; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; Bossuyt X, 1996, J PHARMACOL EXP THER, V276, P891; Kanai N, 1996, AM J PHYSIOL-RENAL, V270, pF319; Hagenbuch B, 1996, SEMIN LIVER DIS, V16, P129, DOI 10.1055/s-2007-1007226; Hassen AM, 1996, DRUG METAB DISPOS, V24, P792; HOLLOWAY LS, 1972, AM J PHYSIOL, V223, P507; HONJO H, 1989, J STEROID BIOCHEM, V34, P521; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; KAWANO J, 1987, BRAIN RES, V409, P391, DOI 10.1016/0006-8993(87)90729-3; KISHIMOT.Y, 1973, J NEUROCHEM, V20, P1489, DOI 10.1111/j.1471-4159.1973.tb00264.x; Kitazawa T, 1998, J PHARMACOL EXP THER, V286, P890; Kullak-Ublick GA, 1998, FEBS LETT, V424, P173, DOI 10.1016/S0014-5793(98)00168-9; OGAWA M, 1994, AM J PHYSIOL, V266, pR392; Ooie T, 1996, PHARMACEUT RES, V13, P1065, DOI 10.1023/A:1016014909431; SakumaSawada N, 1997, RES COMMUN MOL PATH, V97, P131; Shimada K, 1999, J CHROMATOGR A, V847, P171, DOI 10.1016/S0021-9673(98)01083-8; STEINGOLD KA, 1986, J CLIN ENDOCR METAB, V62, P761; SUZUKI H, 1987, J PHARMACOL EXP THER, V242, P660; Takasawa K, 1997, J PHARMACOL EXP THER, V281, P369; Takasawa K, 1997, J PHARMACOL EXP THER, V282, P1509; TSUJI A, 1992, LIFE SCI, V51, P1427, DOI 10.1016/0024-3205(92)90537-Y; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	31	16	16	ROYAL PHARMACEUTICAL SOC GREAT BRITAIN	LONDON	1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND	0022-3573			J PHARM PHARMACOL	J. Pharm. Pharmacol.	MAR	2000	52	3					281	288		10.1211/0022357001773968		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	301AE	WOS:000086285300004		
J	Kotani, A				Kotani, A			Theoretical study of resonant X-ray emission in f and d electron systems - impurity Anderson model and effects of translational symmetry	JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS			English	Article; Proceedings Paper	International Workshop on Inelastic X-ray Scattering	OCT 18-21, 1998	LONG ISL CITY, NEW YORK	US DOE, Div Mat Sci, Argonne Natl Lab, Blake Ind, Brookhaven Natl Lab, Brookhaven Sci Assoc, Oak Ridge Natl Lab, Synchrotron Radiat Res Ctr		resonant X-ray emission	SPECTRA; SPECTROSCOPY; EXCITATIONS; LA2CUO4	A short review is given of theoretical studies on resonant X-ray emission spectroscopy (RXES) in f and d electron systems. Impurity Anderson model (or small cluster model), where only a single metal ion with for d electrons is taken into account, has often been used in the analysis of RXES of f and d electron systems. We first show that the impurity Anderson model can be applied successfully to the analysis of RXES in some rare earth compounds and transition metal compounds. Then we study effects of translational symmetry, beyond the impurity Anderson model, in RXES of early transition metal compounds, TiO2 for instance, with a simplified one-dimensional d-p model. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Kotani, A (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 1068666, Japan.						Hill JP, 1998, PHYS REV LETT, V80, P4967, DOI 10.1103/PhysRevLett.80.4967; Kuiper P, 1998, PHYS REV LETT, V80, P5204, DOI 10.1103/PhysRevLett.80.5204; Butorin SM, 1996, PHYS REV LETT, V77, P574, DOI 10.1103/PhysRevLett.77.574; Duda LC, 1998, J PHYS SOC JPN, V67, P416, DOI 10.1143/JPSJ.67.416; Ide T, 1998, J PHYS SOC JPN, V67, P3621, DOI 10.1143/JPSJ.67.3621; Kotani A, 1998, J ELECTRON SPECTROSC, V92, P171, DOI 10.1016/S0368-2048(98)00119-4; Kotani A, 1996, J ELECTRON SPECTROSC, V78, P7, DOI 10.1016/S0368-2048(96)80017-X; Nakazawa M, 1996, J PHYS SOC JPN, V65, P2303, DOI 10.1143/JPSJ.65.2303; OKADA K, 1993, J ELECTRON SPECTROSC, V62, P131, DOI 10.1016/0368-2048(93)80010-J; TANAKA S, 1993, J PHYS SOC JPN, V62, P464, DOI 10.1143/JPSJ.62.464; Tezuka Y, 1996, J PHYS SOC JPN, V65, P312, DOI 10.1143/JPSJ.65.312	11	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3697			J PHYS CHEM SOLIDS	J. Phys. Chem. Solids	MAR	2000	61	3					419	424		10.1016/S0022-3697(99)00329-7		6	Chemistry, Multidisciplinary; Physics, Condensed Matter	Chemistry; Physics	286XL	WOS:000085474100019		
J	Hill, JP; Kao, CC; Hamalainen, K; Huotari, S; Berman, LE; Caliebe, WAL; Matsubara, M; Kotani, A; Peng, JL; Greene, RL				Hill, JP; Kao, CC; Hamalainen, K; Huotari, S; Berman, LE; Caliebe, WAL; Matsubara, M; Kotani, A; Peng, JL; Greene, RL			Energy and polarization dependence of resonant inelastic X-ray scattering in Nd2CuO4	JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS			English	Article; Proceedings Paper	International Workshop on Inelastic X-ray Scattering	OCT 18-21, 1998	LONG ISL CITY, NEW YORK	US DOE, Div Mat Sci, Argonne Natl Lab, Blake Ind, Brookhaven Natl Lab, Brookhaven Sci Assoc, Oak Ridge Natl Lab, Synchrotron Radiat Res Ctr		X-ray	EMISSION SPECTROSCOPY; K-EDGE; SPECTRA; LA2CUO4; EXCITATIONS; ABSORPTION; CUO	We report the energy and polarization dependence of resonant inelastic X-ray scattering from Nd2CuO4. An energy loss feature at similar to 6 eV is observed in the vicinity of the Cu K-edge. Numerical calculations based on the Anderson impurity model identify this as a charge transfer excitation to the anti-bonding state. The incident polarization is shown to select the intermediate states participating in the resonance process. Resonances are observed at 8990 and 9000 eV with the incident polarization perpendicular and parallel to the CuO planes, respectively. In contrast to our single-site model calculations, no resonances are observed associated with the 1s3d(10)L intermediate states, suggesting that non-local effects play a role. (C) 2000 Elsevier Science Ltd. All rights reserved.	Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan; Univ Maryland, Dept Phys & Astron, Ctr Superconduct Res, College Pk, MD 20742 USA	Hill, JP (reprint author), Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA.		Hamalainen, Keijo/A-3986-2010; Hill, John/F-6549-2011	Hamalainen, Keijo/0000-0002-9234-9810; 			ABBAMONTE P, 1998, MAT9810095 LANL COND; Hill JP, 1998, PHYS REV LETT, V80, P4967, DOI 10.1103/PhysRevLett.80.4967; Kuiper P, 1998, PHYS REV LETT, V80, P5204, DOI 10.1103/PhysRevLett.80.5204; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759; HAMALAINEN K, IN PRESS; Kao CC, 1996, PHYS REV B, V54, P16361, DOI 10.1103/PhysRevB.54.16361; Moewes A, 1998, PHYS REV B, V58, P15951; Okada K, 1997, J ELECTRON SPECTROSC, V86, P119, DOI 10.1016/S0368-2048(97)00056-X; Platzman PM, 1998, PHYS REV B, V57, P11107, DOI 10.1103/PhysRevB.57.11107; TAN ZQ, 1990, PHYS REV B, V42, P1037, DOI 10.1103/PhysRevB.42.1037; TANAKA S, 1993, J PHYS SOC JPN, V62, P464, DOI 10.1143/JPSJ.62.464; TANAKA S, 1991, J PHYS SOC JPN, V60, P3893, DOI 10.1143/JPSJ.60.3893; TRANQUADA JM, 1991, PHYS REV B, V44, P5176, DOI 10.1103/PhysRevB.44.5176; VEENENDAAL MA, 1993, PHYS REV B, V47, P5307; Wu ZY, 1996, PHYS REV B, V54, P13409, DOI 10.1103/PhysRevB.54.13409	15	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3697			J PHYS CHEM SOLIDS	J. Phys. Chem. Solids	MAR	2000	61	3					425	429		10.1016/S0022-3697(99)00330-3		5	Chemistry, Multidisciplinary; Physics, Condensed Matter	Chemistry; Physics	286XL	WOS:000085474100020		
J	Iwazumi, T; Nakamura, T; Shoji, H; Kobayashi, K; Kishimoto, S; Katano, R; Isozumi, Y; Nanao, S				Iwazumi, T; Nakamura, T; Shoji, H; Kobayashi, K; Kishimoto, S; Katano, R; Isozumi, Y; Nanao, S			Magnetic circular dichroism of Gd 3d-2p and 4d-2p X-ray emission in ferrimagnetic Gd-Co amorphous	JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS			English	Article; Proceedings Paper	International Workshop on Inelastic X-ray Scattering	OCT 18-21, 1998	LONG ISL CITY, NEW YORK	US DOE, Div Mat Sci, Argonne Natl Lab, Blake Ind, Brookhaven Natl Lab, Brookhaven Sci Assoc, Oak Ridge Natl Lab, Synchrotron Radiat Res Ctr		magnetic circular dichroism	RESONANT RAMAN-SCATTERING; METAL	The magnetic circular dichroism (MCD) of the Gd X-ray emission spectra (XES) in the 3d-2p and 4d-2p radiative transitions of ferrimagnetic Gd-Co amorphous were observed when the incident X-ray energies were exactly on and sufficiently higher than the Gd L-3 and L-2 absorption edges. The obtained results at the high-energy off-resonance correspond well with a recent theoretical analysis based on an atomic calculation with the full multiplet included. The magnifying feature of the magnetic-resonance effects of the MCD-XES at the on-resonance is consistent with the results of the MCD of the X-ray absorption spectrum. (C) 2000 Elsevier Science Ltd. All rights reserved.	Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; NEC Corp Ltd, Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan; Kyoto Univ, Chem Res Inst, Uji 6110011, Japan; Kyoto Univ, Radioisotope Res Ctr, Kyoto 6068501, Japan	Iwazumi, T (reprint author), Inst Mat Struct Sci, Photon Factory, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.						Krisch MH, 1996, PHYS REV B, V54, P12673; Caliebe WA, 1996, J APPL PHYS, V79, P6509, DOI 10.1063/1.361927; deGroot FMF, 1997, PHYS REV B, V56, P7285, DOI 10.1103/PhysRevB.56.7285; Iwazumi T, 1997, PHYS REV B, V56, P14267; Iwazumi T, 1998, J ELECTRON SPECTROSC, V92, P257, DOI 10.1016/S0368-2048(98)00132-7; IWAZUMI T, 1995, REV SCI INSTRUM, V66, P1691, DOI 10.1063/1.1145885; Jo T, 1998, J PHYS SOC JPN, V67, P1457, DOI 10.1143/JPSJ.67.1457; KOBAYASHI K, 1995, J MAGN MAGN MATER, V140, P283, DOI 10.1016/0304-8853(94)00619-9; Meisel A., 1989, XRAY SPECTRA CHEM BI; SCHUTZ G, 1988, Z PHYS B CON MAT, V73, P67, DOI 10.1007/BF01312156	10	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3697			J PHYS CHEM SOLIDS	J. Phys. Chem. Solids	MAR	2000	61	3					453	456		10.1016/S0022-3697(99)00335-2		4	Chemistry, Multidisciplinary; Physics, Condensed Matter	Chemistry; Physics	286XL	WOS:000085474100025		
J	Ozaki, T; Enomoto, S; Minai, Y; Ambe, S; Ambe, F; Makide, Y				Ozaki, T; Enomoto, S; Minai, Y; Ambe, S; Ambe, F; Makide, Y			Beneficial effect of rare earth elements on the growth of Dryopteris erythrosora	JOURNAL OF PLANT PHYSIOLOGY			English	Article						beneficial effect; Dryopteris erythrosora; multitracer; rare earth element	LANTHANIDE IONS; TRACE-ELEMENTS; CALCIUM; MULTITRACER; PROTEIN; PLANTS	Lanthanum was demonstrated to be beneficial to the growth of Dryopteris erythrosora, a fern species which accumulates rare earth, elements (REEs) under natural conditions. The enhancement of its growth by La was much greater than that by Ca. The uptake rates of REEs were evaluated to be higher than that of Zn and almost equal to those of Sr and Co. The region in the mesophyll where REEs were concentrated was not the same as that of Ca. In mesophyll cells, REEs were observed mainly in chloroplasts. These observations suggest that REEs do not behave as a <super Ca> as was suggested for some plants, but that they are transferred to chloroplasts by special mechanisms, possibly for fulfilling yet unknown functions or being stored as a mechanism of detoxification.	Univ Tokyo, Sch Sci, Isotope Ctr, Tokyo 113, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 35101, Japan; Musashi Univ, Fac Humanities, Tokyo 176, Japan	Ozaki, T (reprint author), Univ Tokyo, Sch Sci, Isotope Ctr, Tokyo 113, Japan.						Ambe S, 1991, ANAL SCI, V7, P317, DOI 10.2116/analsci.7.Supple_317; AMBE S, 1995, J RADIOAN NUCL CH AR, V195, P305, DOI 10.1007/BF02035970; AMBE S, 1991, CHEM LETT, P149, DOI 10.1246/cl.1991.149; KINRAIDE TB, 1992, PLANT PHYSIOL, V99, P1461, DOI 10.1104/pp.99.4.1461; EVANS CH, 1983, TRENDS BIOCHEM SCI, V8, P445, DOI 10.1016/0968-0004(83)90032-4; Bargagli R., 1998, TRACE ELEMENTS TERRE, P1; BATRA S, 1982, ACTA PHYSIOL SCAND, V114, P447, DOI 10.1111/j.1748-1716.1982.tb07008.x; COSSA A, 1870, GAZZ CHIM ITAL, V9, P118; DAS T, 1988, BIOL TRACE ELEM RES, V18, P201, DOI 10.1007/BF02917504; DOGGENWE.CF, 1965, P NATL ACAD SCI USA, V53, P425, DOI 10.1073/pnas.53.2.425; EVANS CH, 1981, BIOCHEM J, V195, P677; Evans C.H., 1990, BIOCH LANTHANIDES, P9; FURIE B, 1975, J BIOL CHEM, V248, P5821; FURIE BC, 1975, J BIOL CHEM, V250, P601; GLADNEY ES, 1980, ANAL CHIM ACTA, V118, P385, DOI 10.1016/S0003-2670(01)93617-7; GOGELEIN H, 1981, BIOCHIM BIOPHYS ACTA, V640, P185, DOI 10.1016/0005-2736(81)90544-7; GOMEZ JE, 1974, BIOCHEMISTRY-US, V13, P3745, DOI 10.1021/bi00715a020; HOOYMANS.JJ, 1969, PLANTA, V88, P369, DOI 10.1007/BF00387465; Kabata-Pendias A, 1984, TRACE ELEMENTS SOILS, P315; KANNO C, 1992, BIOSCI BIOTECH BIOCH, V56, P900; KIRKBY EA, 1984, PLANT CELL ENVIRON, V140, P65; KOYAMA M, 1987, J RADIOAN NUCL CH AR, V112, P489, DOI 10.1007/BF02132381; LAUL JC, 1982, RARE EARTHS MODERN S, V3, P351; Liu B, 1997, J RADIOANAL NUCL CH, V223, P3, DOI 10.1007/BF02223355; Marschner H., 1995, MINERAL NUTR HIGHER, P405, DOI 10.1016/B978-012473542-2/50012-2; Ozaki T, 1997, J RADIOANAL NUCL CH, V217, P117, DOI 10.1007/BF02055359; POLYA GM, 1987, BIOCHIM BIOPHYS ACTA, V931, P68, DOI 10.1016/0167-4889(87)90051-6; RENGEL Z, 1994, J PLANT PHYSIOL, V143, P47; ROBINSON WO, 1958, GEOCHIM COSMOCHIM AC, V14, P55, DOI 10.1016/0016-7037(58)90093-0; SUREK B, 1987, PLANTA, V171, P565, DOI 10.1007/BF00392307; TAKATA M, 1966, J GEN PHYSIOL, V50, P461, DOI 10.1085/jgp.50.2.461; WYTTENBACH A, 1994, BIOL TRACE ELEM RES, V41, P13, DOI 10.1007/BF02917214	32	14	19	GUSTAV FISCHER VERLAG	JENA	VILLENGANG 2, D-07745 JENA, GERMANY	0176-1617			J PLANT PHYSIOL	J. Plant Physiol.	MAR	2000	156	3					330	334				5	Plant Sciences	Plant Sciences	300WA	WOS:000086275100008		
J	Ito, M; Watanabe, K; Kita, Y; Kawahara, T; Crawford, DJ; Yahara, T				Ito, M; Watanabe, K; Kita, Y; Kawahara, T; Crawford, DJ; Yahara, T			Phylogeny and phytogeography of Eupatorium (Eupatorieae, Asteraceae): Insights from sequence data of the nrDNA ITS regions and cpDNA RFLP	JOURNAL OF PLANT RESEARCH			English	Article						Arcto-Tertiary geoflora; Asteraceae; divergence time; Eupatorium; North American-Asian-European disjunction phytogeography	EASTERN NORTH-AMERICA; DISJUNCT SECTION RYTIDOSPERMUM; NUCLEAR RIBOSOMAL DNA; CHLOROPLAST-DNA; LIQUIDAMBAR HAMAMELIDACEAE; MAGNOLIA MAGNOLIACEAE; MOLECULAR DIVERGENCE; SUNFLOWER FAMILY; GENUS; BIOGEOGRAPHY	The relationships of eastern North American-eastern Asian-European disjuncts in the genus Eupatorium were examined by sequencing the internal transcribed spacers (TTS) of nuclear ribosomal DNA and restriction site analysis of chloroplast DNA, Molecular data provided strong evidence that (1) this genus originated in North America, (2) the genus diverged into three morphological species groups, Eutrochium, Traganthes and Uncasia in North America, and (3) one of the North American Uncasia lineages migrated into temperate Europe and eastern Asia over the Bering land bridge. The estimated divergence times support a late Miocene to early Pliocene migration from North America to Eurasia via the Bering land bridge. A European species was sister to all of the eastern Asian species examined. The disjunct distribution pattern of the genus Eupatorium is incongruent with the classical Arcto-Tertiary geoflora concept.	Chiba Univ, Fac Sci, Dept Biol, Chiba 2638522, Japan; Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; Univ Tokyo, Grad Sch Sci, Dept Bot, Tokyo 1130033, Japan; Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido 0628516, Japan; Ohio State Univ, Dept Plant Sci, Columbus, OH 43210 USA; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Ito, M (reprint author), Chiba Univ, Fac Sci, Dept Biol, Chiba 2638522, Japan.	mito@lycoris.s.chiba-u.ac.jp					Li JH, 1997, RHODORA, V99, P229; Wen J, 1998, AM J BOT, V85, P866, DOI 10.2307/2446422; CHANEY RW, 1947, ECOL MONOGR, V17, P139, DOI 10.2307/1943260; Qiu YL, 1995, AM J BOT, V82, P1589, DOI 10.2307/2446188; WEN J, 1995, PLANT SYST EVOL, V196, P173, DOI 10.1007/BF00982958; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; SUH YB, 1993, AM J BOT, V80, P1042, DOI 10.2307/2445752; HOEY MT, 1991, AM J BOT, V78, P938, DOI 10.2307/2445172; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; Schnabel A, 1998, AM J BOT, V85, P1753, DOI 10.2307/2446510; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; JANSEN RK, 1987, CURR GENET, V11, P553, DOI 10.1007/BF00384619; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73; Wen J, 1996, BIOCHEM SYST ECOL, V24, P735, DOI 10.1016/S0305-1978(97)81212-4; Qiu YL, 1995, AM J BOT, V82, P1582, DOI 10.2307/2446187; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; PARKS CR, 1990, AM J BOT, V77, P1243, DOI 10.2307/2444585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Axelrod DI, 1960, EVOLUTION DARWIN, P227; COREY EL, 1955, PLANT TAXONOMY; COX CB, 1990, J BIOGEOGR, V17, P117, DOI 10.2307/2845321; Cunningham C.W., 1994, P405; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; ENGLER A, 1979, VERSUCH ENTWICKLUNGS, V1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; GRAY A., 1878, AM J SCI, V16, P183; Gray A, 1878, AM J SCI, V3, P85; Gray A., 1859, MEM AM ACAD ARTS, V6, P377, DOI 10.2307/25057953; HARA H, 1952, J FAC SCI U TOKYO  1, V6, P29; HARA H, 1956, BOTANY, V6, P343; Hasebe M, 1998, J PLANT RES, V111, P441, DOI 10.1007/BF02507809; ILTIS HH, 1983, P US JAP SCI SEM OR, P49; Ito M, 1998, J PLANT RES, V111, P217, DOI 10.1007/BF02512173; Ito M, 2000, J PLANT RES, V113, P91, DOI 10.1007/PL00013919; ITO M, 1992, AM J BOT S7, V76; KAWAHARA T, 1989, Plant Species Biology, V4, P37, DOI 10.1111/j.1442-1984.1989.tb00046.x; KAZEMPOUR O, 1999, J PLANT RES, V112, P35; King R. M., 1987, MISSOURI BOT GARD, V22, P1; KING R M, 1970, Taxon, V19, P769, DOI 10.2307/1219289; KING R M, 1970, Phytologia, V19, P431; KITA Y, 2000, UNPUB PLANT SYST EVO; LAMONT EE, 1990, BRITTONIA, V42, P279, DOI 10.2307/2806817; Li H. - L, 1972, FLORISTICS PALEOFLOR, P65; Li W.H., 1997, MOL EVOLUTION; SANG T, 1995, SYST BOT, V20, P55, DOI 10.2307/2419632; SULLIVAN VI, 1975, CAN J BOT, V53, P582; SULLIVAN VI, 1976, CAN J BOT, V54, P2907; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243; Watanabe Kuniaki, 1998, Korean Journal of Plant Taxonomy, V28, P83; WATANABE K, 1990, PLANT SYST EVOL, V170, P215, DOI 10.1007/BF00937705; WATANABE K, 1995, ANN MO BOT GARD, V82, P581, DOI 10.2307/2399838; WATANABE Y, 1986, ASIA PAC J PHARMACOL, V1, P99; Wen J., 1996, CURRENT TOPICS MOL E, P37; White T J, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; WOLFE J A, 1987, Journal of the Faculty of Science Hokkaido University Series IV Geology and Mineralogy, V22, P1; WOLFE JA, 1987, ANN MO BOT GARD, V74, P785, DOI 10.2307/2399450; WOLFE JA, 1981, VICARIANCE BIOGEOGRA, P413; Xiang QY, 1998, EVOLUTION, V52, P988, DOI 10.2307/2411231; YAHARA T, 1995, FLORA JAPAN B, V3, P110	63	17	18	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAR	2000	113	1109					79	89		10.1007/PL00013913		11	Plant Sciences	Plant Sciences	308DN	WOS:000086695400010		
J	Murata, T				Murata, T			Preprophase band in fern protonemata: Mechanism of development and comparison with flowering plants	JOURNAL OF PLANT RESEARCH			English	Article						Adiantum; cytokinesis; fern protonema; microtubule; nuclear position; preprophase band	ADIANTUM-CAPILLUS-VENERIS; CELL PLATE FORMATION; GUARD MOTHER CELLS; CORTICAL MICROTUBULES; PLASMA-MEMBRANE; APICAL GROWTH; DIVISION; ORGANIZATION; LIGHT; ORIENTATION	In multicellular plants, oriented cell division is one of the essential processes in development. Fern protonemata provide a unique system for the study of cell division because of their simple tissue organization and photo-regulation of cell division. The site of cell division seems to be regulated by a preprophase band of microtubules. Displacement of organelles by centrifugation revealed mechanisms involved in preprophase band development and function in protonemata of Adiantum capillus-veneris L. This review focuses on mechanisms of preprophase band development in fern protonemata.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Murata, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan.						TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; NAGATA T, 1992, INT REV CYTOL, V132, P1; Mineyuki Y, 1999, INT REV CYTOL, V187, P1; Samuels AL, 1996, PROTOPLASMA, V195, P144, DOI 10.1007/BF01279193; COOKE TJ, 1995, INT J PLANT SCI, V156, P367, DOI 10.1086/297258; BONSIGNORE CL, 1985, PROTOPLASMA, V129, P28, DOI 10.1007/BF01282302; BURGESS J, 1968, PLANTA, V80, P1, DOI 10.1007/BF00387183; CHO SO, 1989, J CELL SCI, V92, P581; CLEARY AL, 1989, PROTOPLASMA, V149, P67, DOI 10.1007/BF01322979; Furuya M, 1997, PLANT PHYSIOL, V113, P677; GALATIS B, 1984, PROTOPLASMA, V122, P11, DOI 10.1007/BF01279433; GUNNING BES, 1978, PLANTA, V143, P145, DOI 10.1007/BF00387787; Hush J, 1996, CELL BIOL INT, V20, P275, DOI 10.1006/cbir.1996.0031; KADOTA A, 1977, DEV GROWTH DIFFER, V19, P357; Kazama H, 1997, J PLANT RES, V110, P489, DOI 10.1007/BF02506810; Lloyd CW, 1982, CYTOSKELETON PLANT G, P229; Lloyd C.W., 1991, CYTOSKELETAL BASIS P, P245; McClinton RS, 1997, PLANTA, V201, P252, DOI 10.1007/s004250050064; MINEYUKI Y, 1990, J CELL SCI, V97, P527; MINEYUKI Y, 1990, J CELL SCI, V97, P283; MINEYUKI Y, 1991, J CELL SCI, V100, P551; MINEYUKI Y, 1980, DEV GROWTH DIFFER, V22, P867; MINEYUKI Y, 1989, PLANTA, V178, P291, DOI 10.1007/BF00391856; MINEYUKI Y, 1991, J PLANT PHYSIOL, V138, P640; MIYATA M, 1979, DEV GROWTH DIFFER, V21, P577; MULLINAX JB, 1989, PROTOPLASMA, V149, P89, DOI 10.1007/BF01322981; MURATA T, 1991, PLANT CELL PHYSIOL, V32, P1145; MURATA T, 1993, J PLANT RES, V106, P305, DOI 10.1007/BF02345974; MURATA T, 1987, PROTOPLASMA, V141, P135, DOI 10.1007/BF01272895; MURATA T, 1991, PLANTA, V183, P391, DOI 10.1007/BF00197738; MURATA T, 1989, PROTOPLASMA, V151, P73, DOI 10.1007/BF01403443; Murata T, 1996, PLANT CELL PHYSIOL, V37, P263; MURATA T, 1999, 16 INT BOT C, P77; Murata T, 1997, PLANTA, V201, P273, DOI 10.1007/s004250050066; MURATA T, 1992, J CELL SCI, V101, P93; MURATA T, 1993, J PLANT RES, V106, P313, DOI 10.1007/BF02345975; MURATA T, 1989, PLANTA, V178, P334, DOI 10.1007/BF00391861; OTA T, 1961, CYTOLOGIA, V26, P428; PANTERIS E, 1995, PROTOPLASMA, V186, P72, DOI 10.1007/BF01276938; PICKETTH.JD, 1969, J CELL SCI, V4, P397; PICKETTH.JD, 1966, J CELL SCI, V1, P121; Raghavan V., 1989, DEV BIOL FERN GAMETO; SAWAMURA S, 1952, B UTSUNOMIYA U, V2, P167; SCHNEPF E, 1973, PROTOPLASMA, V78, P145, DOI 10.1007/BF01281528; VENVERLOO CJ, 1990, PROTOPLASMA, V155, P85, DOI 10.1007/BF01322618; WADA M, 1972, PLANT PHYSIOL, V49, P110, DOI 10.1104/pp.49.2.110; Wada M., 1991, CYTOSKELETAL BASIS P, P277; WADA M, 1978, BOT MAG TOKYO, V91, P113, DOI 10.1007/BF02498255; WADA M, 1988, BOT MAG TOKYO, V101, P111, DOI 10.1007/BF02488888; WADA M, 1980, BOT MAG TOKYO, V93, P237, DOI 10.1007/BF02489325; WADA M, 1989, ANNU REV PLANT PHYS, V40, P169; WADA M, 1970, Development Growth and Differentiation, V12, P109; WADA M, 1975, PLANTA, V126, P213, DOI 10.1007/BF00388964; WADA M, 1983, PLANT CELL PHYSIOL, V24, P1441; WADA M, 1974, PHYSIOL PLANTARUM, V32, P377, DOI 10.1111/j.1399-3054.1974.tb03155.x; Wick SM, 1991, CYTOSKELETAL BASIS P, P231	56	1	1	BOTANICAL SOC JAPAN	TOKYO	TOSHIN BUILDING HONGO 2-27-2 BUNKYO-KU, TOKYO, 113, JAPAN	0918-9440			J PLANT RES	J. Plant Res.	MAR	2000	113	1109					111	118		10.1007/PL00013911		8	Plant Sciences	Plant Sciences	308DN	WOS:000086695400014		
J	Thomke, S; Fujimoto, T				Thomke, S; Fujimoto, T			The effect of "front-loading" problem-solving on product development performance	JOURNAL OF PRODUCT INNOVATION MANAGEMENT			English	Article							INNOVATION	In recent years, there has been a growing interest in the link between problem-solving capabilities and product development performance. In this article, the authors apply a problem-solving perspective to the management of product development and suggest how shifting the identification mid solving of problems-a concept that they define as front-loading-can reduce development time and cost and thus free up resources to be more innovative in the marketplace. The authors develop a framework of front-loading problem-solving and present related examples and case evidence front development practice. These examples include Boeing's and Chrysler's experience with the use of "digital mock-ups" to identify interference problems that are very costly to solve if identified further dol downstream-sometimes as late as during or-after first frill-scale assembly. lit the article, the authors propose that front-loading cart he achieved using a number of different approaches, two of which are discussed iii detail: (I) project-to-project knowledge transfer-leverage previous projects by transferring problem and solution-specific information to new projects; and (2) rapid problem-solving-leverage advanced technologies and methods to increase the overall rate at which development problems are identified and solved. Methods for improving project-to-project knowledge transfer include the effective use of "post-mortems," which are records of post-project learning and thus carl be instrumental in carrying forward the knowledge front current and past projects. As the article suggests, rapid problem-solving carl be achieved by optimally combining new technologies (such as computer simulation) that allow for faster problem-solving cycles with traditional technologies (such as late stage prototypes), which usually provide higher-fidelity. A field study of front-looking at Toyota Motor Corporation shows how ct systematic effort to front-load its development process has, iii effect, shifted problem-identification and problem-solving to earlier stages of product development. They conclude the at-tide with a discussion of other approaches to front-load problem-solving in product development and propose how a problem-solving perspective cart help managers to build capabilities for higher development performance. (C) 2000 Elsevier Science Inc.	Univ Tokyo, Fac Econ, Tokyo 113, Japan; Harvard Univ, Sch Business, Boston, MA 02163 USA	Fujimoto, T (reprint author), Univ Tokyo, Fac Econ, Tokyo 113, Japan.						Adler Paul S., 1995, ORG SCI, V6; ALLEN TJ, 1966, IEEE T ENG MANAGE, VEM13, P72; Griffin A, 1997, J ENG TECHNOL MANAGE, V14, P1, DOI 10.1016/S0923-4748(97)00004-0; Thomke SH, 1998, MANAGE SCI, V44, P743, DOI 10.1287/mnsc.44.6.743; GUPTA AK, 1990, CALIF MANAGE REV, V32, P24; Thomke SH, 1998, RES POLICY, V27, P55, DOI 10.1016/S0048-7333(98)00024-9; AOSHIMA Y, 1996, THESIS MIT; ARGYRIS C, 1982, REASONING LEARNING A; Boehm B., 1981, SOFTWARE ENG EC; Brooks Fred, 1982, MYTHICAL MAN MONTH; BROWN SL, 1995, ACAD MANAGE REV, V20, P343, DOI 10.2307/258850; Clark K. B., 1989, J ENG TECHNOL MANAGE, V6, P25, DOI 10.1016/0923-4748(89)90013-1; Clark K.B., 1991, PRODUCT DEV PERFORMA; COOPER RG, 1994, J PROD INNOVAT MANAG, V11, P381, DOI 10.1016/0737-6782(94)90028-0; CRAWFORD CM, 1992, J PROD INNOVAT MANAG, V9, P188, DOI 10.1111/1540-5885.930188; Cusumano M., 1995, MICROSOFT SECRETS; Cusumano M.A., 1998, THINKING LEAN MULTIP; Fujimoto T, 1989, THESIS HARVARD BUSIN; GAREL G, 1998, 5 EIASM INT PROD DEV; Iansiti M., 1997, TECHNOLOGY INTEGRATI; JAGAWA T, 1995, IBEC 95; KRISHNAN V, 1997, MANAGEMENT SCI, V43; LIKER J, 1992, COMMUNICATIONS ACM, V35; MARPLES DL, 1961, IRE TRANS ENG MANAGE, V8, P55; MCDONOUGH EF, 1992, J PROD INNOVAT MANAG, V9, P44, DOI 10.1016/0737-6782(92)90060-P; Meyer C., 1993, FAST CYCLE TIME; Meyer M.H., 1997, POWER PRODUCT PLATFO; NELSON RR, 1994, FUNDAMENTAL ISSUES S; Petroski H., 1992, ENG IS HUMAN; Pisano C. P., 1996, DEV FACTORY; Sabbagh K., 1996, 21 CENTURY JET MAKIN, V777; Schwartz N.L., 1982, MARKET STRUCTURE INN; Scott-Morton M., 1967, THESIS HARVARD BUSIN; Senge P, 1990, 5 DISCIPLINE ART PRA; Simon H. A., 1969, SCI ARTIFICIAL; SMITH P. G., 1998, DEV PRODUCTS HALF TI; TERWIESCH C, 1998, 9845TM INSEAD MAN SC; THOMKE S, 1998, 99053 HARV BUS SCH; THOMKE S, 1998, DIGITAL AUTO PROJECT; Thomke SH, 1997, RES POLICY, V26, P105, DOI 10.1016/S0048-7333(96)00918-3; VERGANTI R, 1997, R D MANAGEMENT; VONHIPPEL E, 1994, MANAGE SCI, V40, P429, DOI 10.1287/mnsc.40.4.429; VONHIPPEL E, 1990, RES POLICY, V19, P407, DOI 10.1016/0048-7333(90)90049-C; VONHIPPEL E, 1994, RES POLICY, V19, P1; Watkins Michael, 1994, STRATEGIES MANAGING; Wheelwright S.C., 1992, REVOLUTIONIZING PROD	46	118	120	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0737-6782			J PROD INNOVAT MANAG	J. Prod. Innov. Manage.	MAR	2000	17	2					128	142		10.1016/S0737-6782(99)00031-4		15	Business; Engineering, Industrial; Management	Business & Economics; Engineering	294GB	WOS:000085902500005		
J	Mino, Y; Oshima, I; Tsuda, T; Okagami, K				Mino, Y; Oshima, I; Tsuda, T; Okagami, K			No relationship between schizophrenic birth and influenza epidemics in Japan	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						influenza; epidemic; Japan; birth; schizophrenia	IN-UTERO EXPOSURE; PRENATAL EXPOSURE; ADULT SCHIZOPHRENIA; MATERNAL INFLUENZA; FOLLOW-UP; ETIOLOGY; RISK	The finding that influenza epidemics are associated with an increased risk of adult schizophrenia has been controversial. Data was obtained from Japan's governmental statistics, the Patient Survey. Index years were defined as 1957/1958, 1962, and 1965, and comparison years were defined 2 years before and 2 years after the index year. Subjects were patients with schizophrenia who were born in the index years of influenza epidemics. Periods 5 months after the influenza epidemics were defined as exposed months. Proportions of patients born during the exposed period in the index years were compared with those of patients born in the corresponding months in the comparison years. The proportions of patients born in the exposed months in the index years were not significantly different from those born in the corresponding months in the comparison years, with odds ratios around 1 in the whole country, the Kanto area, and the Shikoku/Kyushu area where a remarkable influenza epidemic was observed in 1957. No difference was observed in analyses stratified by sex. In Japan, there was no relationship between influenza epidemics and schizophrenic birth. (C) 2000 Elsevier Science Ltd. All rights reserved.	Okayama Univ, Sch Med, Dept Hyg & Prevent Med, Okayama 7008558, Japan; Univ Tokyo, Fac Med, Sch Hlth Sci, Dept Mental Hlth, Tokyo 1130033, Japan; Natl Federat Families Mentally Ill, Res Inst Mental Hlth & Welf Zenkaren, Tokyo 110, Japan	Mino, Y (reprint author), Okayama Univ, Sch Med, Dept Hyg & Prevent Med, 2-5-1 Shikatacho, Okayama 7008558, Japan.						ADAMS W, 1993, BRIT J PSYCHIAT, V163, P522, DOI 10.1192/bjp.163.4.522; Izumoto Y, 1999, BIOL PSYCHIAT, V46, P119, DOI 10.1016/S0006-3223(98)00359-X; KENDELL RE, 1989, ARCH GEN PSYCHIAT, V46, P878; MCGRATH JJ, 1994, SCHIZOPHR RES, V14, P1, DOI 10.1016/0920-9964(94)90002-7; Cannon M, 1996, BRIT J PSYCHIAT, V168, P368, DOI 10.1192/bjp.168.3.368; BRADBURY TN, 1985, PSYCHOL BULL, V98, P569, DOI 10.1037//0033-2909.98.3.569; Morgan V, 1997, SCHIZOPHR RES, V26, P25, DOI 10.1016/S0920-9964(97)00033-9; BOYD JH, 1986, SCHIZOPHRENIA BULL, V12, P173; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; BARR CE, 1990, ARCH GEN PSYCHIAT, V47, P869; CROW TJ, 1992, BRIT J PSYCHIAT, V161, P390, DOI 10.1192/bjp.161.3.390; CROW TJ, 1994, BRIT J PSYCHIAT, V164, P588, DOI 10.1192/bjp.164.5.588; *DIV HLTH WELF STA, 1957, ANN MORB SCH REP COM; JABLENSKY A, 1995, EPIDEMIOL REV, V17, P10; KAJI M, 1997, INFLUENZA KAZE COLD; Kelsey JL, 1996, METHODS OBSERVATIONA; KUNUGI H, 1995, AM J PSYCHIAT, V152, P450; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189; OCALLAGHAN E, 1991, LANCET, V337, P1248, DOI 10.1016/0140-6736(91)92919-S; SHAM PC, 1992, BRIT J PSYCHIAT, V160, P461, DOI 10.1192/bjp.160.4.461; *STAT INF DEP MIN, 1993, STAT COMM DIS; *STAT INF DEP MIN, 1995, PAT SURV 1993; SUSSER E, 1994, AM J PSYCHIAT, V151, P922; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; TAKEI N, 1994, AM J PSYCHIAT, V151, P117; WHO, 1978, MENT DIS GLOSS GUID	26	19	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956			J PSYCHIAT RES	J. Psychiatr. Res.	MAR-APR	2000	34	2					133	138		10.1016/S0022-3956(00)00003-0		6	Psychiatry	Psychiatry	309AN	WOS:000086745200007		
J	Ihn, H; Yazawa, N; Kubo, M; Yamane, K; Sato, S; Fujimoto, M; Kikuchi, K; Soma, Y; Tamaki, K				Ihn, H; Yazawa, N; Kubo, M; Yamane, K; Sato, S; Fujimoto, M; Kikuchi, K; Soma, Y; Tamaki, K			Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease	JOURNAL OF RHEUMATOLOGY			English	Article						Th2 lymphocyte; ELISA; interleukin 6; CD30	SYSTEMIC-SCLEROSIS; TH2-TYPE CYTOKINES; LINEAR SCLERODERMA; T-CELLS; ABNORMALITIES; EXPRESSION; INTERLEUKIN-2; INVOLVEMENT; ANTIBODIES; SPECTRUM	Objective. To determine serum soluble CD30 (sCD30) levels in patients with localized scleroderma. Methods. Serum soluble CD30 levels were assayed by a sensitive ELISA in 55 patients with localized scleroderma. in 15 with systemic sclerosis (SSc), and in 20 healthy controls. Results, Serum levels of sCD30 were significantly higher in patients with localized scleroderma than in healthy controls. Serum levels of sCD30 were correlated with the number of sclerotic lesions, the number of involved areas, levels of anti-histone antibody IgM, and levels of interleukin 6. sCD30 levels in sera from patients with SSc were also significantly higher than in healthy controls. Conclusion. These results suggest possible involvement of Th2 cells in the immunopathogenesis in localized scleroderma. and serum sCD30 levels may be helpful in following the outcome of the disease.	Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 113, Japan; Kanazawa Med Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan	Ihn, H (reprint author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						CALIGARISCAPPIO F, 1995, CLIN EXP RHEUMATOL, V13, P339; LEROY EC, 1988, J RHEUMATOL, V15, P202; FALINI B, 1995, BLOOD, V85, P1; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; GOLDMAN M, 1991, IMMUNOL TODAY, V12, P223, DOI 10.1016/0167-5699(91)90034-Q; CHRISTIANSON HB, 1956, ARCH DERMATOL, V74, P629; IHN H, 1992, ARCH DERMATOL RES, V284, P391, DOI 10.1007/BF00372068; DELPRETE G, 1995, FASEB J, V9, P81; FALANGA V, 1986, ANN INTERN MED, V104, P849; Gerli R, 1995, CLIN EXP IMMUNOL, V102, P547; Giacomelli R, 1997, CLIN EXP IMMUNOL, V108, P42, DOI 10.1046/j.1365-2249.1997.d01-991.x; Ihn H, 1996, BRIT J DERMATOL, V134, P843; IHN H, 1994, J AM ACAD DERMATOL, V31, P591; IHN H, 1995, ARCH DERMATOL RES, V287, P193, DOI 10.1007/BF01262331; Mavilia C, 1997, AM J PATHOL, V151, P1751; RODNAN GP, 1977, ARTHRITIS RHEUM, V20, P133; RODNAN GR, 1981, B RHEUM DIS, V31, P7; ROMAGNANI S, 1995, J LEUKOCYTE BIOL, V57, P726; SATO S, 1993, ARTHRITIS RHEUM, V36, P1137, DOI 10.1002/art.1780360815; SCAROLA JA, 1975, ARTHRITIS RHEUM, V18, P526; TAKEHARA K, 1983, ARTHRITIS RHEUM, V26, P612, DOI 10.1002/art.1780260506; TAKEHARA K, 1990, ARCH DERMATOL, V126, P1368, DOI 10.1001/archderm.126.10.1368; WOO TY, 1985, ARCH DERMATOL, V121, P1403, DOI 10.1001/archderm.121.11.1403	23	31	32	J RHEUMATOL PUBL CO	TORONTO	920 YONGE ST, SUITE 115, TORONTO, ONTARIO M4W 3C7, CANADA	0315-162X			J RHEUMATOL	J. Rheumatol.	MAR	2000	27	3					698	702				5	Rheumatology	Rheumatology	290WG	WOS:000085700400025		
J	Fukuyama, M				Fukuyama, M			Discrete symmetry breaking for certain short-range interactions	JOURNAL OF STATISTICAL PHYSICS			English	Article						Gibbs measure; phase transition; lattice spin system; discrete symmetry breaking		Georgii's theorem ensures that, restricted to two-dimensional planes, a single ocean (i.e., infinite connected component) of a ground state and islands (i.e.. finite connected components) are observed in lattice spin systems at sufficiently; low temperature. This paper extends his results for higher dimensional hyperplanes. Our proof is mainly based on a third of Peierls argument and is different from Georgii's, which relies on the percolation method.	Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan	Fukuyama, M (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan.						GEORGII HO, 1981, COMMUN MATH PHYS, V81, P455, DOI 10.1007/BF01208268; Georgii HO, 1988, GIBBS MEASURES PHASE; Sinai Y. G., 1982, THEORY PHASE TRANSIT	3	1	1	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715			J STAT PHYS	J. Stat. Phys.	MAR	2000	98	5-6					1049	1061		10.1023/A:1018607526690		13	Physics, Mathematical	Physics	304CQ	WOS:000086465500002		
J	Xu, Y; Aizawa, T				Xu, Y; Aizawa, T			Surface wave velocity determination by using reflection coefficient method on the liquid-anisotropic-solid interface	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							ACOUSTIC-WAVES	Reflection coefficient of a plane wave impinging from liquid onto a liquid-anisotropic-solid interface is useful to theoretically predict the Rayleigh surface wave (RSW) velocity and the pseudo surface wave (PSW) velocity dispersions. In the present letter, several incomplete results proposed by previous investigation are restudied to attempt giving more appropriate physical understanding in theory. It is found that PSW velocity determined by the reflection coefficient analysis is just a nonleaky effect surface wave on the liquid-anisotropic-solid interface but not the leaky one. (C) 2000 Acoustical Society of America. [S0001-4966(00)00801-8].	Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan	Xu, Y (reprint author), Univ Tokyo, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						Darinskii AN, 1998, WAVE MOTION, V28, P241, DOI 10.1016/S0165-2125(98)00009-2; MAZNEV AA, 1995, PHYS LETT A, V197, P423, DOI 10.1016/0375-9601(94)00985-X; LIM TC, 1968, J APPL PHYS, V39, P4319, DOI 10.1063/1.1656967; ARIKAN O, 1989, J ACOUST SOC AM, V85, P1, DOI 10.1121/1.397726; ATALAR A, 1983, J ACOUST SOC AM, V73, P435, DOI 10.1121/1.388991; BREKHOVSKIKH LM, 1980, WAVES LAYERED MEDIA, P45; Farnell G. W., 1970, PHYS ACOUSTICS, VVI, P109; LIM TC, 1969, J ACOUST SOC AM, V45, P845, DOI 10.1121/1.1911556; NAYFEH AH, 1991, WAVE MOTION, V14, P55, DOI 10.1016/0165-2125(91)90048-S; Tamura S, 1996, PHYS REV B, V54, P5151, DOI 10.1103/PhysRevB.54.5151	10	0	0	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0001-4966			J ACOUST SOC AM	J. Acoust. Soc. Am.	MAR	2000	107	3					1777	1780		10.1121/1.428576		4	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	291YR	WOS:000085767800068		
J	Voorhees, AS; Araki, S; Sakai, R; Sato, H				Voorhees, AS; Araki, S; Sakai, R; Sato, H			An ex post cost-benefit analysis of the nitrogen dioxide air pollution control program in Tokyo	JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION			English	Article								The benefits and costs of past nitrogen dioxide (NO2) control policies were calculated for Tokyo, Japan, using environmental, economic, political, demographic, and medical data from 1973 to 1994. The benefits of NO2 control were estimated as medical expenses and lost work time due to hypothetical no-control air concentrations of NO2. Direct costs were calculated as annualized capital expenditures and 1 year's operating costs for regulated industries plus governmental agency expenses. The major findings were as follows: (1) Using Tokyo's average medical cost of pollution-related illness, the best net estimate of the avoided medical costs due to incidence of phlegm and sputum in adults was 730 billion yen ($6.08 billion; 1 U.S. dollar = 120 yen). (2) The best net estimate of the avoided medical costs due to incidence of lower respiratory illness in children was 93 billion yen ($775 million). (3) Using Tokyo's average duration of pollution-related illness and average wages, the best net estimate of the avoided costs of lost wages in workers was 760 billion yen ($6.33 billion). (4) The best net estimate of the avoided costs of lost wages in mothers caring for their sick children was 100 billion yen ($833 million). (5) Using Tokyo-specific data, the best net costs were estimated as 280 billion yen ($2.33 billion). (6) Using human health and productivity benefits, and annualized capital cost and operating cost estimates, the best net benefits-to-costs ratio was 6:1 (upper limit 44:1; lower limit 0.3:1). Benefit calculations were sensitive to assumptions of mobile source emissions and certain health impacts that were not included. Cost calculations were highly dependent on assumptions of flue gas volume and fuel use. For comparative purposes, we identified other studies for air pollution-related illness. Assumptions that formed the basis for most of the inputs in the present study, such as duration of illness, medical treatment costs, per person illness in children, and lost wages for working mothers, were similar to those recommended in the literature. Lost wages in sick workers and per capita illness incidence in adults were higher than numbers reported elsewhere. Further advances in cost-benefit analysis (CBA) procedures to evaluate the economic effectiveness of NO2 controls in Tokyo are recommended to estimate impacts and values for additional human health benefits, ecosystem health and productivity effects, and nonliving system effects, as well as benefits of ancillary reductions in other pollutants. The present study suggests that Tokyo's past NO2 control policies in total were economically quite effective.	Univ Tokyo, Grad Sch Med, Dept Publ Hlth & Occupat Med, Bunkyo Ku, Tokyo 113, Japan	Voorhees, AS (reprint author), Univ Tokyo, Grad Sch Med, Dept Publ Hlth & Occupat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						AUSTIN DH, 1997, 9734 RES FUT; BABA H, 1998, COMMUNICATION    MAY; BURTRAW D, 1997, 9731REV RES FUT; Cropper M., 1997, 1860 WORLD BANK; *EH PECH ASS INC, 1995, SAMPL CIT COST AN AL; *ENV AG GOV JAP, 1997, JID NOX HO TOK CHIIK; *ENV AG GOV JAP, 1997, KYU SHIT CHIIK BETS; *ENV AG GOV JAP, 1992, BAIEN TEIG GIJ MAN; *ENV AG GOV JAP, 1985, OUTL AIR POLL CONTR; *ENV AG GOV JAP, 1995, IPP KANK TAIK SOK KY; *ENV AG GOV JAP, 1993, KANK HAK HEIS 5 NEN; *ENV AG GOV JAP, 1995, JID HAISH GAS SOK KY; *EUR COMM, 1996, EXT EXT EN RES PROJ, V1; Freeman A. M., 1993, MEASUREMENT ENV RESO; HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662; KENKEL D, 1994, VALUING HLTH POLICY, P42; KRUPNICK A, 1998, 9846 RES FUT; *NAT PERS AUTH, 1994, KOKK KOM KYUYO TO JI; NEUFFER W, 1999, COMMUNICATION    JAN; NISHIKAWA F, 1998, COMMUNICATION    MAY; NISHIKAWA F, 1998, COMMUNICATION    JUN; *ORG EC COOP DEV, 1992, OECD ENV MON, V22; *ORG EC COOP DEV, 1994, OECD ENV PERF REV JA; *ORG EC COOP DEV, 1994, PROJ POL APPR INT EC; Organization for Economic Co-operation and Development, 1995, EC APPR ENV PROJ POL; Ostro B., 1995, 1453 WORLD BANK; Ostro B, 1994, 1301 WORLD BANK; SCHWARTZ J, 1990, AM REV RESPIR DIS, V141, P62; Scura L., 1994, EC ANAL ENV IMPACTS; TACHIKAWA H, 1996, COMMUNICATION    JUL; *TOK METR GOV, 1995, TOK NO JOS ROD JIJ; *TOK METR GOV, 1972, DAI 24 KAI TOK TO TO; *TOK METR GOV, 1996, ENV PROT TOK; *TOK METR GOV, 1994, DAI 46 KAI TOK TO TO; *TOK METR GOV, 1995, BAIEN HASS SHIS UCH; *TOK METR GOV, 1994, TOK TO JID KOG BOSH; *TOK METR GOV, 1974, TOM KOG KAR BOEI SUR; *US EPA, 1998, EPA454R97013; *US EPA, 1997, 450R97002 EPA; *US EPA, 1990, EPA2301290084; *US EPA, 1994, EPA400F92007; *US EPA, 1993, EPA600891049CF; *US EPA, 1993, EPA600891049AF; VOORHEES AS, 1997, P 90 ANN M EXH AIR W	44	12	12	AIR & WASTE MANAGEMENT ASSOC	PITTSBURGH	ONE GATEWAY CENTER, THIRD FL, PITTSBURGH, PA 15222 USA	1047-3289			J AIR WASTE MANAGE	J. Air Waste Manage. Assoc.	MAR	2000	50	3					391	410				20	Engineering, Environmental; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	334MH	WOS:000088189900007		
J	Tanabe, Y; Seino, H; Ishii, Y; Hidai, M				Tanabe, Y; Seino, H; Ishii, Y; Hidai, M			Reaction mechanism of the C N triple bond cleavage of beta-ketonitriles on a molybdenum(0) center	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							RUTHENIUM-CATALYZED ALDOL; DINITROGEN COMPLEXES; MICHAEL REACTIONS; ORGANONITROGEN COMPOUNDS; NITRIDO-COMPLEXES; IMIDO-COMPLEXES; HYDROGEN-BOND; LIGANDS; CHEMISTRY; TUNGSTEN	The molybdenum dinitrogen complex trans-[Mo(N(2))(2)(dppe)(2)] (2) reacted with 2-2.5 equiv of various beta-ketonitriles at room temperature to afford the (nitrido)(nitrile-enolato) complexes trans-(Mo(N)(NCCR(1)-COR(2))(dppe)(2)] (4; R(1) = H, R(2) = 4-MeOCOC(6)H(4), 4-ClC(6)H(4), 4-Tol, 4-MeOC(6)H(4), 2-C(4)H(3)O, 2-C(4)H(3)S, Pr(i); R(1) = CN, R(2) = Me, Ph; dppe = Ph(2)PCH(2)CH(2)PPh(2) via the C=N triple bond cleavage of the nitriles on the molybdenum center. On the other hand, the reaction of complex 2 with ? equiv of pivaloylacetonititrile at room temperature led to the isolation of the (alkylideneamido)(nitrile-enolato) complex trans-[Mo(NCHCH(2)COBu(l)(NCCHCOBu(l))(dppe)(2)] (5k), which further underwent the cleavage of the C=N double bond of the alkylideneamido ligand to give the corresponding (nitrido)(nitrile-enolato) complex trans-[Mo(N)(NCCHCOBu(l))(dppe)(2)] together with 4,4-dimethyl-1-penten-3-one. Furthermore, treatment of 2 with large excess amounts of 3-chlorobenzoylacetonitrile followed by anion metathesis with [NHEt(3)][OTf] (OTf = OSO(2)CF(3)) resulted in me isolation of the cationic (imido)(nitrile-enolato) complex trans-[Mo{NCH(2)CH(2)CO(C(6)H(4)Cl-4)}{NCCHCO-(C(6)H(4)Cl-4)}(dppe)(2)][OTf] (6c(+)[OTf](-)). The solid-state structures of 4h . 1.5C(2)H(4)Cl(2) (R(1) = CN, R(2) = Me), 5k . C(6)H(6), and 6c(+)[OTf](-) were determined by single-crystal X-ray analyses. The detailed NMR analysis of the reaction of 2 with aroylacetonitriles revealed that the (alkylideneamido)(nitrile-enolato) complexes trans-[Mo-NCHCH(2)COR)(NCCHCOR)(dppe)(2)] (5) act as the key intermediates for the C=N triple bond fission. and the rate constants for the conversion of the complexes 5 into the nitrido complexes 4 showed good correlation with the Hammett sigma(p) or sigma(a) constants for the aroyl substituents, when positive rho values were obtained (rho(p), 1.42; rho(a), 0.41). A reaction mechanism for the nitrido complex formation is proposed, which includes (1) the substitution of a dinitrogen ligand in 2 with a beta-ketonitrile molecule, (2) the fast protonation of the nitrite ligand by a second beta-ketonitrile molecule leading to the formation of complex 5, (3) the relatively slow proton shift from the a-position of the carbonyl group to the amido carbon in the alkylideneamido ligand to form an enolated imido ligand. and (4) the fast elimination of a vinyl ketone from the imido ligand giving the nitrido complex 4 as the final product.	Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Hidai, M (reprint author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.						[Anonymous], 1974, INT TABLES XRAY CRYS, V4; Hidai M, 1996, J MOL CATAL A-CHEM, V107, P105, DOI 10.1016/1381-1169(95)00165-4; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Chisholm MH, 1999, CHEM-EUR J, V5, P2318, DOI 10.1002/(SICI)1521-3765(19990802)5:8<2318::AID-CHEM2318>3.0.CO;2-G; Michelin RA, 1996, COORDIN CHEM REV, V147, P299, DOI 10.1016/0010-8545(94)01128-1; Murahashi SI, 1995, J AM CHEM SOC, V117, P12436, DOI 10.1021/ja00155a008; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; KAIM W, 1994, COORDIN CHEM REV, V129, P157, DOI 10.1016/0010-8545(94)85020-8; APPLETON TG, 1978, INORG CHEM, V17, P738, DOI 10.1021/ic50181a048; CHISHOLM MH, 1995, ANGEW CHEM INT EDIT, V34, P110, DOI 10.1002/anie.199501101; SCHROCK RR, 1982, J AM CHEM SOC, V104, P4291, DOI 10.1021/ja00379a061; [Anonymous], 1992, INT TABLES XRAY CRYS, VC; Seino H, 1998, INORG CHIM ACTA, V280, P163, DOI 10.1016/S0020-1693(98)00060-7; ARNOLD DP, 1980, J ORGANOMET CHEM, V199, P119, DOI 10.1016/S0022-328X(00)84529-5; BADDLEY WH, 1973, J ORGANOMET CHEM, V60, pC74, DOI 10.1016/S0022-328X(00)80641-5; BECK W, 1973, CHEM BER-RECL, V106, P2144, DOI 10.1002/cber.19731060708; Beurskens P. T., 1992, DIRDIF PROGRAM SYSTE; Braga D, 1996, CHEM COMMUN, P571, DOI 10.1039/cc9960000571; Braga D, 1997, J CHEM SOC DALTON, P1727, DOI 10.1039/a607690d; CARTER BJ, 1979, J ORGANOMET CHEM, V181, P105, DOI 10.1016/S0022-328X(00)85741-1; Chapman N. B., 1978, CORRELATION ANAL CHE; CHATT J, 1977, J INDIAN CHEM SOC, V54, P13; CHATT J, 1978, J CHEM SOC DALTON, P1638, DOI 10.1039/dt9780001638; CHATT J, 1980, J CHEM SOC DALTON, P121, DOI 10.1039/dt9800000121; DASILVA JJRF, 1993, J ORGANOMET CHEM, V461, P141; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; Dilworth J. R., 1980, INORG SYNTH, V20, P119, DOI 10.1002/9780470132517.ch31; Dorsch JB, 1932, J AM CHEM SOC, V54, P2960, DOI 10.1021/ja01346a047; Dunbar K.R., 1992, COMMENTS INORG CHEM, V13, P313, DOI 10.1080/02603599208048466; Endres H, 1987, COMPREHENSIVE COORDI, V2, P261; ESJORNSON D, 1990, INORG CHEM, V29, P2055, DOI 10.1021/ic00336a006; FAIRHURST SA, 1995, J CHEM SOC DALTON, P1973, DOI 10.1039/dt9950001973; Field LD, 1998, ORGANOMETALLICS, V17, P2394, DOI 10.1021/om970829v; FLEURY JP, 1964, B SOC CHIM FR, P413; HENDERSON RA, 1989, J CHEM SOC DALTON, P425, DOI 10.1039/dt9890000425; Hidai M, 1999, COORDIN CHEM REV, V185-6, P99, DOI 10.1016/S0010-8545(98)00250-1; Hidai M, 1996, B CHEM SOC JPN, V69, P819, DOI 10.1246/bcsj.69.819; HIDAI M, 1989, REACTIONS COORDINATE, V2, P53; HIDAI M, 1993, ACS SYM SER, V535, P346; HIRANO M, 1993, CHEM LETT, P2057, DOI 10.1246/cl.1993.2057; Hirano M, 1998, J ORGANOMET CHEM, V569, P3, DOI 10.1016/S0022-328X(98)00768-2; HUGHES DL, 1990, J CHEM SOC DALTON, P2021, DOI 10.1039/dt9900002021; Kroeker EH, 1934, J AM CHEM SOC, V56, P1171, DOI 10.1021/ja01320a055; LENARDA M, 1972, J ORGANOMET CHEM, V39, P217, DOI 10.1016/S0022-328X(00)88921-4; LONG RS, 1947, J AM CHEM SOC, V69, P990, DOI 10.1021/ja01197a004; MCGILLIGAN BS, 1988, J CHEM SOC DALTON, P1737, DOI 10.1039/dt9880001737; Melander L.C., 1980, REACTION RATES ISOTO; MIZUHO Y, 1991, CHEM LETT, P2127, DOI 10.1246/cl.1991.2127; *MOL STRUCT CORP, 1992, TEXS CRYST AN PACK; Murahashi SI, 1996, B CHEM SOC JPN, V69, P1805, DOI 10.1246/bcsj.69.1805; OVERBERGER CG, 1963, J POLYM SCI        C, V1, P325; POMBEIRO AJL, 1988, J CHEM SOC CHEM COMM, P1052, DOI 10.1039/c39880001052; Seino H, 1999, ORGANOMETALLICS, V18, P4165, DOI 10.1021/om9904605; SHORTER J, 1994, PURE APPL CHEM, V66, P2451, DOI 10.1351/pac199466122451; Song JS, 1996, J AM CHEM SOC, V118, P11134, DOI 10.1021/ja962193p; Steiner T, 1999, CHEM COMMUN, P313, DOI 10.1039/a808974d; Steiner T, 1997, CHEM COMMUN, P727, DOI 10.1039/a603049a; TATSUMI T, 1975, INORG CHEM, V14, P2530, DOI 10.1021/ic50152a047; THOMAS JL, 1975, J AM CHEM SOC, V97, P5943, DOI 10.1021/ja00853a066	59	39	39	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAR 1	2000	122	8					1690	1699		10.1021/ja9921928		10	Chemistry, Multidisciplinary	Chemistry	289NV	WOS:000085629600016		
J	Nakamura, E; Yamanaka, M; Mori, S				Nakamura, E; Yamanaka, M; Mori, S			Complexation of Lewis acid with trialkylcopper(III): On the origin of BF3-acceleration of cuprate conjugate addition	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							REDUCTIVE ELIMINATION; MECHANISM; SUBSTITUTION; REAGENT		Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Nakamura, E (reprint author), Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		Mori, Seiji/F-4825-2010; NAKAMURA, EIICHI/G-5041-2014	Mori, Seiji/0000-0001-7819-5125; 			Eujen R, 1996, J ORGANOMET CHEM, V519, P7, DOI 10.1016/S0022-328X(96)06142-6; KOMIYA S, 1976, J AM CHEM SOC, V98, P7255, DOI 10.1021/ja00439a024; KOMIYA S, 1977, J AM CHEM SOC, V99, P8440, DOI 10.1021/ja00468a010; MATSUZAWA S, 1989, TETRAHEDRON, V45, P349, DOI 10.1016/0040-4020(89)80064-X; BERTZ SH, 1995, J AM CHEM SOC, V117, P11023, DOI 10.1021/ja00149a032; DORIGO AE, 1995, ANGEW CHEM INT EDIT, V34, P476, DOI 10.1002/anie.199504761; Mori S, 1999, CHEM-EUR J, V5, P1534; SNYDER JP, 1995, J AM CHEM SOC, V117, P11025, DOI 10.1021/ja00149a033; Frantz DE, 1997, J AM CHEM SOC, V119, P3383, DOI 10.1021/ja9636348; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Bera JK, 1998, ORGANOMETALLICS, V17, P4136, DOI 10.1021/om980373x; FERINGA BL, 1997, ANGEW CHEM INT EDIT, V36, P2621; KRAUSS SR, 1981, J AM CHEM SOC, V103, P141, DOI 10.1021/ja00391a026; LIPSHUTZ BH, 1990, J AM CHEM SOC, V112, P5869, DOI 10.1021/ja00171a031; MARUYAMA K, 1977, J AM CHEM SOC, V99, P8068, DOI 10.1021/ja00466a059; MUKAIYAM.T, 1973, CHEM LETT, P1011, DOI 10.1246/cl.1973.1011; Nakamura E, 1997, J AM CHEM SOC, V119, P4900, DOI 10.1021/ja964209h; Nakamura E, 1999, J AM CHEM SOC, V121, P8941, DOI 10.1021/ja991324u; Neumann D., 1993, ANGEW CHEM INT EDIT, V32, P1482; SMITH AB, 1981, J AM CHEM SOC, V103, P194, DOI 10.1021/ja00391a038	20	54	54	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAR 1	2000	122	8					1826	1827		10.1021/ja993124o		2	Chemistry, Multidisciplinary	Chemistry	289NV	WOS:000085629600041		
J	Matsumoto, M; Kitaoka, S; Matsubara, H; Kuramoto, S; Kanno, M				Matsumoto, M; Kitaoka, S; Matsubara, H; Kuramoto, S; Kanno, M			Analysis of trace amounts of emitted gases during fracture of high-purity alumina under ultrahigh vacuum - Effects of sintering atmosphere and sintering time on gas emission behavior	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						sintering atmosphere; sintering time; ultrahigh vacuum; mass spectrometer; pore coalescence; alumina	CERAMICS	The effects of sintering atmosphere and sintering time on gas emission behavior during fracture of high-purity Al2O3 were investigated under ultrahigh vacuum using a mass spectrometer to examine the behavior of gases in the material. The gas in the sintering atmosphere was predominantly emitted at the moment of fracture for all specimens. The total amount of gas emitted from a specimen sintered in O-2 was less than that of a specimen sintered in air or Ar, showing that the mobility of O-2 in the material was much higher than that of N-2 or Ar. During prolonged sintering, the density of specimens decreased, while the amount of emitted gas increased. Entrapped gases in the sintered body were concluded to bring about the density decrease during grain growth.	Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Japan Fine Ceram Ctr, Nagoya, Aichi 4568587, Japan	Matsumoto, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						KINGERY WD, 1965, J AM CERAM SOC, V48, P546, DOI 10.1111/j.1151-2916.1965.tb14665.x; NICHOLS FA, 1966, J APPL PHYS, V37, P4599, DOI 10.1063/1.1708102; COBLE RL, 1961, J APPL PHYS, V32, P793, DOI 10.1063/1.1736108; GRESKOVICH C, 1981, J AM CERAM SOC, V64, P725, DOI 10.1111/j.1151-2916.1981.tb15895.x; BROOK RJ, 1969, J AM CERAM SOC, V52, P56, DOI 10.1111/j.1151-2916.1969.tb12664.x; BROOK RJ, 1957, J AM CERAM SOC, V40, P80; COBLE RL, 1962, J AM CERAM SOC, V45, P123, DOI 10.1111/j.1151-2916.1962.tb11099.x; DICKINSON JT, 1987, J VAC SCI TECHNOL A, V5, P1162, DOI 10.1116/1.574627; KINGERY WD, 1959, J AM CERAM SOC, V42, P6, DOI 10.1111/j.1151-2916.1959.tb09134.x; Kitaoka S, 1997, J CERAM SOC JPN, V105, P915, DOI 10.2109/jcersj.105.915; Matsumoto M, 1997, SCRIPTA MATER, V37, P2047, DOI 10.1016/S1359-6462(97)00374-6; Peak Y. K, 1988, J AM CERAM SOC, V71; SHELBY JE, 1996, HDB GAS DIFFUSION SO, P85; SONG KW, 1994, J NUCL MATER, V209, P263; SWALIN RA, 1972, THERMODYNAMICS SOLID, P180; YAMAKAWA A, 1994, NIPPON SERAM KYO GAK, V102, P262	16	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAR	2000	108	3					217	223		10.2109/jcersj.108.1255_217		7	Materials Science, Ceramics	Materials Science	294TV	WOS:000085927200003		
J	Imaoka, M				Imaoka, M			Studies on the conditions of glass formation	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Editorial Material									Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Imaoka, M (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.							0	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAR	2000	108	3					S19	S19		10.2109/jcersj.108.1255_S19		1	Materials Science, Ceramics	Materials Science	294TV	WOS:000085927200001		
J	Imaoka, M				Imaoka, M			Studies on the conditions of glass formation	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			Japanese	Reprint								Studies have been made on the conditions of the formation of multicomponent glass es assuming that the one to one correspondence between the glassy stale and the glass structure does hold good. This idea is strongly supported by the experimental results of the glass formation range of the systems of berate, silicate, germanate, tellurite glasses, etc. The conditions of glass formation may be divided into two groups, namely, one puts stress on the geometry of the structure, and the other on the strength of chemical bonds. The former is represented by Zachariasen's rule, and the latter by the mixed bond, and electronegativity theories etc. However, the author pointed out that the conditions regarding the bond strength are implied by those of geometry being necessary for giving glassy state. According to the picture of glass structure consisting of network and modifier ions Zachriasen's rules are to be applied to the network. The important point in this rule is that the valency of the ion of the network is equal to its coordination number, i.e. Z/S (electrostatic valency) = 1. For multicomponent glasses this condition is to be ex tended as follows: (1) A cation whose valency is less than the coordinate number, an intermediate ion, may join in the network to take the office of a network former if the condition Z/S = l is satisfied by making up the difference with the positive charge of an attached modifier. (2) In order to form glass at least one dimentional continuity should exist in the structure. In addition oxygen polyhedra should share corners, and the central ion of the polyhedra should be small. These conditions of glass formation are supported strongly by the experimental survey of the area of glass formation covering many polycomponent glasses. Furthermore, the glass forming range involving b-subgroup ions as Pb may be explained by the idea that Pb-ion itself helps the formation of network of four coordinated Pb. On the other hand, glass formation range changes by the influence of modifier ions. It was concluded from geometrical calculation that the radius of a modifier ion being most suitable to the network atom is 6 coordination. It the network is formed by four coordinated ions the most suitable radius ratio is R-m/R-n = 2, where R-m and R-n are respectively the radii of modifier and network ions.	Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Imaoka, M (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.						BRADY GW, 1957, J CHEM PHYS, V27, P300, DOI 10.1063/1.1743690; Warren BE, 1938, J AM CERAM SOC, V21, P259, DOI 10.1111/j.1151-2916.1938.tb15774.x; Pauling L, 1929, J AM CHEM SOC, V51, P1010, DOI 10.1021/ja01379a006; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; SUN KH, 1947, J AM CERAM SOC, V30, P277, DOI 10.1111/j.1151-2916.1947.tb19654.x; Bair GJ, 1936, J AM CERAM SOC, V19, P339, DOI 10.1111/j.1151-2916.1936.tb19848.x; BAYNTON PL, 1956, 4 C INT VERR PAR, P52; DIETZEL A, 1948, GLASTECH BER, V22, P43; Ito T, 1939, Z KRISTALLOGR, V102, P13; LEVIN EM, 1957, J AM CERAM SOC, V40, P95, DOI 10.1111/j.1151-2916.1957.tb12583.x; MOORE H, 1951, J GLASS TECH, V35, P43; RAWSON H, 1956, 4TH P INT C GLASS PA, P62; SMEKAL A, 1949, GLASTECH BER, V22, P278; STANWORTH JE, 1952, NATURE, V169, P581, DOI 10.1038/169581b0; STEHLIK B, 1949, COLLECTION CZECHOSLA, V14, P597; STEVELS JM, 1948, PROGR THEORY PHYSICA, P91; Warren BE, 1940, J AM CERAM SOC, V23, P301, DOI 10.1111/j.1151-2916.1940.tb14194.x; WINTER A, 1957, J AM CERAM SOC, V40, P54, DOI 10.1111/j.1151-2916.1957.tb12574.x	18	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAR	2000	108	3					S20	S33				14	Materials Science, Ceramics	Materials Science	294TV	WOS:000085927200002		
J	Maeda, J; Nomoto, S; Matsuoka, S; Izumi, T; Umeda, T; Shiohara, Y				Maeda, J; Nomoto, S; Matsuoka, S; Izumi, T; Umeda, T; Shiohara, Y			Coarsening of Y211 phase particles in the Y-Ba-Cu-O superconducting system	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						superconductor; YBCO; coarsening; Y211 phase	YBA2CU3O7-X; Y2BACUO5; LIQUID; MELT	It is important to understand the coarsening behavior of the Y2BaCuO5 phase particles in Ba-Cu-O melts, since the particle-size distribution of the Y2BaCuO5 particles entrapped in the YBa2Cu3Ox superconducting phase largely affect the superconducting properties. In this paper, we have investigated the dependence of the volume fractions of the high-temperature stable phase Y2BaCuO5 particles in the Ba-Cu-O melt on the coarsening behavior. Consequently, it was found that the coarsening rate constants between the volume fraction of V-f = 10-15% and V-f = 20-30% were significantly different. Furthermore, the particle-size-distributions for the V-f = 20 and 30%, were investigated and discussed.	ISTEC, Superconduct Res Lab, Tokyo 1350062, Japan; Ishikawajima Syst Technol Co Ltd, Tokyo 1350016, Japan; Univ Tokyo, Grad Sch Engn, Dept Met, Tokyo 1138656, Japan	Maeda, J (reprint author), ISTEC, Superconduct Res Lab, Tokyo 1350062, Japan.						LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; IZUMI T, 1993, J CRYST GROWTH, V128, P757, DOI 10.1016/S0022-0248(07)80039-X; IZUMI T, 1993, J MATER RES, V8, P1240, DOI 10.1557/JMR.1993.1240; DEHOFF RT, 1991, ACTA METALL MATER, V39, P2349, DOI 10.1016/0956-7151(91)90016-T; GRIFFITH ML, 1994, J MATER RES, V9, P1633, DOI 10.1557/JMR.1994.1633; Ikuta H, 1998, SUPERCOND SCI TECH, V11, P1345, DOI 10.1088/0953-2048/11/11/001; KRAUNS C, 1994, J MATER RES, V9, P1513, DOI 10.1557/JMR.1994.1513; KRAUNS C, 1994, Z PHYS B CON MAT, V96, P207, DOI 10.1007/BF01313285; TOMOKIYO Y, 1994, PHYSICA C, V219, P288, DOI 10.1016/0921-4534(94)90381-6; VOORHEES PW, 1984, METALL TRANS A, V15, P1081, DOI 10.1007/BF02644701	10	1	1	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	MAR	2000	64	3					184	189				6	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	312KT	WOS:000086943000002		
J	Seki, F				Seki, F			Detection of high density of cube oriented grains in a pure aluminum sheet for capacitor	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Letter						cube texture; recrystallization; texture control; aluminum capacitor foil; crystallographic orientation distribution; electron backscatter diffraction pattern : EBSP		For production of pure aluminum capacitor foils, it is essential to develop a cube texture in the thin foil. This letter presents a detection of layers containing high density of cube oriented grains in an aluminum sheet of 500 mu m thickness, annealed at 300 degrees C. The cube oriented grains formed during an intermediate annealing, probably contribute to the highly-developed cube texture through an additional process. Distribution of the crystallographic orientation in inhomogeneous textures of a transverse section were studied by electron back scatter diffraction pattern measurements.	Univ Tokyo, Sch Engn, Dept Mat Sci, Tokyo 1138656, Japan	Seki, F (reprint author), Univ Tokyo, Sch Engn, Dept Mat Sci, Tokyo 1138656, Japan.						Ito K., 1993, Journal of Japan Institute of Light Metals, V43; KOHARA S, 1958, T METALL SOC AIME, V211, P875; NAKASHIMA S, 1984, TEXTURES, P79; SAIMOTO S, 1993, P TEXTURES MICROSTRU, V21, P109; Seki F., 1998, Journal of Japan Institute of Light Metals, V48, DOI 10.2464/jilm.48.507	5	5	5	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	MAR	2000	64	3					218	219				2	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	312KT	WOS:000086943000008		
J	Asano, T; Asano, Y				Asano, T; Asano, Y			Recent developments in maximum flow algorithms	JOURNAL OF THE OPERATIONS RESEARCH SOCIETY OF JAPAN			English	Article							NETWORK FLOW; TIME	Goldberg and Rao recently proposed the blocking Row method based on a binary length function to obtain a better algorithm for the maximum flow problem. The previous algorithms based on the blocking flow method proposed by Dinic use the unit length function: every residual edge is of length 1, In this paper, we survey properties of the distance function defined by a length function and give an overview on the representative maximum Row algorithms proposed so far in a systematic way by utilizing these properties. Among them are included two new algorithms: the Goldberg-Rao algorithm which finds a maximum Row on an integral capacity network N of it vertices and m edges in O(min(m(1/2), n(2/3)}m log(n(2)/m) log U) time, where U is the maximum edge capacity of IV, and the Karger-Levine algorithm which finds a maximum flow on an undirected network N with unit capacity and no parallel edges in O(m + n nu(3/2)) time, where v is the value of a maximum flow of N.	Chuo Univ, Dept Informat & Syst Engn, Bunkyo Ku, Tokyo 1128551, Japan; Univ Tokyo, Tokyo, Japan							Ahuja R. K., 1993, NETWORK FLOWS THEORY; AHUJA RK, 1989, SIAM J COMPUT, V18, P939, DOI 10.1137/0218065; AHUJA RK, 1989, OPER RES, V37, P748, DOI 10.1287/opre.37.5.748; ALON N, 1990, INFORM PROCESS LETT, V35, P201, DOI 10.1016/0020-0190(90)90024-R; [Anonymous], 1989, HDB OPERATIONS RES M; Goldberg AV, 1998, J ACM, V45, P783, DOI 10.1145/290179.290181; Goldberg AV, 1999, SIAM J DISCRETE MATH, V12, P1, DOI 10.1137/S089548019733103X; EDMONDS J, 1972, J ACM, V19, P248, DOI 10.1145/321694.321699; ASANO T, 1994, JOUHOU KOUZOU; Benczur A. A., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, DOI 10.1145/237814.237827; CHERIYAN J, 1995, SIAM J COMPUT, V24, P203, DOI 10.1137/S0097539791221529; CHERIYAN J, 1989, SIAM J COMPUT, V18, P1057, DOI 10.1137/0218072; CHERIYAN J, 1990, LECT NOTES COMPUT SC, V443, P235; Cherkassky BV, 1997, ALGORITHMICA, V19, P390, DOI 10.1007/PL00009180; Cherkassky B.V., 1977, MATH METHODS SOLUTIO, V7, P112; Cormen T.H., 1990, INTRO ALGORITHMS; Dantzig G.B., 1951, ACTIVITY ANAL PRODUC, P359; Dinic E.A., 1970, SOV MATH DOKL, V11, P1277; Dinic E.A., 1973, ISSLEDOVANIYA DISKRE; Even S., 1975, SIAM Journal on Computing, V4, DOI 10.1137/0204043; Ford L. R., 1956, CAN J MATH, V8, P399, DOI 10.4153/CJM-1956-045-5; GABOW HN, 1985, J COMPUT SYST SCI, V31, P148; GALIL Z, 1980, J COMPUT SYST SCI, V21, P203, DOI 10.1016/0022-0000(80)90035-5; Goldberg A. V, 1985, MITLCSTM291; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; GOLDBERG AV, 1990, MATH OPER RES, V15, P430, DOI 10.1287/moor.15.3.430; GOLDSTEIN J, 1990, J EPILEPSY, V3, P101, DOI 10.1016/0896-6974(90)90158-U; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, DOI 10.1137/0202019; IBARAKI T, 1992, RISAN SAITEKIKAHOU T; IMAI H, 1983, J OPER RES SOC JPN, V26, P61; IWANO K, 1993, DISCRETE STRUCTURES, V2, P79; Karger D. R., 1997, P 29 ACM S THEOR COM, P240, DOI 10.1145/258533.258596; Karger D. R., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, DOI 10.1145/276698.276714; Karger David R, 1998, P 9 ANN ACM SIAM S D, P490; Karger D. R., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, DOI 10.1145/237814.237829; Karzanov A. V., 1973, MATH VOPROSY UPRAVLE, V5; Karzanov A.V., 1974, SOV MATH DOKL, V15, P434; KING V, 1994, J ALGORITHM, V17, P447, DOI 10.1006/jagm.1994.1044; KING V, 1992, ACM SIAM S DISCRETE, V3, P157; MALHOTRA VM, 1978, INFORM PROCESS LETT, V7, P277, DOI 10.1016/0020-0190(78)90016-9; NAGAMOCHI H, 1992, ALGORITHMICA, V7, P583, DOI 10.1007/BF01758778; Phillips S, 1998, ALGORITHMICA, V21, P245, DOI 10.1007/PL00009214; SHILOACH Y, 1978, STANCS78802; SLEATOR DD, 1983, J COMPUT SYST SCI, V26, P362, DOI 10.1016/0022-0000(83)90006-5; SUNAGA T, 1958, RAAG MEMORIES, V2, P444; Tarjan R. E., 1983, DATA STRUCTURES NETW	46	6	6	OPERATIONS RES SOC JAPAN	BUNKYO-KU TOKYO	GAKKAI-CENTER BLDG 4-16 YAYOI 1-CHOME, BUNKYO-KU TOKYO, 113, JAPAN	0453-4514			J OPER RES SOC JPN	J. Oper. Res. Soc. Jpn.	MAR	2000	43	1					2	31				30	Operations Research & Management Science	Operations Research & Management Science	295ZR	WOS:000085999000002		
J	Matsui, T; Matsui, Y				Matsui, T; Matsui, Y			A survey of algorithms for calculating power indices of weighted majority games	JOURNAL OF THE OPERATIONS RESEARCH SOCIETY OF JAPAN			English	Article								For measuring an individual's voting power of a voting game, some power indices are proposed. In this paper, we discuss the problems for calculating the Shapley-Shubik index, the Banzhaf index and the Deegan-Packel index of weighted majority games.	Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan; Tokai Univ, Hiratsuka, Kanagawa 25912, Japan			Matsui, Tomomi/B-8863-2015	Matsui, Tomomi/0000-0003-0106-0980			Shapley LS, 1954, AM POLIT SCI REV, V48, P787, DOI 10.2307/1951053; Banzhaf J.F., 1965, RUTGERS LAW REV, V19, P317; Barlow R.E., 1972, STAT INFERENCE ORDER; Bellman R., 1956, NAV RES LOG, V3, P67, DOI 10.1002/nav.3800030107; BRAMS SJ, 1975, UNPUB POWER SIZE NEW; Deegan J., 1978, International Journal of Game Theory, V7, DOI 10.1007/BF01753239; DENG XT, 1994, MATH OPER RES, V19, P257, DOI 10.1287/moor.19.2.257; Dubey P., 1975, International Journal of Game Theory, V4, DOI 10.1007/BF01780630; Dubey P., 1979, Mathematics of Operations Research, V4, DOI 10.1287/moor.4.2.99; Garey M.R., 1979, COMPUTERS INTRACTABI; Graham R. L., 1972, Information Processing Letters, V1, DOI 10.1016/0020-0190(72)90045-2; Karp R., 1972, COMPLEXITY COMPUTER, P85, DOI DOI 10.1007/978-1-4684-2001-2_; Lucas W.F., 1983, POLITICAL RELATED MO, P183; LUCAS WF, 1982, 533 CORN U SCH OP RE; Mann I, 1962, RM3158PR RAND CORP; Mann I, 1960, RM2651 RAND CORP; MATSUI Y, 1998, METR9801 U TOK DEP M; MEGIDDO N, 1974, SIAM J APPL MATH, V26, P607, DOI 10.1137/0126057; MUTO S, 1908, VOTING SYSTEMS GAME; Nash J. F., 1972, MANAGE SCI, V54, P286, DOI 10.1287/mnsc.18.5.64; OGAWA R, COMMUNICATION; OWEN G, 1975, NAV RES LOG, V22, P741, DOI 10.1002/nav.3800220409; Owen G., 1995, GAME THEORY; Preparata F. P., 1985, COMPUTATIONAL GEOMET; Shapley L.S., 1953, CONTRIBUTIONS THEORY, P307; SUZUKI M, 1985, COOPERATIVE GAME THE; von Neumann J., 1953, THEORY GAMES EC BEHA	27	26	26	OPERATIONS RES SOC JAPAN	BUNKYO-KU TOKYO	GAKKAI-CENTER BLDG 4-16 YAYOI 1-CHOME, BUNKYO-KU TOKYO, 113, JAPAN	0453-4514			J OPER RES SOC JPN	J. Oper. Res. Soc. Jpn.	MAR	2000	43	1					71	86				16	Operations Research & Management Science	Operations Research & Management Science	295ZR	WOS:000085999000005		
J	Park, N; Okano, H; Imai, H				Park, N; Okano, H; Imai, H			A path-exchange-type local search algorithm for vehicle routing and its efficient search strategy	JOURNAL OF THE OPERATIONS RESEARCH SOCIETY OF JAPAN			English	Article								This paper proposes a fast path-exchange-type local search algorithm for vehicle routing problems (VRPs) that uses a new search strategy to restrict the search to promising neighbors. An efficient search strategy for path exchange that uses edge lengths to give search radii is proposed. Intensive numerical experiments with VRP instances of up to 10,000 vertices were conducted, and the results are compared with those given by the k-Opt algorithms. It is shown that our algorithm is faster than the 3-Opt and yields the quality of the solution comparable with the 4-Opt.	IBM Res Corp, Tokyo Res Lab, Kanagawa 2428502, Japan; Univ Tokyo, Tokyo, Japan							LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Taillard E, 1997, TRANSPORT SCI, V31, P170, DOI 10.1287/trsc.31.2.170; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; TAILLARD E, 1993, NETWORKS, V23, P661, DOI 10.1002/net.3230230804; Bentley J. L., 1992, ORSA Journal on Computing, V4; Gendreau M., 1997, LOCAL SEARCH COMBINA, P311; Glover F., 1990, ORSA Journal on Computing, V2; Glover F., 1989, ORSA Journal on Computing, V1; JOHNSON DS, 1996, UNPUB NEAR OPTIMAL S; JOHNSON DS, 1996, P 7 AC SIAM S DISCR; KILBY P, 1997, P 2 INT C MET; KINDERVATER GAP, 1997, WIL INT S D, P337; KUBO M, 1997, P 9 RAMP S, P28; OKANO H, 1997, RT0225 IBM; Or I., 1976, THESIS NW U EVANSTON; Osman I. H., 1993, Annals of Operations Research, V41, DOI 10.1007/BF02023004; Potvin J.-Y., 1996, INFORMS Journal of Computing, V8, DOI 10.1287/ijoc.8.2.158; Rochat Y., 1995, Journal of Heuristics, V1, DOI 10.1007/BF02430370; SAVELSBERGH MWP, 1990, EUR J OPER RES, V47, P75, DOI 10.1016/0377-2217(90)90091-O; THANGIAH SR, 1993, P IEEE INT C DEV MAN, P146; THANGIAH SR, 1991, 7 IEEE C ART INT APP, P332	21	8	8	OPERATIONS RES SOC JAPAN	BUNKYO-KU TOKYO	GAKKAI-CENTER BLDG 4-16 YAYOI 1-CHOME, BUNKYO-KU TOKYO, 113, JAPAN	0453-4514			J OPER RES SOC JPN	J. Oper. Res. Soc. Jpn.	MAR	2000	43	1					197	208				12	Operations Research & Management Science	Operations Research & Management Science	295ZR	WOS:000085999000013		
J	Hukushima, K				Hukushima, K			Random fixed point of three-dimensional random-bond Ising models	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						domain wall renormalization group; fixed point; random system; spin glass; MC simulation	NISHIMORI MULTICRITICAL POINT; WALL RENORMALIZATION-GROUP; SPIN-GLASS; CRITICAL-BEHAVIOR; CRITICAL EXPONENTS; EXPANSION; SYSTEMS; MAGNET	The fixed-point structure of three-dimensional bond-disordered Ising models is investigated using the numerical domain wall renormalization-group method. It is found that, in the +/-J Ising model, there exists a non-trivial fixed point along the phase boundary between the paramagnetic and ferromagnetic phases. The fixed-point Hamiltonian of the +/-J model numerically coincides with that of the unfrustrated random Ising models, strongly suggesting that both belong to the same universality class. Another fixed point corresponding to the multicritical point is also found in the +/-J model. Critical properties associated with the fixed point are qualitatively consistent with theoretical predictions.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Hukushima, K (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 1068666, Japan.		Hukushima, Koji/C-6840-2009	Hukushima, Koji/0000-0003-1153-1758			MCMILLAN WL, 1984, PHYS REV B, V30, P476, DOI 10.1103/PhysRevB.30.476; Ballesteros HG, 1998, PHYS REV B, V58, P2740, DOI 10.1103/PhysRevB.58.2740; GRINSTEIN G, 1976, PHYS REV B, V13, P1329, DOI 10.1103/PhysRevB.13.1329; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; BARRETT PH, 1986, PHYS REV B, V34, P3513, DOI 10.1103/PhysRevB.34.3513; BIRGENEAU RJ, 1983, PHYS REV B, V27, P6747, DOI 10.1103/PhysRevB.27.6747; LEDOUSSAL P, 1988, PHYS REV LETT, V61, P625, DOI 10.1103/PhysRevLett.61.625; HARRIS AB, 1974, J PHYS C SOLID STATE, V7, P1671, DOI 10.1088/0022-3719/7/9/009; HEUER HO, 1993, J PHYS A-MATH GEN, V26, pL333, DOI 10.1088/0305-4470/26/6/007; HISHIMORI H, 1981, PROG THEOR PHYS, V66, P1169; Hukushima K, 1999, PHYS REV E, V60, P3606, DOI 10.1103/PhysRevE.60.3606; Ito N, 1999, J PHYS SOC JPN, V68, P803, DOI 10.1143/JPSJ.68.803; JANSSEN HK, 1995, J PHYS A-MATH GEN, V28, P6073, DOI 10.1088/0305-4470/28/21/012; Kawashima N, 1996, PHYS REV B, V53, pR484, DOI 10.1103/PhysRevB.53.R484; LEDOUSSAL P, 1989, PHYS REV B, V40, P9249, DOI 10.1103/PhysRevB.40.9249; MARINARI E, 1997, NUMERICAL SIMULATION, P59; MCMILLAN WL, 1984, PHYS REV B, V29, P4026, DOI 10.1103/PhysRevB.29.4026; MITCHELL PW, 1986, PHYS REV B, V34, P4719, DOI 10.1103/PhysRevB.34.4719; NASH AE, 1993, PHYS REV B, V47, P5805, DOI 10.1103/PhysRevB.47.5805; Ozeki Y, 1998, J PHYS A-MATH GEN, V31, P5451, DOI 10.1088/0305-4470/31/24/007; OZEKI Y, 1987, J PHYS SOC JPN, V56, P1568, DOI 10.1143/JPSJ.56.1568; Singh RRP, 1996, PHYS REV B, V54, P364, DOI 10.1103/PhysRevB.54.364; SINGH RRP, 1991, PHYS REV LETT, V67, P899, DOI 10.1103/PhysRevLett.67.899; Sorensen ES, 1998, EUROPHYS LETT, V44, P504, DOI 10.1209/epl/i1998-00502-1	24	26	26	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					631	634		10.1143/JPSJ.69.631		4	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800002		
J	Ohwada, K; Nakao, H; Nakatogawa, H; Takesue, N; Fujii, Y; Isobe, M; Ueda, Y; Wakabayashi, Y; Murakami, Y				Ohwada, K; Nakao, H; Nakatogawa, H; Takesue, N; Fujii, Y; Isobe, M; Ueda, Y; Wakabayashi, Y; Murakami, Y			Pressure-induced phase transition in NaV2O5 at low temperature	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						NaV2O5; spin-gap system; charge order; low temperature and high pressure	SPIN-PEIERLS COMPOUND; X-RAY; ALPHA'-NAV2O5; LADDER	Pressure effect on phase transition in NaV2O5 has been studied at low temperature by x-ray scattering. In addition to two well-known phases at ambient pressure such as P-phase (a x b x c orthorhombic unit cell at T > T-c0 = 35 K) and C-1/4-phase (2a x 2b x 4c supercell at T < T-c0), we discovered a new high-pressure phase C-0-phase, which has a 2a x 2b x Ic supercell and is considered to be a new ground state above 0.02 GPa at T < 20 K. By measuring temperature dependence of superlattice intensity from the single crystal up to 1.24 GPa for the C-1/4- and Go-phases, we obtain the temperature-pressure phase diagram. The P-to-C-1/4 phase transition is significantly suppressed as (dT(c0)/dP) similar to -11(1) (K/GPa) at 0.1 MPa (1 atm.) while the C-1/4- to-Co phase transition takes place at P-c = 0.92 GPa nearly independent of temperature below 20 K.	Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, Tokai, Ibaraki 3191106, Japan; Univ Tokyo, Inst Solid State Phys, Mat Design & Characterizat Lab, Minato Ku, Tokyo 1068666, Japan	Ohwada, K (reprint author), Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, 106-1 Shirakata, Tokai, Ibaraki 3191106, Japan.		Wakabayashi, Yusuke/F-1621-2010; Isobe, Masahiko/B-5616-2015	Wakabayashi, Yusuke/0000-0003-3107-0338; 			BAK P, 1980, PHYS REV B, V21, P5297, DOI 10.1103/PhysRevB.21.5297; Fujii Y, 1997, J PHYS SOC JPN, V66, P326, DOI 10.1143/JPSJ.66.326; Callen H. B., 1966, THERMODYNAMICS; Isobe M, 1996, J PHYS SOC JPN, V65, P1178, DOI 10.1143/JPSJ.65.1178; Koppen M, 1998, PHYS REV B, V57, P8466, DOI 10.1103/PhysRevB.57.8466; Loa I, 1999, PHYS REV B, V60, pR6945, DOI 10.1103/PhysRevB.60.R6945; Meetsma A, 1998, ACTA CRYSTALLOGR C, V54, P1558, DOI 10.1107/S0108270198004855; Menoni C. S., 1984, High Temperatures - High Pressures, V16; NAKAO H, 1998, THESIS U TOKYO; Nishimoto S, 1998, J PHYS SOC JPN, V67, P2996, DOI 10.1143/JPSJ.67.2996; Ohama T, 1999, PHYS REV B, V59, P3299, DOI 10.1103/PhysRevB.59.3299; Ohwada K, 1999, J PHYS SOC JPN, V68, P3286, DOI 10.1143/JPSJ.68.3286; OHWADA K, 1999, 3474 ISSP A; OTWINOWSKI Z, 1996, PROCESSING XRAY DIFF, V276; Powell DK, 1998, PHYS REV B, V58, pR2937, DOI 10.1103/PhysRevB.58.R2937; SCKINC Y, 1998, THESIS U TOKYO; Seo H, 1998, J PHYS SOC JPN, V67, P2602, DOI 10.1143/JPSJ.67.2602; Shimomura S, 1996, PHYS REV B, V53, P8975, DOI 10.1103/PhysRevB.53.8975; Shimomura S, 1996, J PHYS SOC JPN, V65, P661, DOI 10.1143/JPSJ.65.661; Smolinski H, 1998, PHYS REV LETT, V80, P5164, DOI 10.1103/PhysRevLett.80.5164	20	9	9	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					639	642		10.1143/JPSJ.69.639		4	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800004		
J	Hashiguchi, T; Takeda, N; Kitagawa, J; Wada, N; Takayanagi, S; Ishikawa, M; Mori, N				Hashiguchi, T; Takeda, N; Kitagawa, J; Wada, N; Takayanagi, S; Ishikawa, M; Mori, N			Pressure effect on transport properties and specific heat of Kondo compound Ce3Pd20Si6	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						Ce3Pd20Si6; high pressure; electrical resistivity; Hall effect; specific heat; Kondo lattice	TEMPERATURE SPECIFIC-HEAT; CRYSTALLINE FIELD; ALLOYS; CERIUM; CECU6	We present the Hall constant, electrical resistivity, and low-temperature specific heat of the Kondo compound Ce3Pd2OSi6 under high pressures. The temperature dependence of the Hall constant and the electrical resistivity shows very large pressure effects which are characteristic of Kondo compounds. On the other hand, the low-temperature specific heat shows little pressure effect. This contrasting result is discussed, taking into account two crystallographic Ce sites with much different Kondo temperatures.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; Hokkaido Univ Educ, Fac Educ, Sapporo, Hokkaido 0028075, Japan	Hashiguchi, T (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Roppongi, Tokyo 1068666, Japan.			Kitagawa, Jiro/0000-0002-3780-1667			ANDRES K, 1975, PHYS REV LETT, V35, P1779, DOI 10.1103/PhysRevLett.35.1779; CORNUT B, 1972, PHYS REV B, V5, P4541, DOI 10.1103/PhysRevB.5.4541; THOMPSON JD, 1985, PHYS REV B, V31, P389, DOI 10.1103/PhysRevB.31.389; YANG HD, 1991, PHYS REV B, V43, P3664, DOI 10.1103/PhysRevB.43.3664; GRIBANOV AV, 1994, J ALLOY COMPD, V204, pL9, DOI 10.1016/0925-8388(94)90057-4; HAMZIC A, 1993, FROTNIERS SOLIDS STA, V2; HORN S, 1985, J MAGN MAGN MATER, V52, P385, DOI 10.1016/0304-8853(85)90310-5; Kitagawa J, 1998, PHYS REV B, V57, P7450, DOI 10.1103/PhysRevB.57.7450; Kitagawa J, 1996, PHYS REV B, V53, P5101, DOI 10.1103/PhysRevB.53.5101; LAWRENCE JM, 1985, PHYS REV LETT, V54, P2537, DOI 10.1103/PhysRevLett.54.2537; MORI N, 1993, JJAP SERIES, V8, P182; MORI N, UNPUB; NICOLASF.M, 1972, SOLID STATE COMMUN, V11, P845, DOI 10.1016/0038-1098(72)90284-0; OOMI G, 1993, J ALLOY COMPD, V192, P236, DOI 10.1016/0925-8388(93)90236-G; Phillips N. E., 1987, Theoretical and Experimental Aspects of Valence Fluctuations. Proceedings of the Fifth International Conference on Valence Fluctuations; SATOH K, 1989, J PHYS SOC JPN, V58, P1012, DOI 10.1143/JPSJ.58.1012; TAKEDA N, 1995, J PHYS SOC JPN, V64, P387, DOI 10.1143/JPSJ.64.387; Takeda N, 1997, PHYSICA B, V230, P145, DOI 10.1016/S0921-4526(96)00573-X	18	5	5	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					667	670		10.1143/JPSJ.69.667		4	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800011		
J	Manaka, H; Yamada, I; Mushnikov, NV; Goto, T				Manaka, H; Yamada, I; Mushnikov, NV; Goto, T			Field-induced magnetization in ferromagnetic and antiferromagnetic alternating Heisenberg chains formed in (CH3)(2)CHNH3CuCl3	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						(CH3)(2)CHNH3CUCl3; ferromagnetic-antiferromagnetic alternating chain; Haldane gap; magnetization process; pulsed magnetic field	S = 1; HALDANE-GAP; ANTI-FERROMAGNET; SIGMA-MODEL; DYNAMICS; STATE; PHASE	We report measurements of the magnetization process of the gap system (CH3)(2) CHNH3 CUCl3, in which ferromagnetic-dominant ferromagnetic and antiferromagnetic alternating Heisenberg chains are formed and then a pair of ferromagnetically coupled S=1/2 spins behaves es as a spin of S = 1. The two critical fields H-c1 and H-c2, corresponding to the elimination of the energy gap and the alignment of all the spins along the direction of an external field H, are detected at 10.4T and around 44 T, respectively, on a scale of the reduced magnetic field gH/2. These values are, in principle, consistent with those estimated from the analysis of the magnetic susceptibility. The critical exponents in the formula such as M(H) proportional to (H - H-c1)(1/delta 1) and 1 - M(H) proportional to (H-c2 - H)(1/delta 2) are found to be delta(1) > 1 and delta(2) > 1.	Chiba Univ, Fac Sci, Dept Phys, Inage Ku, Chiba 2638522, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1058666, Japan	Manaka, H (reprint author), Chiba Univ, Fac Sci, Dept Phys, Inage Ku, Yayoi Cho, Chiba 2638522, Japan.		Mushnikov, Nikolay/K-9076-2013	Mushnikov, Nikolay/0000-0002-6354-2558			AFFLECK I, 1991, PHYS REV B, V43, P3215, DOI 10.1103/PhysRevB.43.3215; Zheludev A, 1996, PHYS REV B, V53, P15004, DOI 10.1103/PhysRevB.53.15004; SAKAI T, 1991, PHYS REV B, V43, P13383, DOI 10.1103/PhysRevB.43.13383; JOLICOEUR T, 1994, PHYS REV B, V50, P9265, DOI 10.1103/PhysRevB.50.9265; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; BORRASALMENAR JJ, 1994, INORG CHEM, V33, P5171, DOI 10.1021/ic00101a006; Sakaguchi T, 1996, J PHYS SOC JPN, V65, P3025, DOI 10.1143/JPSJ.65.3025; DIEDERIX KM, 1979, PHYS REV B, V19, P420, DOI 10.1103/PhysRevB.19.420; HIDA K, 1992, PHYS REV B, V45, P2207, DOI 10.1103/PhysRevB.45.2207; Chitra R, 1997, PHYS REV B, V55, P5816, DOI 10.1103/PhysRevB.55.5816; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; DELICA T, 1991, EUROPHYS LETT, V15, P55, DOI 10.1209/0295-5075/15/1/010; Hida K, 1998, J PHYS SOC JPN, V67, P1416, DOI 10.1143/JPSJ.67.1416; HODGSON RP, 1985, J PHYS C SOLID STATE, V18, P6385, DOI 10.1088/0022-3719/18/34/009; Manaka H, 1998, PHYSICA B, V246, P513, DOI 10.1016/S0921-4526(97)00975-7; Manaka H, 1998, J PHYS SOC JPN, V67, P3913, DOI 10.1143/JPSJ.67.3913; Manaka H, 1997, J PHYS SOC JPN, V66, P564, DOI 10.1143/JPSJ.66.564; SAKAI T, 1998, PHYS REV B, V57, P8091; SAKAI T, 1995, J PHYS SOC JPN, V64, P251; Suzuki T., COMMUNICATION; TAKAHASHI M, 1991, J PHYS SOC JPN, V60, P760, DOI 10.1143/JPSJ.60.760; TROYER M, 1994, PHYS REV B, V50, P13515, DOI 10.1103/PhysRevB.50.13515	22	20	20	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					675	678		10.1143/JPSJ.69.675		4	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800013		
J	Arita, R; Onoda, S; Kuroki, K; Aoki, H				Arita, R; Onoda, S; Kuroki, K; Aoki, H			Magnetic properties of the Hubbard model on three-dimensional lattices: Fluctuation-exchange and two-particle self-consistent studies	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						three-dimensional Hubbard model; ferromagnetism; antiferromagnetism; fluctuation exchange approximation; two-particle self-consistent approximation	ELECTRON-SYSTEMS; CONSERVING APPROXIMATIONS; PHASE-DIAGRAM; FERROMAGNETISM; DENSITY; SUPERCONDUCTIVITY; PSEUDOGAP	The relation between three-dimensional lattice structure and magnetism in correlated electron systems is explored for face centered cubic (FCC), body centered cubic (BCC), and simple cubic (SC) lattices. In particular, we question which lattice structure has the strongest tendency toward the ferromagnetism or antiferromagnetism. We employ the Hubbard model to calculate the spin susceptibility and the single-particle spectrum with the fluctuation-exchange (FLEX) and the two-particle self-consistent (TPSC) approximations in the weak coupling regime. We have shown that (i) ferromagnetic spin fluctuations become dominant when the Fermi level lies around a sharp peak (divergence) in the density of states (D(E)) near the bottom of the band, which occurs for FCC with/without next nearest neighbor hoppings (t') or BCC with an appropriate value of t' Among the cases studied, the ferromagnetic fluctuation is found to be the strongest for FCC with a finite t' (ii) When the peak in D(E) resides around the band center as in bipartite SC or BCC, antiferromagnetic fluctuations become dominant when the band is close to the half-filling, with the fluctuation being much stronger in BCC.	Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan	Arita, R (reprint author), Univ Tokyo, Dept Phys, Hongo, Tokyo 1130033, Japan.		Aoki, Hideo/A-2525-2009; Arita, Ryotaro/D-5965-2012; Onoda, Shigeki/B-4322-2013	Aoki, Hideo/0000-0002-7332-9355; Arita, Ryotaro/0000-0001-5725-072X; Onoda, Shigeki/0000-0001-6063-3166			Obermeier T, 1997, PHYS REV B, V56, pR8479; NAGAOKA Y, 1966, PHYS REV, V147, P392, DOI 10.1103/PhysRev.147.392; BAYM G, 1962, PHYS REV, V127, P1391, DOI 10.1103/PhysRev.127.1391; MIELKE A, 1993, COMMUN MATH PHYS, V158, P341, DOI 10.1007/BF02108079; Hlubina R, 1999, PHYS REV B, V59, P9600, DOI 10.1103/PhysRevB.59.9600; KANAMORI J, 1963, PROG THEOR PHYS, V30, P275, DOI 10.1143/PTP.30.275; Daul S, 1998, PHYS REV B, V58, P2635, DOI 10.1103/PhysRevB.58.2635; Hlubina R, 1997, PHYS REV LETT, V78, P1343, DOI 10.1103/PhysRevLett.78.1343; WHITE SR, 1993, PHYS REV B, V48, P10345, DOI 10.1103/PhysRevB.48.10345; BICKERS NE, 1989, PHYS REV LETT, V62, P961, DOI 10.1103/PhysRevLett.62.961; GUTZWILLER MC, 1963, PHYS REV LETT, V10, P159, DOI 10.1103/PhysRevLett.10.159; Kohno M, 1997, PHYS REV B, V56, P15015, DOI 10.1103/PhysRevB.56.15015; HASEGAWA H, 1980, J PHYS SOC JPN, V49, P178, DOI 10.1143/JPSJ.49.178; MORIYA T, 1978, J PHYS SOC JPN, V45, P397, DOI 10.1143/JPSJ.45.397; BICKERS NE, 1989, ANN PHYS-NEW YORK, V193, P206, DOI 10.1016/0003-4916(89)90359-X; BAYM G, 1961, PHYS REV, V124, P287, DOI 10.1103/PhysRev.124.287; LIEB EH, 1989, PHYS REV LETT, V62, P1201, DOI 10.1103/PhysRevLett.62.1201; VIDBERG HJ, 1977, J LOW TEMP PHYS, V29, P179, DOI 10.1007/BF00655090; Vilk YM, 1997, J PHYS I, V7, P1309, DOI 10.1051/jp1:1997135; Kino H, 1998, J PHYS SOC JPN, V67, P3691, DOI 10.1143/JPSJ.67.3691; Arita R, 1999, PHYS REV B, V60, P14585, DOI 10.1103/PhysRevB.60.14585; Arita R, 1998, PHYS REV B, V57, P10609, DOI 10.1103/PhysRevB.57.10609; Arita R, 1998, PHYS REV B, V57, pR6854, DOI 10.1103/PhysRevB.57.R6854; DAHM T, 1995, PHYS REV B, V52, P1297, DOI 10.1103/PhysRevB.52.1297; Daul S, 1997, Z PHYS B CON MAT, V103, P293, DOI 10.1007/s002570050376; Deisz JJ, 1996, PHYS REV LETT, V76, P1312, DOI 10.1103/PhysRevLett.76.1312; Hanisch T, 1997, PHYS REV B, V56, P13960, DOI 10.1103/PhysRevB.56.13960; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; HUBBARD J, 1979, PHYS REV B, V19, P2626, DOI 10.1103/PhysRevB.19.2626; Kontani H, 1998, PHYS REV LETT, V80, P5619, DOI 10.1103/PhysRevLett.80.5619; KUBO K, 1983, PROG THEOR PHYS, V69, P1345, DOI 10.1143/PTP.69.1345; LIANG S, 1995, EUROPHYS LETT, V32, P173, DOI 10.1209/0295-5075/32/2/014; MCQUEEN PG, 1993, PHYS REV LETT, V71, P129, DOI 10.1103/PhysRevLett.71.129; NOLTING W, 1991, PHYS REV B, V43, P1117, DOI 10.1103/PhysRevB.43.1117; Penc K, 1996, PHYS REV B, V54, P4056, DOI 10.1103/PhysRevB.54.4056; Sakamoto H, 1996, J PHYS SOC JPN, V65, P3732, DOI 10.1143/JPSJ.65.3732; Schmalian J, 1998, PHYS REV LETT, V81, P4232, DOI 10.1103/PhysRevLett.81.4232; SINGWI KS, 1981, SOLID STATE PHYS, V36, P177; USAMI K, 1980, J MAGN MAGN MATER, V20, P171, DOI 10.1016/0304-8853(80)90455-2; VOLLHARDT D, CONDMAT9804112; Wegner T, 1998, PHYS REV B, V57, P6211, DOI 10.1103/PhysRevB.57.6211	41	13	13	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					785	795		10.1143/JPSJ.69.785		11	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800028		
J	Seo, H				Seo, H			Charge ordering in organic ET compounds	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						charge ordering; organic conductors; BEDT-TTF; extended Hubbard model; Hartree approximation	2-DIMENSIONAL HUBBARD-MODEL; METAL-INSULATOR-TRANSITION; PHASE-DIAGRAM; BEDT-TTF; ELECTRONIC-STRUCTURES; ANTIFERROMAGNETIC PHASES; MOLECULAR SUPERCONDUCTOR; MONTE-CARLO; CONDUCTORS; CRYSTAL	The charge ordering phenomena in quasi two-dimensional 1/4-filled organic compounds (ET)(2)X (ET=BEDT-TTF) are investigated theoretically for the theta and alpha-type structures, based on the Hartree approximation for the extended Hubbard models with both on-site and intersite Coulomb interactions. It is found that charge ordered states of stripe-type are stabilized for the relevant values of Coulomb energies, while the spatial pattern of the stripes sensitively depends on the anisotropy of the models. By comparing the results of calculations with the experimental facts, where the effects of quantum fluctuation is incorporated by mapping the stripe-type charge ordered states to the S = 1/2 Heisenberg Hamiltonians, the actual charge patterns in the insulating phases of theta-(ET)(2)MM'(SCN)(4) and alpha-(ET)(2)I-3 are deduced. Furthermore, to obtain a unified view among the theta, alpha and kappa-(ET)(2)X families, the stability of the charge ordered state in competition with the dimeric antiferromagnetic state viewed as the Mott insulating state, which is typically realized in kappa-type compounds, and with the paramagnetic metallic state, is also pursued by extracting essential parameters.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Seo, H (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan.	hseo@swan.issp.u-tokyo.ac.jp	Seo, Hitoshi/G-1060-2011				AN GZ, 1991, PHYS REV B, V44, P9410, DOI 10.1103/PhysRevB.44.9410; HIRSCH JE, 1984, PHYS REV B, V29, P5554, DOI 10.1103/PhysRevB.29.5554; BENDER K, 1984, MOL CRYST LIQ CRYST, V107, P45, DOI 10.1080/00268948408072071; Mori H, 1998, PHYS REV B, V57, P12023, DOI 10.1103/PhysRevB.57.12023; Park SK, 1998, PHYS REV B, V58, P3717, DOI 10.1103/PhysRevB.58.3717; Nogami Y, 1999, SYNTHETIC MET, V103, P1911, DOI 10.1016/S0379-6779(98)00616-X; Mori H, 1998, B CHEM SOC JPN, V71, P797, DOI 10.1246/bcsj.71.797; SCHULZ HJ, 1990, PHYS REV LETT, V64, P1445, DOI 10.1103/PhysRevLett.64.1445; Kino H, 1996, J PHYS SOC JPN, V65, P2158, DOI 10.1143/JPSJ.65.2158; MOLDENHAUER J, 1993, SYNTHETIC MET, V60, P31, DOI 10.1016/0379-6779(93)91180-A; KATO M, 1990, J PHYS SOC JPN, V59, P1047, DOI 10.1143/JPSJ.59.1047; Nad F, 1998, EUR PHYS J B, V3, P301, DOI 10.1007/s100510050316; SANO K, 1994, J PHYS SOC JPN, V63, P1250, DOI 10.1143/JPSJ.63.1250; Seo H, 1997, J PHYS SOC JPN, V66, P1249, DOI 10.1143/JPSJ.66.1249; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; ROTHAEMEL B, 1986, PHYS REV B, V34, P704, DOI 10.1103/PhysRevB.34.704; PENC K, 1994, PHYS REV B, V49, P9670, DOI 10.1103/PhysRevB.49.9670; Mori T, 1999, B CHEM SOC JPN, V72, P179, DOI 10.1246/bcsj.72.179; Mori T, 1999, B CHEM SOC JPN, V72, P2011, DOI 10.1246/bcsj.72.2011; Watanabe M, 1999, J PHYS SOC JPN, V68, P2654, DOI 10.1143/JPSJ.68.2654; Moritomo Y, 1996, NATURE, V380, P141, DOI 10.1038/380141a0; Nakamura T, 1997, SYNTHETIC MET, V86, P2053, DOI 10.1016/S0379-6779(97)81023-5; Mori T, 1998, B CHEM SOC JPN, V71, P2509, DOI 10.1246/bcsj.71.2509; Anisimov VI, 1996, PHYS REV B, V54, P4387, DOI 10.1103/PhysRevB.54.4387; KUWAHARA H, 1995, SCIENCE, V270, P961, DOI 10.1126/science.270.5238.961; Kuroki K, 1999, PHYS REV B, V60, P3060, DOI 10.1103/PhysRevB.60.3060; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; KINO H, 1995, J PHYS SOC JPN, V64, P2726, DOI 10.1143/JPSJ.64.2726; McKenzie RH, 1997, SCIENCE, V278, P820, DOI 10.1126/science.278.5339.820; Kino H, 1998, J PHYS SOC JPN, V67, P3691, DOI 10.1143/JPSJ.67.3691; NAKAMURA T, 1995, SYNTHETIC MET, V70, P1293, DOI 10.1016/0379-6779(94)02855-S; BULAEVSKII LN, 1963, SOV PHYS JETP-USSR, V17, P684; BULAEVSK.LN, 1969, FIZ TVERD TELA+, V11, P921; Castet F, 1996, J PHYS I, V6, P583, DOI 10.1051/jp1:1996231; CHIBA R, COMMUNICATIONS; Ducasse L, 1997, SYNTHETIC MET, V85, P1627, DOI 10.1016/S0379-6779(97)80375-X; FRITSCH A, 1991, J PHYS I, V1, P855; FUKUYAMA H, 1999, IN PRESS PHYSICA B; GIAMARCHI T, 1990, PHYS REV B, V42, P10641, DOI 10.1103/PhysRevB.42.10641; Gros C, 1999, PHYS REV LETT, V82, P976, DOI 10.1103/PhysRevLett.82.976; HEIDMANN CP, 1992, SOLID STATE COMMUN, V84, P711, DOI 10.1016/0038-1098(92)90464-K; Hiraki K, 1996, MOL CRYST LIQ CRYS A, V285, P157, DOI 10.1080/10587259608030794; HIRSCH JE, 1983, PHYS REV LETT, V50, P1168, DOI 10.1103/PhysRevLett.50.1168; Imamura Y, 1999, J CHEM PHYS, V111, P5986, DOI 10.1063/1.479894; Imamura Y, 1998, CHEM PHYS LETT, V298, P15, DOI 10.1016/S0009-2614(98)01212-3; ISHIGURO T, 1998, ORGANIC SUPERCONDUCT, pCH5; Kanoda K, 1997, PHYSICA C, V282, P299, DOI 10.1016/S0921-4534(97)00266-9; Kanoda K, 1997, HYPERFINE INTERACT, V104, P235, DOI 10.1023/A:1012696314318; KATO R, 1999, ADV SYNTHETIC METALS, pCH4; KINO H, 1995, J PHYS SOC JPN, V64, P1877, DOI 10.1143/JPSJ.64.1877; Kino H, 1995, J PHYS SOC JPN, V64, P4523, DOI 10.1143/JPSJ.64.4523; KINO H, 1996, THESIS U TOKYO, P45; KOBAYASHI H, 1986, CHEM LETT, P833, DOI 10.1246/cl.1986.833; KOBAYASHI H, 1986, CHEM LETT, P789, DOI 10.1246/cl.1986.789; KOMATSU T, 1995, B CHEM SOC JPN, V68, P2233, DOI 10.1246/bcsj.68.2233; Kondo H, 1998, J PHYS SOC JPN, V67, P3695, DOI 10.1143/JPSJ.67.3695; LAMBIN P, 1984, PHYS REV B, V29, P3430, DOI 10.1103/PhysRevB.29.3430; MAESATO M, IN PRESS REV SCI INS; MAYAFFRE H, 1994, EUROPHYS LETT, V28, P205, DOI 10.1209/0295-5075/28/3/009; MCKENZIE R, 1999, PHYS REV LETT, V82, P1522; McKenzie R. H., 1998, COMMENTS CONDENS MAT, V18, P309; MILA F, 1995, PHYS REV B, V52, P4788, DOI 10.1103/PhysRevB.52.4788; MILA F, 1993, EUROPHYS LETT, V24, P133, DOI 10.1209/0295-5075/24/2/010; MIYAGAWA K, COMMUNICATION; Miyagawa K, 1997, PHYS REV B, V56, pR8487; MIYAGAWA K, PREPRINT; MORI H, 1993, SYNTHETIC MET, V55, P2443; MORI H, 1990, B CHEM SOC JPN, V63, P2183, DOI 10.1246/bcsj.63.2183; Mori T, 1996, PHYSICA C, V264, P22, DOI 10.1016/0921-4534(96)80005-0; MORI T, 1984, CHEM LETT, P957, DOI 10.1246/cl.1984.957; Nakamura T, 1996, MOL CRYST LIQ CRYS A, V285, P57, DOI 10.1080/10587259608030778; Nakamura T, 1997, SYNTHETIC MET, V86, P1991, DOI 10.1016/S0379-6779(97)80992-7; Nakamura T, 1999, SYNTHETIC MET, V103, P1898, DOI 10.1016/S0379-6779(98)00599-2; OSHIMA K, 1988, PHYS REV B, V38, P938, DOI 10.1103/PhysRevB.38.938; PRATT FL, 1995, PHYS REV LETT, V74, P3892, DOI 10.1103/PhysRevLett.74.3892; SCO H, 1997, J PHYS SOC JPN, V66, P3352; SCO H, 1998, J PHYS SOC JPN, V67, P1848; Seo H, 1998, J PHYS SOC JPN, V67, P2602, DOI 10.1143/JPSJ.67.2602; TAJIMA H, COMMUNICATIONS; Tajima N, 1999, SYNTHETIC MET, V103, P1958, DOI 10.1016/S0379-6779(98)00884-4; Takahashi T., COMMUNICATION; TAKHIROV TG, 1990, MOL CRYST LIQ CRYST, V185, P215, DOI 10.1080/00268949008038504; Thalmeier P, 1998, EUROPHYS LETT, V44, P242, DOI 10.1209/epl/i1998-00463-3; TOKURA Y, 1993, SOLID STATE PHYS, V28, P557; Tranquada JM, 1996, PHYS REV B, V54, P12318, DOI 10.1103/PhysRevB.54.12318; Yamase H, 1999, J PHYS SOC JPN, V68, P1082, DOI 10.1143/JPSJ.68.1082	86	236	236	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					805	820		10.1143/JPSJ.69.805		16	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800030		
J	Shimada, H; Ootuka, Y; Kobayashi, S; Katsumoto, S; Endo, A				Shimada, H; Ootuka, Y; Kobayashi, S; Katsumoto, S; Endo, A			Quantum charge fluctuations in quantum dots	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						quantum dot; Coulomb oscillation; single electron charging effect; quantum charge fluctuations; single electron transistor; SET	SINGLE-ELECTRON TRANSISTOR; COULOMB-BLOCKADE OSCILLATIONS; POINT CONTACTS; CONDUCTANCE; CAPACITANCE; REGIME	Influence of the quantum charge fluctuations in a quantum dot on its charging effect has been investigated by using a quantum-dot device having four quantum point contacts (QPC's) which connect the dot to the reservoirs. The charging effect was detectable at combined tunnel conductance of four QPC's up to near 8e(2)/h beyond the intuitive criterion e(2)/h. We observed anomalously nonlinear dependences of the conductances at the tops (G(top)) and bottoms (G(bot)) of the Coulomb oscillation on the tunnel conductances of QPC's, G(QPC)'s The result on G(top) indicates that a transition from Coulombically regulated tunnelings to non-correlated tunnelings occurs by increasing G(QPC)'s. The result on G(bot) shows the existence of leakage conductance beyond the 2nd-order cotunneling contribution. The offset voltage in the current-voltage characteristics of the device showed significant decrease with the increase of G(QPC)'s, indicating the shrinkage of the effective charging energy. The results on G(top) and G(bot) can be explained in the light of the shrinkage of the effective charging energy.	Univ Tokyo, Cryogen Ctr, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Japan Sci & Technol Corp, JSP, CREST Project, Yokohama, Kanagawa, Japan	Shimada, H (reprint author), Univ Tokyo, Cryogen Ctr, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	crcsim@crc.u-tokyo.ac.jp					FLENSBERG K, 1993, PHYS REV B, V48, P11156, DOI 10.1103/PhysRevB.48.11156; Furusaki A, 1995, PHYS REV B, V52, P16676, DOI 10.1103/PhysRevB.52.16676; Joyez P, 1997, PHYS REV LETT, V79, P1349, DOI 10.1103/PhysRevLett.79.1349; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; AVERIN DV, 1990, PHYS REV LETT, V65, P2446, DOI 10.1103/PhysRevLett.65.2446; Wang XH, 1996, PHYS REV B, V53, P12621, DOI 10.1103/PhysRevB.53.12621; Averin D. V., 1991, MESOSCOPIC PHENOMENA, P173; AVERIN DV, 1989, PHYS LETT A, V140, P251, DOI 10.1016/0375-9601(89)90934-1; Berman D, 1999, PHYS REV LETT, V82, P161, DOI 10.1103/PhysRevLett.82.161; Chouvaev D, 1999, PHYS REV B, V59, P10599, DOI 10.1103/PhysRevB.59.10599; FLENSBERG K, 1994, PHYSICA B, V203, P432, DOI 10.1016/0921-4526(94)90092-2; FURUSAKI A, 1995, PHYS REV LETT, V75, P709, DOI 10.1103/PhysRevLett.75.709; FURUSAKI A, COMMUNICATION; GOLUBEV DS, 1994, PHYS REV B, V50, P8736, DOI 10.1103/PhysRevB.50.8736; Golubev DS, 1996, JETP LETT+, V63, P1007, DOI 10.1134/1.567117; Goppert G, 1999, EUROPHYS LETT, V45, P249, DOI 10.1209/epl/i1999-00154-7; GRABERT H, 1994, PHYS REV B, V50, P17361; GRABERT H, 1992, SINGLE CHARGE TUNNCL; KONIG J, 1995, EUROPHYS LETT, V31, P31, DOI 10.1209/0295-5075/31/1/006; Konig J, 1998, PHYS REV LETT, V81, P3511, DOI 10.1103/PhysRevLett.81.3511; KOUWENHOVEN LP, 1991, Z PHYS B CON MAT, V85, P367, DOI 10.1007/BF01307632; MATVEEV KA, 1995, PHYS REV B, V51, P17; MOLCNKAMP LW, 1995, PHYS REV LETT, V75, P4282; ODIGIRI T, 1990, P 20 INT C PHYS SEM, P2676; Ono K, 1998, SOLID STATE ELECTRON, V42, P1407, DOI 10.1016/S0038-1101(98)00039-2; Ono K, 1997, J PHYS SOC JPN, V66, P1261, DOI 10.1143/JPSJ.66.1261; OOTUKA Y, 1993, CRYOGENICS, V33, P923, DOI 10.1016/0011-2275(93)90108-Z; PASQUIER C, 1993, PHYS REV LETT, V70, P69, DOI 10.1103/PhysRevLett.70.69; Shimada H, 1996, CZECH J PHYS, V46, P2285, DOI 10.1007/BF02571134; SHOELLER H, 1994, PHYS REV B, V50, P18436; TAYLOR RP, 1992, PHYS REV LETT, V69, P1989, DOI 10.1103/PhysRevLett.69.1989; VANDERVAART NC, 1993, PHYSICA B, V189, P99, DOI 10.1016/0921-4526(93)90150-5; Wang X, 1997, EUROPHYS LETT, V38, P545, DOI 10.1209/epl/i1997-00281-7	33	0	0	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					828	835		10.1143/JPSJ.69.828		8	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800032		
J	Takeda, N; Ishikawa, M				Takeda, N; Ishikawa, M			Superconducting and magnetic properties of filled skutterudite compounds RERu4Sb12 (RE=La, Ce, Pr, Nd and Eu)	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						filled skutterudite; Van Vleck paramagnetism; superconductivity; non-Fermi liquid	LAFE4P12 STRUCTURE; SYSTEM; METAL; TRANSITION; EARTH	We have studied superconducting and magnetic properties of RERu4Sb12 prepared by an Sb-flux method and found that LaRu4Sb12 is superconducting below 3.58 K and PrRu4Sb12 is a Van Vleck paramagnet which becomes superconducting below 1.04 K. CeRu4Sb12 is a unique substance which shows intermediate-valence behavior with a characteristic broad peak around 100 K in the magnetic susceptibility and Kondo-like behavior in the electrical resistivity at high temperatures. Furthermore, non-Fermi liquid behavior is observed in the specific heat and electrical resistivity at low temperatures. NdRu4Sb12 and EuRu4Sb12 show a magnetic transition at 1.3 K and 3.3 K, respectively.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Takeda, N (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 1068666, Japan.						AMITSUKA H, 1994, J PHYS SOC JPN, V63, P736, DOI 10.1143/JPSJ.63.736; Steglich F, 1996, J PHYS-CONDENS MAT, V8, P9909, DOI 10.1088/0953-8984/8/48/016; Danebrock ME, 1996, J PHYS CHEM SOLIDS, V57, P381, DOI 10.1016/0022-3697(95)00277-4; BRAUN DJ, 1980, J LESS-COMMON MET, V72, P147, DOI 10.1016/0022-5088(80)90260-X; Sekine C, 1997, PHYS REV LETT, V79, P3218, DOI 10.1103/PhysRevLett.79.3218; MCMILLAN WL, 1968, PHYS REV, V167, P331, DOI 10.1103/PhysRev.167.331; BUCHER E, 1968, HELV PHYS ACTA, V41, P723; ZULICKE U, 1995, PHYS REV B, V51, P8996, DOI 10.1103/PhysRevB.51.8996; TAKABATAKE T, 1988, J PHYS SOC JPN, V57, P2763, DOI 10.1143/JPSJ.57.2763; ORLANDO TP, 1979, PHYS REV B, V19, P4545, DOI 10.1103/PhysRevB.19.4545; LEA KR, 1962, J PHYS CHEM SOLIDS, V23, P1381, DOI 10.1016/0022-3697(62)90192-0; Shirotani I, 1997, PHYS REV B, V56, P7866, DOI 10.1103/PhysRevB.56.7866; FULDE P, 1972, ADV PHYS, V21, P1, DOI 10.1080/00018737200101258; GRANDJEAN F, 1984, J PHYS CHEM SOLIDS, V45, P877, DOI 10.1016/0022-3697(84)90128-8; BRAUN DJ, 1980, J SOLID STATE CHEM, V32, P357, DOI 10.1016/S0022-4596(80)80031-4; BRAUN DJ, 1977, ACTA CRYSTALLOGR, V33, P3401; COSTA GA, 1982, SOLID STATE COMMUN, V44, P67, DOI 10.1016/0038-1098(82)90715-3; IHSIKAW M, 1982, SUPERCONDUCTIVITY TE, V2, P143; MACKAY HB, 1989, J LOW TEMP PHYS, V41, P639; MIRANDA E, 1997, PHYS REV LETT, V78, P29; MORIYA T, 1995, J PHYS SOC JPN, V64, P960, DOI 10.1143/JPSJ.64.960; MURAO T, 1957, PROG THEOR PHYS, V18, P215, DOI 10.1143/PTP.18.215; Shirotani I, 1996, J PHYS CHEM SOLIDS, V57, P211, DOI 10.1016/0022-3697(95)00197-2; Sugawara H, 1998, J MAGN MAGN MATER, V177, P359, DOI 10.1016/S0304-8853(97)00481-2; SUNDSTROM LJ, 1978, HDB PHYSICS CHEM RAR, V1, P379, DOI 10.1016/S0168-1273(78)01009-0; TAKEDA N, UNPUB; TORIKACHVILI MS, 1987, PHYS REV B, V36, P8660, DOI 10.1103/PhysRevB.36.8660; vonLohneysen H, 1996, J PHYS-CONDENS MAT, V8, P9689, DOI 10.1088/0953-8984/8/48/003	28	142	142	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					868	873		10.1143/JPSJ.69.868		6	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800036		
J	Kitagawa, J; Takeda, N; Ishikawa, M; Nakayama, M; Kimura, N; Komatsubara, T				Kitagawa, J; Takeda, N; Ishikawa, M; Nakayama, M; Kimura, N; Komatsubara, T			Third-order magnetic susceptibility and quadrupolar order parameter of Kondo-lattice compound Ce3Pd20Ge6	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						Ce3Pd20Ge6; quadrupolar ordering; crystalline-electric-field effect; third order magnetic susceptibility	NONLINEAR SUSCEPTIBILITY; FIELD; CEB6; CEXLA1-XB6; PHASE	We present a report on crystalline-electric-field effects observed in the electrical resistivity and the specific heat of Ce3Pd20Ge6, which are discussed within an energy level scheme of the Gamma(8) ground state and the Gamma(7) excited state at 50 K for both inequivalent crystallographic sites of Ce atom. The third-order magnetic susceptibility was deduced from the magnetization measurement in the paramagnetic phase of a single-crystalline sample in magnetic fields applied along [0 0 1] and [1 1 1]. In order to explain the temperature dependence of the third-order magnetic susceptibility along [0 0 1], a positive total quadrupolar pair interaction constant of 22 mK is required in addition to a small antiferromagnetic exchange interaction, thereby suggesting ferroquadrupolar ordering with the Gamma(3) symmetry in this compound.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 9808578, Japan	Kitagawa, J (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 1068666, Japan.			Kitagawa, Jiro/0000-0002-3780-1667			RAMIREZ AP, 1994, PHYS REV LETT, V73, P3018, DOI 10.1103/PhysRevLett.73.3018; ZIRNGIEBL E, 1984, PHYS REV B, V30, P4052, DOI 10.1103/PhysRevB.30.4052; CORNUT B, 1972, PHYS REV B, V5, P4541, DOI 10.1103/PhysRevB.5.4541; MORIN P, 1982, J MAGN MAGN MATER, V30, P257, DOI 10.1016/0304-8853(82)90206-2; ERKELENS WAC, 1987, J MAGN MAGN MATER, V63-4, P61, DOI 10.1016/0304-8853(87)90522-1; Hiroi M, 1997, PHYS REV B, V55, P8339, DOI 10.1103/PhysRevB.55.8339; Keller L, 1999, PHYSICA B, V259-61, P336, DOI 10.1016/S0921-4526(98)00801-1; Kitagawa J, 1999, PHYSICA B, V259-61, P332, DOI 10.1016/S0921-4526(98)01166-1; Kitagawa J, 1999, J PHYS SOC JPN, V68, P3413, DOI 10.1143/JPSJ.68.3413; KITAGAWA J, 1997, THESIS U TOKYO; Kitagawa J, 1998, PHYS REV B, V57, P7450, DOI 10.1103/PhysRevB.57.7450; KITAGAWA J, 1999, JPN J APPL PHYS SER, V11, P197; Kitagawa J, 1996, PHYS REV B, V53, P5101, DOI 10.1103/PhysRevB.53.5101; Kitagawa J, 1997, J ALLOY COMPD, V256, P48, DOI 10.1016/S0925-8388(96)03020-4; MIYAKO Y, 1993, PHYSICA B, V186-88, P236, DOI 10.1016/0921-4526(93)90539-I; MORIN P, 1981, PHYS REV B, V23, P5936, DOI 10.1103/PhysRevB.23.5936; Morin P., 1990, HDB FERROMAGNETIC MA, V5, P1, DOI 10.1016/S1574-9304(05)80061-6; MORIN P, 1988, J MAGN MAGN MATER, V71, P151, DOI 10.1016/0304-8853(88)90080-7; ONUKI Y, 1984, J PHYS SOC JPN, V53, P2734, DOI 10.1143/JPSJ.53.2734; RAMIREZ AP, 1992, PHYS REV LETT, V68, P2680, DOI 10.1103/PhysRevLett.68.2680; Sakai O, 1997, J PHYS SOC JPN, V66, P3005, DOI 10.1143/JPSJ.66.3005; SATO N, 1984, J PHYS SOC JPN, V53, P3967, DOI 10.1143/JPSJ.53.3967; SCHOENES J, 1987, J MAGN MAGN MATER, V63-4, P43, DOI 10.1016/0304-8853(87)90516-6; Shiina R, 1997, J PHYS SOC JPN, V66, P1741, DOI 10.1143/JPSJ.66.1741; Suzuki O, 1999, PHYSICA B, V259-61, P334, DOI 10.1016/S0921-4526(98)00787-X; Umeo K, 1997, J PHYS SOC JPN, V66, P2133, DOI 10.1143/JPSJ.66.2133	26	8	8	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					883	887		10.1143/JPSJ.69.883		5	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800039		
J	Ito, M; Yasui, Y; Kanada, M; Harashina, H; Yoshii, S; Murata, K; Sato, M; Okumura, H; Kakurai, K				Ito, M; Yasui, Y; Kanada, M; Harashina, H; Yoshii, S; Murata, K; Sato, M; Okumura, H; Kakurai, K			Neutron diffraction study of pyrochlore compound R2Ru2O7 (R=Y, Nd) above and below the spin freezing temperature	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						Y2Ru2O7; Nd2Ru2O7; spin glass; neutron Rietveld analysis		Neutron Rietveld analyses have been carried out on Y2Ru2O7 and Nd2Ru2O7 to clarify the primary mechanism of the transition at T-G to the spin-glass-like state which is accompanied by the specific heat jump. The results indicate that the lattice system does not seem to participate in the transition and changes of the neutron diffraction data with decreasing temperature through T-G can consistently be understood by the ordering of magnetic moments at Ru sites to an almost long range ordered state, even though the low temperature phase is glassy in the macroscopic sense.	Nagoya Univ, Div Mat Sci, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Univ Tokyo, ISSP, Neutron Scattering Lab, Tokai, Ibaraki 3191195, Japan; Japan Sci & Technol Corp, JST, CREST, Yokohama, Kanagawa, Japan	Ito, M (reprint author), Nagoya Univ, Div Mat Sci, Dept Phys, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.						ALEONARD R, 1962, J APPL PHYS, V33, P1205; Lee KS, 1997, J SOLID STATE CHEM, V131, P405, DOI 10.1006/jssc.1997.7497; SUBRAMANIAN MA, 1983, PROG SOLID STATE CH, V15, P55, DOI 10.1016/0079-6786(83)90001-8; RAJU NP, 1992, PHYS REV B, V46, P5405, DOI 10.1103/PhysRevB.46.5405; Yoshii S, 1999, J PHYS SOC JPN, V68, P3034, DOI 10.1143/JPSJ.68.3034; Blote W. J., 1969, PHYSICA, V43, P549; BOUCHARD RJ, 1971, MATER RES BULL, V6, P669, DOI 10.1016/0025-5408(71)90100-0; Izumi F., 1993, RIETVELD METHOD; LONGO JM, 1969, MATER RES BULL, V4, P191, DOI 10.1016/0025-5408(69)90056-7; Sleight A W, 1972, NBS SPEC PUBL, V364, P227; Yoshii S, 2000, J PHYS SOC JPN, V69, P17, DOI 10.1143/JPSJ.69.17	11	32	32	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					888	894		10.1143/JPSJ.69.888		7	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800040		
J	Yamamoto, T; Saiga, Y; Arikawa, M; Kuramoto, Y				Yamamoto, T; Saiga, Y; Arikawa, M; Kuramoto, Y			Exact dynamics of the SU(K) Haldane-Shastry model	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						dynamical structure factor; SU(K) Haldane-Shastry model; U(K) spin Calogero-Sutherland model; spinon; fractional statistics; orbital degeneracy	CALOGERO-SUTHERLAND MODEL; INVERSE-SQUARE EXCHANGE; LONG-RANGE INTERACTIONS; T-J MODEL; ONE-DIMENSION; FRACTIONAL STATISTICS; HEISENBERG CHAIN; QUANTUM-SYSTEMS; SPIN; ANTIFERROMAGNET	The dynamical structure factor S(q, omega) of the SU(K) (K = 2, 3, 4) Haldane-Shastry model is derived exactly at zero temperature for arbitrary size of the system. The result is interpreted in terms of free quasi-particles which are generalization of spinons in the SU(2) case; the excited states relevant to S(q, omega) consist of K quasi-particles each of which is characterized by a set of K - 1 quantum numbers. Near the boundaries of the region where S(q, omega) is nonzero, S(q, omega) shows the power-law singularity. It is found that the divergent singularity occurs only in the lowest edges starting from (q, omega) = (0, 0) toward positive and negative q. The analytic result is checked numerically for finite systems via exact diagonalization and recursion methods.	Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Yamamoto, T (reprint author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.						Bouwknegt P, 1996, NUCL PHYS B, V482, P345, DOI 10.1016/S0550-3213(96)00565-2; AFFLECK I, 1986, NUCL PHYS B, V265, P409, DOI 10.1016/0550-3213(86)90167-7; Suzuki J, 1998, J PHYS A-MATH GEN, V31, P6887, DOI 10.1088/0305-4470/31/32/012; HALDANE FDM, 1991, PHYS REV LETT, V66, P1529, DOI 10.1103/PhysRevLett.66.1529; Azaria P, 1999, PHYS REV LETT, V83, P624, DOI 10.1103/PhysRevLett.83.624; LESAGE F, 1995, NUCL PHYS B, V435, P585, DOI 10.1016/0550-3213(94)00453-L; SHASTRY BS, 1988, PHYS REV LETT, V60, P639, DOI 10.1103/PhysRevLett.60.639; Karbach M, 1997, PHYS REV B, V55, P12510, DOI 10.1103/PhysRevB.55.12510; CALOGERO F, 1969, J MATH PHYS, V10, P2191, DOI 10.1063/1.1664820; HALDANE FDM, 1992, PHYS REV LETT, V69, P2021, DOI 10.1103/PhysRevLett.69.2021; POLYCHRONAKOS AP, 1993, PHYS REV LETT, V70, P2329, DOI 10.1103/PhysRevLett.70.2329; Bouwknegt P, 1999, NUCL PHYS B, V547, P501, DOI 10.1016/S0550-3213(99)00095-4; HALDANE FDM, 1991, PHYS REV LETT, V67, P937, DOI 10.1103/PhysRevLett.67.937; HA ZNC, 1992, PHYS REV B, V46, P9359, DOI 10.1103/PhysRevB.46.9359; MULLER G, 1981, PHYS REV B, V24, P1429, DOI 10.1103/PhysRevB.24.1429; HALDANE FDM, 1988, PHYS REV LETT, V60, P635, DOI 10.1103/PhysRevLett.60.635; BERNARD D, 1993, J PHYS A-MATH GEN, V26, P5219, DOI 10.1088/0305-4470/26/20/010; Arikawa M, 1999, J PHYS SOC JPN, V68, P3782, DOI 10.1143/JPSJ.68.3782; AZARIA P, 1999, CODMAT9910218; Bougourzi AH, 1998, PHYS REV B, V57, P11429, DOI 10.1103/PhysRevB.57.11429; BOUGOURZI AH, 1996, PHYS REV B, V54, P12699; BOUWKNEGT P, 1999, HEPTH9903176; Efetov K. B., 1997, SUPERSYMMETRY DISORD; Frischmuth B, 1999, PHYS REV LETT, V82, P835, DOI 10.1103/PhysRevLett.82.835; HA ZNC, 1994, PHYS REV LETT, V73, P1574, DOI 10.1103/PhysRevLett.73.1574; HA ZNC, 1995, NUCL PHYS B, V435, P604, DOI 10.1016/0550-3213(94)00537-O; HA ZNC, 1995, PHYS REV LETT, V74, P620, DOI 10.1103/PhysRevLett.74.620; HALDANE FDM, 1994, CORRELATION EFFECTS, P92507; HALDANE FDM, 1993, PHYS REV LETT, V71, P4005; Isobe M, 1996, J PHYS SOC JPN, V65, P1178, DOI 10.1143/JPSJ.65.1178; ITOI C, 1999, CONDMAT9910109; Jimbo M, 1994, ALGEBRAIC ANAL SOLVA; Kato Y, 1997, J PHYS SOC JPN, V66, P1954, DOI 10.1143/JPSJ.66.1954; Kato Y, 1996, J PHYS SOC JPN, V65, P1622, DOI 10.1143/JPSJ.65.1622; KAWAKAMI N, 1992, PHYS REV B, V46, P1005, DOI 10.1103/PhysRevB.46.1005; Kirillov AN, 1997, COMMUN MATH PHYS, V185, P441, DOI 10.1007/s002200050098; KURAMOTO Y, 1991, PHYS REV LETT, V67, P1338, DOI 10.1103/PhysRevLett.67.1338; Kuramoto Y, 1995, J PHYS SOC JPN, V64, P4518, DOI 10.1143/JPSJ.64.4518; LAUGHLIN RB, 1998, P IN C AS PAC CTR TH; LEE YL, 1999, CONDMAT9909394; Li YQ, 1998, PHYS REV LETT, V81, P3527, DOI 10.1103/PhysRevLett.81.3527; Li YQ, 1999, PHYS REV B, V60, P12781, DOI 10.1103/PhysRevB.60.12781; Macdonald I. G., 1995, SYMMETRIC FUNCTIONS; Mila F, 1999, PHYS REV LETT, V82, P3697, DOI 10.1103/PhysRevLett.82.3697; NIEMEIJE.T, 1967, PHYSICA, V36, P377, DOI 10.1016/0031-8914(67)90235-2; Pati SK, 1998, PHYS REV LETT, V81, P5406, DOI 10.1103/PhysRevLett.81.5406; SUTHERLAND B, 1993, PHYS REV LETT, V71, P5, DOI 10.1103/PhysRevLett.71.5; SUTHERLA.B, 1971, J MATH PHYS, V12, P251, DOI 10.1063/1.1665585; Takemura K, 1997, J PHYS A-MATH GEN, V30, P3685, DOI 10.1088/0305-4470/30/10/039; UGLOV D, 1997, QALG9705010; Uglov D, 1998, COMMUN MATH PHYS, V191, P663, DOI 10.1007/s002200050283; Yamamoto T, 1999, J PHYS A-MATH GEN, V32, P3341, DOI 10.1088/0305-4470/32/18/309; YAMAMOTO T, IN PRESS PHYS REV LE; YAMASHITA Y, 1999, CONDMAT9905211; YAMASHITA Y, 1999, CONDMAT9908237; Yamashita Y, 1998, PHYS REV B, V58, P9114, DOI 10.1103/PhysRevB.58.9114	56	13	13	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					900	925		10.1143/JPSJ.69.900		26	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800042		
J	Jung, MH; Min, BH; Kwon, YS; Oguro, I; Iga, F; Fujita, T; Ekino, T; Kasuya, T; Takabatake, T				Jung, MH; Min, BH; Kwon, YS; Oguro, I; Iga, F; Fujita, T; Ekino, T; Kasuya, T; Takabatake, T			Anisotropic transport and magnetic properties and magnetic-polaron-like behavior in CeTe2-x	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						low-density carrier system; CeTe2-x; anisotropy; magnetic polaron; charge density wave	OPTICAL-PROPERTIES; GD MONOPNICTIDES; SINGLE-CRYSTALS; MECHANISM; SYSTEMS; CESB	Highly anisotropic properties of CeTe2-x with the layered Cu2Sb-type structure have been found by the measurements of electrical resistivity rho(T), magnetic susceptibility chi(T) and mag netization M(B) on single crystals for x = 0.15-0.18. Both M(B parallel to c) and M(B perpendicular to c) at 2K exhibit a metamagnetic transition at 0.04T. M(B parallel to c) saturates rapidly to a value of 1.06 mu(B)/f.u. at around B = 0.2 T, whereas M(B perpendicular to c) gradually increases to a value of 0.75 mu(B)/f.u. at 5.5 T. The absence of hysteresis and remanence in nl(B) indicates an antiferromagnetic ground state. The resistivity ratio rho(parallel to)c/rho perpendicular to(c) increases from 3 to 150 on cooling from 300 It to 1.5 K(. Both rho(parallel to)c, and pi, exhibit a sharp peak at 6 K before the onset of long-range magnetic order at T-N = 4.3 K, where chi(T) exhibits a sharp peak. Measurements of the Hall coefficient R-H(T), specific heat C(T), magnetoresistance rho(B) and electron tunneling have been done for polycrystals with x = 0.13 and 0.18. Electron-tunneling spectra at 77 K revealed the presence of a charge density wave with a pseudogap of 0.35 eV. It is found that C(T) exhibits a peak at TN With a significant tail up to 10K, whereas Ra(T) continuously increases. The magnetic entropy at TN is only 0.7R In 2, being indicative of a, short-range order above TN. At 1.5 K, rho(B) shows a peak at 0.075 T and then decreases rapidly for B less than or equal to 1 T, resulting in a negative magnetoresistance of 20%. These results are analogous to those found in EuTe0.9, GdAs0.95 and CeSb, where low-density carriers form a pseudo-localized state and align the 4f spins within a magnetic polaron.	Hiroshima Univ, ADSM, Dept Quantum Matter, Higashihiroshima 7398526, Japan; Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan; Hiroshima Univ, Fac Integrated Arts & Sci, Higashihiroshima 7398521, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808576, Japan	Jung, MH (reprint author), Hiroshima Univ, ADSM, Dept Quantum Matter, Higashihiroshima 7398526, Japan.		Takabatake, Toshiro/L-2882-2014	Takabatake, Toshiro/0000-0002-3293-8592			Li DX, 1996, PHYS REV B, V54, P10483, DOI 10.1103/PhysRevB.54.10483; EKINO T, 1995, PHYS REV LETT, V75, P4262, DOI 10.1103/PhysRevLett.75.4262; DIMASI E, 1995, PHYS REV B, V52, P14516, DOI 10.1103/PhysRevB.52.14516; Bud'ko SL, 1998, PHYS REV B, V57, P13624, DOI 10.1103/PhysRevB.57.13624; DiMasi E., 1995, Physica B, V206-207, DOI 10.1016/0921-4526(94)00467-A; DiMasi E, 1996, PHYS REV B, V54, P13587, DOI 10.1103/PhysRevB.54.13587; Jung MH, 1997, PHYSICA B, V240, P83, DOI 10.1016/S0921-4526(97)00361-X; Jung MH, 1997, PHYSICA B, V230, P151, DOI 10.1016/S0921-4526(96)00575-3; KASUYA T, 1992, J PHYS SOC JPN, V61, P2628, DOI 10.1143/JPSJ.61.2628; KASUYA T, 1995, J APPL PHYS, V77, P3200, DOI 10.1063/1.358673; Kasuya T, 1997, J MAGN MAGN MATER, V171, P251, DOI 10.1016/S0304-8853(97)00083-8; KASUYA T, 1993, PHYSICA B, V186-88, P9, DOI 10.1016/0921-4526(93)90484-N; Kasuya T, 1997, J MAGN MAGN MATER, V166, pL1, DOI 10.1016/S0304-8853(96)00659-2; KASUYA T, 1993, J PHYS SOC JPN, V62, P3364, DOI 10.1143/JPSJ.62.3364; KASUYA T, 1995, J ALLOY COMPD, V219, P290, DOI 10.1016/0925-8388(94)05043-0; Kikuchi A, 1998, J PHYS SOC JPN, V67, P1308, DOI 10.1143/JPSJ.67.1308; KWON YS, 1995, J MAGN MAGN MATER, V140, P1173, DOI 10.1016/0304-8853(94)01297-0; Li DX, 1996, PHYS REV B, V53, P8473, DOI 10.1103/PhysRevB.53.8473; MORI N, 1993, PHYSICA B, V186-88, P444, DOI 10.1016/0921-4526(93)90599-2; NOTING W, 1996, PHYS REV B, V54, P14455; OLIVEIRA NF, 1972, PHYS REV B-SOLID ST, V5, P2634, DOI 10.1103/PhysRevB.5.2634; PARK JG, 1998, PHYSICA B, V241, P684; SHAPIRA Y, 1972, PHYS REV B-SOLID ST, V5, P2647, DOI 10.1103/PhysRevB.5.2647; Suzuki T, 1993, JPN J APPL PHYS SERI, V8, P44; TAKAHASHI H, 1985, J PHYS C SOLID STATE, V18, P2697, DOI 10.1088/0022-3719/18/13/016; TAKAHASHI M, 1983, J PHYS SOC JPN, V52, P3127, DOI 10.1143/JPSJ.52.3127; TAKEDA T, 1975, J PHYS SOC JPN, V39, P1443, DOI 10.1143/JPSJ.39.1443; TAYOR KNR, 1972, PHYSICS RARE EARTH S; WANG R, 1966, INORG CHEM, V5, P142, DOI 10.1021/ic50035a034	29	20	20	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	MAR	2000	69	3					937	944		10.1143/JPSJ.69.937		8	Physics, Multidisciplinary	Physics	299MF	WOS:000086201800044		
J	Yin, YF				Yin, YF			Genetic-algorithms-based approach for bilevel programming models	JOURNAL OF TRANSPORTATION ENGINEERING-ASCE			English	Article							NETWORK DESIGN PROBLEM; SIMULATED ANNEALING APPROACH; USER-OPTIMAL FLOWS; ROAD NETWORK	Many decision-making problems in transportation system planning and management can be formulated as bilevel programming models, which are intrinsically nonconvex and hence difficult to solve for the global optimum. Therefore, successful implementations of bilevel models rely largely on the development of an efficient algorithm in handling realistic complications. In spite of various intriguing attempts that were made in solving the bilevel models, these algorithms are unfortunately either incapable of finding the global optimum or very computationally intensive and impractical for problems of a realistic size. In this paper, a genetic-algorithms-based (GAB) approach is proposed to efficiently solve these models. The performance of the algorithm is illustrated and compared with the previous sensitivity-analysis-based algorithm using numerical examples. The computation results show that the GAB approach is efficient and much simpler than previous heuristic algorithms. Furthermore, it is believed that the GAB approach can more likely achieve the global optimum based on the globality and parallelism of genetic algorithms.	Univ Tokyo, Dept Civil Engn, Transp Res & Infrastruct Ping Lab, Bunkyo Ku, Tokyo 113, Japan	Yin, YF (reprint author), Univ Tokyo, Dept Civil Engn, Transp Res & Infrastruct Ping Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Allsop R. E., 1989, MATH TRANSPORT PLANN, P1; FRIESZ TL, 1993, EUR J OPER RES, V65, P44, DOI 10.1016/0377-2217(93)90143-B; Yang H, 1996, TRANSPORT RES A-POL, V30, P319; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; LEBLANC LJ, 1986, TRANSPORT RES B-METH, V20, P259, DOI 10.1016/0191-2615(86)90021-4; ASAKURA Y, 1990, P 5 WORLD C TRANSP R, P351; Chan K. S., 1998, P 3 C HONG KONG SOC, P247; FISK CS, 1984, TRANSPORT RES B-METH, V18, P301, DOI 10.1016/0191-2615(84)90013-4; FRIESZ TL, 1992, TRANSPORT SCI, V26, P18, DOI 10.1287/trsc.26.1.18; Golberg D.E., 1989, GENETIC ALGORITHMS S; Sheffi Y., 1985, URBAN TRANSPORTATION; Wong SC, 1997, TRANSPORT RES B-METH, V31, P397, DOI 10.1016/S0191-2615(97)00002-7; YANG H, 1994, TRANSPORT RES B-METH, V28, P123, DOI 10.1016/0191-2615(94)90021-3; Yang H, 1995, TRANSPORT RES B-METH, V29, P231, DOI 10.1016/0191-2615(95)00003-V; YANG HF, 1994, CHIN J PREV MED, V28, P6	15	96	106	ASCE-AMER SOC CIVIL ENGINEERS	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2398 USA	0733-947X			J TRANSP ENG-ASCE	J. Transp. Eng.-ASCE	MAR-APR	2000	126	2					115	120		10.1061/(ASCE)0733-947X(2000)126:2(115)		6	Engineering, Civil; Transportation Science & Technology	Engineering; Transportation	284NG	WOS:000085338000003		
J	Homma, Y; Yamaguchi, O; Kageyama, S; Nishizawa, O; Yoshida, M; Kawabe, K				Homma, Y; Yamaguchi, O; Kageyama, S; Nishizawa, O; Yoshida, M; Kawabe, K			Nocturia in the adult: Classification on the basis of largest voided volume and nocturnal urine production	JOURNAL OF UROLOGY			English	Article						urination disorders; polyuria; classification	FREQUENCY; POLYURIA; PREVALENCE; SYMPTOMS; PATTERNS; PEOPLE; TRACT; WOMEN; MEN	Purpose: We propose a criterion to clarify the underlying etiologies of nocturia. Materials and Methods: Frequency-volume charts were recorded for 24 hours by 35 men and 32 women who were subjectively free of lower urinary tract symptoms and had no evidence of voiding disorders. At least 5 subjects were included in each of 5 age groups of 20 to 49, 50 to 59, 60 to 69, 70 to 79, 80 to 89 years for both genders. The charts were used to make a tentative criterion, which was validated in 39 elderly individuals with nocturnal frequency. Results: Correlation and regression analyses indicated that the quotients of nocturnal urine output divided by body weight (U(N)/BW) and largest voided volume divided by body weight (V(L)/BW) were useful classification factors. Cutoffs,:which were set close to worst quartiles, were 10 ml./kg. for U(N)/BW and 4 ml./kg. for V(L)/BW, respectively. Correction by body weight made the same criterion applicable irrespective of weight. Symptomatic elderly patients were classified into 3 mutually exclusive groups of nocturnal polyuria (U(N)/BW greater than 10 ml./kg.), low bladder capacity (V(L)/BW less than 4 ml./kg.) and combined nocturia. Of 20 subjects who voided 2 times a night 11 (55%) were classified as having nocturnal polyuria and 15 of 19 who voided 3 or 4 times (79%) were classified as having low bladder capacity or combined nocturia. Conclusions: The criterion provides a reasonable distinction of etiologies of nocturia, and may be usefulness in examination and treatment.	Univ Tokyo, Dept Urol, Tokyo, Japan; Fukushima Med Coll, Fukushima, Japan; Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan; Shinshu Univ, Matsumoto, Nagano 390, Japan; Kumamoto Univ, Sch Med, Kumamoto 860, Japan	Homma, Y (reprint author), Univ Tokyo, Dept Urol, Tokyo, Japan.						Abrams P, 1996, Scand J Urol Nephrol Suppl, V179, P47; KASSIS A, 1993, BRIT J UROL, V72, P708, DOI 10.1111/j.1464-410X.1993.tb16252.x; Pressman MR, 1996, ARCH INTERN MED, V156, P545, DOI 10.1001/archinte.156.5.545; Madersbacher S, 1998, UROLOGY, V51, P206, DOI 10.1016/S0090-4295(97)00616-X; Weiss JP, 1998, NEUROUROL URODYNAM, V17, P467, DOI 10.1002/(SICI)1520-6777(1998)17:5<467::AID-NAU2>3.0.CO;2-B; MCCORMACK M, 1992, BRIT J UROL, V69, P17, DOI 10.1111/j.1464-410X.1992.tb15450.x; Oster JR, 1997, ARCH INTERN MED, V157, P721, DOI 10.1001/archinte.157.7.721; ASPLUND R, 1992, SCAND J UROL NEPHROL, V26, P345; Asplund R, 1999, BJU INT, V83, P591; ASPLUND R, 1991, J INTERN MED, V229, P131; BRITTON JP, 1990, BRIT J UROL, V66, P175, DOI 10.1111/j.1464-410X.1990.tb14898.x; FINKBEINER AE, 1993, INT UROGYNECOL J PEL, V4, P168, DOI 10.1007/BF00571628; Homma Y, 1994, Scand J Urol Nephrol Suppl, V157, P27; Hunsballe JM, 1997, J UROLOGY, V158, P830, DOI 10.1016/S0022-5347(01)64330-1; KIRKLAND JL, 1983, BRIT MED J, V287, P1665; Matthiesen TB, 1996, J UROLOGY, V156, P1292, DOI 10.1016/S0022-5347(01)65572-1; SAITO M, 1993, BRIT J UROL, V72, P38, DOI 10.1111/j.1464-410X.1993.tb06453.x; SOMMER P, 1990, BRIT J UROL, V66, P12, DOI 10.1111/j.1464-410X.1990.tb14855.x; STONE C I, 1976, Urology, V8, P46, DOI 10.1016/0090-4295(76)90052-2	19	41	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347			J UROLOGY	J. Urol.	MAR	2000	163	3					777	781		10.1016/S0022-5347(05)67802-0		5	Urology & Nephrology	Urology & Nephrology	282YX	WOS:000085250300022		
J	Wake, T; Saiki, K; Koma, A				Wake, T; Saiki, K; Koma, A			Epitaxial growth and surface structure of cuprous halide thin films	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS			English	Article							HETEROEPITAXIAL GROWTH; BAND-STRUCTURE; ALKALI-HALIDE; CUCL; GAAS; TRANSITION; CRYSTALS; MODEL; SI	The surface atomic and electronic structures of cuprous halide CuX (X = Cl, Br, and I) films, which were grown on various GaAs faces, have been studied by reflection high-energy electron diffraction, Auger electron spectroscopy, and electron energy loss spectroscopy. Epitaxial growth in a layer by layer fashion was observed commonly on all GaAs faces, except on a GaAs (1 1 1) As 2 x 2 race. The growth mode at the initial stage was affected by the lattice misfit of CuX to GaAs. Auger electron spectra and electron energy loss spectra of CuX depend on the crystal race of the substrate. These results indicate that CuX have both ionic and covalent Features in the film growth process. (C) 2000 American Vacuum Society. [S0734-2101(00)08002-7].	Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1130033, Japan	Saiki, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Saiki, Koichiro/E-4496-2011				TASKER PW, 1979, PHILOS MAG A, V39, P119; NISHIDA N, 1995, SURF SCI, V324, P149, DOI 10.1016/0039-6028(94)00708-X; YANASE A, 1992, SURF SCI, V278, pL105; PHILLIPS JC, 1970, REV MOD PHYS, V42, P317, DOI 10.1103/RevModPhys.42.317; LEVINE JD, 1966, PHYS REV, V144, P751, DOI 10.1103/PhysRev.144.751; PASHLEY MD, 1989, PHYS REV B, V40, P10481, DOI 10.1103/PhysRevB.40.10481; CHEN W, 1992, J VAC SCI TECHNOL A, V10, P2071, DOI 10.1116/1.578027; DASSANAYAKE UM, 1993, J VAC SCI TECHNOL B, V11, P1467, DOI 10.1116/1.586914; FROHLICH D, 1982, SOLID STATE COMMUN, V43, P189, DOI 10.1016/0038-1098(82)90108-9; GOLDMANN A, 1983, J PHYS C SOLID STATE, V16, P1335, DOI 10.1088/0022-3719/16/7/019; KAHN A, 1992, PHYS REV LETT, V68, P3200, DOI 10.1103/PhysRevLett.68.3200; NETZER FP, 1987, XRAY SPECTROSCOPY AT; SAIKI K, 1991, SURF SCI, V250, P27, DOI 10.1016/0039-6028(91)90706-X; SAIKI K, 1994, SURF SCI, V301, P29, DOI 10.1016/0039-6028(94)91285-8; Saiki K, 1997, APPL SURF SCI, V113, P9, DOI 10.1016/S0169-4332(96)00888-4; SCUH DK, 1990, CHEM MATER, V2, P492; Setzer C, 1998, SURF SCI, V402, P782, DOI 10.1016/S0039-6028(97)01060-1; SINGH RK, 1989, PHYS REV B, V40, P11278, DOI 10.1103/PhysRevB.40.11278; Tanaka S, 1998, J ELECTRON SPECTROSC, V88, P689, DOI 10.1016/S0368-2048(97)00200-4; TONG SY, 1984, PHYS REV LETT, V52, P1693, DOI 10.1103/PhysRevLett.52.1693; TONG WM, 1994, PHYS REV LETT, V72, P3374, DOI 10.1103/PhysRevLett.72.3374; TSAI MH, 1992, J VAC SCI TECHNOL A, V10, P2511, DOI 10.1116/1.578090; TSUKADA M, 1987, PHYS CHEM MINER, V15, P35, DOI 10.1007/BF00307606; UENO K, 1990, APPL PHYS LETT, V56, P327, DOI 10.1063/1.102817; WESTPHAL D, 1982, J PHYS C SOLID STATE, V15, P6661, DOI 10.1088/0022-3719/15/32/026; WU MC, 1990, VACUUM, V41, P1418, DOI 10.1016/0042-207X(90)93976-P	26	0	0	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0734-2101			J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A-Vac. Surf. Films	MAR-APR	2000	18	2					536	542		10.1116/1.582220		7	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	293BG	WOS:000085831200041		
J	Kawakatsu, H; Toshiyoshi, H; Saya, D; Fukushima, K; Fujita, H				Kawakatsu, H; Toshiyoshi, H; Saya, D; Fukushima, K; Fujita, H			Fabrication of a silicon based nanometric oscillator with a tip form mass for scanning force microcopy operating in the GHz range	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article; Proceedings Paper	1999 STM Conference	JUL 18-23, 1999	SEOUL, SOUTH KOREA	STM			CANTILEVERS; MICROSCOPE	The detectable force resolution of a mechanical oscillator used in scanning force microscopy call be improved by increasing its natural frequency f(o) and quality factor Q, and by decreasing the spring constant k and the temperature of operation T. For an oscillator having a structure that can be modeled as a concentrated mass-spring model, decreasing the mass of the oscillator is desirable since high f(o) can then be obtained without increasing the spring constant k. We have developed a novel fabrication technique for fabricating a nanometric oscillator by selective etching of silicon on insulator (SOI) wafers. The oscillator has the form of a tip supported by an elastic neck, and the tip serves as the mass. The tip and the neck length measure approximately 100 nm when fabricated using a separation by implanted oxygen wafer, and are around 1000 nm when fabricated using a bonded SOI wafer. The tips were made of silicon and the necks were made of silicon dioxide. The oscillator could be tailored to have its natural frequency in the range of 0.01-1 GHz and a spring constant between 10(-1) and 10(2) N/m. The thin neck, whose diameter is of the order of 10 nm is not brittle and can survive angular bending of around 30 degrees. (C) 2000 American Vacuum Society. [S0734-211X(00)05902-3].	Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan	Kawakatsu, H (reprint author), Univ Tokyo, Inst Ind Sci, 7-22-1 Roppongi, Tokyo 1068558, Japan.						Chui BW, 1996, APPL PHYS LETT, V69, P2767, DOI 10.1063/1.117669; Cleland AN, 1996, APPL PHYS LETT, V69, P2653, DOI 10.1063/1.117548; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522; Paloczi GT, 1998, APPL PHYS LETT, V73, P1658, DOI 10.1063/1.122237; Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177; NICHOLS FA, 1965, J APPL PHYS, V36, P1826, DOI 10.1063/1.1714360; ARIKADO T, 1981, ECS SOFT BOUND S SER, P66; BINH VT, 1994, SURF SCI, V301, pL224, DOI 10.1016/0039-6028(94)91277-7; BINH VT, 1976, SURF SCI, V57, P184, DOI 10.1016/0039-6028(76)90176-X; Brugger J, 1997, MICROELECTRON ENG, V35, P401, DOI 10.1016/S0167-9317(96)00210-9; DRECHSLER M, 1987, J PHYS PARIS C, V6, P209; DRECHSLE.M, 1969, SURF SCI, V14, P457, DOI 10.1016/0039-6028(69)90093-4; EPHRATH LM, 1979, J ELECTROCHEM SOC, V126, P1419, DOI 10.1149/1.2129291; FIOR GO, 1988, SOLID STATE TECHNOL, V31, P109; HASHIGUCHI G, 1994, JPN J APPL PHYS 2, V33, pL1649; HASHIGUCHI G, 1995, JPN J APPL PHYS 1, V34, P1493, DOI 10.1143/JJAP.34.1493; HEINECKE RA, 1975, SOLID STATE ELECT, V18, P3954; KAWAKATSU H, IN PRESS APPL SURF S; Kawakatsu H, 1999, JPN J APPL PHYS 1, V38, P3954, DOI 10.1143/JJAP.38.3954; KAWAKATSU H, UNPUB VAC SCI TECH B; Kawakatsu H, 1999, JPN J APPL PHYS 1, V38, P3962, DOI 10.1143/JJAP.38.3962; LEHMANN HW, 1978, J VAC SCI TECHNOL, V15, P319, DOI 10.1116/1.569581; Wago K, 1997, REV SCI INSTRUM, V68, P1823, DOI 10.1063/1.1147967	24	6	6	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAR-APR	2000	18	2					607	611		10.1116/1.591246		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	306FQ	WOS:000086587000001		
J	Tanaka, S; Kaneko, S; Watanabe, T				Tanaka, S; Kaneko, S; Watanabe, T			Self-excited oscillations of dual cylindrical flexible weir shells due to overflow fluid	JOURNAL OF VIBRATION AND CONTROL			English	Article						fluid-structure interaction; sloshing; shell vibration; time delay system	VIBRATION	Self-excited oscillations of the structure coupled with inner fluid occurred in the insulation wall cooling system of the fast breeder reactor Super-Phenix-l (SPX-1) in France during test operations. In this system, lower temperature sodium going up along the inside of the main vessel in a feeding plenum brims over a cylindrical flexible weir shell and flows into a restitution plenum. It is reported that the self-excited oscillations were found to occur at the same natural frequency of the sloshing in the restitution plenum, the free surface of the fluid in both feeding and restitution plenums oscillated at large amplitudes, and the cylindrical shell was found to oscillate with an oval vibration mode instability. Such an instability is called a coupled sloshing mode. In this study, the authors analyzed and performed experiments on the instability of a multiple cylindrical structure system that has dual flexible weir shells. They measured self-excited oscillations changing various parameters such as discharge flow rate, difference of the liquid heights between feeding and restitution plenums, and so on. In the experiment, it was found that dual cylindrical shells oscillate in and out of phase with each other with an oval vibration mode under the specific conditions. Comparison between theoretically and experimentally obtained instability regions was made showing good agreement.	Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Tanaka, S (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						Aita S., 1986, ASME PVP, V104, P41; Aita S., 1986, ASME PVP, V104, P51; Blevins R.D., FORMULAS NATURAL FRE; Chiba M, 1997, J PRESS VESS-T ASME, V119, P68, DOI 10.1115/1.2842269; Fujita K., 1993, ASME PVP, V258, P143; Fujita K, 1996, J FLUID STRUCT, V10, P79, DOI 10.1006/jfls.1996.0007; Henderson F.M., 1966, OPEN CHANNEL FLOW; KANEKO S, 1993, ASME PVP, V258, P151; NAGAKURA H, 1998, T JSME, V64, P136; NAGAKURA H, 1998, T JSME, V64, P98; NAGAKURA H, 1998, T JSME, V64, P127; Nagakura H., 1995, ASME FLUID STRUCTURE, V310, P15	12	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1077-5463			J VIB CONTROL	J. Vib. Control	MAR	2000	6	3					351	373		10.1177/107754630000600302		23	Acoustics; Engineering, Mechanical; Mechanics	Acoustics; Engineering; Mechanics	285MF	WOS:000085392300002		
J	Masuda, M; Nagai, Y; Oshima, N; Tanaka, K; Murakami, H; Igarashi, H; Okayama, H				Masuda, M; Nagai, Y; Oshima, N; Tanaka, K; Murakami, H; Igarashi, H; Okayama, H			Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of Wee1, Ppa2, and Rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr	JOURNAL OF VIROLOGY			English	Article							DNA-DAMAGE CHECKPOINT; PROTEIN-R VPR; NIM1/CDR1 MITOTIC INDUCER; HIV-1 VPR; NEGATIVE REGULATION; NUCLEAR IMPORT; VIRION INCORPORATION; TYROSINE KINASE; DIVISION CYCLE; S-PHASE	Accessory protein Vpr of human immunodeficiency virus type 1 (HIV-1) arrests cell cycling at G(2)/M phase in human and simian cells. Recently, it has been shown that Vpr also causes cell cycle arrest in the fission yeast Schizosaccharomyces pombe, which shares the cell cycle regulatory mechanisms with higher eukaryotes including humans. In this study, in order to identify host cellular factors involved in Vpr-induced cell cycle arrest, the ability of Vpr to cause elongated cellular morphology (cdc phenotype) typical of G(2)/M cell cycle arrest in wild-type and various mutant strains of S. pombe was examined, Our results indicated that Vpr caused the cde phenotype in wild-type S. pombe as well as in strains carrying mutations, such as the cdc2-3w, Delta cdc25, ran1-1, Delta chk1, Delta mik1, and Delta ppa1 strains. However, other mutants, such as the cdc2-1w, Delta wee1, Delta ppa2, and Delta rad24 strains, failed to show a distinct cdc phenotype in response to Vpr expression. Results of these genetic studies suggested that Wee1, Ppa2, and Rad24 might be required for induction of cell cycle arrest by HIV-I Vpr, Cell proliferation was inhibited by Vpr expression in all of the strains examined including the ones that did not show the cdc phenotype. The results supported the previously suggested possibility that Vpr affects the cell cycle and cell proliferation through different pathways.	Univ Tokyo, Grad Sch Med, Dept Microbiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	Masuda, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Microbiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mmasuda@m.u-tokyo.ac.jp					Alfa C, 1993, EXPT FISSION YEAST L; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; HE JL, 1995, J VIROL, V69, P6705; Breeding CS, 1998, MOL BIOL CELL, V9, P3399; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Kanoh J, 1998, MOL BIOL CELL, V9, P3321; RE F, 1995, J VIROL, V69, P6859; Stewart SA, 1997, J VIROL, V71, P5579; Jowett JB, 1999, J VIROL, V73, P7132; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; KINOSHITA N, 1993, GENE DEV, V7, P1059, DOI 10.1101/gad.7.6.1059; JOWETT JBM, 1995, J VIROL, V69, P6304; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Bouhamdan M, 1996, J VIROL, V70, P697; Planelles V, 1996, J VIROL, V70, P2516; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; MITCHISON JM, 1990, BIOESSAYS, V12, P189, DOI 10.1002/bies.950120409; Okayama H, 1996, ADV CANCER RES, V69, P17, DOI 10.1016/S0065-230X(08)60859-3; ADACHI A, 1986, J VIROL, V59, P284; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Chen MZ, 1999, J VIROL, V73, P3236; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Fletcher TM, 1996, EMBO J, V15, P6155; [Anonymous], 1991, METHOD ENZYMOL; Bartz SR, 1996, J VIROL, V70, P2324; Bodeus M, 1997, RES VIROLOGY, V148, P207, DOI 10.1016/S0923-2516(97)83990-8; Caspari T, 1999, BIOCHIMIE, V81, P173, DOI 10.1016/S0300-9084(99)80050-9; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; Kewalramani VN, 1996, VIROLOGY, V218, P326, DOI 10.1006/viro.1996.0201; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; LEE M, 1988, TRENDS GENET, V4, P287, DOI 10.1016/0168-9525(88)90171-0; LEE MS, 1994, J BIOL CHEM, V269, P30530; Macreadie IG, 1997, FEBS LETT, V410, P145, DOI 10.1016/S0014-5793(97)00542-5; Mahalingam S, 1998, P NATL ACAD SCI USA, V95, P3419, DOI 10.1073/pnas.95.7.3419; Mahalingam S, 1997, J VIROL, V71, P6339; Masuda M, 1996, VIROLOGY, V215, P142, DOI 10.1006/viro.1996.0017; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCCONNELL CL, 1993, GROUND WATER, V31, P75, DOI 10.1111/j.1745-6584.1993.tb00830.x; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MILLAR JBA, 1991, EMBO J, V10, P4301; Nishida T., 1997, CORNEA FUNDAMENTALS, V1, P3; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; PLANELLES V, 1995, J VIROL, V69, P5883; Poon B, 1997, J VIROL, V71, P3961; ROGEL ME, 1995, J VIROL, V69, P882; ROWLEY R, 1992, EMBO J, V11, P1335; Selig L, 1997, J VIROL, V71, P4842; Stivahtis GL, 1997, J VIROL, V71, P4331; WithersWard ES, 1997, J VIROL, V71, P9732; Zhang CS, 1997, VIROLOGY, V230, P103, DOI 10.1006/viro.1997.8459; Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208; Zhao YQ, 1996, J VIROL, V70, P5821	69	58	59	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2000	74	6					2636	2646		10.1128/JVI.74.6.2636-2646.2000		11	Virology	Virology	286LH	WOS:000085447100016		
J	Kaneko, K; Koyaguchi, T				Kaneko, K; Koyaguchi, T			Simultaneous crystallization and melting at both the roof and floor of crustal magma chambers: Experimental study using NH4Cl-H2O binary eutectic system	JOURNAL OF VOLCANOLOGY AND GEOTHERMAL RESEARCH			English	Article							COMPOSITIONAL CONVECTION; MUSHY LAYER; SOLIDIFICATION; FLUID; DIFFERENTIATION; RESERVOIRS; DYNAMICS; BOUNDARY; LIQUID; MODEL	Thermal and compositional evolution of magmas after emplacement of basalt into continental crust has been investigated by means of fluid dynamic experiments using a cold solid mixture with eutectic composition and a hot liquid with higher salinity in the NH4Cl-H2O binary eutectic system. The experiments were designed to simulate cases where crystallization of a basalt magma is accompanied by melting at both the roof and floor of a crustal magma chamber. The results show that thermal and compositional convection occur simultaneously in the solution; the thermal convection is driven by cooling at the roof and the compositional convection is driven by melting and crystallization at the floor. The roof was rapidly melted by the convective heat flux, which resulted in formation of a separate eutectic melt layer (the upper liquid layer) with negligible mixing of the underlying liquid (the lower liquid layer). On the other hand, a mushy layer formed at the floor. The compositional convection at the floor carried a low heat flux, so that the heat transfer at the floor was basically explained by simple heat conduction. The thermal boundary layer in the lower liquid layer at the interface with the upper liquid layer became thicker with time and subsequently temperature decreased upward throughout the lower liquid layer. Compositional gradient with NH4Cl content decreasing upward formed by compositional convection in the lower liquid layer. The formation of these gradients resulted in formation of double-diffusive convecting layers in the lower liquid layer. The upward hear transfer was suppressed when compared with the case where the liquid region is homogenized by vigorous convection. These experimental results imply that, when a basalt magma is emplaced in continental crust, floor melting does not always enhance the cooling of the magma, but it may even reduce the total heat loss from the magma to the crusts due to suppression of convection by formation of a stabilizing compositional gradient. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan	Kaneko, K (reprint author), Geol Survey Japan, Dept Geochem, 1-1-3 Higashi, Tsukuba, Ibaraki 3058567, Japan.						HUPPERT HE, 1988, J PETROL, V29, P599; Koyaguchi T, 1999, J PETROL, V40, P241, DOI 10.1093/petrology/40.2.241; TAIT S, 1989, NATURE, V338, P571, DOI 10.1038/338571a0; LANGMUIR CH, 1989, NATURE, V340, P199, DOI 10.1038/340199a0; SPARKS RSJ, 1984, PHILOS T R SOC A, V310, P511, DOI 10.1098/rsta.1984.0006; WORSTER MG, 1991, J FLUID MECH, V224, P335, DOI 10.1017/S0022112091001787; MCBIRNEY AR, 1985, J VOLCANOL GEOTH RES, V24, P1, DOI 10.1016/0377-0273(85)90026-5; HUPPERT HE, 1988, J FLUID MECH, V188, P107, DOI 10.1017/S0022112088000655; WORSTER MG, 1986, J FLUID MECH, V167, P481, DOI 10.1017/S0022112086002938; CAMPBELL IH, 1987, J GEOL, V95, P155; Cardoso SSS, 1996, J VOLCANOL GEOTH RES, V73, P157, DOI 10.1016/0377-0273(96)00028-5; CHEN CF, 1995, J FLUID MECH, V293, P81, DOI 10.1017/S0022112095001649; CHEN FL, 1993, J APPL PHYS, V74, P7531, DOI 10.1063/1.354979; HILLS RN, 1983, Q J MECH APPL MATH, V36, P505, DOI 10.1093/qjmam/36.4.505; HUPPERT HE, 1989, J FLUID MECH, V198, P293, DOI 10.1017/S0022112089000145; HUPPERT HE, 1981, EARTH PLANET SC LETT, V54, P144, DOI 10.1016/0012-821X(81)90075-3; HUPPERT HE, 1990, J FLUID MECH, V212, P204; JAUPART C, 1995, J GEOPHYS RES-SOL EA, V100, P17615, DOI 10.1029/95JB01239; KERR RC, 1994, J FLUID MECH, V280, P255, DOI 10.1017/S0022112094002922; KERR RC, 1990, J FLUID MECH, V217, P331, DOI 10.1017/S002211209000074X; KRISHNAM.R, 1970, J FLUID MECH, V42, P295, DOI 10.1017/S0022112070001271; MCBIRNEY AR, 1980, J VOLCANOL GEOTH RES, V7, P357, DOI 10.1016/0377-0273(80)90038-4; TAIT S, 1992, J GEOPHYS RES-SOL EA, V97, P6735, DOI 10.1029/92JB00016; Turner J. S., 1973, BUOYANCY EFFECTS FLU; WASHBURN EW, INT CRITICAL TABLE; WOODS AW, 1991, PHYS FLUIDS A-FLUID, V3, P1393, DOI 10.1063/1.858018; WOODS AW, 1989, J FLUID MECH, V199, P29, DOI 10.1017/S0022112089000285; WORSTER MG, 1992, J FLUID MECH, V237, P649, DOI 10.1017/S0022112092003562	28	14	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0377-0273			J VOLCANOL GEOTH RES	J. Volcanol. Geotherm. Res.	MAR	2000	96	3-4					161	174		10.1016/S0377-0273(99)00145-6		14	Geosciences, Multidisciplinary	Geology	306NL	WOS:000086602700002		
J	Nakamura, J				Nakamura, J			On the structures of the milnor K-groups of some complete discrete valuation fields	K-THEORY			English	Article						Milnor K-group; complete discrete valuation field		For a complete discrete valuation field K, the unit group of K has a natural decreasing filtration with respect to the valuation, and the graded quotients of this filtration are written in terms of the residue field. The Milnor K-group of a field is a generalization of the unit group. The Milnor K-group of K has a natural decreasing filtration of the same kind. However, if K is of mixed characteristics and has an absolute ramification index greater than one, the structure is not yet known. The aim of this paper is to determine the structure of the Milnor K-group of some special K, which are of mixed characteristics (0, p), whose residue fields are allowed to be imperfect, and which are of absolute ramification index p(p - 1).	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan							TATE J, 1976, INVENT MATH, V36, P257, DOI 10.1007/BF01390012; ILLUSIE L, 1979, ANN SCI ECOLE NORM S, V12, P501; [Anonymous], 1983, ADV STUD PURE MATH; BLOCH S., 1977, PUBL MATH-PARIS, V47, P187; BLOCH S, 1986, PUBL MATH IHES, V63, P107, DOI 10.1007/BF02831624; GRAHAM J, 1973, LECT NOTES MATH, V342, P474; KNESER M, 1951, MATH NACHR, V6, P89, DOI 10.1002/mana.19510060204; KURIHARA M, 1988, INVENT MATH, V93, P451, DOI 10.1007/BF01394341; KURIHARA M, 1987, COMPOS MATH, V63, P237; Kurihara M, 1998, J REINE ANGEW MATH, V498, P201; KURIHARA M, STRUCTURE MILNOR K G; Serre J.P., 1979, GRAD TEXTS MATH, V67	12	0	0	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0920-3036			K-THEORY	K-Theory	MAR	2000	19	3					269	309		10.1023/A:1007884731933		41	Mathematics	Mathematics	306ZA	WOS:000086627500004		
J	Kikuchi, R; Essaki, K; Tsutsumi, A; Kaganoi, S; Kurimura, H; Sasaki, T; Ogawa, T				Kikuchi, R; Essaki, K; Tsutsumi, A; Kaganoi, S; Kurimura, H; Sasaki, T; Ogawa, T			Thermochemical recuperative combined cycle with methane-steam reforming combustion	KAGAKU KOGAKU RONBUNSHU			Japanese	Article						theromchemical recuperation; methane-steam reforming; high thermal efficiency; load leveling; combined cycle simulation; Aspen Plus		Thermochemical recuperative combined cycles with methane-steam reforming are proposed for improving their thermal efficiency and for peak-load leveling. For targeting higher thermal efficiency, a cycle with methane-steam reforming reaction heated by gas turbine exhaust was analyzed. The inlet temperature of gas turbine was set at 1,350 degrees C. Low-pressure steam extracted from a steam turbine is mixed with methane, and then this mixture is heated by part of the gas turbine exhaust to promote a reforming reaction. The rest of the exhaust heat is used tu produce steam, which drives steam turbines to generate electricity. The effect of steam-to-methane ratio (S/C) on thermal efficiency of the cycle, as well as on methane conversion, is investigated by using the ASPEN Plus process simulator. The methane feed rate was fixed at constant and S/C ratio was varied from 2.25 to 4.75. Methane conversion shows an increasing trend toward the ratio and has a maximum value of 17.9% at S/C=4.0. Thermal efficiency for the system is about 51%, which is 1% higher than that calculated for a conventional 1,300 degrees C class combined cycle under similar conditions. A thermochemical recuperative combined cycle is designed for peak-load leveling. In night lime operation from 20 : 00 to 8 : 00 it stores hydrogen produced by methane steam reforming at S/C=3.9 to save power generation. The gas turbine inlet temperature is 1,330 degrees C. In daytime operation from 8 : 00 to 20 : 00 the chemically recuperated combined cycle operated at S/C=2.0 is driven by the mixture of methane and the stored hydrogen. The output at night-time operation decreases down to 0.70 of that for a combined cycle operated at constant load with the same methane feed rate. whereas daytime operation generated power 1.26 times larger than that of the combined cycle.	Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138656, Japan; Toshiba Corp, Power & Ind Syst Res & Dev Ctr, Yokohama, Kanagawa 2300015, Japan; Toshiba Corp, Power & Ind Syst Res & Dev Ctr, Kawasaki, Kanagawa 2100862, Japan	Kikuchi, R (reprint author), Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138656, Japan.		Kikuchi, Ryuji/H-4255-2015; Tsutsumi, Atsushi/K-8988-2012	Tsutsumi, Atsushi/0000-0001-9679-4383			ADELMAN ST, 1998, ASME, V117, P16; CARCASCI C, 1998, ENERGY CONVERS MGMT, V16, P1693; ECHIGO R, 1997, NIHON KIKAIGAKKAI B, V63, P271; Harvey S, 1997, ENERG CONVERS MANAGE, V38, P1671, DOI 10.1016/S0196-8904(96)00208-7; HATANAKA T, 1997, P NIH KIK NETS KOUEN, pA123; HIRAYAMA T, 1996, NIHON GAS TURBINE GA, V95, P47; Jin HG, 1999, IND ENG CHEM RES, V38, P126, DOI 10.1021/ie9803265; KESSER KF, 1994, J ENG GAS TURB POWER, V116, P277, DOI 10.1115/1.2906817; Kuroda K, 1996, MITSUBISHI JUKO GIHO, V33, P346; MURASHIMA S, 1996, NIHON KIKAIGAKKAI B, V62, P333; WHITE GA, 1975, HYDROCARBON PROC JUL, P130; YAMADA I, 1996, NIHON GAS TURBINE GA, V95, P42	12	3	3	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0386-216X			KAGAKU KOGAKU RONBUN	Kag. Kog. Ronbunshu	MAR	2000	26	2					257	262				6	Engineering, Chemical	Engineering	305HN	WOS:000086533600019		
J	Yokoyama, M; Mitomi, N; Tetsuka, K; Tayama, N; Niimi, S				Yokoyama, M; Mitomi, N; Tetsuka, K; Tayama, N; Niimi, S			Role of laryngeal movement and effect of aging on swallowing pressure in the pharynx and upper esophageal sphincter	LARYNGOSCOPE			English	Article						laryngeal movement; swallowing pressure; upper esophageal sphincter; aging; manofluorography		Objectives: Describe contribution of laryngeal movement to pressure changes at the upper esophageal sphincter (UES) and the effect of aging on the swallowing function Study Design: Manofluorography an 56 nondysphagic adults divided into three age groups: the 21- to 31-year-old group (n = 32), the 61- to 74-years-old group (n = 12) and the 75- to 89-year-old group (n = 12). Analyses of the bolus transit time, the amplitudes and durations of pharyngeal pressures, the timing of a pressure fall at the UES and the laryngeal movements. Methods: Intraluminal strain-gauge sensors recorded pressure changes in the oropharynx, hypopharynx and the UES. Motion pictures of the videotapes were fed into a personal computer, and movements of the hyoid bone were measured in both the horizontal and vertical directions as an indication of laryngeal movement. Results: In 26- and 70-year-old men with calcification of the thyroid cartilage, it was determined that the larynx and hyoid bone moved in consonance until the end of the rapid hyoid movements in both the superior and anterior directions. In the 21- to 31-year-old group, the magnitude of the pressure fall at the UES was maximal before or almost at the same time as the bolus arrival, in preparation for smooth passage of the bolus from the pharynx to the esophagus. The rapid superior movements of the hyoid bone started significantly early as compared with its anterior movements (P =.0001). The rapid anterior movements of the hyoid bone started simultaneously with the pressure fall at the UES. In the elderly, all segmental transit times mere significantly increased. The timing of the pressure fall at the UES was significantly delayed and the UES pressure reached its minimum value after arrival of the bolus at the UES. The minimum pressure at the UES increased to a significantly positive value. The rapid anterior movements of the hyoid were significantly delayed, suggesting that this delay causes the delay in the pressure fall at the UES. Conclusions: The rapid superior and anterior movements of the hyoid bone are considered to start at the same time as those of the larynx. In the young group, it is suggested that superior laryngeal movement protects the lower airway prior to the anterior laryngeal movement, causing the pressure fall at the UES to enable the passage of a bolus into the UES, In the elderly, smooth passage of the bolus from the pharynx to the esophagus is hindered and the system that prevents aspiration is rendered inefficient by changes in the swallowing pressures and laryngeal movements with aging.	Tokyo Metropolitan Bokutoh Hosp, Dept Otolaryngol, Sumida Ku, Tokyo 1308575, Japan; JR Tokyo Hosp, Dept Otolaryngol, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Otolaryngol, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Speech Physiol, Tokyo, Japan	Yokoyama, M (reprint author), Tokyo Metropolitan Bokutoh Hosp, Dept Otolaryngol, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.						HEENEMAN H, 1986, J OTOLARYNGOL, V15, P214; KAHRILAS PJ, 1992, GASTROENTEROLOGY, V103, P128; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V95, P52; EKBERG O, 1986, INVEST RADIOL, V21, P408, DOI 10.1097/00004424-198605000-00009; ASOH R, 1978, GASTROENTEROLOGY, V74, P514; ATKINSON M, 1957, J CLIN INVEST, V36, P581, DOI 10.1172/JCI103457; CERENKO D, 1989, OTOLARYNG HEAD NECK, V100, P57; DOTY RW, 1956, J NEUROPHYSIOL, V19, P44; ELLIOTT JL, 1988, GERIATRICS, V43, P95; MAEYAMA T, 1975, OTOL FUKUOKA, V21, P787; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; MENDELSOHN MS, 1987, LARYNGOSCOPE, V97, P483; Sheth N, 1988, Dysphagia, V2, P209, DOI 10.1007/BF02414428; SOKOL EM, 1966, GASTROENTEROLOGY, V51, P960; Tracy J F, 1989, Dysphagia, V4, P90, DOI 10.1007/BF02407151; Yoshida T, 1979, OTOLOGIA FUKUOKA, V25, P824	16	51	54	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0023-852X			LARYNGOSCOPE	Laryngoscope	MAR	2000	110	3	1				434	439		10.1097/00005537-200003000-00021		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	291QR	WOS:000085748000020		
J	Zhao, M; Kiyoi, H; Yamamoto, Y; Ito, M; Towatari, M; Omura, S; Kitamura, T; Ueda, R; Saito, H; Naoe, T				Zhao, M; Kiyoi, H; Yamamoto, Y; Ito, M; Towatari, M; Omura, S; Kitamura, T; Ueda, R; Saito, H; Naoe, T			In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor	LEUKEMIA			English	Article						FLT3; leukemia; tyrosine kinase inhibitor; in vivo treatment; herbimycin A	INTERNAL TANDEM DUPLICATION; ACUTE MYELOID-LEUKEMIA; HERBIMYCIN-A; HEMATOPOIETIC-CELLS; FLT3 LIGAND; C-KIT; CONSTITUTIVE ACTIVATION; BCR/ABL ONCOPROTEIN; RECEPTOR; GENE	Somatic mutation of the FLT3 gene, in which the juxtamembrane domain has an internal tandem duplication, is found in 20% of human acute myeloid leukemias and causes constitutive tyrosine phosphorylation of the products. In this study, we observed that the transfection of mutant FLT3 gene into an IL3-dependent murine cell line, 32D, abrogated the IL3-dependency. Subcutaneous injection of the transformed 32D cells caused leukemia in addition to subcutaneous tumors in C3H/MeJ mice. To develop a FLT3-targeted therapy, we examined tyrosine kinase inhibitors for in vitro growth suppression of the transformed 32D cells. A tyrosine kinase inhibitor, herbimycin A, remarkably inhibited the growth of the transformed 32D cells at 0.1 mu M, at which concentration it was ineffective in parental 32D cells. Herbimycin A suppressed the constitutive tyrosine phosphorylation of the mutant FLT3 but not the phosphorylation of the ligand-stimulated wild-type FLT3. In mice transplanted with the transformed 32D cells, the administration of herbimycin A prolonged the latency of disease or completely prevented leukemia, depending on the number of cells inoculated and schedule of drug administration. These results suggest that mutant FLT3 is a promising target for tyrosine kinase inhibitors in the treatment of leukemia.	Nagoya Univ, Sch Med, Dept Infect Dis, Nagoya, Aichi 4668560, Japan; Nagoya Univ, Sch Med, Dept Internal Med 1, Nagoya, Aichi 4668560, Japan; Nagoya Univ, Sch Med, Dept Pathol, Nagoya, Aichi 4668560, Japan; Kitasato Inst, Tokyo 108, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan; Nagoya City Univ, Sch Med, Dept Internal Med 2, Nagoya, Aichi 467, Japan	Naoe, T (reprint author), Nagoya Univ, Sch Med, Dept Infect Dis, Nagoya, Aichi 4668560, Japan.		Yamamoto, Yukiya/E-9529-2010	Yamamoto, Yukiya/0000-0002-7439-4925			DOSIL M, 1993, MOL CELL BIOL, V13, P6572; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; Nakao M, 1996, LEUKEMIA, V10, P1911; Murakami Y, 1998, BIOL PHARM BULL, V21, P1030; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Horiike S, 1997, LEUKEMIA, V11, P1442, DOI 10.1038/sj.leu.2400770; Lyman SD, 1998, BLOOD, V91, P1101; Nakano Y, 1999, BRIT J HAEMATOL, V104, P659, DOI 10.1046/j.1365-2141.1999.01256.x; MORI S, 1993, EMBO J, V12, P2257; Kiyoi H, 1999, BLOOD, V93, P3074; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372; Drexler HG, 1996, LEUKEMIA, V10, P588; HONMA Y, 1995, INT J CANCER, V60, P685, DOI 10.1002/ijc.2910600519; Kiyoi H, 1997, LEUKEMIA, V11, P1447, DOI 10.1038/sj.leu.2400756; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; LEVITZKI A, 1991, TRENDS PHARMACOL SCI, V12, P171, DOI 10.1016/0165-6147(91)90538-4; Lisovsky M, 1996, BLOOD, V88, P3987; OGAWARA H, 1986, J ANTIBIOT, V39, P606; OKABE M, 1992, BLOOD, V80, P1330; OKABE M, 1994, LEUKEMIA RES, V18, P867, DOI 10.1016/0145-2126(94)90169-4; Riordan FA, 1998, ONCOGENE, V16, P1533, DOI 10.1038/sj.onc.1201680; ROSNET O, 1993, BLOOD, V82, P1110; Tsujimura T, 1996, BLOOD, V87, P273; UEHARA Y, 1989, CANCER RES, V49, P780; UEHARA Y, 1985, JPN J CANCER RES, V76, P672; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; UMEZAWA H, 1986, J ANTIBIOT, V39, P170	30	71	72	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0887-6924			LEUKEMIA	Leukemia	MAR	2000	14	3					374	378		10.1038/sj.leu.2401680		5	Oncology; Hematology	Oncology; Hematology	291QW	WOS:000085748400005		
J	Yoshida, M; Suzuki, T				Yoshida, M; Suzuki, T			HTLV-1 Tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity	LEUKEMIA			English	Meeting Abstract									Univ Tokyo, Inst Med Sci, Dept Mol Cell Biol, Tokyo, Japan								0	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0887-6924			LEUKEMIA	Leukemia	MAR	2000	14	3				38	561	561				1	Oncology; Hematology	Oncology; Hematology	291QW	WOS:000085748400077		
J	Inoue, K; Kohno, T; Takakura, S; Hayashi, Y; Mizoguchi, H; Yokota, J				Inoue, K; Kohno, T; Takakura, S; Hayashi, Y; Mizoguchi, H; Yokota, J			Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines	LEUKEMIA RESEARCH			English	Article						microsatellite instability (MSI); leukemia; lymphoma; BAX; T-cell acute lymphoblastic leukemia (T-ALL)	II RECEPTOR GENE; MISMATCH REPAIR GENE; FRAMESHIFT MUTATIONS; COLORECTAL-CANCER; ENDOMETRIAL CARCINOMA; SOMATIC MUTATIONS; MUTATOR PHENOTYPE; GASTRIC-CANCER; COLON; MALIGNANCIES	Allelic status of the BAT26 and BAT25 loci was examined in 117 leukemia/lymphoma cell lines consisting of 44 B-lymphoid lineage cell lines, 30 T-lymphoid cell lines and 43 myeloid cell lines to define the lineage specificity of microsatellite instability (MSI) in hematological malignancies. Seventeen (15%) cell lines were defined as having MSI. The incidence of MSI was significantly (P < 0.01) higher in cell lines of lymphoid lineage (15/74; 20%) than in those of myeloid lineage (2/43; 5%). In the cell lines of lymphoid lineage, the incidence of MSI in T cell acute lymphoblastic leukemia CT-ALL) (11/30; 37%) was significantly (P < 0.01) higher than those in B-lineage malignancies (4/44; 9%). The 17 cell lines with MSI were subjected to the mutation analysis of the coding microsatellites in 13 candidate genes. Frameshift mutations were most frequently detected in the BAX gene (14/17, 82%), while the hMSH3, hMSH6, TGF beta RII, DRP and IGFIIR genes were less frequently mutated (24-47%). The present result indicates that MSI is involved in the development and/or progression of lymphoid malignancies, especially of T-ALL, through the inactivation of BAX and several other genes. (C) 2000 Elsevier Science Ltd. All rights reserved.	Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 1040045, Japan; Tokyo Womens Med Coll, Dept Hematol, Tokyo 1628666, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 1038655, Japan	Yokota, J (reprint author), Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, 1-1 Tsukiji 5-chome, Tokyo 1040045, Japan.						Souza RF, 1996, NAT GENET, V14, P255, DOI 10.1038/ng1196-255; RISINGER JI, 1993, CANCER RES, V53, P5100; PARSONS R, 1995, CANCER RES, V55, P5548; Gurin CC, 1999, CANCER RES, V59, P462; Tashiro H, 1997, CANCER RES, V57, P3935; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Ouyang H, 1997, CANCER RES, V57, P1851; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Boland CR, 1998, CANCER RES, V58, P5248; Yamamoto H, 1997, CANCER RES, V57, P4420; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4; Fey MF, 1997, LEUKEMIA LYMPHOMA, V28, P11; Gartenhaus RB, 1997, LEUKEMIA LYMPHOMA, V25, P455; HAN HJ, 1993, CANCER RES, V53, P5087; Hangaishi A, 1997, BLOOD, V89, P1740; HEJNA JA, 1995, GENOMICS, V29, P285, DOI 10.1006/geno.1995.1247; Hosoya N, 1998, JPN J CANCER RES, V89, P33; KANEKO H, 1995, BLOOD, V86, P1236; Kodera T, 1999, GENE CHROMOSOME CANC, V26, P267, DOI 10.1002/(SICI)1098-2264(199911)26:3<267::AID-GCC13>3.0.CO;2-V; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.0.CO;2-3; LIU B, 1994, CANCER RES, V54, P4590; Lowsky R, 1997, BLOOD, V89, P2276; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; Molenaar JJ, 1998, BLOOD, V92, P230; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; ROBLEDO M, 1995, LEUKEMIA, V9, P960; Rooke HM, 1999, LEUKEMIA, V13, P535, DOI 10.1038/sj.leu.2401384; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; Shinmura K, 1998, CARCINOGENESIS, V19, P247, DOI 10.1093/carcin/19.2.247; WADA C, 1994, BLOOD, V83, P3449; Yoshinaga K, 1998, JPN J CANCER RES, V89, P985	37	33	34	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	MAR	2000	24	3					255	262		10.1016/S0145-2126(99)00182-4		8	Oncology; Hematology	Oncology; Hematology	290NA	WOS:000085681200010		
J	Nagata, T; Fukuda, H; Fukuda, R; Koike, I				Nagata, T; Fukuda, H; Fukuda, R; Koike, I			Bacterioplankton distribution and production in deep Pacific waters: Large-scale geographic variations and possible coupling with sinking particle fluxes	LIMNOLOGY AND OCEANOGRAPHY			English	Article							PARTICULATE ORGANIC-MATTER; SUB-ARCTIC PACIFIC; MID-NORTH-ATLANTIC; TOP-DOWN CONTROL; BACTERIAL PRODUCTION; PROTEIN-SYNTHESIS; MARINE-BACTERIA; NE ATLANTIC; BOTTOM-UP; OCEAN	Bacterial abundance and leucine incorporation rate were measured throughout the water column (depth, 4,000-6,000 mr at stations occupied in the equatorial, subtropical, and subarctic Pacific as well as in the Bering Sea during three cruises conducted between 1993 and 1997. In general, depth-dependent decreases of bacterial abundance and leucine incorporation in the bathypelagic layer (depth, >1,000 m) were well described by a power function with. remarkably uniform exponents among distant locations: average exponents were -0.900 and -1.33 for abundance and leucine incorporation, respectively. Depth profiles of bacterial properties were complex at some subarctic stations, suggesting lateral transport of organic carbon by local eddies. Organic carbon fluxes from abyssal sediment to overlying water would explain increases in bacterial abundance and leucine incorporation in near-bottom layers. Biomass was twofold to fourfold and the production was threefold to sevenfold greater in subarctic than in subtropical regions. This latitudinal pattern was consistent with the basin-scale distribution of sinking fluxes of particulate organic carbon (POC) reported in the literature. Rates of bacterial carbon uptake accounted for 51% (range, 31-153) and 23% (14-58) of deep sinking POC fluxes in subarctic and subtropical regions, respectively. Average turnover time of deep bacterial assemblages was estimated to be 1-30 yr. These results suggest that deep bacterial biomass and production are generally coupled with sinking POC fluxes and that organic carbon is substantially transformed within bathypelagic environments via a sinking POC --> dissolved organic carbon --> bacteria pathway, as previously suggested in the mesopelagic zone.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Nagata, T (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.		Martinez-Vicente, Victor/F-5131-2010	Martinez-Vicente, Victor/0000-0003-3492-583X			MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; BILLEN G, 1990, HYDROBIOLOGIA, V207, P37, DOI 10.1007/BF00041438; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943; Druffel ERM, 1996, J GEOPHYS RES-OCEANS, V101, P20543, DOI 10.1029/96JC01850; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Cherrier J, 1999, LIMNOL OCEANOGR, V44, P730; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P753, DOI 10.1016/0967-0645(93)90056-S; BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; KIRCHMAN DL, 1992, MAR ECOL PROG SER, V82, P301, DOI 10.3354/meps082301; BAUER JE, 1995, NATURE, V373, P686, DOI 10.1038/373686a0; BERGER WH, 1991, LIMNOL OCEANOGR, V36, P1899; Broeker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07); DUCKLOW HW, 1985, CONT SHELF RES, V4, P445, DOI 10.1016/0278-4343(85)90004-4; Dufour PH, 1996, DEEP-SEA RES PT I, V43, P1305, DOI 10.1016/0967-0637(96)00060-X; HONJO S, 1995, DEEP-SEA RES PT II, V42, P831, DOI 10.1016/0967-0645(95)00034-N; JANNASCH HW, 1982, APPL ENVIRON MICROB, V43, P1116; KIRCHMAN DL, 1986, MAR ECOL PROG SER, V32, P47, DOI 10.3354/meps032047; Koppelmann R, 1999, MAR ECOL PROG SER, V179, P27, DOI 10.3354/meps179027; Patching JW, 1997, DEEP-SEA RES PT I, V44, P1655, DOI 10.1016/S0967-0637(97)00040-X; PATTERSON DJ, 1993, J MAR BIOL ASSOC UK, V73, P67; SIMON M, 1992, DEEP-SEA RES, V39, P1997, DOI 10.1016/0198-0149(92)90010-Q; STOLZENBACH KD, 1994, DEEP-SEA RES PT I, V41, P469, DOI 10.1016/0967-0637(94)90091-4; TAKAHASHI K, 1997, BIOGEOCHEMICAL PROCE; TAYLOR G T, 1991, Global Biogeochemical Cycles, V5, P289, DOI 10.1029/91GB01543; TURLEY CM, 1995, DEEP-SEA RES PT I, V42, P1453, DOI 10.1016/0967-0637(95)00056-C; TURLEY CM, 1988, DEEP-SEA RES, V35, P1079, DOI 10.1016/0198-0149(88)90001-5; TURLEY CM, 1994, MAR ECOL PROG SER, V115, P191, DOI 10.3354/meps115191; WILLIAMS PJL, IN PRESS MICROBIAL E; WILLIAMS PM, 1976, NATURE, V262, P810, DOI 10.1038/262810a0; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180	39	84	89	AMER SOC LIMNOLOGY OCEANOGRAPHY	WACO	5400 BOSQUE BLVD, STE 680, WACO, TX 76710-4446 USA	0024-3590			LIMNOL OCEANOGR	Limnol. Oceanogr.	MAR	2000	45	2					426	435				10	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	292YB	WOS:000085822300017		
J	Oozeki, Y; Watanabe, Y				Oozeki, Y; Watanabe, Y			Comparison of somatic growth and otolith increment growth in laboratory-reared larvae of Pacific saury, Cololabis saira, under different temperature conditions	MARINE BIOLOGY			English	Article							COD GADUS-MORHUA; CLUPEA-HARENGUS; MICROSTRUCTURE; ATLANTIC; SALMON; AGE; SARDINE; WIDTHS	The relationship between somatic growth and incremental growth of otoliths of Pacific saury, Cololabis saira (Brevoort), larvae under different temperature conditions was studied in the laboratory for three age groups (0 to 9, 10 to 20 and 20 to 30 d posthatch). Larvae were incubated from hatching to 9 d at 24, 20, and 16 degrees C. Further, larvae initially reared at an ambient temperature of 21.7 degrees C were transferred to experimental temperatures of 22, 18, and 14 degrees C on Day 10 and reared to Day 20 and similarly from Day 20 and reared to Day 30 posthatch. Growth trajectories of larvae sampled at the end of the three experiments were back-calculated using the biological intercept method and compared to the measured values 0 and 5 d after the start of each experiment. Back-calculated knob length at the different temperatures indicated no significant difference to the measured knob lengths except for the cases at 20 degrees C from hatching to 9-d-old larvae and at 14 degrees C from 20- to 30-d-old larvae. The close correlation between somatic and otolith growth shown in this study indicated the feasibility of estimating the growth history of Pacific saury larvae using otolith readings.	Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368638, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1640014, Japan	Oozeki, Y (reprint author), Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368638, Japan.						Molony BW, 1998, J EXP MAR BIOL ECOL, V221, P257, DOI 10.1016/S0022-0981(97)00131-7; MOSEGAARD H, 1988, CAN J FISH AQUAT SCI, V45, P1514, DOI 10.1139/f88-180; SECOR DH, 1992, CAN J FISH AQUAT SCI, V49, P1439, DOI 10.1139/f92-159; VOLK EC, 1984, CAN J FISH AQUAT SCI, V41, P126, DOI 10.1139/f84-012; WATANABE Y, 1991, JPN J ICHTHYOL, V38, P11; BARKMAN RC, 1987, J FISH BIOL, V31, P683, DOI 10.1111/j.1095-8649.1987.tb05271.x; Bolz GR, 1996, FISH B-NOAA, V94, P387; BROTHERS E B, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P369; BUTLER JL, 1991, CAN J FISH AQUAT SCI, V48, P1713, DOI 10.1139/f91-203; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; CAMPANA SE, 1991, ICES J MAR SCI, V48, P303, DOI 10.1093/icesjms/48.3.303; Campana Steven E., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P73; Fukushima S., 1990, B TOHOKU NATL FISH R, V52, P17; GEFFEN AJ, 1995, J PLANKTON RES, V17, P783, DOI 10.1093/plankt/17.4.783; Hattori S., 1964, Bulletin of the Tokai Fisheries Research Laboratory, V40, P1; *JAP SAUR FISH ASS, 1996, DAT SAUR FISH 1995, P1; JENKINS GP, 1990, MAR ECOL PROG SER, V63, P93, DOI 10.3354/meps063093; Kimura K., 1956, B TOHOKU REG FISH R, V7, P1; MAILLET GL, 1990, FISH B-NOAA, V88, P155; MARSHALL SL, 1982, CAN J FISH AQUAT SCI, V39, P542, DOI 10.1139/f82-077; MATSUMIYA Y, 1978, Nippon Suisan Gakkaishi, V44, P451; MOKSNESS E, 1992, ICES J MAR SCI, V49, P223, DOI 10.1093/icesjms/49.2.223; MOLONY BW, 1990, J FISH BIOL, V37, P541; NEILSON JD, 1985, FISH B-NOAA, V83, P91; Odate S., 1956, B TOHOKU REG FISH R, V7, P70; Paperno R, 1997, FISH B-NOAA, V95, P521; REGNER S, 1994, MAR BIOL, V119, P169, DOI 10.1007/BF00349553; RICE JA, 1985, T AM FISH SOC, V114, P532, DOI 10.1577/1548-8659(1985)114<532:EOAFBC>2.0.CO;2; SCOR DH, 1992, RAPP PV REUN CONS IN, V191, P431; Summerfelt RC, 1987, AGE GROWTH FISH, P453; SUTHERS IM, 1992, MAR ECOL PROG SER, V84, P31, DOI 10.3354/meps084031; TZENG WN, 1989, T AM FISH SOC, V118, P168, DOI 10.1577/1548-8659(1989)118<0168:VODGII>2.3.CO;2; Watanabe Y, 1997, MAR BIOL, V127, P369, DOI 10.1007/s002270050023; Watanabe Y, 1997, CAN J FISH AQUAT SCI, V54, P1067, DOI 10.1139/cjfas-54-5-1067; Yusa T., 1960, B TOHOKU REG FISH R, V17, P1	35	25	29	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0025-3162			MAR BIOL	Mar. Biol.	MAR	2000	136	2					349	359		10.1007/s002270050693		11	Marine & Freshwater Biology	Marine & Freshwater Biology	303ZK	WOS:000086457900018		
J	Yoshinaga, J; Nakama, A; Morita, M; Edmonds, JS				Yoshinaga, J; Nakama, A; Morita, M; Edmonds, JS			Fish otolith reference material for quality assurance of chemical analyses	MARINE CHEMISTRY			English	Article						fish otolith; calcium carbonate; elemental analysis; certified reference material	CERTIFIED REFERENCE MATERIAL; STRONTIUM-CALCIUM RATIOS; TRACE-ELEMENT ANALYSIS; MICROPROBE; LARVAL	A certified reference material (CRM) for major, minor and trace element analysis was prepared from sagittal otolith of red emperor (Lutjanus sebae) at National Institute for Environmental Studies (NIES), Japan in collaboration with Western Australian Marine Research Laboratories (WAMRL), Australia. Otoliths (1.4 kg) were cleaned, pulverized, sieved to pass a 105-mu m screen and homogenized, and 375 vials, each containing 3 g, were prepared. Certified value was determined for Na, Mg, K, Ca, Sr and Pa through a collaboration involving NIES and five other laboratories. The certified value (mean of the means reported from the collaborating laboratories plus or minus the 95% confidence interval) were 97.0 +/- 4.2 mu mol/g (0.223 +/- 0.010%) for Na, 0.88 +/- 0.06 mu mol/g (21 +/- 1 mu g/g) for Me, 7.21 +/- 0.20 mu mol/g (282 +/- 8 mu g/g) for K, 9.69 +/- 0.11 mmol/g (38.8 +/- 0.5%) for Ca, 26.9 +/- 0.5 mu mol/g (0.236 +/- 0.005%) for Sr and 21.1 +/- 0.6 nmol/g (2.89 +/- 0.09 mu g/g) for Ba. Reference values were given for Cu [12 nmol/g (0.74 mu g/g)], Zn [7.2 nmol/g (0.47 mu g/g)], Cd [0.025 nmol/g (0.0028 mu g/g)] and Pb [0.11 nmol/g (0.023 mu g/g)] based on definitive analyses at NIES. This CRM will be of practical value for the quality assurance of solution-based elemental analysis of fish otoliths and other marine aragonites. (C) 2000 Published by Elsevier Science B.V. All rights reserved.	Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; Western Australia Marine Res Labs, North Beach, WA 6020, Australia	Morita, M (reprint author), Univ Tokyo, Inst Environm Studies, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	junyosh@chemsys.t.u-tokyo.ac.jp; nakama@nies.go.jp; mmorita@nies.go.jp; jedmonds@dmu.ac.uk					Yoshinaga J, 1999, J ANAL ATOM SPECTROM, V14, P1589, DOI 10.1039/a904572d; GRUBBS FE, 1972, TECHNOMETRICS, V14, P847, DOI 10.2307/1267134; Campana SE, 1997, CAN J FISH AQUAT SCI, V54, P2068, DOI 10.1139/cjfas-54-9-2068; DEGENS ET, 1969, MAR BIOL, V2, P105, DOI 10.1007/BF00347005; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; EDMONDS JS, 1989, CAN J FISH AQUAT SCI, V46, P50, DOI 10.1139/f89-007; EDMONDS JS, 1991, AUST J MAR FRESH RES, V42, P383; Fassett J. D., 1989, ANAL CHEM, V61, P643; HALDEN NM, 1995, ENVIRON BIOL FISH, V43, P333, DOI 10.1007/BF00001166; OKAMOTO K, 1985, ANALYST, V110, P785, DOI 10.1039/an9851000785; OKAMOTO K, 1988, MAR ENVIRON RES, V26, P199, DOI 10.1016/0141-1136(88)90027-X; OKAMOTO K, 1991, ACS SYM SER, V445, P257; SECOR D. H., 1995, RECENT DEV FISH OTOL; Thorrold SR, 1997, LIMNOL OCEANOGR, V42, P102; THRESHER RE, 1994, FISH B, V92, P87; TOWNSEND DW, 1995, MAR ECOL PROG SER, V119, P37, DOI 10.3354/meps119037; Yoshinaga J, 1998, ANAL SCI, V14, P1121, DOI 10.2116/analsci.14.1121	17	94	96	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4203			MAR CHEM	Mar. Chem.	MAR	2000	69	1-2					91	97		10.1016/S0304-4203(99)00098-5		7	Chemistry, Multidisciplinary; Oceanography	Chemistry; Oceanography	297GB	WOS:000086072800008		
J	Manabe, A; Takahashi, K; Shibata, R; Takeuchi, M; Morita, M; Hosoya, R				Manabe, A; Takahashi, K; Shibata, R; Takeuchi, M; Morita, M; Hosoya, R			Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia	MEDICAL AND PEDIATRIC ONCOLOGY			English	Article						NK cell leukemia; cyclophosphamide; corticosteroids; drug sensitivity assay; bone marrow stroma			St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; Natl Canc Ctr, Dept Pediat, Tokyo 104, Japan; Funabashi Futawa Hosp, Dept Pediat, Chiba, Japan	Manabe, A (reprint author), Univ Tokyo, Inst Med Sci, Dept Pediat Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						LOUGHRAN TP, 1993, BLOOD, V82, P1; CAMPANA D, 1993, LEUKEMIA, V7, P482; Ohnuma K, 1997, LEUKEMIA LYMPHOMA, V25, P387; Teshima T, 1996, LANCET, V347, P1124, DOI 10.1016/S0140-6736(96)90325-6; YAMAMOTO T, 1993, BLOOD, V81, P1342	5	5	5	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0098-1532			MED PEDIATR ONCOL	Med. Pediatr. Oncol.	MAR	2000	34	3					224	225		10.1002/(SICI)1096-911X(200003)34:3<224::AID-MPO14>3.0.CO;2-4		2	Oncology; Pediatrics	Oncology; Pediatrics	289XA	WOS:000085646200014		
J	Sugiura, N; Hoshino, H				Sugiura, N; Hoshino, H			Hydrogen-isotopic compositions in Allan Hills 84001 and the evolution of the martian atmosphere	METEORITICS & PLANETARY SCIENCE			English	Article							SNC METEORITES; ALH84001; MARS; CARBON; WATER	Hydrogen-isotopic compositions of carbonate and maskelynite in Allan Hills (ALH) 84001 were measured by secondary ion mass spectrometry (SIMS). The delta D values of both minerals show considerable deviation. The deviation seems to be caused by addition of varying amounts of terrestrial wafer in the case of carbonate. In the case of maskelynite, H is heterogeneously distributed and the deviation in delta D values seems to be due to mixing of this indigenous heavy H with isotopically normal H present in the SIMS chamber. The indigenous delta D value in ALH 84001 seems to be similar to 2000 parts per thousand. Carbonate rather than maskelynite seems to be the main carrier of H in ALH 84001. Because ALH 84001 is similar to 4 Ga old, the H-isotopic composition suggests that a large fraction of the initial martian atmosphere had already escaped by 4 Ga.	Univ Tokyo, Dept Earth & Planetary Phys, Bunkyo Ku, Tokyo 1138654, Japan	Sugiura, N (reprint author), Univ Tokyo, Dept Earth & Planetary Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.		Sugiura, Naoji/A-1855-2009				DELOULE E, 1995, CHEM GEOL, V125, P19, DOI 10.1016/0009-2541(95)00070-3; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214; Bjoraker G. L., 1989, B AM ASTRON SOC, V21, P991; Boctor NZ, 1999, METEORIT PLANET SCI, V34, pA14; BOCTOR NZ, 1999, LUNAR PLANET SCI, V30; Boctor NZ, 1998, METEORIT PLANET SCI, V33, pA18; BOCTOR NZ, 1998, LUNAR PLANET SCI, V29; BORG LE, 1999, LUNAR PLANET SCI, V30; Deloule E., 1991, STABLE ISOTOPE GEOCH, P53; GRADY MM, 1988, GEOCHIM COSMOCHIM AC, V52, P2855, DOI 10.1016/0016-7037(88)90152-4; Jakosky BM, 1997, REV GEOPHYS, V35, P1, DOI 10.1029/96RG02903; Kring DA, 1998, GEOCHIM COSMOCHIM AC, V62, P2155, DOI 10.1016/S0016-7037(98)00133-1; LESHIN LA, 1996, METEORIT PLANET SCI, V31, pA79; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; LESHIN LA, 1998, LUNAR PLANET SCI, V29; MCKAY G, 1998, LUNAR PLANET SCI, V29; MCKEEGAN K, 1985, GEOCHIM COSMOCHIM AC, V149, P1971; MINITTI ME, 1997, LUNAR PLANET SCI, V28; Miyagi I., 1995, B VOLCANOL SOC JPN, V40, P349; ROMANEK CS, 1994, NATURE, V372, P654; Sugiura N, 1998, METEORIT PLANET SCI, V33, P393; SUGIURA N, 1999, LUNAR PLANET SCI, V30; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8	25	19	20	METEORITICAL SOC	FAYETTEVILLE	DEPT CHEMISTRY/BIOCHEMISTRY, UNIV ARKANSAS, FAYETTEVILLE, AR 72701 USA	0026-1114			METEORIT PLANET SCI	Meteorit. Planet. Sci.	MAR	2000	35	2					373	380				8	Geochemistry & Geophysics	Geochemistry & Geophysics	297WG	WOS:000086105200014		
J	Nakamoto, T; Yamagata, T; Sakai, R; Ogawa, S; Honda, H; Ueno, H; Hirano, N; Yazaki, Y; Hirai, H				Nakamoto, T; Yamagata, T; Sakai, R; Ogawa, S; Honda, H; Ueno, H; Hirano, N; Yazaki, Y; Hirai, H			CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases	MOLECULAR AND CELLULAR BIOLOGY			English	Article							FOCAL ADHESION KINASE; MEDIATED CELL-ADHESION; COLLAGENASE GENE-EXPRESSION; ABL TYROSINE KINASE; NUCLEAR EXPORT; DIRECT BINDING; V-CRK; TRANSCRIPTIONAL ACTIVATION; SYNOVIAL FIBROBLASTS; SIGNAL-TRANSDUCTION	p130(cas) (Cas) is a docking protein that contains an SH3 domain and multiple tyrosine residues. p130(cas) is located at focal adhesions, is tyrosine phosphorylated in response to integrin stimulation, and is thought to transmit signals, via c-Crk and other proteins, for the remodeling of actin stress fibers and cell movement. In a search for the ligands of the SH3 domain of p130(cas) by far-Western screening,,ve cloned a novel protein named CIZ (for Gas-interacting zinc finger protein). CIZ consists of the following: a putative leucine zipper; a serine/threonine-rich region; a proline-rich sequence; five, six, or eight Kruppel-type C2H2 zinc fingers; and the glutamine-alanine repeat. CIZ binds Gas in cells and is located in the nucleus and at focal adhesions. We showed that CIZ is a nucleocytoplasmic shuttling protein, by using the transient interspecies heterokaryon formation assay. In order to search for the targets of CIZ in nucleus, we determined the DNA binding consensus of CIZ as (GIC)AAAAA(A) by cyclic amplification and selection of targets analysis. The consensus-like sequences are found in several promoters of matrix metalloproteinases (MMPs), which are the enzymes used to degrade the extracellular matrix proteins. CIZ binds to a consensus-like sequence in the MMP-1 (collagenase) promoter. Overexpression of CIZ upregulates the transcriptions from MMP-1, MMP-3 (stromelysin), and MMP-7 (matrilysin) promoters, and this transactivation was enhanced in the presence of Gas. Furthermore, the stable overexpression of CIZ promoted the production of MMP-7 in culture medium, In summary, CIZ, a novel zinc finger protein, binds Cas, is a nucleocytoplasmic shuttling protein, and regulates the expression of MMPs.	Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Hirai, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.						AGGELER J, 1984, J CELL BIOL, V98, P1662, DOI 10.1083/jcb.98.5.1662; ANGEL P, 1987, MOL CELL BIOL, V7, P2256; SAKAI R, 1994, EMBO J, V13, P3748; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Liu F, 1996, J BIOL CHEM, V271, P31290; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Honda H, 1998, NAT GENET, V19, P361; Sune C, 1997, MOL CELL BIOL, V17, P6029; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; TANAKA T, 1994, J BIOL CHEM, V269, P24020; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; GAIRE M, 1994, J BIOL CHEM, V269, P2032; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; VUORI K, 1995, J BIOL CHEM, V270, P22259; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; NISHI K, 1994, J BIOL CHEM, V269, P6320; Nakamoto T, 1996, J BIOL CHEM, V271, P8959; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; Astier A, 1997, J BIOL CHEM, V272, P228; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; HAMAGUCHI M, 1995, ONCOGENE, V10, P1037; Harte MT, 1996, J BIOL CHEM, V271, P13649; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398; Pawlak A, 1998, MAMM GENOME, V9, P745, DOI 10.1007/s003359900856; Petch Leslie A., 1995, Journal of Cell Science, V108, P1371; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; QUINONES S, 1989, J BIOL CHEM, V264, P8339; SAKAI R, 1994, J BIOL CHEM, V269, P32740; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Ueki K, 1998, FEBS LETT, V432, P197, DOI 10.1016/S0014-5793(98)00862-X; UENO H, 1995, J BIOL CHEM, V270, P20135; Vincenti MP, 1996, ARTHRITIS RHEUM, V39, P574, DOI 10.1002/art.1780390406; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830	59	76	81	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0270-7306			MOL CELL BIOL	Mol. Cell. Biol.	MAR	2000	20	5					1649	1658		10.1128/MCB.20.5.1649-1658.2000		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	284PY	WOS:000085342200019		
J	Honda, ZI; Suzuki, T; Kono, H; Okada, M; Yamamoto, T; Ra, C; Morita, Y; Yamamoto, K				Honda, ZI; Suzuki, T; Kono, H; Okada, M; Yamamoto, T; Ra, C; Morita, Y; Yamamoto, K			Sequential requirements of the N-terminal palmitoylation site and SH2 domain of Src family kinases in the initiation and progression of Fc epsilon RI signaling	MOLECULAR AND CELLULAR BIOLOGY			English	Article							PROTEIN-TYROSINE KINASE; AFFINITY IGE RECEPTOR; CELL ANTIGEN RECEPTOR; IMMUNOGLOBULIN-E; MEMBRANE DOMAINS; MAST-CELLS; TRANSFECTED CELLS; UNIQUE DOMAIN; T-LYMPHOCYTES; BETA-SUBUNIT	Initial biochemical signaling originating from high-affinity immunoglobulin E receptor (Fc epsilon RI) has been ascribed to Src family kinases. To understand the mechanisms by which individual kinases drive the signaling, we conducted reconstitution experiments: Fc epsilon RI signaling in RBL2H3 cells was first suppressed by a membrane-anchored, gain-of-function C-terminal Src kinase and then reconstructed with Src family kinases whose C-terminal negative regulatory sequence was replaced with a c-myc epitope. Those constructs derived from Lyn and Fyn, which are associated with detergent-resistant membranes (DRMs), physically interacted with resting Fc epsilon RI and reconstructed clustering-induced signaling that leads to calcium mobilization and ERK1 and -2 activation. c-Src-derived construct, which was excluded from DRMs, failed to interact with Fc epsilon RI and to restore the signaling, whereas creation of palmitoylatable Cys3 enabled it to interact with DRMs and with Fc epsilon RI and to restore the signaling. Deletion of Src homology 3 (SH3) domain from the Lyn-derived construct did not alter its ability to transduce the series of signaling. Deletion of SH2 domain did not affect its association with DRMs and with Fc epsilon RI nor clustering-induced tyrosine phosphorylation of Fc epsilon RI beta and gamma subunits, but it almost abrogated the next step of tyrosine phosphorylation of Syk and its recruitment to Fc epsilon RI. These findings suggest that Lyn and Fyn could, but c-Src could not, drive Fc epsilon RI signaling and that N-terminal palmitoylation and SH2 domain are required in sequence for the initial interaction with Fc epsilon RI and for the signal progression to the molecular assembly.	Univ Tokyo, Fac Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan; Osaka Univ, Inst Prot Res, Div Prot Metab, Osaka, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan	Honda, ZI (reprint author), Univ Tokyo, Fac Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Amoui M, 1997, EUR J IMMUNOL, V27, P321, DOI 10.1002/eji.1830270146; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; EISEMAN E, 1992, NATURE, V355, P78; RA C, 1989, J BIOL CHEM, V264, P15323; Field KA, 1999, J BIOL CHEM, V274, P1753, DOI 10.1074/jbc.274.3.1753; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; NIWA H, 1991, GENE, V108, P193; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Honda H, 1998, NAT GENET, V19, P361; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; SCHARENBERG AM, 1995, EMBO J, V14, P3385; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Field KA, 1997, J BIOL CHEM, V272, P4276; Honda Z, 1997, J BIOL CHEM, V272, P25753, DOI 10.1074/jbc.272.41.25753; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Nishizumi H, 1997, J IMMUNOL, V158, P2350; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; GOUNNI AS, 1994, NATURE, V367, P183; BEAVEN MA, 1993, IMMUNOL TODAY, V14, P222, DOI 10.1016/0167-5699(93)90167-J; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Straus DB, 1996, J BIOL CHEM, V271, P9976; AOKI Y, 1995, J BIOL CHEM, V270, P15658; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; CARON L, 1992, MOL CELL BIOL, V12, P2720; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; COOPER JA, 1986, MOL CELL BIOL, V6, P4467; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Hartley D, 1996, J BIOL CHEM, V271, P21939; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Jouvin M H, 1995, Semin Immunol, V7, P29, DOI 10.1016/1044-5323(95)90005-5; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KIHARA H, 1994, J BIOL CHEM, V269, P22427; KINET JP, 1992, CURR OPIN IMMUNOL, V4, P43, DOI 10.1016/0952-7915(92)90122-U; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; MIYAZAKI J, 1989, GENE, V79, P269; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1991, J BIOL CHEM, V266, P24249; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; RESH MD, 1993, BIOCHIM BIOPHYS ACTA, V1155, P307, DOI 10.1016/0304-419X(93)90012-2; Rider LG, 1996, J IMMUNOL, V157, P2374; SCHARENBERG AM, 1994, J ALLERGY CLIN IMMUN, V94, P1142, DOI 10.1016/0091-6749(94)90323-9; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385; SHIUE L, 1995, MOL CELL BIOL, V15, P272; STEPHAN V, 1992, J BIOL CHEM, V267, P5434; Suzuki T, 1998, J IMMUNOL, V161, P3694; Timson Gauen Lisa K., 1992, Molecular and Cellular Biology, V12, P5438; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	88	32	32	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0270-7306			MOL CELL BIOL	Mol. Cell. Biol.	MAR	2000	20	5					1759	1771		10.1128/MCB.20.5.1759-1771.2000		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	284PY	WOS:000085342200029		
J	Katagiri, K; Hattori, M; Minato, N; Irie, S; Takatsu, K; Kinashi, T				Katagiri, K; Hattori, M; Minato, N; Irie, S; Takatsu, K; Kinashi, T			Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase	MOLECULAR AND CELLULAR BIOLOGY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SMALL GTPASE RAP1; CELL-ADHESION; DEPENDENT ACTIVATION; ADP-RIBOSYLATION; UP-REGULATION; HL-60 CELLS; MONOCYTIC DIFFERENTIATION; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN	To identify the intracellular signals which increase the adhesiveness of leukocyte function-associated antigen 1 (LFA-1), we established an assay system for activation-dependent adhesion through LFA-1/intercellular adhesion molecule 1 ICAM-1 using mouse lymphoid cells reconstituted with human LFA-1 and then introduced constitutively active forms of signaling molecules. We found that the phorbol myristate acetate (PMA)responsive protein kinase C (PKC) isotypes (alpha, beta I, beta II, and delta) or phosphatidylinositol-3-OH kinase (PI 3-kinase) itself activated LFA-1 to bind ICAM-1. H-Ras and Pac activated LFA-1 in a PI 3-kinase-dependent manner, whereas Rho and R-Ras had little effect. Unexpectedly, Rap1 was demonstrated to function as the most potent activator of LFA-1. Distinct from H-Ras and Pac, Rap1 increased the adhesiveness independently of PI 3-kinase, indicating that Rap1 is a novel activation signal for the integrins. Rap1 induced changes in the conformation and affinity of LFA-1 and, interestingly, caused marked LFA-1/ICAM-1-mediated cell aggregation. Furthermore, a dominant negative form of Rap1 (Rap1N17) inhibited T-cell receptor-mediated LFA-1 activation in Jurkat T cells and LFA-1/ICAM-1-dependent cell aggregation upon differentiation of HL-60 cells into macrophages, suggesting that Rap1 is critically involved in physiological processes. These unique functions of Rap1 in controlling cellular adhesion through LFA-1 suggest a pivotal role as an immunological regulator.	Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, Tokyo 108, Japan; Nippi Inc, Inst Biomatrix, Adachi Ku, Tokyo 120, Japan; Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto 6068501, Japan	Kinashi, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.						SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Mellor H, 1998, BIOCHEM J, V332, P281; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Lu CF, 1997, J IMMUNOL, V159, P268; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; GENOT EM, 1995, J BIOL CHEM, V270, P9833; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Uberall F, 1997, J BIOL CHEM, V272, P4072; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; AXELSSON B, 1988, J IMMUNOL, V141, P29122; Betz SF, 1998, P NATL ACAD SCI USA, V95, P7909, DOI 10.1073/pnas.95.14.7909; Chan ASH, 1997, J IMMUNOL, V159, P934; COOK SJ, 1993, EMBO J, V12, P3475; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; HAUSS P, 1993, CELL IMMUNOL, V150, P439, DOI 10.1006/cimm.1993.1211; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HUG H, 1993, BIOCHEM J, V291, P329; Katagiri K, 1999, J LEUKOCYTE BIOL, V65, P778; Katagiri K, 1996, BLOOD, V87, P4276; KATAGIRI K, 1991, J IMMUNOL, V146, P701; KATAGIRI K, 1994, BLOOD, V84, P1780; Kinashi T, 1999, J IMMUNOL, V162, P2850; KINASHI T, 1995, BLOOD, V86, P2086; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; M'Rabet L, 1998, BLOOD, V92, P2133; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; Newton AC, 1996, CURR BIOL, V6, P806, DOI 10.1016/S0960-9822(02)00600-0; Nishida K, 1999, ONCOGENE, V18, P407, DOI 10.1038/sj.onc.1202301; OKADA T, 1994, J BIOL CHEM, V269, P3563; O'Rourke AM, 1998, J IMMUNOL, V161, P5800; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; PARDI R, 1992, IMMUNOL TODAY, V13, P224, DOI 10.1016/0167-5699(92)90159-5; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SHAMES RS, 1993, INFLAMMATION, V17, P371, DOI 10.1007/BF00918998; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Sun RJ, 1996, INVAS METAST, V16, P39; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; Tominaga Y, 1998, J IMMUNOL METHODS, V212, P61, DOI 10.1016/S0022-1759(97)00207-X; Tominaga Y, 1998, J IMMUNOL, V161, P4016; VANKOOYK Y, 1993, CELL ADHES COMMUN, V1, P21, DOI 10.3109/15419069309095679; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; WAYS DK, 1992, J BIOL CHEM, V267, P4799; YAMASHIRO S, 1993, LEUKEMIA RES, V17, P129, DOI 10.1016/0145-2126(93)90057-R; Zell T, 1996, J IMMUNOL, V156, P883	75	237	244	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0270-7306			MOL CELL BIOL	Mol. Cell. Biol.	MAR	2000	20	6					1956	1969		10.1128/MCB.20.6.1956-1969.2000		14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	288CX	WOS:000085545200006		
J	Mito, T; Endo, K				Mito, T; Endo, K			PCR survey of Hox genes in the crinoid and ophiuroid: Evidence for anterior conservation and posterior expansion in the echinoderm hox gene cluster	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article							HOMEOBOX GENES; EVOLUTION; ORGANIZATION; SEQUENCE; ORIGIN	To help elucidate the cluster organization of Hox genes in echinoderms, we amplified a homeobox region by polymerase chain reaction (PCR) and cloned and sequenced the PCR products for the comatulid crinoid Oxycomanthus japonicus and the ophiuroid Stegophiura sladeni. The crinoid had at least three anterior, four medial, and four posterior genes, and the ophiuroid had at least one anterior, three medial, and six (one of which being a possible trans-paralog) posterior genes. The survey of the crinoid detected all three anterior complements (PG1-3 genes). It was inferred that the Hox genes of each species are organized into a single cluster and that a novel cognate group of echinoderm posterior genes (tentatively termed HboxP9) exists among echinoderms in addition to the known posterior genes Hbox4, Hbox7, and Hbox10. The results, combined with the data of other echinoderm classes, strongly suggest that the presence of a single Hox gene cluster is a common feature among echinoderms and that the cluster has the general features of the deuterostome Hox gene cluster, i.e., the anterior conservation and posterior expansion. The results of the ophiuroid imply that the posterior genes in this class diversified after the phylum Echinodermata had been established. (C) 2000 Academic Press.	Univ Tokyo, Inst Geol, Tokyo 1130033, Japan	Mito, T (reprint author), Univ Tokyo, Inst Geol, Tokyo 1130033, Japan.						Adachi J., 1996, MOLPHY VERSION 2 3 P; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Prince VE, 1998, DEVELOPMENT, V125, P407; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Brooke NM, 1998, NATURE, V392, P920; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; HASEGAWA M, 1994, MOL BIOL EVOL, V11, P142; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Littlewood DTJ, 1997, BIOL J LINN SOC, V61, P409, DOI 10.1111/j.1095-8312.1997.tb01799.x; DIGREGORIO A, 1995, GENE, V156, P253, DOI 10.1016/0378-1119(95)00035-5; Zhang JZ, 1996, GENETICS, V142, P295; Aparicio S, 1997, NAT GENET, V16, P79, DOI 10.1038/ng0597-79; BALAVOINE G, 1995, P NATL ACAD SCI USA, V92, P7227, DOI 10.1073/pnas.92.16.7227; BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291; CARTWRIGHT P, 1993, MOL PHYLOGENET EVOL, V2, P185, DOI 10.1006/mpev.1993.1019; Dayhoff M. O., 1978, ATLAS PROTEIN SEQU S, V5, P3; DICK MH, 1994, MOL PHYLOGENET EVOL, V3, P146, DOI 10.1006/mpev.1994.1017; Falciani F, 1996, P NATL ACAD SCI USA, V93, P8479, DOI 10.1073/pnas.93.16.8479; Garcia-Fernandez Jordi, 1996, International Journal of Developmental Biology, V40, p71S; HOLLAND P, 1992, BIOESSAYS, V14, P267, DOI 10.1002/bies.950140412; Irvine SQ, 1997, MOL PHYLOGENET EVOL, V7, P331, DOI 10.1006/mpev.1997.0407; Lowe CJ, 1997, NATURE, V389, P718; Martinez P, 1997, J MOL EVOL, V44, P371, DOI 10.1007/PL00006156; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; Mito T, 1997, MOL PHYLOGENET EVOL, V8, P218, DOI 10.1006/mpev.1997.0417; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Popodi E, 1996, MOL BIOL EVOL, V13, P1078; RFF RA, 1996, SHAPE LIFE GENES DEV; RUDDLE FH, 1994, DEVELOPMENT, P155; vanderHoeven F, 1996, MECH DEVELOP, V54, P9, DOI 10.1016/0925-4773(95)00455-6	31	28	29	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903			MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	MAR	2000	14	3					375	388		10.1006/mpev.1999.0707		14	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	296MZ	WOS:000086029300006		
J	Nagai, Y; Miyazaki, M; Aoki, R; Zama, T; Inouye, S; Hirose, K; Iino, M; Hagiwara, M				Nagai, Y; Miyazaki, M; Aoki, R; Zama, T; Inouye, S; Hirose, K; Iino, M; Hagiwara, M			A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo	NATURE BIOTECHNOLOGY			English	Article						phosphorylation; FRET; green fluorescent protein; imaging; PKA	RESONANCE ENERGY-TRANSFER; DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; INHIBITOR; CELLS; CREB; EXPRESSION; BINDING; GENE	We have developed a method for visualizing phosphorylation of proteins in living cells using a novel fluorescent indicator composed of two green fluorescent protein (GFP) variants joined by the kinase-inducible domain (KID) of the transcription factor cyclic adenosine monophosphate (cAMP)-responsive element binding protein (CREB). Phosphorylation of KID by the cAMP-dependent protein kinase A (PKA) decreased the fluorescence resonance energy transfer (FRET) among the flanking GFPs, By transfecting COS-7 cells with an expression vector encoding this indicator protein (termed ART for cAMP-responsive tracer), we were able to visualize activation dynamics of PKA in living cells.	Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Tokyo 1138510, Japan; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Tokyo, Fac Med, Dept Pharmacol, Tokyo 1130033, Japan	Hagiwara, M (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Tokyo 1138510, Japan.						ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; INOUYE S, 1994, FEBS LETT, V341, P277, DOI 10.1016/0014-5793(94)80472-9; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; HAGIWARA M, 1987, MOL PHARMACOL, V31, P523; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852; KEMP BE, 1980, J BIOL CHEM, V255, P2914; Lee CL, 1999, NAT BIOTECHNOL, V17, P759; MIYAWAKI A, 1997, NATURE, V388, P852; Sakaguchi H, 1999, J NEUROSCI, V19, P3973; Suzuki Y, 1998, NATURE, V396, P380; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315	21	142	147	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2000	18	3					313	316				4	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	292AC	WOS:000085771100030		
J	Satoh, S; Daigo, Y; Furukawa, Y; Kato, T; Miwa, N; Nishiwaki, T; Kawasoe, T; Ishiguro, H; Fujita, M; Tokino, T; Sasaki, Y; Imaoka, S; Murata, M; Shimano, T; Yamaoka, Y; Nakamura, Y				Satoh, S; Daigo, Y; Furukawa, Y; Kato, T; Miwa, N; Nishiwaki, T; Kawasoe, T; Ishiguro, H; Fujita, M; Tokino, T; Sasaki, Y; Imaoka, S; Murata, M; Shimano, T; Yamaoka, Y; Nakamura, Y			AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1	NATURE GENETICS			English	Article							BETA-CATENIN GENE; TUMOR-SUPPRESSOR; APC; ACTIVATION; ADENOVIRUS; APOPTOSIS; PATHWAY; EXON-3	The Wnt signalling pathway is essential for development and organogenesis(1-3). Wnt signalling stabilizes beta-catenin, which accumulates in the cytoplasm, binds to T-cell factor (TCF; also known as lymphocyte enhancer-binding factor, LEF) and then upregulates downstream genes(4-6). Mutations in CTNNB1 (encoding beta-catenin) or ape (adenomatous polyposis coli) have been reported in human neoplasms including colon cancers and hepatocellular carcinomas(7-13) (HCCs), Because HCCs tend to show accumulation of beta-catenin more often than mutations in CTNNB1, we looked for mutations in AXIN1, encoding a key factor for Wnt signalling, in 6 HCC cell lines and 100 primary HCCs. Among the 4 cell lines and 87 HCCs in which we did not detect CTNNB1 mutations, we identified AXIN1 mutations in 3 cell lines and 6 mutations in 5 of the primary HCCs. In cell lines containing mutations in either gene, we observed increased DNA binding of TCF associated with beta-catenin in nuclei. Adenovirus mediated gene transfer of wild-type AXIN1 induced apoptosis in hepatocellular and colorectal cancer cells that had accumulated beta-catenin as a consequence of either APC, CTNNB1 or AXIN1 mutation, suggesting that axin may be an effective therapeutic molecule for suppressing growth of hepatocellular and colorectal cancers.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; Sapporo Med Univ, Sch Med, Canc Res Inst, Dept Mol Biol, Sapporo, Hokkaido, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; Municipal Ikeda Hosp, Osaka, Japan; Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kyoto, Japan	Nakamura, Y (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.						Fukuchi T, 1998, CANCER RES, V58, P3526; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Nakamura Y, 1997, NAT MED, V3, P499, DOI 10.1038/nm0597-499; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Tsuda M, 1999, NATURE, V400, P276; Zhang ZH, 1998, NATURE, V395, P698; Ihara A, 1996, HEPATOLOGY, V23, P1441, DOI 10.1002/hep.510230621; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Tetsu O, 1999, NATURE, V398, P422; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Zurawel RH, 1998, CANCER RES, V58, P896; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Miyoshi Y, 1998, CANCER RES, V58, P2524; Chan EF, 1999, NAT GENET, V21, P410; DING SF, 1993, CANCER DETECT PREV, V17, P405; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Iwao K, 1998, CANCER RES, V58, P1021; Lee YJ, 1999, J BIOL CHEM, V274, P1566, DOI 10.1074/jbc.274.3.1566; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Nagai H, 1997, ONCOGENE, V14, P2927, DOI 10.1038/sj.onc.1201136; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Takahashi M, 1996, J BIOL CHEM, V271, P26536; Voeller HJ, 1998, CANCER RES, V58, P2520	28	675	700	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					245	250		10.1038/73448		6	Genetics & Heredity	Genetics & Heredity	288XW	WOS:000085590600013		
J	Takahashi, H; Nakanishi, T; Kami, K; Arata, Y; Shimada, I				Takahashi, H; Nakanishi, T; Kami, K; Arata, Y; Shimada, I			A novel NMR method for determining the interfaces of large protein-protein complexes	NATURE STRUCTURAL BIOLOGY			English	Article							B-DOMAIN; STAPHYLOCOCCUS-AUREUS; SPIN DIFFUSION; CHEMICAL-SHIFT; FC FRAGMENT; BINDING; RELAXATION; ANTIBODY; RESONANCE; CRYSTAL	Identification of the interfaces of large (M-r > 50,000) protein-protein complexes in solution by high resolution NMR has typically been achieved using experiments involving chemical shift perturbation and/or hydrogen-deuterium exchange of the main chain amide groups of the proteins. Interfaces identified using these techniques, however, are not always identical to those revealed using X-ray crystallography. In order to identify the contact residues in a large protein-protein complex more accurately, we developed a novel NMR method that uses cross-saturation phenomena in combination with TROSY detection in an optimally deuterium labeled system.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Water Res Inst, Tsukuba, Ibaraki 3050047, Japan	Shimada, I (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.						AKASAKA K, 1981, J MAGN RESON, V45, P337, DOI 10.1016/0022-2364(81)90130-X; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; KATO K, 1995, STRUCTURE, V3, P79, DOI 10.1016/S0969-2126(01)00136-8; Enokizono J, 1997, J MOL BIOL, V270, P8, DOI 10.1006/jmbi.1997.1090; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; LANGONE JJ, 1982, ADV IMMUNOL, V32, P157; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; ENDO S, 1985, BIOCHEMISTRY-US, V24, P1561, DOI 10.1021/bi00327a041; Gouda H, 1998, BIOCHEMISTRY-US, V37, P129, DOI 10.1021/bi970923f; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; HUANG CC, 1991, J MOL GRAPHICS, V9, P230, DOI 10.1016/0263-7855(91)80016-S; ITO W, 1987, J BIOCHEM-TOKYO, V102, P643; Jendeberg L, 1996, BIOCHEMISTRY-US, V35, P22, DOI 10.1021/bi9512814; Kupce E, 1995, J MAGN RESON SER B, V109, P329, DOI 10.1006/jmrb.1995.9985; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; TORIGOE H, 1990, BIOCHEMISTRY-US, V29, P8787, DOI 10.1021/bi00489a040	21	222	229	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1072-8368			NAT STRUCT BIOL	Nat. Struct. Biol.	MAR	2000	7	3					220	223				4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	289YE	WOS:000085648900018		
J	Toda, T; Kobayashi, K; Kondo-Iida, E; Sasaki, J; Nakamura, Y				Toda, T; Kobayashi, K; Kondo-Iida, E; Sasaki, J; Nakamura, Y			The Fukuyama congenital muscular dystrophy story	NEUROMUSCULAR DISORDERS			English	Review						Fukuyama congenital muscular dystrophy; Fukutin; retrotransposon; founder mutation; chromosome 9q31; migration disorder; Walker-Warburg syndrome; muscle-eye-brain-disease	WALKER-WARBURG SYNDROME; CENTRAL NERVOUS-SYSTEM; FCMD CANDIDATE REGION; LINKAGE-DISEQUILIBRIUM; PRENATAL-DIAGNOSIS; SKELETAL-MUSCLE; GENE; LOCALIZATION; MUTATION; BRAIN	Fukuyama congenital muscular dystrophy is one of the most common autosomal recessive disorders in the Japanese population, characterized by congenital muscular dystrophy in combination with cortical dysgenesis (micropolygyria). Recently, we have identified the gene responsible for fukuyama congenital muscular dystrophy on 9q31, which encodes a novel 461-amino-acid protein termed fukutin. Most fukuyama congenital muscular dystrophy-bearing chromosomes are derived from a single ancestral founder (87%), and a 3 kb-retrotransposal insertion into the 3' untranslated region of this gene was found to be a founder mutation. Two independent point mutations causing premature termination confirmed that that this gene is responsible for Fukuyama congenital muscular dystrophy. Fukuyama congenital muscular dystrophy is the first human disease to be caused by an ancient retrotransposal integration. Fukutin contains an amino-terminal signal sequence, which together with results from transfection experiments suggests that it is an extracellular protein. Discovery of the fukuyama congenital muscular dystrophy gene represents an important step toward greater understanding of the pathogenesis of muscular dystrophies and also of normal brain development. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med,Minato Ku, Tokyo 1088639, Japan	Toda, T (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	toda@ims.u-tokyo.ac.jp					DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; FUKUYAMA Y, 1984, BRAIN DEV-JPN, V6, P373; DOBYNS WB, 1985, AM J MED GENET, V22, P157, DOI 10.1002/ajmg.1320220118; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; Kobayashi K, 1998, HUM GENET, V103, P323, DOI 10.1007/s004390050824; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; Jong YJ, 2000, NEUROMUSCULAR DISORD, V10, P108, DOI 10.1016/S0960-8966(99)00091-7; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Corman B, 1999, AM J HUM GENET, V64, P126, DOI 10.1086/302206; Eberhart DE, 1998, NAT MED, V4, P1002, DOI 10.1038/1988; FOWLER M, 1973, CLIN STUDIES MYOLO 2, P192; Fukuyama Y, 1960, PAEDIATR U TOKYO, V4, P5; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; Ishii H, 1997, NEUROMUSCULAR DISORD, V7, P191, DOI 10.1016/S0960-8966(97)00462-8; KAMOSHITA S, 1976, ARCH NEUROL-CHICAGO, V33, P513; Kondo E, 1996, AM J MED GENET, V66, P169, DOI 10.1002/(SICI)1096-8628(19961211)66:2<169::AID-AJMG8>3.0.CO;2-M; KondoIida E, 1997, HUM GENET, V99, P427, DOI 10.1007/s004390050384; KRIJGSMAN JB, 1980, NEUROPADIATRIE, V11, P108, DOI 10.1055/s-2008-1071382; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MATSUMURA K, 1993, LANCET, V341, P521, DOI 10.1016/0140-6736(93)90279-P; Miyake M, 1997, GENOMICS, V40, P284, DOI 10.1006/geno.1996.4584; Moghadaszadeh B, 1998, AM J HUM GENET, V62, P1439, DOI 10.1086/301882; Nakano I, 1996, ACTA NEUROPATHOL, V91, P313; NONAKA I, 1982, MUSCLE NERVE, V5, P102, DOI 10.1002/mus.880050204; PETERS ACB, 1984, BRAIN DEV-JPN, V6, P406; Pihko H, 1997, DEVEL NEUR, V13, P99; SAITO K, 1998, AM J MED GENET, V76, P310; Saito Y, 1999, ACTA NEUROPATHOL, V98, P330; Santavuori P, 1977, NEUROPAEDIATRIE    S, V8, P553, DOI 10.1055/s-0028-1091594; Takai Y, 1998, HUM REPROD, V13, P320, DOI 10.1093/humrep/13.2.320; TODA T, 1995, ANN NEUROL, V37, P99, DOI 10.1002/ana.410370118; Toda T, 1996, AM J HUM GENET, V59, P1313; TODA T, 1994, AM J HUM GENET, V55, P946; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; VOIT T, 1995, NEUROPEDIATRICS, V26, P148, DOI 10.1055/s-2007-979745; WEWER UM, 1995, NEUROLOGY, V45, P2099; Yamamoto T, 1999, PEDIATR NEUROL, V20, P31, DOI 10.1016/S0887-8994(98)00089-7; Yamamoto T, 1997, BRAIN DEV-JPN, V19, P35, DOI 10.1016/S0387-7604(96)00056-3; YOSHIOKA M, 1991, AM J NEURORADIOL, V12, P63	45	51	51	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966			NEUROMUSCULAR DISORD	Neuromusc. Disord.	MAR	2000	10	3					153	159		10.1016/S0960-8966(99)00109-1		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	303BG	WOS:000086400500001		
J	Abe, K; Saito, H				Abe, K; Saito, H			The p44/42 mitogen-activated protein kinase cascade is involved in the induction and maintenance of astrocyte stellation mediated by protein kinase C	NEUROSCIENCE RESEARCH			English	Article						mitogen-activated protein kinase; protein kinase C; cyclic AMP; astrocyte; stellation	RAT CORTICAL ASTROCYTES; BLOOD-BRAIN-BARRIER; MAP KINASE; STIMULATED STELLATION; ENDOTHELIAL-CELLS; SENILE DEMENTIA; ALZHEIMER-TYPE; INHIBITOR; PATHWAY; GF-109203X	The mitogen-activated protein kinase (MAPK) is known to be involved in the differentiation of various types of cells. To understand the role of p44/42 MAPK (ERK1/2) in astrocyte differentiation, we investigated the effects of U0126 and PD98059, specific inhibitors of the MAPK-activaiing enzyme MEK, on astrocyte morphology in culture. Cultured rat cortical astrocytes exhibited Battened, polygonal morphology in the absence of stimulation, but differentiated into process-bearing stellate cells in response to the membrane-permeable cyclic AMP analog dibutyryl cyclic AMP (dBcAMP) or the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA). dBcAMP-induced astrocyte stellation was not affected by MEK inhibitors, while PMA-induced astrocyte stellation was significantly blocked by U0126 (0.1-10 mu M) and PD98059 (10-30 mu M). Western blot analysis with an antibody specific for phosphorylated ERKl/2 revealed that PMA, but not dBcAMP, induced phosphorylation of ERK 1/2 in a time- and concentration-dependent manner. The PMA-induced astrocyte stellation and ERK1/2 phosphorylation were blocked by specific PKC inhibitors, GF-109203X (0.01-1 mu M) and calphostin C (1 mu M). In addition, when U0126 or PD98059 was added after treatment with PMA, stellate astrocytes returned to polygonal. These results suggest that the MEK/ERK cascade is involved in the induction and maintenance of astrocyte stellation mediated by PKC, but not by cyclic AMP signaling. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tokyo 1130033, Japan	Abe, K (reprint author), Univ Tokyo, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tokyo 1130033, Japan.	kazuhoab@mol.f.u-tokyo.ac.jp					Abe K, 1999, BRAIN RES, V850, P150, DOI 10.1016/S0006-8993(99)02121-6; Abe K, 1998, BRAIN RES, V804, P63, DOI 10.1016/S0006-8993(98)00657-X; ABE K, 1989, EUR J PHARMACOL, V171, P59, DOI 10.1016/0014-2999(89)90429-9; Abe K, 1997, JPN J PHARMACOL, V75, P433, DOI 10.1254/jjp.75.433; ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Ueda Y, 1996, J BIOL CHEM, V271, P23512; SEGER R, 1995, FASEB J, V9, P726; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; JORGENSEN OS, 1990, J NEUROL SCI, V98, P63; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Roberson ED, 1999, J NEUROSCI, V19, P4337; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; BECK DW, 1986, BRAIN RES, V381, P131, DOI 10.1016/0006-8993(86)90700-6; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Abe K, 1996, JPN J PHARMACOL, V72, P299, DOI 10.1254/jjp.72.299; DAVISCOX MI, 1994, MICROSC RES TECHNIQ, V29, P319, DOI 10.1002/jemt.1070290409; DEBAULT LE, 1980, SCIENCE, V207, P653, DOI 10.1126/science.6101511; DUFFY PE, 1980, NEUROLOGY, V30, P778; Fedoroff S, 1986, ASTROCYTES DEV MORPH, V1, P35; HEIKKILA J, 1993, BIOCHEM BIOPH RES CO, V197, P1185, DOI 10.1006/bbrc.1993.2602; Kato M, 1997, J NEUROCHEM, V68, P1889; MARQUARDT B, 1994, ONCOGENE, V9, P3213; MASON CA, 1988, J NEUROSCI, V8, P3124; MOBLEY PL, 1986, BRAIN RES, V398, P366, DOI 10.1016/0006-8993(86)91497-6; MOONEN G, 1976, CELL TISSUE RES, V163, P365; SCHECHTER R, 1981, J NEUROPATH EXP NEUR, V40, P95, DOI 10.1097/00005072-198103000-00002	36	39	39	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	MAR	2000	36	3					251	257		10.1016/S0168-0102(99)00134-0		7	Neurosciences	Neurosciences & Neurology	294AG	WOS:000085887300009		
J	Shin, M; Kurita, H; Tago, M; Kirino, T				Shin, M; Kurita, H; Tago, M; Kirino, T			Stereotactic radiosurgery for tentorial dural arteriovenous fistulae draining into the vein of Galen: Report of two cases	NEUROSURGERY			English	Article						gamma knife; radiosurgery; tentorial dural arteriovenous fistula; vein of Galen	MALFORMATIONS; ANEURYSMS; SINUS; EMBOLIZATION; ASSOCIATION; MANAGEMENT; BRAIN	OBJECTIVE AND IMPORTANCE: Treatment of tentorial dural arteriovenous fistulae (DAVFs) primarily draining into the vein of Galen remains a therapeutic challenge. We present two cases of ruptured galenic DAVFs that were successfully treated with gamma knife radiosurgery. CLINICAL PRESENTATION: Patient 1, a 66-year-old woman, experienced a sudden onset of headache and loss of consciousness. Neuroimaging studies revealed intraventricular hemorrhage and a DAVF with aneurysmal dilation of the vein of Galen. The DAVF was supplied by tentorial branches of the right meningohypophyseal artery and bilateral supracerebellar arteries, which drained directly into the vein of Galen. Patient 2, a 64-year-old woman, experienced subarachnoid hemorrhage. Cerebral angiography revealed a galenic DAVF at the falcotentorial junction, which was supplied by bilateral supracerebellar arteries. This patient had an aneurysm at the origin of the left supracerebellar artery. INTERVENTION: Both patients were treated with gamma knife radiosurgery. In each case, the fistula was exclusively targeted and a dose of move than 20 Gy was delivered. Complete obliteration of the fistula was confirmed 27 and 29 months after radiosurgery for Patients 1 and 2, respectively, whereas the normal venous structures of the galenic system were preserved. CONCLUSION: Gamma knife radiosurgery is an effective treatment modality for DAVFs primarily draining into the vein of Galen. Irradiation doses of more than 20 GY, strictly limited to the fistulae, seem to be sufficient for successful obliteration of these high-risk vascular lesions, with minimal invasiveness.	Tokyo Univ Hosp, Fac Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Univ Hosp, Fac Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan	Shin, M (reprint author), Tokyo Univ Hosp, Fac Med, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						THOMPSON BG, 1994, J NEUROSURG, V80, P617, DOI 10.3171/jns.1994.80.4.0617; HOUSER OW, 1972, RADIOLOGY, V105, P55; ITO M, 1995, NEUROSURGERY, V37, P1187; Guo WY, 1998, AM J NEURORADIOL, V19, P1081; GRISOLI F, 1984, J NEUROSURG, V60, P1059, DOI 10.3171/jns.1984.60.5.1059; LEWIS AI, 1994, J NEUROSURG, V81, P851, DOI 10.3171/jns.1994.81.6.0851; BROWN RD, 1994, J NEUROSURG, V81, P531, DOI 10.3171/jns.1994.81.4.0531; BATJER H, 1986, NEUROSURGERY, V18, P29; AWAD IA, 1990, J NEUROSURG, V72, P839, DOI 10.3171/jns.1990.72.6.0839; STEINER L, 1992, J NEUROSURG, V77, P1, DOI 10.3171/jns.1992.77.1.0001; LASJAUNIAS P, 1986, J NEUROSURG, V64, P724, DOI 10.3171/jns.1986.64.5.0724; LUNSFORD LD, 1991, J NEUROSURG, V75, P512, DOI 10.3171/jns.1991.75.4.0512; BARNWELL SL, 1989, J NEUROSURG, V71, P352, DOI 10.3171/jns.1989.71.3.0352; CHANDLER HC, 1993, NEUROSURGERY, V33, P139; HALBACH VV, 1989, AM J NEURORADIOL, V10, P393; HAYASHI S, 1981, J NEUROSURG, V55, P971, DOI 10.3171/jns.1981.55.6.0971; KAECH D, 1987, NEUROSURGERY, V21, P575; Link MJ, 1996, J NEUROSURG, V84, P804, DOI 10.3171/jns.1996.84.5.0804; MAYBERG MR, 1988, J NEUROSURG, V68, P288, DOI 10.3171/jns.1988.68.2.0288; MULLAN S, 1994, J NEUROSURG, V80, P606, DOI 10.3171/jns.1994.80.4.0606; OKAMOTO S, 1984, SURG NEUROL, V22, P335, DOI 10.1016/0090-3019(84)90135-6; OREILLY GV, 1981, J COMPUT ASSIST TOMO, V5, P899, DOI 10.1097/00004728-198112000-00022; OSTERGAARD JR, 1984, NEUROSURGERY, V14, P358; TOMSICK TA, 1995, AM J NEURORADIOL, V16, P861	24	33	34	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2000	46	3					730	733		10.1097/00006123-200003000-00039		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	290PH	WOS:000085684200100		
J	Ishioka, K; Yamada, M; Hayashi, YY; Yoden, S				Ishioka, K; Yamada, M; Hayashi, YY; Yoden, S			Technical approach for the design of a high-resolution spectral model on a sphere: Application to decaying turbulence	NONLINEAR PROCESSES IN GEOPHYSICS			English	Article							FLOW	Several technical suggestions to construct a high-resolution spectral model on a sphere (the T682 barotropic model) are presented and their implementation in FORTRAN77 libraries is provided as a free software package ISPACK (http://www.gfd-dennou.org/arch/ispack/). A test experiment on decaying turbulence is conducted to demonstrate the ability of the model.	Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan; Hokkaido Univ, Div Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan; Kyoto Univ, Dept Geophys, Kyoto 6068502, Japan	Ishioka, K (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan.		YODEN, SHIGEO/P-9065-2014				ALPERT BK, 1991, SIAM J SCI STAT COMP, V12, P158, DOI 10.1137/0912009; Stuhne GR, 1996, J COMPUT PHYS, V128, P58, DOI 10.1006/jcph.1996.0196; Taylor M, 1997, J COMPUT PHYS, V130, P92, DOI 10.1006/jcph.1996.5554; BOER GJ, 1992, J GEOPHYS RES-ATMOS, V97, P12771; Fornberg B, 1997, GEOPHYS RES LETT, V24, P3245, DOI 10.1029/97GL03272; ISHIOKA K, 1999, ISPACK 0 4 1; Press W. H., 1992, NUMERICAL RECIPES FO; RITCHIE H, 1995, MON WEATHER REV, V123, P489, DOI 10.1175/1520-0493(1995)123<0489:IOTSLM>2.0.CO;2; *SGKS GROUP, 1995, DCL 5 1; YODEN S, 1999, IN PRESS NUOVO CIM C; YODEN S, 1993, J ATMOS SCI, V50, P631, DOI 10.1175/1520-0469(1993)050<0631:ANEOTD>2.0.CO;2	11	5	5	EUROPEAN GEOPHYSICAL SOCIETY	KATLENBURG-LINDAU	MAX-PLANCK-STR 13, 37191 KATLENBURG-LINDAU, GERMANY	1023-5809			NONLINEAR PROC GEOPH	Nonlinear Process Geophys.	MAR-JUN	2000	7	1-2					105	110				6	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	338RX	WOS:000088434000009		
J	Okano, K; Asaoka, Y; Yoshida, T; Furuya, T; Tomabechi, K; Ogawa, Y; Sekimura, N; Hiwatari, R; Yamamoto, T; Ishikawa, T; Fukai, Y; Hatayama, A; Inoue, N; Kohyama, A; Shinya, K; Murakami, Y; Senda, I; Yamazaki, S; Mori, S; Adachi, J; Takemoto, M				Okano, K; Asaoka, Y; Yoshida, T; Furuya, T; Tomabechi, K; Ogawa, Y; Sekimura, N; Hiwatari, R; Yamamoto, T; Ishikawa, T; Fukai, Y; Hatayama, A; Inoue, N; Kohyama, A; Shinya, K; Murakami, Y; Senda, I; Yamazaki, S; Mori, S; Adachi, J; Takemoto, M			Compact reversed shear tokamak reactor with a superheated steam cycle	NUCLEAR FUSION			English	Article; Proceedings Paper	17th IAEA Fusion Energy Conference	OCT 19-24, 1998	YOKOHAMA, JAPAN	IAEA			FUSION	The compact reversed shear tokamak CREST is a cost competitive reactor concept based on a reversed shear high beta plasma and water cooled ferritic steel components. The moderate aspect ratio A = 3.4 and the elongation k = 2.0 of CREST are very similar to the case of the ITER advanced mode plasma. Presentation of such a concept based on the ITER project should be worth while for formulating a fusion development strategy. The achievement of a competitive cost of electricity (COE) is the first priority for electric power industries. High beta and high thermal efficiency are the most effective parameters for achieving a competitive COE. In order to achieve a high efficiency power plant, a superheated steam cycle has been adopted which permits a high thermal efficiency (eta = 41%). Current profile control and high speed plasma rotation by neutral beam current drive stabilize the ideal MHD activity up to the Troyon coefficient beta(N) = 5.5. A cost assessment has shown that CREST could generate about 1.16 GW(e) electric power at a competitive cost.	Cent Res Inst Elect Power Ind, Komae, Tokyo, Japan; Univ Tokyo, Fac Engn, Tokyo 113, Japan; Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 223, Japan; Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan; Toshiba Res & Dev Ctr, Kawasaki, Kanagawa 210, Japan; Kawasaki Heavy Ind Ltd, Nucl Syst Div, Tokyo, Japan	Okano, K (reprint author), Cent Res Inst Elect Power Ind, 2-11-1 Iwato Kita, Komae, Tokyo, Japan.			Hiwatari, Ryoji/0000-0001-7201-4311; Furuya, Masahiro/0000-0002-1221-2874			GRUBER R, 1981, COMPUT PHYS COMMUN, V21, P323, DOI 10.1016/0010-4655(81)90013-8; ASAOKA Y, 1999, IN PRESS IAEA TECH C; Asaoka Y, 1996, FUSION TECHNOL, V30, P853; HATAYAMA A, 1996, US JAP WORKSH POW RE; NAITOU H, 1988, NUCL FUSION, V28, P1751, DOI 10.1088/0029-5515/28/10/004; NAJMABAD F, 1997, FUSION ENERGY 1996, V3, P383; Najmabadi F, 1998, FUSION ENG DES, V41, P365, DOI 10.1016/S0920-3796(97)00153-1; NISHIO S, 1997, FUSION ENERGY 1996, V3, P693; OKANO K, 1998, P 17 IEEE NPSS S FUS, V2, P1043; Okano K, 1998, FUSION ENG DES, V41, P511, DOI 10.1016/S0920-3796(97)00193-2; OKANO K, 1990, PLASMA PHYS CONTR F, V32, P225, DOI 10.1088/0741-3335/32/4/001; Seki Y., 1991, PLASMA PHYS CONTROLL, V3, P473; Seki Y, 1997, J FUSION ENERG, V16, P205, DOI 10.1023/A:1021839219543; YOSHIDA H, 1993, FUSION TECHNOL, V2, P1547	14	39	40	INT ATOMIC ENERGY AGENCY	VIENNA	WAGRAMERSTRASSE 5, PO BOX 100, A-1400 VIENNA, AUSTRIA	0029-5515			NUCL FUSION	Nucl. Fusion	MAR	2000	40	3Y			3		635	646		10.1088/0029-5515/40/3Y/326		12	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	302GZ	WOS:000086358500027		
J	Tokimatsu, K; Hondo, H; Ogawa, Y; Okano, K; Yamaji, K; Katsurai, M				Tokimatsu, K; Hondo, H; Ogawa, Y; Okano, K; Yamaji, K; Katsurai, M			Evaluation of CO2 emissions in the life cycle of tokamak fusion power reactors	NUCLEAR FUSION			English	Article; Proceedings Paper	17th IAEA Fusion Energy Conference	OCT 19-24, 1998	YOKOHAMA, JAPAN	IAEA			COST	Global warming is one of the most serious problems which human beings are currently facing. Carbon dioxide (CO2) from power plants is considered one of the major causes of global warming. In the present study, CO2 emissions from tokamak fusion power plants are compared with those from present power generating technologies. Plasma parameters are calculated by a systems code that couples the ITER physics, toroidal field coil shape and cost calculation. CO2 emissions from construction and operation are evaluated by multiplying component volume by the CO2 emission intensities of the component materials. The reactor building, balance of plant, etc., are scaled from the ITER reference power reactor ('ITER-like') by use of the Generomak model. The most important finding is that CO2 emissions from fusion reactors are less than those from photovoltaic systems and less than double those from fission reactors. The other findings are that: (i) Most CO2 emissions from fusion reactors are from materials. (ii) CO2 emissions from reactor construction account for almost 60-70% of the total, with the rest coming from reactor operation. (iii) The reversed shear reactor can reduce CO2 emissions by half compared with the ITER-like reactor. It is concluded that tokamak fusion reactors are excellent for their low CO2 emission intensity, and that they can be one of the effective energy supply technologies to solve global warming.	Univ Tokyo, Sch Engn, Tokyo, Japan; Cent Res Inst Elect Power Ind, Socioecon Res Ctr, Tokyo 201, Japan; Cent Res Inst Elect Power Ind, Komae Res Lab, Tokyo 201, Japan	Tokimatsu, K (reprint author), Res Inst Innovat Technol Earth, Syst Anal Global Environm Lab, Minato Ku, 7th Floor,No 3 Toyokaiji Bldg,2-23-1 Nishi Shimba, Tokyo 1050003, Japan.						SHEFFIELD J, 1986, FUSION TECHNOL, V9, P199; BATHKE CG, 1995, P 16 IEEE NPSS S FUS, V2, P1139, DOI 10.1109/FUSION.1995.534428; BUNDE R, 1985, NUCL ENG DES FUSION, V3, P1, DOI 10.1016/0167-899X(85)90031-X; CONN RW, 1991, 13TH P INT C PLASM P, V3, P659; *EUR SAF ENV ASS F, 1995, REP EUR SAF ENV ASS; GALAMBOS JD, 1995, NUCL FUSION, V35, P551, DOI 10.1088/0029-5515/35/5/I06; HATAYAMA A, 1994, FUSION TECHNOL, V26, P27; Hondo H, 1996, Y95013 CRIEPI; *IAEA, 1996, ITER EDA DOC SER IAE, V7; INOUE N, 1993, PLASMA PHYS CONTROLL, V3, P347; *ITER SAN DIEG JOI, 1994, ITERTAC4 SAN DIEG JO; KOZAKI Y, 1978, UNPUB ANAL REALIZATI; KRAKOWSKI RA, 1988, J FUSION ENERG, V7, P49, DOI 10.1007/BF01108258; MILLER RL, 1997, 4 INT S FUS NUCL TEC; NISHIO S, 1994, FUSION ENG DES, V25, P289, DOI 10.1016/0920-3796(94)90072-8; OHI K, 1997, COMMUNICATION; *SCI TECHN AG, 1987, ASS SUP TECHN RES EN; Seki Y., 1991, PLASMA PHYS CONTROLL, V3, P473; SHIMAZU Y, 1986, FUSION REACTOR SYSTE; TOKIMATSU K, 1998, THESIS U TOKYO; Tokimatsu K, 1998, NUCL FUSION, V38, P885, DOI 10.1088/0029-5515/38/6/307; UCHIYAMA Y, 1995, Y94009 CRIEPI; YOSHIDA T, 1997, COMMUNICATION; YOSHIDA T, 1994, T94001 CRIEPI KOM RE	24	3	3	INT ATOMIC ENERGY AGENCY	VIENNA	WAGRAMERSTRASSE 5, PO BOX 100, A-1400 VIENNA, AUSTRIA	0029-5515			NUCL FUSION	Nucl. Fusion	MAR	2000	40	3Y			3		653	659		10.1088/0029-5515/40/3Y/328		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	302GZ	WOS:000086358500029		
J	Tanabe, T; Noda, K; Yosiyuki, T; Hosino, M; Watanabe, I; Chida, K; Watanabe, T; Honma, T; Katayama, I; Arakaki, Y; Haruyama, Y; Saito, M; Nomura, I; Hosono, K				Tanabe, T; Noda, K; Yosiyuki, T; Hosino, M; Watanabe, I; Chida, K; Watanabe, T; Honma, T; Katayama, I; Arakaki, Y; Haruyama, Y; Saito, M; Nomura, I; Hosono, K			A liquid-helium-free superconducting electron cooler at the storage ring TARN II	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						electron cooling; adiabatic expansion; superconducting solenoid	DISSOCIATIVE RECOMBINATION; BEAM; HEH+	A superconducting electron cooler with an adiabatic expansion factor of 100 was designed for high-precision experiments and high-speed cooling. The gun solenoid is a liquid-helium-free superconducting magnet with a 20-cm room-temperature bore, which can produce a magnetic field of up to 3.5 T, An electron beam is expanded from a diameter of 5 to 50 mm in a gradually decreasing solenoid field from 3.5 T to 35 mT. With this cooler, a transverse electron temperature on the order of 1 meV was attained. The longitudinal cooling force was measured with an induction accelerator as functions of the ion and electron currents, and the expansion factor. The longitudinal cooling force does not depend much on the expansion factor. (C) 2000 Elsevier Science B.V. All rights reserved.	High Energy Accelerator Res Org, Tanashi, Tokyo 1888501, Japan; Natl Inst Radiol Sci, Chiba 2638555, Japan; Toshiba Corp, Keihin Prod Operat, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Ctr Nucl Study, Tanashi, Tokyo 1888501, Japan; Kyoto Prefectural Univ, Sakyo Ku, Kyoto 6060823, Japan; Natl Inst Fus Sci, Toki 5095292, Japan; Himeji Inst Technol, Himeji, Hyogo 6712201, Japan	Tanabe, T (reprint author), High Energy Accelerator Res Org, Tanashi, Tokyo 1888501, Japan.						DANARED H, 1994, PHYS REV LETT, V72, P3775, DOI 10.1103/PhysRevLett.72.3775; BEUTELSPACHER M, 1998, P EUR PART ACC C EPA, P508; Danared H., 1998, P 6 EUR PART ACC C S, P1031; ELLERT C, 1992, NUCL INSTRUM METH A, V314, P399, DOI 10.1016/0168-9002(92)90230-2; ELLISON TJP, 1989, PROCEEDINGS OF THE 1989 IEEE PARTICLE ACCELERATOR CONFERENCE, VOLS 1-3, P633, DOI 10.1109/PAC.1989.73205; HERRMANNSFELDT WB, 1979, SLAC226; Katayama T., 1990, PART ACCEL, V32, P105; KUDELAINEN VI, 1982, ZH EKSP TEOR FIZ, V56, P1191; Pastuszka S, 1996, NUCL INSTRUM METH A, V369, P11, DOI 10.1016/0168-9002(95)00786-5; POTH H, 1990, PHYS REP, V196, P135, DOI 10.1016/0370-1573(90)90040-9; Tanabe T, 1998, J PHYS B-AT MOL OPT, V31, pL297, DOI 10.1088/0953-4075/31/7/003; TANABE T, 1991, NUCL INSTRUM METH A, V307, P7, DOI 10.1016/0168-9002(91)90126-B; TANABE T, 1993, PHYS REV LETT, V70, P422, DOI 10.1103/PhysRevLett.70.422; TANABE T, 1996, P 5 EUR PART ACC C S, P1190; TANABE T, 1995, PHYS REV LETT, V75, P1066, DOI 10.1103/PhysRevLett.75.1066; TANABE T, 1995, AIP C P, V360, P329; TANABE T, 1997, P 1997 PART ACC C VA, P1557; URATA M, 1995, IEEE T APPL SUPERCON, V5, P169, DOI 10.1109/77.402516	18	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	MAR 1	2000	441	3					326	338		10.1016/S0168-9002(99)00994-8		13	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	295JH	WOS:000085962600004		
J	Hayashi, K; Hayashi, H; Oshika, T; Hayashi, F				Hayashi, K; Hayashi, H; Oshika, T; Hayashi, F			Fourier analysis of irregular astigmatism after trabeculectomy	OPHTHALMIC SURGERY AND LASERS			English	Article							CORNEAL TOPOGRAPHY DATA; VIDEOKERATOGRAPHY DATA; INTRAOCULAR-PRESSURE; ADJUNCTIVE MITOMYCIN; GLAUCOMA; SURGERY; IMPROVEMENT; REDUCTION; INDEXES	OBJECTIVE: To examine irregular astigmatism following trabeculectomy using Fourier analysis of videokeratography data. PATIENTS AND METHODS: Forty eyes of 40 glaucoma patients, undergoing primary trabeculectomy, underwent videokeratographic examinations preoperatively, and at 2 weeks and 1, 3, 6, and 12 months postoperatively. The dioptric data of the central cornea were decomposed into spherical, regular astigmatic, and irregular astigmatic (decentration and higher-order irregularity) components using Fourier analysis. RESULTS: The mean spherical equivalent did not change throughout the observation period. The regular astigmatic component fi om 2 weeks to 6 months post- operatively was greater than the preoperative diopter, but the increase tvas not significant, In contrast, the decentration component increased significantly after surgery, but returned to the preoperative level by 12 months. The higher-order irregularity component also presented a transient increase postoperatively. CONCLUSIONS: Irregular astigmatism, particularly decentration component, increases significantly after trabeculectomy, but returns re the preoperative level 12 months after surgery.	Hayashi Eye Hosp, Hakata Ku, Fukuoka 812, Japan; Fukuoka Univ, Sch Med, Dept Ophthalmol, Fukuoka 81401, Japan; Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 113, Japan	Hayashi, K (reprint author), Hayashi Eye Hosp, Hakata Ku, 4-7 13 Hakataekimae, Fukuoka 812, Japan.			HAYASHI, KEN/0000-0002-7297-1477			KITAZAWA Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1693; Irak I, 1996, AM J OPHTHALMOL, V122, P690; KUPIN TH, 1995, AM J OPHTHALMOL, V119, P30; KITAZAWA Y, 1993, OPHTHALMOLOGY, V100, P1624; Keller PR, 1998, J CATARACT REFR SURG, V24, P1447; HJORTDAL JO, 1995, OPHTHAL PHYSL OPT, V15, P171, DOI 10.1016/0275-5408(95)90569-N; Dietze PJ, 1997, J GLAUCOMA, V6, P99; KATZ LJ, 1989, AM J OPHTHALMOL, V107, P485; Olsen T, 1997, J CATARACT REFR SURG, V23, P337; ROSEN WJ, 1992, OPHTHALMIC SURG LAS, V23, P395; CLARIDGE KG, 1995, EYE, V9, P292; CUNLIFFE IA, 1992, EYE, V6, P618; GANDOLFI SA, 1995, OPHTHALMIC SURG LAS, V26, P121; HOSKINS HD, 1984, OPHTHALMIC SURG LAS, V15, P731; Olsen T, 1996, J CATARACT REFR SURG, V22, P318; Oshika T, 1998, INVEST OPHTH VIS SCI, V39, P705; RAASCH TW, 1995, OPTOMETRY VISION SCI, V72, P809, DOI 10.1097/00006324-199511000-00006; SCHWARTZ B, 1985, OPHTHALMOLOGY, V92, P1396; Scott IU, 1998, ARCH OPHTHALMOL-CHIC, V116, P286; SHIN DH, 1989, ARCH OPHTHALMOL-CHIC, V115, P1599; TOMDOKORO A, 1999, CORNEA, V18, P412; Tomidokoro A, 1998, CORNEA, V17, P517, DOI 10.1097/00003226-199809000-00009; TSAI CS, 1991, OPHTHALMOLOGY, V98, P1412; VERON SA, 1999, BR J OPHTHALMOL, V83, P779; WATSON PG, 1981, OPHTHALMOLOGY, V88, P175; WILSON SE, 1991, ARCH OPHTHALMOL-CHIC, V109, P349	26	9	9	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0022-023X			OPHTHALMIC SURG LAS	Ophthalmic Surg. Lasers	MAR-APR	2000	31	2					94	99				6	Ophthalmology; Surgery	Ophthalmology; Surgery	295JJ	WOS:000085962700002		
J	Takase, M				Takase, M			Embeddings of Z(2)-homology 3-spheres in R-5 up to regular homotopy	PACIFIC JOURNAL OF MATHEMATICS			English	Article								Let F : M3 --> R-5 be an embedding of an (oriented) Z(2)-homology 3-sphere M-3 in R-5. Then F bounds an embedding of an oriented manifold W-4 in R-5. It is well known that the signature sigma(W-4) of W-4 is equal to the mu-invariant of M-3 modulo 16. In this paper we prove that sigma(W-4) itself completely determines the regular homotopy class of F.	Univ Tokyo, Meguro Ku, Tokyo 153, Japan	Takase, M (reprint author), Univ Tokyo, Meguro Ku, 3-8-1 Komaba, Tokyo 153, Japan.						HUGHES JF, 1992, PAC J MATH, V156, P155; HIRSCH MW, 1961, ANN MATH, V74, P494, DOI 10.2307/1970293; HUGHES JF, 1985, COMMENT MATH HELV, V60, P615, DOI 10.1007/BF02567435; COCHRAN T, 1984, TOPOLOGY, V23, P257, DOI 10.1016/0040-9383(84)90009-0; Hirsch Morris W, 1959, T AM MATH SOC, V93, P242, DOI 10.2307/1993453; SMALE S, 1963, B AM MATH SOC, V69, P131, DOI 10.1090/S0002-9904-1963-10901-5; SMALE S, 1959, ANN MATH, V69, P327, DOI 10.2307/1970186; WHITNEY H, 1949, ANN MATH, V50, P270, DOI 10.2307/1969452; WU WT, 1962, SCI SINICA, V13, P335	9	5	5	PACIFIC JOURNAL MATHEMATICS	BERKELEY	PO BOX 4163, BERKELEY, CA 94704-0163 USA	0030-8730			PAC J MATH	Pac. J. Math.	MAR	2000	193	1					249	256				8	Mathematics	Mathematics	288AB	WOS:000085538700014		
J	Kanamitsu, S; Ito, K; Sugiyama, Y				Kanamitsu, S; Ito, K; Sugiyama, Y			Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: Use of maximum unbound concentration of inhibitor at the inlet to the liver	PHARMACEUTICAL RESEARCH			English	Article						drug interaction; prediction; physiologically-based pharmacokinetics; tolbutamide, sulfaphenazole	IN-VITRO; TOLBUTAMIDE; METABOLISM; SULFAPHENAZOLE; CLEARANCE; BINDING; PLASMA	Purpose. To assess the degree to which the maximum unbound concentration of inhibitor at the inlet to the liver (I-inlet,I-u,I-max) used in the prediction of drug-drug interactions, overestimates the unbound concentration in the liver. Methods. The estimated value of I-inlet,I-u,I-max was compared with the unbound concentrations in systemic blood, liver, and inlet to the liver, obtained in a simulation study based on a physiological flow model. As an example, a tolbutamide/sulfaphenazole interaction was predicted taking the plasma concentration profile of the inhibitor into consideration. Results. The value of I-inlet,I-u,I-max differed from the concentration in each compartment. depending on the intrinsic metabolic clearance in the liver, first-order absorption rate constant, non-hepatic clearance and liver-to-blood concentration ratio (Kp) of the inhibitor. The AUC of tolbutamide was predicted to increase 4-fold when co-administered with sulfaphenazole, which agreed well with in vivo observations and was comparable with the predictions based on a fixed value of I-inlet,I-u,I-max The blood concentration of tolbutamide was predicted to increase when it was co-administered with as little as 1/100 of the clinical dose of sulfaphenazole. Conclusions. Although I-inlet,I-u,I-max overestimated the unbound concentration in the liver, the tolbutamide/sulfaphenazole interaction could be successfully predicted by using a fixed value of I-inlet,I-u,I-max, indicating that the unbound concentration of sulfaphenazole in the liver after its clinical dose is by far larger than the concentration to inhibit CYP2C9 mediated metabolism and that care should be taken when it is coadministered with drugs that are substrates of CYP2C9.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Ito K, 1998, ANNU REV PHARMACOL, V38, P461, DOI 10.1146/annurev.pharmtox.38.1.461; Ito K, 1998, PHARMACOL REV, V50, P387; BISCHOFF KB, 1971, J PHARM SCI, V60, P1128, DOI 10.1002/jps.2600600803; DEDRICK RL, 1973, J PHARMACOKINET BIOP, V1, P435, DOI 10.1007/BF01059667; Bertz RJ, 1997, CLIN PHARMACOKINET, V32, P210; BACK DJ, 1989, PHARMACOL THERAPEUT, V44, P147, DOI 10.1016/0163-7258(89)90064-8; CHRISTENSEN LK, 1963, LANCET, V2, P1298; MINERS JO, 1988, BIOCHEM PHARMACOL, V37, P1137, DOI 10.1016/0006-2952(88)90522-9; MONTANDON B, 1975, J PHARMACOKINET BIOP, V3, P277, DOI 10.1007/BF01066923; NELSON E, 1961, J PHARMACOL EXP THER, V132, P103; PEART GF, 1987, EUR J CLIN PHARMACOL, V33, P397, DOI 10.1007/BF00637637; SUGITA O, 1981, BIOCHEM PHARMACOL, V30, P3347, DOI 10.1016/0006-2952(81)90611-0; SUGITA O, 1984, J PHARM SCI, V73, P631, DOI 10.1002/jps.2600730513; SUGITA O, 1984, DRUG METAB DISPOS, V12, P131; TANIOKU K, 1960, HIFUKA NO RINSHO, V2, P717; THOMAS RC, 1966, J MED CHEM, V9, P507, DOI 10.1021/jm00322a014; VERONESE ME, 1990, CLIN PHARMACOL THER, V47, P403; vonMoltke LL, 1998, BIOCHEM PHARMACOL, V55, P113; VREE TB, 1990, PHARM WEEKBLAD, V12, P243, DOI 10.1007/BF01967825	19	96	99	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741			PHARMACEUT RES	Pharm. Res.	MAR	2000	17	3					336	343		10.1023/A:1007509324428		8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	306KC	WOS:000086595000013		
J	Murphy, PM; Baggiolini, M; Charo, IF; Hebert, CA; Horuk, R; Matsushima, K; Miller, LH; Oppenheim, JJ; Power, CA				Murphy, PM; Baggiolini, M; Charo, IF; Hebert, CA; Horuk, R; Matsushima, K; Miller, LH; Oppenheim, JJ; Power, CA			International union of pharmacology. XXII. Nomenclature for chemokine receptors	PHARMACOLOGICAL REVIEWS			English	Review							PROTEIN-COUPLED RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SARCOMA-ASSOCIATED HERPESVIRUS; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN INTERLEUKIN-8 RECEPTOR; HIGH-AFFINITY BINDING; HUMAN BETA-CHEMOKINE; NEUTROPHIL-ACTIVATING PEPTIDE-2; EOSINOPHIL EOTAXIN RECEPTOR	Chemokine receptors comprise a large family of seven transmembrane domain G protein-coupled receptors differentially expressed in diverse cell types. Biological activities have been most clearly defined in leukocytes, where chemokines coordinate development, differentiation, anatomic distribution, trafficking, and effector functions and thereby regulate innate and adaptive immune responses. Pharmacological analysis of chemokine receptors is at an early stage of development. Disease indications have been established in human immunodeficiency virus/acquired immune deficiency syndrome and in Plasmodium vivax malaria, due to exploitation of CCR5 and Duffy, respectively, by the pathogen for cell entry. Additional indications are emerging among inflammatory and immunologically mediated diseases, but selection of targets in this area still remains somewhat speculative. Small molecule antagonists with nanomolar affinity have been reported for 7 of the 18 known chemokine receptors but have not yet been studied in clinical trials. Virally encoded chemokine receptors, as well as chemokine agonists and antagonists, and chemokine scavengers have been identified in medically important poxviruses and herpesviruses, again underscoring the importance of the chemokine system in microbial pathogenesis and possibly identifying specific strategies for modulating chemokine action therapeutically. The purpose of this review is to update current concepts of the biology and pharmacology of the chemokine system, to summarize key information about each chemokine receptor, and to describe a widely accepted receptor nomenclature system, ratified by the International Union of Pharmacology, that is facilitating clear communication in this area.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Univ Bern, Theodor Kocher Inst, Bern, Switzerland; Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Genentech Inc, S San Francisco, CA 94080 USA; Berlex Biosci, Dept Immunol, Richmond, CA USA; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 113, Japan; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, Div Basic Sci, Frederick, MD 21702 USA; Serono Pharmaceut Res Inst, Geneva, Switzerland	Murphy, PM (reprint author), NIAID, Host Def Lab, NIH, Bldg 10,Room 11N113, Bethesda, MD 20892 USA.						Agostini C, 1998, J IMMUNOL, V161, P6413; AHUJA SK, 1992, NAT GENET, V2, P31, DOI 10.1038/ng0992-31; AHUJA SK, 1993, J BIOL CHEM, V268, P20691; Ahuja SK, 1996, J BIOL CHEM, V271, P225; ALBRECHT JC, 1992, J VIROL, V66, P5047; Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691; Loetscher M, 1997, CURR BIOL, V7, P652, DOI 10.1016/S0960-9822(06)00292-2; Liao F, 1999, J IMMUNOL, V162, P186; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Trentin L, 1999, J CLIN INVEST, V104, P115, DOI 10.1172/JCI7335; MYERS SJ, 1995, J BIOL CHEM, V270, P5786; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551; SCHWEICKART VL, 1994, GENOMICS, V23, P643, DOI 10.1006/geno.1994.1553; WALZ A, 1990, J EXP MED, V171, P449, DOI 10.1084/jem.171.2.449; MALLINSON G, 1995, BRIT J HAEMATOL, V90, P823, DOI 10.1111/j.1365-2141.1995.tb05202.x; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; Najakshin AM, 1999, EUR J IMMUNOL, V29, P375, DOI 10.1002/(SICI)1521-4141(199902)29:02<375::AID-IMMU375>3.0.CO;2-6; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Youn BS, 1999, BLOOD, V94, P2533; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Soto H, 1998, P NATL ACAD SCI USA, V95, P8205, DOI 10.1073/pnas.95.14.8205; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Luster AD, 1998, NEW ENGL J MED, V338, P436; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Combadiere C, 1998, BIOCHEM BIOPH RES CO, V253, P728, DOI 10.1006/bbrc.1998.9849; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Grimaldi JC, 1999, J LEUKOCYTE BIOL, V65, P846; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Gunn MD, 1998, NATURE, V391, P799; Zaballos A, 1999, J IMMUNOL, V162, P5671; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Dairaghi DJ, 1997, J BIOL CHEM, V272, P28206, DOI 10.1074/jbc.272.45.28206; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Suzuki G, 1999, J IMMUNOL, V162, P5981; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Wang JF, 1998, BLOOD, V92, P756; Alcami A, 1998, J IMMUNOL, V160, P624; Wuyts A, 1997, BIOCHEMISTRY-US, V36, P2716, DOI 10.1021/bi961999z; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO;2-A; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Sozzani S, 1998, BLOOD, V92, P4036; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Matthews AN, 1998, P NATL ACAD SCI USA, V95, P6273, DOI 10.1073/pnas.95.11.6273; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Saeki H, 1999, J IMMUNOL, V162, P2472; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Zhang YJ, 1998, J VIROL, V72, P9337; DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Nicholas J, 1996, J VIROL, V70, P5975; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Kitaura M, 1996, J BIOL CHEM, V271, P7725; Rubbert A, 1998, J IMMUNOL, V160, P3933; Blanpain C, 1999, BLOOD, V94, P1899; Roos RS, 1997, J BIOL CHEM, V272, P17251, DOI 10.1074/jbc.272.28.17251; WOLPE SD, 1989, FASEB J, V3, P2565; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599; Daelemans D, 2000, MOL PHARMACOL, V57, P116; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Pal R, 1997, SCIENCE, V278, P695, DOI 10.1126/science.278.5338.695; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Samson M, 1996, GENOMICS, V36, P522, DOI 10.1006/geno.1996.0498; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Gerszten RE, 1999, NATURE, V398, P718; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Napolitano M, 1996, J IMMUNOL, V157, P2759; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Chaudhuri A, 1997, BLOOD, V89, P701; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; HAYASHI S, 1995, J IMMUNOL, V154, P814; Kurihara T, 1996, J BIOL CHEM, V271, P11603; Rucker J, 1997, J VIROL, V71, P8999; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Tsou CL, 1998, J EXP MED, V188, P603, DOI 10.1084/jem.188.3.603; Lalani AS, 1997, J VIROL, V71, P4356; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gershengorn MC, 1998, J CLIN INVEST, V102, P1469, DOI 10.1172/JCI4461; Ahuja SK, 1996, J BIOL CHEM, V271, P20545; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Boring L, 1996, J BIOL CHEM, V271, P7551; Dunstan CAN, 1996, J BIOL CHEM, V271, P32770; Modi WS, 1999, MOL BIOL EVOL, V16, P180; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Samson M, 1998, EUR J IMMUNOL, V28, P1689, DOI 10.1002/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I; Zingoni A, 1998, J IMMUNOL, V161, P547; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; LEE J, 1995, J IMMUNOL, V155, P2158; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; Rabin RL, 1999, J IMMUNOL, V162, P3840; BURGSTAHLER R, 1995, BIOCHEM BIOPH RES CO, V215, P737, DOI 10.1006/bbrc.1995.2525; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Sozzani S, 1997, J IMMUNOL, V159, P1993; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; BALDWIN JM, 1993, EMBO J, V12, P1693; Goya I, 1998, J IMMUNOL, V160, P1975; Mellado M, 1999, NATURE, V400, P723, DOI 10.1038/23382; NEOTE K, 1994, BLOOD, V84, P44; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; LEE J, 1992, J BIOL CHEM, V267, P16283; POWER CA, 1995, J BIOL CHEM, V270, P19495; BIRKENBACH M, 1993, J VIROL, V67, P2209; MOSER B, 1991, J BIOL CHEM, V266, P10666; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; WALZ DA, 1977, THROMB RES, V11, P893, DOI 10.1016/0049-3848(77)90117-7; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shinkai A, 1999, J IMMUNOL, V163, P1602; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Sozzani S, 1998, J IMMUNOL, V161, P1083; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Ruiz ME, 1998, J IMMUNOL, V161, P4169; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Nardelli B, 1999, J IMMUNOL, V162, P435; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Green SP, 1996, J BIOL CHEM, V271, P25400; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Yang AG, 1997, P NATL ACAD SCI USA, V94, P11567, DOI 10.1073/pnas.94.21.11567; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Goila R, 1998, FEBS LETT, V436, P233, DOI 10.1016/S0014-5793(98)01137-5; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Luo H, 1997, GENOME RES, V7, P932; Petering H, 1999, BLOOD, V93, P694; Kennedy KJ, 1998, J NEUROIMMUNOL, V92, P98, DOI 10.1016/S0165-5728(98)00187-8; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703; MOROHASHI H, 1995, J LEUKOCYTE BIOL, V57, P180; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1997, NATURE, V388, P296; BENBARUCH A, 1995, J BIOL CHEM, V270, P22123; Bridger GJ, 1999, J MED CHEM, V42, P3971, DOI 10.1021/jm990211i; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Zhang SM, 1999, J IMMUNOL, V162, P4938; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.immunol.12.1.593; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Horuk R, 1997, J IMMUNOL, V158, P2882; VanSnick J, 1996, J IMMUNOL, V157, P2570; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Palframan RT, 1998, BLOOD, V91, P2240; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Lee B, 1998, J VIROL, V72, P7450; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Raport CJ, 1996, J BIOL CHEM, V271, P17161; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; CHAUDHURI A, 1995, BLOOD, V85, P615; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Su SB, 1996, J LEUKOCYTE BIOL, V60, P658; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Kellermann SA, 1999, J IMMUNOL, V162, P3859; Gupta SK, 1999, J IMMUNOL, V163, P2368; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Ludwig A, 1997, BLOOD, V90, P4588; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Kuang YN, 1996, J BIOL CHEM, V271, P3975; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Zimmerman PA, 1997, MOL MED, V3, P23; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baird JW, 1999, J BIOL CHEM, V274, P33496, DOI 10.1074/jbc.274.47.33496; Bais C, 1998, NATURE, V391, P86; Bais C, 1998, NATURE, V392, P210, DOI 10.1038/32472; BARELLA L, 1995, BIOCHEM J, V309, P773; Bazan HA, 1998, J VIROL, V72, P4485; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beisser PS, 1998, J VIROL, V72, P2352; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Bonini JA, 1997, DNA CELL BIOL, V16, P1249, DOI 10.1089/dna.1997.16.1249; BROADDUS VC, 1994, J IMMUNOL, V152, P2960; Broxmeyer HE, 1999, J EXP MED, V189, P1987, DOI 10.1084/jem.189.12.1987; Broxmeyer HE, 1996, J EXP MED, V184, P1825, DOI 10.1084/jem.184.5.1825; Broxmeyer HE, 1997, STEM CELLS, V15, P69; Camarda G, 1999, J VIROL, V73, P9843; CAMPBELL JJ, 1999, J IMMUNOL, V163, P2160; CAO JX, 1995, VIROLOGY, V209, P207, DOI 10.1006/viro.1995.1244; Cesarman E, 1999, SEMIN CANCER BIOL, V9, P165, DOI 10.1006/scbi.1998.0118; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Chen JD, 1997, NAT MED, V3, P1110, DOI 10.1038/nm1097-1110; Choe H, 1998, J VIROL, V72, P6113; CHUNTHARAPAI A, 1994, J IMMUNOL, V153, P5682; Clemons MJ, 1998, BLOOD, V92, P1532; CLORE GM, 1995, FASEB J, V9, P57; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147; COMBADIERE C, 1995, DNA CELL BIOL, V14, P673, DOI 10.1089/dna.1995.14.673; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; COULIN F, 1997, EUR J BIOCHEM, V248, P7; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; Daniels GD, 1999, J LEUKOCYTE BIOL, V65, P684; DavisPoynter NJ, 1997, J VIROL, V71, P1521; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dilloo D, 1996, NAT MED, V2, P1090, DOI 10.1038/nm1096-1090; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fleming P, 1999, J VIROL, V73, P6800; FORSTER R, 1994, BLOOD, V84, P830; FOXMAN EF, 1997, J CELL BIOL, V139, P349; Frade JMR, 1997, J IMMUNOL, V159, P5576; Frodl R, 1998, J RECEPT SIGNAL TR R, V18, P321, DOI 10.3109/10799899809047750; GAO JL, 1995, J BIOL CHEM, V270, P17494; GAO JL, 1994, J BIOL CHEM, V269, P28539; Gao JL, 1996, BIOCHEM BIOPH RES CO, V223, P679, DOI 10.1006/bbrc.1996.0955; Gerard Craig, 1999, P41; Gerard C, 1997, J CLIN INVEST, V100, P2022, DOI 10.1172/JCI119734; Geras-Raaka E, 1998, J EXP MED, V187, P801, DOI 10.1084/jem.187.5.801; Geras-Raaka E, 1998, J EXP MED, V188, P405, DOI 10.1084/jem.188.2.405; Geras-Raaka E, 1998, BIOCHEM BIOPH RES CO, V253, P725, DOI 10.1006/bbrc.1998.9557; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gonzalo JA, 1999, J IMMUNOL, V163, P403; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Gupta SK, 1998, BIOCHEM MOL BIOL INT, V44, P673; Hadida F, 1998, J EXP MED, V188, P609, DOI 10.1084/jem.188.3.609; HADLEY TJ, 1994, J CLIN INVEST, V94, P985, DOI 10.1172/JCI117465; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; HARRISON JK, 1994, NEUROSCI LETT, V169, P85, DOI 10.1016/0304-3940(94)90362-X; Heath DB, 1997, J ROY ANTHROPOL INST, V3, P178, DOI 10.2307/3034391; HEESEN M, 1997, J IMMUNOL, V158, P261; HESSELGESSER J, 1995, J BIOL CHEM, V270, P11472, DOI 10.1074/jbc.270.19.11472; Hesselgesser J, 1998, J BIOL CHEM, V273, P15687, DOI 10.1074/jbc.273.25.15687; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Heveker N, 1998, CURR BIOL, V8, P369, DOI 10.1016/S0960-9822(98)70155-1; HOMEY B, IN PRESS J IMMUNOL; Hoogewerf AJ, 1996, BIOCHEM BIOPH RES CO, V218, P337, DOI 10.1006/bbrc.1996.0059; Horuk R, 1998, J BIOL CHEM, V273, P386, DOI 10.1074/jbc.273.1.386; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; Howard OMZ, 1998, J MED CHEM, V41, P2184, DOI 10.1021/jm9801253; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Humbles AA, 1997, J EXP MED, V186, P601, DOI 10.1084/jem.186.4.601; Isegawa Y, 1998, J VIROL, V72, P6104; Jenh CH, 1999, J IMMUNOL, V162, P3765; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; KAISER E, 1993, EUR J IMMUNOL, V23, P2532, DOI 10.1002/eji.1830231023; Kanbe K, 1999, VIROLOGY, V265, P264, DOI 10.1006/viro.1999.0036; Kitayama J, 1998, J CLIN INVEST, V101, P2017, DOI 10.1172/JCI2688; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kowalska MA, 1999, BRIT J HAEMATOL, V104, P220, DOI 10.1046/j.1365-2141.1999.01169.x; Krathwohl MD, 1997, P NATL ACAD SCI USA, V94, P9875, DOI 10.1073/pnas.94.18.9875; LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357; Lalani AS, 1999, CYTOKINE GROWTH F R, V10, P219, DOI 10.1016/S1359-6101(99)00018-0; Lapham CK, 1999, NAT MED, V5, P303, DOI 10.1038/6523; Liao F, 1997, GENOMICS, V40, P175, DOI 10.1006/geno.1996.4544; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; LINDLEY IJD, 1993, IMMUNOL TODAY, V14, P24; Ling K, 1999, P NATL ACAD SCI USA, V96, P7922, DOI 10.1073/pnas.96.14.7922; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; Lomize AL, 1999, J COMPUT AID MOL DES, V13, P325, DOI 10.1023/A:1008050821744; MARCUS RD, 1995, REV AM HIST, V23, P618; Marshall E, 1998, EUR J CANCER, V34, P1023, DOI 10.1016/S0959-8049(97)10141-1; MASSUNG RF, 1993, VIROLOGY, V197, P511, DOI 10.1006/viro.1993.1625; Meyer A, 1996, J BIOL CHEM, V271, P14445; Michael NL, 1998, J VIROL, V72, P6040; MOORE MW, 1995, SCIENCE, V269, P1591, DOI 10.1126/science.269.5230.1591; Murphy Philip M., 1996, Methods (Orlando), V10, P104, DOI 10.1006/meth.1996.0084; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Ng HP, 1999, J MED CHEM, V42, P4680, DOI 10.1021/jm990316l; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2000, J IMMUNOL, V164, P1488; Nilsson G, 1999, BLOOD, V93, P2791; Ochensberger B, 1999, EUR J IMMUNOL, V29, P11, DOI 10.1002/(SICI)1521-4141(199901)29:01<11::AID-IMMU11>3.0.CO;2-B; Olson WC, 1999, J VIROL, V73, P4145; OPPENHEIM JJ, 2000, ROLE CHEMOTACTIC FAC; Owman C, 1998, P NATL ACAD SCI USA, V95, P9530, DOI 10.1073/pnas.95.16.9530; PAN L, 1997, NATURE, V389, P1001; Pease JE, 1998, SEMIN IMMUNOL, V10, P169, DOI 10.1006/smim.1998.0129; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Pleskoff O, 1998, J VIROL, V72, P6389; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; POST TW, 1995, J IMMUNOL, V155, P5299; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; POWER CA, 1995, CYTOKINE, V7, P479, DOI 10.1006/cyto.1995.0065; Ransohoff RM, 1999, J NEUROIMMUNOL, V98, P57, DOI 10.1016/S0165-5728(99)00082-X; Reid S, 1999, BLOOD, V93, P1524; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Sabroe I, 1998, J IMMUNOL, V161, P6139; Saederup N, 1999, P NATL ACAD SCI USA, V96, P10881, DOI 10.1073/pnas.96.19.10881; Sallusto F, 1999, CURR TOP MICROBIOL, V246, P123; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Schwarz MK, 1999, CURR OPIN CHEM BIOL, V3, P407, DOI 10.1016/S1367-5931(99)80061-1; SCHWEICKART VL, 2000, IN PRESS J BIOL CHEM; Shimizu N, 2000, J VIROL, V74, P619, DOI 10.1128/JVI.74.2.619-626.2000; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Sozzani S, 1999, J LEUKOCYTE BIOL, V66, P1; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Struyf S, 1998, EUR J IMMUNOL, V28, P1262, DOI 10.1002/(SICI)1521-4141(199804)28:04<1262::AID-IMMU1262>3.0.CO;2-G; Su SB, 1997, BLOOD, V90, P605; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Tang T, 1998, DNA SEQUENCE, V9, P129, DOI 10.3109/10425179809072188; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; THOMAS KM, 1991, J BIOL CHEM, V266, P14839; THOMAS KM, 1990, J BIOL CHEM, V265, P20061; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Unger VM, 1997, NATURE, V389, P203; VANHOUTTE PM, 1998, IUPHAR COMPENDIUM RE, P31; Vieira J, 1998, J VIROL, V72, P8158; VIRGIN HW, 1997, J VIROL, V71, P5994; Wells TNC, 1997, J LEUKOCYTE BIOL, V61, P545; WHITE JK, 1994, GENOMICS, V24, P295, DOI 10.1006/geno.1994.1619; Wong LM, 1997, J BIOL CHEM, V272, P1038; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Xu YN, 1999, AIDS RES HUM RETROV, V15, P419, DOI 10.1089/088922299311169; Yang D, 1999, J IMMUNOL, V163, P1737; Yang Y, 1998, BLOOD, V92, P3912; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; Youn BS, 1997, J IMMUNOL, V159, P5201; Yu CR, 2000, J IMMUNOL, V164, P1293; Zaitseva MB, 1998, J IMMUNOL, V161, P3103; Zhang LQ, 1998, J VIROL, V72, P5035; Zhou YH, 1998, J IMMUNOL, V160, P4018; ZIMMERMAN PA, 1999, IN PRESS P NATL ACAD; Zou P, 1999, J VIROL, V73, P5926	422	1286	1333	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0031-6997			PHARMACOL REV	Pharmacol. Rev.	MAR	2000	52	1					145	176				32	Pharmacology & Pharmacy	Pharmacology & Pharmacy	291FJ	WOS:000085723200007		
J	Koizumi, H; Kamimura, Y; Suzuki, T				Koizumi, H; Kamimura, Y; Suzuki, T			Core structure of a screw dislocation in a diamond-like structure	PHILOSOPHICAL MAGAZINE A-PHYSICS OF CONDENSED MATTER STRUCTURE DEFECTS AND MECHANICAL PROPERTIES			English	Article							CONDENSED PHASES; SILICON; MODEL	The core structure of a screw dislocation in the diamond lattice has been calculated with the Stillinger-Weber potential for the interatomic interaction. The non-dissociated screw dislocation positioned at the centre of a unit hexagon normal to the dislocation line is a stable configuration A. A perfect screw centred on a longer edge of the unit hexagon is also a stable configuration B. Configuration B is more stable and has a lower energy than configuration A. Dissociated configurations of width w = na (a is the repeat distance in the slip direction and n = 1,2,3,...) are also stable. The geometrical feature of configuration B explains the cross-slip observed in III-V compounds at low temperatures. The Peierls stress of the perfect screw dislocation is 0.044G, where G is the shear modulus. This value corresponds to the experimental values of III-V compounds deduced from the temperature dependence of the critical shear stress at low temperatures.	Meiji Univ, Dept Phys, Kawasaki, Kanagawa 2148571, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Koizumi, H (reprint author), Meiji Univ, Dept Phys, Kawasaki, Kanagawa 2148571, Japan.						Alexander H., 1986, Dislocations in solids. Vol.7; Suzuki T, 1999, PHYS STATUS SOLIDI A, V171, P47, DOI 10.1002/(SICI)1521-396X(199901)171:1<47::AID-PSSA47>3.0.CO;2-X; KEATING PN, 1966, PHYS REV, V145, P637, DOI 10.1103/PhysRev.145.637; VITEK V, 1970, PHILOS MAG, V21, P1049, DOI 10.1080/14786437008238490; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; KEATING PN, 1966, PHYS REV, V149, P674, DOI 10.1103/PhysRev.149.674; TERSOFF J, 1986, PHYS REV LETT, V56, P632, DOI 10.1103/PhysRevLett.56.632; BULATOV VV, 1995, PHILOS MAG A, V72, P453; Harrison W. A., 1980, ELECT STRUCTURE PROP, P176; HIRTH JP, 1982, THEORY DISLOCATIONS, P434; Justo JF, 1997, MATER RES SOC SYMP P, V469, P217; Kirchner HOK, 1998, ACTA MATER, V46, P305, DOI 10.1016/S1359-6454(97)00150-X; REN Q, 1995, PHYS REV B, V52, P13223, DOI 10.1103/PhysRevB.52.13223; Simmons G., 1971, SINGLE CRYSTAL ELAST; Suzuki T, 1998, PHIL MAG LETT, V77, P173, DOI 10.1080/095008398178471; Suzuki T, 1999, PHILOS MAG A, V79, P2637	16	38	39	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0141-8610			PHILOS MAG A	Philos. Mag. A-Phys. Condens. Matter Struct. Defect Mech. Prop.	MAR	2000	80	3					609	620				12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Physics, Applied; Physics, Condensed Matter	Materials Science; Metallurgy & Metallurgical Engineering; Physics	293VF	WOS:000085873500007		
J	Kramer, KW; Gudel, HU; Roessli, B; Fischer, P; Donni, A; Wada, N; Fauth, F; Fernandez-Diaz, MT; Hauss, T				Kramer, KW; Gudel, HU; Roessli, B; Fischer, P; Donni, A; Wada, N; Fauth, F; Fernandez-Diaz, MT; Hauss, T			Magnetic ordering in the erbium honeycomb lattices of ErX3 (X = Cl, Br, I)	PHYSICA B			English	Article; Proceedings Paper	2nd European Conference on Neutron Scattering (ECNS 99)	SEP 01-04, 1999	BUDAPEST, HUNGARY	European Neutron Scattering Assoc, Budapest Neutron Ctr, Atominstitut Vienna, Forsch Zentrum Julich, HMI Berlin, ILL Grenoble, IRI Delft, ISIS Didcot, LLB Saclay, NFL Sudsvik, NPI Rez, Nuclear & Technol Inst Lisbon, PSI Villigen, Riso Natl Lab, TU Munich, Australian Nuclear Sci & Technol Org, European Phys Soc, Hungarian Acad Sci, Hungarian Minist Educ, Neutronentechn Komponenten GmbH, Ordela Inc, Oxford Instruments, Ingenieurburo Stronciwilk, Swiss Neutron, Neutron Round Table, OMFB, Natl Comm Technol Dev, Paks Nuclear Power Plant, Adv Ceram Copr, CERCA, Eurisys Mesures, Goodfellow Cambridge Ltd, KJ Lesker Co, Mirrotron Ltd		antiferromagnetism; triangular systems; two-dimensional systems		Unusual two-dimensional (2D) and three-dimensional (3D) magnetic ordering phenomena were observed in the insulating, transparent erbium trihalides ErX3 (X = Cl, Br, I) in the milli-Kelvin temperature range. The layer-type crystal structures of ErCl3 (AlCl3-type structure) and ErBr3/ErI3 (BiI3-type structure) are closely related. All three compounds show a new type of two-sublattice 120 degrees antiferromagnetic order in the erbium honeycomb layers with an infinite rotational degeneracy. The magnetic structures were determined by powder and single-crystal neutron diffraction. ErCl3 shows short-range 2D magnetic order above 350 mK to several Kelvin and a transition to 3D magnetic order at 350 mK with a k-vector of (2/3, 0, - 1/12). ErBr3 and ErI3 display short-range 2D magnetic order from 400 mK to several Kelvin, long-range 2D order between 280 and 400 mK and short-range 3D order below 280 mK with a correlation Length of 15 Angstrom along the c-axis and (1/3, 1/3, 0). The differences between ErCl3 and ErBr3/ErI3 are due to different geometrical layer stackings. Far ErBr3/ErI3 a threefold ambiguity in the magnetic layer stacking causes the disorder along the c-axis. The ordered magnetic moments at saturation increase from 3.3 to 4.7 and 5.5 mu(B)/Ei(3+) for ErCl3, ErBr3 and ErI3, respectively. (C)2000 Elsevier Science B.V. All rights reserved.	Univ Bern, Dept Chem & Biochem, CH-3000 Bern 9, Switzerland; Paul Scherrer Inst, Neutron Scattering Lab, CH-5232 Villigen, Switzerland; ETH Zurich, CH-5232 Villigen, Switzerland; Niigata Univ, Dept Phys, Niigata 9502181, Japan; Univ Tokyo, Grad Sch Arts & Sci, Inst Phys, Tokyo 1538902, Japan; Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; Hahn Meitner Inst Kernforsch Berlin GmbH, D-14109 Berlin, Germany	Kramer, KW (reprint author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3000 Bern 9, Switzerland.		Kramer, Karl/J-5021-2013; Fernandez-Diaz, Maria Teresa/D-7373-2014; Fauth, Francois/K-9643-2014; HauSS, Thomas/O-4667-2015	Kramer, Karl/0000-0001-5524-7703; Fauth, Francois/0000-0001-9465-3106; 			FAIRALL CW, 1971, PHYS LETT A, VA 35, P405, DOI 10.1016/0375-9601(71)90167-8; Kramer K, 1996, EUR J SOL STATE INOR, V33, P273; Kramer KW, 1999, PHYS REV B, V60, pR3724, DOI 10.1103/PhysRevB.60.R3724; Meyer G., 1989, INORG SYNTH, V25, P146, DOI 10.1002/9780470132562.ch35	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	MAR	2000	276						674	675		10.1016/S0921-4526(99)01724-X		2	Physics, Condensed Matter	Physics	303FZ	WOS:000086413000306		
J	Cingolani, R; Rinaldi, R; Lipsanen, H; Sopanen, M; Virkkala, R; Maijala, K; Tulkki, J; Ahopelto, J; Uchida, K; Miura, N; Arakawa, Y				Cingolani, R; Rinaldi, R; Lipsanen, H; Sopanen, M; Virkkala, R; Maijala, K; Tulkki, J; Ahopelto, J; Uchida, K; Miura, N; Arakawa, Y			Influence of Coulomb and exchange interaction on quantum dot magnetoluminescence up to B=45 T	PHYSICA STATUS SOLIDI A-APPLIED RESEARCH			English	Article; Proceedings Paper	6th International Conference on Optics of Excitons in Confined Systems (OECS-6)	AUG 30-SEP 02, 1999	ASCONA, SWITZERLAND				MAGNETIC-FIELD; STRAIN	The influence of the direct and exchange Coulomb interaction on Landau level formation in strain induced QD has been studied by high-field (45 T) magneto-luminescence measurements and by many-electron many-hole Hartree-Fock calculations. At high magnetic fields the degeneracy of the QD electron and hole ground states is increased as several zero-field eigenstates merge into the lowest Landau level. This leads to removal of the state filling and accordingly in high magnetic field the QD luminescence is emitted from the lowest Landau level. Using a generalization of Koopmans theorem for electron-hale many particle systems, we have studied the enhancement of the direct and exchange Coulomb interaction in squeezed carrier states. The results show that for 6 to 8 electron-hole pairs the direct and exchange interaction both reduce the diamagnetic shift by 15 to 25 %.	Univ Lecce, INFM Lecce, Dip Ingn Innovaz, I-73100 Lecce, Italy; Helsinki Univ Technol, Optoelect Lab, FIN-02015 HUT, Finland; Helsinki Univ Technol, Lab Computat Engn, FIN-02015 HUT, Finland; VTT Elect, FIN-02044 VTT, Finland; Univ Tokyo, Inst Solid State Phys, MegaGauss Lab, Minato Ku, Tokyo, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Cingolani, R (reprint author), Univ Lecce, INFM Lecce, Dip Ingn Innovaz, Via Arnesano, I-73100 Lecce, Italy.		Cingolani, Roberto/B-9191-2011; Lipsanen, Harri/C-4336-2013; Sopanen, Markku/L-2501-2013; Rinaldi, Rosaria/N-3560-2015	Lipsanen, Harri/0000-0003-2487-4645; Sopanen, Markku/0000-0002-3731-5044; Rinaldi, Rosaria/0000-0003-2798-9341			Tarucha S, 1996, PHYS REV LETT, V77, P3613, DOI 10.1103/PhysRevLett.77.3613; ASHOORI RC, 1993, PHYS REV LETT, V71, P613, DOI 10.1103/PhysRevLett.71.613; Brasken M, 1997, PHYS REV B, V55, P9275, DOI 10.1103/PhysRevB.55.9275; Fock V, 1928, Z PHYS, V47, P446, DOI 10.1007/BF01390750; Jensen F., 1999, INTRO COMPUTATIONAL; Lipsanen H, 1996, SOLID STATE ELECTRON, V40, P601, DOI 10.1016/0038-1101(95)00372-X; Rinaldi R, 1998, PHYS REV B, V57, P9763, DOI 10.1103/PhysRevB.57.9763; Rinaldi R, 1996, PHYS REV LETT, V77, P342, DOI 10.1103/PhysRevLett.77.342; Rinaldi R, 1998, INT J MOD PHYS B, V12, P471, DOI 10.1142/S0217979298000302	9	3	3	WILEY-V C H VERLAG GMBH	BERLIN	MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY	0031-8965			PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Res.	MAR	2000	178	1					263	268		10.1002/1521-396X(200003)178:1<263::AID-PSSA263>3.0.CO;2-U		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	303TG	WOS:000086440500047		
J	Hofmann, HF				Hofmann, HF			Nonclassical correlations of phase noise and photon number in quantum nondemolition measurements	PHYSICAL REVIEW A			English	Article							OBSERVERS	The continuous transition from a low resolution quantum nondemolition measurement of light field intensity to a precise measurement of photon number is described using a generalized measurement postulate. In the intermediate regime, quantization appears as a weak modulation of measurement probability. In this regime, the measurement result is strongly correlated with the amount of phase decoherence introduced by the measurement interaction. In particular, the accidental observation of half integer photon numbers preserves phase coherence in the light field, while the accidental observation of quantized values increases decoherence. The quantum mechanical nature of this correlation is discussed and the implications for the general interpretation of quantization are considered.	Univ Tokyo, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Hofmann, HF (reprint author), Univ Tokyo, Fac Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844; BRUNE M, 1990, PHYS REV LETT, V65, P976, DOI 10.1103/PhysRevLett.65.976; PEGG DT, 1989, PHYS REV A, V39, P1665, DOI 10.1103/PhysRevA.39.1665; Beller M, 1998, PHYS TODAY, V51, P29, DOI 10.1063/1.882436; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807; [Anonymous], 1999, PHYS TODAY, V52, P11; IMOTO N, 1985, PHYS REV A, V32, P2287, DOI 10.1103/PhysRevA.32.2287; Bell J.S., 1964, Physics, V1; FRIBERG SR, 1992, PHYS REV LETT, V69, P3165, DOI 10.1103/PhysRevLett.69.3165; Goldstein S, 1999, PHYS TODAY, V52, P15; Goldstein S, 1998, PHYS TODAY, V51, P38, DOI 10.1063/1.882241; Goldstein S, 1998, PHYS TODAY, V51, P42, DOI 10.1063/1.882184; HEISENBERG W, 1958, PHYSIKALISCHE PRINZI, P42; HOFMANN HF, QUANTPH9907018; HOLLAND MJ, 1991, PHYS REV LETT, V67, P1716, DOI 10.1103/PhysRevLett.67.1716; KITAGAWA M, 1987, PHYS REV A, V35, P5270, DOI 10.1103/PhysRevA.35.5270; LEVENSON MD, 1986, PHYS REV LETT, V57, P2473, DOI 10.1103/PhysRevLett.57.2473; MERMIN ND, 1990, PHYS TODAY, V43, P9; Meystre P., 1999, ELEMENTS QUANTUM OPT; Schrodinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI DOI 10.1007/BF01491914; SIEGMAN AE, 1995, APPL PHYS B-LASERS O, V60, P247, DOI 10.1007/BF01135870; SIEGMANN AE, 1996, COHERENCE QUANTUM OP, V7; Susskind L., 1964, Physics, V1; von Neumann J., 1955, MATH FDN QUANTUM MEC; Wheeler J.A., 1983, QUANTUM THEORY MEASU, P152; WHEELER JA, 1983, QUANTUM THEORY MEASU, P3; YAMAMOTO Y, 1986, PHYS REV A, V34, P4025, DOI 10.1103/PhysRevA.34.4025	27	7	7	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1050-2947			PHYS REV A	Phys. Rev. A	MAR	2000	61	3					art. no.	033815				10	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	293DM	WOS:000085836300113		
J	Roche, S; Moulopoulos, K				Roche, S; Moulopoulos, K			Anomalous electronic conductance in quasicrystals	PHYSICAL REVIEW B			English	Article							QUASI-CRYSTALS; FIBONACCI LATTICE; PHASON DEFECTS; WAVE-FUNCTIONS; TRANSPORT; CONDUCTIVITY; LOCALIZATION; SYSTEMS	Subtle quantum interference effects in one-dimensional quasicrystals are reported. Quite opposite to their metallic counterparts, quasiperiodic systems are shown to exhibit interesting variations of their conducting properties upon disruption of their long-range order. A sudden phason change in the structure leads to a series of transitions that proceed from extremely simple and regular to highly complex self-similar resistive patterns.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138654, Japan; Univ Cyprus, Dept Nat Sci, CY-1678 Nicosia, Cyprus	Roche, S (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.		Roche, Stephan/B-1116-2012	Roche, Stephan/0000-0003-0323-4665			Roche S, 1997, PHYS REV LETT, V79, P2518, DOI 10.1103/PhysRevLett.79.2518; Macia E, 1999, PHYS REV B, V60, P10032, DOI 10.1103/PhysRevB.60.10032; LUBENSKY TC, 1986, PHYS REV LETT, V57, P1440, DOI 10.1103/PhysRevLett.57.1440; BAAKE M, 1993, INT J MOD PHYS B, V7, P1527, DOI 10.1142/S021797929300247X; BAAKE M, 1992, PHYS LETT A, V168, P199, DOI 10.1016/0375-9601(92)90575-7; BERGER C, 1994, HOUCHES SUMMER SCH P, V61; CODDENS G, 1991, EUROPHYS LETT, V16, P271, DOI 10.1209/0295-5075/16/3/009; DASSARMA S, 1988, PHYS REV B, V37, P1097, DOI 10.1103/PhysRevB.37.1097; Delahaye J, 1998, PHYS REV LETT, V81, P4204, DOI 10.1103/PhysRevLett.81.4204; DUBOIS JM, 1994, ANN CHIM-SCI MAT, V19, P3; FUJIWARA T, 1999, SPRINGER SERIES SOLI, V126, P169; GODA M, 1989, J PHYS SOC JPN, V58, P3624, DOI 10.1143/JPSJ.58.3624; Goldman A I, 1997, NEW HORIZONS QUASICR; Klein H, 1996, PHILOS MAG A, V73, P309; KOHMOTO M, 1986, INT J MOD PHYS B, V1, P31; KOHMOTO M, 1983, PHYS REV LETT, V50, P1873; KOHMOTO M, 1986, PHYS REV B, V34, P563, DOI 10.1103/PhysRevB.34.563; KOHMOTO M, 1983, PHYS REV LETT, V50, P1870, DOI 10.1103/PhysRevLett.50.1870; KOLLAR J, 1986, PHYS LETT A, V117, P203, DOI 10.1016/0375-9601(86)90741-3; KRONIG RD, 1966, MATH PHYSICS ONE DIM, P243; KUBO H, 1991, J PHYS SOC JPN, V60, P2729, DOI 10.1143/JPSJ.60.2729; KUBO H, 1993, J PHYS SOC JPN, V62, P2601, DOI 10.1143/JPSJ.62.2601; MACIA E, 1994, PHYS REV B, V49, P9503, DOI 10.1103/PhysRevB.49.9503; Macia E, 1996, PHYS REV LETT, V76, P2957, DOI 10.1103/PhysRevLett.76.2957; Moulopoulos K, 1996, PHYS REV B, V53, P212, DOI 10.1103/PhysRevB.53.212; MOULOPOULOS K, 1995, J PHYS-CONDENS MAT, V7, P8883, DOI 10.1088/0953-8984/7/47/009; Roche S, 1998, PHYS REV B, V58, P11338, DOI 10.1103/PhysRevB.58.11338; Roche S, 1997, J MATH PHYS, V38, P1794, DOI 10.1063/1.531914; Roche S, 1998, ANN CHIM-SCI MAT, V23, P953, DOI 10.1016/S0151-9107(99)80007-5; Shechtman D., 1984, PHYS REV LETT, V53, P1951; SIRE C, 1994, IT LECT QUASICRYSTAL; SUTO A, 1994, QUASICRYSTALS, P483; TRUB A, 1994, J PHYS I, V4, P1855, DOI 10.1051/jp1:1994226; WIJNANDS F, 1989, J PHYS A-MATH GEN, V22, P3267, DOI 10.1088/0305-4470/22/16/017; YAMAMOTO S, 1995, PHYS REV B, V51, P8841, DOI 10.1103/PhysRevB.51.8841	35	7	7	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	2000	61	9					6048	6056		10.1103/PhysRevB.61.6048		9	Physics, Condensed Matter	Physics	290ZE	WOS:000085707100047		
J	Horii, S; Mizutani, U; Ikuta, H; Yamada, Y; Ye, JH; Matsushita, A; Hussey, NE; Takagi, H; Hirabayashi, I				Horii, S; Mizutani, U; Ikuta, H; Yamada, Y; Ye, JH; Matsushita, A; Hussey, NE; Takagi, H; Hirabayashi, I			Growth and anisotropic resistivity of PrBa2Cu4O8 and Pr2Ba4Cu7O15-gamma single crystals: A direct probe of metallic Cu-O double chains	PHYSICAL REVIEW B			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; TRANSPORT; STATE; PR; YBA2CU3O7-DELTA; CROSSOVER; YBA2CU4O8; PRESSURE; COMPOUND; PLANE	We have successfully grown single crystals of PrBa2Cu4O8 (Pr124) and Pr2Ba4Cu7O15-y (Pr247) by means of a flux method under high pressure oxygen gas of 11 atm in Al2O3 or MgO crucibles. The most appropriate starting composition for the crystal growth was found to be Pr:Ba:Cu=1:2:3 for both Pr124 and Pr247, by examining the generated phases in samples prepared with widely varying composition and sintering temperature. The temperature dependence of resistivity of Pr124 single crystals exhibited no superconductivity, at least down to 2 K. Resistivity along the b-axis direction showed a highly conductive behavior, of which the origin is attributed to the double-chain site because of the large anisotropy between a- and b-axis resistivities. The anisotropy in resistivity between the a- and b-axis directions was found to be about 17 at room temperature, 275 at 85 K, and 190 at 5 K.	Nagoya Univ, Dept Crystalline Mat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; Nagoya Univ, Ctr Integrated Res Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; Shimane Univ, Interdisciplinary Fac Sci & Engn, Matsue, Shimane 6908504, Japan; Natl Res Inst Met, Tsukuba, Ibaraki 3050047, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; ISTEC, Superconduct Res Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan	Horii, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.		HORII, SHIGERU/B-4703-2009; Takagi, Hidenori/B-2935-2010; xu, hua/L-8643-2013; YE, Jinhua/H-2755-2011; Hussey, Nigel/F-9699-2015				SODERHOLM L, 1987, NATURE, V328, P604, DOI 10.1038/328604a0; JEROME D, 1991, SCIENCE, V252, P1509, DOI 10.1126/science.252.5012.1509; Zou ZG, 1998, PHYS REV LETT, V80, P1074, DOI 10.1103/PhysRevLett.80.1074; ERB A, 1995, PHYSICA C, V245, P245, DOI 10.1016/0921-4534(95)00123-9; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; Horii S, 1998, PHYSICA C, V302, P10, DOI 10.1016/S0921-4534(98)00157-9; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; BIWA T, UNPUB; BUCHER B, 1995, PHYS REV B, V51, P3309, DOI 10.1103/PhysRevB.51.3309; EMERY VJ, 1983, J PHYS-PARIS, V44, P977; GAGNON R, 1994, PHYS REV B, V50, P3458, DOI 10.1103/PhysRevB.50.3458; Goto M, 1997, PHYSICA C, V282, P1133, DOI 10.1016/S0921-4534(97)00694-1; Hayashi A, 1998, PHYS REV B, V58, P2678, DOI 10.1103/PhysRevB.58.2678; Hussey NE, 1998, PHYS REV LETT, V80, P2909, DOI 10.1103/PhysRevLett.80.2909; Hussey NE, 1997, PHYS REV B, V56, P11423; MATSUSHITA A, 1995, PHYSICA C, V242, P381, DOI 10.1016/0921-4534(94)02444-8; Mizokawa T, 1999, PHYS REV B, V60, P12335, DOI 10.1103/PhysRevB.60.12335; MORRIS DE, 1989, PHYS REV B, V39, P7347, DOI 10.1103/PhysRevB.39.7347; Usagawa T, 1997, JPN J APPL PHYS 2, V36, pL1583; SEIJI N, 1994, PHYSICA C, V227, P377, DOI 10.1016/0921-4534(94)90096-5; Tagami M, 1997, J CRYST GROWTH, V171, P409, DOI 10.1016/S0022-0248(96)00690-2; TAGAMI M, 1997, THESIS U TOKYO; TAKENAKA K, 1992, PHYS REV B, V46, P5833, DOI 10.1103/PhysRevB.46.5833; Terasaki I, 1996, PHYS REV B, V54, P11993, DOI 10.1103/PhysRevB.54.11993; TIERNAN WM, 1991, PHYS REV B, V44, P4661, DOI 10.1103/PhysRevB.44.4661; YAMADA Y, 1994, PHYSICA C, V231, P131, DOI 10.1016/0921-4534(94)90152-X; Zou ZG, 1997, JPN J APPL PHYS 2, V36, pL18, DOI 10.1143/JJAP.36.L18	27	52	52	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	2000	61	9					6327	6333		10.1103/PhysRevB.61.6327		7	Physics, Condensed Matter	Physics	290ZE	WOS:000085707100077		
J	Hussey, NE; Takagi, H; Iye, Y; Tajima, S; Rykov, AI; Yoshida, K				Hussey, NE; Takagi, H; Iye, Y; Tajima, S; Rykov, AI; Yoshida, K			Charge confinement on the CuO2 planes in slightly overdoped YBa2CU3O7-delta and the role of metallic chains	PHYSICAL REVIEW B			English	Article							NORMAL-STATE MAGNETORESISTANCE; VALENCE-BOND STATE; TRANSPORT-PROPERTIES; SINGLE-CRYSTAL; DIMENSIONAL CROSSOVER; RESISTIVITY; LA2-XSRXCUO4; DEPENDENCE; DYNAMICS; INPLANE	We have probed the origin of the metallic c-axis transport in slightly overdoped YBa2CU3O7-partial derivative (partial derivative approximate to 0.05) via measurements of the normal-state c-axis magnetoresistance (MR). An orbital contribution to the transverse MR, a signature of coherent band motion, arises only from the component of the magnetic field perpendicular to the CuO chains. This result implies that the chains are primarily responsible for coherent c-axis transport in YBa2CU3O7-partial derivative and that those regions of the CuO2 planes not hybridized with the chains remain effectively two dimensional, even in the absence of a normal-state gap.	Int Superconduct Technol Ctr, Superconducting Res Lab, Tokyo 135, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan	Hussey, NE (reprint author), Loughborough Univ Technol, Dept Phys, Loughborough LE11 3TU, Leics, England.		Takagi, Hidenori/B-2935-2010; Hussey, Nigel/F-9699-2015				Alexandrov AS, 1996, PHYS REV LETT, V77, P4796, DOI 10.1103/PhysRevLett.77.4796; ANDERSEN OK, 1994, PHYS REV B, V49, P4145, DOI 10.1103/PhysRevB.49.4145; ANDERSON PW, 1988, PHYS REV LETT, V60, P132, DOI 10.1103/PhysRevLett.60.132; Ando Y, 1996, PHYS REV LETT, V77, P2065, DOI 10.1103/PhysRevLett.77.2065; TAKENAKA K, 1994, PHYS REV B, V50, P6534, DOI 10.1103/PhysRevB.50.6534; ITO T, 1991, NATURE, V350, P596, DOI 10.1038/350596a0; Cooper JR, 1996, J PHYS I, V6, P2237, DOI 10.1051/jp1:1996215; ABRAHAMS E, 1979, PHYS REV LETT, V42, P673, DOI 10.1103/PhysRevLett.42.673; Ioffe LB, 1998, PHYS REV B, V58, P11631, DOI 10.1103/PhysRevB.58.11631; HARRIS JM, 1995, PHYS REV LETT, V75, P1391, DOI 10.1103/PhysRevLett.75.1391; Hussey NE, 1996, PHYS REV LETT, V76, P122, DOI 10.1103/PhysRevLett.76.122; TAMASAKU K, 1994, PHYS REV LETT, V72, P3088, DOI 10.1103/PhysRevLett.72.3088; NAKAMURA Y, 1993, PHYS REV B, V47, P8369, DOI 10.1103/PhysRevB.47.8369; Kimura T, 1996, PHYS REV B, V53, P8733, DOI 10.1103/PhysRevB.53.8733; Bernhard C, 1999, PHYS REV B, V59, pR6631, DOI 10.1103/PhysRevB.59.R6631; Clarke DG, 1997, ADV PHYS, V46, P545, DOI 10.1080/00018739700101538; COOPER SL, 1994, PHYSICAL PROPERTIES, V4; FRIEDMANN TA, 1990, PHYS REV B, V42, P6217, DOI 10.1103/PhysRevB.42.6217; GAGNON R, 1994, PHYS REV B, V50, P3458, DOI 10.1103/PhysRevB.50.3458; GOTO I, UNPUB; Hussey NE, 1998, PHYS REV LETT, V80, P2909, DOI 10.1103/PhysRevLett.80.2909; Hussey NE, 1998, PHYS REV B, V57, P5505, DOI 10.1103/PhysRevB.57.5505; Hussey NE, 1997, PHYS REV B, V56, P11423; Hussey NE, 1998, PHYS REV B, V58, pR611, DOI 10.1103/PhysRevB.58.R611; MASSIDDA S, 1991, PHYSICA C, V176, P159, DOI 10.1016/0921-4534(91)90709-8; NAGAOSA N, 1995, PHYS REV B, V52, P10561, DOI 10.1103/PhysRevB.52.10561; Nakamura F, 1996, PHYS REV B, V54, P10061, DOI 10.1103/PhysRevB.54.10061; RYKOV AI, 1996, ADV SUPERCONDUCTIVIT, V8, P341; Tajima S, 1997, PHYS REV B, V55, P6051, DOI 10.1103/PhysRevB.55.6051; Terasaki I, 1995, PHYS REV B, V52, P16246, DOI 10.1103/PhysRevB.52.16246; WAKU K, UNPUB; YAN YF, 1995, PHYS REV B, V52, P4503	32	11	11	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	2000	61	10					R6475	R6478		10.1103/PhysRevB.61.R6475		4	Physics, Condensed Matter	Physics	295UG	WOS:000085985800008		
J	Saito, K; Takesue, S; Miyashita, S				Saito, K; Takesue, S; Miyashita, S			Energy transport in the integrable system in contact with various types of phonon reservoirs	PHYSICAL REVIEW E			English	Article							QUANTUM BROWNIAN-MOTION; HARMONIC CHAIN; GENERAL ENVIRONMENT; HEAT BATHS; OSCILLATOR	We study how energy transport in an integrable system is affected by the spectral densities of heat reservoirs. The model investigated here is the quantum harmonic chain with both ends in contact with two heat reservoirs at different temperatures. The master equation for the reduced density matrix is derived on the assumption that the reservoirs are composed of an infinite number of independent harmonic oscillators. We evaluate temperature profile and energy flux in the stationary state for the master equation and discuss how they depend on the types of spectral densities. When we attach the reservoirs of the same type of spectral density, we find that the temperature profile is independent of the types. On the other hand, when the two reservoirs have different types of spectral densities, the energy profile near the ends of the chain depends on the types. When the coupling is finite, the temperature profile near the ends shows a wide variation of behavior dependent on spectral densities and temperatures of reservoirs. This dependence is discussed with the Fokker-Planck equations obtained in the classical Limit.	Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Kyoto Univ, Fac Integrated Human Studies, Kyoto 6068501, Japan	Saito, K (reprint author), Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.		saito, keiji/A-4593-2010; MIYASHITA, SEIJI/G-5079-2014				HU BL, 1993, PHYS REV D, V47, P1576, DOI 10.1103/PhysRevD.47.1576; HU BL, 1992, PHYS REV D, V45, P2843, DOI 10.1103/PhysRevD.45.2843; CALDEIRA AO, 1983, ANN PHYS-NEW YORK, V149, P374, DOI 10.1016/0003-4916(83)90202-6; FORD GW, 1965, J MATH PHYS, V6, P504, DOI 10.1063/1.1704304; RIEDER Z, 1967, J MATH PHYS, V8, P1073, DOI 10.1063/1.1705319; ZURCHER U, 1990, PHYS REV A, V42, P3267, DOI 10.1103/PhysRevA.42.3267; CALDEIRA AO, 1983, PHYSICA A, V121, P587, DOI 10.1016/0378-4371(83)90013-4; GRABERT H, 1988, PHYS REP, V168, P115, DOI 10.1016/0370-1573(88)90023-3; ZURCHER U, 1990, PHYS REV A, V42, P3278, DOI 10.1103/PhysRevA.42.3278; Kohler S, 1997, PHYS REV E, V55, P300, DOI 10.1103/PhysRevE.55.300; LINDBLAD G, 1976, COMMUN MATH PHYS, V48, P119, DOI 10.1007/BF01608499; ISHII K, 1970, PROG THEOR PHYS SUPP, V45, P56; Karrlein R, 1997, PHYS REV E, V55, P153, DOI 10.1103/PhysRevE.55.153; KUBO R, 1985, STAT PHYSICS, V2; Louisell W H, 1973, QUANTUM STAT PROPERT; Miyashita S, 1998, PHYS REV A, V57, P2046, DOI 10.1103/PhysRevA.57.2046; Peierls R. E., 1955, QUANTUM THEORY SOLID; SAITO K, UNPUB; Saito K, 1996, PHYS REV E, V54, P2404, DOI 10.1103/PhysRevE.54.2404; Visco DP, 1998, PHYS REV E, V57, P224, DOI 10.1103/PhysRevE.57.224; VISSCHER WM, 1971, PROG THEOR PHYS, V46, P729, DOI 10.1143/PTP.46.729; VISSCHER WM, 1975, PHYS REV A, V12, P675, DOI 10.1103/PhysRevA.12.675; WEIDLICH W, 1965, Z PHYS, V185, P30, DOI 10.1007/BF01381300	23	65	65	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1063-651X			PHYS REV E	Phys. Rev. E	MAR	2000	61	3					2397	2409		10.1103/PhysRevE.61.2397		13	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	295XM	WOS:000085994000036		
J	Kagi, H; Parise, JB; Cho, H; Rossman, GR; Loveday, JS				Kagi, H; Parise, JB; Cho, H; Rossman, GR; Loveday, JS			Hydrogen bonding interactions in phase A [Mg7Si2O8(OH)(6)] at ambient and high pressure	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						hydrogen bonding; neutron diffraction; dense hydrous magnesium silicate (DHMS); crystal structure; high pressure	NEUTRON POWDER DIFFRACTION; CHEMICAL-SHIFT TENSORS; STATE NMR-SPECTROSCOPY; MULTIPLE PULSE NMR; SYSTEM MGO-SIO2-H2O; MAGNETIC-RESONANCE; CRYSTAL-STRUCTURE; INFRARED-SPECTRA; SOLIDS; SILICATES	Neutron powder diffraction data of phase A (Mg7Si2O8(OH)(6)) were collected at ambient pressure and 3.2 GPa (calculated from the compressibility of phase A) from the deuterated compound, and the structure was refined using the Rietveld method. The derived crystal structure implies that hydrogen atoms occupy two distinct sites in phase A, both forming hydrogen bonds of different lengths with the same oxygen atom. This picture is supported by IR spectra, which exhibit two absorption bands at 3400 and 3513 cm(-1) corresponding to OH stretching vibrations, and proton NMR spectra, which display two peaks with equal intensities and isotropic chemical shifts of 3.7 and 5 ppm. The D-D distance [D(1)-D(2) distance] at ambient pressure was found to be 2.09 +/- 0.02 Angstrom from the neutron diffraction data and 2.09 +/- 0.05 Angstrom from the NMR spectra. At 3.2 GPa, there is no statistically significant increase in the O-D interatomic distance while the hydrogen bonding interaction D ... O appears to increase for one of the hydrogen sites, D(1), which has the stronger hydrogen bonding interaction compared with the other hydrogen, D(2), at ambient pressure. The O-D bond valences, determined indirectly from the D ... O distances were 0.86 and 0.91 at ambient pressure, and 0.83 and 0.90 at 3.2 GPa, for D(1) and D(2), respectively.	Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Tokyo 1130033, Japan; SUNY Stony Brook, Dept Geosci, Ctr High Pressure Res, NSF Funded Sci & Technol Ctr, Stony Brook, NY 11794 USA; Pacific NW Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	Kagi, H (reprint author), Univ Tokyo, Grad Sch Sci, Earthquake Chem Lab, Tokyo 1130033, Japan.						Abragam A., 1961, PRINCIPLES NUCL MAGN; AKAOGI M, 1986, PHYS CHEM MINER, V13, P161, DOI 10.1007/BF00308158; DITCHFIELD R, 1976, J CHEM PHYS, V65, P3123, DOI 10.1063/1.433526; HORIUCHI H, 1979, AM MINERAL, V64, P593; BESSON JM, 1992, PHYSICA B, V180, P907, DOI 10.1016/0921-4526(92)90505-M; Yusa H, 1997, GEOPHYS RES LETT, V24, P1831, DOI 10.1029/97GL51794; NAKAMOTO K, 1955, J AM CHEM SOC, V77, P6480, DOI 10.1021/ja01629a013; BURUM DP, 1981, J MAGN RESON, V43, P463, DOI 10.1016/0022-2364(81)90058-5; BURUM DP, 1979, J CHEM PHYS, V71, P944, DOI 10.1063/1.438385; SEARS REJ, 1988, J CHEM PHYS, V88, P2284, DOI 10.1063/1.454062; Xia X, 1998, AM MINERAL, V83, P68; Chen JH, 1998, GEOPHYS RES LETT, V25, P575, DOI 10.1029/98GL00043; PARISE JB, 1994, AM MINERAL, V79, P193; PAKE GE, 1948, J CHEM PHYS, V16, P327, DOI 10.1063/1.1746878; BERGLUND B, 1980, J CHEM PHYS, V73, P2037, DOI 10.1063/1.440423; Yang HX, 1997, AM MINERAL, V82, P651; PACALO REG, 1992, AM MINERAL, V77, P681; MENG Y, 1993, GEOPHYS RES LETT, V20, P1147, DOI 10.1029/93GL01400; RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558; Inoue T, 1998, EARTH PLANET SC LETT, V160, P107, DOI 10.1016/S0012-821X(98)00077-6; Parise JB, 1999, PHYS REV LETT, V83, P328, DOI 10.1103/PhysRevLett.83.328; Brown ID, 1995, CAN J PHYS, V73, P676; Burnley PC, 1996, AM MINERAL, V81, P317; Cho H, 1999, J MAGN RESON, V141, P164, DOI 10.1006/jmre.1999.1859; Cho H, 1996, J MAGN RESON SER A, V121, P8, DOI 10.1006/jmra.1996.0130; DITCHFIELD R, 1976, CHEM PHYS, V13, P187, DOI 10.1016/0301-0104(76)80001-8; Faust J, 1996, GEOPHYS RES LETT, V23, P427, DOI 10.1029/96GL00417; FINGER LW, 1991, AM MINERAL, V76, P1; Gwanmesia G.D., 1992, HIGH PRESSURE RES AP, P117; Haeberlen U., 1976, HIGH RESOLUTION NMR; KAGI H, 1997, EOS T AM GEOPHYS UN, V78, pS312; KUDOH Y, 1998, EOS, V79, pF895; KURIBAYASHI T, 1998, EOS, V79, pF867; Larson A. C., 1986, 86748 LAUR; LUTH RW, 1995, GEOCHIM COSMOCHIM AC, V59, P679, DOI 10.1016/0016-7037(95)00319-U; Lutz H. D., 1995, STRUCT BOND, V82, P86; Lutz HD, 1997, J MOL STRUCT, V404, P63, DOI 10.1016/S0022-2860(96)09362-3; LUTZ HD, 1995, J MOL STRUCT, V351, P205, DOI 10.1016/0022-2860(95)08813-B; MUNTEAN JV, 1988, J MAGN RESON, V76, P540, DOI 10.1016/0022-2364(88)90356-3; Nelmes R.J., 1993, T AM CRYSTALLOGR ASS, V29, P19; Parise JB, 1998, REV HIGH PRESSURE SC, V7, P211; Parise JB, 1998, PHYS CHEM MINER, V25, P130, DOI 10.1007/s002690050095; Pawley AR, 1996, CONTRIB MINERAL PETR, V124, P90, DOI 10.1007/s004100050176; Pawley AR, 1995, CONTRIB MINERAL PETR, V122, P301, DOI 10.1007/s004100050129; RATCLIFFE CI, 1985, CHEM PHYS LETT, V120, P427, DOI 10.1016/0009-2614(85)85634-7; Slichter C P, 1990, PRINCIPLES MAGNETIC; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; TAYLOR RE, 1979, J CHEM PHYS, V71, P4541, DOI 10.1063/1.438207; TYCKO R, 1990, J CHEM PHYS, V92, P5776, DOI 10.1063/1.458398; Weidner D.J., 1992, HIGH PRESSURE RES, V8, P617, DOI 10.1080/08957959208206311; WILLIAMS Q, 1992, HIGH PRESSURE RES AP, P289; WILSON RM, 1995, NUCL INSTRUM METH A, V354, P145, DOI 10.1016/0168-9002(94)01038-2	52	35	35	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-1791			PHYS CHEM MINER	Phys. Chem. Miner.	MAR	2000	27	4					225	233		10.1007/s002690050251		9	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	303ZV	WOS:000086458800001		
J	Henderson, D; Segur, H; Smolka, LB; Wadati, M				Henderson, D; Segur, H; Smolka, LB; Wadati, M			The motion of a falling liquid filament	PHYSICS OF FLUIDS			English	Article							CAPILLARY INSTABILITY; DROP FORMATION; JET	When a liquid drop falls from a fluid source with a slow flow rate, it remains attached to the source by an elongating liquid filament until the filament pinches off. For many fluids, this pinch-off occurs first near the end of the filament, where the filament joins to the liquid drop. For other fluids, the filament pinches off at one or more interior points. In this paper, we study the motion of this filament, and we make two points. First, the flow in this filament is not that of a uniform jet. Instead, we show experimentally that a different solution of the Navier-Stokes equations describes the motion of this filament before it pinches off. Second, we propose a criterion for the location of the first pinch-off. In particular, we analyze the linearized stability of the exact solution, both for an inviscid fluid and for a very viscous fluid. Our criterion for pinch-off is based on this stability analysis. It correctly predicts whether a given filament pinches off first near its ends or at points within its interior for all of our experimental data. (C) 2000 American Institute of Physics. [S1070-6631(00)02403-X].	Penn State Univ, Dept Math, William G Pritchard Fluid Mech Lab, University Pk, PA 16802 USA; Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	Henderson, D (reprint author), Penn State Univ, Dept Math, William G Pritchard Fluid Mech Lab, University Pk, PA 16802 USA.						Abramowitz M., 1964, HDB MATH FUNCTIONS; Henderson DM, 1997, PHYS FLUIDS, V9, P3188, DOI 10.1063/1.869435; SHI XD, 1994, SCIENCE, V265, P219, DOI 10.1126/science.265.5169.219; PEREGRINE DH, 1990, J FLUID MECH, V212, P25, DOI 10.1017/S0022112090001835; FRANKEL I, 1985, J FLUID MECH, V155, P289, DOI 10.1017/S0022112085001811; KELLER JB, 1983, SIAM J APPL MATH, V43, P268, DOI 10.1137/0143018; ZHANG XG, 1995, PHYS FLUIDS, V7, P1184, DOI 10.1063/1.868577; EGGERS J, 1993, PHYS REV LETT, V71, P3458, DOI 10.1103/PhysRevLett.71.3458; Tomotika S, 1936, PROC R SOC LON SER-A, V153, P0302, DOI 10.1098/rspa.1936.0003; EGGERS J, 1995, PHYS FLUIDS, V7, P941, DOI 10.1063/1.868570; BATCHELOR G. K., 1967, INTRO FLUID DYNAMICS; BECHTEL SE, 1995, PHYS FLUIDS, V7, P2956, DOI 10.1063/1.868673; BENDER C.M., 1978, ADV MATH METHODS SCI; Bowman F., 1958, INTRO BESSEL FUNCTIO; BRENNER MP, 1994, PHYS REV LETT, V73, P3391, DOI 10.1103/PhysRevLett.73.3391; CHANDRASEKHAR S, 1961, HYDRODYNAMIC HYDROMA, pCH12; FRANKEL I, 1987, J FLUID MECH, V185, P361, DOI 10.1017/S0022112087003215; Hellwig G., 1964, DIFFERENTIAL OPERATO; INCE EL, 1944, ORDINARY DIFFERENTIA, pCH10; Plateau J.A.F., 1873, STATIQUE EXPT THEORE; RAYLEIGH JWS, 1879, P LOND MATH SOC, V10, P4; Rayleigh L., 1892, PHILOS MAG, V34, P145; Schulkes RMSM, 1996, J FLUID MECH, V309, P277, DOI 10.1017/S0022112096001632; SCORIA J, 1990, EXP THERM FLUID SCI, V3, P291; STONE HA, 1986, J FLUID MECH, V173, P131, DOI 10.1017/S0022112086001118; Whittaker E T, 1980, COURSE MODERN ANAL	26	28	28	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	1070-6631			PHYS FLUIDS	Phys. Fluids	MAR	2000	12	3					550	565		10.1063/1.870261		16	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	282VN	WOS:000085241100010		
J	Suzuki, M; Bannai, M; Matsumuro, M; Furuhata, Y; Ikemura, R; Kuranaga, E; Kaneda, Y; Nishihara, M; Takahashi, M				Suzuki, M; Bannai, M; Matsumuro, M; Furuhata, Y; Ikemura, R; Kuranaga, E; Kaneda, Y; Nishihara, M; Takahashi, M			Suppression of copulatory behavior by intracerebroventricular infusion of antisense oligodeoxynucleotide of granulin in neonatal male rats	PHYSIOLOGY & BEHAVIOR			English	Article						granulin; sex steroid; sexual differentiation of the brain; antisense oligodeoxynucleotide	CENTRAL NERVOUS-SYSTEM; SEXUAL-DIFFERENTIATION; VENTROMEDIAL NUCLEUS; IN-VIVO; OLIGONUCLEOTIDES; HYPOTHALAMUS; EXPRESSION; PRECURSOR; SEQUENCE; LESIONS	Sexual dimorphism of the rodent brain is manifested by the epigenetic action of gonadal steroids. Our previous research identified the granulin (grn) precursor gene as a sex steroid-inducible gene, which was shown to be expressed more abundantly in male than female neonates at the mediobasal hypothalamic area. Grn is a 6-kDa polypeptide promoting or inhibiting the growth of epithelial cells and hematocytes in vitro. In this study, effects on male sexual behavior of male were pursued under conditions in which grn gene expression was suppressed during the critical period. To this end, an antisense oligodeoxynucleotide (ODN) of the grn precursor gene was designed, incorporated into inactivated Sendai virus (HVJ)-liposome complexes, and infused into the third ventricle of 2-day-old male rats. Two different control treatments were used: the first consisted of a control sequence ODN that had little homology to known mRNAs; the second of vehicle (HVJ-liposome) alone. After maturation, animals treated with antisense ODN of grn displayed significantly lower scores than control males on various parameters assessing sexual behavior; i.e., mount, intromission, and ejaculation. The antisense ODN, however, did not affect body growth or serum concentrations of testosterone and luteinizing hormone. Further, there was no significant difference in the volume of the sexual dimorphic nucleus of the preoptic area between antisense ODN-treated and control animals. It was shown that inadequate expression of the grn gene in the brain of male neonatal rats during the critical period suppressed the induction of some type of male sexual behavior, suggesting the grn was involved in the process of masculinization of the rat brain. (C) 2000 Elsevier Science Inc. All rights reserved.	Univ Tokyo, Dept Vet Physiol Vet Med Sci, Bunkyo Ku, Tokyo 1138657, Japan; Osaka Univ, Sch Med, Div Gen Therapy Sci, Suita, Osaka 5650871, Japan	Nishihara, M (reprint author), Univ Tokyo, Dept Vet Physiol Vet Med Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Aguan K, 1996, NEUROENDOCRINOLOGY, V64, P449, DOI 10.1159/000127151; MATSUMOTO A, 1986, NEUROENDOCRINOLOGY, V42, P232, DOI 10.1159/000124445; Kitajima I, 1997, J BIOL CHEM, V272, P27099, DOI 10.1074/jbc.272.43.27099; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; RHEES RW, 1990, DEV BRAIN RES, V52, P17, DOI 10.1016/0165-3806(90)90217-M; BARRACLOUGH C, 1961, ENDOCRINOLOGY, V68, P62; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; MCEWEN BS, 1977, HORM BEHAV, V9, P249, DOI 10.1016/0018-506X(77)90060-5; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; MORISHITA R, 1994, J CLIN INVEST, V93, P1458, DOI 10.1172/JCI117123; ARAI Y, 1978, PSYCHONEUROENDOCRINO, V3, P31, DOI 10.1016/0306-4530(78)90039-2; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Bannai M, 1998, BRAIN RES, V784, P305, DOI 10.1016/S0006-8993(97)01349-8; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; BHANDARI V, 1993, ENDOCRINOLOGY, V133, P2682, DOI 10.1210/en.133.6.2682; BLOCH GJ, 1988, J COMP NEUROL, V275, P604, DOI 10.1002/cne.902750408; CHRISTENSEN LW, 1977, BRAIN RES BULL, V2, P137, DOI 10.1016/0361-9230(77)90010-7; Desire L, 1998, DEV DYNAM, V212, P63, DOI 10.1002/(SICI)1097-0177(199805)212:1<63::AID-AJA6>3.0.CO;2-0; Duenas M, 1996, NEUROSCIENCE, V74, P531, DOI 10.1016/0306-4522(96)00142-X; Eck S L, 1991, Curr Opin Biotechnol, V2, P897, DOI 10.1016/S0958-1669(05)80128-4; Engelhard H, 1996, BIOCHEM BIOPH RES CO, V227, P400, DOI 10.1006/bbrc.1996.1519; HAYASHI S, 1974, ENDOCRINOL JAPON, V21, P453; Katoh S, 1996, BIOCHEM BIOPH RES CO, V229, P653, DOI 10.1006/bbrc.1996.1859; Kondo Y, 1997, ENDOCR J, V44, P873, DOI 10.1507/endocrj.44.873; MADRID JA, 1993, PHYSIOL BEHAV, V53, P329, DOI 10.1016/0031-9384(93)90213-Y; MCCARTHY MM, 1993, ENDOCRINOLOGY, V133, P433, DOI 10.1210/en.133.2.433; Meisel Robert L., 1994, P3; MILLER LDP, 1991, DEV BRAIN RES, V61, P189; SAITO TR, 1988, EXP ANIM TOKYO, V37, P489; Sakai RR, 1996, NEUROENDOCRINOLOGY, V64, P425, DOI 10.1159/000127148; Suzuki M, 1995, ENDOCR J, V42, P789, DOI 10.1507/endocrj.42.789; Suzuki M, 1998, NEUROSCI LETT, V242, P127, DOI 10.1016/S0304-3940(98)00008-1; ToranAllerand CD, 1996, J STEROID BIOCHEM, V56, P169, DOI 10.1016/0960-0760(95)00234-0; UHLMANN E., 1990, CHEM REV, V90, P544; Yamada K, 1996, AM J PHYSIOL-REG I, V271, pR1212; ZHENG HG, 1989, P NATL ACAD SCI USA, V86, P3758, DOI 10.1073/pnas.86.10.3758	38	31	32	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	MAR	2000	68	5					707	713		10.1016/S0031-9384(99)00241-3		7	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	307PT	WOS:000086662300014		
J	Someya, N; Kataoka, N; Komagata, T; Hirayae, K; Hibi, T; Akutsu, K				Someya, N; Kataoka, N; Komagata, T; Hirayae, K; Hibi, T; Akutsu, K			Biological control of cyclamen soilborne diseases by Serratia marcescens strain B2	PLANT DISEASE			English	Article						antifungal low-molecular-weight compounds; chitinolytic enzymes; Fusarium oxysporum f. sp cyclaminis; Rhizoctonia solani	GROWTH-PROMOTING RHIZOBACTERIA; INDUCED SYSTEMIC RESISTANCE; PLANT-GROWTH; INDUCTION; CUCUMBER; CHITINASE; TOBACCO; GENES	Cyclamen plants were treated with a highly chitinolytic bacterium, Serratia marcescens strain B2, and then challenge inoculated with Rhizoctonia solani sclerotia or Fusarium oxysporum f. sp. cyclaminis conidia. The bacterium suppressed these fungal diseases of cyclamen plants, especially the damping off caused by R. solani, in a greenhouse. Strain B2 survived at approximately 10(6) to 10(7) CFU/g in soil for 4 months after the initial application under greenhouse conditions. Chitinolytic enzymes and antifungal low-molecular-weight compounds were present in filtrates of S. marcescens B2, which suppressed germination of R. solani sclerotia in vitro.	Ibaraki Univ, Fac Agr, Ami, Ibaraki 30003, Japan; Univ Tokyo, Fac Agr, Bunkyo Ku, Tokyo 113, Japan; Kyushu Natl Agr Expt Stn, Kumamoto 86111, Japan; Ibaraki Hort Res Inst, Minori, Ibaraki 31902, Japan; Ibaraki Univ, Fac Agr, Ami, Ibaraki 3000393, Japan	Akutsu, K (reprint author), Ibaraki Univ, Fac Agr, Ami, Ibaraki 30003, Japan.						Akutsu K., 1993, Annals of the Phytopathological Society of Japan, V59, P18; TAKEUCHI Y, 1990, PLANT PHYSIOL, V93, P673, DOI 10.1104/pp.93.2.673; LOTAN T, 1990, PLANT PHYSIOL, V93, P811, DOI 10.1104/pp.93.2.811; LIU L, 1995, PHYTOPATHOLOGY, V85, P695, DOI 10.1094/Phyto-85-695; ORDENTLICH A, 1988, PHYTOPATHOLOGY, V78, P84; JONES JDG, 1986, EMBO J, V5, P467; Wei G, 1996, PHYTOPATHOLOGY, V86, P221, DOI 10.1094/Phyto-86-221; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339; GRIMONT PAD, 1981, PROKARYOTES HDB HABI, P1187; IYOZUMI H, 1993, ANN PHYTOPATHOL SOC, V59, P723; Iyozumi Hiroyuki, 1996, Annals of the Phytopathological Society of Japan, V62, P559; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; LIU L, 1995, PHYTOPATHOLOGY, V85, P843, DOI 10.1094/Phyto-85-843; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Okamoto Hiroshi, 1998, Annals of the Phytopathological Society of Japan, V64, P294; Okamoto Hiroshi, 1998, Annals of the Phytopathological Society of Japan, V64, P287; Press CM, 1997, MOL PLANT MICROBE IN, V10, P761, DOI 10.1094/MPMI.1997.10.6.761; SHAPIRA R, 1989, PHYTOPATHOLOGY, V79, P1246, DOI 10.1094/Phyto-79-1246; SUNDHEIM L, 1988, PHYSIOL MOL PLANT P, V33, P483, DOI 10.1016/0885-5765(88)90013-6; WEI G, 1991, Phytopathology, V81, P1508, DOI 10.1094/Phyto-81-1508; YAMAMOTO M, 1992, ANN PHYTOPATHOL SOC, V58, P582	21	47	49	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0191-2917			PLANT DIS	PLANT DIS.	MAR	2000	84	3					334	340		10.1094/PDIS.2000.84.3.334		7	Plant Sciences	Plant Sciences	286QG	WOS:000085456200022		
J	Tsukaya, H; Shoda, K; Kim, GT; Uchimiya, H				Tsukaya, H; Shoda, K; Kim, GT; Uchimiya, H			Heteroblasty in Arabidopsis thaliana (L.) Heynh	PLANTA			English	Article						Arabidopsis (mutant lec1); cotyledon; foliage leaf; heteroblasty; mutant (Arabidopsis)	SHOOT APICAL MERISTEM; MUTATIONAL ANALYSIS; LEAF MORPHOGENESIS; PHASE-CHANGE; EMF GENES; COTYLEDON; ELONGATION; MUTANT; LEAVES; CELLS	Heteroblasty in Arabidopsis thaliana was analyzed in a variety of plants with mutations in leaf morphology using a tissue-specific beta-glucuronidase gene marker. Some mutants exhibited their mutant phenotypes specifically in foliage leaves. The phenotypes associated with the foliage-leaf-specific mutations were also found to be induced ectopically in cotyledons in the presence of the led mutation. Moreover, the features of an emf1 led double mutant showed that cotyledons can be partially converted into carpelloids. When heteroblastic traits were examined in foliage leaves in the presence of certain mutations or natural deviations by histochemical. analysis of the expression of the tissue-specific marker gene, it was found that ectopic expression of the developmental program for the first foliage leaves in led cotyledons seemed to affect the heteroblastic features of the first set of foliage leaves, while foliage leaves beyond the third position appeared normal. Similarly, in wird-type plants, discrepancies in heteroblastic features, relative to standard features, of foliage leaves at early positions seemed to be eliminated in foliage leaves at later positions. These results suggest that heteroblasty in foliage leaves might be affected in part by the heteroblastic stage of the preceding foliage leaves but is finally controlled autonomously at each leaf position.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Atom Energy Res Inst, Adv Sci Res Ctr, Takasaki, Gumma 37012, Japan	Tsukaya, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Tsukaya, Hirokazu/A-2614-2013	Tsukaya, Hirokazu/0000-0002-4430-4538			Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; WEST MAL, 1994, PLANT CELL, V6, P1731; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; MEINKE DW, 1992, SCIENCE, V258, P1647, DOI 10.1126/science.258.5088.1647; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; BARTON MK, 1993, DEVELOPMENT, V119, P823; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; TSUKAYA H, 1993, DEVELOPMENT, V118, P751; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Arber A, 1941, BIOL REV CAMB PHILOS, V16, P81, DOI 10.1111/j.1469-185X.1941.tb01096.x; Chen LJ, 1997, PLANT CELL, V9, P2011, DOI 10.1105/tpc.9.11.2011; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Evans MMS, 1997, ANNU REV PLANT PHYS, V48, P673, DOI 10.1146/annurev.arplant.48.1.673; Fernandez DE, 1997, DEVELOPMENT, V124, P1149; FINKELSTEIN RR, 1984, PLANTA, V162, P125, DOI 10.1007/BF00410208; Gifford E.M., 1987, MORPHOLOGY EVOLUTION; Kaplan DR, 1997, PLANT CELL, V9, P1903; Kim GT, 1999, P NATL ACAD SCI USA, V96, P9433, DOI 10.1073/pnas.96.16.9433; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; MCLELLAN T, 1995, INT J PLANT SCI, V156, P581, DOI 10.1086/297280; OKADA K, 1992, AUST J PLANT PHYSIOL, V19, P439; ROBBELEN GERHARD, 1957, BER DEUTSCH BOT GES, V70, P39; SUNG ZR, 1992, SCIENCE, V258, P1645, DOI 10.1126/science.258.5088.1645; Telfer A, 1997, DEVELOPMENT, V124, P645; Tsukaya H, 1997, MOL GEN GENET, V256, P231; TSUKAYA H, 1994, PLANTA, V195, P309; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Tsukaya H, 1995, J PLANT RES, V108, P407, DOI 10.1007/BF02344229; Tsukaya H, 1997, DEVELOPMENT, V124, P1275; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; YANG CH, 1995, DEV BIOL, V169, P421, DOI 10.1006/dbio.1995.1158	35	33	33	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0032-0935			PLANTA	Planta	MAR	2000	210	4					536	542		10.1007/s004250050042		7	Plant Sciences	Plant Sciences	303ZN	WOS:000086458200003		
J	Yoshimura, K; Ouchi, K; Wakita, S; Uda, K; Harii, K				Yoshimura, K; Ouchi, K; Wakita, S; Uda, K; Harii, K			Surgical correction of cryptotia with superiorly based superficial mastoid fascia and skin paddle	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							RECONSTRUCTION; FLAP	An approach for the correction of cryptotia using a superiorly based superficial mastoid fascial flap and a skin paddle is introduced. The buried portion of the auricle was exposed through an incision made along the upper part of the helix, followed by an appropriate correction of the deformed cartilage. Protrusion of the upper portion of the auricle was accomplished using anchoring sutures. A small skin paddle was elevated from the caudal portion of the auricular sulcus with the superiorly based superficial mastoid fascia as the nutrient pedicle and transferred to the temporal skin defect. The procedure was performed in eight auricles in a total of seven patients with cryptotia. A satisfactory contour and protrusion of the auricle were maintained postoperatively, leaving the scar within the auricular sulcus.	Univ Tokyo, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimura, K (reprint author), Univ Tokyo, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Yoshimura, Kotaro/C-8524-2009				HIROSE T, 1985, BRIT J PLAST SURG, V38, P352, DOI 10.1016/0007-1226(85)90241-3; Yoshimura K, 1999, BRIT J PLAST SURG, V52, P530, DOI 10.1054/bjps.1999.3148; PARK C, 1991, PLAST RECONSTR SURG, V88, P404, DOI 10.1097/00006534-199109000-00004; MATSUO K, 1990, CLIN PLAST SURG, V17, P383; Anze M, 1971, Keisei Geka, V14, P263; Chana JS, 1997, ANN PLAS SURG, V39, P261, DOI 10.1097/00000637-199709000-00007; ELSAHY NI, 1989, ANN PLAS SURG, V23, P66, DOI 10.1097/00000637-198907000-00011; Fukuda O, 1968, Keisei Geka, V11, P117; KOBAYASHI S, 1995, PLAST RECONSTR SURG, V96, P42, DOI 10.1097/00006534-199507000-00006; KUBO I, 1933, OTORHINOLARYNGOLOGIE, V6, P105; MUTIMER KL, 1988, PLAST RECONSTR SURG, V81, P601, DOI 10.1097/00006534-198804000-00021; NAKAJIMA T, 1991, BRIT J PLAST SURG, V44, P406, DOI 10.1016/0007-1226(91)90196-Q; ONIZUKA T, 1978, PLAST RECONSTR SURG, V62, P734, DOI 10.1097/00006534-197811000-00013; ONO I, 1995, PLAST RECONSTR SURG, V96, P461, DOI 10.1097/00006534-199508000-00033; PARK S, 1994, ANN PLAS SURG, V32, P441, DOI 10.1097/00000637-199404000-00023; Sharma RK, 1996, PLAST RECONSTR SURG, V97, P25, DOI 10.1097/00006534-199601000-00003; Song RY, 1996, PLAST RECONSTR SURG, V98, P657, DOI 10.1097/00006534-199609001-00009; WASHIO H, 1973, PLAST RECONSTR SURG, V52, P648, DOI 10.1097/00006534-197312000-00008; YANAI A, 1988, PLAST RECONSTR SURG, V82, P965, DOI 10.1097/00006534-198812000-00005; Yoshimura K, 1998, AESTHET PLAST SURG, V22, P352, DOI 10.1007/s002669900216	20	13	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052			PLAST RECONSTR SURG	Plast. Reconstr. Surg.	MAR	2000	105	3					836	841		10.1097/00006534-200003000-00002		6	Surgery	Surgery	292HB	WOS:000085787600002		
J	Yoshimura, K; Harii, K; Aoyama, T; Iga, T				Yoshimura, K; Harii, K; Aoyama, T; Iga, T			Experience with a strong bleaching treatment for skin hyperpigmentation in orientals	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Editorial Material							RETINOIC ACID TREATMENT; TOPICAL TRETINOIN; PHOTODAMAGED SKIN; PHOTOAGED SKIN; INVITRO; MELASMA; LESIONS; ATROPHY; INVIVO; LASER	Although a variety of topical treatments have been used for skin hyperpigmentation, the effectiveness of each varies after prolonged treatment. In this study, 136 Oriental patients who were followed up for more than 12 weeks were analyzed. The treatment protocol was composed of two steps: bleaching (2 to 6 weeks) and healing (2 to 6 weeks); 0.1% to 0.4% all-trans retinoic acid aqueous gel was originally prepared and applied concomitantly with hydroquinone-lactic acid ointment for bleaching. After obtaining sufficient improvement of the hyperpigmentation, a corticosteroid was applied topically with hydroquinone and ascorbic acid for healing. Improvement was evaluated with a narrow-band reflectance spectrophotometer. The results were successful in more than 80 percent of cases of senile lentigines and postinflammatory hyperpigmentations, especially on the face. Sixty percent of cases of news spilus were also successfully treated. Although the transient adverse effects of this treatment may be more severe than conventional treatment, this strong bleaching protocol improves a variety of hyperpigmented lesions, including nevus spilus, with a higher success rate and a shorter treatment period than conventional protocols.	Univ Tokyo, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Dept Pharm, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimura, K (reprint author), Univ Tokyo, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Yoshimura, Kotaro/C-8524-2009				ALSTER TS, 1997, MANUAL CUTANEOUS LAS, P45; Apfelberg DB, 1997, PLAST RECONSTR SURG, V99, P1817, DOI 10.1097/00006534-199706000-00003; [Anonymous], 1995, ARCH DERMATOL; PATHAK MA, 1986, J AM ACAD DERMATOL, V15, P894, DOI 10.1016/S0190-9622(86)70247-8; GRIFFITHS CEM, 1994, J AM ACAD DERMATOL, V30, P76; Bhawan J, 1998, INT J DERMATOL, V37, P286, DOI 10.1046/j.1365-4362.1998.00433.x; EICHNER R, 1986, J AM ACAD DERMATOL, V15, P789, DOI 10.1016/S0190-9622(86)70235-1; MAEDA K, 1991, J SOC COSMET CHEM, V42, P361; KLIGMAN AM, 1986, J AM ACAD DERMATOL, V15, P836, DOI 10.1016/S0190-9622(86)70242-9; Fisher GJ, 1996, FASEB J, V10, P1002; KLIGMAN AM, 1975, ARCH DERMATOL, V111, P40; ARNOLD J, 1975, DERMATOLOGICA, V151, P274; GANO SE, 1979, CUTIS, V23, P239; GRIFFITHS CEM, 1993, BRIT J DERMATOL, V129, P415, DOI 10.1111/j.1365-2133.1993.tb03169.x; GRIFFITHS CEM, 1995, ARCH DERMATOL, V131, P1037, DOI 10.1001/archderm.131.9.1037; Helander SD, 1996, DRUG AGING, V8, P12; Kang SW, 1997, ARCH DERMATOL, V133, P1280, DOI 10.1001/archderm.133.10.1280; KENNETH AA, 1965, JAMA-J AM MED ASSOC, V194, P117; KLIGMAN LH, 1984, CONNECT TISSUE RES, V12, P139, DOI 10.3109/03008208408992779; LESNIK RH, 1989, J AM ACAD DERMATOL, V21, P186, DOI 10.1016/S0190-9622(89)70159-6; LEYDEN JJ, 1974, ARCH DERMATOL, V110, P619, DOI 10.1001/archderm.110.4.619; Leyden JJ, 1998, PLAST RECONSTR SURG, V102, P1667, DOI 10.1097/00006534-199810000-00053; Mcmichael AJ, 1996, BRIT J DERMATOL, V135, P60; NAU H, 1993, SKIN PHARMACOL, V6, P35; NORDLUND JJ, 1988, DERMATOL CLIN, V6, P185; ORTONNE JP, 1992, BRIT J DERMATOL, V127, P43, DOI 10.1111/j.1365-2133.1992.tb16987.x; RAFAL ES, 1992, NEW ENGL J MED, V326, P368, DOI 10.1056/NEJM199202063260603; SCHWARTZ E, 1991, J INVEST DERMATOL, V96, P975, DOI 10.1111/1523-1747.ep12476385; TAYLOR CR, 1993, INT J DERMATOL, V32, P908, DOI 10.1111/j.1365-4362.1993.tb01417.x; Ulland AE, 1997, J SURG RES, V70, P84, DOI 10.1006/jsre.1997.5099; YOSHIMURA K, IN PRESS AESTHETIC P; Yoshimura K, 1999, AESTHET PLAST SURG, V23, P285, DOI 10.1007/s002669900285	32	30	33	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052			PLAST RECONSTR SURG	Plast. Reconstr. Surg.	MAR	2000	105	3					1097	1108		10.1097/00006534-200003000-00040		12	Surgery	Surgery	292HB	WOS:000085787600039		
J	Li, YY; Bridgwater, J				Li, YY; Bridgwater, J			Prediction of extrusion pressure using an artificial neural network	POWDER TECHNOLOGY			English	Article						artificial neural network; paste extrusion; extrusion pressure	PASTE EXTRUSION; DIES; BACKPROPAGATION; PARAMETERS; EXTRUDER; GEOMETRY; MODEL; FLOW; DROP	A three layer feed-forward artificial neutral network (ANN) model was used for the description of extrusion pressure. The studies employ experimental data obtained from capillary flow experiments using a paste containing 5A zeolite, bentonite and water. On comparing the experimental data, the predictions using the Benbow-Bridgwater equation and the ANN model predictions, it is found that the ANN model is capable of predicting the extrusion pressure well. The neural network model shows how the significant parameters influencing extrusion pressure can be found. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England; Univ Cambridge, Dept Chem Engn, Cambridge CB2 3RA, England	Li, YY (reprint author), Univ Tokyo, Dept Ind Chem & Met, Suzuki & Sakoda Lab, 7-22-1 Roppongi, Tokyo, Japan.						WIDROW B, 1990, P IEEE, V78, P1415, DOI 10.1109/5.58323; Horrobin DJ, 1998, CHEM ENG SCI, V53, P3215, DOI 10.1016/S0009-2509(98)00105-5; Maier HR, 1998, ENVIRON MODELL SOFTW, V13, P193, DOI 10.1016/S1364-8152(98)00020-6; Person TJ, 1997, J RHEOL, V41, P249, DOI 10.1122/1.550877; Akdogan H, 1996, FOOD RES INT, V29, P423, DOI 10.1016/S0963-9969(96)00036-1; Azlan H. M., 1999, ARTIF INTELL, V13, P55; Benbow J., 1993, PASTE FLOW EXTRUSION; BENBOW JJ, 1989, AM CERAM SOC BULL, V68, P1821; Benbow JJ, 1998, J MATER SCI, V33, P5827, DOI 10.1023/A:1004458217898; BENBOW JJ, 1971, CHEM ENG SCI, V26, P1467, DOI 10.1016/0009-2509(71)80066-0; BENBOW JJ, 1991, POWDER TECHNOL, V65, P393, DOI 10.1016/0032-5910(91)80201-S; BLACKBURN S, 1994, J MATER SCI, V29, P4157, DOI 10.1007/BF00414194; BOEHM H, 1994, BRIT CERAM T, V93, P169; BULSARI AB, 1995, NEURAL NETWORK CHEM; BURBIDGE AS, 1995, CHEM ENG RES DES, V73, P810; Chen Y, 1997, J AM CERAM SOC, V80, P1841; Chester D.L., 1990, P INT JOINT C NEUR N, V1, P265; CHO S, 1996, P 1996 IEEE INT C EV, P685; Daponte P., 1998, Measurement, V23, DOI 10.1016/S0263-2241(98)00013-X; Hassoun M., 1995, FUNDAMENTALS ARTIFIC; Hecht-Nielsen R., 1989, INT JOINT C NEURAL N, P593, DOI DOI 10.1109/IJCNN.1989.118638; Hinton G. E., 1992, Scientific American (International Edition), V267; Kim CJ, 1997, J MATER SCI, V32, P5233, DOI 10.1023/A:1018646223426; Kosaki M, 1996, IEEE ELECTR INSUL M, V12, P17, DOI 10.1109/57.537191; Lang U, 1998, J REINF PLAST COMP, V17, P1110; LI YY, UNPUB POWDER TECHNOL; Morris A. J., 1994, T ICHEME A, V72, P3; NELSON M. A., 1991, PRACTICAL GUIDE NEUR; PADMANABHAN M, 1989, J FOOD SCI, V54, P709, DOI 10.1111/j.1365-2621.1989.tb04687.x; SHAH RD, 1995, PHARMACEUT RES, V12, P496, DOI 10.1023/A:1016237509740; Sheppard T, 1998, Z METALLKD, V89, P327; TRAVNICKOVA J, 1989, SILIKATY, V33, P11; Warner B, 1996, AM STAT, V50, P284, DOI 10.2307/2684922; WIDROW B, 1993, INT J INTELL SYST, V8, P453, DOI 10.1002/int.4550080403; Yang M, 1996, SEPAR SCI TECHNOL, V31, P1259, DOI 10.1080/01496399608006949; YEUNG DS, 1994, IEEE INT C NEUR NETW, V7, P4353	36	31	32	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0032-5910			POWDER TECHNOL	Powder Technol.	MAR 1	2000	108	1					65	73		10.1016/S0032-5910(99)00254-5		9	Engineering, Chemical	Engineering	290FA	WOS:000085664600007		
J	Li, J; Li, L				Li, J; Li, L			Finite dislocation loop in anisotropic two phase medium	PROGRESS IN NATURAL SCIENCE			English	Article						finite dislocation loop; anisotropic medium; phase boundary		A scheme for calculating the stress field of a finite dislocation loop in multiphase medium is proposed. Taking the gamma/alpha-Fe two phase medium as an example, adopting appropriate boundary condition, the "infinity field", "image field", resultant stress field produced by the finite dislocation loop, as well as the "image force" exerting on the loop, are calculated.	Univ Tokyo, Cluster Mech Engn, Tokyo 113, Japan; Engn Coll Capital Steel, Beijing 100041, Peoples R China	Li, J (reprint author), Univ Tokyo, Cluster Mech Engn, Tokyo 113, Japan.						FAND IMG, 1966, GEN FUNCTIONS, V5, P75; HIRTH JP, 1982, THEORY DISLOCATIONS, P37; Li Guo-Wang, 1992, Acta Physica Sinica, V41; LIU WX, 1989, ELECT MICROSCOPIC AN, P368; NABARRO FRN, 1979, DISLOCATIONS SOLIDS, V1, P46; NABARRO FRN, 1979, DISLOCATIONS SOLIDS, V4, P110; Nye J. F., 1957, PHYSICAL PROPERTIES, P33; Yang Shun-hua, 1990, Acta Physica Sinica, V39; Yang Shun-hua, 1991, Acta Physica Sinica, V40; Yang Shun-Hua, 1989, Acta Physica Sinica, V38; YANG SH, 1988, THEORETICAL BASIS DI, V1, P165; YANG SH, 1988, THEORETICAL BASIS DI, V1, P1	12	1	1	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	1002-0071			PROG NAT SCI	Prog. Nat. Sci.	MAR	2000	10	3					183	191				9	Materials Science, Multidisciplinary; Multidisciplinary Sciences	Materials Science; Science & Technology - Other Topics	290NR	WOS:000085682700004		
J	Fukui, S; Kamiya, M; Koike, M; Kugaya, A; Okamura, H; Nakanishi, T; Imoto, S; Kanagawa, K; Uchitomi, Y				Fukui, S; Kamiya, M; Koike, M; Kugaya, A; Okamura, H; Nakanishi, T; Imoto, S; Kanagawa, K; Uchitomi, Y			Applicability of a western-developed psychosocial group intervention for Japanese patients with primary breast cancer	PSYCHO-ONCOLOGY			English	Article							STRUCTURED PSYCHIATRIC INTERVENTION; TRUTH; WOMEN; SUPPORT; ATTITUDES; OUTCOMES; SURGERY; THERAPY; TRIAL; CARE	This paper examines the applicability of psychosocial group intervention for Japanese patients with primary breast cancer. The study included two phases. First, we examined the applicability for Japanese patients of an intervention model developed in a Western country. The model, based on the work of Fawzy and Fawzy (1994) on a structured psychosocial group intervention for cancer patients, is a series of six 1.5-h sessions that incorporate health education, coping-skills training, relaxation training and psychological support. Second, we formulated a Japanese version of the intervention model by modifying areas identified as inappropriate by participants in the first-phase study. We then evaluated this by conducting sessions of the modified model with 44 additional breast cancer patients. Of the ten participants in the first-phase pilot study, three (30%) dropped out and several inappropriate areas were reported. The areas requiring significant change were the provision of medical information and communication style with family members and doctors. No participants dropped out of the modified version, and very few found any program areas to be inappropriate. The findings suggests that psychosocial group intervention is applicable for Japanese breast cancer patients when the model accounts for cultural differences. Copyright (C) 2000 John Wiley & Sons, Ltd.	Natl Canc Ctr, Res Inst E, Psychoncol Div, Kashiwa, Chiba 2778577, Japan; Univ Tokyo, Fac Med, Dept Community Hlth Nursing, Tokyo 113, Japan; Natl Canc Ctr Hosp E, Div Breast Surg, Chiba, Japan; Jikei Med Univ, Kashiwa Hosp, Div Psychiat, Chiba, Japan	Uchitomi, Y (reprint author), Natl Canc Ctr, Res Inst E, Psychoncol Div, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.						FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575; HATTORI H, 1991, SOC SCI MED, V32, P1007, DOI 10.1016/0277-9536(91)90158-9; Ganz PA, 1996, BREAST CANCER RES TR, V38, P183, DOI 10.1007/BF01806673; Kissane DW, 1997, PSYCHO-ONCOL, V6, P25, DOI 10.1002/(SICI)1099-1611(199703)6:1<25::AID-PON240>3.0.CO;2-N; BRIDGE LR, 1988, BRIT MED J, V297, P1169; SPIEGEL D, 1981, ARCH GEN PSYCHIAT, V38, P527; ASAI A, 1995, WESTERN J MED, V163, P36; Braden CJ, 1998, CANCER PRACT, V6, P87, DOI 10.1046/j.1523-5394.1998.1998006087.x; Cella D F, 1993, Cancer Pract, V1, P56; Cope DG, 1995, CANCER NURS, V18, P472, DOI 10.1097/00002820-199512000-00008; Coward D D, 1998, Oncol Nurs Forum, V25, P75; DALLAVORGIA P, 1992, J MED ETHICS, V18, P67, DOI 10.1136/jme.18.2.67; FAWZY FI, 1990, ARCH GEN PSYCHIAT, V47, P720; Fawzy FI, 1996, PSYCHO-ONCOL, V5, P81, DOI 10.1002/(SICI)1099-1611(199606)5:2<81::AID-PON215>3.3.CO;2-6; Fawzy Fawzy I., 1994, General Hospital Psychiatry, V16, P149, DOI 10.1016/0163-8343(94)90098-1; FREEDMAN B, 1993, ARCH INTERN MED, V153, P572, DOI 10.1001/archinte.153.5.572; GOLDBERG JA, 1992, EUR J SURG ONCOL, V18, P327; Graham P, 1998, ACTA PAEDIATR JAPON, V40, P164; Hong G. K., 1989, J STRATEGIC SYSTEMIC, V8, P14; Hosaka T, 1996, PSYCHO-ONCOL, V5, P59, DOI 10.1002/(SICI)1099-1611(199603)5:1<59::AID-PON209>3.3.CO;2-F; Imoto S, 1997, JPN J CLIN ONCOL, V27, P310, DOI 10.1093/jjco/27.5.310; INOUE E, 1986, SHI KANGAERU, P173; Ishiwata R, 1994, Camb Q Healthc Ethics, V3, P60; KEMENY MM, 1988, CANCER, V62, P1231, DOI 10.1002/1097-0142(19880915)62:6<1231::AID-CNCR2820620631>3.0.CO;2-8; Leszcz M, 1998, INT J GROUP PSYCHOTH, V48, P245; LONG SO, 1982, SOC SCI MED, V16, P2101, DOI 10.1016/0277-9536(82)90259-3; LONG SO, 1986, SOC SCI MED, V22, P81, DOI 10.1016/0277-9536(86)90311-4; Marchioro G, 1996, EUR J CANCER, V32A, P1612, DOI 10.1016/0959-8049(96)00134-7; McArdle JMC, 1996, BRIT MED J, V312, P813; MCGILL D, 1987, CONTEMP FAM THER, V9, P283, DOI 10.1007/BF00897666; Meyer TJ, 1996, J PSYCHOSOM RES, V41, P409, DOI 10.1016/S0022-3999(96)00170-5; NILCHAIKOVIT T, 1993, GEN HOSP PSYCHIAT, V15, P41, DOI 10.1016/0163-8343(93)90090-B; Sagara M, 1998, CANCER NURS, V21, P274, DOI 10.1097/00002820-199808000-00009; Singer MK, 1993, Soc Sci Med, V37, P295; SINGER MK, 1997, CULT MED PSYCHIAT, V21, P449; Spiegel David, 1997, Seminars in Oncology, V24, P36; SURBONE A, 1992, JAMA-J AM MED ASSOC, V268, P1661; SUZUKI K, 1992, NIPPON IJI SINPO, V3543, P43; TAMURA T, 1992, FAM PROCESS, V31, P319, DOI 10.1111/j.1545-5300.1992.00319.x; TAYLOR SE, 1985, CANCER, V55, P2506, DOI 10.1002/1097-0142(19850515)55:10<2506::AID-CNCR2820551033>3.0.CO;2-0; TUI P, 1988, AM J ORTHOPSYCHIAT, V58, P136; Watts A. W., 1961, PSYCHOTHERAPY E W	42	13	13	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	1057-9249			PSYCHO-ONCOL	Psycho-Oncol.	MAR-APR	2000	9	2					169	177		10.1002/(SICI)1099-1611(200003/04)9:2<169::AID-PON441>3.0.CO;2-V		9	Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences, Biomedical	Oncology; Psychology; Biomedical Social Sciences	310ZE	WOS:000086859000009		
J	Kawazumi, N; Shibukawa, Y				Kawazumi, N; Shibukawa, Y			The meromorphic solutions of the Bruschi-Calogero equation	PUBLICATIONS OF THE RESEARCH INSTITUTE FOR MATHEMATICAL SCIENCES			English	Article							LIE-ALGEBRAS; SYSTEMS	We give all the meromorphic functions defined near the origin 0 is an element of C satisfying a functional equation investigated by Bruschi and Calogero [1], [2].	Univ Tokyo, Dept Math Sci, Tokyo 1538914, Japan; Hokkaido Univ, Fac Sci, Dept Math, Sapporo, Hokkaido 0600810, Japan							RUIJSENAARS SNM, 1986, ANN PHYS-NEW YORK, V170, P370, DOI 10.1016/0003-4916(86)90097-7; CALOGERO F, 1975, LETT NUOVO CIMENTO, V13, P411, DOI 10.1007/BF02790495; OLSHANETSKY MA, 1981, PHYS REP, V71, P313, DOI 10.1016/0370-1573(81)90023-5; OCHIAI H, 1994, P JPN ACAD A-MATH, V70, P62; BRUSCHI M, 1987, COMMUN MATH PHYS, V109, P481, DOI 10.1007/BF01206147; BRUSCHI M, 1990, SIAM J MATH ANAL, V21, P1019, DOI 10.1137/0521056; CALOGERO F, 1976, LETT NUOVO CIMENTO, V16, P77, DOI 10.1007/BF02824328; CONWAY JB, 1978, FUNCTIONS ONE COMPLE; Hurwitz A., 1964, VORLESUNGEN ALLGEMEI; MOSER J, 1975, ADV MATH, V16, P197, DOI 10.1016/0001-8708(75)90151-6; Olshanetsky M. A., 1994, DYNAMICAL SYSTEMS, P87; OLSHANETSKY MA, 1976, INVENT MATH, V37, P93, DOI 10.1007/BF01418964; OLSHANETSKY MA, 1982, MATHPHYS REV, V3, P151; Oshima T., 1995, J MATH SCI-UNIV TOKY, V2, P1; Pontryagin L.S., 1966, TOPOLOGICAL GROUPS, Vsecond; Whittaker E. T., 1902, COURSE MODERN ANAL	16	1	1	KYOTO UNIV	KYOTO	RES INST MATH SCI, KYOTO, 606, JAPAN	0034-5318			PUBL RES I MATH SCI	Publ. Res. Inst. Math. Sci.	MAR	2000	36	1					85	109		10.2977/prims/1195143227		25	Mathematics	Mathematics	317UF	WOS:000087244800003		
J	Zhao, H; Kanda, K				Zhao, H; Kanda, K			Translation and validation of the Standard Chinese version of the EORTC QLQ-C30	QUALITY OF LIFE RESEARCH			English	Article						EORTC QLQ-C30; gynecological cancer; psychometric property; quality of life; Standard Chinese	OF-LIFE QUESTIONNAIRE; CANCER; RELIABILITY; VALIDITY	The majority of quality of life (QOL) questionnaires have been developed and used in English-speaking or Western European countries. The aims of this study were to provide the Standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30 version 2.0), and evaluate its psychometric properties. The translation process included independent translation, back translation, a pilot test with gynecological cancer patients, and a review and approval by the original developers. Participants in the major study included gestational trophoblastic disease patients (n = 68), ovarian cancer patients (n = 105), and other types of gynecological cancer patients (n = 18). The average completion time of the Standard Chinese version was 8.1 +/- 2.9 min. All item-subscale correlation coefficients exceeded the criterion of item-convergent validity (r > 0.40) except item 1, 5, 20, and 25, and all items correlated significantly higher with their own subscale than with other subscales except item 1, 20, and 25. The correlation coefficients among all subscales were significant but modest (r = 0.40-0.70). Seven out of nine subscales met the minimal standards of reliability (Cronbach's alpha > 0.70). In conclusion, the Standard Chinese version of the EORTC QLQ-C30 is a valid instrument overall in assessing the QOL of Chinese gynecological cancer patients.	Univ Tokyo, Grad Sch Med, Dept Nursing Amd, Bunkyo Ku, Tokyo 1130033, Japan	Zhao, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Nursing Amd, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; OSOBA D, 1994, QUAL LIFE RES, V3, P353, DOI 10.1007/BF00451727; [Anonymous], 1951, PSYCHOMETRIKA; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Kaasa S, 1995, EUR J CANCER, V31A, P2260, DOI 10.1016/0959-8049(95)00296-0; Osoba D, 1997, QUAL LIFE RES, V6, P103; CAI RH, 1997, YB PUBLIC HLTH PEOPL, P426; Cancer Committee of the International Federation of Gynecology and Obstetrics, 1989, GYNECOL ONCOL, V25, P383; CHEN H, 1996, CHIN J PREV MED, V30, P229; Chen KP, 1996, GAME ECON BEHAV, V16, P1, DOI 10.1006/game.1996.0071; Fayers P, 1995, EORTC QLQ C30 SCORIN; Hays R. D., 1988, USERS GUIDE MULTITRA; *INT FED GYN OBST, 1985, ANN REP RES TREATM G, V19, P280; LUO J, 1997, CHINESE J ONCOL, V19, P437; NGAN HYS, 1998, COMMUNICATION; RINGDAL GI, 1993, QUAL LIFE RES, V2, P129, DOI 10.1007/BF00435732	16	52	57	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0962-9343			QUAL LIFE RES	Qual. Life Res.	MAR	2000	9	2					129	137		10.1023/A:1008981520920		9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	350PY	WOS:000089111400001		
J	Tsukakoshi, O; Hayashi, T; Yamamuro, K; Nakamura, M				Tsukakoshi, O; Hayashi, T; Yamamuro, K; Nakamura, M			Development of a high precision quadrupole mass filter using the zero-method control circuit	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A high precision quadrupole mass filter has been developed using the zero-method control circuit. With this method, peak values of a control voltage are compared with a high-precision reference voltage and detected by a diode and signal-producing resistance connected in series. The dc component of the signal is selectively amplified and fed back to a module in the amplifying system of the rf voltage so as to minimize the voltage in excess of the reference voltage. An instrument has been constructed and the doublet of He-4(+)-D-2(+) has been successfully separated. (C) 2000 American Institute of Physics. [S0034-6748(00)00903-5].	Ulvac Japan Ltd, Kanagawa 2538543, Japan; Chiba Inst Technol, Chiba 2750016, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Tsukakoshi, O (reprint author), Ulvac Japan Ltd, 2500 Hagisono Chigasaki, Kanagawa 2538543, Japan.						Dawson P.H., 1976, QUADRUPOLE MASS SPEC; HAYASHI T, Patent No. 5734163; HIROKI S, 1994, J VAC SCI TECHNOL A, V12, P2711, DOI 10.1116/1.579093; HIROKI S, 1991, REV SCI INSTRUM, V62, P44; March R.E., 1989, QUADRUPOLE STORAGE M	5	0	0	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0034-6748			REV SCI INSTRUM	Rev. Sci. Instrum.	MAR	2000	71	3					1332	1336		10.1063/1.1150459		5	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	290QZ	WOS:000085688600012		
J	Varghese, S; Katsumura, Y; Makuuchi, K; Yoshii, F				Varghese, S; Katsumura, Y; Makuuchi, K; Yoshii, F			Production of soluble protein free latex by radiation process	RUBBER CHEMISTRY AND TECHNOLOGY			English	Article							RUBBER ELONGATION-FACTOR; HEVEA-BRASILIENSIS; IDENTIFICATION; BIOSYNTHESIS; ANAPHYLAXIS; CONTACT	During irradiation of natural rubber (NR) latex for vulcanization. the latex proteins undergo disintegration which leaves a high soluble protein content in latex products. In order to follow up the effects of radiation on NR proteins, held latex was irradiated with gamma -rays and the soluble protein concentration in the rubber phase and serum phase were analyzed. It was found that the water solubility of proteins in the latex increases with increasing dose. The soluble protein content in the cream phase (rubber) decreased where as that in the serum phase increased with radiation dose. SDS-PAGE analysis revealed that the 27 kD protein together with 14 kD appear in the radiation vulcanized latex up to a radiation dose of 160 kGy and at 320 kGy they disappear due to the disintegration by radiation. A new process for the preparation of protein free latex has been developed. In the new process the radiation-prevulcanized, centrifuged latex is subjected to dilution and then centrifuged. In the case of field latex, it is irradiated first and then centrifuged after dilution. The new process results in prevulcanized latex almost free from soluble proteins. Tensile strength of samples produced by the new process is comparable to that from the conventional radiation process.	Japan Atom Energy Res Inst, Takasaki Radiat Chem Res Estab, Takasaki, Gunma 37012, Japan; Univ Tokyo, Fac Engn, Dept Quantum Engn & Syst Sci, Tokyo 113, Japan	Varghese, S (reprint author), Rubber Res Inst India, Kottayam 686009, Kerala, India.						ALENIUS H, 1993, P INT RUBB TECH C WO; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; ARCHER BL, 1963, BIOCHEM J, V89, P565; *ASTM, 1995, ANN BOOK ASTM STAND, P302; *BCA, 1906, BCA PROT ASS INSTR 2; Burfield D. R., 1986, J RUBBER RES, V1, P202; CARDOSA MJ, 1994, J NAT RUBB RES, V9, P205; CORNISH K, 1993, EUR J BIOCHEM, V218, P267, DOI 10.1111/j.1432-1033.1993.tb18374.x; CZUPPON AB, 1993, J ALLERGY CLIN IMMUN, V92, P690, DOI 10.1016/0091-6749(93)90012-5; DAUZAC J, 1989, PHYSL RUBBER TREE LA; ELVING N, 1992, P INT LAT C SENS LAT, P34; GEERTSMA RE, 1996, 605148007 AST NAT I; HASAMA H, 1992, J NAT RUBBER RES, V7, P102; ICHIKAWA N, 1993, NATURAL RUBBER CURRE, P101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARCHER B, 1995, J RUBBER RES I MALAY, V61, P603; LEYNADIER F, 1989, ANAESTHESIA, V44, P547, DOI 10.1111/j.1365-2044.1989.tb11438.x; MAKUUCHI K, 1995, J SOC RUBBER IND JPN, V68, P263; MINOURA Y, 1961, J APPL POLYM SCI, V5, P233, DOI 10.1002/app.1961.070051416; MORALES C, 1989, CLIN EXP ALLERGY, V19, P425, DOI 10.1111/j.1365-2222.1989.tb02409.x; SUBRAMANIAN A, 1992, P INT LAT C SENS LAT, P63; Sunderasan E., 1993, Journal of Natural Rubber Research, V8, P293; SUSSMAN GL, 1995, ANN INTERN MED, V122, P43; TAKESHI YMS, 1995, J ALLERGY CLIN IMMUN, V96, P677; TRUSCOTT W, 1992, P INT LAT C SENS LAT, P65; TSUCHIYA T, 1992, RADIAT PHYS CHEM, V39, P541; TURJANMAA K, 1989, ALLERGY, V44, P181, DOI 10.1111/j.1398-9995.1989.tb02259.x; YIP E, 1993, P INT RUBB TECH C WO; Yip E., 1994, J RUBBER RES, V9, P79	29	1	2	AMER CHEMICAL SOC INC	AKRON	RUBBER DIV UNIV AKRON PO BOX 499, AKRON, OH 44309-0499 USA	0035-9475			RUBBER CHEM TECHNOL	Rubber Chem. Technol.	MAR-APR	2000	73	1					80	88		10.5254/1.3547582		9	Polymer Science	Polymer Science	431UX	WOS:000168651100008		
J	Kitamura, A; Matsui, H; Oda, M				Kitamura, A; Matsui, H; Oda, M			Constraints on the timing of systems tract development with respect to sixth-order (41 ka) sea-level changes: an example from the Pleistocene Omma Formation, Sea of Japan	SEDIMENTARY GEOLOGY			English	Article						sequence stratigraphy; regressive systems tract; Early Pleistocene; ecostratigraphy; planktonic foraminifera; Sea of Japan	QUATERNARY	The middle part of the Omma Formation exposed along the Sea of Japan coast in central Japan comprises 11 sixth-order (41 ka) depositional sequences that were deposited in the inner to outer shelf environments and accumulated during oxygen isotope stages 50 to 28. Warm-water planktonic foraminifera intruded into the Sea of Japan during interglacial periods and were extirpated in the following glacial period. The stratigraphic distribution of these microfossils provides datum that allows the timing of systems tract formation and the degree of truncation at the superjacent ravinement surface to be constrained. The disappearance datum of warm-water planktonic foraminifera demonstrates unequivocally that the regressive systems tract was deposited during falling sea-level. Sixth-order cyclothems of the Omma Formation include the following architectural elements in ascending stratigraphic order: (1) a basal sequence boundary that is superposed on the ravinement surface; (2) a transgressive systems tract (2-5 m thick) consisting of a basal shell bed (0.3 m thick) (a condensed onlap shell bed) and overlying fine- to very fine-grained sandstone; (3) a maximum flooding horizon that coincides with the horizon that has the maximum concentration of sand-size biogenic grains; (4) a highstand systems tract (2-3 m thick) consisting of fine-grained sandstone and sandy siltstone; and (5) a resgressive systems tract (<1 m thick) comprising fine-grained sandstone with a coarsening-upward trend. (C) 2000 Elsevier Science B.V. All rights reserved.	Shizuoka Univ, Fac Sci, Inst Geosci, Shizuoka 4228529, Japan; Univ Tokyo, Inst Geol, Tokyo 1138654, Japan; Kumamoto Univ, Fac Sci, Dept Earth Sci, Kumamoto 8608555, Japan	Kitamura, A (reprint author), Shizuoka Univ, Fac Sci, Inst Geosci, Shizuoka 4228529, Japan.	seakita@ipc.shizuoka.ac.jp					Abbott S.T., 1994, ORBITAL FORCING CYCL, V19, P367; BERGER WH, 1994, GEOLOGY, V22, P463, DOI 10.1130/0091-7613(1994)022<0463:QTSFTO>2.3.CO;2; KITAMURA A, 1994, PALAEOGEOGR PALAEOCL, V112, P345, DOI 10.1016/0031-0182(94)90080-9; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Kitamura A, 1999, PALAEOGEOGR PALAEOCL, V152, P305, DOI 10.1016/S0031-0182(99)00047-4; Beu A, 1998, SEDIMENT GEOL, V122, P129, DOI 10.1016/S0037-0738(98)00102-X; Bruun P., 1962, J WATERWAYS HARBORS, V88, P117; Carter RM, 1998, SEDIMENT GEOL, V122, P165, DOI 10.1016/S0037-0738(98)00104-3; KATOH O., 1996, J OCEANOGR, V52, P491, DOI 10.1007/BF02239051; KITAMURA A, 1995, MEM GEOL SOC JPN, V45, P110; Kitamura A., 1993, J SEDIMENTOL SOC JPN, V38, P67; Kitamura A., 1991, Science Reports of Kanazawa University, V36, P31; Kitamura Akihisa, 1994, Journal of the Geological Society of Japan, V100, P463; Kitamura A., 1990, Journal of the Geological Society of Japan, V96, P19; Kitamura A, 1997, PALAEOGEOGR PALAEOCL, V135, P51, DOI 10.1016/S0031-0182(97)00029-1; KITAMURA A, 1998, JPN SEDIMENT GEOL, V122, P151; Kondo Y, 1998, SEDIMENT GEOL, V122, P109, DOI 10.1016/S0037-0738(98)00101-8; Naish T, 1997, GEOL SOC AM BULL, V109, P978, DOI 10.1130/0016-7606(1997)109<0978:SSOSOK>2.3.CO;2; Ohmura I., 1989, MAGNETOSTRATIGRAPHY, p111 ; Sato Tokiyuki, 1992, P457; Takayama T., 1988, J JPN ASS PET TECHNO, V53, P9; Takemoto Ayumi, 1997, Paleontological Research, V1, P291	22	18	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0037-0738			SEDIMENT GEOL	Sediment. Geol.	MAR 1	2000	131	1-2					67	76		10.1016/S0037-0738(99)00126-8		10	Geology	Geology	295VR	WOS:000085989000005		
J	Ogura, T				Ogura, T			Chemistry of oxygen reduction by cytochrome c oxidase - Resonance Raman spectroscopic study	SEIKAGAKU			Japanese	Article							HYDROGEN-PEROXIDE; PARACOCCUS-DENITRIFICANS; ABSORPTION-SPECTRA; ELECTRON-TRANSFER; 2.8 ANGSTROM; COMPOUND-A; DIOXYGEN; INTERMEDIATE; TEMPERATURE; HEME		Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; CREST, Meguro Ku, Tokyo 1538902, Japan							Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; GIBSON QH, 1963, BIOCHEM J, V86, P541; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; PAULING L, 1964, NATURE, V203, P182, DOI 10.1038/203182b0; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; CHANCE B, 1975, J BIOL CHEM, V250, P9226; GRIFFITH JS, 1956, PROC R SOC LON SER-A, V235, P23, DOI 10.1098/rspa.1956.0062; HAN S, 1990, P NATL ACAD SCI USA, V87, P8408, DOI 10.1073/pnas.87.21.8408; HASHIMOTO S, 1986, P NATL ACAD SCI USA, V83, P2417, DOI 10.1073/pnas.83.8.2417; Kitagawa T, 1997, PROG INORG CHEM, V45, P431; KITAGAWA T, 1994, COORDIN CHEM REV, V135, P685, DOI 10.1016/0010-8545(94)80081-2; KUMAR C, 1984, J BIOL CHEM, V259, P2073; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Mogi T., 1998, J BIOCH MOL BIOL BIO, V2, P79; OGURA T, 1985, BIOCHEMISTRY-US, V24, P7746, DOI 10.1021/bi00347a037; Ogura T, 1996, J AM CHEM SOC, V118, P5443, DOI 10.1021/ja951922i; OGURA T, 1983, J AM CHEM SOC, V105, P7781, DOI 10.1021/ja00364a072; OGURA T, 1989, BIOCHEMISTRY-US, V28, P8022, DOI 10.1021/bi00446a008; OGURA T, 1988, REV SCI INSTRUM, V59, P1316, DOI 10.1063/1.1139716; OGURA T, 1991, B CHEM SOC JPN, V64, P2901, DOI 10.1246/bcsj.64.2901; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OGURA T, 1990, J AM CHEM SOC, V112, P5630, DOI 10.1021/ja00170a032; OLIVEBERG M, 1989, BIOCHIM BIOPHYS ACTA, V977, P322, DOI 10.1016/S0005-2728(89)80087-8; ORII Y, 1988, ANN NY ACAD SCI, V550, P105, DOI 10.1111/j.1749-6632.1988.tb35327.x; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P76, DOI 10.1021/bi9511705; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P8580, DOI 10.1021/bi952096t; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; Sucheta A, 1998, BIOCHEMISTRY-US, V37, P17905, DOI 10.1021/bi981092w; TAKAHASHI S, 1995, J BIOL CHEM, V270, P8405; VANGELDE.BF, 1969, BIOCHIM BIOPHYS ACTA, V189, P1, DOI 10.1016/0005-2728(69)90219-9; Verkhovsky MI, 1996, BIOCHEMISTRY-US, V35, P16241, DOI 10.1021/bi961433a; Verkhovsky MI, 1999, NATURE, V400, P480; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; Wikstrom M., 1981, CYTOCHROME OXIDASE S	39	0	0	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0037-1017			SEIKAGAKU	Seikagaku	MAR	2000	72	3					163	172				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	304FC	WOS:000086471700003		
J	Yamaguchi, H; Nakanishi, H; Nishizawa, NK; Mori, S				Yamaguchi, H; Nakanishi, H; Nishizawa, NK; Mori, S			Induction of the IDI1 gene in Fe-deficient barley roots: A gene encoding a putative enzyme that catalyses the methionine salvage pathway for phytosiderophore production	SOIL SCIENCE AND PLANT NUTRITION			English	Article						barley; Fe-deficiency; iron; methionine salvage pathway; phytosiderophore	DEEP-WATER RICE; IRON-DEFICIENCY; HORDEUM-VULGARE; BIOSYNTHESIS; PLANTS; NICOTIANAMINE; EXPRESSION; GROWTH	IDI1, a cDNA induced by Fe-deficiency, was isolated from Fe-deficient barley roots by differential hybridization screening, IDI1 transcripts in roots increased with Fe-deficiency treatment. IDI1 cDNA encoded a protein with 198 amino acids. The IDI1 protein is homologous to the bacterial protein E-2, which catalyzes the formation of a 2-keto-methylthiobutyric acid in the methionine salvage pathway. IDI1 protein is postulated to be an enzyme that participates in the pathway providing methionine for phytosiderophore production in Fe-deficient barley roots.	Univ Tokyo, Plant Mol Physiol Lab, Tokyo 1138657, Japan; Japan Sci & Technol Corp, CREST, Wako, Saitama 3320012, Japan	Yamaguchi, H (reprint author), Univ Tokyo, Plant Mol Physiol Lab, Tokyo 1138657, Japan.		Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058			YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; MIYAZAKI JH, 1987, PHYSIOL PLANTARUM, V69, P366, DOI 10.1111/j.1399-3054.1987.tb04302.x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORGAN PW, 1962, PHYSIOL PLANTARUM, V15, P420, DOI 10.1111/j.1399-3054.1962.tb08045.x; WALTER A, 1994, PHYSIOL PLANTARUM, V92, P493; ROMHELD V, 1987, PHYSIOL PLANTARUM, V70, P231, DOI 10.1111/j.1399-3054.1987.tb06137.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; HIGUCHI K, 1994, PLANT SOIL, V165, P173, DOI 10.1007/BF00008059; Itai Reiko, 1998, Plant and Cell Physiology, V39, pS147; MA JF, 1995, J BIOL CHEM, V270, P16549; NAITO S, 1988, PLANT MOL BIOL, V11, P109, DOI 10.1007/BF00015664; Nakanishi H, 1999, J EXP BOT, V50, P637, DOI 10.1093/jexbot/50.334.637; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; OKUMURA N, 1991, PLANT MOL BIOL, V17, P531, DOI 10.1007/BF00040651; OKUMURA N, 1994, PLANT MOL BIOL, V25, P705, DOI 10.1007/BF00029608; RASKIN I, 1984, PLANT PHYSIOL, V76, P947, DOI 10.1104/pp.76.4.947; RASKIN I, 1984, PLANTA, V160, P66, DOI 10.1007/BF00392467; ROMHELD V, 1986, IRON TRANSPORT MICRO, P353; Sambrook J., 1989, MOL CLONING LAB MANU; SCHLENK F, 1983, ADV ENZYMOL RAMB, V54, P195; SHOJIMA S, 1989, PLANT CELL PHYSIOL, V30, P673; Suzuki K, 1998, PLANT PHYSIOL, V116, P725, DOI 10.1104/pp.116.2.725; Takagi S, 1976, SOIL SCI PLANT NUTR, V22, P4232; TAKAHASHI M, 1997, PLANT NUTR SUSTAINAB, P279; WRAY JW, 1995, J BIOL CHEM, V270, P3147	29	22	22	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	MAR	2000	46	1					1	9				9	Plant Sciences; Environmental Sciences; Soil Science	Plant Sciences; Environmental Sciences & Ecology; Agriculture	290PM	WOS:000085684600001		
J	Mineta, K; Akahoshi, E; Takahashi, K; Horiguchi, T; Hayashi, H; Ohyama, T; Ikarashi, T; Fujiwara, T; Chino, M				Mineta, K; Akahoshi, E; Takahashi, K; Horiguchi, T; Hayashi, H; Ohyama, T; Ikarashi, T; Fujiwara, T; Chino, M			Localization of MT2a gene promoter expression is different from the site(s) of copper accumulation in the roots of transgenic Arabidopsis thaliana	SOIL SCIENCE AND PLANT NUTRITION			English	Article						Arabidopsis thaliana; copper; electron probe X-ray micro-analysis; beta-glucuronidase; metallothionein	METALLOTHIONEIN-LIKE GENE; HIGHER-PLANTS; TRANSCRIPTION; PETUNIA; FAMILY; TOMATO	Accumulation of mRNA for MT2a, a metallothionein of Arabidopsis thaliana, is known to be upregulated by excess copper (Cu), We compared the localization of the promoter activity of the MT2a gene and the accumulation site(s) of Cu in the roots of transgenic A. thaliana. Open reading frame of the beta-glucuronidase (GUS) gene was fused with the MT2a gene promoter and introduced into A, thaliana, Strong GUS activity was observed in the region near or within the stele in the presence of Cu at a high concentration (high-Cu condition), Electron probe X-ray micro-analysis demonstrated that under high-Cu conditions, Cu accumulated most abundantly in the cortex, where GUS activity was not significantly induced. These results indicate that the sites showing the MT2a promoter activity and Cu accumulation did not coincide with each other, suggesting that Cu is not a direct activator of the MT2a promoter.	Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Niigata Univ, Fac Agr, Niigata 9502181, Japan	Mineta, K (reprint author), Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan.		FUJIWARA, Toru/A-4119-2011; MINETA, Katsuhiko /A-5455-2012	MINETA, Katsuhiko /0000-0002-4727-045X			AKAHOSHI E, 1999, THESIS U TOKYO TOKYO; Clendennen SK, 1997, PLANT PHYSIOL, V115, P463, DOI 10.1104/pp.115.2.463; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Giritch A, 1998, PLANT MOL BIOL, V37, P701, DOI 10.1023/A:1006001701919; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; Choi D, 1996, PLANT PHYSIOL, V112, P353, DOI 10.1104/pp.112.1.353; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Garcia-Hernandez M, 1998, PLANT PHYSIOL, V118, P387, DOI 10.1104/pp.118.2.387; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; ZHOU JM, 1995, MOL GEN GENET, V248, P318, DOI 10.1007/BF02191599; ROBINSON NJ, 1993, BIOCHEM J, V295, P1; RADTKE F, 1993, EMBO J, V12, P1355; HSIEH HM, 1995, PLANT MOL BIOL, V28, P381, DOI 10.1007/BF00020388; JEFFERSON RA, 1987, EMBO J, V6, P3901; Murphy A, 1997, PLANT PHYSIOL, V113, P1293, DOI 10.1104/pp.113.4.1293; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; CHINO M., 1966, Journal of the Science of Soil and Manure, V37, P372; EVANS IM, 1990, FEBS LETT, V262, P29; FordhamSkelton AP, 1997, PLANT MOL BIOL, V34, P659, DOI 10.1023/A:1005836632678; HUIREGTSE JM, 1989, P NATL ACAD SCI USA, V86, P65; IKARASHI T, 1986, SOIL SCI PLANT NUTR, V32, P315; Mezitt LA, 1996, PLANT MOL BIOL, V32, P251, DOI 10.1007/BF00039385; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURPHY A, 1995, PLANT PHYSIOL, V109, P945, DOI 10.1104/pp.109.3.945; Sambrook J., 1989, MOL CLONING LAB MANU; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Whitelaw CA, 1997, PLANT MOL BIOL, V33, P503, DOI 10.1023/A:1005769121822; ZHOU JM, 1994, PLANT CELL, V6, P875	31	3	3	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	MAR	2000	46	1					189	197				9	Plant Sciences; Environmental Sciences; Soil Science	Plant Sciences; Environmental Sciences & Ecology; Agriculture	290PM	WOS:000085684600019		
J	Kuzuhara, Y; Isobe, A; Awazuhara, M; Fujiwara, T; Hayashi, H				Kuzuhara, Y; Isobe, A; Awazuhara, M; Fujiwara, T; Hayashi, H			Glutathione levels in phloem sap of rice plants under sulfur deficient conditions	SOIL SCIENCE AND PLANT NUTRITION			English	Article						glutathione; phloem; rice; sulfate; sulfur deficiency	LONG-DISTANCE TRANSPORT; CHEMICAL-COMPOSITION; METABOLISM; SPRUCE; WHEAT; ROOTS	Glutathione which is an abundant reduced sulfur compound in plants is considered to play important roles in the transmission of the sulfur nutrient status between organs within the plant body and in the long-distance transport of reduced sulfur. We determined the concentrations of glutathione, gamma-glutamylcysteine (gamma-EC), and sulfate in the rice phloem sap collected,by the insect laser technique. Phloem sap was collected from the plants cultured in sulfur-deficient and control solutions. The concentration of glutathione in the rice phloem sap was higher than that of sulfate in both control and sulfur-deficient plants. Under sulfur-deficient condition, the concentration of glutathione in the phloem sap did not decrease, whereas the sulfate concentration decreased significantly. The pattern of changes in gamma-EC concentration was similar to that of glutathione. These data indicate the presence of mechanisms for the maintenance of a constant glutathione concentration in the phloem sap in rice plants under sulfur deficiency, whereas the sulfate concentration was found to be relatively unstable.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	Kuzuhara, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.		FUJIWARA, Toru/A-4119-2011				HAYASHI H, 1986, PLANT CELL PHYSIOL, V27, P1387; Smith FW, 1997, PLANT J, V12, P875, DOI 10.1046/j.1365-313X.1997.12040875.x; Valle EM, 1998, PLANT CELL PHYSIOL, V39, P458; FUKUMORITA T, 1983, SOIL SCI PLANT NUTR, V29, P185; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; KAWABE S, 1980, PLANT CELL PHYSIOL, V21, P1319; SCHUPP R, 1992, BOT ACTA, V105, P180; Bourgis F, 1999, PLANT CELL, V11, P1485, DOI 10.1105/tpc.11.8.1485; MEUWLY P, 1992, PLANT PHYSIOL, V99, P8, DOI 10.1104/pp.99.1.8; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; RENNENBERG H, 1979, PLANTA, V147, P57, DOI 10.1007/BF00384591; HELL R, 1990, PLANTA, V180, P603, DOI 10.1007/BF02411460; Hell R, 1997, PLANTA, V202, P138, DOI 10.1007/s004250050112; HARRINGTON HM, 1980, PLANT PHYSIOL, V65, P151, DOI 10.1104/pp.65.1.151; BELL CI, 1995, J EXP BOT, V46, P73, DOI 10.1093/jxb/46.1.73; BONAS U, 1982, PLANTA, V155, P82, DOI 10.1007/BF00402936; FRENEY JR, 1978, AUST J AGR RES, V29, P727, DOI 10.1071/AR9780727; Lappartient AG, 1996, PLANT PHYSIOL, V111, P147; Lencioni L, 1997, J PLANT NUTR, V20, P405, DOI 10.1080/01904169709365260; Leustek T, 1996, PHYSIOL PLANTARUM, V97, P411, DOI 10.1034/j.1399-3054.1996.970228.x; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; SCHUPP R, 1992, J EXP BOT, V43, P1243, DOI 10.1093/jxb/43.9.1243	22	22	22	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	MAR	2000	46	1					265	270				6	Plant Sciences; Environmental Sciences; Soil Science	Plant Sciences; Environmental Sciences & Ecology; Agriculture	290PM	WOS:000085684600027		
J	Kuramochi, K; Watanabe, H; Kitahara, T				Kuramochi, K; Watanabe, H; Kitahara, T			Synthetic study on oximidines: A concise synthesis of (Z)-enamides	SYNLETT			English	Article						enamide; Curtius rearrangement; isocyanate; DPPA; oximidine	MODIFIED CURTIUS REACTION; CONVENIENT REAGENT	A stereoselective synthesis of (Z)-enamides was achieved by Curtius rearrangement and addition of RLi or RMgBr to isocyanate. Its utility was shown by the construction of the side-chain moiety of oximidines.	Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Kitahara, T (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						SHIOIRI T, 1972, J AM CHEM SOC, V94, P6203, DOI 10.1021/ja00772a052; NINOMIYA K, 1974, TETRAHEDRON, V30, P2151, DOI 10.1016/S0040-4020(01)97352-1; WEINSTOCK J, 1961, J ORG CHEM, V26, P3511, DOI 10.1021/jo01067a604; BENISHAI D, 1965, TETRAHEDRON LETT, P4523; BRETTLE R, 1988, J CHEM SOC PERK T 1, P2185, DOI 10.1039/p19880002185; BROSSI A, 1977, ORG SYNTH, V56, P3; HOSOKAWA T, 1992, TETRAHEDRON LETT, V33, P6643, DOI 10.1016/S0040-4039(00)61007-9; Kim JW, 1999, J ORG CHEM, V64, P153, DOI 10.1021/jo9814997; KRAISER C, 1971, J ORG SYNTH, V51, P48; LEN GR, 1978, SYNTHESIS-STUTTGART, P489; ROSENKRANZ G, 1956, J ORG CHEM, V21, P520, DOI 10.1021/jo01111a009; SMITH MB, 1992, CHEM LETT, P247, DOI 10.1246/cl.1992.247; STILLE JK, 1980, J ORG CHEM, V45, P2139, DOI 10.1021/jo01299a021; Taber DF, 1998, J AM CHEM SOC, V120, P13285, DOI 10.1021/ja981700v; ZIEGENBEIN W, 1957, CHEM BER-RECL, V90, P2291, DOI 10.1002/cber.19570901026	15	59	59	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0936-5214			SYNLETT	Synlett	MAR	2000		3					397	399				3	Chemistry, Organic	Chemistry	300LM	WOS:000086254500034		
J	Matsuo, J; Odashima, K; Kobayashi, S				Matsuo, J; Odashima, K; Kobayashi, S			Gallium nonafluorobutanesulfonate as an efficient catalyst in Friedel-Crafts acylation	SYNLETT			English	Article						Friedel-Crafts reaction; catalyst; gallium; acylation	LEWIS-ACID CATALYSTS; AROMATIC-COMPOUNDS; TRIFLUOROMETHANESULFONIC ACID; HAFNIUM TRIFLATE; SYSTEM; ANHYDRIDES; CHLORIDES	Catalytic Friedel-Crafts acylation of even inactivated benzenes has been successfully carried out using a gallium compound. In the presence of a catalytic amount of gallium nonafluorobutanesulfonate (1-5 mol%), aromatics including inactivated benzenes such as fluorobenzene, chlorobenzene, and dichlorobenzene reacted with carboxylic acid chlorides or anhydrides to afford the corresponding aromatic ketones in good to excellent yields. Contrary to traditional understandings, catalytic Friedel-Crafts acylation was successfully carried out using the group 13 compound.	Univ Tokyo, Grad Sch Pharmaceut Sci, CREST, Japan Sci & Technol Corp,Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, CREST, Japan Sci & Technol Corp,Bunkyo Ku, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				Desmurs JR, 1997, TETRAHEDRON LETT, V38, P8871, DOI 10.1016/S0040-4039(97)10401-4; Kobayashi S, 1998, TETRAHEDRON LETT, V39, P4697, DOI 10.1016/S0040-4039(98)00881-8; OLAH GA, 1988, J AM CHEM SOC, V110, P2560, DOI 10.1021/ja00216a032; Effenberger F, 1996, J AM CHEM SOC, V118, P12572, DOI 10.1021/ja9624331; EFFENBERGER F, 1988, CHEM BER-RECL, V121, P125, DOI 10.1002/cber.19881210119; EFFENBERGER F, 1988, CHEM BER-RECL, V121, P117, DOI 10.1002/cber.19881210118; EFFENBERGER F, 1983, CHEM BER-RECL, V116, P1195, DOI 10.1002/cber.19831160331; EFFENBER.F, 1972, ANGEW CHEM INT EDIT, V11, P300, DOI 10.1002/anie.197203001; HACHIYA I, 1995, TETRAHEDRON LETT, V36, P409, DOI 10.1016/0040-4039(94)02221-V; HACHIYA I, 1995, B CHEM SOC JPN, V68, P2053, DOI 10.1246/bcsj.68.2053; HANAMOTO T, 1997, B CHEM SOC JPN, V70, P1241; HARADA T, 1991, SYNTHESIS-STUTTGART, P1216; Heaney H., 1991, COMPREHENSIVE ORGANI, V2, P733; Izumi J, 1996, CHEM LETT, P739, DOI 10.1246/cl.1996.739; KAWADA A, 1994, SYNLETT, P545; KAWADA A, 1993, J CHEM SOC CHEM COMM, P1157, DOI 10.1039/c39930001157; Kawada A, 1996, CHEM COMMUN, P183, DOI 10.1039/cc9960000183; KOBAYASHI H, 1995, CHEM LETT, P307, DOI 10.1246/cl.1995.307; Mikami K, 1996, SYNLETT, P171; MUKAIYAMA T, 1991, CHEM LETT, P1059, DOI 10.1246/cl.1991.1059; MUKAIYAMA T, 1992, CHEM LETT, P435, DOI 10.1246/cl.1992.435; MUKAIYAMA T, 1986, CHEM LETT, P165, DOI 10.1246/cl.1986.165; Nishikido J, 1998, SYNLETT, P1347; Olah G., 1963, FRIEDEL CRAFTS RELAT, VI-IV; Olah G. A., 1973, FRIEDEL CRAFTS CHEM; PEARSON DE, 1972, SYNTH-INT J METHODS, P533; PIVSAART S, 1994, J CHEM SOC PERK T 1, P1703, DOI 10.1039/p19940001703; Repichet S, 1998, EUR J ORG CHEM, P2743; ROBERTS RMG, 1983, TETRAHEDRON, V39, P137, DOI 10.1016/S0040-4020(01)97639-2; SUZUKI K, 1993, B CHEM SOC JPN, V66, P3729, DOI 10.1246/bcsj.66.3729	30	52	53	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0936-5214			SYNLETT	Synlett	MAR	2000		3					403	405				3	Chemistry, Organic	Chemistry	300LM	WOS:000086254500036		
J	Tokuyama, H; Kaburagi, Y; Chen, XQ; Fukuyama, T				Tokuyama, H; Kaburagi, Y; Chen, XQ; Fukuyama, T			Synthesis of 2,3-disubstituted indoles by palladium-mediated coupling of 2-iodoindoles	SYNTHESIS-STUTTGART			English	Article						2-iodoindole; 2-stannylindole; isonitrile; radical cyclization; palladium-mediated coupling		N-Unprotected 2-iodoindoles are synthesized by treatment of 2-stannylindoles with iodine, which in turn are prepared by tin-mediated radical cyclization of 2-alkenylphenylisocyanides. Palladium-catalyzed coupling reactions of N-unprotected 2-iodoindoles with terminal acetylenes, terminal olefins, carbonylation, and the Suzuki coupling reaction with phenyl berate proceed smoothly to furnish the corresponding 2,3-disubstituted indoles in good to excellent yields.	Univ Tokyo, Japan Sci & Technol Corp, CREST, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan	Fukuyama, T (reprint author), Univ Tokyo, Japan Sci & Technol Corp, CREST, Grad Sch Pharmaceut Sci,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						PINDUR U, 1988, J HETEROCYCLIC CHEM, V25, P1; GASSMAN PG, 1974, J AM CHEM SOC, V96, P5495, DOI 10.1021/ja00824a028; FUKUYAMA T, 1994, J AM CHEM SOC, V116, P3127, DOI 10.1021/ja00086a054; Kobayashi Y, 1998, J HETEROCYCLIC CHEM, V35, P1043; Saxton J. E., 1983, INDOLES 4; Sundberg R. J., 1996, INDOLES; TAKAGI K, 1975, B CHEM SOC JPN, V48, P3298, DOI 10.1246/bcsj.48.3298; WALLOW TI, 1994, J ORG CHEM, V59, P5034, DOI 10.1021/jo00096a056	8	45	45	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0039-7881			SYNTHESIS-STUTTGART	Synthesis	MAR	2000		3					429	434				6	Chemistry, Organic	Chemistry	294EG	WOS:000085897900016		
J	Smith, MTS; Umenai, T				Smith, MTS; Umenai, T			Smoking among Buddhist monks in Phnom Penh, Cambodia	TOBACCO CONTROL			English	Letter									Univ Tokyo, Fac Med, Grad Sch Int Hlth, Dept Hlth Policy & Planning, Tokyo 113, Japan	Smith, MTS (reprint author), Univ Tokyo, Fac Med, Grad Sch Int Hlth, Dept Hlth Policy & Planning, Tokyo 113, Japan.						CHITANONDH H, 1991, TOBACCO USE UPDATE; Smith M, 1998, J Epidemiol, V8, P85; SWADDIWUDHIPONG W, 1993, INT J EPIDEMIOL, V22, P660, DOI 10.1093/ije/22.4.660; 1993, MMWR MORB MORTAL WKL, V42, P367	4	6	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563			TOB CONTROL	Tob. Control	MAR	2000	9	1					111	111		10.1136/tc.9.1.111		1	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	291DG	WOS:000085718400028		
J	Kim, JS; Kubota, H; Nam, SY; Doi, K; Saegusa, J				Kim, JS; Kubota, H; Nam, SY; Doi, K; Saegusa, J			Expression of cytokines and proteases in mast cells in the lesion of subcapsular cell hyperplasia in mouse adrenal glands	TOXICOLOGIC PATHOLOGY			English	Article						mast cell; cytokine; protease; subcapsular cell hyperplasia; adrenal gland; mouse	FIBROBLAST GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE CELLS; C-KIT LIGAND; MESSENGER-RNA; TNF-ALPHA; ENDOTHELIAL-CELLS; TRYPTASE; PROLIFERATION; HEPARIN	To examine the possible roles of mast cells in the pathogenesis of subcapsular cell hyperplasia (SCH) in the adrenal glands of mice, we investigated the expression of certain cytokines, including stem cell factor (SCF), tumor necrosis factor-alpha (TNF-alpha), nerve growth factor (NGF), and basic fibroblast growth factor (bFGF), and mast cell-specific proteases, such as mouse mast cell protease (mMCP)-2 and mMCP-7. The mRNAs of c-kit (SCF receptor), bFGF TNF-alpha, mMCP-2, and mMCP-7 were expressed in both the adrenal glands and the ml,use bone marrow-derived mast cells (mBMMCs). Immunoreactivities for cytokines (SCE NGF, TNF-alpha) and proteases (mMCP-2, mMCP-7) were exclusively located in the mast cells in SCH lesions. The immature mBMMCs did not express the mRNAs of SCF and NGF, whereas the mast cells in the SCH lesions showed the expression of SCF and NGF These findings suggest that SCH may provide a favorable microenvironment for functional maturation of mast cells to produce SCF and NGF, and the mast cells in SCH lesions synthesize SCF and NGF and may, in part, use them in autocrine fashion for their survival and differentiation. Therefore, mast cells may contribute to SCH pathogenesis by producing a range of multifunctional cytokines and proteases.	Univ Tokyo, Dept Vet Pathol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Doi, K (reprint author), Univ Tokyo, Dept Vet Pathol, Grad Sch Agr & Life Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	akunio@hongo.ecc.u-tokyo.ac.jp					Abraham SN, 1997, INFECT IMMUN, V65, P3501; ADACHI S, 1995, EXP HEMATOL, V23, P58; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; HORIGOME K, 1994, J BIOL CHEM, V269, P2695; IEMURA A, 1994, AM J PATHOL, V144, P321; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.immunol.7.1.59; DASTYCH J, 1994, J IMMUNOL, V152, P213; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; QU ZH, 1995, AM J PATHOL, V147, P564; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U; KITAMURA Y, 1978, BLOOD, V52, P447; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033; Cairns JA, 1996, J IMMUNOL, V156, P275; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; GALLI SJ, 1990, LAB INVEST, V62, P5; GORDON JR, 1994, J EXP MED, V180, P2027, DOI 10.1084/jem.180.6.2027; Compton SJ, 1998, J IMMUNOL, V161, P1939; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; GORDON JR, 1990, IMMUNOL TODAY, V11, P458, DOI 10.1016/0167-5699(90)90176-A; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; AYE MT, 1992, EXP HEMATOL, V20, P523; BATTEGAY EJ, 1995, J IMMUNOL, V154, P6040; BROWN JK, 1995, AM J RESP CELL MOL, V13, P227; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575; CLAMAN HN, 1993, MAST CELL HLTH DIS, P653; DUNN TB, 1970, J NATL CANCER I, V44, P1323; Dunn T B, 1979, IARC Sci Publ, V23, P475; ENERBACK L, 1974, HISTOCHEMISTRY, V42, P301, DOI 10.1007/BF00492678; FACCINI JM, 1990, MOUSE HISTOPATHOLOGY, P171; FOREMAN JC, 1993, IMMUNOPHARMACOLOGY M, P1; GALLI SJ, 1991, CURR OPIN IMMUNOL, V3, P865, DOI 10.1016/S0952-7915(05)80005-6; Galli SJ, 1993, ADV IMMUNOL, V55, P1, DOI 10.1016/S0065-2776(08)60508-8; Galli Stephen J., 1995, International Archives of Allergy and Immunology, V107, P51; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; GHILDYAL N, 1993, J IMMUNOL, V151, P3206; Goodman DG, 1983, MONOGRAPHS PATHOLOGY, P66; Gospodarowicz Denis, 1989, Critical Reviews in Oncogenesis, V1, P1; HAFEZ MM, 1988, CANCER RES, V48, P3765; Hunt JE, 1996, J BIOL CHEM, V271, P2851; KAWAMOTO K, 1995, BLOOD, V86, P4638; Kendall JC, 1997, J ALLERGY CLIN IMMUN, V99, P113; Kim JS, 1997, EXP ANIM TOKYO, V46, P303, DOI 10.1538/expanim.46.303; Kim JS, 1997, EXP ANIM TOKYO, V46, P103, DOI 10.1538/expanim.46.103; KLAGSBRUN M, 1992, CANC BIOL, V3, P81; LESLIE CC, 1990, AM J RESP CELL MOL, V2, P99; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; MATSUDA H, 1991, J EXP MED, V174, P7, DOI 10.1084/jem.174.1.7; Meininger C J, 1992, Semin Cancer Biol, V3, P73; NADEL JA, 1991, ANN NY ACAD SCI, V629, P319; NAKAHATA T, 1982, BLOOD, V60, P352; NORRBY K, 1994, MICROVASC RES, V48, P96, DOI 10.1006/mvre.1994.1041; NORRBY K, 1984, CELL TISSUE RES, V235, P339; Schollmeier K, 1990, Am J Respir Cell Mol Biol, V3, P11; SCHWARTZ LB, 1994, METHOD ENZYMOL, V244, P88; WILLIAMS N, 1992, BLOOD, V79, P58; WOOLLEY GW, 1950, RECENT PROG HORM RES, V5, P383	59	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	MAR-APR	2000	28	2					297	303		10.1177/019262330002800209		7	Pathology; Toxicology	Pathology; Toxicology	298NP	WOS:000086146300009		
J	Matsui, T; Yamamori, K; Furukawa, K; Kono, M				Matsui, T; Yamamori, K; Furukawa, K; Kono, M			Purification and some properties of a tetrodotoxin binding protein from the blood plasma of kusafugu, Takifugu niphobles	TOXICON			English	Article							ANHYDROTETRODOTOXIN	A tetrodotoxin binding protein has been purified from the plasma of the puffer fish kusafugu, Takifugu niphobles, through DEAF-cellulose treatment, ammonium sulfate fractionation, Sephadex gelfiltrations and Sephacryl S-200 and Cellulofine A-500 column chromatography, Final purification by HPLC on a TSK G-3000 SL column yielded a protein which showed only a. single protein peak, The molecular weight of the protein was estimated to be 116,000 and 91,000 by SDS-PAGE and mass spectrometry, respectively. A blast search on the amino-terminal amino acid sequence of the purified protein revealed that the protein had no homology to any other protein on data base. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Kitasato Univ, Sch Fisheries Sci, Sanriku, Iwate 0220101, Japan; Univ Tokyo, Fac Agr, Fisheries Res Lab, Shizuoka 4310201, Japan	Matsui, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.						MATSUI T, 1989, NIPPON SUISAN GAKK, V55, P2199; YASUMOTO T, 1985, AGR BIOL CHEM TOKYO, V49, P3077; YASUMOTO T, 1986, AGR BIOL CHEM TOKYO, V50, P793; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUI T, 1990, NIPPON SUISAN GAKK, V56, P705; NOGUCHI T, 1986, J BIOCHEM-TOKYO, V99, P311	7	50	53	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	MAR	2000	38	3					463	468		10.1016/S0041-0101(99)00166-X		6	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	261ND	WOS:000084014500013		
J	Uchida, H; Tanaka, H; Kitoh, Y; Yanagisawa, K; To, H; Tago, K; Mizuta, K; Fujimura, A; Tominaga, S; Hashizume, K; Kobayashi, E				Uchida, H; Tanaka, H; Kitoh, Y; Yanagisawa, K; To, H; Tago, K; Mizuta, K; Fujimura, A; Tominaga, S; Hashizume, K; Kobayashi, E			Mechanisms of immunomodulation induced by blood transfusion: Identification of humoral factors	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	35th Annual Congress of the Japan-Society-for-Transplantation	SEP 15-16, 1999	TSUKUBA, JAPAN	Japan Soc Transplantat			HLA		Jichi Med Sch, Ctr Mol Med, Div Organ Replacement Res, Tochigi 3290498, Japan; Jichi Med Sch, Dept Clin Pharmacol, Tochigi, Japan; Jichi Med Sch, Dept Biochem, Tochigi, Japan; Univ Tokyo, Fac Med, Dept Pediat Surg, Tokyo 113, Japan	Kobayashi, E (reprint author), Jichi Med Sch, Ctr Mol Med, Div Organ Replacement Res, Tochigi 3290498, Japan.		UCHIDA, Hiroo/E-4437-2015	UCHIDA, Hiroo/0000-0002-1818-6697			BARKLEY SC, 1987, TRANSPLANTATION, V44, P30, DOI 10.1097/00007890-198707000-00008; Lord R, 1995, Transpl Immunol, V3, P174, DOI 10.1016/0966-3274(95)80045-X; Toungouz M, 1996, TRANSPLANTATION, V61, P497, DOI 10.1097/00007890-199602150-00031; UCHIDA H, 1998, P JPN IMMUNOL, V28, P370; WOOD KJ, 1985, TRANSPLANTATION, V39, P56, DOI 10.1097/00007890-198501000-00006	5	2	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	MAR	2000	32	2					255	256		10.1016/S0041-1345(99)00948-3		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	294UN	WOS:000085928900006		
J	Kozaki, K; Sakurai, E; Kubota, K; Iwamoto, H; Hama, K; Narumi, Y; Uchiyama, M; Kikuchi, K; Degawa, H; Matsuno, N; Kozaki, M; Nagao, T				Kozaki, K; Sakurai, E; Kubota, K; Iwamoto, H; Hama, K; Narumi, Y; Uchiyama, M; Kikuchi, K; Degawa, H; Matsuno, N; Kozaki, M; Nagao, T			Prediction of kidney nonfunction after transplantation with machine perfusion preservation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	35th Annual Congress of the Japan-Society-for-Transplantation	SEP 15-16, 1999	TSUKUBA, JAPAN	Japan Soc Transplantat			PROCUREMENT; DONORS		Univ Tokyo, Hachioji Med Ctr, Dept Surg 5, Hachioji, Tokyo 1730998, Japan; Univ Tokyo, Hachioji Med Ctr, HLA Lab Ctr, Hachioji, Tokyo, Japan	Kozaki, K (reprint author), Univ Tokyo, Hachioji Med Ctr, Dept Surg 5, 1163 Tatemachi, Hachioji, Tokyo 1730998, Japan.						GRUNDMANN R, 1975, SURGERY, V77, P451; BELZER FO, 1967, LANCET, V2, P536; BELZER FO, 1972, TRANSPLANTATION, V14, P363, DOI 10.1097/00007890-197209000-00013; COLLINS GM, 1973, TRANSPLANTATION, V16, P378; GRUNDMAN.R, 1974, SURGERY, V75, P178; KOZAKI K, 1995, TRANSPLANT P, V27, P757; KOZAKI M, 1991, TRANSPLANT P, V23, P2575; KOZAKI M, 1992, TRANSPLANT P, V24, P1271; MATSUNO N, 1993, TRANSPLANT P, V25, P1516; MATSUNO N, 1993, TRANSPLANT P, V25, P3095; TOLEDOPE.LH, 1973, TRANSPLANTATION, V16, P385; TOLKEDOPEREYRA LH, 1978, DIALYSIS TRANSPLANT, V7, P976	12	11	11	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	MAR	2000	32	2					275	276		10.1016/S0041-1345(99)00955-0		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	294UN	WOS:000085928900013		
J	Tanaka, M				Tanaka, M			Journal bearing performance under starved lubrication	TRIBOLOGY INTERNATIONAL			English	Article; Proceedings Paper	5th International Tribology Conference (AUSTRIB 98)	DEC 06-09, 1998	BRISBANE, AUSTRALIA			hydrodynamic lubrication; starved lubrication; journal bearing		The hydrodynamic performance of a journal bearing under starved lubrication conditions is studied theoretically and experimentally. When lubricant is supplied to a journal bearing from an oil groove at an insufficient oil flow rate, the hydrodynamic oil film cannot cover the full width of the bearing at the inlet of the convergent bearing clearance, and the covered width increases gradually with the decrease in film thickness in the circumferential direction. This phenomenon affects the static and dynamic performance of the journal bearing. The oil film boundary in the bearing clearance is calculated numerically for a constant load and a constant speed under the assumption of laminar, iso-viscous lubrication. Measurements are in good agreement with predictions. Some more calculations of journal centre loci are given. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Dept Mech Engn & Engn Synth, Bunkyo Ku, Tokyo 1138656, Japan	Tanaka, M (reprint author), Univ Tokyo, Dept Mech Engn & Engn Synth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tanaka@ingram.t.u-tokyo.ac.jp					ARTILES A, 1985, J TRIBOL-T ASME, V107, P1; BONNEAU D, 1982, ASME T, V105, P173; TANAKA M, 1991, J TRIBOL-T ASME, V113, P615, DOI 10.1115/1.2920668	3	11	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X			TRIBOL INT	Tribol. Int.	MAR-APR	2000	33	3-4					259	264		10.1016/S0301-679X(00)00040-2		6	Engineering, Mechanical	Engineering	343YC	WOS:000088729700016		
J	Morita, T; Kurosawa, MK; Higuchi, T				Morita, T; Kurosawa, MK; Higuchi, T			A cylindrical micro-ultrasonic motor (stator transducer size: 1.4 mm in diameter and 5.0 mm long)	ULTRASONICS			English	Article; Proceedings Paper	1st Joint Meeting Ultrasonics International Conference/World Congress on Ultrasonics (UI 99/WCU 99)	JUN 29-JUL 01, 1999	TECH UNIV DENMARK, LYNGBY, DENMARK	Tech Univ Denmark	TECH UNIV DENMARK	cylindrical transducer; equivalent circuit; hydrothermal method; micro-actuator; PZT thin film; ultrasonic motor	PZT THIN-FILM; ZIRCONATE-TITANATE PZT; HYDROTHERMAL METHOD	Ultrasonic motors are suitable for a micro-actuator because of a direct drive, no brake and their simple construction; In order to fabricate micro-ultrasonic motors, a piezoelectric thin film is essential. In this study, a hydrothermal method was adopted to deposit a PZT thin film. The dimensions of the stator transducer were: outer diameter, 1.4 mm; inner diameter, 1.2 mm; and length, 5.0 mm. The resonance frequency of the stator transducer was 227 kKz, and the vibration amplitude was 58 nm(p-p) at an input voltage of 4.0 Vp-p. The maximum revolution speed was 680 rpm, and the maximum starting torque was 0.67 mu Nm. The experimental conditions were 20 Vp-p and 5.3 mN pre-load. The motor property versus scale was investigated using an equivalent circuit. The calculated results indicated that the output torque of the 100 mu M diameter motor was 27 nNm. (C) 2000 Published by Elsevier Science B.V. All rights reserved.	RIKEN, Inst Phys & Chem Res, Div Fundamental Technol Dev, Wako, Saitama 3810198, Japan; Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan; Univ Tokyo, Grad Sch Engn, Dept Precis Machinery Engn, Bunkyo Ku, Tokyo 113, Japan	Morita, T (reprint author), RIKEN, Inst Phys & Chem Res, Div Fundamental Technol Dev, Hirosawa 2-1, Wako, Saitama 3810198, Japan.	tmorita@postman.riken.go.jp	Kurosawa, Minoru/L-7902-2014	Kurosawa, Minoru/0000-0001-6750-9141			Morita T, 1995, SENSOR ACTUAT A-PHYS, V50, P75, DOI 10.1016/0924-4247(96)80087-2; SHIMOMURA K, 1991, JPN J APPL PHYS 1, V30, P2174, DOI 10.1143/JJAP.30.2174; Morita T, 1998, IEEE T ULTRASON FERR, V45, P1178, DOI 10.1109/58.726441; MURALT P, 1995, SENSOR ACTUAT A-PHYS, V48, P157, DOI 10.1016/0924-4247(95)00994-9; Flynn A. M., 1992, Journal of Microelectromechanical Systems, V1, DOI 10.1109/84.128055; FLYNN AM, 1990, P IEEE ULTR S, P1163; Morita T, 1999, JPN J APPL PHYS 1, V38, P3347, DOI 10.1143/JJAP.38.3347; Morita T, 1997, JPN J APPL PHYS 1, V36, P2998, DOI 10.1143/JJAP.36.2998; NAKAMURA K, 1995, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE PROCEEDINGS, 1995, P374; Tani K., 1998, Proceedings MEMS 98. IEEE. Eleventh Annual International Workshop on Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.98CH36176), DOI 10.1109/MEMSYS.1998.659789; TRIMMER W, 1989, SENSOR ACTUATOR, V20, P17, DOI 10.1016/0250-6874(89)87097-0	11	28	43	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X	1874-9968		ULTRASONICS	Ultrasonics	MAR	2000	38	1-8					33	36		10.1016/S0041-624X(99)00141-9		4	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	307PQ	WOS:000086662100007		
J	Takasaki, M; Kurosawa, MK; Higuchi, T				Takasaki, M; Kurosawa, MK; Higuchi, T			Optimum contact conditions for miniaturized surface acoustic wave linear motor	ULTRASONICS			English	Article; Proceedings Paper	1st Joint Meeting Ultrasonics International Conference/World Congress on Ultrasonics (UI 99/WCU 99)	JUN 29-JUL 01, 1999	TECH UNIV DENMARK, LYNGBY, DENMARK	Tech Univ Denmark	TECH UNIV DENMARK	linear motor; micro-actuator; miniaturization; surface acoustic wave; ultrasonic motor		This paper reports the successful operation of a 70 MHz driving surface acoustic wave (SAW) linear motor with a miniaturized stator transducer. This paper also deals with an investigation into an optimized slider design for the miniaturized SAW linear motor. The performance of three silicon type sliders, with different projection size, was compared. Output forces of the three sliders were measured with change of pre-load. It was found that the slider with smaller projection tended to produce greater output force. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan	Takasaki, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Precis Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.		Kurosawa, Minoru/L-7902-2014	Kurosawa, Minoru/0000-0001-6750-9141			KUROSAWA MK, 1998, US9833 IEICE, P55; OSAKABE N, 1998, P IEEE WORKSH MICR E; TAKASAKI M, 1998, P IEEE ULTR S SEND J, P679	3	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X			ULTRASONICS	Ultrasonics	MAR	2000	38	1-8					51	53		10.1016/S0041-624X(99)00093-1		3	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	307PQ	WOS:000086662100011		
J	Yamamoto, K; Kokubo, A; Sakai, K; Takagi, K				Yamamoto, K; Kokubo, A; Sakai, K; Takagi, K			Nonlinear piezoelectricity in PZT ceramics for generating ultrasonic phase conjugate waves	ULTRASONICS			English	Article; Proceedings Paper	1st Joint Meeting Ultrasonics International Conference/World Congress on Ultrasonics (UI 99/WCU 99)	JUN 29-JUL 01, 1999	TECH UNIV DENMARK, LYNGBY, DENMARK	Tech Univ Denmark	TECH UNIV DENMARK	nonlinear piezoelectricity; phase conjugate wave; PZNT91/9 piezoelectric single crystal; PZT ceramics	CONNECTION; BUBBLES	We have succeeded in the generation of acoustic phase conjugate waves with nonlinear PZT piezoelectric ceramics and applied them to ultrasonic imaging systems. Our aim is to make a phase conjugator with 100% efficiency. For this purpose, it is important to clarify the mechanism of acoustic phase conjugation through nonlinear piezoelectricity. The process is explained by the parametric interaction via the third-order nonlinear piezoelectricity between the incident acoustic wave at angular frequency omega and the pump electric field at 2 omega. We solved the coupling equations including the third-ordered nonlinear piezoelectricity and theoretically derived the amplitude efficiency of the acoustic phase conjugation. We compared the efficiencies between the theoretical and experimental values for PZT ceramics with eight different compositions. Pb[(Zn1/3Nb2/3)(1-x)Ti-X]O-3 (X = 0.09, PZNT91/9) piezoelectric single crystals have been investigated for high-performance ultrasonic transducer application, because these have large piezoelectric constants, high electrical-mechanical coupling factors and high dielectric constants. We found that they have third-order nonlinear piezoelectric constants much larger than PZT and are hopeful that the material as a phase conjugator has over 100% efficiency. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Yamamoto, K (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						Shimanuki S, 1998, JPN J APPL PHYS 1, V37, P3382, DOI 10.1143/JJAP.37.3382; KUWATA J, 1982, JPN J APPL PHYS 1, V21, P1298, DOI 10.1143/JJAP.21.1298; BUNKIN FV, 1983, SOV PHYS ACOUST, V28, P440; Bunkin F. V., 1981, Soviet Technical Physics Letters, V7; CHO Y, 1993, REV SCI INSTRUM, V64, P1244, DOI 10.1063/1.1144124; FINK M, 1992, IEEE T ULTRASON FERR, V39, P555, DOI 10.1109/58.156174; OHNO M, 1999, IN PRESS J ACOUST SO; ZELDOVIC.BY, 1972, JETP LETT-USSR, V15, P109; PREOBRAZHENSKY V, 1996, P IEEE ULTR S, V1, P889; SATO T, 1989, ACOUST IMAGING, V17, P361; VLASOV DV, 1983, SOV PHYS ACOUST+, V29, P69; Yamamoto K, 1996, JPN J APPL PHYS 1, V35, P3210, DOI 10.1143/JJAP.35.3210; ZABOLOTSKAYA EA, 1984, SOV PHYS ACOUST+, V30, P462	13	3	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X			ULTRASONICS	Ultrasonics	MAR	2000	38	1-8					830	833		10.1016/S0041-624X(99)00070-0		4	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	307PQ	WOS:000086662100166		
J	Funakoshi, Y; Nakayama, H; Uetsuka, K; Nishimura, R; Sasaki, N; Doi, K				Funakoshi, Y; Nakayama, H; Uetsuka, K; Nishimura, R; Sasaki, N; Doi, K			Cellular proliferative and telomerase activity in canine mammary gland tumors	VETERINARY PATHOLOGY			English	Article						dog; mammary gland tumor; PCNA; telomerase activity; TUNEL	NUCLEAR ANTIGEN PCNA; HUMAN BREAST-CANCER; PROGNOSIS; CELLS; EXPRESSION; 19A2	In canine mammary tumors, we examined the telomerase activity, proliferative activity by proliferative cell nuclear antigen (PCNA) immunohistochemistry, and percentage of apoptotic cells by the deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) method. The relationship between these measures and histopathologic malignancy was also investigated. PCNA index was highest in malignant tumors (adenocarcinoma: 27.0%; malignant mixed tumor: 15.7%), followed by benign tumors (adenoma: 4.4%; benign mixed tumor: 5.3%), hyperplasia (2.1%), and normal mammary gland (0.9%). In adenoma and adenocarcinoma, papillary and solid types showing higher cellularity tended to have higher PCNA indices than did cystic and tubular types. Although the TUNEL index was <1% in all cases, the relationship between this measure and histopathologic diagnosis showed the same tendency as observed in PCNA immunostaining. Telomerase activity was detectable in all adenomas, benign mixed tumors, and adenocarcinomas examined. In contrast, all normal mammary glands, hyperplasias, and malignant mixed tumors were negative for telomerase. Relative telomerase activity (RTA) of adenocarcinoma (56.5) was significantly higher than that of adenoma (27.8) and benign mixed tumor (33.9), and a significant positive correlation (P < 0.001) was noted between RTA and PCNA index. No significant correlations were noted between either PCNA or TUNEL index and clinical features such as metastasis and tumor diameter. PCNA index and telomerase activity may be useful markers for judging malignancy of canine mammary tumors.	Univ Tokyo, Grad Sch Agr & Life sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life sci, Dept Vet Sci, Tokyo 1138657, Japan	Doi, K (reprint author), Univ Tokyo, Grad Sch Agr & Life sci, Dept Vet Pathol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Wright WE, 1996, DEV GENET, V18, P173; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Sugino T, 1996, INT J CANCER, V69, P301, DOI 10.1002/(SICI)1097-0215(19960822)69:4<301::AID-IJC11>3.0.CO;2-8; Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116; Chiu CP, 1996, STEM CELLS, V14, P239; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Hoos A, 1998, INT J CANCER, V79, P8, DOI 10.1002/(SICI)1097-0215(19980220)79:1<8::AID-IJC2>3.0.CO;2-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Biller BJ, 1998, AM J VET RES, V59, P1526; BOSTOCK DE, 1992, VET PATHOL, V29, P381; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BRODEY RS, 1983, J AM ANIM HOSP ASSOC, V19, P61; Clark GM, 1997, J NATL CANCER I, V89, P1874, DOI 10.1093/jnci/89.24.1874; HE W, 1994, BIOTECH HISTOCHEM, V69, P203, DOI 10.3109/10520299409106288; HELLMEN E, 1993, VET PATHOL, V30, P20; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LIPPONEN P, 1994, EUR J CANCER, V30A, P2068, DOI 10.1016/0959-8049(94)00342-3; Lohr CV, 1997, VET PATHOL, V34, P212; Moulton JE, 1990, TUMORS DOMESTIC ANIM, V3rd, P518; NARITA T, 1993, JPN J CLIN ONCOL, V23, P20; Nawaz S, 1997, AM J CLIN PATHOL, V107, P542; PREZIOSI R, 1995, J COMP PATHOL, V113, P301, DOI 10.1016/S0021-9975(05)80117-3; SIITONEN SM, 1993, AM J PATHOL, V142, P1081; Yamagami T, 1996, J VET MED SCI, V58, P1079; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	29	53	55	AMER COLL VET PATHOLOGIST	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0300-9858			VET PATHOL	Vet. Pathol.	MAR	2000	37	2					177	183		10.1354/vp.37-2-177		7	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	291UL	WOS:000085754600008		
J	Uchida, K; Kaneko, T; Miyazaki, H; Hasegawa, S; Hirano, T				Uchida, K; Kaneko, T; Miyazaki, H; Hasegawa, S; Hirano, T			Excellent salinity tolerance of Mozambique tilapia (Oreochromis mossambicus): Elevated chloride cell activity in the branchial and opercular epithelia of the fish adapted to concentrated seawater	ZOOLOGICAL SCIENCE			English	Article							MITOCHONDRIA-RICH CELLS; CHUM SALMON FRY; LASER-SCANNING MICROSCOPY; EEL ANGUILLA-ANGUILLA; ATPASE ALPHA-SUBUNIT; FRESH-WATER; K+-ATPASE; FUNDULUS-HETEROCLITUS; EURYHALINE TELEOST; GILL EPITHELIUM	Changes in morphology and cellular activity of the chloride cells in branchial and opercular epithelia were examined in tilapia, Oreochromis mossambicus, adapted to fresh water (FW), seawater (SW) and concentrated SW (180% SW). The tilapia are adaptable to a wide range of salinity, maintaining the plasma osmolality within physiological levels. Gill Na+, K+-ATPase activity was remarkably increased in response to elevated environmental salinity. Using immunocytochemical staining with an antiserum specific for cx-subunit of Na+, K+-ATPase, chloride cells were detected on the afferent half of the filament epithelia. The size of immunoreactive chloride cells was twice larger in SW and four times larger in 180% SW than in FW. Confocal laser scanning microscopic observations revealed the frequent occurrence of chloride cell complexes under hypersaline conditions. By electron microscopy, a deeply invaginated apical crypt and well-developed tubular network were observed in chloride cells of SW- and 180% SW-adapted fish, indicating enhanced cellular activity. Chloride cells present in the opercular membrane were also developed in response to increased salinity. These findings suggest that highly activated chloride cells in branchial and opercular epithelia may be responsible for salt secretion in hyperosmotic environments. The excellent salinity tolerance of tilapia appears to be attributed to their ability to develop chloride cells in response to increased environmental salinity.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Uchida, K (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan.						Uchida K, 1996, J EXP ZOOL, V276, P193, DOI 10.1002/(SICI)1097-010X(19961015)276:3<193::AID-JEZ3>3.0.CO;2-I; FOSKETT JK, 1982, SCIENCE, V215, P164, DOI 10.1126/science.7053566; Witters H, 1996, CELL TISSUE RES, V283, P461, DOI 10.1007/s004410050557; HOOTMAN SR, 1979, ANAT REC, V193, P99, DOI 10.1002/ar.1091930107; KARNAKY KJ, 1976, J CELL BIOL, V70, P157, DOI 10.1083/jcb.70.1.157; CUTLER CP, 1995, COMP BIOCHEM PHYS B, V111, P567, DOI 10.1016/0305-0491(95)00037-9; Uchida K, 1996, ZOOL SCI, V13, P655; Perry SF, 1997, ANNU REV PHYSIOL, V59, P325, DOI 10.1146/annurev.physiol.59.1.325; BEREITERHAHN J, 1976, BIOCHIM BIOPHYS ACTA, V423, P1, DOI 10.1016/0005-2728(76)90096-7; Boeuf G., 1993, FISH ECOPHYSIOLOGY, P105; BONGA SEW, 1989, CELL TISSUE RES, V255, P235; Clarke W. Craig, 1995, P317; CUTLER CP, 1995, FISH PHYSIOL BIOCHEM, V14, P423, DOI 10.1007/BF00003380; DANGE AD, 1985, MAR BIOL, V87, P101, DOI 10.1007/BF00397011; Evans David H., 1993, P315; Flik G., 1995, CELLULAR MOL APPROAC, P317; Goss G.G., 1995, CELLULAR MOL APPROAC, P257; Hirai N, 1999, ZOOL SCI, V16, P43, DOI 10.2108/zsj.16.43; HOOTMAN SR, 1980, AM J PHYSIOL, V238, pR199; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; HWANG PP, 1987, MAR BIOL, V94, P643, DOI 10.1007/BF00431411; Hwang PP, 1998, FISH PHYSIOL BIOCHEM, V18, P363, DOI 10.1023/A:1007711606064; HWANG PP, 1988, J MORPHOL, V196, P15, DOI 10.1002/jmor.1051960103; KARNAKY KJ, 1984, AM J PHYSIOL, V246, pR770; KISEN G, 1994, COMP BIOCHEM PHYS B, V107, P255, DOI 10.1016/0305-0491(94)90047-7; KULTZ D, 1995, CELL TISSUE RES, V279, P65, DOI 10.1007/BF00300692; KULTZ D, 1992, COMP BIOCHEM PHYS B, V102, P293, DOI 10.1016/0305-0491(92)90125-B; Lee TH, 1996, FISH PHYSIOL BIOCHEM, V15, P513, DOI 10.1007/BF01874924; Li J, 1997, J EXP BIOL, V200, P1499; Lin H., 1995, CELLULAR MOL APPROAC, P229; Marshall WS, 1995, CELLULAR MOL APPROAC, P1; Marshall WS, 1997, J EXP ZOOL, V277, P23, DOI 10.1002/(SICI)1097-010X(19970101)277:1<23::AID-JEZ3>3.3.CO;2-J; McCormick S. D., 1995, CELLULAR MOL APPROAC, P285; MCCORMICK SD, 1992, P NATL ACAD SCI USA, V89, P3635, DOI 10.1073/pnas.89.8.3635; Nakano K, 1997, FISHERIES SCI, V63, P338; PISAM M, 1981, ANAT REC, V200, P401, DOI 10.1002/ar.1092000403; PISAM M, 1991, INT REV CYTOL, V130, P191, DOI 10.1016/S0074-7696(08)61504-1; PISAM M, 1989, AM J ANAT, V184, P311, DOI 10.1002/aja.1001840406; Pullin R.S.V., 1991, P280; SASAI S, 1999, CAN J ZOOL, V76, P1480; Shikano T, 1998, J EXP BIOL, V201, P3031; Shiraishi K, 1997, CELL TISSUE RES, V288, P583, DOI 10.1007/s004410050844; SURESH AV, 1992, AQUACULTURE, V106, P201, DOI 10.1016/0044-8486(92)90253-H; Uchida K, 1997, MAR BIOL, V129, P247, DOI 10.1007/s002270050165; Ura K, 1996, ZOOL SCI, V13, P219, DOI 10.2108/zsj.13.219; VanDerHeijden AJH, 1997, J EXP BIOL, V200, P55; Verbost PM, 1997, J COMP PHYSIOL B, V167, P205, DOI 10.1007/s003600050066; Vonck APMA, 1998, COMP BIOCHEM PHYS A, V119, P441, DOI 10.1016/S1095-6433(97)00450-9; BONGA SEW, 1990, CELL TISSUE RES, V259, P575, DOI 10.1007/BF01740786; YOSHIKAWA JSM, 1993, COMP BIOCHEM PHYS A, V105, P311, DOI 10.1016/0300-9629(93)90213-N; YOUNG PS, 1988, GEN COMP ENDOCR, V71, P389, DOI 10.1016/0016-6480(88)90267-5; Zadunaisky J.A., 1997, P87	52	103	106	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2000	17	2					149	160		10.2108/zsj.17.149		12	Zoology	Zoology	312TV	WOS:000086960100003		
J	Takagi, Y; Ishii, K; Ozaki, N; Nagasawa, H				Takagi, Y; Ishii, K; Ozaki, N; Nagasawa, H			Immunolocalization of gastrolith matrix protein (GAMP) in the gastroliths and exoskeleton of crayfish, Procambarus clarkii	ZOOLOGICAL SCIENCE			English	Article							ORGANIC MATRIX; SHELL	Gastrolith matrix protein (GAMP) is a novel protein purified from gastroliths of the crayfish, Procambarus clarkii, and has been suggested to be associated with calcium carbonate deposition. In the present study, a specific antibody against CAMP was raised and distribution of CAMP immunoreactivity was studied in crayfish gastrolith and exoskeleton. Localization of calcium carbonate in the exoskeleton, determined by silver nitrate staining and energy dispersive X-ray microanalysis, was compared with that of GAMP immunoreactivity. Crystalline forms of calcium carbonate were also determined. SDS-PAGE and Western blotting revealed that the gastrolith extract contained a major band which was GAMP-immunopositive and showed the same mobility as that of purified CAMP. The exoskeleton extract showed smear bands, but no immunoreaction was detected. By using immunohistochemistry, the anti-CAMP antiserum reacted almost uniformly with gastrolith matrix irrespective of gastrolith size. Epithelial cells of the gastrolith disc were also immunopositive. In the exoskeleton, exocuticle was strongly CAMP-immunopositive, whereas the endocuticle and membrane layer was slightly positive. The epicuticle was immunonegative. Calcium carbonate was detected in exocuticle, endocuticle and a part of the membrane layer, but not in the epicuticle. Thus, the distribution of CAMP immunoreactivity roughly corresponded with that of calcium carbonate. X-ray diffraction study showed that calcium carbonate in the gastrolith was amorphous, whereas that in the exoskeleton consisted of calcite crystals. These data indicate that a GAMP-immunoreactive substance is commonly distributed in the mineralized tissues of the crayfish, but may exist in a chemically different form in other tissues.	Univ Tokyo, Ocean Res Inst, Otsuchi Marine Res Ctr, Otsuchi, Iwate 0281102, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Takagi, Y (reprint author), Univ Tokyo, Ocean Res Inst, Otsuchi Marine Res Ctr, Akahama 2-106-1, Otsuchi, Iwate 0281102, Japan.						Tsutsui N, 1999, ZOOL SCI, V16, P619, DOI 10.2108/zsj.16.619; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Ishii K, 1998, BIOSCI BIOTECH BIOCH, V62, P291, DOI 10.1271/bbb.62.291; Ishii K, 1996, BIOSCI BIOTECH BIOCH, V60, P1479; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; Dauphin Y, 1996, MAR BIOL, V125, P525; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; IIJIMA M, 1991, COMP BIOCHEM PHYS A, V98, P379; KAWAGUCHI T, 1993, J EXP MAR BIOL ECOL, V170, P11, DOI 10.1016/0022-0981(93)90126-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; SCOTT JE, 1978, BIOCHEM J, V169, P697; SUCOV HM, 1987, DEV BIOL, V120, P507, DOI 10.1016/0012-1606(87)90254-5; TRAVIS DF, 1960, BIOL BULL, V118, P137, DOI 10.2307/1539064; Watabe N., 1991, P9; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023	15	14	16	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2000	17	2					179	184		10.2108/zsj.17.179		6	Zoology	Zoology	312TV	WOS:000086960100006		
J	Moroki, Y; Takeuchi, S; Igarashi, K; Hara, H; Shiokawa, K				Moroki, Y; Takeuchi, S; Igarashi, K; Hara, H; Shiokawa, K			Effects of bromo-cyclic GMP and bromo-cyclic AMP on embryonic development of Xenopus laevis	ZOOLOGICAL SCIENCE			English	Article							AMPHIBIAN EMBRYOS; SPEMANN ORGANIZER; GASTRULATION; INDUCTION; MESODERM; NOGGIN; SEM	Low molecular signalling molecules such as cAMP and cGMP are expected to have important functions in early morphogenetic processes in animal development. We examined the effect of 8-bromocyclic GMP (Br-cGMP) on Xenopus embryogenesis, using 8-bromo-cyclic AMP (Br-cAMP) as a reference. When Xenopus gastrulae were cultured in the medium which contained these analogues, their development was affected in specific and dosage-dependent manners: While Br-cAMP induced anomaly only in head part (swelling of myelencephalon with enlarged ventricle), Br-cGMP induced shortening in body length often accompanied by bending of the cephalo-caudal axis. In embryos treated with Br-cGMP at a high dose, cellular movement was inhibited as revealed by SEM and this resulted in the formation of tadpoles with unclosed yolk plug. Br-cGMP at lower doses induced severe inhibition of the development of notochord and muscles. Since HPLC analyses revealed that both analogues were uptaken into embryonic cells, we assumed that the morphological effects observed were induced by the interference of the normal functioning of cGMP and cAMP, respectively, by Br-cGMP and Br-cAMP. Based on the results obtained, we assume that while cGMP is involved mainly in the differentiation of mesodermal structures, especially in formation of notochord and muscles, cAMP is involved mainly in the differentiation of neural structures.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Inst Zool,Lab Mol Embryol,Bunkyo Ku, Tokyo 1130033, Japan; Kanagawa Univ, Fac Sci, Dept Sci Biol, Hiratsuka, Kanagawa 2591205, Japan; Chiba Univ, Fac Pharmaceut Sci, Inage Ku, Chiba 2688522, Japan; Taisho Pharmaceut Co Ltd, Med Res Labs, Mol Biol Lab, Ohmiya, Saitama 3300031, Japan	Shiokawa, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Inst Zool,Lab Mol Embryol,Bunkyo Ku, Tokyo 1130033, Japan.						JACOBSON AG, 1978, ZOON, V6, P13; Shibata M, 1998, INT J DEV BIOL, V42, P675; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; KELLER RE, 1980, J EMBRYOL EXP MORPH, V60, P201; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Holtfreter J, 1944, J EXP ZOOL, V95, P171, DOI 10.1002/jez.1400950203; ASASHIMA M, 1990, ROUX ARCH DEV BIOL, V198, P330, DOI 10.1007/BF00383771; Holtfreter J, 1943, J EXP ZOOL, V94, P261, DOI 10.1002/jez.1400940302; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; KELLER R, 1989, J EXP ZOOL, V251, P134, DOI 10.1002/jez.1402510204; KELLER R, 1991, GASTRULATION MOVEMEN; KELLER R, 1988, DEVELOPMENT, V103, P193; KELLER R E, 1977, Wilhelm Roux's Archives of Developmental Biology, V182, P165, DOI 10.1007/BF00848055; KUBOTA HY, 1978, J EMBRYOL EXP MORPH, V44, P71; LOVTRUPREIN H, 1975, EXP CELL RES, V94, P216, DOI 10.1016/0014-4827(75)90546-7; MACFARLAND RT, 1995, ZOOL SCI, V12, P151; NAKATSUJI N, 1974, J EMBRYOL EXP MORPH, V32, P795; NAKATZUJI N, 1975, Wilhelm Roux's Archives of Developmental Biology, V178, P1, DOI 10.1007/BF00848358; Nieuwkoop P.D., 1956, NORMAL TABLE XENOPUS; NIITSUHOSOYA N, 1987, DEV GROWTH DIFFER, V29, P563; OTTE AP, 1989, CELL, V58, P641, DOI 10.1016/0092-8674(89)90099-8; SASAI Y, 1995, REGULATION NEURAL IN; Schechtman A Mandel, 1942, UNIV CALIFORNIA PUBL ZOOL, V51, P1; Schutter A P, 1975, Exp Cell Res, V96, P7, DOI 10.1016/S0014-4827(75)80030-9; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; Spemann H., 1938, EMBRYONIC DEV INDUCT; Vogt W, 1929, WILHELM ROUX ARCH EN, V120, P384, DOI 10.1007/BF02109667; Vogt W., 1922, VERHANDL DTSCH ZOOL, V27, P49	30	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2000	17	2					191	200		10.2108/zsj.17.191		10	Zoology	Zoology	312TV	WOS:000086960100008		
J	Ichikawa, T; Kobayashi, H; Nozaki, M				Ichikawa, T; Kobayashi, H; Nozaki, M			Seasonal migration of the hagfish, Eptatretus burgeri, Girard	ZOOLOGICAL SCIENCE			English	Article								The seasonal migration of the hagfish, Eptatretus burgeri, was studied in the sea near the Misaki Marine Biological Station of University of Tokyo during the period from October 1970 to October 1975. The hagfish was caught by a cylindrical trap (80 cm in length, 15 cm in diameter) with a funnel-shaped one way entry at both ends. Sardines were used for baits. The hagfish were found in water of 6 to 10 m depths in Koajiro Bay and Moroiso Bay near the Station from mid October to mid July of the following year, but they were absent from the bays at other times. On the other hand, they were found throughout the year in offshore water of 50 m depth, about 1,600 m west of the Station. Two hundred and nine hagfish caught in water of 50 m depth in October and November were marked by making a small triangle cut on the tail fin and releasing them at the original place of capture. Sixty five marked hagfish in total (31.1%) were recaptured in Koajiro Bay and Moroiso Bay. Among 1,323 hagfish marked in Koajiro Bay in April, May and June, 23 marked hagfish (1.7%) were recaptured in water of 50 and 100 m depths. The mean total lengths of the hagfish collected in Koajiro Bay and water of 50 m depth during November through April were 43.3+/-0.7 cm (+/-SEM, n=1,796), and 34.3+/-0.9 cm (+/-SEM, n=689), respectively. Data on monthly collections of the hagfish in both Koajiro Bay and water of 50 m depth indicated that when they migrate from shallow to deep water and the reverse, larger hagfish more than 39 cm in total length move first being followed by smaller ones, but many hagfish less than 35 cm in length remain in water of 50 m depth throughout the year. We failed to collect either fertilized eggs or juveniles by net sweeping of the bottom of water of 40 to 110 m depth. Furthermore, we could not find hagfish less than 20 cm in either shallow water or water of 50 m depth. It seems that the spawning ground of E. burgeri may not be at the 50 m depth but at a deeper place than 100 m depth. Finally, the present study demonstrated directly the seasonal migration of the hagfish, E. burgeri, between shallow and deeper waters of Sagami Bay by the marking experiments.	Univ Tokyo, Fac Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan	Nozaki, M (reprint author), Univ Tokyo, Fac Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan.						Adam H, 1963, BIOL MYXINE, P1; OOKASOUDA S, 1985, ZOOL SCI, V2, P749; CONEL JL, 1931, BASHFORD DEAN MEMORI, V1, P64; Dean B, 1904, J COLL SCI IMP U TOK, V19, P1; FERNHOLM B, 1974, MAR BIOL, V27, P351, DOI 10.1007/BF00394371; GORBMAN A, 1983, FISH PHYSIOL, V9, P1; KOBAYASHI H, 1972, Japanese Journal of Ichthyology, V19, P191; Martini FH, 1998, BIOLOGY OF HAGFISHES, P57; NOZAKI M, 2000, IN PRESS ZOOL SCI, V17; PATZNER RA, 1977, ACTA ZOOL-STOCKHOLM, V58, P223; PATZNER RA, 1978, ACTA ZOOL-STOCKHOLM, V59, P57; Patzner RA, 1998, BIOLOGY OF HAGFISHES, P378; SHELTON RGJ, 1978, J MAR BIOL ASSOC UK, V58, P81; TSUNEKI K, 1983, JPN J ICHTHYOL, V29, P429	14	12	12	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2000	17	2					217	223		10.2108/zsj.17.217		7	Zoology	Zoology	312TV	WOS:000086960100011		
J	Nozaki, M; Ichikawa, T; Tsuneki, K; Kobayashi, H				Nozaki, M; Ichikawa, T; Tsuneki, K; Kobayashi, H			Seasonal development of gonads of the hagfish, Eptatretus burgeri, correlated with their seasonal migration	ZOOLOGICAL SCIENCE			English	Article								Seasonal development of gonads was studied in the hagfish, Eptatretus burgeri, caught near the Misaki Marine Biological Station facing the Sagami Bay of the Pacific coast of Japan, during periods from October 1971 to March 1973 and from November 1977 to December 1978. The hagfish were collected at water depths of 6 to 10 m (shallow water) in Koajiro Bay close to the Station or water depths of 50 and 100 m (deep water), about 1,600 and 4.800 m west to the Station. They were collected monthly from both shallow and deep waters, but they could not be collected from shallow water during warmer summer months (July-September) due to seasonal migration. The mean total lengths of the females collected in both shallow and deep waters during January to April were 40.7+/-0.4 cm (+/-SEM; n=317) and 34.5+/-0.3 cm (+/-SEM; n=556), respectively, In both locations, developing eggs longer than 5 mm were found in females larger than 39 cm in total length. There was no difference in the annual growth curves of developing eggs between shallow and deep water: the sizes of the developing eggs were the smallest in October, and was the largest in September. There was no apparent difference in testicular development between two locations, so these data were combined. Testicular development occurs in males larger than 38 cm in total length. The testis weight was the heaviest in July, and was the lightest in September. In autumn and winter, most testicular follicles contained only spermatogonia. In spring, follicles containing spermatocytes increased. Follicles with spermatids or maturing sperms were relatively abundant in summer. Although egg deposition is supposed to occur in September and/or early October somewhere in deep water, both testis weight and spermatogenesis were minimal at this time. Why testis development is lowest at the time when females presumably deposit eggs is discussed in relation to the question of the location of the spawning ground.	Univ Tokyo, Fac Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan	Nozaki, M (reprint author), Niigata Univ, Fac Sci, Sado Marine Biol Stn, Niigata 9522135, Japan.						CONEL JL, 1931, BASHFORD DEAN MEMORI, V1, P64; Dean B, 1904, J COLL SCI IMP U TOK, V19, P1; Fange R., 1963, BIOL MYXINE, P530; FERNHOLM B, 1974, MAR BIOL, V27, P351, DOI 10.1007/BF00394371; FERNHOLM B, 1975, Acta Zoologica (Stockholm), V56, P199; GORBMAN A, 1983, FISH PHYSIOL, V9, P1; Gorbman A., 1978, P49; ICHIKAWA T, 2000, IN PRESS ZOOLOGICAL, V17; KOBAYASHI H, 1972, Japanese Journal of Ichthyology, V19, P191; PATZNER RA, 1977, ACTA ZOOL-STOCKHOLM, V58, P223; PATZNER RA, 1978, ACTA ZOOL-STOCKHOLM, V59, P57; TSUNEKI K, 1983, JPN J ICHTHYOL, V29, P429	12	12	12	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2000	17	2					225	232		10.2108/zsj.17.225		8	Zoology	Zoology	312TV	WOS:000086960100012		
J	Abe, W; Takeda, M				Abe, W; Takeda, M			A new Calcarobiotus (Tardigrada : Macrobiotidae) from the Imperial Palace of Japan	ZOOLOGICAL SCIENCE			English	Article								A new semiterrestrial tardigrade species of the genus Calcarobiotus is described from the Imperial Palace of Japan as the third species of the genus which has been previously known only from South Africa. The new species, Calcarobiotus imperialis, is closely related to C. occultus Dastych, but can be distinguished from the latter mainly by the absence of a spine on the tip of each egg process, and by having larger pores on egg surface, a narrower buccal tube, and larger claws.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Shinjuku Ku, Tokyo 1690073, Japan; Natl Sci Museum, Dept Zool, Shinjuku Ku, Tokyo 1690073, Japan	Abe, W (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Shinjuku Ku, 3-23-1 Hyakunincho, Tokyo 1690073, Japan.	w-abe@kahaku.go.jp					BERTOLANI R, 1993, ZOOL SCR, V22, P127, DOI 10.1111/j.1463-6409.1993.tb00347.x; Bertolani R, 1996, INVERTEBR BIOL, V115, P299, DOI 10.2307/3227019; Dastych Hieronim, 1993, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V90, P175; Pilato G., 1981, Animalia (Catania), V8, P51	4	7	7	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2000	17	2					259	263		10.2108/zsj.17.259		5	Zoology	Zoology	312TV	WOS:000086960100016		
J	Miyachi, H; Yano, K; Ikebukuro, K; Kono, M; Hoshina, S; Karube, I				Miyachi, H; Yano, K; Ikebukuro, K; Kono, M; Hoshina, S; Karube, I			Application of chimeric RNA-DNA oligonucleotides to the detection of pathogenic microorganisms using surface plasmon resonance	ANALYTICA CHIMICA ACTA			English	Article						DNA sensing; surface plasmon resonance (SPR); chimeric RNA-DNA oligonucleotide; rTth DNA polymerase; polymerase chain reaction (PCR	LINKED IMMUNOSORBENT-ASSAY; ESCHERICHIA-COLI; MIXED CULTURES; SHIGA TOXIN; LOW NUMBERS; SALMONELLA; POLYMERASE; SPECIMENS; VEROTOXIN; CYTOTOXIN	Chimeric oligonucleotides consisting of 21 bases of ribonucleic acid (RNA) with six bases of deoxyribonucleic acid (DNA) at the 3'-hydroxyl terminus (chimeric RNA-DNA primer) and the recombinant thermostable DNA polymerase derived from Thermus thermophilus (rTth DNA polymerase) were utilized to efficiently amplify DNA fragments using the conventional polymerase chain reaction (PCR). The reaction required the use of both DIVA polymerase and reverse transcriptase during each thermal cycle to form a double-stranded DNA in which one terminus was an RNA:DNA hybrid. Due to the ability of rTth DNA polymerase to function as both the DNA polymerase and reverse transcriptase, a chimeric RNA-DNA primer was shown to serve as a primer in the conventional PCR procedure. We further demonstrate the advantages of using these PCR products to identify microorganisms using surface plasmon resonance (SPR) technology. This detection system was able to distinguish Shiga toxin-producing Escherichia coli O157:H7 strains from other bacteria such as Salmonella typhimurium and S. enteritidis. (C)2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Jikei Univ, Dept Lab Med, Minato Ku, Sch Med, Tokyo 1058461, Japan	Karube, I (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			Alberts B, 1994, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15; Paton AW, 1996, J CLIN MICROBIOL, V34, P1622; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450; DONOHUEROLFE A, 1986, J CLIN MICROBIOL, V24, P65; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276; GALAN JE, 1992, J BACTERIOL, V174, P4338; ARAJ GF, 1987, J CLIN MICROBIOL, V25, P2150; ASHKENAZI S, 1990, J MED MICROBIOL, V32, P255; AUER T, 1995, BIOCHEMISTRY-US, V34, P4994, DOI 10.1021/bi00015a010; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; DOWNES FP, 1989, J CLIN MICROBIOL, V27, P1292; Fauci A. S., 1998, HARRISONS PRINCIPLES; Hoeprich P. D., 1994, INFECT DIS TREATISE; KAI E, 1999, ANAL CHEM, V71, P769; KARMALI MA, 1985, J CLIN MICROBIOL, V22, P614; KRYSINSKI EP, 1977, APPL ENVIRON MICROB, V33, P947; LAW D, 1992, J MED MICROBIOL, V36, P198; LINN S, 1991, CELL, V66, P185, DOI 10.1016/0092-8674(91)90608-2; RAMOTAR K, 1995, J CLIN MICROBIOL, V33, P519; Sambrook J., 1989, MOL CLONING LAB MANU; SAWATA S, 1997, NUCL ACIDS S SER, V37, P247; SHIBATA H, 1995, GENOME RES, V5, P400, DOI 10.1101/gr.5.4.400; SMITH HR, 1993, J CLIN PATHOL, V46, P10, DOI 10.1136/jcp.46.1.10; VANPOUCKE LSG, 1990, APPL ENVIRON MICROB, V56, P924	28	19	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670			ANAL CHIM ACTA	Anal. Chim. Acta	FEB 29	2000	407	1-2					1	10		10.1016/S0003-2670(99)00779-5		10	Chemistry, Analytical	Chemistry	285EZ	WOS:000085377900001		
J	Ha, SD; Kataoka, H; Suzuki, A; Kim, BJ; Kim, HJ; Hwang, SH; Kong, JY				Ha, SD; Kataoka, H; Suzuki, A; Kim, BJ; Kim, HJ; Hwang, SH; Kong, JY			Cloning and sequence analysis of cDNA for diuretic hormone receptor from the Bombyx mori	MOLECULES AND CELLS			English	Article						Bombyx mori; diuretic hormone receptor; G-protein coupled receptor; malpighian tubules	MOLECULAR-CLONING; TOBACCO HORNWORM; MANDUCA-SEXTA; EXPRESSION CLONING; SECRETIN RECEPTOR; IDENTIFICATION; PEPTIDE; GENE	The insect diuretic hormone (DH) binds to their receptor in malpighian tubules, and stimulates water secretion and cAMP synthesis. Complementary DNA encoding a diuretic hormone receptor was cloned from the malpighian tubules of Bombyx mori, The cloned cDNA encodes a protein consisting of 391 amino acid residues with the seven transmembrane domains, The receptor protein is homologous with that of other insects, and is structurally related to G-protein coupled receptors such as corticotropin relating factor (CRF), secretin, and vasoactive intestinal peptide.	Pukyong Natl Univ, Fac Food Sci & Biotechnol, Pusan 608737, South Korea; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	Kong, JY (reprint author), Pukyong Natl Univ, Fac Food Sci & Biotechnol, Pusan 608737, South Korea.						SHIBAHARA S, 1983, EMBO J, V2, P775; BLACKBURN MB, 1991, BIOCHEM BIOPH RES CO, V181, P927, DOI 10.1016/0006-291X(91)92025-F; REAGAN JD, 1994, J BIOL CHEM, V269, P9; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; KAY I, 1992, REGUL PEPTIDES, V42, P111, DOI 10.1016/0167-0115(92)90091-8; KATAOKA H, 1989, P NATL ACAD SCI USA, V86, P2976, DOI 10.1073/pnas.86.8.2976; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; ERSPAMER V, 1980, N-S ARCH PHARMACOL, V312, P265, DOI 10.1007/BF00499156; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GADE G, 1997, PROGR CHEM ORGANIC N, V71, P29; Kim B, 1998, MOL CELLS, V8, P750; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEDERIS K, 1983, CAN J BIOCHEM CELL B, V61, P602; LEHMBERG E, 1991, BIOCHEM BIOPH RES CO, V179, P1036, DOI 10.1016/0006-291X(91)91923-Z; PATEL DR, 1995, MOL PHARMACOL, V47, P467; Reagan JD, 1996, INSECT BIOCHEM MOLEC, V26, P1, DOI 10.1016/0965-1748(95)00074-7; REAGAN JD, 1995, INSECT BIOCHEM MOLEC, V25, P875, DOI 10.1016/0965-1748(95)00049-2; SREEDHARAN SP, 1991, P NATL ACAD SCI USA, V88, P4986, DOI 10.1073/pnas.88.11.4986	18	15	15	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	#04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE	1016-8478			MOL CELLS	Mol. Cells	FEB 29	2000	10	1					13	17		10.1007/s100590070003		5	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	291DQ	WOS:000085719200003		
J	Krasznai, Z; Marian, T; Izumi, H; Damjanovich, S; Balkay, L; Tron, L; Morisawa, M				Krasznai, Z; Marian, T; Izumi, H; Damjanovich, S; Balkay, L; Tron, L; Morisawa, M			Membrane hyperpolarization removes inactivation of Ca2+ channels, leading to Ca2+ influx and subsequent initiation of sperm motility in the common carp	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							TROUT SPERM; RAINBOW-TROUT; CYCLIC-AMP; FLAGELLAR MOVEMENT; ADENYLATE-CYCLASE; INTRACELLULAR PH; SEMINAL PLASMA; SPERMATOZOA; CALCIUM; POTASSIUM	Change of osmolality surrounding spawned sperm from isotonic to hypotonic causes the initiation of sperm motility in the common carp. Here we show that membrane-permeable cAMP does not initiate motility of carp sperm that is quiescent in isotonic solution, and that motility of the demembranated sperm can be reactivated without cAMP. Furthermore, the cAMP level does not change during the initiation of sperm motility, and inhibitors of protein kinase do not affect sperm motility, suggesting that no cAMP-dependent system is necessary for the regulation of sperm motility. Sperm motility could not be initiated in Ca2+-free hypoosmotic solutions, and significant increase in the intracellular Ca2+ level was observed by a Ca-sensitive fluorescence dye during hypoosmolality-induced active motion period. The demembranated sperm cells were fully reactivated in the solutions containing 10(-7) to 10(-5) M Ca2+. Ca2+ channel blockers such as verapamil and omega-conotoxin reversibly inhibited the initiation of sperm motility, suggesting that Ca2+ influx is the prerequisite for the initiation of carp sperm motility. Motility of intact sperm was completely blocked; however, that of the demembranated sperm was not inhibited by the calmodulin inhibitor W7, suggesting that the calmodulin bound close to the plasma membrane participated in the initiation of sperm motility. Flow cytometric membrane potential measurements and spectrophotometric measurements by using fluorescence dyes showed transient membrane hyperpolarization on hypoosmolality-induced motility. This article discusses the role of membrane hyperpolarization on removal of inactivation of Ca2+ channels, leading to Ca2+ influx at the initiation of carp sperm motility.	Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary; Univ Debrecen, Med & Hlth Sci Ctr, Positron Emiss Tomog Ctr, H-4012 Debrecen, Hungary; Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, Kanagawa 23802, Japan	Krasznai, Z (reprint author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary.	Krasznal@jaguar.dote.hu	Damjanovich, Sandor/A-9284-2011				CHRISTEN R, 1987, EUR J BIOCHEM, V166, P667, DOI 10.1111/j.1432-1033.1987.tb13565.x; TAKAI H, 1995, J CELL SCI, V108, P1175; PERCHEC G, 1995, J CELL SCI, V108, P747; MORISAWA M, 1980, SCIENCE, V210, P1145, DOI 10.1126/science.7444445; EBERHARD M, 1991, BIOCHEM BIOPH RES CO, V180, P209, DOI 10.1016/S0006-291X(05)81278-1; MARIAN T, 1993, J HISTOCHEM CYTOCHEM, V41, P291; MORISAWA M, 1982, NATURE, V295, P703, DOI 10.1038/295703a0; Izumi H, 1999, DEV BIOL, V213, P246, DOI 10.1006/dbio.1999.9367; LINDEMANN CB, 1978, CELL, V13, P9, DOI 10.1016/0092-8674(78)90133-2; Hoffmann EK, 1995, INT REV CYTOL, V161, P173; MORISAWA M, 1983, J EXP BIOL, V107, P95; TASH JS, 1983, BIOL REPROD, V28, P75, DOI 10.1095/biolreprod28.1.75; BOITANO S, 1991, J CELL SCI, V98, P343; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; BABCOCK DF, 1992, P NATL ACAD SCI USA, V89, P6001, DOI 10.1073/pnas.89.13.6001; COOK SP, 1994, DEV BIOL, V165, P10, DOI 10.1006/dbio.1994.1229; COSSON MP, 1989, CELL MOTIL CYTOSKEL, V14, P424, DOI 10.1002/cm.970140312; COSSON MP, 1988, CELL MOTIL CYTOSKEL, V10, P518, DOI 10.1002/cm.970100408; DREVIUS LO, 1966, EXP CELL RES, V42, P136, DOI 10.1016/0014-4827(66)90327-2; Emri M, 1998, AQUACULTURE, V167, P85, DOI 10.1016/S0044-8486(98)00309-3; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; HAYASHI H, 1987, J BIOL CHEM, V262, P16692; HILLE B, 1991, IONIC CHANNELS EXCIT, P108; KRASZNAI Z, 1995, AQUACULTURE, V129, P123, DOI 10.1016/0044-8486(94)00234-F; KRASZNAI Z, 1995, J PHOTOCH PHOTOBIO B, V28, P93, DOI 10.1016/1011-1344(94)07099-A; Marian T, 1997, CYTOMETRY, V27, P374, DOI 10.1002/(SICI)1097-0320(19970401)27:4<374::AID-CYTO9>3.0.CO;2-C; MORISAWA M, 1987, J EXP ZOOL, V242, P199, DOI 10.1002/jez.1402420211; OKUNO M, 1989, CELL MOTIL CYTOSKEL, V14, P194, DOI 10.1002/cm.970140206; Perchec G, 1996, CELL MOTIL CYTOSKEL, V35, P113, DOI 10.1002/(SICI)1097-0169(1996)35:2<113::AID-CM4>3.3.CO;2-L; Perchec Poupard G, 1997, J Reprod Fertil, V110, P315; TANIMOTO S, 1988, DEV GROWTH DIFFER, V30, P117; TANIMOTO S, 1994, MOL REPROD DEV, V39, P409, DOI 10.1002/mrd.1080390409; YOSHIDA M, 1994, DEV GROWTH DIFFER, V36, P589; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	34	104	108	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 29	2000	97	5					2052	2057		10.1073/pnas.040558097		6	Multidisciplinary Sciences	Science & Technology - Other Topics	289QJ	WOS:000085633200019		
J	Noma, K; Ohtsubo, E				Noma, K; Ohtsubo, E			Tnat1 and Tnat2 from Arabidopsis thaliana: Novel transposable elements with tandem repeat sequences	DNA RESEARCH			English	Article						Arabidopsis thaliana; transposable element; tandem repeats; target site duplication	ZEA-MAYS; FAMILY; GENES; MAIZE; ALIGNMENT; TOURIST; GENOMES	A computer-aided homology search of databases found that the nucleotide sequences flanking ATLN44, a non-LTR retrotransposon (LINE) from Arabidopsis thaliana, are repeated in the A. thaliana genome. These sequences are homologous to flanking sequences of 664 bp with terminal inverted repeat sequences of about 70 bp. The 664-bp sequence and most of the 14 homologues identified were flanked by direct repeat sequences of 9 bp. These findings indicate that the repeated sequence, named Tnat1, is a transposable element tl-lat duplicates a 9-bp sequence at the target site on transposition and that ATLN44 is inserted in one Tnat1 member. Interestingly, all of the Tnat1 members had tandem repeats comprised of several units of a 60-bp sequence, the number of repeats differing among Tnat1 members. Of the Tnat1 members identified, one was inserted into another sequence repeated in the A. thaliana genome: that sequence is about 770 bp long and has terminal inverted repeat sequences of about 110 bp. The sequence is flanked by direct repeats of a 9-bp sequence, indicating that it is another transposable element, named Tnat2, from A. thaliana. Moreover, Tnat2 members had a tandem repeat about 240 bp long. Tnat1 and Tnat2 with tandem repeats in their internal regions show no homology to each other or to any of the elements identified previously; therefore they appear to be novel transposable elements.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Ohtsubo, E (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; BUREAU TE, 1994, P NATL ACAD SCI USA, V91, P1411, DOI 10.1073/pnas.91.4.1411; KUNZE R, 1989, EMBO J, V8, P3177; BENNETZEN JL, 1996, TRANSPOSABLE ELEMENT, P195; Berg DE, 1989, MOBILE DNA; Charrier B, 1999, PLANT J, V18, P431, DOI 10.1046/j.1365-313X.1999.00469.x; FEDOROFF NV, 1989, CELL, V56, P181, DOI 10.1016/0092-8674(89)90891-X; GABRIEL A, 1993, REVERSE TRANSCRIPTAS, P275; GIERL A, 1996, TRANSPOSABLE ELEMENT, P145; GIERL A, 1988, EMBO J, V7, P4045; HERSHBERGER RJ, 1995, GENETICS, V140, P1087; Hutchison III C.A, 1989, MOBILE DNA, P593; KUNZE R, 1996, TRANSPOSABLE ELEMENT, P161; Noma K, 1999, MOL GEN GENET, V261, P71; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Saedler H, 1996, TRANSPOSABLE ELEMENT; TENZEN T, 1994, MOL GEN GENET, V245, P441, DOI 10.1007/BF00302256; UMEDA M, 1991, JPN J GENET, V66, P569, DOI 10.1266/jjg.66.569	23	13	13	UNIVERSAL ACADEMY PRESS INC	TOKYO	ORDER DEPT., C P O BOX 235, TOKYO, 100-8691, JAPAN	1340-2838			DNA RES	DNA Res.	FEB 28	2000	7	1					1	7		10.1093/dnares/7.1.1		7	Genetics & Heredity	Genetics & Heredity	357CU	WOS:000089481600001		
J	Nishiyama, T; Hiwatashi, Y; Sakakibara, K; Kato, M; Hasebe, M				Nishiyama, T; Hiwatashi, Y; Sakakibara, K; Kato, M; Hasebe, M			Tagged mutagenesis and gene-trap in the moss, Physcomitrella patens by shuttle mutagenesis	DNA RESEARCH			English	Article						tagging; gene-trap; Physcomitrella patens; homologous recombination; shuttle mutagenesis	SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; RESISTANT MUTANTS; DNA; TRANSFORMATION; LOCALIZATION	The moss, Physcomitrella patens has been used as a useful material in many fields, because of its simple body plan., ease of gene targeting, and other reasons. Although many mutants have been reported, no method to isolate the corresponding genes was reported. We developed a gene tagging and gene-trap system in P. patens by using the shuttle mutagenesis technique, which has been used in the budding yeast. In 5264 tagged lines, 203 mutants with altered developmental or morphological phenotypes were obtained. In 129 of 4757 gene-trap lines, beta-glucuronidase (GUS) activity was detected in some tissue. Although multiple copies of a tag were detected in many tagged lines by Southern analyses, most copies are likely integrated at the same locus according to PCR analyses.	Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Kyoto, Japan	Hasebe, M (reprint author), Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan.		Nishiyama, Tomoaki/J-8897-2015	HIWATASHI, YUJI/0000-0002-3996-0549; Nishiyama, Tomoaki/0000-0003-1279-7806			MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Kammerer W, 1996, MOL GEN GENET, V250, P380; CHUCK G, 1993, PLANT CELL, V5, P371; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Reski R, 1998, BOT ACTA, V111, P1; KONCZ C, 1992, PLANT MOL BIOL, V20, P963, DOI 10.1007/BF00027166; JEFFERSON RA, 1987, EMBO J, V6, P3901; RossMacdonald P, 1997, P NATL ACAD SCI USA, V94, P190, DOI 10.1073/pnas.94.1.190; Hasebe M, 1998, P NATL ACAD SCI USA, V95, P6222, DOI 10.1073/pnas.95.11.6222; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Boyd PJ, 1988, METHODS BRYOLOGY, P47; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; COURTICE GRM, 1983, J BRYOL, V12, P595; Cove DJ, 1997, TRENDS PLANT SCI, V2, P99, DOI 10.1016/S1360-1385(96)10056-X; COVE DJ, 1987, DEV MUTANTS HIGHER P, P181; FEATHERSTONE DR, 1990, MOL GEN GENET, V222, P217, DOI 10.1007/BF00633821; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; GUERINEAU F, 1990, PLANT MOL BIOL, V15, P127, DOI 10.1007/BF00017730; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI 10.1007/BF02667740; SAMBROOK J, 1989, MOL CLOING LAB MANUA; SCHAEFER D, 1991, MOL GEN GENET, V226, P418; SCHAEFER D, 1994, THESIS U LAUSANNE LA; Schumaker KS, 1997, PLANT CELL, V9, P1099, DOI 10.1105/tpc.9.7.1099; Schumaker KS, 1998, ANNU REV PLANT PHYS, V49, P501, DOI 10.1146/annurev.arplant.49.1.501; SEIFERT HS, 1986, GENETIC ENG PRINCIPL, P123; SEIFERT HS, 1986, P NATL ACAD SCI USA, V83, P735, DOI 10.1073/pnas.83.3.735; Tan B. C., 1979, J HATTORI BOT LAB, V46, P327; WALPERT L, 1998, PRINCIPLES DEV	35	141	145	UNIVERSAL ACADEMY PRESS INC	TOKYO	ORDER DEPT., C P O BOX 235, TOKYO, 100-8691, JAPAN	1340-2838			DNA RES	DNA Res.	FEB 28	2000	7	1					9	17		10.1093/dnares/7.1.9		9	Genetics & Heredity	Genetics & Heredity	357CU	WOS:000089481600002		
J	Ikegaya, H; Iwase, H; Hatanaka, K; Sakurada, K; Matsuda, Y; Kobayashi, M; Takatori, T				Ikegaya, H; Iwase, H; Hatanaka, K; Sakurada, K; Matsuda, Y; Kobayashi, M; Takatori, T			Postmortem changes in cytochrome c oxidase activity in various organs of the rat and in human heart	FORENSIC SCIENCE INTERNATIONAL			English	Article						cytochrome c oxidase; postmortem change	DEATH; LIVER; TIME	Cytochrome c oxidase (COX), a mitochondrial enzyme, is inactivated by cyanide or carbon monoxide (CO) intoxication. To test whether cytochrome c has potential as an indicator of these toxins in cadavers, we measured COX activity in the main organs of the rat, and in the human heart, at Various times after death. Each tissue sample or organ was homogenized and the COX activity in the mitochondrial fraction was measured using ferrous cytochrome c as the substrate. COX activity was significantly higher in rat brain, heart and kidney than in lung and liver from 0 to 4 days after death. The loss of COX activity was significantly slower in the brain and heart than in the lung, liver and kidney. Most importantly, COX activity correlated with the time-since-death for each of the rat organs we tested (r(2) =0.70-0.95), but for the human heart (r(2)=0.47). It may be possible that COX activity is likely to be a useful indicator of the time-since-death, and is worth pursuing as an indicator of the tissue cyanide and CO content. (C) 2000 Elsevier Science ireland Ltd. All rights reserved.	Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan; Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan	Ikegaya, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ANTHONY G, 1990, FEBS LETT, V277, P97, DOI 10.1016/0014-5793(90)80817-3; MERLE P, 1980, EUR J BIOCHEM, V105, P499, DOI 10.1111/j.1432-1033.1980.tb04525.x; MERLE P, 1981, BIOCHIM BIOPHYS ACTA, V669, P222, DOI 10.1016/0005-2795(81)90244-0; BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0; AZZI A, 1980, BIOCHIM BIOPHYS ACTA, V594, P231, DOI 10.1016/0304-4173(80)90002-6; BALASOORIYA BAW, 1984, FORENSIC SCI INT, V26, P93, DOI 10.1016/0379-0738(84)90065-3; BUSE G, 1978, H-S Z PHYSIOL CHEM, V359, P1011; CABRAL F, 1978, J BIOL CHEM, V253, P297; GOS T, 1993, INT J LEGAL MED, V106, P25, DOI 10.1007/BF01225020; MERLE P, 1982, EUR J BIOCHEM, V125, P239, DOI 10.1111/j.1432-1033.1982.tb06674.x; ROHDICH F, 1993, BIOCHEMISTRY-US, V32, P8499, DOI 10.1021/bi00084a015; SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x; VERHEUL FEAM, 1979, BIOCHIM BIOPHYS ACTA, V548, P397, DOI 10.1016/0005-2728(79)90144-0; Yamamura W, 1988, BIOCHEMISTRY-US, V27, P4909	14	10	11	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	FEB 28	2000	108	3					181	186		10.1016/S0379-0738(99)00215-7		6	Medicine, Legal	Legal Medicine	291TB	WOS:000085751200004		
J	Yang, D; Herath, S; Musiake, K				Yang, D; Herath, S; Musiake, K			Comparison of different distributed hydrological models for characterization of catchment spatial variability	HYDROLOGICAL PROCESSES			English	Article						distributed physically-based hydrological model; spatial variability; catchment area function	RUNOFF; FLOW; INFILTRATION	Most physically-based hydrological models rely on either spatially distributed or lumped characterizations of topography and other spatial variations. Three disturbed hydrological models with different treatments of topography, namely the MIKE SHE, TOPMODEL and GB model (geomorphology-based hydrological model) are discussed in this paper. A regular square grid system is used by MIKE SHE for representation of catchment spatial variability and as the fundamental computation units. TOPMODEL characterizes the topography using a distributed topographic index, In(a/tan beta). The areas with the same In(a/tan beta) are assumed to be hydrologically similar. Then, the catchment is divided into a number of segments corresponding to the topographic index intervals. The GB model employs the catchment area function and width function to lump the topography and divide the catchment into a series of flow interval-hillslopes. The catchment spatial variations are averaged over each flow interval and represented by one-dimensional distribution functions with respect to the flow distance from the catchment outlet. The hillslope elements are the fundamental computational units in the GB model. The above three models are applied to the Seki River in Japan. The model structure and performance are compared and discussed in the paper. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Yang, D (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						FREEZE RA, 1972, WATER RESOUR RES, V8, P609, DOI 10.1029/WR008i003p00609; Robinson JS, 1996, HYDROL PROCESS, V10, P845, DOI 10.1002/(SICI)1099-1085(199606)10:6<845::AID-HYP375>3.0.CO;2-7; Robinson JS, 1995, WATER RESOUR RES, V31, P3089, DOI 10.1029/95WR01948; MOORE RJ, 1985, HYDROLOG SCI J, V30, P273, DOI 10.1080/02626668509490989; QUINN PF, 1995, HYDROL PROCESS, V9, P161, DOI 10.1002/hyp.3360090204; QUINN P, 1991, HYDROL PROCESS, V5, P59, DOI 10.1002/hyp.3360050106; JACKSON CR, 1992, WATER RESOUR RES, V28, P2533, DOI 10.1029/92WR00664; BEVEN K, 1989, J HYDROL, V105, P157, DOI 10.1016/0022-1694(89)90101-7; Beven K, 1994, TR11094 LANC U CTR R; CABRAL MC, 1992, ADV WATER RESOUR, V15, P311, DOI 10.1016/0309-1708(92)90017-V; DHI, 1993, MIKE SHE TECHN REF M; Freeze R.A., 1972, WATER RESOUR RES, V8, P1273; Kristensen KJ, 1975, NORD HYDROL, V6, P70; LOAGUE KM, 1988, WATER RESOUR RES, V24, P1501, DOI 10.1029/WR024i009p01501; Mesa O.J., 1986, SCALE PROBLEMS HYDRO, P1; NADEN PS, 1992, HYDROLOG SCI J, V37, P53, DOI 10.1080/02626669209492561; Refsgaard J., 1996, DISTRIBUTED HYDROLOG, P16; Refsgaard J.C., 1995, COMPUTER MODELS WATE; WMO, 1975, 7 WMO; Yang D, 1998, ANN J HYDRAULIC ENG, V42, P169	20	35	45	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0885-6087			HYDROL PROCESS	Hydrol. Process.	FEB 28	2000	14	3					403	416		10.1002/(SICI)1099-1085(20000228)14:3<403::AID-HYP945>3.0.CO;2-3		14	Water Resources	Water Resources	300HJ	WOS:000086247000004		
J	Itoh, K; Tosaka, H; Nakajima, K; Nakagawa, M				Itoh, K; Tosaka, H; Nakajima, K; Nakagawa, M			Application of surface-subsurface flow coupled with numerical simulator to runoff analysis in an actual field	HYDROLOGICAL PROCESSES			English	Article						runoff analysis; numerical simulation; surface-subsurface combined flow		A numerical simulator that treats three dimensional, multiphase, surface-subsurface combined flows was applied to actual runoff analysis. A sensitivity study of hydraulic surface/subsurface interaction parameters required in numerical simulation was carried out utilizing short-term data, and a set of parameters that reproduces an actual hydrograph was obtained. To improve reproducibility of the hydrograph, a modification of discretization in expressing riverbed was introduced, so that a more realistic hydrograph is reproduced and a better quantitative estimation about base and side flow is realized. Applying the result of the sensitivity study to long-term runoff analysis, the hydrograph in one year was reproduced satisfactorily with the same hydraulic parameters obtained in the short-term runoff analysis. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, Tokyo 1138656, Japan; OYO Corp, Omiya, Saitama 3308632, Japan	Itoh, K (reprint author), Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, 731 Hongo, Tokyo 1138656, Japan.						Ambroise B, 1996, WATER RESOUR RES, V32, P2135, DOI 10.1029/95WR03716; Refsgaard JC, 1996, WATER RESOUR RES, V32, P2189, DOI 10.1029/96WR00896; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Corey A.T., 1966, J IRRIGATION DRAINAG, V92, P61; KIM J, 1988, B KYOTO U EXPT FORES, V60, P174; KUBOTA J, 1987, B KYOTO U EXPT FORES, V59, P147; Kubota J, 1983, B KYOTO U FORESTS, V55, P162; Ohte N., 1989, Journal of the Japanese Forestry Society, V71, P137; Suzuki M., 1979, Journal of the Japanese Forestry Society, V61, P391; Suzuki M., 1979, Journal of the Japanese Forestry Society, V61, P202; TOSAKA H, 1998, J JAPAN SOC GEOINFOR, V9, P181; TOSAKA H, 1996, J JAPAN ASS GROUNDWA, V38, P253	12	4	5	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0885-6087			HYDROL PROCESS	Hydrol. Process.	FEB 28	2000	14	3					417	430		10.1002/(SICI)1099-1085(20000228)14:3<417::AID-HYP946>3.0.CO;2-O		14	Water Resources	Water Resources	300HJ	WOS:000086247000005		
J	Tosaka, H; Itoh, K; Furuno, T				Tosaka, H; Itoh, K; Furuno, T			Fully coupled formulation of surface flow with 2-phase subsurface flow for hydrological simulation	HYDROLOGICAL PROCESSES			English	Article						surface/subsurface coupled flow; dynamic wave; 2-phase flow	DISTRIBUTED MODELING SYSTEM; EUROPEEN; SHE	With the aim of realizing a surface-subsurface-coupled fluid flow simulation, the authors discuss surface flow models that can be used in the framework of the 2-phase subsurface numerical simulation system. In this paper, three surface flow models, i.e., a kinematic wave model (KW), a diffusion wave model (DW), and a linearized diffusion wave model (LDW), are explained by approximating the momentum equation, and are transformed into a set of nonlinear functions which can be solved simultaneously with the 2-phase subsurface flow. By incorporating these into a 2-phase numerical simulation system, comparison studies are carried out using experimental data and a held scale model. So far as the results of the study are concerned, it is concluded that the DW model gives reasonable performance for any case, the LDW model provides mostly identical results with the DW model with some restrictions, while the KW model is not applicable for the physical modelling of continuous flow through multiple slopes with different angles. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, Tokyo 113, Japan; Oyo Corp, Toro, Saitama, Japan	Tosaka, H (reprint author), Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, 731, Tokyo 113, Japan.						ABBOTT MB, 1986, J HYDROL, V87, P61, DOI 10.1016/0022-1694(86)90115-0; Ambroise B, 1996, WATER RESOUR RES, V32, P2135, DOI 10.1029/95WR03716; Refsgaard JC, 1996, WATER RESOUR RES, V32, P2189, DOI 10.1029/96WR00896; ABBOTT MB, 1986, J HYDROL, V87, P45, DOI 10.1016/0022-1694(86)90114-9; Aziz K, 1983, PETROLEUM RESERVOIR; CHESHIRE IM, 1980, EUROPEAN OFFSHORE PE, V179, P325; HINO M, 1989, NUMERICAL FORECAST F, P41; TOSAKA H, 1995, P PAMG 95 OS JAP, P55; TOSAKA H, 1998, P JAP SOC ENG GEOL 1, P293; TOSAKA H, 1998, J JAPAN SOC GEOINFOR, V9, P181; TOSAKA H, 1996, J JAPAN ASS GROUNDWA, V38, P253; TOSAKA H, 1987, J JAPAN ASS PETROLEU, V52, P307; VINSOME PKW, 1976, SPE5729; YAMAISHI T, 1998, J JAPAN ASS GROUNDWA, V40, P167	14	9	9	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0885-6087			HYDROL PROCESS	Hydrol. Process.	FEB 28	2000	14	3					449	464		10.1002/(SICI)1099-1085(20000228)14:3<449::AID-HYP948>3.0.CO;2-9		16	Water Resources	Water Resources	300HJ	WOS:000086247000007		
J	Nakaegawa, T; Oki, T; Musiake, K				Nakaegawa, T; Oki, T; Musiake, K			The effects of heterogeneity within an area on areally averaged evaporation	HYDROLOGICAL PROCESSES			English	Article						heterogeneity; aggregation; evaporation; subarea and intrasubarea scale	SPATIAL VARIABILITY; LAND SURFACES; FLUXES; MODEL; EVAPOTRANSPIRATION; TEMPERATURE; IMPACT; SCALE	Unresolved heterogeneity in a numerical simulation has a significant impact on the hydrological land surface processes, and the areally averaged quantities do not give the actual Values of different phenomena. In the present study, the equation for computing the areally averaged evaporation taking account of the two hierarchical distributions of the physical quantities, namely subarea and intrasubarea scale distributions, and its components are explained based on the equation. Using the derived equation, numerical experiments to identify the effect of the intrasubarea scale distribution of the temperature and soil moisture content at soil surface are conducted. The estimated evaporation by the mean parameter method can be in the opposite direction because of a slight underestimation of the area representative saturated specific humidity. The effect of the soil moisture distribution is significantly larger than that of the temperature distribution. Normal and uniform distributions with the same mean value and variance of the soil moisture have different effects on the area representative evaporation and the difference between the two reaches some 10%. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Tokyo, Inst Ind Sci, Dept 5, Minato Ku, Tokyo 1068558, Japan	Nakaegawa, T (reprint author), Univ Tokyo, Inst Ind Sci, Dept 5, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.		Oki, Taikan/E-5778-2010	Oki, Taikan/0000-0003-4067-4678			MAHFOUF JF, 1991, J APPL METEOROL, V30, P1354, DOI 10.1175/1520-0450(1991)030<1354:CSOVFO>2.0.CO;2; WOOD EF, 1988, J HYDROL, V102, P29, DOI 10.1016/0022-1694(88)90090-X; Entekhabi D, 1989, J CLIMATE, V2, P816, DOI 10.1175/1520-0442(1989)002<0816:LSHPFA>2.0.CO;2; AVISSAR R, 1989, MON WEATHER REV, V117, P2113, DOI 10.1175/1520-0493(1989)117<2113:APOHLS>2.0.CO;2; FAMIGLIETTI JS, 1995, WATER RESOUR RES, V31, P699, DOI 10.1029/94WR02820; Giorgi F, 1997, REV GEOPHYS, V35, P413, DOI 10.1029/97RG01754; LEE TJ, 1992, J APPL METEOROL, V31, P480, DOI 10.1175/1520-0450(1992)031<0480:ETSSSH>2.0.CO;2; Giorgi F, 1996, J CLIMATE, V9, P1150, DOI 10.1175/1520-0442(1996)009<1150:ARMSOT>2.0.CO;2; Bloschl G, 1995, SCALE ISSUES HYDROLO, P9; DICKINSON RE, 1986, NCARTNMINUS275PLUSST; ENTEKHABI D, 1991, SURV GEOPHYS, V12, P205, DOI 10.1007/BF01903419; HAHN DG, 1976, J ATMOS SCI, V33, P246; HENDERSONSELLER.A, 1992, IGPO PUBL SERIES, V5; JOHNSON KD, 1993, J CLIMATE, V6, P1009, DOI 10.1175/1520-0442(1993)006<1009:TIAVOI>2.0.CO;2; Kalma J. D., 1995, SCALE ISSUES HYDROLO; KIMURA F, 1991, ATMOS ENVIRON B-URB, V25, P155, DOI 10.1016/0957-1272(91)90050-O; KONDO J, 1990, J APPL METROLOGY, V29, P304; KOSTER RD, 1989, J CLIMATE, V5, P1380; LI B, 1994, J CLIMATE, V7, P527, DOI 10.1175/1520-0442(1994)007<0527:TIOSVO>2.0.CO;2; MANABE S, 1969, MON WEATHER REV, V97, P739, DOI 10.1175/1520-0493(1969)097<0739:CATOC>2.3.CO;2; PITMAN AJ, 1995, SCALE ISSUES HYDROLO, P475; Richards J. M., 1971, BRIT J APPL PHYS, V4, pL15; SCHMUGGE T, 1978, WATER RESOUR BULL, V14, P169; SELLERS PJ, 1992, J GEOPHYS RES-ATMOS, V97, P18345; SELLERS PJ, 1986, J ATMOS SCI, V43, P505, DOI 10.1175/1520-0469(1986)043<0505:ASBMFU>2.0.CO;2; SETH A, 1994, J GEOPHYS RES-ATMOS, V99, P18651, DOI 10.1029/94JD01330; SUGITA M, 1990, WATER RESOUR RES, V26, P2937, DOI 10.1029/WR026i012p02937; WETZEL PJ, 1988, MON WEATHER REV, V116, P600, DOI 10.1175/1520-0493(1988)116<0600:EFNSAF>2.0.CO;2	28	9	9	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0885-6087			HYDROL PROCESS	Hydrol. Process.	FEB 28	2000	14	3					465	479		10.1002/(SICI)1099-1085(20000228)14:3<465::AID-HYP949>3.0.CO;2-G		15	Water Resources	Water Resources	300HJ	WOS:000086247000008		
J	Dutta, D; Herath, S; Musiake, K				Dutta, D; Herath, S; Musiake, K			Flood inundation simulation in a river basin using a physically based distributed hydrologic model	HYDROLOGICAL PROCESSES			English	Article						distributed hydrologic model; simulation of flood inundation; Ichinomiya river basin	FLOWS	A physically based distributed hydrologic model is developed in this study for flood inundation simulation combining newly developed overland and channel network flow simulation models with evapotranspiration, unsaturated zone and saturated zone models. The overland flow and river flow models are validated individually with test data, and then coupled with other models. The model can take fine resolution spatial data as input preserving spatial heterogeneity of physical characteristics of a river basin. River embankments play an important role in flood prevention. The model can incorporate river embankment data in flood inundation simulation. The model is applied in a river catchment in Japan to simulate a flood event in 1996. Outputs from the model show good agreements with observed flood hydrographs and surveyed flood inundation. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Tokyo, INCEDE, IIS, Minato Ku, Tokyo 1068558, Japan	Dutta, D (reprint author), Univ Tokyo, INCEDE, IIS, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.		Dutta, Dushmanta/C-5147-2011				AKAN AO, 1981, J HYDR ENG DIV-ASCE, V107, P719; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; ZHANG WH, 1989, WATER RESOUR RES, V25, P2019, DOI 10.1029/WR025i009p02019; Field WG, 1998, J HYDRAUL RES, V36, P29; Cui GR, 1998, J HYDRAUL RES, V36, P379; FENNEMA RJ, 1989, J HYDRAUL RES, V27, P321; FREAD D, 1988, NWS DAMBREAK MODEL T; GEE DM, 1990, HYDR ENG P 1990 NAT, P773; HERATH S, 1990, P 5 INT C URB STORM, P111; INOUE K, 1994, P 5 JSPS VCC SEM INT, P388; IWASA Y, 1982, NATURAL DISASTER SCI, V4, P1; Jha R, 1997, ANN J HYDRAULIC ENG, V41, P227; Rahman M, 1997, J HYDRAUL RES, V35, P243; SAMULES PG, 1985, SR61 HYDR RES	14	41	41	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0885-6087			HYDROL PROCESS	Hydrol. Process.	FEB 28	2000	14	3					497	519		10.1002/(SICI)1099-1085(20000228)14:3<497::AID-HYP951>3.0.CO;2-U		23	Water Resources	Water Resources	300HJ	WOS:000086247000010		
J	Jha, R; Herath, S; Musiake, K				Jha, R; Herath, S; Musiake, K			River network solution for a distributed hydrological model and applications	HYDROLOGICAL PROCESSES			English	Article						distributed hydrological model; flood forecasting; river network solution; Thailand		A simultaneous solution for one-dimensional unsteady flow routing for a network of rivers has been developed, which can be used either with a complete distributed hydrological model, a simple rainfall-runoff model or as a stand alone river routing model. Either dynamic or kinematic solution schemes can be selected to simulate the river flows. The river network is either generated from the Digital Elevation Model (DEM) or directly input to the model. The model can handle any number of upstream channels and computational points. A sparse matrix solution algorithm is used to solve the 2N x 2N matrix resulting from N nodes in the network. A submodule generates the initial water depth and discharge at each computational point from equilibrium discharge in the absence of observed initial conditions. The model is applied in three sub-catchments of the Chao Phraya river basin, Thailand, considering three different conditions. The simulated results show good agreement with observed discharges and provide insight to water level fluctuations, especially where tributaries join the main channel. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Tokyo, Inst Ind Sci, Dept 5, Minato Ku, Tokyo 1068558, Japan	Jha, R (reprint author), Univ Tokyo, Inst Ind Sci, Dept 5, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						Abbott MB, 1967, J HYD RES, V5, P97; ABBOTT MB, 1988, COMPUTATIONAL FLUID; AKAN A, 1981, ASCE HYDRAULIC DIVIS, V107, P719; AMEIN M, 1975, J WATERWAY DIV-ASCE, V101, P93; Amein M., 1970, J HYDRAULICS DIVISIO, V96, P2481; PONCE VM, 1977, J HYDR ENG DIV-ASCE, V103, P1461; Baltzer R. A., 1968, J HYDR DIV ASCE, V94, P1083; CHAUDHURY YM, 1973, WATER RESOURCES RES, V9; CHOI GW, 1993, WATER RESOUR RES, V29, P321, DOI 10.1029/92WR01949; Chow V.T., 1988, APPL HYDROLOGY; CUNG JA, 1980, PRACTICAL ASPECTS CO; FREAD DL, 1976, S INL WAT NAV FLOOD, V1, P16; FREAD DL, 1973, WATER RESOUR RES, V9, P918, DOI 10.1029/WR009i004p00918; ISAACSON E, 1956, NUMERICAL SOLUTION F; JHA R, 1997, THESIS U TOKYO JAPAN; Kristensen KJ, 1975, NORD HYDROL, V6, P70; Liggett J.A., 1975, UNSTEADY FLOW OPEN C, P29; Press W. H., 1992, NUMERICAL RECIPES FO; SEVUK AS, 1973, P INT ASS HYDR RES 5, V5, P169; YEN B, 1976, RIVERS, P212; Yen B. C., 1986, ADV HYDROSCIENCE, V14	21	10	10	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0885-6087			HYDROL PROCESS	Hydrol. Process.	FEB 28	2000	14	3					575	592		10.1002/(SICI)1099-1085(20000228)14:3<575::AID-HYP955>3.0.CO;2-N		18	Water Resources	Water Resources	300HJ	WOS:000086247000014		
J	Noguchi, H; Kawashima, T; Miyamura, T				Noguchi, H; Kawashima, T; Miyamura, T			Element free analyses of shell and spatial structures	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN ENGINEERING			English	Article						meshless; element free Galerkin; shell; membrane; geometrically non-linear	FREE GALERKIN METHOD; INTEGRATION	The element free analyses of shell and spatial structures are conducted. The original element free Galerkin method proposed by Belytschko et al. is enhanced to analyse three-dimensional thin structures. By using the mapping technique the geometry of arbitrary curved surface is expanded in the two-dimensional space, and the bases of convected co-ordinate system are utilized for the expression of strain and stress components in the virtual work principle. Only nodal data are generated on this two-dimensional space and the convected co-ordinates are used in the moving least-squares interpolation method for the approximation of displacement field. For shell, the formulation allows transverse shear strain, therefore, it results in the Mindlin plate when the surface is flat and membrane state is negligible. In order to avoid shear and membrane locking, bi-cubic and quartic basis functions are adopted for the interpolation. For membrane structure, as geometrical stiffness to support the structure cannot be negligible, geometrically non-linear analysis is essential and the total Lagrangian method is adopted for the formulation. Several numerical examples are demonstrated to show the validity of the proposed method and the satisfactory results are obtained in comparison to the theoretical or the finite element results. Copyright (C) 2000 John Wiley & Sons, Ltd.	Keio Univ, Dept Syst Design Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; Univ Tokyo, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1130033, Japan	Noguchi, H (reprint author), Keio Univ, Dept Syst Design Engn, Kohoku Ku, 14-1 3 Chome, Yokohama, Kanagawa 2238522, Japan.						Ahmad S., 1970, INT J NUMER METH ENG, V2, P419, DOI DOI 10.1002/NME.1620020310; PUGH EDL, 1978, INT J NUMER METH ENG, V12, P1059, DOI 10.1002/nme.1620120702; BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205; LU YY, 1994, COMPUT METHOD APPL M, V113, P397, DOI 10.1016/0045-7825(94)90056-6; LIU WK, 1995, INT J NUMER METH FL, V20, P1081, DOI 10.1002/fld.1650200824; SIMO JC, 1989, COMPUT METHOD APPL M, V73, P53, DOI 10.1016/0045-7825(89)90098-4; Belytschko T, 1995, COMPUT MECH, V17, P186; Krysl P, 1996, INT J SOLIDS STRUCT, V33, P3057, DOI 10.1016/0020-7683(95)00265-0; BELYTSCHKO T, 1994, MODEL SIMUL MATER SC, V2, P519, DOI 10.1088/0965-0393/2/3A/007; ARGYRIS J, 1982, COMPUT METHOD APPL M, V32, P85, DOI 10.1016/0045-7825(82)90069-X; Beissel S, 1996, COMPUT METHOD APPL M, V139, P49, DOI 10.1016/S0045-7825(96)01079-1; Donning BM, 1998, COMPUT METHOD APPL M, V152, P47, DOI 10.1016/S0045-7825(97)00181-3; Duarte CA, 1996, COMPUT METHOD APPL M, V139, P237, DOI 10.1016/S0045-7825(96)01085-7; Hinton E., 1984, FINITE ELEMENT SOFTW; KRYSL P, 1985, COMPUTATIONAL MECH, V16, P1; MIYAMURA T, 1997, J STRUCTURES CONSTRU, V494, P91; MONAGHAN JJ, 1988, COMPUT PHYS COMMUN, V48, P89, DOI 10.1016/0010-4655(88)90026-4; NAGASHIMA T, 1996, P C COMP ENG SCI, V1, P3; Nayroles B, 1992, COMPUT MECH, V10, P307, DOI 10.1007/BF00364252; NOGUCHI H, 1993, COMPUT STRUCT, V47, P699, DOI 10.1016/0045-7949(93)90352-E; NOGUCHI H, 1997, P ICES97, P918; RAMM E, 1986, STATE ART TEXTS FINI	22	85	95	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0029-5981			INT J NUMER METH ENG	Int. J. Numer. Methods Eng.	FEB 28	2000	47	6					1215	1240		10.1002/(SICI)1097-0207(20000228)47:6<1215::AID-NME834>3.0.CO;2-M		26	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Engineering; Mathematics	280BX	WOS:000085083300005		
J	Mushnikov, NV; Andreev, AV; Goto, T				Mushnikov, NV; Andreev, AV; Goto, T			Effects of substitution of uranium for yttrium on band metamagnetism of Y(Co0.92Al0.08)(2)	JOURNAL OF ALLOYS AND COMPOUNDS			English	Article						YCo2; itinerant metamagnetism; high magnetic fields; alloying effect	ITINERANT-ELECTRON METAMAGNETISM; PRESSURE; UCOAL	The influence of substitution of U for Y on the magnetic properties of the Y1-xUx(Co0.92Al0.08)(2) solid solutions has been studied for x less than or equal to 0.1. Y(Co0.92Al0.08)(2) is an exchange-enhanced Pauli paramagnet which exhibits a metamagnetic transition to a field-induced ferromagnetic state at a critical field B-c=25.6 T at 4.2 K and a broad maximum at T-max=60 K in the temperature dependence of the magnetic susceptibility. B-c and T-max increase while the paramagnetic susceptibility decreases with increasing U content. The obtained results have been analyzed using a phenomenological theory of itinerant metamagnetism. (C) 2000 Elsevier Science S.A. All rights reserved.	Acad Sci Czech Republ, Inst Phys, Joint Lab Magnet Studies, Prague 12116 2, Czech Republic; Charles Univ, Prague 12116 2, Czech Republic; Inst Phys Met, Ekaterinburg 620219, Russia; Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2770855, Japan	Andreev, AV (reprint author), Acad Sci Czech Republ, Inst Phys, Joint Lab Magnet Studies, Ke Karlovu 5, Prague 12116 2, Czech Republic.		Andreev, Alexander/B-6057-2011; Mushnikov, Nikolay/K-9076-2013	Mushnikov, Nikolay/0000-0002-6354-2558			ALEKSANDRYAN VV, 1985, ZH EKSP TEOR FIZ, V62, P153; Andreev AV, 1997, J MAGN MAGN MATER, V169, P229, DOI 10.1016/S0304-8853(96)00755-X; Mushnikov NV, 1999, J PHYS-CONDENS MAT, V11, P8095, DOI 10.1088/0953-8984/11/41/312; Andreev AV, 1997, PHYS REV B, V55, P5847, DOI 10.1103/PhysRevB.55.5847; AOKI M, 1992, PHYSICA B, V177, P259, DOI 10.1016/0921-4526(92)90108-5; GOTO T, 1994, J APPL PHYS, V76, P6682, DOI 10.1063/1.358167; Ishikawa F, 1998, PHYSICA B, V246, P498, DOI 10.1016/S0921-4526(97)00971-X; Levitin R. Z., 1988, Soviet Physics - Uspekhi, V31, DOI 10.1070/PU1988v031n08ABEH004922; MITAMURA H, UNPUB; SAKAKIBARA T, 1990, J MAGN MAGN MATER, V90-1, P131; Sechovsky V., 1988, FERROMAGNETIC MATERI, V4, P309; YOSHIMURA K, 1985, SOLID STATE COMMUN, V56, P767, DOI 10.1016/0038-1098(85)90305-9	12	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-8388			J ALLOY COMPD	J. Alloy. Compd.	FEB 28	2000	298	1-2					73	76		10.1016/S0925-8388(99)00672-6		4	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	277NL	WOS:000084939600012		
J	Katsufuji, T; Hwang, HY; Cheong, SW				Katsufuji, T; Hwang, HY; Cheong, SW			Anomalous magnetotransport properties of R2Mo2O7 near the magnetic phase boundary	PHYSICAL REVIEW LETTERS			English	Article							PYROCHLORE COMPOUNDS; MAGNETORESISTANCE	The magnetic and transport properties of pyrochlore R2Mo2O7 have been studied with variation of the rare earth (R). The change of the mean ionic radius of R, which induces change of the lattice structure, determines the magnetic ground state (ferromagnetic or spin glass), and the magnetic phase boundary is correlated with the metal-insulator crossover. Furthermore, we found enhanced magnetoresistance and unusual residual anomalous Hall effect at low temperatures near the phase boundary, which can be attributed to the coexistence of both phases.	Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Katsufuji, T (reprint author), Univ Tokyo, Dept Adv Mat Sci, Tokyo 1138656, Japan.		Hwang, Harold/I-6943-2012				ADACHI K, 1979, J PHYS SOC JPN, V46, P1474, DOI 10.1143/JPSJ.46.1474; ALI N, 1989, J SOLID STATE CHEM, V83, P178, DOI 10.1016/0022-4596(89)90067-4; Uehara M, 1999, NATURE, V399, P560; Millis AJ, 1998, NATURE, V392, P147, DOI 10.1038/32348; Matl P, 1998, PHYS REV B, V57, P10248, DOI 10.1103/PhysRevB.57.10248; Moreo A, 1999, SCIENCE, V283, P2034, DOI 10.1126/science.283.5410.2034; Gardner JS, 1999, PHYS REV LETT, V83, P211, DOI 10.1103/PhysRevLett.83.211; GREEDAN JE, 1987, J SOLID STATE CHEM, V68, P300, DOI 10.1016/0022-4596(87)90316-1; KANBAYASI A, 1978, J PHYS SOC JPN, V44, P108, DOI 10.1143/JPSJ.44.108; RHYNE JJ, 1968, PHYS REV, V172, P523, DOI 10.1103/PhysRev.172.523; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Subramanian MA, 1997, J PHYS IV, V7, P625, DOI 10.1051/jp4:19971258	12	89	89	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 28	2000	84	9					1998	2001		10.1103/PhysRevLett.84.1998		4	Physics, Multidisciplinary	Physics	288WX	WOS:000085588400038		
J	Ohishi, N; Otsuka, S; Kawabe, K; Tsubono, K				Ohishi, N; Otsuka, S; Kawabe, K; Tsubono, K			Estimation of thermal noise by a direct measurement of the mechanical conductance	PHYSICS LETTERS A			English	Article						thermal noise; fluctuation-dissipation theorem; anti-resonance; gravitational waves	GRAVITATIONAL-WAVE DETECTORS; MIRRORS	We present a new method for estimating the thermal noise at off-resonant frequencies in a mechanical system. Zn this method, the mechanical conductance is directly measured at anti-resonant frequencies, and then the fluctuation-dissipation theorem is applied to the measured conductance in order to evaluate the thermal noise. To confirm the validity of this method, we demonstrated a direct measurement of the mechanical conductance of a 2-mode oscillator at an anti-resonant frequency. The measured conductance was in good agreement with the value calculated by the normal-mode expansion. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Ohishi, N (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kawabe, Keita/G-9840-2011				SAULSON PR, 1990, PHYS REV D, V42, P2437, DOI 10.1103/PhysRevD.42.2437; Levin Y, 1998, PHYS REV D, V57, P659, DOI 10.1103/PhysRevD.57.659; Bondu F, 1998, PHYS LETT A, V246, P227, DOI 10.1016/S0375-9601(98)00450-2; BONDU F, 1995, PHYS LETT A, V198, P74, DOI 10.1016/0375-9601(94)00983-V; CALLEN HB, 1952, PHYS REV, V86, P702, DOI 10.1103/PhysRev.86.702; GILLESPIE A, 1993, PHYS LETT A, V178, P357, DOI 10.1016/0375-9601(93)90861-S; GILLESPIE A, 1995, PHYS REV D, V52, P577, DOI 10.1103/PhysRevD.52.577; GILLESPIE A, 1995, THESIS; GONZALEZ GI, 1995, PHYS LETT A, V201, P12, DOI 10.1016/0375-9601(95)00194-8; Kajima M, 1999, PHYS LETT A, V264, P251, DOI 10.1016/S0375-9601(99)00828-2; Nakagawa N, 1997, REV SCI INSTRUM, V68, P3553, DOI 10.1063/1.1148321; OHISHI N, 1997, P TAMA WORKSH GRAV W, P369; Tsubono K, 1997, P TAMA WORKSH GRAV W, P183	13	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9601			PHYS LETT A	Phys. Lett. A	FEB 28	2000	266	4-6					228	233		10.1016/S0375-9601(99)00867-1		6	Physics, Multidisciplinary	Physics	291YQ	WOS:000085767700002		
J	Nakao, H				Nakao, H			Multi-scaling properties of truncated Levy flights	PHYSICS LETTERS A			English	Article						truncated Levy flights; multi-scaling properties	STOCHASTIC-PROCESS; CONVERGENCE; TURBULENCE	Multi-scaling properties of one-dimensional truncated Levy flights are studied. Due to the broken self-similarity of the distribution of jumps, they are expected to possess multi-scaling properties in contrast to the ordinary Levy flights. We argue this fact based on a smoothly truncated Levy distribution, and derive the functional form of the scaling exponents. Specifically, they exhibit bi-fractal behavior, which is the simplest case of multi-scaling. (C) 2000 Published by Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan	Nakao, H (reprint author), Univ Tokyo, Grad Sch Math Sci, 3-8-1 Komaba, Tokyo 1538914, Japan.		Nakao, Hiroya/B-9264-2015	Nakao, Hiroya/0000-0003-3394-0392			BENZI R, 1991, PHYS REV LETT, V67, P2299, DOI 10.1103/PhysRevLett.67.2299; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Ivanova K, 1999, EUR PHYS J B, V8, P665, DOI 10.1007/s100510050734; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; Vandewalle N, 1998, EUR PHYS J B, V4, P257, DOI 10.1007/s100510050376; Bergstrom H., 1952, ARK MAT, V2, P375, DOI 10.1007/BF02591503; Bohr T., 1998, DYNAMICAL SYSTEMS AP; BOUCHAUD JP, CONDMAT9905413; CHECHKIN AV, CONDMAT9907234; CHESSA A, 1999, PHYS REV E, V59, P12; CONT R, CONDMAT9705087; Dubrulle B, 1998, EUR PHYS J B, V4, P143, DOI 10.1007/s100510050362; Feller W., 1971, INTRO PROBABILITY TH, V2; Frisch U., 1995, TURBULENCE LEGACY; NAKAO H, 1999, EUR PHYS J B, V10, P345; Sato AH, 1998, PHYSICA A, V250, P231, DOI 10.1016/S0378-4371(97)00569-4; Shlesinger M. F., 1995, LEVY FLIGHTS RELATED; Sornette D, 1998, PHYSICA A, V250, P295, DOI 10.1016/S0378-4371(97)00543-8	18	47	47	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9601			PHYS LETT A	Phys. Lett. A	FEB 28	2000	266	4-6					282	289		10.1016/S0375-9601(00)00059-1		8	Physics, Multidisciplinary	Physics	291YQ	WOS:000085767700012		
J	Akutsu, T; Halldorsson, MM				Akutsu, T; Halldorsson, MM			On the approximation of largest common subtrees and largest common point sets	THEORETICAL COMPUTER SCIENCE			English	Article						approximation algorithms; common subtree; common point set; computational biology	SUPERSEQUENCES; SUBSEQUENCES	This paper considers the approximability of the largest common subtree and the largest common point-set problems, which have applications in molecular biology. It is shown that the problems cannot be approximated within a factor of n(1-epsilon) in polynomial time for any epsilon > 0 Unless NP subset of or equal to ZPP, while a general search algorithm which approximates both problems within a factor of O(n/log n) is presented. For trees of bounded degree, an improved algorithm which approximates the largest common subtree within a factor of O(n/ log(2) n) is presented. Moreover, several variants of the largest common subtree problem are studied. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 108, Japan	Halldorsson, MM (reprint author), Univ Iceland, Inst Sci, Dunhaga 3, IS-107 Reykjavik, Iceland.						AKUTSU T, 1993, IEICE T FUND ELECTR, VE76A, P1488; AKUTSU T, 1994, LECT NOTES COMPUTER, V834, P405; Anderson S., 1984, J MOL GRAPHICS, V2, P8; VRIEND G, 1991, PROTEINS, V11, P52, DOI 10.1002/prot.340110107; MAIER D, 1978, J ACM, V25, P322, DOI 10.1145/322063.322075; AKUTSU T, 1992, IEICE T INF SYST, VE75D, P95; ALT H, 1988, DISCRETE COMPUT GEOM, V3, P237, DOI 10.1007/BF02187910; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; STOBAUGH RE, 1985, J CHEM INF COMP SCI, V25, P271, DOI 10.1021/ci00047a025; Garey M.R., 1979, COMPUTERS INTRACTABI; Hastad J, 1996, AN S FDN CO, P627, DOI 10.1109/SFCS.1996.548522; JIANG T, 1995, SIAM J COMPUT, V24, P1122, DOI 10.1137/S009753979223842X; Keselman D., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), DOI 10.1109/SFCS.1994.365717; KHANNA S, 1995, APPROXIMATION ALGORI; MCGREGOR JJ, 1982, SOFTWARE PRACT EXPER, V12, P23, DOI 10.1002/spe.4380120103; REYNER SW, 1977, SIAM J COMPUT, V6, P730, DOI 10.1137/0206053; Takahashi Y., 1987, ANAL SCI, V3, P23, DOI 10.2116/analsci.3.23	17	26	28	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3975	1879-2294		THEOR COMPUT SCI	Theor. Comput. Sci.	FEB 28	2000	233	1-2					33	50		10.1016/S0304-3975(97)00278-8		18	Computer Science, Theory & Methods	Computer Science	274YV	WOS:000084793400003		
J	Sasaki, M; Noguchi, K; Fuwa, H; Tachibana, K				Sasaki, M; Noguchi, K; Fuwa, H; Tachibana, K			Convergent synthesis of an HIJK ring model of ciguatoxin via Suzuki cross-coupling reaction	TETRAHEDRON LETTERS			English	Article						coupling reactions; polyethers; Suzuki reactions; toxins	STEREOSELECTIVE SYNTHESIS; A,B,C-RING SYSTEM; OXONENE RING; CONSTRUCTION; ETHERS; STRATEGY; PART; OXEPENE; TOXINS	Convergent synthesis of HIJK ring model compound 1 of ciguatoxin is described. The present synthesis relied on a palladium-catalyzed Suzuki cross-coupling reaction between eight-membered ketene acetal phosphate 2 and seven-membered alkylborane 6. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Sch Sci, Dept Chem, CREST,Japan Sci & Technol Corp,JST,Bunkyo Ku, Tokyo 1130033, Japan	Sasaki, M (reprint author), Univ Tokyo, Sch Sci, Dept Chem, CREST,Japan Sci & Technol Corp,JST,Bunkyo Ku, Tokyo 1130033, Japan.		Fuwa, Haruhiko/D-1773-2010				ALVAREZ E, 1995, CHEM REV, V95, P1953, DOI 10.1021/cr00038a008; Alvarez E, 1996, TETRAHEDRON LETT, V37, P2865, DOI 10.1016/0040-4039(96)00408-X; Ami E, 1997, BIOSCI BIOTECH BIOCH, V61, P2019; Oka T, 1998, TETRAHEDRON, V54, P1, DOI 10.1016/S0040-4020(97)10253-8; Nicolaou KC, 1997, J AM CHEM SOC, V119, P5467, DOI 10.1021/ja970619+; SCHEUER PJ, 1994, TETRAHEDRON, V50, P3, DOI 10.1016/S0040-4020(01)80733-X; Sasaki M, 1999, ORG LETT, V1, P1075, DOI 10.1021/ol990885n; Sasaki M, 1998, TETRAHEDRON LETT, V39, P9027, DOI 10.1016/S0040-4039(98)02025-5; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; NICOLAOU KC, 1990, J AM CHEM SOC, V112, P6263, DOI 10.1021/ja00173a013; ITO Y, 1978, J ORG CHEM, V43, P1011, DOI 10.1021/jo00399a052; Atsuta H, 1997, SYNLETT, P307; Hosokawa S, 1999, J ORG CHEM, V64, P37, DOI 10.1021/jo980088n; Inoue M, 1997, TETRAHEDRON LETT, V38, P1611, DOI 10.1016/S0040-4039(97)00125-1; Inoue M, 1998, ANGEW CHEM INT EDIT, V37, P965, DOI 10.1002/(SICI)1521-3773(19980420)37:7<965::AID-ANIE965>3.0.CO;2-P; Inoue M, 1999, TETRAHEDRON, V55, P10949, DOI 10.1016/S0040-4020(99)00620-1; Inoue M, 1999, J ORG CHEM, V64, P9416, DOI 10.1021/jo990989b; Isobe M, 1998, CHEM COMMUN, P2665, DOI 10.1039/a804940h; Isobe M, 1996, CHEM LETT, P473, DOI 10.1246/cl.1996.473; KADOTA I, 1998, TETRAHEDRON LETT, V39, P7373; LEY SV, 1994, SYNTHESIS-STUTTGART, P639; Maeda K, 1999, CHEM COMMUN, P1063, DOI 10.1039/a903063h; Mori Y, 1997, CHEM-EUR J, V3, P849, DOI 10.1002/chem.19970030604; Oguri H, 1999, SYNTHESIS-STUTTGART, P1431; Oguri H, 1997, TETRAHEDRON, V53, P3057, DOI 10.1016/S0040-4020(97)00071-9; Oguri H, 1999, TETRAHEDRON LETT, V40, P5405, DOI 10.1016/S0040-4039(99)01017-5; Oishi T, 1996, SYNLETT, P1165; Oishi T, 1997, CHEM COMMUN, P1289, DOI 10.1039/a702158e; Oishi T., 1998, CHEM COMMUN, P1359; Oka T, 1997, TETRAHEDRON LETT, V38, P8053, DOI 10.1016/S0040-4039(97)10107-1; Oka T, 1996, TETRAHEDRON, V52, P12091, DOI 10.1016/0040-4020(96)00700-4; Oka T, 1998, TETRAHEDRON, V54, P21, DOI 10.1016/S0040-4020(97)10254-X; Saeeng R, 1999, TETRAHEDRON LETT, V40, P1911, DOI 10.1016/S0040-4039(99)00041-6; SASAKI M, 1993, TETRAHEDRON LETT, V34, P8489, DOI 10.1016/S0040-4039(00)61366-7; SASAKI M, 1994, J ORG CHEM, V59, P715, DOI 10.1021/jo00083a008; Sasaki M, 1999, TETRAHEDRON LETT, V40, P1337, DOI 10.1016/S0040-4039(98)02606-9; Sasaki M, 1998, TETRAHEDRON LETT, V39, P2783, DOI 10.1016/S0040-4039(98)00338-4; Sasaki M, 1999, J ORG CHEM, V64, P9399, DOI 10.1021/jo990988j; Oishi T, 1997, CHEM LETT, P845, DOI 10.1246/cl.1997.845	39	53	53	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 26	2000	41	9					1425	1428		10.1016/S0040-4039(99)02307-2		4	Chemistry, Organic	Chemistry	289JK	WOS:000085617000027		
J	Nagumo, M; Yagi, T; Saitoh, H				Nagumo, M; Yagi, T; Saitoh, H			Deformation-induced defects controlling fracture toughness of steel revealed by tritium desorption behaviors	ACTA MATERIALIA			English	Article						fracture & fracture toughness; steel; vacancy; microstructure; thermal desorption analysis	HEAT-AFFECTED ZONE; LOW-CARBON STEELS; DUCTILE CRACK-GROWTH; TRANSITION REGION; INITIATION; RESISTANCE; HYDROGEN; RELEVANT; TENSILE; STRESS	Defects induced by plastic deformation have been revealed by means of room temperature desorption and thermal desorption spectroscopy of tritium with regards to the ductile crack growth resistance and brittle fracture initiation in steels in the ductile-to-brittle transition region. Tritium, as a probe for detecting defects, was introduced into non-deformed or deformed samples. Three steels, the microstructures of which are characterized by the constrains factor for slip extension, were employed. The residual tritium in a specimen after three days at room temperature increased to the extent corresponding to the constraint factors when plastic deformation was applied. The thermally desorbed tritium, with a peak desorption rate around 150 degrees C, also increased according to the constraint factors. Referring to the previous analysis of the R-curves, the constraint for the extension of slip across grain boundaries is shown to control both the ductile crack growth resistance and the brittle fracture initiation through the deformation microstructures that evolve vacancy clusters or microvoids. (C) 2000 Acta Metallurgica Inc. Published by Elsevier Science Ltd All rights reserved.	Waseda Univ, Dept Mat Sci & Engn, Tokyo 1698555, Japan; Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Nagumo, M (reprint author), Waseda Univ, Dept Mat Sci & Engn, Okubo 3-4-1, Tokyo 1698555, Japan.						Van Stone R. H., 1985, International Metals Reviews, V30; MACKENZIE AC, 1977, ENG FRACT MECH, V9, P167, DOI 10.1016/0013-7944(77)90062-5; Ohya K, 1996, METALL MATER TRANS A, V27, P2574, DOI 10.1007/BF02652351; VEHANEN A, 1982, PHYS REV B, V25, P762, DOI 10.1103/PhysRevB.25.762; MCMAHON CJ, 1965, ACTA METALL MATER, V13, P591, DOI 10.1016/0001-6160(65)90121-5; SAITO H, 1995, J JPN I MET, V59, P910; ESSMANN U, 1979, PHILOS MAG A, V40, P731; MECKING H, 1980, SCRIPTA METALL MATER, V14, P815, DOI 10.1016/0036-9748(80)90295-1; THOMPSON AW, 1984, SCRIPTA METALL MATER, V18, P127, DOI 10.1016/0036-9748(84)90489-7; RICE JR, 1969, J MECH PHYS SOLIDS, V17, P201, DOI 10.1016/0022-5096(69)90033-7; AOKI M, 1994, J JPN I MET, V10, P1141; BEGLEY A, 1974, ASTM STP, V560, P170; BRAY JW, 1992, METALL TRANS A, V23, P485, DOI 10.1007/BF02801166; CHOO WY, 1982, METALL TRANS A, V13, P135, DOI 10.1007/BF02642424; COTTRELL AH, 1958, T AM I MIN MET ENG, V212, P192; FARKAS D, 1997, 5 INT C FUND FRACT G, P104; HAHN GT, 1984, METALL TRANS A, V15, P947, DOI 10.1007/BF02644685; DAVIS CL, 1994, METALL MATER TRANS A, V25, P563, DOI 10.1007/BF02651598; KOIDE M, 1994, MAT SCI ENG A-STRUCT, V176, P171, DOI 10.1016/0921-5093(94)90972-5; LAURENT JP, 1973, INT J APPL RADIAT IS, V24, P213, DOI 10.1016/0020-708X(73)90044-6; MCCLINTO.FA, 1968, J APPL MECH, V35, P363; Nagumo M, 1999, SCRIPTA MATER, V40, P313, DOI 10.1016/S1359-6462(98)00436-9; NEEDLEMANN A, 1983, STP ASTM, V803, P1; RITCHIE RO, 1973, J MECH PHYS SOLIDS, V21, P395, DOI 10.1016/0022-5096(73)90008-2; RITCHIE RO, 1979, METALL TRANS A, V10, P1557, DOI 10.1007/BF02812022; RITCHIE RO, 1985, METALL TRANS A, V16, P233, DOI 10.1007/BF02816050; SAADA J, 1961, PHYSICA, V27, P657; SLEESWYK AW, 1962, ACTA METALL MATER, V10, P803, DOI 10.1016/0001-6160(62)90094-9; TAKAMURA JI, 1969, T IRON STEEL I JPN, V9, P216; TANI T, 1995, METALL MATER TRANS A, V26, P391, DOI 10.1007/BF02664675; THOMPSON AW, 1987, METALL TRANS A, V18, P1877, DOI 10.1007/BF02647017; WILLIAMS JC, 1969, ASTM STP, V453, P215; WILSON KL, 1978, J NUCL MATER, V76-7, P291, DOI 10.1016/0022-3115(78)90160-5; Xia L, 1995, J MECH PHYS SOLIDS, V43, P223; YAGI T, 1995, TETSU TO HAGANE, V81, P225; Yokoyama K, 1998, METALL MATER TRANS A, V29, P551, DOI 10.1007/s11661-998-0136-8; Yoshida H, 1998, ISIJ INT, V38, P196, DOI 10.2355/isijinternational.38.196; YOSHIDA H, UNPUB MAT T A; Yoshida H, 1998, METALL MATER TRANS A, V29, P279, DOI 10.1007/s11661-998-0179-x	39	30	30	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454			ACTA MATER	Acta Mater.	FEB 25	2000	48	4					943	951		10.1016/S1359-6454(99)00392-4		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	289DM	WOS:000085605300013		
J	El-Nahas, AM; Tajima, N; Hirao, K				El-Nahas, AM; Tajima, N; Hirao, K			Do Cu2+NH3 and Cu2+OH2 exist? theory confirms 'yes!'	CHEMICAL PHYSICS LETTERS			English	Article							TRANSITION-METAL IONS; SPACE SCF METHOD; GAS-PHASE; MOLECULAR CALCULATIONS; ELECTRONIC-STRUCTURE; BINDING-ENERGIES; BASIS-SETS; COMPLEXES; WATER; THERMOCHEMISTRY	CCSD(T) and MRMP calculations with TZP + quality basis sets are used to study the interaction of Cu2+ with up to two ligand molecules L (L = H2O, H2S, NH3, and PH3). The dissociation to Cu+ and L+ is much more stable than the formation of Cu2+ L adducts (by 76-100 kcal/mol). Nevertheless, it might be possible to obtain a one-ligand complex for H2O and NH3; barrier heights of 7 and 9 kcal/mol, respectively, are assigned for the dissociation process, Two ligands from H2O and NH3 can give more stable complexes with Cu2+ as the barrier heights reach 40 kcal/mol. In order to obtain stable complexes of PH3 or H2S with Cu2+, at least two ligands are required. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	El-Nahas, AM (reprint author), El Menoufia Univ, Fac Sci, Dept Chem, Shebin El Kom, Egypt.						Stace AJ, 1997, J AM CHEM SOC, V119, P10239, DOI 10.1021/ja9722436; HOLLAND PM, 1982, J CHEM PHYS, V76, P4195, DOI 10.1063/1.443497; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975; Walter D, 1998, J AM CHEM SOC, V120, P3176, DOI 10.1021/ja973202c; HIRAO K, 1992, CHEM PHYS LETT, V196, P397, DOI 10.1016/0009-2614(92)85710-R; DALLESKA NF, 1994, J AM CHEM SOC, V116, P3519, DOI 10.1021/ja00087a044; BLADES AT, 1990, INT J MASS SPECTROM, V102, P251, DOI 10.1016/0168-1176(90)80064-A; HIRAO K, 1993, CHEM PHYS LETT, V201, P59, DOI 10.1016/0009-2614(93)85034-L; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; HIRAO K, 1992, CHEM PHYS LETT, V190, P374, DOI 10.1016/0009-2614(92)85354-D; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; ROOS BO, 1980, CHEM PHYS, V48, P157, DOI 10.1016/0301-0104(80)80045-0; POPLE JA, 1987, J CHEM PHYS, V87, P5968, DOI 10.1063/1.453520; BLADES AT, 1990, J CHEM PHYS, V92, P5900, DOI 10.1063/1.458360; CORONGIU G, 1978, J CHEM PHYS, V69, P4885, DOI 10.1063/1.436518; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; BLADES AT, 1990, INT J MASS SPECTROM, V101, P325, DOI 10.1016/0168-1176(90)87020-H; ARMENTROUT PB, 1995, ACCOUNTS CHEM RES, V28, P430, DOI 10.1021/ar00058a005; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Carpenter J. E., 1988, J MOL STRUC-THEOCHEM, V169, P41, DOI 10.1016/0166-1280(88)80248-3; CLEMMER DE, 1991, J PHYS CHEM-US, V95, P3084, DOI 10.1021/j100161a025; Cotton F.A., 1988, ADV INORGANIC CHEM; El-Nahas AM, 1999, J MOL STRUC-THEOCHEM, V469, P201, DOI 10.1016/S0166-1280(99)00073-1; ELNAHAS AM, IN PRESS J PHYS CHEM; Frisch M.J., 1998, GAUSSIAN 98; HIRAO K, 1992, INT J QUANTUM CHEM S, V26, P517; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MAGNERA TF, 1989, J AM CHEM SOC, V111, P4100, DOI 10.1021/ja00193a051; MARINELLI PJ, 1989, J AM CHEM SOC, V111, P1401; Roos B. O., 1980, INT J QUANTUM CHEM S, V18, P175; SIEGBAHN P, 1980, PHYS SCRIPTA, V21, P323, DOI 10.1088/0031-8949/21/3-4/014; Wu JL, 1999, CHEM PHYS LETT, V303, P243, DOI 10.1016/S0009-2614(99)00204-3	33	40	40	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	FEB 25	2000	318	4-5					333	339		10.1016/S0009-2614(00)00003-8		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	289YV	WOS:000085650300007		
J	Hashimotio, T; Kojima, K; Tange, T; Sasaki, S				Hashimotio, T; Kojima, K; Tange, T; Sasaki, S			Changes in carbon storage in fallow forests in the tropical lowlands of Borneo	FOREST ECOLOGY AND MANAGEMENT			English	Article						Indonesia; shifting cultivation; fallow forest; biomass; CO2 absorption; global warming	DIOXIDE; BIOMASS	The range of CO2 emissions to the atmosphere from tropical land-use change has long been debated. A major source of uncertainty is attributable to the fluxes of CO2 due to changes in tropical land use. For example, estimate is different depending on whether the biomass or carbon content of tropical forests is totally lost by burning or recovered by regrowth. To estimate CO2 absorption by fallow forests after shifting cultivation, we investigated the floristic composition and measured the biomass of fallow forests in East Kalimantan, Indonesia. Above-ground biomass of fallow forests were 8-10 t/ha at one-year-old stands and 45-56 t/ha at 10-12-year-old stands, regardless of the floristic composition. It seems reasonable to suppose that 7.4% of carbon released to the atmosphere by tropical rain forest destruction is reabsorbed and stored by fallow forests in Indonesia. If this is a universal trend in other tropical forests, a significant amount of CO2 is reabsorbed in fallow forests. We consider that fallow forests like the one studied here are substantial carbon sinks and help to offset the effects of anthropogenic CO2 emissions. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo 1138657, Japan; Nihon Univ, Coll Bioresource Sci, Kanagawa 2520813, Japan	Hashimotio, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						HOUGHTON RA, 1991, CLIMATIC CHANGE, V19, P99, DOI 10.1007/BF00142217; MALINGREAU JP, 1985, AMBIO, V14, P314; YAMAKURA T, 1986, VEGETATIO, V68, P71; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; DETWILER RP, 1988, SCIENCE, V239, P42, DOI 10.1126/science.239.4835.42; BACKER CA, 1963, FLORA JAVA, V1, P171; BROECKER WS, 1979, SCIENCE, V206, P409, DOI 10.1126/science.206.4417.409; *FAO, 1993, FOR RES ASS 1990 TRO, P59; HALL CAS, 1991, CAN J FOREST RES, V21, P118, DOI 10.1139/x91-016; HOUGHTON JT, 1996, 1996 CLIMATE CHANGE, P9; MYERS N, 1991, CLIMATIC CHANGE, V19, P3, DOI 10.1007/BF00142209; Schimel DS, 1996, CLIMATE CHANGE 1995, P76; Sukardjo S., 1990, B NAGOYA U FOR, V10, P1	13	27	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1127			FOREST ECOL MANAG	For. Ecol. Manage.	FEB 25	2000	126	3					331	337		10.1016/S0378-1127(99)00104-8		7	Forestry	Forestry	280WE	WOS:000085126100006		
J	Watanabe, K; Iguchi, K; Hosoya, K; Nishida, M				Watanabe, K; Iguchi, K; Hosoya, K; Nishida, M			Phylogenetic relationships of the Japanese minnows, Pseudorasbora (Cyprinidae), as inferred from mitochondrial 16S rRNA gene sequences	ICHTHYOLOGICAL RESEARCH			English	Article						Pseudorasbora; Cyprinidae; mitochondrial DNA; 16S rRNA; molecular phylogeny	MOLECULAR PHYLOGENY; EVOLUTION; FISHES; DNA	The phylogenetic relationships among three Pseudorasbora fishes (Cyprinidae, Sarcocheiichthyinae) occurring in Japan (P. parva, P. pumila pumila and P. pumila subsp. sensu Nakamura [1963]) were inferred from nucleotide sequences of the mitochondrial 16S rRNA gene. The sequences, of 1240 bp, were determined and compared for 22 specimens from 2-8 populations for each taxon, with a single Pungtungia herzi specimen as an outgroup. A total of 171 sites (13.8%) were variable among the specimens, but only 0-2 sites within each population. The phylogenetic relationships estimated by neighbor-joining, maximum-parsimony and maximum-likelihood methods confirmed a sister relationship between the two P. pumila subspecies, with a high level of confidence. However, their genetic distinction from each other (4.1+/-0.4SD% sequence difference on average) was at a level similar to that between them and P. parva (5.9+/-0.5%). The geographic distribution of the two P. pumila subspecies, which are separated by the Fossa Magna region, suggests that the genetic divergence of the two subspecies originated from a vicariant process separating the freshwater ichthyofaunas of eastern and western Honshu. Pseudorasbora parva populations were divided into two genetic groups (1.8+/-0.2% sequence difference), one group comprising continental and part of the Japanese populations, and the other the remaining Japanese populations. This suggests that at least two genetically divergent lineages had been originally distributed in Japan, but a strong possibility remains that the present situation has resulted from artificial transplantation.	Fukui Prefectural Univ, Dept Marine Biosci, Fukui 9170003, Japan; Natl Res Inst Fisheries Sci, Nagano 3860031, Japan	Watanabe, K (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, 1-15-1 Minamidai, Tokyo, Japan.		Watanabe, Katsutoshi/H-3414-2011				Simons AM, 1998, MOL PHYLOGENET EVOL, V9, P308, DOI 10.1006/mpev.1997.0467; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.2307/2408332; BARGELLONI L, 1994, MOL BIOL EVOL, V11, P854; Cheng QT, 1987, SYSTEMATIC SYNOPSIS; *ENV AG JAP, 1991, THREAT SPEC JAP RED; Eschmeyer W.N., 1998, SPECIAL PUBLICATION, V1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Goldstein Paul, 1993, LAT AM ANTIQ, V4, P22, DOI 10.2307/972135; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOSOYA K, 1993, FISHES JAPAN PICTORI, P212; Kawamura Kouichi, 1997, Japanese Journal of Ichthyology, V44, P57; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kitaura J, 1998, MOL BIOL EVOL, V15, P626; Kumar S., 1993, MEGA MOL EVOLUTIONAR; LU YL, 1977, CYPRINID FISHES CHIN, V2, P439; MEYER A, 1993, P ROY SOC B-BIOL SCI, V252, P231, DOI 10.1098/rspb.1993.0070; Miya M, 1998, MOL PHYLOGENET EVOL, V10, P11, DOI 10.1006/mpev.1997.0479; Miya M, 1996, ICHTHYOL RES, V43, P375, DOI 10.1007/BF02347637; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nakamura M., 1963, KEYS FRESHWATER FISH; Nakamura M., 1969, NIPPON NO KOI KA GYO; NISHIMURA S, 1980, NIHON KAI NO SEIRITS; Page R, 1998, MOL EVOLUTION PHYLOG; SWOFFORD DL, 1999, PAUP STAR PHYLOGENET; TATSUKAWA K, 1989, NIPPON NO TRANSUIGYO, P282; UCHIYAMA R, 1987, TANSUIGYO, V13, P74; UCHIYAMA R, 1989, NIPPON NO TANSUIGYO, P302; Watanabe K, 1998, ICHTHYOL RES, V45, P259, DOI 10.1007/BF02673924	29	15	18	ICHTHYOLOGICAL SOC JAPAN	TOKYO	BUSINESS CENTER ACADEMIC SOC JAPAN, 5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113, JAPAN	1341-8998			ICHTHYOL RES	Ichthyol. Res.	FEB 25	2000	47	1					43	50		10.1007/BF02674312		8	Zoology	Zoology	308JF	WOS:000086706300005		
J	Kanamori, H; Krieg, S; Mao, CJ; Di Pippo, VA; Wang, S; Zajchowski, DA; Shapiro, DJ				Kanamori, H; Krieg, S; Mao, CJ; Di Pippo, VA; Wang, S; Zajchowski, DA; Shapiro, DJ			Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR RISK-FACTORS; MESSENGER-RNA; CYTOTOXIC LYMPHOCYTES; POSTMENOPAUSAL WOMEN; RESPONSE ELEMENT; RECEPTOR; EXPRESSION; INDUCTION; PROTEASES; MECHANISMS	Although liver is an estrogen target tissue, the number of hepatic genes known to be directly induced by estrogen is very small. We identified proteinase inhibitor 9, or PI-9, as being rapidly and strongly induced by estrogen in an estrogen receptor-positive human liver cell line (HepG2-ER7), Since PI-9 mRNA was also induced by estrogen in a human liver biopsy sample, PI-9 is a genuine estrogen-regulated human gene. PI-9 is a potent inhibitor of granzyme B and of granzyme B-mediated apoptosis. Estrogens induced PI-9 mRNA within 2 h, PI-9 mRNA levels reached a plateau of 30-40-fold induction in 4 h, and induction was not blocked by cycloheximide, indicating that induction of PI-9 mRNA is a primary response. The antiestrogen trans-hydroxytamoxifen was a partial agonist for PI-9 mRNA induction, whereas the antiestrogen ICI 182,780 was a pure antagonist. Western blot analysis showed that estrogen strongly increases PI-9 protein levels. Inhibition of transcription with actinomycin D resulted in identical rates of PI-B mRNA decay in the presence and absence of estrogen, We isolated genomic clones containing the PI-9 promoter region, identified a putative transcription start site, and carried out transient transfections of PI-g-luciferase reporter gene constructs. The estrogen, moxestrol, elicited a robust induction from the PI-9-luciferase reporter, Mutational inactivation of three potential imperfect estrogen response elements in the PI-9 5'-flanking region had no effect on moxestrol estrogen receptor induction.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan; Berlex Biosci, Dept Canc Res, Richmond, CA 94804 USA	Shapiro, DJ (reprint author), Univ Illinois, Dept Biochem, 413 RAL,600 S Mathews Ave, Urbana, IL 61801 USA.						KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Sun JR, 1996, J BIOL CHEM, V271, P27802; Bird CH, 1998, MOL CELL BIOL, V18, P6387; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; NABULSI AA, 1993, NEW ENGL J MED, V328, P1069, DOI 10.1056/NEJM199304153281501; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; LOVE RR, 1994, J NATL CANCER I, V86, P1534, DOI 10.1093/jnci/86.20.1534; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Atkinson EA, 1998, J BIOL CHEM, V273, P21261, DOI 10.1074/jbc.273.33.21261; ATTARDI B, 1993, MOL ENDOCRINOL, V7, P668, DOI 10.1210/me.7.5.668; Barkhem T, 1997, J STEROID BIOCHEM, V62, P53, DOI 10.1016/S0960-0760(97)00017-4; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Darmon AJ, 1998, CRIT REV IMMUNOL, V18, P255; Dean DM, 1996, MOL ENDOCRINOL, V10, P1489, DOI 10.1210/me.10.12.1489; Froelich CJ, 1998, IMMUNOL TODAY, V19, P30, DOI 10.1016/S0167-5699(97)01184-5; Harlow E.D., 1988, ANTIBODIES LAB MANUA; Hayashi J, 1998, ARCH INTERN MED, V158, P177, DOI 10.1001/archinte.158.2.177; IWAMURA K, 1979, ACTA HEPATO-GASTRO, V26, P267; IWAMURA K, 1976, Tokai Journal of Experimental and Clinical Medicine, V1, P41; Kanamori H, 1999, BIOTECHNIQUES, V26, P1018; Krams S M, 1995, Transpl Immunol, V3, P162, DOI 10.1016/0966-3274(95)80043-3; KRATTENMACHER R, 1994, J STEROID BIOCHEM, V48, P207, DOI 10.1016/0960-0760(94)90146-5; LEE JH, 1995, DNA CELL BIOL, V14, P419, DOI 10.1089/dna.1995.14.419; Lipsett MB, 1978, REPRODUCTIVE ENDOCRI, P80; Mattick S, 1997, J STEROID BIOCHEM, V60, P285, DOI 10.1016/S0960-0760(96)00198-7; Roger T, 1998, BIOCHEM J, V330, P429; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; SPRECHER CA, 1995, J BIOL CHEM, V270, P29854; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; TAM SP, 1985, J BIOL CHEM, V260, P1670; TORA L, 1989, EMBO J, V8, P1981; ZAJCHOWSKI DA, 1991, MOL ENDOCRINOL, V5, P1613; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632	39	34	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	2000	275	8					5867	5873		10.1074/jbc.275.8.5867		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	286XQ	WOS:000085474500085		
J	Fujiki, Y; Sato, T; Ito, M; Watanabe, A				Fujiki, Y; Sato, T; Ito, M; Watanabe, A			Isolation and characterization of cDNA, clones for the E1 beta and E2 subunits of the branched-chain alpha-ketoacid dehydrogenase complex in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAIZE ROOT-TIPS; SENESCENCE-ASSOCIATED GENE; COENZYME-A CARBOXYLASE; HIGHER-PLANT CELLS; ZEA-MAYS L; ACID DEHYDROGENASE; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; PEROXISOMAL DEGRADATION; ASPARAGINE SYNTHETASE; METABOLIC-REGULATION	Branched-chain alpha-ketoacid dehydrogenase (BCKDH) has been known in mammals to be a key enzyme of the catabolic pathway of branched-chain amino acids. We have isolated two cDNA clones encoding the E1 beta and E2 subunits of BCKDH, respectively, from Arabidopsis thaliana. Proteins encoded in these cDNA sequences had putative mitochondrial targeting sequences and conserved domains reported for their mammalian counterparts. Northern blot and immunoblot analyses showed that transcripts from the respective genes and E2 protein markedly accumulated in leaves kept in the dark. We found that the activity of BCKDH in the leaf extracts also increased when plants were placed in the dark. Addition of sucrose to detached leaves inhibited the accumulation of transcripts, whereas application of a photosynthesis inhibitor strongly induced the expression of these genes even under light illumination. These observations indicate that the cellular sugar level is likely responsible for the dark-induced expression of these genes. The transcript levels of these genes were also high in senescing leaves, in which photosynthetic activity is low and free amino acids from degraded protein are likely to serve as an alternative energy source.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Watanabe, A (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.		Fujiki, Yuki/F-1580-2011; Ito, Masaki/G-4252-2013				VONHEIJNE G, 1986, EMBO J, V5, P1335; GUAN YH, 1995, J BIOL CHEM, V270, P5412; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; LAM HM, 1995, PLANT CELL, V7, P887; JOURNET EP, 1986, J BIOL CHEM, V261, P3193; MITA S, 1995, PLANT PHYSIOL, V107, P895, DOI 10.1104/pp.107.3.895; Chevalier C, 1996, PLANT J, V9, P1, DOI 10.1046/j.1365-313X.1996.09010001.x; ALBAN C, 1993, PLANT PHYSIOL, V102, P957; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; AZUMI Y, 1991, PLANT PHYSIOL, V95, P577, DOI 10.1104/pp.95.2.577; Aubert S, 1996, FEBS LETT, V383, P175, DOI 10.1016/0014-5793(96)00244-X; DIEUAIDE M, 1992, PLANT PHYSIOL, V99, P595, DOI 10.1104/pp.99.2.595; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Anderson MD, 1998, PLANT PHYSIOL, V118, P1127, DOI 10.1104/pp.118.4.1127; Ap Rees T., 1990, PLANT PHYSL BIOCH MO, P106; BAYSDORFER C, 1988, PLANT PHYSIOL, V88, P1381, DOI 10.1104/pp.88.4.1381; BLOCK KP, 1988, METHOD ENZYMOL, V166, P201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; BRETHARTE MS, 1994, PLANT PHYSIOL, V105, P19; BROUQUISSE R, 1991, PLANT PHYSIOL, V96, P619, DOI 10.1104/pp.96.2.619; Chuang DT, 1995, METABOLIC MOL BASES, P1239; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DANNER DJ, 1989, J BIOL CHEM, V264, P7742; DAVIES DD, 1978, PLANT PHYSIOL, V61, P54, DOI 10.1104/pp.61.1.54; DUNFORD R, 1990, PHYTOCHEMISTRY, V29, P41, DOI 10.1016/0031-9422(90)89006-U; FUJIKI Y, 1997, PLANT PHYSIOL, V114, pS95; FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P4133; GENIX P, 1990, PLANT PHYSIOL, V94, P717, DOI 10.1104/pp.94.2.717; GERBLING H, 1989, PLANT PHYSIOL, V91, P1387, DOI 10.1104/pp.91.4.1387; GERBLING H, 1993, BOT ACTA, V106, P380; GOODWIN GW, 1988, METHOD ENZYMOL, V166, P189; GRIFFIN TA, 1988, J BIOL CHEM, V263, P14008; GUEST JR, 1987, FEMS MICROBIOL LETT, V44, P417, DOI 10.1111/j.1574-6968.1987.tb02324.x; HARPER AE, 1989, ANN NY ACAD SCI, V573, P267, DOI 10.1111/j.1749-6632.1989.tb15003.x; HUMMEL KB, 1988, J BIOL CHEM, V263, P6165; JAMES F, 1993, PLANT PHYSIOL BIOCH, V31, P845; KERR PS, 1985, PLANT PHYSIOL, V78, P576, DOI 10.1104/pp.78.3.576; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; LAU KS, 1988, BIOCHEMISTRY-US, V27, P1971; LEUTHY MH, 1994, BIOCHIM BIOPHYS ACTA, V1187, P95; LUETHY MH, 1998, PLANT PHYSIOL, V118, P329; MITSUBUCHI H, 1991, J BIOL CHEM, V266, P14686; NOBUKUNI Y, 1990, BIOCHEMISTRY-US, V29, P1154, DOI 10.1021/bi00457a009; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P516, DOI 10.1104/pp.66.3.516; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMIDT GW, 1981, J CELL BIOL, V91, P468, DOI 10.1083/jcb.91.2.468; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shimada Y, 1998, PLANT CELL PHYSIOL, V39, P139; Somerville CR, 1982, METHODS CHLOROPLAST, P129; STITT M, 1985, PLANTA, V166, P354, DOI 10.1007/BF00401173; Truernit E, 1996, PLANT CELL, V8, P2169, DOI 10.1105/tpc.8.12.2169; YEAMAN SJ, 1989, BIOCHEM J, V257, P625; YOSHIDA KT, 1994, PLANT CELL PHYSIOL, V35, P1003	55	37	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	2000	275	8					6007	6013		10.1074/jbc.275.8.6007		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	286XQ	WOS:000085474500102		
J	Kanazawa, H; Kunito, Y; Matsushima, Y; Okubo, S; Mashige, F				Kanazawa, H; Kunito, Y; Matsushima, Y; Okubo, S; Mashige, F			Stereospecific analysis of lorazepam in plasma by chiral column chromatography with a circular dichroism-based detector	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	23rd International Symposium on High Performance Liquid Phase Separations and Related Techniques	MAY 30-JUN 04, 1999	GRANADA, SPAIN			enantiomer separation; circular dichroism detection; detection, LC; lorazepam; benzodiazepines	PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; MEDETOMIDINE; ANESTHETICS	The chiral separation of lorazepam was achieved on a chiral column with UV and circular dichroism (CD) detection. The good resolution of lorazepam enantiomers was obtained on the column of beta-cyclodextrin derivative immobilized silica gel under reversed-phase conditions. The enantiomeric separation and identification of lorazepam were succeeded by CD detector. The method described allows the quantitation of the stereoisomers of lorazepam in human plasma following the administration of a therapeutic dose of the racemic drug. Chiroptical detection is useful for the pharmacokinetic study of chiral drugs. (C) 2000 Elsevier Science B.V. All rights reserved.	Kyoritsu Coll Pharm, Minato Ku, Tokyo 1058512, Japan; Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Clin Lab,Bunkyo Ku, Tokyo 1130033, Japan	Kanazawa, H (reprint author), Kyoritsu Coll Pharm, Minato Ku, Shibakoen 1-5-30, Tokyo 1058512, Japan.						LU XL, 1994, J CHROMATOGR A, V666, P249, DOI 10.1016/0021-9673(94)80387-0; CORBELLA A, 1973, J CHEM SOC CHEM COMM, P721, DOI 10.1039/c39730000721; KANAZAWA H, 1993, J CHROMATOGR, V631, P215, DOI 10.1016/0021-9673(93)80524-C; KANAZAWA H, 1999, CHROMATOGRAPHY, V20, P81; KANAZAWA H, 1995, BIOMED CHROMATOGR, V9, P188, DOI 10.1002/bmc.1130090408; Kanazawa H, 1998, J CHROMATOGR A, V797, P227, DOI 10.1016/S0021-9673(97)00928-X; KUDO K, 1999, CHROMATOGRAPHY, V20, P59; Nishikawa T, 1997, J CHROMATOGR A, V767, P93, DOI 10.1016/S0021-9673(96)01097-7; PIRKLE WH, 1984, J CHROMATOGR, V291, P291, DOI 10.1016/S0021-9673(00)95031-3; SAITO S, 1999, CHROMATOGRAPHY, V20, P71; STINSON SC, 1995, CHEM ENG NEWS, V73, P44, DOI 10.1021/cen-v073n041.p044; SYNOVEC RE, 1986, J CHROMATOGR, V368, P85, DOI 10.1016/S0021-9673(00)91049-5; WESTWOOD SA, 1981, J CHROMATOGR, V204, P103, DOI 10.1016/S0021-9673(00)81644-1	13	32	32	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673			J CHROMATOGR A	J. Chromatogr. A	FEB 25	2000	871	1-2					181	188		10.1016/S0021-9673(99)01244-3		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	289TE	WOS:000085637400020		
J	Fujii, Y; Wadati, M				Fujii, Y; Wadati, M			Operator-valued Riemann-Hilbert problem for correlation functions of the XXZ spin chain	JOURNAL OF PHYSICS A-MATHEMATICAL AND GENERAL			English	Article							ANTIFERROMAGNET; EQUATION	The generating functional of correlation functions for the XXZ spin chain is considered in the thermodynamic limit. We derive a system of integro-difference equations that prescribe this functional. On the basis of this system we establish the operator-valued Riemann-Hilbert problem for correlation functions of the XXZ spin chain.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Fujii, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						Deift PA, 1997, ANN MATH, V146, P149, DOI 10.2307/2951834; Essler FHL, 1996, J PHYS A-MATH GEN, V29, P5619, DOI 10.1088/0305-4470/29/17/032; ESSLER FHL, 1995, COMMUN MATH PHYS, V174, P191, DOI 10.1007/BF02099470; ESSLER FHL, 1995, NUCL PHYS B, V446, P448, DOI 10.1016/0550-3213(95)00263-R; FRAHM H, 1996, AMS CRM P LECT NOTES, V9, P133; FRAHM H, 1994, NUCL PHYS B, V428, P694, DOI 10.1016/0550-3213(94)90370-0; Fujii Y, 1999, J PHYS SOC JPN, V68, P3227, DOI 10.1143/JPSJ.68.3227; Fujii Y, 1999, J PHYS SOC JPN, V68, P2228, DOI 10.1143/JPSJ.68.2228; Jimbo M., 1980, Physica D, V1D, DOI 10.1016/0167-2789(80)90006-8; Korepin V. E., 1993, QUANTUM INVERSE SCAT; KOREPIN VE, 1994, PHYS LETT A, V190, P182, DOI 10.1016/0375-9601(94)90074-4	11	5	5	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0305-4470			J PHYS A-MATH GEN	J. Phys. A-Math. Gen.	FEB 25	2000	33	7					1351	1361		10.1088/0305-4470/33/7/305		11	Physics, Multidisciplinary; Physics, Mathematical	Physics	292KF	WOS:000085792600008		
J	Amino, H; Wang, H; Hirawake, H; Saruta, F; Mizuchi, D; Mineki, R; Shindo, N; Murayama, K; Takamiya, S; Aoki, T; Kojima, S; Kita, K				Amino, H; Wang, H; Hirawake, H; Saruta, F; Mizuchi, D; Mineki, R; Shindo, N; Murayama, K; Takamiya, S; Aoki, T; Kojima, S; Kita, K			Stage-specific isoforms of Ascaris suum complex II: the fumarate reductase of the parasitic adult and the succinate dehydrogenase of free-living larvae share a common iron-sulfur subunit	MOLECULAR AND BIOCHEMICAL PARASITOLOGY			English	Article						Ascaris suum; succinate dehydrogenase; fumarate reductase; iron-sulfur protein; Caenorhabditis elegans	ELECTRON-TRANSFER COMPLEXES; C-ELEGANS GENOME; UBIQUINONE OXIDOREDUCTASE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; PROTEIN SUBUNIT; CDNA CLONING; MUSCLE MITOCHONDRIA; LIVER-MITOCHONDRIA; RESPIRATORY-CHAIN	Complex II of adult Ascaris suum muscle exhibits high fumarate reductase (FRD) activity and plays a key role in anaerobic electron-transport during adaptation to their microaerobic habitat. In contrast larval (L2) complex II shows a much lower FRD activity than the adult enzyme, and functions as succinate dehydrogenase (SDH) in aerobic respiration. We have reported the stage-specific isoforms of complex II in A. suum mitochondria, and showed that at least the flavoprotein subunit (Fp) and the small subunit of cytochrome b (cybS) of the larval complex II differ from those of adult. In the present study, complete cDNAs for the iron-sulfur subunit (Ip) of complex II, which with Fp forms the catalytic portion of complex IT, have been cloned and sequenced from anaerobic adult ii. suum, and the free-living nematode, Caenorhabditis elegans. The amino acid sequences of the Ip subunits of these two nematodes are similar, particularly around the three cysteine-lich regions that are thought to comprise the iron-sulfur clusters of the enzyme. The Ip from A. suum larvae was also characterized because Northern hybridization showed that the adult Ip is also expressed in L2. The Ip of larval complex II was recognized by the antibody against adult Ip. and was indistinguishable from the adult Ip by peptide mapping. The N-terminal 42 amino acid sequence of Ip in the larval complex II purified by DEAE-cellulofine column chromatography was identical to that of the mature form of the adult Ip. Furthermore. the amino acid composition of larval Ip determined by micro-analysis on a PVDF membrane is almost the same as that of adult Ip. These results, together with the fact, that homology probing by RT-PCR, using degenerated primers. failed to find a larval-specific Tp, suggest that the two different stage-specific forms of the A. suum complex II share a common Ip subunit, even though the adult enzyme functions as a FRD, while larval enzyme acts as an SDH. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; Juntendo Univ, Sch Med, Cent Lab Med Sci, Div Biochem Anal, Tokyo 113, Japan; Juntendo Univ, Sch Med, Dept Parasitol, Tokyo 113, Japan; Univ Tokyo, Inst Med Sci, Dept Parasitol, Tokyo 1130033, Japan	Kita, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kitak@m.u-tokyo.ac.jp					Kita K, 1997, INT J PARASITOL, V27, P617, DOI 10.1016/S0020-7519(97)00016-7; TIELENS AGM, 1994, PARASITOL TODAY, V10, P346, DOI 10.1016/0169-4758(94)90245-3; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; FUTAI M, 1973, BIOCHEMISTRY-US, V12, P2468, DOI 10.1021/bi00737a016; Tielens AGM, 1998, BBA-BIOENERGETICS, V1365, P71, DOI 10.1016/S0005-2728(98)00045-0; LEMIRE BD, 1986, METHOD ENZYMOL, V126, P377; KITA K, 1990, BIOCHEM BIOPH RES CO, V166, P101, DOI 10.1016/0006-291X(90)91916-G; AU HC, 1995, GENE, V159, P249, DOI 10.1016/0378-1119(95)00162-Y; AU HC, 1994, GENE, V149, P261, DOI 10.1016/0378-1119(94)90158-9; Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BARRETT J, 1978, PARASITOLOGY, V76, P269; BROOMFIELD PLE, 1992, CURR GENET, V22, P117, DOI 10.1007/BF00351470; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; COLE ST, 1982, EUR J BIOCHEM, V126, P211, DOI 10.1111/j.1432-1033.1982.tb06768.x; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; DARLISON MG, 1984, BIOCHEM J, V223, P507; GOULD SJ, 1989, P NATL ACAD SCI USA, V86, P1934, DOI 10.1073/pnas.86.6.1934; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; HATATANAKA A, 1988, FEBS LETT, V242, P183, DOI 10.1016/0014-5793(88)81012-3; Hederstedt L., 1992, MOL MECH BIOENERGETI, P163; Hirawake H, 1997, CYTOGENET CELL GENET, V79, P132, DOI 10.1159/000134700; HIRAWAKE H, 1994, J BIOCHEM-TOKYO, V116, P221; HOBOHM U, 1995, J MOL BIOL, V251, P390, DOI 10.1006/jmbi.1995.0442; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; KITA K, 1988, COMP BIOCHEM PHYS B, V89, P31, DOI 10.1016/0305-0491(88)90256-8; KITA K, 1992, PARASITOL TODAY, V8, P155, DOI 10.1016/0169-4758(92)90009-Q; KITA K, 1988, BIOCHIM BIOPHYS ACTA, V935, P130, DOI 10.1016/0005-2728(88)90210-1; KITA K, 1992, ELECTROPHORESIS, V13, P506, DOI 10.1002/elps.11501301106; Komuniecki R., 1995, Molecular approaches to parasitology., P109; KURAMOCHI T, 1995, COMP BIOCHEM PHYS B, V111, P491, DOI 10.1016/0305-0491(95)00022-Z; KURAMOCHI T, 1994, MOL BIOCHEM PARASIT, V68, P177, DOI 10.1016/0166-6851(94)90163-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsson M, 1998, ARCH MICROBIOL, V170, P27, DOI 10.1007/s002030050611; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NILSEN TW, 1989, MOL CELL BIOL, V9, P3543; ROOS MH, 1994, MOL BIOCHEM PARASIT, V66, P273, DOI 10.1016/0166-6851(94)90154-6; Saruta F, 1996, BBA-BIOENERGETICS, V1276, P1, DOI 10.1016/0005-2728(96)00070-9; SARUTA F, 1995, J BIOL CHEM, V270, P928; Shindo N, 1997, ANAL BIOCHEM, V249, P79, DOI 10.1006/abio.1997.2155; Shindo N, 1998, ANAL BIOCHEM, V264, P251, DOI 10.1006/abio.1998.2853; Skinner W., 1998, Current Genetics, V34, P393, DOI 10.1007/s002940050412; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TAKAMIYA S, 1993, BIOCHIM BIOPHYS ACTA, V1141, P65, DOI 10.1016/0005-2728(93)90190-Q; TAKAMIYA S, 1986, BIOCHIM BIOPHYS ACTA, V848, P99, DOI 10.1016/0005-2728(86)90165-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNDEN G, 1984, BIOCHIM BIOPHYS ACTA, V767, P460, DOI 10.1016/0005-2728(84)90044-6; VanHellemond JJ, 1997, PARASITOLOGY, V115, P177, DOI 10.1017/S003118209700125X; Waldeck AR, 1997, J BIOL CHEM, V272, P19373, DOI 10.1074/jbc.272.31.19373; WANG H, 1992, Japanese Journal of Parasitology, V41, P122; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WILKINS MR, 1999, 2 D PROTEOME ANAL PR, P531	55	32	33	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-6851	1872-9428		MOL BIOCHEM PARASIT	Mol. Biochem. Parasitol.	FEB 25	2000	106	1					63	76		10.1016/S0166-6851(99)00200-5		14	Biochemistry & Molecular Biology; Parasitology	Biochemistry & Molecular Biology; Parasitology	288GC	WOS:000085553500006		
J	Masuda, K; Sakaguchi, M; Fujiwara, S; Kurata, K; Yamashita, K; Odagiri, T; Nakao, Y; Matsuki, N; Ono, K; Watari, T; Hasegawa, A; Tsujimoto, H				Masuda, K; Sakaguchi, M; Fujiwara, S; Kurata, K; Yamashita, K; Odagiri, T; Nakao, Y; Matsuki, N; Ono, K; Watari, T; Hasegawa, A; Tsujimoto, H			Positive reactions to common allergens in 42 atopic dogs in Japan	VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY			English	Article						dog; atopic dermatitis; allergens; house dust mites; Japanese cedar pollen; Japan	2 MAJOR ALLERGENS; CRYPTOMERIA-JAPONICA POLLEN; SKIN-DISEASE; FOOD ALLERGY; CANINE ATOPY; DIAGNOSIS; HYPERSENSITIVITY; POLLINOSIS; DERMATITIS; RESPONSES	Clinically important allergens for the diagnosis and treatment of atopic dermatitis vary geographically. In order to identify the most prevalent allergens in atopic dogs in Japan, 42 dogs with a clinical diagnosis of atopy were tested using both in vivo (intradermal skin test (IDST)) and in vitro (antigen-specific IgE assay) allergy tests. Allergens used for IDST included 26 allergen extracts from eight allergen groups: trees, weeds, grasses, house dust mites (HDM), molds, foods, epithelia, and arthropods. Immunodot assay was used to measure antigen-specific IgE against 24 allergens from these eight groups and against fish such as cod and sole. In the 42 dogs, the most common positive allergen reaction was to HDM on both IDST (29/42 dogs or 69%) and in vitro testing (23/42 or 54.8%). The second most frequent positive allergen reaction was to Japanese cedar pollen (21/42 or 50.0% for IDST and 7/42 or 16.7% for in vitro testing). In both tests, less than 20% of dogs had positive reactions to molds or foods. Positive reactions to cat epithelia were frequently found on IDST, but rarely found on in vitro testing. Agreement between the two tests was found in 26 instances: HDM (21 dogs), Japanese cedar pollen (five dogs) and wheat (one dog). In this study, the two most common allergens involved in atopic dermatitis in dogs in Japan were HDM and Japanese cedar pollen. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo 1138657, Japan; Hitachi Chem Co Ltd, Pharmaceut Res Lab, Chiba, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Nihon Univ, Sch Vet Med, Dept Pathobiol, Kanagawa, Japan	Masuda, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						SCOTT DW, 1981, J AM ANIM HOSP ASSOC, V17, P91; STURE GH, 1995, VET IMMUNOL IMMUNOP, V44, P293, DOI 10.1016/0165-2427(94)05306-D; HASHIMOTO M, 1995, CLIN EXP ALLERGY, V25, P848, DOI 10.1111/j.1365-2222.1995.tb00027.x; YASUEDA H, 1989, INT ARCH ALLER A IMM, V88, P402; WILLEMSE T, 1986, J SMALL ANIM PRACT, V27, P771, DOI 10.1111/j.1748-5827.1986.tb02119.x; ROSSER EJ, 1993, J AM VET MED ASSOC, V203, P259; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; AUGUST JR, 1982, J AM ANIM HOSP ASSOC, V18, P164; Carlotti D. N., 1992, Pratique Médicale & Chirurgicale de l'Animal de Compagnie, V27, P53; CODNER EC, 1993, J AM VET MED ASSOC, V202, P739; CODNER EC, 1995, J AM VET MED ASSOC, V206, P812; DEWECK AL, 1995, INT ARCH ALLERGY IMM, V107, P13; De Weck AL, 1998, PRAKT TIERARZT, V79, P6; HALLIWEL.RE, 1971, VET REC, V89, P209; Hashimoto M, 1997, INT ARCH ALLERGY IMM, V112, P88; Inoue S., 1986, IGAKU NO AYUMI, V136, P959; JEFFERS JG, 1991, J AM VET MED ASSOC, V198, P245; KUNKLE G, 1992, J AM VET MED ASSOC, V200, P677; NESBITT GH, 1984, COMP CONT EDUC PRACT, V6, P73; NESBITT GH, 1978, J AM VET MED ASSOC, V172, P55; Otani T, 1984, Arerugi, V33, P454; PucheuHaston CM, 1996, AM J VET RES, V57, P1000; ROHAC M, 1991, MOL IMMUNOL, V28, P897, DOI 10.1016/0161-5890(91)90054-N; Sakamoto H, 1997, EXP ANIM TOKYO, V46, P67, DOI 10.1538/expanim.46.67; SASAKI Y, 1995, J VET MED SCI, V57, P683; SCHICK RO, 1986, J AM VET MED ASSOC, V189, P1493; SOUSA CA, 1990, VET CLIN N AM-SMALL, V20, P1419; WILLEMSE A, 1984, J AM VET MED ASSOC, V184, P1277; Yasueda Hiroshi, 1997, Allergology International, V46, P135, DOI 10.2332/allergolint.46.135	29	51	51	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2427			VET IMMUNOL IMMUNOP	Vet. Immunol. Immunopathol.	FEB 25	2000	73	2					193	204		10.1016/S0165-2427(99)00166-X		12	Immunology; Veterinary Sciences	Immunology; Veterinary Sciences	283ZG	WOS:000085305500007		
J	Kuwahara, C; Kubosaki, A; Nishimura, T; Nasu, Y; Nakamura, Y; Saeki, K; Matsumoto, Y; Onodera, T				Kuwahara, C; Kubosaki, A; Nishimura, T; Nasu, Y; Nakamura, Y; Saeki, K; Matsumoto, Y; Onodera, T			Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						prion protein; insulin; retrovirus vector; PI3-kinase; wortmannin	PHOSPHATIDYLINOSITOL 3-KINASE; NEURITE OUTGROWTH; MESSENGER-RNA; SCRAPIE; IDENTIFICATION; DISEASES	In order to understand the fundamental and putative roles of PrPc in the central nervous system, neuronal cell lines were established. Cells were immortalized by recombinant retrovirus vector-mediated transduction of SV40 T-antigen gene,Among these, two cell lines were selected based on their RT-PCR expressions of neuron-specific neurofilament (NF-H, NF-M) and cell morphology. These cell lines showed the properties of neuronal progenitor cells in antigenicity, morphology and responses to differentiating agents. Expression of PrPc was detected by immunocytochemical analysis. These cell lines responded to differentiating agents such as dibutyl cyclic AMP (dcAMP) and phorbol 12-myristate 13-acetate (PMA) before developing into neuronal-like cells. Neurite extensions were observed 20 min after incubation with the differentiating agents. Treatment with nerve growth factor (NGF) and insulin induced cell differentiation and enhanced expression of PrP gene (Prnp) mRNA and protein. The latter phenomenon was not inhibited by wortmannin, which is a specific inhibitor of phosphatidylinositol 3-kinase. These results suggest that PrPc plays an important role in the differentiation-mediated classic signaling pathway of neuronal cell. (C) 2000 Academic Press.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Mol Immunol, Bunkyo Ku, Tokyo 1130032, Japan	Kuwahara, C (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Mol Immunol, Bunkyo Ku, Tokyo 1130032, Japan.						Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; GUNNING PW, 1981, J NEUROSCI, V1, P1085; ONODERA T, 1993, MICROBIOL IMMUNOL, V37, P311; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; LEVY E, 1987, EUR J BIOCHEM, V166, P71, DOI 10.1111/j.1432-1033.1987.tb13485.x; LIEBERBURG I, 1987, BRAIN RES, V417, P363, DOI 10.1016/0006-8993(87)90465-3; MOBLEY W C, 1987, Society for Neuroscience Abstracts, V13, P186; OKUDA T, 1994, J BIOL CHEM, V269, P3563; Paterno GD, 1997, MOL BRAIN RES, V49, P247, DOI 10.1016/S0169-328X(97)00157-5; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Saeki K, 1996, BIOCHEM BIOPH RES CO, V219, P47, DOI 10.1006/bbrc.1996.0179; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; YONEZAWA K, 1992, J BIOL CHEM, V267, P25958	19	20	20	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 24	2000	268	3					763	766		10.1006/bbrc.2000.2152		4	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	289UH	WOS:000085640000019		
J	Hirai, H; Kondo, T; Hasegawa, M; Yagi, T; Yamamoto, Y; Komai, T; Nagashima, K; Sakashita, M; Fujihisa, H; Aoki, K				Hirai, H; Kondo, T; Hasegawa, M; Yagi, T; Yamamoto, Y; Komai, T; Nagashima, K; Sakashita, M; Fujihisa, H; Aoki, K			Methane hydrate behavior under high pressure	JOURNAL OF PHYSICAL CHEMISTRY B			English	Article							CLATHRATE; TEMPERATURE	Phases changes in a water-methane system were investigated in a pressure range from 0.2 to 5.5 GPa using a diamond anvil cell. In-situ X-ray diffractometry and optical microscopy revealed methane hydrate behavior from growth to decomposition into high-pressure ice and solid methane at room temperature. Methane hydrate crystallized at 0.2-0.3 GPa from liquid, and it was compressed continuously until 2.3 GPa, maintaining structure I. Below 0.7 GPa the cage occupancy was unchanged. At 1.5 GPa methane hydrate partly decomposed to ice IV and fluid methane. The remaining methane hydrate kept structure I, but the cage occupancy was changed; i.e., small cages became vacant. At 2.1 GPa, coexisting ice VI transformed to ice VII and fluid methane solidified to phase I, while methane hydrate remained. At this pressure, structure I of methane hydrate was still maintained, and an additional change of cage occupancy occurred. The change in the cage occupancy is consistent with the change in compressibility observed on the compression curve. At 2.3 GPa, all of the methane hydrate decomposed into ice VII and phase I of solid methane.	Univ Tsukuba, Inst Geosci, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan; Natl Inst Resources & Environm, Tsukuba, Ibaraki 305, Japan; Natl Inst Mat Chem, Tsukuba, Ibaraki 305, Japan	Hirai, H (reprint author), Univ Tsukuba, Inst Geosci, Tsukuba, Ibaraki 305, Japan.						MCMULLAN RK, 1965, J CHEM PHYS, V42, P2725, DOI 10.1063/1.1703228; Tse JS, 1997, J PHYS CHEM A, V101, P4491, DOI 10.1021/jp963006c; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; RIPMEESTER JA, 1987, NATURE, V325, P135, DOI 10.1038/325135a0; MAK TCW, 1965, J CHEM PHYS, V42, P2732, DOI 10.1063/1.1703229; BROWNSTE.S, 1967, J CHEM PHYS, V46, P1454, DOI 10.1063/1.1840873; CALVERT LD, 1969, ACTA CRYSTALL A-CRYS, VA 25, pS131; Davidson D., 1983, NATURAL GAS HYDRATES; Davidson D. W., 1973, WATER COMPREHENSIVE, V2; DAVIDSON DW, 1984, NATURE, V311, P142, DOI 10.1038/311142a0; DYADIN YA, 1997, MENNDELEEV COMMUN, V1, P34; HAZEN RM, 1980, APPL PHYS LETT, V37, P288, DOI 10.1063/1.91909; HEBERT P, 1987, PHYS REV B, V36, P9196, DOI 10.1103/PhysRevB.36.9196; Hutz U, 1996, FLUID PHASE EQUILIBR, V117, P178, DOI 10.1016/0378-3812(95)02951-6; Jeffrey G. A., 1984, INCLUSION COMPOUNDS, V1; KUHS WF, 1997, INCLUSION PHENOM MOL, V19, P65; RIPMEESTER JA, 1988, J PHYS CHEM-US, V92, P337, DOI 10.1021/j100313a018; Sloan E.D., 1990, CLATHRATE HYDRATE NA; TSE JS, 1999, COMMUNICATION; Vos WL, 1996, CHEM PHYS LETT, V257, P524, DOI 10.1016/0009-2614(96)00583-0	20	56	57	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1089-5647			J PHYS CHEM B	J. Phys. Chem. B	FEB 24	2000	104	7					1429	1433		10.1021/jp9926490		5	Chemistry, Physical	Chemistry	289EC	WOS:000085606700003		
J	Iijima, K; Yoshizumi, M; Hashimoto, M; Kim, S; Eto, M; Ako, J; Liang, YQ; Sudoh, N; Hosoda, K; Nakahara, K; Toba, K; Ouchi, Y				Iijima, K; Yoshizumi, M; Hashimoto, M; Kim, S; Eto, M; Ako, J; Liang, YQ; Sudoh, N; Hosoda, K; Nakahara, K; Toba, K; Ouchi, Y			Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene	CIRCULATION			English	Article						red wine; polyphenol; atherosclerosis; smooth muscle cells	LOW-DENSITY-LIPOPROTEIN; ELEMENT-BINDING PROTEIN; TRANSFORMING GROWTH-FACTOR-BETA-1; ENDOTHELIAL-CELLS; DOWN-REGULATION; TRANSCRIPTION; ATHEROSCLEROSIS; CONSUMPTION; OXIDATION; INDUCTION	Background-Red wine polyphenols have been shown to contribute to the "French paradox" phenomenon, which consists of lower morbidity and mortality from coronary heart disease in the French population. Although vascular smooth muscle cell (VSMC) proliferation plays an important role in the progression of atherosclerotic lesions, the effects of red wine polyphenols on VSMC proliferation have not been elucidated. Methods and Results-We extracted the total polyphenolic fraction from red wine (RW-PF) by column chromatography. Treatment with RW-PF showed a potent inhibitory effect on the proliferation and DNA synthesis of cultured rat aortic smooth muscle cells (RASMCs). In contrast, the inhibitory effect of RW-PF on the proliferation of bovine carotid endothelial cells was observed only at much higher concentrations. To elucidate the molecular mechanisms of this antiproliferative effect of RW-PF on RASMCs, we investigated the effects of RW-PF on cell cycle regulation. RW-PF downregulated the expression of cyclin A mRNA and cyclin A promoter activity. In addition, RW-PF decreased the binding of nuclear proteins to the activating transcription factor (ATF) site in the cyclin A promoter and downregulated the mRNA levels of transcription factors, cAMP-responsive element-binding protein (CREB), and ATF-1, Conclusions-These results suggest that the downregulation of cyclin A gene expression may contribute to the antiproliferative effect of red wine polyphenols on RASMCs through the inhibition of transcription factor expression.	Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan	Ouchi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Akishita M, 1997, ATHEROSCLEROSIS, V130, P1, DOI 10.1016/S0021-9150(96)06023-6; Morey AK, 1997, ENDOCRINOLOGY, V138, P3330, DOI 10.1210/en.138.8.3330; BATESMITH EC, 1975, PHYTOCHEMISTRY, V14, P1107, DOI 10.1016/0031-9422(75)85197-1; STLEGER AS, 1979, LANCET, V1, P1017; AVIRAM M, 1993, ATHEROSCLEROSIS, V98, P1, DOI 10.1016/0021-9150(93)90217-I; Duthie GG, 1998, EUR J CLIN NUTR, V52, P733, DOI 10.1038/sj.ejcn.1600635; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Folin O, 1912, J BIOL CHEM, V12, P239; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; KONDO K, 1994, LANCET, V344, P1152, DOI 10.1016/S0140-6736(94)90656-4; LEE ME, 1990, J BIOL CHEM, V265, P10446; PERRELLA MA, 1994, J BIOL CHEM, V269, P14595; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Tsai JC, 1996, J CLIN INVEST, V97, P146, DOI 10.1172/JCI118383; Tsai JC, 1996, J BIOL CHEM, V271, P3667; WALKER WH, 1995, ENDOCRINOLOGY, V136, P3534, DOI 10.1210/en.136.8.3534; YOSHIZUMI M, 1992, J BIOL CHEM, V267, P9467; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918; Yoshizumi M, 1997, J BIOL CHEM, V272, P22259, DOI 10.1074/jbc.272.35.22259; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; 1993, NUTR REV, V51, P185	29	82	89	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	FEB 22	2000	101	7					805	811				7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	286CQ	WOS:000085426400013		
J	Ito, T; Seldin, MF; Taketo, MM; Kubo, T; Natori, S				Ito, T; Seldin, MF; Taketo, MM; Kubo, T; Natori, S			Gene structure and chromosome mapping of mouse transcription elongation factor S-II (Tcea1)	GENE			English	Article						chromosome mapping; gene structure; processed pseudogene; Tcea1; Tcea1-ps1; transcript elongation	RNA-POLYMERASE-II; ASCITES TUMOR-CELLS; FACTOR-SII; FACTOR TFIIS; MOLECULAR-CLONING; PURIFICATION; EXPRESSION; PROTEINS; GENOME; CDNA	We report the organization and chromosome localization of the mouse transcription elongation factor S-II gene (Tcea1). This gene was found to be a single copy gene consisting of 10 exons spanning approximately 30 kb. Its organization was the same as those of the mouse testis-specific S-II gene (Tcea2) and Xenopus general S-II gene (xTFIIS.oA), but different from that of the human S-II gene family. We also identified a processed pseudogene (Tcea1-ps1) with a sequence highly homologous to those of S-II cDNAs but containing a translation termination codon within its open reading frame. Linkage analysis showed that Tcea1 and Tcea1-ps1 are mapped on mouse chromosomes 1 and 15, respectively. Relationships between Tcea1 and S-II cDNAs isolated so far are discussed. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif Davis, Dept Biol Chem, Rowe Program Genet, Davis, CA 95616 USA	Natori, S (reprint author), Inst Phys & Chem Res, Natori Special Lab, Hirosawa 2-1, Wako, Saitama 3510198, Japan.		Ito, Takahiro/F-5006-2011				VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wu Q, 1999, MOL CELL BIOL, V19, P3225; REINES D, 1989, J BIOL CHEM, V264, P10799; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Astrom AK, 1999, CANCER RES, V59, P918; BISHOP D T, 1985, Genetic Epidemiology, V2, P349; CHEAH KSE, 1991, MAMM GENOME, V1, P171, DOI 10.1007/BF00351064; DICKIE MM, 1950, J HERED, V41, P193; DiMarco SP, 1996, GENOMICS, V36, P185, DOI 10.1006/geno.1996.0443; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Green EL, 1981, GENETICS PROBABILITY, P77; HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Ito T, 1998, MAMM GENOME, V9, P915, DOI 10.1007/s003359900897; Latham KE, 1998, DEVELOPMENT, V125, P929; MARSHALL TK, 1990, NUCLEIC ACIDS RES, V18, P6293, DOI 10.1093/nar/18.21.6293; *MIT WHIT I CTR GE, 1999, GEN PHYS MAPS MOUS; NAKANISHI T, 1992, J BIOL CHEM, V267, P13200; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991; NAKANISHI Y, 1981, FEBS LETT, V130, P69, DOI 10.1016/0014-5793(81)80667-9; NATORI S, 1982, MOL CELL BIOCHEM, V46, P173; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; PARK HR, 1994, GENE, V139, P263; Plant KE, 1996, NUCLEIC ACIDS RES, V24, P3514, DOI 10.1093/nar/24.18.3514; SEKIMIZU K, 1979, BIOCHEMISTRY-US, V18, P1582, DOI 10.1021/bi00575a031; Seldin MF, 1998, MAMM GENOME, V8, pS1, DOI 10.1007/s003359900646; SELDIN MF, 1994, MAMM GENOME, V5, P193, DOI 10.1007/BF00352358; SIVARAMAN L, 1990, J BIOL CHEM, V265, P14554; Taira Y, 1998, GENES CELLS, V3, P289, DOI 10.1046/j.1365-2443.1998.00188.x; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; WATSON ML, 1992, MAMM GENOME, V2, P158, DOI 10.1007/BF00302874; XU QH, 1994, J BIOL CHEM, V269, P3100; YOO OJ, 1991, NUCLEIC ACIDS RES, V19, P1073, DOI 10.1093/nar/19.5.1073; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	38	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119			GENE	Gene	FEB 22	2000	244	1-2					55	63		10.1016/S0378-1119(00)00007-X		9	Genetics & Heredity	Genetics & Heredity	290DJ	WOS:000085660700007		
J	Matsukawa, S; Kuwata, S; Hidai, M				Matsukawa, S; Kuwata, S; Hidai, M			Syntheses, structures, and reactivities of mono- and dinuclear iridium thiolato complexes containing nitrosyl ligands	INORGANIC CHEMISTRY			English	Article							BRIDGED DIRUTHENIUM COMPLEXES; ROUSSIN RED SALT; X-RAY STRUCTURE; OXIDATIVE ADDITION; MOLECULAR-STRUCTURES; CRYSTAL; CLUSTERS; SULFIDE; CO; METAL	Reactions of the iridium(III) nitrosyl complex [Ir(NO)Cl-2(PPh3)(2)] (1) with hydrosulfide and arenethiolate anions afforded the square-pyramidal iridium(III) complex [Ir(NO)(SH)(2)(PPh3)(2)] (2) with a bent nitrosyl ligand and a series of the square-planar iridium(I) complexes [Ir(NO)(SAr)(2)(PPh3)] (3a, Ar = C6H2Me3-2,4,6 (Mes); 3b, Ar = C6H3Me2-2,6 (Xy); 3c, Ar = C6H2Pr3i-2,4,6) containing a linear nitrosyl ligand, respectively. Complex 1 also reacted with alkanethiolate anions or alkanethiols to give the thiolato-bridged diiridium complexes [Ir(NO)(mu-SPri)(SPri)(PPh3)](2) (4) and [Ir(NO)(mu-SBut)(PPh3)](2) (5). Complex 4 contains two square-pyramidal iridium(III) centers with a bent nitrosyl ligand, whereas 5 contains two tetrahedral iridium(0) centers with a linear nitrosyl ligand and has an Ir-Ir bond. Upon treatment with benzoyl chloride, 3a and 3b were converted into the (diaryl disulfide)- and thiolato-bridged dichlorodiiridium(III) complexes [{IrCl(mu-SC6HnMe4-nCH2)(PPh3)}(2)(mu-ArSSAr)] (6a, Ar = Mes, n = 2; 6b, Ar = Xy, n = 3) accompanied by a loss of the nitrosyl ligands and cleavage of a C-H bond in an ortho methyl group of the thiolato ligands. Similar treatment of 4 gave the dichlorodiiridium complex [Ir(NO)(PPh3)(mu-SPri)(3)IrCl2(PPh3)] (7), which has an octahedral dichloroiridium(III) center and a distorted trigonal bipyramidal Ir(I) atom with a linear nitrosyl ligand. The detailed structures of 3a, 4, 5, 6a, and 7 have been determined by X-ray crystallography.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Hidai, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Hongo, Tokyo 1138656, Japan.		Kuwata, Shigeki/C-4920-2011	Kuwata, Shigeki/0000-0002-3165-9882			Ahmad N, 1974, INORG SYNTH, V15, P45, DOI 10.1002/9780470132463.ch13; SEYFERTH D, 1986, ORGANOMETALLICS, V5, P539, DOI 10.1021/om00134a024; SONG J, 1993, J AM CHEM SOC, V115, P327, DOI 10.1021/ja00054a047; MINGOS DMP, 1989, ADV INORG CHEM RAD, V34, P293; WONG GB, 1978, INORG CHEM, V17, P578, DOI 10.1021/ic50181a012; TAKAHASHI A, 1993, J ORGANOMET CHEM, V456, P243, DOI 10.1016/0022-328X(93)80433-C; ANDERSON GK, 1980, CHEM SOC REV, V9, P185, DOI 10.1039/cs9800900185; Iwasa T, 1999, INORG CHEM, V38, P2851, DOI 10.1021/ic981274e; BERNAL I, 1976, ISR J CHEM, V15, P153; Beurskens PT, 1994, DIRDIF 94 PROGRAM SY; BLOWER PJ, 1985, J CHEM SOC DALTON, P1533, DOI 10.1039/dt9850001533; BONNET JJ, 1979, J AM CHEM SOC, V101, P5940, DOI 10.1021/ja00514a013; BROWNLEE GS, 1975, INORG CHEM, V14, P323, DOI 10.1021/ic50144a023; BUTLER AR, 1988, ADV INORG CHEM RAD, V32, P335, DOI 10.1016/S0898-8838(08)60235-4; CARRILLO D, 1992, COORDIN CHEM REV, V119, P137, DOI 10.1016/0010-8545(92)80032-M; CHENG PT, 1975, INORG CHEM, V14, P327, DOI 10.1021/ic50144a024; CLAVER C, 1987, INORG CHEM, V26, P3479, DOI 10.1021/ic00268a014; COLLMAN JP, 1969, J AM CHEM SOC, V91, P5659, DOI 10.1021/ja01048a050; COTTON FA, 1988, INORG CHEM, V27, P2131, DOI 10.1021/ic00285a024; DEV S, 1990, INORG CHEM, V29, P4797, DOI 10.1021/ic00348a039; DOLCETTI G, 1972, INORG CHIM ACTA, V6, P531, DOI 10.1016/S0020-1693(00)91853-X; ELAMANE M, 1985, ORGANOMETALLICS, V4, P773, DOI 10.1021/om00123a027; Foster MW, 1999, J AM CHEM SOC, V121, P4093, DOI 10.1021/ja9901056; GLADFELTER WL, 1985, ADV ORGANOMET CHEM, V24, P41; GUILMET E, 1983, ORGANOMETALLICS, V2, P1123, DOI 10.1021/om50003a010; HASHIZUME K, 1995, ORGANOMETALLICS, V14, P5367, DOI 10.1021/om00011a063; Hidai M, 1996, ACS SYM SER, V653, P310; HIDAI M, 1994, J ORGANOMET CHEM, V473, P1, DOI 10.1016/0022-328X(94)80099-5; Johnson B. F. G., 1987, COMPREHENSIVE COORDI, V2, P99; KALCK P, 1982, ORGANOMETALLICS, V1, P1211, DOI 10.1021/om00069a019; Konno T, 1997, CHEM LETT, P85, DOI 10.1246/cl.1997.85; Lee J., 1999, INORG CHEM, V38, P4578, DOI 10.1021/ic990402b; Lewkebandara TS, 1998, POLYHEDRON, V17, P1; MASON R, 1972, J ORGANOMET CHEM, V46, pC61, DOI 10.1016/S0022-328X(00)88309-6; Matsukawa S, 1998, INORG CHEM COMMUN, V1, P368, DOI 10.1016/S1387-7003(98)00094-X; MAZANY AM, 1983, INORG CHEM, V22, P2593, DOI 10.1021/ic00160a025; Mizobe Y, 1998, INORG CHIM ACTA, V273, P238, DOI 10.1016/S0020-1693(97)06063-5; *MOL STRUCT CORP, TEXSAN CRYST STRUCT; Nagashima Shigehiro, 1998, Nature Structural Biology, V5, P347, DOI 10.1038/nsb0598-347; Nishibayashi Y, 1997, CHEM COMMUN, P859, DOI 10.1039/a701115f; Nishio M, 1997, INORG CHIM ACTA, V265, P59, DOI 10.1016/S0020-1693(97)05709-5; Nishio M, 1996, ANGEW CHEM INT EDIT, V35, P872, DOI 10.1002/anie.199608721; Nishio M, 1997, INORG CHIM ACTA, V263, P119, DOI 10.1016/S0020-1693(97)05598-9; Ogasawara M, 1997, J AM CHEM SOC, V119, P8642, DOI 10.1021/ja970563j; PALERMO RE, 1983, J AM CHEM SOC, V105, P4310, DOI 10.1021/ja00351a032; Qu JP, 1998, CHEM LETT, P1003, DOI 10.1246/cl.1998.1003; RANDALL CR, 1988, J CHEM SOC CHEM COMM, P986, DOI 10.1039/c39880000986; REED CA, 1973, J CHEM SOC DALTON, P1014, DOI 10.1039/dt9730001014; REED CA, 1970, J CHEM SOC A, P3054, DOI 10.1039/j19700003054; REED J, 1973, INORG CHEM, V12, P2949, DOI 10.1021/ic50130a042; Richter-Addo G. B., 1992, METAL NITROSYLS; Sato T, 1998, J ORGANOMET CHEM, V569, P99, DOI 10.1016/S0022-328X(98)00778-5; Schweitzer D, 1998, J AM CHEM SOC, V120, P10996, DOI 10.1021/ja981117e; SOONG SL, 1988, ORGANOMETALLICS, V7, P556, DOI 10.1021/om00092a051; Takagi Y, 1997, ORGANOMETALLICS, V16, P4445, DOI 10.1021/om970307f; TRIECHEL PM, 1983, INORG CHEM, V22, P3960; TRIECHEL PM, 1991, INORG CHEM, V30, P379	57	17	17	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669			INORG CHEM	Inorg. Chem.	FEB 21	2000	39	4					791	798		10.1021/ic990805b		8	Chemistry, Inorganic & Nuclear	Chemistry	286WP	WOS:000085472100027		
J	Kamikouchi, A; Takeuchi, H; Sawata, M; Natori, S; Kubo, T				Kamikouchi, A; Takeuchi, H; Sawata, M; Natori, S; Kubo, T			Concentrated expression of Ca2+/calmodulin-dependent protein kinase II and protein kinase C in the mushroom bodies of the brain of the honeybee Apis mellifera L	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						cDNA cloning; gene expression; in situ hybridization; intracellular Ca2+ signal transduction; Kenyon cells	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MOLECULAR-CLONING; PREFERENTIAL EXPRESSION; CA2+ CALMODULIN; DROSOPHILA-MELANOGASTER; MUTANT MICE; GENE; SUBUNIT; HERMISSENDA; ACTIVATION	We have previously used the differential display method to identify a gene that is expressed preferentially in the mushroom bodies of worker honeybees and to show that it encodes a putative inositol 1,4,5-trisphosphate receptor(IP3R) homologue (Kamikouchi et al. [1998] Biochem. Biophys. Res. Commun. 242:181-186). In the present study, we examined whether the expression of some of the genes for proteins involved in the intracellular Ca2+ signal transduction is also concentrated in the mushroom bodies of the honeybee by isolating cDNA fragments that encode the Ca2+/calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC) homologues of the honeybee, In situ hybridization analysis revealed that the expression of these genes was also concentrated in the mushroom bodies of the honeybee brain: The CaMKII gene was expressed preferentially in the large-type Kenyon cells of the mushroom bodies, whereas that for PKC was expressed in both the large and small types of Kenyon cells. The expression of the genes for IP3R and CaMKII was concentrated in the mushroom bodies of the queen and drone as well as in those of the worker bee. Furthermore, the enzymatic activities of CaMKII and PKC were found to be higher in the mushroom bodies/central bodies than in the optic and antennal lobes of the worker bee brain. These results suggest that the function of the intracellular Ca2+ signal transduction is enhanced in Kenyon cells in comparison to other neuronal cell types in the honeybee brain. (C) 2000 Wiley-Liss, Inc.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kubo, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.		TAKEUCHI, HIDEAKI/G-4969-2014				ALTFELDER K, 1991, INSECT BIOCHEM, V21, P479, DOI 10.1016/0020-1790(91)90101-J; MIKOSHIBA K, 1993, TRENDS PHARMACOL SCI, V14, P86, DOI 10.1016/0165-6147(93)90069-V; Heisenberg M, 1998, LEARN MEMORY, V5, P1; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; ONO Y, 1986, FEBS LETT, V206, P347, DOI 10.1016/0014-5793(86)81010-9; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; YASUDA I, 1990, BIOCHEM BIOPH RES CO, V166, P1220, DOI 10.1016/0006-291X(90)90996-Z; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; FURUICHI T, 1995, J NEUROCHEM, V64, P953; Rybak J, 1998, LEARN MEMORY, V5, P133; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Muller U, 1997, J NEUROBIOL, V33, P33, DOI 10.1002/(SICI)1097-4695(199707)33:1<33::AID-NEU4>3.0.CO;2-E; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; GRONENBERG W, 1987, EXP BIOL, V46, P115; Ito K, 1998, LEARN MEMORY, V5, P52; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; CROW T, 1993, J NEUROPHYSIOL, V69, P636; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; ERBER J, 1978, PHYSIOL ENTOMOL, V3, P77, DOI 10.1111/j.1365-3032.1978.tb00137.x; FARLEY J, 1986, NATURE, V319, P220, DOI 10.1038/319220a0; FRISCH K, 1967, SCIENCE, V158, P1072, DOI 10.1126/science.158.3804.1072; GRIFFITH LC, 1993, J NEUROCHEM, V61, P1534, DOI 10.1111/j.1471-4159.1993.tb13650.x; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HASAN G, 1992, DEVELOPMENT, V116, P967; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Ito T, 1996, FEBS LETT, V385, P21, DOI 10.1016/0014-5793(96)00340-7; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; Menzel R, 1990, NEUROBIOLOGY COMP CO, P237; Mobbs P.G., 1985, P299; MOBBS PG, 1984, J INSECT PHYSIOL, V30, P43, DOI 10.1016/0022-1910(84)90107-0; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; OHSAKO S, 1993, J BIOL CHEM, V268, P2053; ONO Y, 1988, NUCLEIC ACIDS RES, V16, P5199, DOI 10.1093/nar/16.11.5199; ONO Y, 1988, J BIOL CHEM, V263, P6927; ROSENTHAL A, 1987, EMBO J, V6, P433; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; WINSTON ML, 1987, BIOL HONEYBB	49	38	38	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9967			J COMP NEUROL	J. Comp. Neurol.	FEB 21	2000	417	4					501	510		10.1002/(SICI)1096-9861(20000221)417:4<501::AID-CNE8>3.0.CO;2-4		10	Neurosciences; Zoology	Neurosciences & Neurology; Zoology	281KK	WOS:000085158700008		
J	Asahi, M; Azuma, T; Ito, S; Ito, Y; Suto, H; Nagai, Y; Tsubokawa, M; Tohyama, Y; Maeda, S; Omata, M; Suzuki, T; Sasakawa, C				Asahi, M; Azuma, T; Ito, S; Ito, Y; Suto, H; Nagai, Y; Tsubokawa, M; Tohyama, Y; Maeda, S; Omata, M; Suzuki, T; Sasakawa, C			Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells	JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						bacterial infection; bacterial adhesion; bacterial protein; protein tyrosine kinase; signal transduction	ESCHERICHIA-COLI EPEC; VACUOLATING CYTOTOXIN; PEPTIC-ULCERATION; SIGNAL-TRANSDUCTION; POSSESSING CAGA; EXPRESSION; INFECTION; GENE; ATTACHMENT; ADHERENCE	Attachment of Helicobacter pylori to gastric epithelial cells induces various cellular responses, including the tyrosine phosphorylation of an unknown 145-kD protein and interleukin 8 production. Here we show that this 145-kD protein is the cagA product of H. pylori, an immuno-dominant,, cytotoxin-associated antigen. Epithelial cells infected with various H. pylori clinical isolates resulted in generation of tyrosine-phosphorylated proteins ranging frost 130 to 145 kD in size that were also induced in vitro by mixing host cell lysate with bacterial lysate. When epithelial cells were infected with [S-35]methionine-labeled H. pylori, a radioactive 145-kD protein was detected in the immunoprecipitates with antiphosphotyrosine antibody or anti-CagA (cytotoxin-associated gene A) antibody. Consistently, the 145-kD protein recognized by the anti-CagA and antiphosphotyrosine antibodies was induced in epithelial cells after infection of wildtype H. pylori bur not the cagA::Km mutant. Furthermore, the amino acid sequence of the phosphorylated 145-kD protein induced by H. pylori infection was identical to the H. pylon CagA sequence. These results reveal that the tyrosine-phosphorylated 145-kD protein is H. pylori CagA protein, which may be delivered from attached bacteria into the host cytoplasm. The identification of the tyrosine-phosphorylated protein will thus provide further insights into understanding the precise roles of CagA protein in H. pylori pathogenesis.	Fukui Univ, Fac Nursing & Welf, Matsuoka, Fukui 9101195, Japan; Fukui Med Univ, Dept Internal Med 2, Fukui 9101193, Japan; Fukui Med Univ, Dept Biol, Fukui 9101193, Japan; Tsubokawa Clin, Fukui 9100854, Japan; Kyoto Univ, Fac Med, Dept Lab Med & Clin Sci, Kyoto 6068397, Japan; Univ Tokyo, Fac Med, Dept Internal Med 2, Tokyo 113, Japan; Univ Tokyo, Inst Med Sci, Dept Bacteriol, Tokyo 1088639, Japan	Asahi, M (reprint author), Fukui Univ, Fac Nursing & Welf, 4-1-1 Kenjojima, Matsuoka, Fukui 9101195, Japan.						Aihara M, 1997, INFECT IMMUN, V65, P3218; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; ROSENSHINE I, 1992, EMBO J, V11, P3551; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Rosenshine I, 1996, EMBO J, V15, P2613; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; DYTOC M, 1993, INFECT IMMUN, V61, P448; MARSHALL BJ, 1984, LANCET, V1, P1311; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Pagliaccia C, 1998, P NATL ACAD SCI USA, V95, P10212, DOI 10.1073/pnas.95.17.10212; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; BLASER MJ, 1995, CANCER RES, V55, P2111; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; BLASER MJ, 1990, J INFECT DIS, V161, P626; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; COVER TL, 1994, J BIOL CHEM, V269, P10566; Sharma SA, 1998, J IMMUNOL, V160, P2401; SMOOT DT, 1993, INFECT IMMUN, V61, P350; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771; APEL I, 1988, ZBL BAKT-INT J MED M, V268, P271; CLOCKER E, 1998, INFECT IMMUN, V66, P2346; Covacci A, 1998, CURR OPIN MICROBIOL, V1, P96, DOI 10.1016/S1369-5274(98)80148-3; COVER TL, 1990, INFECT IMMUN, V58, P603; CRABTREE JE, 1992, J CLIN PATHOL, V45, P733, DOI 10.1136/jcp.45.8.733; FIGURA N, 1990, HELICOBACTER PYLORI, P86; GOODWIN CS, 1986, J CLIN PATHOL, V39, P353, DOI 10.1136/jcp.39.4.353; Kodama K, 1998, J GASTROENTEROL, V33, P14; Maeda S, 1997, DIGEST DIS SCI, V42, P1841, DOI 10.1023/A:1018846723379; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Segal ED, 1997, BIOMED PHARMACOTHER, V51, P5, DOI 10.1016/S0753-3322(97)87073-4; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Segal ED, 1997, P NATL ACAD SCI USA, V94, P7595, DOI 10.1073/pnas.94.14.7595; Segal Gil, 1998, Trends in Microbiology, V6, P253, DOI 10.1016/S0966-842X(98)01308-0; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7	38	335	349	ROCKEFELLER UNIV PRESS	NEW YORK	1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA	0022-1007			J EXP MED	J. Exp. Med.	FEB 21	2000	191	4					593	602		10.1084/jem.191.4.593		10	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	287MK	WOS:000085509600002		
J	Yasuda, T; Maeda, A; Kurosaki, M; Tezuka, T; Hironaka, K; Yamamoto, T; Kurosaki, T				Yasuda, T; Maeda, A; Kurosaki, M; Tezuka, T; Hironaka, K; Yamamoto, T; Kurosaki, T			Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-gamma 2 activation by regulating B cell linker protein-PLC-gamma 2 binding	JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						adaptor molecule; antigen receptor; lymphocyte; negative regulator; signaling	BRUTONS TYROSINE KINASE; ANTIGEN RECEPTOR; PROTOONCOGENE PRODUCT; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN PRODUCT; NEGATIVE REGULATOR; SH3 DOMAIN; IN-VIVO; V-CBL; PHOSPHORYLATION	Accumulating evidence indicates that the Cbl protein plays a negative role in immune receptor signaling; however, the mode of Cbl action in B cell receptor (BCR) signaling still remains unclear. DT40 B cells deficient in Cbl showed enhanced BCR-mediated phospholipase C (PLC)-gamma 2 activation, thereby leading to increased apoptosis. A possible explanation for the involvement of Cbl in PLC-gamma 2 activation was provided by findings that Cbl interacts via its Src homology 2 (SH2) domain with B cell linker protein (BLNK) after BCR ligation. BLNK is a critical adaptor molecule for PLC-gamma 2 tyrosine phosphorylation through its binding to the PLC-gamma 2 SH2 domains. As a consequence of the interaction between Cbl and BLNK, die BCR-induced recruitment of PLC-gamma 2 to BLNK and the subsequent PLC-gamma 2 tyrosine phosphorylation were inhibited. Thus, our data suggest that Cbl negatively regulates the PLC-gamma 2 pathway by inhibiting the association of PLC-gamma 2 with BLNK.	Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan; Univ Tokyo, Inst Med Sci, Dept Oncol, Tokyo 1080071, Japan	Kurosaki, T (reprint author), Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan.		Kurosaki, Tomohiro/D-1306-2009				ANDONIOU CE, 1994, EMBO J, V13, P4515; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; KEANE MM, 1995, ONCOGENE, V10, P2367; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; JONGEWARD GD, 1995, GENETICS, V139, P1553; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Thien CBF, 1998, IMMUNOL CELL BIOL, V76, P473, DOI 10.1046/j.1440-1711.1998.00768.x; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Reedquist KA, 1996, J BIOL CHEM, V271, P8435; TAKATA M, 1994, EMBO J, V13, P1341; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Thien CBF, 1999, J IMMUNOL, V162, P7133; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Barber DL, 1997, BLOOD, V89, P3166; BLAKE TJ, 1991, ONCOGENE, V6, P653; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; CHEN CLH, 1982, J IMMUNOL, V129, P2580; CORY GOC, 1995, J EXP MED, V182, P611, DOI 10.1084/jem.182.2.611; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; Fu C, 1997, J BIOL CHEM, V272, P27362, DOI 10.1074/jbc.272.43.27362; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141; Goitsuka R, 1998, J IMMUNOL, V161, P5804; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Ishiai M, 1999, J IMMUNOL, V163, P1746; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; MARCILLA A, 1995, J BIOL CHEM, V270, P9115; Marengere LEM, 1997, J IMMUNOL, V159, P70; Matsuo T, 1996, FEBS LETT, V382, P11, DOI 10.1016/0014-5793(96)00122-6; Meng WY, 1999, NATURE, V398, P84; Murphy MA, 1998, MOL CELL BIOL, V18, P4872; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187; REEDQUIST KA, 1994, P NATL ACAD SCI USA, V91, P4135, DOI 10.1073/pnas.91.10.4135; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Smit L, 1997, CRIT REV ONCOGENESIS, V8, P359; Songyang Z, 1993, Cell, V72, P767; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; van Leeuwen JEM, 1999, J BIOL CHEM, V274, P5153, DOI 10.1074/jbc.274.8.5153; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zhang ZH, 1999, J BIOL CHEM, V274, P4883, DOI 10.1074/jbc.274.8.4883; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	67	69	69	ROCKEFELLER UNIV PRESS	NEW YORK	1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA	0022-1007			J EXP MED	J. Exp. Med.	FEB 21	2000	191	4					641	650		10.1084/jem.191.4.641		10	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	287MK	WOS:000085509600007		
J	Ichimaru, S				Ichimaru, S			Comment on "Zero temperature phases of the electron gas"	PHYSICAL REVIEW LETTERS			English	Article							ENERGIES		Univ Tokyo, Tokyo 1130033, Japan	Ichimaru, S (reprint author), Univ Tokyo, Tokyo 1130033, Japan.		Kye, Yong Uk/O-9121-2014				CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Ichimaru S, 1997, PHYS LETT A, V235, P83, DOI 10.1016/S0375-9601(97)00520-3; IYETOMI H, 1993, PHYS REV B, V47, P11703, DOI 10.1103/PhysRevB.47.11703; Ortiz G, 1999, PHYS REV LETT, V82, P5317, DOI 10.1103/PhysRevLett.82.5317; TANAKA S, 1989, PHYS REV B, V39, P1036, DOI 10.1103/PhysRevB.39.1036; VOSKO SH, 1980, CAN J PHYS, V58, P1200; Young DP, 1999, NATURE, V397, P412	7	4	4	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 21	2000	84	8					1842	1842		10.1103/PhysRevLett.84.1842		1	Physics, Multidisciplinary	Physics	285HK	WOS:000085383500053		
J	Ichimaru, S				Ichimaru, S			Radiative proton-capture reactions of high-Z nuclei in the sun and in liquid-metallic hydrogen	PHYSICS LETTERS A			English	Article						radiative proton-capture reactions; thermonuclear reactions; pycnonuclear reactions; liquid-metallic hydrogen; solar interior	FUSION CROSS-SECTIONS; DENSE STELLAR MATTER; ENHANCEMENT; ELEMENTS; STARS	Thermonuclear and pycnonuclear reaction rates and enhancement factors of radiative proton captures of high-Z nuclei as well as those of p-p and p-d reactions are evaluated for the solar interior and in dense liquid-metallic hydrogen. It is predicted that proton capture of nuclei such as C-12, N-14, O-16, and F-19 may take place at considerably high rates owing to strong screening by K-shell electrons, if the density of metallic hydrogen exceeds similar to 70 g/cm(3) and the temperature remains just above solidification. (C) 2000 Published by Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Ichimaru, S (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.		Kye, Yong Uk/O-9121-2014				ALLEN CW, 1973, ASTROPHYSICAL QUANTI, P16; Ichimaru S, 1999, PHYS PLASMAS, V6, P2649, DOI 10.1063/1.873221; BAHCALL JN, 1988, REV MOD PHYS, V60, P297, DOI 10.1103/RevModPhys.60.297; FOWLER WA, 1984, REV MOD PHYS, V56, P149, DOI 10.1103/RevModPhys.56.149; Adelberger EG, 1998, REV MOD PHYS, V70, P1265, DOI 10.1103/RevModPhys.70.1265; ICHIMARU S, 1993, REV MOD PHYS, V65, P255, DOI 10.1103/RevModPhys.65.255; Wallerstein G, 1997, REV MOD PHYS, V69, P995, DOI 10.1103/RevModPhys.69.995; KRAUSS A, 1987, NUCL PHYS A, V465, P150, DOI 10.1016/0375-9474(87)90302-2; FOWLER WA, 1967, ARA A, V5, P523; ICHIMARU S, 1994, STATISTICAL PLASMA P, V2; Ichimaru S, 1996, PUBL ASTRON SOC JPN, V48, P613; Ichimaru S, 1999, PHYS LETT A, V258, P354, DOI 10.1016/S0375-9601(99)00349-7; Ichimaru S, 1997, PHYS LETT A, V235, P83, DOI 10.1016/S0375-9601(97)00520-3; ICHIMARU S, IN PRESS PHYS PLASMA; JANCOVICI B, 1977, J STAT PHYS, V17, P357, DOI 10.1007/BF01014403; Kitamura H, 1998, J PHYS SOC JPN, V67, P950, DOI 10.1143/JPSJ.67.950; Ogata S, 1997, ASTROPHYS J, V481, P883, DOI 10.1086/304086	17	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9601			PHYS LETT A	Phys. Lett. A	FEB 21	2000	266	2-3					167	172		10.1016/S0375-9601(00)00040-2		6	Physics, Multidisciplinary	Physics	289KW	WOS:000085620900010		
J	Miyanaga, K; Seki, M; Furusaki, S				Miyanaga, K; Seki, M; Furusaki, S			Analysis of pigment accumulation heterogeneity in plant cell population by image-processing system	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						plant cell culture; heterogeneous cell population; anthocyanin; image-processing system	ANTHOCYANIN PRODUCTION; SUSPENSION-CULTURES; EUPHORBIA-MILLII; WILD CARROT; STRAWBERRY; SELECTION	Plant-cultured cells are often highly heterogeneous in secondary metabolite productivity. The industrial application for large-scale metabolite production requires establishment of a stable high-producing cell line. In this study, image analysis of the individual cell is investigated as a method for evaluation of a heterogeneous cell population, and compared with the conventional method of estimation, which is based on average-cell productivity. Among strawberry cells producing anthocyanins, cells with a wide-range of pigment concentration were observed and maximum anthocyanin content was 10 times higher than the average value. In addition, a change of the frequency distribution was revealed in batch cultivation. (C) 2000 John Wiley & Sons, Inc.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Kyushu Univ, Grad Sch Engn, Dept Chem Syst & Engn, Fukuoka 812, Japan	Seki, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						YAMAKAWA T, 1983, AGR BIOL CHEM TOKYO, V47, P997; DO CB, 1990, PLANT CELL REP, V9, P143, DOI 10.1007/BF00232091; Berzin I, 1999, J CHEM ENG JPN, V32, P229, DOI 10.1252/jcej.32.229; DOUGALL DK, 1990, PLANT CELL TISS ORG, V23, P79, DOI 10.1007/BF00035827; DOUGALL DK, 1980, PLANTA, V149, P292, DOI 10.1007/BF00384569; IBRAHIM RK, 1971, LLOYD, V34, P175; LINSMAIE.EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; MATSUMOT.T, 1973, AGR BIOL CHEM TOKYO, V37, P561; MORI T, 1994, J FOOD SCI, V59, P588, DOI 10.1111/j.1365-2621.1994.tb05569.x; MORI T, 1993, J FOOD SCI, V58, P788, DOI 10.1111/j.1365-2621.1993.tb09359.x; NOZUE M, 1985, PLANT CELL REP, V4, P252, DOI 10.1007/BF00269370; Ozeki Y, 1996, J PLANT RES, V109, P343, DOI 10.1007/BF02344483; SAKAMOTO K, 1994, PLANT CELL TISS ORG, V36, P21, DOI 10.1007/BF00048311; Sato K, 1996, PLANT SCI, V113, P91, DOI 10.1016/0168-9452(95)05694-7; SMITH MAL, 1995, J BIOTECHNOL, V40, P1, DOI 10.1016/0168-1656(95)00025-L; STRAUS J, 1959, PLANT PHYSIOL, V34, P536, DOI 10.1104/pp.34.5.536; YAMAMOTO Y, 1989, AGR BIOL CHEM TOKYO, V53, P417; YAMAMOTO Y, 1982, THEOR APPL GENET, V61, P113, DOI 10.1007/BF00273877; ZENK MH, 1977, PLANT TISSUE CULTURE, P22; ZHONG JJ, 1991, BIOTECHNOL BIOENG, V38, P653, DOI 10.1002/bit.260380610	20	18	18	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0006-3592			BIOTECHNOL BIOENG	Biotechnol. Bioeng.	FEB 20	2000	67	4					493	497		10.1002/(SICI)1097-0290(20000220)67:4<493::AID-BIT13>3.0.CO;2-U		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	275BW	WOS:000084800400013		
J	Ito, K; Tsuyumoto, I; Harata, A; Sawada, T				Ito, K; Tsuyumoto, I; Harata, A; Sawada, T			Ultrafast energy transfer of silver ultrafine particles in aqueous solutions as investigated by the ultrafast lensing effect technique	CHEMICAL PHYSICS LETTERS			English	Article							TRANSIENT REFLECTIVITY MEASUREMENTS; SURFACE-PLASMONS; METAL PARTICLES; SPECTROSCOPY; FEMTOSECOND; DYNAMICS	Ultrafast relaxation dynamics of silver ultrafine particles in aqueous solutions was measured by an ultrafast lensing effect (ULE) method using two types of samples with SDS (sodium dodecyl sulfate) and without SDS. The fit to the ULE time evolution required three exponential components: one for the increase and two others for the decrease. The time constants were estimated as 1, 3, 7 ps for the sample without SDS and as I, 2, and 23 ps for the sample with SDS. The ultrafast relaxation dynamics was discussed in connection with the behavior of photoexcited electrons. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Sch English, Dept Appl Chem, Tokyo 1138656, Japan; Kanazawa Inst Technol, Fac Engn, Dept Environm Syst Engn, Nonoichi, Ishikawa 9218501, Japan; Kyushu Univ, Grad Sch Engn Sci, Dept Mol & Mat Sci, Fukuoka 8168580, Japan	Sawada, T (reprint author), Univ Tokyo, Sch English, Dept Appl Chem, 7-3-1 Hongo, Tokyo 1138656, Japan.						Steffen T, 1998, J PHYS CHEM A, V102, P4213, DOI 10.1021/jp973422c; Gretchikhine A, 1999, J APPL PHYS, V85, P1283, DOI 10.1063/1.369259; DOUHAL A, 1998, J PHYS CHEM-US, V102, P1660; FURUI G, 1999, IN PRESS PHYS CHEM A, V103; GROENEVELD RHM, 1990, PHYS REV LETT, V64, P784, DOI 10.1103/PhysRevLett.64.784; Harata A, 1998, PHYS REV B, V58, P7319, DOI 10.1103/PhysRevB.58.7319; HENGLEIN A, 1993, J PHYS CHEM-US, V97, P5457, DOI 10.1021/j100123a004; Hibara A, 1997, CHEM PHYS LETT, V272, P1, DOI 10.1016/S0009-2614(97)00496-X; Hibara A, 1999, JPN J APPL PHYS 1, V38, P2983, DOI 10.1143/JJAP.38.2983; Ito K, 1997, CHEM PHYS LETT, V275, P349, DOI 10.1016/S0009-2614(97)00741-0; Iwai S, 1998, J CHEM PHYS, V109, P5963, DOI 10.1063/1.477221; Morishita T, 1999, J PHYS CHEM B, V103, P5984, DOI 10.1021/jp984729u; Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711; ROBERTI TW, 1995, J CHEM PHYS, V102, P3860, DOI 10.1063/1.468545; SheikBahae M, 1997, OPT LETT, V22, P399, DOI 10.1364/OL.22.000399; Tanaka T, 1997, J APPL PHYS, V82, P4033, DOI 10.1063/1.365713; TERAZIMA M, 1994, J CHEM PHYS, V100, P2481, DOI 10.1063/1.466496; TERAZIMA M, 1994, CHEM PHYS LETT, V230, P87, DOI 10.1016/0009-2614(94)01126-5	18	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	FEB 18	2000	318	1-3					1	6		10.1016/S0009-2614(99)01439-6		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	287WE	WOS:000085529000001		
J	Finley, JP				Finley, JP			Diagrammatic CASPT2 using an internally contracted basis	CHEMICAL PHYSICS LETTERS			English	Article							MULTIREFERENCE PERTURBATION-THEORY	The diagrammatic CASP2 method is derived for an internally contracted basis. The wave-operator is efficient to compute and does not require orthogonalizing the internally contracted basis set and dingonalizing the zeroth-order Hamiltonian H(0). The wave-operator also has a simple form that is a generalization of Moller-Plesset perturbation theory. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; Chem Ctr Lund, Dept Theoret Chem, S-22100 Lund, Sweden	Finley, JP (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	finley@qcl.t.u-tokyo.ac.jp					ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; HIRAO K, 1992, CHEM PHYS LETT, V190, P374, DOI 10.1016/0009-2614(92)85354-D; Finley JP, 1998, J CHEM PHYS, V108, P1081, DOI 10.1063/1.475469; BARTLETT RJ, 1975, J CHEM PHYS, V62, P325; Finley JP, 1998, CHEM PHYS LETT, V283, P277, DOI 10.1016/S0009-2614(97)01410-3; Finley JP, 1998, J CHEM PHYS, V109, P7725, DOI 10.1063/1.477418; FINLEY JP, IN PRESS J CHEM PHYS; Levy B., 1968, INT J QUANTUM CHEM, V2, P307, DOI 10.1002/qua.560020210; POPLE JA, 1976, INT J QUANTUM CHEM, P1; ROOS BO, 1982, CHEM PHYS, V66, P197, DOI 10.1016/0301-0104(82)88019-1; Szabo A, 1982, MODERN QUANTUM CHEM	11	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	FEB 18	2000	318	1-3					190	195		10.1016/S0009-2614(00)01447-5		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	287WE	WOS:000085529000031		
J	Hirao, I; Madin, K; Endo, Y; Yokoyama, S; Ellington, AD				Hirao, I; Madin, K; Endo, Y; Yokoyama, S; Ellington, AD			RNA aptamers that bind to and inhibit the ribosome-inactivating protein, pepocin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICIN-A-CHAIN; N-GLYCOSIDASE ACTIVITY; SUBCELLULAR-LOCALIZATION; IDENTITY ELEMENTS; ESCHERICHIA-COLI; LOOP; RECOGNITION; RESOLUTION; MECHANISM; PURIFICATION	Pepocin, isolated from Cucurbita pepo, is a ribosome-inactivating protein (RIP). RIPs site-specifically recognize and depurinate an adenosine at position 4324 in rat 28 S rRNA, rendering the ribosome incapable of interacting with essential elongation factors. Aptamers that target pepocin were isolated from a degenerate RNA pool by in vitro selection. A conserved hairpin motif, quite different from the sequence of the toxin-substrate domain in rat 28 S rRNA, was identified in the aptamer sequences. The aptamers selectively bind to pepocin with dissociation constants between 20 and 30 nM and inhibit the N-glycosidase activity of pepocin on rat liver 28 S rRNA, Competitive binding experiments using aptamer variants suggest that the conserved hairpin region in the anti-pepocin aptamer binds near the catalytic site on pepocin and prevents the interaction of pepocin and 28 S rRNA. Anti-RIP aptamers have potential use in diagnostic systems for the detection of pepocin or could be used as therapy to prevent the action of pepocin in mammalian cells.	Univ Texas, Dept Biochem, Austin, TX 78712 USA; RIKEN, JST, ERATO, Yokoyama CytoLog Project, Wako, Saitama 3510198, Japan; Ehime Univ, Dept Appl Chem, Matsuyama, Ehime 790, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	Ellington, AD (reprint author), Univ Texas, Dept Biochem, ICMB A4800,26th & Speedway, Austin, TX 78712 USA.		Hirao, Ichiro/G-3041-2012				Bell SD, 1998, J BIOL CHEM, V273, P14309, DOI 10.1074/jbc.273.23.14309; ENDO Y, 1987, J BIOL CHEM, V262, P8128; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; KARMALI MA, 1985, J INFECT DIS, V151, P775; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; ENDO Y, 1988, J BIOL CHEM, V263, P8735; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; SZEWCZAK AA, 1995, J MOL BIOL, V247, P81, DOI 10.1006/jmbi.1994.0124; BARTEL DP, 1995, RNA PROTEIN INTERACT, P248; BASKERVILLE S, 1998, RNA STRUCTURE FUNCTI, P203; CONRAD RC, 1995, NUCL ACID PROTEIN IN, P285; Convery MA, 1998, NAT STRUCT BIOL, V5, P133, DOI 10.1038/nsb0298-133; ENDO Y, 1991, J MOL BIOL, V221, P193, DOI 10.1016/0022-2836(91)90814-M; ENDO Y, 1988, BIOCHIM BIOPHYS ACTA, V954, P224, DOI 10.1016/0167-4838(88)90075-1; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; HIRAO I, 1999, IN PRESS MOL DIVERSI; Hornung V, 1998, BIOCHEMISTRY-US, V37, P7260, DOI 10.1021/bi972969e; INWARD CD, 1995, J INFECTION, V30, P213, DOI 10.1016/S0163-4453(95)90693-2; MILFORD DV, 1990, ARCH DIS CHILD, V65, P716; Orita M, 1996, NUCLEIC ACIDS RES, V24, P611, DOI 10.1093/nar/24.4.611; ORITA M, 1993, NUCLEIC ACIDS RES, V21, P5670, DOI 10.1093/nar/21.24.5670; Rowsell S, 1998, NAT STRUCT BIOL, V5, P970, DOI 10.1038/2946; WEEKS KM, 1995, BIOCHEMISTRY-US, V34, P7728, DOI 10.1021/bi00023a020; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; Yoshinari S, 1997, BIOSCI BIOTECH BIOCH, V61, P324; Yoshinari S, 1996, EUR J BIOCHEM, V242, P585, DOI 10.1111/j.1432-1033.1996.0585r.x	27	22	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 18	2000	275	7					4943	4948		10.1074/jbc.275.7.4943		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	285FC	WOS:000085378200058		
J	Asagoshi, K; Yamada, T; Terato, H; Ohyama, Y; Monden, Y; Arai, T; Nishimura, S; Aburatani, H; Lindahl, T; Ide, H				Asagoshi, K; Yamada, T; Terato, H; Ohyama, Y; Monden, Y; Arai, T; Nishimura, S; Aburatani, H; Lindahl, T; Ide, H			Distinct repair activities of human 7,8-dihydro-8 oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI FPG PROTEIN; APURINIC APYRIMIDINIC SITES; BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ENDONUCLEASE-III; SUBSTRATE-SPECIFICITY; MUTAGENIC SUBSTRATE; IONIZING-RADIATION; ABASIC SITES	7,8-Dihydro-8-oxoguanine (8-oxoG) and 2,6-diamino-4-hydroxyformamidopyrimidine (Fapy) are major DNA lesions formed by reactive oxygen species and are involved in mutagenic and/or lethal events in cells. Both lesions are repaired by human 7,8 dihydro-8-oxoguanine DNA glycosylase (hOGG1) and formamidopyrimidine DNA glycosylase (Fpg) in human and Escherichia coli cells, respectively. In the present study, the repair activities of hOGG1 and Fpg were compared using defined oligonucleotides containing 8-oxoG and a methylated analog of Fapy (me-Fapy) at the same site. The k(cat)/K-m values of hOGG1 for 8-oxoG and me-Fapy were comparable, and this was also the case for Fpg, However, the k(cat)/K-m values of hOGG1 for both lesions were approximately 80-fold lower than those of Fpg, Analysis of the Schiff base intermediate by NaBH4 trapping implied that lower substrate affinity and slower hydrolysis of the intermediate for hOGG1 than Fpg accounted for the difference. hOGG1 and Fpg showed distinct preferences of the base opposite 8-oxoG, with the activity differences being 19.8- (hOGG1) and 12-fold (Fpg) between the most and least preferred bases. Surprisingly, such preferences were almost abolished and less than a-fold for both enzymes when me-Fapy was a substrate, suggesting that, unlike 8-oxoG, me-Fapy is not subjected to paired base-dependent repair. The repair efficiency of me-Fapy randomly incorporated in M13 DNA varied at the sequence level, but orders of preferred and unpreferred repair sites were quite different for hOGG1 and Fpg. The distinctive activities of hOGG1 and Fpg including enzymatic parameters (k(cat)/K-m), paired base, and sequence context effects may originate from the differences in the inherent architecture of the DNA binding domain and catalytic mechanism of the enzymes.	Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; Banyu Tsukuba Res Inst, Merck Res Labs, Tsukuba, Ibaraki 3002611, Japan; Univ Tokyo, RCAST, Genomesci Div, Bunkyo Ku, Tokyo 1130033, Japan; Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Ide, H (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.						MICHAELS ML, 1992, J BACTERIOL, V174, P6321; TCHOU J, 1995, J BIOL CHEM, V270, P11671, DOI 10.1074/jbc.270.19.11671; Ye N, 1998, J MOL BIOL, V284, P269, DOI 10.1006/jmbi.1998.2138; Hatahet Z, 1998, P NATL ACAD SCI USA, V95, P8556, DOI 10.1073/pnas.95.15.8556; Karahalil B, 1998, NUCLEIC ACIDS RES, V26, P1228, DOI 10.1093/nar/26.5.1228; Eide L, 1996, P NATL ACAD SCI USA, V93, P10735, DOI 10.1073/pnas.93.20.10735; Aburatani H, 1997, CANCER RES, V57, P2151; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Senturker S, 1998, NUCLEIC ACIDS RES, V26, P5270, DOI 10.1093/nar/26.23.5270; Monden Y, 1999, BIOCHEM BIOPH RES CO, V258, P605, DOI 10.1006/bbrc.1999.0649; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; David SS, 1998, CHEM REV, V98, P1221, DOI 10.1021/cr980321h; Bruner SD, 1998, CURR BIOL, V8, P393, DOI 10.1016/S0960-9822(98)70158-7; CHENG KC, 1992, J BIOL CHEM, V267, P166; Girard PM, 1997, NUCLEIC ACIDS RES, V25, P3204, DOI 10.1093/nar/25.16.3204; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; PAVLOV YI, 1994, BIOCHEMISTRY-US, V33, P4695, DOI 10.1021/bi00181a029; OCONNOR TR, 1993, J BIOL CHEM, V268, P9063; Slupska MM, 1996, J BACTERIOL, V178, P3885; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; CASTAING B, 1993, NUCLEIC ACIDS RES, V21, P2899, DOI 10.1093/nar/21.12.2899; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; BAILLY V, 1989, BIOCHEM J, V262, P581; CHETSANGA CJ, 1981, BIOCHEMISTRY-US, V20, P5201, DOI 10.1021/bi00521a016; Cunningham RP, 1996, CURR BIOL, V6, P1230, DOI 10.1016/S0960-9822(96)00703-8; GRAVES R, 1992, CARCINOGENESIS, V13, P1455, DOI 10.1093/carcin/13.8.1455; Hang B, 1998, J BIOL CHEM, V273, P33406, DOI 10.1074/jbc.273.50.33406; HATAHET Z, 1998, DNA DAMAGE REPAIR, V1, P229; HAYASHIBARA KC, 1991, J AM CHEM SOC, V113, P5104, DOI 10.1021/ja00013a080; IDE H, 1993, BIOCHEM MOL BIOL INT, V31, P485; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; OCONNOR TR, 1988, NUCLEIC ACIDS RES, V16, P5878; Rabow LE, 1997, BIOCHEMISTRY-US, V36, P5084, DOI 10.1021/bi963005a; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; TUDEK B, 1992, NUCLEIC ACIDS RES, V20, P3079, DOI 10.1093/nar/20.12.3079; You HJ, 1998, BIOCHEMISTRY-US, V37, P6033, DOI 10.1021/bi973042h	43	97	98	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 18	2000	275	7					4956	4964		10.1074/jbc.275.7.4956		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	285FC	WOS:000085378200060		
J	Kanazawa, H; Atsumi, R; Matsushima, Y; Kizu, J				Kanazawa, H; Atsumi, R; Matsushima, Y; Kizu, J			Determination of theophylline and its metabolites in biological samples by liquid chromatography-mass spectrometry	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	23rd International Symposium on High Performance Liquid Phase Separations and Related Techniques	MAY 30-JUN 04, 1999	GRANADA, SPAIN			column switching; theophylline; caffeine	PLASMA; MEDETOMIDINE; ANESTHETICS	Liquid chromatography-mass spectrometry (LC-MS) is a powerful tool for analysis of drugs and their metabolites. We used a column-switching system in combination with atmospheric pressure chemical ionization LC-MS (LC-APCI-MS) for the determination of theophylline and its metabolites in biological samples. The separation was carried out on a reversed-phase column using methanol-20 mM ammonium acetate as a mobile phase at a flow-rate of 1 ml/min in 30 min. In the mass spectrum, the molecular ions of these drugs and metabolites were clearly observed as base peaks. This method is sufficiently sensitive and accurate for the pharmacokinetic studies of these drugs. (C) 2000 Elsevier Science BN. All rights reserved.	Kyoritsu Coll Pharm, Tokyo 1058512, Japan; Univ Tokyo, Dept Pharm, Branch Hosp, Fac Med,Bunkyo Ku, Tokyo 1128688, Japan	Kanazawa, H (reprint author), Kyoritsu Coll Pharm, 1-5-30 Shiba Koen, Tokyo 1058512, Japan.						FUHR U, 1992, BIOCHEM PHARMACOL, V43, P225, DOI 10.1016/0006-2952(92)90282-N; KANAZAWA H, 1993, J CHROMATOGR, V631, P215, DOI 10.1016/0021-9673(93)80524-C; KANAZAWA H, 1995, BIOMED CHROMATOGR, V9, P188, DOI 10.1002/bmc.1130090408; Kanazawa H, 1998, J CHROMATOGR A, V797, P227, DOI 10.1016/S0021-9673(97)00928-X; KIZU J, 1999, CHROMATOGRAPHY, V19, P217; Kizu J, 1999, BIOMED CHROMATOGR, V13, P15, DOI 10.1002/(SICI)1099-0801(199902)13:1<15::AID-BMC766>3.3.CO;2-4; MACMANUS ME, 1988, J PHARM PHARMACOL, V40, P388; MUIR KT, 1982, J CHROMATOGR, V231, P73, DOI 10.1016/S0378-4347(00)80510-1; NALINE E, 1987, J CHROMATOGR-BIOMED, V419, P177, DOI 10.1016/0378-4347(87)80276-1; Sakairi M, 1998, J CHROMATOGR A, V794, P391, DOI 10.1016/S0021-9673(97)01220-X	10	39	44	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673			J CHROMATOGR A	J. Chromatogr. A	FEB 18	2000	870	1-2					87	96		10.1016/S0021-9673(99)00891-2		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	286QD	WOS:000085455900011		
J	Matsuura, Y; Stewart, M; Kawamoto, M; Kamiya, N; Saeki, K; Yasunaga, T; Wakabayashi, T				Matsuura, Y; Stewart, M; Kawamoto, M; Kamiya, N; Saeki, K; Yasunaga, T; Wakabayashi, T			Structural basis for the higher Ca2+-activation of the regulated actin-activated myosin ATPase observed with Dictyostelium/tetrahymena actin chimeras	JOURNAL OF MOLECULAR BIOLOGY			English	Article						Dictyostelium actin; gelsolin; X-ray crystallography; mutant; calcium regulation	PROTEIN-PROTEIN INTERFACES; MUSCLE THIN-FILAMENTS; RAY FIBER DIFFRACTION; SKELETAL-MUSCLE; BINDING-SITES; ATOMIC MODEL; BETA-ACTIN; TROPONIN-T; I COMPLEX; F-ACTIN	Replacement of residues 228-230 or 228-232 of subdomain 4 in Dictyostelium actin with the corresponding Tetrahymena sequence (QTA to KAY replacement: half chimera-1; QTAAS to KAYKE replacement: full chimera) leads to a higher Ca2+-activation of the regulated acto-myosin subfragment-l ATPase activity. The ratio of ATPase activation in the presence of tropomyosin-troponin and Ca2+ to that without tropomyosin-troponin becomes about four times as large as the ratio for the wild-type actin. To understand the structural basis of this higher Ca2+-activation, we have determined the crystal structures of the 1:1 complex of Dictyostelium mutant actins (half chimera-1 and full chimera) with gelsolin segment-1 to 2.0 Angstrom and 2.4 Angstrom resolution, respectively, together with the structure of wild-type actin as a control. Although there were local changes on the surface of the subdomain 4 and the phenolic side-chain of Tyr230 displaced the side-chain of Leu236 from a non-polar pocket to a more solvent-accessible position, the structures of the actin chimeras showed that the mutations in the 228-232 region did not introduce large changes in the overall actin structure. This suggests that residues near position 230 formed part of the tropomyosin binding site on actin in actively contracting muscle. The higher Ca2+-activation observed with A230Y-containing mutants can be understood in terms of a three-state model for thin filament regulation in which, in the presence of both Ca2+ and myosin heads, the local changes of actin generated by the mutation (especially its phenolic side-chain) facilitate the transition of thin filaments from a "closed" state to an "open" state. Between 394 and 469 water molecules were identified in the different structures and it was found that actin recognizes hydrated forms of the adenine base and the Ca ion in the nucleotide binding site. (C) 2000 Academic Press.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Japan Synchrotron Radiat Res Inst, Mikazuki, Hyogo 6795198, Japan; RIKEN, Harima Inst, Mikazuki, Hyogo 6795143, Japan	Wakabayashi, T (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Yasunaga, Takuo/C-8316-2009	Yasunaga, Takuo/0000-0002-2494-9603			ALKHAYAT HA, 1995, J MOL BIOL, V252, P611, DOI 10.1006/jmbi.1995.0524; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; EBASHI S, 1964, J BIOCHEM-TOKYO, V55, P604; Xu C, 1999, BIOPHYS J, V77, P985; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; BRUNGER AT, 1992, NATURE, V355, P412; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DAHIYA R, 1994, J BIOL CHEM, V269, P29457; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Geeves M. A., 1995, Biophysical Journal, V68; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HOLMES KC, 1995, BIOPHYS J S, V68, P2; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; Ishikawa T, 1999, J BIOCHEM-TOKYO, V126, P200; ISHIKAWA T, 1994, BIOCHEM BIOPH RES CO, V203, P951, DOI 10.1006/bbrc.1994.2274; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KAMIYA N, 1995, REV SCI INSTRUM, V66, P1703, DOI 10.1063/1.1145888; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEHRER SS, 1994, J MUSCLE RES CELL M, V15, P232; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; MANNHERZ HG, 1992, J MOL BIOL, V226, P899, DOI 10.1016/0022-2836(92)90641-V; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; ROMANS P, 1985, J MOL BIOL, V186, P321, DOI 10.1016/0022-2836(85)90108-1; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; SAEKI K, 2000, IN PRESS BIOCHEMISTR; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SHETERLINE P, 1996, PROTEIN PROFILE ACT; Squire JM, 1998, FASEB J, V12, P761; STEWART M, 1975, NATURE, V257, P331, DOI 10.1038/257331a0; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; TOYOSHIMA C, 1985, J BIOCHEM-TOKYO, V97, P245; WAKABAYASHI T, 1975, J MOL BIOL, V93, P477, DOI 10.1016/0022-2836(75)90241-7; WEEDS AG, 1977, J MOL BIOL, V111, P129, DOI 10.1016/S0022-2836(77)80119-8; WHITBY FG, 1992, J MOL BIOL, V227, P441, DOI 10.1016/0022-2836(92)90899-U	59	27	27	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836			J MOL BIOL	J. Mol. Biol.	FEB 18	2000	296	2					579	595		10.1006/jmbi.1999.3467		17	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	290VQ	WOS:000085698900021		
J	Nitta-Komatsubara, Y; Abe, K; Aoki, M; Isoyama, S				Nitta-Komatsubara, Y; Abe, K; Aoki, M; Isoyama, S			Altered ischemic induction of immediate early gene and heat shock protein 70 mRNAs after preconditioning in rat hearts	LIFE SCIENCES			English	Article						immediate early gene; heat shock protein 70; preconditioning; ischemia; heart	MYOCARDIAL-INFARCTION; CARDIAC MYOCYTES; ANGINA-PECTORIS; STRESS PROTEINS; TRANSGENIC MICE; 2ND WINDOW; EXPRESSION; PROTECTION; RESISTANCE; PROTOONCOGENE	Immediate early genes and heat shock protein (HSP) 70s, which may play a role in adaptation and cellular protection, respectively, are induced by ischemia in hearts. We examined if the induction of immediate early gene (c-fos, c-myc, c-jun, and junB) and HSP70 mRNAs by ischemia is affected by ischemic preconditioning. Transient ischemia (5 or 10 minute) was applied to Wistar rat (n=75) hearts, by tightening a snare placed around left coronary arterial branches 7 days before applying ischemia. Rats without earlier ischemia (control group, C) and rats with 5-minute ischemia 12 or 24 hours earlier (EI12 or 24 group) were given IO-minute ischemia and sacrificed at 0, 0.5, 1, 2, and 4 hour. RNA was extracted from the ischemic region and Northern blot analysis was performed. The induction of c-fos and c-myc mRNAs was significantly increased in EI12 but not in EI24 compared with that in C. The induction of c-jun and junB mRNAs showed no change in both EI12 and EI24 compared with that in C. The induction of HSP72 and 73 mRNAs was decreased in EI12 and decreased further in EI24. Thus, ischemic preconditioning altered the induction of immediate early gene and HSP70 mRNAs by ischemia. The effect of preconditioning differed among genes studied and changed with time after preconditioning. Ischemic preconditioning alters protective and adaptive responses to ischemia at the gene level.	Tohoku Bunka Gakuen Univ, Fac Med Sci & Welf, Aoba Ku, Sendai, Miyagi 9808550, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; Okayama Univ, Dept Neurol, Okayama, Japan; Tohoku Univ, Sch Med, Inst Brain Dis, Dept Neurol, Sendai, Miyagi 980, Japan	Isoyama, S (reprint author), Tohoku Bunka Gakuen Univ, Fac Med Sci & Welf, Aoba Ku, 6-45-16 Kunimi, Sendai, Miyagi 9808550, Japan.						BRAND T, 1992, CIRC RES, V71, P1351; Takano H, 1998, CIRCULATION, V98, P441; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Yellon DM, 1998, CARDIOVASC RES, V37, P21, DOI 10.1016/S0008-6363(97)00214-9; KLONER RA, 1995, CIRCULATION, V91, P37; TAKAHASHI T, 1992, J CLIN INVEST, V89, P939, DOI 10.1172/JCI115675; MARBER MS, 1993, CIRCULATION, V88, P1264; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; ZHENG JS, 1994, CIRC RES, V74, P1034; MICHEL JB, 1994, J CLIN INVEST, V94, P277, DOI 10.1172/JCI117318; NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795; OTTANI F, 1995, CIRCULATION, V91, P291; ANZAI T, 1994, AM J CARDIOL, V74, P755, DOI 10.1016/0002-9149(94)90428-6; GLOWER DD, 1987, CARDIOVASC RES, V21, P328, DOI 10.1093/cvr/21.5.328; KNOLL R, 1994, CARDIOVASC RES, V28, P1062, DOI 10.1093/cvr/28.7.1062; KUZUYA T, 1993, CIRC RES, V72, P1293; LIU YG, 1992, AM J PHYSIOL, V263, pH1107; Marber MS, 1996, ANN NY ACAD SCI, V793, P123, DOI 10.1111/j.1749-6632.1996.tb33510.x; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; NAKAGAWA Y, 1995, J AM COLL CARDIOL, V25, P1076, DOI 10.1016/0735-1097(94)00542-X; Neufer PD, 1998, AM J PHYSIOL-CELL PH, V274, pC341; Plumier JCL, 1996, J MOL CELL CARDIOL, V28, P1251, DOI 10.1006/jmcc.1996.0115; Sato Shigeru, 1992, Neurological Research, V14, P375; SHIDA M, 1993, J MOL CELL CARDIOL, V25, P1025, DOI 10.1006/jmcc.1993.1115; Tajima M, 1997, AM J PHYSIOL-HEART C, V273, pH526; Toussaint O, 1998, ANN NY ACAD SCI, V851, P450, DOI 10.1111/j.1749-6632.1998.tb09023.x; WEBSTER KA, 1994, CIRC RES, V74, P679; Yamashita N, 1998, J MOL CELL CARDIOL, V30, P1181, DOI 10.1006/jmcc.1998.0682; YELLON DM, 1995, J MOL CELL CARDIOL, V27, P1023, DOI 10.1016/0022-2828(95)90071-3; YELLON DM, 1992, J MOL CELL CARDIOL, V24, P113, DOI 10.1016/0022-2828(92)93148-D	31	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205			LIFE SCI	Life Sci.	FEB 18	2000	66	13					1261	1270		10.1016/S0024-3205(00)00430-6		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	286EA	WOS:000085429600010		
J	Pan, SH; Hudson, EW; Lang, KM; Eisaki, H; Uchida, S; Davis, JC				Pan, SH; Hudson, EW; Lang, KM; Eisaki, H; Uchida, S; Davis, JC			Imaging the effects of individual zinc impurity atoms on superconductivity in Bi2Sr2CaCu2O8+delta	NATURE			English	Article							D-WAVE SUPERCONDUCTORS; SCANNING-TUNNELING-MICROSCOPY; STATES; PROBE; SUBSTITUTION; TRANSITION; MOMENTS; GAP; NMR; CU	Although the crystal structures of the copper oxide high-temperature superconductors are complex and diverse, they all contain some crystal planes consisting of only copper and oxygen atoms in a square lattice: superconductivity is believed to originate from strongly interacting electrons in these CuO2 planes, Substituting a single impurity atom for a copper atom strongly perturbs the surrounding electronic environment and can therefore be used to probe high-temperature superconductivity at the atomic scale. This has provided the motivation for several experimental(1-8) and theoretical studies(9-20). Scanning tunnelling microscopy (STM) is an ideal technique for the study of such effects at the atomic scale, as it has been used very successfully to probe individual impurity atoms in several other systems(21-25). Here we use STM to investigate the effects of individual zinc impurity atoms in the high-temperature superconductor Bi2Sr2CaCu2O8+delta. We find intense quasiparticle scattering resonances(26) at the Zn sites, coincident with strong suppression of superconductivity within similar to 15 Angstrom of the scattering sites. Imaging of the spatial dependence of the quasiparticle density of states in the vicinity of the impurity atoms reveals the long-sought four-fold symmetric quasiparticle 'cloud' aligned with the nodes of the d-wave superconducting gap which is believed to characterize superconductivity in these materials.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Tokyo, Dept Superconduct, Tokyo 1138656, Japan; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Davis, JC (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Hudson, Eric/C-2746-2008				ANDERSEN OK, 1994, PHYS REV B, V49, P4145, DOI 10.1103/PhysRevB.49.4145; Fukuzumi Y, 1996, PHYS REV LETT, V76, P684, DOI 10.1103/PhysRevLett.76.684; LEE PA, 1993, PHYS REV LETT, V71, P1887, DOI 10.1103/PhysRevLett.71.1887; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Nachumi B, 1996, PHYS REV LETT, V77, P5421, DOI 10.1103/PhysRevLett.77.5421; Salkola MI, 1997, PHYS REV B, V55, P12648, DOI 10.1103/PhysRevB.55.12648; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Yazdani A, 1997, SCIENCE, V275, P1767, DOI 10.1126/science.275.5307.1767; Tsuchiura H, 1999, J PHYS SOC JPN, V68, P2510, DOI 10.1143/JPSJ.68.2510; Atkinson WA, 1999, SCIENCE, V285, P57, DOI 10.1126/science.285.5424.57; BALATSKY AV, 1995, PHYS REV B, V51, P15547, DOI 10.1103/PhysRevB.51.15547; Basov DN, 1998, PHYS REV LETT, V81, P2132, DOI 10.1103/PhysRevLett.81.2132; BONN DA, 1994, PHYS REV B, V50, P4051, DOI 10.1103/PhysRevB.50.4051; BYERS JM, 1993, PHYS REV LETT, V71, P3363, DOI 10.1103/PhysRevLett.71.3363; Flatte ME, 1999, SOLID STATE PHYS, V52, P137, DOI 10.1016/S0081-1947(08)60019-3; Fong HF, 1999, PHYS REV LETT, V82, P1939, DOI 10.1103/PhysRevLett.82.1939; Franz M, 1996, PHYS REV B, V54, pR6897; Hirschfeld PJ, 1996, PHYS REV LETT, V77, P3909, DOI 10.1103/PhysRevLett.77.3909; Hudson EW, 1999, SCIENCE, V285, P88, DOI 10.1126/science.285.5424.88; ISHIDA K, 1991, PHYSICA C, V179, P29, DOI 10.1016/0921-4534(91)90007-L; MAEDA A, 1990, PHYS REV B, V41, P4112, DOI 10.1103/PhysRevB.41.4112; MAHAJAN AV, 1994, PHYS REV LETT, V72, P3100, DOI 10.1103/PhysRevLett.72.3100; MOTOHIRA N, 1989, NIPPON SERAM KYO GAK, V97, P1009; Nagaosa N, 1997, PHYS REV LETT, V79, P3755, DOI 10.1103/PhysRevLett.79.3755; Salkola MI, 1996, PHYS REV LETT, V77, P1841, DOI 10.1103/PhysRevLett.77.1841; SALKOLA MI, 1998, PHYS REV B, V58, P5126; SUN Y, 1995, PHYS REV B, V51, P6059, DOI 10.1103/PhysRevB.51.6059; WELLS BO, 1992, PHYS REV B, V46, P11830, DOI 10.1103/PhysRevB.46.11830; WHITE PJ, 1999, ZN IMPURITIES BI2SR2; Wittneven C, 1998, PHYS REV LETT, V81, P5616, DOI 10.1103/PhysRevLett.81.5616; Yazdani A, 1999, PHYS REV LETT, V83, P176, DOI 10.1103/PhysRevLett.83.176; ZHENG JF, 1994, PHYS REV LETT, V72, P1490, DOI 10.1103/PhysRevLett.72.1490	32	571	573	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					746	750				5	Multidisciplinary Sciences	Science & Technology - Other Topics	286BE	WOS:000085423100045		
J	Matsushita, F; Miyawaki, A; Mikoshiba, K				Matsushita, F; Miyawaki, A; Mikoshiba, K			Vomeroglandin/CRP-ductin is strongly expressed in the glands associated with the mouse vomeronasal organ: Identification and characterization of mouse vomeroglandin	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							SRCR SUPERFAMILY; PROTEIN; RECEPTOR; DOMAIN; FAMILY; BRAIN	Vomeroglandin, a subform of mouse CRP-ductin, is a protein strongly expressed in the glands of mouse vomeronasal system. Both the proteins contain several of scavenger receptor cysteine-rich and CUB domains and one ZP domain. This domain arrangement is similar to those of rat Ebnerin, human DMBT1, and rabbit hensin, In situ hybridization analysis shows strong expression of vomeroglandin mRNA in the glands of vomeronasal system. Immunological analyses detect both membrane-bound and secreted forms of vomeroglandin, The secreted protein seems to be localized in the lumen of the vomeronasal organ, playing a certain role in the pheromone perception. (C) 2000 Academic Press.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1080071, Japan; Kyoto Univ, Dept Agr Chem, Fac Agr, Sakyo Ku, Kyoto 6068502, Japan	Matsushita, F (reprint author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Cell Biol, Toyoake, Aichi 4701192, Japan.		Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235			Al-Awqati Q, 1998, AM J PHYSIOL-RENAL, V275, pF183; AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571; Flower DR, 1996, BIOCHEM J, V318, P1; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Cheng H, 1996, ANAT REC, V244, P327; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI XJ, 1995, J BIOL CHEM, V270, P17674; MIYAWAKI A, 1994, EMBO J, V13, P5835; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; MONKAWA T, 1995, J BIOL CHEM, V270, P14700; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; RYO Y, 1993, J NEUROSCI RES, V36, P19, DOI 10.1002/jnr.490360104; TAKAMI S, 1994, CELL TISSUE RES, V277, P211, DOI 10.1007/s004410050149; Takito J, 1996, J CLIN INVEST, V98, P2324, DOI 10.1172/JCI119044	19	28	30	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 16	2000	268	2					275	281		10.1006/bbrc.2000.2104		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	286DB	WOS:000085427400006		
J	Hong, Y; Suzuki, S; Yatoh, S; Mizutani, M; Nakajima, T; Bannai, S; Sato, H; Soma, M; Okuda, Y; Yamada, N				Hong, Y; Suzuki, S; Yatoh, S; Mizutani, M; Nakajima, T; Bannai, S; Sato, H; Soma, M; Okuda, Y; Yamada, N			Effect of hypoxia on nitric oxide production and its synthase gene expression in rat smooth muscle cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							PULMONARY CIRCULATION; MOUSE MACROPHAGES; INDUCTION; LIPOPOLYSACCHARIDE; MESSENGER; CLONING; GAMMA	It has not been clarified yet as to whether hypoxia and inflammation affect NO synthesis. In this study, we investigated the transcription of inducible nitric oxide synthase (iNOS) mRNA and the production of nitric oxide (NO) in rat smooth muscle cells (SMCs) cultured under hypoxic conditions in the presence and absence of proinflammatory cytokine interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS), We found that hypoxia inhibited the production of NO but did not affect the transcription of iNOS mRNA in rat SMCs treated with IFN-gamma, LPS, or both, These results indicate that O-2 is involved in the regulation of NO synthesis in inflammatory tissues. (C) 2000 Academic Press.	Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Fac Med, Dept Internal Med 2, Tokyo, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Biochem, Tsukuba, Ibaraki 305, Japan; Mochida Pharmaceut Co Ltd, Pharmacovigilance Div, Tokyo, Japan	Suzuki, S (reprint author), Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 305, Japan.						ADNOT S, 1991, J CLIN INVEST, V87, P155, DOI 10.1172/JCI114965; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Melillo G, 1996, J IMMUNOL, V157, P2638; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; ARCHER SL, 1995, CIRC RES, V77, P21; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; ISAACSON TC, 1994, J APPL PHYSIOL, V76, P933; Kolyada AY, 1996, BIOCHEM BIOPH RES CO, V220, P600, DOI 10.1006/bbrc.1996.0449; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; LYONS CR, 1992, J BIOL CHEM, V267, P6370; NATHAN C, 1992, FASEB J, V6, P3051; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Paul A, 1997, BRIT J PHARMACOL, V120, P940, DOI 10.1038/sj.bjp.0700976; SEIP WF, 1980, J CLIN MICROBIOL, V11, P226; SIRSJO A, 1994, FEBS LETT, V338, P191, DOI 10.1016/0014-5793(94)80363-3; WARREN JB, 1989, CLIN SCI, V77, P671; Wileman SM, 1995, BRIT J PHARMACOL, V116, P3243; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	21	17	17	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 16	2000	268	2					329	332		10.1006/bbrc.2000.2140		4	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	286DB	WOS:000085427400016		
J	Li, X; Guo, M; Mori, E; Mori, T				Li, X; Guo, M; Mori, E; Mori, T			Activation of caspase-3 in molt4 cells by apoptosis-inducing nucleosides from CD57(+)HLA-DRbright natural suppressor cell line	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							MURINE OVARY; DNA FRAGMENTATION; DEATH; FAS; PROTEASES; CLEAVAGE; IDENTIFICATION; SPECIFICITIES; EXPRESSION; INHIBITOR	Apoptosis-inducing nucleosides (ATNs), which were released and isolated from CD57(+)HLA-DRbright natural suppressor (57.DR-NS) cell line derived from human decidual tissue, induced apoptosis in Molt4 cells. The addition of caspase-3 inhibitor into the reaction blocked the cleavage of caspase-3 and apoptosis in Molt4 cells treated with AINs, detected by how cytometrical or spectrofluorometrical analysis and DNA fragmentation assay. Furthermore, by means of immunoblotting, the processing of caspase-3 was shown with the appearance of their catalytically active subunits of 20 and 11 kDa during the generation of apoptosis in Molt4 cells treated with AINs. This processing of caspase-3 into active subunits was also blocked by the addition of caspase-3 inhibitor. Thus, it was definitely revealed that the activation of caspase-3 was a key feature in the caspase cascade of AINs-induced apoptosis in Molt4 cells. (C) 2000 Academic Press.	Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, Tokyo 1080071, Japan	Mori, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1080071, Japan.						KROEMER G, 1995, FASEB J, V9, P1277; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Cohen GM, 1997, BIOCHEM J, V326, P1; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Enari M, 1998, NATURE, V391, P43; Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Patel T, 1996, FASEB J, V10, P587; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Guchelaar HJ, 1997, PHARM WORLD SCI, V19, P119, DOI 10.1023/A:1008654316572; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Sakahira H, 1998, NATURE, V391, P96; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; DIVE C, 1991, BRIT J CANCER, V64, P192, DOI 10.1038/bjc.1991.269; GUO MW, 1994, BIOCHEM BIOPH RES CO, V203, P1438, DOI 10.1006/bbrc.1994.2346; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Li X, 1999, INT J ONCOL, V14, P687; Mori T, 1998, BIOCHEM BIOPH RES CO, V251, P416, DOI 10.1006/bbrc.1998.9423; Mori T, 1997, HORM RES, V48, P11; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Xu JP, 1997, ZYGOTE, V5, P321	29	10	11	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 16	2000	268	2					514	520		10.1006/bbrc.2000.2166		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	286DB	WOS:000085427400049		
J	Sunahara, S; Nakamura, K; Nakao, K; Gondo, Y; Nagata, Y; Katsuki, M				Sunahara, S; Nakamura, K; Nakao, K; Gondo, Y; Nagata, Y; Katsuki, M			The oocyte-specific methylated region of the U2afbp-rs/U2af1-rs1 gene is dispensable for its imprinted methylation	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						U2afbp-rs/U2af1-rs1; genomic imprinting; differentially methylated region; gene targeting	ALLELE-SPECIFIC METHYLATION; MOUSE CHROMOSOME-11; SNRPN GENE; CPG ISLAND; U2AF1-RS1; HUMAN-CHROMOSOME-15; EXPRESSION; TRANSGENE; SEQUENCE; DEFINE	Imprinted genes harbor discrete regions which are differentially methylated in gametes; usually the final differential methylation patterns in adults are established during embryogenesis through modifications of the initial methylation patterns in gametes. Previous reports have shown that a 200-bp region termed region II within the CpG island of the mouse imprinted U2afbp-rs gene is methylated in oocytes but not in sperm, suggesting that this region is a center for the propagation of methylated CpGs on the maternal allele and is also a candidate for an imprinting control element. To determine whether region II is required for the imprinted methylation of this gene at the endogenous locus, we generated mice carrying a deletion of this region. We herein show that parental methylation differences still exist in the CpG island on the region II-deleted allele. These findings suggest that region II is dispensable for the imprinted methylation Of the U2afbp-rs gene. (C) 2000 Academic Press.	Univ Tokyo, Div DNA Biol & Embryo Engn, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, CREST, Ctr Med Expt, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 8908520, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2440804, Japan	Katsuki, M (reprint author), Univ Tokyo, Div DNA Biol & Embryo Engn, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Ainscough J. F. X., 1996, Epigenetic mechanisms of gene regulation., P173; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; GONDO Y, 1994, BIOCHEM BIOPH RES CO, V202, P830, DOI 10.1006/bbrc.1994.2005; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Hatada I, 1997, J BIOL CHEM, V272, P9120; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Brenton JD, 1999, P NATL ACAD SCI USA, V96, P9242, DOI 10.1073/pnas.96.16.9242; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Elson DA, 1997, MOL CELL BIOL, V17, P309; Feil R, 1997, J BIOL CHEM, V272, P20893, DOI 10.1074/jbc.272.33.20893; HATADA I, 1993, NUCLEIC ACIDS RES, V21, P5577; HATADA I, 1995, NUCLEIC ACIDS RES, V23, P36, DOI 10.1093/nar/23.1.36; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; Shemer R., 1996, Epigenetic mechanisms of gene regulation., P215; Shibata H, 1996, GENOMICS, V35, P248, DOI 10.1006/geno.1996.0348; Shibata H, 1997, GENOMICS, V44, P171, DOI 10.1006/geno.1997.4877; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52	23	18	18	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 16	2000	268	2					590	595		10.1006/bbrc.2000.2189		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	286DB	WOS:000085427400061		
J	Yokoska, J; Tsukamoto, T; Miura, K; Shiokawa, K; Mizumoto, K				Yokoska, J; Tsukamoto, T; Miura, K; Shiokawa, K; Mizumoto, K			Cloning and characterization of mRNA capping enzyme and mRNA (guanine-7-)-methyltransferase cDNAs from Xenopus laevis	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							EUKARYOTIC MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; CAP STRUCTURE; MATURATION; BINDING	The mRNA cap structure, which is synthesized by a series of reactions catalyzed by capping enzyme, mRNA (guanine-7-)-methyltransferase, and mRNA (ribose-2'-O-)-methyltransferase, has crucial roles for RNA processing and translation. Methylation of the cap structure is also implicated in polyadenylation-mediated translational activation during Xenopus oocyte maturation. Here we isolated two Xenopus laevis cDNAs, xCAP1a and xCAP1b, for mRNA capping enzyme and one cDNA for mRNA (guanine-7-)-methyltransferase, xCMT1, which encode 598, 511, and 402 amino acids, respectively. The deduced amino acid sequence of xCAP1a was highly homologous to that of human capping enzyme hCAP1a, having all the characteristic regions including N-terminal RNA 5'-triphosphatase as well as C-terminal mRNA guanylyltransferase domains which are conserved among animal mRNA guanylyltransferases, whereas in xCAP1b the most C-terminal motif was missing. The amino acid sequence of xcMT1 was also similar to human (guanine-7-)-methyltransferase, hCMT1a, with all the conserved motifs among cellular (guanine-7-)-methyl-transferases, except for its N-terminal portion. The recombinant xCAP1a and xCMT1 exhibited cap formation and mRNA (guanine-7-)-methyltransferase activities, respectively. RT-PCR analysis showed that mRNA for xCAPla and xCMT1 exist abundantly in fertilized eggs as maternal mRNAs, but xCMT1 mRNA gradually decreased in its amount in later stages of early development. (C) 2000 Acaaemic Press.	Univ Tokyo, Mol Embryol Lab, Dept Biol Sci, Grad Sch Sci,Bunkyo Ku, Tokyo 1130033, Japan; Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1088641, Japan; Gakushuin Univ, Inst Biomol Sci, Toshima Ku, Tokyo 1718588, Japan	Shiokawa, K (reprint author), Univ Tokyo, Mol Embryol Lab, Dept Biol Sci, Grad Sch Sci,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Caponigro G, 1996, MICROBIOL REV, V60, P233; Saha N, 1999, J BIOL CHEM, V274, P16553, DOI 10.1074/jbc.274.23.16553; SHEETS MD, 1995, NATURE, V374, P511, DOI 10.1038/374511a0; Pillutla RC, 1998, GENOMICS, V54, P351, DOI 10.1006/geno.1998.5604; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; BANERJEE AK, 1980, MICROBIOL REV, V44, P175; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FILIPOWICZ W, 1978, FEBS LETT, V96, P1, DOI 10.1016/0014-5793(78)81049-7; Gillian-Daniel DL, 1998, MOL CELL BIOL, V18, P6152; ITO N, 1987, J BIOL CHEM, V262, P1989; ITOH N, 1984, J BIOL CHEM, V259, P3923; Kuge H, 1995, EMBO J, V14, P6301; MIZUMOTO K, 1987, PROG NUCLEIC ACID RE, V34, P1; NEWKOOP PD, 1967, NORMAL TABLE XENOPUS; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; SHIOKAWA K, 1981, DEV GROWTH DIFFER, V23, P579; SHIOKAWA K, 1994, INT J DEV BIOL, V38, P249; TAKAGI T, 1997, CELL, V89, P967; THIEBAUD CH, 1977, CHROMOSOMA, V59, P253, DOI 10.1007/BF00292781; Tsukamoto T, 1998, BIOCHEM BIOPH RES CO, V251, P27, DOI 10.1006/bbrc.1998.9402; Tsukamoto T, 1998, BIOCHEM BIOPH RES CO, V243, P101, DOI 10.1006/bbrc.1997.8038	25	11	12	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 16	2000	268	2					617	624		10.1006/bbrc.2000.2188		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	286DB	WOS:000085427400066		
J	Sugishita, Y; Shimizu, T; Yao, A; Kinugawa, K; Nojiri, T; Harada, K; Matsui, H; Nagai, R; Takahashi, T				Sugishita, Y; Shimizu, T; Yao, A; Kinugawa, K; Nojiri, T; Harada, K; Matsui, H; Nagai, R; Takahashi, T			Lipopolysaccharide augments expression and secretion of vascular endothelial growth factor in rat ventricular myocytes	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							FACTOR MESSENGER-RNA; NITRIC-OXIDE SYNTHASE; PERMEABILITY FACTOR; FACTOR GENE; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL REGULATION; CARDIAC MYOCYTES; GLIOMA-CELLS; HYPOXIA; VEGF	Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, is highly expressed in the myocardium under various stimuli including hypoxia and ischemia. On the other hand, lipopolysaccharide (LPS) causes systemic inflammatory response syndrome (SIRS), which consists of systemic pathophysiological changes related to vascular hyperpermeability. To test the hypothesis that VEGF is one of the important mediators of SIRS, we examined effects of LPS on the VEGF expression and secretion in cultured neonatal rat ventricular myocytes, LPS (10 mu g/ml) rapidly (within 1 h) augmented the levels of VEGF mRNA in these cells. Pharmacological inhibition of nucleic factor-kappa B or tyrosine kinases did not affect the LPS-induced augmentation of VEGF mRNA expression, while these treatments markedly suppressed the up-regulation of inducible nitric oxide synthase (iNOS) expression by LPS, The VEGF concentrations in the conditioned media were also significantly increased by the LPS treatment of 6 h, in conclusion, LPS augments VEGF expression and secretion in rat ventricular myocytes, suggesting that VEGF may be involved in pathogenesis of SIRS, LPS may induce VEGF mRNA through the signaling pathways that are distinct from those responsible for the iNOS induction. (C) 2000 Academic Press.	Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Takahashi, T (reprint author), Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						LIU YX, 1995, CIRC RES, V77, P638; Damert A, 1997, BIOCHEM J, V327, P419; Yang RB, 1998, NATURE, V395, P284; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Ryuto M, 1996, J BIOL CHEM, V271, P28220; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Seko Y, 1999, BIOCHEM BIOPH RES CO, V254, P462, DOI 10.1006/bbrc.1998.9969; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; LEVY AP, 1995, CIRC RES, V76, P758; Cohen T, 1996, J BIOL CHEM, V271, P736; Xu FP, 1998, J APPL PHYSIOL, V85, P53; Levy AP, 1996, J BIOL CHEM, V271, P2746; Yang RB, 1999, J IMMUNOL, V163, P639; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Claffey KP, 1998, MOL BIOL CELL, V9, P469; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5; BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; LEVY AP, 1995, J BIOL CHEM, V270, P13333; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; STAVRI GT, 1995, CIRCULATION, V92, P11; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; BERKMAN RA, 1993, J CLIN INVEST, V91, P153, DOI 10.1172/JCI116165; Berse B, 1999, CLIN EXP IMMUNOL, V115, P176; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FUKUI M, 1995, J NIPPON MED SCH, V62, P469; Goddard CM, 1996, AM J PHYSIOL-HEART C, V270, pH1446; GOTLOIB L, 1992, CIRC SHOCK, V36, P45; HASHIMOTO E, 1994, AM J PHYSIOL, V267, pH1984; Kinugawa K, 1997, CIRC RES, V81, P911; Kinugawa KI, 1997, AM J PHYSIOL-HEART C, V272, pH35; KINUGAWA KI, 1995, CARDIOVASC RES, V30, P419, DOI 10.1016/S0008-6363(95)00063-1; Ladoux A, 1997, BIOCHEM BIOPH RES CO, V240, P552, DOI 10.1006/bbrc.1997.7708; LADOUX A, 1993, BIOCHEM BIOPH RES CO, V195, P1005, DOI 10.1006/bbrc.1993.2144; LADOUX A, 1994, BIOCHEM BIOPH RES CO, V204, P794, DOI 10.1006/bbrc.1994.2529; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Levy A P, 1989, Growth Factors, V2, P9, DOI 10.3109/08977198909069077; Perez-Ruiz M, 1999, HEPATOLOGY, V29, P1057, DOI 10.1002/hep.510290416; SHIMA DT, 1995, FEBS LETT, V370, P203, DOI 10.1016/0014-5793(95)00831-S; Shimizu T, 1998, CARDIOVASC RES, V38, P405, DOI 10.1016/S0008-6363(98)00005-4; STAVRI GT, 1995, FEBS LETT, V358, P311, DOI 10.1016/0014-5793(94)01458-D; STEIN I, 1995, MOL CELL BIOL, V15, P5363; TISCHER E, 1991, J BIOL CHEM, V266, P11947	50	12	15	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 16	2000	268	2					657	662		10.1006/bbrc.2000.2165		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	286DB	WOS:000085427400073		
J	Hagan, PG; Nienaber, CA; Isselbacher, EM; Bruckman, D; Karavite, DJ; Russman, PL; Evangelista, A; Fattori, R; Suzuki, T; Oh, JK; Moore, AG; Malouf, JF; Pape, LA; Gaca, C; Sechtem, U; Lenferink, S; Deutsch, HJ; Diedrichs, H; Robles, JMY; Llovet, A; Gilon, D; Das, SK; Armstrong, WF; Deeb, GM; Eagle, KA				Hagan, PG; Nienaber, CA; Isselbacher, EM; Bruckman, D; Karavite, DJ; Russman, PL; Evangelista, A; Fattori, R; Suzuki, T; Oh, JK; Moore, AG; Malouf, JF; Pape, LA; Gaca, C; Sechtem, U; Lenferink, S; Deutsch, HJ; Diedrichs, H; Robles, JMY; Llovet, A; Gilon, D; Das, SK; Armstrong, WF; Deeb, GM; Eagle, KA			The International Registry of Acute Aortic Dissection (IRAD) - New insights into an old disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THORACIC AORTA; SURGICAL-MANAGEMENT; PERCUTANEOUS FENESTRATION; DIAGNOSIS; ANEURYSMS; CT; ECHOCARDIOGRAPHY; COMPLICATIONS; EXPERIENCE; NECROPSY	Context Acute aortic dissection is a life-threatening medical emergency associated with high rates of morbidity and mortality. Data are limited regarding the effect of recent imaging and therapeutic advances on patient care and outcomes in this setting. Objective To assess the presentation, management, and outcomes of acute aortic dissection. Design Case series with patients enrolled between January 1996 and December 1998. Data were collected at presentation and by physician review of hospital records. Setting The International Registry of Acute Aortic Dissection, consisting of 12 international referral centers. Participants A total of 464 patients (mean age, 63 years; 65.3% male), 62.3% of whom had type A dissection. Main Outcome Measures Presenting history, physical findings, management, and mortality, as assessed by history and physician review of hospital records. Results While sudden onset of severe sharp pain was the single most common presenting complaint, the clinical presentation was diverse. Classic physical findings such as aortic regurgitation and pulse deficit were noted in only 31.6% and 15.1% of patients, respectively, and initial chest radiograph and electrocardiogram were frequently not helpful (no abnormalities were noted in 12.4% and 31.3% of patients, respectively). Computed tomography was the initial imaging modality used in 61.1%, Overall in-hospital mortality was 27.4%, Mortality of patients with type A dissection managed surgically was 26%; among those not receiving surgery (typically because of advanced age and comorbidity), mortality was 58%. Mortality of patients with type B dissection treated medically was 10.7%. Surgery was performed in 20% of patients with type B dissection; mortality in this group was 31.4%. Conclusions Acute aortic dissection presents with a wide range of manifestations, and classic findings are often absent. A high clinical index of suspicion is necessary. Despite recent advances, in-hospital mortality rates remain high. Our data support the need for continued improvement in prevention, diagnosis, and management of acute aortic dissection.	Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiol, Ann Arbor, MI 48109 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Massachusetts, Worcester, MA 01605 USA; Hosp Gen Univ Valle Hebron, Barcelona, Spain; Hosp 12 Octubre, E-28041 Madrid, Spain; Univ Hosp S Orsola, Bologna, Italy; Univ Tokyo, Tokyo, Japan; Mayo Clin, Rochester, MN USA; Univ Hamburg, Hosp Eppendorf, D-20246 Hamburg, Germany; Robert Bosch Krankenhaus, Stuttgart, Germany; Univ Cologne, Cologne, Germany; Hadassah Univ Hosp, IL-91120 Jerusalem, Israel	Eagle, KA (reprint author), Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.						Acierno LJ, 1994, HIST CARDIOLOGY; *AM HEART ASS, 1998, 1998 HEART STROK STA; EAGLE KA, 1989, CURR PROB CARDIOLOGY, V14, P225, DOI 10.1016/S0146-2806(89)80010-6; GRIEPP RB, 1975, J THORAC CARDIOV SUR, V70, P1051; WHEAT MW, 1965, J THORAC CARDIOV SUR, V50, P364; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; WILLIAMS DM, 1990, RADIOLOGY, V174, P450; Kouchoukos NT, 1997, NEW ENGL J MED, V336, P1876, DOI 10.1056/NEJM199706263362606; CIGARROA JE, 1993, NEW ENGL J MED, V328, P35, DOI 10.1056/NEJM199301073280107; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; KHANDHERIA BK, 1993, CIRCULATION, V87, P1765; BARNER HB, 1991, ANN THORAC SURG, V52, P1354; WARDEN HE, 1954, J THORAC SURG, V28, P331; BICKERSTAFF LK, 1982, SURGERY, V92, P1103; ERBEL R, 1989, LANCET, V1, P457; SLATER EE, 1976, AM J MED, V60, P625, DOI 10.1016/0002-9343(76)90496-4; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; HIRST AE, 1958, MEDICINE, V37, P217; NIENABER CA, 1995, CIRCULATION, V92, P1465; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642; YAMADA T, 1988, RADIOLOGY, V168, P347; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; LINDSAY J, 1967, CIRCULATION, V35, P880; Armstrong WF, 1998, AM HEART J, V136, P1051, DOI 10.1016/S0002-8703(98)70162-0; BAER S, 1956, JAMA-J AM MED ASSOC, V161, P689; BAVARIA JE, 1995, ANN THORAC SURG, V60, P345, DOI 10.1016/0003-4975(95)00447-S; BLANKENSHIP JC, 1989, J AM COLL CARDIOL, V14, P1579, DOI 10.1016/0735-1097(89)90402-6; BOGGS BR, 1987, J THORAC CARDIOV SUR, V93, P838; BUTLER J, 1990, BRIT MED J, V300, P517; Chavan A, 1997, CIRCULATION, V96, P2124; CHIRILLO F, 1990, EUR HEART J, V11, P311; Daily P O, 1970, Ann Thorac Surg, V10, P237; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DEBAKEY ME, 1955, ANN SURG, V142, P586, DOI 10.1097/00000658-195510000-00005; EAGLE KA, 1986, AM J CARDIOL, V57, P322, DOI 10.1016/0002-9149(86)90912-4; EARNEST F, 1979, MAYO CLIN PROC, V54, P43; FANN JI, 1995, CIRCULATION, V92, P113; GODWIN JD, 1980, RADIOLOGY, V136, P125; HAMADA S, 1992, RADIOLOGY, V183, P155; JAMIESON WRE, 1982, CAN J SURG, V25, P145; LEONARD JC, 1979, BRIT MED J, V2, P260; NIENABER CA, 1992, CIRCULATION, V85, P434; OGARA PT, 1995, CIRCULATION, V92, P1376; ROBERTS CS, 1991, ANN SURG, V213, P356, DOI 10.1097/00000658-199104000-00011; ROBERTS WC, 1981, AM HEART J, V101, P195, DOI 10.1016/0002-8703(81)90666-9; SVENSSON LG, 1990, CIRCULATION, V82, P24; WALKER PJ, 1993, J VASC SURG, V18, P1042; WILSON SK, 1982, ARCH PATHOL LAB MED, V106, P175; WOLFE WG, 1977, CIRCULATION, V56, P503	50	1094	1234	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					897	903		10.1001/jama.283.7.897		7	Medicine, General & Internal	General & Internal Medicine	281WT	WOS:000085185000028		
J	Koike, M; Kondo, Y; Ikeda, H; Gregory, GL; Anderson, BE; Sachse, GW; Blake, DR; Liu, SC; Singh, HB; Thompson, AM; Kita, K; Zhao, Y; Sugita, T; Shetter, RE; Toriyama, N				Koike, M; Kondo, Y; Ikeda, H; Gregory, GL; Anderson, BE; Sachse, GW; Blake, DR; Liu, SC; Singh, HB; Thompson, AM; Kita, K; Zhao, Y; Sugita, T; Shetter, RE; Toriyama, N			Impact of aircraft emissions on reactive nitrogen over the North Atlantic Flight Corridor region	JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES			English	Article							TROPOSPHERE; STRATOSPHERE	The impact of aircraft emissions on reactive nitrogen in the upper troposphere (UT) and lowermost stratosphere (LS) was estimated using the NOy-O-3 correlation obtained during the Subsonic Assessment (SASS) Ozone and Nitrogen Oxide Experiment (SONEX) carried out over the U.S. continent and North Atlantic Flight Corridor (NAFC) region in October and November 1997. To evaluate the large-scale impact, we made a reference NOy-O-3 relationship in air masses, upon which aircraft emissions were considered to have little impact. For this purpose, the integrated input of NO, from aircraft into an air mass along a 10-day back trajectory (Delta NOy) was calculated based on the Abatement of Nuisance Caused by Air Traffic/European Commission (ANCAT/EC2) emission inventory. The excess NOy (dNO(y)) was calculated from the observed NO, and the reference NOy-O-3 relationship. As a result, a weak positive correlation was found between the dNO(y) and Delta NOy and dNO(y) and NOx/NOy values, while no positive correlation between the dNO(y) and CO values was found suggesting that dNO(y) values can be used as a measure of the NOx input from aircraft emissions. The excess NOy values calculated from another NOy-O-3 reference relationship made using in situ condensation nuclei data also agreed with these dNO(y) values, within the uncertainties. At the NAFC region (45 degrees N-60 degrees N) the median value of dNO(y) in the troposphere increased with altitude above 9 km and reached 70 parts per trillion by volume (pptv) (20% of NOy) at 11 km. The excess NOx was estimated to be about half of the dNO(y) values, corresponding to 30% of the observed NOx level. Higher dNO(y), values were generally found in air masses where O-3 = 75-125 ppbv, suggesting a more pronounced effect around the tropopause. The median value of dNO(y) in the stratosphere at the NAFC region at 8.5-11.5 km was about 120 pptv. The higher dNO(y) values in the LS were probably due to the accumulated effect of aircraft emissions, given the long residence time of affected air in the LS. Similar dNO(y) values were also obtained in air masses sampled over the U.S. continent.	Nagoya Univ, Solar Terr Environm Lab, Aichi 4428507, Japan; NASA, Langley Res Ctr, Hampton, VA 23681 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; Univ Tokyo, Fac Sci, Dept Earth & Planetary Phys, Bunkyo Ku, Tokyo 113, Japan; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Natl Ctr Atmospher Res, Boulder, CO 80303 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Koike, M (reprint author), Nagoya Univ, Solar Terr Environm Lab, Aichi 4428507, Japan.	koike@stelab.nagoya-u.ac.jp; kondo@stelab.nagoya-u.ac.jp; hibiki@stelab.nagoya-u.ac.jp; g.l.gregory@larc.nasa.gov; b.e.anderson@larc.nasa.gov; g.w.sachse@larc.nasa.gov; drblake@uci.edu; shaw.liu@eas.gatech.edu; hsingh@mail.arc.nasa.gov; thompson@gator1.gsfc.nasa.gov; kita@grl.s.u-tokyo.ac.jp; yzhao@stelab.nagoya-u.ac.jp; tsugita@nies.go.jp; toriyama@stelab.nagoya-u.ac.jp	Koike, Makoto/F-4366-2011; Kondo, Yutaka/D-1459-2012; Thompson, Anne /C-3649-2014; 	Thompson, Anne /0000-0002-7829-0920; Sugita, Takafumi/0000-0002-0508-7040			Anderson BE, 1999, GEOPHYS RES LETT, V26, P3069, DOI 10.1029/1999GL900276; Gerz T, 1998, J GEOPHYS RES-ATMOS, V103, P25905, DOI 10.1029/98JD02282; Brasseur GP, 1998, ATMOS ENVIRON, V32, P2329, DOI 10.1016/S1352-2310(97)00486-X; Clarke AD, 1998, J GEOPHYS RES-ATMOS, V103, P16397, DOI 10.1029/97JD02987; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; BAUGHEUM SL, 1996, 4700 NASA; Brasseur GP, 1996, J GEOPHYS RES-ATMOS, V101, P1423, DOI 10.1029/95JD02363; GARDNER RM, 1998, ANCATEC2 AIRCRAFT EM; Gettelman A, 1998, GEOPHYS RES LETT, V25, P2129, DOI 10.1029/98GL51545; HAMM S, 1989, GEOPHYS RES LETT, V16, P483, DOI 10.1029/GL016i006p00483; JAEGLE LD, 1998, GEOPHYS RES LETT, V25, P17009; Klemm O, 1998, J GEOPHYS RES-ATMOS, V103, P31217, DOI 10.1029/98JD02624; Koike M, 1997, J GEOPHYS RES-ATMOS, V102, P28385, DOI 10.1029/97JD02085; Kondo Y, 1996, J GEOPHYS RES-ATMOS, V101, P1809, DOI 10.1029/95JD02611; Kondo Y, 1999, GEOPHYS RES LETT, V26, P3065, DOI 10.1029/1999GL900376; Kondo Y, 1997, J GEOPHYS RES-ATMOS, V102, P28663, DOI 10.1029/96JD03819; Lamarque JF, 1996, J GEOPHYS RES-ATMOS, V101, P22955, DOI 10.1029/96JD02160; MAHIEU E, 1995, J ATMOS CHEM, V20, P299, DOI 10.1007/BF00694499; MURPHY DM, 1993, J GEOPHYS RES-ATMOS, V98, P8751, DOI 10.1029/92JD00681; Pruppacher H. R., 1997, MICROPHYSICS CLOUDS; RIDLEY BA, 1994, J GEOPHYS RES-ATMOS, V99, P25519, DOI 10.1029/94JD02210; RINSLAND CP, 1982, J GEOPHYS RES-OC ATM, V87, P1119, DOI 10.1029/JC087iC13p11119; Schlager H, 1997, J GEOPHYS RES-ATMOS, V102, P10739, DOI 10.1029/96JD03748; Shetter RE, 1999, J GEOPHYS RES-ATMOS, V104, P5647, DOI 10.1029/98JD01381; Singh HB, 1999, GEOPHYS RES LETT, V26, P3053, DOI 10.1029/1999GL900588; TURMAN BN, 1982, J GEOPHYS RES-OC ATM, V87, P1191, DOI 10.1029/JC087iC02p01191; Witte JC, 1997, J GEOPHYS RES-ATMOS, V102, P28169, DOI 10.1029/97JD02704; ZIEREIS H, 1986, NATURE, V321, P503, DOI 10.1038/321503a0	28	19	19	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-897X			J GEOPHYS RES-ATMOS	J. Geophys. Res.-Atmos.	FEB 16	2000	105	D3					3665	3677		10.1029/1999JD901013		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	286ZP	WOS:000085479000011		
J	Sakurada, I; Yamasaki, S; Gottlich, R; Iida, T; Kanai, M; Shibasaki, M				Sakurada, I; Yamasaki, S; Gottlich, R; Iida, T; Kanai, M; Shibasaki, M			Direct chlorohydrin and acetoxy alcohol synthesis from olefins promoted by a Lewis acid, bis(trimethylsilyl) peroxide and (CH3)(3)SiX	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							BAEYER-VILLIGER OXIDATION; EPOXIDES; EPOXIDATION		Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Shibasaki, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.						Denmark SE, 1998, J ORG CHEM, V63, P2428, DOI 10.1021/jo9801420; DALE JA, 1973, J AM CHEM SOC, V95, P512, DOI 10.1021/ja00783a034; El-Qisairi A, 1998, J ORG CHEM, V63, P2790, DOI 10.1021/jo972015u; Hamed O, 1998, ORGANOMETALLICS, V17, P5184, DOI 10.1021/om980636n; Iida T, 1997, J AM CHEM SOC, V119, P4783, DOI 10.1021/ja9702576; Davies A. G., 1982, COMPREHENSIVE ORGANO, V2, P519; DEHNICKE VKZ, 1961, ANORG ALLG CHEM, V308, P72; Fukazawa T, 1996, TETRAHEDRON-ASYMMETR, V7, P1649, DOI 10.1016/0957-4166(96)00199-1; Gottlich R, 1997, SYNLETT, P971; IRIE R, 1994, SYNLETT, P255; LAROCK RC, 1989, COMPREHENSIVE ORGANI, P325; MATSUBARA S, 1983, B CHEM SOC JPN, V56, P2029, DOI 10.1246/bcsj.56.2029; Nugent WA, 1998, J AM CHEM SOC, V120, P7139, DOI 10.1021/ja981031l; SUZUKI M, 1982, J ORG CHEM, V47, P902, DOI 10.1021/jo00344a035; WILSON CV, 1957, ORG REACTIONS, V9, P350; Yudin AK, 1997, J AM CHEM SOC, V119, P11536, DOI 10.1021/ja973043x	16	25	25	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 16	2000	122	6					1245	1246		10.1021/ja993492s		2	Chemistry, Multidisciplinary	Chemistry	285HT	WOS:000085384200044		
J	Yamazaki, O; Yamashita, T; Horie, K				Yamazaki, O; Yamashita, T; Horie, K			Preparation and properties of poly(amide acid) gels	REACTIVE & FUNCTIONAL POLYMERS			English	Article						poly(amide acid); diisocyanates; crosslinking; gel	VOLUME PHASE-TRANSITION; RIGID-ROD POLYIMIDE; WATER MIXED-SOLVENT; POLY(ACRYLAMIDE) GELS; FLUORESCENCE; ACETONE; POLYMER; SOL	Poly(amide acid) gels were first synthesized by the reaction of a poly(amide acid) with diisocyanates as crosslinking agents. Poly(amide acid) was synthesized from 3,3',4,4'-benzophenonetetracarboxylic dianhydride (BTDA) and bis(4-amino-3-ethylphenyl)methane (DEDPM). From the change in the IR spectra, the key process of crosslinking was determined to be the decarboxylation from the reaction product of the carboxyl group and isocyanate group. The gels markedly change their volume with the composition change of NMP-water mixed solvent. Thermal properties of the poly(amide acid) gels are also studied. (C) 2000 Elsevier Science B.V. All rights reserved.	Lintec Corp, Warabishi, Saitama 335, Japan; Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 113, Japan	Yamazaki, O (reprint author), Lintec Corp, 5-14-42 Nishikicho, Warabishi, Saitama 335, Japan.						SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1; DINEHART RA, 1967, J APPL POLYM SCI, V11, P609, DOI 10.1002/app.1967.070110501; ASANO M, 1995, MACROMOLECULES, V28, P5861, DOI 10.1021/ma00121a024; CHATGE ND, 1983, POLYM SCI PC, V21, P3055; CHENG SZD, 1991, MACROMOLECULES, V24, P5856, DOI 10.1021/ma00021a021; CHENG SZD, 1991, MACROMOLECULES, V24, P1883, DOI 10.1021/ma00008a028; Ghosh M. K., 1996, POLYIMIDES FUNDAMENT; HIGUCHI H, 1991, CHEM MATER, V3, P188, DOI 10.1021/cm00013a038; Horie K., 1995, PHOTOSENSITIVE POLYI; HU YX, 1992, MACROMOLECULES, V25, P7324, DOI 10.1021/ma00052a039; HU YX, 1993, MACROMOLECULES, V26, P1761, DOI 10.1021/ma00059a041; LEE SK, 1993, POLYM INT, V30, P115, DOI 10.1002/pi.4990300117; MEYER GW, 1995, POLYMER, V36, P2203; Pfeifer J., 1985, P 2 INT C POL SYNTH, P130; RUBNER R, 1979, PHOTOGR SCI ENG, V23, P303; YODA N, 1984, J MACROMOL SCI CHEM, VA21, P1641, DOI 10.1080/00222338408082082	16	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148			REACT FUNCT POLYM	React. Funct. Polym.	FEB 16	2000	43	1-2					173	181		10.1016/S1381-5148(99)00050-4		9	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	288FD	WOS:000085550900021		
J	Toriba, A; Adzuma, K; Santa, T; Imai, K				Toriba, A; Adzuma, K; Santa, T; Imai, K			Development of an amino acid sequence and D/L configuration determination method of peptide with a new fluorescence Edman reagent, 7-methylthio-4-(2,1,3-benzoxadiazolyl) isothiocyanate	ANALYTICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ENANTIOMERIC SEPARATION; ACHATINA-FULICA; PHASE; RESIDUES; PROTEINS; ISOMERIZATION; DEGRADATION; CYSTEINE	On the basis of the relationship between the fluorescence characteristics of the benzofurazan compounds and the Hammett constants (sigma(p)), a new fluorescence Edman reagent, 7-methylthio-4-(2,1,3-benzoxadiazolyl) isothiocyanate (MTBD-NCS) was designed and synthesized. MTBD-thiohydantoin (TH)-amino acid derivatives produced by the Edman sequencing method gave fluorescence, whereas other degradation byproducts such as MTBD-thiocarbamoyl (TC)- or carbamoyl (CA)-amino acids did not fluoresce. MTBD-NCS was applicable as an Edman sequencing reagent to the simultaneous determination of both the sequence and D/L-configuration of amino acids in peptides. Boron trifluoride (BF3) and HCl/methanol were adopted as the cyclization/cleavage and conversion reagents to suppress the amino acid residue racemization. The MTBD-TH-amino acids were separated on a reversed-phase column for amino acid sequencing, and their enantiomers were resolved on two types of polysaccharide-based chiral stationary phases for D/L-configuration determination. The method was successfully applied to the sequence and D/L-configuration determination of D-amino acid-containing peptide [D-Ala(2)]-deltorphin II.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Imai, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		TORIBA, Akira/D-8415-2015	TORIBA, Akira/0000-0002-6411-4088			Ichihara H, 1999, ANAL BIOCHEM, V269, P379, DOI 10.1006/abio.1999.4032; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; ROHER AE, 1993, J BIOL CHEM, V268, P3072; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; CAVINS JF, 1970, ANAL BIOCHEM, V35, P489, DOI 10.1016/0003-2697(70)90211-3; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663; DAVIES JS, 1984, J CHEM SOC PERK T 2, P1723, DOI 10.1039/p29840001723; EDMAN P, 1950, ACTA CHEM SCAND, V4, P277, DOI 10.3891/acta.chem.scand.04-0277; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fukushima T, 1997, ANAL CHEM, V69, P1793, DOI 10.1021/ac961105g; HIRANO H, 1986, BIOL CHEM H-S, V367, P1259, DOI 10.1515/bchm3.1986.367.2.1259; Huang Y, 1999, ANAL BIOCHEM, V270, P257, DOI 10.1006/abio.1999.4031; Iida T, 1998, ANALYST, V123, P2829, DOI 10.1039/a806109b; Iida T, 1998, J CHROMATOGR A, V813, P267, DOI 10.1016/S0021-9673(98)00358-6; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; KRUFT V, 1991, ANAL BIOCHEM, V193, P306, DOI 10.1016/0003-2697(91)90026-P; Kurosu Y, 1998, J CHROMATOGR A, V802, P129, DOI 10.1016/S0021-9673(97)01224-7; Matsunaga H, 1997, ANALYST, V122, P931, DOI 10.1039/a701213f; MATSUNAGA H, 1995, ANAL CHEM, V67, P4276, DOI 10.1021/ac00119a012; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; MURAMOTO K, 1978, AGR BIOL CHEM TOKYO, V42, P1559; MURAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P300; MURAMOTO K, 1984, ANAL BIOCHEM, V141, P446, DOI 10.1016/0003-2697(84)90069-1; NOKIHARA K, 1992, ANAL LETT, V25, P513; OHTA N, 1991, BIOCHEM BIOPH RES CO, V178, P486, DOI 10.1016/0006-291X(91)90133-R; SCALONI A, 1991, ANAL BIOCHEM, V197, P305, DOI 10.1016/0003-2697(91)90396-B; Tarr G E, 1977, Methods Enzymol, V47, P335; Toriba A, 1999, ANALYST, V124, P43, DOI 10.1039/a807520d; Toyooka T, 1996, ANAL SCI, V12, P779, DOI 10.2116/analsci.12.779; Uchiyama S, 1998, J CHEM SOC PERK T 2, P2165, DOI 10.1039/a803641a; Yang XJ, 1997, ANALYST, V122, P1365, DOI 10.1039/a703914j	33	25	25	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700			ANAL CHEM	Anal. Chem.	FEB 15	2000	72	4					732	739		10.1021/ac9910381		8	Chemistry, Analytical	Chemistry	285HE	WOS:000085383000012		
J	Kim, YH; Takahashi, M; Noguchi, N; Suzuki, E; Suzuki, K; Taniguchi, N; Niki, E				Kim, YH; Takahashi, M; Noguchi, N; Suzuki, E; Suzuki, K; Taniguchi, N; Niki, E			Inhibition of c-jun expression induces antioxidant enzymes under serum deprivation	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						apoptosis; antioxidant enzymes; antisense c-jun; F-MEL cells; serum deprivation	NF-KAPPA-B; MANGANESE SUPEROXIDE-DISMUTASE; PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; HIPPOCAMPAL-NEURONS; RESPONSE ELEMENT; HEPG2 CELLS; GENE	We previously reported that antisense c-jun suppressed apoptosis induced by serum deprivation in F-MEL cells. To elucidate the molecular mechanisms responsible for this suppression of apoptosis we investigated the activities and protein expression of antioxidant materials in the cell under serum deprivation, In the parental F-MEL cells enzyme activities of catalase, glutathione S-transferase (GST), and glutathione peroxidase (GPx) increased to reach the maximum at 24-72 h after removal of serum and then decreased to initial levels or a little less. Superoxide dismutase (SOD) maintained the initial level for 72 h and increased 1.5- to a-fold at 96 h. Glutathione (GSH) levels increased at 24 h and then dropped significantly to one-third the initial level. On the other hand, in c-junAS (+) cells, in which antisense c-jun was expressed and c-Jun protein expression was reduced to undetectable level. We found 1.9-, 2.7-, 4.8-, and 15.8-fold increase in the activities of catalase, GST, SOD, and GPx, respectively, at 96 h, GSH maintained almost the same level as the initial. Enhancement of these enzyme activities in c-junAS (+) cells was induced under serum deprivation. Western blottings for catalase, GST, and SOD also showed enhanced increase in protein expression, supporting the increase in enzyme activities. Cellular peroxide level under serum deprivation was monitored by how cytometry using DCFH-DA as a probe. We found that the peroxide level increased at 24 h and then decreased at 72 and 96 h in c-junAS (+) cells, and reduction of the peroxide level coincided with an increase in antioxidant enzyme activities. These results indicate that antioxidant materials such as catalase, GST, SOD, GPx, and GSH are induced by serum deprivation when c-jun expression is inhibited in F-MEL cells. The link between inhibition of c-jun expression and enhancement of cellular antioxidant defense is discussed. (C) 2000 Academic Press.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Grad Sch Mat Sci, Nara Inst Sci & Technol, Res Inst Innovat Technol Earth, Kizu, Kyoto 6190292, Japan; Osaka Univ, Sch Med, Dept Biochem, Suita, Osaka 5650087, Japan	Niki, E (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						ANDERSON AJ, 1995, J NEUROCHEM, V65, P1487; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Musonda CA, 1998, CARCINOGENESIS, V19, P1583, DOI 10.1093/carcin/19.9.1583; Ikeda K, 1999, BIOCHEM PHARMACOL, V57, P1361, DOI 10.1016/S0006-2952(99)00055-6; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; Wang XT, 1998, BIOCHEM J, V333, P291; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; LIN KT, 1995, J BIOL CHEM, V270, P16487; Jabs T, 1999, BIOCHEM PHARMACOL, V57, P231, DOI 10.1016/S0006-2952(98)00227-5; Chen YR, 1996, J BIOL CHEM, V271, P31929; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Jones PL, 1997, MOL CELL BIOL, V17, P6970; Hampton MB, 1998, ANN NY ACAD SCI, V854, P328, DOI 10.1111/j.1749-6632.1998.tb09913.x; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Anuszewska EL, 1997, BIOCHEM PHARMACOL, V54, P597, DOI 10.1016/S0006-2952(97)00206-2; Borrello S, 1997, ARCH BIOCHEM BIOPHYS, V348, P289, DOI 10.1006/abbi.1997.0355; Brady TC, 1997, AM J PHYSIOL-LUNG C, V273, pL1002; Briehl MM, 1997, ONCOL RES, V9, P281; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; HIRAMATSU M, 1992, J NEUROCHEM, V58, P1160, DOI 10.1111/j.1471-4159.1992.tb09375.x; Ishikawa Y, 1997, BIOCHEM BIOPH RES CO, V240, P496, DOI 10.1006/bbrc.1997.7665; Islam KN, 1997, FREE RADICAL BIO MED, V22, P1007, DOI 10.1016/S0891-5849(96)00493-5; Jyonouchi H, 1998, AM J RESP CELL MOL, V19, P426; Kim YH, 1998, BIOTECHNOL BIOENG, V58, P65, DOI 10.1002/(SICI)1097-0290(19980405)58:1<65::AID-BIT7>3.0.CO;2-S; Lai CC, 1996, J MOL CELL CARDIOL, V28, P1157, DOI 10.1006/jmcc.1996.0106; Lee J, 1995, MICROBIOL-SGM, V141, P3127; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; LI Y, 1992, J BIOL CHEM, V267, P15097; Liu SX, 1996, BIOCHEMISTRY-US, V35, P11517, DOI 10.1021/bi960572p; Muller JM, 1997, METHODS, V11, P301, DOI 10.1006/meth.1996.0424; Nicotera P, 1995, ADV NEUROIMMUNOL, V5, P411, DOI 10.1016/0960-5428(95)00025-9; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SMITH MJ, 1994, BIOTECHNOL BIOENG, V44, P720; STEIN B, 1993, EMBO J, V12, P3879; Tagami M, 1999, LAB INVEST, V79, P609; TOHYAMA N, 1990, J EXP MED, V171, P389, DOI 10.1084/jem.171.2.389; VASLIOU V, 1995, BIOCHEM PHARMACOL, V12, P2057; YAMAMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V86, P271; Yang YX, 1998, MOL BRAIN RES, V60, P40, DOI 10.1016/S0169-328X(98)00164-8	40	6	6	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-9861			ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	FEB 15	2000	374	2					339	346		10.1006/abbi.1999.1604		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	285GT	WOS:000085381900029		
J	Mori, M; Konno, T; Ozawa, T; Murata, M; Imoto, K; Nagayama, K				Mori, M; Konno, T; Ozawa, T; Murata, M; Imoto, K; Nagayama, K			Novel interaction of the voltage-dependent sodium channel (VDSC) with calmodulin: Does VDSC acquire calmodulin-mediated Ca2+-sensitivity?	BIOCHEMISTRY			English	Article							LIGHT-CHAIN KINASE; BINDING DOMAIN; FUNCTIONAL-ANALYSIS; EXPRESSION SYSTEM; BETA-SUBUNIT; RAT-BRAIN; CALCIUM; PROTEIN; SEQUENCE; ACTIVATION	The voltage-dependent sodium channel (VDSC) interacts with intracellular molecules to modulate channel properties and localizations in neuronal cells. To study protein interactions, we applied yeast two-hybrid screening to the cytoplasmic C-terminal domain of the main pore-forming alpha-subunit. We found a novel interaction between the C-terminal domain and calmodulin (CaM). By two-hybrid interaction assays, we specified the interaction site of VDSC in a C-terminal region, which is composed of 38 amino acid residues and contains both IQ-Like and Baa motifs. Using a fusion protein of the C-terminal domain, we showed that interaction with CaM occurred in the presence and absence of Ca2+. Two synthetic peptides, each covering the IQ-like (NaIQ) or the Baa motifs (NaBaa), were used to examine the binding property by a gel mobility shift assay. Although the NdIQ and NaBaa sequences are overlapped, NaBaa binds only to Ca2+-bound Ca2+CaM, whereas NaIQ binds to both Ca2+CaM and Ca2+-free apoCaM. Fluorescence spectroscopy of dansylated CaM showed Ca2+-dependent spectral changes not only for NaBaa CaM but also for NaIQ . CaM. The results, taken together with other results, indicate that whereas the NaBaa CaM complex is formed in a Ca2+-dependent manner, the NaIQ . CgM complex has two conformational states, distinct with respect to the peptide binding site and the CaM conformation, depending on the Ca2+ concentration. These observations suggest the possibility that VDSC is functionally modulated through the direct CaM interaction and the Ca2+-dependent conformational transition of the complex.	Grad Univ Adv Studies, Natl Inst Physiol Sci, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; Natl Inst Physiol Sci, Dept Mol Physiol, Ctr Brain Expt, Okazaki, Aichi 4448585, Japan; Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 4448585, Japan; Univ Tokyo, Dept Chem, Tokyo 1130033, Japan	Nagayama, K (reprint author), Grad Univ Adv Studies, Natl Inst Physiol Sci, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan.						ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Rhoads AR, 1997, FASEB J, V11, P331; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; SCHWARZENBACH G, 1957, HELV CHIM ACTA, V40, P1886, DOI 10.1002/hlca.19570400640; Dietrich PS, 1998, J NEUROCHEM, V70, P2262; Xia XM, 1998, NATURE, V395, P503; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Scaloni A, 1998, J MOL BIOL, V277, P945, DOI 10.1006/jmbi.1998.1629; URBAUER JL, 1995, BIOCHEMISTRY-US, V34, P8099, DOI 10.1021/bi00025a016; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Zuhlke RD, 1999, NATURE, V399, P159; BLUMENTHAL DK, 1988, BIOCHEM BIOPH RES CO, V156, P860, DOI 10.1016/S0006-291X(88)80923-9; BROCKERHOFF SE, 1994, J CELL BIOL, V124, P315, DOI 10.1083/jcb.124.3.315; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHAPMAN ER, 1992, BIOCHEMISTRY-US, V31, P12819, DOI 10.1021/bi00166a016; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; CHEN RF, 1968, ANAL BIOCHEM, V25, P412, DOI 10.1016/0003-2697(68)90116-4; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CIMLER BM, 1985, J BIOL CHEM, V260, P784; COMTE M, 1983, BIOCHEM J, V209, P269; DEDMAN JR, 1978, J BIOL CHEM, V253, P343; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KLEVIT RE, 1983, METHOD ENZYMOL, V102, P82; Lee A, 1999, NATURE, V399, P155; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; Nelson MR, 1998, CALMODULIN AND SIGNAL TRANSDUCTION, P17; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OLWIN BB, 1983, METHOD ENZYMOL, V102, P148; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Press WH, 1988, NUMERICAL RECIPES C; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; SAIMI Y, 1990, SCIENCE, V249, P1441, DOI 10.1126/science.2169650; SAIMI Y, 1994, FEBS LETT, V350, P155, DOI 10.1016/0014-5793(94)00782-9; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Wriggers W, 1998, BIOPHYS J, V74, P1622	51	68	69	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	FEB 15	2000	39	6					1316	1323		10.1021/bi9912600		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	285NX	WOS:000085396100017		
J	Saeki, K; Wakabayashi, T				Saeki, K; Wakabayashi, T			A230Y mutation of actin on subdomain 4 is sufficient for higher calcium activation of actin-activated myosin adenosinetriphosphatase in the presence of tropomyosin-troponin	BIOCHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; THIN-FILAMENTS; DICTYOSTELIUM-DISCOIDEUM; BINDING-SITES; TETRAHYMENA ACTIN; DYE-BINDING; I COMPLEX; F-ACTIN; SUBFRAGMENT-1; PROTEINS	To probe the mechanism by which Ca2+ activates muscle contraction through tropomyosin and troponin, we have produced mutant actins using Dictyostelium discoideum. We focused on the sequence 228-232 (QTAAS) that is located in subdomain 4 of actin, because the chimera actin in which this sequence was replaced by KAYKE showed not only poorer tropomyosin binding bur also the unexpected "higher Ca2+ activation" [Saeki, K., et al. (1996) Biochemistry 35, 14465-14472]. We found that this higher Ca2+ activation is solely due to the A230Y mutagenesis. Because A230Y mutant actin showed normal tropomyosin binding, the higher Ca2+ activation is not the consequence of poorer tropomyosin binding. The significance of these results is discussed in view of a three-state model [McKillop, D. F., Geeves, M. A. (1993) Biophys. J. 65, 693-701].	Univ Tokyo, Dept Phys, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	Wakabayashi, T (reprint author), Univ Tokyo, Dept Phys, Sch Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						ALKHAYAT HA, 1995, J MOL BIOL, V252, P611, DOI 10.1006/jmbi.1995.0524; EBASHI S, 1968, J BIOCHEM-TOKYO, V64, P465; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; EBASHI S, 1964, J BIOCHEM-TOKYO, V55, P604; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CROSBIE RH, 1994, BIOPHYS J, V67, P1957; EARLY AE, 1987, GENE, V59, P99, DOI 10.1016/0378-1119(87)90270-8; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; EISENBER.E, 1974, J BIOL CHEM, V249, P4742; ELSALEH SC, 1984, J BIOL CHEM, V259, P1014; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HIRONO M, 1990, J BIOCHEM-TOKYO, V107, P32; HIRONO M, 1987, J MOL BIOL, V194, P181, DOI 10.1016/0022-2836(87)90367-6; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; Ishikawa T, 1999, J BIOCHEM-TOKYO, V126, P200; ISHIKAWA T, 1994, BIOCHEM BIOPH RES CO, V203, P951, DOI 10.1006/bbrc.1994.2274; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; JOHNSON P, 1978, BIOCHEM BIOPH RES CO, V82, P1013, DOI 10.1016/0006-291X(78)90884-7; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MIKAWA T, 1981, J BIOCHEM-TOKYO, V89, P1951; MIKI M, 1989, J BIOCHEM-TOKYO, V106, P651; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; MILLIGAN RA, 1987, J CELL BIOL, V105, P29, DOI 10.1083/jcb.105.1.29; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHTSUKI I, 1972, J BIOCHEM-TOKYO, V72, P369; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PARRY DAD, 1974, BIOCHEM BIOPH RES CO, V57, P216, DOI 10.1016/S0006-291X(74)80379-7; Press W.H., 1992, NUMERICAL RECIPES C; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; Sambrook J., 1989, MOL CLONING LAB MANU; SHETERLINE P, 1996, PROTEIN PROFILE ACTI; STEWART M, 1975, NATURE, V257, P331, DOI 10.1038/257331a0; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; SZENTGYORGYI A, 1951, CHEM MUSCLE CONTRACT; SZILAGYI L, 1982, BIOCHIM BIOPHYS ACTA, V709, P204, DOI 10.1016/0167-4838(82)90462-9; TOYOSHIMA C, 1985, J BIOCHEM-TOKYO, V97, P219; WAKABAYASHI T, 1975, J MOL BIOL, V93, P477, DOI 10.1016/0022-2836(75)90241-7; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0	57	9	9	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	FEB 15	2000	39	6					1324	1329		10.1021/bi991297k		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	285NX	WOS:000085396100018		
J	Kojima, M; Tanokura, M; Maeda, M; Kimura, K; Amemiya, Y; Kihara, H; Takahashi, K				Kojima, M; Tanokura, M; Maeda, M; Kimura, K; Amemiya, Y; Kihara, H; Takahashi, K			pH-dependent unfolding of aspergillopepsin II studied by small-angle X-ray scattering	BIOCHEMISTRY			English	Article							ACID PROTEINASE-A; MOLTEN GLOBULE; CYTOCHROME-C; CIRCULAR-DICHROISM; NIGER	Aspergillopepsin II (EC 3.4.23.6) secreted from the fungus Aspergillus niger var, macrosporus is a non-pepsin-type acid proteinase. It consists of two polypeptide chains (i.e., a heavy chain and a light chain), which are bound noncovalently to each other. The pH titration analysis using small-angle X-ray scattering (SAXS) as well as circular dichroism (CD) and gel filtration indicated that the enzyme was unfolded around a neutral pH with concomitant dissociation of the two chains. Detailed analyses showed that the midpoint pH values for the unfolding are not coincident with one another (pH 6.1 in circular dichroism and gel filtration, pH 6.4 in zero-angle intensity of SAXS, pH 6.8 in radius of gyration). The difference between these values suggested the existence of an intermediate state during the unfolding. Further analyses of the SAXS data showed that the heavy chain just after the dissociation still kept molecular compactness and that it gradually increased its dimensions as the pH was further raised. Noncoincidence of the two phenomena (i.e., chain dissociation and swelling) led to elucidation of a novel intermediate state during unfolding, which was confirmed by the subsequent singular value decomposition (SVD) analysis.	Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Dokkyo Univ, Sch Med, Ctr Med Informat, Mibu, Tochigi 3210293, Japan; Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Kansai Med Univ, Phys Lab, Hirakata, Osaka 5731136, Japan	Takahashi, K (reprint author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	kenjitak@ls.toyaku.ac.jp					Kataoka M, 1997, PROTEIN SCI, V6, P422; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Chen LL, 1996, J MOL BIOL, V261, P658, DOI 10.1006/jmbi.1996.0491; TANOKURA M, 1976, BIOPOLYMERS, V15, P393, DOI 10.1002/bip.1976.360150215; Arai M, 1998, J MOL BIOL, V275, P149, DOI 10.1006/jmbi.1997.1456; Bilgin N, 1998, BIOCHEMISTRY-US, V37, P8163, DOI 10.1021/bi9802869; Fukada H, 1995, THERMOCHIM ACTA, V267, P373, DOI 10.1016/0040-6031(95)02494-8; Glatter O., 1982, SMALL ANGLE XRAY SCA; GOTO Y, 1991, J MOL BIOL, V222, P679, DOI 10.1016/0022-2836(91)90504-Y; KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064; KOJIMA M, 1995, ADV EXP MED BIOL, V362, P611; NAKAYAMA S, 1983, J BIOCHEM-TOKYO, V95, P465; OGUSHI M, 1983, FEBS LETT, V164, P21; Press W. H., 1989, NUMERICAL RECIPES AR; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; Semisotnov GV, 1996, J MOL BIOL, V262, P559, DOI 10.1006/jmbi.1996.0535; TAKAHASHI K, 1991, J BIOL CHEM, V266, P19480; TAKAHASHI K, 1995, METHOD ENZYMOL, V248, P146	19	29	29	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	FEB 15	2000	39	6					1364	1372		10.1021/bi991584o		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	285NX	WOS:000085396100023		
J	Honda, H; Ushijima, T; Wakazono, K; Oda, H; Tanaka, Y; Aizawa, S; Ishikawa, T; Yazaki, Y; Hirai, H				Honda, H; Ushijima, T; Wakazono, K; Oda, H; Tanaka, Y; Aizawa, S; Ishikawa, T; Yazaki, Y; Hirai, H			Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML	BLOOD			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; BONE-MARROW; BCR-ABL; TYROSINE KINASE; PHILADELPHIA-CHROMOSOME; P53-DEFICIENT MICE; CHRONIC PHASE; GENE; INDUCTION	Chronic myelogenous leukemia (CML) begins with an indolent chronic phase but inevitably progresses to a fatal blast crisis. Although the Philadelphia chromosome, which generates p210(bcr/abl) is a unique chromosomal abnormality in the chronic phase, additional chromosomal abnormalities are frequently detected in the blast crisis, suggesting that superimposed genetic events are responsible for disease progression. To investigate whether loss of p53 plays a role in the evolution of CML, we crossmated p210(bcr/abl)-transgenic (BCR/ABL(tg/-)) mice with p53-heterozygous (p53(+/-)) mice and generated p210(bcr/abl)-transgenic, p53-heterozygous (BCR/ABL(tg)/-p53(+/-)) mice, in which a somatic alteration in the residual normal p53 allele directly abrogates p53 function. The BCR/ABL(tg/-)p53(+/-) mice died in a short period compared with their wild-type (BCWABL(-/-)p53(+/+)), p53 heterozygous (BCR/ABL(-/-)p53(+/-)), and p210(bcr/abl) transgenic (BCR/ABL(tg/-)p53(+/+)) litter mates. They had rapid proliferation of blast cells, which was preceded by subclinical or clinical signs of a myeloproliferative disorder resembling human CML, The blast cells were clonal in origin and expressed p210(bcr/abl) with an increased kinase activity. Interestingly, the residual normal p53 allele was frequently and preferentially lost in the tumor tissues, implying that a certain mechanism facilitating the loss of p53 allele exists in p210(bcr/abl)-expressing hematopoietic cells. Our study presents in vivo evidence that acquired loss of p53 contributes to the blastic transformation of p21(bcr/abl)-expresslng hematopoietic cells and provides insights into the molecular mechanism for blast crisis of human CML.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138655, Japan; Natl Canc Ctr, Res Inst, Div Carcinogenesis, Tokyo 104, Japan; Univ Tokyo, Dept Pathol, Tokyo, Japan; Kumamoto Univ, Sch Med, Dept Morphogenesis, Inst Mol Embryol & Genet, Kumamoto 860, Japan	Hirai, H (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Honda H, 1998, BLOOD, V91, P2067; DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; MILLER C, 1986, NATURE, V319, P783, DOI 10.1038/319783a0; Skorski T, 1996, P NATL ACAD SCI USA, V93, P13137, DOI 10.1073/pnas.93.23.13137; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Wang JCY, 1998, BLOOD, V91, P2406; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; CHAMPLIN RE, 1985, BLOOD, V65, P1039; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Pear WS, 1998, BLOOD, V92, P3780; HARVEY M, 1993, FASEB J, V7, P938; Sirard C, 1996, BLOOD, V87, P1539; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; TSUKADA T, 1993, ONCOGENE, V8, P3313; DEKLEIN A, 1982, NATURE, V300, P765; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; DALEY GQ, 1993, LEUKEMIA LYMPHOMA, V11, P57, DOI 10.3109/10428199309047865; ELEFANTY AG, 1992, MOL CELL BIOL, V12, P1755; ELEFANTY AG, 1990, EMBO J, V9, P1069; FELNSTEIN E, 1991, P NATL ACAD SCI USA, V88, P6293; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Honda H, 1996, BIOCHEM BIOPH RES CO, V223, P422, DOI 10.1006/bbrc.1996.0909; Honda H, 1997, BIOCHEM BIOPH RES CO, V234, P376, DOI 10.1006/bbrc.1997.6650; JACKS T, 1994, CURR BIOL, V1, P4; KELLIHER MA, 1993, ONCOGENE, V8, P1249; KELMAN Z, 1989, BLOOD, V74, P2318; MANO H, 1990, ONCOGENE, V5, P1781; NAKAI H, 1995, LEUKEMIA LYMPHOMA, V19, P213, DOI 10.3109/10428199509107891; ROWLEY JD, 1982, ADV CANCER RES, V36, P103, DOI 10.1016/S0065-230X(08)60423-6; Sallouk H., 1997, Blood, V90, p251A; USHIJIMA T, 1995, MOL CARCINOGEN, V12, P23, DOI 10.1002/mc.2940120105	36	70	77	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 15	2000	95	4					1144	1150				7	Hematology	Hematology	283DV	WOS:000085261600008		
J	Kagami, S; Nakajima, H; Kumano, K; Suzuki, K; Suto, A; Imada, K; Davey, HW; Saito, Y; Takatsu, K; Leonard, WJ; Iwamoto, I				Kagami, S; Nakajima, H; Kumano, K; Suzuki, K; Suto, A; Imada, K; Davey, HW; Saito, Y; Takatsu, K; Leonard, WJ; Iwamoto, I			Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue	BLOOD			English	Article							INDUCED AIRWAY HYPERRESPONSIVENESS; COLONY-STIMULATING FACTOR; MAMMARY-GLAND FACTOR; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTORS; ACTIVATES STAT5; NATURAL-KILLER; DEFICIENT MICE; MOUSE AIRWAYS	Antigen-induced eosinophil recruitment into the airways of sensitized mice is mediated by CD4(+) T cells and their cytokines, especially IL-5. In this study, we found that the antigen-induced airway eosinophilia was diminished in Stat5a-deficient (Stat5a(-/-)) mice and Stat5b-deficient (Stat5b(-/-)) mice. We also found that antigen-induced CD4(+) T-cell infiltration and IL-5 production in the airways were diminished in Stat5a(-/-) mice and Stat5b(-/-) mice. Moreover, antigen-induced proliferation of splenocytes was diminished in Stat5a(-/-) mice and Stat5b(-/-) mice, suggesting that the generation of antigen-primed T cells may be compromised in Stat5a(-/-) mice and Stat5b(-/-) mice and this defect may account for the diminished antigen induced T-cell infiltration into the airways. Interestingly, IL-4 and IL-5 production from anti-CD3-stimulated splenocytes was diminished in Stat5a(-/-) mice and Stat5b(-/-) mice. However, antigen-specific IgE and IgG1 production was diminished in Stat5a(-/-) mice but not in Stat5b(-/-) mice, whereas antigen-specific IgG2a production was increased in Stat5a(-/-) mice, suggesting the enhanced Th1 responses in Stat5a(-/-) mice. Finally, we found that eosinophilo-poiesis induced by the administration of recombinant IL-5 was also diminished in Stat5a(-/-) mice and Stat5b(-/-) mice. Together, these results indicate that both Stat5a and Stat5b are essential for induction of antigen-induced eosinophil recruitment into the airways and that the defects in antigen-induced eosinophil recruitment in Stat5a(-/-) mice and Stat5b(-/-) mice result from both impaired IL-5 production in the airways and diminished IL-5 responsiveness of eosinophils. (C) 2000 by The American Society of Hematology.	Chiba Univ, Sch Med, Dept Internal Med 2, Chiba 2608670, Japan; NHLBI, Lab Mol Immunol, Bethesda, MD 20892 USA; AgResearch, Hamilton, New Zealand; Univ Tokyo, Inst Med Sci, Dept Immunol, Tokyo, Japan	Nakajima, H (reprint author), Chiba Univ, Sch Med, Dept Internal Med 2, 1-8-1 Inohana, Chiba 2608670, Japan.						Adachi T, 1998, AM J PHYSIOL-CELL PH, V275, pC623; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; MUI ALF, 1995, EMBO J, V14, P1166; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265; RENZ H, 1992, J ALLERGY CLIN IMMUN, V89, P1127, DOI 10.1016/0091-6749(92)90296-E; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; WAKAO H, 1994, EMBO J, V13, P2182; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Iwamoto I, 1996, AM J RESP CRIT CARE, V154, P1257; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Feldman GM, 1997, BLOOD, V90, P1768; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.med.44.1.85; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; NAKAJIMA H, 1992, AM REV RESPIR DIS, V146, P374; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; OVARY Z, 1986, HDB EXPT IMMUNOLOGY, V1; Pazdrak K, 1997, J EXP MED, V186, P561, DOI 10.1084/jem.186.4.561; Pazdrak K, 1998, J EXP MED, V188, P421, DOI 10.1084/jem.188.3.421; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Roboz G J, 1999, Curr Opin Hematol, V6, P164, DOI 10.1097/00062752-199905000-00007; SCHLINDER C, 1995, ANNU REV BIOCHEM, V64, P621; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; WAKAO H, 1995, EMBO J, V14, P2527; Walker C, 1998, J IMMUNOL, V161, P1962; WALSH GM, 1991, J IMMUNOL, V146, P3419; Wang LH, 1999, J IMMUNOL, V162, P3897; Wardlaw AJ, 1995, ADV IMMUNOL, V60, P151, DOI 10.1016/S0065-2776(08)60586-6; Wise JT, 1999, J IMMUNOL, V162, P5592; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407	60	57	57	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 15	2000	95	4					1370	1377				8	Hematology	Hematology	283DV	WOS:000085261600038		
J	Futaki, M; Yamashita, T; Yagasaki, H; Toda, T; Yabe, M; Kato, S; Asano, S; Nakahata, T				Futaki, M; Yamashita, T; Yagasaki, H; Toda, T; Yabe, M; Kato, S; Asano, S; Nakahata, T			The IVS4+4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients	BLOOD			English	Article							GROUP-C GENE; GLUCOCEREBROSIDASE GENE; GAUCHER DISEASE; COMPLEMENTATION; FACC; DIAGNOSIS; POLYMORPHISMS; VARIABILITY; FREQUENCY; PATHWAY	Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H), Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mutations of this gene. The most common mutation is IVS4 + 4A to T (IVS4), a splice mutation in intron 4, which has been found only in patients of Ashkenazi Jewish ancestry. When we screened 29 Japanese patients (20 unrelated patients and 4 families) using polymerase chain reaction-single strand conformation polymorphism, we found 8 unrelated patients homozygous for IVS4. This is apparently the first non-Ashkenazi-Jewish population for whom this mutation has been detected. The Ashkenazi Jewish patients homozygous for IVS4 have a severe phenotype, in comparison with other FA patients. Our analyses of Japanese patients indicate no significant difference between IVS4 homozygotes and other patients with regard to severity of a clinical phenotype. Thus, ethnic background may have a significant effect on a clinical phenotype in FA patients carrying the same mutation. (C) 2000 by The American Society of Hematology.	Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Pediat, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med, Tokyo 1088639, Japan; Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 25911, Japan	Yamashita, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						ALTER BP, 1993, BRIT J HAEMATOL, V85, P9, DOI 10.1111/j.1365-2141.1993.tb08638.x; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Kupfer GM, 1997, NAT GENET, V17, P487, DOI 10.1038/ng1297-487; Yamashita T, 1996, BLOOD, V87, P4424; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; de Winter JP, 1998, NAT GENET, V20, P281; Gillio AP, 1997, BLOOD, V90, P105; SEYSCHAB H, 1995, BLOOD, V85, P2233; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1989, BLOOD, V73, P39; DAHL N, 1990, AM J HUM GENET, V47, P275; DAndrea AD, 1996, NAT GENET, V14, P240, DOI 10.1038/ng1196-240; DAndrea AD, 1997, BLOOD, V90, P1725; FARNDON PA, 1994, GENOMICS, V23, P486, DOI 10.1006/geno.1994.1528; Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F; GIBSON RA, 1993, HUM MOL GENET, V2, P35, DOI 10.1093/hmg/2.1.35; JOENJE H, 1995, BLOOD, V86, P215; Joenje H, 1996, HUM GENET, V97, P280, DOI 10.1007/BF02185753; LIU JM, 1994, BLOOD, V84, P3995; MASUNO M, 1990, HUM GENET, V84, P203; MORRIS DJ, 1994, GENOMICS, V23, P23, DOI 10.1006/geno.1994.1454; MURERORLANDO M, 1993, LANCET, V342, P686, DOI 10.1016/0140-6736(93)91800-2; Nakamura A, 1999, J HUM GENET, V44, P48, DOI 10.1007/s100380050106; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Savoia A, 1997, HUM GENET, V99, P93; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; Tachibana A, 1999, HUM MUTAT, V13, P237, DOI 10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.0.CO;2-F; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; VERLANDER PC, 1995, BLOOD, V86, P4034; Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085; ZAKRZEWSKI S, 1983, HUM GENET, V64, P55, DOI 10.1007/BF00289479	37	39	39	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 15	2000	95	4					1493	1498				6	Hematology	Hematology	283DV	WOS:000085261600055		
J	Hayashi, Y; Honma, Y; Niitsu, N; Taki, T; Bessho, F; Sako, M; Mori, T; Yanagisawa, M; Tsuji, K; Nakahata, T				Hayashi, Y; Honma, Y; Niitsu, N; Taki, T; Bessho, F; Sako, M; Mori, T; Yanagisawa, M; Tsuji, K; Nakahata, T			SN-1, a novel leukemic cell line with t(11;16)(q23;p13): Myeloid characteristics and resistance to retinoids and vitamin D-3	CANCER RESEARCH			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RUBINSTEIN-TAYBI SYNDROME; MLL GENE; CHROMOSOMAL TRANSLOCATIONS; MYELOMONOCYTIC LEUKEMIA; CLINICAL-SIGNIFICANCE; 11Q23 TRANSLOCATIONS; DROSOPHILA-TRITHORAX; PROTEIN P300; CBP	The MLL gene is fused with the cAMP-responsive element binding protein-binding protein (CBP) gene in t(11;16)(q23;p13), which has been reported to be associated with therapy-related acute leukemia, We established a novel myeloid cell line, SN-1, from a patient with T-cell acute Lymphoblastic Leukemia with t(11;16)(q23;p13) having in-frame MLL CBP fusion transcripts. The majority of the SN-I cells were positive for myeloperoxidase when examined using an electron microscope and expressed CD13, CD33, CD56, and HLA-DR antigens, but not CD7, CD10, CD19, CD34, or CD41 antigens, suggesting that these cells are of myeloid origin. SN-1 cells underwent functional and morphological differentiation when treated with actinomycin D or sodium butyrate, but not with all-trans-retinoic acid (ATRA) or 1 alpha,25-dihydroxyvitamin D-3 (VD3). Exposure of SN-I cells to ATRA hardly affected cell growth and differentiation, whereas the growth of HL-60 and NB4 cells treated with ATRA was effectively inhibited, and differentiation into mature granulocytes was induced, SN-1 cells were relatively insensitive to VD3 with respect to inhibiting the cell growth and inducing the ability to reduce nitroblue tetrazolium, lysozyme activity, and morphological differentiation, although the expression of CD11b was slightly induced by VD3. These results suggest that the cell line was impaired in the signal transduction systems of ATRA and VD3. This cell line should be useful for the study of the role of CBP as a transcriptional regulator in leukemia differentiation and for the functional analysis of the MLL-CBP fusion gene, which will provide new insights into leukemogenesis caused by 11q23 translocations.	Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; Saitama Canc Ctr, Res Inst, Dept Chemotherapy, Ina, Saitama 3620806, Japan; Osaka City Gen Hosp, Dept Pediat, Osaka 5340021, Japan; Keio Univ, Sch Med, Dept Pediat, Tokyo 1600016, Japan; Univ Tokyo, Inst Med Sci, Dept Clin Oncol, Tokyo 1088639, Japan	Hayashi, Y (reprint author), Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Rowley JD, 1997, BLOOD, V90, P535; MACLEOD RAF, 1993, BLOOD, V82, P3221; LANGE B, 1987, BLOOD, V70, P192; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; LANOTTE M, 1991, BLOOD, V77, P1080; Taki T, 1996, LEUKEMIA, V10, P1303; PUI CH, 1990, BLOOD, V76, P1449; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Ida K, 1997, BLOOD, V90, P4699; SUPER HJG, 1993, BLOOD, V82, P3705; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Taki T, 1997, BLOOD, V89, P3945; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; BESSHO F, 1981, AM J CLIN PATHOL, V75, P684; CHEN A, 1994, BLOOD, V84, P2122; COHEN A, 1991, BLOOD, V78, P94; COLLINS SJ, 1980, INT J CANCER, V25, P213, DOI 10.1002/ijc.2910250208; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; DREXLER HG, 1995, LEUKEMIA, V9, P480; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; HERSHFIELD MS, 1984, P NATL ACAD SCI-BIOL, V81, P253, DOI 10.1073/pnas.81.1.253; HUNGER SP, 1993, BLOOD, V81, P3197; Kakuda H, 1996, BRIT J HAEMATOL, V95, P306, DOI 10.1046/j.1365-2141.1996.d01-1909.x; KOEFFLER HP, 1983, BLOOD, V62, P709; Kuriyama M, 1996, J BIOL CHEM, V271, P607; Makishima M, 1996, BLOOD, V87, P3384; Matsuo Y, 1998, LEUKEMIA RES, V22, P567, DOI 10.1016/S0145-2126(98)00050-2; MCCABE NR, 1992, P NATL ACAD SCI USA, V89, P11794, DOI 10.1073/pnas.89.24.11794; MORI T, 1995, LEUKEMIA, V9, P1233; OHYASHIKI K, 1986, CANCER RES, V46, P3642; PUI CH, 1995, LEUKEMIA, V9, P762; ROWLEY JD, 1990, CANCER RES, V50, P3816; RUBNITZ JE, 1994, BLOOD, V84, P570; Rubnitz JE, 1996, LEUKEMIA, V10, P74; Satake N, 1997, GENE CHROMOSOME CANC, V20, P60, DOI 10.1002/(SICI)1098-2264(199709)20:1<60::AID-GCC9>3.3.CO;2-O; SOTOMATSU M, 1993, LEUKEMIA, V7, P1615; STONG RC, 1985, BLOOD, V65, P21; Taki T, 1996, ONCOGENE, V13, P2121; YAMAMOTO K, 1993, ONCOGENE, V8, P2617	53	15	15	AMER ASSOC CANCER RESEARCH	BIRMINGHAM	PO BOX 11806, BIRMINGHAM, AL 35202 USA	0008-5472			CANCER RES	Cancer Res.	FEB 15	2000	60	4					1139	1145				7	Oncology	Oncology	287JQ	WOS:000085503100059		
J	Tanaka, R; Murota, K				Tanaka, R; Murota, K			Quantitative analysis for controllability of symmetric control systems	INTERNATIONAL JOURNAL OF CONTROL			English	Article								This paper is concerned with the controllability of systems possessing symmetries. In particular, we aim to give a lower bound for the number of functioning modules needed to ensure the controllability of the entire symmetric system. Our concern is the characteristics derived from the symmetry of the systems, and not from the numerical information nor from the sparsity of the connections among the modules. If structurally independent modules are connected, only one functioning module would suffice to ensure the controllability. For symmetric systems, however, it is shown that we need mon than one functioning module for the entire system to be controllable. We treat systems of general symmetry and show the lower bound based on group representation theory.	Keio Univ, Dept Appl Phys & PhysicoInformat, Yokohama, Kanagawa 2238522, Japan; Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan; Univ Tokyo, Dept Math Engn & Informat Phys, Tokyo 1138654, Japan	Tanaka, R (reprint author), Keio Univ, Dept Appl Phys & PhysicoInformat, Yokohama, Kanagawa 2238522, Japan.						AKERS SB, 1987, IEEE T COMPUT, V36, P885; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201; GRIZZLE JW, 1985, IEEE T AUTOMAT CONTR, V30, P248, DOI 10.1109/TAC.1985.1103927; HAZEWINKEL M, 1983, INT J CONTROL, V37, P1371, DOI 10.1080/00207178308933051; HUISMAN LM, 1994, IEEE T PARALL DISTR, V5, P94, DOI 10.1109/71.262592; Iwata S., 1993, JAPAN J IND APPL MAT, V10, P97; Karavay MF, 1996, AUTOMAT REM CONTR+, V57, P899; LUNZE J, 1986, INT J CONTROL, V44, P1617, DOI 10.1080/00207178608933690; Miller W., 1972, SYMMETRY GROUPS THEI; NIJMEIJER H, 1985, MATH SYST THEORY, V18, P79, DOI 10.1007/BF01699462; SILJAK DD, 1980, INT J CONTROL, V31, P303, DOI 10.1080/00207178008961043; SUNDARESHAN MK, 1991, AUTOMATICA, V27, P383, DOI 10.1016/0005-1098(91)90086-H; Tanaka R., 1999, Transactions of the Society of Instrument and Control Engineers, V35; TANAKA R, 1998, 9812 U TOK; VANDERSCHAFT A, 1981, SYST CONTROL LETT, V1, P108, DOI 10.1016/S0167-6911(81)80046-1; VIDYASAGAR M, 1985, AUTOMATICA, V21, P599, DOI 10.1016/0005-1098(85)90008-1; Welsh D.J.A., 1976, MATROID THEORY	17	5	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0020-7179			INT J CONTROL	Int. J. Control	FEB 15	2000	73	3					254	264		10.1080/002071700219795		11	Automation & Control Systems	Automation & Control Systems	274FN	WOS:000084753200008		
J	Higuchi, T; Tsukamoto, T; Tezuka, Y; Kobayashi, K; Yamaguchi, S; Shin, S				Higuchi, T; Tsukamoto, T; Tezuka, Y; Kobayashi, K; Yamaguchi, S; Shin, S			Photoemission study on protonic conductor CaZrO3: Evidence of the exchange mechanism of proton and hole	JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS			English	Article						CaZrO3; photoemission; electronic structure; proton; hole; oxygen vacancy	P-TYPE SRTIO3; CALCIUM ZIRCONATE; SRCEO3	The exchange mechanism of proton and hole in protonic conductor CaZrO3 has been investigated by photoemission spectroscopy. The Fermi level is higher by about 1.0 eV through proton doping; indicating that protons exchange with holes. The defect chemical calculation proves that the change of the number of the protons, holes, and the oxygen vacancies by the proton doping accords with the photoemission process.	Sci Univ Tokyo, Dept Appl Phys, Tokyo 1620825, Japan; Hirosaki Univ, Fac Sci & Engn, Hirosaki, Aomori 0368561, Japan; Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 3058565, Japan; Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan	Higuchi, T (reprint author), Sci Univ Tokyo, Dept Appl Phys, Tokyo 1620825, Japan.		Higuchi, Tohru/C-6544-2012; KOBAYASHI, Kiyoshi/H-2921-2011	KOBAYASHI, Kiyoshi/0000-0001-9644-1879			KURITA N, 1995, J ELECTROCHEM SOC, V142, P1552, DOI 10.1149/1.2048611; Kobayashi K, 1998, SOLID STATE IONICS, V108, P355, DOI 10.1016/S0167-2738(98)00063-0; Higuchi T, 1998, PHYS REV B, V57, P6978, DOI 10.1103/PhysRevB.57.6978; KROGER FA, 1956, SOLID STATE PHYS, V3, P307; SHIN S, 1990, SOLID STATE IONICS, V40-1, P910, DOI 10.1016/0167-2738(90)90151-G; Sata N, 1996, PHYS REV B, V54, P15795, DOI 10.1103/PhysRevB.54.15795; Sata N, 1996, SOLID STATE IONICS, V86-8, P629, DOI 10.1016/0167-2738(96)00226-3; Higuchi T, 1998, SOLID STATE IONICS, V108, P349, DOI 10.1016/S0167-2738(98)00062-9; HIRAMOTO K, UNPUB; IWAHARA H, 1980, SOLID STATE IONICS, V3, P359; KOBAYASHI K, 1998, THESIS NAGOYA I TECH; Matsumoto M, 1996, J ELECTRON SPECTROSC, V78, P179, DOI 10.1016/S0368-2048(96)80056-9; Shimojo F, 1996, J PHYS SOC JPN, V65, P1143, DOI 10.1143/JPSJ.65.1143; SHIN S, 1995, PHYS REV B, V52, P11853, DOI 10.1103/PhysRevB.52.11853; Yajima T., 1992, KEIKINZOKU, V42, P263; YAMAGUCHI S, 1999, IN PRESS SOLID STATE; YEH JJ, 1993, ATOMIC DATA NUCL DAT, V32, P1	17	22	22	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 2	Jpn. J. Appl. Phys. Part 2 - Lett.	FEB 15	2000	39	2B					L133	L136		10.1143/JJAP.39.L133		4	Physics, Applied	Physics	322YW	WOS:000087538100004		
J	Sasaki, N; Aizawa, H; Tsukuda, M				Sasaki, N; Aizawa, H; Tsukuda, M			Fourier expansion method for noncontact atomic force microscopy image simulations - Application to Si(111) root 3 x root 3-Ag surface	JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS & EXPRESS LETTERS			English	Article						noncontact atomic-force microscopy; DFT; LDA; Si(111)root 3 x root 3-Ag surface; HCT model; tip-surface interaction force; frequency shift; image	RESOLUTION; AFM	A Fourier expansion method is proposed to simulate noncontact atomic force microscopy images. The three-dimensional distribution of the tip-surface interaction force obtained by the fil st principles density functional calculations is efficiently used for calculating frequency shifts of the resonant frequency. The two-dimensional periodicity of the surface, which is the basis of this method, can be rigorously described. For a case study of this method, we theoretically simulate noncontact atomic-force microscopy (NC-AFM) images of a Si(111) root 3 x root 3 R 30 degrees-Ag rigid surface with the first-principles density functional calculation. Force spectroscopies and AFM images for different tip heights are calculated.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Sasaki, N (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	naru@cms.phys.s.u-tokyo.ac.jp					Aizawa H, 1999, SURF SCI, V429, pL509, DOI 10.1016/S0039-6028(99)00424-0; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Sugawara Y, 1999, SURF INTERFACE ANAL, V27, P456, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<456::AID-SIA536>3.0.CO;2-I; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Minobe T, 1999, APPL SURF SCI, V140, P298, DOI 10.1016/S0169-4332(98)00544-3; Sasaki N, 1998, JPN J APPL PHYS 2, V37, pL533, DOI 10.1143/JJAP.37.L533; Sasaki N, 1999, APPL SURF SCI, V140, P339, DOI 10.1016/S0169-4332(98)00551-0; Sasaki N, 1999, JPN J APPL PHYS 1, V38, P192, DOI 10.1143/JJAP.38.192; SASAKI N, IN PRESS APPL SURF S; Yokoyama K, 1999, PHYS REV LETT, V83, P5023, DOI 10.1103/PhysRevLett.83.5023	12	5	5	JAPAN SOC APPLIED PHYSICS	TOKYO	KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN	0021-4922			JPN J APPL PHYS 2	Jpn. J. Appl. Phys. Part 2 - Lett. Express Lett.	FEB 15	2000	39	2B					L174	L177		10.1143/JJAP.39.L174		4	Physics, Applied	Physics	322YW	WOS:000087538100017		
J	Hasegawa, T; Koike, I; Mukai, H				Hasegawa, T; Koike, I; Mukai, H			Dissolved organic nitrogen dynamics in coastal waters and the effect of copepods	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						DON; nitrogen dynamics; N-15 tracer; food web structure; copepods	N-15 TRACER METHOD; FREE AMINO-ACIDS; DILUTION TECHNIQUE; CHESAPEAKE BAY; MARINE; REGENERATION; AMMONIUM; RELEASE; PHYTOPLANKTON; CARBON	The dynamics of freshly released and N-15 labeled dissolved organic nitrogen ((DON)-N-15) in the < 94 mu m planktonic assemblages of coastal waters and the effects of herbivorous copepods on those dynamics were assessed by applying (NH4+)-N-15 under laboratory conditions. At the same time, the rate of NH4+ uptake and regeneration in the < 94 mu m planktonic assemblages, and the rates of ingestion and NH: regeneration by copepods were evaluated by N-15 accumulation in the particulate organic nitrogen (PON) fraction and in the copepods, and N-15(4)+ isotope dilution during the incubation. Under conditions of high ambient Chlorophyll a, the presence of copepods stimulated total community (DON)-N-15 release which was correlated with high ingestion rates of the copepods. The copepods primarily grazed on N-15 tagged phytoplankton and 'sloppy feeding' would be a mechanism responsible for the (DON)-N-15 release. On the other hand, the addition of copepods gave a negative effect on (DON)-N-15 release in <94 mu m plankton assemblages at the occasions when ambient Chlorophyll a concentrations were low and nitrogen-Chlorophyll a ratios were high. The micrograzer and other organic particles that less labeled by N-15 tracer, would be the important foods for the copepods under those conditions, while the possible (DON)-N-15 release by the micrograzer would be repressed by copepods grazing. When a stimulating effect of the copepods addition on relative (DON)-N-15 accumulation was found, the copepods sometimes released more N-15 labeled DON than 15N assimilated into their body. Even under those conditions, the rates of (DON)-N-15 release by copepods normalized to ambient zooplankton biomass are rather minor compared to those by planktonic assemblages of <94 mu m, suggesting the importance of microzooplankton and phytoplankton on (DON)-N-15 release in this coastal waters. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; Hokkaido Univ, Akkeshi Marine Biol Stn, Akkeshi, Hokkaido 0881113, Japan	Hasegawa, T (reprint author), Univ Tokyo, Ocean Res Inst, 1-15-1 Minamidai, Tokyo 1648639, Japan.		sasmito, sigit/E-8715-2013	sasmito, sigit/0000-0001-5864-8596			FOGG GE, 1983, BOT MAR, V26, P3, DOI 10.1515/botm.1983.26.1.3; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; LAMPERT W, 1978, LIMNOL OCEANOGR, V23, P831; Strom SL, 1997, LIMNOL OCEANOGR, V42, P1364; BRATBAK G, 1992, MAR ECOL PROG SER, V83, P273, DOI 10.3354/meps083273; Biddanda B, 1997, LIMNOL OCEANOGR, V42, P506; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805; DORTCH Q, 1982, J EXP MAR BIOL ECOL, V61, P243, DOI 10.1016/0022-0981(82)90072-7; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P751; GLIBERT PM, 1982, LIMNOL OCEANOGR, V27, P639; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196; OVIATT C, 1995, MAR ECOL PROG SER, V116, P171, DOI 10.3354/meps116171; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078; BRONK DA, 1993, MAR ECOL PROG SER, V96, P291, DOI 10.3354/meps096291; BLACKBURN TH, 1979, APPL ENVIRON MICROB, V37, P760; BREMNER JM, 1965, ANAL CHIM ACTA, V32, P485, DOI 10.1016/S0003-2670(00)88973-4; Axler R.P., 1986, CAN J FISH AQUAT SCI, V43, P130; BANOUB MW, 1973, J MAR BIOL ASSOC UK, V53, P695; BRONK DA, 1991, MAR ECOL PROG SER, V77, P171, DOI 10.3354/meps077171; BRONK DA, 1993, MAR BIOL, V115, P501, DOI 10.1007/BF00349849; CAPERON J, 1979, MAR BIOL, V54, P33, DOI 10.1007/BF00387049; DARO MH, 1978, HELGOLAND WISS MEER, V31, P241, DOI 10.1007/BF02296999; FUHRMAN JA, 1987, MAR ECOL PROG SER, V37, P45, DOI 10.3354/meps037045; GLIBERT PM, 1992, MAR ECOL PROG SER, V82, P65, DOI 10.3354/meps082065; HARRISON WG, 1983, J PLANKTON RES, V5, P539, DOI 10.1093/plankt/5.4.539; JACKSON GA, 1985, DEEP-SEA RES, V32, P223, DOI 10.1016/0198-0149(85)90030-5; KANDA J, 1987, J PLANKTON RES, V9, P79, DOI 10.1093/plankt/9.1.79; Kanda J, 1998, INT J ENVIRON AN CH, V72, P163, DOI 10.1080/03067319808035888; Liu KK, 1996, MAR CHEM, V54, P273, DOI 10.1016/0304-4203(96)00034-5; McCarthy J. J., 1983, NITROGEN MARINE ENV, P487; MCCARTHY JJ, 1986, LIMNOL OCEANOGR, V31, P690; MILLER CA, 1998, J PLANKTON RES, V20, P1998; MILLER CA, 1995, LIMNOL OCEANOGR, V40, P1005; MOTODA S, 1977, PRODUCTIVITY BIOCENO, P223; NAGATA T, 1991, LIMNOL OCEANOGR, V36, P433; POULET SA, 1974, MAR BIOL, V25, P109, DOI 10.1007/BF00389260; Roman M.R., 1983, P347; ROY S, 1989, MAR ECOL PROG SER, V52, P145, DOI 10.3354/meps052145; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Sharp J. H., 1983, NITROGEN MARINE ENV, P1; SLAWYK G, 1995, MAR ECOL PROG SER, V124, P289, DOI 10.3354/meps124289; Strickland J. D., 1972, B FISH RES BOARD CAN, V197, P310; Suzuki R., 1990, J OCEANOGR SOC JPN, V46, P143; TAGUCHI S, 1975, J EXP MAR BIOL ECOL, V19, P145, DOI 10.1016/0022-0981(75)90043-X; TUPAS L, 1991, MAR ECOL PROG SER, V70, P273, DOI 10.3354/meps070273; TUPAS LM, 1994, POLAR BIOL, V14, P195; WHEELER PA, 1989, LIMNOL OCEANOGR, V34, P1025	47	17	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981			J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	FEB 15	2000	244	2					219	238		10.1016/S0022-0981(99)00145-8		20	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	277WV	WOS:000084957300004		
J	Nishino, K; Kato, M; Yokouchi, K; Yamanouchi, K; Naito, K; Tojo, H				Nishino, K; Kato, M; Yokouchi, K; Yamanouchi, K; Naito, K; Tojo, H			Establishment of fetal gonad/mesonephros coculture system using EGFP transgenic mice	JOURNAL OF EXPERIMENTAL ZOOLOGY			English	Article							TESTICULAR CELL-CULTURE; PLASMINOGEN-ACTIVATOR; SERTOLI CELLS; IV COLLAGENASE; CORD FORMATION; TESTIS; DIFFERENTIATION; MOUSE; SECRETION; TISSUE	In developing mouse embryos, the Sertoli cells, Leydig cells, and seminiferous cords are differentiated in the XY gonads. The migration of mesonephric cells into the gonads is required during the developmental stage for seminiferous cord formation in the male gonads. In previous experiments, an organ coculture system has been used to examine morphologically developing gonads. However, by the process used in this system for fixing and staining the gonad/ mesonephros complexes for examination, the kinetics of cell migration and the character of migrating cells cannot be observed. In the present study, we established an improved organ coculture system, using transgenic mice ubiquitously expressing Enhanced Green Fluorescent; Protein (EGFP). In this system, time-dependent morphological changes in male-specific migration were observable in the gonad/mesonephros complex. The cell migration occurred at around 20 hr of coculture and began to spread at 25 hr with increases in the number of migrating cells occurring at 45 hr of coculture. No degenerative changes were detected at the end of coculture. Our results indicate that the present coculture system is very useful for investigating the mechanism of cell migration, as well as the characteristics of the migrating cells, in developing gonads. (C) 2000Wiley-Liss,Inc.	Univ Tokyo, Lab Appl Genet, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Tojo, H (reprint author), Univ Tokyo, Lab Appl Genet, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						AILENBERG M, 1991, BIOCHEM J, V279, P75; BUEHR M, 1993, DEVELOPMENT, V117, P273; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Brennan J, 1998, J EXP ZOOL, V281, P494, DOI 10.1002/(SICI)1097-010X(19980801)281:5<494::AID-JEZ14>3.0.CO;2-9; Grima J, 1996, J ANDROL, V17, P263; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; JOST A, 1988, PHILOS T ROY SOC B, V322, P55, DOI 10.1098/rstb.1988.0113; LACROIX M, 1977, MOL CELL ENDOCRINOL, V9, P227, DOI 10.1016/0303-7207(77)90124-1; MAGRE S, 1984, P NATL ACAD SCI-BIOL, V81, P7831, DOI 10.1073/pnas.81.24.7831; MARZOWSKI J, 1985, BIOL REPROD, V32, P1237, DOI 10.1095/biolreprod32.5.1237; MERCHANTLARIOS H, 1993, INT J DEV BIOL, V37, P407; MORENOMENDOZA N, 1995, DEV BIOL, V169, P51, DOI 10.1006/dbio.1995.1125; PATSAVOUDI E, 1985, J ENDOCRINOL, V105, P235, DOI 10.1677/joe.0.1050235; SANG QX, 1990, BIOL REPROD, V43, P956, DOI 10.1095/biolreprod43.6.956; SANG QX, 1990, BIOL REPROD, V43, P946, DOI 10.1095/biolreprod43.6.946; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; ULISSE S, 1994, ENDOCRINOLOGY, V135, P2479, DOI 10.1210/en.135.6.2479; VIHKO KK, 1987, ENDOCRINOLOGY, V120, P142	20	8	8	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0022-104X			J EXP ZOOL	J. Exp. Zool.	FEB 15	2000	286	3					320	327		10.1002/(SICI)1097-010X(20000215)286:3<320::AID-JEZ11>3.0.CO;2-8		8	Zoology	Zoology	280KJ	WOS:000085101700011		
J	You, YZ; Suginohara, N; Fukasawa, M; Yasuda, I; Kaneko, I; Yoritaka, H; Kawamiya, M				You, YZ; Suginohara, N; Fukasawa, M; Yasuda, I; Kaneko, I; Yoritaka, H; Kawamiya, M			Roles of the Okhotsk Sea and Gulf of Alaska in forming the North Pacific Intermediate Water	JOURNAL OF GEOPHYSICAL RESEARCH-OCEANS			English	Article							SHALLOW SALINITY MINIMA; POTENTIAL VORTICITY; NEUTRAL SURFACES; WORLDS OCEANS; CIRCULATION; DISTRIBUTIONS; THERMOCLINE; TRANSPORTS; REGION; ZONE	Recently obtained World Ocean Circulation Experiment (WOCE) sections and pre-WOCE hydrography are used to study the water - mass structure and formation and transformation of North Pacific Intermediate Water (NPIW). Five neutral density surfaces are selected and mapped, encompassing NPIW from 400 to 900 m in the subtropical latitudes with a distance of similar to 100 m between a pair of surfaces. NPIW is defined as a subtropical gyre salinity minimum which is well followed by a neutral density surface sigma(N)=26.9. Formation and transformation of NPIW is examined by the mapped Turner angle on neutral density surfaces. Apparent diffusive double diffusion is found in the Alaskan gyre on sigma(N)=26.5 neutral surface, in the northwest subpolar gyre and the Okhotsk Sea on sigma(N)=26.9 neutral surface, and mainly in the Okhotsk Sea on the two deep neutral surfaces sigma(N)=27.2 and sigma(N)=27.4. These diffusive regions indicate transformation sources for NPIW. Along with additional information of potential vorticity and stream function, it is found that there are two different NPIW formation sources: one in the Gulf of Alaska characterized by high potential vorticity and the ether in the Okhotsk Sea characterized by low potential vorticity. The former lies shallower at sigma(N)=26.2-26.5, but its effect deepens to NPIW core density level at sigma(N)=26.8 on the basis of potential vorticity distribution. The latter includes the influence of the northwest subpolar gyre and extends much deeper to sigma(N)=27.3. We call them Gulf of Alaska Intermediate Water (GAIW) and Okhotsk Intermediate Water (OIW), respectively. GAIW contributes to NPIW in the eastern part of the subtropical gyre east of date line, whilst OIW dominates in the west and entire lower part of NPIW. Seasonal flow stream function mapped on neutral surfaces shows that the contribution of GAIW to NPIW occurs mainly in the wintertime, because in winter a significant northward shift of zero wind stress curl makes the Gulf of Alaska an additional source for NPIW.	Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, Tokyo 1538904, Japan; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Phys, Tokyo 1538914, Japan; Maritime Safety Agcy, Hydrog Dept, Ocean Res Lab, Tokyo 1040045, Japan; Meteorol Res Inst, Oceanog Res Dept, Tsukuba, Ibaraki 3050052, Japan; Tokai Univ, Fac Marine Sci & Technol, Shimizu, Shizuoka 4240902, Japan; Univ New S Wales, Sch Math, Ctr Environm Modeling & Predict, Sydney, NSW, Australia	You, YZ (reprint author), Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						Freeland HJ, 1998, J GEOPHYS RES-OCEANS, V103, P15613, DOI 10.1029/98JC00368; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Yasuda I, 1996, J PHYS OCEANOGR, V26, P448, DOI 10.1175/1520-0485(1996)026<0448:DAMONP>2.0.CO;2; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; MCDOUGALL TJ, 1987, J PHYS OCEANOGR, V17, P1950, DOI 10.1175/1520-0485(1987)017<1950:NS>2.0.CO;2; TALLEY LD, 1991, DEEP-SEA RES, V38, pS171; TALLEY LD, 1988, J PHYS OCEANOGR, V18, P89, DOI 10.1175/1520-0485(1988)018<0089:PVDITN>2.0.CO;2; TALLEY LD, 1995, J PHYS OCEANOGR, V25, P475, DOI 10.1175/1520-0485(1995)025<0475:NPIWIT>2.0.CO;2; GORDON AL, 1977, J PHYS OCEANOGR, V7, P309, DOI 10.1175/1520-0485(1977)007<0309:APFZIT>2.0.CO;2; QIU B, 1995, J PHYS OCEANOGR, V25, P168, DOI 10.1175/1520-0485(1995)025<0168:WITSOT>2.0.CO;2; Yasuda I, 1997, J GEOPHYS RES-OCEANS, V102, P893, DOI 10.1029/96JC02938; MCDOUGALL TJ, 1992, DEEP-SEA RES, V39, P1931, DOI 10.1016/0198-0149(92)90006-F; Aydin M, 1998, J GEOPHYS RES-OCEANS, V103, P30923, DOI 10.1029/1998JC900014; Baumgartner A., 1975, WORLD WATER BALANCE; BINGHAM FM, 1994, J PHYS OCEANOGR, V24, P141, DOI 10.1175/1520-0485(1994)024<0141:TSIONP>2.0.CO;2; HASUNUMA K, 1978, BULL, V9; *JAMSTEC, 1996, CRUISE REP P8S; Kaneko I, 1998, J GEOPHYS RES-OCEANS, V103, P12959, DOI 10.1029/97JC03761; Kawabe M, 1998, J GEOPHYS RES-OCEANS, V103, P12941, DOI 10.1029/97JC03197; Kawai H, 1972, KUROSHIO ITS PHYSICA, P235; LEVITUS S, 1982, 13 US DEP COMM; McDougall T., 1988, SMALL SCALE TURBULEN, p[3, 135]; *NODC, 1994, WORLD OC ATL CD ROM; PRELIER RH, 1998, SEA, V11, P428; REID JL, 1965, J HOPKINS OCEANOGR S, V5; REID JL, 1973, DEEP-SEA RES, V20, P51, DOI 10.1016/0011-7471(73)90042-9; Rienecker MM, 1996, J GEOPHYS RES-OCEANS, V101, P1011, DOI 10.1029/95JC03015; RUDDICK B, 1983, DEEP-SEA RES, V30, P1105, DOI 10.1016/0198-0149(83)90063-8; SVERDRUP HU, 1942, OCEANS THEIR PHYSICS; SWIFT J, 1990, 9036 SIO; Talley L. D., 1991, Deep-Sea Research, Part A (Oceanographic Research Papers), V38; Talley LD, 1997, J PHYS OCEANOGR, V27, P1795, DOI 10.1175/1520-0485(1997)027<1795:NPIWTI>2.0.CO;2; TALLEY LD, 1982, J PHYS OCEANOGR, V12, P1189, DOI 10.1175/1520-0485(1982)012<1189:DACOLS>2.0.CO;2; TSUCHIYA M, 1968, J HOPKINS OCEANOGR S, V4; Tsujino H, 1998, J GEOPHYS RES-OCEANS, V103, P18665, DOI 10.1029/98JC01682; VANSCOY KA, 1991, J GEOPHYS RES, V96, P16810; VERONIS G, 1972, J MAR RES, V30, P227; Warner MJ, 1996, J GEOPHYS RES-OCEANS, V101, P20525, DOI 10.1029/96JC01849; YOU Y, 1990, J GEOPHYS RES-OCEANS, V95, P13235, DOI 10.1029/JC095iC08p13235; You YZ, 1996, DEEP-SEA RES PT I, V43, P291, DOI 10.1016/0967-0637(96)00007-6; YOU YZ, 1995, J PHYS OCEANOGR, V25, P1891, DOI 10.1175/1520-0485(1995)025<1891:DMWMCA>2.0.CO;2; You YZ, 1999, DEEP-SEA RES PT II, V46, P393, DOI 10.1016/S0967-0645(98)00111-8; You YZ, 1999, DEEP-SEA RES PT I, V46, P109, DOI 10.1016/S0967-0637(98)00058-2; You YZ, 1998, J GEOPHYS RES-OCEANS, V103, P30941, DOI 10.1029/1998JC900008; YUAN XJ, 1992, J PHYS OCEANOGR, V22, P1302, DOI 10.1175/1520-0485(1992)022<1302:SSMITN>2.0.CO;2	46	44	47	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0148-0227			J GEOPHYS RES-OCEANS	J. Geophys. Res.-Oceans	FEB 15	2000	105	C2					3253	3280		10.1029/1999JC900304		28	Oceanography	Oceanography	284ML	WOS:000085336100003		
J	Takeda, K; Oshima, H; Hayakawa, Y; Akiba, H; Atsuta, M; Kobata, T; Kobayashi, K; Ito, M; Yagita, H; Okumura, K				Takeda, K; Oshima, H; Hayakawa, Y; Akiba, H; Atsuta, M; Kobata, T; Kobayashi, K; Ito, M; Yagita, H; Okumura, K			CD27-mediated activation of murine NK cells	JOURNAL OF IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; NK1.1(+) T-CELLS; RECEPTOR SUPERFAMILY; MOLECULAR-CLONING; CD27; COSTIMULATION; RESPONSES; ANTIGEN; SIGNAL; GAMMA	CD27, a member of the TNF receptor superfamily, has been implicated in T cell activation, T cell development, and T cell-dependent Ab production by B cells. In the present study we examined the expression and function of CD27 on murine NK cells. Murine NK cells constitutively expressed CD27 on their surface. Stimulation with immobilized anti-CD27 mAb or murine CD27 ligand (CD70) transfectans solely could induce proliferation and IFN-gamma production of freshly isolated NK cells and enhanced the proliferation and IFN-gamma production of anti-NK1.1-sutimulated NK cells. Although NK cell cytotoxicity was not triggered by anti-CD27 mAb or against CD70 transfectants, prestimulation via CD27 enhanced the cytotoxic activity of NK cells in an IFN-gamma-dependent manner. These results suggest that CD27-mediated activation may be involved in the NK cell-mediated innate immunity against virus-infected or transformed cells expressing CD70.	Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; Japan Sci & Technol Corp, CREST, Chiyoda Ku, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Surg 1, Tokyo 113, Japan; Toyama Med & Pharmaceut Univ, Res Inst Wakan Yaku, Dept Pathogen Biochem, Toyama, Japan; Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan	Takeda, K (reprint author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.						AGEMATSU K, 1994, J IMMUNOL, V153, P1421; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Akiba H, 1999, J IMMUNOL, V162, P7058; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.immunol.11.1.191; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Wolthers KC, 1996, EUR J IMMUNOL, V26, P1700, DOI 10.1002/eji.1830260806; Melero I, 1998, CELL IMMUNOL, V190, P167, DOI 10.1006/cimm.1998.1396; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; RYAN JC, 1992, J IMMUNOL, V149, P1631; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; WU TC, 1995, J EXP MED, V182, P1415, DOI 10.1084/jem.182.5.1415; GRUSS HJ, 1995, BLOOD, V85, P3378; KOBATA T, 1994, J IMMUNOL, V153, P5422; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; AZUMA M, 1992, J IMMUNOL, V149, P1115; Brown C. L., 1970, Wood Science, V3, P8; HACKETT J, 1986, J IMMUNOL, V136, P3124; Herbst H, 1996, J PATHOL, V179, P54, DOI 10.1002/(SICI)1096-9896(199605)179:1<54::AID-PATH537>3.0.CO;2-2; HINTZEN RQ, 1994, IMMUNOL TODAY, V15, P307, DOI 10.1016/0167-5699(94)90077-9; Hunter CA, 1997, J IMMUNOL, V158, P2285; ITOH K, 1985, J IMMUNOL, V134, P3124; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Kaneko Y, 1996, EUR J IMMUNOL, V26, P3061, DOI 10.1002/eji.1830261236; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; NANDI D, 1994, J IMMUNOL, V152, P3361; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; SUGITA K, 1992, J IMMUNOL, V149, P1199; Takeda K, 1996, J IMMUNOL, V156, P3366; TING AT, 1995, J BIOL CHEM, V270, P16415; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187; Yang FC, 1996, IMMUNOLOGY, V88, P289, DOI 10.1111/j.1365-2567.1996.tb00017.x	40	76	78	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	FEB 15	2000	164	4					1741	1745				5	Immunology	Immunology	283VK	WOS:000085296600016		
J	Schmid, M; Steinwandt, R; Muller-Quade, J; Rotteler, M; Beth, T				Schmid, M; Steinwandt, R; Muller-Quade, J; Rotteler, M; Beth, T			Decomposing a matrix into circulant and diagonal factors	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						matrix factorization; diagonal and circulant matrices		Let K be a field of characteristic not equal 2. It is proven that for K is not an element of {F-3, F-5} each square matrix with entries in K can be written as a product of circulant and diagonal matrices with entries in K, (C) 2000 Elsevier Science Inc. All rights reserved.	Univ Karlsruhe, Inst Algorithmen & Kognit Syst, Fak Informat, D-76128 Karlsruhe, Germany; Univ Tokyo, Imai Lab, Inst Ind Sci, Dept 3,Minato Ku, Tokyo, Japan	Steinwandt, R (reprint author), Univ Karlsruhe, Inst Algorithmen & Kognit Syst, Fak Informat, Fasanengarten 5, D-76128 Karlsruhe, Germany.						Borevich Z I, 1981, J SOVIET MATH, V17, P1951, DOI 10.1007/BF01465451; BOREVICH ZI, 1981, J SOVIET MATH, V17, P1718, DOI 10.1007/BF01091757; Bosma W, 1997, J SYMB COMPUT, V24, P235, DOI 10.1006/jsco.1996.0125; COHN PM, 1984, ALGEBR, V1; Friedland S., 1985, LINEAR MULTILINEAR A, V18, P1, DOI 10.1080/03081088508817670; LAFFEY TJ, 1991, NATO ADV SCI I C-MAT, V333, P95; Muller-Quade J, 1998, PHYSICA D, V120, P196, DOI 10.1016/S0167-2789(98)00055-4; MULLERQUQDE J, 1998, THESIS U KARLSRUHE; SUZUKI M, 1982, GRUNDLEHREN MATH WIS, V1247; VANDERLUGT A, 1992, WILEY SERIES PURE AP; VAVILOV NA, 1981, J SOVIET MATH, V17, P1960, DOI 10.1007/BF01465452	11	4	5	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0024-3795			LINEAR ALGEBRA APPL	Linear Alg. Appl.	FEB 15	2000	306	1-3					131	143		10.1016/S0024-3795(99)00250-5		13	Mathematics, Applied; Mathematics	Mathematics	283NL	WOS:000085281600010		
J	Ujiie, Y				Ujiie, Y			Mud diapirs observed in two piston cores from the landward slope of the northern Ryukyu Trench, northwestern Pacific Ocean	MARINE GEOLOGY			English	Article						mud diapir; northern Ryukyu Trench; porosity; exotic microfossils	BARBADOS RIDGE COMPLEX; ACCRETIONARY COMPLEX; VOLCANOS; SEA; MELANGES; PRESSURE; EASTERN; ISLAND; ARC	Two piston cores were collected from the cones of two mud volcanoes identified by a side-scan sonar survey east of Tanega-shima Island on the landward slope of the northern Ryukyu Trench to clarify the internal nature of the mud diapir. The upper part (Unit I) of both cores consists of normal hemipelagic sediments, whereas the lower portions (Unit II) of the cores are composed of mud-supported breccia. Distinct decrease in porosity from Unit II to Unit I indicates that the pore fluid pressure for mud diapirism was changed after expulsion on the sea floor due to the extruding conditions associated with dewatering and degassing. The Late Eocene to Pleistocene planktonic foraminifera found in the clasts, and calcareous nannofossils from muddy matrix in Unit II suggest that the various-aged surrounding rocks of the diapiric vents were torn off and taken into the mud diapir via hydraulic fracturing under intrusive conditions. Based on the planktonic oxygen isotope stratigraphy, AMS C-14 measurements and tephrochronology, Unit I represents continuous deposition of hemipelagic mud after similar to 38 and similar to 17 ka to the two cores, respectively, and marks the time cessation of diapiric activity in these mud volcanoes. The findings of this study reveal the detailed behavior of mud diapirs from first stage (intruding) to final stage (extruding) in diapirism. Although these mud volcanoes are located near sites, the activities show a wide age spectrum. Therefore, it is possible that there is a characteristic relationship between the mud diapir development and the tectonic setting of this region. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Ocean Res Inst, Nankano Ku, Tokyo 1648639, Japan	Ujiie, Y (reprint author), Univ Tokyo, Ocean Res Inst, Nankano Ku, Minami Dai 1-15-1, Tokyo 1648639, Japan.						BROWN KM, 1990, J GEOPHYS RES-SOLID, V95, P8969, DOI 10.1029/JB095iB06p08969; CAMERLENGHI A, 1992, EARTH PLANET SC LETT, V109, P493, DOI 10.1016/0012-821X(92)90109-9; Slack JF, 1998, GEOLOGY, V26, P439, DOI 10.1130/0091-7613(1998)026<0439:BRMVOT>2.3.CO;2; BARBER AJ, 1986, AAPG BULL, V70, P1729; SENO T, 1984, TECTONOPHYSICS, V102, P53, DOI 10.1016/0040-1951(84)90008-8; OKADA H, 1980, MAR MICROPALEONTOL, V5, P321, DOI 10.1016/0377-8398(80)90016-X; Bolli H.M., 1985, P155; BROWN K, 1988, TECTONICS, V7, P613, DOI 10.1029/TC007i003p00613; CITA MB, 1996, MAR GEOL, V132, P273; Folk R L, 1957, J SEDIMENT PETROL, V27, P3, DOI DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D; Hada S., 1988, Modern Geology, V12; HANKEN NM, 1979, J PALEONTOL, V53, P738; Hayasaka S., 1988, Modern Geology, V12; IWASAKI T, 1990, GEOPHYS J INT, V102, P631, DOI 10.1111/j.1365-246X.1990.tb04587.x; LEPICHON X, 1987, EARTH PLANET SC LETT, V83, P199, DOI 10.1016/0012-821X(87)90066-5; LEPICHON X, 1990, J GEOPHYS RES-SOLID, V95, P8931, DOI 10.1029/JB095iB06p08931; Lewis JC, 1996, GEOLOGY, V24, P303, DOI 10.1130/0091-7613(1996)024<0303:DADIAA>2.3.CO;2; MOORE JC, 1984, INITIAL REP DEEP SEA, V78, P601; Okada H., 1979, J GEOL SOC JPN, V85, P187; ORANGE DL, 1990, GEOL SOC AM BULL, V102, P935, DOI 10.1130/0016-7606(1990)102<0935:CHIRSZ>2.3.CO;2; Orange DL, 1999, GEOL SOC AM BULL, V111, P992, DOI 10.1130/0016-7606(1999)111<0992:WFEOAT>2.3.CO;2; RIDD MF, 1970, AM ASSOC PETR GEOL B, V54, P601; Robertson A.H.F., 1998, P OC DRILL PROGR SCI, V160, P665; SHI YL, 1985, GEOPHYS RES LETT, V12, P773, DOI 10.1029/GL012i011p00773; SHIMIZU H, 1985, J GEOL SOC JPN, V91, P691; UJIIE H, 1996, NATURE JAPAN, P93; UJIIE H, 1992, GEOL SURV JPN, V5, P337; Ujiie K, 1997, TECTONICS, V16, P305, DOI 10.1029/96TC03367; WESTBROOK GK, 1983, GEOLOGY, V11, P279, DOI 10.1130/0091-7613(1983)11<279:LDAMVE>2.0.CO;2; YASUDA H, 1985, FOSSILS, V39, P17	30	8	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0025-3227			MAR GEOL	Mar. Geol.	FEB 15	2000	163	1-4					149	+		10.1016/S0025-3227(99)00113-9		17	Geosciences, Multidisciplinary; Oceanography	Geology; Oceanography	296BX	WOS:000086004100009		
J	Song, DY; Takeda, N; Kawamoto, H				Song, DY; Takeda, N; Kawamoto, H			Corrosion, oxidation and strength properties of Nicalon SiC fibre under loading	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						oxidation; degradation; scanning electron microscopy	SILICON-CARBIDE; ELEVATED-TEMPERATURES; FIBERS; DEGRADATION	Hot corrosion and oxidation behavior of Nicalon fibres in air under loading were investigated and compared. Degradation of Nicalon fibres exposed at temperatures over 900 degrees C in the presence of Na2SO4 was extremely severe compared with that in oxidation environment without Na2SO4. This is attributed to the rapid oxidation-dissolution of the fibres due to the formation of the liquid Na2SiO3. Room temperature strength of Nicalon fibre after oxidation decreased with increasing exposure temperature. Reduction of tensile strengths was most significant under the combined condition of exposure temperature and applied loading. This evident strength reduction is caused by the combination of applied load and the reaction between the inherent SiO2 and free carbon in the fibre. Fracture surfaces of oxidized fibres exhibited mirror-heckle regions, whereas the fracture surfaces of fibres corroded were planar. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Ctr Collaborat Res, Meguro Ku, Tokyo 1538904, Japan; Japan Fine Ceram Ctr, Atsuta Ku, Nagoya, Aichi 4568587, Japan	Song, DY (reprint author), Univ Tokyo, Ctr Collaborat Res, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						GOGOTSI Y, 1994, J MATER SCI LETT, V13, P395, DOI 10.1007/BF00278008; JACOBSON NS, 1985, J AM CERAM SOC, V68, P432, DOI 10.1111/j.1151-2916.1985.tb10170.x; ECKEL AJ, 1989, J AM CERAM SOC, V72, P455, DOI 10.1111/j.1151-2916.1989.tb06152.x; EMIG G, 1995, J MATER SCI, V30, P5813, DOI 10.1007/BF00356726; FAREED AS, 1987, AM CERAM SOC BULL, V66, P353; FOX DS, 1990, CERAM T, V10, P227; GOGOTSI Y, 1994, J MATER SCI LETT, V13, P680, DOI 10.1007/BF00271233; KIM HE, 1991, J AM CERAM SOC, V74, P666, DOI 10.1111/j.1151-2916.1991.tb04079.x; MCKEE DW, 1976, J AM CERAM SOC, V59, P441, DOI 10.1111/j.1151-2916.1976.tb09514.x; PYSHER DJ, 1989, J AM CERAM SOC, V72, P284, DOI 10.1111/j.1151-2916.1989.tb06115.x; Sawyer L.C., 1986, CERAM ENG SCI P, V7, P914; SIMON G, 1984, J MATER SCI, V19, P3658, DOI 10.1007/BF00552278	12	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093			MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	FEB 15	2000	278	1-2					82	87				6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	276FU	WOS:000084865600012		
J	Song, DY; Takeda, N; Ogihara, S				Song, DY; Takeda, N; Ogihara, S			A method of stress analysis for interfacial properly evaluation in thermoplastic composites	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						stress analysis; interphase; thermoplastic composite; fiber surface treatment; interfacial strength; micro-grid method	FIBER; MATRIX	An analysis of stress transfer between the fiber and matrix in a single fiber reinforced composite which is useful to evaluate the effect of the properties of the interphase layer between the fibers and matrix is presented. The model is based on a concentric cylinder and considers an interphase surrounding the fiber to simulate a surface-treated layer as the product of processing conditions of short fiber reinforced thermoplastic composites. Stress and displacement fields in a single fiber composite under uniaxial tension in fiber direction are analyzed. The analysis presented here is used to predict the deformation of a short fiber in a thermoplastic composite. The analysis is compared with the experimental results obtained by using the micro-grid method. (C) 2000 Elsevier Science SIA. All rights reserved.	Univ Tokyo, Ctr Collaborat Res, Meguro Ku, Tokyo 1538904, Japan; Sci Univ Tokyo, Dept Mech Engn, Noda, Chiba 278, Japan	Song, DY (reprint author), Univ Tokyo, Ctr Collaborat Res, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						ASLOUN EM, 1989, J MATER SCI, V24, P1835, DOI 10.1007/BF01105713; CHON CT, 1980, J MATER SCI, V15, P931, DOI 10.1007/BF00552105; GRAY RJ, 1984, J MATER SCI, V19, P861, DOI 10.1007/BF00540456; MCCARTNEY LN, 1989, P ROY SOC LOND A MAT, V425, P215, DOI 10.1098/rspa.1989.0104; MIKATA Y, 1985, J APPL MECH, V52, P197; Song DY, 1996, COMPOS PART A-APPL S, V27, P357, DOI 10.1016/1359-835X(95)00037-3; SONG DY, 1994, THESIS U TOKYO; TAKEDA N, 1994, COMP INTERFACES, V2, P143; YIP HWC, 1976, J ADHESION, V8, P155, DOI 10.1080/00218467608075080	9	10	10	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093			MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	FEB 15	2000	278	1-2					242	246				5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	276FU	WOS:000084865600030		
J	Torizawa, T; Yamamoto, N; Suzuki, T; Nobuoka, K; Komatsu, Y; Morioka, H; Nikaido, O; Ohtsuka, E; Kato, K; Shimada, I				Torizawa, T; Yamamoto, N; Suzuki, T; Nobuoka, K; Komatsu, Y; Morioka, H; Nikaido, O; Ohtsuka, E; Kato, K; Shimada, I			DNA binding mode of the Fab fragment of a monoclonal antibody specific for cyclobutane pyrimidine dimer	NUCLEIC ACIDS RESEARCH			English	Article							VARIANT ANTIDANSYL ANTIBODIES; CARBONYL CARBON RESONANCES; NUCLEAR-MAGNETIC-RESONANCE; SPIN-LABEL ANTIBODY; THYMINE DIMERS; STRANDED-DNA; HYDROLYZING AUTOANTIBODIES; CRYSTAL-STRUCTURES; COMBINING SITE; SPECTROSCOPY	Monoclonal antibodies specific for the cyclobutane pyrimidine dimer (CPD) are widely used for detection and quantification of DNA photolesions. However, the mechanisms of antigen binding by anti-CPD antibodies are little understood. Here we report NMR analyses of antigen recognition by TDM-P, which is a mouse monoclonal antibody specific for the cis-syn-cyclobutane thymine dimer (T[c,s]T), P-31 NMR and surface plasmon resonance data indicated that the epitope recognized by TDM-P comprises hexadeoxy-nucleotides centered on the CPD, Chemical shift perturbations observed for TDM-P Fab upon binding to d(T[c,s]T) and d(TAT[c,s]TAT) were examined in order to identify the binding sites for these antigen analogs. It was revealed that d(T[c,s]T) binds to the central part of the antibody-combining site, while the CPD-flanking nucleotides bind to the positively charged area of the V-H domain via electrostatic interactions. By applying a novel NMR method utilizing a pair of spin-labeled DNA analogs, the orientation of DNA with respect to the antigen-binding site was determined: CPD-containing oligonucleotides bind to TDM-2 in a crooked form, draping the 3'-side of the nucleotides onto the H1 and H3 segments, with the 5'-side on the H2 and L3 segments. These data provide valuable information for antibody engineering of TDM-2.	Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan	Shimada, I (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.						ANGLISTER J, 1985, NATURE, V315, P65, DOI 10.1038/315065a0; MURATA T, 1990, NUCLEIC ACIDS RES, V18, P7279, DOI 10.1093/nar/18.24.7279; Sanders DB, 1999, J AM CHEM SOC, V121, P5127, DOI 10.1021/ja982660y; KAINOSHO M, 1982, BIOCHEMISTRY-US, V21, P6273, DOI 10.1021/bi00267a036; YAMAGUCHI Y, 1995, J IMMUNOL METHODS, V181, P259, DOI 10.1016/0022-1759(95)00010-8; MARTINEZYAMOUT M, 1994, J MOL BIOL, V244, P301, DOI 10.1006/jmbi.1994.1731; ANGLISTER J, 1984, BIOCHEMISTRY-US, V23, P1138, DOI 10.1021/bi00301a016; Gololobov GV, 1997, MOL IMMUNOL, V34, P1083, DOI 10.1016/S0161-5890(97)00129-6; SETLOW RB, 1978, NATURE, V271, P713, DOI 10.1038/271713a0; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; TAYLOR JS, 1987, J AM CHEM SOC, V109, P6735, DOI 10.1021/ja00256a030; BARRY MM, 1994, J BIOL CHEM, V269, P3623; BRAUN RP, 1987, J IMMUNOL, V139, P175; CONWAY NE, 1991, PRACTICAL APPROACH S, P211; DEJONG EAM, 1988, J MAGN RESON, V80, P197, DOI 10.1016/0022-2364(88)90291-0; Friedberg ED, 1995, DNA REPAIR MUTAGENES; GABIBOV AG, 1994, APPL BIOCHEM BIOTECH, V47, P293, DOI 10.1007/BF02787941; Gorenstein D. G., 1984, PHOSPHORUS 31 NMR PR, P7; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kalsi JK, 1996, MOL IMMUNOL, V33, P471, DOI 10.1016/0161-5890(95)00138-7; KATO K, 1989, J BIOCHEM-TOKYO, V105, P867; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; KATO K, 1991, BIOCHEMISTRY-US, V30, P270, DOI 10.1021/bi00215a037; Kobayashi H, 1998, PROTEIN ENG, V11, P1089, DOI 10.1093/protein/11.11.1089; Kobayashi H, 1998, J BIOCHEM-TOKYO, V123, P182; Komatsu Y, 1997, NUCLEIC ACIDS RES, V25, P3889, DOI 10.1093/nar/25.19.3889; MAHER VM, 1982, P NATL ACAD SCI-BIOL, V79, P2613, DOI 10.1073/pnas.79.8.2613; MIZUNO T, 1991, MUTAT RES, V254, P175, DOI 10.1016/0921-8777(91)90009-E; MOL CD, 1994, J BIOL CHEM, V269, P3605; MOL CD, 1994, J BIOL CHEM, V269, P3615; Nakagawa A, 1998, J INVEST DERMATOL, V110, P143, DOI 10.1046/j.1523-1747.1998.00100.x; POKKULURI PR, 1994, J MOL BIOL, V243, P283, DOI 10.1006/jmbi.1994.1654; Ramos A, 1998, J AM CHEM SOC, V120, P10992, DOI 10.1021/ja982496e; ROONGTA VA, 1990, BIOCHEMISTRY-US, V29, P5245, DOI 10.1021/bi00474a005; ROZA L, 1988, PHOTOCHEM PHOTOBIOL, V48, P627, DOI 10.1111/j.1751-1097.1988.tb02873.x; RYCYNA RE, 1988, BIOCHEMISTRY-US, V27, P3152, DOI 10.1021/bi00409a006; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; STOLLAR B D, 1975, Critical Reviews in Biochemistry, V3, P45; TAKAHASHI H, 1992, BIOCHEMISTRY-US, V31, P2464, DOI 10.1021/bi00124a005; THERIAULT TP, 1993, J PHYS CHEM-US, V97, P3034, DOI 10.1021/j100114a034; TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761; Torizawa T, 1999, J MOL BIOL, V290, P731, DOI 10.1006/jmbi.1999.2926; Torizawa T, 1998, FEBS LETT, V429, P157, DOI 10.1016/S0014-5793(98)00582-1; VONHIPPEL PH, 1986, DNA LIGAND INTERAC A, V137, P159	46	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048			NUCLEIC ACIDS RES	Nucleic Acids Res.	FEB 15	2000	28	4					944	951		10.1093/nar/28.4.944		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	284ZN	WOS:000085362900013		
J	Rosner, R; Forbes, TG; Uchida, Y; Pudritz, RE; Harra, L; Weiss, NO; Priest, ER				Rosner, R; Forbes, TG; Uchida, Y; Pudritz, RE; Harra, L; Weiss, NO; Priest, ER			Solar and stellar flares - Discussion	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Editorial Material									Univ Chicago, Chicago, IL 60637 USA; Univ Tokyo, Tokyo, Japan; UCL, Mullard Space Sci Lab, London WC1E 6BT, England; Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland	Rosner, R (reprint author), Univ Chicago, Chicago, IL 60637 USA.							0	0	0	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X			PHILOS T R SOC A	Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.	FEB 15	2000	358	1767					726	727				2	Multidisciplinary Sciences	Science & Technology - Other Topics	290HE	WOS:000085670200011		
J	Golub, L; Harra, L; Priest, ER; Uchida, Y; Pudritz, RE; Lynden-Bell, D				Golub, L; Harra, L; Priest, ER; Uchida, Y; Pudritz, RE; Lynden-Bell, D			Solar activity studies through coronal X-ray observations - Discussion	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland; Univ Tokyo, Tokyo, Japan; Queens Univ, Belfast, Antrim, North Ireland	Golub, L (reprint author), Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA.							0	0	0	ROYAL SOC LONDON	LONDON	6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X			PHILOS T ROY SOC A	Philos. Trans. R. Soc. Lond. Ser. A-Math. Phys. Eng. Sci.	FEB 15	2000	358	1767					654	655				2	Multidisciplinary Sciences	Science & Technology - Other Topics	290HE	WOS:000085670200003		
J	Gough, D; Parnell, CE; Golub, L; Hide, R; Siebenburgen, RV; Priest, ER; Uchida, Y; Kerr, R; Galsgaard, K				Gough, D; Parnell, CE; Golub, L; Hide, R; Siebenburgen, RV; Priest, ER; Uchida, Y; Kerr, R; Galsgaard, K			Magnetic reconnection and some solar applications - Discussion	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Editorial Material									Univ Cambridge, Cambridge CB2 1TN, England; Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland; Univ Tokyo, Tokyo, Japan; NCAR, Boulder, CO USA	Gough, D (reprint author), Univ Cambridge, Cambridge CB2 1TN, England.							0	0	0	ROYAL SOC LONDON	LONDON	6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X			PHILOS T ROY SOC A	Philos. Trans. R. Soc. Lond. Ser. A-Math. Phys. Eng. Sci.	FEB 15	2000	358	1767					686	688				3	Multidisciplinary Sciences	Science & Technology - Other Topics	290HE	WOS:000085670200007		
J	Shukurov, A; Pudritz, RE; Mirabel, IF; Uchida, Y; Roxburgh, IW; Barker, K; Lynden-Bell, D; Brandenburg, A; Blandford, RD				Shukurov, A; Pudritz, RE; Mirabel, IF; Uchida, Y; Roxburgh, IW; Barker, K; Lynden-Bell, D; Brandenburg, A; Blandford, RD			Jets from accretion discs - Discussion	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Editorial Material									Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; CEA Saclay, Gif Sur Yvette, France; Univ Tokyo, Tokyo, Japan; Univ London Queen Mary & Westfield Coll, London E1 4NS, England; Astron Inst, Cambridge, England; CALTECH, Pasadena, CA 91125 USA	Shukurov, A (reprint author), Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Brandenburg, Axel/I-6668-2013	Brandenburg, Axel/0000-0002-7304-021X			HEYVAERTS J, 1989, ASTROPHYS J, V347, P1055, DOI 10.1086/168195	1	0	0	ROYAL SOC LONDON	LONDON	6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X			PHILOS T ROY SOC A	Philos. Trans. R. Soc. Lond. Ser. A-Math. Phys. Eng. Sci.	FEB 15	2000	358	1767					756	758				3	Multidisciplinary Sciences	Science & Technology - Other Topics	290HE	WOS:000085670200015		
J	Pudritz, RE; Brandenburg, A; Hughes, DW; Uchida, Y; Horne, K; Priest, ER; Falle, S				Pudritz, RE; Brandenburg, A; Hughes, DW; Uchida, Y; Horne, K; Priest, ER; Falle, S			Dynamo-generated turbulence and outflows from accretion discs - Discussion	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Editorial Material									Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; Univ Tokyo, Tokyo, Japan; Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland			Brandenburg, Axel/I-6668-2013	Brandenburg, Axel/0000-0002-7304-021X				0	0	0	ROYAL SOC LONDON	LONDON	6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X			PHILOS T ROY SOC A	Philos. Trans. R. Soc. Lond. Ser. A-Math. Phys. Eng. Sci.	FEB 15	2000	358	1767					774	776				3	Multidisciplinary Sciences	Science & Technology - Other Topics	290HE	WOS:000085670200017		
J	Lynden-Bell, D; Blandford, RD; Falle, S; Mirabel, IF; Uchida, Y; Shukurov, A; Priest, ER; Mestel, L				Lynden-Bell, D; Blandford, RD; Falle, S; Mirabel, IF; Uchida, Y; Shukurov, A; Priest, ER; Mestel, L			Quasar jets and their fields - Discussion	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Editorial Material									Inst Astron, Cambridge, England; Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; CEA Saclay, Gif Sur Yvette, France; Univ Tokyo, Tokyo, Japan; Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland; Univ New Hampshire, Durham, NH 03824 USA	Lynden-Bell, D (reprint author), Inst Astron, Cambridge, England.						BLANDFORD RD, 2000, UNPUB	1	0	0	ROYAL SOC LONDON	LONDON	6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X			PHILOS T ROY SOC A	Philos. Trans. R. Soc. Lond. Ser. A-Math. Phys. Eng. Sci.	FEB 15	2000	358	1767					827	829				3	Multidisciplinary Sciences	Science & Technology - Other Topics	290HE	WOS:000085670200023		
J	Amo, Y; Tominaga, Y				Amo, Y; Tominaga, Y			Low-frequency Raman study of water isotopes	PHYSICA A			English	Article						random telegraph process; low-frequency Raman scattering; water	LIQUID WATER; LIGHT-SCATTERING; SUPERCOOLED WATER; AQUEOUS-SOLUTIONS; HEAVY-WATER; DYNAMICS; ABSORPTION; RELAXATION; SPECTRUM; MODEL	Depolarized low-frequency Raman spectra of H2O, D2O, (H2O)-O-18, and (D2O)-O-18 are measured from 266 to 350 K. The reduced Raman spectra below 250 cm(-1) are reproduced by a superposition of one relaxation mode and two damped harmonic oscillators. The multiple random telegraph model, which takes into account the inertia and memory effects is applied to analyze the central relaxation component. The 180 cm(-1) mode corresponds to vibration of the oxygen atom, The hydrogen isotopes affect the relaxation time causing its variation. The relaxation time is considered to correspond to the duration of fluctuation of the local structure in liquid water. The intensity of the 50 cm(-1) mode decreases with increasing temperature and finally vanishes above about 300-310 K, The 50 cm(-1) mode can be distinguished from the relaxation mode when the relaxation time is more than five times longer than the period of the 50 cm(-1) vibration mode. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo, Japan; Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Tominaga, Y (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo, Japan.						ABDRAKHMANOV BM, 1990, CHEM PHYS, V143, P297, DOI 10.1016/0301-0104(90)89107-2; ALIOTTA F, 1986, J CHEM PHYS, V84, P4731, DOI 10.1063/1.450007; HASTED JB, 1985, CHEM PHYS LETT, V118, P622, DOI 10.1016/0009-2614(85)85366-5; MIZOGUCHI K, 1992, J CHEM PHYS, V97, P1961, DOI 10.1063/1.463133; CHANG YJ, 1993, J CHEM PHYS, V99, P7289, DOI 10.1063/1.465710; Walrafen GE, 1996, J PHYS CHEM-US, V100, P10363, DOI 10.1021/jp960140o; CASTNER EW, 1995, J CHEM PHYS, V102, P653, DOI 10.1063/1.469177; KRISHNAMURTHY S, 1983, J CHEM PHYS, V79, P5863, DOI 10.1063/1.445756; WALRAFEN GE, 1986, J CHEM PHYS, V85, P6970, DOI 10.1063/1.451384; Palese S, 1996, J PHYS CHEM-US, V100, P10380, DOI 10.1021/jp960266l; BELLISSENTFUNEL MC, 1995, PHYS REV E, V51, P4558, DOI 10.1103/PhysRevE.51.4558; BROOKER MH, 1981, J CHEM PHYS, V74, P2795, DOI 10.1063/1.441450; BROOKER MH, 1989, J RAMAN SPECTROSC, V20; CONDE O, 1983, J PHYS, V44, P523; CONDE O, 1984, MOL PHYS, V53, P951, DOI 10.1080/00268978400102761; Kauzmann W., 1969, STRUCTURE PROPERTIES; McConnell J. R., 1980, ROTATIONAL BROWNIAN; Mizoguchi K, 1998, J CHEM PHYS, V109, P1867, DOI 10.1063/1.476763; MONTROSE CJ, 1974, J CHEM PHYS, V60, P5025, DOI 10.1063/1.1681017; NIELSEN OF, 1985, J CHEM PHYS, V82, P1183, DOI 10.1063/1.448491; Nielsen O. F., 1979, Chemical Physics Letters, V60, DOI 10.1016/0009-2614(79)80625-9; NIELSEN OF, 1989, J RAMAN SPECTROSC, V20, P221, DOI 10.1002/jrs.1250200405; OHMINE I, 1995, J PHYS CHEM-US, V99, P6767, DOI 10.1021/j100018a004; RICCI MA, 1990, J PHYS-CONDENS MAT, V2, pSA183; SHIBATA F, 1989, PHYSICA A, V161, P42, DOI 10.1016/0378-4371(89)90389-0; Ujike T, 1999, J CHEM PHYS, V110, P1558, DOI 10.1063/1.477797; WALRAFEN GE, 1990, J PHYS CHEM-US, V94, P2237, DOI 10.1021/j100369a008; Wang Y, 1996, J CHEM PHYS, V104, P1, DOI 10.1063/1.470868; WANG Y, 1994, J CHEM PHYS, V101, P3453, DOI 10.1063/1.467530	29	20	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371			PHYSICA A	Physica A	FEB 15	2000	276	3-4					401	412		10.1016/S0378-4371(99)00457-4		12	Physics, Multidisciplinary	Physics	282PQ	WOS:000085227600004		
J	Hoshi, K; Hatsugai, Y				Hoshi, K; Hatsugai, Y			Landau levels from the Bethe Ansatz equations	PHYSICAL REVIEW B			English	Article							HOFSTADTER PROBLEM; WAVE-FUNCTIONS; MAGNETIC-FIELDS; BLOCH ELECTRONS; QUANTUM GROUP	The Bethe ansatz (BA) equations for the two-dimensional Bloch electrons in a uniform magnetic field are treated in the weak-field limit. We have calculated energies near the lower boundary of the energy spectrum up to the first nontrivial order. It corresponds to calculating a finite size correction for the excitation energies of the BA solvable lattice models and gives the Landau levels in the present problem.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Hoshi, K (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	hatsugai@coral.t.u-tokyo.ac.jp	Hatsugai, Yasuhiro/G-3793-2010	Hatsugai, Yasuhiro/0000-0001-6933-5552			Abanov AG, 1998, NUCL PHYS B, V525, P571, DOI 10.1016/S0550-3213(98)00346-0; Abanov AG, 1998, PHYS REV LETT, V81, P2112, DOI 10.1103/PhysRevLett.81.2112; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; HATSUGAI Y, 1993, PHYS REV LETT, V71, P3697, DOI 10.1103/PhysRevLett.71.3697; HIRAMOTO H, 1992, INT J MOD PHYS B, V6, P281, DOI 10.1142/S0217979292000153; THOULESS DJ, 1983, PHYS REV B, V28, P4272, DOI 10.1103/PhysRevB.28.4272; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; FADDEEV LD, 1995, COMMUN MATH PHYS, V169, P181, DOI 10.1007/BF02101600; HATSUGAI Y, 1993, PHYS REV B, V48, P14851; Hatsugai Y, 1996, PHYS REV B, V53, P9697, DOI 10.1103/PhysRevB.53.9697; HATSUGAI Y, 1994, PHYS REV LETT, V73, P1134, DOI 10.1103/PhysRevLett.73.1134; Krasovsky IV, 1999, PHYS REV B, V59, P322, DOI 10.1103/PhysRevB.59.322; Shapere A., 1989, GEOMETRIC PHASES PHY; Wiegmann P. B., 1994, Modern Physics Letters B, V8, DOI 10.1142/S0217984994000315; WIEGMANN PB, 1994, NUCL PHYS B, V422, P495, DOI 10.1016/0550-3213(94)90443-X; WIEGMANN PB, 1999, PROG THEOR PHYS SUPP, V134, P171, DOI 10.1143/PTPS.134.171; WIEGMANN PB, 1994, PHYS REV LETT, V72, P1890, DOI 10.1103/PhysRevLett.72.1890; ZAK J, 1964, PHYS REV, V134, P1602	18	5	5	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	2000	61	7					4409	4412		10.1103/PhysRevB.61.4409		4	Physics, Condensed Matter	Physics	287GB	WOS:000085497200010		
J	Hikami, K				Hikami, K			Unified approach to quasi-particle excitations in the edge states of paired Hall states	PHYSICAL REVIEW B			English	Article							CONFORMAL FIELD-THEORY; LONG-RANGE INTERACTIONS; QUANTUM HALL; EXCLUSION STATISTICS; YANGIAN SYMMETRY; CHARACTER; ALGEBRA; LEVEL; SPIN	We consider the edge states of the quantum Hall paired states,which were introduced as the ground-state wave function for v = 5/2. We propose that the paired Hall states such as the Haldane-Rezayi state and the Pfaffian state have the supersymmetry, and we clarify the exclusion statistics of the quasi-particle excitations. By use of an idea of the "restricted partition function" for the quasi-particle excitations and its relationship with the q-special functions, we explicitly compute the distribution functions for the quasi-particle. We;also calculate the specific heat and show that our results coincide with previously reported results based on the conformal field theory. We further show that there is a duality between the Pfaffian state and the Haldane-Rezayi state.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Hikami, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						Andrews George E., 1976, THEORY PARTITIONS; LAUGHLIN RB, 1983, PHYS REV LETT, V50, P1395, DOI 10.1103/PhysRevLett.50.1395; Schoutens K, 1997, PHYS REV LETT, V79, P2608, DOI 10.1103/PhysRevLett.79.2608; WEN XG, 1994, NUCL PHYS B, V422, P476; HALDANE FDM, 1988, PHYS REV LETT, V60, P956, DOI 10.1103/PhysRevLett.60.956; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; Guruswamy S, 1998, NUCL PHYS B, V519, P661, DOI 10.1016/S0550-3213(98)00059-5; Morf RH, 1998, PHYS REV LETT, V80, P1505, DOI 10.1103/PhysRevLett.80.1505; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Schoutens K, 1998, PHYS REV LETT, V81, P1929, DOI 10.1103/PhysRevLett.81.1929; WEN XG, 1990, PHYS REV LETT, V64, P2206, DOI 10.1103/PhysRevLett.64.2206; HALDANE FDM, 1992, PHYS REV LETT, V69, P2021, DOI 10.1103/PhysRevLett.69.2021; Bouwknegt P, 1999, NUCL PHYS B, V547, P501, DOI 10.1016/S0550-3213(99)00095-4; HALDANE FDM, 1991, PHYS REV LETT, V67, P937, DOI 10.1103/PhysRevLett.67.937; BOUWKNEGT P, 1994, PHYS LETT B, V338, P448, DOI 10.1016/0370-2693(94)90799-4; Nayak C, 1996, NUCL PHYS B, V479, P529, DOI 10.1016/0550-3213(96)00430-0; Milovanovic M, 1996, PHYS REV B, V53, P13559, DOI 10.1103/PhysRevB.53.13559; BERKOVICH A, 1999, STAT PHYSICS EVE 21, P240; BERNARD D, 1994, NUCL PHYS B, V428, P612, DOI 10.1016/0550-3213(94)90366-2; Das Sarma S., 1997, PERSPECTIVES QUANTUM; DIFRANCESCO P, 1997, CONFORMAL FIELD THER; Gurarie V, 1997, NUCL PHYS B, V498, P513, DOI 10.1016/S0550-3213(97)00351-9; HIKAMI K, 1995, NUCL PHYS B, V441, P530, DOI 10.1016/0550-3213(95)00035-Q; HIKAMI K, IN PRESS NUCL PHYS B; HIKAMI K, 1995, PHYS LETT A, V205, P364, DOI 10.1016/0375-9601(95)00606-4; Hikami K, 1998, PHYS REV LETT, V80, P4374, DOI 10.1103/PhysRevLett.80.4374; ISO S, 1995, NUCL PHYS B, V443, P581, DOI 10.1016/0550-3213(95)00135-F; Macdonald I. G., 1995, SYMMETRIC FUNCTIONS; SCHOUTENS K, 1987, PHYS LETT B, V194, P75, DOI 10.1016/0370-2693(87)90772-6; TSUI DC, 1982, PHYS REV LETT, V48, P1559, DOI 10.1103/PhysRevLett.48.1559; van Elburg RAJ, 1998, PHYS REV B, V58, P15704, DOI 10.1103/PhysRevB.58.15704; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776; WU YS, 1995, PHYS REV LETT, V75, P890, DOI 10.1103/PhysRevLett.75.890	33	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	2000	61	7					4473	4476		10.1103/PhysRevB.61.4473		4	Physics, Condensed Matter	Physics	287GB	WOS:000085497200026		
J	Yasuhira, T; Uchida, K; Matsuda, YH; Miura, N; Twardowski, A				Yasuhira, T; Uchida, K; Matsuda, YH; Miura, N; Twardowski, A			Giant Faraday rotation spectra of Zn1-xMnxSe observed in high magnetic fields up to 150 T	PHYSICAL REVIEW B			English	Article							OPTICAL-TRANSITION; MN2+ IONS; SEMICONDUCTORS; CD1-XMNXTE	We have observed interesting features in the energy and field dependencies of Faraday rotation spectra in Zn1-xMnxSe under high magnetic fields up to 150 T. Continuous magneto-optical spectra were measured on a two-dimensional plane as a function of magnetic field and photon energy. As the rotation angle is obtained as continuous lines on the plane, we can detect any small change of the Faraday rotation, such as the stepwise small increase corresponding to the crossover of the magnetic energy levels of Mn ion pairs. In a sample with a relatively low Mn concentration (x = 0.015), we found that the sign of the field coefficient of the Faraday rotation is reversed at some field due to the competition between the paramagnetic component due to the magnetization of Mn ions and the diamagnetic component due to the interband transition in the matrix crystal. We also found that the diamagnetic part in high fields shows a peculiar energy dependence, taking a minimum around 2.4 eV. This result suggests that the diamagnetic part is determined not only by the interband transition but also by the d-d transition in Mn ions. The magnetic-field dependence of the diamagnetic part showed a kinklike behavior at around B = 80 T.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland	Yasuhira, T (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan.						AGGARWAL RL, 1985, PHYS REV B, V32, P5132, DOI 10.1103/PhysRevB.32.5132; GAJ JA, 1979, SOLID STATE COMMUN, V29, P435, DOI 10.1016/0038-1098(79)91211-0; BARTHOLOMEW DU, 1986, PHYS REV B, V34, P6943, DOI 10.1103/PhysRevB.34.6943; LEE YR, 1988, PHYS REV B, V38, P10600, DOI 10.1103/PhysRevB.38.10600; BOSWARVA IM, 1962, PROC R SOC LON SER-A, V269, P125, DOI 10.1098/rspa.1962.0166; BOSWARVA IM, 1964, PROC R SOC LON SER-A, V278, P588, DOI 10.1098/rspa.1964.0084; EBINA A, 1965, J PHYS CHEM SOLIDS, V26, P1497; EUNSOON C, 1990, PHYS REV B, V42, P5201; FONER S, 1989, PHYS REV B, V39, P11793, DOI 10.1103/PhysRevB.39.11793; Furdyna J.K., 1988, J APPL PHYS R, V29, P64; GAJ JA, 1978, SOLID STATE COMMUN, V25, P193, DOI 10.1016/0038-1098(78)91477-1; ISSACS ED, 1991, PHYS REV B, V43, P3351; JIMENEZGONZALEZ HJ, 1992, PHYS REV B, V45, P14011, DOI 10.1103/PhysRevB.45.14011; KOLODZIEJCZAK J, 1962, PHYS REV, V128, P2655, DOI 10.1103/PhysRev.128.2655; LASCARAY JP, 1987, SOLID STATE COMMUN, V61, P401, DOI 10.1016/0038-1098(87)90595-3; LEE YR, 1986, PHYS REV B, V33, P7383, DOI 10.1103/PhysRevB.33.7383; Masterson HJ, 1997, J APPL PHYS, V81, P799, DOI 10.1063/1.365553; MIURA N, 1994, PHYSICA B, V201, P40, DOI 10.1016/0921-4526(94)91047-2; NIKITIN PI, 1993, IEEE T MAGN, V29, P3422, DOI 10.1109/20.281183; SAVCHUK AI, 1992, IEEE T MAGN, V28, P3246, DOI 10.1109/20.179773; Vatamanyuk P. P., 1988, Soviet Physics - JETP, V67; YASUHIRA T, 1998, P 24 INT C PHYS SEM; Yasuhira T, 1999, J PHYS SOC JPN, V68, P3436, DOI 10.1143/JPSJ.68.3436; Zheng YX, 1997, J APPL PHYS, V81, P5154, DOI 10.1063/1.365153	24	10	10	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	2000	61	7					4685	4688		10.1103/PhysRevB.61.4685		4	Physics, Condensed Matter	Physics	287GB	WOS:000085497200064		
J	Yamanaka, T; Ino, S				Yamanaka, T; Ino, S			Surface electron standing waves and adatom heights on Si(111)-root 3 X root 3-(Ga,In,Sn) surfaces	PHYSICAL REVIEW B			English	Article							RAY SPECTROSCOPY; DIFFRACTION; RHEED; SN/GE(111); STATES; PHASE; ATOMS	GaK and SnL x-ray emissions from Si(111)-root 3x root 3-Ga and -Sn surfaces induced by irradiation of an electron beam were measured as functions of the incident glancing angle. By analyzing anomalous x-ray intensities under Bragg conditions, which are due to the formation of electron standing waves, the heights of Ga and Sn were determined. Compared with the previous result for Si(111)-root 3x root 3-In structures, the height of Sn was found to be higher than that of In, although their atomic numbers and covalent radii are very close. The effects of atomic size and electronic structures on adatom height will be discussed.	Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 113, Japan	Yamanaka, T (reprint author), Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0600811, Japan.	yama@cat.hokudai.ac.jp					KEATING PN, 1966, PHYS REV, V145, P637, DOI 10.1103/PhysRev.145.637; MAKSYM PA, 1981, SURF SCI, V110, P423, DOI 10.1016/0039-6028(81)90649-X; TAFTO J, 1982, PHYS REV LETT, V48, P560, DOI 10.1103/PhysRevLett.48.560; GOLOVCHENKO JA, 1982, PHYS REV LETT, V49, P560, DOI 10.1103/PhysRevLett.49.560; HASEGAWA S, 1985, JPN J APPL PHYS 2, V24, pL387, DOI 10.1143/JJAP.24.L387; NICHOLLS JM, 1985, PHYS REV B, V32, P1333, DOI 10.1103/PhysRevB.32.1333; TAFTO J, 1983, PHYS REV LETT, V51, P654, DOI 10.1103/PhysRevLett.51.654; Carpinelli JM, 1996, NATURE, V381, P398, DOI 10.1038/381398a0; Avila J, 1999, PHYS REV LETT, V82, P442, DOI 10.1103/PhysRevLett.82.442; BATTERMA.BW, 1969, PHYS REV LETT, V22, P703, DOI 10.1103/PhysRevLett.22.703; Carpinelli JM, 1997, PHYS REV LETT, V79, P2859, DOI 10.1103/PhysRevLett.79.2859; CONWAY KM, 1989, SURF SCI, V215, P555, DOI 10.1016/0039-6028(89)90275-6; COWAN PL, 1980, PHYS REV LETT, V44, P1680, DOI 10.1103/PhysRevLett.44.1680; HANADA T, 1995, PHYS REV B, V51, P13320, DOI 10.1103/PhysRevB.51.13320; ICHIMIYA A, 1983, JPN J APPL PHYS 1, V22, P176, DOI 10.1143/JJAP.22.176; Kidd TE, 1999, PHYS REV LETT, V83, P2789, DOI 10.1103/PhysRevLett.83.2789; MARTINEZ RE, 1992, PHYS REV LETT, V69, P1061, DOI 10.1103/PhysRevLett.69.1061; MCRAE EG, 1979, REV MOD PHYS, V51, P541, DOI 10.1103/RevModPhys.51.541; MITURA Z, 1993, PHYS REV LETT, V70, P2904, DOI 10.1103/PhysRevLett.70.2904; NEWBURY DE, 1986, ADV SCANNING ELECT M, P3; NICHOLLS JM, 1987, PHYS REV B, V35, P4137, DOI 10.1103/PhysRevB.35.4137; NOGAMI J, 1989, J VAC SCI TECHNOL A, V7, P1919, DOI 10.1116/1.576029; NOGAMI J, 1988, SURF SCI, V203, pL631, DOI 10.1016/0039-6028(88)90182-3; PAULING L, 1960, NATURE CHEM BOND; SHIMIZU R, 1983, JPN J APPL PHYS 1, V22, P1631, DOI 10.1143/JJAP.22.1631; SPENCE JCH, 1983, J MICROSC-OXFORD, V130, P147; SPENCE JCH, 1987, RHEED REFLECTION ELE, P117; Uhrberg RIG, 1998, PHYS REV LETT, V81, P2108, DOI 10.1103/PhysRevLett.81.2108; WOICIK JC, 1993, PHYS REV LETT, V71, P1204, DOI 10.1103/PhysRevLett.71.1204; YAMANAKA T, 1995, PHYS REV LETT, V75, P669, DOI 10.1103/PhysRevLett.75.669; YAMANAKA T, 1993, SURF SCI, V294, P53, DOI 10.1016/0039-6028(93)90158-G; ZEGENHAGEN J, 1989, PHYS REV B, V39, P1298, DOI 10.1103/PhysRevB.39.1298	32	13	13	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	2000	61	8					R5074	R5077		10.1103/PhysRevB.61.R5074		4	Physics, Condensed Matter	Physics	290ZD	WOS:000085707000006		
J	Chodos, A; Cooper, F; Mao, WJ; Minakata, H; Singh, A				Chodos, A; Cooper, F; Mao, WJ; Minakata, H; Singh, A			Two-dimensional model with chiral condensates and Cooper pairs having a QCD-like phase structure	PHYSICAL REVIEW D			English	Article							GROSS-NEVEU MODEL; FINITE-TEMPERATURE; COLOR SUPERCONDUCTIVITY; SYMMETRY-BREAKING; FIELD-THEORIES; 2 DIMENSIONS; DENSITY; TRANSITION; BEHAVIOR; MATTER	We generalize our previous model to an O(N) symmetric two-dimensional model which possesses chiral symmetry breaking ([<(psi)over bar>psi] condensate) and superconducting (Cooper pair [psi psi] condensates) phases at large N. At zero temperature and density, the model can be solved analytically in the large-N limit. We perform the renormalization explicitly and obtain a closed form expression of the effective potential. There exists a renormalization group invariant parameter delta that determines which of the [<(psi)over bar>psi] (delta>0) or [psi psi] (delta<0) condensates exist in the vacuum. At finite temperatures and densities, we map out the phase structure of the model by a detailed numerical analysis of the renormalized effective potential. For delta positive and sufficiently large, the phase diagram in the mu-T (chemical potential-temperature) plane exactly mimics the features expected for QCD with two light flavors of quarks. At low temperatures there exists low-mu, chiral symmetry breaking and high-mu Cooper pair condensate regions which are separated by a first-order phase transition. At high mu, when the temperature is raised, the system undergoes a second-order phase transition from the superconducting phase to an unbroken phase in which both condensates vanish. For a range of values of delta the theory possesses a tricritical point (mu(tc), and T-tc); for mu > mu(tc) (mu < mu(tc)) the phase transition from the low temperature chiral symmetry breaking phase to unbroken phase is first order (second order). For the range of delta in which the system mimics QCD, we expect the model to be useful for the investigation of dynamical aspects of nonequilibrium phase transitions, and to provide information relevant to the study of relativistic heavy ion collisions and the dense interiors of neutron stars.	Yale Univ, Dept Phys, New Haven, CT 06520 USA; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; Tokyo Metropolitan Univ, Dept Phys, Tokyo 1920397, Japan; Univ Tokyo, Inst Cosm Ray Res, Res Ctr Cosm Neutrinos, Tokyo 1888502, Japan	Chodos, A (reprint author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	alan.chodos@yale.edu; cooper@schwinger.lanl.gov; maow@physics.bc.edu; minakata@phys.metro-u.ac.jp; singh@lanl.gov					Alford M, 1998, NUCL PHYS A, V638, p515C, DOI 10.1016/S0375-9474(98)00350-9; HUBBARD J, 1959, PHYS REV LETT, V3, P77, DOI 10.1103/PhysRevLett.3.77; Cooper F, 1996, PHYS REV C, V54, P3298, DOI 10.1103/PhysRevC.54.3298; BAILIN D, 1984, PHYS REP, V107, P325, DOI 10.1016/0370-1573(84)90145-5; WITTEN E, 1978, NUCL PHYS B, V145, P110, DOI 10.1016/0550-3213(78)90416-9; Alford M, 1998, PHYS LETT B, V422, P247, DOI 10.1016/S0370-2693(98)00051-3; DOLAN L, 1974, PHYS REV D, V9, P3320, DOI 10.1103/PhysRevD.9.3320; Alford M, 1999, NUCL PHYS B, V537, P443, DOI 10.1016/S0550-3213(98)00668-3; HABER HE, 1982, PHYS REV D, V25, P502, DOI 10.1103/PhysRevD.25.502; Rapp R, 1998, PHYS REV LETT, V81, P53, DOI 10.1103/PhysRevLett.81.53; Berges J, 1999, NUCL PHYS B, V538, P215, DOI 10.1016/S0550-3213(98)00620-8; COLEMAN S, 1973, COMMUN MATH PHYS, V31, P259, DOI 10.1007/BF01646487; IWASAKI M, 1995, PHYS LETT B, V350, P163, DOI 10.1016/0370-2693(95)00322-C; PISARSKI RD, 1984, PHYS REV D, V29, P338, DOI 10.1103/PhysRevD.29.338; GROSS DJ, 1974, PHYS REV D, V10, P3235, DOI 10.1103/PhysRevD.10.3235; BARDUCCI A, 1994, PHYS REV D, V49, P426, DOI 10.1103/PhysRevD.49.426; Chodos A, 1997, NUCL PHYS B, V490, P687, DOI 10.1016/S0550-3213(97)00094-1; CHODOS A, 1994, PHYS LETT A, V191, P39, DOI 10.1016/0375-9601(94)90557-6; Chodos A, 1999, PHYS LETT B, V449, P260, DOI 10.1016/S0370-2693(99)00084-2; COLEMAN S, 1985, ASPECTS SYMMETRY, P354; Evans N, 1999, PHYS LETT B, V449, P281, DOI 10.1016/S0370-2693(99)00093-3; Evans N, 1999, NUCL PHYS B, V551, P275, DOI 10.1016/S0550-3213(99)00175-3; HARRINGTON BJ, 1975, PHYS REV D, V11, P779, DOI 10.1103/PhysRevD.11.779; INAGAKI T, 1995, P 4 WORKSH THERM FIE, P121; JACOBS L, 1974, PHYS REV D, V10, P3956, DOI 10.1103/PhysRevD.10.3956; KENNEDY M, 1996, PHYS REV D, V54, P2213; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; OJIMA I, RIFP267; RAJAGOPAL K, HEPPH9908360; Schafer T, 1999, PHYS LETT B, V450, P325, DOI 10.1016/S0370-2693(99)00162-8; Schafer T, 1999, PHYS REV LETT, V82, P3956, DOI 10.1103/PhysRevLett.82.3956; Schafer T., 1998, Nuclear Physics A, VA642, DOI 10.1016/S0375-9474(98)00497-7; Stratonovich R., 1957, SOV PHYS DOKL, V2, P416; WOLFF U, 1985, PHYS LETT B, V157, P303, DOI 10.1016/0370-2693(85)90671-9	34	33	35	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	FEB 15	2000	61	4							045011	10.1103/PhysRevD.61.045011		12	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	285HG	WOS:000085383200046		
J	Kasuya, S; Kawasaki, M				Kasuya, S; Kawasaki, M			Q-ball formation through the Affleck-Dine mechanism	PHYSICAL REVIEW D			English	Article							DARK-MATTER; STANDARD MODEL; BARYOGENESIS; SOLITONS; MSSM	We present the full nonlinear calculation of the formation of a Q ball through the Affleck-Dine (AD) mechanism by numerical simulations. It is shown that large Q balls are actually produced by the fragmentation of the condensate of a scalar field whose potential is very flat. We find that the typical size of a Q ball is determined by the most developed mode of linearized fluctuations, and almost all the initial charges which the AD condensate carries are absorbed into the formed Q balls, whose sizes and the charges depend only on the initial charge densities.	Ochanomizu Univ, Dept Phys, Bunkyo Ku, Tokyo 1128610, Japan; Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	Kasuya, S (reprint author), Ochanomizu Univ, Dept Phys, Bunkyo Ku, Tokyo 1128610, Japan.						AFFLECK I, 1985, NUCL PHYS B, V249, P361, DOI 10.1016/0550-3213(85)90021-5; Laine M, 1998, NUCL PHYS B, V532, P376, DOI 10.1016/S0550-3213(98)00474-X; Enqvist K, 1999, NUCL PHYS B, V538, P321, DOI 10.1016/S0550-3213(98)00695-6; Khlebnikov SY, 1996, PHYS REV LETT, V77, P219, DOI 10.1103/PhysRevLett.77.219; COLEMAN S, 1985, NUCL PHYS B, V262, P263, DOI 10.1016/0550-3213(85)90286-X; Kusenko A, 1998, PHYS LETT B, V418, P46, DOI 10.1016/S0370-2693(97)01375-0; Kusenko A, 1997, PHYS LETT B, V405, P108, DOI 10.1016/S0370-2693(97)00584-4; Dine M, 1996, NUCL PHYS B, V458, P291, DOI 10.1016/0550-3213(95)00538-2; Kusenko A, 1998, PHYS REV LETT, V80, P3185, DOI 10.1103/PhysRevLett.80.3185; Kusenko A, 1997, PHYS LETT B, V404, P285, DOI 10.1016/S0370-2693(97)00582-0; Enqvist K, 1998, PHYS LETT B, V425, P309, DOI 10.1016/S0370-2693(98)00271-8; Dvali G, 1998, PHYS LETT B, V417, P99, DOI 10.1016/S0370-2693(97)01378-6; COHEN A, 1986, NUCL PHYS B, V272, P301, DOI 10.1016/0550-3213(86)90004-0; Enqvist K, 1998, PHYS REV LETT, V81, P3071, DOI 10.1103/PhysRevLett.81.3071; ENQVIST K, HEPPH9908316; Enqvist K, 1998, PHYS LETT B, V440, P59, DOI 10.1016/S0370-2693(98)01078-8; Kasuya S., UNPUB; KHLEBNIKOV S, HEPPH9902272; Kusenko A, 1998, PHYS LETT B, V423, P104, DOI 10.1016/S0370-2693(98)00133-6	19	153	153	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	FEB 15	2000	61	4							041301	10.1103/PhysRevD.61.041301		4	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	285HG	WOS:000085383200001		
J	Nagai, T; Aruga, J; Minowa, O; Sugimoto, T; Ohno, Y; Noda, T; Mikoshiba, K				Nagai, T; Aruga, J; Minowa, O; Sugimoto, T; Ohno, Y; Noda, T; Mikoshiba, K			Zic2 regulates the kinetics of neurulation	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							SONIC-HEDGEHOG; MOUSE ZIC1; GENE; MUTATIONS; EMBRYOS; PATTERN; FAMILY	Mutation in human ZIC2, a zinc finger protein homologous to Drosophila odd-paired, causes holoprosencephaly (HPE), which is a common, severe malformation of the brain in humans. However, the pathogenesis is largely unknown. Here we show that reduced expression (knockdown) of mouse Zic2 causes neurulation delay, resulting in HPE and spina bifida. Differentiation of the most dorsal neural plate, which gives rise to both roof plate and neural crest cells, also was delayed as indicated by the expression lag of a roof plate marker, Wnt3a, In addition the development of neural crest derivatives such as dorsal root ganglion was impaired. These results suggest that the Zic2 expression level is crucial for the timing of neurulation, Because the Zic2 knockdown mouse is the first mutant with HPE and spina bifida to survive to the perinatal period, the mouse will promote analyses of not only the neurulation but also the pathogenesis of human HPE.	RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; RIKEN, Tsukuba Life Sci Ctr, Mol Neurobiol Lab, Tsukuba, Ibaraki 3050074, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Toshima Ku, Tokyo 1708455, Japan; Univ Tsukuba, Div Res Facilitat, Tsukuba, Ibaraki 3058577, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan	Aruga, J (reprint author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Aruga, Jun/H-5837-2011				Saito T, 1996, DEV BIOL, V180, P143, DOI 10.1006/dbio.1996.0291; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; STUART ET, 1994, ANNU REV GENET, V28, P219; BROWN S, 1995, AM J HUM GENET, V57, P859; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Aruga J, 1998, J NEUROSCI, V18, P284; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Aruga J, 1996, J BIOL CHEM, V271, P1043; Brewster R, 1998, NATURE, V393, P579; Edmonds L D, 1990, MMWR CDC Surveill Summ, V39, P19; Green MR, 1989, CURR OPIN CELL BIOL, V1, P519, DOI 10.1016/0955-0674(89)90014-8; Hogan B, 1994, MANIPULATING MOUSE E; Ming JE, 1998, CLIN GENET, V53, P155; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; SUZUKI A, 1994, BIOCHEM J, V298, P275; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; VANSTRAATEN HWM, 1993, DEVELOPMENT, V117, P1163	21	152	155	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 15	2000	97	4					1618	1623		10.1073/pnas.97.4.1618		6	Multidisciplinary Sciences	Science & Technology - Other Topics	285VU	WOS:000085409600061		
J	Sugiura, I; Nureki, O; Ugaji-Yoshikawa, Y; Kuwabara, S; Shimada, A; Tateno, M; Lorber, B; Giege, R; Moras, D; Yokoyama, S; Konno, M				Sugiura, I; Nureki, O; Ugaji-Yoshikawa, Y; Kuwabara, S; Shimada, A; Tateno, M; Lorber, B; Giege, R; Moras, D; Yokoyama, S; Konno, M			The 2.0 angstrom crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules	STRUCTURE WITH FOLDING & DESIGN			English	Article						methionyl-tRNA synthetase; RNA-binding molecule; Rossmann fold; Thermus thermophilus; tRNA	SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ZINC-BINDING; ANTICODON RECOGNITION; EXTREME THERMOPHILE; PROTEIN; ADENYLATE; DOMAIN; ACID; RESOLUTION	Background: The 20 aminoacyl-tRNA synthetases are divided into two classes, I and II. The 10 Glass I synthetases are considered to have in common:the: catalytic domain structure based on the Rossmann fold, which is totally different from the class II catalytic domain structure. The class I synthetases are further divided,into three subclasses, a, b and c, according to sequence homology: No conserved structural features for tRNA recognition by class I synthetases have been established. Results: We determined the crystal structure of the class la methionyl-tRNA synthetase (MetRS) at 2.0 Angstrom resolution, using MetRS from an extreme thermophile, Thermus thermophilus HB8. The T. thermophilus MetRS structure is in full agreement with the biochemical and genetic data from Escherichia coli MetRS. The conserved 'anticodon-binding' residues are spatially clustered on an a-helix-bundle domain. The Rossmann-fold and anticodon-binding: domains are connected by a beta-alpha-alpha-beta-alpha topology ('SC fold') domain that contains the class 1 specific KMSKS motif, Conclusions: The ct-helix-bundle domain identified in the MetRS structure is the signature of the class la enzymes, as it was also identified in:the class la structures of the isoleucyl- and arginyl-tRNA synthetases. The beta-alpha-alpha-beta-alpha topology domain, which can now be identified in all known structures of the class a and Ib synthetases, is likely to dock with the inner side Of the L-shaped tRNA, thereby positioning the anticodon stem.	Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Ochanomizu Univ, Dept Chem, Fac Sci, Bunkyo Ku, Tokyo 1128610, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch, France	Yokoyama, S (reprint author), Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.						Cusack S, 1996, EMBO J, V15, P6321; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; Cusack S, 1998, STRUCTURE, V6, P101, DOI 10.1016/S0969-2126(98)00011-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; FOURMY D, 1995, BIOCHEMISTRY-US, V34, P15681, DOI 10.1021/bi00048a012; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; NUREKI O, 1995, SCIENCE, V267, P1958, DOI 10.1126/science.7701318; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; ARNEZ JG, 1995, EMBO J, V14, P4143; AULD DS, 1995, SCIENCE, V267, P1994, DOI 10.1126/science.7701322; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; *BIOS TECHN, 1993, INS 2 US GUID VERS 2; BLANQUET S, 1976, J MOL BIOL, V103, P765, DOI 10.1016/0022-2836(76)90208-4; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; BRUNGER AT, 1993, XPLOR VERSION 3 1 SY; BRUNIE S, 1990, J MOL BIOL, V216, P411, DOI 10.1016/S0022-2836(05)80331-6; CASSIO D, 1971, EUR J BIOCHEM, V20, P283, DOI 10.1111/j.1432-1033.1971.tb01393.x; CAVARELLI J, 1993, NATURE, V362, P181, DOI 10.1038/362181a0; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; DELAFORTELLE E, 1996, METHODS ENZ, V276, P72; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; FOURMY D, 1993, J MOL BIOL, V231, P1068, DOI 10.1006/jmbi.1993.1352; FOURMY D, 1993, J MOL BIOL, V231, P1078, DOI 10.1006/jmbi.1993.1353; GHOSH G, 1990, BIOCHEMISTRY-US, V29, P2220, DOI 10.1021/bi00461a003; GHOSH G, 1991, BIOCHEMISTRY-US, V30, P11767, DOI 10.1021/bi00115a005; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KIGAWA T, 1995, J BIOMOL NMR, V6, P129; KIM HY, 1993, BIOCHEMISTRY-US, V32, P10506, DOI 10.1021/bi00090a029; KOHDA D, 1987, J BIOL CHEM, V262, P558; LANDRO JA, 1993, P NATL ACAD SCI USA, V90, P2261, DOI 10.1073/pnas.90.6.2261; LANDRO JA, 1994, BIOCHEMISTRY-US, V33, P14213, DOI 10.1021/bi00251a033; LANDRO JA, 1994, J BIOL CHEM, V269, P20217; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LIU JH, 1995, J BIOL CHEM, V270, P15162; LOGAN DT, 1995, EMBO J, V14, P4156; MEINNEL T, 1991, P NATL ACAD SCI USA, V88, P291, DOI 10.1073/pnas.88.1.291; METTITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869; NUREKI O, 1991, J BIOL CHEM, V266, P3268; NUREKI O, 1993, J BIOL CHEM, V268, P15368; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; ROGERS MJ, 1994, P NATL ACAD SCI USA, V91, P291, DOI 10.1073/pnas.91.1.291; ROULD MA, 1992, NUCLEIC ACIDS MOL BI, V6, P225; SHIBA K, 1992, P NATL ACAD SCI USA, V89, P1880, DOI 10.1073/pnas.89.5.1880	54	63	65	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0969-2126			STRUCT FOLD DES	Struct. Fold. Des.	FEB 15	2000	8	2					197	208		10.1016/S0969-2126(00)00095-2		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	284QJ	WOS:000085343200011		
J	Kataoka, K; Matsumoto, T; Yokoyama, M; Okano, T; Sakurai, Y; Fukushima, S; Okamoto, K; Kwon, GS				Kataoka, K; Matsumoto, T; Yokoyama, M; Okano, T; Sakurai, Y; Fukushima, S; Okamoto, K; Kwon, GS			Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance	JOURNAL OF CONTROLLED RELEASE			English	Article; Proceedings Paper	5th Symposium on Controlled Drug Delivery	APR 01-03, 1998	NOORDWIJK AAN ZEE, NETHERLANDS	Alza Corp, 3M Medica GmbH, N V Organon, Akzo Nobel, Cordis Corp, Depotech Corp, DSM Fine Chem, Emisphere Technol Inc, Janssen Pharmaceut, Merck KgaA, Novaritis Pharms AG, Pharmacia & Upjohn AB, Inst Rech Int Servier, TheraTech		doxorubicin; poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) block copolymer; polymer micelle; drug carrier; long circulation	ACID) BLOCK-COPOLYMER; POLYION COMPLEX MICELLES; SELF-ASSOCIATION; POLYMERIC MICELLES; AQUEOUS-SOLUTION; DRUG VEHICLES; ADRIAMYCIN; DAUNORUBICIN; DELIVERY; L-ASPARTATE)	Doxorubicin (DOX) was physically loaded into micelles prepared from poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) block copolymer (PEG-PBLA) by an o/w emulsion method with a substantial drug loading level (15 to 20 w/w%). DOX-loaded micelles were narrowly distributed in size with diameters of approximately 50-70 nm. Dimer derivatives of DOX as well as DOX itself were revealed to be entrapped in the micelle, the former seems to improve micelle stability due to its low water solubility and possible interaction with benzyl residues of PBLA segments through pi-pi stacking. Release of DOX compounds from the micelles proceeded in two stages: an initial rapid release was followed by a stage of slow and long-lasting release of DOX. Acceleration of DOX release can be obtained by lowering the surrounding pH from 7.4 to 5.0, suggesting a pH-sensitive release of DOX from the micelles. A remarkable improvement in blood circulation of DOX was achieved by use of PEG-PBLA micelle as a carrier presumably due to the reduced reticuloendothelial system uptake of the micelles through a steric stabilization mechanism. Finally, DOX loaded in the micelle showed a considerably higher antitumor activity compared to free DOX against mouse C26 tumor by i.v. injection, indicating a promising feature for PEG-PBLA micelle as a long-circulating carrier system useful in modulated drug delivery. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Sci Univ Tokyo, Dept Mat Sci, Noda, Chiba 278, Japan; Sci Univ Tokyo, Res Inst Biosci, Noda, Chiba 278, Japan; Tokyo Womens Med Univ, Inst Biomed Engn, Shinjuku Ku, Tokyo 162, Japan; Nippon Kayaku Co Ltd, Kita Ku, Tokyo 115, Japan; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	Kataoka, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Okano, Teruo/J-4028-2012; Kwon, Glen/A-1919-2014; Kataoka, Kazunori/K-7108-2012	Kataoka, Kazunori/0000-0002-8591-413X			Kwon G, 1997, J CONTROL RELEASE, V48, P195, DOI 10.1016/S0168-3659(97)00039-4; Kabanov AV, 1996, MACROMOLECULES, V29, P6797, DOI 10.1021/ma960120k; KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2; KWON G, 1994, J CONTROL RELEASE, V29, P17, DOI 10.1016/0168-3659(94)90118-X; Yokoyama M, 1998, J CONTROL RELEASE, V50, P79, DOI 10.1016/S0168-3659(97)00115-6; YOKOYAMA M, 1994, J CONTROL RELEASE, V32, P269, DOI 10.1016/0168-3659(94)90237-2; BADER H, 1984, ANGEW MAKROMOL CHEM, V123, P457, DOI 10.1002/apmc.1984.051230121; KABANOV AV, 1989, FEBS LETT, V258, P343, DOI 10.1016/0014-5793(89)81689-8; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1; HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019; YOKOYAMA M, 1991, CANCER RES, V51, P3229; BEIJNEN JH, 1986, INT J PHARM, V32, P123, DOI 10.1016/0378-5173(86)90170-5; KWON G, 1993, LANGMUIR, V9, P945, DOI 10.1021/la00028a012; Kataoka K, 1996, MACROMOLECULES, V29, P8556, DOI 10.1021/ma961217+; YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269; BARTHELE.V, 1974, FEBS LETT, V46, P5, DOI 10.1016/0014-5793(74)80322-4; BEART PM, 1971, NATURE-NEW BIOL, V234, P78; CAMMAS S, 1995, MACROMOL CHEM PHYSIC, V196, P1899, DOI 10.1002/macp.1995.021960609; Cammas S, 1996, NATO ADV SCI INST SE, V327, P83; Cammas S, 1997, MAT SCI ENG C-BIOMIM, V4, P241, DOI 10.1016/S0928-4931(97)00007-6; EKSBORG S, 1978, J PHARM SCI, V67, P782, DOI 10.1002/jps.2600670613; HOES CJT, 1993, MAKROMOL CHEM-M SYMP, V70-1, P119, DOI 10.1002/masy.19930700115; JANSSEN MJH, 1985, INT J PHARM, V23, P1, DOI 10.1016/0378-5173(85)90217-0; YOKOYAMA M, 1987, MAKROMOL CHEM-RAPID, V8, P431; Kataoka K, 1998, MACROMOLECULES, V31, P6071, DOI 10.1021/ma971838i; KATAOKA K, 1997, CONTROLLED DRUG DELI, P49; Kreuter J., 1994, COLLOIDAL DRUG DELIV, P219; Kwon G. S., 1995, PHARMACEUT RES, V12, P200; KWON GS, 1993, PHARMACEUT RES, V10, P970, DOI 10.1023/A:1018998203127; MARTIN SR, 1980, BIOPOLYMERS, V19, P713, DOI 10.1002/bip.1980.360190318; MCLENNAN IJ, 1985, CAN J CHEM, V63, P1233, DOI 10.1139/v85-210; MENOZZI M, 1984, J PHARM SCI, V73, P766, DOI 10.1002/jps.2600730615; RIGHETTI PG, 1979, FEBS LETT, V101, P51, DOI 10.1016/0014-5793(79)81293-4; Scholes PD, 1997, CONTROLLED DRUG DELI, P73; Yokoyama M, 1993, DRUG DELIV, V1, P11, DOI 10.3109/10717549309031336; Yokoyama M, 1996, J CONTROL RELEASE, V39, P351, DOI 10.1016/0168-3659(95)00165-4; YOKOYAMA M, IN PRESS J DRUG TARG	38	393	422	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659			J CONTROL RELEASE	J. Control. Release	FEB 14	2000	64	1-3					143	153		10.1016/S0168-3659(99)00133-9		11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	285FK	WOS:000085378900014		
J	Ito, K; Adachi, J; Hall, R; Motoki, S; Shigemasa, E; Soejima, K; Yagishita, A				Ito, K; Adachi, J; Hall, R; Motoki, S; Shigemasa, E; Soejima, K; Yagishita, A			Photoelectron angular distributions from dissociative photoionization channels of fixed-in-space molecular hydrogen	JOURNAL OF PHYSICS B-ATOMIC MOLECULAR AND OPTICAL PHYSICS			English	Article								The angular distribution of photoelectrons from fixed-in-space molecular hydrogen has been measured in the 44-76 eV photon energy range for an ionic state, with a state energy of 38 eV measured from the H-2 ground state, dissociating to H+ + H(n = 2). The photoelectrons are ejected nearly isotropically at 44 eV when their energy is relatively low, while ejection perpendicular to the molecular axis becomes more and more favoured as the photon energy increases. This behaviour is possibly explained in terms of direct photoionization to the 2p pi(u), and 2s sigma(g) states of H-2(+); the former being favoured at 44 eV, and the latter at photon energies far from threshold.	Natl Lab High Energy Phys, KEK, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Univ Paris 06, DIAM, F-75252 Paris, France; Univ Tokyo, Grad Sch Sci & Technol, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4440864, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 9502102, Japan	Ito, K (reprint author), Natl Lab High Energy Phys, KEK, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan.		Shigemasa, Eiji/K-1149-2013				DEHMER JL, 1978, PHYS REV A, V18, P164, DOI 10.1103/PhysRevA.18.164; DILL D, 1976, J CHEM PHYS, V65, P1130, DOI 10.1063/1.433187; SHIGEMASA E, 1995, PHYS REV LETT, V74, P359, DOI 10.1103/PhysRevLett.74.359; Watanabe N, 1997, PHYS REV LETT, V78, P4910, DOI 10.1103/PhysRevLett.78.4910; GARDNER JL, 1975, PHYS REV A, V12, P1404, DOI 10.1103/PhysRevA.12.1404; HATHERLY PA, 1995, J PHYS B-AT MOL OPT, V28, P2643, DOI 10.1088/0953-4075/28/13/016; ITO K, 1996, J CHEM PHYS, V104, P8849; MURAI T, COMMUNICATION; Sharp T. E., 1971, ATOM DATA, V2, P119; SHIGEMASA E, 1992, REV SCI INSTRUM, V63, P1505, DOI 10.1063/1.1143005; SHIGEMASA E, 1995, 952 KEK; SHIGEMASA E, 1998, PHYS REV LETT, V80, P1662; Shigemasa E, 1998, J SYNCHROTRON RADIAT, V5, P777, DOI 10.1107/S0909049597019791; YAGISHITA A, 1998, PHOTONIC ELECT ATOMI, P149	14	26	26	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0953-4075			J PHYS B-AT MOL OPT	J. Phys. B-At. Mol. Opt. Phys.	FEB 14	2000	33	3					527	533		10.1088/0953-4075/33/3/320		7	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	287AG	WOS:000085480600022		
J	Muto, S; Aoki, H				Muto, S; Aoki, H			Persistence of vibrational modes in a classical two-dimensional electron liquid	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Letter							DYNAMICS; CRYSTAL	Vibrational density of states of a classical two-dimensional electron system obtained with a molecular-dynamics simulation is shown to have a peak in both solid and Liquid phases. From an exact diagonalization of the dynamical matrix, the peak is identified to be vibrational modes having wavelengths of the order of the electron spacing, and the result is interpreted as persistent vibrational modes with short wavelengths in a liquid.	Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Muto, S (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.						GRIMES CC, 1979, PHYS REV LETT, V42, P795, DOI 10.1103/PhysRevLett.42.795; BONSALL L, 1977, PHYS REV B, V15, P1959, DOI 10.1103/PhysRevB.15.1959; Muto S, 1999, PHYS REV B, V59, P14911, DOI 10.1103/PhysRevB.59.14911; HANSEN JP, 1979, PHYS REV LETT, V43, P979, DOI 10.1103/PhysRevLett.43.979; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; KALIA RK, 1981, PHYS REV B, V23, P4794, DOI 10.1103/PhysRevB.23.4794; NOSE S, 1984, J CHEM PHYS, V81, P511	7	1	1	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0953-8984			J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	FEB 14	2000	12	6					L83	L86		10.1088/0953-8984/12/6/103		4	Physics, Condensed Matter	Physics	287MT	WOS:000085510400003		
J	Takekuma, S; Takekuma, H; Matsumoto, T; Yoshida, Z				Takekuma, S; Takekuma, H; Matsumoto, T; Yoshida, Z			Influence of metal complexes on the formation of gamma-cyclodextrin-bicapped C-60(n-) (n : 1 and 2) in aqueous solution	TETRAHEDRON LETTERS			English	Article						complexes; cyclodextrins; electron transfer; fullerenes	ELECTROCHEMICAL DETECTION; C70 FULLERENES; C-60(2-); GENERATION; FULLERIDES; REDUCTION; SALTS; C60	A facile electron transfer from a reducing agent, Na2S2O4 to C-60 in gamma-cyclodextrin-bicapped C-60-complex (1) in aqueous solution at ambient temperature under argon, leading to the simultaneous formation of 'C-60(1-)' and 'C-60(2-)' has been accomplished by using excess (18-crown-6):iron(III) chloride (1:1) complex as mediator for the electron transfer. (C) 2000 Elsevier Science Ltd. All rights reserved.	Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Osaka 5778502, Japan; Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Yoshida, Z (reprint author), Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Osaka 5778502, Japan.						YOSHIDA ZI, 1994, ANGEW CHEM INT EDIT, V33, P1597, DOI 10.1002/anie.199415971; ZHOU FM, 1992, J AM CHEM SOC, V114, P11004, DOI 10.1021/ja00053a072; DUBOIS D, 1991, J AM CHEM SOC, V113, P4364, DOI 10.1021/ja00011a069; Komiya N, 1997, J MOL CATAL A-CHEM, V117, P21, DOI 10.1016/S1381-1169(96)00263-4; BAUSCH JW, 1991, J AM CHEM SOC, V113, P3205, DOI 10.1021/ja00008a077; BHYAPPA P, 1993, J AM CHEM SOC, V115, P11004; BOSSARD C, 1993, J CHEM SOC CHEM COMM, P333, DOI 10.1039/c39930000333; BOYD PDW, 1995, J AM CHEM SOC, V117, P2907, DOI 10.1021/ja00115a024; CARON C, 1993, J AM CHEM SOC, V115, P8505, DOI 10.1021/ja00071a093; CHEN J, 1994, J CHEM SOC CHEM COMM, P2177, DOI 10.1039/c39940002177; DOUTHWAITE RE, 1994, J CHEM SOC CHEM COMM, P267, DOI 10.1039/c39940000267; DUBOIS D, 1991, J AM CHEM SOC, V113, P7773, DOI 10.1021/ja00020a056; KHALED MM, 1994, J AM CHEM SOC, V116, P3465, DOI 10.1021/ja00087a037; LAWSON DR, 1992, J ELECTROCHEM SOC, V139, pL68, DOI 10.1149/1.2221179; LIU XH, 1994, J AM CHEM SOC, V116, P5489, DOI 10.1021/ja00091a071; Marconi G, 1996, CHEM PHYS LETT, V260, P589, DOI 10.1016/0009-2614(96)00915-3; MINGFEI W, 1996, TETRAHEDRON LETT, V37, P7409; Nakanishi I, 1997, CHEM LETT, P707, DOI 10.1246/cl.1997.707; OHSAWA Y, 1992, J CHEM SOC CHEM COMM, P781, DOI 10.1039/c39920000781; SUBRAMANIAN R, 1994, J CHEM SOC CHEM COMM, P1847, DOI 10.1039/c39940001847; XIE QS, 1992, J AM CHEM SOC, V114, P3978, DOI 10.1021/ja00036a056; 1999, 16 FULL GEN S JAN 20, P209; 1998, 15 FULL GEN S JUL 22, P274	23	13	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 12	2000	41	7					1043	1046		10.1016/S0040-4039(99)02229-7		4	Chemistry, Organic	Chemistry	284WZ	WOS:000085357000014		
J	Asanuma, H; Liang, XG; Komiyama, M				Asanuma, H; Liang, XG; Komiyama, M			meta-Aminoazobenzene as a thermo-insensitive photo-regulator of DNA-duplex formation	TETRAHEDRON LETTERS			English	Article						azo; azo compounds; isomerization; phosphoramidites; photochemistry	BINDING-PROPERTIES; AZOBENZENE; OLIGONUCLEOTIDES; LINKER	meta-Aminoazobenzene has been introduced in the side chain of oligonucleotides as a photo-responsive molecule. Compared with the para-aminoazobenzene which was previously used, the thermal cis-->trans isomerization was much slower: the half-lives of the cis-isomers of m- and p-aminoazobenzene were 13.2 h and 20 min at 50 degrees C, respectively. By using the present oligonucleotides, duplex formation and dissociation was efficiently regulated on photo-irradiation without being disturbed by the thermal isomerization. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Komiyama, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.						SHIMOMURA M, 1987, J AM CHEM SOC, V109, P5175, DOI 10.1021/ja00251a022; WILLNER I, 1991, J AM CHEM SOC, V113, P4013, DOI 10.1021/ja00010a065; Asanuma H, 1999, ANGEW CHEM INT EDIT, V38, P2393, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2393::AID-ANIE2393>3.0.CO;2-7; SHINKAI S, 1983, J AM CHEM SOC, V105, P1851, DOI 10.1021/ja00345a029; Asanuma H, 1998, TETRAHEDRON LETT, V39, P9015, DOI 10.1016/S0040-4039(98)02022-X; Endo M, 1997, J ORG CHEM, V62, P846, DOI 10.1021/jo9611780; Hamachi I, 1998, CHEM LETT, P537, DOI 10.1246/cl.1998.537; Hartley GS, 1938, J CHEM SOC, P633, DOI 10.1039/jr9380000633; HOHSAKA T, 1994, J AM CHEM SOC, V116, P413, DOI 10.1021/ja00080a064; Lee SY, 1998, POLYM BULL, V40, P1, DOI 10.1007/s002890050215; WURTHNER F, 1995, J CHEM SOC PERK T 2, P1727, DOI 10.1039/p29950001727; Yamana K, 1998, NUCLEOS NUCLEOT, V17, P233, DOI 10.1080/07328319808005172; Yamana K, 1996, TETRAHEDRON LETT, V37, P637, DOI 10.1016/0040-4039(95)02220-1	13	22	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 12	2000	41	7					1055	1058		10.1016/S0040-4039(99)02233-9		4	Chemistry, Organic	Chemistry	284WZ	WOS:000085357000017		
J	Nagano, K; Toba, K; Akishita, M; Watanabe, T; Kozaki, K; Eto, M; Hashimoto, M; Sudoh, N; Ako, J; Yoshizumi, M; Ouchi, Y				Nagano, K; Toba, K; Akishita, M; Watanabe, T; Kozaki, K; Eto, M; Hashimoto, M; Sudoh, N; Ako, J; Yoshizumi, M; Ouchi, Y			Prostanoids regulate proliferation of vascular smooth muscle cells induced by arginine vasopressin	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						[Arg(8)]vasopressin; prostanoid; smooth muscle cell; cell proliferation	ENDOTHELIAL-CELLS; ANGIOTENSIN-II; PROSTACYCLIN ANALOG; MESSENGER-RNA; DNA-SYNTHESIS; NEUROHYPOPHYSEAL HORMONES; LOCAL GENERATION; NITRIC-OXIDE; RAT AORTA; PROSTAGLANDIN	The aim of the present study was to investigate the effect of arginine [Arg(8)]vasopressin (vasopressin) on proliferation of vascular smooth muscle cells and the mechanisms underlying the action of vasopressin. To clarify these issues, we used two different types of vascular smooth muscle cells, cultured adult rat aortic smooth muscle cells and A10 cells, a cell line derived from fetal rat aorta. Vasopressin (10(-8) to 10(-6) M) significantly stimulated the proliferation of rat aortic smooth muscle cells in a dose-dependent manner. In contrast, vasopressin significantly inhibited the proliferation of A10 cells. This inhibition was abolished when A10 cells were treated with indomethacin. Vasopressin stimulated the production of prostanoids several-fold in A10 cells but not in rat aortic smooth muscle cells. These effects were completely blocked by the vasopressin V-1 receptor antagonist, 1-{1-[4-(3-acetylamino-propoxy)benzoyl]4-piperidyl)-3,4-dihydro-2(1H)-quinolinone (OPC21268), but not by the vasopressin V-2 receptor antagonist, (+/-)-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzol]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride (OPC31260). These results indicate that vasopressin has diverse effect on proliferation of vascular smooth muscle cells through the vasopressin V-1 receptor, depending on the production of growth regulatory prostanoids. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Toba, K (reprint author), Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ALTURA BM, 1977, FED PROC, V36, P1853; CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; ANG VTY, 1984, J CLIN ENDOCR METAB, V58, P688; SACHINIDIS A, 1995, HYPERTENSION, V26, P771; NUSSEY SS, 1984, NATURE, V310, P64, DOI 10.1038/310064a0; IVELL R, 1984, P NATL ACAD SCI-BIOL, V81, P2006, DOI 10.1073/pnas.81.7.2006; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; ASADA Y, 1994, PROSTAG LEUKOTR ESS, V51, P245, DOI 10.1016/0952-3278(94)90187-2; BOSWELL MC, 1981, EXP MOL PATHOL, V35, P265; BURCH RM, 1982, AM J PHYSIOL, V243, pF593; CIRCHTON CA, 1993, AM J PHYSIOL, V264, pH1878; FOO NC, 1991, ENDOCRINOLOGY, V128, P2118; GEISTERFER AAT, 1989, HYPERTENSION, V14, P413; HAMADA M, 1990, ATHEROSCLEROSIS, V81, P191, DOI 10.1016/0021-9150(90)90066-R; HASSID A, 1983, AM J PHYSIOL, V245, pC278; HIRASAWA Y, 1995, EUR J PHARMACOL, V272, P39, DOI 10.1016/0014-2999(94)0062S-5; HIRSCH AT, 1989, J CLIN INVEST, V84, P418, DOI 10.1172/JCI114182; KOH E, 1993, ARTERY, V20, P242; LIM ATW, 1984, NATURE, V310, P61, DOI 10.1038/310061a0; LINCOLN J, 1990, CELL TISSUE RES, V259, P341, DOI 10.1007/BF00318457; LobaccaroHenri C, 1996, J STEROID BIOCHEM, V59, P63, DOI 10.1016/S0960-0760(96)00091-X; LOESCH A, 1991, ANAT EMBRYOL, V183, P129; MATSUMOTO T, 1984, BIOL RES PREG PERIN, V5, P11; MEEKER RB, 1991, NEUROENDOCRINOLOGY, V54, P236, DOI 10.1159/000125881; MITCHELL MD, 1980, ADV PROSTAGLANDIN TH, V3, P891; MIZUNO K, 1991, AM J HYPERTENS, V4, pS67; MORISAKI N, 1988, ATHEROSCLEROSIS, V71, P165, DOI 10.1016/0021-9150(88)90140-2; MURASE T, 1992, J HYPERTENS, V10, P1505, DOI 10.1097/00004872-199210120-00011; Nagano K, 1997, BIOCHEM BIOPH RES CO, V231, P831, DOI 10.1006/bbrc.1997.6102; OLIVER JA, 1984, J CLIN INVEST, V74, P1247, DOI 10.1172/JCI111534; OWEN NE, 1986, AM J PHYSIOL, V250, pC584; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SCHWARTZ SM, 1983, P SOC EXP BIOL MED, V173, P1; SHIROTANI M, 1991, PROSTAGLANDINS, V41, P97, DOI 10.1016/0090-6980(91)90023-9; SIMON J, 1995, HYPERTENSION, V25, P1030; SPATZ M, 1994, J AUTONOM NERV SYST, V49, pS123; STALLONE JN, 1991, AM J PHYSIOL, V260, pH453; SUZUKI S, 1989, J CLIN INVEST, V84, P427, DOI 10.1172/JCI114183; TAGAWA T, 1993, J CLIN INVEST, V92, P1483, DOI 10.1172/JCI116726; TERRAGNO NA, 1979, FED PROC, V38, P75; TURLA MB, 1991, CIRC RES, V68, P288; UEHARA Y, 1988, PROSTAGLANDINS, V36, P847, DOI 10.1016/0090-6980(88)90061-5; YANAGISAWA H, 1990, AM J PHYSIOL, V258, pF85; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	44	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 11	2000	389	1					25	33		10.1016/S0014-2999(99)00873-0		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	286YH	WOS:000085476100003		
J	Yasukawa, T; Suzuki, T; Ishii, N; Ueda, T; Ohta, S; Watanabe, K				Yasukawa, T; Suzuki, T; Ishii, N; Ueda, T; Ohta, S; Watanabe, K			Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA(Lys) with the MERRF encephalomyopathy pathogenic mutation	FEBS LETTERS			English	Article						mitochondrial disease; mitochondrial tRNA; anticodon; post-transcriptional modification; cybrid	STROKE-LIKE EPISODES; TRANSFER RNALEU(UUR) GENE; CELLS LACKING MTDNA; TRANSFER-RNA; LACTIC-ACIDOSIS; PROTEIN-SYNTHESIS; POINT MUTATION; MELAS; DNA; MYOPATHY	A mitochondrial tRNA(Lys) gene mutation at nucleotide position 8344 is responsible for the myoclonus epilepsy associated with ragged-red fibers (MERRF) subgroup of mitochondrial encephalomyopathies. Here, we show that normally modified uridine at the anticodon wobble position remains unmodified in the purified mutant tRNA(Lys). We hale reported a similar modification defect at the same position in two mutant mitochondrial tRNAs(Leu)(UUR) in another subgroup, mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), indicating this defect is common in the two hinds of tRNA molecules with the respective mutations of the two major mitochondrial encephalomyopathies. We therefore suggest the defect in the anticodon is responsible, through the translational process, for the pathogenesis of mitochondrial diseases. (C) 2000 Federation of European Biochemical Societies.	Nippon Med Sch, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, Kawasaki, Kanagawa 2110063, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1138656, Japan	Ohta, S (reprint author), Nippon Med Sch, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, Kosugi Cho, Kawasaki, Kanagawa 2110063, Japan.		Ueda, Takuya/K-5217-2014; Suzuki, Tsutomu/J-1776-2015	Ueda, Takuya/0000-0002-7760-8271; Suzuki, Tsutomu/0000-0002-9731-1731			YONEDA M, 1994, MOL CELL BIOL, V14, P2699; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; HECKMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P3159, DOI 10.1073/pnas.77.6.3159; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; BARRELL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3164, DOI 10.1073/pnas.77.6.3164; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584; Howell N, 1999, INT REV CYTOL, V186, P49; INAGAKI Y, 1995, J MOL BIOL, V251, P486, DOI 10.1006/jmbi.1995.0450; Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; SAMUELSSON T, 1983, J BIOL CHEM, V258, P3178; SUZUKI T, 1999, J MASS SPECTROM SOC, V47, P168; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Watanabe Kimitsuna, 1995, P225; YASUKAWA T, IN PRESS J BIOL CHEM	31	70	72	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	FEB 11	2000	467	2-3					175	178		10.1016/S0014-5793(00)01145-5		4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	285ZF	WOS:000085417700009		
J	Sugiyama, H; Nonaka, T; Kishimoto, T; Komoriya, K; Tsuji, K; Nakahata, T				Sugiyama, H; Nonaka, T; Kishimoto, T; Komoriya, K; Tsuji, K; Nakahata, T			Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells	FEBS LETTERS			English	Article						peroxyzome proliferator-activated receptor; mast cell; cytokine	FIBROBLAST GROWTH-FACTOR; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; PPAR-GAMMA; TNF-ALPHA; RAT; INTERLEUKIN-3; ADIPOGENESIS; RELEASE; LIGAND	We examined the expression of peroxisome proliferator-activated receptors (PPARs) and the role of PPARs in cytokine production in mouse hone marrow-derived mast cells (mBMMCs). mBMMCs expressed PPAR beta strongly and gamma slightly, but not a. Activation of mBMMCs with antigen or calcium ionophore resulted in the increased expression of PPAR gamma mRNA specifically. 15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PCJ(2)) and troglitazone, all PPAR gamma ligands, attenuated the antigen-induced cytokine production by mBMMCs. Carbaprostacyclin, a PPAR beta ligand, also inhibited cytokine production, whereas PPAR alpha ligands did not. These results suggest that PPAR beta and gamma might be included in the negative regulation of mast cell activation. (C) 2000 Federation of European Biochemical Societies.	Teijin Inst Biomed Res, Pharmaceut Dev Labs, Dept Pharmacol Res, Tokyo 1918512, Japan; Univ Tokyo, Inst Med Sci, Dept Clin Oncol, Minato Ku, Tokyo 1088639, Japan	Sugiyama, H (reprint author), Teijin Inst Biomed Res, Pharmaceut Dev Labs, Dept Pharmacol Res, 4-3-2 Asahigaoka Hino, Tokyo 1918512, Japan.						Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Qu ZH, 1998, INT ARCH ALLERGY IMM, V115, P47, DOI 10.1159/000023829; QU ZH, 1995, AM J PATHOL, V147, P564; RAZIN E, 1984, J IMMUNOL, V132, P1479; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Jiang CY, 1998, NATURE, V391, P82; GORDON JR, 1990, IMMUNOL TODAY, V11, P458, DOI 10.1016/0167-5699(90)90176-A; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Derek W, 1999, NAT MED, V5, P698; Haberl C, 1998, MEDIAT INFLAMM, V7, P79; ISHIZAKA T, 1984, PROG ALLERGY, V34, P188; JONES PS, 1995, EUR J BIOCHEM, V233, P219, DOI 10.1111/j.1432-1033.1995.219_1.x; Latruffe N, 1997, BIOCHIMIE, V79, P81, DOI 10.1016/S0300-9084(97)81496-4; NEGISHI M, 1995, J LIPID MEDIAT CELL, V12, P443, DOI 10.1016/0929-7855(95)00029-P; NEMETH A, 1980, EUR J CELL BIOL, V20, P272; NIHG Y, 1996, GENOME RES, V6, P742; NILSSON G, 1995, SCAND J IMMUNOL, V42, P76, DOI 10.1111/j.1365-3083.1995.tb03628.x; Pessina A, 1997, EXP HEMATOL, V25, P536; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; Simpson AECM, 1997, INFLAMM RES, V46, P65, DOI 10.1007/s000110050078; WILLIAMS CMM, 1995, IMMUNOLOGY, V86, P244; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0	28	27	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	FEB 11	2000	467	2-3					259	262		10.1016/S0014-5793(00)01169-8		4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	285ZF	WOS:000085417700026		
J	Makino, S; Makino, T; Abe, K; Hashimoto, J; Tatsuta, T; Kitagawa, M; Mori, H; Ogura, T; Fujii, T; Fushinobu, S; Wakagi, T; Matsuzawa, H				Makino, S; Makino, T; Abe, K; Hashimoto, J; Tatsuta, T; Kitagawa, M; Mori, H; Ogura, T; Fujii, T; Fushinobu, S; Wakagi, T; Matsuzawa, H			Second transmembrane segment of FtsH plays a role in its proteolytic activity and homo-oligomerization (vol 460, pg 554, 1999)	FEBS LETTERS			English	Correction									Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Ikoma 6300101, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Kumamoto 8620976, Japan; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Makino, S (reprint author), AIST NIBHT CREST Ctr Struct Biol, 1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.		Fushinobu, Shinya/E-4987-2011	Fushinobu, Shinya/0000-0003-1346-6435			Makino S, 1999, FEBS LETT, V460, P554, DOI 10.1016/S0014-5793(99)01411-8	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	FEB 11	2000	467	2-3					365	365		10.1016/S0014-5793(00)01158-3		1	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	285ZF	WOS:000085417700046		
J	Yasukawa, T; Suzuki, T; Suzuki, T; Ueda, T; Ohta, S; Watanabe, K				Yasukawa, T; Suzuki, T; Suzuki, T; Ueda, T; Ohta, S; Watanabe, K			Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RNALEU(UUR) GENE; CELLS LACKING MTDNA; TRANSFER-RNA; MYCOPLASMA-CAPRICOLUM; PROTEIN-SYNTHESIS; POINT MUTATION; TRANSCRIPTION TERMINATION; MYOCLONIC EPILEPSY; CODON RECOGNITION; DIABETES-MELLITUS	The mitochondrial tRNA(Leu)(UUR) (R = A or Gr) gene possesses several hot spots for pathogenic mutations. A point:mutation at nucleotide position 3243 or 3271 is associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes and maternally inherited diabetes with deafness. Detailed studies on two tRNAs(Leu)(UUR) with the 3243 or 3271 mutation revealed some common characteristics in cybrid cells: (i) a decreased life span, resulting in a 70% decrease in the amounts of the tRNAs in the steady state, (ii) a slight decrease in the ratios of aminoacyl-tRNAs(Leu)(UUR) versus uncharged tRNAs(Leu)(UUR), and (iii) accurate aminoacylation with leucine without any misacylation. As a marked result, both of the mutant tRNA molecules were deficient in a modification of uridine that occurs in the normal tRNA(Leu)(UUR) at the first position of the anticodon, The lack of this modification may lead to the mistranslation of leucine into non-cognate phenylalanine codons by mutant tRNAsLeU(UUR), according to the mitochondrial wobble rule, and/or a decrease in the rate of mitochondrial protein synthesis. This finding could explain why two different mutations (3243 and 3271) manifest indistinguishable clinical features.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Nippon Med Sch, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, Kawasaki, Kanagawa 2110063, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1138656, Japan	Ohta, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Ueda, Takuya/K-5217-2014; Suzuki, Tsutomu/J-1776-2015	Ueda, Takuya/0000-0002-7760-8271; Suzuki, Tsutomu/0000-0002-9731-1731			ANDACHI Y, 1987, P NATL ACAD SCI USA, V84, P7398, DOI 10.1073/pnas.84.21.7398; ANDACHI Y, 1989, J MOL BIOL, V209, P37, DOI 10.1016/0022-2836(89)90168-X; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; HECKMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P3159, DOI 10.1073/pnas.77.6.3159; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; KING MP, 1992, MOL CELL BIOL, V12, P480; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; HAYASHI J, 1990, BIOCHEM BIOPH RES CO, V167, P216, DOI 10.1016/0006-291X(90)91753-F; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; BANKS JF, 1994, ANAL CHEM, V66, P406, DOI 10.1021/ac00075a015; BARRELL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3164, DOI 10.1073/pnas.77.6.3164; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123; Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189; HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; INAGAKI Y, 1995, J MOL BIOL, V251, P486, DOI 10.1006/jmbi.1995.0450; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; MICHEAL WM, 1996, FEBS LETT, V433, P93; SAMUELSSON T, 1983, J BIOL CHEM, V258, P3178; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Suzuki T, 1996, FEBS LETT, V381, P195, DOI 10.1016/0014-5793(96)00107-X; SUZUKI T, 1999, J MASS SPECTROM SOC, V47, P168; Suzuki Y, 1996, DIABETES CARE, V19, P1304; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; Watanabe Kimitsuna, 1995, P225	44	134	142	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4251	4257		10.1074/jbc.275.6.4251		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	283RJ	WOS:000085288800076		
J	Cha, SH; Sekine, T; Kusuhara, H; Yu, E; Kim, JY; Kim, DK; Sugiyama, Y; Kanai, Y; Endou, H				Cha, SH; Sekine, T; Kusuhara, H; Yu, E; Kim, JY; Kim, DK; Sugiyama, Y; Kanai, Y; Endou, H			Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION TRANSPORTER; RAT-KIDNEY; FUNCTIONAL EXPRESSION; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PROTEIN; BRAIN; LIVER; IDENTIFICATION; MECHANISMS	A cDNA encoding a novel multispecific organic anion transporter, OAT4, was isolated from a human kidney cDNA library, The OAT4 cDNA consisted of 2210 base pairs that encoded a 550-amino acid residue protein with 12 putative membrane-spanning domains. The amino acid sequence of OAT4 showed 38 to 44% identity to those of other members of the OAT family. Northern blot analysis revealed that OAT4 mRNA is abundantly expressed in the placenta as well as in the kidney. When expressed in Xenopus oocytes, OAT4 mediated the high affinity transport of estrone sulfate (K-m = 1.01 mu M) and dehydroepiandrosterone sulfate (K-m = 0.63 mu M) in a sodium-independent manner. OAT4 also mediated the transport of ochratoxin A. OAT4-mediated transport of estrone Sulfate was inhibited by several sulfate conjugates, such as p-nitrophenyl sulfate, alpha-naphthyl sulfate, beta-estradiol sulfate, and 4-methylumbelliferyl sulfate. By contrast, glucuronide conjugates showed little or no inhibitory effect on the OAT4-mediated transport of estrone sulfate. OAT4 interacted with chemically heterogeneous anionic compounds, such as nonsteroidal antiinflammatory drugs, diuretics, sulfobromophthalein, penicillin G, and bile salts, whereas tetraethylammonium, an organic cation, did not. OAT4 is the first member of the multispecific organic anion transporter family, which is expressed abundantly in the placenta. OAT4 might be responsible for the elimination and detoxification of harmful anionic substances from the fetus.	Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 1818611, Japan; Univ Tokyo, Dept Biopharmaceut, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Endou, H (reprint author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.						Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; Tojo A, 1999, J AM SOC NEPHROL, V10, P464; SIMONSON GD, 1994, J CELL SCI, V107, P1065; Ullrich KJ, 1997, J MEMBRANE BIOL, V158, P95, DOI 10.1007/s002329900247; Race JE, 1999, BIOCHEM BIOPH RES CO, V255, P508, DOI 10.1006/bbrc.1998.9978; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765; Kuze K, 1999, J BIOL CHEM, V274, P1519, DOI 10.1074/jbc.274.3.1519; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Griffiths M, 1997, BIOCHEM J, V328, P739; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471; Allikmets R, 1998, CANCER RES, V58, P5337; Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Beaulieu E, 1997, BIOCHEM J, V326, P539; Tsuda M, 1999, J PHARMACOL EXP THER, V289, P1301; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Kekuda R, 1998, J BIOL CHEM, V273, P15971, DOI 10.1074/jbc.273.26.15971; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Schomig E, 1998, FEBS LETT, V425, P79, DOI 10.1016/S0014-5793(98)00203-8; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295; Mori K, 1997, FEBS LETT, V417, P371, DOI 10.1016/S0014-5793(97)01325-2; Hosoyamada M, 1999, AM J PHYSIOL-RENAL, V276, pF122; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; SHIMADA H, 1987, AM J PHYSIOL, V253, pF795; Jariyawat S, 1999, J PHARMACOL EXP THER, V290, P672; Bradbury M, 1979, CONCEPT BLOOD BRAIN; BRANCHAUD CL, 1983, J CLIN ENDOCR METAB, V56, P761; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Matthews JC, 1998, AM J PHYSIOL-CELL PH, V274, pC603; MOLLER JV, 1983, PHARMACOL REV, V34, P315; Morgan DJ, 1997, CLIN EXP PHARMACOL P, V24, P869, DOI 10.1111/j.1440-1681.1997.tb02707.x; Okuda M, 1996, BIOCHEM BIOPH RES CO, V224, P500, DOI 10.1006/bbrc.1996.1056; Pardridge WM, 1991, PEPTIDE DRUG DELIVER; PETZINGER E, 1994, REV PHYSIOL BIOCH P, V123, P47, DOI 10.1007/BFb0030903; Rapoport S. I., 1976, BLOOD BRAIN BARRIER; SCHUETZ JD, 1993, J CLIN INVEST, V92, P1018, DOI 10.1172/JCI116607; SHIN BC, 1997, ENDOCRINOLOGY, V138, P3397; ULLRICH KJ, 1993, CLIN INVESTIGATOR, V71, P843; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	44	283	289	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4507	4512		10.1074/jbc.275.6.4507		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	283RJ	WOS:000085288800109		
J	Taninaka, C; Ohtani, H; Hanada, E; Kotaki, H; Sato, H; Iga, T				Taninaka, C; Ohtani, H; Hanada, E; Kotaki, H; Sato, H; Iga, T			Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection	JOURNAL OF CHROMATOGRAPHY B			English	Article						erythromycin; clarithromycin; roxithromycin; azithromycin	ELECTROCHEMICAL DETECTION; SERUM; URINE	In this study, a high-performance liquid chromatographic method was developed for the quantitative determination of erythromycin (EM), roxithromycin (RXM), and azithromycin (AZM) in rat plasma with amperometric detection under a standardized common condition using clarithromycin (CAM) as an internal standard. This method was also proved to be applicable for the determination of CAM by employing RXM as an internal standard. Each drug was extracted from 150 mu l of plasma sample spiked with internal standard under an alkaline condition with tert.-butyl methyl ether. The detector cell potential for the oxidation of the drugs was set at +950 mV. The linearity of the calibration curves were preserved over the concentration ranges of 0.1-10 mu g/ml for EM and RXM, and 0.03-3.0 mu g/ml for CAM and AZM. Coefficients of variation and relative error were less than 9% and +/-7%, respectively. The analytical method presented here was proved to be useful for the investigation of the pharmacokinetic characteristics of EM, CAM, RXM, and AZM in rats. (C) 2000 Elsevier Science B.V. All rights reserved.	Tokyo Univ Hosp, Dept Pharm, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pharm,Minato Ku, Tokyo 1080071, Japan	Sato, H (reprint author), Tokyo Univ Hosp, Dept Pharm, Fac Med, Bunkyo Ku, 3-1 Hongo 7 Chome, Tokyo 1138655, Japan.						BELL SC, 1969, APPL MICROBIOL, V17, P88; CHEN ML, 1983, J CHROMATOGR, V278, P91, DOI 10.1016/S0378-4347(00)84759-3; CHU SY, 1991, J CHROMATOGR-BIOMED, V571, P199, DOI 10.1016/0378-4347(91)80446-J; ESUMI Y, 1988, CHEMOTHERAPY, V36, P148; GRGURINOVICH N, 1988, J CHROMATOGR-BIOMED, V433, P298, DOI 10.1016/S0378-4347(00)80612-X; Hanada E, 1997, J CHROMATOGR B, V692, P478, DOI 10.1016/S0378-4347(97)00011-X; HEDENMO M, 1995, J CHROMATOGR A, V692, P161, DOI 10.1016/0021-9673(94)00610-L; JANECEK M, 1993, J CHROMATOGR-BIOMED, V619, P63, DOI 10.1016/0378-4347(93)80446-B; Kees F, 1998, J CHROMATOGR A, V812, P287, DOI 10.1016/S0021-9673(97)01279-X; LAAKSO S, 1990, J CHROMATOGR-BIOMED, V526, P475, DOI 10.1016/S0378-4347(00)82529-3; MORIMOTO S, 1990, J ANTIBIOT, V43, P295; ROTSCH TD, 1991, PHARMACEUT RES, V8, P989, DOI 10.1023/A:1015844705331; SHEPARD RM, 1990, J ANTIMICROB CHEMOTH, V25, P49; SHEPARD RM, 1991, J CHROMATOGR-BIOMED, V565, P321, DOI 10.1016/0378-4347(91)80393-Q; STUBBS C, 1985, J PHARM SCI, V74, P1126, DOI 10.1002/jps.2600741027; SUWA T, 1988, CHEMOTHERAPY, V36, P205; TORESON H, 1995, J CHROMATOGR B, V673, P81, DOI 10.1016/0378-4347(95)00251-D; TSUJI K, 1978, J CHROMATOGR, V147, P359, DOI 10.1016/S0021-9673(00)85147-X	18	84	90	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4347			J CHROMATOGR B	J. Chromatogr. B	FEB 11	2000	738	2					405	411		10.1016/S0378-4347(99)00512-5		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	286ZU	WOS:000085479400022		
J	Drabik, T; Thienpont, H; Ishikawa, M				Drabik, T; Thienpont, H; Ishikawa, M			Optics in computing: introduction to the feature issue	APPLIED OPTICS			English	Editorial Material								This issue of Applied Optics features 21 papers that describe the implementation of optics in computer systems and applications. This feature is the eighth in a series on the application of optics in the field of computing. (C) 2000 Optical Society of America.	Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; Univ Libre Brussels, Dept Appl Phys & Photon TONA TW, Lab Photon, B-150 Brussels, Belgium; Univ Tokyo, Dept Engn, Tokyo, Japan	Drabik, T (reprint author), Georgia Inst Technol, Sch Elect & Comp Engn, 777 Atlantic Dr NW, Atlanta, GA 30332 USA.	tim.drabik@ee.gatech.edu						0	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 10	2000	39	5					669	670		10.1364/AO.39.000669		2	Optics	Optics	284EU	WOS:000085318400001		
J	Gourlay, J; Yang, TY; Ishikawa, M; Walker, AC				Gourlay, J; Yang, TY; Ishikawa, M; Walker, AC			Low-order adaptive optics for free-space optoelectronic interconnects	APPLIED OPTICS			English	Article							SYSTEMS; DESIGN	The concept of adaptive optics for improving the cost-performance of free-space optoelectronic interconnects is discussed. Adaptive optics as a design option for optical interconnect systems is presented and discussed. A practical demonstrator that performs low-order correction was built and tested. Slowly varying misalignments, including thermal effects, were compensated for in a 622-Mbit/s free-space optical data link. (C) 2000 Optical Society of America.	Heriot Watt Univ, Dept Phys, Edinburgh EH141 4AS, Midlothian, Scotland; Univ Tokyo, Dept Math Engn & Informat Phys, Tokyo 113, Japan	Gourlay, J (reprint author), Heriot Watt Univ, Dept Phys, Edinburgh EH141 4AS, Midlothian, Scotland.	j.gourlay@hw.ac.uk					VDOVIN G, 1995, APPL OPTICS, V34, P2968, DOI 10.1364/AO.34.002968; BOISSET GC, 1995, IEEE PHOTONIC TECH L, V7, P676, DOI 10.1109/68.388762; Boisset GC, 1998, J LIGHTWAVE TECHNOL, V16, P847, DOI 10.1109/50.669016; Ghosh AK, 1996, IETE TECH REV, V13, P163; Gourlay J, 1998, COMPUTER, V31, P38, DOI 10.1109/2.652914; Gourlay J, 1997, OPT COMMUN, V137, P17, DOI 10.1016/S0030-4018(96)00756-0; Hirabayashi K, 1998, APPL OPTICS, V37, P2985, DOI 10.1364/AO.37.002985; LUI Y, 1998, APPL OPTICS, V37, P2895; MALINVERNI P, 1998, TECHNOLOGY ROADMAP O; MCCORMICK FB, 1991, OPTOMECHANICS DIMENS, V1533, P97; Morozov VN, 1996, OPT ENG, V35, P2034, DOI 10.1117/1.600782; NARUSE M, 1998, COMMUNICATION   0720; PATRA SK, 1994, OPT ENG, V33, P1561, DOI 10.1117/12.168412; Roggemann MC, 1997, REV MOD PHYS, V69, P437, DOI 10.1103/RevModPhys.69.437; WALKER AC, 1998, APPL OPTICS, V37, P2823; WILLIAMS EW, 1994, CD ROM OPTICAL DISK	16	6	6	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 10	2000	39	5					714	720		10.1364/AO.39.000714		7	Optics	Optics	284EU	WOS:000085318400007		
J	Tolias, KF; Hartwig, JH; Ishihara, H; Shibasaki, Y; Cantley, LC; Carpenter, CL				Tolias, KF; Hartwig, JH; Ishihara, H; Shibasaki, Y; Cantley, LC; Carpenter, CL			Type I alpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly	CURRENT BIOLOGY			English	Article							ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; PLATELET ACTIVATION; STRESS FIBERS; PROTEIN; RHO; NUCLEATION; FILAMENTS; FILOPODIA; GELSOLIN	Actin polymerization is essential for a variety of cellular processes including movement, cell division and shape change. The induction of actin polymerization requires the generation of free actin filament barbed ends, which results from the severing or uncapping of pre-existing actin filaments [1,2], or de novo nucleation, initiated by the Arp2/3 complex [3-7]. Although little is known about the signaling pathways that regulate actin assembly, small GTPases of the Rho family appear to be necessary [8-11]. In thrombin-stimulated platelets, the Rho family GTPase Rad induces actin polymerization by stimulating the uncapping of actin filament barbed ends [2]. The mechanism by which Pac regulates uncapping is unclear, however. We previously demonstrated that Pac interacts with a type I phosphatidylinositol-4-phosphate B-kinase (PIP 5-kinase) in a GTP-independent manner [12,13], Because PIP B-kinases synthesize phosphatidylinositol-4,5-bisphosphate (PI(4,5)P-2), a lipid that dissociates capping proteins from the barbed ends of actin filaments [14-16], they are good candidates for mediating the effects of Pac on actin assembly. Here, we have identified the Rac-associated PIP 5-kinase as the PIP B-kinase isoforms alpha and beta When added to permeabilized platelets, PIP B-kinase alpha induced actin filament uncapping and assembly. In contrast, a kinase-inactive PIP 5 kinase alpha mutant failed to induce actin assembly and blocked assembly stimulated by thrombin or Pac. Furthermore, thrombin- or Pac-induced actin polymerization was inhibited by a point mutation in the carboxyl terminus of Pac that disrupts PIP L-kinase binding, These results demonstrate that PIP B-kinase alpha is a critical mediator of thrombin- and Rac dependent actin assembly.	Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Tokyo, Dept Internal Med 3, Tokyo 113, Japan	Carpenter, CL (reprint author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, 75 Francis St, Boston, MA 02115 USA.		Cantley, Lewis/D-1800-2014	Cantley, Lewis/0000-0002-1298-7653			Machesky LM, 1997, BIOCHEM J, V328, P105; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; DAVIES TA, 1989, J BIOL CHEM, V264, P19600; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tolias KF, 1998, MOL CELL BIOL, V18, P762	18	180	186	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0960-9822			CURR BIOL	Curr. Biol.	FEB 10	2000	10	3					153	156		10.1016/S0960-9822(00)00315-8		4	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	284VT	WOS:000085354100019		
J	Ito, K; Uno, M; Nakamura, Y				Ito, K; Uno, M; Nakamura, Y			A tripeptide 'anticodon' deciphers stop codons in messenger RNA	NATURE			English	Article							RELEASE FACTOR-2; AMINO-ACID; ESCHERICHIA-COLI; PEPTIDE; TRANSLATION; SUPPRESSOR; MUTANT	The two translational release factors of prokaryotes, RF1 and RF2, catalyse the termination of polypeptide synthesis at UAG/UAA and UGA/UAA stop codons, respectively(1-3). However, how these polypeptide release factors read both non-identical and identical stop codons is puzzling(4), Here we describe the basis of this recognition. Swaps of each of the conserved domains between RF1 and RF2 in an RF1-RF2. hybrid led to the identification of a domain that could switch recognition specificity. A genetic selection among clones encoding random variants of this domain showed that the tripeptides Pro-Ala-Thr and Ser-Pro-Phe determine release-factor specificity in vivo in RF1 and RF2, respectively. An in vitro release study of tripeptide variants indicated that the first and third amino acids independently discriminate the second and third purine bases, respectively. Analysis with stop codons containing base analogues indicated that the C2 amino group of purine may be the primary target of discrimination of G from A. These findings show that the discriminator tripeptide of bacterial release factors is functionally equivalent to that of the anticodon of transfer RNA, irrespective of the difference between protein and RNA.	Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, Tokyo 1088639, Japan	Nakamura, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; AULD DS, 1995, SCIENCE, V267, P1994, DOI 10.1126/science.7701322; Buckingham RH, 1997, MOL MICROBIOL, V24, P449, DOI 10.1046/j.1365-2958.1997.3711734.x; GRICK FHC, 1966, J MOL BIOL, V19, P548; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; KAWAKAMI K, 1988, J BACTERIOL, V170, P5378; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; Nakamura Y, 1998, GENES CELLS, V3, P263; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; SOLL D, 1967, J MOL BIOL, V29, P113, DOI 10.1016/0022-2836(67)90184-2; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Yoshimura K, 1999, GENES CELLS, V4, P253, DOI 10.1046/j.1365-2443.1999.00260.x	16	187	192	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					680	684				5	Multidisciplinary Sciences	Science & Technology - Other Topics	283RD	WOS:000085288200060		
J	Breitweg, J; Chekanov, S; Derrick, M; Krakauer, D; Magill, S; Musgrave, B; Pellegrino, A; Repond, J; Stanek, R; Yoshida, R; Mattingly, MCK; Abbiendi, G; Anselmo, F; Antonioli, P; Bari, G; Basile, M; Bellagamba, L; Boscherini, D; Bruni, A; Bruni, G; Romeo, CG; Castellini, G; Cifarelli, L; Cindolo, F; Contin, A; Coppola, N; Corradi, M; De Pasquale, S; Giusti, P; Iacobucci, G; Laurenti, G; Levi, G; Margotti, A; Massam, T; Nania, R; Palmonari, F; Pesci, A; Polini, A; Sartorelli, G; Garcia, YZ; Zichichi, A; Amelung, C; Bornheim, A; Brock, I; Coboken, K; Crittenden, J; Deffner, R; Hartmann, H; Heinloth, K; Hilger, E; Jakob, HP; Kappes, A; Katz, UF; Kerger, R; Paul, E; Rautenberg, J; Schnurbusch, H; Stifutkin, A; Tandler, J; Voss, KC; Weber, A; Wieber, H; Bailey, DS; Barret, O; Brook, NH; Foster, B; Heath, GP; Heath, HF; McFall, JD; Piccioni, D; Rodrigues, E; Scott, J; Tapper, RJ; Capua, M; Mastroberardino, A; Schioppa, M; Susinno, G; Jeoung, HY; Kim, JY; Lee, JH; Lim, IT; Ma, KJ; Pac, MY; Caldwell, A; Liu, W; Liu, X; Mellado, B; Sacchi, R; Sampson, S; Sciulli, F; Chwastowski, J; Eskreys, A; Figiel, J; Klimek, K; Olkiewicz, K; Przybycien, MB; Stopa, P; Zawiejski, L; Adamczyk, L; Bednarek, B; Jelen, K; Kisielewska, D; Kowal, AM; Kowalski, T; Przybycien, M; Rulikowska-Zarebska, E; Suszycki, L; Zajac, J; Kotanski, A; Bauerdick, LAT; Behrens, U; Bienlein, JK; Burgard, C; Desler, K; Drews, G; Fox-Murphy, A; Fricke, U; Goebel, F; Gottlicher, P; Graciani, R; Haas, T; Hain, W; Hartner, GF; Hasell, D; Hebbel, K; Johnson, KF; Kasemann, M; Koch, W; Kotz, U; Kowalski, H; Lindemann, L; Lohr, B; Martinez, M; Milite, M; Monteiro, T; Moritz, M; Notz, D; Pelucchi, F; Petrucci, MC; Piotrzkowski, K; Rohde, M; Saull, PRB; Savin, AA; Schneekloth, U; Selonke, F; Sievers, M; Stonjek, S; Tassi, E; Wolf, G; Wollmer, U; Youngman, C; Zeuner, W; Coldewey, C; Grabosch, HJ; Viani, ALD; Meyer, A; Schlenstedt, S; Straub, PB; Barbagli, G; Gallo, E; Pelfer, P; Maccarone, G; Votano, L; Bamberger, A; Eisenhardt, S; Markun, P; Raach, H; Wolfle, S; Bussey, PJ; Doyle, AT; Lee, SW; Macdonald, N; McCance, GJ; Saxon, DH; Sinclair, LE; Skillicorn, IO; Waugh, R; Bohnet, I; Gendner, N; Holm, U; Meyer-Larsen, A; Salehi, H; Wick, K; Garfagnini, A; Gialas, I; Gladilin, LK; Kcira, D; Klanner, R; Lohrmann, E; Poelz, G; Zetsche, F; Goncalo, R; Long, KR; Miller, DB; Tapper, AD; Walker, R; Mallik, U; Wang, SM; Cloth, P; Filges, D; Ishii, T; Kuze, M; Nagano, K; Tokushuku, K; Yamada, S; Yamazaki, Y; Ahn, SH; An, SH; Hong, SJ; Lee, SB; Nam, SW; Park, SK; Lim, H; Park, IH; Son, D; Barreiro, F; Garcia, G; Glasman, C; Gonzalez, O; Labarga, L; del Peso, J; Redondo, I; Terron, J; Barbi, M; Corriveau, F; Hanna, DS; Hartmann, J; Ochs, A; Padhi, S; Riveline, M; Stairs, DG; Wing, M; Tsurugai, T; Bashkirov, V; Dolgoshein, BA; Bashindzhagyan, GL; Ermolov, PF; Golubkov, YA; Khein, LA; Korotkova, NA; Korzhavina, IA; Kuzmin, VA; Lukina, OY; Proskuryakov, AS; Shcheglova, LM; Solomin, AN; Zotkin, SA; Bokel, C; Botje, M; Brummer, N; Engelen, J; Koffeman, E; Kooijman, P; van Sighem, A; Tiecke, H; Tuning, N; Velthuis, JJ; Verkerke, W; Vossebeld, J; Wiggers, L; de Wolf, E; Bylsma, B; Durkin, LS; Gilmore, J; Ginsburg, CM; Kim, CL; Ling, TY; Nylander, P; Boogert, S; Cooper-Sarkar, AM; Devenish, RCE; Grosse-Knetter, J; Matsushita, T; Ruske, O; Sutton, MR; Walczak, R; Bertolin, A; Brugnera, R; Carlin, R; Dal Corso, F; Dondana, S; Dosselli, U; Dusini, S; Limentani, S; Morandin, M; Posocco, M; Stanco, L; Stroili, R; Voci, C; Iannotti, L; Oh, BY; Okrasinski, JR; Toothacker, WS; Whitmore, JJ; Iga, Y; D'Agostini, G; Marini, G; Nigro, A; Cormack, C; Hart, JC; McCubbin, NA; Shah, TP; Epperson, D; Heusch, C; Sadrozinski, HFW; Seiden, A; Wichmann, R; Williams, DC; Pavel, N; Abramowicz, H; Dagan, S; Kananov, S; KReisel, A; Levy, A; Abe, T; Fusayasu, T; Umemori, K; Yamashita, T; Hamatsu, R; Hirose, T; Inuzuka, M; Kiatmura, S; Nishimura, T; Arneodo, M; Cartiglia, N; Cirio, R; Costa, M; Ferrero, MI; Maselli, S; Monaco, V; Peroni, C; Ruspa, M; Solano, A; Staiano, A; Dardo, M; Bailey, DC; Fagerstroem, CP; Galea, R; Koop, T; Levman, GM; Martin, JF; Orr, RS; Polenz, S; Sabetfakhri, A; Simmons, D; Butterworth, JM; Catterall, CD; Hayes, ME; Heaphy, EA; Jones, TW; Lane, JB; Weest, BJ; Ciborowski, J; Ciesielski, R; Grzelak, G; Nowak, RJ; Pawlak, JM; Pawlak, R; Smalska, B; Tymieniecka, T; Wroblewski, AK; Zakrzewski, JA; Zarnecki, AF; Adamus, M; Gadaj, T; Deppe, O; Eisenberg, Y; Hochman, D; Karshon, U; Badgett, WF; Chapin, D; Cross, R; Foudas, C; Mattingly, S; Reeder, DD; Smith, WH; Vaiciulis, A; Wildschek, T; Wodarczyk, M; Deshpande, A; Dhawan, S; Hughes, VW; Bhadra, S; Cole, JE; Frisken, WR; Hall-Wilton, R; Khakzad, M; Menary, S; Schmidke, WB				Breitweg, J; Chekanov, S; Derrick, M; Krakauer, D; Magill, S; Musgrave, B; Pellegrino, A; Repond, J; Stanek, R; Yoshida, R; Mattingly, MCK; Abbiendi, G; Anselmo, F; Antonioli, P; Bari, G; Basile, M; Bellagamba, L; Boscherini, D; Bruni, A; Bruni, G; Romeo, CG; Castellini, G; Cifarelli, L; Cindolo, F; Contin, A; Coppola, N; Corradi, M; De Pasquale, S; Giusti, P; Iacobucci, G; Laurenti, G; Levi, G; Margotti, A; Massam, T; Nania, R; Palmonari, F; Pesci, A; Polini, A; Sartorelli, G; Garcia, YZ; Zichichi, A; Amelung, C; Bornheim, A; Brock, I; Coboken, K; Crittenden, J; Deffner, R; Hartmann, H; Heinloth, K; Hilger, E; Jakob, HP; Kappes, A; Katz, UF; Kerger, R; Paul, E; Rautenberg, J; Schnurbusch, H; Stifutkin, A; Tandler, J; Voss, KC; Weber, A; Wieber, H; Bailey, DS; Barret, O; Brook, NH; Foster, B; Heath, GP; Heath, HF; McFall, JD; Piccioni, D; Rodrigues, E; Scott, J; Tapper, RJ; Capua, M; Mastroberardino, A; Schioppa, M; Susinno, G; Jeoung, HY; Kim, JY; Lee, JH; Lim, IT; Ma, KJ; Pac, MY; Caldwell, A; Liu, W; Liu, X; Mellado, B; Sacchi, R; Sampson, S; Sciulli, F; Chwastowski, J; Eskreys, A; Figiel, J; Klimek, K; Olkiewicz, K; Przybycien, MB; Stopa, P; Zawiejski, L; Adamczyk, L; Bednarek, B; Jelen, K; Kisielewska, D; Kowal, AM; Kowalski, T; Przybycien, M; Rulikowska-Zarebska, E; Suszycki, L; Zajac, J; Kotanski, A; Bauerdick, LAT; Behrens, U; Bienlein, JK; Burgard, C; Desler, K; Drews, G; Fox-Murphy, A; Fricke, U; Goebel, F; Gottlicher, P; Graciani, R; Haas, T; Hain, W; Hartner, GF; Hasell, D; Hebbel, K; Johnson, KF; Kasemann, M; Koch, W; Kotz, U; Kowalski, H; Lindemann, L; Lohr, B; Martinez, M; Milite, M; Monteiro, T; Moritz, M; Notz, D; Pelucchi, F; Petrucci, MC; Piotrzkowski, K; Rohde, M; Saull, PRB; Savin, AA; Schneekloth, U; Selonke, F; Sievers, M; Stonjek, S; Tassi, E; Wolf, G; Wollmer, U; Youngman, C; Zeuner, W; Coldewey, C; Grabosch, HJ; Viani, ALD; Meyer, A; Schlenstedt, S; Straub, PB; Barbagli, G; Gallo, E; Pelfer, P; Maccarone, G; Votano, L; Bamberger, A; Eisenhardt, S; Markun, P; Raach, H; Wolfle, S; Bussey, PJ; Doyle, AT; Lee, SW; Macdonald, N; McCance, GJ; Saxon, DH; Sinclair, LE; Skillicorn, IO; Waugh, R; Bohnet, I; Gendner, N; Holm, U; Meyer-Larsen, A; Salehi, H; Wick, K; Garfagnini, A; Gialas, I; Gladilin, LK; Kcira, D; Klanner, R; Lohrmann, E; Poelz, G; Zetsche, F; Goncalo, R; Long, KR; Miller, DB; Tapper, AD; Walker, R; Mallik, U; Wang, SM; Cloth, P; Filges, D; Ishii, T; Kuze, M; Nagano, K; Tokushuku, K; Yamada, S; Yamazaki, Y; Ahn, SH; An, SH; Hong, SJ; Lee, SB; Nam, SW; Park, SK; Lim, H; Park, IH; Son, D; Barreiro, F; Garcia, G; Glasman, C; Gonzalez, O; Labarga, L; del Peso, J; Redondo, I; Terron, J; Barbi, M; Corriveau, F; Hanna, DS; Hartmann, J; Ochs, A; Padhi, S; Riveline, M; Stairs, DG; Wing, M; Tsurugai, T; Bashkirov, V; Dolgoshein, BA; Bashindzhagyan, GL; Ermolov, PF; Golubkov, YA; Khein, LA; Korotkova, NA; Korzhavina, IA; Kuzmin, VA; Lukina, OY; Proskuryakov, AS; Shcheglova, LM; Solomin, AN; Zotkin, SA; Bokel, C; Botje, M; Brummer, N; Engelen, J; Koffeman, E; Kooijman, P; van Sighem, A; Tiecke, H; Tuning, N; Velthuis, JJ; Verkerke, W; Vossebeld, J; Wiggers, L; de Wolf, E; Bylsma, B; Durkin, LS; Gilmore, J; Ginsburg, CM; Kim, CL; Ling, TY; Nylander, P; Boogert, S; Cooper-Sarkar, AM; Devenish, RCE; Grosse-Knetter, J; Matsushita, T; Ruske, O; Sutton, MR; Walczak, R; Bertolin, A; Brugnera, R; Carlin, R; Dal Corso, F; Dondana, S; Dosselli, U; Dusini, S; Limentani, S; Morandin, M; Posocco, M; Stanco, L; Stroili, R; Voci, C; Iannotti, L; Oh, BY; Okrasinski, JR; Toothacker, WS; Whitmore, JJ; Iga, Y; D'Agostini, G; Marini, G; Nigro, A; Cormack, C; Hart, JC; McCubbin, NA; Shah, TP; Epperson, D; Heusch, C; Sadrozinski, HFW; Seiden, A; Wichmann, R; Williams, DC; Pavel, N; Abramowicz, H; Dagan, S; Kananov, S; KReisel, A; Levy, A; Abe, T; Fusayasu, T; Umemori, K; Yamashita, T; Hamatsu, R; Hirose, T; Inuzuka, M; Kiatmura, S; Nishimura, T; Arneodo, M; Cartiglia, N; Cirio, R; Costa, M; Ferrero, MI; Maselli, S; Monaco, V; Peroni, C; Ruspa, M; Solano, A; Staiano, A; Dardo, M; Bailey, DC; Fagerstroem, CP; Galea, R; Koop, T; Levman, GM; Martin, JF; Orr, RS; Polenz, S; Sabetfakhri, A; Simmons, D; Butterworth, JM; Catterall, CD; Hayes, ME; Heaphy, EA; Jones, TW; Lane, JB; Weest, BJ; Ciborowski, J; Ciesielski, R; Grzelak, G; Nowak, RJ; Pawlak, JM; Pawlak, R; Smalska, B; Tymieniecka, T; Wroblewski, AK; Zakrzewski, JA; Zarnecki, AF; Adamus, M; Gadaj, T; Deppe, O; Eisenberg, Y; Hochman, D; Karshon, U; Badgett, WF; Chapin, D; Cross, R; Foudas, C; Mattingly, S; Reeder, DD; Smith, WH; Vaiciulis, A; Wildschek, T; Wodarczyk, M; Deshpande, A; Dhawan, S; Hughes, VW; Bhadra, S; Cole, JE; Frisken, WR; Hall-Wilton, R; Khakzad, M; Menary, S; Schmidke, WB		ZEUS Collaboration	Measurement of the E-T(2),jet/Q(2) dependence of forward-jet production at HERA	PHYSICS LETTERS B			English	Article							INITIAL STATE RADIATION; QCD COHERENCE; SMALL-X; DISTRIBUTIONS; SCATTERING; GENERATOR; CASCADES	The forward-jet cross section in deep inelastic e(+)p scattering has been measured using the ZEUS detector at HERA with an integrated luminosity of 6.36 pb(-1). The jet cross section is presented as a function of jet transverse energy squared, E-T,jet(2), and Q(2) in the kinematic ranges 10(-2) < E-T,jet(2)/Q(2) < 10(2) and 2.5.10(-4) < x < 8.0.10(-2). Since the perturbative QCD predictions for this cross section are sensitive to the treatment of the log(E-T,jet(2)/Q(2)) terms, this measurement provides an important test. The measured cross section is compared to the predictions of a next-to-leading order pQCD calculation as well as to various leading-order Monte Carlo models. Whereas the predictions of all models agree with the measured cross section in the region of small E-T,jet(2)/Q(2), only one model, which includes a resolved photon component, describes the data over the whole kinematic range. (C) 2000 Elsevier Science B.V. All rights reserved.	Argonne Natl Lab, Argonne, IL 60439 USA; Andrews Univ, Berrien Springs, MI 49104 USA; Univ Bologna, Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-5300 Bonn, Germany; Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; Univ Calabria, Dept Phys, I-87036 Cosenza, Italy; Ist Nazl Fis Nucl, Cosenza, Italy; Chonnam Natl Univ, Kwangju, South Korea; Columbia Univ, Nevis Labs, Irvington, NY USA; Inst Nucl Phys, Krakow, Poland; Acad Min & Met, Fac Phys & Nucl Tech, Krakow, Poland; Jagiellonian Univ, Dept Phys, PL-31007 Krakow, Poland; Deutsch Elekt Synchrotron DESY, Hamburg, Germany; DESY Zeuthen, Zeuthen, Germany; Univ Florence, I-50121 Florence, Italy; Ist Nazl Fis Nucl, I-50125 Florence, Italy; Ist Nazl Fis Nucl, Lab Nazl Frascati, Frascati, Italy; Univ Freiburg i Br, Fak Phys, Freiburg i Br, Germany; Univ Glasgow, Dept Phys & Astron, Glasgow, Lanark, Scotland; Univ Hamburg, Inst Exp Phys 1, Hamburg, Germany; Univ Hamburg, Inst Expt Phys 2, D-2000 Hamburg, Germany; Univ London Imperial Coll Sci Technol & Med, High Energy Nucl Phys Grp, London, England; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Forschungszentrum Julich, Inst Kernphys, D-5170 Julich, Germany; KEK, Inst Particle & Nucl Studies, Tsukuba, Ibaraki, Japan; Korea Univ, Seoul 136701, South Korea; Kyungpook Natl Univ, Taegu 702701, South Korea; Univ Autonoma Madrid, Dept Fis Teor, Madrid, Spain; McGill Univ, Dept Phys, Montreal, PQ, Canada; Meiji Gakuin Univ, Fac Gen Educ, Yokohama, Kanagawa, Japan; Moscow Engn Phys Inst, Moscow, Russia; Moscow MV Lomonosov State Univ, Inst Nucl Phys, Moscow, Russia; NIKHEF, Amsterdam, Netherlands; Univ Amsterdam, Amsterdam, Netherlands; Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; Univ Oxford, Dept Phys, Oxford, England; Univ Padua, Dipartimento Fis, Padua, Italy; Ist Nazl Fis Nucl, Padua, Italy; Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Polytech Univ, Sagamihara, Kanagawa, Japan; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; Ist Nazl Fis Nucl, Rome, Italy; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ Siegen, Fachbereich Phys, D-5900 Siegen, Germany; Tel Aviv Univ, Sch Phys, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel; Univ Tokyo, Dept Phys, Tokyo 113, Japan; Tokyo Metropolitan Univ, Dept Phys, Tokyo, Japan; Univ Turin, Dipartimento Fis Sperimentale, Turin, Italy; Ist Nazl Fis Nucl, I-10125 Turin, Italy; Univ Turin, Fac Sci 2, Alessandria, Italy; Ist Nazl Fis Nucl, Alessandria, Italy; Univ Toronto, Dept Phys, Toronto, ON, Canada; UCL, Dept Phys & Astron, London, England; Warsaw Univ, Inst Expt Phys, Warsaw, Poland; Inst Nucl Studies, PL-00681 Warsaw, Poland; Weizmann Inst Sci, Dept Particle Phys, IL-76100 Rehovot, Israel; Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; Yale Univ, Dept Phys, New Haven, CT USA; York Univ, Dept Phys, Toronto, ON M3J 2R7, Canada	Breitweg, J (reprint author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.		De Pasquale, Salvatore/B-9165-2008; Morandin, Mauro/A-3308-2016; Wing, Matthew/C-2169-2008; Bashkirov, Vladimir/A-4818-2008; Doyle, Anthony/C-5889-2009; Golubkov, Yury/E-1643-2012; Proskuryakov, Alexander/J-6166-2012; Katz, Uli/E-1925-2013; Wiggers, Leo/B-5218-2015; Tassi, Enrico/K-3958-2015; Gladilin, Leonid/B-5226-2011	Morandin, Mauro/0000-0003-4708-4240; Katz, Uli/0000-0002-7063-4418; Wiggers, Leo/0000-0003-1060-0520; Gladilin, Leonid/0000-0001-9422-8636			ADLOFF C, UNPUB EUR PHYS J C; Adloff C, 1999, NUCL PHYS B, V538, P3, DOI 10.1016/S0550-3213(98)00745-7; Andersson B, 1996, NUCL PHYS B, V463, P217, DOI 10.1016/0550-3213(96)00022-3; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; CATANI S, 1990, PHYS LETT B, V234, P339, DOI 10.1016/0370-2693(90)91938-8; MARCHESINI G, 1995, NUCL PHYS B, V445, P49, DOI 10.1016/0550-3213(95)00149-M; GRIBOV VN, 1972, SOV J NUCL PHYS+, V15, P438; CIAFALONI M, 1988, NUCL PHYS B, V296, P49, DOI 10.1016/0550-3213(88)90380-X; LONNBLAD L, 1992, COMPUT PHYS COMMUN, V71, P15, DOI 10.1016/0010-4655(92)90068-A; CATANI S, 1990, NUCL PHYS B, V336, P18, DOI 10.1016/0550-3213(90)90342-B; Dokshitzer Y. L., 1977, SOV PHYS JETP, V46, P641, DOI DOI 10.1016/0550-3213(77)90384-4; INGELMAN G, 1992, 1991 P WORKSH PHYS H, V3, P1366; JUNG H, 1995, COMPUT PHYS COMMUN, V86, P147, DOI 10.1016/0010-4655(94)00150-Z; Jung H, 1999, EUR PHYS J C, V9, P383, DOI 10.1007/s100520050031; Kramer G, 1998, EUR PHYS J C, V5, P665; Kramer G, 1999, PHYS LETT B, V453, P295, DOI 10.1016/S0370-2693(99)00376-7; Kuraev E. A., 1977, SOV PHYS JETP, V45, P199; BALITSKII YY, 1978, SOV J NUCL PHYS+, V28, P822; MUELLER AH, 1991, J PHYS G NUCL PARTIC, V17, P1443, DOI 10.1088/0954-3899/17/10/001; Parisi G, 1977, NUCL PHYS B, VB126, P297; POTTER BP, COMMUNICATION; Schuler GA, 1996, PHYS LETT B, V376, P193, DOI 10.1016/0370-2693(96)00265-1; Breitweg J, 1999, EUR PHYS J C, V6, P239, DOI 10.1007/s100520050335	23	25	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	FEB 10	2000	474	1-2					223	233		10.1016/S0370-2693(99)01478-1		11	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	285KG	WOS:000085387800031		
J	Ishitani, H; Komiyama, S; Hasegawa, Y; Kobayashi, S				Ishitani, H; Komiyama, S; Hasegawa, Y; Kobayashi, S			Catalytic asymmetric Strecker synthesis. Preparation of enantiomerically pure alpha-amino acid derivatives from aldimines and tributyltin cyanide or achiral aldehydes, amines, and hydrogen cyanide using a chiral zirconium catalyst	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							LANTHANIDE TRIFLATE; FACILE SYNTHESIS; BETA-AMINO; AMINONITRILES; COMPLEX	Catalytic enantioselective Stocker-type reactions of aldimines with tributyltin cyanide (Bu3SnCN) proceeded smoothly in the presence of a novel chiral zirconium catalyst. High levels of enantioselectivities in the synthesis of alpha-amino nitrile derivatives with wide substrate generality were obtained via these reactions. In addition, hydrogen cyanide (HCN) was successfully used instead of Bu3SnCN as the cyanide source. Catalytic asymmetric Strecker amino acid synthesis starting from achiral aldehydes, amines, and HCN using a chiral zirconium catalyst has also been achieved. The three-component asymmetric process reported here significantly improves upon the original Stocker reaction, and has advantages over previous reactions using unstable imines (Schiff bases) as starting materials. Moreover, high yields and enantioselectivities have been obtained even in the reactions using aliphatic aldehydes, and both enantiomers of various types of alpha-amino acid derivatives can be prepared. As demonstrations to show the utility of this reaction, efficient syntheses of homophenylalanine, leucine amide, and pipecolic acid derivatives have been performed. Finally, two novel binuclear zirconium complexes (3 and 4) are postulated to be active chiral catalysts in the reactions of aldimines with Bu3SnCN and the three-component reactions, respectively, and low loading levels of the chiral catalysts (1-2.5 mol %) have been accomplished in both cases.	Univ Tokyo, CREST, Japan Sci & Technol Corp, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan; Sci Univ Tokyo, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan	Kobayashi, S (reprint author), Univ Tokyo, CREST, Japan Sci & Technol Corp, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				Sigman MS, 1998, J AM CHEM SOC, V120, P4901, DOI 10.1021/ja980139y; SASAI H, 1995, J ORG CHEM, V60, P7388, DOI 10.1021/jo00128a005; Kobayashi S, 1998, ANGEW CHEM INT EDIT, V37, P979, DOI 10.1002/(SICI)1521-3773(19980420)37:7<979::AID-ANIE979>3.0.CO;2-5; Kobayashi S, 1998, J AM CHEM SOC, V120, P431, DOI 10.1021/ja973527t; DUTHALER RO, 1994, TETRAHEDRON, V50, P1539, DOI 10.1016/S0040-4020(01)80840-1; Ishitani H, 1998, ANGEW CHEM INT EDIT, V37, P3186, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3186::AID-ANIE3186>3.0.CO;2-E; Sigman MS, 1998, J AM CHEM SOC, V120, P5315, DOI 10.1021/ja980299+; Krueger CA, 1999, J AM CHEM SOC, V121, P4284, DOI 10.1021/ja9840605; Corey EJ, 1999, ORG LETT, V1, P157, DOI 10.1021/ol990623l; COX PJ, 1992, TETRAHEDRON LETT, V33, P2253, DOI 10.1016/S0040-4039(00)74182-7; Iyer MS, 1996, J AM CHEM SOC, V118, P4910, DOI 10.1021/ja952686e; Barrett G. C., 1985, CHEM BIOCH AMINO ACI; BROWN JM, 1972, J CHEM SOC DALTON, P338, DOI 10.1039/dt9720000338; CACCHI S, 1980, SYNTHESIS-STUTTGART, P243; DAVIES AG, 1971, J CHEM SOC C, P3972, DOI 10.1039/j39710003972; HARUSAWA S, 1987, TETRAHEDRON LETT, V28, P4189, DOI 10.1016/S0040-4039(00)95575-8; ISHITANI H, 1997, J AM CHEM SOC, V119, P6984; JACOBSON RA, 1946, J AM CHEM SOC, V68, P2628, DOI 10.1021/ja01216a059; JACOBSON RA, 1945, J AM CHEM SOC, V67, P1996, DOI 10.1021/ja01227a039; Kobayashi S, 1997, SYNLETT, P115; KOBAYASHI S, 1995, TETRAHEDRON LETT, V36, P5773, DOI 10.1016/0040-4039(95)01096-Z; Kobayashi S, 1998, J CHEM SOC CHEM COMM, P981; KRONENTHAL DR, 1982, J ORG CHEM, V47, P2765, DOI 10.1021/jo00135a016; LEBLANC JP, 1992, TETRAHEDRON LETT, V33, P6295, DOI 10.1016/S0040-4039(00)60956-5; LUIJTEN JGA, 1995, INVESTIGATIONS FIELD, P106; MAI K, 1984, TETRAHEDRON LETT, V25, P4583, DOI 10.1016/S0040-4039(01)91205-5; McGrath ME, 1997, NAT STRUCT BIOL, V4, P105, DOI 10.1038/nsb0297-105; OJIMA I, 1975, CHEM LETT, P331, DOI 10.1246/cl.1975.331; SAHOO SP, 1995, BIOORG MED CHEM LETT, V5, P2441, DOI 10.1016/0960-894X(95)00425-S; Shafran Y. M., 1989, RUSS CHEM REV, V58, P148, DOI 10.1070/RC1989v058n02ABEH003432; Strecker A, 1850, LIEBIGS ANN CHEM, V75, P27; TANAKA M, 1980, TETRAHEDRON LETT, V21, P2959, DOI 10.1016/0040-4039(80)88008-7; TERADA M, 1994, TETRAHEDRON LETT, V35, P6693, DOI 10.1016/S0040-4039(00)73470-8; WALIA JS, 1974, CHEM LETT, P1005, DOI 10.1246/cl.1974.1005; Williams R. M., 1989, SYNTHESIS OPTICALLY; WILLIAMS RM, 1992, CHEM REV, V92, P889, DOI 10.1021/cr00013a007; Yamada M, 1998, TETRAHEDRON LETT, V39, P9019, DOI 10.1016/S0040-4039(98)02023-1	37	172	172	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 9	2000	122	5					762	766		10.1021/ja9935207		5	Chemistry, Multidisciplinary	Chemistry	283UP	WOS:000085294700002		
J	Nakamura, M; Hirai, A; Nakamura, E				Nakamura, M; Hirai, A; Nakamura, E			Iron-catalyzed olefin carbometalation	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							GRIGNARD-REAGENTS; MONOSUBSTITUTED ALKENES; ZINCATED HYDRAZONE; ALDOL REACTION; CYCLOPROPENE; ACETALS; ALLYLZINCATION; HALIDES; ESTERS		Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Nakamura, E (reprint author), Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		nakamura, masaharu/A-8664-2013; NAKAMURA, EIICHI/G-5041-2014	nakamura, masaharu/0000-0002-1419-2117; 			AOKI S, 1988, J AM CHEM SOC, V110, P3296, DOI 10.1021/ja00218a048; SEKIYA K, 1988, TETRAHEDRON LETT, V29, P5155, DOI 10.1016/S0040-4039(00)80706-6; NAKAMURA E, 1987, J AM CHEM SOC, V109, P8056, DOI 10.1021/ja00260a018; KLEIN S, 1995, J AM CHEM SOC, V117, P8853, DOI 10.1021/ja00139a020; TAKAYA H, 1986, J ORG CHEM, V51, P629, DOI 10.1021/jo00355a012; Lautens M, 1996, J ORG CHEM, V61, P7246, DOI 10.1021/jo961615a; YANAGISAWA A, 1989, J AM CHEM SOC, V111, P366, DOI 10.1021/ja00183a056; TAMURA M, 1971, J AM CHEM SOC, V93, P1487, DOI 10.1021/ja00735a030; Kondakov DY, 1996, J AM CHEM SOC, V118, P1577, DOI 10.1021/ja953655m; NAKAMURA E, 1988, J AM CHEM SOC, V110, P1297, DOI 10.1021/ja00212a051; MIYASHITA A, 1980, J AM CHEM SOC, V102, P7932, DOI 10.1021/ja00547a020; KONDAKOV DY, 1995, J AM CHEM SOC, V117, P10771, DOI 10.1021/ja00148a031; Davies S. G., 1982, ORGANOTRANSITION MET; FUJIMURA T, 1991, J ORG CHEM, V56, P2810; Gomez-Bengoa E, 1998, J AM CHEM SOC, V120, P7649, DOI 10.1021/ja980499l; KOCHI JK, 1978, ORGANOMETALLIC MECH, P246; KUBOTA K, 1993, J AM CHEM SOC, V115, P5867, DOI 10.1021/ja00066a082; Kubota K, 1997, ANGEW CHEM INT EDIT, V36, P2491, DOI 10.1002/anie.199724911; Marek I, 1999, J CHEM SOC PERK T 1, P535, DOI 10.1039/a807060a; Nakamura E, 1997, TETRAHEDRON LETT, V38, P7099, DOI 10.1016/S0040-4039(97)01712-7; Nakamura E, 1997, J AM CHEM SOC, V119, P5457, DOI 10.1021/ja9706357; Nakamura E, 1997, J ORG CHEM, V62, P792, DOI 10.1021/jo962140q; Nakamura E, 1998, TETRAHEDRON LETT, V39, P2157, DOI 10.1016/S0040-4039(98)00145-2; NAKAMURA E, 1992, J ORG CHEM, V57, P5809, DOI 10.1021/jo00048a004; NAKAMURA M, 1995, J AM CHEM SOC, V117, P1179, DOI 10.1021/ja00108a055; Nakamura M, 1998, J SYN ORG CHEM JPN, V56, P632; NAKAMURA S, 1991, SYNLETT, P539; NEUMANN SM, 1975, J ORG CHEM, V40, P599, DOI 10.1021/jo00893a013; PEARSON AJ, 1992, COMPREHENSIVE ORGANO, V8, P939; Pfaltz A, 1999, COMPREHENSIVE ASYMME, P431; SMITH RS, 1976, J ORG CHEM, V41, P502, DOI 10.1021/jo00865a019; YANAGISAWA A, 1991, SYNLETT, P513	32	143	144	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 9	2000	122	5					978	979		10.1021/ja983066r		2	Chemistry, Multidisciplinary	Chemistry	283UP	WOS:000085294700039		
J	Tone, Y; Tanahashi, N; Tanaka, K; Fujimuro, M; Yokosawa, H; Toh-e, A				Tone, Y; Tanahashi, N; Tanaka, K; Fujimuro, M; Yokosawa, H; Toh-e, A			Nob1p, a new essential protein, associates with the 26S proteasome of growing Saccharomyces cerevisiae cells	GENE			English	Article						proteolysis; two-hybrid screening; yeast	20S PROTEASOME; REGULATORY PARTICLE; UBIQUITIN SYSTEM; YEAST; GENE; DEGRADATION; IDENTIFICATION; PURIFICATION; INHIBITORS; MACROPAIN	Nob1p, which interacts with Nin1p/Rpn12, a subunit of the 19S regulatory particle (RP) of the yeast 26S proteasome, has been identified by two-hybrid screening. NOB1 was found to be an essential gene, encoding a protein of 459 amino acid residues. Nob1p was detected in growing cells but not in cells in the stationary phase. During the transition to the stationary phase, Nob1p was degraded, at least in part, by the 26S proteasome. Nob1p was found only in proteasomal fractions in a glycerol gradient centrifugation profile and immuno-coprecipitated with Rpt1, which is an ATPase component of the yeast proteasomes. These results suggest that association of Nob1p with the proteasomes is essential for the function of the proteasomes in growing cells. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo 1138613, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0600812, Japan	Toh-e, A (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	toh-e@biol.s.u-tokyo.ac.jp					Lee DH, 1996, J BIOL CHEM, V271, P27280; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Papa FR, 1999, MOL BIOL CELL, V10, P741; MA CP, 1992, J BIOL CHEM, V267, P10515; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; NISOGI H, 1992, EXP CELL RES, V200, P48, DOI 10.1016/S0014-4827(05)80070-9; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Schauber C, 1998, NATURE, V391, P715; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; TOHE A, 1995, CURR GENET, V27, P293, DOI 10.1007/BF00352095; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fujimuro M, 1998, FEBS LETT, V423, P149, DOI 10.1016/S0014-5793(98)00084-2; Fujimuro M, 1998, BIOCHEM BIOPH RES CO, V251, P818, DOI 10.1006/bbrc.1998.9560; Glickman MH, 1998, MOL CELL BIOL, V18, P3149; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; HEINEMEYER W, 1994, BIOCHEMISTRY-US, V33, P12229, DOI 10.1021/bi00206a028; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; Kominami K, 1997, MOL BIOL CELL, V8, P171; LAEMMLI UK, 1970, NATURE, V307, P183; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303; Miller J. H., 1972, EXPT MOL GENETICS; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; PETERS JM, 1994, J BIOL CHEM, V269, P7709; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; SAMBROOK J, 1989, MOL CLONING LAB MANU; [Anonymous], 1991, METHOD ENZYMOL; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; TANAKA K, 1988, J BIOL CHEM, V263, P16209	39	38	43	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	FEB 8	2000	243	1-2					37	45		10.1016/S0378-1119(99)00566-1		9	Genetics & Heredity	Genetics & Heredity	285GR	WOS:000085381800005		
J	Yagi, Y; Matsushita, SI; Tryk, DA; Koda, T; Fujishima, A				Yagi, Y; Matsushita, SI; Tryk, DA; Koda, T; Fujishima, A			Observation of light propagation in single layers of composite two-dimensional arrays	LANGMUIR			English	Article							LATEX-PARTICLES; CRYSTALS; SPHERES	Composite two-dimensional (2D) polystyrene (PSt) arrays, composed of three types of PSt particles, red fluorescent, green fluorescent, and nonfluorescent, were prepared from an aqueous suspension These arrays form as a result of water evaporation and capillary forces. Using fluorescence microscopy and phase-contrast microscopy, we observed several interesting types of light propagation phenomena in single layers of the array, including anisotropic light propagation, an additive effect for light intensity, and a novel switch function. These characteristic light propagation phenomena indicate some of the possibilities of the 2D array as a photonic device.	Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Japan Womens Univ, Fac Sci, Dept Math & Phys Sci, Bunkyo Ku, Tokyo 1128681, Japan	Fujishima, A (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Tryk, Donald/D-5931-2012; Fujishima, Akira/G-7701-2012; Matsushita, Sachiko/D-5251-2015	Tryk, Donald/0000-0003-4660-9674; Matsushita, Sachiko/0000-0001-8699-295X			Dimitrov AS, 1996, LANGMUIR, V12, P1303, DOI 10.1021/la9502251; Miguez H, 1997, APPL PHYS LETT, V71, P1148, DOI 10.1063/1.119849; Trau M, 1996, SCIENCE, V272, P706, DOI 10.1126/science.272.5262.706; Matsushita SI, 1998, LANGMUIR, V14, P6441, DOI 10.1021/la981106z; Bogomolov VN, 1997, PHYS REV E, V55, P7619, DOI 10.1103/PhysRevE.55.7619; HAYASHI S, 1991, J COLLOID INTERF SCI, V144, P538, DOI 10.1016/0021-9797(91)90419-9; Park SH, 1999, LANGMUIR, V15, P266, DOI 10.1021/la980658e; DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0; Imhof A, 1997, NATURE, V389, P948; DENKOV ND, 1992, LANGMUIR, V8, P3183, DOI 10.1021/la00048a054; Fujimura T, 1997, MAT SCI ENG B-SOLID, V48, P94, DOI 10.1016/S0921-5107(97)00087-1; FUJIMURA T, 1997, OPT LETT, V22, P1; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; MASTUSHITA S, 1997, LANGMUIR, V13, P2582; MATSUSHITA IS, 1995, LANGMUIR, V15; MICHELETTO R, 1995, LANGMUIR, V11, P3333, DOI 10.1021/la00009a012; Miyazaki H, 1998, PHYS REV B, V58, P6920, DOI 10.1103/PhysRevB.58.6920; Picard G, 1997, LANGMUIR, V13, P264, DOI 10.1021/la950841x; Foresi JS, 1997, NATURE, V390, P143; YABLONOVITCH E, 1993, J OPT SOC AM B, V10, P283, DOI 10.1364/JOSAB.10.000283	20	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	FEB 8	2000	16	3					1180	1184		10.1021/la9905867		5	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	281UJ	WOS:000085178900043		
J	Chamberlain, RV; Slowinska, K; Majda, M; Buhlmann, P; Aoki, H; Umezawa, Y				Chamberlain, RV; Slowinska, K; Majda, M; Buhlmann, P; Aoki, H; Umezawa, Y			Electrostatically-induced inclusion of anions in cyclodextrin monolayers on electrodes	LANGMUIR			English	Article							SELF-ASSEMBLED MONOLAYERS; HOST-GUEST INTERACTION; BETA-CYCLODEXTRIN; ALPHA-CYCLODEXTRIN; THIOLATED CYCLODEXTRIN; MOLECULAR RECOGNITION; CHLORIDE CHANNELS; INORGANIC ANIONS; NMR-SPECTROSCOPY; AQUEOUS-SOLUTION	Oxidative mercury-thiolate bond formation accounts for the assembly of densely packed monolayers of per-2,3-methylated per-6-thiolated alpha-, beta-, and gamma-cyclodextrins on the hanging mercury drop electrode. Inclusion of inorganic ions and uncharged hydrophobic guests into these monolayers was investigated by capacitance measurements. In the range of potentials where the electrode is positively charged, the inter facial capacitance depends on the type of electrolyte anions and on the applied potential. This can be explained with electrostatic double-layer forces. Whereas the smaller and less well solvated anions Cl-, NO3-, and ClO4- are included in the cyclodextrin cavities of these monolayers, the larger and more strongly solvated anions F-, SO42-, and H2PO4- are excluded. Anion inclusion constants can be obtained from the dependence of the interfacial capacitance on the anion concentration. The potential dependence of these inclusion constants shows that the nonelectrostatic contribution to the driving force for NO3- inclusion is negligibly small. Competitive binding of hydrophobic guest molecules decreases the interfacial capacitance. Fitting Langmuir isotherms to the plots of the interfacial capacitance as a function of adamantanol concentration yielded the binding constants 1.0 x 10(4) and 2.6 x 10(4) M-1 for the beta- and gamma-cyclodextrin monolayers, respectively. Binding of adamantanol to alpha-cyclodextrin monolayers could not be observed, apparently because this guest is too large for the internal cavity of the alpha-cyclodextrin receptor. In contrast, 1-hexanol binds to alpha-cyclodextrin monolayers with the binding constant 8.9 x 10(4) M-1. This shows that changes in the capacitance can serve as a general signal transduction mode to monitor interactions between cyclodextrin monolayers and charged or neutral guests, Also, the extension of these types of measurements into solid electrodes and the application to other guest-selective host monolayers open the possibility of designing a novel type of electrochemical sensors for electroinactive analytes.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Majda, M (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Buhlmann, Philippe/J-3157-2015	Buhlmann, Philippe/0000-0001-9302-4674			AKERFELDT KS, 1996, COMPREHENSIVE SUPRAM, V10, P659; Weisser M, 1997, SENSOR ACTUAT B-CHEM, V38, P58, DOI 10.1016/S0925-4005(97)80172-4; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; BOTSI A, 1995, J ORG CHEM, V60, P4017, DOI 10.1021/jo00118a018; He PA, 1997, ANAL CHIM ACTA, V337, P217, DOI 10.1016/S0003-2670(96)00410-2; Lipkowitz KB, 1998, CHEM REV, V98, P1829, DOI 10.1021/cr9700179; Gafni Y, 1996, CHEM-EUR J, V2, P759, DOI 10.1002/chem.19960020706; Maeda Y, 1997, LANGMUIR, V13, P4187, DOI 10.1021/la9701384; CASU B, 1979, CARBOHYD RES, V76, P59, DOI 10.1016/0008-6215(79)80006-3; Motesharei K, 1997, J AM CHEM SOC, V119, P11306, DOI 10.1021/ja9727171; MATSUI Y, 1979, B CHEM SOC JPN, V52, P2808, DOI 10.1246/bcsj.52.2808; Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i; Lee JY, 1998, J PHYS CHEM B, V102, P9940, DOI 10.1021/jp9828235; NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011; Wang Y, 1998, J PHYS CHEM B, V102, P9922, DOI 10.1021/jp982824x; Slowinski K, 1997, J AM CHEM SOC, V119, P11910, DOI 10.1021/ja971921l; MARCUS Y, 1993, J CHEM SOC FARADAY T, V89, P713, DOI 10.1039/ft9938900713; MARCUS Y, 1994, BIOPHYS CHEM, V51, P111, DOI 10.1016/0301-4622(94)00051-4; Weisser M, 1996, J PHYS CHEM-US, V100, P17893, DOI 10.1021/jp961547w; ROJAS MT, 1995, J AM CHEM SOC, V117, P336, DOI 10.1021/ja00106a036; Muller M, 1998, BRAIN RES, V781, P307, DOI 10.1016/S0006-8993(97)01259-6; GADELLE A, 1991, ANGEW CHEM INT EDIT, V30, P78, DOI 10.1002/anie.199100781; BERTRAND GL, 1989, J PHYS CHEM-US, V93, P6863, DOI 10.1021/j100355a057; CRAMER F, 1967, J AM CHEM SOC, V89, P14, DOI 10.1021/ja00977a003; SMITH CP, 1993, LANGMUIR, V9, P1, DOI 10.1021/la00025a001; Bender M. L., 1978, CYCLODEXTRIN CHEM; Beulen MWJ, 1998, LANGMUIR, V14, P6424, DOI 10.1021/la980936+; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243; Buhlmann P, 1998, ELECTROANAL, V10, P1149; BUVARI A, 1973, B CHEM SOC JPN, V46, P3703; CROMWELL WC, 1985, J PHYS CHEM-US, V89, P326, DOI 10.1021/j100248a029; DELEVIE R, 1988, CHEM REV, V88, P599, DOI 10.1021/cr00086a001; DEMOZ A, 1993, LANGMUIR, V9, P1046, DOI 10.1021/la00028a028; FRANCIOLINI F, 1990, BIOCHIM BIOPHYS ACTA, V1031, P247, DOI 10.1016/0304-4157(90)90009-2; Frumkin A, 1933, Z PHYS CHEM A-CHEM T, V164, P121; FUHRHOP JH, 1990, LANGMUIR, V6, P497, DOI 10.1021/la00092a034; Fyles T. M., 1996, COMPREHENSIVE SUPRAM, V10, P53; GELB RI, 1995, SUPRAMOL CHEM, V4, P279, DOI 10.1080/10610279508028937; GELB RI, 1983, J PHYS CHEM-US, V87, P3349, DOI 10.1021/j100240a033; GODINEZ LA, 1995, J PHYS CHEM-US, V99, P17449, DOI 10.1021/j100048a022; Godinez LA, 1996, SUPRAMOL CHEM, V8, P17, DOI 10.1080/10610279608233964; Hallani M, 1998, J MEMBRANE BIOL, V161, P163, DOI 10.1007/s002329900323; HARATA K, 1987, B CHEM SOC JPN, V60, P497, DOI 10.1246/bcsj.60.497; Henke C, 1996, ANAL CHEM, V68, P3158, DOI 10.1021/ac9512261; HERSEY A, 1986, J CHEM SOC FARAD T 1, V82, P1271, DOI 10.1039/f19868201271; Hromadova M, 1999, J ELECTROANAL CHEM, V465, P51, DOI 10.1016/S0022-0728(99)00054-6; Ju HX, 1998, LANGMUIR, V14, P300, DOI 10.1021/la970356x; Kano K, 1995, J INCLUS PHENOM MOL, V22, P285, DOI 10.1007/BF00707781; Kolb D.M., 1993, STRUCTURE ELECTRIFIE, P65; Lahav M, 1997, ISRAEL J CHEM, V37, P185; Mansoura MK, 1998, BIOPHYS J, V74, P1320; Matsui Y, 1997, B CHEM SOC JPN, V70, P535, DOI 10.1246/bcsj.70.535; Nelles G, 1996, J AM CHEM SOC, V118, P5039, DOI 10.1021/ja9539812; ODASHIMA K, 1993, ANAL CHEM, V65, P927, DOI 10.1021/ac00055a016; ROHRBACH RP, 1977, J PHYS CHEM-US, V81, P944, DOI 10.1021/j100525a003; RYGHKOV GY, 1998, J GEN PHYSIOL, V111, P653; Stine KJ, 1999, J ELECTROANAL CHEM, V465, P209, DOI 10.1016/S0022-0728(99)00098-4; SZEJTLI J, 1997, CHEM REV, V97, P1325; Xiao KP, 1999, ANAL CHEM, V71, P1183, DOI 10.1021/ac9809635; YAMASHOJI Y, 1993, CHEM LETT, P1029, DOI 10.1246/cl.1993.1029	61	36	36	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	FEB 8	2000	16	3					1388	1396		10.1021/la990826i		9	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	281UJ	WOS:000085178900074		
J	Takeuchi, D; Nakamura, T; Aida, T				Takeuchi, D; Nakamura, T; Aida, T			Bulky titanium bis(phenolate) complexes as novel initiators for living anionic polymerization of epsilon-caprolactone	MACROMOLECULES			English	Article							RING-OPENING POLYMERIZATION; CATIONIC ZIRCONOCENE COMPLEX; MOLECULAR-WEIGHT; OLEFIN POLYMERIZATION; ALUMINUM PORPHYRIN; LEWIS-ACID; CATALYSTS; LACTONES; LIGAND; VERSATILE	Bulky bis(phenolate) complexes of titanium alcoholates were found to initiate living polymerization of epsilon-caprolactone, affording a polyester with a narrow molecular weight distribution. By changing the initial monomer-to-initiator mole ratio, the molecular weight of the polymer was controlled over a wide range. H-1 NMR studies on the produced polymer showed the presence of an alkoxy group originating from the initiator at the polymer terminal, indicating that the polymerization takes place at the titanium alcoholate bond of the initiator. Use of titanium complexes prepared with nonbridged hindered phenols or a less bulky bisphenol resulted in a poorly controlled chain growth or no polymerization.	Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Aida, T (reprint author), Tokyo Inst Technol, Res Lab Resources Utilizat, Midori Ku, 4259 Nagatsuda Cho, Yokohama, Kanagawa 2268503, Japan.		Aida, Takuzo/I-9117-2012; Takeuchi, Daisuke/E-5149-2014	Takeuchi, Daisuke/0000-0001-6150-4083			AKATSUKA M, 1995, MACROMOLECULES, V28, P1320, DOI 10.1021/ma00108a075; Kowalski A, 1998, MACROMOL RAPID COMM, V19, P567, DOI 10.1002/(SICI)1521-3927(19981101)19:11<567::AID-MARC567>3.0.CO;2-T; COLLINS S, 1992, J AM CHEM SOC, V114, P5460, DOI 10.1021/ja00039a088; DUDA A, 1990, MACROMOLECULES, V23, P1640, DOI 10.1021/ma00208a013; Mecerreyes D, 1999, MACROMOLECULES, V32, P5175, DOI 10.1021/ma982005a; OKUDA J, 1993, MACROMOLECULES, V26, P5530, DOI 10.1021/ma00072a036; Kageyama K, 1998, MACROMOLECULES, V31, P4069, DOI 10.1021/ma980270q; OKUDA J, 1995, CHEM BER, V128, P221, DOI 10.1002/cber.19951280304; Britovsek GJP, 1999, ANGEW CHEM INT EDIT, V38, P428, DOI 10.1002/(SICI)1521-3773(19990215)38:4<428::AID-ANIE428>3.0.CO;2-3; YASUDA H, 1992, J AM CHEM SOC, V114, P4908, DOI 10.1021/ja00038a069; ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005; VANDERLINDEN A, 1995, J AM CHEM SOC, V117, P3008, DOI 10.1021/ja00116a006; Shen YQ, 1996, MACROMOLECULES, V29, P8289, DOI 10.1021/ma9518060; BRINTZINGER HH, 1995, ANGEW CHEM INT EDIT, V34, P1143, DOI 10.1002/anie.199511431; BOFFA LS, 1994, MACROMOLECULES, V27, P6993, DOI 10.1021/ma00101a044; CASIRAGHI G, 1981, SYNTHESIS-STUTTGART, P143; DILWORTH JR, 1986, J ORGANOMET CHEM, V315, pC9, DOI 10.1016/0022-328X(86)80421-1; FLORIANI C, 1989, ANGEW CHEM INT EDIT, V28, P66, DOI 10.1002/anie.198900661; Hayakawa M, 1997, MACROMOL CHEM PHYSIC, V198, P1305, DOI 10.1002/macp.1997.021980502; Hayakawa M, 1996, MACROMOL RAPID COMM, V17, P865, DOI 10.1002/marc.1996.030171204; IHARA E, 1995, MACROMOLECULES, V28, P7886, DOI 10.1021/ma00127a040; Isoda M, 1997, MACROMOLECULES, V30, P57, DOI 10.1021/ma961265u; MIYATAKE T, 1993, MAKROMOL CHEM-M SYMP, V66, P203, DOI 10.1002/masy.19930660118; Ouhadi T., 1975, MAKROMOL CHEM S, V1, P191; Sernetz FG, 1997, MACROMOLECULES, V30, P1562, DOI 10.1021/ma961443j; SOGA K, 1994, MACROMOLECULES, V27, P7938, DOI 10.1021/ma00104a063; Stevels WM, 1996, MACROMOLECULES, V29, P3332, DOI 10.1021/ma951813o; TAKEUCHI D, 1995, MACROMOLECULES, V28, P651, DOI 10.1021/ma00106a035; Takeuchi D, 1996, MACROMOLECULES, V29, P8096, DOI 10.1021/ma960937d; Yamashita M, 1996, MACROMOLECULES, V29, P1798, DOI 10.1021/ma951400n	30	103	105	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	FEB 8	2000	33	3					725	729		10.1021/ma991441+		5	Polymer Science	Polymer Science	282YC	WOS:000085248500013		
J	Shen, B; Someya, T; Moriwaki, O; Arakawa, Y				Shen, B; Someya, T; Moriwaki, O; Arakawa, Y			Effect of carrier confinement on photoluminescence from modulation-doped AlxGa1-xN/GaN heterostructures	APPLIED PHYSICS LETTERS			English	Article							2-DIMENSIONAL ELECTRON-GAS; CHARGE	Photoluminescence (PL) of modulation-doped Al0.22Ga0.78N/GaN heterostructures was investigated. The PL peak related to recombination between the two-dimensional electron gases (2DEG) and photoexcited holes is located at 3.448 eV at 40 K, which is 45 meV below the free excitons (FE) emission in GaN. The peak can be observed at temperatures as high as 80 K. The intensity of the 2DEG PL peak is enhanced significantly by incorporating a thin Al0.12Ga0.88N layer into the GaN layer near the heterointerface to suppress the diffusion of photoexcited holes. The energy separation of the 2DEG peak and the GaN FE emission decreases with increasing temperature. Meanwhile, the 2DEG peak energy increases with increasing excitation intensity. These results are attributed to the screening effect of electrons on the bending of the conduction band at the heterointerface, which becomes stronger when temperature or excitation intensity is increased. (C) 2000 American Institute of Physics. [S0003-6951(00)00606-9].	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Minato Ku, Tokyo 1068558, Japan	Shen, B (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						Asbeck PM, 1997, ELECTRON LETT, V33, P1230, DOI 10.1049/el:19970843; Bergman JP, 1996, APPL PHYS LETT, V69, P3456, DOI 10.1063/1.117250; YUAN YR, 1985, J APPL PHYS, V58, P397, DOI 10.1063/1.335692; Yu ET, 1997, APPL PHYS LETT, V71, P2794, DOI 10.1063/1.120138; BERGMAN JP, 1991, PHYS REV B, V43, P4771, DOI 10.1103/PhysRevB.43.4771; Bernardini F, 1997, PHYS REV B, V56, P10024; Gaska R, 1998, APPL PHYS LETT, V72, P64, DOI 10.1063/1.120645; Kovalev D, 1996, PHYS REV B, V54, P2518, DOI 10.1103/PhysRevB.54.2518; PLOOG K, 1983, ADV PHYS, V32, P285, DOI 10.1080/00018738300101561; Ramvall P, 1999, APPL PHYS LETT, V74, P3866, DOI 10.1063/1.124206; YUAN YR, 1984, APPL PHYS LETT, V45, P739, DOI 10.1063/1.95381	11	31	31	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 7	2000	76	6					679	681		10.1063/1.125859		3	Physics, Applied	Physics	279YY	WOS:000085075200007		
J	Hikami, K; Basu-Mallick, B				Hikami, K; Basu-Mallick, B			Supersymmetric Polychronakos spin chain: Motif, distribution function, and character	NUCLEAR PHYSICS B			English	Article						integrable model; supersymmetry; Haldane-Shastry spin chain; Yangian; Young diagram; character formula	CONFORMAL FIELD-THEORY; LONG-RANGE INTERACTIONS; YANGIAN SYMMETRY; EXCLUSION STATISTICS; REPRESENTATION; EXCHANGE	Degeneracy patterns and hyper-multiplet structure in the spectrum of the su(m|n) supersymmetric Polychronakos spin chain are studied by use of the "motif". Using the recursion relation of the supersymmetric Rogers-Szego polynomials which are closely related to the partition function of the N spin chain, we give the representation for the motif in terms of the supersymmetric skew Young diagrams. We also study the distribution function for quasi-particles. The character formulae for N --> infinity are briefly discussed. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan	Hikami, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Hongo 7-3-1, Tokyo 1130033, Japan.	hikami@phys.s.u-tokyo.ac.jp; biru@monet.phys.s.u-tokyo.ac.jp					Andrews George E., 1976, THEORY PARTITIONS; Schoutens K, 1997, PHYS REV LETT, V79, P2608, DOI 10.1103/PhysRevLett.79.2608; HALDANE FDM, 1988, PHYS REV LETT, V60, P956, DOI 10.1103/PhysRevLett.60.956; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; HALDANE FDM, 1992, PHYS REV LETT, V69, P2021, DOI 10.1103/PhysRevLett.69.2021; Bouwknegt P, 1999, NUCL PHYS B, V547, P501, DOI 10.1016/S0550-3213(99)00095-4; HALDANE FDM, 1991, PHYS REV LETT, V67, P937, DOI 10.1103/PhysRevLett.67.937; HALDANE FDM, 1988, PHYS REV LETT, V60, P635, DOI 10.1103/PhysRevLett.60.635; BALANTEKIN AB, 1982, J MATH PHYS, V23, P1239, DOI 10.1063/1.525508; BARS I, 1983, J MATH PHYS, V24, P2253, DOI 10.1063/1.525970; Basu-Mallick B, 1999, NUCL PHYS B, V540, P679, DOI 10.1016/S0550-3213(98)00784-6; BASUMALLICK B, 1999, J PHYS SOC JPN, V68, P32; BERKOVICH A, 1999, STAT PHYSICS EVE 21, P240; BERNARD D, 1994, NUCL PHYS B, V428, P612, DOI 10.1016/0550-3213(94)90366-2; FRAHM H, 1993, J PHYS A, V26, P473; FRENKEL E, 1993, DUKE MATH J INT MATH, V2, P53; FULTON W, 1997, YOUNG TABLE; Haldane FDM, 1994, SPRINGER SERIES SOLI, V118, P3; HIKAMI K, 1995, NUCL PHYS B, V441, P530, DOI 10.1016/0550-3213(95)00035-Q; HIKAMI K, 1995, PHYS LETT A, V205, P364, DOI 10.1016/0375-9601(95)00606-4; Hikami K, 1998, PHYS REV LETT, V80, P4374, DOI 10.1103/PhysRevLett.80.4374; HIKAMI K, 1995, J PHYS SOC JPN, V64, P1047, DOI 10.1143/JPSJ.64.1047; Hikami K, 1997, J PHYS A-MATH GEN, V30, P2447, DOI 10.1088/0305-4470/30/7/023; KIRILLOV AN, 1995, PROG THEOR PHYS SUPP, P61; Kirillov AN, 1997, COMMUN MATH PHYS, V185, P441, DOI 10.1007/s002200050098; MACDONALD JG, 1995, SYMMETRIC FUNCTIONS; POLYCHRONAKOS AP, 1994, NUCL PHYS B, V419, P553, DOI 10.1016/0550-3213(94)90344-1; SCHOUTENS K, 1994, PHYS LETT B, V331, P335, DOI 10.1016/0370-2693(94)91061-8	28	23	23	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213			NUCL PHYS B	Nucl. Phys. B	FEB 7	2000	566	3					511	528		10.1016/S0550-3213(99)00585-4		18	Physics, Particles & Fields	Physics	289KU	WOS:000085620700002		
J	Orito, S; Maeno, T; Matsunaga, H; Abe, K; Anraku, K; Asaoka, Y; Fujikawa, M; Imori, M; Ishino, M; Makida, Y; Matsui, N; Matsumoto, H; Mitchell, J; Mitsui, T; Moiseev, A; Motoki, M; Nishimura, J; Nozaki, M; Ormes, J; Saeki, T; Sanuki, T; Sasaki, M; Seo, ES; Shikaze, Y; Sonoda, T; Streitmatter, R; Suzuki, J; Tanaka, K; Ueda, I; Yajima, N; Yamagami, T; Yamamoto, A; Yoshida, T; Yoshimura, K				Orito, S; Maeno, T; Matsunaga, H; Abe, K; Anraku, K; Asaoka, Y; Fujikawa, M; Imori, M; Ishino, M; Makida, Y; Matsui, N; Matsumoto, H; Mitchell, J; Mitsui, T; Moiseev, A; Motoki, M; Nishimura, J; Nozaki, M; Ormes, J; Saeki, T; Sanuki, T; Sasaki, M; Seo, ES; Shikaze, Y; Sonoda, T; Streitmatter, R; Suzuki, J; Tanaka, K; Ueda, I; Yajima, N; Yamagami, T; Yamamoto, A; Yoshida, T; Yoshimura, K			Precision measurement of cosmic-ray antiproton spectrum	PHYSICAL REVIEW LETTERS			English	Article							SOLAR MINIMUM; BLACK-HOLES; FLUX; MODULATION; ATMOSPHERE	The energy spectrum of cosmic-ray antiprotons ((p) over bar's) has been measured in the range 0.18-3.56 GeV, based on 458 (p) over bar's collected by BESS in a recent solar-minimum period. We have detected for the first time a characteristic peak at 2 GeV of (p) over bar's originating from cosmic-ray interactions with the interstellar gas. The peak spectrum is reproduced by theoretical calculations, implying that the propagation models are basically correct and that different cosmic-ray species undergo a universal propagation. Future BESS data with still higher statistics will allow us to study the solar modulation and the propagation in detail and to search for primary (p) over bar components.	Univ Tokyo, Tokyo 1130033, Japan; High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Maryland, College Pk, MD 20742 USA; Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Kyoto Univ, Kyoto 6068502, Japan	Orito, S (reprint author), Univ Tokyo, Tokyo 1130033, Japan.		MOTOKI, Masakazu/B-4212-2009				Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Boezio M, 1999, ASTROPHYS J, V518, P457, DOI 10.1086/307251; HAWKING SW, 1975, COMMUN MATH PHYS, V43, P199, DOI 10.1007/BF02345020; Asaoka Y, 1998, NUCL INSTRUM METH A, V416, P236, DOI 10.1016/S0168-9002(98)00772-4; BERGSTROM L, ASTROPH9902012; BIEBER JW, ASTROPH9903163; Boezio M, 1997, ASTROPHYS J, V487, P415, DOI 10.1086/304593; BOGOMOLOV EA, 1979, P 16 INT COSM RAY C, P330; Bottino A, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.123503; FISK LA, 1971, J GEOPHYS RES, V76, P221, DOI 10.1029/JA076i001p00221; GOLDEN RL, 1979, PHYS REV LETT, V43, P1196, DOI 10.1103/PhysRevLett.43.1196; Labrador AW, 1997, ASTROPHYS J, V480, P371, DOI 10.1086/303960; Maki K, 1996, PHYS REV LETT, V76, P3474, DOI 10.1103/PhysRevLett.76.3474; MATSUNAGA H, 1997, THESIS U TOKYO; Matsunaga H, 1998, PHYS REV LETT, V81, P4052, DOI 10.1103/PhysRevLett.81.4052; MENN W, 1997, P 25 INT COSM RAY C, V3, P409; Mitchell JW, 1996, PHYS REV LETT, V76, P3057, DOI 10.1103/PhysRevLett.76.3057; Mitsui T., 1996, THESIS U TOKYO; Mitsui T, 1996, PHYS LETT B, V389, P169, DOI 10.1016/S0370-2693(96)01363-9; Moiseev A, 1997, ASTROPHYS J, V474, P479, DOI 10.1086/303463; ORITO S, 1987, P ASTROMAG WORKSH, P111; Pfeifer C, 1996, PHYS REV C, V54, P882, DOI 10.1103/PhysRevC.54.882; SANUKI T, 1998, NEW ERA NEUTRINO PHY, P123; Stephens SA, 1998, ASTROPHYS J, V505, P266, DOI 10.1086/306142; Stephens SA, 1997, ASTROPART PHYS, V6, P229, DOI 10.1016/S0927-6505(96)00058-8; WEBBER WR, 1987, P 20 INT COSM RAY C, P325; YAMAMOTO A, 1988, IEEE T MAGN, V24, P1421, DOI 10.1109/20.11508; YOSHIMURA K, 1995, PHYS REV LETT, V75, P3792, DOI 10.1103/PhysRevLett.75.3792	28	226	226	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 7	2000	84	6					1078	1081		10.1103/PhysRevLett.84.1078		4	Physics, Multidisciplinary	Physics	281UE	WOS:000085178500005		
J	Fukugita, M; Liu, GC; Sugiyama, N				Fukugita, M; Liu, GC; Sugiyama, N			Limits on neutrino mass from cosmic structure formation	PHYSICAL REVIEW LETTERS			English	Article							LARGE-SCALE STRUCTURE; DARK-MATTER; COSMOLOGICAL CONSTANT; CLUSTER EVOLUTION; GALAXY CLUSTERS; NEARBY GALAXIES; UNIVERSE; ANISOTROPIES; DENSITY; FIELDS	We consider the effect of three species of neutrinos with nearly degenerate mass on the cosmic structure formation in a low-matter-density universe within a hierarchical clustering scenario with a flat Gaussian initial perturbation spectrum. The matching condition for fluctuation powers at the COBE scale and at the cluster scale leads to a strong upper limit on neutrino mass. For a flat universe with matter density parameter Omega = 0.3, we obtain m(nu) < 0.6 eV for the Hubble constant H-0 < 80 km s(-1) Mpc(-1) Allowing for the more generous parameter space limited by Omega < 0.4, H-0 < 80 km s(-1) Mpc(-1) and age t(0) > 11.5 Gyr, the limit is 0.9 eV.	Univ Tokyo, Inst Cosm Ray Res, Tokyo 188, Japan; Inst Adv Study, Princeton, NJ 08540 USA; Kyoto Univ, Dept Phys, Kyoto 606, Japan	Fukugita, M (reprint author), Univ Tokyo, Inst Cosm Ray Res, Tokyo 188, Japan.						KLYPIN A, 1993, ASTROPHYS J, V416, P1, DOI 10.1086/173210; Reichart DE, 1999, ASTROPHYS J, V518, P521, DOI 10.1086/307288; Eke VR, 1998, MON NOT R ASTRON SOC, V298, P1145, DOI 10.1046/j.1365-8711.1998.01713.x; Ellis J, 1999, PHYS LETT B, V458, P310, DOI 10.1016/S0370-2693(99)00545-6; Tegmark M, 1999, ASTROPHYS J, V514, pL69, DOI 10.1086/311943; COPI CJ, 1995, SCIENCE, V267, P192, DOI 10.1126/science.7809624; FUKUGITA M, 1990, PHYS REV D, V42, P1285, DOI 10.1103/PhysRevD.42.1285; Bahcall NA, 1998, ASTROPHYS J, V504, P1, DOI 10.1086/306088; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; EFSTATHIOU G, 1990, NATURE, V348, P705, DOI 10.1038/348705a0; TREMAINE S, 1979, PHYS REV LETT, V42, P407, DOI 10.1103/PhysRevLett.42.407; Hu W, 1998, PHYS REV LETT, V80, P5255, DOI 10.1103/PhysRevLett.80.5255; Seljak U, 1996, ASTROPHYS J, V469, P437, DOI 10.1086/177793; WHITE SDM, 1993, NATURE, V366, P429, DOI 10.1038/366429a0; Carlberg RG, 1997, ASTROPHYS J, V478, P462, DOI 10.1086/303805; Eke VR, 1996, MON NOT R ASTRON SOC, V282, P263; STRAUSS MA, 1995, PHYS REP, V261, P271, DOI 10.1016/0370-1573(95)00013-7; Blanchard A, 1998, ASTRON ASTROPHYS, V332, pL49; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Bridle SL, 1999, MON NOT R ASTRON SOC, V310, P565, DOI 10.1046/j.1365-8711.1999.02960.x; BAHCALL NA, 1995, ASTROPHYS J, V447, pL81, DOI 10.1086/309577; BAHCALL NA, 1975, ASTROPHYS J, V198, P249, DOI 10.1086/153601; BANDAY AJ, ASTROPH9908070; Baudis L, 1999, PHYS REV LETT, V83, P41, DOI 10.1103/PhysRevLett.83.41; BELESEV AI, 1995, PHYS LETT B, V350, P263, DOI 10.1016/0370-2693(95)00335-I; Bennett C. L., 1996, ASTROPHYS J LETT, V464, P1; Bond JR, 1999, PHILOS T R SOC A, V357, P57, DOI 10.1098/rsta.1999.0314; Bunn EF, 1997, ASTROPHYS J, V480, P6, DOI 10.1086/303955; DAVIS M, 1983, ANNU REV ASTRON ASTR, V21, P109, DOI 10.1146/annurev.aa.21.090183.000545; Dekel A., 1997, CRITICAL DIALOGUES C, P175; Dodelson S, 1997, PHYS REV D, V56, P3207, DOI 10.1103/PhysRevD.56.3207; EFSTATHIOU G, 1992, MON NOT R ASTRON SOC, V258, pP1; EFSTATHIOU G, 1999, MON NOT R ASTRON SOC, V303, P47; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Hamilton A. J. S., 1998, EVOLVING UNIVERSE, P185; Hancock S, 1998, MON NOT R ASTRON SOC, V294, pL1; JING YP, 1993, ASTROPHYS J, V411, P450, DOI 10.1086/172847; Peacock JA, 1997, MON NOT R ASTRON SOC, V284, P885; PEEBLES PJE, 1995, ASTROPHYS J, V449, P52, DOI 10.1086/176031; PRIMACK JR, IN PRESS P 10 REC BL; SMIRNOV AY, 1999, IN PRESS P C PHYS ST; VIANA PTP, IN PRESS P C COSM CO; WHITE SDM, 1993, MON NOT R ASTRON SOC, V262, P1023; Zehavi I, 1999, NATURE, V401, P252, DOI 10.1038/45748	44	56	56	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 7	2000	84	6					1082	1085		10.1103/PhysRevLett.84.1082		4	Physics, Multidisciplinary	Physics	281UE	WOS:000085178500006		
J	Yamamoto, T; Saiga, Y; Arikawa, M; Kuramoto, Y				Yamamoto, T; Saiga, Y; Arikawa, M; Kuramoto, Y			Exact dynamical structure factor of the degenerate Haldane-Shastry model	PHYSICAL REVIEW LETTERS			English	Article							CALOGERO-SUTHERLAND MODEL; ANTIFERROMAGNETIC HEISENBERG CHAIN; INVERSE-SQUARE EXCHANGE; LONG-RANGE INTERACTIONS; T-J MODEL; FRACTIONAL STATISTICS; ONE-DIMENSION; GROUND-STATE; SPIN; SYSTEMS	The dynamical structure factor S(q,omega) of the K-component (K = 2, 3, 4) spin chain with a 1/r(2) interaction is derived exactly at zero temperature for the arbitrary size of the system. The result is interpreted in terms of a free quasiparticle picture which is a generalization of the spinon picture in the SU(2) case. The excited states consist of K quasiparticles each of which is characterized by a set of K - 1 quantum numbers. Divergent singularities of S(q, omega) at the spectral edges are derived analytically. The analytic result is checked numerically for finite systems.	Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Yamamoto, T (reprint author), Max Planck Inst Phys Komplexer Syst, Nothnizer Str 38, D-01187 Dresden, Germany.						AFFLECK I, 1986, NUCL PHYS B, V265, P409, DOI 10.1016/0550-3213(86)90167-7; Suzuki J, 1998, J PHYS A-MATH GEN, V31, P6887, DOI 10.1088/0305-4470/31/32/012; HALDANE FDM, 1991, PHYS REV LETT, V66, P1529, DOI 10.1103/PhysRevLett.66.1529; Azaria P, 1999, PHYS REV LETT, V83, P624, DOI 10.1103/PhysRevLett.83.624; LESAGE F, 1995, NUCL PHYS B, V435, P585, DOI 10.1016/0550-3213(94)00453-L; SHASTRY BS, 1988, PHYS REV LETT, V60, P639, DOI 10.1103/PhysRevLett.60.639; Karbach M, 1997, PHYS REV B, V55, P12510, DOI 10.1103/PhysRevB.55.12510; HALDANE FDM, 1992, PHYS REV LETT, V69, P2021, DOI 10.1103/PhysRevLett.69.2021; POLYCHRONAKOS AP, 1993, PHYS REV LETT, V70, P2329, DOI 10.1103/PhysRevLett.70.2329; Bouwknegt P, 1999, NUCL PHYS B, V547, P501, DOI 10.1016/S0550-3213(99)00095-4; HALDANE FDM, 1991, PHYS REV LETT, V67, P937, DOI 10.1103/PhysRevLett.67.937; HA ZNC, 1992, PHYS REV B, V46, P9359, DOI 10.1103/PhysRevB.46.9359; HALDANE FDM, 1988, PHYS REV LETT, V60, P635, DOI 10.1103/PhysRevLett.60.635; Frischmuth B, 1999, PHYS REV LETT, V82, P835, DOI 10.1103/PhysRevLett.82.835; HA ZNC, 1994, PHYS REV LETT, V73, P1574, DOI 10.1103/PhysRevLett.73.1574; HA ZNC, 1995, NUCL PHYS B, V435, P604, DOI 10.1016/0550-3213(94)00537-O; HA ZNC, 1995, PHYS REV LETT, V74, pE620; HALDANE FDM, 1994, CORRELATION EFFECTS, P92507; HALDANE FDM, 1993, PHYS REV LETT, V71, P4055, DOI 10.1103/PhysRevLett.71.4055; Isobe M, 1996, J PHYS SOC JPN, V65, P1178, DOI 10.1143/JPSJ.65.1178; Kato Y, 1997, J PHYS SOC JPN, V66, P1954, DOI 10.1143/JPSJ.66.1954; Kato Y, 1996, J PHYS SOC JPN, V65, P1622, DOI 10.1143/JPSJ.65.1622; Kuramoto Y, 1995, J PHYS SOC JPN, V64, P4518, DOI 10.1143/JPSJ.64.4518; Li YQ, 1998, PHYS REV LETT, V81, P3527, DOI 10.1103/PhysRevLett.81.3527; Mila F, 1999, PHYS REV LETT, V82, P3697, DOI 10.1103/PhysRevLett.82.3697; Pati SK, 1998, PHYS REV LETT, V81, P5406, DOI 10.1103/PhysRevLett.81.5406; SUTHERLAND B, 1993, PHYS REV LETT, V71, P5, DOI 10.1103/PhysRevLett.71.5; Takemura K, 1997, J PHYS A-MATH GEN, V30, P3685, DOI 10.1088/0305-4470/30/10/039; Uglov D, 1998, COMMUN MATH PHYS, V191, P663, DOI 10.1007/s002200050283; Yamamoto T, 1999, J PHYS A-MATH GEN, V32, P3341, DOI 10.1088/0305-4470/32/18/309; Yamashita Y, 1998, PHYS REV B, V58, P9114, DOI 10.1103/PhysRevB.58.9114	31	12	12	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 7	2000	84	6					1308	1311		10.1103/PhysRevLett.84.1308		4	Physics, Multidisciplinary	Physics	281UE	WOS:000085178500062		
J	Li, S; Kurata, K; Takakura, T				Li, S; Kurata, K; Takakura, T			Direct solar radiation penetration into row crop canopies in a lean-to greenhouse	AGRICULTURAL AND FOREST METEOROLOGY			English	Article						row crop canopy; direct solar radiation; lean-to greenhouse; scale-model experiment	PHOTOSYNTHESIS; MODEL	Experiments were conducted using model row crop canopies inside a model lean-to greenhouse (ratio 1 : 15) under artificial light to investigate the relations between row orientations and amount of direct solar radiation received by the canopy leaves. The model leaves were round in shape, horizontal in leaf inclination. The difference between the azimuthal directions of every two vertically neighbouring leaves was 90 degrees. The east-west (E-W) and north-south (N-S) row canopies consist of 110 (5 rows x 22 plants/row) and 98 (14 rows x 7 plants/row) plants, respectively, and both gave a leaf area index of 1.16. Solar cells, each with a detecting area of 1.0 cm x 1.0 cm, were set on the surface of the upper 10 leaves of each measuring plant to detect the solar radiation reaching it. At 35 degrees N, EW row canopy showed higher normalized daily canopy irradiance than that of N-S row canopy during the winter and early spring months, while the results became the opposite for the pest of the year. At 45 and 55 degrees N, on the other hand, NS row canopy showed higher normalized daily canopy irradiance than E-W row canopy throughout the year. Moreover, magnitude of the differences in normalized daily canopy irradiance between row orientations was bigger in summer and late spring months than in winter and early spring months. Further analyses showed that the differences between E-W and N-S row canopies mentioned above were mainly due to the differences of normalized canopy irradiance during almost the whole day in spring and summer, and the differences in the integral value over the day of normalized canopy irradiance in winter. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Biol & Environm Engn, Bunkyo Ku, Tokyo 113, Japan	Li, S (reprint author), Clemson Univ, Dept Hort, Clemson, SC 29634 USA.						ALLEN LH, 1977, AGRON, V66, P41; GOUDRIAAN J, 1988, AGR FOREST METEOROL, V43, P155, DOI 10.1016/0168-1923(88)90089-5; GIJZEN H, 1989, AGR FOREST METEOROL, V48, P1, DOI 10.1016/0168-1923(89)90004-X; Iwakiri S, 1974, J AGROMETEOROL, V30, P17; KURATA K, 1984, INTRO ENV ENG; KURATA K, 1988, Journal of Agricultural Meteorology, V44, P15; LANG ARG, 1976, AGR METEOROL, V16, P5, DOI 10.1016/0002-1571(76)90065-0; Li Shumin, 1994, Journal of Agricultural Meteorology, V50, P207; Li S., 1995, ACTA HORTIC, V399, P127; LI SA, 1995, THESIS U TOKYO; LIU B, 1987, SCI VEGETABLE CULTIV; MANN JE, 1980, AGRON J, V72, P131; MUTSAERS HJW, 1980, J AGR SCI, V95, P381; MYNENI RB, 1986, AGR FOREST METEOROL, V37, P205, DOI 10.1016/0168-1923(86)90031-6; NEDERHOFF EM, 1984, ACTA HORTIC, V148, P525; WHITFIELD DM, 1986, AGR FOREST METEOROL, V36, P297, DOI 10.1016/0168-1923(86)90009-2; YANG X, 1990, T ASAE, V33, P917; YANG XS, 1990, AGR FOREST METEOROL, V51, P93, DOI 10.1016/0168-1923(90)90009-U	18	6	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1923			AGR FOREST METEOROL	Agric. For. Meteorol.	FEB 5	2000	100	2-3					243	253		10.1016/S0168-1923(99)00044-1		11	Agronomy; Forestry; Meteorology & Atmospheric Sciences	Agriculture; Forestry; Meteorology & Atmospheric Sciences	285PR	WOS:000085397900011		
J	Abe, A; Saeki, K; Yasunaga, T; Wakabayashi, T				Abe, A; Saeki, K; Yasunaga, T; Wakabayashi, T			Acetylation at the N-terminus of actin strengthens weak interaction between actin and myosin	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						actin N-terminal acetylation; actin-activated myosin ATPase; actomyosin interaction; histidine-tagged actin	RABBIT SKELETAL-MUSCLE; DICTYOSTELIUM-DISCOIDEUM ACTIN; SITE-DIRECTED MUTAGENESIS; YEAST ACTIN; AMINO TERMINUS; DYE-BINDING; SUBFRAGMENT-1; PROTEINS; TROPOMYOSIN; METHIONINE	The N-terminus of all actins so far studied is acetylated. Although the pathways of acetylation have been well studied, its functional importance has been unclear. A negative charge cluster in the actin N-terminal region is shown to be important for the function of actomyosin. Acetylation at the N-terminus removes a positive charge and increases the amount of net negative charges in the N-terminal region. This may augment the role of the negative charge cluster. To examine this possibility, actin with a nonacetylated N-terminus (nonacetylated actin) was produced. The nonacetylated actin polymerized and depolymerized normally. In actin-activated heavy meromyosin ATPase assays, the nonacetylated actin showed higher K-app without significantly changing V-max, compared with those of wild-type actin, This is in contrast to the effect of the N-terminal negative charge cluster, which increases V-max without changing K-app. These results indicate that the acetylation at the N-terminus of actin strengthens weak actomyosin interaction. (C) 2000 Academic Press.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Wakabayashi, T (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Yasunaga, Takuo/C-8316-2009	Yasunaga, Takuo/0000-0002-2494-9603			Abe A, 1999, BIOPHYS J, V76, pA39; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Buzan J, 1999, P NATL ACAD SCI USA, V96, P2823, DOI 10.1073/pnas.96.6.2823; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; ASPENSTROM P, 1991, EUR J BIOCHEM, V200, P35, DOI 10.1111/j.1432-1033.1991.tb21045.x; ASPENSTROM P, 1992, FEBS LETT, V303, P59, DOI 10.1016/0014-5793(92)80477-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1991, J BIOL CHEM, V266, P16825; COOK RK, 1993, J BIOL CHEM, V268, P2410; HENNESSEY ES, 1991, EUR J BIOCHEM, V197, P345, DOI 10.1111/j.1432-1033.1991.tb15917.x; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTIN DJ, 1987, J BIOL CHEM, V262, P6350; MIKAWA T, 1981, J BIOCHEM-TOKYO, V89, P1951; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143; RUBENSTEIN PA, 1987, METHOD CELL BIOL, V28, P231; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; Sambrook J., 1989, MOL CLONING LAB MANU; SHEFF DR, 1992, J BIOL CHEM, V267, P2671; SHEFF DR, 1992, J BIOL CHEM, V267, P20217; SKOOG B, 1986, TRAC-TREND ANAL CHEM, V5, P82, DOI 10.1016/0165-9936(86)80045-0; SOLOMON TL, 1988, J BIOL CHEM, V263, P19662; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; SUTOH K, 1993, ADV EXP MED BIOL, V332, P241; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0	36	24	24	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 5	2000	268	1					14	19		10.1006/bbrc.1999.2069		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	281RA	WOS:000085173500004		
J	Asanuma, H; Yoshida, T; Liang, XG; Komiyama, M				Asanuma, H; Yoshida, T; Liang, XG; Komiyama, M			Azobenzene-appended oligonucleotides form unexpectedly stable triple-helixes	CHEMISTRY LETTERS			English	Article							DNA; INTERCALATION; CLEAVAGE; DUPLEXES	Modified oligo(T)s carrying an azobebzene at the 5'-ends form unexpectedly stable triple-helixes with oligo(A)/oligo(T) double-helix. The tripler-stabilizing activity of the azobenzene is comparable with (or greater than) that of thymine.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Asanuma, H (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan.						Kool ET, 1997, CHEM REV, V97, P1473, DOI 10.1021/cr9603791; Boutorine AS, 1996, J AM CHEM SOC, V118, P9469, DOI 10.1021/ja960062i; LYNG R, 1992, BIOPOLYMERS, V32, P1201, DOI 10.1002/bip.360320910; Asanuma H, 1998, TETRAHEDRON LETT, V39, P9015, DOI 10.1016/S0040-4039(98)02022-X; Asseline U, 1997, NEW J CHEM, V21, P5; Barre FX, 1999, NUCLEIC ACIDS RES, V27, P743, DOI 10.1093/nar/27.3.743; COLLIER DA, 1991, NUCLEIC ACIDS RES, V19, P4219, DOI 10.1093/nar/19.15.4219; Giovannangeli C, 1996, BIOCHEMISTRY-US, V35, P10539, DOI 10.1021/bi952993x; Giovannangeli C, 1997, P NATL ACAD SCI USA, V94, P79, DOI 10.1073/pnas.94.1.79; Grant KB, 1996, BIOCHEMISTRY-US, V35, P12313, DOI 10.1021/bi9608469; ORSON FM, 1994, NUCLEIC ACIDS RES, V22, P479, DOI 10.1093/nar/22.3.479; Puri N, 1997, TETRAHEDRON, V53, P10409, DOI 10.1016/S0040-4020(97)00631-5; Robertson JM, 1939, J CHEM SOC, P232, DOI 10.1039/jr9390000232; Sartorius J, 1997, J CHEM SOC PERK T 2, P2319, DOI 10.1039/a702628e; UHLMANN E, 1990, CHEM REV, V90, P543, DOI 10.1021/cr00102a001; Yamana K, 1997, TETRAHEDRON LETT, V38, P5815, DOI 10.1016/S0040-4039(97)01329-4; Yamana K., 1985, NUCLEIC ACIDS RES S, V16, P169; Yamana K, 1998, NUCLEOS NUCLEOT, V17, P233, DOI 10.1080/07328319808005172	18	5	5	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					108	109				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600011		
J	Yoshida, H; Saigo, K; Hiratani, K				Yoshida, H; Saigo, K; Hiratani, K			Synthesis of bis(2-hydroxynaphthamide) derivatives behaving as a fluorophore for anions	CHEMISTRY LETTERS			English	Article							RECEPTOR; RECOGNITION	Bis(2-hydroxynaphthamide) derivatives have been synthesized via tandem Claisen rearrangement in high yields. These compounds are found to make complexes with anions and emit luminescence, serving as anion sensing fluorophores.	Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Hiratani, K (reprint author), Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan.						KELLY TR, 1994, J AM CHEM SOC, V116, P7072, DOI 10.1021/ja00095a009; Schmidtchen FP, 1997, CHEM REV, V97, P1609, DOI 10.1021/cr9603845; SHIONOYA M, 1992, J AM CHEM SOC, V114, P5714, DOI 10.1021/ja00040a034; LEHN JM, 1978, J AM CHEM SOC, V100, P4914, DOI 10.1021/ja00483a059; BEER PD, 1993, J CHEM SOC CHEM COMM, P828, DOI 10.1039/c39930000828; Hiratani K, 1997, J AM CHEM SOC, V119, P12677, DOI 10.1021/ja9722887; JACOBSON S, 1986, J AM CHEM SOC, V108, P7640; Nishizawa S, 1998, ANAL SCI, V14, P595, DOI 10.2116/analsci.14.595; Watanabe S, 1998, J AM CHEM SOC, V120, P229, DOI 10.1021/ja973263a	9	21	21	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					116	117				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600015		
J	Yoshikawa, H; Nishikiori, S				Yoshikawa, H; Nishikiori, S			Photoinduced color change of methylviologen in polycyano-polycadmate host clathrates	CHEMISTRY LETTERS			English	Article							CADMIUM CYANIDE HOST; ELECTRON-TRANSFER; SOLID-PHASE; FRAMEWORKS; PHOTOCHEMISTRY; VIOLOGENS; REDUCTION; ZEOLITES; CATION	A series of polycyano-polycadmate host clathrates accommodating a methylviologen dication and an organic molecule has been prepared. Some of them showed a color change from white to blue under UV-VIS light. which comes from the reduction of the methylviologen dication to its monocation radical. This phenomenon depends on the species of the coexistent organic guest and the crystal structure of the clathrates.	Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Nishikiori, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Komaba, Tokyo 1538902, Japan.						Alvaro M, 1997, J PHYS CHEM B, V101, P3043, DOI 10.1021/jp9628850; Park YS, 1999, J AM CHEM SOC, V121, P3193, DOI 10.1021/ja980912p; KANEKO M, 1980, NATURE, V285, P468, DOI 10.1038/285468a0; BIRD CL, 1981, CHEM SOC REV, V10, P49, DOI 10.1039/cs9811000049; HOSKINS BF, 1990, J AM CHEM SOC, V112, P1546, DOI 10.1021/ja00160a038; YOON KB, 1993, CHEM REV, V93, P321, DOI 10.1021/cr00017a015; NISHIKIORI S, 1992, J AM CHEM SOC, V114, P8590, DOI 10.1021/ja00048a035; ABRAHAMS BF, 1991, J AM CHEM SOC, V113, P3045, DOI 10.1021/ja00008a037; BOCKMAN TM, 1990, J ORG CHEM, V55, P4127, DOI 10.1021/jo00300a033; WHITE BG, 1969, T FARADAY SOC, V65, P2000, DOI 10.1039/tf9696502000; EBBESEN TW, 1983, J PHYS CHEM-US, V87, P3717, DOI 10.1021/j100242a028; HUBIG SM, 1995, J PHYS CHEM-US, V99, P17578, DOI 10.1021/j100049a018; Iwamoto T, 1997, J CHEM SOC DALTON, P4127, DOI 10.1039/a702539d; Iwamoto T, 1996, J INCLUS PHENOM MOL, V24, P61, DOI 10.1007/BF01053426; IWAMOTO T, 1996, COMPREHENSIVE SUPRAM, V6, P644; JOHNSON CS, 1963, J CHEM PHYS, V39, P58, DOI 10.1063/1.1734033; KIM CH, 1995, CHEM LETT, P409, DOI 10.1246/cl.1995.409; KIM J, 1993, J CHEM SOC CHEM COMM, P1400, DOI 10.1039/c39930001400; Kitazawa T, 1998, J MATER CHEM, V8, P671, DOI 10.1039/a707250c; KITAZAWA T, 1988, CHEM LETT, P459, DOI 10.1246/cl.1988.459; KITAZAWA T, 1994, J CHEM SOC DALTON, P1029, DOI 10.1039/dt9940001029; Kitazawa T, 1999, CHEM COMMUN, P891, DOI 10.1039/a901613i; KITAZAWA T, 1988, CHEM LETT, P1729, DOI 10.1246/cl.1988.1729; KITAZAWA T, 1994, J CHEM SOC DALTON, P3695, DOI 10.1039/dt9940003695; KITAZAWA T, 1995, J CHEM SOC DALTON, P3715, DOI 10.1039/dt9950003715; MACFARLA.AJ, 1969, J CHEM SOC A, P1517, DOI 10.1039/j19690001517; MAO Y, 1995, J PHYS CHEM-US, V99, P9909, DOI 10.1021/j100024a038; MAU AWH, 1986, J CHEM SOC FARAD T 2, V82, P869, DOI 10.1039/f29868200869; WOLSZCZAK M, 1985, RADIAT PHYS CHEM, V26, P625, DOI 10.1016/0146-5724(85)90099-8	29	31	31	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					142	143				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600028		
J	Yoshizawa, S; Watanabe, K; Miura, K; Hirao, I				Yoshizawa, S; Watanabe, K; Miura, K; Hirao, I			The effect of hairpin DNA fragments on Escherichia coli poly(U)-dependent poly(Phe) synthesis	CHEMISTRY LETTERS			English	Article							RIBOSOMES; SITE	In the poly(U)-dependent poly(Phe) synthesis, we found that small hairpin DNA fragments overcome the decline in the translation efficiency caused by an excess amount of E. coli tRNA(Phe). Of these fragments, hairpin DNAs with similar sequences to the unmodified D-arm or T Psi C-arm of tRNA(Phe) were most effective.	RIKEN, Inst Phys & Chem Res, JST, ERATO,Yokoyama Cytolog Project, Wako, Saitama 3510198, Japan; CNRS, ICSN, Lab RMN, F-91190 Gif Sur Yvette, France; Univ Tokyo, Fac Engn, Dept Chem & Biotechnol, Tokyo 113, Japan; Gakushuin Univ, Inst Biomol Sci, Tokyo 171, Japan	Hirao, I (reprint author), RIKEN, Inst Phys & Chem Res, JST, ERATO,Yokoyama Cytolog Project, Wako, Saitama 3510198, Japan.		Hirao, Ichiro/G-3041-2012				BERGEMANN K, 1983, J BIOL CHEM, V258, P5105; DABROWSKI M, 1995, EMBO J, V14, P4872; Ehrenberg M., 1990, RIBOSOMES PROTEIN SY, P101; HAYASHI H, 1966, NATURE, V209, P376, DOI 10.1038/209376a0; KUECHLER E, 1971, NATURE-NEW BIOL, V234, P216; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; RHEINBERGER HJ, 1981, P NATL ACAD SCI-BIOL, V78, P5310, DOI 10.1073/pnas.78.9.5310; SHIMIZU N, 1970, J BIOCHEM-TOKYO, V67, P373; SPIRIN AS, 1990, RIBOSOME, P56; WURMBACH P, 1979, P NATL ACAD SCI USA, V76, P2143, DOI 10.1073/pnas.76.5.2143	10	0	0	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					154	155				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600034		
J	Sakurai, H; Tanabe, K; Naraska, K				Sakurai, H; Tanabe, K; Naraska, K			Palladium-catalyzed synthesis of alpha-diketones from acylchromates, iodoarenes, and carbon monoxide	CHEMISTRY LETTERS			English	Article							ORGANOTIN REAGENTS; COUPLING REACTIONS; COMPLEXES; HALIDES	A three-component coupling of tetramethylammonium pentacarbonyl(acyl)chromates, aryl iodides, and CO rakes place under CO atmosphere in the presence of a catalytic amount of Pd(PPh3)(4) to afford the corresponding unsymmetrical alpha-diketones in good yield. By performing the reaction under argon atmosphere, unsymmetrical ketones are prepared instead of alpha-diketones.	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Naraska, K (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ANDERSON GK, 1984, ACCOUNTS CHEM RES, V17, P67, DOI 10.1021/ar00098a005; VERLHAC JB, 1985, TETRAHEDRON LETT, V26, P6075, DOI 10.1016/S0040-4039(00)95129-3; STORK G, 1989, TETRAHEDRON LETT, V30, P2173, DOI 10.1016/S0040-4039(00)99640-0; BATES RW, 1995, COMPREHENSIVE ORGANO, V12, P349; Hanzawa Y, 1998, TETRAHEDRON LETT, V39, P6249, DOI 10.1016/S0040-4039(98)01287-8; KOGA T, 1988, CHEM LETT, P1141, DOI 10.1246/cl.1988.1141; KWON HB, 1990, J ORG CHEM, V55, P3114, DOI 10.1021/jo00297a029; Sakurai H, 1999, CHEM LETT, P309; STILLE JK, 1986, ANGEW CHEM INT EDIT, V25, P508, DOI 10.1002/anie.198605081; SUGITA N, 1978, INORG CHEM, V17, P2809, DOI 10.1021/ic50188a025; YAMAMOTO A, 1991, PURE APPL CHEM, V63, P687, DOI 10.1351/pac199163050687; Yamane M, 2000, CHEM LETT, P174	12	15	15	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					168	169				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600041		
J	Yamane, M; Ishibashi, Y; Sakurai, H; Narasaka, K				Yamane, M; Ishibashi, Y; Sakurai, H; Narasaka, K			Double acylation of alkenes with acylchromates promoted by cationic Pd(II) complex	CHEMISTRY LETTERS			English	Article							CARBON-MONOXIDE; OLEFINS; COPOLYMERIZATION; INSERTION; CATALYSIS; ACYLIRON; HALIDES	Double acylation of alkenes such as norbornene and vinyl-silane proceeds by the use of acylchromate complexes and a cationic Pd(II) complex. When two different acylchromates are added successively to a mixture of alkene and the Pd complex, unsymmetrical diketones are obtained almost selectively.	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Narasaka, K (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						FREEMAN F, 1994, J ORG CHEM, V59, P3695, DOI 10.1021/jo00092a034; SEN A, 1982, J AM CHEM SOC, V104, P3520, DOI 10.1021/ja00376a053; VERLHAC JB, 1985, TETRAHEDRON LETT, V26, P6075, DOI 10.1016/S0040-4039(00)95129-3; DRENT E, 1991, J ORGANOMET CHEM, V417, P235, DOI 10.1016/0022-328X(91)80176-K; ARAKAWA S, 1977, J ORG CHEM, V42, P3800, DOI 10.1021/jo00444a003; BRUMBAUGH JS, 1990, ORGANOMETALLICS, V9, P1735, DOI 10.1021/om00156a010; DRENT E, 1990, PURE APPL CHEM, V62, P661, DOI 10.1351/pac199062040661; Hanzawa Y, 1998, TETRAHEDRON LETT, V39, P6249, DOI 10.1016/S0040-4039(98)01287-8; Hanzawa Y, 1999, ANGEW CHEM INT EDIT, V38, P2395, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2395::AID-ANIE2395>3.0.CO;2-W; HEGEDUS LS, 1982, ORGANOMETALLICS, V1, P1188, DOI 10.1021/om00069a015; Kang SK, 1998, SYNTHESIS-STUTTGART, P1249; KOGA T, 1988, CHEM LETT, P1141, DOI 10.1246/cl.1988.1141; MILSTEIN D, 1988, ACCOUNTS CHEM RES, V21, P428, DOI 10.1021/ar00155a007; Nozaki K, 1997, J AM CHEM SOC, V119, P12779, DOI 10.1021/ja973199x; OZAWA F, 1991, J CHEM SOC CHEM COMM, P1469, DOI 10.1039/c39910001469; Parlevliet FJ, 1999, ORGANOMETALLICS, V18, P3394, DOI 10.1021/om990209p; Sakurai H, 1999, CHEM LETT, P309; STILLE JK, 1974, ADV CHEM SER, V57, P1799; Tsuji J., 1980, ORGANIC SYNTHESIS PA; TSUJI J, 1969, ACCOUNTS CHEM RES, V2, P144, DOI 10.1021/ar50017a003; YAMAMOTO A, 1985, PURE APPL CHEM, V57, P1799, DOI 10.1351/pac198557121799	21	11	11	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					174	175				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600044		
J	Sun, S; Tsubaki, N; Fujimoto, K				Sun, S; Tsubaki, N; Fujimoto, K			Promotional effect of noble metal to co-based Fischer-Tropsch catalysts prepared from mixed cobalt salts	CHEMISTRY LETTERS			English	Article							CARBON-MONOXIDE; HYDROGENATION; DISPERSION; SUPPORT	Addition of very small amount of Ru, Pt and Pd exhibited great effect on the Co-based catalysts prepared by mixing impregnation of cobalt (II) nitrate and cobalt (II) acetate. Added small amount of Ru to this kind of catalyst showed extremely high activity, while no apparent CH4 selectivity change was observed. However, added Pt and Pd hardly exerted effect on the activity of Co-based catalyst, but increased CH4 selectivity remarkably.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Tsubaki, N (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.						Anderson RB, 1984, FISCHER TROPSCH SYNT; REUEL RC, 1984, J CATAL, V85, P63, DOI 10.1016/0021-9517(84)90110-6; JOHNSON BG, 1991, J CATAL, V128, P231, DOI 10.1016/0021-9517(91)90080-N; IGLESIA E, 1992, J CATAL, V137, P212, DOI 10.1016/0021-9517(92)90150-G; DEES MJ, 1990, J CATAL, V124, P530, DOI 10.1016/0021-9517(90)90199-T; FUJIMOTO K, 1980, J CATAL, V61, P7, DOI 10.1016/0021-9517(80)90333-4; HAGGIN J, 1990, CHEM ENG NEWS, V23, P27; HEAL MJ, 1978, J CATAL, V51, P314, DOI 10.1016/0021-9517(78)90269-5; ISCHI S, 1985, SURF SCI, V161, P349; NIJS HH, 1980, J CATAL, V65, P328, DOI 10.1016/0021-9517(80)90310-3; SATO K, 1984, J CHEM SOC FARAD T 1, V80, P841, DOI 10.1039/f19848000841; SOLED SL, 1995, MATER RES SOC SYMP P, V368, P113; Sun SL, 1999, CHEM LETT, P343; Vannice M. A., 1982, CATALYSIS SCI TECHNO, V3	14	11	11	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					176	177				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600045		
J	Matsuo, J; Tsuchiya, T; Odashima, K; Kobayashi, S				Matsuo, J; Tsuchiya, T; Odashima, K; Kobayashi, S			Lewis acid catalysis in supercritical carbon dioxide. Use of scandium tris(heptadecafluorooctanesulfonate) as a Lewis acid catalyst in Diels-Alder and aza Diels-Alder reactions	CHEMISTRY LETTERS			English	Article							COMMERCIAL FORMALDEHYDE SOLUTION; SILYL ENOL ETHERS; HOMOGENEOUS CATALYSIS; QUINOLINE DERIVATIVES; COUPLING REACTIONS; ORGANIC-SYNTHESIS; AQUEOUS-MEDIA; WATER; FLUIDS; TRIFLUOROMETHANESULFONATES	Diels-Alder reactions of carbonyl dienophiles with dienes and aza Diels-Alder reactions of imines with a diene have been successfully carried out using scandium tris(heptadecafluorooctanesulfonate) (Sc(OSO2C8F17)(3)) as a Lewis acid catalyst in supercritical carbon dioxide (scCO(2)). It was revealed that the length of perfluorocarbon chains of the scandium catalyst was an essential factor for the catalytic activity in scCO(2).	Univ Tokyo, CREST, Japan Sci & Technol Corp, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, CREST, Japan Sci & Technol Corp, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				Kainz S, 1997, ANGEW CHEM INT EDIT, V36, P1628, DOI 10.1002/anie.199716281; YATES P, 1960, J AM CHEM SOC, V82, P4436, DOI 10.1021/ja01501a085; INANAGA J, 1995, NEW J CHEM, V19, P707; KOBAYASHI S, 1994, J ORG CHEM, V59, P3590, DOI 10.1021/jo00092a017; Hadida S, 1997, J AM CHEM SOC, V119, P7406, DOI 10.1021/ja971120i; SAVAGE PE, 1995, AICHE J, V41, P1723, DOI 10.1002/aic.690410712; Shezad N, 1999, TETRAHEDRON LETT, V40, P2221, DOI 10.1016/S0040-4039(99)00176-8; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Jessop PG, 1999, CHEM REV, V99, P475, DOI 10.1021/cr970037a; BURK MJ, 1995, J AM CHEM SOC, V117, P8277, DOI 10.1021/ja00136a029; Carroll MA, 1998, CHEM COMMUN, P1395, DOI 10.1039/a802235f; Carruthers W, 1990, CYCLOADDITION REACTI; Clifford AA, 1998, J CHEM SOC FARADAY T, V94, P1451, DOI 10.1039/a800873f; HANAMOTO T, 1997, B CHEM SOC JPN, V70, P1241; HOLLIS TK, 1992, J AM CHEM SOC, V114, P5464, DOI 10.1021/ja00039a090; HYATT JA, 1984, J ORG CHEM, V49, P5097, DOI 10.1021/jo00200a016; IKUSHIMA Y, 1991, B CHEM SOC JPN, V64, P282, DOI 10.1246/bcsj.64.282; ISAACS NS, 1992, J CHEM SOC CHEM COMM, P876, DOI 10.1039/c39920000876; KERWIN JF, 1982, TETRAHEDRON LETT, V23, P3739, DOI 10.1016/S0040-4039(00)87694-7; KIM S, 1988, CHEM ENG COMMUN, V63, P49, DOI 10.1080/00986448808940302; KOBAYASHI H, 1995, CHEM LETT, P307, DOI 10.1246/cl.1995.307; KOBAYASHI S, 1995, CHEM LETT, P423, DOI 10.1246/cl.1995.423; Kobayashi S, 1999, EUR J ORG CHEM, P15; Kobayashi S., 1999, LANTHANIDES CHEM USE; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P3755, DOI 10.1016/S0040-4039(00)79220-3; KOBAYASHI S, 1995, SYNLETT, P233; Kobayashi S., 1998, ORGANIC SYNTHESIS WA, P262; KOBAYASHI S, 1995, SYNTHESIS-STUTTGART, P1195; KOBAYASHI S, 1991, CHEM LETT, P2187, DOI 10.1246/cl.1991.2187; KOBAYASHI S, 1994, SYNLETT, P689; Morgenstern DA, 1996, ACS SYM SER, V626, P132; Morita DK, 1998, CHEM COMMUN, P1397, DOI 10.1039/a802621a; Nishikido J, 1998, SYNLETT, P1347; Oakes RS, 1999, CHEM COMMUN, P1459; PAULAITIS ME, 1987, PURE APPL CHEM, V59, P61, DOI 10.1351/pac198759010061; Renslo AR, 1997, J ORG CHEM, V62, P4530, DOI 10.1021/jo9704523; Schinzer D., 1989, SELECTIVITIES LEWIS; SUBRAMANIAM B, 1986, IND ENG CHEM PROC DD, V25, P1, DOI 10.1021/i200032a001; Weinstein RD, 1996, J PHYS CHEM-US, V100, P12337, DOI 10.1021/jp960180s; Yamamoto H., 1999, LEWIS ACID REAGENTS	40	36	36	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					178	179				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600046		
J	Kato, T; Suzuki, T; Irie, T				Kato, T; Suzuki, T; Irie, T			Layered thin-film composite consisting of polymers and calcium carbonate: A novel organic/inorganic material with an organized structure	CHEMISTRY LETTERS			English	Article							LANGMUIR MONOLAYERS; CRYSTALLIZATION; BIOMINERALIZATION; HYDROXYAPATITE; GROWTH	Layered polymer/calcium carbonate (CaCO3) composite films have been successfully obtained by alternate repetition of spin-coating of polysaccharides and thin film crystallization of CaCO3 in the presence of an acid polymer. SEM images show layered structures consisting of brick of the inorganic crystal and mortar of the polymer.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Kato, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.						Kato T, 1999, CHEM LETT, P199; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Aizenberg J, 1999, NATURE, V398, P495; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; Marentette JM, 1997, ADV MATER, V9, P647, DOI 10.1002/adma.19970090813; Ueyama N, 1998, MACROMOLECULES, V31, P7119, DOI 10.1021/ma9716847; Falini G, 1998, CHEM-EUR J, V4, P1048, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1048::AID-CHEM1048>3.0.CO;2-U; Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858; Litvin AL, 1997, ADV MATER, V9, P124, DOI 10.1002/adma.19970090205; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Gower LA, 1998, J CRYST GROWTH, V191, P153, DOI 10.1016/S0022-0248(98)00002-5; TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x; CALVERT P, 1988, J MATER SCI, V23, P3801, DOI 10.1007/BF01106796; Lin H, 1996, J CERAM SOC JPN, V104, P291, DOI 10.2109/jcersj.104.291; WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6; Zhang SK, 1998, LANGMUIR, V14, P6761, DOI 10.1021/la970962s	22	73	73	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB 5	2000		2					186	187				2	Chemistry, Multidisciplinary	Chemistry	289EY	WOS:000085608600050		
J	Teramoto, S				Teramoto, S			Doctors' attitudes to complementary medicine	LANCET			English	Letter									Tokyo Univ Hosp, Dept Geriatr Med, Tokyo 1138655, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Dept Geriatr Med, Tokyo 1138655, Japan.						Imanishi J, 1999, LANCET, V354, P1735, DOI 10.1016/S0140-6736(05)76729-5; ISHIBASHI A, 1998, JPN J ORIENTAL MED, V49, P61; SCRIBA PC, 1998, JPN J ORIENTAL MED, V49, P57	3	5	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					501	502		10.1016/S0140-6736(00)82062-0		2	Medicine, General & Internal	General & Internal Medicine	283ZW	WOS:000085306800062		
J	Akine, S; Goto, K; Kawashima, T				Akine, S; Goto, K; Kawashima, T			Synthesis, structure, and redox properties of a quinone-bridged calix[6]arene	TETRAHEDRON LETTERS			English	Article						benzoquinones; calixarenes; electrochemistry; X-ray crystal structures	CALIX<4>HYDROQUINONE; CALIX<4>QUINONE; OXIDATION; BINDING; GUESTS; ACID	The bridged calix[6]arene 1, where a 1,4-benzoquinone moiety is covalently anchored in the cavity of the calix[6]arene macrocycle with a rigid cone conformation, was synthesized and its structure was determined by X-ray analysis. The cyclic voltammogram showed that the reduction potential of 1 is negatively shifted in comparison with the reference compounds without the calixarene macrocycle, whose shift can be explained in terms of the interaction between the quinone moiety and the oxygen atoms at the lower rim of the calixarene framework. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Goto, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Akine S, 1999, B CHEM SOC JPN, V72, P2781, DOI 10.1246/bcsj.72.2781; AKINE S, IN PRESS J INCL PHEN; Alvarez J, 1998, CHEM COMMUN, P1455, DOI 10.1039/a800846i; ROBBINS TA, 1994, J AM CHEM SOC, V116, P111, DOI 10.1021/ja00080a014; CASNATI A, 1993, RECL TRAV CHIM PAY B, V112, P384; CHAMBERS JQ, 1974, CHEM QUINONOID COMPO, pCH14; Cram D. J., 1994, MONOGRAPHS SUPRAMOLE; Gutsche C. D, 1989, MONOGRAPHS SUPRAMOLE; Gutsche C. D., 1991, CALIXARENES VERSATIL; Gutsche C. D., 1998, MONOGRAPHS SUPRAMOLE; MORITA Y, 1992, J ORG CHEM, V57, P3658, DOI 10.1021/jo00039a027; MORITA Y, 1989, CHEM LETT, P1349, DOI 10.1246/cl.1989.1349; Pochini A., 1996, COMPREHENSIVE SUPRAM, V2, P103; ROBBINS TA, 1993, J AM CHEM SOC, V115, P12199, DOI 10.1021/ja00078a082; Saiki T, 1996, CHEM LETT, P993, DOI 10.1246/cl.1996.993; Saiki T, 1996, J ORG CHEM, V61, P2924, DOI 10.1021/jo960068q; Saiki T, 1997, ANGEW CHEM INT EDIT, V36, P2223, DOI 10.1002/anie.199722231; SUGA K, 1991, J CHEM SOC FARADAY T, V87, P1575, DOI 10.1039/ft9918701575; Wang Y, 1998, CHEM COMMUN, P1457, DOI 10.1039/a800845k	19	12	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 5	2000	41	6					897	901		10.1016/S0040-4039(99)02171-1		5	Chemistry, Organic	Chemistry	283ZH	WOS:000085305600027		
J	Horiuchi, M; Hayashida, W; Akishita, M; Yamada, S; Lehtonen, JYA; Tamura, K; Daviet, L; Chen, YQE; Hamai, M; Cui, TX; Iwai, M; Minokoshi, Y				Horiuchi, M; Hayashida, W; Akishita, M; Yamada, S; Lehtonen, JYA; Tamura, K; Daviet, L; Chen, YQE; Hamai, M; Cui, TX; Iwai, M; Minokoshi, Y			Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1	CIRCULATION RESEARCH			English	Article						angiotensin; cytokine; receptor; transcription	II TYPE-2 RECEPTOR; TRANSCRIPTION FACTOR IRF-1; IFN-INDUCIBLE GENES; SMOOTH-MUSCLE CELLS; AT2 BINDING-SITES; GROWTH-FACTOR; R3T3 CELLS; DIFFERENTIAL DISTRIBUTION; ENDOTHELIAL-CELLS; HUMAN HEART	The expression of angiotensin II type 2 (AT(2)) receptor is closely associated with cell growth, differentiation, and/or injury. We examined the effect of interferon (IFN)-gamma on AT, receptor expression in mouse fibroblast R3T3 cells and demonstrated that IFN-gamma treatment increased the expression of AT(2) receptor mRNA as well as its binding. Interferon regulatory factor (IRF)-1 was induced in mouse fibroblast R3T3 cells after IFN-gamma stimulation, and electrophoretic mobility shift assay showed an increase in IRF-1 binding with the IRF-specific binding sequence in the AT, receptor gene promoter region after IFN-gamma stimulation. The IRF-1 gene promoter contains an IFN-gamma-activated sequence (GAS) motif for possible binding of signal transducer(s) and activator(s) of transcription (STAT). Indeed, in R3T3 cells, IFN-gamma treatment resulted in rapid activation of Janus kinase (Jak) 1, Jak2, and STAT1 via tyrosine phosphorylation. Electrophoretic mobility shift assay with the GAS probe revealed increased STAT1 binding to the IRF-1 gene promoter in response to IFN-gamma stimulation. Transfection of GAS-binding oligonucleotides inhibited the effect of IFN-gamma on IRF-1 production, resulting in the AT, receptor trans-activation. Taken together, our data show that IFN-gamma upregulates AT, receptor expression in R3T3 cells via the activation of the intracellular Jak/STAT pathway and product:ion of IRF-1.	Ehime Univ, Sch Med, Dept Med Biochem, Shigenobu, Ehime 7910295, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Kyoto Univ, Grad Sch Med, Dept Med, Kyoto, Japan; Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan	Horiuchi, M (reprint author), Ehime Univ, Sch Med, Dept Med Biochem, Shigenobu, Ehime 7910295, Japan.						ABDOLLAHI A, 1991, CELL GROWTH DIFFER, V2, P401; AKISHITA M, 1997, CIRCULATION S1, V96, P547; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; FUJITA T, 1988, EMBO J, V7, P3397; DUDLEY DT, 1993, REGUL PEPTIDES, V44, P199, DOI 10.1016/0167-0115(93)90243-2; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Kambayashi Y, 1996, EUR J BIOCHEM, V239, P558, DOI 10.1111/j.1432-1033.1996.0558u.x; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; HARADA H, 1994, MOL CELL BIOL, V14, P1500; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Hayashida W, 1996, J BIOL CHEM, V271, P21985; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Nagano H, 1998, AM J PATHOL, V152, P1187; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; KIRCHHOFF S, 1993, NUCLEIC ACIDS RES, V21, P2881, DOI 10.1093/nar/21.12.2881; Booz GW, 1996, HYPERTENSION, V28, P635; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Haywood GA, 1997, CIRCULATION, V95, P1201; Horiuchi M, 1997, J BIOL CHEM, V272, P11952, DOI 10.1074/jbc.272.18.11952; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; DUDLEY DT, 1991, MOL PHARMACOL, V40, P360; TANAKA N, 1993, MOL CELL BIOL, V13, P4531; Wharton J, 1998, J PHARMACOL EXP THER, V284, P323; Yamada T, 1998, LIFE SCI, V63, pPL289, DOI 10.1016/S0024-3205(98)00448-2; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; PINE R, 1990, MOL CELL BIOL, V10, P2448; VISWANATHAN M, 1992, PEPTIDES, V13, P783, DOI 10.1016/0196-9781(92)90187-8; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; NAKAJIMA M, 1993, BIOCHEM BIOPH RES CO, V197, P393, DOI 10.1006/bbrc.1993.2492; Ohkubo N, 1997, CIRCULATION, V96, P3954; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; VADDI K, 1994, CIRCULATION, V90, P694; Bachmaier K, 1997, CIRCULATION, V96, P585; Csikos T, 1998, BIOCHEM BIOPH RES CO, V243, P142, DOI 10.1006/bbrc.1997.8042; DAMELL JE, 1994, SCIENCE, V264, P1415; Dimmeler S, 1997, CIRC RES, V81, P970; Dzau VJ, 1996, EUR HEART J, V17, P978; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Geng YJ, 1996, ARTERIOSCL THROM VAS, V16, P19; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HORIUCHI M, 1995, J BIOL CHEM, V270, P20225; Ichiki T, 1996, Kidney Int Suppl, V55, pS14; ICHIKI T, 1995, CIRC RES, V77, P1070; INABA T, 1995, J CLIN INVEST, V95, P1133, DOI 10.1172/JCI117761; Kijima K, 1996, HYPERTENSION, V27, P529; LOPEZ J, 1994, AM J PHYSIOL, V36, pH844; Marra F, 1996, J CLIN INVEST, V98, P1218, DOI 10.1172/JCI118905; MILLAN MA, 1991, P NATL ACAD SCI USA, V88, P11440, DOI 10.1073/pnas.88.24.11440; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; REIS LFL, 1992, EMBO J, V11, P185; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SIMS SH, 1993, MOL CELL BIOL, V13, P690; TANAKA N, 1992, ADV IMMUNOL, V52, P263, DOI 10.1016/S0065-2776(08)60877-9; Viswanathan M, 1996, PEPTIDES, V17, P695, DOI 10.1016/0196-9781(96)00064-2; WANG WZ, 1995, CIRC RES, V77, P1095; YAMADA G, 1991, P NATL ACAD SCI USA, V88, P532, DOI 10.1073/pnas.88.2.532	60	22	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7330			CIRC RES	Circ.Res.	FEB 4	2000	86	2					233	240				8	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	284PW	WOS:000085342000020		
J	Suzuki, E; Nagata, D; Yoshizumi, M; Kakoki, M; Goto, A; Omata, M; Hirata, Y				Suzuki, E; Nagata, D; Yoshizumi, M; Kakoki, M; Goto, A; Omata, M; Hirata, Y			Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor - Possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR-BETA; DEPENDENT KINASES; CDK INHIBITOR; ARRESTED FIBROBLASTS; POTENTIAL MEDIATOR; DOWN-REGULATION; G(1) PHASE; P27(KIP1); EXPRESSION	Vascular endothelial cells are unique in that they exit from the cell cycle when they come into contact with each other. Although the phenomenon is called "contact inhibition," little is known about the cellular mechanisms involved. Here we show that the phosphatase inhibitor sodium orthovanadate (SOV) induced the reentry of contact-inhibited human umbilical vascular endothelial cells (HUVECs) into the cell cycle and that reentry was associated with activation of the extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI 3-K)/Akt pathways. SOV stimulated [H-3]thymidine uptake of contact-inhibited HUVECs in a time- and dose-dependent manner. SOV-induced increase in [SH]thymidine uptake was significantly inhibited by the mitogen-activated protein kinase kinase inhibitor PD98059 and by the PI 3-K inhibitor LY294002, SOV also stimulated the expression of cyclin D1, cyclin E, and cyclin A, and the activity of CDK2 kinase, whereas it decreased the expression of p27(kip1). In marked contrast, growth media alone did not induce these changes. Furthermore, these SOV-induced changes were abolished by pretreatment with PD98059 and LY294002, SOV stimulated phosphorylation of ERK and Akt in contact-inhibited HUVECs, while growth media alone did not. This phosphorylation was associated with inhibition of phosphatase activity in the cells. Finally, overexpression of high cell density-enhanced protein tyrosine phosphatase 1 inhibited c-fos and cyclin A promoter activity. Taken together, our results suggest that in contact-inhibited HUVECs, increased phosphatase activity suppressed the ERK and PI 3-K/Akt pathways, resulting in exit from the cell cycle by down-regulation of cyclin D1, cyclin E, and cyclin A and by upregulation of p27(kip1).	Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, Tokyo 1138655, Japan	Suzuki, E (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Weber JD, 1997, BIOCHEM J, V326, P61; Vinals F, 1999, MOL CELL BIOL, V19, P2763; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; Keane MM, 1996, CANCER RES, V56, P4236; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; DIAZMECO MT, 1994, EMBO J, V13, P2842; HARPER JW, 1995, MOL BIOL CELL, V6, P387; Olson MF, 1998, NATURE, V394, P295; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; HARPER JW, 1993, CELL, V75, P805; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Aktas H, 1997, MOL CELL BIOL, V17, P3850; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/S0968-0004(96)10016-5; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; GAITS F, 1995, BIOCHEM J, V311, P97; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Harrington EO, 1997, J BIOL CHEM, V272, P7390; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Kato A, 1997, J BIOL CHEM, V272, P8065; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; Kosaka C, 1996, AM J PHYSIOL-CELL PH, V270, pC170; Kuramochi S, 1996, FEBS LETT, V378, P7, DOI 10.1016/0014-5793(95)01415-2; PALLEN CJ, 1991, P NATL ACAD SCI USA, V88, P6996, DOI 10.1073/pnas.88.16.6996; PINES J, 1995, BIOCHEM J, V308, P697; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Suzuki E, 1999, CIRC RES, V84, P611; Takuwa N, 1997, MOL CELL BIOL, V17, P5348; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Winston J, 1996, J BIOL CHEM, V271, P11253; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; ZHOU W, 1993, J BIOL CHEM, V268, P23041	46	57	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3637	3644		10.1074/jbc.275.5.3637		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	281FD	WOS:000085146500082		
J	Takiguchi, M; Murakami, M; Nakagawa, I; Saito, I; Hashimoto, A; Uede, T				Takiguchi, M; Murakami, M; Nakagawa, I; Saito, I; Hashimoto, A; Uede, T			CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice	LIFE SCIENCES			English	Article						CTLA4IgG; adenovirus vector; gene therapy; lupus; MRL/lpr mice	T-CELL ACTIVATION; FAS MESSENGER-RNA; MRL-LPR MICE; MURINE LUPUS; AUTOIMMUNE-DISEASE; APOPTOSIS GENE; CD28 RECEPTOR; RENAL-DISEASE; LPR/LPR MICE; ANTIGEN	MRL/MP-lpr/lpr (MRL/lpr) mice spontaneously develop an autoimmune syndrome closely resembling systemic lupus erythematosus (SLE) in humans, characterized by hypergammaglobulinemia, various autoantibody production, and the development of fatal glomerulonephritis. We have previously demonstrated that systemic administration of soluble form of CTLA4IgG prevented autoantibody-related diseases in MRL/lpr mice. To test the potential protective effects of CTLA4IgG gene delivery on the development of lupus nephritis, we injected MRL/lpr mice with, a recombinant adenovirus vector containing CTLA4IgG gene, Adex1CACTLA4IgG (AdCTLA4IgG). It was demonstrated that a single administration of intravenous injection of AdCTLA4IgG into MRL/lpr mice resulted in almost complete amelioration of lupus nephritis.	Hokkaido Univ, Inst Immunol Sci, Sect Immunopathogenesis, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Sapporo, Hokkaido 0600818, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1080071, Japan	Uede, T (reprint author), Hokkaido Univ, Inst Immunol Sci, Sect Immunopathogenesis, N15 W7, Sapporo, Hokkaido 0600815, Japan.		Takiguchi, Mitsuyoshi/G-3662-2012				ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; NIWA H, 1991, GENE, V108, P193; ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.immunol.11.1.191; Peng SL, 1996, J IMMUNOL, V156, P4041; SANTORO TJ, 1988, J EXP MED, V167, P1713, DOI 10.1084/jem.167.5.1713; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; SEAMAN WE, 1983, J IMMUNOL, V130, P1713; WU JG, 1993, J EXP MED, V178, P461, DOI 10.1084/jem.178.2.461; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Chu EB, 1996, J IMMUNOL, V156, P1262; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Huggins ML, 1999, LUPUS, V8, P29, DOI 10.1191/096120399678847308; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; KOH DR, 1995, EUR J IMMUNOL, V25, P2558, DOI 10.1002/eji.1830250923; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Mathisen PM, 1998, IMMUNOL TODAY, V19, P103, DOI 10.1016/S0167-5699(97)01214-0; MORSE HC, 1982, J IMMUNOL, V129, P2612; Nakagawa I, 1998, HUM GENE THER, V9, P1739, DOI 10.1089/hum.1998.9.12-1739; Ravirajan CT, 1996, CLIN EXP IMMUNOL, V105, P306, DOI 10.1046/j.1365-2249.1996.d01-770.x; RAZ E, 1995, LUPUS, V4, P286, DOI 10.1177/096120339500400409; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SAYEGH MH, 1995, J AM SOC NEPHROL, V6, P1143; SCHMIDTWOLF GD, 1995, IMMUNOL TODAY, V16, P173, DOI 10.1016/0167-5699(95)80116-2; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Takiguchi M, 1999, LAB INVEST, V79, P317; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; WOFSY D, 1985, J IMMUNOL, V134, P852; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	41	27	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205			LIFE SCI	Life Sci.	FEB 4	2000	66	11					991	1001		10.1016/S0024-3205(99)00664-5		11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	282FR	WOS:000085207800004		
J	Ikegami, S; Harada, A; Hirokawa, N				Ikegami, S; Harada, A; Hirokawa, N			Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice	NEUROSCIENCE LETTERS			English	Article						tau; gene targeting; FTDP-17; muscle weakness; hyperactivity; fear conditioning	MICROTUBULE-ASSOCIATED PROTEINS; ORGANIZATION; MUTATION; ISOFORMS; DEMENTIA; FTDP-17; SYSTEM; AXONS	Tau, one of the major neuronal microtubule-associated proteins (MAPs), is important for neuronal cell morphogenesis and axonal maintenance. Tau is also known to be a component of the paired helical filaments (PHFs) in Alzheimer's disease patients. Recently, mutations in the tau gene were found in a hereditary neurodegenarative disease called frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) which exhibits various neurological and neuropathological characteristics including PHF-like intracellular tau deposit formation. Currently, the phenotype of the disease is thought to be due to: (1) the toxicity of mutant tau molecules and and/or; (2) the loss of function of normal tau molecules in patients' brains. To test the latter hypothesis, we performed behavioral and neurological tests on tau-deficient mice. Tau-deficient mice showed muscle weakness in the wire-hanging test, hyperactivity in a novel environment, and impairment in the contextual fear conditioning. They also had a tendency to fall more easily in the rod-walking test. These phenotypes parallel some signs and symptoms of FTDP-17 patients. Our results show that the loss of tau protein may itself lead to some of the neurological characteristics observed in FTDP-17 patients. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Mitsubishi Kasei Inst Life Sci, Machida, Tokyo 1948511, Japan; Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	Hirokawa, N (reprint author), Mitsubishi Kasei Inst Life Sci, 11 Minamiooya, Machida, Tokyo 1948511, Japan.						Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Osada T, 1999, J NEUROSCI, V19, P6068	14	97	97	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	FEB 4	2000	279	3					129	132		10.1016/S0304-3940(99)00964-7		4	Neurosciences	Neurosciences & Neurology	282QV	WOS:000085230400001		
J	Islam, A; Kageyama, H; Takada, N; Kawamato, T; Takayasu, H; Isogai, E; Ohira, M; Hashizume, K; Kobayashi, H; Kaneko, Y; Nakagawara, A				Islam, A; Kageyama, H; Takada, N; Kawamato, T; Takayasu, H; Isogai, E; Ohira, M; Hashizume, K; Kobayashi, H; Kaneko, Y; Nakagawara, A			High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma	ONCOGENE			English	Article						Survivin; prognostic factor; apoptosis; 17q gain; neuroblastoma	ANTI-APOPTOSIS GENE; DEATH; CHROMOSOME-17; HYBRIDIZATION; MARKERS; CANCER	Survivin (SVV) is a family member of inhibitor of apoptosis proteins (IAPs) and its expression is cell cycle regulated. The gene is mapped to chromosome 17q25, the region of which is frequently gained in advanced stages of neuroblastoma (NBL). However, the role of SVV in NBL is poorly understood. Here we studied the clinical and biological role of SVV in NBL. A 1.9 kb SVV transcript was expressed in all of 9 NBL cell lines at higher levels than those in adult cancer cell lines. In 34 primary NBLs, high levels of SVV expression was significantly associated with age greater than 12 months (two sample t-test: P = 0.0003), advanced stages (P = 0.0136), sporadic tumors (P = 0.0027) and low levels of TrkA expression (P = 0.0030). In NBL cell lines, SVV mRNA expression was dramatically down-regulated in CHP134 and IMR32 cells undergoing apoptosis after treatment with all-tr mls retinoic acid (RA) or serum deprivation, It was only moderately decreased in cells (SH-SY5Y and CHP901) undergoing RA-induced differentiation, On the other hand, in proliferating NBL cells or RA-treated SK-N-AS line which is refractory to RA, the SVV mRNA remained at steady state levels or rather up-regulated. Furthermore, transfection of SVV into CHP134 cells induced remarkable inhibition of the RA-induced apoptosis, Collectively, our results suggest that high expression of SVV is a strong prognostic indicator for the advanced stage neuroblastomas, and that it could be one of the candidate genes for the 17q gain.	Chiba Canc Ctr, Inst Res, Div Biochem, Chuoh Ku, Chiba 2608717, Japan; Univ Tokyo, Dept Pediat Surg, Bunkyo Ku, Tokyo 1130033, Japan; Saitama Canc Ctr Hosp, Dept Canc Chemotherapy, Ina, Saitama 3620806, Japan	Nakagawara, A (reprint author), Chiba Canc Ctr, Inst Res, Div Biochem, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.						Lu CD, 1998, CANCER RES, V58, P1808; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Li FZ, 1998, NATURE, V396, P580; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466; Adida C, 1998, AM J PATHOL, V152, P43; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Plantaz D, 1997, AM J PATHOL, V150, P81; Yang E, 1996, BLOOD, V88, P386; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Barinaga M, 1998, SCIENCE, V280, P32, DOI 10.1126/science.280.5360.32; Brown N, 1999, NEW ENGL J MED, V340, P1954; CARON H, 1995, MED PEDIATR ONCOL, V24, P215, DOI 10.1002/mpo.2950240402; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIANSEN H, 1992, GENE CHROMOSOME CANC, V5, P141, DOI 10.1002/gcc.2870050208; Hoehner JC, 1997, BRIT J CANCER, V75, P1185, DOI 10.1038/bjc.1997.203; INAZAWA J, 1993, GENOMICS, V17, P153, DOI 10.1006/geno.1993.1297; IOANNOU PA, 1994, NAT GENET, V6, P84; Kaneko M, 1998, MED PEDIATR ONCOL, V31, P1, DOI 10.1002/(SICI)1096-911X(199807)31:1<1::AID-MPO1>3.0.CO;2-H; Kobayashi H, 1996, BRIT J HAEMATOL, V94, P105, DOI 10.1046/j.1365-2141.1996.d01-1762.x; Lastowska M, 1997, GENE CHROMOSOME CANC, V19, P143; Nakagawara A, 1997, CANCER RES, V57, P4578; Nakagawara A, 1998, MED PEDIATR ONCOL, V31, P113, DOI 10.1002/(SICI)1096-911X(199808)31:2<113::AID-MPO14>3.0.CO;2-O; Nakagawara A, 1998, Hum Cell, V11, P115; SHIMADA H, 1984, J NATL CANCER I, V73, P405	26	275	304	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 3	2000	19	5					617	623		10.1038/sj.onc.1203358		7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	281ZU	WOS:000085192000003		
J	Hayakawa, F; Towatari, M; Kiyoi, H; Tanimoto, M; Kitamura, T; Saito, H; Naoe, T				Hayakawa, F; Towatari, M; Kiyoi, H; Tanimoto, M; Kitamura, T; Saito, H; Naoe, T			Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines	ONCOGENE			English	Article						Flt3; tandem duplication; MAP kinase; STAT proteins; AML	RECEPTOR TYROSINE KINASES; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC-CELLS; GENE; LIGAND; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; FAMILY; TRANSCRIPTION	We have recently identified an internal tandem duplication of the human Flt3 gene in approximately 20% of acute myeloid leukemia (ARIL) cases. In the present study, the,wild-type and the mutant Flt3 genes were transfected into two IL-3-dependent cell lines, 32D and BA/F3 cells. Mutant Flt3-transfected cells exhibited autonomous growth while wild-type Flt3-transfected cells with the continuous stimulation of Flt3 ligand exhibited a minimal proliferation. Cells expressing mutant Flt3 showed constitutive activation of STAT5 and MAP kinase, In contrast, Flt3 ligand stimulation caused rapid activation of MAP kinase but not STAT5 in cells expressing wild-type Flt3, Finally, we found constitutive activation of MAP kinase and STAT5 in all clinical samples of AML patients with mutant Flt3, Our study shows the significance of internal tandem duplication of Flt3 receptors for leukemia cell expansion.	Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Sch Med, Dept Infect Dis, Showa Ku, Nagoya, Aichi 4668550, Japan; Univ Tokyo, Inst Med Sci, Dept Hemopoiet Factors, Minato Ku, Tokyo 108, Japan	Towatari, M (reprint author), Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.						ADACHI, 1999, J IMMUNOL, V162, P1496; Valgeirsdottir S, 1998, ONCOGENE, V16, P505, DOI 10.1038/sj.onc.1201555; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; PANG L, 1995, J BIOL CHEM, V270, P13585; Towatari M, 1997, LEUKEMIA, V11, P479, DOI 10.1038/sj.leu.2400617; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; ROSNET O, 1991, ONCOGENE, V6, P1641; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Horiike S, 1997, LEUKEMIA, V11, P1442, DOI 10.1038/sj.leu.2400770; Chin H, 1998, BLOOD, V91, P3734; CADENA DL, 1992, FASEB J, V6, P2332; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; WAKAO H, 1994, EMBO J, V13, P2182; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372; Mui ALF, 1996, EMBO J, V15, P2425; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; BRODSKY AR, 1999, BLOOD, V93, P1749; Drexler HG, 1996, LEUKEMIA, V10, P588; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Hayakawa F, 1998, BRIT J HAEMATOL, V101, P521, DOI 10.1046/j.1365-2141.1998.00720.x; Lavagna-Sevenier C, 1998, LEUKEMIA, V12, P301, DOI 10.1038/sj.leu.2400921; Lavagna-Sevenier C, 1998, J BIOL CHEM, V273, P14962, DOI 10.1074/jbc.273.24.14962; Lisovsky M, 1996, BLOOD, V88, P3987; McKenna HJ, 1996, EXP HEMATOL, V24, P378; MERCEDES D, 1993, MOL CELL BIOL, V13, P6572; Perkins GR, 1996, BLOOD, V87, P3669; PIACIBELLO W, 1995, BLOOD, V86, P4105; ROSNET O, 1993, BLOOD, V82, P1110; ROSNET O, 1991, GENOMICS, V9, P380, DOI 10.1016/0888-7543(91)90270-O; TORIGOE T, 1992, BLOOD, V80, P617; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443	34	338	346	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 3	2000	19	5					624	631		10.1038/sj.onc.1203354		8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	281ZU	WOS:000085192000004		
J	Kanomata, T; Sugawara, Y; Kaneko, T; Kamishima, K; Katori, HA; Goto, T				Kanomata, T; Sugawara, Y; Kaneko, T; Kamishima, K; Katori, HA; Goto, T			Giant magnetovolume effect of CrTe	JOURNAL OF ALLOYS AND COMPOUNDS			English	Article						chromium telluride; magnetovolume effect; itinerant elecron ferromagnet; magnetization	BAND-STRUCTURE; PRESSURE; SUSCEPTIBILITY; CR-1-DELTA-TE	The pressure change of the spontaneous magnetization sigma(s) of the itinerant electron ferromagnet CrTe has been determined in the ranges of hydrostatic pressure and temperature of 0-6.1 kbar and 4.2-70 K, respectively. The spontaneous magnetization decreases linearly with pressure at temperatures from 4.2 to 70 K. The values of d sigma(s)/dp and d In sigma(s)/dp at 4.2 K are found to be -0.92 emu g(-1) kbar(-1) and -1.2x10(-2) kbar(-1), respectively. (C) 2000 Elsevier Science S.A. All rights reserved.	Tohoku Gakuin Univ, Fac Engn, Dept Appl Phys, Tagajo, Miyagi 9858537, Japan; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 106, Japan	Kanomata, T (reprint author), Tohoku Gakuin Univ, Fac Engn, Dept Appl Phys, Tagajo, Miyagi 9858537, Japan.		Kamishima, Kenji/B-2738-2012; Katori, Hiroko/C-8794-2013				OHTA S, 1993, J PHYS-CONDENS MAT, V5, P2759, DOI 10.1088/0953-8984/5/17/010; DIJKSTRA J, 1989, J PHYS-CONDENS MAT, V1, P9141, DOI 10.1088/0953-8984/1/46/008; Shimada K, 1996, PHYS REV B, V53, P7673, DOI 10.1103/PhysRevB.53.7673; GAIDUKOV LG, 1961, SOV PHYS JETP-USSR, V12, P636; Galkin A. A., 1972, Soviet Physics - Solid State, V14; GOTO T, 1994, J APPL PHYS, V76, P6682, DOI 10.1063/1.358167; GRAZHDAN.NP, 1965, SOV PHYS JETP-USSR, V21, P840; GRAZHDANKINA NP, 1971, ZH EKSP TEOR FIZ, V32, P1025; GRAZHDANKINA NP, 1976, SOV PHYS JETP, V44, P775; IDO H, 1967, J PHYS SOC JPN, V22, P1418, DOI 10.1143/JPSJ.22.1418; IPSER H, 1983, J LESS-COMMON MET, V92, P265, DOI 10.1016/0022-5088(83)90493-9; LAMBERTANDRON B, 1979, SOV PHYS JETP, V49, P151; LONZARICH GG, 1985, J PHYS C SOLID STATE, V18, P4339, DOI 10.1088/0022-3719/18/22/017; NAGASAKI H, 1969, J PHYS CHEM SOLIDS, V30, P2405, DOI 10.1016/0022-3697(69)90064-X; ONO F, 1992, PHYSICA B, V177, P127, DOI 10.1016/0921-4526(92)90081-3; Shanditsev V. A., 1973, Soviet Physics - Solid State, V15; SHIMADA K, 1993, JPN J APPL PHYS 1, V32, P355; Takagaki M, 1998, J MAGN MAGN MATER, V177, P1385, DOI 10.1016/S0304-8853(97)00433-2; Takagaki M, 1998, J PHYS SOC JPN, V67, P1014, DOI 10.1143/JPSJ.67.1014; TAKAHASHI Y, 1986, J PHYS SOC JPN, V55, P3553, DOI 10.1143/JPSJ.55.3553	20	7	7	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-8388			J ALLOY COMPD	J. Alloy. Compd.	FEB 2	2000	297	1-2					5	8		10.1016/S0925-8388(99)00570-8		4	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	270AJ	WOS:000084513000003		
J	Kubo, K; Kanehisa, H; Kawakami, Y; Fukunaga, T				Kubo, K; Kanehisa, H; Kawakami, Y; Fukunaga, T			Elasticity of tendon structures of the lower limbs in sprinters	ACTA PHYSIOLOGICA SCANDINAVICA			English	Article						compliance; medial gastrocnemius; performance; sprint; ultrasonography; vastus lateralis	MEDIAL GASTROCNEMIUS-MUSCLE; ISOMETRIC CONTRACTIONS; MECHANICAL-PROPERTIES; STIFFNESS; RAT; STRETCH; ARCHITECTURE; PERFORMANCE; LIGAMENTS; EXERCISE	The present study aims to investigate the elasticity of tendon structures of the lower limbs in sprinters and its relation with sprint performance. Subjects were 10 male sprinters and 14 controls whose anthropometric variables and isometric maximum strength were similar. The elongation iii of the tendon and aponeurosis of vastus lateralis (VL) and medial gastrocnemius muscles (MG) during isometric knee extension and planter flexion, respectively, were determined using a real-time ultrasonic apparatus in vivo, while the subjects developed a gradually increasing torque from zero (relax) to maximal effort (MVC) within 5 s. While sprinters compared with controls showed significantly greater L above 500 N (about 50% of MVC) and higher dL/dF for VL at less than 20% of MVC during knee extension, there were no significant differences between the two groups in L and dL/dF for MG at every 10% of MVC during planter flexion. Moreover, the average value of dL/dF above 50% of MVC, proposed as the compliance of tendon structures, did not significantly differ between sprinters and controls in either VL or MG. In a regression analysis within sprinters, the compliance of VL was negatively correlated to 100-m sprint time, r= -0.757 (P < 0.05), but that of MG was not, r= 0.228 (P > 0.05). Thus the present results indicate that the elasticity of tendon structures of VL and MG at high force production levels, which might be assumed to associate with the storage and subsequent release of energy during exercises involving the stretch-shortening cycle, are similar in both sprinters and controls. For sprinters, however, the tendon structures of VL are more compliant than that for controls at low force production levels, and its elasticity at high force production levels may influence sprint performance.	Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Tokyo 1538902, Japan	Fukunaga, T (reprint author), Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.		fukunaga, tetsuo/C-6635-2009				AE M, 1985, BIOMECHANICS B, V9, P343; ALEXANDER RM, 1984, AM ZOOL, V24, P85; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86; WICKIEWICZ TL, 1984, J APPL PHYSIOL, V57, P435; NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511; KER RF, 1981, J EXP BIOL, V93, P283; PROSKE U, 1987, J BIOMECH, V20, P75, DOI 10.1016/0021-9290(87)90269-7; COOK CS, 1995, EXP PHYSIOL, V80, P477; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033; Fukunaga T, 1997, J BIOMECH, V30, P457, DOI 10.1016/S0021-9290(96)00171-6; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; DANIELSEN CC, 1988, J BIOMECH, V21, P207, DOI 10.1016/0021-9290(88)90171-6; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219; FUKASHIRO S, 1995, EUR J APPL PHYSIOL O, V71, P555, DOI 10.1007/BF00238560; WOO SLY, 1982, BIORHEOLOGY, V19, P397; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; Cook CS, 1996, EUR J APPL PHYSIOL O, V72, P380, DOI 10.1007/BF00599700; RIGBY BJ, 1959, J GEN PHYSIOL, V43, P265, DOI 10.1085/jgp.43.2.265; DEVITA P, 1992, MED SCI SPORT EXER, V24, P108; WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P51; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158; TIPTON CM, 1975, MED SCI SPORT EXER, V7, P165; WILSON GJ, 1991, J APPL PHYSIOL, V70, P825; BENEDICT J V, 1968, Journal of Biomechanics, V1, P53, DOI 10.1016/0021-9290(68)90038-9; BOBBERT MF, 1986, J BIOMECH, V19, P887, DOI 10.1016/0021-9290(86)90184-3; Booth F W, 1975, Exerc Sport Sci Rev, V3, P83; BRAND JM, 1986, LANCET, V1, P307; Butler D L, 1978, Exerc Sport Sci Rev, V6, P125; Cavagna G A, 1977, Exerc Sport Sci Rev, V5, P89; DIAMANT J, 1972, P R SOC LOND, V180, P239; ETTEMA GJC, 1992, J EXP BIOL, V165, P121; FOX LE, 1979, SPORTS PHYSL; GRIFFITHS RI, 1989, J EXP BIOL, V147, P439; Ito L, 1998, J APPL PHYSIOL, V85, P1230; MACDOUGALL JD, 1984, J APPL PHYSIOL, V57, P1399; MORGAN DL, 1977, AM J PHYSIOL, V232, pC45; NAKAGAWA T, 1989, RADIOISOTOPES, V38, P434; POUSSON M, 1991, PFLUG ARCH EUR J PHY, V419, P127, DOI 10.1007/BF00372997; POUSSON MJ, 1990, J BIOMECH, V21, P343; Putnam CA, 1989, BIOMECHANICS SPORTS, P1; SCHENAU GJ, 1985, MED SCI SPORT EXER, V17, P422; Shorten MR, 1987, MED SPORT SCI, V25, P1; Simonsen Erik B., 1995, Journal of Sports Sciences, V13, P291, DOI 10.1080/02640419508732242; STONE MH, 1988, MED SCI SPORT EXER, V20, pS162, DOI 10.1249/00005768-198810001-00013; VIIDIK A, 1986, BIOCH EXERCISE, V6, P545; Williams K R, 1985, Exerc Sport Sci Rev, V13, P389; WILSON GJ, 1992, MED SCI SPORT EXER, V24, P116	48	74	79	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0001-6772			ACTA PHYSIOL SCAND	Acta Physiol. Scand.	FEB	2000	168	2					327	335				9	Physiology	Physiology	296GR	WOS:000086016500007		
J	Aizawa, T; Zhou, C				Aizawa, T; Zhou, C			Bulk mechanical alloying for solid-state synthesis of functional materials	ADVANCED ENGINEERING MATERIALS			English	Article								Bulk mechanical alloying is an alternative solid-sate process, that can overcome several intrinsic difficulties in conventional mechanical alloying processes. The present process is adaptable to industrial production of functional alloys and compounds because of short processing times and the absence of contamination. With the aid of theoretical simulations in understanding the mechanical behavior, a pass schedule for each material system can be rationally deduced.	Univ Tokyo, Dept Met, Bunkyo Ku, Tokyo 1138363, Japan; Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138363, Japan	Aizawa, T (reprint author), Univ Tokyo, Dept Met, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138363, Japan.						AIZAWA T, 1999, P 4 NAT C COMPUTATIO, P321; Aizawa T, 1999, J ALLOY COMPD, V291, P248, DOI 10.1016/S0925-8388(99)00263-7; Aizawa T., 1999, Materials Science Forum, V312-314; AIZAWA T, 1999, J JAPAN SOC POWDER P, V46, P1097; AIZAWA T, 1993, J FACULTY ENG U TOKY, V42, P57; AIZAWA T, 1999, IN PRESS MAT SCI ENG; AIZAWA T, 1999, P 6 INT C TECHN PLAS, P419; AIZAWA T, 1997, CERAM ENG SCI P AM C, V18, P581; KIMURA Y, 1995, MATER T JIM, V36, P289; GILMAN PS, 1983, ANNU REV MATER SCI, V13, P279, DOI 10.1146/annurev.ms.13.080183.001431; AIZAWA T, 1995, MATER T JIM, V36, P138; BEAN CP, 1956, J APPL PHYS, V27, P1448, DOI 10.1063/1.1722287; IWAISOKO Y., 1998, J JAPAN SOC POWDER P, V45, P958; Kihara J, 1997, MATER SCI FORUM, V235-2, P41; Kobayashi O, 1996, MATER T JIM, V37, P1497; ZHOU C, 1999, IN PRESS SCR MAT; ZHOU C, 1999, THESIS U TOKYO; ZHOU C, 1997, MATER SCI FORUM, V272, P913	18	12	12	WILEY-V C H VERLAG GMBH	BERLIN	MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY	1438-1656			ADV ENG MATER	Adv. Eng. Mater.	FEB	2000	2	1-2					29	32		10.1002/(SICI)1527-2648(200002)2:1/2<29::AID-ADEM29>3.3.CO;2-D		4	Materials Science, Multidisciplinary	Materials Science	357JN	WOS:000089494900011		
J	Teramoto, S; Suzuki, M; Matsuse, T; Ohga, E; Ishii, T; Ouchi, Y				Teramoto, S; Suzuki, M; Matsuse, T; Ohga, E; Ishii, T; Ouchi, Y			Inhibitory effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radicals produced by bronchoalveolar lavage cells in young and aged guinea pigs	AGING-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						ACE inhibitors; age; alacepril; lisinopril; lung disease; oxygen radicals	OBSTRUCTIVE PULMONARY-DISEASE; SUPEROXIDE ANION; GLUTATHIONE METABOLISM; OXIDATIVE DAMAGE; CAPTOPRIL; LUNG; GENERATION; BLOOD; MICE; ANTIOXIDANT	We examined the effect of angiotensin-converting enzyme (ACE) inhibitors and age on oxygen radical formation by bronchoalveolar lavage (BAL) cells. Lung-free cells, including pulmonary alveolar macrophages, were harvested from young (4-month-old) and aged (28-month-old) male guinea pigs using BAL. The oxygen radicals produced by BAL cells were measured by a lucigenin-dependent chemiluminescence method using a photon counter. Although spontaneous oxygen radical production by BAL cells from young and aged guinea pigs did not differ, the oxygen radical generation after maximal stimulation with phorbol-myristate acetate (PMA) was greater than that produced without PMA stimulation in both young and aged animals. ACE inhibitors with and without an SH-group (alacepril and lisinopril, respectively) were tested for their effect on oxygen radical formation by BAL cells; both ACE inhibitors inhibited oxygen radical production and generation by BAL cells from both young and aged guinea pigs in a dose-dependent manner. However, the alacepril concentration giving 50% inhibition (IC50) of oxygen radical generation by BAL cells was smaller than the IC50 of lisinopril in both young and aged guinea pigs. These results indicate that ACE inhibitors, in particular those with an SH-group, effectively reduce oxygen radical production by BAL cells from young and aged guinea pigs, and suggest that treatment with ACE inhibitors may be useful for ameliorating oxidant-associated pulmonary disorders in young and aged patients. (Aging Clin. Exp. Res. 12: 22-28, 2000) (C)2000, Editrice Kurtis.	Tokyo Univ Hosp, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						WARD WF, 1990, INT J RADIAT ONCOL, V19, P1405; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055; Wong HR, 1997, AM J PHYSIOL-LUNG C, V273, pL1; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341; HARMAN D, 1956, J GERONTOL, V11, P298; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Poli G, 1997, FREE RADICAL BIO MED, V22, P287, DOI 10.1016/S0891-5849(96)00327-9; Bartosz M, 1997, FREE RADICAL BIO MED, V23, P729, DOI 10.1016/S0891-5849(97)00014-2; CLAPPERTON M, 1995, BRIT J CLIN PHARMACO, V40, P31; CORRBERAND J, 1986, MECH AGEING DEV, V36, P57; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V154, P813; GLASSOCK RJ, 1991, SEMIN NEPHROL, V11, P138; HIRAWA N, 1994, J HYPERTENS, V12, P909; Ingham NJ, 1998, BRAIN RES, V788, P60, DOI 10.1016/S0006-8993(97)01513-8; JANSSEN YM, 1993, LAB INVEST, V68, P261; Kleber FX, 1996, DRUGS, V51, P89, DOI 10.2165/00003495-199651010-00007; LAPENNA D, 1993, FREE RADIC BIOL MED, V14, P643; LIPSCHITZ DA, 1986, J GERONTOL, V41, P690; MARTIN MFR, 1984, LANCET, V1, P1325; MIRA ML, 1993, FREE RADICAL RES COM, V19, P173, DOI 10.3109/10715769309111600; Noda Y, 1997, RES COMMUN MOL PATH, V96, P125; Pitt B, 1997, AM J CARDIOL, V79, P24, DOI 10.1016/S0002-9149(97)00126-4; Preuss JMH, 1998, EUR J PHARMACOL, V345, P71, DOI 10.1016/S0014-2999(97)01585-9; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; SCHWAB R, 1988, SEMIN ONCOL, V10, P20; Suzuki M, 1998, J ASTHMA, V35, P267, DOI 10.3109/02770909809068217; SUZUKI S, 1993, PHARMACOLOGY, V47, P61, DOI 10.1159/000139079; TERAMOTO S, 1994, LUNG, V172, P223, DOI 10.1007/BF00164439; TERAMOTO S, 1995, EUR RESPIR J, V8, P450, DOI 10.1183/09031936.95.08030450; Teramoto S, 1996, J ASTHMA, V33, P149, DOI 10.3109/02770909609054546; TERAMOTO S, 1995, BIOCHEM MOL MED, V55, P66, DOI 10.1006/bmme.1995.1033; Teramoto S, 1996, LUNG, V174, P119; TERAMOTO S, 1999, BRIT J ANAESTH, V83, P101; TERAMOTO S, 1995, CHEMOTHERAPY, V41, P222; Teramoto S, 1998, AM J RESP CRIT CARE, V158, P1914; Teraoka M, 1998, AM J MED GENET, V78, P424, DOI 10.1002/(SICI)1096-8628(19980806)78:5<424::AID-AJMG6>3.0.CO;2-L; WARD WF, 1993, RADIAT RES, V135, P81, DOI 10.2307/3578400; WILLIAMS GH, 1988, NEW ENGL J MED, V319, P1517	39	4	4	EDITRICE KURTIS S R L	MILAN	VIA LUIGI ZOJA 30, 20153 MILAN, ITALY	0394-9532			AGING-CLIN EXP RES	Aging-Clin. Exp. Res.	FEB	2000	12	1					22	28				7	Geriatrics & Gerontology	Geriatrics & Gerontology	290TZ	WOS:000085695100003		
J	Keicho, N; Ohashi, J; Tamiya, G; Nakata, K; Taguchi, Y; Azuma, A; Ohishi, N; Emi, M; Park, MH; Inoko, H; Tokunaga, K; Kudoh, S				Keicho, N; Ohashi, J; Tamiya, G; Nakata, K; Taguchi, Y; Azuma, A; Ohishi, N; Emi, M; Park, MH; Inoko, H; Tokunaga, K; Kudoh, S			Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC MICROSATELLITE MARKERS; CLASS-I REGION; CYSTIC-FIBROSIS; HLA ANTIGENS; JAPANESE; ALLELES; GENE	Diffuse panbronchiolitis affecting East Asians is strongly associated with the class I human leukocyte antigen (HLA) alleles. Recent observations suggest that a major disease-susceptibility gene may be located between the HLA-B and HLA-A loci in the class I region of the major histocompatibility complex on chromosome 6. To test this possibility, we analyzed 14 polymorphic markers in 92 Japanese patients and 93 healthy controls. Of these, seven marker alleles, including HLA-B54 and HLA-A11, were significantly associated with the disease. Maximum-likelihood haplotype analysis and subsequent direct determination of individual haplotypes identified a group of disease-associated haplotypes, one of which contained all seven disease-associated marker alleles. Another haplotype, containing HLA-B*5504, was also associated with the disease. All these haplotypes seem to have diverged from a common ancestral haplotype in East Asians and share a specific segment containing three consecutive markers between the S and TFIIH loci in the class I region. Furthermore, one of the markers within the candidate region showed the highest delta value, indicating the strongest association. Of 20 Korean patients with diffuse panbronchiolitis, 17 also shared the combination of the disease-associated marker alleles within the candidate region. These results indicate that an HLA-associated major susceptibility gene for diffuse panbronchiolitis is probably located within the 200 kb in the class I region 300 kb telomeric of the HLA-B locus on the chromosome 6p21.3.	Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1138655, Japan; Nippon Med Sch, Dept Internal Med 4, Tokyo 113, Japan; Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Tokyo 113, Japan; Toranomon Gen Hosp, Div Resp Dis, Tokyo, Japan; Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Kanagawa 2591100, Japan; Tenri Hosp, Dept Resp Med, Nara, Japan; Seoul Natl Univ, Coll Med, Dept Clin Pathol, Seoul, South Korea	Keicho, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		OHASHI, JUN/G-5907-2015				DEVLIN B, 1995, GENOMICS, V29, P311; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; HOMMA H, 1983, CHEST, V83, P63, DOI 10.1378/chest.83.1.63; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Bannai M, 1997, TISSUE ANTIGENS, V49, P376, DOI 10.1111/j.1399-0039.1997.tb02765.x; Chu Ya-Chiung, 1992, Journal of the Formosan Medical Association, V91, P912; Corne J, 1996, LANCET, V348, P1465, DOI 10.1016/S0140-6736(05)65888-6; FRASER RG, 1990, DIAGNOSIS DIS CHEST, V3, P2224; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; HOIBY N, 1994, THORAX, V49, P531, DOI 10.1136/thx.49.6.531; Imanishi T., 1992, HLA 1991, V1, P1065; Imanishi T, 1992, HLA 1991, V1, P76; Keicho N, 1998, AM J RESP CRIT CARE, V158, P846; KIM YW, 1992, INTERNAL MED, V31, P695, DOI 10.2169/internalmedicine.31.695; Park MH, 1999, AM J RESP CRIT CARE, V159, P526; Park MH, 1998, TISSUE ANTIGENS, V51, P347; SUGIYAMA Y, 1990, AM REV RESPIR DIS, V141, P1459; Tamiya G, 1999, TISSUE ANTIGENS, V54, P221, DOI 10.1034/j.1399-0039.1999.540302.x; Tamiya G, 1998, TISSUE ANTIGENS, V51, P337; Tokunaga K, 1996, PREHISTORIC MONGOLOI, P187; Tsang KWT, 1998, THORAX, V53, P274	24	46	49	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					501	507		10.1086/302786		7	Genetics & Heredity	Genetics & Heredity	337QL	WOS:000088373100017		
J	Araki, S; Sato, H; Yokoyama, K; Murata, K				Araki, S; Sato, H; Yokoyama, K; Murata, K			Subclinical neurophysiological effects of lead: A review on peripheral, central, and autonomic nervous system effects in lead workers	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Review						lead poisoning; neurotoxicity; subclinical health effect; dose-effects (and response) relationship; peripheral nerve conduction velocity; distribution of nerve conduction velocities; evoked potentials (SEP, VEP, BAEP); P300; computerized static posturography; electrocardiographic R-R interval variability	R INTERVAL VARIABILITY; SOMATOSENSORY EVOKED-POTENTIALS; CONDUCTION VELOCITIES; EXPOSED WORKERS; ELECTROPHYSIOLOGICAL EVALUATION; ENVIRONMENTAL-HEALTH; POSTURAL SWAY; ZINC; COPPER; NEUROTOXICITY	Background The peripheral nerve conduction velocity (NCV), distribution of nerve conduction velocities (DCV), somatosensory, visual, and brainstem auditor?; evoked potentials (SEP, VET: and BAEP, respectively), event-related potential (P300), computerized static posturography with spectral analysis (postural balance), and electrocardiographic R-R interval variability (CVRR) With spectral analysis appear to be promising techniques for assessing subclinical effects of lead on the peripheral, central and autonomic nervous systems. This article presents art overview of research addressing subclinical neurophysiological effects of lead in workers exposed to lead. Methods We reviewed 102 articles to examine the effects and dose-effects relationships of lead on peripheral, central, and autonomic nervous System function together with reversibility of the effects, interaction between lend and other metals, and relative sensitivity and specificity of each technique. Background and methodology were also reviewed. Results and Conclusion Available data suggest that, on a group basis, the reduction in the NCV together with the effects on the P300 latency, postural balance, and CVRR, occurs at a mean blood lead concentration (BPb) as low as 30-40 mu g/dL; the effects on the latencies of the short-latency SEI: VEP, and BAEP, as well as the DCV start at a BPb as low as 40-50 mu g/dL. Further cross-sectional and preferably prospective studies by using each of those methods are needed to establish more precise dose-effects (and response) relationships of lead. (C) 2000 Wiley-Liss, Inc.	Univ Tokyo, Grad Sch Med, Fac Med, Dept Publ Hlth & Occupat Med,Bunkyo Ku, Tokyo 1130033, Japan	Araki, S (reprint author), Univ Tokyo, Grad Sch Med, Fac Med, Dept Publ Hlth & Occupat Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ABBATE C, 1995, INT ARCH OCC ENV HEA, V66, P389, DOI 10.1007/BF00383145; AMINOFF MJ, 1986, ELECTRODIAGNOSIS CLI; MURATA K, 1992, J AUTONOM NERV SYST, V37, P199, DOI 10.1016/0165-1838(92)90041-E; BARKER AT, 1979, IEEE T BIO-MED ENG, V26, P76, DOI 10.1109/TBME.1979.326512; BAKER EL, 1984, BRIT J IND MED, V41, P352; FITZPATRICK RC, 1992, J PHYSIOL-LONDON, V458, P69; MALLIANI A, 1991, CIRCULATION, V84, P482; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; ARAKI S, 1993, ENVIRON RES, V61, P308, DOI 10.1006/enrs.1993.1075; ARAKI S, 1993, ENVIRON RES, V63, P133, DOI 10.1006/enrs.1993.1135; ARAKI S, 1992, AM J IND MED, V21, P539, DOI 10.1002/ajim.4700210409; ARAKI S, 1980, INT ARCH OCC ENV HEA, V46, P151, DOI 10.1007/BF00378193; Araki S, 1976, SCAND J WORK ENV HEA, V4, P225; Araki S, 1994, NEUROBEHAVIORAL METH; ARAKI S, 1993, ENVIRON RES, V62, P325, DOI 10.1006/enrs.1993.1117; Araki Shunichi, 1994, Annals Academy of Medicine Singapore, V23, P710; ARAKI S, 1982, INT ARCH OCC ENV HEA, V49, P241, DOI 10.1007/BF00377933; ARAKI S, 1987, INT ARCH OCC ENV HEA, V59, P177, DOI 10.1007/BF00378495; ARAKI S, 1986, AM J IND MED, V9, P535, DOI 10.1002/ajim.4700090605; Araki S, 1997, ENVIRON RES, V73, P42, DOI 10.1006/enrs.1997.3708; ARAKI S, 1986, AM J IND MED, V10, P163; ARAKI S, 1986, BRIT J IND MED, V43, P321; Asahina M, 1994, Rinsho Shinkeigaku, V34, P1105; ASHBY JAS, 1980, BRIT J IND MED, V37, P133; AUDESIRK G, 1985, PROG NEUROBIOL, V24, P199, DOI 10.1016/0301-0082(85)90006-1; AZAZI ME, 1985, ACTA OPHTHALMOL, V63, P574; BALOH RW, 1979, J OCCUP ENVIRON MED, V21, P490; BORDO BM, 1982, SCAND J WORK ENV HEA, V8, P142; BUCHTHAL F, 1979, BRIT J IND MED, V36, P135; Camm AJ, 1996, CIRCULATION, V93, P1043; CHEN ZQ, 1985, SCAND J WORK ENV HEA, V11, P26; CHIA SE, 1994, OCCUP ENVIRON MED, V51, P768; DIENER HC, 1984, ELECTROEN CLIN NEURO, V57, P134, DOI 10.1016/0013-4694(84)90172-X; EISEN A, 1986, ELECTRODIAGNOSIS CLI, P535; FELDMAN RG, 1977, ARCH NEUROL-CHICAGO, V34, P481; FELDMAN RG, 1998, OCCUPATIONAL ENV NEU, P30; FOX DA, 1979, SCIENCE, V206, P78, DOI 10.1126/science.314667; Fujimura Y, 1998, J OCCUP HEALTH, V40, P9, DOI 10.1539/joh.40.9; GENNART JP, 1992, INT ARCH OCC ENV HEA, V64, P49, DOI 10.1007/BF00625951; GOODIN DS, 1986, ELECTRODIAGNOSIS CLI, P575; GRANDJEAN P, 1978, SCAND J WORK ENV HEA, V4, P295; HAEGERARONSEN B, 1976, ARCH ENVIRON HEALTH, V31, P215; HAENNINEN H, 1978, J OCCUP ENVIRON MED, V20, P683; Hazemann P, 1987, Electromyogr Clin Neurophysiol, V27, P183; HE FS, 1988, INT ARCH OCC ENV HEA, V61, P141, DOI 10.1007/BF00381618; HIRATA M, 1993, ENVIRON RES, V63, P60, DOI 10.1006/enrs.1993.1127; HOLDSTEIN Y, 1986, J LARYNGOL OTOL, V100, P1031, DOI 10.1017/S0022215100100519; HORIGUCHI S, 1988, Osaka City Medical Journal, V34, P237; JEYARATNAM J, 1986, BRIT J IND MED, V43, P626; JEYARATNAM J, 1985, BRIT J IND MED, V42, P173; KAJIYAMA K, 1993, ENVIRON RES, V60, P248, DOI 10.1006/enrs.1993.1033; Kimura J, 1989, ELECTRODIAGNOSIS DIS; LANDRIGAN PJ, 1976, J PEDIATR-US, V89, P904, DOI 10.1016/S0022-3476(76)80594-X; LANDRIGAN PJ, 1989, BRIT J IND MED, V46, P593; LILIS R, 1977, ENVIRON RES, V14, P255, DOI 10.1016/0013-9351(77)90037-8; LILLE F, 1988, J TOXICOL-CLIN TOXIC, V26, P103; LINZ DH, 1992, J OCCUP ENVIRON MED, V34, P638; MANTERE P, 1984, SCAND J WORK ENV HEA, V10, P43; MUIJSER H, 1987, SCAND J WORK ENV HEA, V13, P56; MURATA K, 1987, International Archives of Occupational and Environmental Health, V59, P11, DOI 10.1007/BF00377674; MURATA K, 1993, ENVIRON RES, V61, P323, DOI 10.1006/enrs.1993.1077; MURATA K, 1987, JPN J EEG EMG, V15, P16; MURATA K, 1995, AM J IND MED, V28, P233, DOI 10.1002/ajim.4700280208; MURATA K, 1991, AM J IND MED, V20, P663, DOI 10.1002/ajim.4700200509; Murata K, 1996, AM J IND MED, V30, P155, DOI 10.1002/(SICI)1097-0274(199608)30:2<155::AID-AJIM6>3.0.CO;2-#; NIELSEN CJ, 1982, ACTA NEUROL SCAND, V65, P241; OTTO D, 1985, ENVIRON RES, V38, P168, DOI 10.1016/0013-9351(85)90082-9; OTTO DA, 1993, ENVIRON RES, V62, P159, DOI 10.1006/enrs.1993.1100; OTTO DA, 1993, NEUROTOXICOLOGY, V14, P191; OTTO DA, 1981, ELECTROEN CLIN NEURO, V52, P229, DOI 10.1016/0013-4694(81)90052-3; PASTERNAK G, 1989, J TOXICOL-CLIN TOXIC, V27, P37; PAULEV PE, 1979, INT ARCH OCC ENV HEA, V43, P37, DOI 10.1007/BF00454278; PURSER DA, 1983, BRIT J IND MED, V40, P402; REPKO JD, 1978, EFFECTS INORGANIC LE; ROSEN I, 1983, SCAND J WORK ENV HEA, V9, P431; SATA F, 1993, ENVIRON RES, V62, P333, DOI 10.1006/enrs.1993.1118; SBORGIA G, 1983, NEUROBEHAVIORAL METH, P283; SCHWARTZ J, 1988, J PEDIATR-US, V112, P12, DOI 10.1016/S0022-3476(88)80111-2; Seppäläinen A M, 1980, Am J Ind Med, V1, P413, DOI 10.1002/ajim.4700010319; SEPPALAINEN AM, 1975, ARCH ENVIRON HEALTH, V30, P180; SEPPALAINEN AM, 1979, NEUROTOXICOLOGY, V1, P313; SEPPALAINEN AM, 1983, NEUROTOXICOLOGY, V4, P181; SEPPALAI.AM, 1972, BRIT J IND MED, V29, P443; SINGER R, 1983, NEUROTOXICOLOGY, V4, P193; SOKOL S, 1986, ELECTRODIAGNOSIS CLI, P441; SOLLIWAY BM, 1994, ENVIRON RES, V67, P168, DOI 10.1006/enrs.1994.1072; SPIVEY GH, 1980, J OCCUP ENVIRON MED, V22, P607; Stockard JJ, 1986, ELECTRODIAGNOSIS CLI, P467; STOLLERY BT, 1991, BRIT J IND MED, V48, P739; TERUYA K, 1991, INT ARCH OCC ENV HEA, V62, P549, DOI 10.1007/BF00381107; TRIEBIG G, 1984, INT ARCH OCC ENV HEA, V53, P189, DOI 10.1007/BF00398813; Vasilescu C, 1973, Rev Roum Neurol, V10, P221; *WHO TASK GROUP EN, 1995, ENV HLTH CRIT WHO, V165; YAGI K, 1989, JPN J OTORHINOLARYNG, V92, P899; YEH JH, 1995, OCCUP ENVIRON MED, V52, P415; Yokoyama K, 1998, INT ARCH OCC ENV HEA, V71, P459, DOI 10.1007/s004200050306; YOKOYAMA K, 1987, JPN J EEG EMG, V15, P282; YOKOYAMA K, 1988, NEUROTOXICOLOGY, V9, P405; YOKOYAMA K, 1992, ENVIRON RES, V59, P440, DOI 10.1016/S0013-9351(05)80047-7; Yokoyama K, 1997, NEUROTOXICOLOGY, V18, P371; YOKOYAMA K, 1994, JAPAN J IND HLTH, V36, P471	101	76	79	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0271-3586			AM J IND MED	Am. J. Ind. Med.	FEB	2000	37	2					193	204				12	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	271KX	WOS:000084593700005		
J	Miki, A; Fujii, T; Ishikawa, Y; Hamai, Y; Yamashita, T; Tadokoro, K; Kozuma, S; Juji, T; Taketani, Y				Miki, A; Fujii, T; Ishikawa, Y; Hamai, Y; Yamashita, T; Tadokoro, K; Kozuma, S; Juji, T; Taketani, Y			Immunotherapy prevents recurrent abortion without influencing natural killer receptor status	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						immunotherapy; in vivo; natural killer receptor; recurrent abortion	CELL ACTIVITY; NK CELLS; RECOGNITION; ACTIVATION; MECHANISM; PREGNANCY; CLONES; SUBSET	PROBLEM: We assessed the expression of natural killer (NK) receptors in recurrent aborters before and after immunotherapy using their husbands' peripheral blood mononuclear cells (PBMCs). METHOD OF STUDY: Using stored PBMCs from recurrent aborters before and after the immunotherapy, the expression of NK receptors, CD158a, CD158b, CD159 and CD94, were analyzed using monoclonal antibodies for respective receptors. The diversity of killer activatory receptors (KARs) and killer inhibitory receptors (KIRs) was also examined using reverse transcriptase-polymerase chain reaction (RT-PCR)single strand conformation polymorphism (SSCP) method. RESULTS. In recurrent aborters, no apparent changes in NK receptor expression and the balance between KARs and KIRs were found before and after the immunotherapy. CONCLUSION: The allo-human leukocyte antigen (HLA)-stimulation caused by the immunotherapy for recurrent aborters did not affect the expression of NK receptors and the ratio of KARs to KIRs regardless of the outcome of subsequent pregnancies, suggesting that recurrent aborters may benefit from the immunotherapy through mechanisms unrelated to alteration in NK receptor status.	Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan; Japanese Red Cross, Cent Blood Ctr, Tokyo, Japan	Fujii, T (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Carp HJA, 1997, HUM REPROD, V12, P250, DOI 10.1093/humrep/12.2.250; CLARK EA, 1979, INT J CANCER, V24, P688, DOI 10.1002/ijc.2910240525; FUJII T, 1988, AM J OBSTET GYNECOL, V158, P1015; Fujii T, 1989, Nihon Sanka Fujinka Gakkai Zasshi, V41, P115; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; Hamai Y, 1998, AM J REPROD IMMUNOL, V40, P63; HIGUCHI K, 1995, AM J REPROD IMMUNOL, V33, P221; KIESSLING R, 1976, J EXP MED, V143, P772, DOI 10.1084/jem.143.4.772; LALA PK, 1990, RES IMMUNOL, V141, P159, DOI 10.1016/0923-2494(90)90136-M; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; Maejima M, 1998, AM J REPROD IMMUNOL, V39, P12; MAKIDA R, 1991, LANCET, V338, P579, DOI 10.1016/0140-6736(91)91153-L; Miki A, 1998, AM J REPROD IMMUNOL, V39, P271; MORETTA A, 1990, J EXP MED, V171, P695, DOI 10.1084/jem.171.3.695; AOKI K, 1994, AM J REPROD IMMUNOL, V32, P55; SUGI T, 1991, AM J REPROD IMMUNOL, V25, P185; WEGMANN TG, 1984, ANN INST PASTEUR IMM, VD135, P309, DOI 10.1016/S0769-2625(84)81196-4	20	2	3	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	8755-8920			AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	FEB	2000	43	2					98	106		10.1111/j.8755-8920.2000.430206.x		9	Immunology; Reproductive Biology	Immunology; Reproductive Biology	285QG	WOS:000085399300006		
J	Yokomizo, T; Masuda, K; Kato, K; Toda, A; Izumi, T; Shimizu, T				Yokomizo, T; Masuda, K; Kato, K; Toda, A; Izumi, T; Shimizu, T			Leukotriene B-4 receptor - Cloning and intracellular signaling	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Scientific Meeting on Leukotrienes as Targets for Trreatment of Asthma and Other Disease - Current Basic and Clinical Research	1998	STOCKHOLM, SWEDEN				CYTOSOLIC PHOSPHOLIPASE A(2); HUMAN POLYMORPHONUCLEAR LEUKOCYTES; COLLAGEN-INDUCED ARTHRITIS; PROTEIN-COUPLED RECEPTOR; CDNA CLONING; CHEMOATTRACTANT RECEPTOR; HIV-1; EXPRESSION; CELLS; 12-HYDROXYDEHYDROGENASE		Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	Yokomizo, T (reprint author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						Akbar GKM, 1996, J BIOL CHEM, V271, P18363; Owman C, 1997, BIOCHEM BIOPH RES CO, V240, P162, DOI 10.1006/bbrc.1997.7628; Gaudreau R, 1998, BIOCHEM J, V335, P15; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; KIKUTA Y, 1993, J BIOL CHEM, V268, P9376; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Iversen L, 1997, SKIN PHARMACOL, V10, P169; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Masuda K, 1999, BIOCHEM J, V342, P79, DOI 10.1042/0264-6021:3420079; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; Serhan CN, 1996, FASEB J, V10, P1147; CHENGAPPA MM, 1993, J VET DIAGN INVEST, V5, P372; OHISHI N, 1990, J BIOL CHEM, V265, P7520; Uozumi N, 1997, NATURE, V390, P618; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; BIOE Y, 1999, EUR J PHARMACOL, V380, P203; BJORK J, 1982, INFLAMMATION, V6, P189, DOI 10.1007/BF00916243; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Ensor CM, 1998, BIOCHEM J, V330, P103; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Griffiths RJ, 1997, J EXP MED, V185, P1123, DOI 10.1084/jem.185.6.1123; KASIMIR S, 1991, BIOCHEM J, V279, P283; Khakh BS, 1998, TRENDS PHARMACOL SCI, V19, P39, DOI 10.1016/S0165-6147(97)01158-9; KUMLIN M, 1990, BIOCHIM BIOPHYS ACTA, V1044, P201, DOI 10.1016/0005-2760(90)90304-G; Martin V, 1999, J BIOL CHEM, V274, P8597, DOI 10.1074/jbc.274.13.8597; OBERLE GP, 1992, KIDNEY INT, V42, P69, DOI 10.1038/ki.1992.262; Owman C, 1996, GENOMICS, V37, P187, DOI 10.1006/geno.1996.0541; Owman C, 1998, P NATL ACAD SCI USA, V95, P9530, DOI 10.1073/pnas.95.16.9530; RAHMAN MA, 1988, J CLIN INVEST, V81, P1945, DOI 10.1172/JCI113542; REYES AA, 1992, KIDNEY INT, V41, P100, DOI 10.1038/ki.1992.13; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SOBERMAN RJ, 1985, P NATL ACAD SCI USA, V82, P2292, DOI 10.1073/pnas.82.8.2292; Toda A, 1999, BIOCHEM BIOPH RES CO, V262, P806, DOI 10.1006/bbrc.1999.1284; YOKOMIZO T, 1993, J BIOL CHEM, V268, P18128; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 1996, J BIOL CHEM, V271, P2844	43	29	31	AMER LUNG ASSOC	NEW YORK	1740 BROADWAY, NEW YORK, NY 10019 USA	1073-449X			AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	FEB	2000	161	2		S			S51	S55				5	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	285FL	WOS:000085379000012		
J	Kurosaki, F; Arisawa, M; Shudo, K; Okamoto, T; Isogai, Y				Kurosaki, F; Arisawa, M; Shudo, K; Okamoto, T; Isogai, Y			Nitric oxide form of a pyridylphenylurea is a potent inducer of shoot formation in plant tissue cultures	ANALYTICAL BIOCHEMISTRY			English	Article									Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Sugitani, Toyama 9300194, Japan; Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Coll Gen Educ, Meguro Ku, Tokyo 1530041, Japan	Kurosaki, F (reprint author), Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Sugitani, Toyama 9300194, Japan.						TAKAHASHI S, 1978, PHYTOCHEMISTRY, V17, P1201, DOI 10.1016/S0031-9422(00)94556-4; GREEN CE, 1987, PLANT TISSUE CELL CU; HILTON MG, 1988, MANIPULATING SECONDA, P239; KUROSAKI F, 1981, CHEM PHARM BULL, V29, P3751; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V72, P248; OKAMOTO T, 1978, CHEM PHARM BULL, V26, P3250; VASIL IK, 1984, CELL CULTURE SOMATIC	7	2	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697			ANAL BIOCHEM	Anal. Biochem.	FEB 1	2000	278	1					81	83		10.1006/abio.1999.4419		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	278QE	WOS:000084999800011		
J	Nagano, R; Tabata, S; Nakanishi, Y; Ohsako, S; Kurohmaru, M; Hayashi, Y				Nagano, R; Tabata, S; Nakanishi, Y; Ohsako, S; Kurohmaru, M; Hayashi, Y			Reproliferation and relocation of mouse male germ cells (gonocytes) during prespermatogenesis	ANATOMICAL RECORD			English	Article						BrdU immunohistochemistry; gonocyte; prespermatogenesis; relocation; reproliferation	C-KIT GENE; SERTOLI CELLS; IN-VITRO; SEMINIFEROUS EPITHELIUM; PROLIFERATIVE ACTIVITY; NEONATAL RATS; TESTIS; FETAL; INVITRO; MICE	In the prespermatogenesis period, male germ cells (gonocytes) begin to reproliferate and move to the basement membrane of the seminiferous tubule. Although these two events-reproliferation and relocation-are important for establishment of spermatogenesis, they have not been greatly analyzed both in a mechanical and in an endocrine or paracrine aspect. In this study, the relationship between reproliferation and relocation of gonocytes was examined, using the thymidine analog bromodeoxyuridine (BrdU) labeling method and transmission electron microscopy (TEM). BrdU was injected into the fetuses [day 13.5 post coitus (dpc) to 18.5 dpc] and pups [day 0.5 post partum (dpp) to 6.5 dpp] of C57BL/66 mice. Two hours later, BrdU positive gonocytes were examined immunohistochemically and these data were analyzed. TEM and LM:observation was carried out as well. Gonocytes began to relocate on the basement membrane from 18.5 dpc (1.4%) while BrdU-labeled gonocytes were first detected on 1.5 dpp (13.6%). Relocated BrdU-negative gonocytes were recognized from 18.5 dpc (1.4%), and relocated BrdU-labeled gonocytes were recognized from 1.5 dpp (8.4%). On the other hand, non-relocated BrdU-labeled gonocytes were detected from 1.5 dpp (5.2%). Gonocyte relocation began 2 days earlier than reproliferation during the late fetal period. After birth, the two events occured at random. These results indicate that the reproliferation of the gonocyte does not correlate with relocation. The two events may be regulated by different mechanisms; Anat Rec 258:210-220, 2000; (C) 2000 Wiley-Liss, Inc.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Anat, Bunkyo Ku, Tokyo 1138657, Japan; Kyusyu Univ, Fac Agr, Dept Anim Sci, Fukuoka 8128581, Japan; Kagoshima Univ, Fac Agr, Lab Anim Reprod, Kagoshima 8900065, Japan; Natl Inst Environm Studies, Environm Hlth Sci Div, Tsukuba, Ibaraki 3050053, Japan	Nagano, R (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Anat, Bunkyo Ku, Tokyo 1138657, Japan.						BEAUMONT HM, 1963, J EMBRYOL EXP MORPH, V11, P715; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233; KLUIN PM, 1984, ANAT EMBRYOL, V169, P73, DOI 10.1007/BF00300588; Li H, 1997, ENDOCRINOLOGY, V138, P1289, DOI 10.1210/en.138.3.1289; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; FRANCHI LL, 1964, J EMBRYOL EXP MORPH, V12, P289; Orth JM, 1997, BIOL REPROD, V57, P676, DOI 10.1095/biolreprod57.3.676; Zhou XH, 1996, ANAT REC, V245, P509; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; MCGUINNESS MP, 1992, ANAT REC, V233, P527, DOI 10.1002/ar.1092330406; BYSCOVE AG, 1995, NATURE, V374, P559; BYSKOV AG, 1993, MOL REPROD DEV, V34, P47, DOI 10.1002/mrd.1080340108; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; COUROT M, 1971, THESIS U PARIS; DeMiguel MP, 1996, ENDOCRINOLOGY, V137, P1885, DOI 10.1210/en.137.5.1885; FEDERICA MF, 1996, ENDOCRINOLOGY, V137, P647; FLICKING.CJ, 1967, Z ZELLFORSCH MIK ANA, V78, P92, DOI 10.1007/BF00344405; Gondos B., 1977, TESTIS, VIV, P1; GONDOS B, 1973, AM J ANAT, V136, P23, DOI 10.1002/aja.1001360104; GRINSTED J, 1979, J REPROD FERTIL, V56, P653; HAMAGUCHI S, 1985, CELL TISSUE RES, V240, P669, DOI 10.1007/BF00216355; HILSCHER B, 1974, CELL TISSUE RES, V154, P443; HILSCHER W, 1976, ANDROLOGIA, V8, P105; HUCKINS C, 1963, ANAT REC, V154, P243; KAWASE E, 1994, DEV BIOL, V161, P91, DOI 10.1006/dbio.1994.1011; KLUIN PM, 1981, INT J ANDROL, V4, P475, DOI 10.1111/j.1365-2605.1981.tb00732.x; ROOSENRU.EC, 1968, AM J ANAT, V122, P275, DOI 10.1002/aja.1001220208; MAEKAWA M, 1991, CELL TISSUE RES, V265, P551, DOI 10.1007/BF00340879; MCGUINNESS MP, 1992, EUR J CELL BIOL, V59, P196; MIETHING A, 1993, ANAT EMBRYOL, V187, P249; MIETHING A, 1989, ANAT EMBRYOL, V179, P503, DOI 10.1007/BF00319594; Nagano R, 1999, J VET MED SCI, V61, P465, DOI 10.1292/jvms.61.465; NOVI AM, 1968, Z ZELLFORSCH MIK ANA, V86, P313, DOI 10.1007/BF00332472; Ohkubo Y, 1996, EXP CELL RES, V222, P291, DOI 10.1006/excr.1996.0037; ORTH JM, 1991, ENDOCRINOLOGY, V129, P1119; Orth JM, 1996, MOL REPROD DEV, V45, P123, DOI 10.1002/(SICI)1098-2795(199610)45:2<123::AID-MRD3>3.0.CO;2-V; ORTH JM, 1995, J ANDROL, V16, P389; ORTH JM, 1990, ENDOCRINOLOGY, V127, P2812; ROSIEPEN G, 1994, J REPROD FERTIL, V100, P299; SAPSFORD CS, 1962, AUST J AGR RES, V13, P487, DOI 10.1071/AR9620487; SAPSFORD C. S., 1962, AUSTRALIAN JOUR ZOOL, V10, P178, DOI 10.1071/ZO9620178; STEINBER.E, 1971, PHYSIOL REV, V51, P1; THOOLEN B, 1990, J HISTOCHEM CYTOCHEM, V38, P267; VANDISSELEMILIANI FMF, 1993, CELL TISSUE RES, V273, P141; VANVORSTENBOSCH CJAHV, 1987, DEVELOPMENT, V99, P553; Waldeyer W., 1906, HDB VERGLEICHENDEN E, P86; WARTENBERG H, 1981, TESTIS, V1, P39; WARTENBERG H, 1976, ANDROLOGIA, V8, P117; ZHOU B, 1993, J UROLOGY, V153, P501; ZHOU BY, 1993, J UROLOGY, V150, P613	52	62	62	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0003-276X			ANAT REC	Anat. Rec.	FEB 1	2000	258	2					210	220				11	Anatomy & Morphology	Anatomy & Morphology	280TX	WOS:000085120800010		
J	Nishiyama, T; Hanaoka, K				Nishiyama, T; Hanaoka, K			Sedation with continuous midazolam infusion during spinal and/or epidural anesthesia	ANESTHESIA AND ANALGESIA			English	Meeting Abstract									Univ Tokyo, Kawaguchi, Japan							RAMSAY MAE, 1974, BRIT MED J, V2, P656	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	FEB	2000	90	2		S		S265						1	Anesthesiology	Anesthesiology	279FQ	WOS:000085034100266		
J	Nishiyama, T; Hanaoka, K; Gyermek, L; Lee, CM				Nishiyama, T; Hanaoka, K; Gyermek, L; Lee, CM			Intrathecal midazolam and glutamate receptor antagonists have synergistic analgesia on formalin induced pain in rats	ANESTHESIA AND ANALGESIA			English	Meeting Abstract									Univ Tokyo, Kawaguchi, Japan; Univ Calif Los Angeles, Harbor Med Ctr, Torrance, CA 90509 USA							1999, ANESTH ANALG, V88, pS370	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	FEB	2000	90	2		S		S333	U200	U200				1	Anesthesiology	Anesthesiology	279FQ	WOS:000085034100333		
J	Coimbra, MRM; Hasegawa, O; Kobayashi, K; Koretsugu, S; Naruse, K; Okamoto, N				Coimbra, MRM; Hasegawa, O; Kobayashi, K; Koretsugu, S; Naruse, K; Okamoto, N			Four microsatellite markers in the Japanese flounder, Paralichthys olivaceus	ANIMAL GENETICS			English	Article									Tokyo Univ Fisheries, Dept Aquat Biosci, Minato Ku, Tokyo 1088477, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Okamoto, N (reprint author), Tokyo Univ Fisheries, Dept Aquat Biosci, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.							0	4	6	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0268-9146			ANIM GENET	Anim. Genet.	FEB	2000	31	1					72	73		10.1111/j.1365-2052.2000.579-6.x		2	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	285BL	WOS:000085368300017		
J	Kogure, K; Kuwano, H; Fujimaki, N; Makuuchi, M				Kogure, K; Kuwano, H; Fujimaki, N; Makuuchi, M			Relation among portal segmentation, proper hepatic vein, and external notch of the caudate lobe in the human liver	ANNALS OF SURGERY			English	Article							INFERIOR VENA-CAVA; COMPLETE RESECTION; SURGICAL ANATOMY; CARCINOMA	Objective To identify portal segmentation and a portal fissure in the caudate lobe of the human liver in relation to the hepatic venous system and the external notch at the caudal edge of the caudate lobe. Summary Background Data Although the anatomy of the caudate lobe has been studied, the detailed anatomy has not yet been clarified; this is necessary to develop safe procedures for caudate lobe resection. Methods A total of 88 formalin-fixed human livers were dissected to visualize the portal vein and hepatic vein systems of the caudate lobe in relation to the external notch. Results The patterns of portal branching were classified into two types. In 58 livers (67.4%), the territories of the first-order portal branches were clearly divided into two areas (the Spiegel lobe and the paracaval portion). in the remaining 28 livers (32.6%), the territories of the second-order portal branches were clearly divided into two areas. These two areas were distinctly separated by an internal plane, which was coincident with the external notch. The caudate lobe had a systematized hepatic venous system that consisted of one (87.5%) or two (11.4%) proper hepatic veins and plural accessory hepatic veins. The proper hepatic veins laid along the internal plane between these two portal areas. Conclusions The caudate lobe exhibited distinct portal segmentation with a portal fissure that was indicated internally by the proper hepatic vein and externally by the notch at the caudal edge of the caudate lobe.	Gunma Univ, Sch Med, Dept Surg 1, Maebashi, Gumma 3718511, Japan; Gunma Univ, Sch Med, Dept Anat 2, Maebashi, Gumma 3718511, Japan; Univ Tokyo, Grad Sch Sci, Dept Surg, Tokyo, Japan	Kogure, K (reprint author), Gunma Univ, Sch Med, Dept Surg 1, 3-39-15 Showamachi, Maebashi, Gumma 3718511, Japan.		幕内, 雅敏/A-2140-2012				HEALEY JE, 1953, AMA ARCH SURG, V66, P599; Miyagawa S, 1998, TRANSPLANTATION, V66, P661, DOI 10.1097/00007890-199809150-00021; YANAGA K, 1994, SURGERY, V115, P757; KOSUGE T, 1994, ARCH SURG-CHICAGO, V129, P280; Bartlett D, 1996, BRIT J SURG, V83, P1076, DOI 10.1002/bjs.1800830812; Couinaud C., 1994, J HEP BIL PANCR SURG, V1, P145; Couinaud C., 1981, CONTROLLED HEPATECTO, P9; Couinaud C., 1989, SURG ANATOMY LIVER R, P123; ELIAS D, 1992, SURG GYNECOL OBSTET, V175, P17; FOUCOU B, 1983, J CHIR-PARIS, V120, P179; FRANCESCHINI LJ, 1995, SURG RADIOL ANAT, V17, P35, DOI 10.1007/BF01629497; HASEGAWA H, 1991, J CHIR-PARIS, V128, P533; HELOURY Y, 1988, SURG RADIOL ANAT, V10, P83, DOI 10.1007/BF02094077; KOGURE K, 1986, ACTA HEPATOL JPN, V27, P1155; Kumon M, 1985, ACTA HEPATOL JPN, V26, P1193; LASSAU JP, 1989, ORGANOGENESE FOIE HU, P17; LAUX G, 1953, CR ASSOC ANAT, V78, P264; MINH TV, 1992, ANN CHIR, V46, P309; MIZUMOTO R, 1988, WORLD J SURG, V12, P2; NAKAMURA S, 1981, SURG GYNECOL OBSTET, V152, P43; NAWAR NNY, 1980, ACTA ANAT, V108, P389; NIMURA Y, 1990, WORLD J SURG, V14, P535; TAKAYAMA T, 1991, SURGERY, V109, P208; Takayama T, 1994, J Am Coll Surg, V179, P72; YAMANE T, 1988, ACTA ANAT, V133, P162	25	38	47	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932			ANN SURG	Ann. Surg.	FEB	2000	231	2					223	228		10.1097/00000658-200002000-00011		6	Surgery	Surgery	280YB	WOS:000085130400011		
J	Kuraishi, H; Itoh, M; Katayama, Y; Ito, T; Hasegawa, A; Sugiyama, J				Kuraishi, H; Itoh, M; Katayama, Y; Ito, T; Hasegawa, A; Sugiyama, J			Ubiquinone systems in fungi. V. Distribution and taxonomic implications of ubiquinones in Eurotiales, Onygenales and the related plectomycete genera, except for Aspergillus, Paecilomyces, Penicillium, and their related teleomorphs	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						coenzyme Q; Eurotiales; Onygenales; ubiquinone	TALAROMYCES	The ubiquinone (coenzyme Q) systems were determined for 176 teleomorphic isolates, 14 anamorphic isolates, and three samples of fruit-bodies of Dendrosphaera eberhardtii, which belonged to Eurotiales, Onygenales, and related taxa. In Eurotiales, Ascosphaera had Q-9, whereas Bettsia had Q-10. All isolates of Monascaceae had the Q-10 system, whereas those of four genera of Pseudeurotiaceae had the Q-10(H(2)) system. The Q-10(H(2)) system was found in genera of Trichocomaceae, except for Aspergillus, Penicillium, Paecilomyces, and their related taxa. However, Thermoascus had the Q-9 system. In Onygenales, members of Arthrodermataceae had Q-9, and those of Gymnoascaceae had Q-10(H(2)). Isolates of Myxotrichaceae were characterized by Q-10(H(2)) with few exceptions, which had Q-10. The quinones of Onygenaceae belonged to complex systems, i.e., Q-9, 0-10 and 0-10(H(2)), and a combination of two systems. Families Onygenaceae and Trichocomaceae are likely a phylogenetic heterogeneity. Ubiquinone analysis provides a very useful criterion of great promise for classifying eurotialean taxa and also for identifying their isolates.	Japan Food Res Labs, Tama Ku, Tokyo 2060025, Japan; Tokyo Univ Agr & Technol, Fac Agr, Tokyo 1838509, Japan; Inst Fermentat Osaka, Yodogawa Ku, Osaka 5328686, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Kuraishi, H (reprint author), Japan Food Res Labs, Tama Ku, 6-11-10 Nagayama, Tokyo 2060025, Japan.		KATAYAMA, Yoko/G-1114-2013				Anderson DL, 1998, MYCOL RES, V102, P541, DOI 10.1017/S0953756297005261; LOBUGLIO KF, 1993, MYCOLOGIA, V85, P592, DOI 10.2307/3760506; CURRAH RS, 1985, MYCOTAXON, V24, P1; CURRAH RS, 1994, ASCOMYCETE SYSTEMATI, P282; CURRAH RS, 1995, ORG COMM 3 INT S MYC, P68; FRISVAD JC, 1990, ANTON LEEUW INT J G, V57, P179, DOI 10.1007/BF00403953; HAWKSWORTH DL, 1995, AINSWORTH BISBYS DIC, P190; *I FERM OS IFO, 1996, LIST CULT; ITO T, 1995, MYCOTAXON, V55, P347; KOBAYASI Y, 1981, B NATL MUS TOKYO B, V7, P15; KURAISHI H, 1990, NATO ADV SCI I A-LIF, V185, P407; KURAISHI H, 1991, B JFCC, V7, P111; KURAISHI H, 1985, T MYCOL SOC JPN, V26, P383; KURAISHI H, 1991, MYCOL RES, V95, P705; Landvik Sara, 1996, Mycoscience, V37, P237, DOI 10.1007/BF02461292; LOBUGLIO KF, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P115; Ogawa H, 1997, MYCOLOGIA, V89, P756, DOI 10.2307/3761132; OGAWA H, 1999, IN PRESS CLASSIFICAT; SUGIYAMA J, 1988, MYCOLOGIA, V80, P115, DOI 10.2307/3807503; Sugiyama Junta, 1998, Mycoscience, V39, P487, DOI 10.1007/BF02460912; TAMURA M, 1999, IN PRESS CLASSIFICAT; TAYLOR JW, 1990, NATO ADV SCI I A-LIF, V185, P357; UDAGAWA S, 1997, NIPPON KINGAKUKAI KA, V38, P143; Yaguchi Takashi, 1993, Transactions of the Mycological Society of Japan, V34, P101; Yaguchi Takashi, 1996, Mycoscience, V37, P55, DOI 10.1007/BF02461457; Yaguchi Takashi, 1994, Mycoscience, V35, P219, DOI 10.1007/BF02268441	26	6	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072			ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	FEB	2000	77	2					179	186		10.1023/A:1002416431944		8	Microbiology	Microbiology	286AW	WOS:000085422300008		
J	Tatsuta, H; Ito, G; Bugrov, AG; Tchernykh, AA; Akimoto, S				Tatsuta, H; Ito, G; Bugrov, AG; Tchernykh, AA; Akimoto, S			Multivariate morphometrics of two Podisma species (Orthoptera : Acrididae) in Kunashiri Island	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Podisma; multivariate morphometrics; chromosomal race; Mantel test; species	CHROMOSOMAL EVOLUTION; GRASSHOPPER; SPECIATION; FERTILITY; BOOTSTRAP; RATES; MICE	We examined morphological variation in Kunashiri populations of P. sapporensis Shiraki and P. tyatiensis Bugrov using multivariate morphometrics to clarify their taxonomic status in comparison with Hokkaido populations of P. sapporensis. Although P. sapporensis in Kunashiri Island has a unique karyotypic characteristic, the neo-X and neo-Y system, cluster analysis indicated that the morphology is included in the range of variation seen in Hokkaido populations with the XO-male determination system. P. tyatiensis is characterized by having short-armed chromosomes compared with other Podisma species, but the morphology of this species did not differed much from P. sapporensis in Hokkaido, either. These results suggest that chromosomal changes do not contribute to phenotypic diversification. P. sapporensis in Kunashiri Island is probably reproductively isolated from P. tyatiensis on the same island because of conspicuous differences in the karyotype, whereas it is highly probable that P. tyatiensis in Kunashiri Island and P. sapporensis in Hokkaido constitute the same biological species.	Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biometr, Bunkyo Ku, Tokyo 1138657, Japan; Hokkaido Univ, Grad Sch Agr, Dept Systemat & Ecol, Sapporo, Hokkaido 0608589, Japan; Novosibirsk State Univ, Dept Gen Biol, Novosibirsk 630090, Russia	Tatsuta, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biometr, Bunkyo Ku, Tokyo 1138657, Japan.		Tatsuta, Haruki/F-2997-2010				Akimoto Shin-Ichi, 1993, Japanese Journal of Entomology, V61, P625; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; MANTEL N, 1967, CANCER RES, V27, P209; SAGE RD, 1993, SYST BIOL, V42, P523, DOI 10.2307/2992487; SITES JW, 1987, SYST ZOOL, V36, P153, DOI 10.2307/2413266; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; ATCHLEY WR, 1973, EVOLUTION, V28, P416; ATCHLEY WR, 1974, AUST J ZOOL, V22, P25, DOI 10.1071/ZO9740025; ATCHLEY WR, 1974, SYST ZOOL, V23, P400, DOI 10.2307/2412545; BRITTONDAVIDIAN J, 1990, GENETICA, V80, P171, DOI 10.1007/BF00137322; Bugrov Alexander G., 1997, Acta Zoologica Cracoviensia, V40, P47; BUGROV AG, 1995, FOLIA BIOL-KRAKOW, V43, P51; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; COYNE JA, 1993, GENETICS, V134, P487; Efron B, 1982, CBMS NSF REGIONAL C, V38; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Gosalvez Jaime, 1997, P355; SEARLE JB, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P309; Howard Daniel J., 1993, P118; JACKSON DA, 1989, CAN J ZOOL, V67, P766; King M, 1993, SPECIES EVOLUTION RO; Manly B.F.J., 1997, RANDOMIZATION BOOTST; Mayr E, 1963, ANIMAL SPECIES EVOLU; Rohlf F.J., 1994, NTSYS PC NUMERICAL T; SAS Institute, 1988, SAS STAT US GUID REL; Sneath PHA, 1973, NUMERICAL TAXONOMY P; Sokal RR, 1995, BIOMETRY; Tatsuta H, 1997, APPL ENTOMOL ZOOL, V32, P527; TATSUTA H, 2000, IN PRESS ANN ENTOMOL, V93; Tatsuta Haruki, 1994, Japanese Journal of Entomology, V62, P225; Tatsuta H, 1998, CAN J ZOOL, V76, P1450, DOI 10.1139/cjz-76-8-1450; TRICKETT AJ, 1994, HEREDITY, V73, P339, DOI 10.1038/hdy.1994.180; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; White M. J. D., 1967, Australian Journal of Zoology, V15, P263, DOI 10.1071/ZO9670263; WHITE M J D, 1969, Australian Journal of Zoology, V17, P313, DOI 10.1071/ZO9690313; White MJD, 1978, MODES SPECIATION, DOI Freeman; WHITE MJD, 1964, EVOLUTION, V18, P417, DOI 10.2307/2406353; YASUDA N, 1989, KAMIKAWACHO NO SHIZE, V14, P47	39	5	5	JAPAN SOC APPL ENTOMOL ZOOL	TOKYO	1-43-11 KOMAGOME TOSHIMA-KU, TOKYO, 170, JAPAN	0003-6862			APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2000	35	1					1	8		10.1303/aez.2000.1		8	Entomology	Entomology	291KD	WOS:000085732500001		
J	Ishikawa, Y; Kanke, T				Ishikawa, Y; Kanke, T			Feeding deterrence of barley seedlings against the migratory locust Locusta migratoria (Orthoptera : Acrididae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Locusta migratoria; feeding deterrent; alkaloid; barley; palpation	MAXILLARY PALPS; SORGHUM-BICOLOR; RESISTANCE; GRAMINE; BEHAVIOR	Barley seedlings strongly deterred feeding of the migratory locust Locusta migratoria. Analysis of feeding-related behavior revealed that approach to barley seedlings and palpation occurred just as with palatable plants, but rejection of the plant occurred immediately after biting. Excision of the maxillary and labial palps had no effect on the rejection of barley seedlings, and feeding of palatable plants occurred as with intact insects. Removal of compounds on the surface of the barley leaves also had no effect, while ethanol extraction of the leaves diminished the deterrence of the barley seedlings. These results indicated that feeding deterrent(s) are localized inside the seedlings. An ethanol extract of barley seedlings exhibited strong deterrence in a feeding assay using a piece of sucrose-impregnated filter paper as the feeding substrate. Fractionation of the ethanol extract revealed that the strongest feeding deterrence was observed with the basic fraction, which contains alkaloids such as gramine. The other fractions also showed weak feeding deterrence. A crude alkaloid extract equivalent to 100 mg of barley leaf inhibited feeding of the locusts by 90%.	Univ Tokyo, Lab Appl Entomol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Ishikawa, Y (reprint author), Univ Tokyo, Lab Appl Entomol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.						ADAMS CM, 1978, ENTOMOL EXP APPL, V23, P101; WOODHEAD S, 1983, PHYSIOL ENTOMOL, V8, P345, DOI 10.1111/j.1365-3032.1983.tb00367.x; ZUNIGA GE, 1986, ENTOMOL EXP APPL, V40, P259; ZUNIGA GE, 1985, PHYTOCHEMISTRY, V24, P945, DOI 10.1016/S0031-9422(00)83158-1; BERNAYS EA, 1974, B ENTOMOL RES, V64, P413; ARGANDONA VH, 1987, PHYTOCHEMISTRY, V26, P1917, DOI 10.1016/S0031-9422(00)81728-8; BENHALIMA T, 1983, ENTOMOL EXP APPL, V33, P329; BERNAYS EA, 1977, ECOL ENTOMOL, V2, P1, DOI 10.1111/j.1365-2311.1977.tb00861.x; Blaney W.M., 1990, P1; BLANEY WM, 1974, J EXP BIOL, V60, P275; BLANEY WM, 1985, ENTOMOL EXP APPL, V39, P273; BLANEY WM, 1970, ENTOMOL EXP APPL, V13, P363; Blaney W. M., 1982, Proceedings of the 5th International Symposium on Insect-Plant Relationships, Wageningen, the Netherlands, 1-4 March 1982, P365; BLANEY WM, 1975, J EXP BIOL, V62, P555; Chapman R.F., 1990, P39; EULER H, 1933, Z PHYSL CHEM, V217, P23; HASKELL PT, 1969, ENTOMOL EXP APPL, V12, P423; ISHIKAWA Y, 2000, IN PRESS APPL ENTOMO, V35; KANEHISA K, 1990, APPL ENTOMOL ZOOL, V25, P251; LEE JC, 1987, INSECTS PLANTS, P125; MOORHOUS.JE, 1971, J INSECT PHYSIOL, V17, P913, DOI 10.1016/0022-1910(71)90107-7; SINOIR Y, 1968, ENTOMOL EXP APPL, V11, P195; SINOIR Y, 1966, HEBD C R SEANCES A D, V262, P2480; SINOIR Y, 1969, ANN NUTR ALIMENT, V23, P167; WOODHEAD S, 1982, ENTOMOL EXP APPL, V31, P296; WOODHEAD S, 1978, ENTOMOL EXP APPL, V24, P123	26	4	5	JAPAN SOC APPL ENTOMOL ZOOL	TOKYO	1-43-11 KOMAGOME TOSHIMA-KU, TOKYO, 170, JAPAN	0003-6862			APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	FEB	2000	35	1					125	130		10.1303/aez.2000.125		6	Entomology	Entomology	291KD	WOS:000085732500020		
J	Yamada, Y; Sumino, H; Okamura, Y; Shimasaki, H; Tominaga, T				Yamada, Y; Sumino, H; Okamura, Y; Shimasaki, H; Tominaga, T			Mossbauer studies on laser evaporated iron atoms and their reactions with oxygen in argon matrices	APPLIED RADIATION AND ISOTOPES			English	Article						Mossbauer spectroscopy; matrix isolation; iron oxide; laser ablation	DENSITY-FUNCTIONAL CALCULATIONS; LOW-TEMPERATURE MATRICES; INFRARED-SPECTRA; FE-57 ATOMS; MOLECULES; OXIDE; NITROGEN; STATE; FEO	Laser-evaporated iron atoms were isolated in low-temperature Ar matrices and their chemical reactions with oxygen were investigated by means of Mossbauer spectroscopy. Reactions of iron atoms with oxygen produce FeO, Fe(O-2), FeO3, (O-2)FeO2 and OFeO isolated in the Ar matrices and their yields vary depending on the concentration of oxygen. Similarly, FeO and Fe(O-2) were obtained by the reaction of iron atoms with N2O. infrared spectroscopy and molecular orbital calculations were applied to support their assignments. (C) 2000 Elsevier Science Ltd. All rights reserved.	Sci Univ Tokyo, Dept Chem, Fac Sci, Shinjyuku Ku, Tokyo, Japan; Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo, Japan	Yamada, Y (reprint author), Sci Univ Tokyo, Dept Chem, Fac Sci, Shinjyuku Ku, 1-3 Kagurazaka, Tokyo, Japan.			Sumino, Hirochika/0000-0002-4689-6231			ABRAMOWITZ S, 1977, CHEM PHYS LETT, V50, P423, DOI 10.1016/0009-2614(77)80357-6; Chertihin GV, 1996, J PHYS CHEM-US, V100, P5261, DOI 10.1021/jp953198w; ALMOND MJ, 1988, J CHEM SOC DALTON, P809, DOI 10.1039/dt9880000809; BAGUS PS, 1973, J CHEM PHYS, V59, P2986, DOI 10.1063/1.1680434; Andrews L, 1996, J AM CHEM SOC, V118, P467, DOI 10.1021/ja953338f; Andrews L, 1996, J PHYS CHEM-US, V100, P11235, DOI 10.1021/jp960674p; BARRETT PH, 1970, PHYS REV LETT, V25, P1601, DOI 10.1103/PhysRevLett.25.1601; BARROW RF, 1969, NATURE, V223, P1359, DOI 10.1038/2231359a0; CHANG S, 1981, INORG CHEM, V20, P2813, DOI 10.1021/ic50223a015; DEVORE TC, 1979, J CHEM PHYS, V70, P4429, DOI 10.1063/1.437985; ENGELKING PC, 1977, J CHEM PHYS, V66, P5054, DOI 10.1063/1.433811; FAN JW, 1995, J CHEM PHYS, V102, P8714, DOI 10.1063/1.468974; Frisch M.J., 1995, GAUSSIAN 94 REVISION; HELMER M, 1994, J CHEM SOC FARADAY T, V90, P395, DOI 10.1039/ft9949000395; HELMER M, 1994, J CHEM SOC FARADAY T, V90, P31, DOI 10.1039/ft9949000031; HUBER H, 1973, CAN J CHEM, V51, P2722, DOI 10.1139/v73-408; KRAUSS M, 1985, J CHEM PHYS, V82, P5584, DOI 10.1063/1.448593; LYNE PD, 1993, INORG CHEM, V32, P4785, DOI 10.1021/ic00074a022; MCNAB TK, 1971, PHYS REV B, V4, P3787, DOI 10.1103/PhysRevB.4.3787; MICKLITZ H, 1974, PHYS REV LETT, V33, P480, DOI 10.1103/PhysRevLett.33.480; MICKLITZ H, 1972, PHYS REV LETT, V28, P1547, DOI 10.1103/PhysRevLett.28.1547; MICKLITZ H, 1972, APPL PHYS LETT, V20, P387, DOI 10.1063/1.1653987; NAGARATHNA HM, 1983, J AM CHEM SOC, V105, P2938, DOI 10.1021/ja00348a002; WEST JB, 1975, J CHEM PHYS, V62, P2566, DOI 10.1063/1.430837; Yamada Y, 1998, RADIOCHIM ACTA, V80, P163; Yamada Y, 1998, HYPERFINE INTERACT, V112, P189, DOI 10.1023/A:1011081804384	26	23	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	FEB	2000	52	2					157	164		10.1016/S0969-8043(99)00128-1		8	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	280AH	WOS:000085079100001		
J	Dou, SZ; Seikai, T; Tsukamoto, K				Dou, SZ; Seikai, T; Tsukamoto, K			Cannibalism in Japanese flounder juveniles, Paralichthys olivaceus, reared under controlled conditions	AQUACULTURE			English	Article						Paralichthys olivaceus; juvenile; cannibalism; starvation; size variation; light; sand; density	PLEURONECTES-PLATESSA; BEHAVIOR; SIZE; PREDATION; PLAICE; SURVIVAL; GROWTH; LARVAE; LIGHT; SEA	Laboratory experiments were conducted to determine the effects of sand substratum, light, starvation, fish density and size variation on cannibalism among Japanese flounder juveniles, Paralichthys olivaceus. Cannibalistic behavior (biting and swallowing) increased significantly with starvation except in darkness, where juveniles could not find and attack their prey. Cannibalism occurred more frequently in heterogeneous than in the homogeneous size groups. Cannibalism was more frequent in light than in darkness at each starvation level. With sufficient food present, sand had no significant effect on cannibalism among homogeneous size juveniles, but played an important role in discouraging predation among members of the heterogeneous size groups. With sufficient food present, the rate of cannibalism was generally low and there were no significant differences in cannibalism among fish density levels of the homogeneous juveniles, With starvation, the cannibalism rate was significantly higher in high density groups than in the lower ones. Our results indicate that size variation, starvation and Light are the major factors affecting cannibalism in flounder juveniles, while sand and fish density only have a limited effect on cannibalism, depending on the nature of other factors. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Kyoto Univ, Fac Agr, Fisheries Res Stn, Kyoto 625, Japan	Dou, SZ (reprint author), Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China.						HECHT T, 1988, J ZOOL, V214, P21; ANSELL AD, 1993, J FISH BIOL, V43, P837, DOI 10.1006/jfbi.1993.1188; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Sakakura Y, 1997, FISHERIES SCI, V63, P42; GILES N, 1986, J FISH BIOL, V29, P107, DOI 10.1111/j.1095-8649.1986.tb04930.x; MEFFE GK, 1984, SOUTHWEST NAT, V29, P500, DOI 10.2307/3671007; TANAKA M, 1989, NETH J SEA RES, V24, P57, DOI 10.1016/0077-7579(89)90170-1; Batty RS, 1995, J FISH BIOL, V47, P931, DOI 10.1111/j.1095-8649.1995.tb06019.x; Dou SZ, 1995, NETH J SEA RES, V34, P195; MINELLO TJ, 1987, FISH B-NOAA, V85, P59; FOLKVORD A, 1991, AQUACULTURE, V97, P41, DOI 10.1016/0044-8486(91)90278-F; Damme P., 1989, J FISH BIOL, V34, P855, DOI 10.1111/j.1095-8649.1989.tb03369.x; De Groot S.J., 1971, Netherlands J Sea Res, V5, P121, DOI 10.1016/0077-7579(71)90008-1; DEANGELI SDL, 1979, ECOL MODEL, V18, P133; DIONNE M, 1985, AM NAT, V126, P16, DOI 10.1086/284392; Fitzgerald Gerard J., 1992, P238; FOX LR, 1975, ECOLOGY, V56, P933, DOI 10.2307/1936303; Furuta S, 1998, NIPPON SUISAN GAKK, V64, P1; Furuta S, 1996, SURVIVAL STRATEGIES IN EARLY LIFE STAGES OF MARINE RESOURCES, P285; GIBSON RN, 1992, J FISH BIOL, V40, P771, DOI 10.1111/j.1095-8649.1992.tb02623.x; Hecht Thomas, 1993, Journal of the World Aquaculture Society, V24, P246, DOI 10.1111/j.1749-7345.1993.tb00014.x; KATAVIC I, 1989, AQUACULTURE, V77, P135, DOI 10.1016/0044-8486(89)90197-X; KAWAMURA G, 1989, NIPPON SUISAN GAKK, V55, P2079; KAWAMURA G, 1985, B JPN SOC SCI FISH, V51, P155; LOADMAN NL, 1986, CAN J FISH AQUAT SCI, V43, P613, DOI 10.1139/f86-073; Qin JG, 1996, AQUACULTURE, V144, P313, DOI 10.1016/0044-8486(96)01299-9; Sakakura Y, 1996, J FISH BIOL, V48, P16, DOI 10.1006/jfbi.1996.0002; VALERIO M, 1986, BIOL BEHAV, V11, P16; YASUNAGA Y, 1980, B JAP SEA REG FISH R, V31, P17	29	37	43	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486			AQUACULTURE	Aquaculture	FEB 1	2000	182	1-2					149	159		10.1016/S0044-8486(99)00256-2		11	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	276WJ	WOS:000084901100012		
J	Mori, E; Yoshitani, N; Mori, T; Takasaki, S				Mori, E; Yoshitani, N; Mori, T; Takasaki, S			Calcium ion-independent recognition of sialyl and nonsialyl N-acetyllactosamine and Le(x) structures by boar sperm	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						boar sperm; adhesion; binding; carbohydrate recognition	PORCINE ZONA-PELLUCIDA; LINKED CARBOHYDRATE CHAINS; GLYCOPROTEIN FAMILY PZP3; EGGS IN-VITRO; SUGAR CHAINS; RECEPTOR ACTIVITY; OVIDUCTAL EPITHELIUM; MOUSE SPERM; BINDING; OLIGOSACCHARIDES	Recognition of defined carbohydrate structures by boar sperm was studied on the basis of oligosaccharide structures of porcine zona pellucida glycoproteins so far elucidated. Boar sperm abundantly adhered to fetuin-Sepharose beads, moderately to asialofetuin-Sepharose beads, but not at all to galactosidase (beta 1-4-linkage-specific)-digested asialofetuin-Sepharose beads. The sperm also adhered to Le(x) oligosaccharide probe-coupled avidin-Sepharose beads, These adhesive activities were retained in the medium containing EDTA instead of calcium ion but abolished after induction of acrosome reaction by pre-incubation of sperm with calcium ionophore, Inhibition study of sperm adhesion to the beads by soluble ligands demonstrated that boar sperm express at least two kinds of carbohydrate recognition molecules, one recognizing both sialyl and nonsialyl N-acetyllactosamines but not the Le(x) structure and the other recognizing the Le(x) structure but not N-acetyllactosamines, Sperm binding to the zona pellucida on fixed porcine oocytes was inhibited by N-glycans of fetuin and their asialo form but not by the asialo, agalacto-N-glycans. Finally, dextran-based multivalent oligosaccharide polymers were prepared and their inhibitory activities in sperm-oocyte binding were examined. The result indicated that the polymer composed of fetuin N-glycans, its asialo-N-glycans, or lacto-N-fucopentaose III causes a remarkable inhibition at the oligosaccharide-based concentration of 50 mu M. Thus, boar sperm are suggested to express multiple carbohydrate recognition molecules which may be involved in the sperm-egg interaction. (C) 2000 Academic Press.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, Tokyo 1088639, Japan	Takasaki, S (reprint author), Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						ABDULLAH M, 1989, J CELL BIOL, V108, P367, DOI 10.1083/jcb.108.2.367; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; DOSTALOVA Z, 1995, EUR J BIOCHEM, V230, P329; Dobrinski I, 1996, AM J VET RES, V57, P1635; Rankin T, 1996, DEVELOPMENT, V122, P2903; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Kudo K, 1998, EUR J BIOCHEM, V252, P492, DOI 10.1046/j.1432-1327.1998.2520492.x; YAMASHITA K, 1988, J BIOL CHEM, V263, P17482; TOPFERPETERSEN E, 1987, FEBS LETT, V226, P38, DOI 10.1016/0014-5793(87)80546-X; Fazeli A, 1997, BIOL REPROD, V56, P430, DOI 10.1095/biolreprod56.2.430; DEMOTT RP, 1995, BIOL REPROD, V52, P1395, DOI 10.1095/biolreprod52.6.1395; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Suarez SS, 1998, BIOL REPROD, V59, P39, DOI 10.1095/biolreprod59.1.39; TOYODA Y, 1974, J REPROD FERTIL, V36, P9; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; Geng JG, 1997, J CELL BIOL, V137, P743, DOI 10.1083/jcb.137.3.743; HIRANO T, 1993, EUR J BIOCHEM, V214, P763, DOI 10.1111/j.1432-1033.1993.tb17978.x; HOKKE CH, 1994, EUR J BIOCHEM, V221, P491, DOI 10.1111/j.1432-1033.1994.tb18762.x; Johnston DS, 1998, J BIOL CHEM, V273, P1888, DOI 10.1074/jbc.273.4.1888; LITSCHER ES, 1995, BIOCHEMISTRY-US, V34, P4662, DOI 10.1021/bi00014a020; MORI E, 1993, BIOCHEM BIOPH RES CO, V196, P196, DOI 10.1006/bbrc.1993.2234; Mori E, 1998, GLYCOCONJUGATE J, V15, P447, DOI 10.1023/A:1006926801717; Mori E, 1997, BIOCHEM BIOPH RES CO, V238, P95, DOI 10.1006/bbrc.1997.7249; MORI E, 1991, BIOCHEMISTRY-US, V30, P2078, DOI 10.1021/bi00222a012; NOGUCHI S, 1992, EUR J BIOCHEM, V209, P883, DOI 10.1111/j.1432-1033.1992.tb17361.x; NOGUCHI S, 1992, EUR J BIOCHEM, V204, P1089, DOI 10.1111/j.1432-1033.1992.tb16733.x; PETERSON RN, 1984, J EXP ZOOL, V231, P137, DOI 10.1002/jez.1402310118; Rankin TL, 1998, DEVELOPMENT, V125, P2415; Raychoudhury SS, 1997, BIOL REPROD, V56, P1268, DOI 10.1095/biolreprod56.5.1268; Shur BD, 1998, GLYCOCONJUGATE J, V15, P537, DOI 10.1023/A:1006951407168; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; TAKASAKI S, 1986, BIOCHEMISTRY-US, V25, P5709, DOI 10.1021/bi00367a054; URCH UA, 1988, BIOL CHEM H-S, V369, P727, DOI 10.1515/bchm3.1988.369.2.727; VANHALBEEK H, 1980, BIOCHIM BIOPHYS ACTA, V623, P295, DOI 10.1016/0005-2795(80)90257-3; YUREWICZ EC, 1991, MOL REPROD DEV, V30, P126, DOI 10.1002/mrd.1080300209	38	7	7	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-9861			ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	FEB 1	2000	374	1					86	92		10.1006/abbi.1999.1642		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	278PX	WOS:000084999100012		
J	Sato, S; Hasegawa, M; Ihn, H; Kikuchi, K; Takehara, K				Sato, S; Hasegawa, M; Ihn, H; Kikuchi, K; Takehara, K			Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						mixed connective tissue disease; systemic sclerosis; anti-U1RNP antibody; antinuclear matrix antibody	CONNECTIVE-TISSUE DISEASE; SYSTEMIC LUPUS-ERYTHEMATOSUS; RNP ANTIBODIES; RHEUMATIC DISEASES; NUCLEAR RIBONUCLEOPROTEIN; ANTIGEN; AUTOANTIBODIES; SM; DERMATOMYOSITIS; POLYMYOSITIS	Serum containing anti-U1RNP antibodies reacts with the nuclear matrix, the relatively insoluble component of the cell nucleus, in addition to U1RNP, In this study, we determine the serum titer and clinical correlations of antinuclear matrix antibodies in samples from patients with anti-U1RNP antibodies. The patients with anti-U1RNP antibodies were classified as having mixed connective tissue disease (MCTD, 15 patients), systemic sclerosis (SSc, 12 patients), systemic lupus erythematosus (SLE, 7 patients), and undifferentiated CTD (UCTD, 9 patients). Antinuclear matrix antibodies were detected using indirect immunofluorescence staining on HCl-treated HEp-2 cells, The antinuclear matrix antibody titer was significantly higher in serum from patients with MCTD or SSc than in serum from patients with SLE or UCTD, The antinuclear matrix antibody titer was significantly increased in serum from patients with sclerodactyly, pitting scars, contracture of the phalanges, and decreased carbon monoxide diffusion capacity. Thus, a higher titer of antinuclear matrix antibodies in serum from patients with anti-U1RNP antibodies may be associated with a clinical diagnosis of MCTD or SSc rather than a diagnosis of SLE or UCTD.	Kanazawa Univ, Sch Med, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan; Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Sato, S (reprint author), Kanazawa Univ, Sch Med, Dept Dermatol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.						Amigues JM, 1996, J RHEUMATOL, V23, P2055; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; TAKEDA Y, 1989, CLIN IMMUNOL IMMUNOP, V50, P213, DOI 10.1016/0090-1229(89)90130-X; Smolen JS, 1998, ARTHRITIS RHEUM, V41, P768, DOI 10.1002/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z; COMBE B, 1989, CLIN EXP IMMUNOL, V75, P18; CRAM DS, 1990, J IMMUNOL, V145, P630; Deng JS, 1996, ARTHRITIS RHEUM, V39, P1300, DOI 10.1002/art.1780390806; FRITZLER MJ, 1984, J IMMUNOL, V132, P1216; GAUDREAU A, 1978, ANN RHEUM DIS, V37, P321, DOI 10.1136/ard.37.4.321; HABETS WJ, 1990, ARTHRITIS RHEUM, V33, P834, DOI 10.1002/art.1780330610; Kasukawa R, 1987, MIXED CONNECTIVE TIS, P41; Kuwana M, 1996, ARTHRITIS RHEUM, V39, P938, DOI 10.1002/art.1780390610; LAZARO MA, 1989, MEDICINE, V68, P58; LEMMER JP, 1982, J RHEUMATOL, V9, P536; MCHUGH N, 1990, J RHEUMATOL, V17, P1320; MUNVES EF, 1983, ARTHRITIS RHEUM, V26, P848, DOI 10.1002/art.1780260705; NETTER HJ, 1988, ARTHRITIS RHEUM, V31, P616, DOI 10.1002/art.1780310506; NIMELSTEIN SH, 1980, MEDICINE, V59, P239; NOTMAN DD, 1975, ANN INTERN MED, V83, P464; REICHLIN M, 1991, CLIN EXP IMMUNOL, V83, P286; REICHLIN M, 1972, NEW ENGL J MED, V286, P908, DOI 10.1056/NEJM197204272861702; REICHLIN M, 1976, NEW ENGL J MED, V295, P1194, DOI 10.1056/NEJM197611182952112; SATO S, 1993, ARTHRITIS RHEUM, V36, P1137, DOI 10.1002/art.1780360815; SHARP GC, 1976, NEW ENGL J MED, V295, P1149, DOI 10.1056/NEJM197611182952101; STCLAIR EW, 1990, CLIN IMMUNOL IMMUNOP, V54, P266; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VENCOVSKY J, 1993, ANN RHEUM DIS, V51, P1313; VERHEIJEN R, 1988, J CELL SCI, V90, P11	31	2	4	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-3696			ARCH DERMATOL RES	Arch. Dermatol. Res.	FEB-MAR	2000	292	2-3					55	59		10.1007/s004030050010		5	Dermatology	Dermatology	286UN	WOS:000085467300002		
J	Sata, M; Suhara, T; Walsh, K				Sata, M; Suhara, T; Walsh, K			Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death - Implications for vascular disease and therapy	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						Fas; adenovirus; smooth muscle cells; endothelial cells; apoptosis	TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; UP-REGULATION; INDUCED APOPTOSIS; DOWN-REGULATION; OXIDIZED LDL; CD95 LIGAND; ATHEROSCLEROSIS; INHIBITION; MECHANISM	Fas ligand (FasL) is a death factor that induces apoptosis in cells bearing its receptor, Fas. Fas and Fast have been detected in the vessel wall, and it has been proposed that Fas-mediated apoptosis has a role in physiological and pathological cell turnover in the vasculature. Here, we evaluated the expression of Fas in the presence and absence of cytokines on both endothelial cells (ECs) and vascular smooth muscle cells (VSMCs). We also examined the sensitivity of ECs and VSMCs to Fas-mediated apoptosis induced by exposure to multiple Fas agonists: soluble Fast, anti-Fas antibody, and membrane-bound Fast resulting from transduction with a replication-defective adenovirus expressing Fast (Adeno-FasL), Cell-surface Fast expression was detected on human ECs with the use of 4 anti-Fast antibodies, whereas cell-surface Fast expression was not detected on VSMCs. Unstimulated ECs expressed relatively low levels of Fas, but expression was upregulated after treatment with tumor necrosis factor-alpha (TNF-alpha) or interferon gamma (IFN-gamma). In contrast, VSMCs expressed relatively high levels of Fas, and treatment with TNF-alpha or IFN-gamma induced little or no upregulation under the conditions of these assays. ECs were resistant to death after exposure to soluble Fast or agonist anti-Fas antibody and also after infection with Adeno-FasL in the presence or absence of cytokine treatment. In contrast, VSMCs remained viable in the presence of soluble Fast or agonist anti-Fas antibody, but they underwent apoptosis after infection with Adeno-FasL, IFN-gamma enhanced Adeno-FasL-induced death of VSMCs, but TNF-alpha did not. These findings provide insights about the potential role of Fas-mediated apoptosis in the vessel wall and suggest strategies to treat proliferative vascular diseases by exploiting the differential sensitivity of ECs and VSMCs to Fast-induced cell death.	Tufts Univ, St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA; Tufts Univ, Sackler Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	Walsh, K (reprint author), Tufts Univ, St Elizabeths Med Ctr, Div Cardiovasc Res, 736 Cambridge St, Boston, MA 02135 USA.						Suhara T, 1998, J IMMUNOL, V160, P4042; RICHARDSON BC, 1994, EUR J IMMUNOL, V24, P2640, DOI 10.1002/eji.1830241111; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Oshimi Y, 1996, J IMMUNOL, V157, P2909; ISIK FF, 1992, AM J PATHOL, V141, P1139; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; JAFFE EA, 1973, J CLIN INVEST, V52, P2757, DOI 10.1172/JCI107471; Sata M, 1998, NAT MED, V4, P415, DOI 10.1038/nm0498-415; Bossi G, 1999, NAT MED, V5, P90; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; RUSSELL PS, 1994, AM J PATHOL, V144, P260; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Irmler M, 1997, NATURE, V388, P190; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Sata M, 1998, P NATL ACAD SCI USA, V95, P1213, DOI 10.1073/pnas.95.3.1213; Biancone L, 1997, J EXP MED, V186, P147, DOI 10.1084/jem.186.1.147; BILLINGHAM ME, 1987, TRANSPLANT P, V19, P19; Cai WJ, 1997, ATHEROSCLEROSIS, V131, P177, DOI 10.1016/S0021-9150(97)06099-1; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Dong CM, 1996, LAB INVEST, V74, P921; FIEDLER P, 1998, SCIENCE, V279, pA2015; Fukuo K, 1997, GERONTOLOGY, V43, P35; Fukuo K, 1996, HYPERTENSION, V27, P823; Geng YJ, 1997, ARTERIOSCL THROM VAS, V17, P2200; Giordano C, 1997, SCIENCE, V275, P960; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Li JH, 1998, J IMMUNOL, V161, P3943; Luo ZY, 1999, CIRCULATION, V99, P1776; McGahon AJ., 1995, CELL DEATH DIFFER, P153; Muruve DA, 1997, HUM GENE THER, V8, P955, DOI 10.1089/hum.1997.8.8-955; PAPOFF G, 1998, SCIENCE, V279, pA2015; Perlman H, 1998, EMBO J, V17, P3576, DOI 10.1093/emboj/17.13.3576; PICKERING JG, 1992, J AM COLL CARDIOL, V20, P1430; Sata M, 1998, J BIOL CHEM, V273, P33103, DOI 10.1074/jbc.273.50.33103; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Smith D, 1998, J IMMUNOL, V160, P4159; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; STOKES TA, 1998, SCIENCE, V279, pA2015, DOI 10.1126/science.279.5359.2015a; Tollefson AE, 1998, NATURE, V392, P726, DOI 10.1038/33712; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784	45	86	92	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-5642			ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	FEB	2000	20	2					309	316				8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	281UM	WOS:000085179200006		
J	Takayanagi, H; Iizuka, H; Juji, T; Nakagawa, T; Yamamoto, A; Miyazaki, T; Koshihara, Y; Oda, H; Nakamura, K; Tanaka, S				Takayanagi, H; Iizuka, H; Juji, T; Nakagawa, T; Yamamoto, A; Miyazaki, T; Koshihara, Y; Oda, H; Nakamura, K; Tanaka, S			Involvement of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis	ARTHRITIS AND RHEUMATISM			English	Article							COLLAGEN-INDUCED ARTHRITIS; BONE-RESORPTION; CELL-FORMATION; T-CELLS; MACROPHAGES; MONOCYTES; LIGAND; OSTEOPROTEGERIN; FIBROBLASTS; CYTOKINE	Objective. To clarify the mechanism by which osteoclasts are formed in culture of rheumatoid synoviocytes by exploring the involvement of receptor activator of nuclear factor KB ligand (RANKL)/osteoclast differentiation factor (ODF). Methods. Osteoclast formation was evaluated in cocultures of rheumatoid synovial fibroblasts and peripheral blood mononuclear cells (PBMC) in the presence of macrophage colony stimulating factor and 1,25-dihydroxyvitamin D-3 (1,25[OH](2)D-3) utilizing separating membrane filters. RANKL/ODF expression was examined by Northern blotting in synovial tissues from 5 rheumatoid arthritis (RA) patients and tissues from patients with giant cell tumor (GCT), osteosarcoma (OS), and osteoarthritis (OA). RANKL/ODF expression and the ability of synovial fibroblasts to support osteoclastogenesis were investigated in coculture with PBMC in the presence or absence of 1,25(OH)(2)D-3, and soluble RANKL/ODF and osteoprotegerin (OPG)/ osteoclastogenesis inhibitory factor (OCIF) were measured by enzyme-linked immunosorbent assay. The effects of OPG/OCIF on the osteoclastogenesis in the primary culture of rheumatoid synoviocytes and the coculture system were determined. Results. Synovial fibroblasts did not induce osteoclastogenesis when separately cocultured with PBMC, Northern blotting revealed that RANKL/ODF was highly expressed in all tissues from RA and GCT patients, but not from OA or OS patients. Cultured rheumatoid synovial fibroblasts efficiently induced osteoclastogenesis in the presence of 1,25(OH)(2)D-3, which was accompanied by up-regulated expression of RANKL/ODF and decreased production of OPG/OCIF, Osteoclastogenesis from synoviocytes was dose-dependently inhibited by OPG/OCIF. Conclusion, RANKL/ODF expressed on synovial fibroblasts is involved in rheumatoid bone destruction by inducing osteoclastogenesis and would therefore be a good therapeutic target.	Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	Tanaka, S (reprint author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Amett FC, 1988, ARTHRITIS RHEUM, V31, P315; Takayanagi H, 1997, BIOCHEM BIOPH RES CO, V240, P279, DOI 10.1006/bbrc.1997.7404; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600; Gravallese EM, 1998, AM J PATHOL, V152, P943; Suzuki Y, 1998, J RHEUMATOL, V25, P1154; BARLAND P, 1962, J CELL BIOL, V14, P207, DOI 10.1083/jcb.14.2.207; Fujikawa Y, 1996, ANN RHEUM DIS, V55, P816, DOI 10.1136/ard.55.11.816; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Kong YY, 1999, NATURE, V397, P315; Bogoch ER, 1998, CAN J SURG, V41, P264; BURMESTER GR, 1983, SCAND J IMMUNOL, V17, P69, DOI 10.1111/j.1365-3083.1983.tb00767.x; Cawston T.E., 1995, MECH MODELS RHEUMATO, P333, DOI 10.1016/B978-012340440-4/50049-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fujikawa Y, 1996, BRIT J RHEUMATOL, V35, P213; Kotake S, 1996, J BONE MINER RES, V11, P88; Suzuki M, 1998, EXP ANIM TOKYO, V47, P211, DOI 10.1538/expanim.47.211; YANG K, 1999, J BONE MINER RES, V14, P518	31	361	389	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0004-3591			ARTHRITIS RHEUM	Arthritis Rheum.	FEB	2000	43	2					259	269		10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W		11	Rheumatology	Rheumatology	284ZM	WOS:000085362800004		
J	Murakami, A; Kaneko, Y; Imanaka, K; Takamoto, S; Yahagi, N				Murakami, A; Kaneko, Y; Imanaka, K; Takamoto, S; Yahagi, N			Easy aortic cannulation: A transxyphoid approach	ARTIFICIAL ORGANS			English	Article						pediatric cardiac surgery; minimally invasive cardiac surgery; atrial septal defects; ventricular septal defects		An easy aortic cannulation technique in minimally invasive pediatric cardiac surgery is described. We have developed a dilator which fits an aortic perfusion cannula. The aortic cannula over the dilator with a hole for passage of a guide wire is inserted into the ascending aorta by the Seldinger technique. Using this technique, the cannula never slips off, even at a slant angle to the aorta owing to the guidance of the guide wire. We recommend this safe and reliable technique for insertion of an aortic cannula into the ascending aorta in minimally invasive pediatric cardiac surgery.	Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1130033, Japan; Teikyo Univ, Mizonokuchi Hosp, Dept Anesthesiol, Kawasaki, Kanagawa, Japan	Murakami, A (reprint author), Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Barbero-Marcial M, 1998, ANN THORAC SURG, V65, P771, DOI 10.1016/S0003-4975(97)01433-1; MCCANN RL, 1991, J VASC SURG, V14, P375	2	3	3	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0160-564X			ARTIF ORGANS	Artif. Organs	FEB	2000	24	2					156	157		10.1046/j.1525-1594.2000.06482.x		2	Engineering, Biomedical; Transplantation	Engineering; Transplantation	296GQ	WOS:000086016400011		
J	Nakajima, Y; Tamura, M; Oasa, Y; Nakajima, T				Nakajima, Y; Tamura, M; Oasa, Y; Nakajima, T			A near-infrared imaging survey of the Lupus 3 dark cloud: A modest cluster of low-mass, pre-main-sequence stars	ASTRONOMICAL JOURNAL			English	Article						open clusters and associations : individual (Lupus); stars : formation; stars : low-mass, brown dwarfs; stars : pre-main-sequence	HERBIG-HARO OBJECTS; T-TAURI STARS; INTRINSIC COLORS; MOLECULAR CLOUDS; PHOTOMETRY; DISKS; L1630; CORE	We present the first report on results of a near-infrared imaging survey of the Lupus 3 dark cloud. This cloud is known to be associated with a modest cluster of T Tauri stars from a previous optical H alpha emission-line star survey. The survey covers 7' x 11', which corresponds to a projected area of similar to 0.35 x 0.55 pc at a distance of 150 pc. Mapping was carried out at J, H, and K-s, to 10 sigma limiting magnitudes of J = 17.0, H = 16.5, and K-s = 15.5. A total of 229 sources brighter than K-s < 15.8 were detected at all bands with a 90% completeness limit. Source classification is performed based on the near-infrared colors. Ten sources are candidates of Lada's Class II pre-main-sequence (PMS) stars, as they have a color excess that cannot be explained by reddening resulting from interstellar dust. We also identified 11 Class I-like candidates that were not detected at J and have a large color excess (H-K-s greater than or equal to 2), which is unlikely to arise from extinction in the Lupus dark cloud. There are four subclusters in this survey area of which three are embedded and mainly consist of the Class I-like candidates. The average density of PMS stars is around 500 pc(-3), suggesting the presence of a modest cluster of embedded PMS stars. We estimate masses of the Class II candidates with aid of an evolutionary model of PMS stars. Ten of them have masses less than 0.08 M. if we assume their age to be 10(6) yr. Hence, we consider them to be young brown dwarf (YBD) candidates. The relative population of YBDs in the Lupus 3 dark cloud is larger than in the Taurus.	Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Natl Astron Observ, Mitaka, Tokyo 1818588, Japan; Univ Tokyo, Dept Astron, Mitaka, Tokyo 1818588, Japan	Nakajima, Y (reprint author), Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan.						Krautter J, 1997, ASTRON ASTROPHYS SUP, V123, P329, DOI 10.1051/aas:1997163; Persson SE, 1998, ASTRON J, V116, P2475, DOI 10.1086/300607; MIZUNO A, 1995, ASTROPHYS J, V445, pL161, DOI 10.1086/187914; Tachihara K, 1996, PUBL ASTRON SOC JPN, V48, P489; Wilking BA, 1997, ASTRON J, V114, P2029, DOI 10.1086/118623; Oasa Y, 1999, ASTROPHYS J, V526, P336, DOI 10.1086/307964; REIPURTH B, 1988, ASTRON ASTROPHYS, V202, P219; BESSELL MS, 1988, PUBL ASTRON SOC PAC, V100, P1134, DOI 10.1086/132281; COHEN M, 1979, ASTROPHYS J SUPPL S, V41, P743, DOI 10.1086/190641; Meyer MR, 1997, ASTRON J, V114, P288, DOI 10.1086/118474; LADA EA, 1991, ASTROPHYS J, V371, P171, DOI 10.1086/169881; WILKING BA, 1989, ASTROPHYS J, V340, P823, DOI 10.1086/167439; HUGHES J, 1994, ASTRON J, V108, P1071, DOI 10.1086/117135; BERTOUT C, 1988, ASTROPHYS J, V330, P350, DOI 10.1086/166476; Testi L, 1999, ASTRON ASTROPHYS, V342, P515; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; LADA CJ, 1992, ASTROPHYS J, V393, P278, DOI 10.1086/171505; WILKING BA, 1983, ASTROPHYS J, V274, P698, DOI 10.1086/161482; GOMEZ M, 1993, ASTRON J, V105, P1927, DOI 10.1086/116567; BESSELL MS, 1991, ASTRON J, V101, P662, DOI 10.1086/115714; Briceno C, 1998, ASTRON J, V115, P2074, DOI 10.1086/300338; Cambresy L, 1999, ASTRON ASTROPHYS, V345, P965; D'Antona F., 1997, Memorie della Societa Astronomica Italiana, V68; HARA A, 1999, IN PRESS PASJ; HARTIGAN P, 1994, ASTROPHYS J, V427, P961, DOI 10.1086/174203; Itoh Y, 1999, ASTRON J, V117, P1471, DOI 10.1086/300782; KOORNNEEF J, 1983, ASTRON ASTROPHYS, V128, P84; KRAUTTER J, 1991, LOW MASS STAR FORMAT, P127; Lada E. A., 1993, PROTOSTARS PLANETS, P245; Li WB, 1997, ASTROPHYS J, V488, P277, DOI 10.1086/304675; MYERS PC, 1983, ASTROPHYS J, V266, P309, DOI 10.1086/160780; OASA Y, 1998, THESIS U TOKYO; SCHWARTZ RD, 1977, ASTROPHYS J SUPPL S, V35, P161, DOI 10.1086/190473; TOKUNAGA A, 1999, IN PRESS ASTROPHYSIC; Wichmann R, 1997, ASTRON ASTROPHYS, V320, P185	35	28	28	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-6256			ASTRON J	Astron. J.	FEB	2000	119	2					873	881		10.1086/301222		9	Astronomy & Astrophysics	Astronomy & Astrophysics	283KX	WOS:000085275700034		
J	Fan, XH; Knapp, GR; Strauss, MA; Gunn, JE; Lupton, RH; Ivezic, Z; Rockosi, CM; Yanny, B; Kent, S; Schneider, DP; Kirkpatrick, JD; Annis, J; Bastian, S; Berman, E; Brinkmann, J; Csabai, I; Federwitz, GR; Fukugita, M; Gurbani, VK; Hennessy, GS; Hindsley, RB; Ichikawa, T; Lamb, DQ; Lindenmeyer, C; Mantsch, PM; McKay, TA; Munn, JA; Nash, T; Okamura, S; Pauls, AG; Pier, JR; Rechenmacher, R; Rivetta, CH; Sergey, G; Stoughton, C; Szalay, AS; Szokoly, GP; Tucker, DL; York, DG				Fan, XH; Knapp, GR; Strauss, MA; Gunn, JE; Lupton, RH; Ivezic, Z; Rockosi, CM; Yanny, B; Kent, S; Schneider, DP; Kirkpatrick, JD; Annis, J; Bastian, S; Berman, E; Brinkmann, J; Csabai, I; Federwitz, GR; Fukugita, M; Gurbani, VK; Hennessy, GS; Hindsley, RB; Ichikawa, T; Lamb, DQ; Lindenmeyer, C; Mantsch, PM; McKay, TA; Munn, JA; Nash, T; Okamura, S; Pauls, AG; Pier, JR; Rechenmacher, R; Rivetta, CH; Sergey, G; Stoughton, C; Szalay, AS; Szokoly, GP; Tucker, DL; York, DG			L dwarfs found in Sloan Digital Sky Survey commissioning imaging data	ASTRONOMICAL JOURNAL			English	Article						stars : low-mass, brown dwarfs; surveys	BROWN DWARF; STANDARD STARS; SYSTEMS; DENIS	This paper describes the discovery of seven dwarf objects of spectral type L (objects cooler than the latest M dwarfs) in commissioning imaging data taken by the Sloan Digital Sky Survey (SDSS). Low-resolution spectroscopy shows that they have spectral types from L0 to L8. Comparison of the SDSS and the Two Micron All Sky Survey (2MASS) photometry for several of these objects indicates the presence of significant opacity at optical wavelengths. This comparison also demonstrates the high astrometric accuracy (better than 1 " for these faint sources) of both surveys. The L dwarfs are shown to occupy a distinctive region of color-color space as measured in the SDSS filters, which should enables their identification in a straightforward way. This should lead eventually to a complete sample of many hundreds of these low-mass objects, or about 1 per 15 deg(2) to i' approximate to 20, in the complete SDSS data set.	Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; Univ Chicago, Ctr Astron & Astrophys, Chicago, IL 60637 USA; Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; CALTECH, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA; Apache Point Observ, Sunspot, NM 88349 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Eotvos Lorand Univ, Dept Phys Complex Syst, H-1117 Budapest, Hungary; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; Inst Adv Study, Princeton, NJ 08540 USA; USN Observ, Washington, DC 20392 USA; Tohoku Univ, Inst Astron, Sendai, Miyagi 9808578, Japan; Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; USN Observ, Flagstaff Stn, Flagstaff, AZ 86002 USA; Univ Tokyo, Sch Sci, Res Ctr Early Universe, Tokyo 1130033, Japan; Univ Tokyo, Sch Sci, Dept Astron, Tokyo 1130033, Japan	Fan, XH (reprint author), Princeton Univ, Dept Astrophys Sci, Peyton Hall, Princeton, NJ 08544 USA.		Csabai, Istvan/F-2455-2012; McKay, Timothy/C-1501-2009; 	McKay, Timothy/0000-0001-9036-6150; Csabai, Istvan/0000-0001-9232-9898			OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Lupton RH, 1999, ASTRON J, V118, P1406, DOI 10.1086/301004; Ruiz MT, 1997, ASTROPHYS J, V491, pL107, DOI 10.1086/311070; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; BESSELL MS, 1988, PUBL ASTRON SOC PAC, V100, P1134, DOI 10.1086/132281; Kirkpatrick JD, 1999, ASTROPHYS J, V519, P802, DOI 10.1086/307414; Gunn JE, 1998, ASTRON J, V116, P3040, DOI 10.1086/300645; Skrutskie MF, 1997, ASTROPHYS SPACE SC L, V210, P25; Burgasser AJ, 1999, ASTROPHYS J, V522, pL65, DOI 10.1086/312221; Cuby JG, 1999, ASTRON ASTROPHYS, V349, pL41; ELIAS JH, 1982, ASTRON J, V87, P1029, DOI 10.1086/113185; BURROWS A, 2000, IN PRESS APJ; Delfosse X, 1997, ASTRON ASTROPHYS, V327, pL25; DOI M, 2000, UNPUB; Fan XH, 1999, ASTRON J, V117, P2528, DOI 10.1086/300848; FAN X, 2000, IN PRESS AJ; Fan XH, 1999, ASTRON J, V118, P1, DOI 10.1086/300944; GOLDMAN B, 2000, IN PRESS A A; GUNN JE, 1995, WIDE FIELD SPECTROSC, P3; KENT SM, 2000, UNPUB; LEIBERT J, 2000, UNSOLVED PROBLEMS ST; LUPTON RH, 2000, UNPUB; MARLEY MR, 2000, IN PRESS ASP C SER; Martin EL, 1997, ASTRON ASTROPHYS, V327, pL29; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; PERSSON SE, 1998, AJ, V116, P247; PETRAVICK D, 1994, P SOC PHOTO-OPT INS, V2198, P935, DOI 10.1117/12.176788; PETRAVICK D, 2000, UNPUB; PIER JR, 2000, UNPUB; PIER JR, 2000, IN PRESS ASP C SER; REBOLO R, 1992, ASTROPHYS J, V389, pL83, DOI 10.1086/186354; REBOLO R, 1998, ASP C SER, V134; SCHNEIDER DP, 2000, UNPUB PASP; SMITH JA, 1998, A AS, V193, P206; Strauss M. A., 1999, APJ, V522, P61; TODY D, 1993, ASTR SOC P, V52, P173; TSVETANOV ZI, 2000, UNPUB APJL; TUCKER DL, 2000, UNPUB; Zapatero Osorio M. R., 1997, Astrophysical Journal, Letters, V491, DOI 10.1086/311073	39	108	108	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256			ASTRON J	Astron. J.	FEB	2000	119	2					928	935		10.1086/301224		8	Astronomy & Astrophysics	Astronomy & Astrophysics	283KX	WOS:000085275700040		
J	Muraishi, H; Tanimori, T; Yanagita, S; Yoshida, T; Moriya, M; Kifune, T; Dazeley, SA; Edwards, PG; Gunji, S; Hara, S; Hara, T; Kawachi, A; Kubo, H; Matsubara, Y; Mizumoto, Y; Mori, M; Muraki, Y; Naito, T; Nishijima, K; Patterson, JR; Rowell, GP; Sako, T; Sakurazawa, K; Susukita, R; Tamura, T; Yoshikoshi, T				Muraishi, H; Tanimori, T; Yanagita, S; Yoshida, T; Moriya, M; Kifune, T; Dazeley, SA; Edwards, PG; Gunji, S; Hara, S; Hara, T; Kawachi, A; Kubo, H; Matsubara, Y; Mizumoto, Y; Mori, M; Muraki, Y; Naito, T; Nishijima, K; Patterson, JR; Rowell, GP; Sako, T; Sakurazawa, K; Susukita, R; Tamura, T; Yoshikoshi, T			Evidence for TeV gamma-ray emission from the shell type SNR RX J1713.7-3946	ASTRONOMY & ASTROPHYSICS			English	Letter						stars : supernovae : individual : RXJ1713.7-3946; gamma rays : observations	CERENKOV IMAGING TECHNIQUE; SUPERNOVA-REMNANTS; SHOCK ACCELERATION; ORIGIN; ELECTRONS; SN-1006	We report the results of TeV gamma-ray observations of the shell type SNR RXJ1713.7-3946 (G347.3-0.5). The discovery of strong non-thermal X-ray emission from the northwest part of the remnant strongly suggests the existence of electrons with energies up to similar to 100 TeV in the remnant, making the SNR a good candidate TeV gamma-ray source. We observed RX J1713.7-3946 from May to August 1998 with the CANGAROO 3.8m atmospheric imaging Cerenkov telescope and obtained evidence for TeV gamma-ray emission from the NW rim of the remnant with the significance of similar to 5.6 sigma. The observed TeV gamma-ray flux from the NW rim region was estimated to be (5.3 +/- 0.9[statistical] +/- 1.6[systematic]) x 10(-12) photons cm(-2) s(-1) at energies greater than or equal to 1.8 +/- 0.9 TeV. The data indicate that the emitting region is much broader than the point spread function of our telescope. The extent of the emission is consistent with that of hard X-rays observed by ASCA. This TeV gamma-ray emission can be attributed to the Inverse Compton scattering of the Cosmic Microwave Background Radiation by shock accelerated ultra-relativistic electrons. Under this assumption, a rather low magnetic field of similar to 11 mu G is deduced for the remnant from our observation.	Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108521, Japan; Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; Univ Adelaide, Dept Phys & Math Phys, Adelaide, SA 5005, Australia; Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Yamagata Univ, Dept Phys, Yamagata 9908560, Japan; Yamanashi Gakuin Univ, Fac Management Informat, Kofu, Yamanashi 4008575, Japan; Nagoya Univ, STE Lab, Nagoya, Aichi 4648601, Japan; Natl Astron Observ, Tokyo 1818588, Japan; Tokai Univ, Dept Phys, Hiratsuka, Kanagawa 2591292, Japan; Ecole Polytech, LPNHE, F-91128 Palaiseau, France; Inst Phys & Chem Res, Sci Computat Lab, Wako, Saitama 3510198, Japan; Kanagawa Univ, Fac Engn, Yokohama, Kanagawa 2218686, Japan	Muraishi, H (reprint author), Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108521, Japan.	yanagita@mito.ipc.ibaraki.ac.jp					Reynolds SP, 1999, ASTROPHYS J, V525, P368, DOI 10.1086/307880; Koyama K, 1997, PUBL ASTRON SOC JPN, V49, pL7; Slane P, 1999, ASTROPHYS J, V525, P357, DOI 10.1086/307893; Esposito JA, 1996, ASTROPHYS J, V461, P820, DOI 10.1086/177104; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; DRURY LO, 1994, ASTRON ASTROPHYS, V287, P959; REYNOLDS PT, 1993, ASTROPHYS J, V404, P206, DOI 10.1086/172269; Allen GE, 1997, ASTROPHYS J, V487, pL97, DOI 10.1086/310878; HARA T, 1993, NUCL INSTRUM METH A, V332, P300, DOI 10.1016/0168-9002(93)90774-C; JONES FC, 1991, SPACE SCI REV, V58, P259, DOI 10.1007/BF01206003; WEEKES TC, 1989, ASTROPHYS J, V342, P379, DOI 10.1086/167599; Buckley JH, 1998, ASTRON ASTROPHYS, V329, P639; Gaisser T. K., 1990, COSMIC RAYS PARTICLE; GREEN DA, 1998, CATALOGUE GALACTIC S; Hillas A M, 1985, 19TH P INT COSM RAY, V3, P445; Mastichiadis A, 1996, ASTRON ASTROPHYS, V311, pL5; MASTICHIADIS A, 1996, A A, V305, P53; NAITO T, 1994, J PHYS G NUCL PARTIC, V20, P477, DOI 10.1088/0954-3899/20/3/009; NAITO T, 1999, UNPUB ASTRON NACHR; PFEFFERMANN E, 1996, 263 MPE, pP267; POHL M, 1996, ASTRON ASTROPHYS, V307, P57; ROWELL GP, 1999, UNPUB A A; Tanimori T, 1998, ASTROPHYS J, V497, pL25, DOI 10.1086/311267; TANIMORI T, 1994, ASTROPHYS J, V429, pL61, DOI 10.1086/187413; TOMIDA H, 1999, THESIS KYOTO U; WEEKES TC, 1999, IN PRESS GEVTEV ASTR; YANAGITA S, 1990, 21ST P INT COSM RAY, V4, P44; YANAGITA S, 1999, P 3 INTEGRAL WORKSH; YOSHIDA T, 1997, P 2 INTEGRAL WORKSH, P85	30	106	110	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361			ASTRON ASTROPHYS	Astron. Astrophys.	FEB	2000	354	1					L57	L61				5	Astronomy & Astrophysics	Astronomy & Astrophysics	295FH	WOS:000085955700015		
J	Kitayama, T; Ikeuchi, S				Kitayama, T; Ikeuchi, S			Formation of subgalactic clouds under ultraviolet background radiation	ASTROPHYSICAL JOURNAL			English	Article						cosmology : theory; diffuse radiation; galaxies : formation; radiative transfer	COLD DARK-MATTER; STAR-FORMATION HISTORY; LYMAN-ALPHA FOREST; HUBBLE DEEP FIELD; GALAXY FORMATION; INTERGALACTIC MEDIUM; ABSORPTION SYSTEMS; ANGULAR-MOMENTUM; DWARF GALAXIES; HIGH-REDSHIFT	The effects of the ultraviolet (UV) background radiation on the formation of subgalactic clouds are studied by means of one-dimensional hydrodynamical simulations. The radiative transfer of the ionizing photons caused by the absorption by H I, He I, and He II, neglecting the emission, is explicitly taken into account. We find that the complete suppression of collapse occurs for the clouds with circular velocities typically in the range V-c similar to 15-40 km s(-1) and the 50% reduction in the cooled gas mass with V-c similar to 20-55 km s(-1). These values depend most sensitively on the collapse epoch of the cloud, the shape of the UV spectrum, and the evolution of the UV intensity. Compared with the optically thin case, previously investigated by Thoul & Weinberg in 1996, the absorption of the external UV photons by the intervening medium systematically lowers the above threshold values by Delta V-c similar to 5 km s(-1). Whether the gas can contract or keeps expanding is roughly determined by the balance between the gravitational force and the thermal pressure gradient when it is maximally exposed to the external UV flux. Based on our simulation results, we discuss a number of implications on galaxy formation, cosmic star formation history, and the observations of quasar absorption lines. In the Appendix, we derive analytical formulae for the photoionization coefficients and heating rates, which incorporate the frequency/direction-dependent transfer of external photons.	Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Kitayama, T (reprint author), Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan.						Anderson SF, 1999, ASTRON J, V117, P56, DOI 10.1086/300698; ANNINOS WY, 1994, ASTROPHYS J, V429, P434, DOI 10.1086/174335; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; COUCHMAN HMP, 1986, MON NOT R ASTRON SOC, V221, P53; Kitayama T, 1996, ASTROPHYS J, V469, P480, DOI 10.1086/177797; Giallongo E, 1996, ASTROPHYS J, V466, P46, DOI 10.1086/177492; SPITZER L, 1971, ASTROPHYS J, V166, P483, DOI 10.1086/150977; Haiman Z, 1996, ASTROPHYS J, V467, P522, DOI 10.1086/177628; Lilly SJ, 1996, ASTROPHYS J, V460, pL1, DOI 10.1086/309975; LACEY C, 1993, MON NOT R ASTRON SOC, V262, P627; Haiman Z, 1996, ASTROPHYS J, V464, P523, DOI 10.1086/177343; EFSTATHIOU G, 1979, MON NOT R ASTRON SOC, V186, P133; WARREN MS, 1992, ASTROPHYS J, V399, P405, DOI 10.1086/171937; Madau P, 1998, ASTROPHYS J, V498, P106, DOI 10.1086/305523; Madau P, 1999, ASTROPHYS J, V514, P648, DOI 10.1086/306975; THOUL AA, 1995, ASTROPHYS J, V442, P480, DOI 10.1086/175455; PRESS WH, 1974, ASTROPHYS J, V187, P425, DOI 10.1086/152650; KAUFFMANN G, 1993, MON NOT R ASTRON SOC, V264, P201; Pettini M, 1998, ASTROPHYS J, V508, P539, DOI 10.1086/306431; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Navarro JF, 1997, ASTROPHYS J, V478, P13, DOI 10.1086/303763; Thoul AA, 1996, ASTROPHYS J, V465, P608, DOI 10.1086/177446; Kitayama T, 1996, MON NOT R ASTRON SOC, V280, P638; Chengalur JN, 1999, MON NOT R ASTRON SOC, V302, pL29, DOI 10.1046/j.1365-8711.1999.02245.x; Eke VR, 1996, MON NOT R ASTRON SOC, V282, P263; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388; Haiman Z, 1997, ASTROPHYS J, V476, P458, DOI 10.1086/303647; Gnedin NY, 1997, ASTROPHYS J, V486, P581, DOI 10.1086/304548; WHITE SDM, 1991, ASTROPHYS J, V379, P52, DOI 10.1086/170483; BABUL A, 1992, MON NOT R ASTRON SOC, V255, P346; BOND JR, 1991, ASTROPHYS J, V379, P440, DOI 10.1086/170520; BARNES J, 1987, ASTROPHYS J, V319, P575, DOI 10.1086/165480; Babul A, 1996, ASTROPHYS J, V458, P100, DOI 10.1086/176795; BALJTLIK S, 1988, APJ, V327, P570; Barkana R, 1999, ASTROPHYS J, V523, P54, DOI 10.1086/307724; BECHTOLD J, 1994, ASTROPHYS J SUPPL S, V91, P1, DOI 10.1086/191937; BERTSCHINGER E, 1985, ASTROPHYS J SUPPL S, V58, P39, DOI 10.1086/191028; BOND JR, 1988, ASTROPHYS J, V324, P627, DOI 10.1086/165923; BOWDERS RL, 1991, NUMERICAL MODELING A; CEN R, 1992, ASTROPHYS J, V393, P22, DOI 10.1086/171482; CEN R, 1992, ASTROPHYS J SUPPL S, V78, P341, DOI 10.1086/191630; CHIBA M, 1994, ASTROPHYS J, V436, P618, DOI 10.1086/174937; Chieze JP, 1997, ASTROPHYS J, V484, P40, DOI 10.1086/304298; COLE S, 1994, MNRAS, V271, P744; Connolly AJ, 1997, ASTROPHYS J, V486, pL11, DOI 10.1086/310829; Cooke AJ, 1997, MON NOT R ASTRON SOC, V284, P552; COUCHMAN HMP, 1985, MON NOT R ASTRON SOC, V214, P137; Efstathiou G., 1992, MNRAS, V256, P43; FUKUGITA M, 1994, MON NOT R ASTRON SOC, V269, P563; GOTT JR, 1975, ASTROPHYS J, V201, P296, DOI 10.1086/153887; Haiman Z, 1998, ASTROPHYS J, V503, P505, DOI 10.1086/306017; Hogan CJ, 1997, ASTRON J, V113, P1495, DOI 10.1086/118366; IKEUCHI S, 1988, MNRAS, V236, pP21; IKEUCHI S, 1986, ASTROPHYS SPACE SCI, V118, P509, DOI 10.1007/BF00651178; IKEUCHI S, 1989, PUBL ASTRON SOC JPN, V41, P1095; Kepner JV, 1997, ASTROPHYS J, V487, P61, DOI 10.1086/304602; Kitayama T, 1997, ASTROPHYS J, V490, P557, DOI 10.1086/304915; Lane W, 1998, ASTRON J, V116, P26, DOI 10.1086/300422; Manrique A, 1996, ASTROPHYS J, V467, P504, DOI 10.1086/177627; MIRALDAESCUDE J, 1990, ASTROPHYS J, V350, P1, DOI 10.1086/168358; MURAKAMI I, 1990, PUBL ASTRON SOC JPN, V42, pL11; MURAKAMI I, 1993, ASTROPHYS J, V409, P42, DOI 10.1086/172640; Okoshi K, 1996, PUBL ASTRON SOC JPN, V48, P441; Osterbrock D. E., 1989, ASTROPHYSICS GASEOUS; PADMANABHAM T, 1993, STRUCTURE FORMATIONU; Quinn T, 1996, MON NOT R ASTRON SOC, V278, pL49; Rauch M, 1998, ANNU REV ASTRON ASTR, V36, P267, DOI 10.1146/annurev.astro.36.1.267; REES MJ, 1986, MON NOT R ASTRON SOC, V218, pP25; Reimers D, 1997, ASTRON ASTROPHYS, V327, P890; Richtmyer R. D., 1967, DIFFERENCE METHODS I; SARGENT WLW, 1980, ASTROPHYS J SUPPL S, V42, P41, DOI 10.1086/190644; SASAKI S, 1994, PUBL ASTRON SOC JPN, V46, P427; Savaglio S, 1997, ASTRON ASTROPHYS, V318, P347; SPITZER L, 1978, PHYSICAL PROCESSES I; SUSA H, 2000, IN PRESS APJ; Tajiri Y, 1998, ASTROPHYS J, V502, P59, DOI 10.1086/305898; Totani T, 1997, ASTROPHYS J, V483, pL75, DOI 10.1086/310743; UMEMURA M, 1993, ASTROPHYS J, V406, P361, DOI 10.1086/172447; UMEMURA M, 1985, ASTROPHYS J, V299, P583, DOI 10.1086/163726; UMEMURA M, 1984, PROG THEOR PHYS, V72, P47, DOI 10.1143/PTP.72.47; VEDEL H, 1994, MNRAS, P271; Viana PTP, 1996, MON NOT R ASTRON SOC, V281, P323; Weinberg DH, 1997, ASTROPHYS J, V477, P8, DOI 10.1086/303683; ZHANG Y, 1995, ASTROPHYS J, V453, pL57	87	59	59	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	FEB 1	2000	529	2	1				615	634		10.1086/308296		20	Astronomy & Astrophysics	Astronomy & Astrophysics	287UL	WOS:000085524800001		
J	Jing, YP; Suto, Y				Jing, YP; Suto, Y			The density profiles of the dark matter halo are not universal	ASTROPHYSICAL JOURNAL			English	Article						cosmology : miscellaneous; galaxies : clusters : general; methods : numerical	N-BODY SIMULATIONS; FLUCTUATIONS; GALAXIES; ORIGIN; CUSPS	We perform a series of high-resolution N-body simulations designed to examine the density profiles of dark matter halos. From 12 simulated halos ranging in mass from 2 x 10(12) to 5 x 10(14) h(-1) M., (represented by similar to 1 million particles within the virial radius), we find a clear systematic correlation between the halo mass and the slope of the density profile at 1% of the virial radius, in addition to the variations of the slope among halos of similar mass. More specifically, the slope is similar to-1.5, -1.3, and -1.1 for galaxy-, group-, and cluster-mass halos, respectively. While we confirm the earlier simulation results that the inner slope is steeper than the universal profile originally proposed by Navarro, Frenk, & White, this mass dependence is inconsistent with several analytical arguments attempting to link the inner slope with the primordial index of the fluctuation spectrum. Thus, we conclude that the dark matter density profiles, especially in the inner region, are not universal.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	Jing, YP (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.		Jing, Yipeng/P-3678-2015				HOFFMAN Y, 1985, ASTROPHYS J, V297, P16, DOI 10.1086/163498; JAIN B, 1995, MON NOT R ASTRON SOC, V276, pL25; Fukushige T, 1997, ASTROPHYS J, V477, pL9, DOI 10.1086/310516; HAMILTON AJS, 1991, ASTROPHYS J, V374, pL1, DOI 10.1086/186057; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; COUCHMAN HMP, 1995, ASTROPHYS J, V452, P797, DOI 10.1086/176348; Avila-Reese V, 1999, MON NOT R ASTRON SOC, V310, P527, DOI 10.1046/j.1365-8711.1999.02968.x; JING YP, 1994, ASTROPHYS J, V432, P438, DOI 10.1086/174582; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Moore B, 1998, ASTROPHYS J, V499, pL5, DOI 10.1086/311333; Evans NW, 1997, ASTROPHYS J, V480, pL103, DOI 10.1086/310629; Jing YP, 1998, ASTROPHYS J, V503, pL9, DOI 10.1086/311530; JING YP, 1999, UNPUB APJ; Jing YP, 1998, ASTROPHYS J, V494, pL5, DOI 10.1086/311163; Kitayama T, 1997, ASTROPHYS J, V490, P557, DOI 10.1086/304915; LOKAS EL, 1999, IN PRESS MNRAS; Ma CP, 1998, ASTROPHYS J, V508, pL5, DOI 10.1086/311711; MOORE B, 1999, UNPUB MNRAS; Nusser A, 1999, MON NOT R ASTRON SOC, V303, P685, DOI 10.1046/j.1365-8711.1999.02197.x; Peacock J. A., 1996, MNRAS, V280, P19; Peebles P. J. E, 1980, LARGE SCALE STRUCTUR; SUGINOHARA T, 1991, ASTROPHYS J SUPPL S, V75, P631, DOI 10.1086/191545; SUTO Y, 1993, PROG THEOR PHYS, V90, P1173; Syer D, 1998, MON NOT R ASTRON SOC, V293, P337	24	165	166	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	FEB 1	2000	529	2	2				L69	L72		10.1086/312463		4	Astronomy & Astrophysics	Astronomy & Astrophysics	287UN	WOS:000085525000002		
J	Kato, N; Morita, H; Sugiyama, T; Kurihara, H; Tsubaki, S; Nabika, T; Kitamura, K; Yamori, Y; Yazaki, Y				Kato, N; Morita, H; Sugiyama, T; Kurihara, H; Tsubaki, S; Nabika, T; Kitamura, K; Yamori, Y; Yazaki, Y			Evaluation of the poly(ADP-ribose) polymerase gene in human stroke	ATHEROSCLEROSIS			English	Article						stroke; susceptibility; polymorphism; association; nitric oxide	CEREBROVASCULAR-DISEASE; ISCHEMIC STROKE; LINKAGE DISEQUILIBRIUM; APOLIPOPROTEIN-E; NITRIC-OXIDE; YOUNG-WOMEN; DNA-DAMAGE; POLYMORPHISM; RISK; ACTIVATION	Nitric oxide (NO) and its reactant product, peroxynitrite, have been implied to mediate neuronal damage following cerebral ischemia. However, the cellular targets of these compounds remain unclear. Studies using poly(ADP-ribose) polymerase (PARP) inhibitors and PARP knock-out mice have recently demonstrated that excessive activation of this nuclear enzyme plays an important role in NO-induced nenrotoxicity. To evaluate the relevance of this plausible candidate gene to human stroke, we undertook a case-control study in Japanese. Participants comprised 213 cerebral infarction cases and 374 age- and sex-matched controls. As a primary investigation, we screened polymorphic sites of the PARP gene, and newly identified a total of four polymorphisms in 1230-bp 5'-flanking sequence. None of them were, however, located on the known promoter components of the gene. Two bi-allelic polymorphisms selected and a CA-repeat polymorphism were subsequently characterized in the case-control study, but none were significantly associated with cerebral infarction in the present study. Our data thus suggest that the tested PARP polymorphisms do not principally contribute to cerebral infarction, although extensive searches would be required to clarify whether the PARP gene plays an important role in the pathogenesis of human stroke. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 113, Japan; Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan; Kitamura Neurosurg Clin, Tokyo, Japan; Shimane Med Univ, Dept Lab Med, Izumo, Shimane 693, Japan	Kato, N (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.						WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; BRASS LM, 1992, STROKE, V23, P221; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Hiramoto M, 1997, STROKE, V28, P2417; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15; KIELY DK, 1993, STROKE, V24, P1366; Qizilbash N, 1995, LANCET, V346, P1647; Markus HS, 1997, STROKE, V28, P1739; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; AUER B, 1989, DNA-J MOLEC CELL BIO, V8, P575, DOI 10.1089/dna.1989.8.575; Brown MJ, 1996, BRIT J CLIN PHARMACO, V42, P21, DOI 10.1046/j.1365-2125.1996.03785.x; Carlsson LE, 1997, STROKE, V28, P1392; Chen CH, 1997, J FORMOS MED ASSOC, V96, P499; DEFAIRE U, 1975, PREV MED, V4, P509, DOI 10.1016/0091-7435(75)90036-5; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; FOUGEROUSSE F, 1992, NUCLEIC ACIDS RES, V20, P1166, DOI 10.1093/nar/20.5.1166; GINSBERG MD, 1989, STROKE, V20, P1627; GRAFFAGNINO C, 1994, STROKE, V25, P1599; Heywood DM, 1997, STROKE, V28, P816; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Kessler C, 1997, ARTERIOSCL THROM VAS, V17, P2880; Longstreth WT, 1998, STROKE, V29, P577; MARMOT MG, 1992, LANCET, V339, P344; MOLINARI GF, 1988, STROKE, V19, P1195; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; National Institute of Neurological Disorders and Stroke Committee, 1990, STROKE, V21, P637; OEI SL, 1994, MOL CELL BIOCHEM, V138, P99, DOI 10.1007/BF00928449; OGURA T, 1990, BIOCHEM BIOPH RES CO, V167, P701, DOI 10.1016/0006-291X(90)92082-B; Ridker PM, 1997, LANCET, V349, P385, DOI 10.1016/S0140-6736(97)80010-4; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; Schmidt R, 1997, STROKE, V28, P951; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Wagner KR, 1998, STROKE, V29, P581; WEIN KH, 1993, BIOCHIM BIOPHYS ACTA, V1176, P69, DOI 10.1016/0167-4889(93)90179-S; ZHANG J, 1995, J NEUROCHEM, V65, P1411	39	11	11	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0021-9150			ATHEROSCLEROSIS	Atherosclerosis	FEB	2000	148	2					345	352		10.1016/S0021-9150(99)00284-1		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	289DR	WOS:000085605700016		
J	Okamura, T; Imai, Y; Kon, Y; Goto, M; Yamamoto, M; Watanabe, T				Okamura, T; Imai, Y; Kon, Y; Goto, M; Yamamoto, M; Watanabe, T			Molecular cloning and characterization of mouse testis poly(A) binding protein II encoded by the Pabp3 gene, which transcomplements meiotic mutant sme2 of S. pombe	BIOCHEMICAL GENETICS			English	Article						mouse testis; poly(A)binding protein; meiosis; Schizosaccharomyces pombe	FISSION YEAST; C-KIT; SCHIZOSACCHAROMYCES-POMBE; W-LOCUS; EXPRESSION; RNA; SEQUENCE; SPERMATOGENESIS; ONCOGENE; MEIOSIS	A cDNA clone from a mouse testis cDNA library was isolated by the transcomplementation method using a Schizosaccharomyces pombe meiotic mutant (sme2) that is defective in meiosis I. The cDNA clone isolated has an open reading frame encoding 302 amino acids constituting a protein with a strong similarity to mouse poly(A) binding protein II (mPABII) and bovine poly(A) binding protein II (PABII). PABII is known to bind to the growing poly(A) tail and stimulates poly(A) polymerase, which catalyzes the polymerization of the mRNA poly(A) tail. Northern blot analysis of the cDNA clone identified as mPABII revealed a single transcript of 1.2 kb. This was detectable exclusively in adult testis. Immunohistochemical analysis using a polyclonal antibody demonstrated that mPABII protein was expressed in the nucleus at specific stages from late pachytene spermatocytes to round spermatids. Genetic mapping showed the Pabp3 gene encoding mPABII to be located near position 19.5 on mouse chromosome 14. These results suggest that mPABII might be involved in specific spermatogenetic cell differentiation.	Hokkaido Univ, Lab Expt Anim Sci, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; Univ Tokyo, Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Natl Inst Basic Biol, Div Cell Proliferat, Okazaki, Aichi 4448585, Japan	Watanabe, T (reprint author), Hokkaido Univ, Lab Expt Anim Sci, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan.		Kon, Yasuhiro/F-8525-2012				Abbadi N, 1997, MAMM GENOME, V7, pS238, DOI 10.1007/s003359900326; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; Imai Y, 1997, MOL CELL BIOL, V17, P1543; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; MANOVA K, 1990, DEVELOPMENT, V110, P1057; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; BRUNET JF, 1986, NATURE, V322, P268, DOI 10.1038/322268a0; DURNAM DM, 1980, P NATL ACAD SCI-BIOL, V77, P6511, DOI 10.1073/pnas.77.11.6511; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; KLEENE KC, 1994, MOL REPROD DEV, V39, P355; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lee YJ, 1998, BBA-GENE STRUCT EXPR, V1395, P40, DOI 10.1016/S0167-4781(97)00147-4; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MONESI V, 1964, J CELL BIOL, V22, P521, DOI 10.1083/jcb.22.3.521; NEMTH A, 1995, NUCLEIC ACIDS RES, V23, P4034; Schmidt EE, 1997, J BIOL CHEM, V272, P5326; SHEETS MD, 1989, GENE DEV, V3, P1401, DOI 10.1101/gad.3.9.1401; WANG MY, 1992, NUCLEIC ACIDS RES, V20, P3519, DOI 10.1093/nar/20.13.3519; WHALE E, 1991, CELL, V66, P759; Yamamoto M, 1996, TRENDS BIOCHEM SCI, V21, P18, DOI 10.1016/S0968-0004(06)80022-8; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	30	2	2	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0006-2928			BIOCHEM GENET	Biochem. Genet.	FEB	2000	38	1-2					1	11		10.1023/A:1001876119130		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	319YR	WOS:000087374300001		
J	Yoshida, M; Fukuda, K; Takagi, T				Yoshida, M; Fukuda, K; Takagi, T			PNAD-CSS: a workbench for constructing a protein name abbreviation dictionary	BIOINFORMATICS			English	Article								Motivation: Since their initial development, integration and construction of databases for molecular-level data have progressed. Though biological molecules ave related to each other and form a complex system, the information is stored in the vast archives of the literature or in diverse databases. There is no unified naming convention for biological object, and biological terms may be ambiguous or polysemic. This makes the integration and interaction of databases difficult. In order to eliminate these problems, machine-readable natural language resources appear to be quite promising. We have developed a workbench for protein name abbreviation dictionary (PNAD) building. Results: We have developed PNAD Construction Support System (PNAD-CSS), which offers various convenient facilities to decrease the construction costs of a protein name abbreviation dictionary of which entries are collected from abstracts in biomedical papers. The system allows the users to concentrate on higher level interpretation by removing some troublesome tasks, e.g. management of abstracts, extracting protein names and their abbreviations, and so on. To extract a pair of protein names and abbreviations, we have developed a hybrid system composed of the PROPER System and the PNAD System. The PNAD System can extract the pairs from parenthetical-paraphrases involved in protein names, the PROPER System identified these pairs, with 98.95% precision, 95.56% recall and 97.58% complete precision. Availability: PROPER System is freely available from http://www.hgc.ims.u-tokyo.ac.jp/service/tooldoc/KeX/intro.html. The other software are also available on request. Contact the authors. Contact: mikio@ims.u-tokyo.ac.jp.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	Yoshida, M (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Andrade MA, 1998, BIOINFORMATICS, V14, P600, DOI 10.1093/bioinformatics/14.7.600; Baeza-Yates R. A., 1992, INFORMATION RETRIEVA, P13; Fukuda K, 1998, Pac Symp Biocomput, P707; Knuth D. E., 1984, TEXBOOK; *NLM, 1998, PUBM NLMS SEARCH SER; Ohta Y, 1997, Proc Int Conf Intell Syst Mol Biol, V5, P218; REID T, 1998, TREND GENETICS GENE; Schulze-Kremer S, 1998, Pac Symp Biocomput, P695; SMADJA F, 1993, COMPUTATIONAL LINGUI, V19; Su Keh-Yih, 1994, P 32 ANN M ASS COMP; Wall L., 1996, PROGRAMMING PERL	11	40	41	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803			BIOINFORMATICS	Bioinformatics	FEB	2000	16	2					169	175		10.1093/bioinformatics/16.2.169		7	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	314BE	WOS:000087033600014		
J	Tsutsui, H; Oka, Y				Tsutsui, H; Oka, Y			Light-sensitive voltage responses in the neurons of the cerebral ganglion of Ciona savignyi (Chordata : Ascidiacea)	BIOLOGICAL BULLETIN			English	Article							GONADOTROPIN-RELEASING-HORMONE; EVOLUTION; SYSTEM	Light-responsive behaviors such as siphon contraction (I), phototropism (2), and gamete release (3, 4) have been described in several ascidian species. The pigmented spots around the siphon openers (5), the epithelial cells of the sperm duct (6, 7), and the cerebral ganglion (8) have been suggested to be the photoreceptor candidates under-lying these behaviors. However, these arguments have not yet been settled because no direct electrophysiological recordings of light-induced receptor potentials have been reported. In this study, we focused on the cerebral ganglion and performed intracellular recordings from the neurons in the ventral side of the cerebral ganglion in an isolated in vitro preparation of the neural complex in Ciona savignyi. We found that 24% (n = 115) of the recorded neurons showed various types of voltage responses to light stimuli. Almost all (27/28) of the recorded voltage responses were "on" responses that included hyperpolarizing and depolarizing responses and could be categorized into five types, except fbr a complex response recorded in one cell; the remaining one (1/28) was a depolarizing "off" response. This is the first report of electrophysiological recordings of light-sensitive voltage responses from ascidian cerebral ganglion neurons.	Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan	Oka, Y (reprint author), Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051			Tsutsui H, 1998, GEN COMP ENDOCR, V112, P426, DOI 10.1006/gcen.1998.7160; Dilly P.N., 1973, MICRON, V4, P11; FRITSCH HAR, 1982, CELL TISSUE RES, V223, P369, DOI 10.1007/BF01258496; GOODBODY I, 1974, ADV MAR BIOL, V11, P1; GORMAN ALF, 1971, SCIENCE, V172, P1052, DOI 10.1126/science.172.3987.1052; Hecht S, 1918, J GEN PHYSIOL, V1, P147, DOI 10.1085/jgp.1.2.147; HISAW FL, 1966, GEN COMP ENDOCR, V7, P1, DOI 10.1016/0016-6480(66)90081-5; KAJIWARA S, 1990, INVERTEBR REPROD DEV, V17, P155, DOI 10.1080/07924259.1990.9672104; LAMBERT CC, 1967, BIOL BULL, V132, P222, DOI 10.2307/1539890; MACKIE GO, 1995, J MAR BIOL ASSOC UK, V75, P141; NUMAKUNAI T, 1973, Bulletin of the Marine Biological Station of Asamushi, V14, P191; OKA Y, 1993, J NEUROSCI, V13, P2161; Oka Y, 1997, GNRH NEURONS GENE BE, P245; Powell JFF, 1996, P NATL ACAD SCI USA, V93, P10461, DOI 10.1073/pnas.93.19.10461; WOOLLACO.RM, 1974, DEV BIOL, V40, P186, DOI 10.1016/0012-1606(74)90118-3; WOOLLACOTT RM, 1977, DEV BIOL, V61, P41, DOI 10.1016/0012-1606(77)90340-2	16	15	15	MARINE BIOLOGICAL LABORATORY	WOODS HOLE	7 MBL ST, WOODS HOLE, MA 02543 USA	0006-3185			BIOL BULL	Biol. Bull.	FEB	2000	198	1					26	28		10.2307/1542800		3	Biology; Marine & Freshwater Biology	Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology	289EA	WOS:000085606500003		
J	Abe, K; Abe, Y; Saito, H				Abe, K; Abe, Y; Saito, H			Evaluation of L-glutamate clearance capacity of cultured rat cortical astrocytes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						L-glutamate; colorimetric measurement; astrocyte; glutamate transporter; culture	TRANSPORTER; BRAIN; EXPRESSION; CLONING	Astrocytes have a function in the uptake of excitatory neurotransmitter L-glutamate ria the glutamate transporter. To evaluate the L-glutamate clearance capacity of astrocytes, we developed a colorimetric method for the determination of L-glutamate concentration and measured changes in extracellular L-glutamate concentration in rat cortical astrocyte cultures. When L-glutamate (50-200 mu M) was added to astrocyte cultures and incubated for 1-8 h, the extracellular L-glutamate concentration declined with time. When L-glutamate was mixed,vith astrocyte culture supernatants only, no significant change in L-glutamate concentration was observed, ruling out the possibility that L-glutamate is spontaneously or enzymatically degraded in the extracellular space. Alternatively, the time-dependent decline of extracellular L-glutamate concentration was blocked by the presence of glutamate uptake inhibitors, indicating that the glutamate uptake system of astrocytes plays a major role in the clearance of extracellular L-glutamate.	Univ Tokyo, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tokyo 1130033, Japan	Abe, K (reprint author), Univ Tokyo, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tokyo 1130033, Japan.						Abe K, 1998, BRAIN RES, V804, P63, DOI 10.1016/S0006-8993(98)00657-X; ABE K, IN PRESS J NEUROCHEM; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; SCHWARCZ R, 1984, LIFE SCI, V35, P19, DOI 10.1016/0024-3205(84)90148-6; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; HISADA R, 1977, J BIOCHEM-TOKYO, V82, P1469; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Abe K, 1996, JPN J PHARMACOL, V72, P299, DOI 10.1254/jjp.72.299; Swanson RA, 1997, J NEUROSCI, V17, P932; FLOTT B, 1991, GLIA, V4, P293, DOI 10.1002/glia.440040307; KANNER BI, 1993, FEBS LETT, V325, P95, DOI 10.1016/0014-5793(93)81421-U; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; TANAKA K, 1993, NEUROSCI RES, V16, P149, DOI 10.1016/0168-0102(93)90082-2	20	20	20	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2000	23	2					204	207				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	282TA	WOS:000085233700013		
J	Hayashi, H; Hiraoka, N; Ikeshiro, Y; Kushiro, T; Morita, M; Shibuya, M; Ebizuka, Y				Hayashi, H; Hiraoka, N; Ikeshiro, Y; Kushiro, T; Morita, M; Shibuya, M; Ebizuka, Y			Molecular cloning and characterization of a cDNA for Glycyrrhiza glabra cycloartenol synthase	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Glycyrrhiza glabra; cDNA cloning; cycloartenol synthase; phytosterol	CELL-SUSPENSION CULTURES; COENZYME-A REDUCTASE; SQUALENE SYNTHASE; FUNCTIONAL EXPRESSION; SQUALENE-2,3-EPOXIDE CYCLASES; PEA-SEEDLINGS; PURIFICATION; ELICITOR; OXIDOSQUALENE; BIOSYNTHESIS	A cDNA clone (GgCAS1) encoding cycloartenol synthase (CAS) has been isolated from Glycyrrhiza glabra (licorice) by cross-hybridization with that of Pisum sativum CAS as a probe. The deduced amino acid sequence of GgCAS1 exhibits 89%, 83% and 81% identity to those of Pisum sativum, Panax ginseng and Arabidopsis thaliana CASs, respectively CAS activity has been detected in the homogenate of the yeast transformed with the expression vector containing the open reading frame of GgCAS1, Southern blot analysis suggested that at least two CAS genes exist in the licorice genome. In Northern blot analysis, the strong signal for CAS mRNA is detected in the cultured Licorice cells of all growth phases, but no significant increase of CAS mRNA expression was observed in the cells treated with the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor, pravastatin.	Niigata Coll Pharm, Niigata 9502081, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Hayashi, H (reprint author), Niigata Coll Pharm, 5-13-2 Kamishineicho, Niigata 9502081, Japan.						ABE I, 1992, CHEM PHARM BULL, V40, P1755; ABE I, 1989, FEBS LETT, V249, P100, DOI 10.1016/0014-5793(89)80024-9; ABE I, 1988, CHEM PHARM BULL, V36, P5031; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706; ENJUTO M, 1994, P NATL ACAD SCI USA, V91, P927, DOI 10.1073/pnas.91.3.927; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Devarenne TP, 1998, ARCH BIOCHEM BIOPHYS, V349, P205, DOI 10.1006/abbi.1997.0463; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; FULTON DC, 1993, PHYTOCHEMISTRY, V32, P705, DOI 10.1016/S0031-9422(00)95157-4; FULTON DC, 1994, PHYTOCHEMISTRY, V35, P1183, DOI 10.1016/S0031-9422(00)94818-0; HATA S, 1987, PLANT CELL PHYSIOL, V28, P709; HATA S, 1986, PLANT GROWTH REGUL, V4, P335; Hayashi H, 1996, BIOL PHARM BULL, V19, P1387; HAYASHI H, 1993, PLANTA MED, V59, P351, DOI 10.1055/s-2006-959699; HAYASHI H, 1988, PLANT CELL REP, V7, P508, DOI 10.1007/BF00272743; HAYASHI H, 1990, PHYTOCHEMISTRY, V29, P3127, DOI 10.1016/0031-9422(90)80170-L; Herrera JBR, 1998, PHYTOCHEMISTRY, V49, P1905; JIANG GJ, 1993, J BIOL CHEM, V268, P12818; Kribii R, 1997, EUR J BIOCHEM, V249, P61, DOI 10.1111/j.1432-1033.1997.00061.x; LINSMAIE.EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Morita M, 1997, BIOL PHARM BULL, V20, P770; Rose M.D., 1990, METHODS YEAST GENETI	26	31	36	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2000	23	2					231	234				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	282TA	WOS:000085233700019		
J	Yamakoshi, Y; Otani, Y; Fujii, S; Endo, Y				Yamakoshi, Y; Otani, Y; Fujii, S; Endo, Y			Dependence of estrogenic activity on the shape of the 4-alkyl substituent in simple phenols	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						estrogen; hydrophobic interaction; structure-activity relationship; reporter gene assay	RECEPTOR; CHEMICALS; CLONING; LIGAND	The ability of certain chemicals to mimic the effects of natural steroid hormones and their potential to disrupt the delicate balance of the endocrine system in animals has attracted much interest in recent years. Alkylphenolic chemicals have been reported to be weakly estrogenic, Estrogen receptor (ER) binding is primarily the result of interaction of the receptor with both a phenolic residue, and a hydrophobic pharmacophore, We have prepared and screened various phenols having a bulky 4-alkyl group, which may interact hydrophobically with the receptor, for estrogenic activity by using a previously described reporter gene assay employing COS-1 cells transfected with rat ER alpha-expression plasmid and an appropriate reporter plasmid, Some of the tested compounds, such as 4-(1-adamantyl)phenol and 4-cycloalkylphenols, exhibited much more potent activity than the typical estrogenic alkylphenol, 4-tert-octylphenol.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Endo, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; STONE R, 1994, SCIENCE, V265, P308, DOI 10.1126/science.8023147; MIKSICEK RJ, 1993, MOL PHARMACOL, V44, P37; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Endo Y, 1999, J MED CHEM, V42, P1501, DOI 10.1021/jm9900725; Routledge EJ, 1997, J BIOL CHEM, V272, P3280; KANEKO S, 1991, MED CHEM RES, V1, P220; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; MURDOCH FE, 1991, MOL CELL ENDOCRINOL, V78, pC103, DOI 10.1016/0303-7207(91)90114-8	11	7	9	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	2000	23	2					259	261				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	282TA	WOS:000085233700026		
J	Furuzono, T; Ishihara, K; Nakabayashi, N; Tamada, Y				Furuzono, T; Ishihara, K; Nakabayashi, N; Tamada, Y			Chemical modification of silk fibroin with 2-methacryloyloxyethyl phosphorylcholine. II. Craft-polymerization onto fabric through 2-methacryloyloxyethyl isocyanate and interaction between fabric and platelets	BIOMATERIALS			English	Article						2-methacryloyloxyethyl phosphorylcholine; 2-methacryloyloxyethyl isocyanate; chemical modification; graft polymerization; silk fabric; silk fibroin	CELLULOSE DIALYSIS MEMBRANE; PHOSPHOLIPID POLAR GROUP; BLOOD COMPATIBILITY; COATING MATERIAL; SIDE-CHAIN; POLYMERS; HEMOCOMPATIBILITY; IMPROVEMENT; POLYURETHANE; ADHESION	2-Methacryloyloxyethyl phosphorylcholine (MPC) was grafted onto silk fabric in a two-step heterogeneous system through the vinyl bonds of 2-methacryloyloxyethyl isocyanate (MOI) modified on the fabric. First, habutae silk fabric was modified with the MOI monomer in anhydrous dimethyl sulfoxide using di-n-butyltin (IV) dilaurate and hydroquinone at 35 degrees C. The saturated weight gain of modified MOI monomer on the fabric was 7.3 wt% versus the original silk. Second, graft polymerization with MPC onto the MOI modified silk was conducted using 2,2'-azo bis[2-(2-imidazolin-2-yl)propane dihydrochloride] (VA-044) as an azo polymerization Initiator. The weight of the grafted MPC eventually gained was about 26.0 wt%. The MOI-modified and MPC-grafted silk fabrics were analyzed by Fourier transform infrared (FT-IR) spectroscopy. To confirm the improved biocompatibility of the silk fabric, platelet adhesion was preliminarily tested measuring lactate dehydrogenase. The number of platelets adhering to polyMPC-grafted silk fabric decreased by about one tenth compared to original and MOI-modified silk after 60 min of contact with human platelet-rich plasma (1.0 x 10(6) platelets cm(-2)). (C) 2000 Elsevier Science Ltd. All rights reserved.	Natl Inst Sericultural & Entomol Sci, Tsukuba, Ibaraki 3058634, Japan; Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Tokyo Med & Dent Univ, Inst Med & Dent Engn, Chiyoda Ku, Tokyo 1010062, Japan	Tamada, Y (reprint author), Natl Inst Sericultural & Entomol Sci, 2-1 Owashi, Tsukuba, Ibaraki 3058634, Japan.						ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5; Matsumoto K, 1997, J POLYM SCI POL CHEM, V35, P1949; TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q; ALLEN PW, 1956, J POLYM SCI, V22, P193, DOI 10.1002/pol.1956.1202210101; GOTOH Y, 1993, BIOCONJUGATE CHEM, V4, P554, DOI 10.1021/bc00024a020; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202; ANTONELLA M, 1998, MISC PUBL NATL I SER, V23, P21; CHEN JY, 1994, POLYMER, V35, P2853, DOI 10.1016/0032-3861(94)90317-4; DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403; Freddi G., 1996, POLYM MAT ENCY, P7734; FURUZONO T, J APPL POLYM SCI; HAYASHI K, 1983, J JPN SOC BIOMATERIA, V1, P59; IDE F, 1977, GRAFT JYUGOU SONO OU, P5; ISHIHARA K, 1994, ARTIF ORGANS, V18, P559, DOI 10.1111/j.1525-1594.1994.tb03379.x; ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207; ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J; ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S; ISHIHARA K, 1992, BIOMATERIALS, V13, P235, DOI 10.1016/0142-9612(92)90190-Y; Kawano H, 1998, KOBUNSHI RONBUNSHU, V55, P334; MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H; SHIOZAKI H, 1988, Journal of Sericultural Science of Japan, V57, P165; TAKAHARA A, 1989, Journal of Biomaterials Science Polymer Edition, V1, P17, DOI 10.1163/156856289X00037; THOMAS MR, 1983, J COATING TECHNOL, V55, P55; TSUKADA M, 1992, J APPL POLYM SCI, V45, P1189, DOI 10.1002/app.1992.070450707	26	78	82	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612			BIOMATERIALS	Biomaterials	FEB	2000	21	4					327	333		10.1016/S0142-9612(99)00177-5		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	275RG	WOS:000084833500001		
J	Nakazawa, T; Takahashi, M; Horiuchi, H; Ohta, A; Takagi, M				Nakazawa, T; Takahashi, M; Horiuchi, H; Ohta, A; Takagi, M			Cloning and characterization of EPD2, a gene required for efficient pseudohyphal formation of a dimorphic yeast, Candida maltosa	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						pseudohyphal growth; CEN; Candida maltosa	HOST-VECTOR SYSTEM; PUTATIVE TRANSCRIPTION FACTOR; PH-REGULATED GENE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; HYPHAL DEVELOPMENT; PLASMA-MEMBRANE; ALBICANS; PROTEIN; IDENTIFICATION	Candida maltosa is a dimorphic fungus and its pseudohyphal growth is partly induced by additional copies of the centromeric DNA (CEN) region(1)), or n-alkane. In the course of analyzing the induction mechanism of pseudohyphal growth, we isolated EPD1, which is similar in sequence to PHR1 and PHR2 of Candida albicans. Epd1p could be involved in cell wall maintenance and is essential for pseudohyphal growth induced by CEN and n-hexadecane at pH 4 and by n-hexadecane at pH 7.(2)) In this paper, we cloned EPD2 of C. maltosa, which is highly similar to EPD1, PNRI, and PHR2. The transcription of EPD2 is induced strongly when cells are grown in SD medium of higher pH (pH 7), but not in SD medium of lower pH (pH 4). This pattern of expression was an inverse of that of EPD1. This alternate expression is similar to that between PHR1 and PHR2. The expression of EPD2 was much higher when C. maltosa was grown on the n-hexadecane solid medium than grown in the n-hexadecane liquid medium. The efficiency of pseudohyphal formation of an epd2 null mutant on n-hexadecane medium at pH 7 or 7.5 was lower than that of the wild-type strain. These results suggest that Epd2p is required for efficient pseudohyphal formation induced by n-hexadecane in the medium at pH 7.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Horiuchi, H (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahhoriu@mail.ecc.u-tokyo.ac.jp	Nakazawa, Takanobu/E-1012-2014	Nakazawa, Takanobu/0000-0002-5049-9140			KRON SJ, 1994, MOL BIOL CELL, V5, P1003; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Ram AFJ, 1998, J BACTERIOL, V180, P1418; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Bailey DA, 1996, J BACTERIOL, V178, P5353; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Popolo L, 1997, J BACTERIOL, V179, P463; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Ohkuma M, 1995, MOL GEN GENET, V249, P447; TAKAGI M, 1986, J BACTERIOL, V167, P551; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; HIKIJI T, 1989, CURR GENET, V16, P261, DOI 10.1007/BF00422112; HOFMANN KH, 1990, ARCH MICROBIOL, V154, P514, DOI 10.1007/BF00245237; Ishii N, 1997, MICROBIOL-UK, V143, P429; KAWAI S, 1991, AGR BIOL CHEM TOKYO, V55, P59; KOMAGATA K, 1964, J GEN APPL MICROBIOL, V4, P323; MALATHI K, 1994, J BIOL CHEM, V269, P22945; MAUERSBERGER S, 1995, NONCONVENTIONAL YEAS, P411; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Nakazawa T, 1998, J BACTERIOL, V180, P2079; Nakazawa T, 1997, J BACTERIOL, V179, P5030; NUOFFER C, 1991, MOL CELL BIOL, V11, P27; OHKUMA M, 1995, DNA CELL BIOL, V14, P163, DOI 10.1089/dna.1995.14.163; OHKUMA M, 1993, BIOSCI BIOTECH BIOCH, V57, P1793; OHKUMA M, 1993, CURR GENET, V23, P205, DOI 10.1007/BF00351497; POPOLO L, 1993, J BACTERIOL, V175, P1879; Popolo L, 1998, J BACTERIOL, V180, P163; RAM AFJ, 1995, FEBS LETT, V358, P165, DOI 10.1016/0014-5793(94)01418-Z; Sambrook J., 1989, MOL CLONING LAB MANU; SOLL DR, 1986, BIOESSAYS, V5, P5, DOI 10.1002/bies.950050103; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; Soll DR, 1996, ASM NEWS, V62, P415; STEWART S, 1990, MICROBIOL REV, V54, P226; Suzuki T, 1998, MICROBIOL-UK, V144, P403; TANI Y, 1979, BIOCHEM BIOPH RES CO, V91, P351, DOI 10.1016/0006-291X(79)90625-9; WRIGHT RM, 1993, CURR GENET, V23, P388, DOI 10.1007/BF00312623	47	10	13	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB	2000	64	2					369	377		10.1271/bbb.64.369		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	292DE	WOS:000085778200024		
J	Takamatsu, A; Fujii, T; Endo, I				Takamatsu, A; Fujii, T; Endo, I			Control of interaction strength in a network of the true slime mold by a microfabricated structure	BIOSYSTEMS			English	Article; Proceedings Paper	3rd International Workshop on Information Processing in Cells and Tissues	AUG 23-24, 1999	INDIANAPOLIS, INDIANA			Physarum polycephalum; coupled oscillators; microfabrication	PHYSARUM-PLASMODIUM	The plasmodium of the true slime mold, Physarum polycephalum, which shows various nonlinear oscillatory phenomena, for example, in its thickness, protoplasmic streaming and concentration of intracellular chemicals, can be regarded as a collective of nonlinear oscillators. The plasmodial oscillators are interconnected by microscale tubes whose dimensions can be closely related to the strength of interaction between the oscillators. Investigation of the collective behavior of the oscillators under the conditions in which the interaction strength can be systematically controlled gives significant information on the characteristics of the system. In this study, we proposed a living model system of a coupled oscillator system in the Physarum plasmodium. We patterned the geometry and dimensions of the microscale tube structure in the plasmodium by a microfabricated structure (microstructure). As the first step, we constructed a two-oscillator system for the plasmodium that has two wells (oscillator part) and a channel (coupling part). We investigated the oscillation behavior by monitoring the thickness oscillation of the plasmodium in the microstructure with various channel widths. It was found that the oscillation behavior of two oscillators dynamically changed depending on the channel width. Based on the results of measurements of the tube dimensions and the velocity of the protoplasmic streaming in the tube, we discuss how the channel width relates to the interaction strength of the coupled oscillator system. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	RIKEN, Inst Phys & Chem Res, Biochem Syst Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Takamatsu, A (reprint author), RIKEN, Inst Phys & Chem Res, Biochem Syst Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.						Nakata S, 1998, PHYSICA D, V115, P313, DOI 10.1016/S0167-2789(97)00240-6; BARANOWSKI Z, 1978, ACTA PROTOZOOL, V17, P377; KAMIYA N, 1950, CYTOLOGIA, V15, P194; KNOWLES DJC, 1978, J GEN MICROBIOL, V108, P17; NATSUME K, 1992, PROTOPLASMA, V166, P55, DOI 10.1007/BF01320143; TAKAMATSU A, 2000, IN PRESS PROTOPLASMA; Takamatsu A., 1998, Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Vol.20 Biomedical Engineering Towards the Year 2000 and Beyond (Cat. No.98CH36286), DOI 10.1109/IEMBS.1998.746118; UEDA T, 1986, EXP CELL RES, V162, P486, DOI 10.1016/0014-4827(86)90352-6; Winfree A. T., 1980, GEOMETRY BIOL TIME; YOSHIMOTO Y, 1981, PROTOPLASMA, V109, P159, DOI 10.1007/BF01287637	10	11	11	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0303-2647			BIOSYSTEMS	Biosystems	FEB	2000	55	1-3					33	38		10.1016/S0303-2647(99)00080-5		6	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	306ZN	WOS:000086628800005		
J	Takami, W; Nojiri, H; Yamane, H; Omori, T				Takami, W; Nojiri, H; Yamane, H; Omori, T			Degradation of trichloroethylene by recombinant E-coli in continuous culture	BIOTECHNOLOGY LETTERS			English	Article						continuous culture; degradation; E. coli; recombinant; trichloroethylene	CLONING; PLASMID; GENES; DIOXYGENASE; BIOREACTOR; STABILITY; BACTERIA; SYSTEM	Trichloroethylene (TCE) degradation by the recombinant E. coli JM109 harboring a TCE-degradative plasmid (pIO720 or pIO72K) in continuous culture was studied. The ampicillin-resistant plasmid, pIO720, contained the cumene dioxygenase genes and the dimethyl sulfide monooxygenase genes. pIO72K was constructed according to replacement of an ampicillin resistance gene on pIO720 by a kanamycin resistance gene. In the case of E. coli JM109 (pIO720) in continuous culture, TCE degradation activity decreased rapidly after continuous culture started, and the remaining number of host cells harboring pIO720 also decreased rapidly. In the case of E. coli JM109 (pIO72K) in continuous culture, TCE degradation activity was stable during continuous culture for at least 300 h and the number of the host cells harboring pIO72K did not decrease. TCE degradation activity of E. coli JM109 (pIO72K) was the highest at a dilution rate of 0.2 h(-1).	Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; Asahi Chem Ind Co Ltd, Fuji, Shizuoka 4168501, Japan	Omori, T (reprint author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Horinouchi M, 1997, FEMS MICROBIOL LETT, V155, P99, DOI 10.1111/j.1574-6968.1997.tb12692.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Chang HL, 1997, WATER RES, V31, P2026, DOI 10.1016/S0043-1354(97)00020-1; Jahng D, 1996, BIOTECHNOL BIOENG, V51, P349, DOI 10.1002/(SICI)1097-0290(19960805)51:3<349::AID-BIT10>3.0.CO;2-H; Aoki H, 1996, J FERMENT BIOENG, V81, P187, DOI 10.1016/0922-338X(96)82207-0; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Zhang SF, 1998, BIOTECHNOL BIOENG, V59, P80, DOI 10.1002/(SICI)1097-0290(19980705)59:1<80::AID-BIT11>3.0.CO;2-6; FUJITA M, 1995, J FERMENT BIOENG, V79, P100, DOI 10.1016/0922-338X(95)94075-3; FURUKAWA K, 1994, J BACTERIOL, V176, P2121; HEALD S, 1994, APPL ENVIRON MICROB, V60, P4634; JEONGYOON K, 1991, BIOTECHNOL BIOENG, V38, P1271; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NANCIB N, 1992, BIOTECHNOL LETT, V14, P643, DOI 10.1007/BF01021635; Radway JC, 1998, BIOTECHNOL LETT, V20, P663, DOI 10.1023/A:1005366406453; Sambrook J., 1989, MOL CLONING LAB MANU; Sharp RR, 1998, BIOTECHNOL BIOENG, V59, P318; Smith LH, 1997, BIOTECHNOL BIOENG, V55, P650, DOI 10.1002/(SICI)1097-0290(19970820)55:4<650::AID-BIT7>3.0.CO;2-G; Takami W, 1999, BIOTECHNOL LETT, V21, P259, DOI 10.1023/A:1005404931086; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3	19	1	1	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0141-5492			BIOTECHNOL LETT	Biotechnol. Lett.	FEB	2000	22	3					211	216		10.1023/A:1005662310748		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	280UB	WOS:000085121200008		
J	Aokl, Y; Tosato, G; Nambu, Y; Iwamoto, A; Yarchoan, R				Aokl, Y; Tosato, G; Nambu, Y; Iwamoto, A; Yarchoan, R			Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas	BLOOD			English	Letter									US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; Univ Tokyo, Inst Med Sci, Tokyo, Japan; NCI, HIV & AIDS Malignancy Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA	Aokl, Y (reprint author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.						Zebrowski BK, 1999, ANN SURG ONCOL, V6, P373, DOI 10.1007/s10434-999-0373-0; Luo JC, 1998, CANCER RES, V58, P2652; AOKI A, IN PRESS BLOOD; Boshoff C, 1998, BLOOD, V91, P1671; Cesarman E, 1999, SEMIN CANCER BIOL, V9, P165, DOI 10.1006/scbi.1998.0118	5	0	0	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 1	2000	95	3					1109	1110				2	Hematology	Hematology	278MN	WOS:000084993700054		
J	Sasaki, T; Akaho, R; Sakamaki, H; Akiyama, H; Yoshino, M; Hagiya, K; Atsumi, M				Sasaki, T; Akaho, R; Sakamaki, H; Akiyama, H; Yoshino, M; Hagiya, K; Atsumi, M			Mental disturbances during isolation in bone marrow transplant patients with leukemia	BONE MARROW TRANSPLANTATION			English	Article						bone marrow transplantation; isolation period; laminar air-flow unit; leukemia; adjustment disorder; psychological distress	PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL MORBIDITY; SURVIVAL; RECIPIENTS; VARIABLES; PREDICTORS; RECOVERY; TIME	The mental status of 39 leukemia patients, who received bone marrow transplants (BMT), was studied during the period of isolation. Mental disorders (diagnosed according to DSM-IV criteria) occurred in 16 patients (41%) during the observation period, The most frequent diagnoses were adjustment disorders, with anxiety and/or depression. Logistic regression analysis suggested higher Tension-Anxiety score in the Profile of Mood States (POMS) prior to isolation (P = 0.011), donation of the bone marrow from unrelated subjects (P = 0.026) and in female patients (P = 0.033). The results are preliminary, but indicate a high frequency of mental disturbances and highlight the importance of psychiatric intervention in BMT patients.	Tokyo Metropolitan Komagome Hosp, Dept Psychiat, Bunkyo Ku, Tokyo, Japan; Tokyo Metropolitan Komagome Hosp, Dept Hematol, Tokyo, Japan; Univ Tokyo, Hlth Serv Ctr, Dept Psychiat, Tokyo, Japan; Yamato Hosp, Dept Psychiat, Kanagawa, Japan	Akaho, R (reprint author), Tokyo Metropolitan Komagome Hosp, Dept Psychiat, Bunkyo Ku, 3-18-22 Hon Komagome, Tokyo, Japan.						ANDRYKOWSKI MA, 1994, BONE MARROW TRANSPL, V13, P357; Molassiotis A, 1997, J PSYCHOSOM RES, V42, P275, DOI 10.1016/S0022-3999(96)00298-X; COLON EA, 1991, PSYCHOSOMATICS, V32, P420; SYRJALA KL, 1993, BONE MARROW TRANSPL, V11, P319; ANDRYKOWSKI MA, 1994, PSYCHOSOM MED, V56, P432; McQuellon RP, 1998, BONE MARROW TRANSPL, V21, P477, DOI 10.1038/sj.bmt.1701115; Baker F, 1997, PSYCHOSOMATICS, V38, P10; Broers S, 1998, J PSYCHOSOM RES, V45, P341, DOI 10.1016/S0022-3999(98)00003-8; HENGEVELD MW, 1988, BONE MARROW TRANSPL, V3, P69; JENKINS PL, 1994, PSYCHOSOMATICS, V35, P361; LEIGH S, 1995, BONE MARROW TRANSPL, V16, P635; Molassiotis A, 1998, CANCER NURS, V21, P205, DOI 10.1097/00002820-199806000-00008; MOLLASIOTIS A, 1997, BONE MARROW TRANSPL, V19, P87; MURPHY KC, 1996, BONE MARROW TRANSPL, V18, P432; Neitzert CS, 1998, BONE MARROW TRANSPL, V22, P409, DOI 10.1038/sj.bmt.1701358; NEUSER J, 1988, J PSYCHOSOM RES, V32, P451, DOI 10.1016/0022-3999(88)90029-3; Schweigkofler H, 1996, NERVENARZT, V67, P799, DOI 10.1007/s001150050057	17	37	39	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	FEB	2000	25	3					315	318		10.1038/sj.bmt.1702117		4	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	285FB	WOS:000085378100013		
J	Fujii, T; Miyamura, K				Fujii, T; Miyamura, K			Observation of molecular alignments and dimer formation of bis(5-alkylsalicylidene)ethylenediaminatonickel(II) in a monolayer	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							SCANNING-TUNNELING-MICROSCOPY; ORIENTED PYROLYTIC-GRAPHITE; METAL-COMPLEXES; AGGREGATION	A monolayer of bis(5-butylsalicylidene)ethylenediaminatonnickel(II) prepared on highly oriented pyrolytic graphite by the Langmuir-Blodgett method, was observed by scanning tunnelling microscopy. The image revealed that one of the monolayers was comprised dimers of complexes, similar to that observed in the crystalline phase. The pi-A isotherms of the analogues of various alkyl chain lengths were measured, and the critical area of the monolayer was found to decrease by 20% when the alkyl chain length decreased from 3 (propyl) to 2 (ethyl). This decrease of the critical area is explained by the presence of CH-pi interactions between the pi conjugated system of the salen moiety, and alpha- and gamma-methylenes of the alkyl side chain.	Sci Univ Tokyo, Fac Sci, Dept Chem, Shinjuku Ku, Tokyo 1628601, Japan; Univ Tokyo, Grad Sch Engn, Course Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Miyamura, K (reprint author), Sci Univ Tokyo, Fac Sci, Dept Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.						MIYAMURA K, 1995, J AM CHEM SOC, V117, P2377, DOI 10.1021/ja00113a038; BINNIG G, 1982, HELV PHYS ACTA, V55, P726; JOSEFOWICZ JY, 1993, SCIENCE, V260, P323, DOI 10.1126/science.260.5106.323; KIMURA M, 1994, JPN J APPL PHYS 1, V33, P6733, DOI 10.1143/JJAP.33.6733; LIPPEL RH, 1988, PHYS REV LETT, V60, P2398; MIYAMURA K, 1989, B CHEM SOC JPN, V62, P45, DOI 10.1246/bcsj.62.45; MIYAMURA K, 1994, J VAC SCI TECHNOL B, V12, P1930, DOI 10.1116/1.587673; MIYAMURA K, 1986, CHEM LETT, P1145, DOI 10.1246/cl.1986.1145; OHTA K, 1992, MOL CRYST LIQ CRYST, V214, P161, DOI 10.1080/10587259208037290; ROBERTS G, 1990, LANGMUIRBLODGETT FIL; SMITH DPE, 1987, P NATL ACAD SCI USA, V84, P969, DOI 10.1073/pnas.84.4.969	11	9	9	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	FEB	2000	73	2					365	368		10.1246/bcsj.73.365		4	Chemistry, Multidisciplinary	Chemistry	289UF	WOS:000085639800012		
J	Kanie, K; Tanaka, Y; Suzuki, K; Kuroboshi, M; Hiyama, T				Kanie, K; Tanaka, Y; Suzuki, K; Kuroboshi, M; Hiyama, T			A convenient synthesis of trifluoromethyl ethers by oxidative desulfurization-fluorination of dithio carbonates	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							FACILE SYNTHESIS; LIQUID-CRYSTALS; HYDROGEN-FLUORIDE; BROMINATION; REACTIVITY; XANTHATES; REAGENTS; AMINES; ALKYL	Trifluoromethyl ethers R-OCF3 are easily synthesized from the corresponding dithiocarbonates R-OCS2Me (R = aryl or primary alkyl) by a reagent system consisting of 70% HF/pyridine and an N-halo imide. When the reaction is applied to R-OCS2Me wherein R = secondary alkyl, tertiary alkyl, or benzylic group, fluorination leading to the corresponding alkyl fluorides R-F is achieved, whereas a combination of 50% HF/pyridine and N-bromosuccinimide affords the corresponding trifluoromethyl ethers R-OCF3 (R = secondary).	Tokyo Inst Technol, Resources Utilizat Res Lab, Midori Ku, Kanagawa 2268503, Japan	Hiyama, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		KIYOSHI, KANIE/F-6660-2014	KIYOSHI, KANIE/0000-0003-1477-6515			ADACHI K, 1997, 15 INT S FLUOR CHEM; ADAMSON J, 1969, CHEM COMMUN, P309; WELCH JT, 1987, TETRAHEDRON, V43, P3123, DOI 10.1016/S0040-4020(01)90286-8; ALDRICH PE, 1964, J ORG CHEM, V29, P11, DOI 10.1021/jo01024a002; FEIRING AE, 1979, J ORG CHEM, V44, P2907, DOI 10.1021/jo01330a017; GOTO Y, 1991, MOL CRYST LIQ CRYST, V209, P1, DOI 10.1080/00268949108036174; OLAH GA, 1979, J ORG CHEM, V44, P3872, DOI 10.1021/jo01336a027; SHEPPARD WA, 1964, J ORG CHEM, V29, P1, DOI 10.1021/jo01024a001; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; KUROBOSHI M, 1992, TETRAHEDRON LETT, V33, P4173, DOI 10.1016/S0040-4039(00)74681-8; Yamazaki T, 1995, J ORG CHEM, V60, P8140, DOI 10.1021/jo00130a012; CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755; Banks RE, 1982, PREPARATION PROPERTI; Barton D.H.R, 1969, CHEM COMMUN, P227; Ben-David I, 1999, J FLUORINE CHEM, V97, P75, DOI 10.1016/S0022-1139(99)00031-7; Boswell G. A., 1974, ORG REACTIONS, V21, P1; Chassaing C, 1997, TETRAHEDRON LETT, V38, P4415, DOI 10.1016/S0040-4039(97)00943-X; CORVAJA C, 1995, TETRAHEDRON LETT, V36, P3543, DOI 10.1016/0040-4039(95)00553-O; COUSSEAU J, 1986, B SOC CHIM FR, P910; FARB HOECHST AG, 1957, Patent No. 765527; Filler R., 1982, BIOMEDICAL ASPECTS F; FUJISAKI S, 1993, B CHEM SOC JPN, V66, P1576, DOI 10.1246/bcsj.66.1576; FUKUHARA T, 1985, NIPPON KAGAKU KAISHI, V10, P1951; Furuta S, 1999, B CHEM SOC JPN, V72, P805, DOI 10.1246/bcsj.72.805; Furuta S, 1998, B CHEM SOC JPN, V71, P1939, DOI 10.1246/bcsj.71.1939; Gray GW, 1991, MOL CRYST LIQ CRYST, V204, P91, DOI 10.1080/00268949108046597; Hansch C., 1979, SUBSTITUENT CONSTANT; Hudlicky M., 1995, ACS MONOGRAPH, VII; IAROVENKO NN, 1958, J GEN CHEM USSR, V28, P2539; JOHRI KK, 1983, J ORG CHEM, V48, P242, DOI 10.1021/jo00150a019; KANEMOTO S, 1989, B CHEM SOC JPN, V62, P2024, DOI 10.1246/bcsj.62.2024; Kanie K, 1999, B CHEM SOC JPN, V72, P2523, DOI 10.1246/bcsj.72.2523; KANIE K, 1995, CHEM LETT, P683, DOI 10.1246/cl.1995.683; Kanie K, 1998, B CHEM SOC JPN, V71, P1973, DOI 10.1246/bcsj.71.1973; Kanie K, 1998, CHEM LETT, P1169, DOI 10.1246/cl.1998.1169; Kanie K, 1999, J FLUORINE CHEM, V97, P201, DOI 10.1016/S0022-1139(99)00049-4; KOBAYASHI H, 1997, FUSSO KAGAKU NYUMON; KOEN MJ, 1995, J CHEM SOC CHEM COMM, P1241, DOI 10.1039/c39950001241; KUROBOSHI M, 1994, SYNLETT, P251; KUROBOSHI M, 1993, YUKI GOSEI KAGAKU KY, V51, P1124; KUROBOSHI M, 1991, SYNLETT, P909; KUROBOSHI M, 1994, J FLUORINE CHEM, V69, P127, DOI 10.1016/0022-1139(94)03139-8; KUROBOSHI M, 1994, TETRAHEDRON LETT, V35, P3983, DOI 10.1016/S0040-4039(00)76719-0; LEE AWM, 1989, SYNTHETIC COMMUN, V19, P547, DOI 10.1080/00397918908050698; LEVY JB, 1985, J ORG CHEM, V50, P5615, DOI 10.1021/jo00350a037; MATHEY F, 1973, TETRAHEDRON LETT, V25, P2253; Matsutani H, 1999, CHEM LETT, P529; NOHIRA H, 1994, NIPPON KAGAKU KAISHI, P467; OLAH GA, 1991, SYNTHETIC FLUORINE C; PATRICK TB, 1980, J ORG CHEM, V45, P1409, DOI 10.1021/jo01296a013; Rozen S, 1996, CHEM REV, V96, P1717, DOI 10.1021/cr941147+; ROZEN S, 1993, J ORG CHEM, V58, P239, DOI 10.1021/jo00053a043; Sharts C. M., 1974, ORG REACTIONS, V21, P125; Welch J.T., 1991, FLUORINE BIOORGANIC; Yamazaki T, 1997, TETRAHEDRON LETT, V38, P6705, DOI 10.1016/S0040-4039(97)01570-0	55	34	34	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	FEB	2000	73	2					471	484		10.1246/bcsj.73.471		14	Chemistry, Multidisciplinary	Chemistry	289UF	WOS:000085639800027		
J	Kuwano, R; Sawamura, M; Shirai, J; Takahashi, M; Ito, Y				Kuwano, R; Sawamura, M; Shirai, J; Takahashi, M; Ito, Y			Asymmetric hydrosilylation of ketones using trans-chelating chiral peralkylbisphosphine ligands bearing primary alkyl substituents on phosphorus atoms	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							CATALYZED ENANTIOSELECTIVE HYDROSILYLATION; PHOSPHINE HYBRID LIGAND; RHODIUM COMPLEX; SELECTIVE REDUCTIONS; CARBONYL-COMPOUNDS; DIFERROCENYL DICHALCOGENIDES; DIPHOSPHINE ETTRAP; PROCHIRAL KETONES; METAL COMPLEXES; HYDROGENATION	Asymmetric hydrosilylation of simple ketones with diphenylsilane proceeded at -40 degrees C in the presence of a rhodium complex (0.001-0.01 molar amount) coordinated with a trans-chelating chiral bisphosphine ligand bearing linear alkyl substituents on the phosphorus atoms, (R,R)-(S,S)-Et-, Pr-, or BuTRAP, giving the corresponding optically active (S)-econdary alcohols with up to 97% ee. The asymmetric hydrosilylation using TRAP ligands with bulkier P-substituents resulted in much lower enantioselectivities. The EtTRAP-rhodium catalyst was also effective for asymmetric hydrosilylation of keto esters with a coordination site for a rhodium atom (up to 98% ee) Optically active symmetrical diols were obtained with up to 99% ee from the corresponding diketones via the asymmetric reduction using 2.5 molar amounts of diphenylsilane.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Sakyo Ku, Kyoto 6068501, Japan; Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Sawamura, M (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Sakyo Ku, Kyoto 6068501, Japan.		Kuwano, Ryoichi/A-9353-2008; Ito, Yoshihiko/G-4296-2010; Sawamura, Masaya/G-1428-2012				BROWN HC, 1988, J AM CHEM SOC, V110, P1539, DOI 10.1021/ja00213a030; MICHELI RA, 1975, J ORG CHEM, V40, P675, DOI 10.1021/jo00894a003; WIPF B, 1983, HELV CHIM ACTA, V66, P485, DOI 10.1002/hlca.19830660209; SAKAKI J, 1993, HELV CHIM ACTA, V76, P2654, DOI 10.1002/hlca.19930760722; Yamanoi Y, 1999, J ORG CHEM, V64, P2988, DOI 10.1021/jo990131m; KITAMURA M, 1988, J AM CHEM SOC, V110, P629, DOI 10.1021/ja00210a070; NISHIYAMA H, 1989, ORGANOMETALLICS, V8, P846, DOI 10.1021/om00105a047; BURK MJ, 1991, TETRAHEDRON-ASYMMETR, V2, P569, DOI 10.1016/S0957-4166(00)86109-1; BRUNNER H, 1989, CHEM BER, V122, P499, DOI 10.1002/cber.19891220318; NISHIYAMA H, 1993, TETRAHEDRON-ASYMMETR, V4, P143, DOI 10.1016/S0957-4166(00)86024-3; SAWAMURA M, 1994, ANGEW CHEM INT EDIT, V33, P111, DOI 10.1002/anie.199401111; NOYORI R, 1989, J AM CHEM SOC, V111, P9134, DOI 10.1021/ja00207a038; NISHIYAMA H, 1991, ORGANOMETALLICS, V10, P500, DOI 10.1021/om00048a029; NOYORI R, 1987, J AM CHEM SOC, V109, P5856, DOI 10.1021/ja00253a051; Pickard RH, 1913, J CHEM SOC, V103, P1923, DOI 10.1039/ct9130301923; NISHIYAMA H, 1992, TETRAHEDRON-ASYMMETR, V3, P1029, DOI 10.1016/S0957-4166(00)86036-X; SAWAMURA M, 1991, TETRAHEDRON-ASYMMETR, V2, P593, DOI 10.1016/S0957-4166(00)86110-8; MORI K, 1975, TETRAHEDRON, V31, P3011, DOI 10.1016/0040-4020(75)80138-4; OJIMA I, 1982, ORGANOMETALLICS, V1, P1390, DOI 10.1021/om00070a024; OJIMA I, 1976, J ORGANOMET CHEM, V122, P83, DOI 10.1016/S0022-328X(00)92750-5; SAWAMURA M, 1995, ORGANOMETALLICS, V14, P4549, DOI 10.1021/om00010a020; Jiang QZ, 1998, ANGEW CHEM INT EDIT, V37, P1100; GOKEL GW, 1972, J ORG CHEM, V37, P3052, DOI 10.1021/jo00985a002; TANI K, 1984, J AM CHEM SOC, V106, P5208, DOI 10.1021/ja00330a029; HAYASHI T, 1991, TETRAHEDRON-ASYMMETR, V2, P601, DOI 10.1016/S0957-4166(00)86112-1; Kuwano R, 1997, B CHEM SOC JPN, V70, P2807, DOI 10.1246/bcsj.70.2807; BAILEY WJ, 1954, J AM CHEM SOC, V76, P2707, DOI 10.1021/ja01639a033; BROWN HC, 1985, J ORG CHEM, V50, P1384, DOI 10.1021/jo00209a008; BROWN HC, 1988, J ORG CHEM, V53, P1231, DOI 10.1021/jo00241a021; BRUNNER H, 1990, J ORGANOMET CHEM, V390, pC81, DOI 10.1016/0022-328X(90)85111-B; BRUNNER H, 1988, J ORGANOMET CHEM, V346, P413, DOI 10.1016/0022-328X(88)80142-6; BRUNNER H, 1991, TETRAHEDRON-ASYMMETR, V2, P919, DOI 10.1016/S0957-4166(00)82204-1; BRUNNER H, 1984, ORGANOMETALLICS, V3, P1354, DOI 10.1021/om00087a006; Brunner H., 1993, CATALYTIC ASYMMETRIC, P303; Brunner H, 1993, HDB ENANTIOSELECTIVE, V1; Brunner H, 1993, HDB ENANTIOSELECTIVE, V2; BURK MJ, 1992, TETRAHEDRON LETT, V33, P2099, DOI 10.1016/0040-4039(92)88150-4; CHEN CP, 1991, TETRAHEDRON LETT, V32, P7175, DOI 10.1016/0040-4039(91)80469-M; CHONG R, 1967, AUST J CHEM, V20, P123, DOI 10.1071/CH9670123; CORRIU RJP, 1975, J ORGANOMET CHEM, V85, P19, DOI 10.1016/S0022-328X(00)89486-3; DAVIES AG, 1952, J CHEM SOC, P3300, DOI 10.1039/jr9520003300; DAVIES SG, 1989, J CHEM SOC PERK T 1, P192, DOI 10.1039/p19890000192; DUMONT W, 1973, J AM CHEM SOC, V95, P8295, DOI 10.1021/ja00806a015; GLADIALI S, 1990, TETRAHEDRON-ASYMMETR, V1, P937; Haag D, 1998, ORGANOMETALLICS, V17, P398, DOI 10.1021/om970423i; HAYASHI T, 1995, TETRAHEDRON-ASYMMETR, V6, P2503, DOI 10.1016/0957-4166(95)00326-K; HAYASHI T, 1976, J ORGANOMET CHEM, V113, P127, DOI 10.1016/S0022-328X(00)96126-6; IMAI T, 1986, J AM CHEM SOC, V108, P7402, DOI 10.1021/ja00283a042; ISHIZAKI T, 1980, NIPPON KAGAKU KAISHI, P1381; Kuwano R, 1999, TETRAHEDRON LETT, V40, P1327, DOI 10.1016/S0040-4039(98)02603-3; ITOH O, 1982, B CHEM SOC JPN, V55, P177, DOI 10.1246/bcsj.55.177; JAOUEN G, 1975, J AM CHEM SOC, V97, P4667, DOI 10.1021/ja00849a032; Kenyon J, 1936, J CHEM SOC, P85, DOI 10.1039/jr9360000085; KOGURE T, 1982, J ORGANOMET CHEM, V234, P249, DOI 10.1016/0022-328X(82)80001-6; KUWANO R, 1995, TETRAHEDRON LETT, V36, P5239; KWART H, 1967, J ORG CHEM, V32, P1867, DOI 10.1021/jo01281a037; Langer T, 1996, TETRAHEDRON-ASYMMETR, V7, P1599, DOI 10.1016/0957-4166(96)00192-9; Lee SG, 1997, TETRAHEDRON-ASYMMETR, V8, P4027, DOI 10.1016/S0957-4166(97)00554-5; Levene PA, 1927, J BIOL CHEM, V75, P587; MONTGOMERY FC, 1976, J ORG CHEM, V41, P2368, DOI 10.1021/jo00876a003; NAGAI U, 1965, TETRAHEDRON, V21, P1701, DOI 10.1016/S0040-4020(01)98640-5; Newman LM, 1996, TETRAHEDRON-ASYMMETR, V7, P1597, DOI 10.1016/0957-4166(96)00191-7; NISHIBAYASHI Y, 1995, ORGANOMETALLICS, V14, P5486, DOI 10.1021/om00012a012; NISHIBAYASHI Y, 1994, J CHEM SOC CHEM COMM, P1375, DOI 10.1039/c39940001375; Nishibayashi Y, 1996, CHEM COMMUN, P847, DOI 10.1039/cc9960000847; Nishibayashi Y, 1996, ORGANOMETALLICS, V15, P370, DOI 10.1021/om950533u; Nishibayashi Y, 1998, ORGANOMETALLICS, V17, P3420, DOI 10.1021/om980399o; NISHIYAMA H, 1992, J ORG CHEM, V57, P4306, DOI 10.1021/jo00041a049; Noyori R., 1994, ASYMMETRIC CATALYSIS; Ojima I., 1993, CATALYTIC ASYMMETRIC; Ojima I., 1985, ASYMMETRIC SYNTHESIS, V5, P103; OJIMA I, 1972, TETRAHEDRON LETT, P5035; OJIMA I, 1977, J ORG CHEM, V42, P1671, DOI 10.1021/jo00430a001; OKAMOTO K, 1975, J CHEM SOC PERK T 2, P1426, DOI 10.1039/p29750001426; Pickard RH, 1914, J CHEM SOC, V105, P1115, DOI 10.1039/ct9140501115; PLATTNER JJ, 1971, J AM CHEM SOC, V93, P1758; SAWAMURA M, 1995, SYNLETT, P347; SHENK TG, 1985, INORG CHEM, V24, P2334; Sudo A, 1997, TETRAHEDRON-ASYMMETR, V8, P3205, DOI 10.1016/S0957-4166(97)00424-2; TANABE T, 1973, B CHEM SOC JPN, V46, P2233, DOI 10.1246/bcsj.46.2233; TANI K, 1989, J ORGANOMET CHEM, V370, P203, DOI 10.1016/0022-328X(89)87285-7; TANI K, 1982, CHEM LETT, P265, DOI 10.1246/cl.1982.265; TERASHIMA S, 1980, J CHEM SOC CHEM COMM, P1026, DOI 10.1039/c39800001026; THEISEN PD, 1988, J ORG CHEM, V53, P2374, DOI 10.1021/jo00245a051; TROST BM, 1986, J ORG CHEM, V51, P2370, DOI 10.1021/jo00362a036; Tsuruta H, 1999, TETRAHEDRON-ASYMMETR, V10, P877, DOI 10.1016/S0957-4166(99)00042-7	86	47	48	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	FEB	2000	73	2					485	496		10.1246/bcsj.73.485		12	Chemistry, Multidisciplinary	Chemistry	289UF	WOS:000085639800028		
J	Wu, HZ; Watanabe, N; Tsukahara, R; Itoh, T; Gohshi, Y; Owari, M				Wu, HZ; Watanabe, N; Tsukahara, R; Itoh, T; Gohshi, Y; Owari, M			Highly sensitive determination of trace rare-earth elements in ultra pure rare-earth compounds by combining ICP-MS with HPLC and electrothermal vaporization	BUNSEKI KAGAKU			Japanese	Article						rare-earth; HPLC; electrothermal vaporization; ICP-MS; coupling technique	PLASMA MASS-SPECTROMETRY	It is very difficult to accurately quantify trace rare-earth elements (REE) in ultra-pure rare-earth compounds by a single analysis method, such as ICP-AES, ICP-MS or electrothermal vaporization (ETV)/ICP-MS. We have developed a highly sensitive and efficient method by coupling the advantages of HPLC, ETV and ICP-MS. HPLC eliminated problems caused by matrix and severe overlapping of oxides and hydroxides peaks coming from the main component observed in ICP-MS. ETV greatly reduced the interference from additives contained in the eluent of HPLC, and provided an efficient introduction method for ICP-MS. The detection limits of other REE in pure Gd2O3 were 0.07 similar to 2 ng/g Gd. The method is applicable to analyses for 7 similar to 8 N pure metal and compounds.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Sumitomo Met Min Co Ltd, Cent Res Lab, Ichikawa, Chiba 2728588, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; Univ Tokyo, Ctr Environm Sci, Bunkyo Ku, Tokyo 1130033, Japan	Wu, HZ (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						FEY W, 1993, FRESEN J ANAL CHEM, V346, P89; PULAKI P, 1994, FRESEN J ANAL CHEM, V350, P194; SHIBATA N, 1991, ANAL CHEM, V63, P636, DOI 10.1021/ac00006a016; STIJFHOORN DE, 1993, SPECTROCHIM ACTA B, V48, P507, DOI 10.1016/0584-8547(93)80055-Y; VAUGHAN MA, 1990, SPECTROCHIM ACTA B, V45, P1289, DOI 10.1016/0584-8547(90)80183-J; Wu HZ, 1999, FRESEN J ANAL CHEM, V363, P424, DOI 10.1007/s002160051214	6	4	6	JAPAN SOC ANALYTICAL CHEM	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	FEB	2000	49	2					91	97		10.2116/bunsekikagaku.49.91		7	Chemistry, Analytical	Chemistry	285FD	WOS:000085378300002		
J	Ohashi, K; Yahara, T				Ohashi, K; Yahara, T			Effects of flower production and predispersal seed predation on reproduction in Cirsium purpuratum	CANADIAN JOURNAL OF BOTANY-REVUE CANADIENNE DE BOTANIQUE			English	Article						plant reprodutive success; predispersal seed predation; Cirsium purpuratum; flower production; plant-animal interaction	IPOMOPSIS-AGGREGATA; INFLORESCENCE SIZE; FLORAL DISPLAY; PLANT SIZE; POLLINATION; FEMALE; EVOLUTION; SUCCESS; FITNESS; CONSEQUENCES	Researchers have often assumed that the reproductive success of a plant increases with flower production. However, if predispersal seed predation also increases with flower production, this may counteract the increase in reproductive success expected with such increased flower production. To investigate this, we examined the effect of flower number and predispersal seed predation on seed production in two field populations of Cirsium purpuratum (Maxim.) Matsum. At both sites, the proportion of seeds or heads preyed upon per plant increased with the number of flowers (florets or heads) on each plant, while the proportion of mature seeds per plant was independent of flower number per plant. Based on these results, we predicted that an increased level of seed predation at the population level would reduce the annual flower production of each plant. The observed pattern of flower production supported this prediction. Our results suggest that increased flower production may not always improve plant reproductive success under the influence of predispersal seed predation.	Univ Tokyo, Coll Arts & Sci, Dept Biol, Meguro Ku, Tokyo 153, Japan	Ohashi, K (reprint author), Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan.						ANDERSSON S, 1988, OECOLOGIA, V76, P125; BELL G, 1985, PROC R SOC SER B-BIO, V224, P223, DOI 10.1098/rspb.1985.0031; DUDASH MR, 1991, ECOLOGY, V72, P1004, DOI 10.2307/1940600; GOMEZ JM, 1994, ECOLOGY, V75, P1023, DOI 10.2307/1939426; Brody AK, 1997, OECOLOGIA, V110, P86, DOI 10.1007/s004420050136; SCHMIDHEMPEL P, 1988, OIKOS, V53, P98, DOI 10.2307/3565669; LOUDA SM, 1982, J ECOL, V70, P43, DOI 10.2307/2259863; Brody AK, 1995, OIKOS, V74, P447, DOI 10.2307/3545989; HAINSWORTH FR, 1984, OECOLOGIA, V63, P405; BRODY AK, 1992, OECOLOGIA, V91, P63; BROYLES S B, 1990, Plant Species Biology, V5, P131, DOI 10.1111/j.1442-1984.1990.tb00198.x; BULLOCK JM, 1994, J ECOL, V82, P101, DOI 10.2307/2261390; CAMPBELL DR, 1991, AM NAT, V137, P713, DOI 10.1086/285190; CHATER E. H., 1931, BULL ENT RES, V22, P225; CRAWLEY M.J., 1992, SEEDS ECOLOGY REGENE, P157; DEJONG TJ, 1994, J ECOL, V82, P399, DOI 10.2307/2261307; DESTEVEN D, 1983, ECOLOGY, V64, P89; DEVLIN B, 1989, AM J BOT, V76, P204, DOI 10.2307/2444662; GALEN C, 1993, EVOLUTION, V47, P1073, DOI 10.2307/2409975; GEBER MA, 1985, ECOLOGY, V66, P762; HEITHAUS ER, 1982, ECOLOGY, V63, P1294, DOI 10.2307/1938857; IWASA Y, 1989, AM NAT, V133, P480, DOI 10.1086/284931; Kudoh H, 1998, OECOLOGIA, V117, P70, DOI 10.1007/s004420050633; Manly B.F.J., 1991, RANDOMIZATION MONTE; MOORE LR, 1978, OECOLOGIA, V34, P203, DOI 10.1007/BF00345167; Morisita M., 1959, MEM FAC SCI KYUSHU E, V2, P215; Ohashi K, 1998, AM J BOT, V85, P219, DOI 10.2307/2446309; Pettersson MW, 1997, ECOGRAPHY, V20, P375, DOI 10.1111/j.1600-0587.1997.tb00382.x; ROBERTSON AW, 1995, OIKOS, V72, P106, DOI 10.2307/3546044; SCHEMSKE DW, 1980, EVOLUTION, V34, P489, DOI 10.2307/2408218; SNOW AA, 1989, ECOLOGY, V70, P1286, DOI 10.2307/1938188; STANTON ML, 1986, SCIENCE, V232, P1625, DOI 10.1126/science.232.4758.1625; Thomson JD, 1988, EVOL ECOL, V2, P65, DOI 10.1007/BF02071589; TRAVIS J, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P255; Waser NM, 1983, POLLINATION BIOL, P242; WILLSON MF, 1974, AM MIDL NAT, V92, P47, DOI 10.2307/2424201; WILLSON MF, 1977, EVOLUTION, V31, P495, DOI 10.2307/2407517; Zar JH, 1984, BIOSTATISTICAL ANAL	38	14	16	NATL RESEARCH COUNCIL CANADA	OTTAWA	RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA	0008-4026			CAN J BOT	Can. J. Bot.-Rev. Can. Bot.	FEB	2000	78	2					230	236				7	Plant Sciences	Plant Sciences	300ZB	WOS:000086282700010		
J	Narita, Y; Asai, A; Kuchino, Y; Kirino, T				Narita, Y; Asai, A; Kuchino, Y; Kirino, T			Actinomycin D and staurosporine, potent apoptosis inducers in vitro, are potentially effective chemotherapeutic agents against glioblastoma multiforme	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						apoptosis; glioblastoma; caspase; actinomycin D; staurosporine	BLOOD-BRAIN-BARRIER; MALIGNANT GLIOMAS; INTRAVENOUS CISPLATIN; SYMPATHETIC NEURONS; PC12 CELLS; PHASE-II; IN-VITRO; PROTEASES; TUMORS; RADIOTHERAPY	Purpose: Although chemotherapeutic protocols that include chloroethylnitrosoureas (CENUs), such as 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), have been a mainstay of treatment for glioblastomas, the clinical outcomes have been unsatisfactory. More effective chemotherapeutic protocols for these tumors will require clear delineation of more cytocidal and cytostatic chemotherapeutic drugs. Methods and Results: In this study, we measured the cytocidal effects of ACNU, cisplatin, actinomycin D, and staurosporine, administered within their therapeutic dose ranges, in the treatment of glioblastoma cells. As assessed by WST-1 colorimetric assay, the number of viable cells decreased markedly in T98G cultures treated with actinomycin D or staurosporine, to less than 20% of the level in control cultures at 72 h, but did not decrease or even increased after 6 days of treatment with ACNU. After treatment with cisplatin for 5 days,cell viability decreased to 30% of control. As assessed by fluorescence microscopic examination of nuclear staining by Hoechst 33258 and by electron microscopy, the majority of dead cells treated with actinomycin D, staurosporine, or cisplatin had morphologic features of apoptosis. Caspase-3 activity increased more than 20-fold in cells treated with actinomycin D, staurosporine, or cisplatin but increased less than fivefold in ACNU-treated cells. In addition to caspase-3 activation, western blot analysis demonstrated cleavage of caspase-2 during the apoptotic process. These findings indicate that actinomycin D and staurosporine potently induce apoptosis, whereas ACNU exerts mainly a cytostatic rather than a cytocidal effect. Conclusion: Actinomycin D and staurosporine and their derivatives are potentially effective chemotherapeutic agents against glioblastoma cells at least in vitro.	Univ Tokyo, Fac Med, Lab Neurosci & Oncol, Bunkyo Ku, Tokyo 113, Japan; Natl Canc Ctr, Res Inst, Div Biophys, Chuo Ku, Tokyo 1040045, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	Asai, A (reprint author), Univ Tokyo, Fac Med, Lab Neurosci & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; SHAPIRO WR, 1989, J NEUROSURG, V71, P1, DOI 10.3171/jns.1989.71.1.0001; Fulton D, 1996, J NEURO-ONCOL, V27, P149; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Weller M, 1997, NEUROLOGY, V48, P1704; Todo T, 1998, NEUROSURGERY, V43, P337, DOI 10.1097/00006123-199808000-00098; Talanian RV, 1997, J BIOL CHEM, V272, P9677; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Bartus RT, 1996, EXP NEUROL, V142, P14, DOI 10.1006/exnr.1996.0175; Emerich DF, 1998, BRAIN RES, V801, P259, DOI 10.1016/S0006-8993(98)00571-X; Fountzilas G, 1997, AM J CLIN ONCOL-CANC, V20, P138, DOI 10.1097/00000421-199704000-00006; Harvey NL, 1996, GENES CELLS, V1, P673, DOI 10.1046/j.1365-2443.1996.00255.x; Hasegawa J, 1996, CANCER RES, V56, P1713; Hellman R, 1998, J NEURO-ONCOL, V37, P55, DOI 10.1023/A:1005867520788; Hueber A, 1998, EUR J PHARMACOL, V352, P111, DOI 10.1016/S0014-2999(98)00335-5; Ikeda Jun, 1996, Neurologia Medico-Chirurgica, V36, P555, DOI 10.2176/nmc.36.555; Ishiyama M., 1995, In Vitro Toxicology, V8, P187; KIYA K, 1992, CANCER CHEMOTH PHARM, V29, P339, DOI 10.1007/BF00686001; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kohno T, 1985, No To Shinkei, V37, P991; Kondo S, 1998, CANCER RES, V58, P962; LEVIN VA, 1985, J NEUROSURG, V63, P218, DOI 10.3171/jns.1985.63.2.0218; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Mineura K, 1989, No To Shinkei, V41, P927; NAGANE M, 1992, JPN J CLIN ONCOL, V22, P143; Schlapbach R, 1997, BBA-MOL CELL RES, V1359, P174, DOI 10.1016/S0167-4889(97)00096-7; Shimura T, 1996, CLIN NEUROPATHOL, V15, P119; SPENCE AM, 1992, J NEURO-ONCOL, V12, P187; Stefanis L, 1998, J NEUROSCI, V18, P9204; STEWART DJ, 1993, J NEURO-ONCOL, V17, P71, DOI 10.1007/BF01054276; TAKAKURA K, 1986, J NEUROSURG, V64, P53, DOI 10.3171/jns.1986.64.1.0053; The commitee of brain tumor registry in Japan, 1992, NEUROL MED CHIR TOKY, V32, P381; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TONN JC, 1994, ANTICANCER RES, V14, P1371; Troy CM, 1997, J NEUROSCI, V17, P1911; Tsujimoto Yoshihide, 1997, Leukemia (Basingstoke), V11, P380; VONHOLST H, 1990, ACTA NEUROCHIR, V104, P13; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wolf CM, 1997, EXP CELL RES, V230, P22, DOI 10.1006/excr.1996.3401; Zunkeler B, 1996, J NEUROSURG, V85, P1056, DOI 10.3171/jns.1996.85.6.1056	41	17	17	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0344-5704			CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	FEB	2000	45	2					149	156		10.1007/s002800050023		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	277QR	WOS:000084945000008		
J	Shinoura, N; Ohashi, M; Yoshida, Y; Kirino, T; Asai, A; Hashimoto, M; Hamada, H				Shinoura, N; Ohashi, M; Yoshida, Y; Kirino, T; Asai, A; Hashimoto, M; Hamada, H			Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas	CANCER GENE THERAPY			English	Article						adenovirus vector; Fas; Bcl-X-L; myelin basic protein; glioma; gene therapy	HUMAN-MALIGNANT GLIOMA; CELL-DEATH; IMMUNOHISTOCHEMICAL ANALYSIS; RECOMBINANT ADENOVIRUSES; RECEPTOR SIGNALS; GENE-EXPRESSION; NERVOUS-SYSTEM; TNF RECEPTOR; BCL-X; PROTEIN	Gliomas express a higher amount of Fas than normal brain tissue. It is of interest to know whether expression of the Fas receptor is unfavorable to the antiapoptotic pathways in gliomas. In this study, we introduced the Fas gene via an adenovirus vector (Adeno-Fas) into the A-172, U251, and U-373 MG glioma cell lines, each of which expresses Fas on the cell surface. infection of Adeno-Fas induced apoptosis in each glioma cell line. In U251 cells and A-172 cells that express the same level of Fas as a result of infection with Adeno-fas, a much higher percentage of U251 cells underwent apoptosis than did A-172 cells. This suggests that each glioma cell line has its own threshold of Fas expression, above which apoptosis is induced, and that the constitutive expression of Fas is below the level of this threshold. It was found that the constitutive expression of the anti-apoptotic gene Bcl-X-L is higher in A-172 cells than in U251 cells. Adenovirus-mediated transduction of the Bcl-X-L gene into U251 cells effectively suppressed Adeno-Fas-mediated apoptosis. These data indicate that the Bcl-X-L gene is one of the important determinants of the threshold for Fas-mediated apoptosis. When U251 and U-373 MG eel Is were transduced with the Fas gene controlled by the myelin basic protein promoter, which had been shown to be active in gliomas but not in neural tissues, the cells underwent markedly enhanced apoptosis. Taken together, these results indicate that the overexpression of Fas alone induced apoptosis in each glioma cell line. The degree of Fas-mediated apoptosis was attenuated by the expression of an anti-apoptotic gene, Bcl-X-L. The adenovirus-mediated induction of Fas gene controlled by a tissue-specific promoter (e.g., myelin basic protein promoter) would be a promising therapeutic approach for malignant glioma.	Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Mol Biotherapy Res, Toshima Ku, Tokyo 1708455, Japan; Univ Tokyo, Dept Neurosurg, Tokyo 113, Japan; Riken Brain Sci Inst, Dev Neurobiol Lab, Riken, Japan; Mol Neurobiol Lab, Riken, Japan	Hamada, H (reprint author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Mol Biotherapy Res, Toshima Ku, 1-37-1 Kami Ike Bukuro, Tokyo 1708455, Japan.						Parsadanian AS, 1998, J NEUROSCI, V18, P1009; LEITHAUSER F, 1993, LAB INVEST, V69, P415; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Ram Z, 1997, NAT MED, V3, P1354, DOI 10.1038/nm1297-1354; Krajewska M, 1997, CANCER RES, V57, P1605; Krajewski S, 1997, AM J PATHOL, V150, P805; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Irmler M, 1997, NATURE, V388, P190; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; BOLDIN MP, 1995, J BIOL CHEM, V270, P387; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; BARGOU RC, 1995, INT J CANCER, V60, P854, DOI 10.1002/ijc.2910600622; Benito A, 1996, BLOOD, V87, P3837; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Foreman KE, 1996, AM J PATHOL, V149, P795; Hashimoto M, 1996, HUM GENE THER, V7, P149, DOI 10.1089/hum.1996.7.2-149; Kondo S, 1996, INT J CANCER, V68, P727, DOI 10.1002/(SICI)1097-0215(19961211)68:6<727::AID-IJC6>3.0.CO;2-5; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; KRISHNA M, 1995, J NEUROSURG, V83, P1017, DOI 10.3171/jns.1995.83.6.1017; MAPARA MY, 1993, EUR J IMMUNOL, V23, P702, DOI 10.1002/eji.1830230320; MIURA M, 1989, GENE, V75, P31; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MIYAO Y, 1993, J NEUROSCI RES, V36, P472, DOI 10.1002/jnr.490360413; Miyao Y, 1997, JPN J CANCER RES, V88, P678; NAKASU S, 1994, ACTA NEUROPATHOL, V88, P520; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3041; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; RensingEhl A, 1996, EUR J IMMUNOL, V26, P2271, DOI 10.1002/eji.1830260945; Sato N, 1998, MOL CELL NEUROSCI, V12, P65, DOI 10.1006/mcne.1998.0703; Shinoura N, 1998, HUM GENE THER, V9, P1983, DOI 10.1089/hum.1998.9.14-1983; Shinoura N, 1998, HUM GENE THER, V9, P2683, DOI 10.1089/hum.1998.9.18-2683; TACHIBANA O, 1995, CANCER RES, V55, P5528; TELLEFSON AE, 1998, NATURE, V392, P726; Wallach D, 1998, CURR OPIN IMMUNOL, V10, P279, DOI 10.1016/S0952-7915(98)80166-0; WELLER M, 1995, CANCER RES, V55, P2936; Yoshida Y, 1997, BIOCHEM BIOPH RES CO, V230, P426, DOI 10.1006/bbrc.1996.5975	43	24	25	STOCKTON PRESS	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	0929-1903			CANCER GENE THER	Cancer Gene Ther.	FEB	2000	7	2					224	232		10.1038/sj.cgt.7700110		9	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Research & Experimental Medicine	299BR	WOS:000086176400008		
J	Kawate, H; Itoh, R; Sakumi, K; Nakabeppu, Y; Tsuzuki, T; Ide, F; Ishikawa, T; Noda, T; Nawata, H; Sekiguchi, M				Kawate, H; Itoh, R; Sakumi, K; Nakabeppu, Y; Tsuzuki, T; Ide, F; Ishikawa, T; Noda, T; Nawata, H; Sekiguchi, M			A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice	CARCINOGENESIS			English	Article							DNA-REPAIR METHYLTRANSFERASE; NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR; O6-METHYLGUANINE-DNA METHYLTRANSFERASE; ESCHERICHIA-COLI; K-RAS; MUTATIONS; CELLS; EXPRESSION; HOMOLOG	Mice with mutations in both alleles of the Mgmt and the Mlh1 gene, the former encoding a DNA repair methyltransferase and the latter a protein functioning at an early step of mismatch repair, are as resistant to the killing action of alkylating agents as are wild-type mice, These mice yielded a large number of tumors when exposed to alkylating carcinogens, but this characteristic was subdued since they also showed a relatively high level of spontaneous tumorigenicity, as a consequence of the defect in mismatch repair. This complexity is now resolved by introducing the Mlh1(+/-) mutation, instead of Mlh1(-/-), in these methyltransferase-deficient mice. Mgmt(-/-) Mlh1(+/-) mice, with about half the amount of MLH1 protein as Mgmt(-/-) Mlh1(+/+) mice, were resistant to the killing action of N-methyl-N-nitrosourea (MNU), up to the level of 30 mg/kg body wt. Eight weeks after exposure to this dose of MNU, 40% of MNU-treated Mgmt(-/-) Mlh1(+/-) mice had thymic lymphomas and there were no tumors in those mice not given the treatment. It seems that the cellular content of MLH1 protein is a critical factor for determining if damaged cells enter into either one of the two pathways leading to mutation induction or to apototic cell death, Loss of Mlh1 expression was frequently observed in tumors of Mgmt(-/-) Mlh1(+/-) mice and this might be related to progression of the tumors.	Fukuoka Dent Coll, Dept Biol, Sawara Ku, Fukuoka 8140193, Japan; Fukuoka Dent Coll, Frontier Res Ctr, Sawara Ku, Fukuoka 8140193, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Biochem, Fukuoka 8128582, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka 8128582, Japan; Univ Tokyo, Fac Med, Dept Pathol, Tokyo 1130033, Japan	Sekiguchi, M (reprint author), Fukuoka Dent Coll, Dept Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.		Nakabeppu, Yusaku/A-8902-2011; Sakumi, Kunihiko/G-4808-2011				DAY RS, 1980, NATURE, V288, P724, DOI 10.1038/288724a0; Iwakuma T, 1996, DNA CELL BIOL, V15, P863, DOI 10.1089/dna.1996.15.863; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Esteller M, 1999, CANCER RES, V59, P793; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; ISHIBASHI T, 1994, MUTAT RES-DNA REPAIR, V315, P199, DOI 10.1016/0921-8777(94)90032-9; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Edelmann W, 1999, CANCER RES, V59, P1301; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; COSTELLO JF, 1994, J BIOL CHEM, V269, P17228; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; DEMPLE B, 1982, J BIOL CHEM, V257, P13776; de Wind N, 1998, CANCER RES, V58, P248; GERSON SL, 1986, CARCINOGENESIS, V7, P745, DOI 10.1093/carcin/7.5.745; GOTH R, 1974, P NATL ACAD SCI USA, V71, P639, DOI 10.1073/pnas.71.3.639; IHARA K, 1994, MOL GEN GENET, V243, P379; ITO T, 1994, MUTAT RES, V314, P273, DOI 10.1016/0921-8777(94)90071-X; Iwakuma T, 1997, CARCINOGENESIS, V18, P1631, DOI 10.1093/carcin/18.8.1631; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; KAWATE H, 1995, CARCINOGENESIS, V16, P1595, DOI 10.1093/carcin/16.7.1595; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; KOLODNER RD, 1995, CANCER RES, V55, P242; NAKATSU Y, 1993, MUTAT RES, V293, P119, DOI 10.1016/0921-8777(93)90063-M; NEWCOMB EW, 1988, CANCER RES, V48, P5514; Papadopoulos N, 1997, HUM MUTAT, V10, P89, DOI 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.0.CO;2-H; ROMACH E, 1994, CARCINOGENESIS, V15, P2275, DOI 10.1093/carcin/15.10.2275; Sakumi K, 1997, CANCER RES, V57, P2415; Sekiguchi M, 1996, J CANCER RES CLIN, V122, P199, DOI 10.1007/BF01209646; SHCHERBAKOVA VP, 1999, MOL CELL BIOL, V19, P3177; SHIRAISHI A, 1992, CARCINOGENESIS, V13, P289, DOI 10.1093/carcin/13.2.289; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Tsuzuki T, 1996, CARCINOGENESIS, V17, P1215, DOI 10.1093/carcin/17.6.1215	38	35	35	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334			CARCINOGENESIS	Carcinogenesis	FEB	2000	21	2					301	305		10.1093/carcin/21.2.301		5	Oncology	Oncology	287JU	WOS:000085503400026		
J	Matsushita, A; Yoshikawa, T; Okano, T; Kasahara, T; Fukada, Y				Matsushita, A; Yoshikawa, T; Okano, T; Kasahara, T; Fukada, Y			Colocalization of pinopsin with two types of G-protein alpha-subunits in the chicken pineal gland	CELL AND TISSUE RESEARCH			English	Article						rod transducin; Gq/11; phototransduction; circadian clock; pinealocyte; immunoelectron microscopy; chicken	CIRCADIAN OSCILLATOR; SUBCELLULAR-LOCALIZATION; PHOTORECEPTOR CELLS; LIGHT; IDENTIFICATION; ROD; TRANSDUCIN; RHYTHM; ORGAN	Pinopsin is a photoreceptive molecule present in the outer segments of chicken pinealocytes. In this paper, the localization of a-subunits of G-proteins, rod transducin (Gt1) and Gq/11, was examined by immunoelectron microscopy to investigate whether these G-proteins colocalize with pinopsin in the outer segments. Ultrathin sections of the chicken pineal gland were double-immunolabeled with antibodies to pinopsin and either Gt1 alpha or Gq/11 alpha. As shown previously, the outer segments around the follicular lumen exhibited divergent morphology with ciliary, bulbous, or lamellate shapes, and most of them displayed pinopsin immunoreactivity. The majority (>90%) of pinopsin-immunopositive outer segments were labeled by anti-Gt1 alpha and/or anti-Gq/11 alpha antibodies. Application of double-immunolabeling to serial sections demonstrated that a large number of the pinopsin-immunopositive outer segments contained both Gt1 alpha and Gq/11 alpha immunoreactivities. These results suggest that Gt1 alpha and Gq/11 alpha are functionally coupled with light-activated pinopsin within a single outer segment.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Yokohama, Kanagawa, Japan	Fukada, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Yoshikawa, Tomoko/D-6740-2012				ZATZ M, 1988, BRAIN RES, V453, P63, DOI 10.1016/0006-8993(88)90143-6; Okano T, 1997, J PINEAL RES, V22, P145, DOI 10.1111/j.1600-079X.1997.tb00316.x; Max M, 1998, J BIOL CHEM, V273, P26820, DOI 10.1074/jbc.273.41.26820; DEGUCHI T, 1979, SCIENCE, V203, P1245, DOI 10.1126/science.424750; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; DEGUCHI T, 1979, NATURE, V282, P94, DOI 10.1038/282094a0; DEGUCHI T, 1981, NATURE, V290, P706, DOI 10.1038/290706a0; FOSTER RG, 1987, CELL TISSUE RES, V248, P161, DOI 10.1007/BF01239977; Hirunagi K, 1997, CELL TISSUE RES, V289, P235, DOI 10.1007/s004410050870; KASAHARA T, 1998, THESIS U TOKYO; KOKAME K, 1993, EXP EYE RES, V57, P135, DOI 10.1006/exer.1993.1108; Nakahara K, 1997, BRAIN RES, V774, P242, DOI 10.1016/S0006-8993(97)81713-1; NAKAMURA A, 1999, IN PRESS BIOCHEMISTR; Okano T, 1997, MOL BRAIN RES, V50, P190, DOI 10.1016/S0169-328X(97)00184-8; Okano T, 1997, J MOL EVOL, V44, pS91, DOI 10.1007/PL00000057; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; TAKAHASHI JS, 1989, RECENT PROG HORM RES, V45, P279; Terakita A, 1996, VISUAL NEUROSCI, V13, P539; VANVEEN T, 1986, P NATL ACAD SCI USA, V83, P912	21	14	15	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0302-766X			CELL TISSUE RES	Cell Tissue Res.	FEB	2000	299	2					245	251		10.1007/s004419900145		7	Cell Biology	Cell Biology	291BF	WOS:000085712400008		
J	Matsuda, N; Ueda, T; Sasaki, Y; Nakano, A				Matsuda, N; Ueda, T; Sasaki, Y; Nakano, A			Overexpression of PRA2, a Rab/Ypt-family small GTPase from pea Pisum sativum, aggravates the growth defect of yeast ypt mutants	CELL STRUCTURE AND FUNCTION			English	Article						vesicular transport; pea Pisum sativum; Rab/Ypt-family small GTPase; PRA2	GDP DISSOCIATION INHIBITOR; RAB GERANYLGERANYL TRANSFERASE; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; VESICULAR TRANSPORT; SECRETORY PATHWAY; GOLGI-APPARATUS; COMPONENT-A	A large number of Rab/Ypt-family small GtPases have been identified from higher plants. While some of them can complement yeast ypt mutants, the expression of Arabidopsis Ara4 protein aggravated the growth defect of a subset of ypt mutants, probably because of the titration of common regulator(s) of yeast Ypt proteins [Ueda, T. et al, (1996) Plant Cell, 8: 2079-2091], PRA2 from pea Pisum sativum encodes an interesting Rab GTPase whose expression is regulated by light [Yoshida, K, et al, (1993) Proc. Natl, Acad, Sci USA, 90: 6636-6640], We examined whether PRA2 complements any of the yeast ypt mutants and found again that PRA2 does not complement but rather confers the growth defect to some of the JP mutants, No growth defect was observed when PRA2 was expressed in the wild-type yeast cells. Unlike the case of Ara4, neither Arabidopsis nor yeast GDI remedied the growth defect by Pra2, indicating that the mechanism of the exacerbation is different. Mutational analysis of PRA2 suggests that the growth inhibition can be ascribed to unidentified factor(s) which prefers the GTP-bound form of Pra2. This yeast system will be useful for identifying such putative regulatory factor(s) from yeast and plants and analyzing their interactions with Pra2.	RIKEN, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Nagoya Univ, Grad Sch Agr Sci, Plant Mol Biol Lab, Chikusa Ku, Aichi 4640814, Japan	Nakano, A (reprint author), RIKEN, Mol Membrane Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nakano@postman.riken.go.jp	Nakano, Akihiko/C-6185-2009; Ueda, Takashi/G-6984-2011; UEDA, TAKASHI/G-4939-2014				ANAI T, 1991, GENE, V108, P259; Lazar T, 1997, TRENDS BIOCHEM SCI, V22, P468, DOI 10.1016/S0968-0004(97)01150-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; Benli M, 1996, EMBO J, V15, P6460; NAGANO Y, 1993, PLANT CELL PHYSIOL, V34, P447; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; BEDNAREK SY, 1994, PLANT PHYSIOL, V104, P591, DOI 10.1104/pp.104.2.591; BURTON JL, 1994, EMBO J, V13, P5547; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHEON CI, 1993, EMBO J, V12, P4125; Collins RN, 1997, J BIOL CHEM, V272, P18281, DOI 10.1074/jbc.272.29.18281; FABRY S, 1995, MOL GEN GENET, V247, P265, DOI 10.1007/BF00293194; FUJIMURA K, 1994, J BIOL CHEM, V269, P9205; GARRETT MD, 1994, EMBO J, V13, P1718; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; KESZENMANPEREYRA D, 1988, CURR GENET, V13, P21, DOI 10.1007/BF00365751; Kim WY, 1996, PLANT MOL BIOL, V31, P783, DOI 10.1007/BF00019466; Loraine AE, 1996, PLANT PHYSIOL, V110, P1337, DOI 10.1104/pp.110.4.1337; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Maniatis T, 1982, MOL CLONING LAB MANU; NAGANO Y, 1995, P NATL ACAD SCI USA, V92, P6314, DOI 10.1073/pnas.92.14.6314; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Nuoffer C, 1997, MOL BIOL CELL, V8, P1305; PARK YS, 1994, PLANT MOL BIOL, V26, P1725, DOI 10.1007/BF00019487; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; Uchimiya H, 1998, J PLANT RES, V111, P257, DOI 10.1007/BF02512180; Ueda T, 1998, GENE, V206, P137, DOI 10.1016/S0378-1119(97)00584-2; Ueda T, 1996, PLANT CELL, V8, P2079; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Yoo JS, 1999, MOL GEN GENET, V261, P80; YOSHIDA K, 1993, P NATL ACAD SCI USA, V90, P6636, DOI 10.1073/pnas.90.14.6636	36	8	8	JAPAN SOC CELL BIOLOGY	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	0386-7196	1347-3700		CELL STRUCT FUNCT	Cell Struct. Funct.	FEB	2000	25	1					11	20		10.1247/csf.25.11		10	Cell Biology	Cell Biology	304KN	WOS:000086482800002		
J	Kitazawa, H; Iida, J; Uchida, A; Haino-Fukushima, K; Itoh, TJ; Hotani, H; Ookata, K; Murofushi, H; Bulinski, JC; Kishimoto, T; Hisanaga, S				Kitazawa, H; Iida, J; Uchida, A; Haino-Fukushima, K; Itoh, TJ; Hotani, H; Ookata, K; Murofushi, H; Bulinski, JC; Kishimoto, T; Hisanaga, S			Ser787 in the proline-rich region of human MAP4 is a critical phosphorylation site that reduces its activity to promote tubulin polymerization	CELL STRUCTURE AND FUNCTION			English	Article						microtubule; MAPs; MAP4; cdc2 kinase; phosphorylation; mitosis	MICROTUBULE-ASSOCIATED PROTEIN; DYNAMIC INSTABILITY; M-PHASE; CELL-CYCLE; CDC2 KINASE; IDENTIFICATION; EXTRACTS; EGGS; VISUALIZATION; PURIFICATION	p34(cdc2) kinase-phosphorylation sires in the microtubule (MT)-binding region of MAP4 were determined by peptide sequence of phosphorylated MTB3, a fragment containing the carboxy-terminal half of human MAP4. In addition to two phosphopeptides containing Ser696 and Ser787 which were previously indicated to be in vivo phosphorylation sites, two novel phosphopeptides, containing Thr892 or Thr901 and Thr917 as possible phosphorylation sites, were isolated, though only in in vitro phosphorylation. The role of phosphorylation at Ser696 and Ser787, which were differently phosphorylated during the cell cycle (Ookata et al., (1997), Biochemistry: 36: 15873-15883), was investigated in MT-polymerization, using MAP4 Ser to Glu mutants, which mimic phosphorylation at each site. Mutation of Ser787 to Glu strikingly reduced the MAP4's MT-polymerization activity, while Glu-mutation at Ser696 did not. These results suggest that Ser787 could be the critical phosphorylation site causing MTs to be dynamic at mitosis.	Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Tokyo Inst Technol, Fac Biosci, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA	Hisanaga, S (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Minami Ohsawa, Tokyo 1920397, Japan.	hisanaga-shinichi@c.metro-u.ac.jp	Uchida, Atsuko /E-3081-2010	Uchida, Atsuko /0000-0002-4658-1504			AIZAWA H, 1991, J BIOL CHEM, V266, P9841; AIZAWA H, 1990, J BIOL CHEM, V265, P13849; AIZAWA T, 1991, TRENDS ENDOCRIN MET, V2, P4, DOI 10.1016/1043-2760(91)90053-P; ANDERSEN SSL, 1994, J CELL BIOL, V127, P1289, DOI 10.1083/jcb.127.5.1289; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Leger J, 1997, J BIOL CHEM, V272, P8441; BULINSKI JC, 1993, MICROTUBULES, P167; CHAPIN SJ, 1995, BIOCHEMISTRY-US, V34, P2289, DOI 10.1021/bi00007a025; FARUKI S, 1994, CELL MOTIL CYTOSKEL, V28, P108, DOI 10.1002/cm.970280203; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; HAMAGUCHI Y, 1985, J CELL BIOL, V100, P1262, DOI 10.1083/jcb.100.4.1262; Hyams JS, 1993, MICROTUBULES; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; MUROFUSHI H, 1986, J CELL BIOL, V103, P1911, DOI 10.1083/jcb.103.5.1911; Nguyen HL, 1997, J CELL SCI, V110, P281; Okumura E, 1996, J CELL BIOL, V132, P125, DOI 10.1083/jcb.132.1.125; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SHIINA N, 1992, EMBO J, V11, P3977; Shiina N, 1999, MOL BIOL CELL, V10, P597; Srsen V, 1999, CELL STRUCT FUNCT, V24, P321, DOI 10.1247/csf.24.321; Stassen MP, 1996, HISTOCHEM CELL BIOL, V106, P341; TOMBES RM, 1991, CELL REGUL, V2, P861; VANDRE DD, 1991, J CELL SCI, V98, P577; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; WEST RR, 1991, J BIOL CHEM, V266, P21886; WOODY RW, 1983, BIOCHEMISTRY-US, V22, P2186, DOI 10.1021/bi00278a020	36	17	19	JAPAN SOC CELL BIOLOGY	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	0386-7196	1347-3700		CELL STRUCT FUNCT	Cell Struct. Funct.	FEB	2000	25	1					33	39		10.1247/csf.25.33		7	Cell Biology	Cell Biology	304KN	WOS:000086482800004		
J	Kitayama, J; Ikeda, S; Kumagai, K; Saito, H; Nagawa, H				Kitayama, J; Ikeda, S; Kumagai, K; Saito, H; Nagawa, H			alpha 6 beta 1 integrin (VLA-6) mediates leukocyte tether and arrest on laminin under physiological shear flow	CELLULAR IMMUNOLOGY			English	Article						PMN; adhesion; laminin; VLA-6; shear flow	ENDOTHELIAL-CELLS; L-SELECTIN; VASCULAR ENDOTHELIUM; NEUTROPHIL ADHESION; CD11B CD18; RECEPTOR; INTERLEUKIN-8; BINDING; CHEMOATTRACTANTS; GLYCOPROTEIN	Polymorphonuclear leukocytes (PMN) were perfused over extracellular matrix protein substrates under laminar shear flow. Under shear below 1.5 dyn/cm(2), many PMN tethered to immobilized laminin but not to fibronectin or vitronectin, Almost all the tethered PMN immediately arrested on laminin. The number of tethered PMN was mostly abrogated by mAbs to integrin alpha 6 Or beta 1 chains at concentrations of more than 5 mu g/ml. Addition of the two mAbs together produced no further inhibition compared with each mAb alone. In contrast, none of the mAbs to alpha 2, alpha 3, and beta 4 chains showed significant inhibition, indicating that PMN tethering to laminin is mostly dependent on alpha 6 beta 1 integrin. The addition of 10-100 ng/ml IL-8 in the assay medium before perfusion partially reduced PMN tethering to laminin. Stimulation with IL-8 also induced detachment of some tethered PMN within 30 s. Thus, IL-8 partially weakens the adhesiveness of alpha 6 beta 1 integrin on PMN in how conditions. (C) 2000 Academic Press.	Univ Tokyo, Div Surg Oncol, Dept Surg, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Surg Ctr, Bunkyo Ku, Tokyo 113, Japan	Kitayama, J (reprint author), Univ Tokyo, Div Surg Oncol, Dept Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.						ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; vandenBrule FA, 1996, EUR J CANCER, V32A, P1598, DOI 10.1016/0959-8049(96)00119-0; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; DETMERS PA, 1990, J EXP MED, V171, P1155, DOI 10.1084/jem.171.4.1155; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; Kitayama J, 1997, J IMMUNOL, V159, P3929; MULLER WA, 1992, J EXP MED, V176, P819, DOI 10.1084/jem.176.3.819; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Finger EB, 1996, J IMMUNOL, V157, P5085; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; BOHNSACK JF, 1992, BLOOD, V79, P1545; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CHENG YF, 1989, J CELL PHYSIOL, V139, P275, DOI 10.1002/jcp.1041390209; CHUNG AE, 1979, CELL, V16, P277, DOI 10.1016/0092-8674(79)90005-9; DERIAN CK, 1995, J IMMUNOL, V154, P308; GAO JX, 1995, IMMUNOLOGY, V85, P485; GOSPODAROWICZ D, 1981, J CELL PHYSIOL, V107, P171, DOI 10.1002/jcp.1041070203; HECHTMAN DH, 1991, J IMMUNOL, V147, P883; HEMLER ME, 1988, IMMUNOL TODAY, V9, P109, DOI 10.1016/0167-5699(88)91280-7; Hilario E, 1996, HISTOL HISTOPATHOL, V11, P915; Jones DA, 1996, J IMMUNOL, V157, P858; Kitayama J, 1998, J CLIN INVEST, V101, P2017, DOI 10.1172/JCI2688; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LEY K, 1993, J IMMUNOL, V151, P6347; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; LUSCINSKAS FW, 1992, J IMMUNOL, V149, P2163; MECHAM RP, 1991, ANNU REV CELL BIOL, V7, P71, DOI 10.1146/annurev.cb.07.110191.000443; Rao C. N., 1983, BIOCHEM BIOPH RES CO, V111, P804; TOKIDA Y, 1990, J BIOL CHEM, V265, P18123; TOZEREN A, 1994, J CELL SCI, V107, P3153; VANDENBRULE FA, 1995, BIOCHEM BIOPH RES CO, V209, P760, DOI 10.1006/bbrc.1995.1564; Weber C, 1996, P NATL ACAD SCI USA, V93, P10939, DOI 10.1073/pnas.93.20.10939; WONG DA, 1995, LEUCOCYTE TYPING, V5, P1667; YANNARIELLOBROWN J, 1988, J CELL BIOL, V106, P1773, DOI 10.1083/jcb.106.5.1773; ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529; ZIMMERMANN GA, 1990, J CELL BIOL, V110, P539	42	8	9	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0008-8749			CELL IMMUNOL	Cell. Immunol.	FEB 1	2000	199	2					97	103		10.1006/cimm.1999.1596		7	Cell Biology; Immunology	Cell Biology; Immunology	295RW	WOS:000085982500005		
J	Sato, K; Nagayama, H; Enomoto, M; Tadokoro, K; Juji, T; Takahashi, TA				Sato, K; Nagayama, H; Enomoto, M; Tadokoro, K; Juji, T; Takahashi, TA			Autocrine activation-induced cell death of T cells by human peripheral blood monocyte-derived CD4(+) dendritic cells	CELLULAR IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; TNF-ALPHA; LIGAND; CORD; LYMPHOCYTES; EXPRESSION; CTLA-4; DIFFERENTIATE; REJECTION; APOPTOSIS	Mature T cells activated by antigen (Ag)-presenting cells are subject to various downmodulatory processes designed to maintain T cell homeostasis, Here we describe experiments in which mature T cells were subjected to apoptosis following stimulation with CD4(+) dendritic cells (DCs) during Ag presentation, The proliferative response of allogeneic T cells was increased by DCs at stimulator to responder (S/R) ratios ranging from 10(-3) to 1, whereas this response was decreased at S/R ratios ranging from 2 to 10. Allogeneic T cells stimulated with DCs at an S/R ratio of 5 underwent apoptosis, whereas this event was not observed in allogeneic T cells stimulated with DCs at an S/R ratio of 0.5, Stimulation of T cells with DCs at an S/R ratio of 5 induced a higher level of expression of CD95 ligand (CD95L) than stimulation of T cells cultured with DCs at an S/R ratio of 0.5, whereas similar levels of expression of CD28 and CD154 were observed in both cells. The abortive proliferation of mature T cells stimulated with DCs was prevented by blocking the CD95-CD95L system. Our results suggest that the CD4(+) DCs play counterregulatory roles in dictating T cell responses during Ag presentation. (C) 2000 Academic Press.	Univ Tokyo, Inst Med Sci, Dept Cell Proc, Minato Ku, Tokyo 1088639, Japan; Japanese Red Cross Cent Blood Ctr, Tokyo 1501211, Japan	Takahashi, TA (reprint author), Univ Tokyo, Inst Med Sci, Dept Cell Proc, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; LARSEN CP, 1990, J EXP MED, V171, P307, DOI 10.1084/jem.171.1.307; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Hart DNJ, 1997, BLOOD, V90, P3245; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Celluzzi CM, 1996, J EXP MED, V183, P283, DOI 10.1084/jem.183.1.283; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Sato K, 1999, J IMMUNOL, V162, P3865; Steinbrink K, 1999, BLOOD, V93, P1634; Austyn J M, 1992, Semin Immunol, V4, P227; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; BERTHOU C, 1995, BLOOD, V85, P1540; BRUGNONI D, 1994, EUR J IMMUNOL, V24, P1919, DOI 10.1002/eji.1830240831; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; Chalmers IMH, 1998, BLOOD, V92, P11; DEEG HJ, 1988, BLOOD, V71, P1138; DURANDY A, 1995, J IMMUNOL, V154, P1560; KANNER SB, 1992, J IMMUNOL, V149, P3482; Kataoka T, 1996, J IMMUNOL, V156, P3678; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Lu LN, 1997, J IMMUNOL, V158, P5676; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Sato K, 1999, BLOOD, V93, P34; Sato K, 1999, EXP HEMATOL, V27, P326, DOI 10.1016/S0301-472X(98)00046-0; Sato K, 1999, J IMMUNOL, V162, P4464; Saunders D, 1996, J EXP MED, V184, P2185, DOI 10.1084/jem.184.6.2185; STEINBECK G, 1991, CORONARY ARTERY DIS, V2, P27; SZABOLCS P, 1995, J IMMUNOL, V154, P5851; Wong B, 1997, J EXP MED, V186, P1939, DOI 10.1084/jem.186.11.1939; Young JW, 1996, J EXP MED, V183, P7, DOI 10.1084/jem.183.1.7	36	5	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0008-8749			CELL IMMUNOL	Cell. Immunol.	FEB 1	2000	199	2					115	125		10.1006/cimm.1999.1608		11	Cell Biology; Immunology	Cell Biology; Immunology	295RW	WOS:000085982500007		
J	Hirano, T; Hirobe, M; Kobayashi, K; Odani, A; Yamauchi, O; Ohsawa, M; Satow, Y; Nagano, T				Hirano, T; Hirobe, M; Kobayashi, K; Odani, A; Yamauchi, O; Ohsawa, M; Satow, Y; Nagano, T			Mechanism of superoxide dismutase-like activity of Fe(II) and Fe(III) complexes of tetrakis-N,N,N ',N ' (2-pyridylmethyl)ethylenediamine	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						superoxide dismutase mimics; tetrakis-N,N,N ',N ' (2-pyridylmethyl)ethylenediamine; free radical; pulse radiolysis; X-ray analysis; pH-titration	COPPER(II) COMPLEXES; TETRADENTATE LIGANDS; CRYSTAL-STRUCTURE; PULSE-RADIOLYSIS; PYRIDYL ARMS; MIMICS; MANGANESE; INJURY; MIMETICS; THERMODYNAMICS	The superoxide dismutase (SOD) activity of iron(II) tetrakis-N,N,N',N'(2-pyridylmethyl)ethylenediamine complex (Fe-TPEN) was reexamined using a pulse radiolysis method. In our previous study (J. Biol. Chem., 264, 9243-9249 (1989)), we reported that this complex has a potent SOD activity in a cyt, c (cytochrome c)-based system (IC50=0.8 mu M) and protects E. coli cells against paraquat toxicity. The present pulse radiolysis experiment revealed that Fe(II)TPEN reacts stoichiometrically with superoxide to form Fe(III)TPEN with a second-order rate constant of 3.9 x 10(6) M-1 s(-1) at pH 7.1, but superoxide did not reduce Fe(III)TPEN to Fe(II)TPEN. The reaction of Fe(III)TPEN and superoxide was biphasic, In the fast reaction, an adduct (Fe(III)TPEN-superoxide complex) was formed at the second-order rate constant of 8.5 x 10(5) M-1 s(-1) at pH 7.4. In the slow one, the adduct reacted with another molecule of the adduct, regenerating Fe(III)TPEN. In the cyt, c method with catalase, this Fe(III)TPEN-superoxide complex showed cyt, c oxidation activity, which had led to overestimation of its SOD activity. Based on the titration data, the main species of complex in aqueous media at neutral pH was indicated to be Fe(III)TPEN(OH-). A spectral change after the reduction with hydrated electron indicates that the OH- ion coordinates directly to Fe(III) by displacing one of the pyridine rings. The X-ray analysis of [Fe(II)TPEN]SO4 supported this structure. From the above results we propose a novel reaction mechanism of FeTPEN and superoxide which resembles a proton catalyzed dismuting process, involving Fe(III)TPEN-superoxide complex.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; Nagoya Univ, Fac Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4640814, Japan	Nagano, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kobayashi, Kazuo/H-9279-2012				ANDEREGG G, 1967, HELV CHIM ACTA, V50, P2330, DOI 10.1002/hlca.19670500817; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; CHANG HR, 1990, J AM CHEM SOC, V112, P6814, DOI 10.1021/ja00175a012; Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521; BAUDRY M, 1993, BIOCHEM BIOPH RES CO, V192, P964, DOI 10.1006/bbrc.1993.1509; FLYNN CM, 1984, CHEM REV, V84, P31, DOI 10.1021/cr00059a003; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Hsu JL, 1996, J BIOL CHEM, V271, P17687; RUSH JD, 1986, J BIOL CHEM, V261, P6730; MANDEL JB, 1988, INORG CHEM, V27, P2990, DOI 10.1021/ic00290a020; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; IGARASHI R, 1992, J PHARMACOL EXP THER, V262, P1214; KOBAYASHI K, 1989, J BIOL CHEM, V264, P15280; ANDEREGG G, 1977, HELV CHIM ACTA, V60, P123, DOI 10.1002/hlca.19770600115; BULL C, 1983, J AM CHEM SOC, V105, P5290, DOI 10.1021/ja00354a019; FAULKNER KM, 1994, ARCH BIOCHEM BIOPHYS, V310, P341, DOI 10.1006/abbi.1994.1176; GANS P, 1985, J CHEM SOC DALTON, P1195, DOI 10.1039/dt9850001195; GOLDSTEIN S, 1990, J AM CHEM SOC, V112, P6489, DOI 10.1021/ja00174a006; HARDY MM, 1994, J BIOL CHEM, V269, P18535; IULIANO L, 1992, ARCH BIOCHEM BIOPHYS, V293, P153, DOI 10.1016/0003-9861(92)90378-A; KIMURA E, 1983, BIOCHIM BIOPHYS ACTA, V745, P37, DOI 10.1016/0167-4838(83)90167-X; KITAJIMA N, 1993, INORG CHEM, V32, P1879, DOI 10.1021/ic00062a001; KORBASHI P, 1986, J BIOL CHEM, V261, P2472; LENGFELDER E, 1979, BIOCHIM BIOPHYS ACTA, V567, P492, DOI 10.1016/0005-2744(79)90135-9; LEUTHAUSER SWC, 1981, J NATL CANCER I, V66, P1077; LIND MD, 1964, INORG CHEM, V3, P34, DOI 10.1021/ic50011a007; LIU ZX, 1994, ARCH BIOCHEM BIOPHYS, V315, P74, DOI 10.1006/abbi.1994.1473; Lowe D, 1996, EUR J PHARMACOL, V304, P81, DOI 10.1016/0014-2999(96)00120-3; MANDEL JB, 1989, INORG CHIM ACTA, V155, P55, DOI 10.1016/S0020-1693(00)89283-X; Moon JO, 1998, BIOL PHARM BULL, V21, P284; NAGANO T, 1989, J BIOL CHEM, V264, P9243; NAGANO T, 1991, FREE RADICAL RES COM, V12-3, P221, DOI 10.3109/10715769109145790; ODANI A, 1992, J AM CHEM SOC, V114, P6294, DOI 10.1021/ja00042a004; PASTERNACK RF, 1979, J AM CHEM SOC, V101, P1026, DOI 10.1021/ja00498a038; Riley DP, 1997, J AM CHEM SOC, V119, P6522, DOI 10.1021/ja964271e; Tan S, 1998, FREE RADICAL BIO MED, V24, P427, DOI 10.1016/S0891-5849(97)00274-8; TSANG PKS, 1990, INORG CHEM, V29, P2848, DOI 10.1021/ic00340a025; Weiss RH, 1996, J BIOL CHEM, V271, P26149; WEISS RH, 1993, J BIOL CHEM, V268, P23049; Xiang DF, 1998, J CHEM SOC DALTON, P1201, DOI 10.1039/a707433f; Yamato K, 1999, CHEM LETT, P295; Yao T, 1994, AM J PHYSIOL, V267, P476	43	7	7	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2000	48	2					223	230				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	282TK	WOS:000085234800011		
J	Endo, Y; Yoshimi, T; Yamakoshi, Y				Endo, Y; Yoshimi, T; Yamakoshi, Y			New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						carborane; dicarba-closo-dodecaborane; estrogen; antagonist; hydrophobic moiety	NEUTRON-CAPTURE THERAPY; ICOSAHEDRAL CARBORANES; DERIVATIVES; CHEMISTRY; RECEPTOR	We have designed and synthesized estrogen antagonists bearing dicarba-closo-dodecaborane (carborane) as a hydrophobic pharmacophore based on the structure of 1-(4-hydroxyphenyl)-1.1 1,12-dicarba-closo-dodecaborane, a potent estrogen agonist that we reported previously. Compounds with a long alkyl chain bearing an amide moiety on the carborane skeleton (6, 7) showed estrogen antagonistic activity in a luciferase reporter gent assay using COS-1 cells transfected with a rat ER alpha-expression plasmid and as an appropriate reporter plasmid.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Endo, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						BREGADZE VI, 1992, CHEM REV, V92, P209, DOI 10.1021/cr00010a002; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u; COULT R, 1993, J ORGANOMET CHEM, V462, P19, DOI 10.1016/0022-328X(93)83337-U; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Endo Y, 1999, BIOORG MED CHEM LETT, V9, P3387, DOI 10.1016/S0960-894X(99)00579-X; Endo Y, 1999, J MED CHEM, V42, P1501, DOI 10.1021/jm9900725; PLESEK J, 1992, CHEM REV, V92, P269, DOI 10.1021/cr00010a005; HAWTHORNE MF, 1993, ANGEW CHEM INT EDIT, V32, P950, DOI 10.1002/anie.199309501; HARPER MJK, 1966, NATURE, V212, P87, DOI 10.1038/212087a0; BEDFORD GR, 1966, NATURE, V212, P733, DOI 10.1038/212733b0; BOWLER J, 1989, Steroids, V54, P71, DOI 10.1016/0039-128X(89)90076-7; Fox MA, 1998, J CHEM SOC DALTON, P401, DOI 10.1039/a707154j; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; MEYER T, 1994, J CANCER RES CLIN, V120, P359, DOI 10.1007/BF01247461; RAY S, 1997, ADV DRUG RES, V29, P171, DOI 10.1016/S0065-2490(97)80015-9	17	21	21	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2000	48	2					312	314				3	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	282TK	WOS:000085234800034		
J	Yabuuchi, K; Rowan, AE; Nolte, RJM; Kato, T				Yabuuchi, K; Rowan, AE; Nolte, RJM; Kato, T			Liquid-crystalline physical gels: Self-aggregation of a gluconamide derivative in mesogenic molecules for the formation of anisotropic functional composites	CHEMISTRY OF MATERIALS			English	Article							ORGANIC LIQUIDS; GELATION; GELATORS	Liquid-crystalline physical gels have been obtained by the self-aggregation of a gluconamide derivative through intermolecular hydrogen bonding in liquid crystals. These liquid-crystalline gels are microphase-separated composites consisting of the solid fibrous aggregates of the gelling agent and the liquid-crystalline phase of mesogenic molecules. Thermoreversible three states, isotropic liquid, normal (isotropic) gel, and liquid-crystalline gel, have been achieved for the mixtures of liquid crystals and the gelling agent. As the concentration of the gelling agent increases, the sol-gel transition temperature and the enthalpy change of the transition from isotropic to anisotropic increase. The increase of the enthalpy change suggests that some mesogenic molecules are anchoring strongly to the surface of the fibrous gelling agents. Variable-temperature infrared spectra show that the association and the dissociation of intermolecular hydrogen bonding of the gelling agent occur in the process of the sol-gel transition. Liquid-crystalline gels are responsive to electric fields in a twisted nematic (TN) cell. These anisotropic gels would be applicable to new dynamically functional materials.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Catholic Univ Nijmegen, Dept Organ Chem, NSR Ctr, NL-6525 ED Nijmegen, Netherlands	Kato, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.		Nolte, Roeland/C-9930-2013; Rowan, Alan/F-9702-2015				Mizoshita N, 1999, ADV MATER, V11, P392, DOI 10.1002/(SICI)1521-4095(199903)11:5<392::AID-ADMA392>3.0.CO;2-Q; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; TACHIBANA T, 1980, B CHEM SOC JPN, V53, P1714, DOI 10.1246/bcsj.53.1714; LIN Y, 1989, J AM CHEM SOC, V111, P5542, DOI 10.1021/ja00197a005; Hanabusa K, 1996, ANGEW CHEM INT EDIT, V35, P1949, DOI 10.1002/anie.199619491; Hafkamp RJH, 1999, J ORG CHEM, V64, P412, DOI 10.1021/jo981158t; MURATA K, 1994, J AM CHEM SOC, V116, P6664, DOI 10.1021/ja00094a023; FUHRHOP JH, 1987, J AM CHEM SOC, V109, P3387, DOI 10.1021/ja00245a032; HIKMET RAM, 1992, ADV MATER, V4, P679, DOI 10.1002/adma.19920041014; BROTIN T, 1991, J CHEM SOC CHEM COMM, P416, DOI 10.1039/c39910000416; Crawford GP, 1996, LIQUID CRYSTALS COMP; Gray GW, 1998, HDB LIQUID CRYSTALS; Hafkamp RJH, 1997, CHEM COMMUN, P545, DOI 10.1039/a608266a; HANABUSA K, 1993, J CHEM SOC CHEM COMM, P390, DOI 10.1039/c39930000390; JEFFREY GA, 1992, LIQ CRYST, V12, P179, DOI 10.1080/02678299208030392; Kato T, 1998, CHEM LETT, P193; Kato T, 1998, ADV MATER, V10, P606, DOI 10.1002/(SICI)1521-4095(199805)10:8<606::AID-ADMA606>3.3.CO;2-K; Kelly SM, 1995, J MATER CHEM, V5, P2047, DOI 10.1039/jm9950502047; Mizoshita N, 1999, CHEM COMMUN, P781, DOI 10.1039/a901035a; PFANNEMULLER B, 1986, LIQ CRYST, V1, P357, DOI 10.1080/02678298608086668; PFANNEMULLER B, 1985, CHEM PHYS LIPIDS, V37, P227, DOI 10.1016/0009-3084(85)90011-8	21	43	43	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0897-4756			CHEM MATER	Chem. Mat.	FEB	2000	12	2					440	443		10.1021/cm9904887		4	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	287JN	WOS:000085502900031		
J	Teramoto, S; Ishii, T; Ouchi, Y				Teramoto, S; Ishii, T; Ouchi, Y			The mechanism of hypoxemia in liver disease with pulmonary hypertension	CHEST			English	Letter							EXHALED NITRIC-OXIDE; HEPATOPULMONARY SYNDROME; HEPATIC CIRRHOSIS; TRANSPLANTATION; OXYGENATION		Tokyo Univ Hosp, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Alexander J, 1997, Liver Transpl Surg, V3, P54, DOI 10.1002/lt.500030108; Durand P, 1998, TRANSPLANTATION, V65, P437, DOI 10.1097/00007890-199802150-00026; Rolla G, 1998, ANN INTERN MED, V129, P375; DAVIS HH, 1978, CHEST, V73, P507, DOI 10.1378/chest.73.4.507; KROWKA MJ, 1994, CHEST, V105, P1528, DOI 10.1378/chest.105.5.1528; KUO PC, 1997, CHEST, V112, P908; MATSUMOTO A, 1995, ANN INTERN MED, V123, P110; Rolla G, 1997, HEPATOLOGY, V26, P842, DOI 10.1002/hep.510260406; Schott R, 1999, CHEST, V115, P1748, DOI 10.1378/chest.115.6.1748; Teramoto S, 1999, ANN INTERN MED, V131, P69; TERAMOTO S, IN PRESS ANN INTERN	11	2	2	AMER COLL CHEST PHYSICIANS	NORTHBROOK	3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA	0012-3692			CHEST	Chest	FEB	2000	117	2					614	614		10.1378/chest.117.2.614		1	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	286MH	WOS:000085449400064		
J	Ogihara, S				Ogihara, S			Composition of clinoptilolite formed from volcanic glass during burial diagenesis	CLAYS AND CLAY MINERALS			English	Article						burial diagenesis; cation exchange; clinoptilolite; volcanic glass; zeolite	HEULANDITE GROUP ZEOLITES; JAPAN	The composition of clinoptilolite formed from volcanic glass was investigated from cuttings collected from the offshore MITI-Somaoki borehole, 52 km east of Soma City, Japan. Unaltered volcanic glass and clinoptilolite-replaced glass were found coexisting in the same silicic tuff at 1000 m depth, but unaltered volcanic glass and clinoptilolite did nor coexist in individual glass shards, and each material analyzed in this study was pure. The SiO2 and Al2O3 contents of the pure clinoptilolite and the pure, unaltered glass were 69.32 and 13.05 wt. %, and 70.03 and 11.54 wt. %, respectively. The SiO2 content was almost the same and the Al2O3 content was greater in the clinoptilolite-replaced glass compared with the unaltered volcanic glass. As a result, the SiO2/Al2O3 ratio in the clinoptilolite-replaced glass (SiO2/Al2O3 = 5.31) was slightly lower than that of the unaltered volcanic glass (SiO2/Al2O3 = 6.07). The extraframework cation composition of the clinoptilolite-replaced glass was three times richer in K (K2O = 7.84 wt. %) than the unaltered volcanic glass (K2O = 2.59 wt. %). The cation selectivity of clinoptilolite, which shows a preference for K to Ca and Na, played an important role in the concentration of K in clinoptilolite during clinoptilolite formation from volcanic glass, although the initial pore waters and the volcanic glass were not especially relative K. Clinoptilolite-replaced glass in the calcite-cemented tuff at 1100 m depth was not enriched in Ca, suggesting that the exchangable-cation composition of clinoptilolite did not change by exposure to Ca-rich solutions at this depth. Apparently, the exchangable-cation composition of clinoptilolite, once formed, is relatively stable and difficult to change, even under conditions in which calcite is precipitating on clinoptilolite crystals.	Univ Tokyo, Inst Geol, Bunkyo Ku, Tokyo 1130033, Japan	Ogihara, S (reprint author), Univ Tokyo, Inst Geol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						AMES LL, 1960, AM MINERAL, V45, P689; BROXTON DE, 1987, CLAY CLAY MINER, V35, P89, DOI 10.1346/CCMN.1987.0350202; BOLES JR, 1972, AM MINERAL, V57, P1463; BOLES JR, 1978, NATURAL ZEOLITES OCC, P235; IIJIMA A, 1971, ADV CHEM SER, V101, P342; *JAP NAT OIL CORP, 1990, IN REP MITI SOM JAP; lijima A., 1986, NENDOKALGAKU, V26, P49; Minato H., 1971, ADV CHEM SER, V101, P311; Ogihara S, 1996, MINER DEPOSITA, V31, P548, DOI 10.1007/BF00196135; OGIHARA S, 1990, EUR J MINERAL, V2, P819; OGIHARA S, 1989, ZEOLITES FACTS FIGUR, P491; PIRSSON LV, 1915, AM J SCI, V40, P181; SHEPPARD R. A., 1968, 597 US GEOL SURV; STONECIPHER SA, 1978, NATURAL ZEOLITES OCC, P221	14	6	8	CLAY MINERALS SOCIETY	BOULDER	PO BOX 4416, BOULDER, CO 80306 USA	0009-8604			CLAY CLAY MINER	Clay Clay Min.	FEB	2000	48	1					106	110		10.1346/CCMN.2000.0480113		5	Chemistry, Physical; Geosciences, Multidisciplinary; Mineralogy; Soil Science	Chemistry; Geology; Mineralogy; Agriculture	287XZ	WOS:000085533900013		
J	Sato, Y; Murakami, M; Miyazawa, K; Hori, K				Sato, Y; Murakami, M; Miyazawa, K; Hori, K			Purification and characterization of a novel lectin from a freshwater cyanobacterium, Oscillatoria agardhii	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY			English	Article						agglutinins; blue-green algae; cyanobacteria; carbohydrate-binding specificity; isolation; lectin; Eucheuma; Myxococcus xanthus; Oscillatoria agardhii; N-terminal sequence	MARINE; EUCHEUMA	In the survey of 14 species of laboratory-cultured cyanobacteria for hemagglutinins, we newly detected the activity in two species, Oscillatoria agardhii; strain NIES-204, and Phormidium foveolarum, Strain NIES-503. From the extract of O. agardhii, which showed the highest activity with trypsin-treated erythrocytes of rabbit, a lectin was purified to homogeneity by the combination of precipitation with (NH4)(2)SO4, pel filtration, hydrophobic chromatography and reverse phase chromatography. The purified lectin, designated OAA, was a monomeric protein with an apparent molecular weight of 13 000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and 16 000 on gel filtration. The amino acid composition was rich in glycine and acidic amino acids. The hemagglutination activity was inhibited by glycoproteins such as yeast mannan, but not by any of the monosaccharides tested. The activity was stable over a wide range of pH (4-11) and at a high temperature of 80 degrees C, and independent on the presence of divalent cations. The features of OAA resembled those of many of lectins from marine macroalgae. The sequence of amino-terminal residues of OAA was determined as ALYNVENQWGGSSAPWNEGG; which was highly homologous to those of lectins from macroalgae of the genus Eucheuma and that of a myxobacterium Myxococcus xanthus hemagglutinin. (C) 2000 Elsevier Science Inc. All rights reserved.	Hiroshima Univ, Fac Appl Biol Sci, Higashihiroshima 7398525, Japan; Univ Tokyo, Grad Sch Agr Life Sci, Bunkyo Ku, Tokyo 113, Japan	Hori, K (reprint author), Hiroshima Univ, Fac Appl Biol Sci, Kagamiyama 1-4-4, Higashihiroshima 7398525, Japan.						FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; Kawakubo A, 1999, J APPL PHYCOL, V11, P149, DOI 10.1023/A:1008062127564; ROMEO JM, 1986, P NATL ACAD SCI USA, V83, P6332, DOI 10.1073/pnas.83.17.6332; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; LUUKKAINEN R, 1993, APPL ENVIRON MICROB, V59, P2204; BOYD WC, 1966, TRANSFUSION, V6, P82; CARMICHAEL WW, 1981, APPL ENVIRON MICROB, V6, P88; HORI K, 1986, B JPN SOC SCI FISH, V52, P323; HORI K, 1990, HYDROBIOLOGIA, V204, P561, DOI 10.1007/BF00040287; HORI K, 1988, BOT MAR, V31, P323; Hori K, 1996, J PHYCOL, V32, P783, DOI 10.1111/j.0022-3646.1996.00783.x; Kawakubo AL, 1997, J APPL PHYCOL, V9, P331, DOI 10.1023/A:1007915006334; LIENER IE, 1986, LECTIN PROPERTIES FU; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Rogers D. J., 1993, Hydrobiologia, V260-261, P589, DOI 10.1007/BF00049075; SAKAMOTO S, 1996, DISTRIBUTION CHARACT, P569; Shagger H, 1987, ANAL BIOCHEM, V166, P368; SHIOMI K, 1990, INTRO APPL PHYCOLOGY, P93; WATANABE MF, 1987, NIPPON SUISAN GAKK, V53, P1643; Yamaguchi M, 1999, COMP BIOCHEM PHYS B, V122, P363, DOI 10.1016/S0305-0491(99)00034-6; Yamaguchi M, 1998, COMP BIOCHEM PHYS B, V119, P593, DOI 10.1016/S0305-0491(98)00033-9; 1997, GEF LIST STRAIN 97 M	22	23	31	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0305-0491			COMP BIOCHEM PHYS B	Comp. Biochem. Physiol. B-Biochem. Mol. Biol.	FEB	2000	125	2					169	177		10.1016/S0305-0491(99)00164-9		9	Biochemistry & Molecular Biology; Zoology	Biochemistry & Molecular Biology; Zoology	319ZP	WOS:000087376600003		
J	Suzuki, H; Jeong, KI; Okutani, T; Doi, K				Suzuki, H; Jeong, KI; Okutani, T; Doi, K			Regional variations in the number and subsets of intraepithelial lymphocytes in the mouse small intestine	COMPARATIVE MEDICINE			English	Article							GERM-FREE MICE; ALPHA-BETA; T-CELLS; MICROBIAL COLONIZATION; CYTOLYTIC ACTIVITY; INTERFERON-GAMMA; MURINE SMALL; EXPRESSION; ANTIGEN; INVIVO	Background and Purpose: Regional variations in the intraepithelial lymphocytes (IELs) in the mouse small intestine were examined. Methods: The small intestine was taken from six 12-week-old BALB/c mice and divided equally into three parts (proximal, middle, and distal). The IELs were isolated from each part of the intestine and analyzed by use of flow cytometry. Results: The number of IELs in the distal part of the small intestine was significantly lower than that in the proximal and middle parts (P < 0.01). The distribution of IEL subsets was markedly different between the proximal and the distal parts, and that in the middle part had an intermediate pattern. The percentage of alpha beta T cells and expression of Thy-1.2 on the alpha beta T and gamma delta T cells were higher in the distal part (P < 0.01). The percentage of CD8 alpha alpha and of double-negative T cells were higher in the proximal part, whereas that of CD4CD8 alpha alpha double-positive T cells was higher in the distal part (P < 0.01). Regional variations were found mainly in the extrathymically developed T cell subsets. Conclusion: Local development of IELs may differ between regions of the small intestine.	Univ Tokyo, Fac Agr, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Fac Agr, Dept Vet Publ Hlth, Bunkyo Ku, Tokyo 1138657, Japan	Suzuki, H (reprint author), Univ Tokyo, Fac Agr, Dept Vet Pathol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						AMANO M, 1993, J IMMUNOL METHODS, V164, P79, DOI 10.1016/0022-1759(93)90278-F; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; BARRETT TA, 1992, J IMMUNOL, V149, P1124; Brown T A, 1996, Adv Dent Res, V10, P62; Fan JY, 1998, CELL IMMUNOL, V188, P55, DOI 10.1006/cimm.1998.1350; FERRARIS RP, 1995, J NUTR, V125, P2172; Gerard B, 1996, EXP CELL RES, V228, P8, DOI 10.1006/excr.1996.0292; HUGHES A, 1991, IMMUNOLOGY, V72, P491; Hummel KP, 1975, BIOL LAB MOUSE, P247; Imaoka A, 1996, EUR J IMMUNOL, V26, P945, DOI 10.1002/eji.1830260434; ITO N, 1986, COLOR ATLAS EXPT ANI, P49; KATO Y, 1995, MICROBIOL IMMUNOL, V39, P291; KAWAGUCHI M, 1993, P NATL ACAD SCI USA, V90, P8591, DOI 10.1073/pnas.90.18.8591; KawaguchiMiyashita M, 1997, IMMUNOLOGY, V91, P628, DOI 10.1046/j.1365-2567.1997.00292.x; LAKE JP, 1991, J IMMUNOL, V147, P1121; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; MOSLEY RL, 1990, INT IMMUNOL, V2, P361, DOI 10.1093/intimm/2.4.361; Nanno M, 1998, IMMUNOL RES, V18, P41, DOI 10.1007/BF02786512; Page ST, 1998, P NATL ACAD SCI USA, V95, P9459, DOI 10.1073/pnas.95.16.9459; PENNEY L, 1995, IMMUNOLOGY, V86, P212; SIDHU NK, 1992, TISSUE CELL, V24, P221, DOI 10.1016/0040-8166(92)90095-O; SMITH HW, 1965, J PATHOL BACTERIOL, V89, P95, DOI 10.1002/path.1700890112; SNIPES RL, 1977, EXPERIENTIA, V33, P1335, DOI 10.1007/BF01920166; Suzuki H, 1999, EXP ANIM TOKYO, V48, P115, DOI 10.1538/expanim.48.115; Ware JA, 1996, BIOCHEM PHARMACOL, V52, P1613, DOI 10.1016/S0006-2952(96)00567-9	26	14	14	AMER ASSOC LABORATORY ANIMAL SCIENCE	MEMPHIS	9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA	1058-2401			COMPARATIVE MED	Comparative Med.	FEB	2000	50	1					39	42				4	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	305WR	WOS:000086564900007		
J	Ishii, K; Ura, T				Ishii, K; Ura, T			An adaptive neural-net controller system for an underwater vehicle	CONTROL ENGINEERING PRACTICE			English	Article						neuro control; identification; adaptive system; autonomous underwater vehicle; disturbance		This paper describes the concept and an example of an adaptive neural-net controller system for an underwater vehicle. The system consists of two parts, a real-world part and an imaginary-world part. The real-world part is a feedback control system for the actual robot. In the imaginary-world part, the model of robot and the controller are adjusted continuously in order to deal with changes of dynamic properties caused by disturbances and so on. The system is designed to be suitable for a computer system with parallel processing ability. In this paper, the adaptability of the controller system is investigated by heading-keeping and path-following experiments in conditions where unpredictable disturbances are applied to the robot. (C) 2000 Elsevier Science Ltd. All lights reserved.	Kyushu Inst Technol, Fukuoka 8208502, Japan; Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan	Ishii, K (reprint author), Kyushu Inst Technol, 680-4 Kawazu, Fukuoka 8208502, Japan.						CRISTI R, 1990, IEEE J OCEANIC ENG, V15, P152, DOI 10.1109/48.107143; YOERGER DR, 1990, IEEE J OCEANIC ENG, V15, P167, DOI 10.1109/48.107145; FUJII T, 1991, P IEEE INNS IJCNN 91, P1973, DOI 10.1109/IJCNN.1991.170670; FUJII T, 1993, P IEEE OCEANS 93, P186; *INMOS LTD, 1989, TRANSP DAT; ISHII K, 1995, IEEE J OCEANIC ENG, V20, P221, DOI 10.1109/48.393077; ISHII K, 1994, P IEEE C ROB AUT, P3216; ITO Y, 1994, PROCEEDINGS OF THE 1994 SYMPOSIUM ON AUTONOMOUS UNDERWATER VEHICLE TECHNOLOGY, P218, DOI 10.1109/AUV.1994.518628; McClelland J., 1986, PARALLEL DISTRIBUTED; Slotine J.J., 1991, APPL NONLINEAR CONTR; SUTO T, 1993, P 8 INT S UNM UNT SU, P222; TAKAHASHI H, 1995, ANAL CELL PATHOL, V9, P243; Ura T., 1989, P ROV 89, P263; YOERGER DR, 1985, IEEE J OCEANIC ENG, V10, P462, DOI 10.1109/JOE.1985.1145131; ZHANG M, 1997, J SHIP NAVAL ARCHITE, V182, P491	15	31	34	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0661			CONTROL ENG PRACT	Control Eng. Practice	FEB	2000	8	2					177	184		10.1016/S0967-0661(99)00153-7		8	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	285QZ	WOS:000085400900009		
